,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
2633,GO:0005576,4.53590074865856e-12,1,56,3750,extracellular region,CC,LTF;VIM;CP;CHI3L2;MOXD1;CHGB;CRTAC1;APOL4;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SPP1;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;GNAL;COL6A2;INA;ADAM12;ADM;SERPING1;SPHKAP;MMP14;C1R;S100A11;PTX3;FABP5;ELFN2;COL3A1;CXCL10;RIMS2;GRIN1;DSCAML1;CD163;SLITRK1;ANXA2;COL4A1;PLA2G2A;SERPINA3;SMOC1;COL5A2;CFI;IFI30
7629,GO:0031012,7.83438046837940e-11,1,19,425,extracellular matrix,CC,CRTAC1;TIMP1;SERPINE1;AEBP1;COL1A1;TNR;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;COL6A2;MMP14;COL3A1;SLITRK1;ANXA2;COL4A1;SMOC1;COL5A2
11634,GO:0044421,9.50846749664649e-11,1,50,3280,extracellular region part,CC,LTF;VIM;CP;CHI3L2;MOXD1;CRTAC1;APOL4;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;IGFBP2;TNR;SPP1;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;INA;ADAM12;ADM;SERPING1;SPHKAP;MMP14;C1R;S100A11;PTX3;FABP5;ELFN2;COL3A1;CXCL10;RIMS2;DSCAML1;SLITRK1;ANXA2;COL4A1;PLA2G2A;SERPINA3;SMOC1;COL5A2;CFI
2664,GO:0005615,1.72423194579811e-10,0.999999999964583,48,3093,extracellular space,CC,LTF;VIM;CP;CHI3L2;MOXD1;CRTAC1;APOL4;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;IGFBP2;SPP1;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;INA;ADAM12;ADM;SERPING1;SPHKAP;MMP14;C1R;S100A11;PTX3;FABP5;ELFN2;COL3A1;CXCL10;RIMS2;DSCAML1;SLITRK1;ANXA2;COL4A1;PLA2G2A;SERPINA3;COL5A2;CFI
11030,GO:0043062,3.80833349792815e-10,0.999999999961358,17,352,extracellular structure organization,BP,FERMT1;TIMP1;SERPINE1;COL1A1;TNR;SPP1;POSTN;COL4A2;COL6A2;ADAM12;MMP14;PDPN;COL3A1;ANXA2;COL4A1;PLA2G2A;COL5A2
7215,GO:0030198,4.8480974367589e-10,0.999999999953709,16,306,extracellular matrix organization,BP,FERMT1;TIMP1;SERPINE1;COL1A1;TNR;SPP1;POSTN;COL4A2;COL6A2;ADAM12;MMP14;PDPN;COL3A1;ANXA2;COL4A1;COL5A2
7035,GO:0022610,6.24725472635802e-10,0.999999999877944,29,1163,biological adhesion,BP,TNFRSF12A;LTF;FERMT1;SRPX2;SERPINE1;CCL2;COL1A1;IGFBP2;TNR;GBP1;SPP1;HOXA7;PLAU;LGALS3;EMILIN2;POSTN;ANXA1;COL6A2;CDHR1;ADAM12;MMP14;PDPN;S100A11;COL3A1;PCDH7;DSCAML1;HLA-DQB1;ANXA2;PTPRT
3622,GO:0007155,2.62338784255518e-09,0.999999999466621,28,1156,cell adhesion,BP,TNFRSF12A;FERMT1;SRPX2;SERPINE1;CCL2;COL1A1;IGFBP2;TNR;GBP1;SPP1;HOXA7;PLAU;LGALS3;EMILIN2;POSTN;ANXA1;COL6A2;CDHR1;ADAM12;MMP14;PDPN;S100A11;COL3A1;PCDH7;DSCAML1;HLA-DQB1;ANXA2;PTPRT
13774,GO:0051239,4.58548759415288e-09,0.999999998763794,42,2551,regulation of multicellular organismal process,BP,TNFRSF12A;LTF;TYMP;VIM;IGF2BP2;FERMT1;TIMP1;SRPX2;SERPINE1;COL1A1;CUX2;KCNIP3;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;ADAM12;ADM;SERPING1;MMP14;SHANK2;PDPN;CSMD3;CACNG2;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;SMOC1;COL5A2
13482,GO:0050793,1.45164276411675e-08,0.999999996043524,38,2200,regulation of developmental process,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;TNR;GBP1;SPP1;HOXA7;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;ADAM12;ADM;MMP14;SHANK2;PDPN;CSMD3;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;PLA2G2A;SMOC1;COL5A2
2635,GO:0005578,1.66130539415534e-08,0.999999997918299,15,337,proteinaceous extracellular matrix,CC,CRTAC1;TIMP1;COL1A1;TNR;EMILIN2;CHI3L1;POSTN;COL4A2;COL6A2;COL3A1;SLITRK1;ANXA2;COL4A1;SMOC1;COL5A2
760,GO:0001944,3.25458917095682e-08,0.999999994395092,19,607,vasculature development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;PDPN;COL3A1;CXCL10;ANXA2;SOCS3;COL4A1
16860,GO:0072358,3.96002718389567e-08,0.99999999309034,19,615,cardiovascular system development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;PDPN;COL3A1;CXCL10;ANXA2;SOCS3;COL4A1
515,GO:0001568,1.04502491635422e-07,0.999999981522571,18,583,blood vessel development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;COL3A1;CXCL10;ANXA2;SOCS3;COL4A1
19520,GO:1903034,2.01604316957021e-07,0.999999985123743,9,132,regulation of response to wounding,BP,TNFRSF12A;SERPINE1;TNR;SPP1;PLAU;ANXA1;SERPING1;PDPN;ANXA2
487,GO:0001525,2.36271527339926e-07,0.999999963273191,15,432,angiogenesis,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;HOXA7;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;CXCL10;ANXA2;COL4A1
12057,GO:0045595,2.36963959203096e-07,0.999999936161933,29,1540,regulation of cell differentiation,BP,TNFRSF12A;LTF;VIM;SERPINE1;COL1A1;CUX2;TNR;GBP1;SPP1;HOXA7;GDF15;LGALS3;POSTN;ANXA1;MMD2;ADM;MMP14;SHANK2;PDPN;CSMD3;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;SOCS3;PLA2G2A;SMOC1;COL5A2
7415,GO:0030574,2.60860991766561e-07,0.999999988165674,7,60,collagen catabolic process,BP,COL1A1;COL4A2;COL6A2;MMP14;COL3A1;COL4A1;COL5A2
11633,GO:0044420,3.69677482966603e-07,0.999999970818007,9,114,extracellular matrix component,CC,TIMP1;COL1A1;TNR;COL4A2;COL3A1;ANXA2;COL4A1;SMOC1;COL5A2
13072,GO:0048514,4.66723727656085e-07,0.99999991793823,16,513,blood vessel morphogenesis,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;HOXA7;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;COL3A1;CXCL10;ANXA2;COL4A1
8754,GO:0032963,5.02696432885235e-07,0.999999966456402,8,103,collagen metabolic process,BP,VIM;COL1A1;COL4A2;COL6A2;MMP14;COL3A1;COL4A1;COL5A2
21157,GO:2000026,6.31507609359328e-07,0.999999817454485,30,1706,regulation of multicellular organismal development,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;COL1A1;CUX2;TNR;SPP1;HOXA7;LGALS3;CHI3L1;COL4A2;ANXA1;MMD2;ADAM12;ADM;MMP14;SHANK2;PDPN;CSMD3;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;COL5A2
8197,GO:0032101,6.33856893957938e-07,0.999999878814265,17,643,regulation of response to external stimulus,BP,LTF;SERPINE1;CCL2;TNR;SPP1;PLAU;ANXA1;GPR17;SERPING1;C1R;PDPN;CXCL10;GRIN1;ANXA2;SOCS3;PLA2G2A;CFI
8458,GO:0032501,6.39455588737608e-07,0.999999774824146,64,5878,multicellular organismal process,BP,TNFRSF12A;LTF;TYMP;VIM;IGF2BP2;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GNAL;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;JPH3;CA10;MMP14;SHANK2;PDPN;GABRG1;CSMD3;GABRB3;NNMT;CACNG2;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;SERPINA3;SMOC1;COL5A2
17965,GO:0098644,6.532863066006e-07,0.999999986325719,5,20,complex of collagen trimers,CC,COL1A1;COL4A2;COL3A1;COL4A1;COL5A2
4761,GO:0010469,7.67423607400054e-07,0.999999887587316,13,393,regulation of signaling receptor activity,BP,TYMP;CHGB;TIMP1;SERPINE1;CCL2;SPP1;PLAU;GDF15;ADM;SHANK2;CACNG2;CXCL10;SHISA7
2484,GO:0005201,8.4124114700749e-07,0.999999954091533,7,66,extracellular matrix structural constituent,MF,COL1A1;EMILIN2;CHI3L1;COL4A2;COL3A1;COL4A1;COL5A2
8198,GO:0032102,8.79549424158271e-07,0.999999894472262,11,258,negative regulation of response to external stimulus,BP,LTF;SERPINE1;CCL2;TNR;SPP1;PLAU;GPR17;SERPING1;GRIN1;ANXA2;SOCS3
2637,GO:0005581,1.3788216252997e-06,0.999999918041506,7,78,collagen trimer,CC,COL1A1;EMILIN2;COL4A2;COL6A2;COL3A1;COL4A1;COL5A2
7031,GO:0022603,1.38610291230812e-06,0.999999665883619,21,943,regulation of anatomical structure morphogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;CCL2;CUX2;TNR;GBP1;SPP1;GDF15;CHI3L1;POSTN;COL4A2;ANXA1;ADAM12;ADM;PDPN;CXCL10;RIMS2;GRIN1;SLITRK1;COL5A2
4958,GO:0010812,1.58372927572715e-06,0.999999931443428,6,51,negative regulation of cell-substrate adhesion,BP,SERPINE1;COL1A1;GBP1;HOXA7;POSTN;MMP14
18219,GO:0099503,1.97622944502993e-06,0.999999547619739,19,865,secretory vesicle,CC,LTF;MOXD1;CHGB;TIMP1;SERPINE1;COL1A1;PLAU;LGALS3;CHI3L1;SERPING1;S100A11;PTX3;FABP5;SVOP;PCDH7;GRIN1;ANXA2;PLA2G2A;SERPINA3
12933,GO:0048167,2.3457693080216e-06,0.999999764560868,9,164,regulation of synaptic plasticity,BP,TNR;SLC8A2;CPLX2;JPH3;KCNB1;SHANK2;RIMS2;GRIN1;SHISA7
1129,GO:0002548,3.32066478818855e-06,0.999999893082263,5,40,monocyte chemotaxis,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
3520,GO:0006954,3.33703295693729e-06,0.999999351739313,15,589,inflammatory response,BP,SERPINE1;CCL2;SPP1;CHI3L1;ANXA1;GPR17;SERPING1;C1R;PTX3;CXCL10;CD163;SOCS3;PLA2G2A;SERPINA3;CFI
4564,GO:0009653,3.41456869543102e-06,0.999998843081212,35,2334,anatomical structure morphogenesis,BP,TNFRSF12A;LTF;TYMP;IGF2BP2;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;TNR;GBP1;SPP1;HOXA7;GDF15;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;CDHR1;ADAM12;ADM;MMP14;SHANK2;PDPN;COL3A1;CXCL10;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;SOCS3;COL4A1;COL5A2
12687,GO:0046903,3.49556801864031e-06,0.999998996033591,25,1426,secretion,BP,LTF;FERMT1;TIMP1;SERPINE1;ABCC3;STEAP3;GBP1;SPP1;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;CPLX2;ADM;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;ANXA2;PLA2G2A;SERPINA3
7175,GO:0030141,3.6411572104194e-06,0.999999203353009,17,736,secretory granule,CC,LTF;MOXD1;CHGB;TIMP1;SERPINE1;COL1A1;PLAU;LGALS3;CHI3L1;SERPING1;S100A11;PTX3;FABP5;PCDH7;ANXA2;PLA2G2A;SERPINA3
4956,GO:0010810,4.06092663481469e-06,0.999999562813591,9,174,regulation of cell-substrate adhesion,BP,FERMT1;SERPINE1;COL1A1;GBP1;HOXA7;PLAU;POSTN;MMP14;PDPN
10872,GO:0042730,4.95152830316591e-06,0.999999910874186,4,20,fibrinolysis,BP,SERPINE1;PLAU;SERPING1;ANXA2
4540,GO:0009605,5.29863159406575e-06,0.999998309902616,29,1859,response to external stimulus,BP,LTF;TYMP;SERPINE1;CCL2;COL1A1;IGFBP2;TNR;GBP1;SPP1;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;GPR17;ADM;SERPING1;MMP14;KCNB1;C1R;PDPN;PTX3;COL3A1;CXCL10;GRIN1;ANXA2;SOCS3;PLA2G2A;CFI
13492,GO:0050806,6.18255793218755e-06,0.999999411933934,8,140,positive regulation of synaptic transmission,BP,CUX2;TNR;SLC8A2;SHANK2;CACNG2;RIMS2;GRIN1;SHISA7
15522,GO:0065008,6.45697647199759e-06,0.999997599213558,42,3311,regulation of biological quality,BP,TNFRSF12A;LTF;VIM;CP;IGF2BP2;MOXD1;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;RBP1;STEAP3;TNR;SLC8A2;SPP1;KCNIP2;PLAU;POSTN;ANXA1;IGF2BP3;GPR17;CPLX2;CDHR1;ADM;SERPING1;JPH3;KCNB1;SHANK2;PDPN;GABRG1;PTX3;GABRB3;CACNG2;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;SHISA7;SERPINA3
15130,GO:0061041,6.73014961602736e-06,0.999999481867572,7,108,regulation of wound healing,BP,TNFRSF12A;SERPINE1;PLAU;ANXA1;SERPING1;PDPN;ANXA2
19521,GO:1903035,7.36446125491559e-06,0.999999572859612,6,72,negative regulation of response to wounding,BP,SERPINE1;TNR;SPP1;PLAU;SERPING1;ANXA2
7943,GO:0031589,7.50372210076371e-06,0.999998866674448,11,295,cell-substrate adhesion,BP,TNFRSF12A;FERMT1;SERPINE1;COL1A1;GBP1;HOXA7;PLAU;POSTN;MMP14;PDPN;COL3A1
13195,GO:0048731,7.78102479537805e-06,0.999996991994906,48,3992,system development,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;TNR;SPP1;KCNIP2;HOXA7;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;CA10;MMP14;SHANK2;PDPN;CSMD3;GABRB3;NNMT;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;SOCS3;COL4A1;SMOC1;COL5A2
2422,GO:0005102,7.98140412456506e-06,0.999997702783982,23,1300,signaling receptor binding,MF,TYMP;CHGB;TIMP1;SRPX2;SERPINE1;CCL2;IGFBP2;SPP1;GDF15;LGALS3;ANXA1;GNAL;ADM;MMP14;SHANK2;PDPN;GABRG1;CACNG2;COL3A1;CXCL10;GRIN1;SHISA7;RTP5
7183,GO:0030155,8.0191130127472e-06,0.999998321118996,15,582,regulation of cell adhesion,BP,FERMT1;SERPINE1;CCL2;COL1A1;IGFBP2;TNR;GBP1;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;HLA-DQB1
3429,GO:0006810,9.17104978615763e-06,0.99999640460656,50,4422,transport,BP,LTF;CP;SNAP91;IGF2BP2;SLCO1A2;APOL4;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;ABCC3;CUX2;KCNIP3;STEAP3;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;IGF2BP3;CPLX2;ADM;SERPING1;JPH3;KCNB1;SHANK2;S100A11;GABRG1;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;CXCL10;PCDH7;RIMS2;GRIN1;CD163;ANXA2;SHISA7;RTP5;PLA2G2A;SERPINA3;CFI
8740,GO:0032940,1.05582965126824e-05,0.999996904518662,23,1322,secretion by cell,BP,LTF;FERMT1;TIMP1;SERPINE1;STEAP3;GBP1;SPP1;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;CPLX2;ADM;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;ANXA2;SERPINA3
13490,GO:0050804,1.07425822968237e-05,0.999998311053397,11,316,modulation of chemical synaptic transmission,BP,CUX2;TNR;SLC8A2;CPLX2;JPH3;KCNB1;SHANK2;CACNG2;RIMS2;GRIN1;SHISA7
18208,GO:0099177,1.07425822968237e-05,0.999998311053397,11,316,regulation of trans-synaptic signaling,BP,CUX2;TNR;SLC8A2;CPLX2;JPH3;KCNB1;SHANK2;CACNG2;RIMS2;GRIN1;SHISA7
7182,GO:0030154,1.14106985452447e-05,0.999995613860665,43,3453,cell differentiation,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;SERPINE1;CCL2;COL1A1;CUX2;TNR;GBP1;SPP1;KCNIP2;HOXA7;GDF15;LGALS3;POSTN;COL4A2;ANXA1;MMD2;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;MMP14;SHANK2;PDPN;CSMD3;GABRB3;COL3A1;CXCL10;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;SOCS3;COL4A1;PLA2G2A;SMOC1;COL5A2
11820,GO:0045055,1.20229000711262e-05,0.999997244654515,16,706,regulated exocytosis,BP,LTF;TIMP1;SERPINE1;PLAU;LGALS3;CHI3L1;CPLX2;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;ANXA2;SERPINA3
7090,GO:0023051,1.2037944551362e-05,0.999995450413762,40,3154,regulation of signaling,BP,TNFRSF12A;LTF;TYMP;CHGB;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SLC8A2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;POSTN;ANXA1;MMD2;GPR17;CPLX2;ADM;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;SHISA7;PLA2G2A
9533,GO:0034774,1.22461113344022e-05,0.999998251545032,10,294,secretory granule lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;SERPING1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
2764,GO:0005788,1.25484656047668e-05,0.999998206275958,10,267,endoplasmic reticulum lumen,CC,CP;CHGB;TIMP1;COL1A1;SPP1;COL4A2;COL6A2;COL3A1;COL4A1;COL5A2
7849,GO:0031410,1.61529208812335e-05,0.999994421863204,30,2073,cytoplasmic vesicle,CC,LTF;VIM;SNAP91;MOXD1;CHGB;TIMP1;SERPINE1;COL1A1;STEAP3;IGFBP2;PLAU;LGALS3;CHI3L1;ANXA1;SERPING1;MMP14;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;PCDH7;GRIN1;CD163;HLA-DQB1;ANXA2;PLA2G2A;SERPINA3
17875,GO:0097708,1.66380010195308e-05,0.999994244546488,30,2076,intracellular vesicle,CC,LTF;VIM;SNAP91;MOXD1;CHGB;TIMP1;SERPINE1;COL1A1;STEAP3;IGFBP2;PLAU;LGALS3;CHI3L1;ANXA1;SERPING1;MMP14;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;PCDH7;GRIN1;CD163;HLA-DQB1;ANXA2;PLA2G2A;SERPINA3
3477,GO:0006887,1.72163057179854e-05,0.999995736060138,17,808,exocytosis,BP,LTF;TIMP1;SERPINE1;PLAU;LGALS3;CHI3L1;ANXA1;CPLX2;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;ANXA2;SERPINA3
13770,GO:0051234,1.72696953925551e-05,0.999993031207487,50,4516,establishment of localization,BP,LTF;CP;SNAP91;IGF2BP2;SLCO1A2;APOL4;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;ABCC3;CUX2;KCNIP3;STEAP3;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;IGF2BP3;CPLX2;ADM;SERPING1;JPH3;KCNB1;SHANK2;S100A11;GABRG1;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;CXCL10;PCDH7;RIMS2;GRIN1;CD163;ANXA2;SHISA7;RTP5;PLA2G2A;SERPINA3;CFI
16471,GO:0071674,1.84440772106971e-05,0.999999131496913,5,55,mononuclear cell migration,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
8124,GO:0031982,1.86624347370938e-05,0.999992613386248,44,3801,vesicle,CC,LTF;VIM;CP;SNAP91;MOXD1;CHGB;CRTAC1;TIMP1;SERPINE1;AEBP1;COL1A1;CUX2;STEAP3;IGFBP2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;COL4A2;ANXA1;GNAL;COL6A2;SERPING1;SPHKAP;MMP14;C1R;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;PCDH7;RIMS2;GRIN1;CD163;HLA-DQB1;ANXA2;PLA2G2A;SERPINA3;CFI
3629,GO:0007162,1.89236603700195e-05,0.999997509405663,9,222,negative regulation of cell adhesion,BP,SERPINE1;COL1A1;TNR;GBP1;HOXA7;LGALS3;POSTN;ANXA1;MMP14
16861,GO:0072359,1.96835894051108e-05,0.999994665693317,19,916,circulatory system development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;PDPN;COL3A1;CXCL10;ANXA2;SOCS3;COL4A1
14598,GO:0060205,1.97847597541119e-05,0.999997008211678,10,310,cytoplasmic vesicle lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;SERPING1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
8125,GO:0031983,2.0303200588133e-05,0.99999692023025,10,311,vesicle lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;SERPING1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
4857,GO:0010646,2.0622142700463e-05,0.999992051508584,39,3103,regulation of cell communication,BP,TNFRSF12A;LTF;TYMP;CHGB;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SLC8A2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;POSTN;ANXA1;MMD2;GPR17;CPLX2;ADM;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A
4544,GO:0009611,2.16176487219561e-05,0.999995343078564,14,562,response to wounding,BP,TNFRSF12A;TIMP1;SERPINE1;COL1A1;TNR;SPP1;PLAU;POSTN;ANXA1;ADM;SERPING1;PDPN;COL3A1;ANXA2
13141,GO:0048646,2.31856118443066e-05,0.999993637095275,19,937,anatomical structure formation involved in morphogenesis,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;GDF15;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;PDPN;CXCL10;ANXA2;COL4A1;COL5A2
8459,GO:0032502,2.34007680258057e-05,0.999990339449963,56,5253,developmental process,BP,TNFRSF12A;LTF;TYMP;VIM;IGF2BP2;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SPP1;KCNIP2;HOXA7;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;CA10;MMP14;SHANK2;PDPN;FABP5;CSMD3;GABRB3;NNMT;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;SOCS3;COL4A1;PLA2G2A;SMOC1;COL5A2
2824,GO:0005886,2.38529187446894e-05,0.999990286506126,48,4229,plasma membrane,CC,TNFRSF12A;VIM;SNAP91;SLCO1A2;FERMT1;SRPX2;PLEKHA4;SERPINE1;ABCC3;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;KCNIP2;PLAU;LGALS3;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;CDHR1;ADAM12;JPH3;MMP14;KCNB1;SHANK2;PDPN;GABRG1;FABP5;CSMD3;GABRB3;CACNG2;CXCL10;PCDH7;KSR2;RIMS2;GRIN1;DSCAML1;CD163;SLITRK1;HLA-DQB1;ANXA2;SHISA7;PLA2G2A;PTPRT
13736,GO:0051179,2.49834384667575e-05,0.999989655447997,58,5638,localization,BP,TNFRSF12A;LTF;CP;SNAP91;IGF2BP2;SLCO1A2;APOL4;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;ABCC3;CUX2;KCNIP3;STEAP3;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;IGF2BP3;MMD2;CPLX2;ADM;SERPING1;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;COL3A1;CXCL10;PCDH7;RIMS2;GRIN1;CD163;ANXA2;SHISA7;RTP5;PLA2G2A;SERPINA3;CFI
21420,GO:2000463,3.43584363513052e-05,0.999998950721652,4,25,positive regulation of excitatory postsynaptic potential,BP,CUX2;SHANK2;RIMS2;GRIN1
3633,GO:0007166,3.4630463639154e-05,0.999986878229941,34,2588,cell surface receptor signaling pathway,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;GBP1;GDF15;LGALS3;POSTN;COL4A2;ANXA1;GPR17;MMP14;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;COL3A1;CXCL10;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PTPRT;IFI30
3525,GO:0006959,3.47773912915456e-05,0.999996497863173,7,154,humoral immune response,BP,LTF;CCL2;SERPING1;C1R;HLA-DQB1;PLA2G2A;CFI
13255,GO:0048856,3.64155956393893e-05,0.999984695379621,53,4897,anatomical structure development,BP,TNFRSF12A;LTF;TYMP;VIM;IGF2BP2;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;TNR;GBP1;SPP1;KCNIP2;HOXA7;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;CA10;MMP14;SHANK2;PDPN;FABP5;CSMD3;GABRB3;NNMT;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;SOCS3;COL4A1;SMOC1;COL5A2
3521,GO:0006955,3.66417201572873e-05,0.999987790485902,25,1692,immune response,BP,LTF;VIM;CCL2;COL1A1;GBP1;PLAU;LGALS3;CHI3L1;ANXA1;GPR17;CPLX2;SERPING1;C1R;S100A11;PTX3;FABP5;COL3A1;CXCL10;HLA-DQB1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI;IFI30
12165,GO:0045765,4.30877075899714e-05,0.999993679075744,9,245,regulation of angiogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;CXCL10
13265,GO:0048869,4.32005947381381e-05,0.999982269009835,43,3636,cellular developmental process,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;SERPINE1;CCL2;COL1A1;CUX2;TNR;GBP1;SPP1;KCNIP2;HOXA7;GDF15;LGALS3;POSTN;COL4A2;ANXA1;MMD2;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;MMP14;SHANK2;PDPN;CSMD3;GABRB3;COL3A1;CXCL10;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;SOCS3;COL4A1;PLA2G2A;SMOC1;COL5A2
13776,GO:0051241,4.37011735940139e-05,0.999987840972628,18,946,negative regulation of multicellular organismal process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;TNR;GBP1;SPP1;HOXA7;PLAU;COL4A2;ANXA1;ADM;SERPING1;COL3A1;CXCL10;ANXA2;COL5A2
10367,GO:0038063,4.58217493661976e-05,0.99999944042532,3,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,COL1A1;COL4A2;COL4A1
16611,GO:0071944,4.66072031226578e-05,0.999980398229994,48,4325,cell periphery,CC,TNFRSF12A;VIM;SNAP91;SLCO1A2;FERMT1;SRPX2;PLEKHA4;SERPINE1;ABCC3;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;KCNIP2;PLAU;LGALS3;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;CDHR1;ADAM12;JPH3;MMP14;KCNB1;SHANK2;PDPN;GABRG1;FABP5;CSMD3;GABRB3;CACNG2;CXCL10;PCDH7;KSR2;RIMS2;GRIN1;DSCAML1;CD163;SLITRK1;HLA-DQB1;ANXA2;SHISA7;PLA2G2A;PTPRT
13107,GO:0048583,4.69258275018087e-05,0.99998076144081,42,3621,regulation of response to stimulus,BP,TNFRSF12A;LTF;TYMP;CHGB;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SPP1;PLAU;GDF15;LGALS3;CHI3L1;POSTN;ANXA1;MMD2;GPR17;ADM;SERPING1;SPHKAP;JPH3;MMP14;C1R;SHANK2;PDPN;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;SHISA7;PLA2G2A;CFI
3518,GO:0006952,4.80073186077773e-05,0.999985173847033,21,1305,defense response,BP,LTF;VIM;SERPINE1;CCL2;GBP1;SPP1;LGALS3;CHI3L1;ANXA1;GPR17;SERPING1;C1R;PTX3;CXCL10;CD163;HLA-DQB1;SOCS3;PLA2G2A;SERPINA3;CFI;IFI30
9636,GO:0035239,5.02661762281396e-05,0.999986983930244,16,732,tube morphogenesis,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;HOXA7;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;COL3A1;CXCL10;ANXA2;COL4A1
1197,GO:0002685,5.05547439252357e-05,0.999994592138747,7,159,regulation of leukocyte migration,BP,SERPINE1;CCL2;HOXA7;LGALS3;ANXA1;MMP14;CXCL10
3702,GO:0007268,5.14176929094279e-05,0.999987975655751,14,598,chemical synaptic transmission,BP,CUX2;TNR;SLC8A2;KCNIP2;CPLX2;JPH3;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;RIMS2;GRIN1;SHISA7
18106,GO:0098916,5.14176929094279e-05,0.999987975655751,14,598,anterograde trans-synaptic signaling,BP,CUX2;TNR;SLC8A2;KCNIP2;CPLX2;JPH3;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;RIMS2;GRIN1;SHISA7
18242,GO:0099537,5.47414192405738e-05,0.999987121126508,14,601,trans-synaptic signaling,BP,CUX2;TNR;SLC8A2;KCNIP2;CPLX2;JPH3;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;RIMS2;GRIN1;SHISA7
18241,GO:0099536,5.61136417210248e-05,0.999986766854933,14,602,synaptic signaling,BP,CUX2;TNR;SLC8A2;KCNIP2;CPLX2;JPH3;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;RIMS2;GRIN1;SHISA7
469,GO:0001501,6.11773612552823e-05,0.999987278838207,12,447,skeletal system development,BP,LTF;TIMP1;AEBP1;COL1A1;HOXA7;CHI3L1;POSTN;MMP14;COL3A1;DSCAML1;ANXA2;COL5A2
3748,GO:0007399,6.20869372518205e-05,0.999976791416366,30,2088,nervous system development,BP,TNFRSF12A;TYMP;VIM;CRTAC1;SRPX2;CCL2;CUX2;TNR;SPP1;KCNIP2;POSTN;ANXA1;MMD2;MDGA2;CPLX2;CDHR1;INA;ADM;CA10;MMP14;SHANK2;CSMD3;GABRB3;COL3A1;FUT9;RIMS2;GRIN1;DSCAML1;SLITRK1;COL4A1
7092,GO:0023056,6.40722707380592e-05,0.999978291473729,24,1565,positive regulation of signaling,BP,TNFRSF12A;LTF;FERMT1;CCL2;COL1A1;CUX2;TNR;SLC8A2;SPP1;GDF15;CHI3L1;MMD2;GPR17;SHANK2;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;SHISA7;PLA2G2A
13675,GO:0051093,6.42537310401617e-05,0.999982993485889,16,775,negative regulation of developmental process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;TNR;GBP1;SPP1;HOXA7;POSTN;COL4A2;ANXA1;COL3A1;CXCL10;ANXA2;COL5A2
7211,GO:0030193,6.47946228130344e-05,0.99999597354953,5,69,regulation of blood coagulation,BP,SERPINE1;PLAU;SERPING1;PDPN;ANXA2
18569,GO:1900046,6.47946228130344e-05,0.99999597354953,5,69,regulation of hemostasis,BP,SERPINE1;PLAU;SERPING1;PDPN;ANXA2
633,GO:0001775,6.54278448149478e-05,0.999979908260169,20,1199,cell activation,BP,LTF;TIMP1;CCL2;COL1A1;IGFBP2;PLAU;LGALS3;CHI3L1;ANXA1;CPLX2;MMP14;PDPN;S100A11;PTX3;FABP5;COL3A1;CXCL10;HLA-DQB1;ANXA2;SERPINA3
767,GO:0001953,6.95150693329344e-05,0.999997392819928,4,31,negative regulation of cell-matrix adhesion,BP,SERPINE1;HOXA7;POSTN;MMP14
7032,GO:0022604,7.11729717066569e-05,0.999984961653157,12,441,regulation of cell morphogenesis,BP,TNFRSF12A;CCL2;CUX2;TNR;GBP1;SPP1;POSTN;ANXA1;PDPN;RIMS2;GRIN1;SLITRK1
1074,GO:0002455,7.23169245351467e-05,0.999997218921343,4,37,humoral immune response mediated by circulating immunoglobulin,BP,SERPING1;C1R;HLA-DQB1;CFI
13047,GO:0048407,7.83757378966093e-05,0.999998778294179,3,11,platelet-derived growth factor binding,MF,COL1A1;COL3A1;COL4A1
18883,GO:1901342,8.41626112249999e-05,0.999986494529314,9,268,regulation of vasculature development,BP,TNFRSF12A;SRPX2;SERPINE1;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;CXCL10
766,GO:0001952,8.46508890240275e-05,0.999992278736595,6,98,regulation of cell-matrix adhesion,BP,FERMT1;SERPINE1;HOXA7;PLAU;POSTN;MMP14
13501,GO:0050818,8.55754653876127e-05,0.999994343014393,5,73,regulation of coagulation,BP,SERPINE1;PLAU;SERPING1;PDPN;ANXA2
1066,GO:0002443,8.6366170251585e-05,0.999978747863974,14,680,leukocyte mediated immunity,BP,LTF;PLAU;LGALS3;CHI3L1;CPLX2;SERPING1;C1R;S100A11;PTX3;FABP5;HLA-DQB1;ANXA2;SERPINA3;CFI
6656,GO:0019834,8.73213279101921e-05,0.999999844492388,2,3,phospholipase A2 inhibitor activity,MF,ANXA1;ANXA2
10369,GO:0038065,9.2305498520793e-05,0.999998478840163,3,11,collagen-activated signaling pathway,BP,COL1A1;COL4A2;COL4A1
21194,GO:2000097,9.6225066874535e-05,0.999999820062084,2,3,regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1;PLAU
7964,GO:0031638,0.000104800369194901,0.999995535845922,4,40,zymogen activation,BP,SERPINE1;PLAU;MMP14;C1R
14646,GO:0060284,0.000105362125631227,0.999970865203821,16,782,regulation of cell development,BP,TNFRSF12A;LTF;VIM;CUX2;TNR;GBP1;SPP1;POSTN;MMD2;SHANK2;PDPN;CSMD3;COL3A1;RIMS2;GRIN1;SLITRK1
17948,GO:0098609,0.000107834976595458,0.999972898574454,14,647,cell-cell adhesion,BP,SRPX2;CCL2;IGFBP2;TNR;LGALS3;ANXA1;CDHR1;PDPN;S100A11;PCDH7;DSCAML1;HLA-DQB1;ANXA2;PTPRT
13108,GO:0048584,0.000110413863047094,0.999959014336791,27,1967,positive regulation of response to stimulus,BP,TNFRSF12A;LTF;FERMT1;SERPINE1;CCL2;COL1A1;CUX2;GBP1;GDF15;LGALS3;CHI3L1;ANXA1;MMD2;GPR17;SERPING1;C1R;SHANK2;PDPN;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;SOCS3;PLA2G2A;CFI
4940,GO:0010769,0.000110582833116336,0.99998160816564,9,259,regulation of cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;TNR;GBP1;SPP1;POSTN;PDPN;GRIN1;SLITRK1
2639,GO:0005583,0.000114940656381346,0.999997914489075,3,12,fibrillar collagen trimer,CC,COL1A1;COL3A1;COL5A2
17964,GO:0098643,0.000114940656381346,0.999997914489075,3,12,banded collagen fibril,CC,COL1A1;COL3A1;COL5A2
8697,GO:0032879,0.000118605238531069,0.99995329577239,31,2357,regulation of localization,BP,SNAP91;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;KCNIP3;GBP1;SPP1;KCNIP2;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMD2;CPLX2;JPH3;MMP14;KCNB1;SHANK2;PDPN;PTX3;CACNG2;COL3A1;CXCL10;RIMS2;GRIN1;ANXA2;SHISA7
16474,GO:0071677,0.000120316518617072,0.999997634752588,3,17,positive regulation of mononuclear cell migration,BP,SERPINE1;LGALS3;CXCL10
12888,GO:0048018,0.00012240966128625,0.999979296546383,9,320,receptor ligand activity,MF,TYMP;CHGB;TIMP1;CCL2;SPP1;GDF15;LGALS3;ADM;CXCL10
7003,GO:0022008,0.000126145643955581,0.999956131633765,23,1439,neurogenesis,BP,TNFRSF12A;VIM;CRTAC1;CCL2;CUX2;TNR;SPP1;KCNIP2;POSTN;ANXA1;MMD2;MDGA2;CDHR1;ADM;MMP14;SHANK2;CSMD3;GABRB3;COL3A1;RIMS2;GRIN1;DSCAML1;SLITRK1
13555,GO:0050896,0.000128772945958112,0.999943524954546,67,7357,response to stimulus,BP,TNFRSF12A;LTF;TYMP;VIM;CHGB;APOL4;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;ABCC3;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SPP1;KCNIP2;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;GNAL;COL6A2;GPR17;CPLX2;INA;ADM;SERPING1;SPHKAP;JPH3;MMP14;KCNB1;C1R;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;GABRB3;NNMT;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;CFI;IFI30
7213,GO:0030195,0.000129143569257364,0.999994162661119,4,43,negative regulation of blood coagulation,BP,SERPINE1;PLAU;SERPING1;ANXA2
18570,GO:1900047,0.000129143569257364,0.999994162661119,4,43,negative regulation of hemostasis,BP,SERPINE1;PLAU;SERPING1;ANXA2
12059,GO:0045597,0.000136939375971402,0.999961216562745,16,831,positive regulation of cell differentiation,BP,TNFRSF12A;LTF;SERPINE1;COL1A1;CUX2;GDF15;ANXA1;MMD2;ADM;MMP14;SHANK2;PDPN;RIMS2;SLITRK1;SOCS3;PLA2G2A
7130,GO:0030054,0.000137535552890946,0.999955280224462,20,1169,cell junction,CC,VIM;FERMT1;SRPX2;PLAU;ANXA1;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;SVOP;GABRB3;CACNG2;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;IFI30
5113,GO:0012505,0.000139536671403858,0.999939124495881,43,3945,endomembrane system,CC,LTF;CP;SNAP91;MOXD1;CHGB;TIMP1;SERPINE1;COL1A1;CUX2;KCNIP3;STEAP3;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;COL6A2;GALNT13;INA;SERPING1;JPH3;MMP14;S100A11;PTX3;FABP5;SVOP;COL3A1;PCDH7;FUT9;GRIN1;ST8SIA3;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;COL5A2
9673,GO:0035295,0.000139616590070448,0.999958778754776,17,895,tube development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;HOXA7;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;MMP14;PDPN;COL3A1;CXCL10;ANXA2;COL4A1
13494,GO:0050808,0.000140702248227411,0.999975824374516,9,263,synapse organization,BP,SRPX2;CUX2;TNR;SHANK2;CACNG2;GRIN1;SLITRK1;COL4A1;SHISA7
9490,GO:0034702,0.000144326995108393,0.999975101554795,9,273,ion channel complex,CC,KCNIP3;KCNIP2;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;SHISA7
11644,GO:0044433,0.000153585456639412,0.999948255547133,21,1360,cytoplasmic vesicle part,CC,LTF;MOXD1;TIMP1;SERPINE1;STEAP3;PLAU;LGALS3;CHI3L1;ANXA1;SERPING1;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;PCDH7;CD163;HLA-DQB1;ANXA2;SERPINA3
953,GO:0002252,0.000162972120562305,0.999951198903502,17,994,immune effector process,BP,LTF;GBP1;PLAU;LGALS3;CHI3L1;ANXA1;CPLX2;SERPING1;C1R;S100A11;PTX3;FABP5;CXCL10;HLA-DQB1;ANXA2;SERPINA3;CFI
3632,GO:0007165,0.000163963461476427,0.999926042088352,51,4994,signal transduction,BP,TNFRSF12A;LTF;TYMP;VIM;CHGB;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;GBP1;SPP1;KCNIP2;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;GNAL;GPR17;ADM;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;GABRB3;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SMOC1;IFI30
18046,GO:0098815,0.000164145233828801,0.999992165081474,4,38,modulation of excitatory postsynaptic potential,BP,CUX2;SHANK2;RIMS2;GRIN1
13502,GO:0050819,0.000165032142104121,0.99999201303022,4,46,negative regulation of coagulation,BP,SERPINE1;PLAU;SERPING1;ANXA2
4858,GO:0010647,0.000169051495486181,0.999939930425849,23,1558,positive regulation of cell communication,BP,TNFRSF12A;LTF;FERMT1;CCL2;COL1A1;CUX2;TNR;SLC8A2;SPP1;GDF15;CHI3L1;MMD2;GPR17;SHANK2;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A
17962,GO:0098641,0.000172632710040907,0.999996103091373,3,19,cadherin binding involved in cell-cell adhesion,MF,ANXA1;S100A11;ANXA2
3701,GO:0007267,0.00017796174704606,0.999937904463384,22,1434,cell-cell signaling,BP,FERMT1;COL1A1;CUX2;IGFBP2;TNR;SLC8A2;SPP1;KCNIP2;GDF15;ANXA1;CPLX2;ADM;JPH3;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;CXCL10;RIMS2;GRIN1;SHISA7
4667,GO:0010033,0.000180441277698397,0.99992481307185,34,2846,response to organic substance,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;GBP1;SPP1;GDF15;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GPR17;INA;ADM;MMP14;KCNB1;GABRB3;NNMT;COL3A1;CXCL10;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;COL5A2;IFI30
10613,GO:0042221,0.000184011598113402,0.999919318379485,41,3737,response to chemical,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;ABCC3;CUX2;IGFBP2;TNR;GBP1;SPP1;KCNIP2;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GPR17;INA;ADM;MMP14;KCNB1;GABRB3;NNMT;COL3A1;CXCL10;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;RTP5;COL5A2;IFI30
7091,GO:0023052,0.000191761204655738,0.999912500029701,54,5421,signaling,BP,TNFRSF12A;LTF;TYMP;VIM;CHGB;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;GNAL;GPR17;CPLX2;ADM;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;GABRB3;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SMOC1;IFI30
11916,GO:0045202,0.000193131887701155,0.999943574244423,16,828,synapse,CC,SRPX2;KCNIP3;SLC8A2;POSTN;CPLX2;KCNB1;SHANK2;GABRG1;SVOP;GABRB3;CACNG2;RIMS2;GRIN1;DSCAML1;SLITRK1;SHISA7
18259,GO:0099565,0.00019797809992784,0.999978738360496,6,120,chemical synaptic transmission, postsynaptic,BP,CUX2;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1
2277,GO:0004857,0.000199000463386809,0.999964072397008,9,314,enzyme inhibitor activity,MF,LTF;TIMP1;SERPINE1;ANXA1;SERPING1;ELFN2;ANXA2;SOCS3;SERPINA3
4646,GO:0009966,0.000201354683654723,0.999915549731734,34,2820,regulation of signal transduction,BP,TNFRSF12A;LTF;TYMP;CHGB;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;GBP1;SPP1;PLAU;GDF15;LGALS3;CHI3L1;POSTN;MMD2;GPR17;ADM;SPHKAP;JPH3;MMP14;SHANK2;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A
3621,GO:0007154,0.0002018839119034,0.999907639047014,54,5433,cell communication,BP,TNFRSF12A;LTF;TYMP;VIM;CHGB;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;GNAL;GPR17;CPLX2;ADM;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;GABRB3;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SMOC1;IFI30
3708,GO:0007275,0.00020339149918205,0.999907832415597,48,4496,multicellular organism development,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;TNR;SPP1;KCNIP2;HOXA7;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;CA10;MMP14;SHANK2;PDPN;CSMD3;GABRB3;NNMT;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;SOCS3;COL4A1;SMOC1;COL5A2
7403,GO:0030545,0.000208237477711956,0.999962129072942,9,343,receptor regulator activity,MF,TYMP;CHGB;TIMP1;CCL2;SPP1;GDF15;LGALS3;ADM;CXCL10
7678,GO:0031091,0.000209837890593589,0.999983081630429,5,84,platelet alpha granule,CC,TIMP1;SERPINE1;SERPING1;PCDH7;SERPINA3
1370,GO:0003008,0.000220662005198349,0.999921748796082,22,1444,system process,BP,TYMP;VIM;COL1A1;CUX2;KCNIP3;TNR;SLC8A2;KCNIP2;POSTN;GNAL;ADM;SERPING1;JPH3;SHANK2;GABRG1;GABRB3;CACNG2;CXCL10;GRIN1;SHISA7;RTP5;SERPINA3
9174,GO:0034097,0.000225382450448106,0.999930550817216,17,1030,response to cytokine,BP,TNFRSF12A;VIM;TIMP1;CCL2;COL1A1;GBP1;CHI3L1;POSTN;ANXA1;GPR17;INA;COL3A1;CXCL10;HLA-DQB1;ANXA2;SOCS3;IFI30
13676,GO:0051094,0.000232893539073852,0.999923205499167,19,1157,positive regulation of developmental process,BP,TNFRSF12A;LTF;SRPX2;SERPINE1;COL1A1;CUX2;GDF15;CHI3L1;ANXA1;MMD2;ADAM12;ADM;MMP14;SHANK2;PDPN;RIMS2;SLITRK1;SOCS3;PLA2G2A
17810,GO:0097529,0.000240509545657207,0.999973095899374,6,143,myeloid leukocyte migration,BP,SERPINE1;CCL2;LGALS3;ANXA1;MMP14;CXCL10
1031,GO:0002376,0.000245087909305994,0.999900156526538,30,2461,immune system process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;IGFBP2;GBP1;HOXA7;PLAU;LGALS3;CHI3L1;ANXA1;GPR17;CPLX2;SERPING1;MMP14;C1R;PDPN;S100A11;PTX3;FABP5;COL3A1;CXCL10;HLA-DQB1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI;IFI30
10539,GO:0042060,0.000245927620878172,0.999944628206332,11,459,wound healing,BP,TNFRSF12A;TIMP1;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;SERPING1;PDPN;COL3A1;ANXA2
19294,GO:1902495,0.000246125203932205,0.999954299047075,9,295,transmembrane transporter complex,CC,KCNIP3;KCNIP2;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;SHISA7
14520,GO:0060078,0.000252301601626843,0.999971617935602,6,125,regulation of postsynaptic membrane potential,BP,CUX2;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1
7216,GO:0030199,0.000262430397408616,0.999985708562963,4,43,collagen fibril organization,BP,COL1A1;COL3A1;ANXA2;COL5A2
16247,GO:0071346,0.000280109654818401,0.999967748740958,6,145,cellular response to interferon-gamma,BP,VIM;CCL2;GBP1;HLA-DQB1;SOCS3;IFI30
11605,GO:0044352,0.000281799259876655,0.999998720886025,2,4,pinosome,CC,MMP14;ANXA2
11606,GO:0044354,0.000281799259876655,0.999998720886025,2,4,macropinosome,CC,MMP14;ANXA2
16246,GO:0071345,0.000283019158707377,0.999914282441959,16,951,cellular response to cytokine stimulus,BP,TNFRSF12A;VIM;TIMP1;CCL2;COL1A1;GBP1;CHI3L1;POSTN;ANXA1;GPR17;INA;CXCL10;HLA-DQB1;ANXA2;SOCS3;IFI30
13775,GO:0051240,0.000288657117430034,0.999897872350619,21,1389,positive regulation of multicellular organismal process,BP,TNFRSF12A;LTF;FERMT1;SRPX2;SERPINE1;COL1A1;CUX2;TNR;SPP1;CHI3L1;POSTN;ANXA1;MMD2;ADAM12;ADM;MMP14;SHANK2;PDPN;RIMS2;SLITRK1;ANXA2
20940,GO:1990351,0.000288891423174039,0.999945147101424,9,303,transporter complex,CC,KCNIP3;KCNIP2;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;SHISA7
14245,GO:0052405,0.000289456794470287,0.99999845360063,2,5,negative regulation by host of symbiont molecular function,BP,PTX3;ANXA2
4652,GO:0009986,0.000290156233446567,0.999923735625348,13,632,cell surface,CC,TNFRSF12A;LTF;SRPX2;TNR;PLAU;ANXA1;CXCL10;GRIN1;DSCAML1;CD163;ANXA2;RTP5;PTPRT
7318,GO:0030334,0.000300719606166597,0.999916278579297,14,697,regulation of cell migration,BP,TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;COL3A1;CXCL10
17560,GO:0097060,0.000309952857495119,0.99994058701062,9,299,synaptic membrane,CC,SRPX2;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;RIMS2;GRIN1;SHISA7
11637,GO:0044425,0.000310583593250682,0.999854968748443,52,5327,membrane part,CC,TNFRSF12A;LTF;SNAP91;MOXD1;SLCO1A2;FERMT1;SRPX2;ABCC3;KCNIP3;STEAP3;IGFBP2;TNR;SLC8A2;KCNIP2;LGALS3;ANXA1;MMD2;MDGA2;GNAL;EMP3;GPR17;GALNT13;CPLX2;CDHR1;ADAM12;JPH3;MMP14;KCNB1;SHANK2;PDPN;GABRG1;CSMD3;SVOP;GABRB3;CACNG2;ELFN2;CXCL10;PCDH7;FUT9;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;ANXA2;SHISA7;RTP5;PLA2G2A;PTPRT
13006,GO:0048306,0.000311319015474947,0.999982039299239,4,54,calcium-dependent protein binding,MF,ANXA1;CPLX2;S100A11;ANXA2
15234,GO:0061302,0.000331619064674137,0.999998102600196,2,5,smooth muscle cell-matrix adhesion,BP,SERPINE1;PLAU
3430,GO:0006811,0.000337531073968971,0.999879094937541,21,1404,ion transport,BP,LTF;CP;SLCO1A2;CCL2;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;LGALS3;ANXA1;JPH3;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;CXCL10;GRIN1;SHISA7;PLA2G2A
18019,GO:0098772,0.000338401533717628,0.999875989011992,22,1531,molecular function regulator,MF,LTF;TYMP;CHGB;TIMP1;SERPINE1;CCL2;KCNIP3;SPP1;KCNIP2;GDF15;LGALS3;ANXA1;ADM;SERPING1;MMP14;CACNG2;ELFN2;CXCL10;GRIN1;ANXA2;SOCS3;SERPINA3
13512,GO:0050840,0.000347997186458558,0.999979447479516,4,48,extracellular matrix binding,MF,SPP1;LGALS3;ANXA2;SMOC1
17939,GO:0098590,0.000369377001637862,0.999881104133175,17,967,plasma membrane region,CC,FERMT1;SRPX2;ABCC3;IGFBP2;SLC8A2;ANXA1;CDHR1;KCNB1;SHANK2;PDPN;GABRG1;GABRB3;CACNG2;RIMS2;GRIN1;ANXA2;SHISA7
3975,GO:0008236,0.000399605047048179,0.999950721464183,6,157,serine-type peptidase activity,MF,LTF;AEBP1;PLAU;MMP14;C1R;CFI
4545,GO:0009612,0.000399663734778319,0.999939803073607,7,195,response to mechanical stimulus,BP,COL1A1;IGFBP2;CHI3L1;POSTN;MMP14;COL3A1;CXCL10
13439,GO:0050727,0.000403399127803582,0.999928874291771,8,283,regulation of inflammatory response,BP,SERPINE1;ANXA1;GPR17;SERPING1;C1R;SOCS3;PLA2G2A;CFI
3673,GO:0007215,0.000407194525426443,0.999962042419358,5,85,glutamate receptor signaling pathway,BP,KCNB1;SHANK2;CACNG2;GRIN1;SHISA7
12166,GO:0045766,0.000418691440263648,0.999948007242062,6,144,positive regulation of angiogenesis,BP,SRPX2;SERPINE1;CHI3L1;ANXA1;ADAM12;ADM
4034,GO:0008328,0.00043333838523014,0.99997284199371,4,49,ionotropic glutamate receptor complex,CC,SHANK2;CACNG2;GRIN1;SHISA7
16223,GO:0071310,0.000434532220513642,0.999818378944213,29,2351,cellular response to organic substance,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;GBP1;SPP1;GDF15;CHI3L1;POSTN;COL4A2;ANXA1;GPR17;INA;KCNB1;GABRB3;COL3A1;CXCL10;HLA-DQB1;ANXA2;SOCS3;COL4A1;COL5A2;IFI30
6248,GO:0017171,0.000458748413687706,0.999941899475534,6,161,serine hydrolase activity,MF,LTF;AEBP1;PLAU;MMP14;C1R;CFI
7319,GO:0030335,0.000459042871859883,0.999897333854782,10,409,positive regulation of cell migration,BP,SRPX2;SERPINE1;COL1A1;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;CXCL10
2062,GO:0004568,0.000478622580916891,0.999996413741169,2,6,chitinase activity,MF,CHI3L2;CHI3L1
2912,GO:0006030,0.000478622580916891,0.999996413741169,2,6,chitin metabolic process,BP,CHI3L2;CHI3L1
2913,GO:0006032,0.000478622580916891,0.999996413741169,2,6,chitin catabolic process,BP,CHI3L2;CHI3L1
18081,GO:0098878,0.000488021448860411,0.999968365409049,4,51,neurotransmitter receptor complex,CC,SHANK2;CACNG2;GRIN1;SHISA7
9292,GO:0034341,0.000499865524789257,0.999935635324828,6,163,response to interferon-gamma,BP,VIM;CCL2;GBP1;HLA-DQB1;SOCS3;IFI30
12934,GO:0048168,0.000505013379652572,0.999966931409436,4,52,regulation of neuronal synaptic plasticity,BP,SLC8A2;JPH3;GRIN1;SHISA7
21222,GO:2000145,0.000518774686107148,0.999847229311906,14,739,regulation of cell motility,BP,TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;COL3A1;CXCL10
14251,GO:0052428,0.000530427167987366,0.999995813760506,2,6,modulation by host of symbiont molecular function,BP,PTX3;ANXA2
3627,GO:0007160,0.00054243230217084,0.999913997599541,7,194,cell-matrix adhesion,BP,FERMT1;SERPINE1;HOXA7;PLAU;POSTN;MMP14;COL3A1
21224,GO:2000147,0.000548297956289768,0.999874479438238,10,420,positive regulation of cell motility,BP,SRPX2;SERPINE1;COL1A1;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;CXCL10
2481,GO:0005198,0.000553866812481861,0.999852738767261,12,587,structural molecule activity,MF,VIM;COL1A1;EMILIN2;CHI3L1;COL4A2;ANXA1;INA;SHANK2;TUBA1C;COL3A1;COL4A1;COL5A2
3524,GO:0006958,0.000566522811168371,0.999980128388679,3,26,complement activation, classical pathway,BP,SERPING1;C1R;CFI
5880,GO:0016485,0.000573945863043285,0.999907909579452,7,223,protein processing,BP,SERPINE1;AEBP1;PLAU;SERPING1;MMP14;C1R;CFI
15183,GO:0061134,0.000583919499583207,0.999922590202401,6,159,peptidase regulator activity,MF,LTF;TIMP1;SERPINE1;SERPING1;MMP14;SERPINA3
1195,GO:0002683,0.000593020684688253,0.999875270423822,9,368,negative regulation of immune system process,BP,LTF;CCL2;GBP1;HOXA7;LGALS3;ANXA1;GPR17;SERPING1;COL3A1
2605,GO:0005509,0.000593089224694978,0.99984114621985,12,553,calcium ion binding,MF,CRTAC1;KCNIP3;KCNIP2;ANXA1;CDHR1;C1R;S100A11;PCDH7;GRIN1;ANXA2;PLA2G2A;SMOC1
7684,GO:0031099,0.000610004388631312,0.999918443624637,6,160,regeneration,BP,TNR;SPP1;POSTN;ANXA1;ADM;NNMT
13149,GO:0048666,0.000623751686092444,0.99978936519202,17,1002,neuron development,BP,TNFRSF12A;VIM;CRTAC1;CUX2;TNR;SPP1;KCNIP2;POSTN;CDHR1;ADM;SHANK2;CSMD3;GABRB3;RIMS2;GRIN1;DSCAML1;SLITRK1
15134,GO:0061045,0.000628310471750528,0.99995609608517,4,60,negative regulation of wound healing,BP,SERPINE1;PLAU;SERPING1;ANXA2
5741,GO:0016192,0.000646049683732389,0.999741502148758,24,1807,vesicle-mediated transport,BP,LTF;SNAP91;TIMP1;SERPINE1;CCL2;CUX2;PLAU;LGALS3;CHI3L1;ANXA1;CPLX2;ADM;SERPING1;KCNB1;S100A11;PTX3;FABP5;CACNG2;PCDH7;RIMS2;CD163;ANXA2;SERPINA3;CFI
11749,GO:0044793,0.000649474084925195,0.999994321604036,2,6,negative regulation by host of viral process,BP,LTF;PTX3
7680,GO:0031093,0.000666190574810534,0.999952618004293,4,63,platelet alpha granule lumen,CC,TIMP1;SERPINE1;SERPING1;SERPINA3
11111,GO:0043200,0.000668959943638489,0.999929976832815,5,104,response to amino acid,BP,COL1A1;COL3A1;GRIN1;COL4A1;COL5A2
13799,GO:0051272,0.000674323186662336,0.99984136058007,10,431,positive regulation of cellular component movement,BP,SRPX2;SERPINE1;COL1A1;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;CXCL10
3869,GO:0008061,0.000678692513041521,0.999993592707844,2,7,chitin binding,MF,CHI3L2;CHI3L1
11610,GO:0044362,0.000691976362211407,0.999993402922605,2,7,negative regulation of molecular function in other organism,BP,PTX3;ANXA2
14218,GO:0052204,0.000691976362211407,0.999993402922605,2,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,PTX3;ANXA2
21316,GO:2000311,0.00069430436698903,0.999974062055919,3,24,regulation of AMPA receptor activity,BP,SHANK2;CACNG2;SHISA7
13841,GO:0051346,0.000694792486810315,0.99985058317186,9,364,negative regulation of hydrolase activity,BP,LTF;TIMP1;SERPINE1;SPOCD1;ANXA1;SERPING1;PTX3;ELFN2;SERPINA3
11363,GO:0043615,0.000727358265577987,0.999992888396629,2,7,astrocyte cell migration,BP,CCL2;MMP14
5657,GO:0016020,0.000731246949407801,0.999647831252059,66,7580,membrane,CC,TNFRSF12A;LTF;VIM;CP;SNAP91;MOXD1;SLCO1A2;APOL4;FERMT1;SRPX2;PLEKHA4;SERPINE1;ABCC3;CUX2;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;KCNIP2;HOXA7;PLAU;LGALS3;ANXA1;MMD2;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;JPH3;MMP14;KCNB1;SHANK2;PDPN;GABRG1;FABP5;CSMD3;SVOP;GABRB3;CACNG2;ELFN2;CXCL10;PCDH7;KSR2;FUT9;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;ANXA2;SHISA7;RTP5;PLA2G2A;PTPRT;CFI
11849,GO:0045087,0.000742946574047234,0.999783597470371,13,742,innate immune response,BP,LTF;VIM;CCL2;GBP1;LGALS3;ANXA1;SERPING1;C1R;PTX3;HLA-DQB1;SOCS3;CFI;IFI30
7205,GO:0030182,0.000764642506679843,0.999721074243997,19,1223,neuron differentiation,BP,TNFRSF12A;VIM;CRTAC1;CUX2;TNR;SPP1;KCNIP2;POSTN;MMD2;MDGA2;CDHR1;ADM;SHANK2;CSMD3;GABRB3;RIMS2;GRIN1;DSCAML1;SLITRK1
20007,GO:1904018,0.000767645717101764,0.999892727195182,6,161,positive regulation of vasculature development,BP,SRPX2;SERPINE1;CHI3L1;ANXA1;ADAM12;ADM
2657,GO:0005604,0.000800922528500734,0.999913176204436,5,88,basement membrane,CC,TIMP1;COL4A2;ANXA2;COL4A1;SMOC1
2278,GO:0004859,0.000815154975930879,0.999991228285636,2,8,phospholipase inhibitor activity,MF,ANXA1;ANXA2
16180,GO:0071230,0.000829441248231163,0.99993751420122,4,61,cellular response to amino acid stimulus,BP,COL1A1;COL3A1;COL4A1;COL5A2
11664,GO:0044459,0.000832853434276523,0.999636034105288,29,2392,plasma membrane part,CC,SLCO1A2;FERMT1;SRPX2;ABCC3;KCNIP3;STEAP3;IGFBP2;SLC8A2;KCNIP2;LGALS3;ANXA1;GNAL;GPR17;CDHR1;MMP14;KCNB1;SHANK2;PDPN;GABRG1;GABRB3;CACNG2;CXCL10;PCDH7;RIMS2;GRIN1;CD163;HLA-DQB1;ANXA2;SHISA7
14894,GO:0060627,0.000862871618674114,0.999790211080334,10,451,regulation of vesicle-mediated transport,BP,SNAP91;SERPINE1;CCL2;LGALS3;ANXA1;CPLX2;KCNB1;PTX3;RIMS2;ANXA2
7813,GO:0031340,0.000868974240202478,0.999990702889759,2,7,positive regulation of vesicle fusion,BP,ANXA1;ANXA2
13471,GO:0050777,0.00089443132612122,0.99989978920385,5,118,negative regulation of immune response,BP,LGALS3;ANXA1;GPR17;SERPING1;COL3A1
10499,GO:0040017,0.000910617715534641,0.99977702667359,10,449,positive regulation of locomotion,BP,SRPX2;SERPINE1;COL1A1;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;CXCL10
14164,GO:0051960,0.000917811995766251,0.999713023520368,14,765,regulation of nervous system development,BP,TNFRSF12A;TYMP;VIM;SRPX2;CUX2;TNR;SPP1;MMD2;SHANK2;CSMD3;COL3A1;RIMS2;GRIN1;SLITRK1
7111,GO:0030023,0.000921431527763013,0.999991159441117,2,5,extracellular matrix constituent conferring elasticity,MF,EMILIN2;COL4A1
9650,GO:0035255,0.00092920732354375,0.99996131710166,3,26,ionotropic glutamate receptor binding,MF,SHANK2;CACNG2;SHISA7
13650,GO:0051049,0.000948457406210013,0.999622884376752,22,1627,regulation of transport,BP,SNAP91;FERMT1;SERPINE1;CCL2;KCNIP3;GBP1;SPP1;KCNIP2;LGALS3;POSTN;ANXA1;CPLX2;JPH3;KCNB1;SHANK2;PTX3;CACNG2;CXCL10;RIMS2;GRIN1;ANXA2;SHISA7
5092,GO:0010975,0.000950472001491899,0.999766055062992,10,427,regulation of neuron projection development,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;SHANK2;CSMD3;RIMS2;GRIN1;SLITRK1
3824,GO:0007613,0.000971381789742471,0.999889498194311,5,104,memory,BP,CUX2;SLC8A2;JPH3;GRIN1;SHISA7
13178,GO:0048699,0.000971677822131486,0.999629061948551,20,1346,generation of neurons,BP,TNFRSF12A;VIM;CRTAC1;CUX2;TNR;SPP1;KCNIP2;POSTN;MMD2;MDGA2;CDHR1;ADM;SHANK2;CSMD3;GABRB3;COL3A1;RIMS2;GRIN1;DSCAML1;SLITRK1
4618,GO:0009888,0.000973147446303934,0.999612285799301,22,1600,tissue development,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;COL1A1;SPP1;HOXA7;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;ADM;MMP14;PDPN;FABP5;COL3A1;CXCL10;SOCS3;COL4A1;COL5A2
815,GO:0002020,0.00099089886884861,0.999886604597351,5,110,protease binding,MF,TIMP1;SERPINE1;COL1A1;COL3A1;ANXA2
15554,GO:0070062,0.000999927141284289,0.999562378298487,28,2418,extracellular exosome,CC,LTF;VIM;CP;CRTAC1;TIMP1;SERPINE1;AEBP1;CUX2;IGFBP2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;COL4A2;ANXA1;GNAL;COL6A2;SERPING1;SPHKAP;C1R;S100A11;FABP5;RIMS2;ANXA2;PLA2G2A;SERPINA3;CFI
13540,GO:0050877,0.00100628714319749,0.999682175278764,14,800,nervous system process,BP,TYMP;COL1A1;CUX2;TNR;SLC8A2;GNAL;JPH3;SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;SHISA7;RTP5
6707,GO:0019932,0.00101930781945886,0.999792623510413,8,298,second-messenger-mediated signaling,BP,GBP1;GNAL;ADM;JPH3;CXCL10;KSR2;RIMS2;GRIN1
20700,GO:1905517,0.00102890897169936,0.999954818349114,3,33,macrophage migration,BP,CCL2;LGALS3;MMP14
1116,GO:0002526,0.00103057891415264,0.999880651928096,5,125,acute inflammatory response,BP,SERPING1;C1R;CD163;SERPINA3;CFI
2284,GO:0004866,0.00103339451251715,0.999880365315202,5,120,endopeptidase inhibitor activity,MF,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
1194,GO:0002682,0.00103890526944461,0.999620718270018,18,1276,regulation of immune system process,BP,LTF;SERPINE1;CCL2;COL1A1;IGFBP2;GBP1;HOXA7;LGALS3;ANXA1;GPR17;SERPING1;MMP14;C1R;COL3A1;CXCL10;HLA-DQB1;SOCS3;CFI
13071,GO:0048513,0.00104019026449206,0.999520259280677,33,2884,animal organ development,BP,LTF;VIM;CRTAC1;FERMT1;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;TNR;SPP1;HOXA7;LGALS3;CHI3L1;ANXA1;MDGA2;INA;ADM;CA10;MMP14;SHANK2;PDPN;GABRB3;NNMT;COL3A1;CXCL10;GRIN1;DSCAML1;ANXA2;SOCS3;COL4A1;SMOC1;COL5A2
3786,GO:0007520,0.00104307960461284,0.999954395349623,3,29,myoblast fusion,BP,GDF15;ADAM12;CXCL10
11609,GO:0044359,0.00104544331952294,0.999987238559535,2,8,modulation of molecular function in other organism,BP,PTX3;ANXA2
14219,GO:0052205,0.00104544331952294,0.999987238559535,2,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,PTX3;ANXA2
11662,GO:0044456,0.00104758712194471,0.999683137452702,13,697,synapse part,CC,SRPX2;KCNIP3;SLC8A2;CPLX2;KCNB1;SHANK2;GABRG1;SVOP;GABRB3;CACNG2;RIMS2;GRIN1;SHISA7
3822,GO:0007611,0.00106938257796127,0.999809153381306,7,223,learning or memory,BP,CUX2;TNR;SLC8A2;JPH3;SHANK2;GRIN1;SHISA7
14172,GO:0051968,0.00108128187915284,0.999952259544841,3,28,positive regulation of synaptic transmission, glutamatergic,BP,TNR;SHANK2;CACNG2
6469,GO:0019221,0.00108349958794307,0.999688165664596,12,686,cytokine-mediated signaling pathway,BP,TNFRSF12A;VIM;TIMP1;CCL2;GBP1;ANXA1;GPR17;CXCL10;HLA-DQB1;ANXA2;SOCS3;IFI30
18781,GO:1901072,0.00111148295651056,0.999985603949484,2,9,glucosamine-containing compound catabolic process,BP,CHI3L2;CHI3L1
19772,GO:1903561,0.00111891854272064,0.999506319539181,28,2434,extracellular vesicle,CC,LTF;VIM;CP;CRTAC1;TIMP1;SERPINE1;AEBP1;CUX2;IGFBP2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;COL4A2;ANXA1;GNAL;COL6A2;SERPING1;SPHKAP;C1R;S100A11;FABP5;RIMS2;ANXA2;PLA2G2A;SERPINA3;CFI
17955,GO:0098632,0.00111986292459491,0.999949568148404,3,31,cell-cell adhesion mediator activity,MF,ANXA1;S100A11;ANXA2
10494,GO:0040012,0.00112338989375594,0.999640989973146,14,802,regulation of locomotion,BP,TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;COL3A1;CXCL10
11132,GO:0043230,0.00113121987867241,0.999500497128237,28,2436,extracellular organelle,CC,LTF;VIM;CP;CRTAC1;TIMP1;SERPINE1;AEBP1;CUX2;IGFBP2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;COL4A2;ANXA1;GNAL;COL6A2;SERPING1;SPHKAP;C1R;S100A11;FABP5;RIMS2;ANXA2;PLA2G2A;SERPINA3;CFI
16472,GO:0071675,0.00114562053742315,0.999947676761141,3,34,regulation of mononuclear cell migration,BP,SERPINE1;LGALS3;CXCL10
1140,GO:0002576,0.00116509972885408,0.999861458631984,5,119,platelet degranulation,BP,TIMP1;SERPINE1;SERPING1;PCDH7;SERPINA3
11177,GO:0043299,0.00118159594506571,0.999700176775513,10,497,leukocyte degranulation,BP,LTF;PLAU;LGALS3;CHI3L1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
1872,GO:0004252,0.00118575815371459,0.999858113092172,5,132,serine-type endopeptidase activity,MF,LTF;PLAU;MMP14;C1R;CFI
2821,GO:0005883,0.00120616690209204,0.999984760070778,2,7,neurofilament,CC,INA;SHANK2
15184,GO:0061135,0.00124886685034889,0.99984895765374,5,126,endopeptidase regulator activity,MF,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
14518,GO:0060076,0.00125144197302786,0.999941702419441,3,29,excitatory synapse,CC,SRPX2;GRIN1;SHISA7
11160,GO:0043269,0.00127803882751787,0.999647606980806,11,554,regulation of ion transport,BP,CCL2;KCNIP3;KCNIP2;LGALS3;JPH3;KCNB1;SHANK2;CACNG2;CXCL10;GRIN1;SHISA7
7058,GO:0022839,0.0012866290362214,0.999728418830933,8,305,ion gated channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;GRIN1
963,GO:0002275,0.00131851372989532,0.999660423871414,10,505,myeloid cell activation involved in immune response,BP,LTF;PLAU;LGALS3;CHI3L1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
11921,GO:0045211,0.00132250738508097,0.999755023882686,7,229,postsynaptic membrane,CC,KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;SHISA7
7349,GO:0030414,0.0013287173171447,0.999837064810072,5,125,peptidase inhibitor activity,MF,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
7056,GO:0022836,0.00135422413177728,0.999711798852921,8,308,gated channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;GRIN1
16014,GO:0070887,0.00136712618134921,0.999368691152223,31,2789,cellular response to chemical stimulus,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;GBP1;SPP1;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;GPR17;INA;KCNB1;GABRB3;COL3A1;CXCL10;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;COL5A2;IFI30
1067,GO:0002444,0.00136723246713843,0.999646132882307,10,508,myeloid leukocyte mediated immunity,BP,LTF;PLAU;LGALS3;CHI3L1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
13797,GO:0051270,0.00137876025613907,0.999549530504291,14,811,regulation of cellular component movement,BP,TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;COL3A1;CXCL10
2643,GO:0005587,0.00138309228294429,0.999982256253847,2,6,collagen type IV trimer,CC,COL4A2;COL4A1
3804,GO:0007584,0.00145168896956916,0.999769677789095,6,192,response to nutrient,BP,COL1A1;IGFBP2;SPP1;POSTN;CXCL10;GRIN1
7749,GO:0031252,0.00145665617542751,0.999651626083474,9,366,cell leading edge,CC,TNFRSF12A;VIM;FERMT1;KCNB1;PDPN;S100A11;GABRG1;ANXA2;SHISA7
7362,GO:0030449,0.001473152534643,0.999926292005806,3,36,regulation of complement activation,BP,SERPING1;C1R;CFI
21280,GO:2000257,0.001473152534643,0.999926292005806,3,36,regulation of protein activation cascade,BP,SERPING1;C1R;CFI
3486,GO:0006898,0.00156177410904027,0.999701761546809,7,253,receptor-mediated endocytosis,BP,SNAP91;SERPINE1;ADM;CACNG2;CD163;ANXA2;CFI
13049,GO:0048468,0.00157726379497433,0.999323591045402,24,1841,cell development,BP,TNFRSF12A;LTF;VIM;CRTAC1;CUX2;TNR;GBP1;SPP1;KCNIP2;GDF15;POSTN;MMD2;CDHR1;ADM;SHANK2;PDPN;CSMD3;GABRB3;COL3A1;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2
14911,GO:0060670,0.00162539339077952,0.999973904937723,2,10,branching involved in labyrinthine layer morphogenesis,BP,ADM;SOCS3
14437,GO:0055102,0.0016572769833632,0.999972662120934,2,11,lipase inhibitor activity,MF,ANXA1;ANXA2
9055,GO:0033628,0.00167772324364271,0.999912008871552,3,37,regulation of cell adhesion mediated by integrin,BP,FERMT1;SERPINE1;PLAU
12967,GO:0048245,0.00167776557294439,0.999972150644194,2,11,eosinophil chemotaxis,BP,CCL2;LGALS3
2825,GO:0005887,0.00169016286301418,0.999338011913829,19,1382,integral component of plasma membrane,CC,SLCO1A2;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;GPR17;CDHR1;MMP14;KCNB1;SHANK2;PDPN;GABRG1;GABRB3;CACNG2;PCDH7;GRIN1;CD163;SHISA7
14650,GO:0060291,0.00169479512453459,0.99984420985647,4,70,long-term synaptic potentiation,BP,TNR;SLC8A2;SHANK2;SHISA7
2434,GO:0005125,0.00169490183218777,0.999779607242411,5,148,cytokine activity,MF,TIMP1;CCL2;SPP1;GDF15;CXCL10
17963,GO:0098642,0.0017073177658835,0.999974257732378,2,7,network-forming collagen trimer,CC,COL4A2;COL4A1
17966,GO:0098645,0.0017073177658835,0.999974257732378,2,7,collagen network,CC,COL4A2;COL4A1
14685,GO:0060333,0.00171662903671577,0.999840777471268,4,83,interferon-gamma-mediated signaling pathway,BP,GBP1;HLA-DQB1;SOCS3;IFI30
10700,GO:0042391,0.00178240670451959,0.999560572269918,9,398,regulation of membrane potential,BP,CUX2;KCNIP2;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;RIMS2;GRIN1
12058,GO:0045596,0.00179503499370278,0.999483070730019,11,575,negative regulation of cell differentiation,BP,LTF;VIM;TNR;GBP1;SPP1;HOXA7;POSTN;ANXA1;COL3A1;CXCL10;COL5A2
8932,GO:0033273,0.00190163717515953,0.999818607715601,4,83,response to vitamin,BP,COL1A1;SPP1;POSTN;CXCL10
13557,GO:0050900,0.0019121235230102,0.999569426952532,8,357,leukocyte migration,BP,SERPINE1;CCL2;COL1A1;HOXA7;LGALS3;ANXA1;MMP14;CXCL10
3800,GO:0007568,0.00196321060919061,0.999609440802495,7,267,aging,BP,TIMP1;SERPINE1;IGFBP2;COL4A2;ADM;SERPING1;COL3A1
1023,GO:0002366,0.00197216926142414,0.999424828415559,11,622,leukocyte activation involved in immune response,BP,LTF;PLAU;LGALS3;CHI3L1;ANXA1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
18450,GO:0120035,0.0019795342293949,0.999422838826319,11,561,regulation of plasma membrane bounded cell projection organization,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;SHANK2;PDPN;CSMD3;RIMS2;GRIN1;SLITRK1
8508,GO:0032590,0.00200247877397869,0.999888250148068,3,37,dendrite membrane,CC,KCNB1;GABRG1;SHISA7
5209,GO:0014812,0.0020107405633819,0.999805939382349,4,74,muscle cell migration,BP,SERPINE1;PLAU;POSTN;ANXA1
12113,GO:0045664,0.00206060522419885,0.99939604418237,11,566,regulation of neuron differentiation,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;MMD2;SHANK2;CSMD3;RIMS2;GRIN1;SLITRK1
958,GO:0002263,0.00209701319505994,0.999383540182674,11,625,cell activation involved in immune response,BP,LTF;PLAU;LGALS3;CHI3L1;ANXA1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
6659,GO:0019838,0.00212949830100279,0.999709126519263,5,128,growth factor binding,MF,SRPX2;COL1A1;IGFBP2;COL3A1;COL4A1
13976,GO:0051604,0.00217874839166453,0.999558183917458,7,283,protein maturation,BP,SERPINE1;AEBP1;PLAU;SERPING1;MMP14;C1R;CFI
13550,GO:0050890,0.00217979838089903,0.999558549820526,7,253,cognition,BP,CUX2;TNR;SLC8A2;JPH3;SHANK2;GRIN1;SHISA7
17970,GO:0098651,0.00218368043041197,0.999961228771094,2,8,basement membrane collagen trimer,CC,COL4A2;COL4A1
17937,GO:0098588,0.00218913083199394,0.999050748758433,23,1879,bounding membrane of organelle,CC,LTF;CP;MOXD1;CUX2;STEAP3;GBP1;PLAU;LGALS3;ANXA1;MMD2;GALNT13;CDHR1;JPH3;SHANK2;FABP5;SVOP;CACNG2;PCDH7;FUT9;ST8SIA3;CD163;HLA-DQB1;ANXA2
16945,GO:0072562,0.00220034582655874,0.999780914650987,4,92,blood microparticle,CC,CP;SERPING1;C1R;SERPINA3
15648,GO:0070208,0.00220392116096497,0.999957964724553,2,11,protein heterotrimerization,BP,COL1A1;COL6A2
7817,GO:0031344,0.00222731840013558,0.999340547288704,11,570,regulation of cell projection organization,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;SHANK2;PDPN;CSMD3;RIMS2;GRIN1;SLITRK1
3758,GO:0007416,0.00224710653808338,0.999689581700948,5,122,synapse assembly,BP,SRPX2;CUX2;SHANK2;GRIN1;SLITRK1
7041,GO:0022617,0.00228736255247244,0.999770891418544,4,78,extracellular matrix disassembly,BP,TIMP1;SPP1;MMP14;PDPN
11190,GO:0043312,0.00228833965876968,0.999413931837237,9,454,neutrophil degranulation,BP,LTF;PLAU;LGALS3;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
14167,GO:0051963,0.00229687408858739,0.999769768934228,4,77,regulation of synapse assembly,BP,SRPX2;CUX2;GRIN1;SLITRK1
12426,GO:0046348,0.00234423029897834,0.999952663427395,2,13,amino sugar catabolic process,BP,CHI3L2;CHI3L1
5682,GO:0016064,0.00236111273340032,0.999760439081027,4,90,immunoglobulin mediated immune response,BP,SERPING1;C1R;HLA-DQB1;CFI
271,GO:0000768,0.00236542451450562,0.999860025207658,3,37,syncytium formation by plasma membrane fusion,BP,GDF15;ADAM12;CXCL10
970,GO:0002283,0.00238060706601626,0.999386673426462,9,457,neutrophil activation involved in immune response,BP,LTF;PLAU;LGALS3;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
3823,GO:0007612,0.00241826616819314,0.999659833883261,5,129,learning,BP,TNR;SLC8A2;JPH3;SHANK2;GRIN1
17954,GO:0098631,0.0024275562265947,0.999854411791561,3,40,cell adhesion mediator activity,MF,ANXA1;S100A11;ANXA2
6608,GO:0019724,0.00244988078269423,0.999748817116458,4,91,B cell mediated immunity,BP,SERPING1;C1R;HLA-DQB1;CFI
17178,GO:0090026,0.00247927762934758,0.999948485086495,2,13,positive regulation of monocyte chemotaxis,BP,SERPINE1;CXCL10
13109,GO:0048585,0.00248309474165273,0.9989922571684,19,1434,negative regulation of response to stimulus,BP,LTF;FERMT1;SERPINE1;CCL2;IGFBP2;TNR;GBP1;SPP1;PLAU;LGALS3;ANXA1;GPR17;ADM;SERPING1;MMP14;COL3A1;GRIN1;ANXA2;SOCS3
15884,GO:0070613,0.00250859882300217,0.999741508432488,4,86,regulation of protein processing,BP,SERPINE1;SERPING1;C1R;CFI
18553,GO:1900025,0.00251093538274737,0.999948093327142,2,12,negative regulation of substrate adhesion-dependent cell spreading,BP,GBP1;POSTN
3516,GO:0006949,0.00252684164230519,0.999846721471058,3,38,syncytium formation,BP,GDF15;ADAM12;CXCL10
17369,GO:0090303,0.00256279436598854,0.999842944247864,3,42,positive regulation of wound healing,BP,SERPINE1;ANXA1;PDPN
326,GO:0000902,0.00257016567768283,0.999066182545425,15,939,cell morphogenesis,BP,TNFRSF12A;CCL2;CUX2;TNR;GBP1;SPP1;POSTN;ANXA1;CDHR1;SHANK2;PDPN;RIMS2;GRIN1;DSCAML1;SLITRK1
17974,GO:0098657,0.00263170224075448,0.999156837878385,12,706,import into cell,BP,SNAP91;SERPINE1;CCL2;STEAP3;LGALS3;ANXA1;ADM;PTX3;CACNG2;CD163;ANXA2;CFI
10570,GO:0042119,0.00266332888934345,0.999302147434319,9,465,neutrophil activation,BP,LTF;PLAU;LGALS3;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
7736,GO:0031226,0.00266563413951946,0.998910985761409,19,1436,intrinsic component of plasma membrane,CC,SLCO1A2;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;GPR17;CDHR1;MMP14;KCNB1;SHANK2;PDPN;GABRG1;GABRB3;CACNG2;PCDH7;GRIN1;CD163;SHISA7
7066,GO:0022851,0.0026709485221433,0.999943805602675,2,11,GABA-gated chloride ion channel activity,MF,GABRG1;GABRB3
1069,GO:0002446,0.00272585204720266,0.999283254396228,9,467,neutrophil mediated immunity,BP,LTF;PLAU;LGALS3;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
327,GO:0000904,0.00272793391515047,0.999122513109958,12,659,cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;TNR;GBP1;SPP1;POSTN;CDHR1;SHANK2;PDPN;GRIN1;DSCAML1;SLITRK1
19647,GO:1903317,0.00272961083144782,0.999711911854227,4,88,regulation of protein maturation,BP,SERPINE1;SERPING1;C1R;CFI
20035,GO:1904062,0.00274616499981613,0.99941991427554,7,273,regulation of cation transmembrane transport,BP,KCNIP3;KCNIP2;JPH3;SHANK2;CACNG2;CXCL10;SHISA7
12123,GO:0045683,0.00274806652959641,0.99994051137602,2,12,negative regulation of epidermis development,BP,FERMT1;HOXA7
17002,GO:0072677,0.00280039593708719,0.999937471194174,2,14,eosinophil migration,BP,CCL2;LGALS3
10190,GO:0036230,0.00284444109768764,0.999247241765067,9,470,granulocyte activation,BP,LTF;PLAU;LGALS3;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
13163,GO:0048681,0.00285530490526635,0.999936968537775,2,12,negative regulation of axon regeneration,BP,TNR;SPP1
9866,GO:0035637,0.00287422007490345,0.999477789520535,6,190,multicellular organismal signaling,BP,TYMP;KCNIP3;TNR;SLC8A2;KCNIP2;CACNG2
21832,GO:2001257,0.00289181213449712,0.999575308660848,5,141,regulation of cation channel activity,BP,KCNIP2;JPH3;SHANK2;CACNG2;SHISA7
5321,GO:0015125,0.00290425524513728,0.999934575470887,2,13,bile acid transmembrane transporter activity,MF,SLCO1A2;ABCC3
14173,GO:0051969,0.00294750632275729,0.999933097374427,2,13,regulation of transmission of nerve impulse,BP,TYMP;TNR
3810,GO:0007596,0.00299545552031714,0.999356807583083,7,292,blood coagulation,BP,SERPINE1;COL1A1;PLAU;SERPING1;PDPN;COL3A1;ANXA2
5876,GO:0016477,0.00302460802296452,0.998810256402452,17,1193,cell migration,BP,TNFRSF12A;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;COL3A1;CXCL10
18552,GO:1900024,0.00303904984376214,0.999801744701294,3,44,regulation of substrate adhesion-dependent cell spreading,BP,GBP1;POSTN;PDPN
11963,GO:0045321,0.0030587493998334,0.998866913263912,15,1066,leukocyte activation,BP,LTF;CCL2;IGFBP2;PLAU;LGALS3;CHI3L1;ANXA1;CPLX2;MMP14;S100A11;PTX3;FABP5;HLA-DQB1;ANXA2;SERPINA3
4942,GO:0010771,0.00308594642514374,0.999663249815877,4,86,negative regulation of cell morphogenesis involved in differentiation,BP,TNR;GBP1;SPP1;POSTN
13699,GO:0051128,0.00308911478289597,0.99856283622665,26,2210,regulation of cellular component organization,BP,TNFRSF12A;VIM;SNAP91;SRPX2;SERPINE1;CCL2;CUX2;IGFBP2;TNR;GBP1;SPP1;GDF15;LGALS3;POSTN;ANXA1;MMP14;SHANK2;PDPN;PTX3;CSMD3;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;SHISA7
9649,GO:0035254,0.0031049005488665,0.999796861598348,3,40,glutamate receptor binding,MF,SHANK2;CACNG2;SHISA7
13500,GO:0050817,0.00312290277908269,0.99932434319783,7,294,coagulation,BP,SERPINE1;COL1A1;PLAU;SERPING1;PDPN;COL3A1;ANXA2
3485,GO:0006897,0.00314604684140049,0.999024847132579,11,629,endocytosis,BP,SNAP91;SERPINE1;CCL2;LGALS3;ANXA1;ADM;PTX3;CACNG2;CD163;ANXA2;CFI
3522,GO:0006956,0.00315750460711456,0.999790394774115,3,48,complement activation,BP,SERPING1;C1R;CFI
7145,GO:0030100,0.00320208633443521,0.999404310876776,6,215,regulation of endocytosis,BP,SNAP91;SERPINE1;CCL2;LGALS3;PTX3;ANXA2
3813,GO:0007599,0.00325496679244881,0.999290412156538,7,297,hemostasis,BP,SERPINE1;COL1A1;PLAU;SERPING1;PDPN;COL3A1;ANXA2
4976,GO:0010830,0.00325908390835624,0.999781613793454,3,46,regulation of myotube differentiation,BP,GDF15;MMP14;CXCL10
13461,GO:0050767,0.00327208005072509,0.998923110001887,12,687,regulation of neurogenesis,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;MMD2;SHANK2;CSMD3;COL3A1;RIMS2;GRIN1;SLITRK1
19025,GO:1901739,0.00327543948698875,0.999920099409886,2,15,regulation of myoblast fusion,BP,GDF15;CXCL10
5265,GO:0014902,0.00328423876263189,0.999635123214964,4,88,myotube differentiation,BP,GDF15;ADAM12;MMP14;CXCL10
16393,GO:0071560,0.00329065033508848,0.999384736817631,6,208,cellular response to transforming growth factor beta stimulus,BP,FERMT1;COL1A1;GDF15;POSTN;COL4A2;COL3A1
14141,GO:0051928,0.00334931353657382,0.999625311000671,4,93,positive regulation of calcium ion transport,BP,CCL2;LGALS3;CXCL10;GRIN1
4898,GO:0010721,0.0033693979057549,0.999261453139442,7,277,negative regulation of cell development,BP,LTF;VIM;TNR;GBP1;SPP1;POSTN;COL3A1
18721,GO:1900449,0.00340433352853398,0.999769306796817,3,42,regulation of glutamate receptor signaling pathway,BP,SHANK2;CACNG2;SHISA7
3464,GO:0006869,0.0034527659281382,0.99923954467104,7,286,lipid transport,BP,SLCO1A2;APOL4;ABCC3;SPP1;ANXA1;ANXA2;PLA2G2A
15523,GO:0065009,0.00356963085086444,0.998233734162579,31,2919,regulation of molecular function,BP,LTF;TYMP;CHGB;CRTAC1;TIMP1;SERPINE1;CCL2;KCNIP3;SPP1;KCNIP2;PLAU;GDF15;CHI3L1;SPOCD1;ANXA1;MMD2;GNAL;ADM;SERPING1;JPH3;MMP14;SHANK2;PTX3;CACNG2;ELFN2;CXCL10;GRIN1;ANXA2;SOCS3;SHISA7;SERPINA3
17349,GO:0090280,0.00360075079628195,0.999908563498949,2,14,positive regulation of calcium ion import,BP,CCL2;LGALS3
18271,GO:0099601,0.00362079719410918,0.999748644094855,3,44,regulation of neurotransmitter receptor activity,BP,SHANK2;CACNG2;SHISA7
1348,GO:0002920,0.00369314072557742,0.999740164695324,3,51,regulation of humoral immune response,BP,SERPING1;C1R;CFI
12535,GO:0046579,0.00371907987664111,0.999739079867235,3,45,positive regulation of Ras protein signal transduction,BP,MMD2;GPR17;COL3A1
7425,GO:0030595,0.00372802571240551,0.999417337505705,5,169,leukocyte chemotaxis,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
1196,GO:0002684,0.00373216033167382,0.998690724956145,13,882,positive regulation of immune system process,BP,LTF;SERPINE1;CCL2;IGFBP2;GBP1;LGALS3;ANXA1;SERPING1;MMP14;C1R;CXCL10;HLA-DQB1;CFI
9491,GO:0034703,0.00375567075622814,0.999278903631303,6,204,cation channel complex,CC,KCNIP3;KCNIP2;KCNB1;CACNG2;GRIN1;SHISA7
16392,GO:0071559,0.00376008072905183,0.999277486793194,6,212,response to transforming growth factor beta,BP,FERMT1;COL1A1;GDF15;POSTN;COL4A2;COL3A1
962,GO:0002274,0.00376179466163823,0.998879056831787,10,581,myeloid leukocyte activation,BP,LTF;PLAU;LGALS3;CHI3L1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
10069,GO:0035988,0.00383408116111645,0.999899453154578,2,14,chondrocyte proliferation,BP,LTF;MMP14
9644,GO:0035249,0.00389738715606735,0.999545826233147,4,88,synaptic transmission, glutamatergic,BP,TNR;SHANK2;CACNG2;GRIN1
7721,GO:0031175,0.0039200118400931,0.998560594054534,14,885,neuron projection development,BP,TNFRSF12A;VIM;CRTAC1;CUX2;TNR;SPP1;POSTN;ADM;SHANK2;CSMD3;RIMS2;GRIN1;DSCAML1;SLITRK1
11684,GO:0044548,0.00396815838297843,0.999894085711981,2,14,S100 protein binding,MF,S100A11;ANXA2
13493,GO:0050807,0.00403377845675663,0.999359250415641,5,148,regulation of synapse organization,BP,SRPX2;CUX2;GRIN1;SLITRK1;SHISA7
15864,GO:0070571,0.0040432541482003,0.999891037962048,2,14,negative regulation of neuron projection regeneration,BP,TNR;SPP1
10068,GO:0035987,0.00404538245361802,0.999707556734604,3,45,endodermal cell differentiation,BP,COL4A2;MMP14;COL5A2
13079,GO:0048523,0.00405749663215779,0.997862519164741,40,4114,negative regulation of cellular process,BP,LTF;VIM;IGF2BP2;FERMT1;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SPP1;HOXA7;LGALS3;POSTN;SPOCD1;ANXA1;IGF2BP3;EMP3;ADM;SERPING1;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;PTX3;GABRB3;ELFN2;COL3A1;CXCL10;GRIN1;ANXA2;SOCS3;SERPINA3;COL5A2
13811,GO:0051291,0.00408712906795495,0.999515776703564,4,100,protein heterooligomerization,BP,COL1A1;COL6A2;GRIN1;ANXA2
13075,GO:0048519,0.00408783875517875,0.99782222921602,43,4543,negative regulation of biological process,BP,LTF;VIM;IGF2BP2;FERMT1;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SPP1;HOXA7;PLAU;LGALS3;POSTN;SPOCD1;COL4A2;ANXA1;IGF2BP3;EMP3;GPR17;ADM;SERPING1;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;PTX3;GABRB3;ELFN2;COL3A1;CXCL10;GRIN1;ANXA2;SOCS3;SERPINA3;COL5A2
19522,GO:1903036,0.0041725964875046,0.999693630212528,3,50,positive regulation of response to wounding,BP,SERPINE1;ANXA1;PDPN
14945,GO:0060712,0.0042575555645542,0.999882179440493,2,14,spongiotrophoblast layer development,BP,ADM;SOCS3
19013,GO:1901700,0.00430333544750174,0.998200641602296,18,1404,response to oxygen-containing compound,BP,LTF;TIMP1;SERPINE1;CCL2;COL1A1;IGFBP2;SPP1;POSTN;ANXA1;COL6A2;ADM;KCNB1;COL3A1;CXCL10;GRIN1;SOCS3;COL4A1;COL5A2
13382,GO:0050663,0.00437430337488859,0.999290223782669,5,169,cytokine secretion,BP,FERMT1;GBP1;CHI3L1;POSTN;ANXA1
7686,GO:0031102,0.00439679310808941,0.999671352107453,3,49,neuron projection regeneration,BP,TNR;SPP1;ADM
18972,GO:1901623,0.00451228266560823,0.999868518239311,2,17,regulation of lymphocyte chemotaxis,BP,CCL2;CXCL10
18453,GO:0120039,0.0046543946176479,0.99848022779911,11,611,plasma membrane bounded cell projection morphogenesis,BP,TNFRSF12A;CUX2;TNR;SPP1;POSTN;SHANK2;PDPN;RIMS2;GRIN1;DSCAML1;SLITRK1
13257,GO:0048858,0.00469808331862705,0.998464009489508,11,612,cell projection morphogenesis,BP,TNFRSF12A;CUX2;TNR;SPP1;POSTN;SHANK2;PDPN;RIMS2;GRIN1;DSCAML1;SLITRK1
14034,GO:0051716,0.00470283202066098,0.997427942360683,54,6151,cellular response to stimulus,BP,TNFRSF12A;LTF;TYMP;VIM;CHGB;FERMT1;TIMP1;SERPINE1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SPP1;KCNIP2;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;GNAL;GPR17;INA;ADM;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;GABRB3;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SMOC1;COL5A2;IFI30
1199,GO:0002687,0.00476362202162287,0.999409244169452,4,113,positive regulation of leukocyte migration,BP,SERPINE1;LGALS3;MMP14;CXCL10
3431,GO:0006812,0.00495331682563137,0.998130486227738,14,966,cation transport,BP,CP;CCL2;KCNIP3;STEAP3;SLC8A2;KCNIP2;LGALS3;JPH3;KCNB1;SHANK2;CACNG2;CXCL10;GRIN1;SHISA7
13526,GO:0050860,0.00496552582556595,0.99984717284344,2,18,negative regulation of T cell receptor signaling pathway,BP,GBP1;LGALS3
17177,GO:0090025,0.00501285774306357,0.999844961195755,2,18,regulation of monocyte chemotaxis,BP,SERPINE1;CXCL10
14555,GO:0060142,0.00502223363675332,0.999844521802331,2,18,regulation of syncytium formation by plasma membrane fusion,BP,GDF15;CXCL10
11041,GO:0043086,0.00504311502417968,0.998334149258587,11,684,negative regulation of catalytic activity,BP,LTF;TIMP1;SERPINE1;SPOCD1;ANXA1;SERPING1;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
2487,GO:0005216,0.00506774787520559,0.998660520483951,8,380,ion channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;GRIN1
6008,GO:0016722,0.00510447861368834,0.999842512633781,2,16,oxidoreductase activity, oxidizing metal ions,MF,CP;STEAP3
3790,GO:0007528,0.00512713682388478,0.999596988396239,3,44,neuromuscular junction development,BP,SHANK2;CACNG2;COL4A1
7750,GO:0031253,0.00516665339343251,0.998774630310447,7,296,cell projection membrane,CC,FERMT1;CDHR1;KCNB1;SHANK2;PDPN;GABRG1;SHISA7
14522,GO:0060080,0.00516699540682926,0.999840726447478,2,15,inhibitory postsynaptic potential,BP,GABRB3;RIMS2
9054,GO:0033627,0.00519182502333468,0.999587157955022,3,52,cell adhesion mediated by integrin,BP,FERMT1;SERPINE1;PLAU
13489,GO:0050803,0.00520090869888245,0.999121870641509,5,158,regulation of synapse structure or activity,BP,SRPX2;CUX2;GRIN1;SLITRK1;SHISA7
9820,GO:0035580,0.00521220148654753,0.999583302048116,3,58,specific granule lumen,CC,LTF;CHI3L1;PTX3
4647,GO:0009967,0.0052430209639972,0.997763798652831,18,1422,positive regulation of signal transduction,BP,TNFRSF12A;LTF;FERMT1;CCL2;COL1A1;CUX2;GDF15;CHI3L1;MMD2;GPR17;SHANK2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;PLA2G2A
9893,GO:0035684,0.00534668282418892,1,1,1,helper T cell extravasation,BP,CCL2
7051,GO:0022824,0.00535785927886647,0.999569440804251,3,51,transmitter-gated ion channel activity,MF,GABRG1;GABRB3;GRIN1
7055,GO:0022835,0.00535785927886647,0.999569440804251,3,51,transmitter-gated channel activity,MF,GABRG1;GABRB3;GRIN1
9072,GO:0033676,0.00540849582575357,1,1,1,double-stranded DNA-dependent ATPase activity,MF,ANXA1
8008,GO:0031700,0.00541428282818992,1,1,1,adrenomedullin receptor binding,MF,ADM
2300,GO:0004890,0.00542293712801267,0.999827389961156,2,16,GABA-A receptor activity,MF,GABRG1;GABRB3
19372,GO:1902711,0.00542293712801267,0.999827389961156,2,16,GABA-A receptor complex,CC,GABRG1;GABRB3
601,GO:0001726,0.00542595514835767,0.99907472443713,5,157,ruffle,CC,TNFRSF12A;FERMT1;PDPN;S100A11;ANXA2
3897,GO:0008112,0.00543416387505088,1,1,1,nicotinamide N-methyltransferase activity,MF,NNMT
7489,GO:0030760,0.00543416387505088,1,1,1,pyridine N-methyltransferase activity,MF,NNMT
13156,GO:0048673,0.00543533351410334,1,1,1,collateral sprouting of intact axon in response to injury,BP,SPP1
13165,GO:0048683,0.00543533351410334,1,1,1,regulation of collateral sprouting of intact axon in response to injury,BP,SPP1
13166,GO:0048685,0.00543533351410334,1,1,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,SPP1
12937,GO:0048172,0.00544182346013907,0.999827715797901,2,15,regulation of short-term neuronal synaptic plasticity,BP,SLC8A2;SHISA7
11466,GO:0044035,0.00544474420192882,1,1,1,multi-organism catabolic process,BP,ANXA2
11493,GO:0044115,0.00544474420192882,1,1,1,development of symbiont involved in interaction with host,BP,ANXA2
11503,GO:0044145,0.00544474420192882,1,1,1,modulation of development of symbiont involved in interaction with host,BP,ANXA2
11505,GO:0044147,0.00544474420192882,1,1,1,negative regulation of development of symbiont involved in interaction with host,BP,ANXA2
11724,GO:0044730,0.00544474420192882,1,1,1,bone sialoprotein binding,MF,ANXA2
14222,GO:0052214,0.00544474420192882,1,1,1,metabolism of substance in other organism involved in symbiotic interaction,BP,ANXA2
14223,GO:0052227,0.00544474420192882,1,1,1,catabolism of substance in other organism involved in symbiotic interaction,BP,ANXA2
14224,GO:0052229,0.00544474420192882,1,1,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,ANXA2
14237,GO:0052360,0.00544474420192882,1,1,1,catabolism by host of symbiont macromolecule,BP,ANXA2
14238,GO:0052361,0.00544474420192882,1,1,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,ANXA2
14239,GO:0052362,0.00544474420192882,1,1,1,catabolism by host of symbiont protein,BP,ANXA2
14240,GO:0052363,0.00544474420192882,1,1,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,ANXA2
14241,GO:0052364,0.00544474420192882,1,1,1,catabolism by host of substance in symbiont,BP,ANXA2
14246,GO:0052416,0.00544474420192882,1,1,1,metabolism by host of symbiont macromolecule,BP,ANXA2
14247,GO:0052417,0.00544474420192882,1,1,1,metabolism by host of symbiont protein,BP,ANXA2
14248,GO:0052418,0.00544474420192882,1,1,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,ANXA2
14249,GO:0052419,0.00544474420192882,1,1,1,metabolism by host of substance in symbiont,BP,ANXA2
20729,GO:1905581,0.00544474420192882,1,1,1,positive regulation of low-density lipoprotein particle clearance,BP,ANXA2
20735,GO:1905597,0.00544474420192882,1,1,1,positive regulation of low-density lipoprotein particle receptor binding,BP,ANXA2
20737,GO:1905599,0.00544474420192882,1,1,1,positive regulation of low-density lipoprotein receptor activity,BP,ANXA2
7965,GO:0031639,0.00544650724579341,0.999823337121607,2,19,plasminogen activation,BP,SERPINE1;PLAU
4294,GO:0009032,0.00544897132567975,1,1,1,thymidine phosphorylase activity,MF,TYMP
5727,GO:0016154,0.00544897132567975,1,1,1,pyrimidine-nucleoside phosphorylase activity,MF,TYMP
11863,GO:0045111,0.0054966066041708,0.999291987574033,4,101,intermediate filament cytoskeleton,CC,VIM;INA;MMP14;SHANK2
709,GO:0001872,0.00550640574957505,1,1,1,(1->3)-beta-D-glucan binding,MF,PTX3
11781,GO:0044866,0.00550640574957505,1,1,1,modulation by host of viral exo-alpha-sialidase activity,BP,PTX3
11782,GO:0044867,0.00550640574957505,1,1,1,modulation by host of viral catalytic activity,BP,PTX3
11784,GO:0044869,0.00550640574957505,1,1,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,PTX3
11785,GO:0044870,0.00550640574957505,1,1,1,modulation by host of viral glycoprotein metabolic process,BP,PTX3
11786,GO:0044871,0.00550640574957505,1,1,1,negative regulation by host of viral glycoprotein metabolic process,BP,PTX3
14244,GO:0052403,0.00550640574957505,1,1,1,negative regulation by host of symbiont catalytic activity,BP,PTX3
19509,GO:1903016,0.00550640574957505,1,1,1,negative regulation of exo-alpha-sialidase activity,BP,PTX3
14097,GO:0051851,0.00553851617994539,0.999547729144353,3,57,modification by host of symbiont morphology or physiology,BP,LTF;PTX3;ANXA2
10275,GO:0036458,0.0055768659267004,1,1,1,hepatocyte growth factor binding,MF,SRPX2
7986,GO:0031667,0.00559212025150701,0.998496058447596,8,416,response to nutrient levels,BP,COL1A1;IGFBP2;SPP1;POSTN;ADM;KCNB1;CXCL10;GRIN1
8906,GO:0033212,0.00563626017078528,1,1,1,iron assimilation,BP,LTF
8907,GO:0033214,0.00563626017078528,1,1,1,iron assimilation by chelation and transport,BP,LTF
10862,GO:0042710,0.00563626017078528,1,1,1,biofilm formation,BP,LTF
11458,GO:0044010,0.00563626017078528,1,1,1,single-species biofilm formation,BP,LTF
11625,GO:0044407,0.00563626017078528,1,1,1,single-species biofilm formation in or on host organism,BP,LTF
18636,GO:1900159,0.00563626017078528,1,1,1,positive regulation of bone mineralization involved in bone maturation,BP,LTF
18651,GO:1900190,0.00563626017078528,1,1,1,regulation of single-species biofilm formation,BP,LTF
18652,GO:1900191,0.00563626017078528,1,1,1,negative regulation of single-species biofilm formation,BP,LTF
18675,GO:1900228,0.00563626017078528,1,1,1,regulation of single-species biofilm formation in or on host organism,BP,LTF
18676,GO:1900229,0.00563626017078528,1,1,1,negative regulation of single-species biofilm formation in or on host organism,BP,LTF
21313,GO:2000308,0.00563626017078528,1,1,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
8774,GO:0032990,0.00563914952859278,0.998109695463059,11,630,cell part morphogenesis,BP,TNFRSF12A;CUX2;TNR;SPP1;POSTN;SHANK2;PDPN;RIMS2;GRIN1;DSCAML1;SLITRK1
11352,GO:0043588,0.00568205281540298,0.998810005614947,6,234,skin development,BP,FERMT1;COL1A1;HOXA7;ANXA1;COL3A1;COL5A2
7057,GO:0022838,0.00569868420515201,0.998463380016078,8,389,substrate-specific channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;GRIN1
13470,GO:0050776,0.00570537819853755,0.997982665836081,12,828,regulation of immune response,BP,LTF;COL1A1;GBP1;LGALS3;ANXA1;GPR17;SERPING1;C1R;COL3A1;HLA-DQB1;SOCS3;CFI
13074,GO:0048518,0.00571034499289652,0.996865003614761,46,5037,positive regulation of biological process,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SLC8A2;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;ANXA1;MMD2;GPR17;ADAM12;ADM;SERPING1;MMP14;KCNB1;C1R;SHANK2;PDPN;PTX3;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;SHISA7;PLA2G2A;CFI
7021,GO:0022407,0.00571717800994537,0.998616660069668,7,336,regulation of cell-cell adhesion,BP,CCL2;IGFBP2;TNR;LGALS3;ANXA1;PDPN;HLA-DQB1
5012,GO:0010876,0.00573742612076331,0.998611676004758,7,316,lipid localization,BP,SLCO1A2;APOL4;ABCC3;SPP1;ANXA1;ANXA2;PLA2G2A
7752,GO:0031256,0.00578011852227504,0.998999301276967,5,158,leading edge membrane,CC,FERMT1;KCNB1;PDPN;GABRG1;SHISA7
15476,GO:0061851,0.00578304030397728,1,1,1,leading edge of lamellipodium,CC,PDPN
20142,GO:1904328,0.00578304030397728,1,1,1,regulation of myofibroblast contraction,BP,PDPN
21065,GO:1990764,0.00578304030397728,1,1,1,myofibroblast contraction,BP,PDPN
8332,GO:0032355,0.00584081693577521,0.999232589031486,4,114,response to estradiol,BP,COL1A1;IGFBP2;POSTN;ANXA1
3921,GO:0008150,0.00590639308792915,0.999311420092133,99,14255,biological_process,BP,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;SLCO1A2;CHGB;CRTAC1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;ABCC3;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;CA10;MMP14;KCNB1;C1R;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;CSMD3;SVOP;GABRB3;NNMT;CACNG2;ELFN2;TUBA1C;COL3A1;CXCL10;PCDH7;KSR2;FUT9;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;CFI;IFI30
15579,GO:0070098,0.00590724926984194,0.999504673124607,3,63,chemokine-mediated signaling pathway,BP,CCL2;GPR17;CXCL10
13346,GO:0050482,0.00592098681273291,0.999799497667588,2,19,arachidonic acid secretion,BP,ANXA1;PLA2G2A
19979,GO:1903963,0.00592098681273291,0.999799497667588,2,19,arachidonate transport,BP,ANXA1;PLA2G2A
10103,GO:0036035,0.00594522188292291,0.999801577009137,2,16,osteoclast development,BP,LTF;ANXA2
5080,GO:0010959,0.00597990324573629,0.998541562516405,7,322,regulation of metal ion transport,BP,CCL2;KCNIP3;KCNIP2;LGALS3;JPH3;CXCL10;GRIN1
9761,GO:0035490,0.00603673068494196,1,1,1,regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
9762,GO:0035491,0.00603673068494196,1,1,1,positive regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
15133,GO:0061044,0.00603673068494196,1,1,1,negative regulation of vascular wound healing,BP,SERPINE1
18877,GO:1901331,0.00603673068494196,1,1,1,positive regulation of odontoblast differentiation,BP,SERPINE1
19451,GO:1902913,0.00603673068494196,1,1,1,positive regulation of neuroepithelial cell differentiation,BP,SERPINE1
7096,GO:0030001,0.00608868328727953,0.997829720750765,12,772,metal ion transport,BP,CP;CCL2;KCNIP3;STEAP3;SLC8A2;KCNIP2;LGALS3;JPH3;KCNB1;CACNG2;CXCL10;GRIN1
13658,GO:0051057,0.00612668052421854,0.999482939396762,3,52,positive regulation of small GTPase mediated signal transduction,BP,MMD2;GPR17;COL3A1
14946,GO:0060713,0.00613517444743696,0.999788400542744,2,19,labyrinthine layer morphogenesis,BP,ADM;SOCS3
590,GO:0001706,0.00617492183424008,0.999477014403677,3,53,endoderm formation,BP,COL4A2;MMP14;COL5A2
14521,GO:0060079,0.00619804092156532,0.999173255967649,4,105,excitatory postsynaptic potential,BP,CUX2;SHANK2;RIMS2;GRIN1
19371,GO:1902710,0.0062552735431093,0.999784336177704,2,17,GABA receptor complex,CC,GABRG1;GABRB3
8773,GO:0032989,0.00628757212608036,0.997477501139832,15,1030,cellular component morphogenesis,BP,TNFRSF12A;CCL2;CUX2;TNR;GBP1;SPP1;POSTN;ANXA1;CDHR1;SHANK2;PDPN;RIMS2;GRIN1;DSCAML1;SLITRK1
2285,GO:0004867,0.00640143713759765,0.999448337086116,3,60,serine-type endopeptidase inhibitor activity,MF,SERPINE1;SERPING1;SERPINA3
17193,GO:0090050,0.00640966203554807,0.99977498059263,2,18,positive regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
8539,GO:0032637,0.0064578169970395,0.999441414191299,3,61,interleukin-8 production,BP,SERPINE1;CHI3L1;ANXA1
18186,GO:0099095,0.00655530034971572,0.999767180984803,2,18,ligand-gated anion channel activity,MF,GABRG1;GABRB3
13464,GO:0050770,0.00670300490239721,0.998797257438659,5,162,regulation of axonogenesis,BP,TNFRSF12A;TNR;SPP1;GRIN1;SLITRK1
9527,GO:0034765,0.0067385766909061,0.998130056785225,8,401,regulation of ion transmembrane transport,BP,KCNIP3;KCNIP2;JPH3;KCNB1;SHANK2;CACNG2;CXCL10;SHISA7
18608,GO:1900120,0.0068063286268079,0.999751241512088,2,20,regulation of receptor binding,BP,CRTAC1;ANXA2
3623,GO:0007156,0.00682022534374063,0.99906780163693,4,93,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDHR1;PCDH7;DSCAML1;PTPRT
14023,GO:0051702,0.00685958389703902,0.999393589343025,3,61,interaction with symbiont,BP,LTF;PTX3;ANXA2
6384,GO:0018964,0.00692350069194499,1,1,1,propylene metabolic process,BP,GRIN1
5073,GO:0010951,0.00702163733866508,0.998723243777769,5,187,negative regulation of endopeptidase activity,BP,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
13541,GO:0050878,0.00706479241693508,0.998022742615774,8,424,regulation of body fluid levels,BP,SERPINE1;COL1A1;PLAU;ADM;SERPING1;PDPN;COL3A1;ANXA2
8507,GO:0032589,0.00707798818721678,0.999370237006553,3,53,neuron projection membrane,CC,KCNB1;GABRG1;SHISA7
5390,GO:0015267,0.00711741904909146,0.998006141973267,8,407,channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;GRIN1
7048,GO:0022803,0.00711741904909146,0.998006141973267,8,407,passive transmembrane transporter activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;GRIN1
4572,GO:0009719,0.00726150652359158,0.996798012179876,18,1435,response to endogenous stimulus,BP,FERMT1;TIMP1;CCL2;COL1A1;IGFBP2;SPP1;GDF15;POSTN;COL4A2;ANXA1;ADM;MMP14;GABRB3;COL3A1;ANXA2;SOCS3;COL4A1;COL5A2
10493,GO:0040011,0.00726458372105382,0.996729048261113,19,1518,locomotion,BP,TNFRSF12A;TYMP;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;HOXA7;PLAU;LGALS3;POSTN;ANXA1;JPH3;MMP14;PDPN;COL3A1;CXCL10
13524,GO:0050858,0.00738839700574847,0.999716156852544,2,22,negative regulation of antigen receptor-mediated signaling pathway,BP,GBP1;LGALS3
11746,GO:0044788,0.00746751150675234,0.999713667300996,2,20,modulation by host of viral process,BP,LTF;PTX3
7450,GO:0030659,0.00763561552370783,0.997329381586269,11,706,cytoplasmic vesicle membrane,CC,MOXD1;PLAU;LGALS3;ANXA1;FABP5;SVOP;GABRB3;CACNG2;PCDH7;CD163;HLA-DQB1
13184,GO:0048706,0.00768772170772781,0.998907472065106,4,115,embryonic skeletal system development,BP,COL1A1;HOXA7;MMP14;DSCAML1
16871,GO:0072376,0.00772215765448465,0.99928568775122,3,66,protein activation cascade,BP,SERPING1;C1R;CFI
14115,GO:0051886,0.00773518814637113,1,1,1,negative regulation of timing of anagen,BP,FERMT1
21795,GO:2001203,0.00773518814637113,1,1,1,positive regulation of transforming growth factor-beta secretion,BP,FERMT1
6128,GO:0016917,0.00776419041444221,0.999697538302608,2,19,GABA receptor activity,MF,GABRG1;GABRB3
13173,GO:0048692,0.00778053601372138,1,1,1,negative regulation of axon extension involved in regeneration,BP,TNR
13266,GO:0048870,0.00786575784972994,0.99658192562136,17,1309,cell motility,BP,TNFRSF12A;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;COL3A1;CXCL10
14011,GO:0051674,0.00786575784972994,0.99658192562136,17,1309,localization of cell,BP,TNFRSF12A;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;HOXA7;PLAU;LGALS3;POSTN;ANXA1;MMP14;PDPN;COL3A1;CXCL10
3439,GO:0006825,0.00792432197621344,0.99968665980765,2,20,copper ion transport,BP,CP;STEAP3
3959,GO:0008209,0.00792494434157877,0.999685397925608,2,21,androgen metabolic process,BP,SPP1;ADM
5269,GO:0014910,0.00793282205850044,0.999263392253706,3,55,regulation of smooth muscle cell migration,BP,SERPINE1;PLAU;POSTN
2642,GO:0005586,0.00809156030112577,1,1,1,collagen type III trimer,CC,COL3A1
18780,GO:1901071,0.0081189541435581,0.999672477835207,2,22,glucosamine-containing compound metabolic process,BP,CHI3L2;CHI3L1
14260,GO:0052547,0.00813002409353498,0.997897572715009,7,358,regulation of peptidase activity,BP,LTF;TIMP1;SERPINE1;SERPING1;MMP14;GRIN1;SERPINA3
11643,GO:0044432,0.00814153469073131,0.996633626875675,15,1172,endoplasmic reticulum part,CC,LTF;CP;MOXD1;CHGB;TIMP1;COL1A1;SPP1;COL4A2;COL6A2;JPH3;COL3A1;HLA-DQB1;COL4A1;PLA2G2A;COL5A2
4655,GO:0009991,0.00815510858237748,0.997659806981225,8,444,response to extracellular stimulus,BP,COL1A1;IGFBP2;SPP1;POSTN;ADM;KCNB1;CXCL10;GRIN1
10830,GO:0042629,0.00823888739133787,0.999666280264393,2,21,mast cell granule,CC,ANXA1;CPLX2
14169,GO:0051965,0.00825084845552897,0.999220953911244,3,59,positive regulation of synapse assembly,BP,SRPX2;CUX2;SLITRK1
5576,GO:0015850,0.00838776975287309,0.998407852494246,5,189,organic hydroxy compound transport,BP,SLCO1A2;ABCC3;SPP1;KCNB1;ANXA2
12897,GO:0048027,0.00840917123655903,0.999654534501512,2,22,mRNA 5'-UTR binding,MF,IGF2BP2;IGF2BP3
4758,GO:0010466,0.00845465631936177,0.99839150614556,5,194,negative regulation of peptidase activity,BP,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
19347,GO:1902618,0.00850352711818748,1,1,1,cellular response to fluoride,BP,COL1A1
16437,GO:0071625,0.00850942064742802,0.999655936131113,2,17,vocalization behavior,BP,SRPX2;SHANK2
1078,GO:0002460,0.00856037329150722,0.998365839406824,5,200,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1;SERPING1;C1R;HLA-DQB1;CFI
7212,GO:0030194,0.00865361999775142,0.999638010930345,2,23,positive regulation of blood coagulation,BP,SERPINE1;PDPN
18571,GO:1900048,0.00865361999775142,0.999638010930345,2,23,positive regulation of hemostasis,BP,SERPINE1;PDPN
16497,GO:0071711,0.00869724563232928,0.999640644120168,2,19,basement membrane organization,BP,FERMT1;COL4A1
2504,GO:0005244,0.00883550009921118,0.998302883589983,5,179,voltage-gated ion channel activity,MF,KCNIP3;KCNIP2;KCNB1;CACNG2;GRIN1
7053,GO:0022832,0.00883550009921118,0.998302883589983,5,179,voltage-gated channel activity,MF,KCNIP3;KCNIP2;KCNB1;CACNG2;GRIN1
11585,GO:0044325,0.00901036830465761,0.99865971333366,4,115,ion channel binding,MF,KCNIP3;KCNIP2;KCNB1;RIMS2
17976,GO:0098660,0.00904010660037758,0.996762354214716,11,710,inorganic ion transmembrane transport,BP,KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;CXCL10;GRIN1
13533,GO:0050867,0.00905357158409683,0.997904686611967,6,285,positive regulation of cell activation,BP,CCL2;IGFBP2;ANXA1;MMP14;PDPN;HLA-DQB1
13161,GO:0048679,0.00906225907118913,0.999612962370107,2,22,regulation of axon regeneration,BP,TNR;SPP1
9567,GO:0035025,0.00910898219979955,0.999609925948503,2,22,positive regulation of Rho protein signal transduction,BP,GPR17;COL3A1
5114,GO:0012506,0.00930245450183591,0.996654542823416,11,725,vesicle membrane,CC,MOXD1;PLAU;LGALS3;ANXA1;FABP5;SVOP;GABRB3;CACNG2;PCDH7;CD163;HLA-DQB1
14409,GO:0055065,0.00939820522091055,0.997003249958299,9,536,metal ion homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
17972,GO:0098655,0.0094175249365162,0.996607423058076,11,719,cation transmembrane transport,BP,KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;SHANK2;CACNG2;CXCL10;GRIN1;SHISA7
3517,GO:0006950,0.00942563422352381,0.994936546511133,32,3316,response to stress,BP,TNFRSF12A;LTF;VIM;TIMP1;SERPINE1;CCL2;COL1A1;TNR;GBP1;SPP1;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;GPR17;ADM;SERPING1;MMP14;C1R;PDPN;PTX3;COL3A1;CXCL10;CD163;HLA-DQB1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI;IFI30
12184,GO:0045807,0.00956175883885522,0.998551233748455,4,123,positive regulation of endocytosis,BP,SERPINE1;CCL2;PTX3;ANXA2
14910,GO:0060669,0.00958161238977043,0.9995774064839,2,23,embryonic placenta morphogenesis,BP,ADM;SOCS3
14676,GO:0060322,0.00958503298209021,0.996539299119793,11,688,head development,BP,CRTAC1;COL1A1;TNR;INA;CA10;MMP14;SHANK2;COL3A1;GRIN1;DSCAML1;COL4A1
13503,GO:0050820,0.00970935743420768,0.999567555750521,2,24,positive regulation of coagulation,BP,SERPINE1;PDPN
2820,GO:0005882,0.0100106064853361,0.99898175289338,3,67,intermediate filament,CC,VIM;INA;SHANK2
1186,GO:0002673,0.0100549680468222,0.998973534390081,3,72,regulation of acute inflammatory response,BP,SERPING1;C1R;CFI
565,GO:0001664,0.0102102726815129,0.997964140859604,5,211,G-protein coupled receptor binding,MF,CCL2;GNAL;ADM;CXCL10;RTP5
6708,GO:0019933,0.0102782166702029,0.998409281286981,4,125,cAMP-mediated signaling,BP,GNAL;ADM;CXCL10;RIMS2
3821,GO:0007610,0.0104391817869564,0.996614932566867,9,523,behavior,BP,SRPX2;CUX2;TNR;SLC8A2;JPH3;SHANK2;GRIN1;SLITRK1;SHISA7
2498,GO:0005230,0.0104610487067479,0.998918652077009,3,67,extracellular ligand-gated ion channel activity,MF,GABRG1;GABRB3;GRIN1
13183,GO:0048705,0.0105272600640187,0.997887688863124,5,192,skeletal system morphogenesis,BP,LTF;COL1A1;HOXA7;MMP14;DSCAML1
3672,GO:0007214,0.010605762381728,0.999508405330235,2,22,gamma-aminobutyric acid signaling pathway,BP,GABRG1;GABRB3
14139,GO:0051924,0.0106416887587965,0.997858075708314,5,199,regulation of calcium ion transport,BP,CCL2;LGALS3;JPH3;CXCL10;GRIN1
5813,GO:0016323,0.0107127227661696,0.99784141036232,5,191,basolateral plasma membrane,CC,ABCC3;SLC8A2;ANXA1;PDPN;ANXA2
4977,GO:0010831,0.0107415956798239,0.999494392405236,2,25,positive regulation of myotube differentiation,BP,GDF15;MMP14
18033,GO:0098797,0.0107447328043697,0.996499118639256,9,532,plasma membrane protein complex,CC,KCNIP3;KCNIP2;GNAL;KCNB1;SHANK2;CACNG2;GRIN1;HLA-DQB1;SHISA7
21446,GO:2000502,0.0107524128528678,0.999971230882266,1,2,negative regulation of natural killer cell chemotaxis,BP,CCL2
7509,GO:0030816,0.0107788873238804,0.999490475800711,2,26,positive regulation of cAMP metabolic process,BP,ADM;CXCL10
19026,GO:1901740,0.0108633722804545,0.999970632394218,1,2,negative regulation of myoblast fusion,BP,CXCL10
5227,GO:0014839,0.0108657870081296,0.999970619300887,1,2,myoblast migration involved in skeletal muscle regeneration,BP,ANXA1
5508,GO:0015718,0.0109070021095637,0.998280749327193,4,133,monocarboxylic acid transport,BP,SLCO1A2;ABCC3;ANXA1;PLA2G2A
19508,GO:1903015,0.0109299792442756,0.999970270156723,1,2,regulation of exo-alpha-sialidase activity,BP,PTX3
13491,GO:0050805,0.0109305595015627,0.998852284651537,3,66,negative regulation of synaptic transmission,BP,TNR;KCNB1;SHANK2
14250,GO:0052422,0.0109418519550162,0.999970205353321,1,2,modulation by host of symbiont catalytic activity,BP,PTX3
5268,GO:0014909,0.0109810981539379,0.998846633077432,3,63,smooth muscle cell migration,BP,SERPINE1;PLAU;POSTN
21459,GO:2000521,0.0109968635503888,0.999969904164168,1,2,negative regulation of immunological synapse formation,BP,LGALS3
16975,GO:0072606,0.0110743236378952,0.999469077168318,2,26,interleukin-8 secretion,BP,CHI3L1;ANXA1
14170,GO:0051966,0.011110337052351,0.998828035126786,3,63,regulation of synaptic transmission, glutamatergic,BP,TNR;SHANK2;CACNG2
5414,GO:0015318,0.0111564363784166,0.995882327193735,11,740,inorganic molecular entity transmembrane transporter activity,MF,SLCO1A2;ABCC3;KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;GRIN1
13232,GO:0048812,0.0112475267234043,0.99606355502756,10,597,neuron projection morphogenesis,BP,TNFRSF12A;CUX2;TNR;SPP1;POSTN;SHANK2;RIMS2;GRIN1;DSCAML1;SLITRK1
14215,GO:0052199,0.0112780781238317,0.999968340712884,1,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,PTX3
20740,GO:1905602,0.0113110426174192,0.999968154835003,1,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
17790,GO:0097493,0.0113620186090499,0.99946593251913,2,17,structural molecule activity conferring elasticity,MF,EMILIN2;COL4A1
21195,GO:2000098,0.0113806453205491,0.999967760566628,1,2,negative regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
9869,GO:0035640,0.0113854801592205,0.999450621915798,2,23,exploration behavior,BP,TNR;JPH3
5509,GO:0015721,0.0114019857744281,0.999446341951456,2,25,bile acid and bile salt transport,BP,SLCO1A2;ABCC3
19024,GO:1901731,0.0115649766286339,0.999966704624163,1,2,positive regulation of platelet aggregation,BP,PDPN
13651,GO:0051050,0.0115842460407891,0.995500214816016,12,856,positive regulation of transport,BP,FERMT1;SERPINE1;CCL2;SPP1;LGALS3;POSTN;ANXA1;KCNB1;PTX3;CXCL10;GRIN1;ANXA2
16928,GO:0072535,0.0116314987710663,0.999966319348853,1,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
21312,GO:2000307,0.0116314987710663,0.999966319348853,1,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
20083,GO:1904207,0.011645128156566,0.99996624013656,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
20084,GO:1904209,0.011645128156566,0.99996624013656,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
1122,GO:0002538,0.0117123254877022,0.999965848225757,1,2,arachidonic acid metabolite production involved in inflammatory response,BP,SERPINE1
1123,GO:0002540,0.0117123254877022,0.999965848225757,1,2,leukotriene production involved in inflammatory response,BP,SERPINE1
16222,GO:0071307,0.0117339254720423,0.999965721766299,1,2,cellular response to vitamin K,BP,POSTN
2016,GO:0004500,0.0117348916352691,0.999965716104298,1,2,dopamine beta-monooxygenase activity,MF,MOXD1
3278,GO:0006589,0.0117348916352691,0.999965716104298,1,2,octopamine biosynthetic process,BP,MOXD1
12420,GO:0046333,0.0117348916352691,0.999965716104298,1,2,octopamine metabolic process,BP,MOXD1
20733,GO:1905595,0.0117972343497696,0.99996534976321,1,2,regulation of low-density lipoprotein particle receptor binding,BP,ANXA2
21030,GO:1990667,0.0117972343497696,0.99996534976321,1,2,PCSK9-AnxA2 complex,CC,ANXA2
10205,GO:0036292,0.0118135821263558,0.999965253375528,1,2,DNA rewinding,BP,ANXA1
18030,GO:0098794,0.0118379833273051,0.996375484101058,8,430,postsynapse,CC,SLC8A2;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;SHISA7
13078,GO:0048522,0.011995516597982,0.993150351978577,41,4509,positive regulation of cellular process,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;SLC8A2;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;ANXA1;MMD2;GPR17;ADM;MMP14;KCNB1;SHANK2;PDPN;PTX3;CACNG2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;SHISA7;PLA2G2A
462,GO:0001300,0.0120208587429056,0.999964019576558,1,2,chronological cell aging,BP,SERPINE1
772,GO:0001958,0.0121079860946531,0.999393317183928,2,25,endochondral ossification,BP,COL1A1;MMP14
10124,GO:0036075,0.0121079860946531,0.999393317183928,2,25,replacement ossification,BP,COL1A1;MMP14
8655,GO:0032804,0.0122546503148817,0.999962601956961,1,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,ANXA2
11415,GO:0043901,0.0122579831899616,0.997998532736166,4,143,negative regulation of multi-organism process,BP,LTF;TIMP1;PTX3;ANXA2
18634,GO:1900157,0.0123927498613214,0.999961751626642,1,2,regulation of bone mineralization involved in bone maturation,BP,LTF
20663,GO:1905429,0.0124283650241895,0.999961530770553,1,2,response to glycine,BP,GRIN1
13110,GO:0048588,0.0124368511793208,0.997400458564678,5,190,developmental cell growth,BP,TNFRSF12A;TNR;SPP1;POSTN;RIMS2
21685,GO:2000866,0.0124871441219651,0.999961164871276,1,2,positive regulation of estradiol secretion,BP,SPP1
8310,GO:0032309,0.0125136325465223,0.999357764781619,2,28,icosanoid secretion,BP,ANXA1;PLA2G2A
12977,GO:0048259,0.0125253974474214,0.998613903415787,3,72,regulation of receptor-mediated endocytosis,BP,SNAP91;SERPINE1;ANXA2
20361,GO:1904768,0.0126121611369767,0.999960380845563,1,2,all-trans-retinol binding,MF,RBP1
11262,GO:0043449,0.0126156614025333,0.999960358780682,1,2,cellular alkene metabolic process,BP,GRIN1
15863,GO:0070570,0.0127037766416135,0.999345679051298,2,26,regulation of neuron projection regeneration,BP,TNR;SPP1
706,GO:0001868,0.0127474493038894,0.999959523521142,1,2,regulation of complement activation, lectin pathway,BP,SERPING1
707,GO:0001869,0.0127474493038894,0.999959523521142,1,2,negative regulation of complement activation, lectin pathway,BP,SERPING1
3845,GO:0008015,0.0128151861607372,0.996018915311881,8,458,blood circulation,BP,KCNIP3;SLC8A2;KCNIP2;POSTN;ADM;SERPING1;CACNG2;CXCL10
15521,GO:0065007,0.0128153360116686,0.993099966838446,78,10209,biological regulation,BP,TNFRSF12A;LTF;TYMP;VIM;CP;SNAP91;IGF2BP2;MOXD1;CHGB;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;GNAL;EMP3;GPR17;CPLX2;CDHR1;ADAM12;ADM;SERPING1;SPHKAP;JPH3;MMP14;KCNB1;C1R;SHANK2;PDPN;S100A11;GABRG1;PTX3;CSMD3;GABRB3;CACNG2;ELFN2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;CFI;IFI30
15851,GO:0070554,0.0128257788652086,0.999959022922601,1,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,CPLX2
7734,GO:0031224,0.0128514364496069,0.992701250057464,38,4199,intrinsic component of membrane,CC,TNFRSF12A;MOXD1;SLCO1A2;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;MMD2;MDGA2;EMP3;GPR17;GALNT13;CDHR1;ADAM12;JPH3;MMP14;KCNB1;SHANK2;PDPN;GABRG1;CSMD3;SVOP;GABRB3;CACNG2;ELFN2;PCDH7;FUT9;GRIN1;DSCAML1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;SHISA7;RTP5;PTPRT
7254,GO:0030246,0.0129025103054538,0.997273336070537,5,222,carbohydrate binding,MF,CHI3L2;LGALS3;CHI3L1;GALNT13;PTX3
6710,GO:0019935,0.0129035517434298,0.997863453204078,4,134,cyclic-nucleotide-mediated signaling,BP,GNAL;ADM;CXCL10;RIMS2
4477,GO:0009306,0.0129398748737602,0.9959723034233,8,474,protein secretion,BP,FERMT1;STEAP3;GBP1;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2
8291,GO:0032281,0.0129876066213528,0.999321757564224,2,27,AMPA glutamate receptor complex,CC,CACNG2;SHISA7
17348,GO:0090279,0.0129891520316238,0.999321634607746,2,27,regulation of calcium ion import,BP,CCL2;LGALS3
18619,GO:1900138,0.0129907571038795,0.999957958427888,1,2,negative regulation of phospholipase A2 activity,BP,ANXA1
9818,GO:0035578,0.0129995599590967,0.998537284709082,3,81,azurophil granule lumen,CC,FABP5;ANXA2;SERPINA3
3467,GO:0006875,0.013149500485736,0.995895453067062,8,472,cellular metal ion homeostasis,BP,LTF;CP;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
12968,GO:0048246,0.013205226410783,0.999301575583563,2,29,macrophage chemotaxis,BP,CCL2;LGALS3
6295,GO:0018149,0.0133555760886537,0.99929226229254,2,27,peptide cross-linking,BP,ANXA1;COL3A1
17078,GO:0080134,0.0133895228584144,0.994127544279993,15,1232,regulation of response to stress,BP,TNFRSF12A;LTF;SERPINE1;TNR;SPP1;PLAU;ANXA1;GPR17;SERPING1;C1R;PDPN;ANXA2;SOCS3;PLA2G2A;CFI
4193,GO:0008594,0.0133928028064374,0.999955306740145,1,2,photoreceptor cell morphogenesis,BP,CDHR1
13169,GO:0048688,0.0133996617471135,0.999955260793794,1,2,negative regulation of sprouting of injured axon,BP,TNR
13421,GO:0050707,0.0134859177715924,0.997734844032307,4,146,regulation of cytokine secretion,BP,FERMT1;GBP1;POSTN;ANXA1
7023,GO:0022409,0.0134994698533981,0.99711474209894,5,224,positive regulation of cell-cell adhesion,BP,CCL2;IGFBP2;ANXA1;PDPN;HLA-DQB1
3843,GO:0008009,0.0135015425541051,0.999273913504498,2,32,chemokine activity,MF,CCL2;CXCL10
14680,GO:0060326,0.0135578140411575,0.997099026664648,5,225,cell chemotaxis,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
14413,GO:0055072,0.0135702144578743,0.998450527739811,3,77,iron ion homeostasis,BP,LTF;CP;STEAP3
5395,GO:0015276,0.0135902098728375,0.997716112601416,4,131,ligand-gated ion channel activity,MF,JPH3;GABRG1;GABRB3;GRIN1
7054,GO:0022834,0.0135902098728375,0.997716112601416,4,131,ligand-gated channel activity,MF,JPH3;GABRG1;GABRB3;GRIN1
13171,GO:0048690,0.0135980849417728,0.99995392131594,1,2,regulation of axon extension involved in regeneration,BP,TNR
5448,GO:0015432,0.0136569564027684,0.999953520070581,1,2,bile acid-exporting ATPase activity,MF,ABCC3
8939,GO:0033283,0.0136569564027684,0.999953520070581,1,2,organic acid-transporting ATPase activity,MF,ABCC3
8940,GO:0033284,0.0136569564027684,0.999953520070581,1,2,carboxylic acid-transporting ATPase activity,MF,ABCC3
8941,GO:0033285,0.0136569564027684,0.999953520070581,1,2,monocarboxylic acid-transporting ATPase activity,MF,ABCC3
1375,GO:0003013,0.0136781486153463,0.995700960573613,8,462,circulatory system process,BP,KCNIP3;SLC8A2;KCNIP2;POSTN;ADM;SERPING1;CACNG2;CXCL10
13810,GO:0051290,0.0137468285353814,0.999258886471897,2,28,protein heterotetramerization,BP,GRIN1;ANXA2
16433,GO:0071621,0.0138190827033432,0.99840864191994,3,83,granulocyte chemotaxis,BP,CCL2;LGALS3;ANXA1
19146,GO:1902106,0.0138324994734163,0.998409868593484,3,76,negative regulation of leukocyte differentiation,BP,LTF;HOXA7;ANXA1
4051,GO:0008355,0.0139165382686225,0.999951729968879,1,2,olfactory learning,BP,GRIN1
16221,GO:0071306,0.0139458656236886,0.999951525582936,1,2,cellular response to vitamin E,BP,COL1A1
7062,GO:0022843,0.013950348930527,0.997637182991156,4,132,voltage-gated cation channel activity,MF,KCNIP2;KCNB1;CACNG2;GRIN1
16216,GO:0071295,0.0139958345271712,0.999239905246408,2,27,cellular response to vitamin,BP,COL1A1;POSTN
3434,GO:0006816,0.014029486983339,0.995969631036596,7,368,calcium ion transport,BP,CCL2;SLC8A2;LGALS3;JPH3;CACNG2;CXCL10;GRIN1
10489,GO:0040007,0.0140539930470323,0.994394372412213,12,854,growth,BP,TNFRSF12A;IGFBP2;TNR;SPP1;POSTN;ANXA1;ADM;MMP14;SHANK2;RIMS2;SLITRK1;SOCS3
6471,GO:0019226,0.014133307567886,0.998367790921726,3,67,transmission of nerve impulse,BP,TYMP;TNR;CACNG2
8114,GO:0031960,0.0142014698790022,0.997578108601065,4,146,response to corticosteroid,BP,COL1A1;IGFBP2;ANXA1;ADM
11492,GO:0044111,0.0143012990295423,0.999949013945125,1,2,development involved in symbiotic interaction,BP,ANXA2
11783,GO:0044868,0.0144142600584241,0.999948202334611,1,2,modulation by host of viral molecular function,BP,PTX3
10699,GO:0042383,0.0144508734915048,0.9975295258701,4,124,sarcolemma,CC,ANXA1;COL6A2;KCNB1;ANXA2
5658,GO:0016021,0.0144787968557352,0.991734508870722,37,4090,integral component of membrane,CC,TNFRSF12A;MOXD1;SLCO1A2;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;MMD2;EMP3;GPR17;GALNT13;CDHR1;ADAM12;JPH3;MMP14;KCNB1;SHANK2;PDPN;GABRG1;CSMD3;SVOP;GABRB3;CACNG2;ELFN2;PCDH7;FUT9;GRIN1;DSCAML1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;SHISA7;RTP5;PTPRT
13235,GO:0048817,0.0146135823219112,0.999946754481764,1,2,negative regulation of hair follicle maturation,BP,FERMT1
13467,GO:0050773,0.0150341420720545,0.997398520796481,4,127,regulation of dendrite development,BP,CUX2;SHANK2;CSMD3;GRIN1
420,GO:0001101,0.0152782696929355,0.996038958801891,6,307,response to acid chemical,BP,COL1A1;IGFBP2;COL3A1;GRIN1;COL4A1;COL5A2
16173,GO:0071222,0.0153590244958959,0.997318098139778,4,151,cellular response to lipopolysaccharide,BP,LTF;SERPINE1;CCL2;CXCL10
4548,GO:0009620,0.0154473232672475,0.999107167494775,2,33,response to fungus,BP,LTF;PTX3
9247,GO:0034220,0.0155444894544536,0.993472030960911,13,980,ion transmembrane transport,BP,KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;CXCL10;GRIN1;SHISA7
13111,GO:0048589,0.0155766201280985,0.994604302325827,9,542,developmental growth,BP,TNFRSF12A;TNR;SPP1;POSTN;ANXA1;ADM;SHANK2;RIMS2;SLITRK1
16501,GO:0071715,0.0156634799240139,0.999090784691601,2,31,icosanoid transport,BP,ANXA1;PLA2G2A
18949,GO:1901571,0.0156634799240139,0.999090784691601,2,31,fatty acid derivative transport,BP,ANXA1;PLA2G2A
2516,GO:0005261,0.0157843123163624,0.995881212051241,6,285,cation channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;CACNG2;GRIN1
10799,GO:0042581,0.0159891333377081,0.997174647709798,4,151,specific granule,CC,LTF;PLAU;CHI3L1;PTX3
20624,GO:1905333,0.0160590517449977,0.99991428150829,1,3,regulation of gastric motility,BP,TYMP
16485,GO:0071695,0.0160594964959899,0.997162717730054,4,137,anatomical structure maturation,BP,LTF;FERMT1;KCNIP2;GRIN1
5297,GO:0015075,0.0161219292442299,0.99372110145371,11,783,ion transmembrane transporter activity,MF,SLCO1A2;ABCC3;KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GABRG1;GABRB3;CACNG2;GRIN1
13150,GO:0048667,0.0162543351801958,0.994329642763157,9,537,cell morphogenesis involved in neuron differentiation,BP,TNFRSF12A;CUX2;TNR;SPP1;CDHR1;SHANK2;GRIN1;DSCAML1;SLITRK1
17530,GO:0097013,0.0162628996705399,0.999912083396187,1,3,phagocytic vesicle lumen,CC,LTF
15970,GO:0070820,0.0162646236085087,0.997111101385434,4,152,tertiary granule,CC,LTF;PLAU;LGALS3;PTX3
8024,GO:0031727,0.0162937291570645,0.999911748518323,1,3,CCR2 chemokine receptor binding,MF,CCL2
2640,GO:0005584,0.0164535196910156,0.999932439070306,1,2,collagen type I trimer,CC,COL1A1
21458,GO:2000520,0.0165055068558184,0.999909430799555,1,3,regulation of immunological synapse formation,BP,LGALS3
19383,GO:1902732,0.0165534712369918,0.999908901668156,1,3,positive regulation of chondrocyte proliferation,BP,LTF
14651,GO:0060292,0.0165796742324135,0.999013683277435,2,28,long term synaptic depression,BP,KCNB1;SHANK2
14700,GO:0060349,0.0166290527489002,0.997951105813637,3,79,bone morphogenesis,BP,LTF;COL1A1;MMP14
8352,GO:0032379,0.0166608937518128,0.999907710975688,1,3,positive regulation of intracellular lipid transport,BP,ANXA2
8355,GO:0032382,0.0166608937518128,0.999907710975688,1,3,positive regulation of intracellular sterol transport,BP,ANXA2
8358,GO:0032385,0.0166608937518128,0.999907710975688,1,3,positive regulation of intracellular cholesterol transport,BP,ANXA2
14217,GO:0052203,0.0166822930210942,0.999907472851513,1,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,PTX3
9524,GO:0034762,0.0166843481397748,0.994564571550688,8,472,regulation of transmembrane transport,BP,KCNIP3;KCNIP2;JPH3;KCNB1;SHANK2;CACNG2;CXCL10;SHISA7
9367,GO:0034446,0.0167653213768437,0.997928017637945,3,79,substrate adhesion-dependent cell spreading,BP,GBP1;POSTN;PDPN
21785,GO:2001189,0.0167903335332989,0.999906265890909,1,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
2753,GO:0005775,0.0168061353889195,0.99698519628137,4,154,vacuolar lumen,CC,FABP5;ANXA2;SERPINA3;IFI30
8380,GO:0032412,0.016854311701921,0.99619453964322,5,213,regulation of ion transmembrane transporter activity,BP,KCNIP2;JPH3;SHANK2;CACNG2;SHISA7
14424,GO:0055085,0.0168718170264548,0.992194990837663,16,1347,transmembrane transport,BP,SLCO1A2;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;SHANK2;GABRG1;SVOP;GABRB3;CACNG2;CXCL10;GRIN1;SHISA7
3770,GO:0007492,0.0168896613808487,0.99790885218624,3,76,endoderm development,BP,COL4A2;MMP14;COL5A2
665,GO:0001816,0.0169849303791785,0.994026059246617,9,618,cytokine production,BP,LTF;IGF2BP2;FERMT1;SERPINE1;GBP1;CHI3L1;POSTN;ANXA1;IGF2BP3
7320,GO:0030336,0.0171984291691243,0.996096420124932,5,216,negative regulation of cell migration,BP,TIMP1;SERPINE1;CCL2;HOXA7;COL3A1
17633,GO:0097187,0.017294003797261,0.999900535173449,1,3,dentinogenesis,BP,SERPINE1
13720,GO:0051153,0.0175544929663099,0.99779097935639,3,82,regulation of striated muscle cell differentiation,BP,GDF15;MMP14;CXCL10
1862,GO:0004175,0.0175934846265031,0.995292133510326,6,328,endopeptidase activity,MF,LTF;PLAU;ADAM12;MMP14;C1R;CFI
20738,GO:1905600,0.017626435711812,0.999896658901966,1,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
20807,GO:1905863,0.0176351799622887,0.999922339477548,1,2,invadopodium organization,BP,PDPN
18973,GO:1901624,0.0176859215140624,0.999895957398426,1,3,negative regulation of lymphocyte chemotaxis,BP,CCL2
14941,GO:0060708,0.01768767263661,0.999895936711562,1,3,spongiotrophoblast differentiation,BP,SOCS3
9518,GO:0034754,0.0177217732601255,0.997756965270885,3,91,cellular hormone metabolic process,BP,RBP1;SPP1;ADM
7820,GO:0031347,0.017775714510362,0.99369964791816,9,622,regulation of defense response,BP,LTF;SERPINE1;ANXA1;GPR17;SERPING1;C1R;SOCS3;PLA2G2A;CFI
15251,GO:0061337,0.0177852953460892,0.99676100573467,4,137,cardiac conduction,BP,KCNIP3;SLC8A2;KCNIP2;CACNG2
1198,GO:0002686,0.0178790529812051,0.998883917078259,2,33,negative regulation of leukocyte migration,BP,CCL2;HOXA7
2759,GO:0005783,0.0179002043712942,0.9912997555636,18,1645,endoplasmic reticulum,CC,LTF;CP;MOXD1;CHGB;TIMP1;COL1A1;KCNIP3;SPP1;CHI3L1;COL4A2;COL6A2;JPH3;COL3A1;GRIN1;HLA-DQB1;COL4A1;PLA2G2A;COL5A2
7677,GO:0031090,0.0179407048059949,0.990287920998921,26,2671,organelle membrane,CC,LTF;CP;MOXD1;CUX2;STEAP3;GBP1;HOXA7;PLAU;LGALS3;ANXA1;MMD2;GALNT13;CDHR1;INA;JPH3;SHANK2;FABP5;SVOP;GABRB3;CACNG2;PCDH7;FUT9;ST8SIA3;CD163;HLA-DQB1;ANXA2
19830,GO:1903672,0.0179651513380006,0.998879071317531,2,31,positive regulation of sprouting angiogenesis,BP,SRPX2;ANXA1
1273,GO:0002790,0.0180275900651293,0.994041171002684,8,505,peptide secretion,BP,FERMT1;STEAP3;GBP1;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2
13782,GO:0051251,0.0180664272708146,0.995842969347593,5,243,positive regulation of lymphocyte activation,BP,CCL2;IGFBP2;ANXA1;MMP14;HLA-DQB1
14851,GO:0060560,0.0181052974559505,0.995839030773004,5,207,developmental growth involved in morphogenesis,BP,TNFRSF12A;TNR;SPP1;POSTN;RIMS2
18741,GO:1900673,0.0181271415953434,0.999890679497548,1,3,olefin metabolic process,BP,GRIN1
16257,GO:0071356,0.0181447245460272,0.995819220935199,5,250,cellular response to tumor necrosis factor,BP,TNFRSF12A;CCL2;COL1A1;CHI3L1;POSTN
7075,GO:0022898,0.01816378467478,0.995819699033666,5,218,regulation of transmembrane transporter activity,BP,KCNIP2;JPH3;SHANK2;CACNG2;SHISA7
16927,GO:0072534,0.018225087005594,0.999917031949637,1,2,perineuronal net,CC,TNR
15020,GO:0060838,0.0182557053477,0.999889116838857,1,3,lymphatic endothelial cell fate commitment,BP,PDPN
15538,GO:0070033,0.0183114350701605,0.999888435984587,1,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,CPLX2
16170,GO:0071219,0.0183192418601817,0.996626815996134,4,159,cellular response to molecule of bacterial origin,BP,LTF;SERPINE1;CCL2;CXCL10
3846,GO:0008016,0.0183449809371387,0.995767392865888,5,218,regulation of heart contraction,BP,KCNIP3;SLC8A2;KCNIP2;ADM;CACNG2
18876,GO:1901329,0.0183766971265458,0.999887636001828,1,3,regulation of odontoblast differentiation,BP,SERPINE1
20531,GO:1905114,0.0185749475747562,0.993369641597624,9,583,cell surface receptor signaling pathway involved in cell-cell signaling,BP,FERMT1;COL1A1;CUX2;IGFBP2;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1
8938,GO:0033280,0.0187953482277728,0.998797087924224,2,32,response to vitamin D,BP,SPP1;CXCL10
4885,GO:0010701,0.0189015752425397,0.99988109722354,1,3,positive regulation of norepinephrine secretion,BP,KCNB1
6805,GO:0021586,0.0190332769998978,0.999879427249871,1,3,pons maturation,BP,GRIN1
18032,GO:0098796,0.0191652327393542,0.991720249631819,13,1047,membrane protein complex,CC,LTF;KCNIP3;KCNIP2;GNAL;CPLX2;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;HLA-DQB1;SHISA7
13167,GO:0048686,0.0191845926508835,0.999877494070803,1,3,regulation of sprouting of injured axon,BP,TNR
7836,GO:0031394,0.0192177876233376,0.999877067903984,1,3,positive regulation of prostaglandin biosynthetic process,BP,ANXA1
21847,GO:2001280,0.0192177876233376,0.999877067903984,1,3,positive regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
17811,GO:0097530,0.019223231690117,0.997490040227185,3,94,granulocyte migration,BP,CCL2;LGALS3;ANXA1
9258,GO:0034242,0.0193052575759552,0.999875941363932,1,3,negative regulation of syncytium formation by plasma membrane fusion,BP,CXCL10
18178,GO:0099081,0.0193250566002832,0.992269882886319,11,749,supramolecular polymer,CC,VIM;FERMT1;COL1A1;COL4A2;ANXA1;INA;SHANK2;TUBA1C;COL3A1;COL4A1;COL5A2
10809,GO:0042592,0.01943001287366,0.990655263302024,17,1500,homeostatic process,BP,LTF;CP;CCL2;RBP1;STEAP3;SLC8A2;SPP1;ANXA1;GPR17;CDHR1;ADM;JPH3;KCNB1;CXCL10;GRIN1;SLITRK1;SERPINA3
21543,GO:2000645,0.0195051614589677,0.999873347307059,1,3,negative regulation of receptor catabolic process,BP,ANXA2
3877,GO:0008076,0.0195502356654808,0.997435838305959,3,86,voltage-gated potassium channel complex,CC,KCNIP3;KCNIP2;KCNB1
18177,GO:0099080,0.0195976597881442,0.992144319771924,11,750,supramolecular complex,CC,VIM;FERMT1;COL1A1;COL4A2;ANXA1;INA;SHANK2;TUBA1C;COL3A1;COL4A1;COL5A2
7069,GO:0022857,0.0198439535769061,0.991689973575421,12,921,transmembrane transporter activity,MF,SLCO1A2;ABCC3;KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GABRG1;SVOP;GABRB3;CACNG2;GRIN1
5669,GO:0016043,0.0202007446114918,0.987827768173205,48,5560,cellular component organization,BP,TNFRSF12A;TYMP;VIM;SNAP91;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SPP1;KCNIP2;GDF15;LGALS3;POSTN;COL4A2;ANXA1;COL6A2;EMP3;CDHR1;INA;ADAM12;ADM;MMP14;KCNB1;SHANK2;PDPN;PTX3;CSMD3;CACNG2;TUBA1C;COL3A1;CXCL10;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;COL4A1;SHISA7;RTP5;PLA2G2A;COL5A2
3519,GO:0006953,0.02024122230604,0.998645586003431,2,36,acute-phase response,BP,CD163;SERPINA3
14261,GO:0052548,0.020290416127746,0.994394575439053,6,335,regulation of endopeptidase activity,BP,LTF;TIMP1;SERPINE1;SERPING1;GRIN1;SERPINA3
13522,GO:0050856,0.0203477094813417,0.99863631843343,2,35,regulation of T cell receptor signaling pathway,BP,GBP1;LGALS3
21223,GO:2000146,0.0204879729577651,0.995136207970579,5,228,negative regulation of cell motility,BP,TIMP1;SERPINE1;CCL2;HOXA7;COL3A1
11108,GO:0043197,0.0205220368363131,0.99609443112757,4,148,dendritic spine,CC,SLC8A2;SHANK2;GRIN1;SHISA7
5302,GO:0015085,0.0206697307168286,0.996064304763727,4,133,calcium ion transmembrane transporter activity,MF,SLC8A2;JPH3;CACNG2;GRIN1
11857,GO:0045104,0.0207369812360567,0.99860409319018,2,31,intermediate filament cytoskeleton organization,BP,VIM;INA
14420,GO:0055080,0.0207554251261332,0.992448116341295,9,613,cation homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
1200,GO:0002688,0.0209561579424065,0.997170192809269,3,100,regulation of leukocyte chemotaxis,BP,SERPINE1;CCL2;CXCL10
14080,GO:0051799,0.0209862546723387,0.999853283738826,1,3,negative regulation of hair follicle development,BP,FERMT1
7424,GO:0030594,0.0210242595044308,0.997163994783814,3,89,neurotransmitter receptor activity,MF,GABRG1;GABRB3;GRIN1
18009,GO:0098751,0.0212023248294928,0.998555871518252,2,31,bone cell development,BP,LTF;ANXA2
3797,GO:0007565,0.0212182062687495,0.995917824873661,4,157,female pregnancy,BP,TIMP1;IGFBP2;SPP1;ADM
10045,GO:0035938,0.0212862074157478,0.999849039147565,1,3,estradiol secretion,BP,SPP1
21684,GO:2000864,0.0212862074157478,0.999849039147565,1,3,regulation of estradiol secretion,BP,SPP1
14087,GO:0051817,0.0212937131759218,0.997113158814545,3,90,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,LTF;PTX3;ANXA2
7189,GO:0030162,0.0212940787795927,0.992216806527753,9,633,regulation of proteolysis,BP,LTF;TIMP1;SERPINE1;SERPING1;MMP14;C1R;GRIN1;SERPINA3;CFI
9758,GO:0035482,0.0213140912254904,0.999829824455111,1,4,gastric motility,BP,TYMP
1210,GO:0002698,0.0213875482623446,0.997093704201217,3,93,negative regulation of immune effector process,BP,LGALS3;ANXA1;SERPING1
6673,GO:0019863,0.0213966238387905,0.999828497944407,1,4,IgE binding,MF,LGALS3
2914,GO:0006040,0.0215369869184673,0.998510693345625,2,36,amino sugar metabolic process,BP,CHI3L2;CHI3L1
8755,GO:0032964,0.0216113735157989,0.998504615166721,2,35,collagen biosynthetic process,BP,VIM;COL1A1
11574,GO:0044309,0.0216762467019723,0.995805455093038,4,150,neuron spine,CC,SLC8A2;SHANK2;GRIN1;SHISA7
12969,GO:0048247,0.0217785645722072,0.998480144836117,2,39,lymphocyte chemotaxis,BP,CCL2;CXCL10
13182,GO:0048704,0.0217931312340437,0.997020882270878,3,88,embryonic skeletal system morphogenesis,BP,HOXA7;MMP14;DSCAML1
17008,GO:0072683,0.0218434472366923,0.999821226096399,1,4,T cell extravasation,BP,CCL2
11856,GO:0045103,0.0218499096447253,0.998485470361283,2,32,intermediate filament-based process,BP,VIM;INA
13159,GO:0048677,0.021859512781194,0.999840756300195,1,3,axon extension involved in regeneration,BP,TNR
5906,GO:0016525,0.0218687812360881,0.997008843678773,3,85,negative regulation of angiogenesis,BP,SERPINE1;COL4A2;CXCL10
6612,GO:0019732,0.0220301242827053,0.999818142874766,1,4,antifungal humoral response,BP,LTF
8377,GO:0032409,0.0221862564283009,0.994624124380208,5,231,regulation of transporter activity,BP,KCNIP2;JPH3;SHANK2;CACNG2;SHISA7
711,GO:0001878,0.0223671397673002,0.999812509220582,1,4,response to yeast,BP,PTX3
4786,GO:0010522,0.0224320786961735,0.996900621776253,3,87,regulation of calcium ion transport into cytosol,BP,JPH3;CXCL10;GRIN1
17192,GO:0090049,0.0224542828640934,0.998416422759962,2,34,regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
15981,GO:0070838,0.0227832862368694,0.992785310212198,7,409,divalent metal ion transport,BP,CCL2;SLC8A2;LGALS3;JPH3;CACNG2;CXCL10;GRIN1
8498,GO:0032571,0.0229006984464248,0.999803412644195,1,4,response to vitamin K,BP,POSTN
20892,GO:1990138,0.022978090295489,0.99547628244841,4,146,neuron projection extension,BP,TNFRSF12A;TNR;POSTN;RIMS2
8067,GO:0031849,0.0230423155452124,0.999800961689043,1,4,olfactory receptor binding,MF,RTP5
5170,GO:0014070,0.0230890565317808,0.990508055174979,11,837,response to organic cyclic compound,BP,CCL2;COL1A1;IGFBP2;SPP1;POSTN;ANXA1;ADM;MMP14;GABRB3;CXCL10;GRIN1
18018,GO:0098771,0.0231339358166339,0.991423732792296,9,624,inorganic ion homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
10697,GO:0042379,0.023143023214619,0.998328800171133,2,41,chemokine receptor binding,MF,CCL2;CXCL10
21093,GO:1990834,0.0231516856576186,0.999799058335196,1,4,response to odorant,BP,MMP14
3371,GO:0006710,0.0232393824236119,0.99979752555171,1,4,androgen catabolic process,BP,SPP1
15947,GO:0070741,0.0232775260721822,0.998324496254191,2,35,response to interleukin-6,BP,CHI3L1;SOCS3
6607,GO:0019722,0.0233010277360864,0.99539020189847,4,153,calcium-mediated signaling,BP,GBP1;JPH3;KSR2;GRIN1
21240,GO:2000181,0.023320064478279,0.996730239445407,3,87,negative regulation of blood vessel morphogenesis,BP,SERPINE1;COL4A2;CXCL10
20996,GO:1990523,0.0233966795607251,0.999794761540173,1,4,bone regeneration,BP,POSTN
11484,GO:0044092,0.0234791443879614,0.989925764919664,12,962,negative regulation of molecular function,BP,LTF;CRTAC1;TIMP1;SERPINE1;SPOCD1;ANXA1;SERPING1;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
18565,GO:1900041,0.0234828022866749,0.999793240180917,1,4,negative regulation of interleukin-2 secretion,BP,GBP1
4009,GO:0008289,0.0234850635979686,0.99127105253359,9,622,lipid binding,MF,LTF;SNAP91;APOL4;PLEKHA4;RBP1;ANXA1;FABP5;ANXA2;PLA2G2A
16910,GO:0072511,0.023514792077728,0.992505319769302,7,412,divalent inorganic cation transport,BP,CCL2;SLC8A2;LGALS3;JPH3;CACNG2;CXCL10;GRIN1
20961,GO:1990410,0.0235445882127579,0.9997921452358,1,4,adrenomedullin receptor signaling pathway,BP,ADM
2483,GO:0005200,0.0236722500428834,0.996660364238139,3,89,structural constituent of cytoskeleton,MF,VIM;INA;TUBA1C
18273,GO:0099604,0.0237209168615281,0.998297564913412,2,27,ligand-gated calcium channel activity,MF,JPH3;GRIN1
18237,GO:0099529,0.0237906060279429,0.998267579876191,2,35,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,GABRG1;GRIN1
20134,GO:1904315,0.0237906060279429,0.998267579876191,2,35,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,GABRG1;GRIN1
15132,GO:0061043,0.0238142277375706,0.999787332602668,1,4,regulation of vascular wound healing,BP,SERPINE1
18420,GO:0106104,0.0238258878311301,0.999810648262266,1,3,regulation of glutamate receptor clustering,BP,SHISA7
20332,GO:1904717,0.0238258878311301,0.999810648262266,1,3,regulation of AMPA glutamate receptor clustering,BP,SHISA7
13561,GO:0050905,0.0238605851618205,0.996625266325034,3,87,neuromuscular process,BP,TNR;JPH3;GRIN1
14751,GO:0060414,0.0238676177756138,0.999809980777626,1,3,aorta smooth muscle tissue morphogenesis,BP,COL3A1
12072,GO:0045617,0.0239540334950178,0.999784815388746,1,4,negative regulation of keratinocyte differentiation,BP,HOXA7
19523,GO:1903037,0.0240910679176011,0.994030748986088,5,261,regulation of leukocyte cell-cell adhesion,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1
9428,GO:0034612,0.0241064582514381,0.994024532137225,5,268,response to tumor necrosis factor,BP,TNFRSF12A;CCL2;COL1A1;CHI3L1;POSTN
21793,GO:2001201,0.0241196101357763,0.999805924840566,1,3,regulation of transforming growth factor-beta secretion,BP,FERMT1
12084,GO:0045629,0.0241821269698037,0.999780676426278,1,4,negative regulation of T-helper 2 cell differentiation,BP,ANXA1
9493,GO:0034705,0.0241914370363452,0.996555865772787,3,93,potassium channel complex,CC,KCNIP3;KCNIP2;KCNB1
19014,GO:1901701,0.0244774267373933,0.989434389268325,12,950,cellular response to oxygen-containing compound,BP,LTF;SERPINE1;CCL2;COL1A1;SPP1;ANXA1;KCNB1;COL3A1;CXCL10;SOCS3;COL4A1;COL5A2
6005,GO:0016715,0.0247120735320175,0.999770906236512,1,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,MOXD1
8802,GO:0033031,0.0250598132083489,0.999764378317865,1,4,positive regulation of neutrophil apoptotic process,BP,ANXA1
13507,GO:0050829,0.0250660220109007,0.998109716745511,2,42,defense response to Gram-negative bacterium,BP,LTF;SERPINE1
18060,GO:0098839,0.0251589505135807,0.998120172691896,2,32,postsynaptic density membrane,CC,CACNG2;GRIN1
12115,GO:0045666,0.0252136931780941,0.992687937235163,6,319,positive regulation of neuron differentiation,BP,TNFRSF12A;CUX2;MMD2;SHANK2;RIMS2;SLITRK1
19608,GO:1903225,0.0254140095632358,0.99978440795935,1,3,negative regulation of endodermal cell differentiation,BP,COL5A2
5101,GO:0010986,0.0254595497581004,0.999756759757566,1,4,positive regulation of lipoprotein particle clearance,BP,ANXA2
18919,GO:1901509,0.0255483344055854,0.999755050983225,1,4,regulation of endothelial tube morphogenesis,BP,CXCL10
21387,GO:2000401,0.025680218636749,0.998041721787602,2,40,regulation of lymphocyte migration,BP,CCL2;CXCL10
726,GO:0001894,0.0258283471113748,0.994720536339175,4,170,tissue homeostasis,BP,LTF;SPP1;CDHR1;SERPINA3
5076,GO:0010955,0.0258857384014046,0.998028251241892,2,35,negative regulation of protein processing,BP,SERPINE1;SERPING1
19648,GO:1903318,0.0258857384014046,0.998028251241892,2,35,negative regulation of protein maturation,BP,SERPINE1;SERPING1
14584,GO:0060179,0.0258887378152089,0.999748443440866,1,4,male mating behavior,BP,GRIN1
12616,GO:0046717,0.0259699882080077,0.996197058495854,3,99,acid secretion,BP,ABCC3;ANXA1;PLA2G2A
666,GO:0001817,0.0260817760982205,0.990763741465454,8,561,regulation of cytokine production,BP,LTF;IGF2BP2;FERMT1;SERPINE1;GBP1;POSTN;ANXA1;IGF2BP3
18968,GO:1901618,0.0261188993152111,0.997992108431751,2,39,organic hydroxy compound transmembrane transporter activity,MF,SLCO1A2;ABCC3
18451,GO:0120036,0.026123892475464,0.987256866170296,16,1351,plasma membrane bounded cell projection organization,BP,TNFRSF12A;VIM;CRTAC1;CUX2;TNR;SPP1;POSTN;EMP3;ADM;SHANK2;PDPN;CSMD3;RIMS2;GRIN1;DSCAML1;SLITRK1
3508,GO:0006935,0.0263086316127096,0.990671553550463,8,526,chemotaxis,BP,TYMP;SERPINE1;CCL2;TNR;PLAU;LGALS3;ANXA1;CXCL10
2510,GO:0005250,0.0263749041462742,0.999738852296886,1,4,A-type (transient outward) potassium channel activity,MF,KCNIP2
18286,GO:0099634,0.0265136616243797,0.997959748401461,2,33,postsynaptic specialization membrane,CC,CACNG2;GRIN1
10672,GO:0042330,0.0265160277417734,0.990584013850556,8,527,taxis,BP,TYMP;SERPINE1;CCL2;TNR;PLAU;LGALS3;ANXA1;CXCL10
21445,GO:2000501,0.026743841676209,0.999713680086769,1,5,regulation of natural killer cell chemotaxis,BP,CCL2
11712,GO:0044691,0.0267605073059595,0.999760810233856,1,3,tooth eruption,BP,COL1A1
12665,GO:0046873,0.0268965699180128,0.991188550042406,7,412,metal ion transmembrane transporter activity,MF,KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;CACNG2;GRIN1
12970,GO:0048248,0.0269284356275401,0.999709691849433,1,5,CXCR3 chemokine receptor binding,MF,CXCL10
14010,GO:0051673,0.0269696085891486,0.999708798484271,1,5,membrane disruption in other organism,BP,LTF
13423,GO:0050709,0.0270021831736267,0.995985257377341,3,101,negative regulation of protein secretion,BP,GBP1;ANXA1;KCNB1
5510,GO:0015722,0.0270346484609838,0.999725546483294,1,4,canalicular bile acid transport,BP,ABCC3
18884,GO:1901343,0.0270588315579548,0.995979844647628,3,93,negative regulation of vasculature development,BP,SERPINE1;COL4A2;CXCL10
10836,GO:0042636,0.0270830295183484,0.999724557565089,1,4,negative regulation of hair cycle,BP,FERMT1
15395,GO:0061669,0.0270933001114483,0.999754786771119,1,3,spontaneous neurotransmitter secretion,BP,RIMS2
12174,GO:0045785,0.0271153607117116,0.991998977906791,6,352,positive regulation of cell adhesion,BP,FERMT1;CCL2;IGFBP2;ANXA1;PDPN;HLA-DQB1
16167,GO:0071216,0.0272722844586883,0.994328898743099,4,178,cellular response to biotic stimulus,BP,LTF;SERPINE1;CCL2;CXCL10
13164,GO:0048682,0.0273996962434298,0.999718040403842,1,4,sprouting of injured axon,BP,TNR
21784,GO:2001188,0.0274341579023045,0.999698622579743,1,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
11891,GO:0045163,0.0274843857507745,0.999747611284314,1,3,clustering of voltage-gated potassium channels,BP,KCNIP2
17003,GO:0072678,0.0274973131771372,0.997821282997903,2,42,T cell migration,BP,CCL2;CXCL10
18127,GO:0098960,0.0275562332130299,0.99782460373851,2,37,postsynaptic neurotransmitter receptor activity,MF,GABRG1;GRIN1
17855,GO:0097647,0.0275814623561036,0.999695358983401,1,5,amylin receptor signaling pathway,BP,ADM
12698,GO:0046923,0.0277738726968332,0.999691069270236,1,5,ER retention sequence binding,MF,KCNIP2
13777,GO:0051246,0.0277805728908217,0.984613186991839,24,2450,regulation of protein metabolic process,BP,LTF;VIM;IGF2BP2;TIMP1;SERPINE1;CCL2;GBP1;GDF15;CHI3L1;IGF2BP3;MMD2;SERPING1;MMP14;C1R;PTX3;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI
13483,GO:0050794,0.0277997343093911,0.98330213629122,70,9109,regulation of cellular process,BP,TNFRSF12A;LTF;TYMP;VIM;SNAP91;IGF2BP2;CHGB;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;GNAL;EMP3;GPR17;CPLX2;ADM;SERPING1;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;PTX3;CSMD3;GABRB3;CACNG2;ELFN2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;IFI30
4045,GO:0008347,0.0283304289928738,0.997727641048005,2,38,glial cell migration,BP,CCL2;MMP14
13531,GO:0050865,0.0283624892612452,0.99059893322731,7,464,regulation of cell activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;MMP14;PDPN;HLA-DQB1
7494,GO:0030801,0.0283695464506735,0.997712406296808,2,43,positive regulation of cyclic nucleotide metabolic process,BP,ADM;CXCL10
3685,GO:0007229,0.0284114938834988,0.995698537368471,3,94,integrin-mediated signaling pathway,BP,FERMT1;TIMP1;COL3A1
9183,GO:0034112,0.0286943212848946,0.999690593999425,1,4,positive regulation of homotypic cell-cell adhesion,BP,PDPN
2644,GO:0005588,0.0287203614261603,0.999724244848738,1,3,collagen type V trimer,CC,COL5A2
17989,GO:0098706,0.0287392603749212,0.999689618106957,1,4,ferric iron import across plasma membrane,BP,STEAP3
13536,GO:0050870,0.0287426532799811,0.993922802958298,4,187,positive regulation of T cell activation,BP,CCL2;IGFBP2;ANXA1;HLA-DQB1
10877,GO:0042737,0.0287826924721655,0.9956064451116,3,113,drug catabolic process,BP,CHI3L2;MOXD1;CHI3L1
7098,GO:0030003,0.0287934431051676,0.989612752621027,8,547,cellular cation homeostasis,BP,LTF;CP;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
4712,GO:0010243,0.0288266756410699,0.987736825059946,11,855,response to organonitrogen compound,BP,TIMP1;COL1A1;ANXA1;ADM;GABRB3;NNMT;COL3A1;GRIN1;SOCS3;COL4A1;COL5A2
6239,GO:0017157,0.0289388931060181,0.993873639497019,4,174,regulation of exocytosis,BP,ANXA1;CPLX2;KCNB1;RIMS2
11525,GO:0044218,0.0292226762366174,0.999657794010095,1,5,other organism cell membrane,CC,LTF
11554,GO:0044279,0.0292226762366174,0.999657794010095,1,5,other organism membrane,CC,LTF
3664,GO:0007204,0.0293256477232794,0.992355362194675,5,255,positive regulation of cytosolic calcium ion concentration,BP,GPR17;ADM;JPH3;CXCL10;GRIN1
1208,GO:0002696,0.0293604159139801,0.992338816428921,5,275,positive regulation of leukocyte activation,BP,CCL2;IGFBP2;ANXA1;MMP14;HLA-DQB1
5673,GO:0016049,0.0293672139927742,0.990199160002434,7,437,cell growth,BP,TNFRSF12A;IGFBP2;TNR;SPP1;POSTN;MMP14;RIMS2
13780,GO:0051249,0.0294711886848236,0.99113300387595,6,370,regulation of lymphocyte activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;MMP14;HLA-DQB1
10034,GO:0035926,0.0294861481220963,0.999651557658935,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
8654,GO:0032803,0.0296833561150584,0.999646852464943,1,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,ANXA2
17978,GO:0098662,0.0297498280296913,0.98847538662861,9,637,inorganic cation transmembrane transport,BP,KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;CACNG2;CXCL10;GRIN1
471,GO:0001503,0.0298356639343367,0.991003027907803,6,342,ossification,BP,LTF;COL1A1;SPP1;MMP14;SMOC1;COL5A2
21075,GO:1990778,0.0298524554887281,0.992182880760987,5,251,protein localization to cell periphery,BP,KCNIP3;GBP1;KCNB1;GRIN1;ANXA2
21054,GO:1990743,0.0299952813508964,0.99966171281649,1,4,protein sialylation,BP,ST8SIA3
10984,GO:0042995,0.0300212127467376,0.984023823395961,20,1861,cell projection,CC,TNFRSF12A;VIM;CRTAC1;FERMT1;KCNIP3;SLC8A2;SPP1;ANXA1;CPLX2;CDHR1;KCNB1;SHANK2;PDPN;S100A11;GABRG1;GABRB3;CACNG2;GRIN1;ANXA2;SHISA7
21567,GO:2000671,0.0300579896179911,0.999637826076293,1,5,regulation of motor neuron apoptotic process,BP,KCNB1
7687,GO:0031103,0.0302784613360499,0.997478271116034,2,40,axon regeneration,BP,TNR;SPP1
14699,GO:0060348,0.0303799701513131,0.993475011125132,4,167,bone development,BP,LTF;COL1A1;MMP14;ANXA2
3506,GO:0006931,0.0304009182616095,0.999652440764134,1,4,substrate-dependent cell migration, cell attachment to substrate,BP,TNFRSF12A
4928,GO:0010757,0.0306294083749294,0.999623836215156,1,5,negative regulation of plasminogen activation,BP,SERPINE1
17714,GO:0097350,0.030659260170679,0.999623097984506,1,5,neutrophil clearance,BP,ANXA1
18038,GO:0098802,0.0307955949675969,0.993354649625465,4,174,plasma membrane receptor complex,CC,SHANK2;CACNG2;GRIN1;SHISA7
7114,GO:0030030,0.030796252390397,0.984664300576132,16,1381,cell projection organization,BP,TNFRSF12A;VIM;CRTAC1;CUX2;TNR;SPP1;POSTN;EMP3;ADM;SHANK2;PDPN;CSMD3;RIMS2;GRIN1;DSCAML1;SLITRK1
14492,GO:0060047,0.0309200154275706,0.991829397896519,5,248,heart contraction,BP,KCNIP3;SLC8A2;KCNIP2;ADM;CACNG2
9495,GO:0034707,0.0309818963448695,0.997383033836801,2,42,chloride channel complex,CC,GABRG1;GABRB3
3798,GO:0007566,0.031021128407064,0.997377937553808,2,42,embryo implantation,BP,TIMP1;SPP1
1275,GO:0002792,0.0310808994638832,0.995118064835174,3,107,negative regulation of peptide secretion,BP,GBP1;ANXA1;KCNB1
20922,GO:1990254,0.0311341458321957,0.999611255548998,1,5,keratin filament binding,MF,VIM
4808,GO:0010572,0.0313035349460169,0.999606986520198,1,5,positive regulation of platelet activation,BP,PDPN
4509,GO:0009409,0.0314357490687459,0.997321665853312,2,43,response to cold,BP,ADM;CXCL10
7834,GO:0031392,0.0315021114122117,0.999601951826235,1,5,regulation of prostaglandin biosynthetic process,BP,ANXA1
21846,GO:2001279,0.0315021114122117,0.999601951826235,1,5,regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
1257,GO:0002762,0.0315338478963147,0.99731332307073,2,41,negative regulation of myeloid leukocyte differentiation,BP,LTF;HOXA7
14944,GO:0060711,0.0317617824288478,0.997278831540937,2,43,labyrinthine layer development,BP,ADM;SOCS3
19705,GO:1903428,0.0317762538114646,0.997279155519713,2,42,positive regulation of reactive oxygen species biosynthetic process,BP,PTX3;GRIN1
18539,GO:0150034,0.0318129628326502,0.991528787729503,5,253,distal axon,CC,CRTAC1;KCNIP3;CPLX2;SHANK2;GRIN1
5093,GO:0010976,0.0318738072346145,0.991511204933674,5,244,positive regulation of neuron projection development,BP,TNFRSF12A;CUX2;SHANK2;RIMS2;SLITRK1
18003,GO:0098742,0.031992205622562,0.993019794491401,4,164,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CDHR1;PCDH7;DSCAML1;PTPRT
3465,GO:0006873,0.0321571186540283,0.988151211689336,8,558,cellular ion homeostasis,BP,LTF;CP;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
13798,GO:0051271,0.0321766341165602,0.99140568039009,5,255,negative regulation of cellular component movement,BP,TIMP1;SERPINE1;CCL2;HOXA7;COL3A1
18810,GO:1901164,0.0323613865956194,0.999579791546762,1,5,negative regulation of trophoblast cell migration,BP,TIMP1
4783,GO:0010519,0.0324304883697342,0.999577983019091,1,5,negative regulation of phospholipase activity,BP,ANXA1
13529,GO:0050863,0.032492305151199,0.991291200620097,5,283,regulation of T cell activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1
1072,GO:0002449,0.0325039442715573,0.992859292456421,4,194,lymphocyte mediated immunity,BP,SERPING1;C1R;HLA-DQB1;CFI
3503,GO:0006928,0.0325559211718461,0.982770535378736,19,1741,movement of cell or subcellular component,BP,TNFRSF12A;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;HOXA7;PLAU;LGALS3;POSTN;ANXA1;SPHKAP;MMP14;PDPN;COL3A1;CXCL10
563,GO:0001661,0.0325586930431354,0.999574617228732,1,5,conditioned taste aversion,BP,GRIN1
1377,GO:0003015,0.0327103113658563,0.991226493357681,5,251,heart process,BP,KCNIP3;SLC8A2;KCNIP2;ADM;CACNG2
13479,GO:0050789,0.0327775356961129,0.98032208767813,73,9666,regulation of biological process,BP,TNFRSF12A;LTF;TYMP;VIM;SNAP91;IGF2BP2;CHGB;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;GNAL;EMP3;GPR17;CPLX2;ADAM12;ADM;SERPING1;SPHKAP;JPH3;MMP14;KCNB1;C1R;SHANK2;PDPN;S100A11;GABRG1;PTX3;CSMD3;GABRB3;CACNG2;ELFN2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;CFI;IFI30
3364,GO:0006701,0.032941744296847,0.999564480156061,1,5,progesterone biosynthetic process,BP,ADM
18205,GO:0099173,0.0331804120757299,0.994666661614293,3,95,postsynapse organization,BP,CUX2;SHANK2;SHISA7
19746,GO:1903522,0.0332354241758914,0.991045901209417,5,258,regulation of blood circulation,BP,KCNIP3;SLC8A2;KCNIP2;ADM;CACNG2
15186,GO:0061138,0.0334212921281341,0.992604288066154,4,172,morphogenesis of a branching epithelium,BP,ADM;MMP14;SOCS3;COL4A1
12214,GO:0045861,0.0334918508343204,0.99095404146242,5,273,negative regulation of proteolysis,BP,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
11306,GO:0043523,0.0334952677484844,0.99257701397245,4,184,regulation of neuron apoptotic process,BP,CCL2;KCNB1;GABRB3;GRIN1
15279,GO:0061387,0.0335559983348752,0.994581718330546,3,96,regulation of extent of cell growth,BP,TNFRSF12A;TNR;SPP1
4256,GO:0008823,0.0336409673708589,0.999545663798062,1,5,cupric reductase activity,MF,STEAP3
14345,GO:0052851,0.0336409673708589,0.999545663798062,1,5,ferric-chelate reductase (NADPH) activity,MF,STEAP3
19525,GO:1903039,0.033845436583668,0.992470006243942,4,196,positive regulation of leukocyte cell-cell adhesion,BP,CCL2;IGFBP2;ANXA1;HLA-DQB1
10838,GO:0042640,0.0338788588994046,0.999539170051289,1,5,anagen,BP,FERMT1
14113,GO:0051884,0.0338788588994046,0.999539170051289,1,5,regulation of timing of anagen,BP,FERMT1
15236,GO:0061304,0.0338878295651217,0.999567490990996,1,4,retinal blood vessel morphogenesis,BP,COL4A1
20338,GO:1904724,0.0339328924601245,0.996971248507079,2,51,tertiary granule lumen,CC,LTF;PTX3
7246,GO:0030234,0.0340189146534492,0.985144685404901,11,895,enzyme regulator activity,MF,LTF;TIMP1;SERPINE1;ANXA1;SERPING1;MMP14;ELFN2;CXCL10;ANXA2;SOCS3;SERPINA3
12978,GO:0048260,0.0340505344219155,0.996968977165071,2,44,positive regulation of receptor-mediated endocytosis,BP,SERPINE1;ANXA2
10719,GO:0042421,0.0342201853319399,0.999510369327608,1,6,norepinephrine biosynthetic process,BP,MOXD1
14175,GO:0051971,0.0342538615426615,0.999528838672736,1,5,positive regulation of transmission of nerve impulse,BP,TNR
12082,GO:0045627,0.0344674976228572,0.999503217104748,1,6,positive regulation of T-helper 1 cell differentiation,BP,ANXA1
3466,GO:0006874,0.0344711620042191,0.989247261257553,6,361,cellular calcium ion homeostasis,BP,SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
11714,GO:0044706,0.0345022599389618,0.99228321587947,4,184,multi-multicellular organism process,BP,TIMP1;IGFBP2;SPP1;ADM
2399,GO:0005047,0.0345112931633677,0.999501945066163,1,6,signal recognition particle binding,MF,LTF
16356,GO:0071495,0.0346078972205532,0.983302669631617,14,1205,cellular response to endogenous stimulus,BP,FERMT1;CCL2;COL1A1;IGFBP2;SPP1;GDF15;POSTN;COL4A2;ANXA1;GABRB3;COL3A1;SOCS3;COL4A1;COL5A2
19346,GO:1902617,0.0346764924573604,0.999517055881132,1,5,response to fluoride,BP,COL1A1
17854,GO:0097646,0.034962553885571,0.999488742172648,1,6,calcitonin family receptor signaling pathway,BP,ADM
14422,GO:0055082,0.0353531750213079,0.98587394839245,9,674,cellular chemical homeostasis,BP,LTF;CP;SLC8A2;GPR17;ADM;JPH3;KCNB1;CXCL10;GRIN1
7188,GO:0030160,0.0355921819927455,0.999522540787987,1,4,GKAP/Homer scaffold activity,MF,SHANK2
10748,GO:0042476,0.0356408796213243,0.99410075423729,3,104,odontogenesis,BP,SERPINE1;COL1A1;ADM
18726,GO:1900454,0.0357049956809865,0.999487764622847,1,5,positive regulation of long term synaptic depression,BP,KCNB1
16583,GO:0071895,0.0357540358284358,0.999465162010604,1,6,odontoblast differentiation,BP,SERPINE1
3626,GO:0007159,0.0357769681516395,0.99016175628866,5,290,leukocyte cell-cell adhesion,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1
2841,GO:0005913,0.0360714647405249,0.994000626502399,3,105,cell-cell adherens junction,CC,ANXA1;S100A11;ANXA2
10729,GO:0042439,0.0361461657696711,0.999453279710498,1,6,ethanolamine-containing compound metabolic process,BP,MOXD1
16550,GO:0071840,0.0362157496263937,0.977151347344336,48,5763,cellular component organization or biogenesis,BP,TNFRSF12A;TYMP;VIM;SNAP91;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SPP1;KCNIP2;GDF15;LGALS3;POSTN;COL4A2;ANXA1;COL6A2;EMP3;CDHR1;INA;ADAM12;ADM;MMP14;KCNB1;SHANK2;PDPN;PTX3;CSMD3;CACNG2;TUBA1C;COL3A1;CXCL10;RIMS2;GRIN1;DSCAML1;SLITRK1;ANXA2;COL4A1;SHISA7;RTP5;PLA2G2A;COL5A2
7173,GO:0030139,0.0362533903682193,0.990000305149345,5,274,endocytic vesicle,CC,LTF;VIM;CACNG2;CD163;HLA-DQB1
10974,GO:0042981,0.0362661203779303,0.981951235577269,15,1390,regulation of apoptotic process,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;STEAP3;GDF15;LGALS3;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
19607,GO:1903224,0.0363045451479009,0.999470285903657,1,5,regulation of endodermal cell differentiation,BP,COL5A2
3854,GO:0008028,0.0363214205519662,0.996640711878799,2,49,monocarboxylic acid transmembrane transporter activity,MF,SLCO1A2;ABCC3
13487,GO:0050801,0.0363738345964206,0.985391400007664,9,676,ion homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
5453,GO:0015459,0.0363825639306206,0.99663854646088,2,46,potassium channel regulator activity,MF,KCNIP3;KCNIP2
510,GO:0001558,0.036436809513988,0.988484958171241,6,365,regulation of cell growth,BP,TNFRSF12A;IGFBP2;TNR;SPP1;MMP14;RIMS2
7354,GO:0030425,0.0365001171890959,0.986220827318199,8,541,dendrite,CC,KCNIP3;SLC8A2;CPLX2;KCNB1;SHANK2;GABRG1;GRIN1;SHISA7
9981,GO:0035821,0.0365006919134446,0.993892313657567,3,115,modification of morphology or physiology of other organism,BP,LTF;PTX3;ANXA2
15099,GO:0060999,0.0365845664690389,0.996629165284709,2,39,positive regulation of dendritic spine development,BP,CUX2;SHANK2
3650,GO:0007187,0.0366700790943453,0.991635497379888,4,196,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,CCL2;ANXA1;GNAL;ADM
17763,GO:0097447,0.0367587429824367,0.986104033604848,8,542,dendritic tree,CC,KCNIP3;SLC8A2;CPLX2;KCNB1;SHANK2;GABRG1;GRIN1;SHISA7
7456,GO:0030667,0.0368817016005535,0.989779813323586,5,276,secretory granule membrane,CC,MOXD1;PLAU;LGALS3;FABP5;PCDH7
13511,GO:0050839,0.0369630095700162,0.987051375615213,7,459,cell adhesion molecule binding,MF,POSTN;ANXA1;MMP14;S100A11;COL3A1;ANXA2;PTPRT
12670,GO:0046879,0.0369850874679264,0.989744151853926,5,274,hormone secretion,BP,SPP1;ANXA1;ADM;KCNB1;RIMS2
2604,GO:0005507,0.0370916474962051,0.996530311788813,2,49,copper ion binding,MF,CP;MOXD1
2120,GO:0004645,0.03710432400876,0.999423688209744,1,6,phosphorylase activity,MF,TYMP
15530,GO:0070011,0.0371236329956278,0.986978889164198,7,486,peptidase activity, acting on L-amino acid peptides,MF,LTF;AEBP1;PLAU;ADAM12;MMP14;C1R;CFI
17220,GO:0090091,0.0371531858169396,0.999445036396194,1,5,positive regulation of extracellular matrix disassembly,BP,PDPN
10495,GO:0040013,0.0371796707387115,0.989678053073803,5,267,negative regulation of locomotion,BP,TIMP1;SERPINE1;CCL2;HOXA7;COL3A1
17236,GO:0090118,0.0372091572522171,0.999443350100979,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
3490,GO:0006904,0.0372332216310854,0.996512044856408,2,48,vesicle docking involved in exocytosis,BP,CPLX2;KCNB1
14497,GO:0060052,0.0372394413114933,0.999419451598033,1,6,neurofilament cytoskeleton organization,BP,INA
13424,GO:0050710,0.0372549848296552,0.996506734589192,2,49,negative regulation of cytokine secretion,BP,GBP1;ANXA1
1894,GO:0004322,0.0372995299235505,0.999440621889483,1,5,ferroxidase activity,MF,CP
6010,GO:0016724,0.0372995299235505,0.999440621889483,1,5,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,CP
8453,GO:0032496,0.0373888909772828,0.989595984855971,5,295,response to lipopolysaccharide,BP,LTF;SERPINE1;CCL2;ADM;CXCL10
19844,GO:1903707,0.0375880232295029,0.99363906932229,3,114,negative regulation of hemopoiesis,BP,LTF;HOXA7;ANXA1
11033,GO:0043066,0.0376236230326067,0.984001608839788,10,807,negative regulation of apoptotic process,BP,LTF;TIMP1;SERPINE1;CCL2;LGALS3;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
13722,GO:0051155,0.0376419653399711,0.996455142531154,2,47,positive regulation of striated muscle cell differentiation,BP,GDF15;MMP14
4788,GO:0010524,0.0377235086168403,0.99644099366466,2,48,positive regulation of calcium ion transport into cytosol,BP,CXCL10;GRIN1
835,GO:0002042,0.0378406096684597,0.99643120169527,2,45,cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
2518,GO:0005267,0.0379204846173135,0.993559058567074,3,116,potassium channel activity,MF,KCNIP3;KCNIP2;KCNB1
16179,GO:0071229,0.0379353965285238,0.991258523994395,4,188,cellular response to acid chemical,BP,COL1A1;COL3A1;COL4A1;COL5A2
11471,GO:0044057,0.0379778338155363,0.986618756362046,7,462,regulation of system process,BP,TYMP;KCNIP3;TNR;SLC8A2;KCNIP2;ADM;CACNG2
15646,GO:0070206,0.0380199509929373,0.996397783224204,2,48,protein trimerization,BP,COL1A1;COL6A2
7982,GO:0031663,0.0380258883508067,0.996394680930437,2,49,lipopolysaccharide-mediated signaling pathway,BP,LTF;CCL2
21797,GO:2001205,0.0380535699909139,0.999417594497299,1,5,negative regulation of osteoclast development,BP,LTF
9142,GO:0033993,0.0382136460775616,0.98370719318319,10,815,response to lipid,BP,LTF;SERPINE1;CCL2;COL1A1;IGFBP2;SPP1;POSTN;ANXA1;ADM;CXCL10
18045,GO:0098814,0.0384058929920501,0.999406673262797,1,5,spontaneous synaptic transmission,BP,RIMS2
14415,GO:0055074,0.0384483329176216,0.987693576799252,6,371,calcium ion homeostasis,BP,SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
14763,GO:0060429,0.0386615042252998,0.982135546007682,12,996,epithelium development,BP,VIM;FERMT1;SERPINE1;HOXA7;LGALS3;ANXA1;ADM;MMP14;PDPN;CXCL10;SOCS3;COL4A1
11034,GO:0043067,0.0386708506777884,0.980588084085581,15,1402,regulation of programmed cell death,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;STEAP3;GDF15;LGALS3;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
6609,GO:0019725,0.0387094126851067,0.983460494916991,10,805,cellular homeostasis,BP,LTF;CP;CCL2;SLC8A2;GPR17;ADM;JPH3;KCNB1;CXCL10;GRIN1
10357,GO:0038044,0.0387680124880982,0.999395340934545,1,5,transforming growth factor-beta secretion,BP,FERMT1
18445,GO:0120025,0.0387744055963436,0.979053471235812,19,1793,plasma membrane bounded cell projection,CC,TNFRSF12A;VIM;CRTAC1;FERMT1;KCNIP3;SLC8A2;ANXA1;CPLX2;CDHR1;KCNB1;SHANK2;PDPN;S100A11;GABRG1;GABRB3;CACNG2;GRIN1;ANXA2;SHISA7
7732,GO:0031214,0.0387784236843167,0.993359306937642,3,112,biomineral tissue development,BP,LTF;COL1A1;SPP1
12633,GO:0046790,0.0390010378046181,0.999387990929089,1,5,virion binding,MF,PTX3
2626,GO:0005544,0.0390251641257563,0.996252285110546,2,47,calcium-dependent phospholipid binding,MF,ANXA1;ANXA2
8800,GO:0033029,0.0391411030177163,0.999358152985951,1,6,regulation of neutrophil apoptotic process,BP,ANXA1
4895,GO:0010718,0.0392202980463292,0.996231338329481,2,44,positive regulation of epithelial to mesenchymal transition,BP,COL1A1;PDPN
8560,GO:0032663,0.0392346284315524,0.996216425300582,2,49,regulation of interleukin-2 production,BP,GBP1;ANXA1
10621,GO:0042246,0.039299442346121,0.996204526278877,2,50,tissue regeneration,BP,POSTN;ANXA1
11395,GO:0043687,0.0393831014857357,0.987318240144236,6,392,post-translational protein modification,BP,CP;CHGB;TIMP1;SPP1;MDGA2;SOCS3
8343,GO:0032370,0.039571325711961,0.996171065945482,2,47,positive regulation of lipid transport,BP,SPP1;ANXA2
8908,GO:0033216,0.039629875401041,0.999341892933056,1,6,ferric iron import,BP,STEAP3
13548,GO:0050885,0.0396648278539456,0.996168200455695,2,43,neuromuscular process controlling balance,BP,TNR;JPH3
9941,GO:0035749,0.0396680541860965,0.999340614132928,1,6,myelin sheath adaxonal region,CC,ANXA2
11465,GO:0044033,0.0396702947875635,0.999321916817706,1,7,multi-organism metabolic process,BP,ANXA2
13779,GO:0051248,0.0399654409052288,0.981437354342936,12,1027,negative regulation of protein metabolic process,BP,LTF;IGF2BP2;TIMP1;SERPINE1;GBP1;IGF2BP3;SERPING1;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
11136,GO:0043235,0.0400219730288294,0.987073066514303,6,351,receptor complex,CC,SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;SHISA7
14701,GO:0060350,0.0401240418496711,0.996088231596825,2,47,endochondral bone morphogenesis,BP,COL1A1;MMP14
15504,GO:0061971,0.0401240418496711,0.996088231596825,2,47,replacement bone morphogenesis,BP,COL1A1;MMP14
4196,GO:0008603,0.0402901414540088,0.999300389627558,1,7,cAMP-dependent protein kinase regulator activity,MF,CXCL10
18122,GO:0098943,0.0403145249923039,0.999299535803776,1,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,CACNG2
2580,GO:0005432,0.0403767996935623,0.999316645586033,1,6,calcium:sodium antiporter activity,MF,SLC8A2
17990,GO:0098711,0.0403852721888247,0.999316356430483,1,6,iron ion import across plasma membrane,BP,STEAP3
15793,GO:0070459,0.0404388270202949,0.999295174971107,1,7,prolactin secretion,BP,ANXA1
19507,GO:1903012,0.0404468391187604,0.999294893414538,1,7,positive regulation of bone development,BP,LTF
6238,GO:0017156,0.0405289603915796,0.992941939772675,3,109,calcium ion regulated exocytosis,BP,CPLX2;KCNB1;RIMS2
11036,GO:0043069,0.0405480826651868,0.982536393954763,10,818,negative regulation of programmed cell death,BP,LTF;TIMP1;SERPINE1;CCL2;LGALS3;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
13460,GO:0050766,0.0406635455787646,0.996001710655954,2,49,positive regulation of phagocytosis,BP,CCL2;PTX3
3759,GO:0007417,0.0408014654714225,0.981660064527765,11,870,central nervous system development,BP,VIM;CRTAC1;TNR;MDGA2;INA;CA10;SHANK2;COL3A1;GRIN1;DSCAML1;COL4A1
6804,GO:0021578,0.0408713048369847,0.999299664659895,1,6,hindbrain maturation,BP,GRIN1
6824,GO:0021626,0.0408713048369847,0.999299664659895,1,6,central nervous system maturation,BP,GRIN1
5607,GO:0015909,0.0408899393240964,0.995964907847084,2,50,long-chain fatty acid transport,BP,ANXA1;PLA2G2A
14166,GO:0051962,0.0409811622131798,0.985325266775979,7,458,positive regulation of nervous system development,BP,TNFRSF12A;SRPX2;CUX2;MMD2;SHANK2;RIMS2;SLITRK1
15021,GO:0060839,0.0409977880920864,0.999275395220319,1,7,endothelial cell fate commitment,BP,PDPN
13701,GO:0051130,0.0411042047141219,0.980226657755248,13,1121,positive regulation of cellular component organization,BP,TNFRSF12A;SRPX2;SERPINE1;CCL2;CUX2;GDF15;ANXA1;SHANK2;PDPN;PTX3;RIMS2;SLITRK1;ANXA2
10718,GO:0042420,0.0411708145978516,0.999269216009582,1,7,dopamine catabolic process,BP,MOXD1
1209,GO:0002697,0.0411808416640273,0.988239522812658,5,300,regulation of immune effector process,BP,LGALS3;ANXA1;SERPING1;C1R;CFI
4631,GO:0009914,0.0411849183520745,0.988243383610189,5,283,hormone transport,BP,SPP1;ANXA1;ADM;KCNB1;RIMS2
17641,GO:0097197,0.041314956978781,0.999264047963164,1,7,tetraspanin-enriched microdomain,CC,PDPN
3408,GO:0006776,0.0415043200955477,0.999257230452168,1,7,vitamin A metabolic process,BP,RBP1
588,GO:0001704,0.0415069347192303,0.99270280693559,3,110,formation of primary germ layer,BP,COL4A2;MMP14;COL5A2
11902,GO:0045182,0.0415148113750263,0.995871764284569,2,49,translation regulator activity,MF,IGF2BP2;IGF2BP3
17837,GO:0097623,0.0416682313817213,0.999251303467392,1,7,potassium ion export across plasma membrane,BP,KCNIP2
12815,GO:0047498,0.0416683638907041,0.99925129866622,1,7,calcium-dependent phospholipase A2 activity,MF,PLA2G2A
2397,GO:0005044,0.0416988855340343,0.995843467231371,2,49,scavenger receptor activity,MF,CD163;CFI
771,GO:0001957,0.041748639569916,0.999269016120438,1,6,intramembranous ossification,BP,COL1A1
10123,GO:0036072,0.041748639569916,0.999269016120438,1,6,direct ossification,BP,COL1A1
13911,GO:0051480,0.041896513443113,0.987985758561892,5,281,regulation of cytosolic calcium ion concentration,BP,GPR17;ADM;JPH3;CXCL10;GRIN1
9153,GO:0034040,0.0420337830559879,0.999258911271582,1,6,lipid-transporting ATPase activity,MF,ABCC3
551,GO:0001649,0.0420507328975972,0.98998980365729,4,191,osteoblast differentiation,BP,LTF;COL1A1;SPP1;SMOC1
3761,GO:0007420,0.0420772282342476,0.982651668072248,9,649,brain development,BP,CRTAC1;TNR;INA;CA10;SHANK2;COL3A1;GRIN1;DSCAML1;COL4A1
954,GO:0002253,0.042081157660822,0.984837589121385,7,504,activation of immune response,BP,LTF;GBP1;LGALS3;SERPING1;C1R;HLA-DQB1;CFI
11392,GO:0043679,0.0421061957317042,0.99254961037574,3,116,axon terminus,CC,KCNIP3;CPLX2;GRIN1
9939,GO:0035747,0.0421923127231375,0.999232192139105,1,7,natural killer cell chemotaxis,BP,CCL2
11315,GO:0043536,0.0423965188589446,0.995738217337306,2,48,positive regulation of blood vessel endothelial cell migration,BP,SRPX2;ANXA1
622,GO:0001763,0.0423996998933657,0.98988385304208,4,185,morphogenesis of a branching structure,BP,ADM;MMP14;SOCS3;COL4A1
14135,GO:0051918,0.0424024671452154,0.999224459781119,1,7,negative regulation of fibrinolysis,BP,SERPINE1
6610,GO:0019730,0.0425815120808779,0.995687129319676,2,58,antimicrobial humoral response,BP,LTF;PLA2G2A
17550,GO:0097049,0.0426506981816362,0.999215275692826,1,7,motor neuron apoptotic process,BP,KCNB1
697,GO:0001849,0.0429193179108077,0.999227079986806,1,6,complement component C1q binding,MF,PTX3
21388,GO:2000402,0.0432676968770279,0.999192209674456,1,7,negative regulation of lymphocyte migration,BP,CCL2
13520,GO:0050854,0.0434309107895822,0.995566244113086,2,52,regulation of antigen receptor-mediated signaling pathway,BP,GBP1;LGALS3
4180,GO:0008559,0.0439302965899544,0.999189906673574,1,6,xenobiotic transmembrane transporting ATPase activity,MF,ABCC3
14417,GO:0055076,0.043988716357475,0.99207495377782,3,123,transition metal ion homeostasis,BP,LTF;CP;STEAP3
21341,GO:2000343,0.0439896698909371,0.999147617279635,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
10355,GO:0038042,0.0440072048748779,0.999164115831823,1,7,dimeric G-protein coupled receptor signaling pathway,BP,ADM
3882,GO:0008083,0.0440668236728895,0.992048454474239,3,131,growth factor activity,MF,TYMP;TIMP1;GDF15
12105,GO:0045656,0.044109712641567,0.999183216759945,1,6,negative regulation of monocyte differentiation,BP,HOXA7
727,GO:0001895,0.0441781612085354,0.995450285227947,2,51,retina homeostasis,BP,LTF;CDHR1
639,GO:0001781,0.0443138461351072,0.999152323226968,1,7,neutrophil apoptotic process,BP,ANXA1
5770,GO:0016247,0.0443874664754058,0.99197658089727,3,121,channel regulator activity,MF,KCNIP3;KCNIP2;CACNG2
2761,GO:0005785,0.0446088684114945,0.999123240017104,1,8,signal recognition particle receptor complex,CC,LTF
951,GO:0002250,0.0448052089778739,0.98690713673831,5,310,adaptive immune response,BP,ANXA1;SERPING1;C1R;HLA-DQB1;CFI
7064,GO:0022849,0.0448318609323325,0.999189350270778,1,5,glutamate-gated calcium ion channel activity,MF,GRIN1
12240,GO:0045916,0.0449841489200689,0.999150210550115,1,6,negative regulation of complement activation,BP,SERPING1
21281,GO:2000258,0.0449841489200689,0.999150210550115,1,6,negative regulation of protein activation cascade,BP,SERPING1
3974,GO:0008235,0.0451134916543928,0.995293137303491,2,54,metalloexopeptidase activity,MF,AEBP1;MMP14
8805,GO:0033034,0.0451508811897284,0.999119705044789,1,7,positive regulation of myeloid cell apoptotic process,BP,ANXA1
893,GO:0002138,0.0453978199030383,0.999091672944669,1,8,retinoic acid biosynthetic process,BP,RBP1
20508,GO:1905049,0.0454094969863044,0.999133914784388,1,6,negative regulation of metallopeptidase activity,BP,TIMP1
8350,GO:0032377,0.0455980160504072,0.999102023861246,1,7,regulation of intracellular lipid transport,BP,ANXA2
8353,GO:0032380,0.0455980160504072,0.999102023861246,1,7,regulation of intracellular sterol transport,BP,ANXA2
8356,GO:0032383,0.0455980160504072,0.999102023861246,1,7,regulation of intracellular cholesterol transport,BP,ANXA2
945,GO:0002237,0.0459858078696883,0.986466854598804,5,311,response to molecule of bacterial origin,BP,LTF;SERPINE1;CCL2;ADM;CXCL10
8566,GO:0032677,0.0459922203084253,0.995148268144345,2,55,regulation of interleukin-8 production,BP,SERPINE1;ANXA1
18125,GO:0098953,0.0461574430683772,0.999060742262604,1,8,receptor diffusion trapping,BP,CACNG2
18134,GO:0098970,0.0461574430683772,0.999060742262604,1,8,postsynaptic neurotransmitter receptor diffusion trapping,BP,CACNG2
18283,GO:0099628,0.0461574430683772,0.999060742262604,1,8,neurotransmitter receptor diffusion trapping,BP,CACNG2
3972,GO:0008233,0.0462820015243445,0.9829775979503,7,510,peptidase activity,MF,LTF;AEBP1;PLAU;ADAM12;MMP14;C1R;CFI
975,GO:0002291,0.0463097873528493,0.999054475563225,1,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
9861,GO:0035630,0.0463800103764052,0.999070670819399,1,7,bone mineralization involved in bone maturation,BP,LTF
19752,GO:1903530,0.0466472097381063,0.981510504138223,8,607,regulation of secretion by cell,BP,FERMT1;GBP1;SPP1;POSTN;ANXA1;CPLX2;KCNB1;RIMS2
6589,GO:0019614,0.0468959879154545,0.999030164220572,1,8,catechol-containing compound catabolic process,BP,MOXD1
10721,GO:0042424,0.0468959879154545,0.999030164220572,1,8,catecholamine catabolic process,BP,MOXD1
21435,GO:2000483,0.0469224135034862,0.999048601963354,1,7,negative regulation of interleukin-8 secretion,BP,ANXA1
5102,GO:0010988,0.0469592020673121,0.999027523783614,1,8,regulation of low-density lipoprotein particle clearance,BP,ANXA2
13472,GO:0050778,0.0469614130551045,0.981357795596321,8,631,positive regulation of immune response,BP,LTF;GBP1;LGALS3;ANXA1;SERPING1;C1R;HLA-DQB1;CFI
16904,GO:0072503,0.0469888404951883,0.984219929847293,6,392,cellular divalent inorganic cation homeostasis,BP,SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
3971,GO:0008228,0.0470134386994545,0.999044872551962,1,7,opsonization,BP,PTX3
7741,GO:0031232,0.0470395080920771,0.999043803088625,1,7,extrinsic component of external side of plasma membrane,CC,ANXA1
15578,GO:0070097,0.0471140099347872,0.999067029611645,1,6,delta-catenin binding,MF,PTPRT
18140,GO:0098978,0.0475540028830802,0.999049352511557,1,6,glutamatergic synapse,CC,SHISA7
18144,GO:0098985,0.0475540028830802,0.999049352511557,1,6,asymmetric, glutamatergic, excitatory synapse,CC,SHISA7
15876,GO:0070588,0.0477615102863953,0.985812252393055,5,275,calcium ion transmembrane transport,BP,SLC8A2;JPH3;CACNG2;CXCL10;GRIN1
21472,GO:2000542,0.0478131256249652,0.999011788860726,1,7,negative regulation of gastrulation,BP,COL5A2
18564,GO:1900040,0.0484210125467035,0.998986255983962,1,7,regulation of interleukin-2 secretion,BP,GBP1
8367,GO:0032395,0.048450395495029,0.998947978058789,1,9,MHC class II receptor activity,MF,HLA-DQB1
21408,GO:2000427,0.0486226756932562,0.998977712257646,1,7,positive regulation of apoptotic cell clearance,BP,CCL2
19122,GO:1902041,0.048664017665636,0.994705271862219,2,55,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1;LGALS3
4617,GO:0009887,0.0487210075139562,0.977454671396301,11,905,animal organ morphogenesis,BP,LTF;SERPINE1;CCL2;COL1A1;HOXA7;ADM;MMP14;SHANK2;COL3A1;DSCAML1;COL5A2
10574,GO:0042129,0.048817361356915,0.990826493232447,3,133,regulation of T cell proliferation,BP,IGFBP2;LGALS3;ANXA1
13870,GO:0051402,0.0488564679664949,0.987792598051841,4,207,neuron apoptotic process,BP,CCL2;KCNB1;GABRB3;GRIN1
1312,GO:0002862,0.0490082277242696,0.998923381298021,1,9,negative regulation of inflammatory response to antigenic stimulus,BP,GPR17
18610,GO:1900122,0.0490718561931777,0.998937174397613,1,8,positive regulation of receptor binding,BP,ANXA2
1641,GO:0003828,0.0491477171688112,0.998983907094461,1,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,ST8SIA3
11600,GO:0044344,0.0494084579171402,0.990679870781917,3,124,cellular response to fibroblast growth factor stimulus,BP,CCL2;COL1A1;POSTN
13860,GO:0051384,0.0494896537845935,0.990653421348947,3,129,response to glucocorticoid,BP,IGFBP2;ANXA1;ADM
10217,GO:0036310,0.0495425667105967,0.998916486800201,1,8,annealing helicase activity,MF,ANXA1
10993,GO:0043005,0.0496079830811289,0.975460809549965,13,1134,neuron projection,CC,VIM;CRTAC1;KCNIP3;SLC8A2;CPLX2;CDHR1;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;GRIN1;SHISA7
8532,GO:0032623,0.0497132971773457,0.994524909579457,2,56,interleukin-2 production,BP,GBP1;ANXA1
4547,GO:0009617,0.0498489223245535,0.983011715194176,6,424,response to bacterium,BP,LTF;SERPINE1;CCL2;ADM;CXCL10;PLA2G2A
19506,GO:1903011,0.0498534976728302,0.998924774201127,1,7,negative regulation of bone development,BP,LTF
14469,GO:0060020,0.0501902632254636,0.998887688317022,1,8,Bergmann glial cell differentiation,BP,VIM
7793,GO:0031313,0.0502892975476828,0.998883251010328,1,8,extrinsic component of endosome membrane,CC,ANXA1
162,GO:0000323,0.0502914544268747,0.979761443322671,8,626,lytic vacuole,CC,CP;ANXA1;CPLX2;FABP5;HLA-DQB1;ANXA2;SERPINA3;IFI30
2743,GO:0005764,0.0502914544268747,0.979761443322671,8,626,lysosome,CC,CP;ANXA1;CPLX2;FABP5;HLA-DQB1;ANXA2;SERPINA3;IFI30
6781,GO:0021548,0.0506775404622879,0.998865768605542,1,8,pons development,BP,GRIN1
13700,GO:0051129,0.0507945454633346,0.979522224179548,8,599,negative regulation of cellular component organization,BP,VIM;TNR;GBP1;SPP1;LGALS3;POSTN;MMP14;CXCL10
5701,GO:0016102,0.050951626792141,0.99883542612729,1,9,diterpenoid biosynthetic process,BP,RBP1
16301,GO:0071420,0.0513963066898165,0.998856491366744,1,7,cellular response to histamine,BP,GABRB3
3470,GO:0006879,0.0514122929572552,0.994229736011376,2,57,cellular iron ion homeostasis,BP,LTF;CP
705,GO:0001867,0.0514428758585997,0.998812635269655,1,9,complement activation, lectin pathway,BP,SERPING1
17570,GO:0097084,0.0515235701647296,0.998827192395384,1,8,vascular smooth muscle cell development,BP,ADM
16263,GO:0071363,0.0515544752275821,0.979154057213703,8,597,cellular response to growth factor stimulus,BP,FERMT1;CCL2;COL1A1;GDF15;POSTN;COL4A2;ANXA1;COL3A1
3634,GO:0007167,0.0516332534897495,0.975875045183705,11,923,enzyme linked receptor protein signaling pathway,BP,VIM;FERMT1;COL1A1;IGFBP2;GDF15;COL4A2;COL3A1;GRIN1;SOCS3;COL4A1;PTPRT
624,GO:0001765,0.0518886098495652,0.998791761056091,1,9,membrane raft assembly,BP,ANXA2
17588,GO:0097113,0.0519326793060458,0.998832249526589,1,7,AMPA glutamate receptor clustering,BP,SHISA7
17866,GO:0097688,0.0519326793060458,0.998832249526589,1,7,glutamate receptor clustering,BP,SHISA7
12699,GO:0046928,0.0520298773698491,0.994136096939902,2,52,regulation of neurotransmitter secretion,BP,CPLX2;RIMS2
6503,GO:0019336,0.0521869999044082,0.998777683416751,1,9,phenol-containing compound catabolic process,BP,MOXD1
9298,GO:0034350,0.0522168655443284,0.998795089567952,1,8,regulation of glial cell apoptotic process,BP,CCL2
9299,GO:0034351,0.0522168655443284,0.998795089567952,1,8,negative regulation of glial cell apoptotic process,BP,CCL2
9210,GO:0034145,0.0522278591971793,0.998775749254479,1,9,positive regulation of toll-like receptor 4 signaling pathway,BP,LTF
7095,GO:0023061,0.0524674660419457,0.981903423610275,6,397,signal release,BP,SPP1;ANXA1;CPLX2;ADM;KCNB1;RIMS2
15097,GO:0060997,0.0525523976394798,0.994058211151916,2,48,dendritic spine morphogenesis,BP,CUX2;SHANK2
9621,GO:0035176,0.0525679460477014,0.994051855489371,2,49,social behavior,BP,SHANK2;GRIN1
14024,GO:0051703,0.0525679460477014,0.994051855489371,2,49,intraspecies interaction between organisms,BP,SHANK2;GRIN1
15131,GO:0061042,0.0526457202176356,0.998755879326438,1,9,vascular wound healing,BP,SERPINE1
3654,GO:0007191,0.0527318222866332,0.998751764758627,1,9,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNAL
15339,GO:0061564,0.0529875040015306,0.979936334555296,7,471,axon development,BP,TNFRSF12A;CRTAC1;TNR;SPP1;GRIN1;DSCAML1;SLITRK1
3953,GO:0008201,0.0536586349771135,0.989533973493154,3,130,heparin binding,MF,LTF;POSTN;CXCL10
16514,GO:0071774,0.0537533660554522,0.989510289290659,3,128,response to fibroblast growth factor,BP,CCL2;COL1A1;POSTN
17824,GO:0097553,0.0537981590528324,0.989514026306089,3,115,calcium ion transmembrane import into cytosol,BP,JPH3;CXCL10;GRIN1
13714,GO:0051147,0.0539187787600928,0.989466225330179,3,127,regulation of muscle cell differentiation,BP,GDF15;MMP14;CXCL10
9056,GO:0033629,0.0540969828581986,0.998705803141546,1,8,negative regulation of cell adhesion mediated by integrin,BP,SERPINE1
13646,GO:0051045,0.0542931537426657,0.998696299238201,1,8,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP1
13272,GO:0048878,0.05449081012095,0.974307150789789,11,961,chemical homeostasis,BP,LTF;CP;RBP1;STEAP3;SLC8A2;GPR17;ADM;JPH3;KCNB1;CXCL10;GRIN1
17607,GO:0097151,0.0547399590378535,0.998701132929032,1,7,positive regulation of inhibitory postsynaptic potential,BP,RIMS2
18052,GO:0098828,0.0547399590378535,0.998701132929032,1,7,modulation of inhibitory postsynaptic potential,BP,RIMS2
3825,GO:0007614,0.0548069611962376,0.99865050134977,1,9,short-term memory,BP,CUX2
5216,GO:0014823,0.0548513096869152,0.993629128180128,2,54,response to activity,BP,POSTN;COL4A2
16286,GO:0071396,0.0548556202859756,0.979060325025987,7,514,cellular response to lipid,BP,LTF;SERPINE1;CCL2;COL1A1;SPP1;ANXA1;CXCL10
19828,GO:1903670,0.054978127248911,0.993603190361986,2,55,regulation of sprouting angiogenesis,BP,SRPX2;ANXA1
21339,GO:2000341,0.0549842512245828,0.998624973429498,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
267,GO:0000733,0.0549844568701838,0.998641652587646,1,9,DNA strand renaturation,BP,ANXA1
7300,GO:0030314,0.055003654267824,0.998688450547392,1,7,junctional membrane complex,CC,JPH3
16284,GO:0071394,0.0551503928619916,0.998633353399275,1,9,cellular response to testosterone stimulus,BP,SPP1
7022,GO:0022408,0.0553710059151768,0.989058381817032,3,135,negative regulation of cell-cell adhesion,BP,TNR;LGALS3;ANXA1
19950,GO:1903909,0.0554444946833545,0.99863980395049,1,8,regulation of receptor clustering,BP,SHISA7
16987,GO:0072657,0.0556540245896716,0.978684870297101,7,528,protein localization to membrane,BP,KCNIP3;GBP1;KCNB1;GRIN1;ANXA2;SHISA7;RTP5
16907,GO:0072507,0.0556590302881453,0.980521467775755,6,408,divalent inorganic cation homeostasis,BP,SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1
11307,GO:0043524,0.0558631364022854,0.988926314178536,3,131,negative regulation of neuron apoptotic process,BP,CCL2;GABRB3;GRIN1
11161,GO:0043270,0.0559248388226371,0.985401978351534,4,214,positive regulation of ion transport,BP,CCL2;LGALS3;CXCL10;GRIN1
12695,GO:0046920,0.0561271936912637,0.998605726029467,1,8,alpha-(1->3)-fucosyltransferase activity,MF,FUT9
1206,GO:0002694,0.0561894467997646,0.980284046885578,6,431,regulation of leukocyte activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;MMP14;HLA-DQB1
7507,GO:0030814,0.0563018626263168,0.993348260211006,2,60,regulation of cAMP metabolic process,BP,ADM;CXCL10
12232,GO:0045906,0.0566513267602774,0.998607778905032,1,7,negative regulation of vasoconstriction,BP,ADM
7811,GO:0031338,0.0568184428552902,0.993261644186967,2,57,regulation of vesicle fusion,BP,ANXA1;ANXA2
19011,GO:1901698,0.0568425248867761,0.973008458369394,11,957,response to nitrogen compound,BP,TIMP1;COL1A1;ANXA1;ADM;GABRB3;NNMT;COL3A1;GRIN1;SOCS3;COL4A1;COL5A2
12067,GO:0045605,0.0569112107067208,0.998543695360642,1,9,negative regulation of epidermal cell differentiation,BP,HOXA7
10533,GO:0042048,0.0569170869666161,0.998594536393575,1,7,olfactory behavior,BP,GRIN1
7989,GO:0031670,0.056943025061113,0.993235787918073,2,58,cellular response to nutrient,BP,COL1A1;POSTN
18207,GO:0099175,0.0569802771139456,0.99324802306667,2,52,regulation of postsynapse organization,BP,CUX2;SHISA7
4801,GO:0010562,0.0570642146878715,0.972884178368008,11,971,positive regulation of phosphorus metabolic process,BP,LTF;CCL2;GDF15;CHI3L1;MMD2;ADM;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
12259,GO:0045937,0.0570642146878715,0.972884178368008,11,971,positive regulation of phosphate metabolic process,BP,LTF;CCL2;GDF15;CHI3L1;MMD2;ADM;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
2745,GO:0005766,0.0571719869869011,0.988551736732188,3,140,primary lysosome,CC,FABP5;ANXA2;SERPINA3
10800,GO:0042582,0.0571719869869011,0.988551736732188,3,140,azurophil granule,CC,FABP5;ANXA2;SERPINA3
4926,GO:0010755,0.0572250359615802,0.998509330050598,1,10,regulation of plasminogen activation,BP,SERPINE1
10167,GO:0036149,0.0573783860989765,0.998501241417637,1,10,phosphatidylinositol acyl-chain remodeling,BP,PLA2G2A
8396,GO:0032429,0.057378908158077,0.998542124803588,1,8,regulation of phospholipase A2 activity,BP,ANXA1
8131,GO:0031995,0.0574871033346104,0.998536559149067,1,8,insulin-like growth factor II binding,MF,IGFBP2
11571,GO:0044306,0.0578503377729312,0.988370765446517,3,131,neuron projection terminus,CC,KCNIP3;CPLX2;GRIN1
6496,GO:0019317,0.0579283362539658,0.998513749426781,1,8,fucose catabolic process,BP,FUT9
10679,GO:0042354,0.0579283362539658,0.998513749426781,1,8,L-fucose metabolic process,BP,FUT9
10680,GO:0042355,0.0579283362539658,0.998513749426781,1,8,L-fucose catabolic process,BP,FUT9
19145,GO:1902105,0.0579856621167431,0.984680023665195,4,223,regulation of leukocyte differentiation,BP,LTF;HOXA7;ANXA1;MMP14
1867,GO:0004185,0.0581634410612587,0.998478161292051,1,9,serine-type carboxypeptidase activity,MF,AEBP1
4965,GO:0010819,0.0582945168130716,0.998452452807555,1,10,regulation of T cell chemotaxis,BP,CXCL10
2517,GO:0005262,0.0583943952180439,0.988243325942997,3,112,calcium channel activity,MF,JPH3;CACNG2;GRIN1
11770,GO:0044848,0.0584168296945778,0.998464721026016,1,9,biological phase,BP,FERMT1
11772,GO:0044851,0.0584168296945778,0.998464721026016,1,9,hair cycle phase,BP,FERMT1
13237,GO:0048819,0.0584168296945778,0.998464721026016,1,9,regulation of hair follicle maturation,BP,FERMT1
17917,GO:0098542,0.0585315371646472,0.981586585351741,5,337,defense response to other organism,BP,LTF;SERPINE1;GBP1;CXCL10;PLA2G2A
14134,GO:0051917,0.0585570580748688,0.998438323827146,1,10,regulation of fibrinolysis,BP,SERPINE1
10951,GO:0042908,0.0586266515843105,0.998477280861059,1,8,xenobiotic transport,BP,ABCC3
10952,GO:0042910,0.0586266515843105,0.998477280861059,1,8,xenobiotic transmembrane transporter activity,MF,ABCC3
12080,GO:0045625,0.0586678614220252,0.99843234110419,1,10,regulation of T-helper 1 cell differentiation,BP,ANXA1
5816,GO:0016328,0.0588646860256378,0.992884106255503,2,56,lateral plasma membrane,CC,ANXA1;KCNB1
8279,GO:0032269,0.0589361322115689,0.971841892529212,11,974,negative regulation of cellular protein metabolic process,BP,LTF;IGF2BP2;TIMP1;SERPINE1;GBP1;IGF2BP3;SERPING1;ELFN2;ANXA2;SOCS3;SERPINA3
9087,GO:0033691,0.0590554129116904,0.998454665245342,1,8,sialic acid binding,MF,ST8SIA3
21542,GO:2000644,0.0591419388437402,0.998425925666459,1,9,regulation of receptor catabolic process,BP,ANXA2
2909,GO:0006026,0.0592408326641587,0.99280408188395,2,59,aminoglycan catabolic process,BP,CHI3L2;CHI3L1
17291,GO:0090197,0.0593580775368854,0.998394810069286,1,10,positive regulation of chemokine secretion,BP,POSTN
5485,GO:0015677,0.0595514920237384,0.998428285921535,1,8,copper ion import,BP,STEAP3
11353,GO:0043589,0.059680875863833,0.998421368278057,1,8,skin morphogenesis,BP,COL1A1
21805,GO:2001223,0.0597608807678568,0.998417082950901,1,8,negative regulation of neuron migration,BP,COL3A1
3498,GO:0006915,0.0598083135316342,0.966923661502668,17,1746,apoptotic process,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;KCNIP3;STEAP3;GDF15;LGALS3;CHI3L1;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
21406,GO:2000425,0.0599979702640669,0.998379487896992,1,9,regulation of apoptotic cell clearance,BP,CCL2
2486,GO:0005215,0.0600589749543965,0.970260654924454,12,1089,transporter activity,MF,SLCO1A2;ABCC3;KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GABRG1;SVOP;GABRB3;CACNG2;GRIN1
7984,GO:0031665,0.0602004554575283,0.998348389509211,1,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,LTF
10569,GO:0042118,0.0602081030638126,0.998367983037925,1,9,endothelial cell activation,BP,CXCL10
15300,GO:0061450,0.0604412642120819,0.99833499489833,1,10,trophoblast cell migration,BP,TIMP1
18809,GO:1901163,0.0604412642120819,0.99833499489833,1,10,regulation of trophoblast cell migration,BP,TIMP1
8089,GO:0031915,0.0606061725786656,0.998346074348442,1,9,positive regulation of synaptic plasticity,BP,CPLX2
11047,GO:0043097,0.0611265439659697,0.998279698572659,1,11,pyrimidine nucleoside salvage,BP,TYMP
2354,GO:0004972,0.0611525120007102,0.998374821943873,1,7,NMDA glutamate receptor activity,MF,GRIN1
13160,GO:0048678,0.0612935432907266,0.992403968523155,2,62,response to axon injury,BP,TNR;SPP1
9041,GO:0033605,0.0614159383896586,0.998280214405927,1,10,positive regulation of catecholamine secretion,BP,KCNB1
10879,GO:0042742,0.0614682554647923,0.987320639818295,3,147,defense response to bacterium,BP,LTF;SERPINE1;PLA2G2A
15018,GO:0060836,0.0615191003323811,0.998321404593845,1,8,lymphatic endothelial cell differentiation,BP,PDPN
2478,GO:0005179,0.0615395658708996,0.992341210159593,2,68,hormone activity,MF,CHGB;ADM
6661,GO:0019841,0.0619376436427865,0.998233192164072,1,11,retinol binding,MF,RBP1
9535,GO:0034776,0.0619545614838909,0.99827075078599,1,9,response to histamine,BP,GABRB3
9987,GO:0035845,0.0622971417672953,0.998251339873498,1,9,photoreceptor cell outer segment organization,BP,CDHR1
15991,GO:0070848,0.0623871796317685,0.973771364970646,8,621,response to growth factor,BP,FERMT1;CCL2;COL1A1;GDF15;POSTN;COL4A2;ANXA1;COL3A1
13154,GO:0048671,0.0624821062858004,0.998267780506133,1,8,negative regulation of collateral sprouting,BP,SPP1
14736,GO:0060395,0.0625251651623232,0.992171148504675,2,60,SMAD protein signal transduction,BP,VIM;GDF15
10767,GO:0042532,0.0626044257217261,0.99821218786461,1,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,SOCS3
13763,GO:0051224,0.0626305935653098,0.98698713966574,3,143,negative regulation of protein transport,BP,GBP1;ANXA1;KCNB1
14027,GO:0051707,0.0627308212138179,0.973587228882277,8,679,response to other organism,BP,LTF;SERPINE1;CCL2;GBP1;ADM;PTX3;CXCL10;PLA2G2A
6009,GO:0016723,0.0628372430478799,0.998198703559657,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,STEAP3
2840,GO:0005912,0.062844062258965,0.97527664742006,7,508,adherens junction,CC,VIM;FERMT1;PLAU;ANXA1;MMP14;S100A11;ANXA2
10714,GO:0042415,0.0629197534117105,0.998193912271601,1,10,norepinephrine metabolic process,BP,MOXD1
15231,GO:0061299,0.0631035080121502,0.998205212210379,1,9,retina vasculature morphogenesis in camera-type eye,BP,COL4A1
10289,GO:0036477,0.0631128508200213,0.971915691412847,9,721,somatodendritic compartment,CC,KCNIP3;SLC8A2;CPLX2;KCNB1;SHANK2;GABRG1;CACNG2;GRIN1;SHISA7
722,GO:0001890,0.0632987947689684,0.986799892142869,3,136,placenta development,BP,SPP1;ADM;SOCS3
11116,GO:0043207,0.0634951179705551,0.973198340793727,8,681,response to external biotic stimulus,BP,LTF;SERPINE1;CCL2;GBP1;ADM;PTX3;CXCL10;PLA2G2A
17771,GO:0097458,0.0636013361399414,0.965794699207555,15,1418,neuron part,CC,VIM;CRTAC1;KCNIP3;SLC8A2;CPLX2;CDHR1;KCNB1;SHANK2;GABRG1;SVOP;GABRB3;CACNG2;RIMS2;GRIN1;SHISA7
13219,GO:0048771,0.0639496165137294,0.986610175140449,3,135,tissue remodeling,BP,SPP1;ANXA1;MMP14
1290,GO:0002829,0.0639505760649891,0.998115029807499,1,11,negative regulation of type 2 immune response,BP,ANXA1
12083,GO:0045628,0.0641717773042282,0.99810180593966,1,11,regulation of T-helper 2 cell differentiation,BP,ANXA1
4574,GO:0009725,0.064483546887587,0.969866664277708,10,876,response to hormone,BP,TIMP1;COL1A1;IGFBP2;SPP1;POSTN;ANXA1;ADM;MMP14;ANXA2;SOCS3
7423,GO:0030593,0.0645533113993522,0.991747263066748,2,69,neutrophil chemotaxis,BP,CCL2;LGALS3
17582,GO:0097107,0.064560398283474,0.998186154581587,1,7,postsynaptic density assembly,BP,SHANK2
17984,GO:0098698,0.064560398283474,0.998186154581587,1,7,postsynaptic specialization assembly,BP,SHANK2
520,GO:0001574,0.0645836221201628,0.998095900996678,1,10,ganglioside biosynthetic process,BP,ST8SIA3
1624,GO:0003730,0.0645846696608072,0.991759911829357,2,62,mRNA 3'-UTR binding,MF,IGF2BP2;IGF2BP3
10853,GO:0042692,0.0645871153392073,0.979129394143883,5,306,muscle cell differentiation,BP,GDF15;ADAM12;ADM;MMP14;CXCL10
21803,GO:2001214,0.0645883684049345,0.998095617616519,1,10,positive regulation of vasculogenesis,BP,ADM
941,GO:0002227,0.0646475573069945,0.998057475181844,1,12,innate immune response in mucosa,BP,LTF
13463,GO:0050769,0.0647044019141748,0.976501892275821,6,404,positive regulation of neurogenesis,BP,TNFRSF12A;CUX2;MMD2;SHANK2;RIMS2;SLITRK1
18139,GO:0098976,0.0648022183001403,0.998135035368192,1,8,excitatory chemical synaptic transmission,BP,GRIN1
17290,GO:0090196,0.0648787451350704,0.99805922423015,1,11,regulation of chemokine secretion,BP,POSTN
7398,GO:0030534,0.0649270259198143,0.986329829380953,3,129,adult behavior,BP,SHANK2;GRIN1;SLITRK1
13647,GO:0051046,0.065041148904837,0.97241391990823,8,652,regulation of secretion,BP,FERMT1;GBP1;SPP1;POSTN;ANXA1;CPLX2;KCNB1;RIMS2
15320,GO:0061515,0.0650822933041045,0.99166084135986,2,62,myeloid cell development,BP,LTF;ANXA2
14846,GO:0060548,0.0651277777797209,0.969509195286729,10,891,negative regulation of cell death,BP,LTF;TIMP1;SERPINE1;CCL2;LGALS3;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
7539,GO:0030855,0.0652297330363266,0.974118397317659,7,525,epithelial cell differentiation,BP,VIM;SERPINE1;HOXA7;LGALS3;ANXA1;PDPN;COL4A1
5947,GO:0016595,0.0652317539109747,0.998057003732509,1,10,glutamate binding,MF,GRIN1
11624,GO:0044406,0.065374497820896,0.998029075466046,1,11,adhesion of symbiont to host,BP,LTF
4963,GO:0010817,0.0654786283935515,0.976140148717449,6,436,regulation of hormone levels,BP,RBP1;SPP1;ANXA1;ADM;KCNB1;RIMS2
16989,GO:0072659,0.0655626137966329,0.981972459524094,4,220,protein localization to plasma membrane,BP,KCNIP3;GBP1;KCNB1;ANXA2
11124,GO:0043220,0.065654070924108,0.998031441578461,1,10,Schmidt-Lanterman incisure,CC,ANXA2
7073,GO:0022890,0.0657948992435072,0.973845360642646,7,517,inorganic cation transmembrane transporter activity,MF,KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;CACNG2;GRIN1
11038,GO:0043083,0.0658736006386242,0.998042057513188,1,9,synaptic cleft,CC,GRIN1
18609,GO:1900121,0.0658799649720645,0.997998090589786,1,11,negative regulation of receptor binding,BP,CRTAC1
17001,GO:0072676,0.066052298188737,0.991446926047932,2,69,lymphocyte migration,BP,CCL2;CXCL10
4224,GO:0008655,0.066238141136952,0.997959472686039,1,12,pyrimidine-containing compound salvage,BP,TYMP
16949,GO:0072567,0.0664767071027571,0.997944560346595,1,12,chemokine (C-X-C motif) ligand 2 production,BP,POSTN
21545,GO:2000647,0.066515872269218,0.997978746452866,1,10,negative regulation of stem cell proliferation,BP,FERMT1
13222,GO:0048788,0.0666530807840901,0.998117740806709,1,6,cytoskeleton of presynaptic active zone,CC,RIMS2
20705,GO:1905523,0.0666642013625194,0.997949526643851,1,11,positive regulation of macrophage migration,BP,MMP14
5067,GO:0010941,0.0667967268881095,0.963816490307589,15,1515,regulation of cell death,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;STEAP3;GDF15;LGALS3;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
5826,GO:0016358,0.0669264802371172,0.981483647664368,4,206,dendrite development,BP,CUX2;SHANK2;CSMD3;GRIN1
1349,GO:0002921,0.0669469934710742,0.997952117409847,1,10,negative regulation of humoral immune response,BP,SERPING1
20457,GO:1904950,0.0669909258242528,0.985692381240652,3,147,negative regulation of establishment of protein localization,BP,GBP1;ANXA1;KCNB1
6028,GO:0016757,0.0670612103620637,0.981409426777859,4,240,transferase activity, transferring glycosyl groups,MF,TYMP;GALNT13;FUT9;ST8SIA3
15513,GO:0062013,0.0670656302001323,0.985674532204957,3,143,positive regulation of small molecule metabolic process,BP,ANXA1;ADM;CXCL10
19703,GO:1903426,0.0671779253364251,0.991229691777355,2,65,regulation of reactive oxygen species biosynthetic process,BP,PTX3;GRIN1
15710,GO:0070307,0.0672884436000162,0.997910443509892,1,11,lens fiber cell development,BP,VIM
1288,GO:0002827,0.0674401054650477,0.997883773380565,1,12,positive regulation of T-helper 1 type immune response,BP,ANXA1
13832,GO:0051336,0.0676649642970273,0.965839091677808,12,1106,regulation of hydrolase activity,BP,LTF;TIMP1;SERPINE1;CCL2;SPOCD1;ANXA1;SERPING1;MMP14;PTX3;ELFN2;GRIN1;SERPINA3
7970,GO:0031644,0.0677102343956458,0.991124129743874,2,64,regulation of neurological system process,BP,TYMP;TNR
14590,GO:0060192,0.0677228010608772,0.997883025467261,1,11,negative regulation of lipase activity,BP,ANXA1
18270,GO:0099590,0.067816751350197,0.997877070897274,1,11,neurotransmitter receptor internalization,BP,CACNG2
14940,GO:0060707,0.0679711393987024,0.997867267141259,1,11,trophoblast giant cell differentiation,BP,SOCS3
4143,GO:0008503,0.0679759655411267,0.997887837936493,1,10,benzodiazepine receptor activity,MF,GABRG1
13465,GO:0050771,0.0682002397924643,0.99103686519394,2,60,negative regulation of axonogenesis,BP,TNR;SPP1
5161,GO:0014061,0.0683376737390335,0.997826322039253,1,12,regulation of norepinephrine secretion,BP,KCNB1
18974,GO:1901626,0.0683732622065652,0.997862746079459,1,10,regulation of postsynaptic membrane organization,BP,SHISA7
9086,GO:0033690,0.0684032483177166,0.997839704656852,1,11,positive regulation of osteoblast proliferation,BP,LTF
2485,GO:0005212,0.068405152804425,0.997807073590442,1,13,structural constituent of eye lens,MF,VIM
5094,GO:0010977,0.0685405192356004,0.985241211895452,3,134,negative regulation of neuron projection development,BP,VIM;TNR;SPP1
16066,GO:0070970,0.0688143887500486,0.997834707833469,1,10,interleukin-2 secretion,BP,GBP1
11373,GO:0043627,0.0689748889073718,0.990852645431753,2,68,response to estrogen,BP,IGFBP2;MMP14
14743,GO:0060402,0.0691660152708706,0.985055677791967,3,131,calcium ion transport into cytosol,BP,JPH3;CXCL10;GRIN1
11056,GO:0043116,0.0692574896296609,0.997784681361154,1,11,negative regulation of vascular permeability,BP,ADM
17099,GO:0086008,0.0696322179704527,0.997742069689013,1,12,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,KCNIP2
18040,GO:0098805,0.0698085534441943,0.961943143368804,15,1513,whole membrane,CC,CP;MOXD1;STEAP3;TNR;PLAU;LGALS3;ANXA1;PDPN;FABP5;SVOP;CACNG2;PCDH7;CD163;HLA-DQB1;ANXA2
21814,GO:2001236,0.069828895532604,0.984833803093305,3,146,regulation of extrinsic apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1;LGALS3
19311,GO:1902533,0.07003035709824,0.96677842528515,10,897,positive regulation of intracellular signal transduction,BP,LTF;CCL2;CHI3L1;MMD2;GPR17;COL3A1;CXCL10;KSR2;SOCS3;PLA2G2A
19945,GO:1903901,0.0702072907996645,0.990593707367744,2,69,negative regulation of viral life cycle,BP,LTF;PTX3
8898,GO:0033197,0.070316197959997,0.997696890165462,1,12,response to vitamin E,BP,COL1A1
14693,GO:0060341,0.0704494886779513,0.967971966817071,9,760,regulation of cellular localization,BP,GBP1;CPLX2;JPH3;KCNB1;CXCL10;RIMS2;GRIN1;ANXA2;SHISA7
19512,GO:1903019,0.0704862908154196,0.99768558350247,1,12,negative regulation of glycoprotein metabolic process,BP,PTX3
16311,GO:0071435,0.0705596155879877,0.997680700577921,1,12,potassium ion export,BP,KCNIP2
13458,GO:0050764,0.0706787713905683,0.990497797476943,2,68,regulation of phagocytosis,BP,CCL2;PTX3
13233,GO:0048813,0.0707700686979406,0.984570246668371,3,128,dendrite morphogenesis,BP,CUX2;SHANK2;GRIN1
15612,GO:0070161,0.0710022541375236,0.97128336332564,7,522,anchoring junction,CC,VIM;FERMT1;PLAU;ANXA1;MMP14;S100A11;ANXA2
5311,GO:0015103,0.0710260576839884,0.984472870922708,3,141,inorganic anion transmembrane transporter activity,MF,ABCC3;GABRG1;GABRB3
14523,GO:0060081,0.0711068297055524,0.997663125998898,1,11,membrane hyperpolarization,BP,CACNG2
6129,GO:0016918,0.0713785562884392,0.997609582719413,1,13,retinal binding,MF,RBP1
780,GO:0001967,0.0713876303859581,0.997644377483192,1,11,suckling behavior,BP,GRIN1
11279,GO:0043488,0.071474672417757,0.984325822007669,3,148,regulation of mRNA stability,BP,VIM;IGF2BP2;IGF2BP3
7821,GO:0031348,0.0715259055490342,0.984306481558364,3,151,negative regulation of defense response,BP,GPR17;SERPING1;SOCS3
13896,GO:0051451,0.0718671798678761,0.997612180861141,1,11,myoblast migration,BP,ANXA1
825,GO:0002031,0.0720377544302416,0.997564614570695,1,13,G-protein coupled receptor internalization,BP,ADM
21796,GO:2001204,0.0720677137600665,0.997622122625869,1,10,regulation of osteoclast development,BP,LTF
8278,GO:0032268,0.0720802168538563,0.956964786201304,21,2288,regulation of cellular protein metabolic process,BP,LTF;VIM;IGF2BP2;TIMP1;SERPINE1;CCL2;GBP1;GDF15;CHI3L1;IGF2BP3;MMD2;SERPING1;MMP14;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3
9320,GO:0034374,0.0724393082409142,0.997573474612522,1,11,low-density lipoprotein particle remodeling,BP,PLA2G2A
9303,GO:0034356,0.0725516208661738,0.997546022959076,1,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NNMT
18262,GO:0099569,0.0725621608864617,0.997701246231552,1,7,presynaptic cytoskeleton,CC,RIMS2
5300,GO:0015079,0.0727436655815355,0.983931266186957,3,149,potassium ion transmembrane transporter activity,MF,KCNIP3;KCNIP2;KCNB1
19027,GO:1901741,0.072842602562187,0.997509126681602,1,13,positive regulation of myoblast fusion,BP,GDF15
12989,GO:0048278,0.073151452742768,0.989970942089517,2,69,vesicle docking,BP,CPLX2;KCNB1
20846,GO:1905954,0.0731696928146141,0.98997619590715,2,66,positive regulation of lipid localization,BP,SPP1;ANXA2
8173,GO:0032060,0.073296502923975,0.997514883750421,1,11,bleb assembly,BP,EMP3
6860,GO:0021700,0.0733159401419961,0.979076857550058,4,228,developmental maturation,BP,LTF;FERMT1;KCNIP2;GRIN1
21382,GO:2000392,0.073782522965857,0.997481343962839,1,11,regulation of lamellipodium morphogenesis,BP,PDPN
8632,GO:0032780,0.0737975260088176,0.997442458624565,1,13,negative regulation of ATPase activity,BP,LTF
10822,GO:0042613,0.0738047490014981,0.997427087270521,1,14,MHC class II protein complex,CC,HLA-DQB1
5428,GO:0015368,0.0740625114533947,0.997461917217487,1,11,calcium:cation antiporter activity,MF,SLC8A2
14697,GO:0060346,0.0740814918696996,0.997485402452129,1,10,bone trabecula formation,BP,COL1A1
12122,GO:0045682,0.0742353474328976,0.98974094533377,2,68,regulation of epidermis development,BP,FERMT1;HOXA7
4537,GO:0009593,0.0747864048116772,0.989602042766999,2,75,detection of chemical stimulus,BP,KCNIP2;RTP5
13695,GO:0051124,0.0748508256683378,0.997463099935325,1,9,synaptic growth at neuromuscular junction,BP,SHANK2
4941,GO:0010770,0.0750991976987836,0.983215748934171,3,133,positive regulation of cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;SLITRK1
10556,GO:0042098,0.0752109290243309,0.983147201159796,3,158,T cell proliferation,BP,IGFBP2;LGALS3;ANXA1
12965,GO:0048243,0.0756321878672302,0.99731182898323,1,13,norepinephrine secretion,BP,KCNB1
7685,GO:0031100,0.0758144201609101,0.989391819343387,2,70,animal organ regeneration,BP,ADM;NNMT
7295,GO:0030307,0.0759515965713216,0.982932939664559,3,142,positive regulation of cell growth,BP,TNFRSF12A;MMP14;RIMS2
11482,GO:0044090,0.0759860562678287,0.997326376465887,1,11,positive regulation of vacuole organization,BP,ANXA2
17289,GO:0090195,0.0763461515786315,0.997260088873524,1,13,chemokine secretion,BP,POSTN
10735,GO:0042448,0.0764688445317983,0.997251146338996,1,13,progesterone metabolic process,BP,ADM
2776,GO:0005811,0.0764751179152865,0.989243996742883,2,71,lipid droplet,CC,RBP1;ANXA2
3969,GO:0008219,0.076476206456169,0.955631189776578,18,1940,cell death,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;KCNIP3;STEAP3;GDF15;LGALS3;CHI3L1;ANXA1;EMP3;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
11957,GO:0045294,0.0765175569174483,0.997288284568158,1,11,alpha-catenin binding,MF,PTPRT
6770,GO:0021537,0.0765999722593441,0.977821219386653,4,225,telencephalon development,BP,CRTAC1;TNR;COL3A1;GRIN1
16957,GO:0072578,0.0766927710517118,0.997302254708132,1,10,neurotransmitter-gated ion channel clustering,BP,SHISA7
4481,GO:0009311,0.0768621059099483,0.989153029065747,2,73,oligosaccharide metabolic process,BP,GALNT13;ST8SIA3
15529,GO:0070008,0.0768744691528276,0.997240297165067,1,12,serine-type exopeptidase activity,MF,AEBP1
14026,GO:0051705,0.076885619040516,0.989180389939576,2,63,multi-organism behavior,BP,SHANK2;GRIN1
1202,GO:0002690,0.0770750754150601,0.98909040765614,2,79,positive regulation of leukocyte chemotaxis,BP,SERPINE1;CXCL10
12138,GO:0045723,0.0775391479655131,0.997172500405018,1,13,positive regulation of fatty acid biosynthetic process,BP,ANXA1
7455,GO:0030666,0.0775483604662683,0.982412344514529,3,151,endocytic vesicle membrane,CC,CACNG2;CD163;HLA-DQB1
20689,GO:1905475,0.0776249084288565,0.982385316459994,3,153,regulation of protein localization to membrane,BP,GBP1;KCNB1;SHISA7
7194,GO:0030168,0.0776768554951232,0.982373804666961,3,149,platelet activation,BP,COL1A1;PDPN;COL3A1
12282,GO:0045981,0.077755453952039,0.988958175211997,2,72,positive regulation of nucleotide metabolic process,BP,ADM;CXCL10
18732,GO:1900544,0.077755453952039,0.988958175211997,2,72,positive regulation of purine nucleotide metabolic process,BP,ADM;CXCL10
7272,GO:0030277,0.077787124738428,0.997154116051203,1,13,maintenance of gastrointestinal epithelium,BP,SERPINA3
615,GO:0001750,0.0778040906718481,0.988966605529608,2,66,photoreceptor outer segment,CC,CDHR1;SHANK2
5606,GO:0015908,0.0778073759511286,0.988949621539305,2,71,fatty acid transport,BP,ANXA1;PLA2G2A
5706,GO:0016114,0.0780791666470566,0.997115748152819,1,14,terpenoid biosynthetic process,BP,RBP1
11106,GO:0043195,0.0783547853794534,0.988840743186909,2,67,terminal bouton,CC,CPLX2;GRIN1
8806,GO:0033036,0.0792723280127019,0.950787394608944,24,2693,macromolecule localization,BP,SNAP91;IGF2BP2;SLCO1A2;APOL4;FERMT1;COL1A1;ABCC3;KCNIP3;STEAP3;GBP1;SPP1;CHI3L1;POSTN;ANXA1;IGF2BP3;MMD2;KCNB1;CACNG2;RIMS2;GRIN1;ANXA2;SHISA7;RTP5;PLA2G2A
5112,GO:0012501,0.0792857699649262,0.954439458289523,17,1816,programmed cell death,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;KCNIP3;STEAP3;GDF15;LGALS3;CHI3L1;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
7029,GO:0022600,0.079296173351643,0.988608186319589,2,74,digestive system process,BP,TYMP;SERPINA3
1400,GO:0003073,0.0794595475413146,0.988574352699739,2,73,regulation of systemic arterial blood pressure,BP,POSTN;ADM
2606,GO:0005513,0.0795520041925009,0.99704165694028,1,12,detection of calcium ion,BP,KCNIP2
4085,GO:0008417,0.0796812253224618,0.997031890316304,1,12,fucosyltransferase activity,MF,FUT9
972,GO:0002286,0.0797499936171457,0.988508941851772,2,73,T cell activation involved in immune response,BP,LGALS3;ANXA1
4022,GO:0008306,0.079795830915832,0.988518005053577,2,67,associative learning,BP,TNR;GRIN1
2051,GO:0004553,0.0798076363861273,0.988490170984751,2,75,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,CHI3L2;CHI3L1
11828,GO:0045064,0.0798410464323706,0.996982084363456,1,14,T-helper 2 cell differentiation,BP,ANXA1
13116,GO:0048598,0.0798596374822201,0.966814584645685,7,539,embryonic morphogenesis,BP,HOXA7;COL4A2;ADM;MMP14;DSCAML1;SOCS3;COL5A2
13713,GO:0051146,0.0799491368990366,0.976513003703848,4,231,striated muscle cell differentiation,BP,GDF15;ADAM12;MMP14;CXCL10
20929,GO:1990266,0.0800235796464922,0.988433271165791,2,78,neutrophil migration,BP,CCL2;LGALS3
15823,GO:0070509,0.0802685707119793,0.988422548578139,2,64,calcium ion import,BP,CCL2;LGALS3
15738,GO:0070365,0.0803361270093628,0.996961579067225,1,13,hepatocyte differentiation,BP,ANXA1
17688,GO:0097286,0.0805123147585046,0.996948030784992,1,13,iron ion import,BP,STEAP3
10166,GO:0036148,0.0805375125167905,0.996946090616873,1,13,phosphatidylglycerol acyl-chain remodeling,BP,PLA2G2A
4541,GO:0009607,0.0806222374231171,0.964217653499353,8,717,response to biotic stimulus,BP,LTF;SERPINE1;CCL2;GBP1;ADM;PTX3;CXCL10;PLA2G2A
17835,GO:0097617,0.0806938242804861,0.99693404077535,1,13,annealing activity,MF,ANXA1
19753,GO:1903531,0.0808376546253446,0.981340946083388,3,158,negative regulation of secretion by cell,BP,GBP1;ANXA1;KCNB1
10734,GO:0042447,0.0809489017161614,0.996896439193488,1,14,hormone catabolic process,BP,SPP1
11122,GO:0043218,0.080993383878273,0.996910879794399,1,13,compact myelin,CC,ANXA2
14742,GO:0060401,0.0810500261900319,0.981295227810041,3,141,cytosolic calcium ion transport,BP,JPH3;CXCL10;GRIN1
5099,GO:0010984,0.0811237868656326,0.99688280638871,1,14,regulation of lipoprotein particle clearance,BP,ANXA2
11278,GO:0043487,0.0812255890786591,0.981216832028904,3,156,regulation of RNA stability,BP,VIM;IGF2BP2;IGF2BP3
12076,GO:0045621,0.0812392114026704,0.988165420718209,2,75,positive regulation of lymphocyte differentiation,BP,ANXA1;MMP14
19758,GO:1903539,0.0814191131577921,0.996898926234044,1,12,protein localization to postsynaptic membrane,BP,GRIN1
6463,GO:0019215,0.0814995349357914,0.996892700482053,1,12,intermediate filament binding,MF,VIM
12046,GO:0045579,0.0815232204889525,0.996869694419793,1,13,positive regulation of B cell differentiation,BP,MMP14
2514,GO:0005254,0.0815471728725501,0.988107375559094,2,71,chloride channel activity,MF,GABRG1;GABRB3
21200,GO:2000106,0.0815841835815496,0.988086654695285,2,75,regulation of leukocyte apoptotic process,BP,LGALS3;ANXA1
629,GO:0001771,0.0816534945357088,0.996859524837833,1,13,immunological synapse formation,BP,LGALS3
21729,GO:2001044,0.081687063534723,0.996856901584529,1,13,regulation of integrin-mediated signaling pathway,BP,TIMP1
14550,GO:0060134,0.0818464655164933,0.996865769447717,1,12,prepulse inhibition,BP,GRIN1
12091,GO:0045638,0.081869096020608,0.988027449262915,2,73,negative regulation of myeloid cell differentiation,BP,LTF;HOXA7
8653,GO:0032802,0.0821008827293145,0.996824470818306,1,13,low-density lipoprotein particle receptor catabolic process,BP,ANXA2
13716,GO:0051149,0.0823724215914506,0.98791199051835,2,73,positive regulation of muscle cell differentiation,BP,GDF15;MMP14
11771,GO:0044849,0.0825474901233173,0.996770677696936,1,14,estrous cycle,BP,ANXA1
1201,GO:0002689,0.0826005491275803,0.996766459339899,1,14,negative regulation of leukocyte chemotaxis,BP,CCL2
5174,GO:0014701,0.0826911914354373,0.996894183001521,1,9,junctional sarcoplasmic reticulum membrane,CC,JPH3
5169,GO:0014069,0.0832580680590004,0.975214874836016,4,221,postsynaptic density,CC,SHANK2;CACNG2;GRIN1;SHISA7
10823,GO:0042622,0.0835276399054689,0.996711339170958,1,13,photoreceptor outer segment membrane,CC,CDHR1
12078,GO:0045623,0.0836130927684075,0.996704498487453,1,13,negative regulation of T-helper cell differentiation,BP,ANXA1
17525,GO:0097006,0.083625093284861,0.987622821092101,2,73,regulation of plasma lipoprotein particle levels,BP,ANXA2;PLA2G2A
15098,GO:0060998,0.0837158559700453,0.987638723439574,2,63,regulation of dendritic spine development,BP,CUX2;SHANK2
18897,GO:1901379,0.0837641167510531,0.987604066264107,2,69,regulation of potassium ion transmembrane transport,BP,KCNIP3;KCNIP2
743,GO:0001921,0.0838351177109226,0.996686690617861,1,13,positive regulation of receptor recycling,BP,ANXA2
13936,GO:0051546,0.0839755406160418,0.996675402194947,1,13,keratinocyte migration,BP,FERMT1
18264,GO:0099572,0.0842455529046272,0.974820198186192,4,222,postsynaptic specialization,CC,SHANK2;CACNG2;GRIN1;SHISA7
3819,GO:0007606,0.0843730104895982,0.987425722925658,2,81,sensory perception of chemical stimulus,BP,GNAL;RTP5
18724,GO:1900452,0.0846877814897064,0.996640690630119,1,12,regulation of long term synaptic depression,BP,KCNB1
15808,GO:0070482,0.0847272569604301,0.970394126984347,5,353,response to oxygen levels,BP,COL1A1;PLAU;POSTN;ADM;MMP14
7819,GO:0031346,0.0847652804411216,0.970391460116518,5,326,positive regulation of cell projection organization,BP,TNFRSF12A;CUX2;SHANK2;RIMS2;SLITRK1
20507,GO:1905048,0.0849768625812697,0.996594332336677,1,13,regulation of metallopeptidase activity,BP,TIMP1
18484,GO:0140029,0.0852108393269053,0.987243640743266,2,76,exocytic process,BP,CPLX2;KCNB1
13091,GO:0048545,0.085278360737755,0.970144610228161,5,355,response to steroid hormone,BP,COL1A1;IGFBP2;SPP1;ANXA1;ADM
15852,GO:0070555,0.0852818682566668,0.979864372821185,3,166,response to interleukin-1,BP,CCL2;CHI3L1;ANXA1
694,GO:0001846,0.0853433690517878,0.996587612427222,1,12,opsonin binding,MF,PTX3
11127,GO:0043225,0.085399573596645,0.996583041942275,1,12,ATPase-coupled anion transmembrane transporter activity,MF,ABCC3
18198,GO:0099133,0.085399573596645,0.996583041942275,1,12,ATP hydrolysis coupled anion transmembrane transport,BP,ABCC3
18544,GO:1900006,0.0855951991430525,0.987192426914464,2,65,positive regulation of dendrite development,BP,CUX2;SHANK2
14577,GO:0060170,0.085859393969848,0.987107449088328,2,71,ciliary membrane,CC,CDHR1;SHANK2
13790,GO:0051259,0.0860186556424341,0.966405475316265,6,469,protein complex oligomerization,BP,COL1A1;GBP1;COL6A2;KCNB1;GRIN1;ANXA2
13514,GO:0050848,0.0861572461344285,0.987037256553277,2,71,regulation of calcium-mediated signaling,BP,GBP1;JPH3
3976,GO:0008237,0.0862119688911718,0.979560498681362,3,160,metallopeptidase activity,MF,AEBP1;ADAM12;MMP14
4209,GO:0008625,0.0863484080534412,0.9869726259314,2,77,extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1;LGALS3
10540,GO:0042063,0.0865005278526537,0.973894938179229,4,244,gliogenesis,BP,VIM;CCL2;ANXA1;MMP14
13801,GO:0051279,0.0866367171155353,0.986935068961576,2,68,regulation of release of sequestered calcium ion into cytosol,BP,JPH3;CXCL10
638,GO:0001780,0.0867207143133527,0.996430203873074,1,14,neutrophil homeostasis,BP,ANXA1
18355,GO:0102567,0.0867472912918113,0.996410179730228,1,15,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,PLA2G2A
18356,GO:0102568,0.0867472912918113,0.996410179730228,1,15,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,PLA2G2A
9208,GO:0034143,0.0869948126374235,0.996389323140337,1,15,regulation of toll-like receptor 4 signaling pathway,BP,LTF
18222,GO:0099512,0.0871685579199123,0.958674305820929,9,742,supramolecular fiber,CC,VIM;FERMT1;COL1A1;ANXA1;INA;SHANK2;TUBA1C;COL3A1;COL5A2
11936,GO:0045236,0.0876262221298104,0.996319948887826,1,16,CXCR chemokine receptor binding,MF,CXCL10
823,GO:0002029,0.0876836169943355,0.996315045981607,1,16,desensitization of G-protein coupled receptor protein signaling pathway,BP,ADM
7016,GO:0022401,0.0876836169943355,0.996315045981607,1,16,negative adaptation of signaling pathway,BP,ADM
11053,GO:0043112,0.0880761985613964,0.978934729682065,3,158,receptor metabolic process,BP,ADM;CACNG2;ANXA2
17421,GO:0090399,0.088158233706908,0.99633005743575,1,13,replicative senescence,BP,SERPINE1
10747,GO:0042475,0.088257229695253,0.986541969736374,2,70,odontogenesis of dentin-containing tooth,BP,SERPINE1;ADM
11092,GO:0043174,0.0883457483972657,0.996258239972219,1,16,nucleoside salvage,BP,TYMP
8289,GO:0032279,0.0884962500691689,0.973102204400632,4,226,asymmetric synapse,CC,SHANK2;CACNG2;GRIN1;SHISA7
6240,GO:0017158,0.0885119361417541,0.98647365530173,2,72,regulation of calcium ion-dependent exocytosis,BP,KCNB1;RIMS2
6231,GO:0017146,0.0885876496444367,0.996348177319747,1,11,NMDA selective glutamate receptor complex,CC,GRIN1
17561,GO:0097061,0.0887055650008093,0.9864505806097,2,66,dendritic spine organization,BP,CUX2;SHANK2
4917,GO:0010744,0.0887787131344048,0.996255804854855,1,14,positive regulation of macrophage derived foam cell differentiation,BP,PLA2G2A
1437,GO:0003159,0.0888152432926883,0.996234010940193,1,15,morphogenesis of an endothelium,BP,CXCL10
15197,GO:0061154,0.0888152432926883,0.996234010940193,1,15,endothelial tube morphogenesis,BP,CXCL10
16312,GO:0071437,0.0888850038009323,0.99624668073543,1,14,invadopodium,CC,PDPN
6691,GO:0019897,0.0890370466430152,0.978607117321161,3,159,extrinsic component of plasma membrane,CC,ANXA1;GNAL;ANXA2
12173,GO:0045780,0.0893137514372405,0.99623153977037,1,13,positive regulation of bone resorption,BP,SPP1
12657,GO:0046852,0.0893137514372405,0.99623153977037,1,13,positive regulation of bone remodeling,BP,SPP1
11215,GO:0043371,0.0893175354209756,0.996209433213904,1,14,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
18800,GO:1901136,0.0893200304805484,0.978501442596104,3,166,carbohydrate derivative catabolic process,BP,TYMP;CHI3L2;CHI3L1
10168,GO:0036150,0.0895050661232372,0.996174274008192,1,15,phosphatidylserine acyl-chain remodeling,BP,PLA2G2A
3811,GO:0007597,0.0895069327333367,0.996174111704748,1,15,blood coagulation, intrinsic pathway,BP,SERPING1
13085,GO:0048535,0.0895434720566541,0.996170933860156,1,15,lymph node development,BP,PDPN
13081,GO:0048525,0.0896800951884906,0.986166334085576,2,80,negative regulation of viral process,BP,LTF;PTX3
9297,GO:0034349,0.0897296317681854,0.996173768458237,1,14,glial cell apoptotic process,BP,CCL2
12079,GO:0045624,0.0897339990639997,0.996137679175014,1,16,positive regulation of T-helper cell differentiation,BP,ANXA1
6675,GO:0019865,0.0897506009292141,0.996136225442751,1,16,immunoglobulin binding,MF,LGALS3
21371,GO:2000379,0.0898388120551853,0.986133923128521,2,78,positive regulation of reactive oxygen species metabolic process,BP,PTX3;GRIN1
6468,GO:0019220,0.0898437095987956,0.949155451574306,15,1549,regulation of phosphate metabolic process,BP,LTF;SRPX2;CCL2;GBP1;GDF15;CHI3L1;SPOCD1;MMD2;ADM;ELFN2;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
21801,GO:2001212,0.0899938496403048,0.996150810880953,1,14,regulation of vasculogenesis,BP,ADM
8509,GO:0032591,0.0900083877207593,0.996171666176917,1,13,dendritic spine membrane,CC,SHISA7
2896,GO:0006004,0.0907191478823007,0.996087425209311,1,14,fucose metabolic process,BP,FUT9
9870,GO:0035641,0.0908140386153637,0.996101611830622,1,13,locomotory exploration behavior,BP,TNR
16724,GO:0072148,0.0909271371089575,0.996049590878348,1,15,epithelial cell fate commitment,BP,PDPN
5392,GO:0015271,0.0910781192849532,0.996055855525313,1,14,outward rectifier potassium channel activity,MF,KCNIP2
10559,GO:0042102,0.0913277775751213,0.985753743665453,2,84,positive regulation of T cell proliferation,BP,IGFBP2;ANXA1
5499,GO:0015698,0.0913426906159966,0.977822220618548,3,156,inorganic anion transport,BP,ABCC3;GABRG1;GABRB3
18143,GO:0098984,0.0913721647465793,0.971921993263767,4,229,neuron to neuron synapse,CC,SHANK2;CACNG2;GRIN1;SHISA7
3945,GO:0008191,0.0913961117881147,0.996008018673457,1,15,metalloendopeptidase inhibitor activity,MF,TIMP1
18029,GO:0098793,0.0914044999809294,0.967347910374907,5,355,presynapse,CC,KCNIP3;CPLX2;SVOP;RIMS2;GRIN1
5946,GO:0016594,0.0914249279823707,0.996005456919076,1,15,glycine binding,MF,GRIN1
14556,GO:0060143,0.0918518697239543,0.995949942929091,1,16,positive regulation of syncytium formation by plasma membrane fusion,BP,GDF15
15745,GO:0070372,0.0920310840513956,0.971622894053131,4,260,regulation of ERK1 and ERK2 cascade,BP,CCL2;GBP1;CHI3L1;PLA2G2A
5591,GO:0015874,0.0920985621791986,0.995927775213075,1,16,norepinephrine transport,BP,KCNB1
3841,GO:0007635,0.0922463980397057,0.995975438004693,1,13,chemosensory behavior,BP,GRIN1
2751,GO:0005773,0.0924148972627896,0.957764318854569,8,715,vacuole,CC,CP;ANXA1;CPLX2;FABP5;HLA-DQB1;ANXA2;SERPINA3;IFI30
19288,GO:1902476,0.0926633487285534,0.985453337536247,2,75,chloride transmembrane transport,BP,GABRG1;GABRB3
11889,GO:0045161,0.0927129926017362,0.995961281989457,1,12,neuronal ion channel clustering,BP,KCNIP2
4978,GO:0010832,0.0928865375274148,0.995894815716858,1,14,negative regulation of myotube differentiation,BP,CXCL10
7094,GO:0023058,0.0929001887594814,0.995839553299204,1,17,adaptation of signaling pathway,BP,ADM
4892,GO:0010715,0.0931270633403199,0.995896828088751,1,13,regulation of extracellular matrix disassembly,BP,PDPN
8928,GO:0033267,0.0931548690751548,0.966547303931756,5,338,axon part,CC,CRTAC1;KCNIP3;CPLX2;SHANK2;GRIN1
13496,GO:0050811,0.0932964593341189,0.995857847952636,1,14,GABA receptor binding,MF,GABRG1
14059,GO:0051770,0.0934152746276964,0.995847100796738,1,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL2
4032,GO:0008324,0.0934809426648628,0.959690963313735,7,570,cation transmembrane transporter activity,MF,KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;CACNG2;GRIN1
7492,GO:0030799,0.0935579413672021,0.985215380362388,2,80,regulation of cyclic nucleotide metabolic process,BP,ADM;CXCL10
11958,GO:0045295,0.0937812755135777,0.995899095983837,1,11,gamma-catenin binding,MF,PTPRT
12543,GO:0046597,0.0939044862205925,0.99576358617269,1,16,negative regulation of viral entry into host cell,BP,PTX3
8590,GO:0032717,0.0947219716394269,0.995688157105668,1,16,negative regulation of interleukin-8 production,BP,ANXA1
18394,GO:0106027,0.0951980990871291,0.984846890967935,2,69,neuron projection organization,BP,CUX2;SHANK2
13733,GO:0051174,0.0953219628576288,0.945567804571905,15,1563,regulation of phosphorus metabolic process,BP,LTF;SRPX2;CCL2;GBP1;GDF15;CHI3L1;SPOCD1;MMD2;ADM;ELFN2;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
7847,GO:0031406,0.0953840205927752,0.97639730642131,3,170,carboxylic acid binding,MF,FABP5;GRIN1;ST8SIA3
18055,GO:0098831,0.0956888046588379,0.995819480035565,1,9,presynaptic active zone cytoplasmic component,CC,RIMS2
3754,GO:0007409,0.0957795744341354,0.961551971422154,6,435,axonogenesis,BP,TNFRSF12A;TNR;SPP1;GRIN1;DSCAML1;SLITRK1
4054,GO:0008360,0.0958841153884037,0.976244934959236,3,154,regulation of cell shape,BP,CCL2;ANXA1;PDPN
13462,GO:0050768,0.0961194419599352,0.969932724976259,4,245,negative regulation of neurogenesis,BP,VIM;TNR;SPP1;COL3A1
7818,GO:0031345,0.0961725150186808,0.976137072610009,3,158,negative regulation of cell projection organization,BP,VIM;TNR;SPP1
15288,GO:0061430,0.0963543181301971,0.995602013969045,1,13,bone trabecula morphogenesis,BP,COL1A1
10732,GO:0042445,0.0965146941632881,0.975990092534603,3,177,hormone metabolic process,BP,RBP1;SPP1;ADM
8130,GO:0031994,0.0965454316063639,0.995584222636736,1,13,insulin-like growth factor I binding,MF,IGFBP2
1037,GO:0002385,0.0965863121315644,0.99548138435215,1,18,mucosal immune response,BP,LTF
10793,GO:0042573,0.0970535115977111,0.995452036126315,1,17,retinoic acid metabolic process,BP,RBP1
4894,GO:0010717,0.0970669056113322,0.984344505228979,2,77,regulation of epithelial to mesenchymal transition,BP,COL1A1;PDPN
9057,GO:0033630,0.0971239914281997,0.995462528219072,1,16,positive regulation of cell adhesion mediated by integrin,BP,FERMT1
15146,GO:0061061,0.0973186350194135,0.957639443759938,7,556,muscle structure development,BP,AEBP1;GDF15;ADAM12;ADM;MMP14;COL3A1;CXCL10
13422,GO:0050708,0.0983771528385921,0.964081974278767,5,371,regulation of protein secretion,BP,FERMT1;GBP1;POSTN;ANXA1;KCNB1
16491,GO:0071702,0.0985772551777706,0.938770317859643,21,2399,organic substance transport,BP,SNAP91;IGF2BP2;SLCO1A2;APOL4;FERMT1;COL1A1;ABCC3;KCNIP3;STEAP3;GBP1;SPP1;CHI3L1;POSTN;ANXA1;IGF2BP3;KCNB1;CACNG2;RIMS2;ANXA2;RTP5;PLA2G2A
7302,GO:0030316,0.0987584072605146,0.983916758655651,2,76,osteoclast differentiation,BP,LTF;ANXA2
7309,GO:0030324,0.0990431530245622,0.97511890859322,3,158,lung development,BP,CHI3L1;MMP14;PDPN
2501,GO:0005237,0.0991392104207632,0.995288967965408,1,15,inhibitory extracellular ligand-gated ion channel activity,MF,GABRG1
11861,GO:0045109,0.0992072569808473,0.995282374986555,1,15,intermediate filament organization,BP,VIM
13518,GO:0050852,0.0992441565789556,0.975013574640031,3,182,T cell receptor signaling pathway,BP,GBP1;LGALS3;HLA-DQB1
12104,GO:0045655,0.099802837765488,0.995203847658733,1,16,regulation of monocyte differentiation,BP,HOXA7
6029,GO:0016758,0.0998043766990778,0.974821757544096,3,175,transferase activity, transferring hexosyl groups,MF,TYMP;GALNT13;FUT9
11095,GO:0043177,0.100071014983095,0.974730128886249,3,172,organic acid binding,MF,FABP5;GRIN1;ST8SIA3
20405,GO:1904861,0.10038625571758,0.995218755531553,1,13,excitatory synapse assembly,BP,SHANK2
11314,GO:0043535,0.100427740271637,0.983479145640612,2,78,regulation of blood vessel endothelial cell migration,BP,SRPX2;ANXA1
9519,GO:0034755,0.100854329467967,0.995100275027535,1,16,iron ion transmembrane transport,BP,STEAP3
14121,GO:0051895,0.100924905719658,0.995114366511247,1,15,negative regulation of focal adhesion assembly,BP,MMP14
19535,GO:1903055,0.100987766628066,0.995108159946903,1,15,positive regulation of extracellular matrix organization,BP,PDPN
15110,GO:0061013,0.101248750321825,0.974310467337196,3,169,regulation of mRNA catabolic process,BP,VIM;IGF2BP2;IGF2BP3
10581,GO:0042136,0.101272461563107,0.983242365194124,2,83,neurotransmitter biosynthetic process,BP,MOXD1;PTX3
18828,GO:1901214,0.101480276902014,0.967641693760862,4,264,regulation of neuron death,BP,CCL2;KCNB1;GABRB3;GRIN1
5575,GO:0015849,0.101509623919409,0.967624946563891,4,269,organic acid transport,BP,SLCO1A2;ABCC3;ANXA1;PLA2G2A
12708,GO:0046942,0.101509623919409,0.967624946563891,4,269,carboxylic acid transport,BP,SLCO1A2;ABCC3;ANXA1;PLA2G2A
13758,GO:0051216,0.101577103490171,0.974199369448037,3,164,cartilage development,BP,TIMP1;COL1A1;CHI3L1
11827,GO:0045063,0.101623591027024,0.995004916401112,1,17,T-helper 1 cell differentiation,BP,ANXA1
10527,GO:0042035,0.101792687912554,0.983094008459324,2,87,regulation of cytokine biosynthetic process,BP,IGF2BP2;IGF2BP3
10490,GO:0040008,0.101924438516839,0.955133040104993,7,589,regulation of growth,BP,TNFRSF12A;IGFBP2;TNR;SPP1;MMP14;RIMS2;SOCS3
10704,GO:0042401,0.102035491452228,0.994931540516724,1,19,cellular biogenic amine biosynthetic process,BP,MOXD1
3502,GO:0006925,0.102051223379435,0.994961963750142,1,17,inflammatory cell apoptotic process,BP,ANXA1
17575,GO:0097094,0.102326299559788,0.994975027681267,1,15,craniofacial suture morphogenesis,BP,MMP14
1139,GO:0002573,0.102443073824502,0.973878348946986,3,169,myeloid leukocyte differentiation,BP,LTF;HOXA7;ANXA2
2509,GO:0005249,0.102763551335004,0.982848691454714,2,84,voltage-gated potassium channel activity,MF,KCNIP2;KCNB1
4897,GO:0010720,0.102775977415815,0.957961830882913,6,461,positive regulation of cell development,BP,TNFRSF12A;CUX2;MMD2;SHANK2;RIMS2;SLITRK1
9402,GO:0034505,0.102894202847789,0.994917981592434,1,15,tooth mineralization,BP,COL1A1
2627,GO:0005545,0.102916709731356,0.994915713868839,1,15,1-phosphatidylinositol binding,MF,SNAP91
4964,GO:0010818,0.103341561290191,0.994813869306195,1,18,T cell chemotaxis,BP,CXCL10
3652,GO:0007189,0.103345207566948,0.982702175972091,2,82,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,GNAL;ADM
696,GO:0001848,0.103577990295278,0.994848850415592,1,15,complement binding,MF,PTX3
12574,GO:0046639,0.103845562278957,0.994799342210702,1,16,negative regulation of alpha-beta T cell differentiation,BP,ANXA1
7308,GO:0030323,0.104336150966827,0.973199675029765,3,162,respiratory tube development,BP,CHI3L1;MMP14;PDPN
4055,GO:0008361,0.104441588597375,0.973169560390758,3,157,regulation of cell size,BP,TNFRSF12A;TNR;SPP1
9974,GO:0035809,0.104728327309738,0.99467092042828,1,18,regulation of urine volume,BP,ADM
13388,GO:0050670,0.104973237291921,0.972937059095366,3,182,regulation of lymphocyte proliferation,BP,IGFBP2;LGALS3;ANXA1
13534,GO:0050868,0.105062433892443,0.982230204375686,2,87,negative regulation of T cell activation,BP,LGALS3;ANXA1
19843,GO:1903706,0.105157548610857,0.960832369982023,5,387,regulation of hemopoiesis,BP,LTF;HOXA7;LGALS3;ANXA1;MMP14
12419,GO:0046332,0.105167612898715,0.982250214239525,2,74,SMAD binding,MF,COL3A1;COL5A2
724,GO:0001892,0.105184999520092,0.982217762457571,2,81,embryonic placenta development,BP,ADM;SOCS3
1311,GO:0002861,0.10537081078004,0.994587889441767,1,19,regulation of inflammatory response to antigenic stimulus,BP,GPR17
3688,GO:0007250,0.105588778652086,0.994581207613569,1,18,activation of NF-kappaB-inducing kinase activity,BP,CHI3L1
2513,GO:0005253,0.10559103701659,0.982102256374238,2,83,anion channel activity,MF,GABRG1;GABRB3
3644,GO:0007179,0.105908429198392,0.972622748521246,3,162,transforming growth factor beta receptor signaling pathway,BP,FERMT1;GDF15;COL3A1
4300,GO:0009056,0.105931956895711,0.934235414156632,20,2305,catabolic process,BP,TYMP;VIM;CHI3L2;IGF2BP2;MOXD1;TIMP1;COL1A1;SPP1;CHI3L1;COL4A2;IGF2BP3;COL6A2;MMP14;FABP5;COL3A1;FUT9;ANXA2;COL4A1;PLA2G2A;COL5A2
8743,GO:0032944,0.106144877233038,0.97250458184039,3,183,regulation of mononuclear cell proliferation,BP,IGFBP2;LGALS3;ANXA1
762,GO:0001946,0.106180695730893,0.99458126685718,1,15,lymphangiogenesis,BP,PDPN
1286,GO:0002825,0.106181833388001,0.994502553334434,1,19,regulation of T-helper 1 type immune response,BP,ANXA1
10342,GO:0038024,0.106183412752847,0.981954524610219,2,80,cargo receptor activity,MF,CD163;CFI
19694,GO:1903409,0.106222833665058,0.981933040760981,2,83,reactive oxygen species biosynthetic process,BP,PTX3;GRIN1
18285,GO:0099632,0.106274887819585,0.994509113487913,1,18,protein transport within plasma membrane,BP,CACNG2
18287,GO:0099637,0.106274887819585,0.994509113487913,1,18,neurotransmitter receptor transport,BP,CACNG2
519,GO:0001573,0.106323019250976,0.994522383028497,1,17,ganglioside metabolic process,BP,ST8SIA3
7955,GO:0031623,0.106332487756039,0.981896753979581,2,85,receptor internalization,BP,ADM;CACNG2
4571,GO:0009713,0.106422390298773,0.994477108219829,1,19,catechol-containing compound biosynthetic process,BP,MOXD1
10720,GO:0042423,0.106422390298773,0.994477108219829,1,19,catecholamine biosynthetic process,BP,MOXD1
3740,GO:0007369,0.106422625000827,0.972429901033164,3,164,gastrulation,BP,COL4A2;MMP14;COL5A2
13649,GO:0051048,0.106475111480747,0.972389409762535,3,178,negative regulation of secretion,BP,GBP1;ANXA1;KCNB1
3827,GO:0007617,0.106493691157173,0.994486018025942,1,18,mating behavior,BP,GRIN1
7995,GO:0031683,0.106577687540283,0.994477138506776,1,18,G-protein beta/gamma-subunit complex binding,MF,GNAL
2622,GO:0005539,0.106725131007766,0.972304174325294,3,173,glycosaminoglycan binding,MF,LTF;POSTN;CXCL10
4550,GO:0009628,0.106772349926268,0.943348222845643,11,1095,response to abiotic stimulus,BP,COL1A1;IGFBP2;PLAU;CHI3L1;POSTN;ANXA1;ADM;MMP14;COL3A1;CXCL10;GRIN1
4479,GO:0009309,0.106873529684811,0.994414303665038,1,20,amine biosynthetic process,BP,MOXD1
2607,GO:0005515,0.107112038409064,0.928249201982771,73,10177,protein binding,MF,TNFRSF12A;LTF;TYMP;VIM;CP;SNAP91;IGF2BP2;MOXD1;CHGB;CRTAC1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;EMILIN2;POSTN;COL4A2;ANXA1;IGF2BP3;GNAL;COL6A2;EMP3;CPLX2;ADAM12;ADM;SERPING1;SPHKAP;MMP14;KCNB1;C1R;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;GABRB3;CACNG2;TUBA1C;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PTPRT;SERPINA3;SMOC1;COL5A2;CFI;IFI30
12365,GO:0046135,0.107298838416346,0.994368844567495,1,20,pyrimidine nucleoside catabolic process,BP,TYMP
19684,GO:1903392,0.107332949469915,0.994436698296567,1,16,negative regulation of adherens junction organization,BP,MMP14
8341,GO:0032368,0.107333520303166,0.981637676511292,2,82,regulation of lipid transport,BP,SPP1;ANXA2
952,GO:0002251,0.107566361798923,0.994340152050388,1,20,organ or tissue specific immune response,BP,LTF
5314,GO:0015108,0.107650510270877,0.981552018991208,2,82,chloride transmembrane transporter activity,MF,GABRG1;GABRB3
7679,GO:0031092,0.108071845180345,0.994358227500431,1,16,platelet alpha granule membrane,CC,PCDH7
3012,GO:0006206,0.108243057331607,0.994299550353238,1,18,pyrimidine nucleobase metabolic process,BP,TYMP
12890,GO:0048020,0.108327355557953,0.994258118335953,1,20,CCR chemokine receptor binding,MF,CCL2
14057,GO:0051767,0.108484455374978,0.994292665714078,1,17,nitric-oxide synthase biosynthetic process,BP,CCL2
14058,GO:0051769,0.108484455374978,0.994292665714078,1,17,regulation of nitric-oxide synthase biosynthetic process,BP,CCL2
3806,GO:0007586,0.108881703391005,0.981190717842459,2,90,digestion,BP,TYMP;SERPINA3
6687,GO:0019887,0.10898433697095,0.971451935579493,3,182,protein kinase regulator activity,MF,LTF;CXCL10;SOCS3
15744,GO:0070371,0.109494666972226,0.964145463465517,4,276,ERK1 and ERK2 cascade,BP,CCL2;GBP1;CHI3L1;PLA2G2A
21454,GO:2000515,0.109953042848585,0.994114155854001,1,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
13961,GO:0051588,0.109995341567904,0.98090622739271,2,84,regulation of neurotransmitter transport,BP,CPLX2;RIMS2
525,GO:0001580,0.110115392148144,0.994048621716118,1,21,detection of chemical stimulus involved in sensory perception of bitter taste,BP,RTP5
8584,GO:0032703,0.110578509757946,0.994027818615411,1,19,negative regulation of interleukin-2 production,BP,GBP1
16998,GO:0072673,0.110869420922465,0.99403347994763,1,17,lamellipodium morphogenesis,BP,PDPN
18190,GO:0099106,0.110894428052466,0.980651997860116,2,86,ion channel regulator activity,MF,KCNIP3;KCNIP2
12985,GO:0048268,0.110969976335275,0.994044911027909,1,16,clathrin coat assembly,BP,SNAP91
10170,GO:0036152,0.110984004729182,0.993966911506364,1,20,phosphatidylethanolamine acyl-chain remodeling,BP,PLA2G2A
16479,GO:0071682,0.111128567928551,0.99396698263872,1,19,endocytic vesicle lumen,CC,LTF
13480,GO:0050790,0.111177379956635,0.932075566427076,18,2006,regulation of catalytic activity,BP,LTF;TIMP1;SERPINE1;CCL2;CHI3L1;SPOCD1;ANXA1;MMD2;GNAL;SERPING1;MMP14;PTX3;ELFN2;CXCL10;GRIN1;ANXA2;SOCS3;SERPINA3
13267,GO:0048871,0.111230948545416,0.963376154098075,4,277,multicellular organismal homeostasis,BP,LTF;SPP1;CDHR1;SERPINA3
10560,GO:0042104,0.111380399236614,0.993939022990138,1,19,positive regulation of activated T cell proliferation,BP,IGFBP2
11157,GO:0043266,0.111746119280881,0.980427642742927,2,83,regulation of potassium ion transport,BP,KCNIP3;KCNIP2
13575,GO:0050920,0.111794150297494,0.970399335290652,3,180,regulation of chemotaxis,BP,SERPINE1;CCL2;CXCL10
13234,GO:0048814,0.111800184286563,0.980437154299619,2,77,regulation of dendrite morphogenesis,BP,CUX2;GRIN1
4820,GO:0010595,0.112078302819529,0.980335619865631,2,83,positive regulation of endothelial cell migration,BP,SRPX2;ANXA1
18829,GO:1901215,0.112239276654881,0.970238494483263,3,175,negative regulation of neuron death,BP,CCL2;GABRB3;GRIN1
4174,GO:0008544,0.112278142232388,0.962914885511522,4,272,epidermis development,BP,FERMT1;HOXA7;ANXA1;FABP5
11431,GO:0043950,0.112298397082399,0.993836530914591,1,19,positive regulation of cAMP-mediated signaling,BP,CXCL10
751,GO:0001934,0.112373235730383,0.94386322595513,9,852,positive regulation of protein phosphorylation,BP,LTF;CCL2;GDF15;CHI3L1;MMD2;KSR2;ANXA2;SOCS3;PLA2G2A
3625,GO:0007158,0.112415312510274,0.993885352898361,1,16,neuron cell-cell adhesion,BP,TNR
12317,GO:0046058,0.112516184524627,0.98020660391139,2,85,cAMP metabolic process,BP,ADM;CXCL10
5814,GO:0016324,0.112728715198741,0.962720539795054,4,265,apical plasma membrane,CC,IGFBP2;ANXA1;SHANK2;PDPN
4876,GO:0010669,0.113005109355493,0.993757017272569,1,19,epithelial structure maintenance,BP,SERPINA3
9193,GO:0034123,0.113098436239526,0.993729766719578,1,20,positive regulation of toll-like receptor signaling pathway,BP,LTF
10820,GO:0042611,0.11321384854168,0.993687771290427,1,22,MHC protein complex,CC,HLA-DQB1
13238,GO:0048820,0.113381872361389,0.993777420144151,1,16,hair follicle maturation,BP,FERMT1
10548,GO:0042089,0.113384172700156,0.979937795948968,2,93,cytokine biosynthetic process,BP,IGF2BP2;IGF2BP3
17391,GO:0090330,0.113445656292117,0.993725866837394,1,18,regulation of platelet aggregation,BP,PDPN
14078,GO:0051797,0.113535347182016,0.993715724972121,1,18,regulation of hair follicle development,BP,FERMT1
708,GO:0001871,0.113552987236763,0.99369500829383,1,19,pattern binding,MF,PTX3
7255,GO:0030247,0.113552987236763,0.99369500829383,1,19,polysaccharide binding,MF,PTX3
14500,GO:0060055,0.113729232267568,0.9936749928133,1,19,angiogenesis involved in wound healing,BP,SERPINE1
11642,GO:0044431,0.11374240672051,0.943036190227839,9,849,Golgi apparatus part,CC,CUX2;GBP1;POSTN;MMD2;GALNT13;MMP14;FUT9;ST8SIA3;HLA-DQB1
3649,GO:0007186,0.113790410860225,0.945545191785035,8,761,G-protein coupled receptor signaling pathway,BP,CCL2;ANXA1;GNAL;GPR17;ADM;GABRG1;GABRB3;CXCL10
2126,GO:0004653,0.114093202164318,0.993633553295945,1,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT13
6326,GO:0018243,0.114093202164318,0.993633553295945,1,19,protein O-linked glycosylation via threonine,BP,GALNT13
15908,GO:0070663,0.114130376358366,0.969499723519178,3,189,regulation of leukocyte proliferation,BP,IGFBP2;LGALS3;ANXA1
3369,GO:0006706,0.114206715065476,0.993603560661358,1,20,steroid catabolic process,BP,SPP1
13466,GO:0050772,0.115003571570385,0.979543551812841,2,77,positive regulation of axonogenesis,BP,TNFRSF12A;SLITRK1
11425,GO:0043931,0.115144136933469,0.993636936907552,1,14,ossification involved in bone maturation,BP,LTF
10562,GO:0042107,0.115179856979366,0.979429974912109,2,94,cytokine metabolic process,BP,IGF2BP2;IGF2BP3
11258,GO:0043434,0.115363692749503,0.955825721175942,5,382,response to peptide hormone,BP,TIMP1;COL1A1;ANXA1;ADM;SOCS3
13669,GO:0051087,0.115515782494885,0.979351327498103,2,89,chaperone binding,MF,CP;PDPN
16577,GO:0071887,0.115869684765919,0.979237900005842,2,93,leukocyte apoptotic process,BP,LGALS3;ANXA1
10308,GO:0036499,0.115899466117714,0.993408261299189,1,20,PERK-mediated unfolded protein response,BP,CCL2
11216,GO:0043372,0.11597158783601,0.993383977897875,1,21,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
21363,GO:2000369,0.116072871721609,0.993471724111773,1,16,regulation of clathrin-dependent endocytosis,BP,SNAP91
10565,GO:0042110,0.116481920990313,0.955255524432389,5,403,T cell activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1
10014,GO:0035886,0.116483902844132,0.993357846452508,1,19,vascular smooth muscle cell differentiation,BP,ADM
14165,GO:0051961,0.116529081648176,0.961015382727367,4,264,negative regulation of nervous system development,BP,VIM;TNR;SPP1;COL3A1
4859,GO:0010648,0.116575559603216,0.935416272821958,12,1234,negative regulation of cell communication,BP,LTF;FERMT1;SERPINE1;IGFBP2;TNR;GBP1;LGALS3;ADM;MMP14;KCNB1;SHANK2;SOCS3
11340,GO:0043567,0.11659993375286,0.993364050037343,1,18,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP2
10816,GO:0042605,0.116690654612188,0.993299833928081,1,21,peptide antigen binding,MF,HLA-DQB1
15528,GO:0070006,0.117121972444001,0.993283228248588,1,19,metalloaminopeptidase activity,MF,MMP14
3977,GO:0008238,0.117253753487053,0.978840923298334,2,94,exopeptidase activity,MF,AEBP1;MMP14
3363,GO:0006700,0.117596616783824,0.993209371544786,1,20,C21-steroid hormone biosynthetic process,BP,ADM
20703,GO:1905521,0.117675863181638,0.993200009091406,1,20,regulation of macrophage migration,BP,MMP14
18171,GO:0099072,0.117685017703896,0.993198927108793,1,20,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,CACNG2
15583,GO:0070102,0.117827153665689,0.993242948979799,1,17,interleukin-6-mediated signaling pathway,BP,SOCS3
13118,GO:0048608,0.11790059080407,0.954558803964426,5,379,reproductive structure development,BP,SPP1;ANXA1;ADM;MMP14;SOCS3
6611,GO:0019731,0.118066309573807,0.993122334173561,1,22,antibacterial humoral response,BP,LTF
7093,GO:0023057,0.118377557748305,0.934237946270225,12,1238,negative regulation of signaling,BP,LTF;FERMT1;SERPINE1;IGFBP2;TNR;GBP1;LGALS3;ADM;MMP14;KCNB1;SHANK2;SOCS3
4891,GO:0010714,0.118784438681711,0.993068330621736,1,20,positive regulation of collagen metabolic process,BP,VIM
8758,GO:0032967,0.118784438681711,0.993068330621736,1,20,positive regulation of collagen biosynthetic process,BP,VIM
17581,GO:0097106,0.118855103019132,0.993176853170441,1,15,postsynaptic density organization,BP,SHANK2
18181,GO:0099084,0.118855103019132,0.993176853170441,1,15,postsynaptic specialization organization,BP,SHANK2
13193,GO:0048729,0.118948549830558,0.945647741405004,7,590,tissue morphogenesis,BP,ADM;MMP14;PDPN;COL3A1;CXCL10;SOCS3;COL4A1
13135,GO:0048640,0.118978864026743,0.978378166652559,2,85,negative regulation of developmental growth,BP,TNR;SPP1
12606,GO:0046697,0.119086064773364,0.993050802666383,1,19,decidualization,BP,SPP1
6325,GO:0018242,0.11925118483868,0.99301249446855,1,20,protein O-linked glycosylation via serine,BP,GALNT13
13509,GO:0050832,0.119330282959746,0.992956920157387,1,23,defense response to fungus,BP,LTF
8339,GO:0032366,0.11937860568015,0.993036523471788,1,18,intracellular sterol transport,BP,ANXA2
8340,GO:0032367,0.11937860568015,0.993036523471788,1,18,intracellular cholesterol transport,BP,ANXA2
19524,GO:1903038,0.119648710693406,0.97815263271401,2,94,negative regulation of leukocyte cell-cell adhesion,BP,LGALS3;ANXA1
19505,GO:1903010,0.119999024181084,0.992962265803713,1,18,regulation of bone development,BP,LTF
5692,GO:0016079,0.120012716989333,0.978079842365242,2,85,synaptic vesicle exocytosis,BP,CPLX2;RIMS2
19925,GO:1903861,0.120153866581629,0.992967104249639,1,17,positive regulation of dendrite extension,BP,RIMS2
10169,GO:0036151,0.120472244633294,0.992848158862774,1,21,phosphatidylcholine acyl-chain remodeling,BP,PLA2G2A
6686,GO:0019886,0.120479298249624,0.977915246752335,2,93,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,HLA-DQB1;IFI30
15301,GO:0061458,0.120492745221226,0.953251010661048,5,382,reproductive system development,BP,SPP1;ANXA1;ADM;MMP14;SOCS3
13568,GO:0050912,0.120493518249781,0.992815741032438,1,23,detection of chemical stimulus involved in sensory perception of taste,BP,RTP5
2849,GO:0005925,0.120496839119502,0.953249573160222,5,381,focal adhesion,CC,VIM;FERMT1;PLAU;ANXA1;MMP14
1274,GO:0002791,0.120503875422902,0.953236278604887,5,397,regulation of peptide secretion,BP,FERMT1;GBP1;POSTN;ANXA1;KCNB1
2625,GO:0005543,0.12066095389612,0.953167847441514,5,379,phospholipid binding,MF,SNAP91;PLEKHA4;ANXA1;ANXA2;PLA2G2A
14432,GO:0055093,0.120965987061176,0.992805341573539,1,20,response to hyperoxia,BP,COL1A1
16872,GO:0072378,0.12101224835271,0.992782402037104,1,21,blood coagulation, fibrin clot formation,BP,SERPING1
15230,GO:0061298,0.121014321618767,0.992890381150267,1,16,retina vasculature development in camera-type eye,BP,COL4A1
16073,GO:0070977,0.1212951923595,0.992887028826656,1,15,bone maturation,BP,LTF
8505,GO:0032587,0.121795161795314,0.977561759355013,2,85,ruffle membrane,CC,FERMT1;PDPN
21086,GO:1990823,0.122383007719259,0.977363206115568,2,92,response to leukemia inhibitory factor,BP,INA;SOCS3
21090,GO:1990830,0.122383007719259,0.977363206115568,2,92,cellular response to leukemia inhibitory factor,BP,INA;SOCS3
723,GO:0001891,0.122394689756691,0.992630329333842,1,20,phagocytic cup,CC,ANXA1
10536,GO:0042056,0.122471157207937,0.992587060342409,1,22,chemoattractant activity,MF,LGALS3
480,GO:0001516,0.122640944164661,0.992566007415325,1,22,prostaglandin biosynthetic process,BP,ANXA1
12467,GO:0046457,0.122640944164661,0.992566007415325,1,22,prostanoid biosynthetic process,BP,ANXA1
17886,GO:0097731,0.12266369811121,0.977299513463189,2,87,9+0 non-motile cilium,CC,CDHR1;SHANK2
17888,GO:0097733,0.12266369811121,0.977299513463189,2,87,photoreceptor cell cilium,CC,CDHR1;SHANK2
4192,GO:0008593,0.123013825344159,0.977185208027414,2,90,regulation of Notch signaling pathway,BP,POSTN;MMP14
7389,GO:0030516,0.123096148700474,0.977193566516107,2,82,regulation of axon extension,BP,TNFRSF12A;TNR
2848,GO:0005924,0.123178979220025,0.951886344739286,5,384,cell-substrate adherens junction,CC,VIM;FERMT1;PLAU;ANXA1;MMP14
13153,GO:0048670,0.123484652285666,0.992515253140921,1,19,regulation of collateral sprouting,BP,SPP1
13441,GO:0050729,0.123546197409621,0.97699798787052,2,99,positive regulation of inflammatory response,BP,SERPINE1;PLA2G2A
16529,GO:0071804,0.123936593793622,0.965693504089942,3,183,cellular potassium ion transport,BP,KCNIP3;KCNIP2;KCNB1
16530,GO:0071805,0.123936593793622,0.965693504089942,3,183,potassium ion transmembrane transport,BP,KCNIP3;KCNIP2;KCNB1
6054,GO:0016798,0.12394050112767,0.976878417331038,2,100,hydrolase activity, acting on glycosyl bonds,MF,CHI3L2;CHI3L1
473,GO:0001505,0.124471972663949,0.95736094228451,4,283,regulation of neurotransmitter levels,BP,MOXD1;CPLX2;PTX3;RIMS2
17104,GO:0086013,0.125068949713438,0.992278323172675,1,21,membrane repolarization during cardiac muscle cell action potential,BP,KCNIP2
3195,GO:0006491,0.125276757881241,0.992313867841534,1,18,N-glycan processing,BP,ST8SIA3
6714,GO:0019955,0.125417817716507,0.976452633481814,2,96,cytokine binding,MF,GBP1;PDPN
7935,GO:0031579,0.125587486801959,0.992195660799274,1,22,membrane raft organization,BP,ANXA2
15103,GO:0061003,0.125636443505337,0.992294213404984,1,17,positive regulation of dendritic spine morphogenesis,BP,CUX2
18693,GO:1900273,0.125640890627092,0.992322494822247,1,16,positive regulation of long-term synaptic potentiation,BP,SHISA7
11645,GO:0044437,0.125745479600701,0.945685590964187,6,525,vacuolar part,CC,CP;FABP5;HLA-DQB1;ANXA2;SERPINA3;IFI30
489,GO:0001530,0.125793409546399,0.99215390763126,1,23,lipopolysaccharide binding,MF,LTF
5054,GO:0010923,0.125809087479003,0.976365337670248,2,88,negative regulation of phosphatase activity,BP,SPOCD1;ELFN2
2435,GO:0005126,0.125863734968394,0.964898646829061,3,202,cytokine receptor binding,MF,CCL2;GDF15;CXCL10
10572,GO:0042127,0.126277547354997,0.927401074061696,13,1403,regulation of cell proliferation,BP,LTF;FERMT1;TIMP1;IGFBP2;PLAU;LGALS3;ANXA1;EMP3;ADM;PDPN;S100A11;CXCL10;ANXA2
8346,GO:0032373,0.126312118695876,0.992183150064659,1,18,positive regulation of sterol transport,BP,ANXA2
8349,GO:0032376,0.126312118695876,0.992183150064659,1,18,positive regulation of cholesterol transport,BP,ANXA2
8650,GO:0032799,0.12664921947491,0.992096087917847,1,20,low-density lipoprotein receptor particle metabolic process,BP,ANXA2
1094,GO:0002495,0.126695433555343,0.976070883701706,2,96,antigen processing and presentation of peptide antigen via MHC class II,BP,HLA-DQB1;IFI30
7131,GO:0030055,0.126970704376409,0.949942651395469,5,387,cell-substrate junction,CC,VIM;FERMT1;PLAU;ANXA1;MMP14
13204,GO:0048745,0.127303719353329,0.99203333698493,1,19,smooth muscle tissue development,BP,COL3A1
21434,GO:2000482,0.127399019403048,0.991963281682195,1,22,regulation of interleukin-8 secretion,BP,ANXA1
7913,GO:0031527,0.127572756178456,0.992048850544432,1,17,filopodium membrane,CC,PDPN
7983,GO:0031664,0.127614820760706,0.991952855931381,1,21,regulation of lipopolysaccharide-mediated signaling pathway,BP,LTF
13644,GO:0051043,0.127816317220549,0.991926795150572,1,21,regulation of membrane protein ectodomain proteolysis,BP,TIMP1
21815,GO:2001237,0.128192157369575,0.975624092301079,2,95,negative regulation of extrinsic apoptotic signaling pathway,BP,SERPINE1;LGALS3
12694,GO:0046916,0.128525713361194,0.975509706670004,2,99,cellular transition metal ion homeostasis,BP,LTF;CP
4710,GO:0010226,0.128596415366489,0.991825482976821,1,21,response to lithium ion,BP,IGFBP2
21392,GO:2000406,0.129320377445813,0.991712901145345,1,22,positive regulation of T cell migration,BP,CXCL10
1098,GO:0002504,0.12948889969677,0.975224337446291,2,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,HLA-DQB1;IFI30
8470,GO:0032526,0.129638863502947,0.975182225572322,2,96,response to retinoic acid,BP,COL1A1;IGFBP2
547,GO:0001637,0.129788766591511,0.991619590970334,1,24,G-protein coupled chemoattractant receptor activity,MF,GPR17
2335,GO:0004950,0.129788766591511,0.991619590970334,1,24,chemokine receptor activity,MF,GPR17
4057,GO:0008373,0.129820056934821,0.991685150427145,1,20,sialyltransferase activity,MF,ST8SIA3
17798,GO:0097503,0.129820056934821,0.991685150427145,1,20,sialylation,BP,ST8SIA3
13440,GO:0050728,0.129884863235821,0.975093846799096,2,100,negative regulation of inflammatory response,BP,GPR17;SOCS3
18517,GO:0140115,0.129964898099231,0.991628006938141,1,22,export across plasma membrane,BP,KCNIP2
17977,GO:0098661,0.129974295624829,0.975098762760388,2,91,inorganic anion transmembrane transport,BP,GABRG1;GABRB3
14939,GO:0060706,0.130553468641954,0.991550085108697,1,22,cell differentiation involved in embryonic placenta development,BP,SOCS3
809,GO:0002009,0.130593298692881,0.943020845237033,6,496,morphogenesis of an epithelium,BP,ADM;MMP14;PDPN;CXCL10;SOCS3;COL4A1
10213,GO:0036303,0.130654144691806,0.991622332883079,1,18,lymph vessel morphogenesis,BP,PDPN
13429,GO:0050715,0.13068901632337,0.974848431794831,2,100,positive regulation of cytokine secretion,BP,FERMT1;POSTN
16299,GO:0071417,0.131169539360918,0.942700514522861,6,496,cellular response to organonitrogen compound,BP,COL1A1;GABRB3;COL3A1;SOCS3;COL4A1;COL5A2
7140,GO:0030073,0.131214171453239,0.962768902426292,3,183,insulin secretion,BP,ANXA1;KCNB1;RIMS2
19546,GO:1903077,0.131324330828995,0.991447455409858,1,22,negative regulation of protein localization to plasma membrane,BP,GBP1
1871,GO:0004222,0.13150132742077,0.974620678839856,2,94,metalloendopeptidase activity,MF,ADAM12;MMP14
7914,GO:0031528,0.131678641356755,0.991418693318957,1,21,microvillus membrane,CC,PDPN
6574,GO:0019538,0.131713308059407,0.907581209507998,39,5052,protein metabolic process,BP,LTF;VIM;CP;IGF2BP2;CHGB;APOL4;TIMP1;SERPINE1;AEBP1;CCL2;IGFBP2;GBP1;SPP1;PLAU;GDF15;CHI3L1;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;ADAM12;SERPING1;MMP14;C1R;PTX3;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;CFI
14682,GO:0060330,0.132059938129713,0.991348911930818,1,22,regulation of response to interferon-gamma,BP,SOCS3
14686,GO:0060334,0.132059938129713,0.991348911930818,1,22,regulation of interferon-gamma-mediated signaling pathway,BP,SOCS3
15096,GO:0060996,0.132078952605315,0.974485480213793,2,84,dendritic spine development,BP,CUX2;SHANK2
5422,GO:0015347,0.132110819202159,0.991342073846055,1,22,sodium-independent organic anion transmembrane transporter activity,MF,SLCO1A2
11417,GO:0043903,0.132286321544737,0.962302890094841,3,201,regulation of symbiosis, encompassing mutualism through parasitism,BP,LTF;PTX3;ANXA2
4148,GO:0008509,0.132598053053661,0.953531898666095,4,297,anion transmembrane transporter activity,MF,SLCO1A2;ABCC3;GABRG1;GABRB3
13104,GO:0048568,0.132618547242578,0.947007472938029,5,396,embryonic organ development,BP,HOXA7;ADM;MMP14;DSCAML1;SOCS3
741,GO:0001919,0.133012241616502,0.991220457346569,1,22,regulation of receptor recycling,BP,ANXA2
19067,GO:1901889,0.133170847233432,0.991238982068889,1,20,negative regulation of cell junction assembly,BP,MMP14
1866,GO:0004181,0.133294948550793,0.991164706716196,1,23,metallocarboxypeptidase activity,MF,AEBP1
2599,GO:0005501,0.133315736511859,0.99116187966018,1,23,retinoid binding,MF,RBP1
4913,GO:0010738,0.133350711702709,0.991263749550951,1,18,regulation of protein kinase A signaling,BP,SPHKAP
16389,GO:0071556,0.13337969212419,0.99112248003175,1,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,HLA-DQB1
17921,GO:0098553,0.13337969212419,0.99112248003175,1,25,lumenal side of endoplasmic reticulum membrane,CC,HLA-DQB1
10742,GO:0042470,0.133425409307488,0.974002883681753,2,101,melanosome,CC,MMP14;ANXA2
13218,GO:0048770,0.133425409307488,0.974002883681753,2,101,pigment granule,CC,MMP14;ANXA2
9314,GO:0034368,0.133587709415007,0.99114235060221,1,22,protein-lipid complex remodeling,BP,PLA2G2A
9315,GO:0034369,0.133587709415007,0.99114235060221,1,22,plasma lipoprotein particle remodeling,BP,PLA2G2A
2769,GO:0005794,0.133656319026433,0.922399595940457,13,1379,Golgi apparatus,CC,COL1A1;CUX2;KCNIP3;GBP1;SPP1;GDF15;POSTN;MMD2;GALNT13;MMP14;FUT9;ST8SIA3;HLA-DQB1
18170,GO:0099068,0.133692260045348,0.991246788479432,1,17,postsynapse assembly,BP,SHANK2
22,GO:0000041,0.133744258219702,0.973907381476926,2,100,transition metal ion transport,BP,CP;STEAP3
3437,GO:0006821,0.134890183222628,0.973568984071504,2,95,chloride transport,BP,GABRG1;GABRB3
3353,GO:0006688,0.135042407767665,0.990943284170145,1,22,glycosphingolipid biosynthetic process,BP,ST8SIA3
3327,GO:0006658,0.135254138349202,0.990879731565417,1,24,phosphatidylserine metabolic process,BP,PLA2G2A
1256,GO:0002761,0.135378996401176,0.973412651066285,2,96,regulation of myeloid leukocyte differentiation,BP,LTF;HOXA7
3436,GO:0006820,0.135597126402515,0.940211800896927,6,523,anion transport,BP,SLCO1A2;ABCC3;ANXA1;GABRG1;GABRB3;PLA2G2A
19923,GO:1903859,0.135603273442638,0.990907402505727,1,20,regulation of dendrite extension,BP,RIMS2
11345,GO:0043576,0.135655406777438,0.990878472120015,1,21,regulation of respiratory gaseous exchange,BP,GRIN1
12364,GO:0046134,0.135894335570442,0.990775641833277,1,25,pyrimidine nucleoside biosynthetic process,BP,TYMP
18027,GO:0098791,0.136528050672204,0.93190080592348,8,765,Golgi subcompartment,CC,CUX2;GBP1;POSTN;MMD2;GALNT13;FUT9;ST8SIA3;HLA-DQB1
13569,GO:0050913,0.136672723827127,0.990666861829954,1,25,sensory perception of bitter taste,BP,RTP5
12111,GO:0045662,0.136690434306319,0.990696621398176,1,23,negative regulation of myoblast differentiation,BP,CXCL10
16089,GO:0070997,0.136939592719179,0.951456304304403,4,295,neuron death,BP,CCL2;KCNB1;GABRB3;GRIN1
13133,GO:0048638,0.137324939406826,0.951288252972167,4,278,regulation of developmental growth,BP,TNFRSF12A;TNR;SPP1;RIMS2
15747,GO:0070374,0.137391395832511,0.960203029097981,3,196,positive regulation of ERK1 and ERK2 cascade,BP,CCL2;CHI3L1;PLA2G2A
2602,GO:0005504,0.137445016423653,0.990573888839293,1,24,fatty acid binding,MF,FABP5
21455,GO:2000516,0.137570004369874,0.990540632858873,1,25,positive regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
14840,GO:0060541,0.137812449332444,0.96004981242995,3,183,respiratory system development,BP,CHI3L1;MMP14;PDPN
6660,GO:0019840,0.138339203687749,0.990447533897413,1,24,isoprenoid binding,MF,RBP1
6456,GO:0019207,0.138493512026163,0.959733755229625,3,202,kinase regulator activity,MF,LTF;CXCL10;SOCS3
833,GO:0002040,0.138724967222526,0.972366941033327,2,94,sprouting angiogenesis,BP,SRPX2;ANXA1
9313,GO:0034367,0.138754029910832,0.990405920234428,1,23,protein-containing complex remodeling,BP,PLA2G2A
10670,GO:0042327,0.138890449399449,0.927417550473662,9,891,positive regulation of phosphorylation,BP,LTF;CCL2;GDF15;CHI3L1;MMD2;KSR2;ANXA2;SOCS3;PLA2G2A
7988,GO:0031669,0.138916480415434,0.959567779214883,3,195,cellular response to nutrient levels,BP,COL1A1;POSTN;KCNB1
5234,GO:0014850,0.139169685486919,0.990386600203502,1,21,response to muscle activity,BP,POSTN
9179,GO:0034105,0.13929530018165,0.990347919864906,1,22,positive regulation of tissue remodeling,BP,SPP1
14702,GO:0060351,0.139510213405889,0.990298214759182,1,23,cartilage development involved in endochondral bone morphogenesis,BP,COL1A1
5271,GO:0014912,0.139572955365711,0.990329285424263,1,21,negative regulation of smooth muscle cell migration,BP,SERPINE1
17225,GO:0090100,0.139855755786255,0.971999249342862,2,96,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FERMT1;GDF15
4754,GO:0010460,0.139940505320505,0.990255850494283,1,22,positive regulation of heart rate,BP,ADM
9678,GO:0035305,0.140461048272803,0.971814004804528,2,94,negative regulation of dephosphorylation,BP,SPOCD1;ELFN2
12664,GO:0046872,0.140669056238207,0.903220260186833,30,3657,metal ion binding,MF,LTF;CP;MOXD1;CRTAC1;TIMP1;AEBP1;COL1A1;KCNIP3;STEAP3;SLC8A2;KCNIP2;POSTN;ANXA1;GNAL;GALNT13;CDHR1;ADAM12;MMP14;C1R;S100A11;COL3A1;PCDH7;KSR2;RIMS2;GRIN1;ANXA2;PLA2G2A;SMOC1;COL5A2;CFI
2500,GO:0005234,0.140671493896338,0.99022149696647,1,19,extracellularly glutamate-gated ion channel activity,MF,GRIN1
17102,GO:0086011,0.140828490744934,0.990091104463346,1,24,membrane repolarization during action potential,BP,KCNIP2
8660,GO:0032809,0.14089783577413,0.990098921068269,1,23,neuronal cell body membrane,CC,KCNB1
11564,GO:0044298,0.14089783577413,0.990098921068269,1,23,cell body membrane,CC,KCNB1
17920,GO:0098552,0.141557885434835,0.942263536833474,5,425,side of membrane,CC,ANXA1;GNAL;CXCL10;CD163;HLA-DQB1
2352,GO:0004970,0.141591935569005,0.990089533635594,1,19,ionotropic glutamate receptor activity,MF,GRIN1
20163,GO:1904376,0.141748794552663,0.98995758541274,1,24,negative regulation of protein localization to cell periphery,BP,GBP1
9084,GO:0033688,0.141939339611319,0.989947932255837,1,23,regulation of osteoblast proliferation,BP,LTF
8803,GO:0033032,0.142406895760032,0.989861528476401,1,24,regulation of myeloid cell apoptotic process,BP,ANXA1
21202,GO:2000108,0.142745055597138,0.989811982604786,1,24,positive regulation of leukocyte apoptotic process,BP,ANXA1
12272,GO:0045956,0.142796621450625,0.9898427438692,1,22,positive regulation of calcium ion-dependent exocytosis,BP,KCNB1
4387,GO:0009164,0.14292939719177,0.989738008242226,1,27,nucleoside catabolic process,BP,TYMP
6715,GO:0019956,0.143526023051128,0.989680038565531,1,25,chemokine binding,MF,PDPN
2106,GO:0004623,0.143570716895531,0.989657701971824,1,26,phospholipase A2 activity,MF,PLA2G2A
17565,GO:0097066,0.14420280348107,0.989596938080999,1,24,response to thyroid hormone,BP,ANXA2
13913,GO:0051482,0.144224724034463,0.989560615168237,1,26,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,GPR17
13228,GO:0048799,0.144260806832409,0.989701611305369,1,19,animal organ maturation,BP,LTF
9181,GO:0034110,0.144871268358597,0.989516398660825,1,23,regulation of homotypic cell-cell adhesion,BP,PDPN
12542,GO:0046596,0.145122605006792,0.989426544574219,1,26,regulation of viral entry into host cell,BP,PTX3
7972,GO:0031646,0.145253343745355,0.989459456960005,1,23,positive regulation of neurological system process,BP,TNR
2822,GO:0005884,0.145368713778067,0.970214805781553,2,97,actin filament,CC,FERMT1;ANXA1
11313,GO:0043534,0.145610130624024,0.970131789562395,2,98,blood vessel endothelial cell migration,BP,SRPX2;ANXA1
5108,GO:0010996,0.146422918367281,0.989328201703405,1,21,response to auditory stimulus,BP,CXCL10
1111,GO:0002521,0.14691815673344,0.939380669160041,5,422,leukocyte differentiation,BP,LTF;HOXA7;ANXA1;MMP14;ANXA2
667,GO:0001818,0.14746252253894,0.95590819326757,3,213,negative regulation of cytokine production,BP,LTF;GBP1;ANXA1
3757,GO:0007413,0.147705683583788,0.989160723107971,1,20,axonal fasciculation,BP,CRTAC1
18396,GO:0106030,0.147705683583788,0.989160723107971,1,20,neuron projection fasciculation,BP,CRTAC1
11148,GO:0043252,0.147743490247765,0.989046676220521,1,25,sodium-independent organic anion transport,BP,SLCO1A2
1289,GO:0002828,0.148201712418699,0.988944383478896,1,27,regulation of type 2 immune response,BP,ANXA1
8512,GO:0032594,0.148281538043006,0.988947660140267,1,26,protein transport within lipid bilayer,BP,CACNG2
4018,GO:0008299,0.148539034531562,0.98889254268963,1,27,isoprenoid biosynthetic process,BP,RBP1
6546,GO:0019433,0.14856089316117,0.988921612006903,1,25,triglyceride catabolic process,BP,FABP5
6191,GO:0017075,0.14916491262206,0.988888933212104,1,22,syntaxin-1 binding,MF,CPLX2
21389,GO:2000403,0.149427213176843,0.988771204181406,1,26,positive regulation of lymphocyte migration,BP,CXCL10
14695,GO:0060343,0.149655992672952,0.98879153172031,1,23,trabecula formation,BP,COL1A1
12090,GO:0045637,0.150000899551795,0.954830062036759,3,200,regulation of myeloid cell differentiation,BP,LTF;HOXA7;LGALS3
6416,GO:0019079,0.150672073519732,0.968425428642524,2,106,viral genome replication,BP,LTF;CCL2
17635,GO:0097191,0.150989652485078,0.954389619299458,3,206,extrinsic apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1;LGALS3
3636,GO:0007169,0.151030677693755,0.92672770789936,7,645,transmembrane receptor protein tyrosine kinase signaling pathway,BP,COL1A1;IGFBP2;COL4A2;GRIN1;SOCS3;COL4A1;PTPRT
15470,GO:0061844,0.151264522881098,0.988426952545306,1,30,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,LTF
12571,GO:0046636,0.151422531722068,0.988477847522888,1,25,negative regulation of alpha-beta T cell activation,BP,ANXA1
18185,GO:0099094,0.151502296776799,0.968182608181871,2,97,ligand-gated cation channel activity,MF,JPH3;GRIN1
7754,GO:0031258,0.151654791484773,0.988503672720554,1,22,lamellipodium membrane,CC,PDPN
12077,GO:0045622,0.151753592487319,0.988408339439908,1,26,regulation of T-helper cell differentiation,BP,ANXA1
3700,GO:0007266,0.152091171634553,0.953942852132194,3,187,Rho protein signal transduction,BP,GPR17;PDPN;COL3A1
13517,GO:0050851,0.152459752245603,0.953725453036719,3,220,antigen receptor-mediated signaling pathway,BP,GBP1;LGALS3;HLA-DQB1
3643,GO:0007178,0.152652130406161,0.943717452536972,4,297,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,VIM;FERMT1;GDF15;COL3A1
14707,GO:0060359,0.153511814343224,0.967468770021707,2,106,response to ammonium ion,BP,GABRB3;GRIN1
19007,GO:1901681,0.153634722054881,0.953234661943743,3,204,sulfur compound binding,MF,LTF;POSTN;CXCL10
788,GO:0001975,0.154715015004547,0.987975619338534,1,24,response to amphetamine,BP,GRIN1
8756,GO:0032965,0.154718272075014,0.987920128607832,1,27,regulation of collagen biosynthetic process,BP,VIM
21350,GO:2000352,0.154762108036258,0.987948272392865,1,25,negative regulation of endothelial cell apoptotic process,BP,SERPINE1
7550,GO:0030867,0.154961865964397,0.987865158005653,1,28,rough endoplasmic reticulum membrane,CC,LTF
1,GO:0000002,0.155073190679797,0.987879948945589,1,26,mitochondrial genome maintenance,BP,TYMP
12289,GO:0045992,0.155394343598853,0.987846593193377,1,25,negative regulation of embryonic development,BP,COL5A2
11959,GO:0045296,0.155904938258074,0.942061014689901,4,309,cadherin binding,MF,ANXA1;S100A11;ANXA2;PTPRT
17380,GO:0090314,0.155915765180189,0.987726670923363,1,27,positive regulation of protein targeting to membrane,BP,KCNB1
11239,GO:0043403,0.156180069283825,0.987683752161648,1,27,skeletal muscle tissue regeneration,BP,ANXA1
2511,GO:0005251,0.156259425306285,0.987688099461005,1,26,delayed rectifier potassium channel activity,MF,KCNB1
14670,GO:0060314,0.15660290829041,0.987650963324494,1,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH3
9083,GO:0033687,0.156683759621764,0.987619083370603,1,26,osteoblast proliferation,BP,LTF
10996,GO:0043009,0.156956456991826,0.927915582923873,6,527,chordate embryonic development,BP,COL1A1;HOXA7;ADM;MMP14;DSCAML1;SOCS3
12479,GO:0046471,0.156961909098326,0.987556328034281,1,27,phosphatidylglycerol metabolic process,BP,PLA2G2A
12120,GO:0045671,0.1571753850778,0.987578143285389,1,24,negative regulation of osteoclast differentiation,BP,LTF
18942,GO:1901564,0.157598016958183,0.886367878457742,44,5941,organonitrogen compound metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;IGF2BP2;MOXD1;CHGB;APOL4;TIMP1;SERPINE1;AEBP1;CCL2;IGFBP2;GBP1;SPP1;PLAU;GDF15;CHI3L1;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;ADAM12;ADM;SERPING1;MMP14;C1R;PTX3;NNMT;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;CFI
10120,GO:0036065,0.158303824230218,0.987372824012197,1,25,fucosylation,BP,FUT9
19754,GO:1903532,0.158410947934067,0.940771818746762,4,322,positive regulation of secretion by cell,BP,FERMT1;SPP1;POSTN;KCNB1
12244,GO:0045920,0.158482551922592,0.987306497677856,1,27,negative regulation of exocytosis,BP,ANXA1
10209,GO:0036296,0.158578442847933,0.987290655041782,1,27,response to increased oxygen levels,BP,COL1A1
12114,GO:0045665,0.158618468906353,0.951040502267385,3,196,negative regulation of neuron differentiation,BP,VIM;TNR;SPP1
10604,GO:0042177,0.158654313976798,0.965711158122209,2,105,negative regulation of protein catabolic process,BP,TIMP1;ANXA2
10834,GO:0042634,0.158960266594226,0.987264599577063,1,25,regulation of hair cycle,BP,FERMT1
9207,GO:0034142,0.158978403161425,0.987207885917147,1,28,toll-like receptor 4 signaling pathway,BP,LTF
491,GO:0001533,0.159208251379273,0.987223587736794,1,25,cornified envelope,CC,ANXA1
7353,GO:0030424,0.159340127280242,0.926515857075536,6,514,axon,CC,CRTAC1;KCNIP3;CPLX2;KCNB1;SHANK2;GRIN1
3432,GO:0006813,0.159480100491789,0.950635114453961,3,207,potassium ion transport,BP,KCNIP3;KCNIP2;KCNB1
12580,GO:0046649,0.159483660532972,0.92640345599274,6,568,lymphocyte activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;MMP14;HLA-DQB1
13389,GO:0050671,0.159901520471557,0.965235280278969,2,117,positive regulation of lymphocyte proliferation,BP,IGFBP2;ANXA1
15673,GO:0070252,0.160014017374513,0.965283509904586,2,95,actin-mediated cell contraction,BP,VIM;PDPN
4627,GO:0009897,0.160028513514474,0.950377501708185,3,214,external side of plasma membrane,CC,ANXA1;CXCL10;CD163
21390,GO:2000404,0.160376740067396,0.986974733168047,1,28,regulation of T cell migration,BP,CXCL10
14158,GO:0051954,0.160430790131053,0.986965676129699,1,28,positive regulation of amine transport,BP,KCNB1
12581,GO:0046651,0.161190477663446,0.949842468127978,3,222,lymphocyte proliferation,BP,IGFBP2;LGALS3;ANXA1
14853,GO:0060562,0.16140746088306,0.939259361688887,4,299,epithelial tube morphogenesis,BP,ADM;MMP14;CXCL10;COL4A1
7384,GO:0030511,0.161845298075893,0.986783130054093,1,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,FERMT1
19918,GO:1903846,0.161845298075893,0.986783130054093,1,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,FERMT1
820,GO:0002026,0.161867051105482,0.986801126892151,1,24,regulation of the force of heart contraction,BP,ADM
8745,GO:0032946,0.161890515977045,0.964536477987484,2,118,positive regulation of mononuclear cell proliferation,BP,IGFBP2;ANXA1
3958,GO:0008207,0.161951950625888,0.986693391732058,1,29,C21-steroid hormone metabolic process,BP,ADM
8799,GO:0033028,0.162216519359319,0.986664561639842,1,28,myeloid cell apoptotic process,BP,ANXA1
7187,GO:0030159,0.162257228595917,0.98673537662,1,24,receptor signaling complex scaffold activity,MF,SHANK2
12044,GO:0045577,0.162587990200171,0.986618800482633,1,27,regulation of B cell differentiation,BP,MMP14
6426,GO:0019098,0.16286005161747,0.986555149998437,1,28,reproductive behavior,BP,GRIN1
12116,GO:0045667,0.16294627614449,0.964212549584679,2,105,regulation of osteoblast differentiation,BP,LTF;SMOC1
567,GO:0001666,0.163419337307338,0.938195191805816,4,323,response to hypoxia,BP,PLAU;POSTN;ADM;MMP14
13151,GO:0048668,0.163450421603425,0.986511138158953,1,25,collateral sprouting,BP,SPP1
777,GO:0001964,0.163621729374747,0.986504070691513,1,24,startle response,BP,GRIN1
15709,GO:0070306,0.16404362409521,0.986389337400679,1,26,lens fiber cell differentiation,BP,VIM
8742,GO:0032943,0.164050100601663,0.948545549451596,3,224,mononuclear cell proliferation,BP,IGFBP2;LGALS3;ANXA1
4916,GO:0010743,0.164108423193778,0.986398785116279,1,25,regulation of macrophage derived foam cell differentiation,BP,PLA2G2A
68,GO:0000139,0.164121412249663,0.918644837279899,7,681,Golgi membrane,CC,CUX2;GBP1;MMD2;GALNT13;FUT9;ST8SIA3;HLA-DQB1
15658,GO:0070232,0.164894584896158,0.986189510203782,1,29,regulation of T cell apoptotic process,BP,LGALS3
11665,GO:0044463,0.164908080204465,0.902618829021111,12,1252,cell projection part,CC,CRTAC1;FERMT1;KCNIP3;SLC8A2;CPLX2;CDHR1;KCNB1;SHANK2;PDPN;GABRG1;GRIN1;SHISA7
18452,GO:0120038,0.164908080204465,0.902618829021111,12,1252,plasma membrane bounded cell projection part,CC,CRTAC1;FERMT1;KCNIP3;SLC8A2;CPLX2;CDHR1;KCNB1;SHANK2;PDPN;GABRG1;GRIN1;SHISA7
21307,GO:2000300,0.165494996369996,0.986160402611514,1,25,regulation of synaptic vesicle exocytosis,BP,RIMS2
4950,GO:0010800,0.165641905108019,0.986094698567148,1,27,positive regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
3493,GO:0006909,0.165741109525691,0.94778468771707,3,218,phagocytosis,BP,CCL2;ANXA1;PTX3
3504,GO:0006929,0.166212681027767,0.986036149253179,1,25,substrate-dependent cell migration,BP,TNFRSF12A
20690,GO:1905476,0.166356847586333,0.985935406255158,1,29,negative regulation of protein localization to membrane,BP,GBP1
13756,GO:0051209,0.166694997244862,0.962909537779265,2,99,release of sequestered calcium ion into cytosol,BP,JPH3;CXCL10
13805,GO:0051283,0.166694997244862,0.962909537779265,2,99,negative regulation of sequestering of calcium ion,BP,JPH3;CXCL10
11137,GO:0043236,0.166949591575512,0.985886682993736,1,26,laminin binding,MF,LGALS3
18585,GO:1900087,0.167252676936624,0.985813936983182,1,27,positive regulation of G1/S transition of mitotic cell cycle,BP,ANXA1
12935,GO:0048169,0.167268890941953,0.985830859790834,1,26,regulation of long-term neuronal synaptic plasticity,BP,GRIN1
11414,GO:0043900,0.167290676120644,0.936166092146777,4,339,regulation of multi-organism process,BP,LTF;TIMP1;PTX3;ANXA2
1436,GO:0003158,0.167375427616667,0.962634673212048,2,106,endothelium development,BP,PDPN;CXCL10
11088,GO:0043169,0.167420545291185,0.882344376787834,30,3736,cation binding,MF,LTF;CP;MOXD1;CRTAC1;TIMP1;AEBP1;COL1A1;KCNIP3;STEAP3;SLC8A2;KCNIP2;POSTN;ANXA1;GNAL;GALNT13;CDHR1;ADAM12;MMP14;C1R;S100A11;COL3A1;PCDH7;KSR2;RIMS2;GRIN1;ANXA2;PLA2G2A;SMOC1;COL5A2;CFI
761,GO:0001945,0.167739152033346,0.985793162235736,1,24,lymph vessel development,BP,PDPN
20844,GO:1905952,0.168464751324262,0.962231030812895,2,109,regulation of lipid localization,BP,SPP1;ANXA2
15910,GO:0070665,0.168708894631328,0.962099686836496,2,121,positive regulation of leukocyte proliferation,BP,IGFBP2;ANXA1
12048,GO:0045581,0.168829083065582,0.985517571662395,1,28,negative regulation of T cell differentiation,BP,ANXA1
13804,GO:0051282,0.168911238054974,0.96210962784881,2,100,regulation of sequestering of calcium ion,BP,JPH3;CXCL10
13781,GO:0051250,0.169906113107616,0.961680365246156,2,117,negative regulation of lymphocyte activation,BP,LGALS3;ANXA1
14727,GO:0060384,0.171460309454173,0.985109584570096,1,25,innervation,BP,GABRB3
2608,GO:0005516,0.172113980005251,0.944918342555284,3,183,calmodulin binding,MF,AEBP1;SLC8A2;GRIN1
5458,GO:0015491,0.172264008810764,0.984901801179024,1,28,cation:cation antiporter activity,MF,SLC8A2
6757,GO:0021522,0.172316523535597,0.984892280620708,1,28,spinal cord motor neuron differentiation,BP,MDGA2
5397,GO:0015278,0.172704318412594,0.984998039398686,1,21,calcium-release channel activity,MF,JPH3
7966,GO:0031640,0.17326468248644,0.984626074783968,1,34,killing of cells of other organism,BP,LTF
11611,GO:0044364,0.17326468248644,0.984626074783968,1,34,disruption of cells of other organism,BP,LTF
19147,GO:1902107,0.173706989370151,0.960289501927223,2,118,positive regulation of leukocyte differentiation,BP,ANXA1;MMP14
4889,GO:0010712,0.174139332766064,0.98450788224688,1,31,regulation of collagen metabolic process,BP,VIM
13576,GO:0050921,0.174299593327054,0.960064315670293,2,120,positive regulation of chemotaxis,BP,SERPINE1;CXCL10
460,GO:0001227,0.174634041139499,0.943667842794538,3,219,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3
8608,GO:0032743,0.174745316448764,0.984429806999556,1,29,positive regulation of interleukin-2 production,BP,ANXA1
4596,GO:0009792,0.174767785659413,0.917229878734552,6,545,embryo development ending in birth or egg hatching,BP,COL1A1;HOXA7;ADM;MMP14;DSCAML1;SOCS3
19404,GO:1902803,0.17479408667962,0.984459501633569,1,27,regulation of synaptic vesicle transport,BP,RIMS2
6996,GO:0021987,0.174797207903244,0.959949892882271,2,103,cerebral cortex development,BP,COL3A1;GRIN1
5171,GO:0014072,0.1756475832981,0.984245407727993,1,30,response to isoquinoline alkaloid,BP,GRIN1
11167,GO:0043278,0.1756475832981,0.984245407727993,1,30,response to morphine,BP,GRIN1
11971,GO:0045335,0.175746789732634,0.959536654585785,2,118,phagocytic vesicle,CC,LTF;VIM
17379,GO:0090313,0.175749056754871,0.984210107875718,1,31,regulation of protein targeting to membrane,BP,KCNB1
13755,GO:0051208,0.176099186365798,0.959468735785633,2,103,sequestering of calcium ion,BP,JPH3;CXCL10
9328,GO:0034383,0.176183863126352,0.98416337719445,1,29,low-density lipoprotein particle clearance,BP,ANXA2
17885,GO:0097730,0.176332797103341,0.959346506392779,2,111,non-motile cilium,CC,CDHR1;SHANK2
11579,GO:0044319,0.176382984037027,0.984165701335497,1,27,wound healing, spreading of cells,BP,PDPN
17447,GO:0090505,0.176382984037027,0.984165701335497,1,27,epiboly involved in wound healing,BP,PDPN
5298,GO:0015077,0.176443076365145,0.93133811314341,4,329,monovalent inorganic cation transmembrane transporter activity,MF,KCNIP3;SLC8A2;KCNIP2;KCNB1
13721,GO:0051154,0.176591448705754,0.984106485680814,1,28,negative regulation of striated muscle cell differentiation,BP,CXCL10
10206,GO:0036293,0.17660916686593,0.931247233357627,4,331,response to decreased oxygen levels,BP,PLAU;POSTN;ADM;MMP14
18984,GO:1901652,0.176672030489481,0.922688889206453,5,441,response to peptide,BP,TIMP1;COL1A1;ANXA1;ADM;SOCS3
10551,GO:0042092,0.176751857680166,0.983992810306554,1,33,type 2 immune response,BP,ANXA1
14009,GO:0051668,0.176819852730378,0.959161491495063,2,112,localization within membrane,BP,CACNG2;SHISA7
11318,GO:0043539,0.177088577138263,0.983960002521021,1,31,protein serine/threonine kinase activator activity,MF,LTF
7381,GO:0030507,0.177601929252287,0.983984656163125,1,25,spectrin binding,MF,GBP1
11650,GO:0044444,0.177864726373606,0.870263584068244,61,8577,cytoplasmic part,CC,LTF;TYMP;VIM;CP;SNAP91;IGF2BP2;MOXD1;CHGB;FERMT1;TIMP1;SERPINE1;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;COL6A2;GALNT13;CPLX2;INA;SERPING1;SPHKAP;JPH3;MMP14;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;CACNG2;COL3A1;PCDH7;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;PLA2G2A;SERPINA3;COL5A2;IFI30
11115,GO:0043204,0.177876685378239,0.958759717119599,2,114,perikaryon,CC,SLC8A2;KCNB1
19747,GO:1903523,0.177972705550243,0.983868797328458,1,27,negative regulation of blood circulation,BP,ADM
4793,GO:0010543,0.178810414099253,0.983652455404559,1,30,regulation of platelet activation,BP,PDPN
14622,GO:0060249,0.179163617837811,0.929875213553783,4,333,anatomical structure homeostasis,BP,LTF;SPP1;CDHR1;SERPINA3
3857,GO:0008037,0.179380237908839,0.95819683807619,2,114,cell recognition,BP,CRTAC1;LGALS3
15299,GO:0061448,0.179423941273729,0.941412468921829,3,216,connective tissue development,BP,TIMP1;COL1A1;CHI3L1
18223,GO:0099513,0.179499661609764,0.914334617842282,6,539,polymeric cytoskeletal fiber,CC,VIM;FERMT1;ANXA1;INA;SHANK2;TUBA1C
3814,GO:0007600,0.179954908128948,0.920774370776079,5,451,sensory perception,BP,COL1A1;GNAL;GABRB3;GRIN1;RTP5
19640,GO:1903305,0.180179702995777,0.957888324934706,2,116,regulation of regulated secretory pathway,BP,KCNB1;RIMS2
2477,GO:0005178,0.18018031345255,0.95790850036997,2,111,integrin binding,MF,MMP14;COL3A1
12247,GO:0045923,0.180254339704481,0.983416190961749,1,28,positive regulation of fatty acid metabolic process,BP,ANXA1
11055,GO:0043114,0.180394078195678,0.983351143058191,1,30,regulation of vascular permeability,BP,ADM
2611,GO:0005520,0.180504273225987,0.983348626971165,1,29,insulin-like growth factor binding,MF,IGFBP2
15906,GO:0070661,0.180993712362289,0.940632318551056,3,235,leukocyte proliferation,BP,IGFBP2;LGALS3;ANXA1
10607,GO:0042181,0.181165661924275,0.983153994365575,1,33,ketone biosynthetic process,BP,ADM
14914,GO:0060674,0.18119536336386,0.9832162653324,1,29,placenta blood vessel development,BP,SOCS3
4406,GO:0009187,0.181585210998328,0.957361658703079,2,115,cyclic nucleotide metabolic process,BP,ADM;CXCL10
11214,GO:0043370,0.181645262979582,0.983076942486576,1,32,regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
11472,GO:0044058,0.181669069473723,0.983072346450836,1,32,regulation of digestive system process,BP,TYMP
18990,GO:1901658,0.181790473797377,0.983005052915403,1,35,glycosyl compound catabolic process,BP,TYMP
11044,GO:0043094,0.181902227610541,0.982997169592916,1,34,cellular metabolic compound salvage,BP,TYMP
12294,GO:0046006,0.181969551567502,0.983014278377569,1,32,regulation of activated T cell proliferation,BP,IGFBP2
10668,GO:0042325,0.182017417939332,0.890438992643859,12,1340,regulation of phosphorylation,BP,LTF;SRPX2;CCL2;GBP1;GDF15;CHI3L1;MMD2;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
13648,GO:0051047,0.182384148637063,0.928126876591721,4,342,positive regulation of secretion,BP,FERMT1;SPP1;POSTN;KCNB1
7987,GO:0031668,0.182434415297252,0.939963119057389,3,223,cellular response to extracellular stimulus,BP,COL1A1;POSTN;KCNB1
713,GO:0001881,0.182441781021409,0.982957161713802,1,30,receptor recycling,BP,ANXA2
7240,GO:0030224,0.182683556820847,0.982910317091997,1,30,monocyte differentiation,BP,HOXA7
19565,GO:1903131,0.182683556820847,0.982910317091997,1,30,mononuclear cell differentiation,BP,HOXA7
10776,GO:0042542,0.182816950972251,0.956864066647957,2,123,response to hydrogen peroxide,BP,COL1A1;ANXA1
17262,GO:0090162,0.182948653305811,0.982898370283585,1,28,establishment of epithelial cell polarity,BP,FERMT1
2282,GO:0004864,0.182996333180054,0.982831771692441,1,31,protein phosphatase inhibitor activity,MF,ELFN2
2789,GO:0005834,0.183454173711719,0.982710021110493,1,33,heterotrimeric G-protein complex,CC,GNAL
20636,GO:1905360,0.183454173711719,0.982710021110493,1,33,GTPase complex,CC,GNAL
3828,GO:0007618,0.183490297861742,0.982718756704724,1,32,mating,BP,GRIN1
9634,GO:0035235,0.183590615799449,0.982819637600682,1,26,ionotropic glutamate receptor signaling pathway,BP,GRIN1
12470,GO:0046461,0.183954793285062,0.982644846684588,1,31,neutral lipid catabolic process,BP,FABP5
12473,GO:0046464,0.183954793285062,0.982644846684588,1,31,acylglycerol catabolic process,BP,FABP5
19533,GO:1903053,0.184183486432283,0.982658188468444,1,28,regulation of extracellular matrix organization,BP,PDPN
725,GO:0001893,0.184421550053739,0.982571543448524,1,30,maternal placenta development,BP,SPP1
7792,GO:0031312,0.184425957902926,0.98253557212918,1,32,extrinsic component of organelle membrane,CC,ANXA1
7139,GO:0030072,0.184783973067635,0.938840647465961,3,219,peptide hormone secretion,BP,ANXA1;KCNB1;RIMS2
16496,GO:0071709,0.184858367060601,0.982548567179699,1,27,membrane assembly,BP,ANXA2
12563,GO:0046627,0.185017125683653,0.982436392729726,1,31,negative regulation of insulin receptor signaling pathway,BP,SOCS3
556,GO:0001654,0.186048076517599,0.926159153946696,4,318,eye development,BP,VIM;COL4A1;SMOC1;COL5A2
8280,GO:0032270,0.186207481471724,0.887414587477557,12,1363,positive regulation of cellular protein metabolic process,BP,LTF;VIM;CCL2;GDF15;CHI3L1;MMD2;MMP14;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
630,GO:0001772,0.186212722464309,0.982182872087592,1,32,immunological synapse,CC,LGALS3
5408,GO:0015298,0.186312541081345,0.982180391540475,1,31,solute:cation antiporter activity,MF,SLC8A2
17783,GO:0097484,0.186350901633684,0.982211061374901,1,29,dendrite extension,BP,RIMS2
3653,GO:0007190,0.186589879703386,0.982125324700519,1,31,activation of adenylate cyclase activity,BP,GNAL
19123,GO:1902042,0.186671090835122,0.982060054475265,1,34,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1
4653,GO:0009987,0.186675261046687,0.886592291423179,90,13224,cellular process,BP,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;CHGB;CRTAC1;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;CSMD3;GABRB3;NNMT;CACNG2;ELFN2;TUBA1C;COL3A1;CXCL10;PCDH7;KSR2;FUT9;RIMS2;GRIN1;DSCAML1;ST8SIA3;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;IFI30
14108,GO:0051879,0.186766412290573,0.982072806247503,1,32,Hsp90 protein binding,MF,GBP1
17446,GO:0090504,0.18705263279882,0.982093165127318,1,28,epiboly,BP,PDPN
516,GO:0001569,0.18720516695204,0.982002830300207,1,31,branching involved in blood vessel morphogenesis,BP,COL4A1
8338,GO:0032365,0.18742269950952,0.981998137212369,1,29,intracellular lipid transport,BP,ANXA2
3357,GO:0006692,0.187690643395532,0.981856196214145,1,34,prostanoid metabolic process,BP,ANXA1
3358,GO:0006693,0.187690643395532,0.981856196214145,1,34,prostaglandin metabolic process,BP,ANXA1
19944,GO:1903900,0.187766302301215,0.954957011833027,2,125,regulation of viral life cycle,BP,LTF;PTX3
11898,GO:0045177,0.187917644347966,0.925130443658486,4,322,apical part of cell,CC,IGFBP2;ANXA1;SHANK2;PDPN
4915,GO:0010742,0.188280206793563,0.98182680217871,1,29,macrophage derived foam cell differentiation,BP,PLA2G2A
17207,GO:0090077,0.188280206793563,0.98182680217871,1,29,foam cell differentiation,BP,PLA2G2A
13062,GO:0048489,0.188418534417272,0.954743109015073,2,115,synaptic vesicle transport,BP,CPLX2;RIMS2
17782,GO:0097480,0.188418534417272,0.954743109015073,2,115,establishment of synaptic vesicle localization,BP,CPLX2;RIMS2
3699,GO:0007265,0.188423697123783,0.91580422680123,5,438,Ras protein signal transduction,BP,MMD2;GPR17;PDPN;COL3A1;KSR2
10578,GO:0042133,0.188885829540138,0.954533607549351,2,122,neurotransmitter metabolic process,BP,MOXD1;PTX3
12573,GO:0046638,0.189855187742583,0.98141928639383,1,34,positive regulation of alpha-beta T cell differentiation,BP,ANXA1
14679,GO:0060325,0.189885593525875,0.981503685924968,1,29,face morphogenesis,BP,COL1A1
11871,GO:0045124,0.189956925868478,0.98146870582405,1,30,regulation of bone resorption,BP,SPP1
16924,GO:0072529,0.190591563256861,0.981269373585628,1,34,pyrimidine-containing compound catabolic process,BP,TYMP
2539,GO:0005319,0.191994740658995,0.953338509677241,2,117,lipid transporter activity,MF,SLCO1A2;ABCC3
749,GO:0001932,0.192195287180695,0.885648483246138,11,1227,regulation of protein phosphorylation,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;MMD2;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
6461,GO:0019212,0.192398412677072,0.980915117930312,1,33,phosphatase inhibitor activity,MF,ELFN2
3873,GO:0008066,0.192491297593217,0.981019606756762,1,27,glutamate receptor activity,MF,GRIN1
4762,GO:0010470,0.192561102844374,0.980898975675435,1,32,regulation of gastrulation,BP,COL5A2
13158,GO:0048675,0.193350656188562,0.952851089359035,2,107,axon extension,BP,TNFRSF12A;TNR
16255,GO:0071354,0.193653808834493,0.980691851870753,1,31,cellular response to interleukin-6,BP,SOCS3
17595,GO:0097120,0.194008640424166,0.98059947847139,1,32,receptor localization to synapse,BP,CACNG2
11731,GO:0044764,0.194425160619806,0.980495105587565,1,33,multi-organism cellular process,BP,LTF
3820,GO:0007608,0.194513536277855,0.980444237892705,1,35,sensory perception of smell,BP,GNAL
3695,GO:0007259,0.194686948740995,0.95224363183414,2,125,JAK-STAT cascade,BP,CCL2;SOCS3
12071,GO:0045616,0.194923068219893,0.980427957697893,1,31,regulation of keratinocyte differentiation,BP,HOXA7
2750,GO:0005771,0.195025950451615,0.980337041132665,1,35,multivesicular body,CC,STEAP3
7144,GO:0030099,0.195661976189141,0.920816888609682,4,344,myeloid cell differentiation,BP,LTF;HOXA7;LGALS3;ANXA2
18578,GO:1900077,0.196009049066908,0.980163432334016,1,33,negative regulation of cellular response to insulin stimulus,BP,SOCS3
17871,GO:0097696,0.19667475578829,0.951448337328467,2,126,STAT cascade,BP,CCL2;SOCS3
10655,GO:0042304,0.196746707638153,0.979990848877499,1,34,regulation of fatty acid biosynthetic process,BP,ANXA1
12023,GO:0045494,0.196789348832355,0.980036420815193,1,31,photoreceptor cell maintenance,BP,CDHR1
1865,GO:0004180,0.197043065922857,0.979896731820406,1,36,carboxypeptidase activity,MF,AEBP1
10547,GO:0042088,0.197321970466809,0.979837530314337,1,36,T-helper 1 type immune response,BP,ANXA1
4912,GO:0010737,0.197798788541801,0.979943174893621,1,26,protein kinase A signaling,BP,SPHKAP
9021,GO:0033572,0.198045494514925,0.979698922979123,1,35,transferrin transport,BP,STEAP3
668,GO:0001819,0.198444049235917,0.919239013718088,4,362,positive regulation of cytokine production,BP,FERMT1;SERPINE1;POSTN;ANXA1
7540,GO:0030856,0.19855120551246,0.950720176997822,2,120,regulation of epithelial cell differentiation,BP,SERPINE1;HOXA7
18279,GO:0099622,0.198771469472494,0.979596262660257,1,32,cardiac muscle cell membrane repolarization,BP,KCNIP2
685,GO:0001837,0.198813691520256,0.950602292846672,2,123,epithelial to mesenchymal transition,BP,COL1A1;PDPN
3924,GO:0008156,0.19908229100129,0.979529842277905,1,32,negative regulation of DNA replication,BP,S100A11
8199,GO:0032103,0.199096614878871,0.931752193192758,3,246,positive regulation of response to external stimulus,BP,SERPINE1;CXCL10;PLA2G2A
568,GO:0001667,0.199107202276264,0.918898707941432,4,332,ameboidal-type cell migration,BP,FERMT1;TIMP1;SRPX2;ANXA1
10716,GO:0042417,0.19926097641883,0.979455464067012,1,34,dopamine metabolic process,BP,MOXD1
13793,GO:0051262,0.199390317408429,0.950362104566897,2,125,protein tetramerization,BP,GRIN1;ANXA2
13336,GO:0050433,0.199576827241732,0.979355447574084,1,36,regulation of catecholamine secretion,BP,KCNB1
7541,GO:0030857,0.19959880023192,0.979400526974391,1,33,negative regulation of epithelial cell differentiation,BP,HOXA7
12674,GO:0046883,0.199914594821343,0.931365731078894,3,232,regulation of hormone secretion,BP,SPP1;ANXA1;KCNB1
12466,GO:0046456,0.200884540364321,0.979043839228674,1,38,icosanoid biosynthetic process,BP,ANXA1
6882,GO:0021772,0.200991692789065,0.979160939072993,1,30,olfactory bulb development,BP,CRTAC1
12192,GO:0045823,0.201058107875518,0.97906809714128,1,34,positive regulation of heart contraction,BP,ADM
4824,GO:0010605,0.201360653370027,0.864079600685996,19,2346,negative regulation of macromolecule metabolic process,BP,LTF;VIM;IGF2BP2;FERMT1;TIMP1;SERPINE1;AEBP1;CUX2;KCNIP3;GBP1;HOXA7;IGF2BP3;SERPING1;S100A11;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
5896,GO:0016504,0.201443817382482,0.978967566384143,1,35,peptidase activator activity,MF,MMP14
8652,GO:0032801,0.201564601909127,0.978995196452935,1,32,receptor catabolic process,BP,ANXA2
10025,GO:0035909,0.201592102670831,0.979031166302498,1,30,aorta morphogenesis,BP,COL3A1
12075,GO:0045620,0.20211081166111,0.978822376793658,1,35,negative regulation of lymphocyte differentiation,BP,ANXA1
3323,GO:0006654,0.202310207311952,0.978813955772061,1,33,phosphatidic acid biosynthetic process,BP,PLA2G2A
5270,GO:0014911,0.202722188466159,0.97878572541917,1,30,positive regulation of smooth muscle cell migration,BP,POSTN
12384,GO:0046189,0.203219826551858,0.978579771672466,1,35,phenol-containing compound biosynthetic process,BP,MOXD1
20019,GO:1904036,0.203706150166022,0.978490174632832,1,34,negative regulation of epithelial cell apoptotic process,BP,SERPINE1
4845,GO:0010634,0.203789152013867,0.948596003191525,2,120,positive regulation of epithelial cell migration,BP,SRPX2;ANXA1
13486,GO:0050798,0.204162525031186,0.978355998112967,1,36,activated T cell proliferation,BP,IGFBP2
19409,GO:1902808,0.204370216806267,0.978343907426773,1,34,positive regulation of cell cycle G1/S phase transition,BP,ANXA1
7232,GO:0030216,0.204773668814874,0.948167439199076,2,126,keratinocyte differentiation,BP,HOXA7;ANXA1
3190,GO:0006486,0.204813547998988,0.928884919593655,3,234,protein glycosylation,BP,GALNT13;FUT9;ST8SIA3
11247,GO:0043413,0.204813547998988,0.928884919593655,3,234,macromolecule glycosylation,BP,GALNT13;FUT9;ST8SIA3
5117,GO:0014002,0.205152228642163,0.978230288696971,1,31,astrocyte development,BP,VIM
9592,GO:0035091,0.205900740365627,0.928350508445384,3,224,phosphatidylinositol binding,MF,SNAP91;PLEKHA4;ANXA2
12012,GO:0045429,0.205913862046567,0.977984189780826,1,35,positive regulation of nitric oxide biosynthetic process,BP,PTX3
20186,GO:1904407,0.205913862046567,0.977984189780826,1,35,positive regulation of nitric oxide metabolic process,BP,PTX3
6997,GO:0021988,0.205924094792568,0.978059312061316,1,31,olfactory lobe development,BP,CRTAC1
7967,GO:0031641,0.206667334926447,0.977833796937737,1,34,regulation of myelination,BP,TYMP
13803,GO:0051281,0.207201293581268,0.977696442043269,1,35,positive regulation of release of sequestered calcium ion into cytosol,BP,CXCL10
4482,GO:0009312,0.207498286406615,0.977581714624047,1,38,oligosaccharide biosynthetic process,BP,GALNT13
12480,GO:0046473,0.207795381729134,0.977580936627414,1,34,phosphatidic acid metabolic process,BP,PLA2G2A
19577,GO:1903169,0.207857694014488,0.946902851677786,2,124,regulation of calcium ion transmembrane transport,BP,JPH3;CXCL10
16923,GO:0072528,0.207864410601526,0.977484786860855,1,39,pyrimidine-containing compound biosynthetic process,BP,TYMP
8277,GO:0032266,0.208002669029657,0.977553391560173,1,33,phosphatidylinositol-3-phosphate binding,MF,PLEKHA4
12251,GO:0045927,0.208132551427612,0.92720877798594,3,224,positive regulation of growth,BP,TNFRSF12A;MMP14;RIMS2
11483,GO:0044091,0.208167323329827,0.977536658567519,1,32,membrane biogenesis,BP,ANXA2
17781,GO:0097479,0.208244290163108,0.946750980813062,2,122,synaptic vesicle localization,BP,CPLX2;RIMS2
15303,GO:0061462,0.209166381098408,0.977253321947781,1,35,protein localization to lysosome,BP,CACNG2
13563,GO:0050907,0.209248941605206,0.977131446885887,1,42,detection of chemical stimulus involved in sensory perception,BP,RTP5
11364,GO:0043616,0.210712277527244,0.976939453657674,1,33,keratinocyte proliferation,BP,FERMT1
12592,GO:0046676,0.211070275917883,0.976819481077059,1,35,negative regulation of insulin secretion,BP,KCNB1
3407,GO:0006775,0.21109798040525,0.976779078789617,1,37,fat-soluble vitamin metabolic process,BP,RBP1
1060,GO:0002437,0.21114816955657,0.97673699330455,1,39,inflammatory response to antigenic stimulus,BP,GPR17
7376,GO:0030501,0.211702052535835,0.976693173330132,1,34,positive regulation of bone mineralization,BP,LTF
971,GO:0002285,0.212045718163553,0.945121297138542,2,132,lymphocyte activation involved in immune response,BP,LGALS3;ANXA1
3311,GO:0006636,0.212142275432324,0.97649372145647,1,40,unsaturated fatty acid biosynthetic process,BP,ANXA1
6217,GO:0017124,0.212162951545504,0.945117884432263,2,121,SH3 domain binding,MF,ADAM12;SHANK2
4386,GO:0009163,0.21224311784686,0.976456824623013,1,41,nucleoside biosynthetic process,BP,TYMP
13469,GO:0050775,0.212603137518426,0.976526877546607,1,32,positive regulation of dendrite morphogenesis,BP,CUX2
1293,GO:0002832,0.212611820936361,0.976414491163564,1,38,negative regulation of response to biotic stimulus,BP,LTF
14677,GO:0060323,0.212871154759104,0.976423856791292,1,34,head morphogenesis,BP,COL1A1
758,GO:0001941,0.213689928025007,0.976254384624151,1,33,postsynaptic membrane organization,BP,SHISA7
4200,GO:0008610,0.213739024602591,0.892561046125788,6,624,lipid biosynthetic process,BP,PLEKHA4;RBP1;ANXA1;ADM;ST8SIA3;PLA2G2A
7390,GO:0030517,0.213858944847075,0.976194994991045,1,34,negative regulation of axon extension,BP,TNR
12879,GO:0048009,0.213976420907765,0.976232212154523,1,31,insulin-like growth factor receptor signaling pathway,BP,IGFBP2
18691,GO:1900271,0.21429350864152,0.976158635535095,1,31,regulation of long-term synaptic potentiation,BP,SHISA7
8344,GO:0032371,0.215021149462785,0.975904953658206,1,35,regulation of sterol transport,BP,ANXA2
8347,GO:0032374,0.215021149462785,0.975904953658206,1,35,regulation of cholesterol transport,BP,ANXA2
7128,GO:0030049,0.215290911205767,0.97590325827591,1,32,muscle filament sliding,BP,VIM
8934,GO:0033275,0.215290911205767,0.97590325827591,1,32,actin-myosin filament sliding,BP,VIM
5488,GO:0015682,0.215299868202887,0.975787978353377,1,38,ferric iron transport,BP,STEAP3
16911,GO:0072512,0.215299868202887,0.975787978353377,1,38,trivalent inorganic cation transport,BP,STEAP3
15569,GO:0070085,0.21543465773787,0.923394130302485,3,241,glycosylation,BP,GALNT13;FUT9;ST8SIA3
21453,GO:2000514,0.215492580114017,0.975727219612024,1,39,regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
4340,GO:0009112,0.215561317615384,0.975711055154799,1,39,nucleobase metabolic process,BP,TYMP
3670,GO:0007212,0.215702042630028,0.975693472792142,1,38,dopamine receptor signaling pathway,BP,GNAL
12156,GO:0045746,0.215892326476956,0.97563313233363,1,39,negative regulation of Notch signaling pathway,BP,MMP14
21804,GO:2001222,0.216012814500242,0.975808941161267,1,29,regulation of neuron migration,BP,COL3A1
15620,GO:0070169,0.21601324761136,0.975672279747482,1,35,positive regulation of biomineral tissue development,BP,LTF
1207,GO:0002695,0.216553412967756,0.943188552032527,2,138,negative regulation of leukocyte activation,BP,LGALS3;ANXA1
12074,GO:0045619,0.217770054853513,0.942671748833844,2,137,regulation of lymphocyte differentiation,BP,ANXA1;MMP14
13565,GO:0050909,0.217830852087335,0.975131077305795,1,42,sensory perception of taste,BP,RTP5
4698,GO:0010165,0.218115903369485,0.975175119154983,1,35,response to X-ray,BP,ANXA1
593,GO:0001709,0.218581976572265,0.975027669658045,1,37,cell fate determination,BP,DSCAML1
13335,GO:0050432,0.218893142515959,0.974920499241175,1,39,catecholamine secretion,BP,KCNB1
405,GO:0001078,0.219102016207141,0.942111094162324,2,134,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,CUX2;KCNIP3
16545,GO:0071827,0.219282931864443,0.97486007376972,1,37,plasma lipoprotein particle organization,BP,PLA2G2A
12154,GO:0045744,0.219356803459828,0.97479413615793,1,40,negative regulation of G-protein coupled receptor protein signaling pathway,BP,ADM
2551,GO:0005342,0.220080155491509,0.941678052379356,2,137,organic acid transmembrane transporter activity,MF,SLCO1A2;ABCC3
12709,GO:0046943,0.220080155491509,0.941678052379356,2,137,carboxylic acid transmembrane transporter activity,MF,SLCO1A2;ABCC3
19012,GO:1901699,0.220249149830252,0.888306086482753,6,586,cellular response to nitrogen compound,BP,COL1A1;GABRB3;COL3A1;SOCS3;COL4A1;COL5A2
3018,GO:0006213,0.220287300781207,0.974528371090609,1,43,pyrimidine nucleoside metabolic process,BP,TYMP
13225,GO:0048791,0.221001214514817,0.974464788098886,1,36,calcium ion-regulated exocytosis of neurotransmitter,BP,RIMS2
8614,GO:0032757,0.221409583471428,0.974298709337471,1,40,positive regulation of interleukin-8 production,BP,SERPINE1
18991,GO:1901659,0.221454311807168,0.974245565930491,1,43,glycosyl compound biosynthetic process,BP,TYMP
2632,GO:0005575,0.222032622758048,0.943398576668215,99,14935,cellular_component,CC,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;SLCO1A2;CHGB;CRTAC1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;ABCC3;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;CA10;MMP14;KCNB1;C1R;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;CSMD3;SVOP;GABRB3;NNMT;CACNG2;ELFN2;TUBA1C;COL3A1;CXCL10;PCDH7;KSR2;FUT9;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;CFI;IFI30
15014,GO:0060828,0.222886263909767,0.91946034216147,3,243,regulation of canonical Wnt signaling pathway,BP,FERMT1;COL1A1;IGFBP2
6874,GO:0021762,0.222983006800291,0.973931165635008,1,39,substantia nigra development,BP,INA
2488,GO:0005217,0.223146583986729,0.974080694387595,1,30,intracellular ligand-gated ion channel activity,MF,JPH3
642,GO:0001784,0.22365788695026,0.973838405635271,1,35,phosphotyrosine residue binding,MF,SOCS3
8100,GO:0031941,0.223692594155637,0.973810267488307,1,36,filamentous actin,CC,FERMT1
5173,GO:0014075,0.223898103140542,0.973759917254285,1,36,response to amine,BP,GRIN1
3826,GO:0007616,0.22405002147628,0.97376324254351,1,34,long-term memory,BP,GRIN1
19309,GO:1902531,0.224460717780821,0.854274407385813,14,1666,regulation of intracellular signal transduction,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;MMD2;GPR17;SPHKAP;JPH3;COL3A1;CXCL10;KSR2;SOCS3;PLA2G2A
4949,GO:0010799,0.224568618888478,0.973558805190569,1,38,regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
740,GO:0001917,0.225319371947361,0.973410254434304,1,36,photoreceptor inner segment,CC,SHANK2
3858,GO:0008038,0.225578289347805,0.973433704494399,1,32,neuron recognition,BP,CRTAC1
12193,GO:0045824,0.225601217410445,0.973286830350357,1,39,negative regulation of innate immune response,BP,SERPING1
18220,GO:0099504,0.226169362429665,0.939066162740441,2,127,synaptic vesicle cycle,BP,CPLX2;RIMS2
16248,GO:0071347,0.226589769757224,0.938806067634477,2,146,cellular response to interleukin-1,BP,CCL2;CHI3L1
4819,GO:0010594,0.227481518146975,0.938474648883839,2,130,regulation of endothelial cell migration,BP,SRPX2;ANXA1
13731,GO:0051172,0.227812112707443,0.846073436686364,17,2098,negative regulation of nitrogen compound metabolic process,BP,LTF;IGF2BP2;TIMP1;SERPINE1;AEBP1;CUX2;KCNIP3;GBP1;HOXA7;IGF2BP3;SERPING1;S100A11;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
7798,GO:0031324,0.228083513199078,0.84432513422113,18,2239,negative regulation of cellular metabolic process,BP,LTF;IGF2BP2;TIMP1;SERPINE1;AEBP1;CUX2;KCNIP3;GBP1;HOXA7;SPOCD1;IGF2BP3;SERPING1;S100A11;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
4005,GO:0008284,0.228365411631248,0.876291089550219,7,755,positive regulation of cell proliferation,BP,LTF;TIMP1;IGFBP2;ANXA1;ADM;CXCL10;ANXA2
14539,GO:0060119,0.22861094775159,0.972590717267206,1,36,inner ear receptor cell development,BP,GABRB3
16543,GO:0071825,0.229023815302834,0.972431537859377,1,39,protein-lipid complex subunit organization,BP,PLA2G2A
7127,GO:0030048,0.229159639217611,0.937790132587666,2,118,actin filament-based movement,BP,VIM;PDPN
9022,GO:0033574,0.229418920526112,0.972299308037557,1,41,response to testosterone,BP,SPP1
21349,GO:2000351,0.229673752165823,0.972267452237578,1,39,regulation of endothelial cell apoptotic process,BP,SERPINE1
9460,GO:0034656,0.229795129581661,0.972174493101725,1,43,nucleobase-containing small molecule catabolic process,BP,TYMP
19511,GO:1903018,0.230068146616388,0.972150847946741,1,40,regulation of glycoprotein metabolic process,BP,PTX3
2400,GO:0005048,0.23054960419269,0.972045486569315,1,39,signal sequence binding,MF,KCNIP2
2286,GO:0004869,0.230565807829514,0.972008502479053,1,41,cysteine-type endopeptidase inhibitor activity,MF,LTF
6317,GO:0018210,0.230582528758689,0.93709447963247,2,131,peptidyl-threonine modification,BP,CHI3L1;GALNT13
11430,GO:0043949,0.2307520114877,0.971977179672441,1,40,regulation of cAMP-mediated signaling,BP,CXCL10
6753,GO:0021517,0.231219821418316,0.971874979024667,1,39,ventral spinal cord development,BP,MDGA2
13253,GO:0048854,0.23125844607592,0.971942631734094,1,35,brain morphogenesis,BP,SHANK2
1694,GO:0003924,0.232389536420659,0.914294790946501,3,271,GTPase activity,MF,GBP1;GNAL;TUBA1C
11480,GO:0044088,0.232470633339793,0.971555242418441,1,39,regulation of vacuole organization,BP,ANXA2
4842,GO:0010631,0.23255725655765,0.914264511111786,3,238,epithelial cell migration,BP,FERMT1;SRPX2;ANXA1
12655,GO:0046850,0.232557615307087,0.971550975237153,1,38,regulation of bone remodeling,BP,SPP1
19388,GO:1902743,0.232856735622119,0.971474232398632,1,38,regulation of lamellipodium organization,BP,PDPN
4622,GO:0009892,0.232994195149843,0.837679321448852,20,2548,negative regulation of metabolic process,BP,LTF;VIM;IGF2BP2;FERMT1;TIMP1;SERPINE1;AEBP1;CUX2;KCNIP3;GBP1;HOXA7;SPOCD1;IGF2BP3;SERPING1;S100A11;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
9920,GO:0035722,0.232998530743377,0.971341529537802,1,44,interleukin-12-mediated signaling pathway,BP,ANXA2
16250,GO:0071349,0.232998530743377,0.971341529537802,1,44,cellular response to interleukin-12,BP,ANXA2
3206,GO:0006509,0.233339791735882,0.971314644561614,1,40,membrane protein ectodomain proteolysis,BP,TIMP1
10740,GO:0042461,0.233707905524721,0.971255233497251,1,38,photoreceptor cell development,BP,CDHR1
17243,GO:0090132,0.233979713175184,0.913486720113674,3,239,epithelium migration,BP,FERMT1;SRPX2;ANXA1
15101,GO:0061001,0.234078120275733,0.971243580500707,1,34,regulation of dendritic spine morphogenesis,BP,CUX2
1864,GO:0004177,0.234385849055959,0.970997062955793,1,43,aminopeptidase activity,MF,MMP14
15657,GO:0070231,0.234565706382834,0.970950387457939,1,43,T cell apoptotic process,BP,LGALS3
3537,GO:0006984,0.234787352413813,0.97090789247942,1,42,ER-nucleus signaling pathway,BP,CCL2
9565,GO:0035023,0.234947465903995,0.935174259377496,2,123,regulation of Rho protein signal transduction,BP,GPR17;COL3A1
17347,GO:0090278,0.235388988073836,0.970783963970716,1,40,negative regulation of peptide hormone secretion,BP,KCNB1
21369,GO:2000377,0.235808749048275,0.934689102063881,2,145,regulation of reactive oxygen species metabolic process,BP,PTX3;GRIN1
967,GO:0002279,0.23633784599199,0.970503567227854,1,42,mast cell activation involved in immune response,BP,CPLX2
11181,GO:0043303,0.23633784599199,0.970503567227854,1,42,mast cell degranulation,BP,CPLX2
19770,GO:1903556,0.236784123870897,0.970342655643841,1,45,negative regulation of tumor necrosis factor superfamily cytokine production,BP,LTF
3763,GO:0007423,0.236967959696832,0.885624376981571,5,476,sensory organ development,BP,VIM;GABRB3;COL4A1;SMOC1;COL5A2
13634,GO:0051028,0.237452409346674,0.933974000700657,2,137,mRNA transport,BP,IGF2BP2;IGF2BP3
13220,GO:0048786,0.237489342923804,0.970357501281852,1,34,presynaptic active zone,CC,RIMS2
18835,GO:1901224,0.237608805296946,0.970154402149588,1,43,positive regulation of NIK/NF-kappaB signaling,BP,CHI3L1
1637,GO:0003823,0.237786992537687,0.970078557252714,1,45,antigen binding,MF,HLA-DQB1
4332,GO:0009100,0.238052344839976,0.896012595142732,4,371,glycoprotein metabolic process,BP,GALNT13;PTX3;FUT9;ST8SIA3
7576,GO:0030900,0.238054970621613,0.896041050947039,4,347,forebrain development,BP,CRTAC1;TNR;COL3A1;GRIN1
21271,GO:2000242,0.238577569492299,0.9698836557553,1,44,negative regulation of reproductive process,BP,TIMP1
18889,GO:1901361,0.239034827511409,0.875674837592786,6,656,organic cyclic compound catabolic process,BP,TYMP;VIM;IGF2BP2;MOXD1;SPP1;IGF2BP3
7634,GO:0031018,0.239182388462012,0.969787453911108,1,40,endocrine pancreas development,BP,ANXA1
13715,GO:0051148,0.239864561820313,0.969606297269626,1,40,negative regulation of muscle cell differentiation,BP,CXCL10
4060,GO:0008376,0.239912791672235,0.969528838629377,1,44,acetylgalactosaminyltransferase activity,MF,GALNT13
16264,GO:0071364,0.240153797050425,0.969547578320478,1,39,cellular response to epidermal growth factor stimulus,BP,COL1A1
12570,GO:0046635,0.240161527506348,0.969448099800623,1,45,positive regulation of alpha-beta T cell activation,BP,ANXA1
19093,GO:1901981,0.240521291292572,0.932566457290814,2,138,phosphatidylinositol phosphate binding,MF,PLEKHA4;ANXA2
4706,GO:0010212,0.240657523604613,0.932487536415571,2,142,response to ionizing radiation,BP,ANXA1;CXCL10
18294,GO:0099738,0.240805336095302,0.969481952327294,1,34,cell cortex region,CC,RIMS2
3267,GO:0006576,0.240853203154105,0.969249252717114,1,46,cellular biogenic amine metabolic process,BP,MOXD1
12183,GO:0045806,0.241319496942154,0.969138022649423,1,45,negative regulation of endocytosis,BP,LGALS3
17241,GO:0090130,0.241528310326155,0.909316845454271,3,244,tissue migration,BP,FERMT1;SRPX2;ANXA1
18150,GO:0099003,0.241801450201353,0.931994715962362,2,134,vesicle-mediated transport in synapse,BP,CPLX2;RIMS2
15916,GO:0070671,0.241931710805781,0.968959425158058,1,46,response to interleukin-12,BP,ANXA2
9736,GO:0035418,0.242253353272705,0.969070825158035,1,35,protein localization to synapse,BP,GRIN1
13754,GO:0051205,0.242291465428351,0.96886241490525,1,46,protein insertion into membrane,BP,RTP5
7457,GO:0030669,0.242616562950022,0.968851683847252,1,41,clathrin-coated endocytic vesicle membrane,CC,HLA-DQB1
3967,GO:0008217,0.242933415949591,0.931418513918422,2,147,regulation of blood pressure,BP,POSTN;ADM
13652,GO:0051051,0.243056935269692,0.892923600079174,4,391,negative regulation of transport,BP,GBP1;LGALS3;ANXA1;KCNB1
5668,GO:0016042,0.243302355347753,0.908279033235504,3,270,lipid catabolic process,BP,SPP1;FABP5;PLA2G2A
3818,GO:0007605,0.243375350040067,0.931272059029223,2,133,sensory perception of sound,BP,COL1A1;GABRB3
11166,GO:0043277,0.243581582991729,0.968590841656126,1,41,apoptotic cell clearance,BP,CCL2
12534,GO:0046578,0.243817478483609,0.908068106704416,3,232,regulation of Ras protein signal transduction,BP,MMD2;GPR17;COL3A1
16959,GO:0072583,0.244654865957761,0.968356272991849,1,38,clathrin-dependent endocytosis,BP,SNAP91
1035,GO:0002381,0.245292310854703,0.968076065132528,1,44,immunoglobulin production involved in immunoglobulin mediated immune response,BP,HLA-DQB1
10919,GO:0042802,0.245320748508966,0.843144787392854,12,1486,identical protein binding,MF,TYMP;VIM;SRPX2;COL1A1;GBP1;ANXA1;S100A11;PTX3;GABRB3;DSCAML1;ST8SIA3;ANXA2
10779,GO:0042551,0.245390187061482,0.968135956681765,1,39,neuron maturation,BP,KCNIP2
1071,GO:0002448,0.245717530570458,0.967959638676569,1,44,mast cell mediated immunity,BP,CPLX2
17100,GO:0086009,0.245844503322526,0.967992675234832,1,40,membrane repolarization,BP,KCNIP2
13508,GO:0050830,0.245847114550432,0.967854908374639,1,49,defense response to Gram-positive bacterium,BP,PLA2G2A
17722,GO:0097366,0.247224057035935,0.967577928803158,1,42,response to bronchodilator,BP,GRIN1
13444,GO:0050732,0.247472262056872,0.967476710327733,1,44,negative regulation of peptidyl-tyrosine phosphorylation,BP,SOCS3
6030,GO:0016763,0.247522212785692,0.967462904695651,1,44,transferase activity, transferring pentosyl groups,MF,TYMP
7842,GO:0031401,0.247679611561405,0.852124015933929,9,1036,positive regulation of protein modification process,BP,LTF;CCL2;GDF15;CHI3L1;MMD2;KSR2;ANXA2;SOCS3;PLA2G2A
13778,GO:0051247,0.24771437847285,0.841297259059401,12,1452,positive regulation of protein metabolic process,BP,LTF;VIM;CCL2;GDF15;CHI3L1;MMD2;MMP14;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
5000,GO:0010862,0.247827499633864,0.967378457611151,1,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,GDF15
8793,GO:0033017,0.247995788120156,0.96748530438303,1,36,sarcoplasmic reticulum membrane,CC,JPH3
10032,GO:0035924,0.24828732427568,0.967301662443889,1,41,cellular response to vascular endothelial growth factor stimulus,BP,ANXA1
3703,GO:0007269,0.248580160630738,0.928820693858979,2,138,neurotransmitter secretion,BP,CPLX2;RIMS2
18292,GO:0099643,0.248580160630738,0.928820693858979,2,138,signal release from synapse,BP,CPLX2;RIMS2
2461,GO:0005160,0.249947581982536,0.966773091343163,1,45,transforming growth factor beta receptor binding,MF,GDF15
4515,GO:0009435,0.250490939983507,0.966591635831206,1,47,NAD biosynthetic process,BP,NNMT
12454,GO:0046426,0.250563721848834,0.966600513269634,1,45,negative regulation of JAK-STAT cascade,BP,SOCS3
20431,GO:1904893,0.250563721848834,0.966600513269634,1,45,negative regulation of STAT cascade,BP,SOCS3
12168,GO:0045773,0.252117865887334,0.966313838482134,1,37,positive regulation of axon extension,BP,TNFRSF12A
19845,GO:1903708,0.252182669724393,0.92706455906396,2,151,positive regulation of hemopoiesis,BP,ANXA1;MMP14
13084,GO:0048534,0.252668554702196,0.859163841093972,7,782,hematopoietic or lymphoid organ development,BP,LTF;HOXA7;LGALS3;ANXA1;MMP14;PDPN;ANXA2
3491,GO:0006906,0.254756011874319,0.925848405572481,2,148,vesicle fusion,BP,ANXA1;ANXA2
1118,GO:0002532,0.255093166622852,0.965286246989743,1,47,production of molecular mediator involved in inflammatory response,BP,SERPINE1
7912,GO:0031526,0.255518420289762,0.965264574677205,1,41,brush border membrane,CC,SHANK2
8467,GO:0032515,0.255633309116748,0.965161716495968,1,45,negative regulation of phosphoprotein phosphatase activity,BP,ELFN2
6751,GO:0021515,0.255696489243609,0.965159871461435,1,44,cell differentiation in spinal cord,BP,MDGA2
6499,GO:0019320,0.25601738923314,0.965020750867149,1,47,hexose catabolic process,BP,FUT9
17227,GO:0090102,0.256579311187056,0.964923089804803,1,43,cochlea development,BP,GABRB3
475,GO:0001508,0.257032876584067,0.924842336269533,2,129,action potential,BP,KCNIP2;KCNB1
11118,GO:0043209,0.257807765530367,0.924343222426078,2,158,myelin sheath,CC,INA;ANXA2
3275,GO:0006584,0.258587893570667,0.964276428291439,1,47,catecholamine metabolic process,BP,MOXD1
4570,GO:0009712,0.258587893570667,0.964276428291439,1,47,catechol-containing compound metabolic process,BP,MOXD1
7724,GO:0031201,0.258754111708734,0.964199312110173,1,49,SNARE complex,CC,CPLX2
10596,GO:0042165,0.258781428261274,0.964191343490385,1,49,neurotransmitter binding,MF,GRIN1
19643,GO:1903311,0.259308528461788,0.899180731151935,3,271,regulation of mRNA metabolic process,BP,VIM;IGF2BP2;IGF2BP3
13532,GO:0050866,0.259420968780044,0.923569331120951,2,156,negative regulation of cell activation,BP,LGALS3;ANXA1
12572,GO:0046637,0.259803634096945,0.963921360777937,1,47,regulation of alpha-beta T cell differentiation,BP,ANXA1
15654,GO:0070228,0.259894252351755,0.963880045874766,1,48,regulation of lymphocyte apoptotic process,BP,LGALS3
9326,GO:0034381,0.260819930781549,0.963638567785265,1,46,plasma lipoprotein particle clearance,BP,ANXA2
19556,GO:1903115,0.261069331055628,0.963719156691262,1,38,regulation of actin filament-based movement,BP,PDPN
10766,GO:0042531,0.261511465876283,0.963404320052519,1,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,SOCS3
19642,GO:1903307,0.261575197785832,0.963416076142154,1,46,positive regulation of regulated secretory pathway,BP,KCNB1
13179,GO:0048701,0.262210867576224,0.963279685919184,1,43,embryonic cranial skeleton morphogenesis,BP,MMP14
15992,GO:0070849,0.262390378374249,0.96322661218237,1,43,response to epidermal growth factor,BP,COL1A1
4654,GO:0009988,0.262569140766649,0.963049647044723,1,51,cell-cell recognition,BP,LGALS3
12110,GO:0045661,0.262834148142688,0.963043526677147,1,46,regulation of myoblast differentiation,BP,CXCL10
16994,GO:0072666,0.263035115987964,0.963054545377987,1,42,establishment of protein localization to vacuole,BP,CACNG2
8126,GO:0031984,0.263250107137963,0.829149144486075,12,1491,organelle subcompartment,CC,LTF;MOXD1;CUX2;GBP1;POSTN;MMD2;GALNT13;JPH3;FUT9;ST8SIA3;HLA-DQB1;PLA2G2A
4004,GO:0008283,0.263586101700883,0.823466814009547,14,1764,cell proliferation,BP,LTF;FERMT1;TIMP1;IGFBP2;PLAU;LGALS3;ANXA1;EMP3;ADM;MMP14;PDPN;S100A11;CXCL10;ANXA2
11243,GO:0043408,0.263818692884319,0.858503463536836,6,652,regulation of MAPK cascade,BP,CCL2;GBP1;GDF15;CHI3L1;KSR2;PLA2G2A
1087,GO:0002478,0.263826113715555,0.921393547083742,2,163,antigen processing and presentation of exogenous peptide antigen,BP,HLA-DQB1;IFI30
14144,GO:0051932,0.263835245168799,0.962797871300409,1,43,synaptic transmission, GABAergic,BP,GABRG1
6692,GO:0019898,0.264143731240701,0.896383566666494,3,264,extrinsic component of membrane,CC,ANXA1;GNAL;ANXA2
7296,GO:0030308,0.264371734239321,0.921158077927101,2,154,negative regulation of cell growth,BP,TNR;SPP1
11833,GO:0045071,0.26506726460294,0.962331403027454,1,49,negative regulation of viral genome replication,BP,LTF
11870,GO:0045123,0.265621567954685,0.962179663454788,1,48,cellular extravasation,BP,CCL2
8592,GO:0032722,0.26667152929447,0.961833986806972,1,50,positive regulation of chemokine production,BP,POSTN
12011,GO:0045428,0.26676850110398,0.961849465645737,1,47,regulation of nitric oxide biosynthetic process,BP,PTX3
17983,GO:0098693,0.266966794990072,0.961878590738658,1,42,regulation of synaptic vesicle cycle,BP,RIMS2
12503,GO:0046503,0.26709213129897,0.961736029133522,1,48,glycerolipid catabolic process,BP,FABP5
17269,GO:0090174,0.267279276700382,0.919726164522471,2,153,organelle membrane fusion,BP,ANXA1;ANXA2
2828,GO:0005891,0.267371638407634,0.961820954993762,1,39,voltage-gated calcium channel complex,CC,CACNG2
13209,GO:0048754,0.268050592136475,0.919390656820239,2,142,branching morphogenesis of an epithelial tube,BP,MMP14;COL4A1
21816,GO:2001238,0.268633492795945,0.961252808033155,1,49,positive regulation of extrinsic apoptotic signaling pathway,BP,TNFRSF12A
2499,GO:0005231,0.268642435351679,0.961297449480859,1,46,excitatory extracellular ligand-gated ion channel activity,MF,GRIN1
11962,GO:0045309,0.268811662037847,0.961281121586328,1,44,protein phosphorylated amino acid binding,MF,SOCS3
5985,GO:0016667,0.268871009110599,0.961125477026098,1,53,oxidoreductase activity, acting on a sulfur group of donors,MF,IFI30
10552,GO:0042093,0.268951828733219,0.961170866291651,1,48,T-helper cell differentiation,BP,ANXA1
13577,GO:0050922,0.269807032087793,0.960959276164425,1,45,negative regulation of chemotaxis,BP,CCL2
18239,GO:0099531,0.270457997216469,0.918164302558165,2,148,presynaptic process involved in chemical synaptic transmission,BP,CPLX2;RIMS2
5506,GO:0015711,0.270957094551844,0.875283779110141,4,399,organic anion transport,BP,SLCO1A2;ABCC3;ANXA1;PLA2G2A
2873,GO:0005975,0.271774179170949,0.86233892560435,5,541,carbohydrate metabolic process,BP,CHI3L2;CHI3L1;GALNT13;FUT9;ST8SIA3
17897,GO:0097755,0.272473627060085,0.960057393999309,1,50,positive regulation of blood vessel diameter,BP,ADM
978,GO:0002294,0.272949239208099,0.959924746731722,1,49,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ANXA1
6684,GO:0019884,0.273592940897228,0.916516451987599,2,167,antigen processing and presentation of exogenous antigen,BP,HLA-DQB1;IFI30
4484,GO:0009314,0.273677389610308,0.873513214430603,4,402,response to radiation,BP,ANXA1;COL3A1;CXCL10;GRIN1
4594,GO:0009790,0.273719842144458,0.837667192716101,8,888,embryo development,BP,COL1A1;HOXA7;COL4A2;ADM;MMP14;DSCAML1;SOCS3;COL5A2
497,GO:0001541,0.274090063648459,0.959569501145045,1,49,ovarian follicle development,BP,MMP14
3307,GO:0006629,0.27411870164773,0.827702820667683,10,1238,lipid metabolic process,BP,APOL4;PLEKHA4;RBP1;SPP1;ANXA1;ADM;FABP5;ST8SIA3;PLA2G2A;SERPINA3
16956,GO:0072577,0.274256426229558,0.959566903496228,1,46,endothelial cell apoptotic process,BP,SERPINE1
14148,GO:0051937,0.27435431118252,0.959457275167793,1,51,catecholamine transport,BP,KCNB1
4172,GO:0008542,0.274413232182529,0.959554650606481,1,44,visual learning,BP,GRIN1
12066,GO:0045604,0.274503510292194,0.959456115419178,1,48,regulation of epidermal cell differentiation,BP,HOXA7
12017,GO:0045453,0.275014795650705,0.959296107838976,1,48,bone resorption,BP,SPP1
13099,GO:0048562,0.275015377125709,0.889953985945954,3,266,embryonic organ morphogenesis,BP,HOXA7;MMP14;DSCAML1
12925,GO:0048146,0.275646198449562,0.959098022121001,1,48,positive regulation of fibroblast proliferation,BP,ANXA2
9681,GO:0035308,0.276038808180948,0.958958611579635,1,49,negative regulation of protein dephosphorylation,BP,ELFN2
973,GO:0002287,0.277172545863746,0.958585393117602,1,50,alpha-beta T cell activation involved in immune response,BP,ANXA1
977,GO:0002293,0.277172545863746,0.958585393117602,1,50,alpha-beta T cell differentiation involved in immune response,BP,ANXA1
2505,GO:0005245,0.277203420802053,0.958741947331786,1,41,voltage-gated calcium channel activity,MF,CACNG2
17975,GO:0098659,0.277287125658222,0.958580704006772,1,48,inorganic cation import across plasma membrane,BP,STEAP3
18268,GO:0099587,0.277287125658222,0.958580704006772,1,48,inorganic ion import across plasma membrane,BP,STEAP3
14678,GO:0060324,0.277310541018321,0.958607631438883,1,46,face development,BP,COL1A1
8945,GO:0033293,0.277652074898509,0.95841859773604,1,51,monocarboxylic acid binding,MF,FABP5
12562,GO:0046626,0.277766140794844,0.958429002359453,1,48,regulation of insulin receptor signaling pathway,BP,SOCS3
17219,GO:0090090,0.277820525661013,0.914397029550725,2,160,negative regulation of canonical Wnt signaling pathway,BP,FERMT1;IGFBP2
13591,GO:0050954,0.278324854299431,0.914194053461984,2,147,sensory perception of mechanical stimulus,BP,COL1A1;GABRB3
2906,GO:0006022,0.278339671194444,0.914143778206826,2,157,aminoglycan metabolic process,BP,CHI3L2;CHI3L1
7534,GO:0030850,0.279908771034263,0.957781608695978,1,46,prostate gland development,BP,ANXA1
12043,GO:0045576,0.280308251617135,0.957556677065797,1,52,mast cell activation,BP,CPLX2
3294,GO:0006612,0.280739967017422,0.912842112981796,2,177,protein targeting to membrane,BP,KCNB1;RTP5
18966,GO:1901616,0.280750126535009,0.957400653574228,1,53,organic hydroxy compound catabolic process,BP,MOXD1
13573,GO:0050918,0.281686259921631,0.957143232301026,1,50,positive chemotaxis,BP,LGALS3
768,GO:0001954,0.281759675632786,0.957206482927136,1,45,positive regulation of cell-matrix adhesion,BP,FERMT1
5781,GO:0016266,0.282033864410471,0.957063679260366,1,48,O-glycan processing,BP,GALNT13
7355,GO:0030426,0.282327092959346,0.912149388156866,2,145,growth cone,CC,CRTAC1;SHANK2
6474,GO:0019229,0.28463545155164,0.956155250231533,1,52,regulation of vasoconstriction,BP,ADM
14854,GO:0060563,0.285033746321506,0.956055749862601,1,50,neuroepithelial cell differentiation,BP,SERPINE1
3205,GO:0006508,0.285844827775948,0.811145519584962,12,1519,proteolysis,BP,LTF;TIMP1;SERPINE1;AEBP1;PLAU;ADAM12;SERPING1;MMP14;C1R;GRIN1;SERPINA3;CFI
18799,GO:1901135,0.28597100738173,0.822978398355434,9,1114,carbohydrate derivative metabolic process,BP,TYMP;CHI3L2;CHI3L1;GALNT13;ADM;PTX3;CXCL10;FUT9;ST8SIA3
4700,GO:0010171,0.286385870823876,0.955663716929857,1,47,body morphogenesis,BP,COL1A1
7542,GO:0030858,0.286810377869863,0.955472349195919,1,50,positive regulation of epithelial cell differentiation,BP,SERPINE1
13712,GO:0051145,0.286845659895126,0.955444828389543,1,51,smooth muscle cell differentiation,BP,ADM
12507,GO:0046513,0.287213980967483,0.955279033122198,1,54,ceramide biosynthetic process,BP,ST8SIA3
15276,GO:0061383,0.287863083738585,0.955195609287255,1,46,trabecula morphogenesis,BP,COL1A1
12593,GO:0046677,0.288057835580089,0.882003839880871,3,290,response to antibiotic,BP,COL1A1;ANXA1;GRIN1
3849,GO:0008021,0.290552170212832,0.907768998511199,2,166,synaptic vesicle,CC,SVOP;GRIN1
11054,GO:0043113,0.291097873522915,0.954099830371009,1,47,receptor clustering,BP,SHISA7
12874,GO:0048002,0.292037052832929,0.906951621342806,2,175,antigen processing and presentation of peptide antigen,BP,HLA-DQB1;IFI30
12435,GO:0046365,0.292563135328629,0.953463190281958,1,56,monosaccharide catabolic process,BP,FUT9
14537,GO:0060113,0.29379761330513,0.953171152081023,1,48,inner ear receptor cell differentiation,BP,GABRB3
15830,GO:0070527,0.293909632062242,0.953065016496604,1,52,platelet aggregation,BP,PDPN
18092,GO:0098900,0.293953100294557,0.953199024030045,1,44,regulation of action potential,BP,KCNB1
3440,GO:0006826,0.293979520486953,0.953010981787985,1,54,iron ion transport,BP,STEAP3
6405,GO:0019058,0.294286760040543,0.878152725676243,3,291,viral life cycle,BP,LTF;CCL2;PTX3
4583,GO:0009749,0.294841841321197,0.905509837610095,2,162,response to glucose,BP,COL6A2;KCNB1
1110,GO:0002520,0.295190662700942,0.827825960086096,7,821,immune system development,BP,LTF;HOXA7;LGALS3;ANXA1;MMP14;PDPN;ANXA2
7011,GO:0022029,0.295238398517004,0.95266302973861,1,49,telencephalon cell migration,BP,TNR
5052,GO:0010921,0.295319414188946,0.905284942010944,2,155,regulation of phosphatase activity,BP,SPOCD1;ELFN2
16294,GO:0071407,0.295550667681965,0.845729163003508,5,530,cellular response to organic cyclic compound,BP,CCL2;COL1A1;SPP1;ANXA1;GABRB3
16185,GO:0071242,0.295981005358727,0.952342907795426,1,53,cellular response to ammonium ion,BP,GABRB3
18833,GO:1901222,0.296221807387774,0.952230742924734,1,55,regulation of NIK/NF-kappaB signaling,BP,CHI3L1
10765,GO:0042509,0.296413085804855,0.952151047178657,1,56,regulation of tyrosine phosphorylation of STAT protein,BP,SOCS3
6391,GO:0019003,0.296899027151249,0.951957259523708,1,58,GDP binding,MF,GBP1
18730,GO:1900542,0.297215541965565,0.904236298937841,2,163,regulation of purine nucleotide metabolic process,BP,ADM;CXCL10
16357,GO:0071496,0.297265177149607,0.876295247637896,3,291,cellular response to external stimulus,BP,COL1A1;POSTN;KCNB1
11869,GO:0045121,0.298022672482888,0.875832806049029,3,285,membrane raft,CC,TNR;PDPN;ANXA2
3201,GO:0006501,0.298499832509999,0.951445434641746,1,55,C-terminal protein lipidation,BP,MDGA2
5074,GO:0010952,0.298571767878779,0.903476297103958,2,171,positive regulation of peptidase activity,BP,MMP14;GRIN1
10589,GO:0042157,0.298601890259698,0.903475327597666,2,167,lipoprotein metabolic process,BP,APOL4;MDGA2
10022,GO:0035904,0.299644620566318,0.951184785928748,1,47,aorta development,BP,COL3A1
4661,GO:0010008,0.299793872775117,0.856091171826403,4,425,endosome membrane,CC,STEAP3;ANXA1;HLA-DQB1;ANXA2
14734,GO:0060393,0.299857898647318,0.950959452352124,1,56,regulation of pathway-restricted SMAD protein phosphorylation,BP,GDF15
18071,GO:0098857,0.299868146953774,0.874672760070814,3,286,membrane microdomain,CC,TNR;PDPN;ANXA2
17618,GO:0097164,0.299989995825283,0.902682713540404,2,179,ammonium ion metabolic process,BP,MOXD1;PLA2G2A
4781,GO:0010517,0.300641031911611,0.950747313647613,1,52,regulation of phospholipase activity,BP,ANXA1
7356,GO:0030427,0.300782768987824,0.902372669386875,2,150,site of polarized growth,CC,CRTAC1;SHANK2
4039,GO:0008333,0.300965124948572,0.950634125471244,1,52,endosome to lysosome transport,BP,CACNG2
13134,GO:0048639,0.301013319484152,0.902243042218503,2,151,positive regulation of developmental growth,BP,TNFRSF12A;RIMS2
976,GO:0002292,0.301098589481638,0.95054068997954,1,55,T cell differentiation involved in immune response,BP,ANXA1
3839,GO:0007632,0.301763816198867,0.950407309390498,1,49,visual behavior,BP,GRIN1
3651,GO:0007188,0.302068606473094,0.90158908240772,2,170,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,GNAL;ADM
5949,GO:0016597,0.302602785735216,0.949983950916781,1,57,amino acid binding,MF,GRIN1
2994,GO:0006171,0.303347857489013,0.949765197379792,1,54,cAMP biosynthetic process,BP,ADM
4582,GO:0009746,0.303741097413676,0.900694608210626,2,166,response to hexose,BP,COL6A2;KCNB1
13625,GO:0051018,0.303795112004751,0.949753400157023,1,46,protein kinase A binding,MF,SPHKAP
12119,GO:0045670,0.304399360704289,0.94942566047992,1,52,regulation of osteoclast differentiation,BP,LTF
6776,GO:0021543,0.304763403457347,0.900189043723511,2,154,pallium development,BP,COL3A1;GRIN1
3696,GO:0007260,0.30621179648744,0.948689466344441,1,58,tyrosine phosphorylation of STAT protein,BP,SOCS3
13256,GO:0048857,0.306612843422305,0.948574452349057,1,56,neural nucleus development,BP,INA
82,GO:0000165,0.307254598293556,0.818627963950535,7,824,MAPK cascade,BP,CCL2;GBP1;GDF15;CHI3L1;KSR2;GRIN1;PLA2G2A
5115,GO:0012507,0.307495266650849,0.948243569544766,1,57,ER to Golgi transport vesicle membrane,CC,HLA-DQB1
12679,GO:0046888,0.307540137931729,0.948242016680102,1,56,negative regulation of hormone secretion,BP,KCNB1
12516,GO:0046530,0.307834318874475,0.948200297561307,1,52,photoreceptor cell differentiation,BP,CDHR1
4728,GO:0010332,0.308846199903174,0.947836139851014,1,52,response to gamma radiation,BP,CXCL10
12680,GO:0046889,0.308870580615455,0.947734047388856,1,58,positive regulation of lipid biosynthetic process,BP,ANXA1
6942,GO:0021885,0.309159054541402,0.947723254939176,1,52,forebrain cell migration,BP,TNR
13481,GO:0050792,0.30917544008099,0.897664585934117,2,178,regulation of viral process,BP,LTF;PTX3
2979,GO:0006140,0.310148379199413,0.897160343739779,2,169,regulation of nucleotide metabolic process,BP,ADM;CXCL10
16277,GO:0071385,0.310995017349477,0.946977796801847,1,57,cellular response to glucocorticoid stimulus,BP,ANXA1
9191,GO:0034121,0.311080786747048,0.946946557217358,1,57,regulation of toll-like receptor signaling pathway,BP,LTF
11211,GO:0043367,0.311939523190739,0.946618739944242,1,58,CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
14512,GO:0060070,0.312721791196053,0.866478230922355,3,292,canonical Wnt signaling pathway,BP,FERMT1;COL1A1;IGFBP2
7273,GO:0030278,0.313384004704493,0.895368637162278,2,167,regulation of ossification,BP,LTF;SMOC1
18300,GO:0101003,0.313461067489084,0.946106204468194,1,55,ficolin-1-rich granule membrane,CC,LGALS3
12991,GO:0048284,0.313506680628625,0.895272014152185,2,174,organelle fusion,BP,ANXA1;ANXA2
12455,GO:0046427,0.314069536752368,0.945836749950655,1,58,positive regulation of JAK-STAT cascade,BP,SOCS3
810,GO:0002011,0.314712658523419,0.945733637544899,1,50,morphogenesis of an epithelial sheet,BP,PDPN
18226,GO:0099516,0.315175101309931,0.94545835380108,1,56,ion antiporter activity,MF,SLC8A2
11970,GO:0045334,0.315220379994546,0.945426303079834,1,57,clathrin-coated endocytic vesicle,CC,HLA-DQB1
15746,GO:0070373,0.315480100846033,0.945315313600223,1,58,negative regulation of ERK1 and ERK2 cascade,BP,GBP1
3677,GO:0007219,0.315688095391706,0.894065820385861,2,170,Notch signaling pathway,BP,POSTN;MMP14
19748,GO:1903524,0.315970208564654,0.9451052863751,1,60,positive regulation of blood circulation,BP,ADM
9273,GO:0034284,0.316090936186614,0.893835390734057,2,171,response to monosaccharide,BP,COL6A2;KCNB1
14730,GO:0060389,0.316203464617942,0.945032451514881,1,59,pathway-restricted SMAD protein phosphorylation,BP,GDF15
10755,GO:0042490,0.316394545134552,0.945055746652649,1,53,mechanoreceptor differentiation,BP,GABRB3
17938,GO:0098589,0.317121044884509,0.863626810800814,3,294,membrane region,CC,TNR;PDPN;ANXA2
4623,GO:0009893,0.3175968229975,0.764102627698517,22,2947,positive regulation of metabolic process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;CUX2;SPP1;HOXA7;GDF15;CHI3L1;ANXA1;MMD2;ADM;MMP14;PTX3;CXCL10;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A
1252,GO:0002757,0.317834821661533,0.843597202882436,4,447,immune response-activating signal transduction,BP,LTF;GBP1;LGALS3;HLA-DQB1
20432,GO:1904894,0.317840677575422,0.944421796668629,1,59,positive regulation of STAT cascade,BP,SOCS3
16993,GO:0072665,0.317870535771725,0.944488516149039,1,54,protein localization to vacuole,BP,CACNG2
18496,GO:0140056,0.318843883579625,0.892286552238162,2,170,organelle localization by membrane tethering,BP,CPLX2;KCNB1
7171,GO:0030136,0.318910326786804,0.892257314837975,2,168,clathrin-coated vesicle,CC,SNAP91;HLA-DQB1
11788,GO:0044877,0.318914256252234,0.809621198914813,7,804,protein-containing complex binding,MF,LTF;VIM;LGALS3;GNAL;MMP14;COL3A1;GRIN1
1368,GO:0003006,0.319076880531561,0.828678428534661,5,554,developmental process involved in reproduction,BP,SPP1;ANXA1;ADM;MMP14;SOCS3
4630,GO:0009913,0.321091762278073,0.890998575085942,2,173,epidermal cell differentiation,BP,HOXA7;ANXA1
20195,GO:1904427,0.321814321736167,0.942938460713085,1,58,positive regulation of calcium ion transmembrane transport,BP,CXCL10
8553,GO:0032652,0.322112436352522,0.942755471098064,1,63,regulation of interleukin-1 production,BP,ANXA1
12118,GO:0045669,0.322409341801229,0.942743633661562,1,56,positive regulation of osteoblast differentiation,BP,LTF
5572,GO:0015844,0.322456576823624,0.942637444340077,1,62,monoamine transport,BP,KCNB1
14551,GO:0060135,0.322495023903874,0.942727609518226,1,55,maternal process involved in female pregnancy,BP,SPP1
1053,GO:0002429,0.32305813042041,0.859700473976746,3,318,immune response-activating cell surface receptor signaling pathway,BP,GBP1;LGALS3;HLA-DQB1
11321,GO:0043542,0.323256970844002,0.889779842862716,2,169,endothelial cell migration,BP,SRPX2;ANXA1
3428,GO:0006809,0.323667656861516,0.942232039699091,1,58,nitric oxide biosynthetic process,BP,PTX3
2628,GO:0005546,0.323708479230972,0.942186861065531,1,60,phosphatidylinositol-4,5-bisphosphate binding,MF,ANXA2
6596,GO:0019674,0.323742118301532,0.942120403349711,1,64,NAD metabolic process,BP,NNMT
15752,GO:0070382,0.324364106757169,0.88910149512676,2,180,exocytic vesicle,CC,SVOP;GRIN1
9177,GO:0034103,0.324637868604454,0.941860241191456,1,58,regulation of tissue remodeling,BP,SPP1
7948,GO:0031594,0.326044007783607,0.941385605939188,1,54,neuromuscular junction,CC,POSTN
16276,GO:0071384,0.326190024531917,0.941218304669457,1,61,cellular response to corticosteroid stimulus,BP,ANXA1
15653,GO:0070227,0.326301688018735,0.941147954004294,1,63,lymphocyte apoptotic process,BP,LGALS3
3805,GO:0007585,0.326441902878738,0.941149981133205,1,59,respiratory gaseous exchange,BP,GRIN1
16684,GO:0072091,0.326989316846697,0.940969317180783,1,57,regulation of stem cell proliferation,BP,FERMT1
4452,GO:0009247,0.32779592194451,0.94055531161656,1,64,glycolipid biosynthetic process,BP,ST8SIA3
8386,GO:0032418,0.327860043218039,0.940556942262351,1,62,lysosome localization,BP,CPLX2
14119,GO:0051893,0.328160716896811,0.940584678012722,1,53,regulation of focal adhesion assembly,BP,MMP14
17231,GO:0090109,0.328160716896811,0.940584678012722,1,53,regulation of cell-substrate junction assembly,BP,MMP14
14156,GO:0051952,0.328290266827155,0.940362811558467,1,64,regulation of amine transport,BP,KCNB1
14025,GO:0051704,0.329120341548139,0.766694485428331,15,2025,multi-organism process,BP,LTF;VIM;TIMP1;SERPINE1;CCL2;IGFBP2;GBP1;SPP1;ADM;SHANK2;PTX3;CXCL10;GRIN1;ANXA2;PLA2G2A
19103,GO:1901992,0.330445594155778,0.93956048614671,1,61,positive regulation of mitotic cell cycle phase transition,BP,ANXA1
5484,GO:0015672,0.33149404632187,0.833925383092293,4,436,monovalent inorganic cation transport,BP,KCNIP3;SLC8A2;KCNIP2;KCNB1
10856,GO:0042698,0.331543682587417,0.939143128314244,1,60,ovulation cycle,BP,ANXA1
7778,GO:0031295,0.33248086282847,0.938678639916929,1,67,T cell costimulation,BP,HLA-DQB1
12049,GO:0045582,0.332742593772594,0.938612883063166,1,64,positive regulation of T cell differentiation,BP,ANXA1
9048,GO:0033619,0.332968799539617,0.938564975946245,1,61,membrane protein proteolysis,BP,TIMP1
6357,GO:0018410,0.333396861222513,0.938366788940672,1,63,C-terminal protein amino acid modification,BP,MDGA2
13978,GO:0051607,0.333683717370385,0.883672676148843,2,186,defense response to virus,BP,GBP1;CXCL10
7375,GO:0030500,0.334000171422943,0.938170301726548,1,60,regulation of bone mineralization,BP,LTF
8543,GO:0032642,0.335791679565535,0.937358947037796,1,67,regulation of chemokine production,BP,POSTN
7777,GO:0031294,0.336087902769331,0.93722793033831,1,68,lymphocyte costimulation,BP,HLA-DQB1
13376,GO:0050657,0.336508413942883,0.88203742835563,2,179,nucleic acid transport,BP,IGF2BP2;IGF2BP3
13377,GO:0050658,0.336508413942883,0.88203742835563,2,179,RNA transport,BP,IGF2BP2;IGF2BP3
7449,GO:0030658,0.337029239182489,0.881710182185389,2,184,transport vesicle membrane,CC,SVOP;HLA-DQB1
11009,GO:0043025,0.337029574410174,0.829955062984507,4,425,neuronal cell body,CC,SLC8A2;CPLX2;KCNB1;SHANK2
12388,GO:0046209,0.337284420666181,0.936840488087787,1,61,nitric oxide metabolic process,BP,PTX3
10808,GO:0042590,0.338621208410471,0.936159985912938,1,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,IFI30
7020,GO:0022406,0.339419750786342,0.880312944841584,2,179,membrane docking,BP,CPLX2;KCNB1
20018,GO:1904035,0.341798748011391,0.934977196692061,1,63,regulation of epithelial cell apoptotic process,BP,SERPINE1
7078,GO:0023014,0.342154470128475,0.791251009408311,7,852,signal transduction by protein phosphorylation,BP,CCL2;GBP1;GDF15;CHI3L1;KSR2;GRIN1;PLA2G2A
16852,GO:0072347,0.342555673698109,0.934652403223332,1,64,response to anesthetic,BP,GRIN1
19683,GO:1903391,0.342668702874755,0.934734399905784,1,56,regulation of adherens junction organization,BP,MMP14
6227,GO:0017137,0.34278310466971,0.878345292021015,2,170,Rab GTPase binding,MF,RIMS2;ANXA2
12569,GO:0046634,0.343340338353081,0.934289118829738,1,67,regulation of alpha-beta T cell activation,BP,ANXA1
9910,GO:0035710,0.344017340833527,0.934022745193899,1,66,CD4-positive, alpha-beta T cell activation,BP,ANXA1
10733,GO:0042446,0.344301724966398,0.933892031464759,1,67,hormone biosynthetic process,BP,ADM
2616,GO:0005525,0.344359421798208,0.845385987446882,3,335,GTP binding,MF,GBP1;GNAL;TUBA1C
17585,GO:0097110,0.344543792240626,0.933926521389323,1,58,scaffold protein binding,MF,VIM
3698,GO:0007264,0.344729287569705,0.809454707015048,5,550,small GTPase mediated signal transduction,BP,MMD2;GPR17;PDPN;COL3A1;KSR2
7049,GO:0022804,0.345094027464528,0.844944108906695,3,303,active transmembrane transporter activity,MF,SLCO1A2;ABCC3;SLC8A2
15618,GO:0070167,0.345183766370597,0.933581797276116,1,63,regulation of biomineral tissue development,BP,LTF
1285,GO:0002824,0.34523765617563,0.933478873995695,1,69,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1
4648,GO:0009968,0.345986359731612,0.774796656280476,9,1142,negative regulation of signal transduction,BP,LTF;FERMT1;SERPINE1;IGFBP2;GBP1;LGALS3;ADM;MMP14;SOCS3
11267,GO:0043462,0.346008809747992,0.933146022600937,1,70,regulation of ATPase activity,BP,LTF
20427,GO:1904888,0.346783308188234,0.932979823974286,1,59,cranial skeletal system development,BP,MMP14
12478,GO:0046470,0.346844132720919,0.932797550362533,1,70,phosphatidylcholine metabolic process,BP,PLA2G2A
16218,GO:0071300,0.347114060152629,0.932763730011875,1,64,cellular response to retinoic acid,BP,COL1A1
13772,GO:0051236,0.34728490682862,0.875583288654298,2,182,establishment of RNA localization,BP,IGF2BP2;IGF2BP3
870,GO:0002088,0.347446918303348,0.932702886804009,1,59,lens development in camera-type eye,BP,VIM
21738,GO:2001057,0.348699909092434,0.932099325716427,1,64,reactive nitrogen species metabolic process,BP,PTX3
8483,GO:0032550,0.349071438766571,0.842145033345151,3,338,purine ribonucleoside binding,MF,GBP1;GNAL;TUBA1C
4333,GO:0009101,0.349298857298761,0.842040415370359,3,310,glycoprotein biosynthetic process,BP,GALNT13;FUT9;ST8SIA3
9804,GO:0035556,0.349463354581817,0.740711103359526,19,2545,intracellular signal transduction,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;MMD2;GNAL;GPR17;ADM;SPHKAP;JPH3;PDPN;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;PLA2G2A
1623,GO:0003729,0.349814896906883,0.874019902126221,2,189,mRNA binding,MF,IGF2BP2;IGF2BP3
3130,GO:0006402,0.351077470911406,0.840769629183646,3,332,mRNA catabolic process,BP,VIM;IGF2BP2;IGF2BP3
8698,GO:0032880,0.351273948596539,0.783910616641118,7,864,regulation of protein localization,BP,FERMT1;GBP1;POSTN;ANXA1;MMD2;KCNB1;SHISA7
1620,GO:0003725,0.351403529775688,0.930943314038916,1,65,double-stranded RNA binding,MF,VIM
10660,GO:0042310,0.3515223581894,0.930865104639262,1,67,vasoconstriction,BP,ADM
13537,GO:0050871,0.353215312256957,0.930130573018674,1,68,positive regulation of B cell activation,BP,MMP14
2793,GO:0005844,0.353218411923815,0.930116237785119,1,69,polysome,CC,VIM
21812,GO:2001234,0.353271287581867,0.871877525477055,2,197,negative regulation of apoptotic signaling pathway,BP,SERPINE1;LGALS3
715,GO:0001883,0.353750550224209,0.838899458256596,3,341,purine nucleoside binding,MF,GBP1;GNAL;TUBA1C
3352,GO:0006687,0.353798210233922,0.929881227416651,1,68,glycosphingolipid metabolic process,BP,ST8SIA3
13212,GO:0048762,0.35424021655676,0.871327724629426,2,185,mesenchymal cell differentiation,BP,COL1A1;PDPN
5568,GO:0015837,0.354386304435974,0.929590956520745,1,71,amine transport,BP,KCNB1
11648,GO:0044440,0.355488352449319,0.81637514168119,4,461,endosomal part,CC,STEAP3;ANXA1;HLA-DQB1;ANXA2
10606,GO:0042180,0.356167592929605,0.870086896797826,2,199,cellular ketone metabolic process,BP,ANXA1;ADM
7840,GO:0031399,0.356188590369796,0.752601464333505,12,1575,regulation of protein modification process,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;MMD2;ELFN2;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
8482,GO:0032549,0.357129788016539,0.836540626834199,3,342,ribonucleoside binding,MF,GBP1;GNAL;TUBA1C
4669,GO:0010035,0.359212186234588,0.813594411068046,4,464,response to inorganic substance,BP,COL1A1;IGFBP2;KCNIP2;ANXA1
19667,GO:1903363,0.359326569496912,0.927504382915022,1,67,negative regulation of cellular protein catabolic process,BP,ANXA2
7286,GO:0030295,0.35932854247885,0.927489662301702,1,68,protein kinase activator activity,MF,LTF
5283,GO:0015031,0.359578401248923,0.746201492010679,13,1750,protein transport,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;CHI3L1;POSTN;ANXA1;KCNB1;CACNG2;RIMS2;RTP5
1259,GO:0002764,0.359864361996353,0.813092669507624,4,476,immune response-regulating signaling pathway,BP,LTF;GBP1;LGALS3;HLA-DQB1
7204,GO:0030178,0.359955902224378,0.867758461789715,2,193,negative regulation of Wnt signaling pathway,BP,FERMT1;IGFBP2
6688,GO:0019888,0.360998218813664,0.926731614504207,1,70,protein phosphatase regulator activity,MF,ELFN2
17197,GO:0090066,0.361224472928413,0.812106731306561,4,448,regulation of anatomical structure size,BP,TNFRSF12A;TNR;SPP1;ADM
18577,GO:1900076,0.361502518833428,0.92656514298735,1,66,regulation of cellular response to insulin stimulus,BP,SOCS3
6682,GO:0019882,0.361643575864925,0.866658468230201,2,206,antigen processing and presentation,BP,HLA-DQB1;IFI30
8515,GO:0032602,0.361791515663528,0.926333143793283,1,74,chemokine production,BP,POSTN
13247,GO:0048844,0.361920943611198,0.926514839580538,1,58,artery morphogenesis,BP,COL3A1
1282,GO:0002821,0.362212854095087,0.926159106784431,1,73,positive regulation of adaptive immune response,BP,ANXA1
3836,GO:0007626,0.362254791752708,0.866389386368981,2,177,locomotory behavior,BP,TNR;GRIN1
8525,GO:0032612,0.362738324321253,0.925939137912592,1,72,interleukin-1 production,BP,ANXA1
7142,GO:0030097,0.363903769009678,0.782867646088529,6,744,hemopoiesis,BP,LTF;HOXA7;LGALS3;ANXA1;MMP14;ANXA2
2775,GO:0005802,0.363951203510513,0.865273906413536,2,189,trans-Golgi network,CC,POSTN;HLA-DQB1
9676,GO:0035303,0.364198620966069,0.865143303518435,2,183,regulation of dephosphorylation,BP,SPOCD1;ELFN2
5908,GO:0016529,0.364724101023179,0.925256905072359,1,59,sarcoplasmic reticulum,CC,JPH3
18948,GO:1901570,0.365426599085872,0.924708436347009,1,75,fatty acid derivative biosynthetic process,BP,ANXA1
16493,GO:0071705,0.365877410416985,0.734830953094978,15,2055,nitrogen compound transport,BP,SNAP91;IGF2BP2;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;CHI3L1;POSTN;ANXA1;IGF2BP3;KCNB1;CACNG2;RIMS2;RTP5
4580,GO:0009743,0.36617413836336,0.86386126189689,2,192,response to carbohydrate,BP,COL6A2;KCNB1
4152,GO:0008514,0.366922941123391,0.863364924243243,2,198,organic anion transmembrane transporter activity,MF,SLCO1A2;ABCC3
7152,GO:0030111,0.367086466965533,0.829556949898509,3,319,regulation of Wnt signaling pathway,BP,FERMT1;COL1A1;IGFBP2
4006,GO:0008285,0.367121161893307,0.792061045177635,5,608,negative regulation of cell proliferation,BP,FERMT1;EMP3;ADM;PDPN;S100A11
7632,GO:0031016,0.368010877412968,0.923654412778046,1,67,pancreas development,BP,ANXA1
714,GO:0001882,0.368807088082448,0.828274194108335,3,349,nucleoside binding,MF,GBP1;GNAL;TUBA1C
17898,GO:0097756,0.369524851895707,0.922915140716049,1,71,negative regulation of blood vessel diameter,BP,ADM
7291,GO:0030301,0.369675957775319,0.922902843046576,1,67,cholesterol transport,BP,ANXA2
4843,GO:0010632,0.370840088845569,0.860931924860779,2,184,regulation of epithelial cell migration,BP,SRPX2;ANXA1
9180,GO:0034109,0.371010381175647,0.922297390781718,1,67,homotypic cell-cell adhesion,BP,PDPN
2013,GO:0004497,0.372061378409741,0.921710957771324,1,75,monooxygenase activity,MF,MOXD1
150,GO:0000302,0.373148309560912,0.859368962933319,2,206,response to reactive oxygen species,BP,COL1A1;ANXA1
11522,GO:0044215,0.373191990235608,0.921258035731124,1,70,other organism,CC,LTF
11523,GO:0044216,0.373191990235608,0.921258035731124,1,70,other organism cell,CC,LTF
11524,GO:0044217,0.373191990235608,0.921258035731124,1,70,other organism part,CC,LTF
14589,GO:0060191,0.373355905606883,0.921182872431624,1,70,regulation of lipase activity,BP,ANXA1
8494,GO:0032561,0.373821504863526,0.82467410023306,3,351,guanyl ribonucleotide binding,MF,GBP1;GNAL;TUBA1C
15971,GO:0070821,0.374454554935643,0.920692166942359,1,69,tertiary granule membrane,CC,PLAU
1262,GO:0002768,0.374785947923378,0.823985713028666,3,347,immune response-regulating cell surface receptor signaling pathway,BP,GBP1;LGALS3;HLA-DQB1
486,GO:0001523,0.375341316843992,0.920269099297057,1,70,retinoid metabolic process,BP,RBP1
6389,GO:0019001,0.37547312909137,0.82348086980196,3,352,guanyl nucleotide binding,MF,GBP1;GNAL;TUBA1C
7799,GO:0031325,0.375486217042611,0.715837548293797,20,2752,positive regulation of cellular metabolic process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;SPP1;HOXA7;GDF15;CHI3L1;ANXA1;MMD2;ADM;MMP14;PTX3;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
19100,GO:1901989,0.375644015454139,0.920101906860639,1,72,positive regulation of cell cycle phase transition,BP,ANXA1
16922,GO:0072527,0.375760339843511,0.919985964386656,1,77,pyrimidine-containing compound metabolic process,BP,TYMP
13185,GO:0048708,0.375779954331711,0.920110473535388,1,67,astrocyte differentiation,BP,VIM
6548,GO:0019439,0.376897913889966,0.784305974087459,5,632,aromatic compound catabolic process,BP,TYMP;VIM;IGF2BP2;MOXD1;IGF2BP3
9492,GO:0034704,0.377211380549217,0.919587749796246,1,59,calcium channel complex,CC,CACNG2
7271,GO:0030276,0.377455729753337,0.919318320420605,1,68,clathrin binding,MF,SNAP91
13762,GO:0051223,0.37817508738787,0.783304966235028,5,611,regulation of protein transport,BP,FERMT1;GBP1;POSTN;ANXA1;KCNB1
8463,GO:0032508,0.379191856117165,0.918479139870045,1,70,DNA duplex unwinding,BP,ANXA1
2744,GO:0005765,0.380789372512696,0.819651766758936,3,336,lysosomal membrane,CC,CP;HLA-DQB1;ANXA2
18068,GO:0098852,0.380789372512696,0.819651766758936,3,336,lytic vacuole membrane,CC,CP;HLA-DQB1;ANXA2
11230,GO:0043393,0.381778074262542,0.853816907271726,2,196,regulation of protein binding,BP,CRTAC1;ANXA2
3315,GO:0006641,0.382207982729647,0.917005590321527,1,74,triglyceride metabolic process,BP,FABP5
11096,GO:0043178,0.382442635988753,0.916964405651212,1,69,alcohol binding,MF,RBP1
18002,GO:0098739,0.383161104646942,0.916624141141035,1,69,import across plasma membrane,BP,STEAP3
5401,GO:0015291,0.383776732058875,0.852499546939548,2,198,secondary active transmembrane transporter activity,MF,SLCO1A2;SLC8A2
6458,GO:0019209,0.384319069570786,0.916003469993607,1,74,kinase activator activity,MF,LTF
21811,GO:2001233,0.385600965321419,0.816094795162928,3,355,regulation of apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1;LGALS3
5567,GO:0015833,0.385904244299911,0.723143076316709,13,1784,peptide transport,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;CHI3L1;POSTN;ANXA1;KCNB1;CACNG2;RIMS2;RTP5
12654,GO:0046849,0.385937502286063,0.915257623032731,1,72,bone remodeling,BP,SPP1
16196,GO:0071260,0.386375789001654,0.914994407065902,1,76,cellular response to mechanical stimulus,BP,COL1A1
2838,GO:0005905,0.386920135695683,0.914878469568204,1,66,clathrin-coated pit,CC,SNAP91
13428,GO:0050714,0.387641493412346,0.849917019928672,2,207,positive regulation of protein secretion,BP,FERMT1;POSTN
17092,GO:0086001,0.38798968498176,0.914417165595404,1,63,cardiac muscle cell action potential,BP,KCNIP2
1622,GO:0003727,0.388438193656861,0.913988829424652,1,77,single-stranded RNA binding,MF,ANXA1
3455,GO:0006855,0.389282057534427,0.913647077435553,1,72,drug transmembrane transport,BP,ABCC3
17830,GO:0097581,0.389574851717105,0.913519691828214,1,71,lamellipodium organization,BP,PDPN
4409,GO:0009190,0.39182161059433,0.912357431741925,1,76,cyclic nucleotide biosynthetic process,BP,ADM
14281,GO:0052652,0.39182161059433,0.912357431741925,1,76,cyclic purine nucleotide metabolic process,BP,ADM
6047,GO:0016787,0.391825700841144,0.709199740165946,16,2218,hydrolase activity,MF,LTF;CHI3L2;AEBP1;ABCC3;GBP1;PLAU;CHI3L1;ANXA1;GNAL;ADAM12;MMP14;C1R;TUBA1C;PLA2G2A;PTPRT;CFI
2771,GO:0005796,0.392238895008252,0.91220816909869,1,72,Golgi lumen,CC,MMP14
12014,GO:0045445,0.393376119501037,0.911595885068849,1,76,myoblast differentiation,BP,CXCL10
2836,GO:0005902,0.393725329401346,0.911479450608657,1,72,microvillus,CC,PDPN
2722,GO:0005737,0.393887980151302,0.685456179488676,68,10141,cytoplasm,CC,LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;CHGB;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;KCNIP2;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;COL6A2;GALNT13;CPLX2;INA;ADM;SERPING1;SPHKAP;JPH3;MMP14;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;CACNG2;TUBA1C;COL3A1;PCDH7;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;PLA2G2A;SERPINA3;COL5A2;IFI30
8501,GO:0032580,0.395195326499943,0.910686671406174,1,77,Golgi cisterna membrane,CC,FUT9
11548,GO:0044267,0.396379969377546,0.68389377780793,32,4601,cellular protein metabolic process,BP,LTF;VIM;CP;IGF2BP2;CHGB;TIMP1;SERPINE1;CCL2;IGFBP2;GBP1;SPP1;GDF15;CHI3L1;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;SERPING1;MMP14;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
6839,GO:0021675,0.397197849667731,0.909793494839396,1,70,nerve development,BP,GABRB3
17757,GO:0097435,0.397537979778081,0.767687003645702,5,588,supramolecular fiber organization,BP,VIM;COL1A1;COL3A1;ANXA2;COL5A2
6465,GO:0019217,0.397733013564886,0.909482082286745,1,73,regulation of fatty acid metabolic process,BP,ANXA1
3655,GO:0007193,0.397986841064875,0.909313917259011,1,76,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,GNAL
12245,GO:0045921,0.398089362546278,0.909262780959905,1,76,positive regulation of exocytosis,BP,KCNB1
11245,GO:0043410,0.398840396569191,0.783050573672492,4,482,positive regulation of MAPK cascade,BP,CCL2;CHI3L1;KSR2;PLA2G2A
7168,GO:0030133,0.398845491358765,0.806250612018387,3,354,transport vesicle,CC,SVOP;GRIN1;HLA-DQB1
3129,GO:0006401,0.399199038784183,0.805972281767021,3,361,RNA catabolic process,BP,VIM;IGF2BP2;IGF2BP3
8506,GO:0032588,0.399228121490776,0.90865487519169,1,79,trans-Golgi network membrane,CC,HLA-DQB1
5407,GO:0015297,0.399681850073654,0.90846625176403,1,76,antiporter activity,MF,SLC8A2
5615,GO:0015918,0.399805414885875,0.908431931441872,1,74,sterol transport,BP,ANXA2
12491,GO:0046488,0.400639214615815,0.841213163901193,2,201,phosphatidylinositol metabolic process,BP,PLEKHA4;PLA2G2A
5700,GO:0016101,0.400772325300366,0.907905058355053,1,77,diterpenoid metabolic process,BP,RBP1
12924,GO:0048145,0.401189783366793,0.907708165500147,1,76,regulation of fibroblast proliferation,BP,ANXA2
10944,GO:0042886,0.402249973752244,0.708577579747137,13,1805,amide transport,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;CHI3L1;POSTN;ANXA1;KCNB1;CACNG2;RIMS2;RTP5
9012,GO:0033559,0.403068815216624,0.906637404325725,1,86,unsaturated fatty acid metabolic process,BP,ANXA1
3355,GO:0006690,0.403353842679611,0.906492637931264,1,86,icosanoid metabolic process,BP,ANXA1
17221,GO:0090092,0.403367165423728,0.839350934879241,2,201,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FERMT1;GDF15
2301,GO:0004896,0.403871882986989,0.90627415044657,1,82,cytokine receptor activity,MF,GPR17
16968,GO:0072593,0.4039896010863,0.838870854629352,2,215,reactive oxygen species metabolic process,BP,PTX3;GRIN1
19885,GO:1903779,0.404285885098266,0.906245996045943,1,69,regulation of cardiac conduction,BP,SLC8A2
12923,GO:0048144,0.40516577192004,0.905677645489043,1,77,fibroblast proliferation,BP,ANXA2
2767,GO:0005791,0.405325739384308,0.905520966848842,1,83,rough endoplasmic reticulum,CC,LTF
13732,GO:0051173,0.405422223967001,0.690424013339091,19,2654,positive regulation of nitrogen compound metabolic process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;SPP1;HOXA7;GDF15;CHI3L1;MMD2;ADM;MMP14;PTX3;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
15250,GO:0061333,0.405967432307909,0.905340029577665,1,72,renal tubule morphogenesis,BP,COL4A1
634,GO:0001776,0.406599053270498,0.904904928961854,1,80,leukocyte homeostasis,BP,ANXA1
15115,GO:0061025,0.406620588008707,0.837061830084435,2,215,membrane fusion,BP,ANXA1;ANXA2
517,GO:0001570,0.407238917988816,0.904672831449258,1,73,vasculogenesis,BP,ADM
13759,GO:0051219,0.407412608642128,0.904568625323651,1,74,phosphoprotein binding,MF,SOCS3
1615,GO:0003714,0.407575220049452,0.836425356197064,2,209,transcription corepressor activity,MF,AEBP1;KCNIP3
3808,GO:0007589,0.40762751518363,0.904415565757214,1,77,body fluid secretion,BP,ANXA2
1083,GO:0002474,0.407684469751701,0.904255148687226,1,88,antigen processing and presentation of peptide antigen via MHC class I,BP,IFI30
3838,GO:0007631,0.407908603843113,0.904206786965199,1,82,feeding behavior,BP,GRIN1
7804,GO:0031330,0.408619522227915,0.835710956289044,2,207,negative regulation of cellular catabolic process,BP,TIMP1;ANXA2
11831,GO:0045069,0.409333428361901,0.903482841232949,1,81,regulation of viral genome replication,BP,LTF
3341,GO:0006672,0.409459700064919,0.903381532111677,1,84,ceramide metabolic process,BP,ST8SIA3
5907,GO:0016528,0.41023005731573,0.903210883726762,1,68,sarcoplasm,CC,JPH3
13562,GO:0050906,0.410934679216928,0.902592653698565,1,86,detection of stimulus involved in sensory perception,BP,RTP5
4044,GO:0008344,0.411215666405205,0.902571907367481,1,76,adult locomotory behavior,BP,GRIN1
8476,GO:0032535,0.412340143331271,0.796029587146778,3,335,regulation of cellular component size,BP,TNFRSF12A;TNR;SPP1
2749,GO:0005770,0.412457797313867,0.832998063440822,2,219,late endosome,CC,STEAP3;ANXA2
17216,GO:0090087,0.413191960937061,0.754713770150915,5,639,regulation of peptide transport,BP,FERMT1;GBP1;POSTN;ANXA1;KCNB1
18765,GO:1901019,0.413196433351724,0.901523108812442,1,77,regulation of calcium ion transmembrane transporter activity,BP,JPH3
15704,GO:0070301,0.41323932938221,0.901434961034574,1,82,cellular response to hydrogen peroxide,BP,ANXA1
3930,GO:0008170,0.413399925426434,0.901363206783521,1,81,N-methyltransferase activity,MF,NNMT
13051,GO:0048471,0.413949232368611,0.75409282682675,5,626,perinuclear region of cytoplasm,CC,SPP1;CHI3L1;MMD2;ANXA2;PLA2G2A
3579,GO:0007045,0.414084145286133,0.901148619872019,1,71,cell-substrate adherens junction assembly,BP,MMP14
12906,GO:0048041,0.414084145286133,0.901148619872019,1,71,focal adhesion assembly,BP,MMP14
11282,GO:0043491,0.414931240964802,0.831312669115587,2,207,protein kinase B signaling,BP,CCL2;CHI3L1
11850,GO:0045088,0.415401224580471,0.793619477695677,3,361,regulation of innate immune response,BP,LTF;SERPING1;SOCS3
2103,GO:0004620,0.415544673550822,0.900209115079636,1,83,phospholipase activity,MF,PLA2G2A
12171,GO:0045778,0.415769243818357,0.900155211159033,1,78,positive regulation of ossification,BP,LTF
8364,GO:0032392,0.416230803195161,0.899884150531732,1,80,DNA geometric change,BP,ANXA1
19545,GO:1903076,0.416575298068515,0.899701677259489,1,80,regulation of protein localization to plasma membrane,BP,GBP1
13977,GO:0051606,0.416758397631203,0.829979303534019,2,220,detection of stimulus,BP,KCNIP2;RTP5
7577,GO:0030901,0.417109966100597,0.899392332647022,1,82,midbrain development,BP,INA
3131,GO:0006403,0.417858686574231,0.829221871829405,2,215,RNA localization,BP,IGF2BP2;IGF2BP3
12567,GO:0046632,0.418108998949066,0.898848533558372,1,83,alpha-beta T cell differentiation,BP,ANXA1
6233,GO:0017148,0.418247038354294,0.82898706005249,2,205,negative regulation of translation,BP,IGF2BP2;IGF2BP3
7169,GO:0030134,0.41840512800852,0.898690693710627,1,83,COPII-coated ER to Golgi transport vesicle,CC,HLA-DQB1
4467,GO:0009266,0.418771892524498,0.828572986414575,2,216,response to temperature stimulus,BP,ADM;CXCL10
12250,GO:0045926,0.418973943201787,0.828422689659028,2,218,negative regulation of growth,BP,TNR;SPP1
11557,GO:0044283,0.422009752603073,0.747291193645689,5,673,small molecule biosynthetic process,BP,TYMP;MOXD1;RBP1;ANXA1;ADM
1032,GO:0002377,0.422406660689934,0.896506811574354,1,86,immunoglobulin production,BP,HLA-DQB1
3889,GO:0008094,0.423724922298196,0.895896921573304,1,78,DNA-dependent ATPase activity,MF,ANXA1
11563,GO:0044297,0.424012758870716,0.76273218507867,4,487,cell body,CC,SLC8A2;CPLX2;KCNB1;SHANK2
5625,GO:0015931,0.424189832861067,0.824705414328585,2,220,nucleobase-containing compound transport,BP,IGF2BP2;IGF2BP3
6229,GO:0017144,0.424406118338239,0.745258197160387,5,685,drug metabolic process,BP,CHI3L2;MOXD1;CHI3L1;ADM;PTX3
1276,GO:0002793,0.424523209963127,0.824449047199751,2,225,positive regulation of peptide secretion,BP,FERMT1;POSTN
6457,GO:0019208,0.424630879809514,0.895337630897355,1,83,phosphatase regulator activity,MF,ELFN2
13657,GO:0051056,0.426068256233175,0.785382557738218,3,324,regulation of small GTPase mediated signal transduction,BP,MMD2;GPR17;COL3A1
6382,GO:0018958,0.426438630114501,0.894351551140823,1,83,phenol-containing compound metabolic process,BP,MOXD1
21209,GO:2000116,0.426533295199395,0.823000570741334,2,227,regulation of cysteine-type endopeptidase activity,BP,LTF;GRIN1
3425,GO:0006805,0.427005313105062,0.893937172678253,1,92,xenobiotic metabolic process,BP,GRIN1
3376,GO:0006721,0.427495303820208,0.893747452172841,1,85,terpenoid metabolic process,BP,RBP1
14752,GO:0060415,0.427785550285499,0.893776432329506,1,72,muscle tissue morphogenesis,BP,COL3A1
15643,GO:0070201,0.430001047500051,0.740534075560451,5,653,regulation of establishment of protein localization,BP,FERMT1;GBP1;POSTN;ANXA1;KCNB1
3662,GO:0007200,0.4302243596307,0.892141883617407,1,94,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,GPR17
18987,GO:1901655,0.430250039129928,0.892254020771003,1,83,cellular response to ketone,BP,SPP1
759,GO:0001942,0.431062804387852,0.891830241695193,1,81,hair follicle development,BP,FERMT1
4641,GO:0009953,0.431340559507419,0.891611375054702,1,86,dorsal/ventral pattern formation,BP,DSCAML1
2279,GO:0004860,0.431584841836794,0.891440232188545,1,89,protein kinase inhibitor activity,MF,SOCS3
6476,GO:0019233,0.432634384132271,0.890916021236899,1,84,sensory perception of pain,BP,GRIN1
18020,GO:0098773,0.434575906137637,0.889856198781016,1,82,skin epidermis development,BP,FERMT1
1595,GO:0003674,0.43535006006417,0.716526587274247,94,14275,molecular_function,MF,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;SLCO1A2;CHGB;CRTAC1;APOL4;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;ABCC3;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;CA10;MMP14;KCNB1;C1R;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;SVOP;GABRB3;NNMT;CACNG2;ELFN2;TUBA1C;COL3A1;CXCL10;PCDH7;KSR2;FUT9;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;CFI;IFI30
11904,GO:0045184,0.436424631536198,0.677512188583711,13,1843,establishment of protein localization,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;CHI3L1;POSTN;ANXA1;KCNB1;CACNG2;RIMS2;RTP5
12883,GO:0048013,0.437490836004748,0.888148220012697,1,87,ephrin receptor signaling pathway,BP,GRIN1
19066,GO:1901888,0.437552932553028,0.888206187624979,1,80,regulation of cell junction assembly,BP,MMP14
2837,GO:0005903,0.437647473713829,0.888152648059274,1,80,brush border,CC,SHANK2
11113,GO:0043202,0.437777998729672,0.887985461569865,1,87,lysosomal lumen,CC,IFI30
9819,GO:0035579,0.438535727596294,0.887567727659222,1,86,specific granule membrane,CC,PLAU
2595,GO:0005488,0.43871440213096,0.664482287841242,84,12653,binding,MF,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;CHGB;CRTAC1;APOL4;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;ABCC3;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;GNAL;COL6A2;EMP3;GALNT13;CPLX2;CDHR1;ADAM12;ADM;SERPING1;SPHKAP;MMP14;KCNB1;C1R;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;GABRB3;CACNG2;TUBA1C;COL3A1;CXCL10;PCDH7;KSR2;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;SMOC1;COL5A2;CFI;IFI30
7018,GO:0022404,0.439086085862699,0.887293870601564,1,83,molting cycle process,BP,FERMT1
7019,GO:0022405,0.439086085862699,0.887293870601564,1,83,hair cycle process,BP,FERMT1
12481,GO:0046474,0.439273875418341,0.813739562515398,2,223,glycerophospholipid biosynthetic process,BP,PLEKHA4;PLA2G2A
10876,GO:0042734,0.439299250397044,0.887260156669683,1,77,presynaptic membrane,CC,RIMS2
3314,GO:0006639,0.441027141212941,0.886121485058771,1,88,acylglycerol metabolic process,BP,FABP5
7178,GO:0030148,0.442660881667436,0.885136479065829,1,92,sphingolipid biosynthetic process,BP,ST8SIA3
5382,GO:0015238,0.444178001948391,0.884272050491134,1,91,drug transmembrane transporter activity,MF,ABCC3
3313,GO:0006638,0.444423541103718,0.88415349215048,1,89,neutral lipid metabolic process,BP,FABP5
4188,GO:0008585,0.444602945320767,0.884100098442893,1,85,female gonad development,BP,MMP14
3783,GO:0007517,0.444831370493523,0.770361352254584,3,344,muscle organ development,BP,AEBP1;COL3A1;CXCL10
15022,GO:0060840,0.445078317753608,0.883958021366738,1,76,artery development,BP,COL3A1
11892,GO:0045165,0.445123396273961,0.809400349035653,2,223,cell fate commitment,BP,PDPN;DSCAML1
7459,GO:0030672,0.446018060635637,0.883216122005347,1,90,synaptic vesicle membrane,CC,SVOP
18218,GO:0099501,0.446018060635637,0.883216122005347,1,90,exocytic vesicle membrane,CC,SVOP
3891,GO:0008104,0.447059738298587,0.656023850035298,17,2415,protein localization,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;CHI3L1;POSTN;ANXA1;MMD2;KCNB1;CACNG2;RIMS2;GRIN1;ANXA2;SHISA7;RTP5
8746,GO:0032947,0.447451726698588,0.882514439462851,1,80,protein-containing complex scaffold activity,MF,SHANK2
20162,GO:1904375,0.447525897777983,0.882361209611654,1,88,regulation of protein localization to cell periphery,BP,GBP1
8188,GO:0032092,0.447828962627453,0.882236415804476,1,84,positive regulation of protein binding,BP,ANXA2
6459,GO:0019210,0.447939833714052,0.882059960189226,1,93,kinase inhibitor activity,MF,SOCS3
8361,GO:0032388,0.448111104465861,0.807160477682532,2,224,positive regulation of intracellular transport,BP,KCNB1;ANXA2
20008,GO:1904019,0.448816962289428,0.881630888591668,1,86,epithelial cell apoptotic process,BP,SERPINE1
3844,GO:0008013,0.449347613237125,0.881419796046154,1,79,beta-catenin binding,MF,PTPRT
8187,GO:0032091,0.449762212288646,0.881013190394865,1,91,negative regulation of protein binding,BP,CRTAC1
13139,GO:0048644,0.449782072092719,0.881180387921329,1,78,muscle organ morphogenesis,BP,COL3A1
6699,GO:0019905,0.45043209010502,0.880667969075074,1,87,syntaxin binding,MF,CPLX2
3534,GO:0006979,0.450884490091415,0.765343158128254,3,390,response to oxidative stress,BP,COL1A1;ANXA1;MMP14
10641,GO:0042277,0.451631814847966,0.804454399590796,2,239,peptide binding,MF,KCNIP2;HLA-DQB1
19458,GO:1902936,0.452398220953975,0.879467424381091,1,90,phosphatidylinositol bisphosphate binding,MF,ANXA2
8359,GO:0032386,0.452953650048094,0.763681363085317,3,371,regulation of intracellular transport,BP,KCNB1;RIMS2;ANXA2
9288,GO:0034333,0.454767425895222,0.87817982434912,1,81,adherens junction assembly,BP,MMP14
14470,GO:0060021,0.454907235650783,0.87806662768414,1,83,roof of mouth development,BP,GABRB3
9264,GO:0034249,0.454912978408788,0.802031385330897,2,221,negative regulation of cellular amide metabolic process,BP,IGF2BP2;IGF2BP3
21210,GO:2000117,0.454938088468561,0.877896290333569,1,95,negative regulation of cysteine-type endopeptidase activity,BP,LTF
18950,GO:1901575,0.455348100799035,0.659948359796551,13,1889,organic substance catabolic process,BP,TYMP;VIM;CHI3L2;IGF2BP2;MOXD1;TIMP1;SPP1;CHI3L1;IGF2BP3;FABP5;FUT9;ANXA2;PLA2G2A
11666,GO:0044464,0.456265380694584,0.681536761340398,92,13950,cell part,CC,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;SLCO1A2;CHGB;CRTAC1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;ABCC3;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;CSMD3;SVOP;GABRB3;NNMT;CACNG2;TUBA1C;COL3A1;CXCL10;PCDH7;KSR2;FUT9;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;COL5A2;IFI30
15114,GO:0061024,0.456808804228592,0.703950132404308,6,803,membrane organization,BP,KCNIP2;ANXA1;CACNG2;ANXA2;SHISA7;RTP5
12525,GO:0046545,0.458002458867012,0.876126469045571,1,89,development of primary female sexual characteristics,BP,MMP14
1608,GO:0003697,0.458164953413865,0.875945508698684,1,96,single-stranded DNA binding,MF,ANXA1
821,GO:0002027,0.458469080108873,0.875884393858922,1,86,regulation of heart rate,BP,ADM
691,GO:0001843,0.459055991917557,0.875543393957182,1,85,neural tube closure,BP,ADM
3445,GO:0006836,0.459086249850905,0.798815442641174,2,228,neurotransmitter transport,BP,CPLX2;RIMS2
13761,GO:0051222,0.459936065231313,0.757896157462513,3,382,positive regulation of protein transport,BP,FERMT1;POSTN;KCNB1
19910,GO:1903828,0.461099991590156,0.874175774507671,1,95,negative regulation of cellular protein localization,BP,GBP1
14805,GO:0060485,0.461724969726593,0.796774144662429,2,231,mesenchyme development,BP,COL1A1;PDPN
7276,GO:0030282,0.461859651069602,0.873735527049423,1,93,bone mineralization,BP,LTF
14887,GO:0060606,0.461962698386407,0.873762544784819,1,86,tube closure,BP,ADM
13964,GO:0051591,0.462277087292877,0.873517305000017,1,90,response to cAMP,BP,COL1A1
7822,GO:0031349,0.463284269105232,0.755087736495912,3,394,positive regulation of defense response,BP,LTF;SERPINE1;PLA2G2A
730,GO:0001906,0.464414521146569,0.872041576528262,1,105,cell killing,BP,LTF
6746,GO:0021510,0.465057741050828,0.871823170176941,1,89,spinal cord development,BP,MDGA2
15249,GO:0061326,0.465727815155648,0.871436653702161,1,87,renal tubule development,BP,COL4A1
18801,GO:1901137,0.466339377432819,0.708859871022797,5,685,carbohydrate derivative biosynthetic process,BP,TYMP;GALNT13;ADM;FUT9;ST8SIA3
14427,GO:0055088,0.466671044217354,0.870751864656193,1,95,lipid homeostasis,BP,RBP1
11086,GO:0043167,0.466737795790608,0.61420858601969,38,5495,ion binding,MF,LTF;CP;SNAP91;MOXD1;CRTAC1;TIMP1;PLEKHA4;AEBP1;COL1A1;ABCC3;KCNIP3;STEAP3;GBP1;SLC8A2;KCNIP2;POSTN;ANXA1;GNAL;GALNT13;CDHR1;ADAM12;MMP14;C1R;S100A11;FABP5;TUBA1C;COL3A1;CXCL10;PCDH7;KSR2;RIMS2;GRIN1;ST8SIA3;ANXA2;PLA2G2A;SMOC1;COL5A2;CFI
2752,GO:0005774,0.467109455238366,0.751896052080812,3,388,vacuolar membrane,CC,CP;HLA-DQB1;ANXA2
1376,GO:0003014,0.467818160206219,0.870028167566751,1,96,renal system process,BP,ADM
3487,GO:0006900,0.468239729889257,0.869801247010817,1,93,vesicle budding from membrane,BP,ANXA2
7025,GO:0022411,0.469075995391588,0.724499933092116,4,526,cellular component disassembly,BP,TIMP1;SPP1;MMP14;PDPN
2666,GO:0005623,0.47001019160006,0.669313160448255,92,13967,cell,CC,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;SLCO1A2;CHGB;CRTAC1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;ABCC3;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;MMP14;KCNB1;SHANK2;PDPN;S100A11;GABRG1;PTX3;FABP5;CSMD3;SVOP;GABRB3;NNMT;CACNG2;TUBA1C;COL3A1;CXCL10;PCDH7;KSR2;FUT9;RIMS2;GRIN1;DSCAML1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;COL5A2;IFI30
12015,GO:0045446,0.472061066881086,0.867446899881215,1,90,endothelial cell differentiation,BP,PDPN
3142,GO:0006417,0.475474055200405,0.744830017022598,3,386,regulation of translation,BP,VIM;IGF2BP2;IGF2BP3
8127,GO:0031985,0.476520378440221,0.864521747648818,1,98,Golgi cisterna,CC,FUT9
3801,GO:0007569,0.477870372816355,0.863681493343534,1,96,cell aging,BP,SERPINE1
7013,GO:0022037,0.478094191149005,0.863587709484947,1,92,metencephalon development,BP,GRIN1
17973,GO:0098656,0.478839261606129,0.783336295846331,2,234,anion transmembrane transport,BP,GABRG1;GABRB3
8687,GO:0032868,0.480013542893646,0.782383472524119,2,238,response to insulin,BP,ADM;SOCS3
367,GO:0000982,0.480163806972706,0.740823768886325,3,387,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,CUX2;KCNIP3;HOXA7
850,GO:0002065,0.480254990284135,0.862124332708015,1,98,columnar/cuboidal epithelial cell differentiation,BP,SERPINE1
6890,GO:0021782,0.480442219451666,0.8620771545588,1,92,glial cell development,BP,VIM
11168,GO:0043279,0.480609003794892,0.861919256210164,1,96,response to alkaloid,BP,GRIN1
4823,GO:0010604,0.481763903804238,0.618711495338699,19,2755,positive regulation of macromolecule metabolic process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;CUX2;SPP1;HOXA7;GDF15;CHI3L1;MMD2;MMP14;CXCL10;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A
12258,GO:0045936,0.481900363706631,0.713184389282207,4,538,negative regulation of phosphate metabolic process,BP,GBP1;SPOCD1;ELFN2;SOCS3
9693,GO:0035335,0.482354634420686,0.86082601476188,1,93,peptidyl-tyrosine dephosphorylation,BP,PTPRT
4802,GO:0010563,0.483116188531397,0.712101648319846,4,539,negative regulation of phosphorus metabolic process,BP,GBP1;SPOCD1;ELFN2;SOCS3
7206,GO:0030183,0.483351285556866,0.860140303749537,1,96,B cell differentiation,BP,MMP14
7027,GO:0022414,0.483639767980892,0.66015699672366,8,1144,reproductive process,BP,TIMP1;IGFBP2;SPP1;ANXA1;ADM;MMP14;GRIN1;SOCS3
5130,GO:0014020,0.483661417414945,0.859989019283556,1,92,primary neural tube formation,BP,ADM
3575,GO:0007041,0.484446024040206,0.859463914334704,1,93,lysosomal transport,BP,CACNG2
2179,GO:0004725,0.485336909116648,0.858868215269854,1,94,protein tyrosine phosphatase activity,MF,PTPRT
3375,GO:0006720,0.485718702630854,0.858512863657071,1,103,isoprenoid metabolic process,BP,RBP1
7454,GO:0030665,0.485725384007099,0.858552831085456,1,99,clathrin-coated vesicle membrane,CC,HLA-DQB1
2,GO:0000003,0.48621474162986,0.657741155030184,8,1147,reproduction,BP,TIMP1;IGFBP2;SPP1;ANXA1;ADM;MMP14;GRIN1;SOCS3
11488,GO:0044106,0.487026408490854,0.857564436501939,1,112,cellular amine metabolic process,BP,MOXD1
11800,GO:0045017,0.487227056959886,0.776545582608731,2,246,glycerolipid biosynthetic process,BP,PLEKHA4;PLA2G2A
4163,GO:0008528,0.487363667539267,0.857333054590211,1,113,G-protein coupled peptide receptor activity,MF,GPR17
3176,GO:0006468,0.488405132810851,0.632642254474841,12,1712,protein phosphorylation,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;MMD2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
7201,GO:0030175,0.488825605842611,0.856625243414806,1,90,filopodium,CC,PDPN
555,GO:0001653,0.490581728355783,0.855190841141967,1,114,peptide receptor activity,MF,GPR17
12489,GO:0046486,0.49075784741335,0.731652822186446,3,396,glycerolipid metabolic process,BP,PLEKHA4;FABP5;PLA2G2A
5798,GO:0016298,0.491032001889302,0.854977482060921,1,105,lipase activity,MF,PLA2G2A
3578,GO:0007044,0.491659828441789,0.854786628433411,1,87,cell-substrate junction assembly,BP,MMP14
4625,GO:0009895,0.491906197077102,0.772747874847684,2,242,negative regulation of catabolic process,BP,TIMP1;ANXA2
13997,GO:0051650,0.492341874342807,0.772406100181281,2,238,establishment of vesicle localization,BP,CPLX2;RIMS2
10654,GO:0042303,0.492638578611454,0.853982994981347,1,98,molting cycle,BP,FERMT1
10833,GO:0042633,0.492638578611454,0.853982994981347,1,98,hair cycle,BP,FERMT1
11391,GO:0043666,0.49284306899698,0.853822334041653,1,100,regulation of phosphoprotein phosphatase activity,BP,ELFN2
7451,GO:0030660,0.493360580913903,0.853419911264734,1,105,Golgi-associated vesicle membrane,CC,HLA-DQB1
12617,GO:0046718,0.493592061541196,0.853264495111526,1,105,viral entry into host cell,BP,PTX3
1283,GO:0002822,0.493713902727312,0.853141899953353,1,109,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1
3196,GO:0006493,0.494152372067504,0.852955292222007,1,99,protein O-linked glycosylation,BP,GALNT13
12566,GO:0046631,0.494248918171224,0.852812411078004,1,106,alpha-beta T cell activation,BP,ANXA1
7918,GO:0031532,0.495438433018,0.852076971895713,1,100,actin cytoskeleton reorganization,BP,ANXA1
7743,GO:0031234,0.49548962829327,0.85198650016675,1,105,extrinsic component of cytoplasmic side of plasma membrane,CC,GNAL
14125,GO:0051899,0.495582023487462,0.852125246278515,1,89,membrane depolarization,BP,CACNG2
8568,GO:0032680,0.496054314940602,0.85158387748081,1,107,regulation of tumor necrosis factor production,BP,LTF
13530,GO:0050864,0.497125452799462,0.850868481050774,1,106,regulation of B cell activation,BP,MMP14
12678,GO:0046887,0.499240998159179,0.84938754026083,1,110,positive regulation of hormone secretion,BP,SPP1
3954,GO:0008202,0.49974628006265,0.766223669761628,2,259,steroid metabolic process,BP,SPP1;ADM
10920,GO:0042803,0.49996002407428,0.678284678675344,5,727,protein homodimerization activity,MF,TYMP;GBP1;ANXA1;S100A11;DSCAML1
10758,GO:0042493,0.500932726167267,0.663475219703117,6,869,response to drug,BP,COL1A1;ABCC3;IGFBP2;ANXA1;NNMT;GRIN1
2299,GO:0004888,0.502333348369075,0.676088133463776,5,719,transmembrane signaling receptor activity,MF,GPR17;GABRG1;GABRB3;GRIN1;HLA-DQB1
8082,GO:0031902,0.502860945512636,0.846863686270256,1,114,late endosome membrane,CC,ANXA2
363,GO:0000978,0.503499451838238,0.720432400912401,3,401,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,CUX2;KCNIP3;HOXA7
4343,GO:0009116,0.504595783549773,0.84567249578086,1,113,nucleoside metabolic process,BP,TYMP
19769,GO:1903555,0.504750977228683,0.845594139740048,1,110,regulation of tumor necrosis factor superfamily cytokine production,BP,LTF
12453,GO:0046425,0.505068700926811,0.845383698202781,1,109,regulation of JAK-STAT cascade,BP,SOCS3
8541,GO:0032640,0.505078904795318,0.845366459841536,1,110,tumor necrosis factor production,BP,LTF
4546,GO:0009615,0.505330516001022,0.761542027163384,2,264,response to virus,BP,GBP1;CXCL10
1292,GO:0002831,0.506794564527207,0.844181969396558,1,109,regulation of response to biotic stimulus,BP,LTF
9459,GO:0034655,0.506855424904344,0.690585699161881,4,577,nucleobase-containing compound catabolic process,BP,TYMP;VIM;IGF2BP2;IGF2BP3
10827,GO:0042626,0.506875616409395,0.844277657413367,1,96,ATPase activity, coupled to transmembrane movement of substances,MF,ABCC3
11032,GO:0043065,0.506906619856827,0.690556018781381,4,561,positive regulation of apoptotic process,BP,TNFRSF12A;ANXA1;ADM;GRIN1
6161,GO:0017015,0.507492542151685,0.843820759201242,1,98,regulation of transforming growth factor beta receptor signaling pathway,BP,FERMT1
4957,GO:0010811,0.507772883185494,0.843587448732043,1,101,positive regulation of cell-substrate adhesion,BP,FERMT1
20430,GO:1904892,0.507798634228067,0.843469813936361,1,110,regulation of STAT cascade,BP,SOCS3
9674,GO:0035296,0.508678237356673,0.842833191622637,1,112,regulation of tube diameter,BP,ADM
17892,GO:0097746,0.508678237356673,0.842833191622637,1,112,regulation of blood vessel diameter,BP,ADM
12811,GO:0047485,0.509452216219488,0.84235180325636,1,106,protein N-terminus binding,MF,KCNIP2
12587,GO:0046660,0.510215242095913,0.841860484900548,1,102,female sex differentiation,BP,MMP14
10365,GO:0038061,0.510419135033232,0.841560718300668,1,117,NIK/NF-kappaB signaling,BP,CHI3L1
4478,GO:0009308,0.510505570595871,0.841473189445104,1,120,amine metabolic process,BP,MOXD1
7662,GO:0031072,0.510541400090947,0.841541968918969,1,110,heat shock protein binding,MF,GBP1
11005,GO:0043021,0.511231879530064,0.841064622776794,1,109,ribonucleoprotein complex binding,MF,LTF
19916,GO:1903844,0.512990786212044,0.839921376025202,1,100,regulation of cellular response to transforming growth factor beta stimulus,BP,FERMT1
20458,GO:1904951,0.513214109381456,0.711706791318326,3,417,positive regulation of establishment of protein localization,BP,FERMT1;POSTN;KCNB1
12142,GO:0045727,0.513470444528574,0.839445932565373,1,112,positive regulation of translation,BP,VIM
20691,GO:1905477,0.51377664551271,0.839248313632361,1,110,positive regulation of protein localization to membrane,BP,KCNB1
16239,GO:0071333,0.51449851832609,0.838754835298375,1,108,cellular response to glucose stimulus,BP,KCNB1
689,GO:0001841,0.514623545253161,0.838759007260389,1,100,neural tube formation,BP,ADM
12047,GO:0045580,0.515383796487979,0.838080436333065,1,112,regulation of T cell differentiation,BP,ANXA1
16683,GO:0072089,0.515732517361721,0.837917706727607,1,104,stem cell proliferation,BP,FERMT1
19755,GO:1903533,0.516093291175844,0.837552332638676,1,114,regulation of protein targeting,BP,KCNB1
11035,GO:0043068,0.516099308351464,0.682049936231515,4,567,positive regulation of programmed cell death,BP,TNFRSF12A;ANXA1;ADM;GRIN1
17253,GO:0090150,0.516189579322488,0.752261498995314,2,285,establishment of protein localization to membrane,BP,KCNB1;RTP5
16494,GO:0071706,0.516559383156625,0.837217847826043,1,114,tumor necrosis factor superfamily cytokine production,BP,LTF
8909,GO:0033218,0.516587199489426,0.751961611360826,2,271,amide binding,MF,KCNIP2;HLA-DQB1
13069,GO:0048511,0.51734556416945,0.751366630469206,2,254,rhythmic process,BP,SERPINE1;ANXA1
12198,GO:0045834,0.518236376032579,0.836051419357662,1,110,positive regulation of lipid metabolic process,BP,ANXA1
16841,GO:0072330,0.518733369030786,0.750125198098502,2,268,monocarboxylic acid biosynthetic process,BP,RBP1;ANXA1
13995,GO:0051648,0.51954596307934,0.749486042351403,2,250,vesicle localization,BP,CPLX2;RIMS2
4223,GO:0008654,0.519825316937331,0.749199456894995,2,263,phospholipid biosynthetic process,BP,PLEKHA4;PLA2G2A
16237,GO:0071331,0.520043202115213,0.834744553811465,1,110,cellular response to hexose stimulus,BP,KCNB1
3333,GO:0006664,0.520899851388679,0.834043100840041,1,118,glycolipid metabolic process,BP,ST8SIA3
19736,GO:1903509,0.520899851388679,0.834043100840041,1,118,liposaccharide metabolic process,BP,ST8SIA3
3050,GO:0006275,0.521078129869844,0.834025848758452,1,107,regulation of DNA replication,BP,S100A11
7170,GO:0030135,0.521625159752326,0.747656047274887,2,259,coated vesicle,CC,SNAP91;HLA-DQB1
16235,GO:0071326,0.523050581600957,0.832543673022373,1,111,cellular response to monosaccharide stimulus,BP,KCNB1
12212,GO:0045859,0.523232957566056,0.656422991360168,5,719,regulation of protein kinase activity,BP,LTF;CHI3L1;MMD2;CXCL10;SOCS3
5442,GO:0015399,0.523278189291276,0.832480555723863,1,102,primary active transmembrane transporter activity,MF,ABCC3
5443,GO:0015405,0.523278189291276,0.832480555723863,1,102,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCC3
3421,GO:0006796,0.524553545690929,0.576929475894377,19,2851,phosphate-containing compound metabolic process,BP,LTF;SRPX2;PLEKHA4;CCL2;GBP1;GDF15;CHI3L1;SPOCD1;MMD2;ADM;NNMT;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT
21270,GO:2000241,0.524876512344709,0.831163613028996,1,115,regulation of reproductive process,BP,TIMP1
6662,GO:0019842,0.525440480051929,0.830710221587679,1,119,vitamin binding,MF,RBP1
2287,GO:0004871,0.525903186396803,0.619759228582761,8,1181,signal transducer activity,MF,GNAL;GPR17;JPH3;GABRG1;GABRB3;KSR2;GRIN1;HLA-DQB1
1280,GO:0002819,0.526392352915748,0.829998783707846,1,120,regulation of adaptive immune response,BP,ANXA1
3948,GO:0008194,0.527631184435116,0.829100615042975,1,118,UDP-glycosyltransferase activity,MF,GALNT13
369,GO:0000987,0.527696262114618,0.698503256301305,3,414,proximal promoter sequence-specific DNA binding,MF,CUX2;KCNIP3;HOXA7
15512,GO:0062012,0.528073978116277,0.698137383681618,3,424,regulation of small molecule metabolic process,BP,ANXA1;ADM;CXCL10
14289,GO:0052689,0.528832372822321,0.828180775925407,1,121,carboxylic ester hydrolase activity,MF,PLA2G2A
12019,GO:0045471,0.529206817991406,0.827949372547092,1,116,response to ethanol,BP,GRIN1
3309,GO:0006633,0.529675253327067,0.827571448062194,1,119,fatty acid biosynthetic process,BP,ANXA1
13543,GO:0050880,0.530839805591611,0.8266923003699,1,120,regulation of blood vessel size,BP,ADM
2839,GO:0005911,0.533337654960694,0.693306403048224,3,399,cell-cell junction,CC,ANXA1;S100A11;ANXA2
9615,GO:0035150,0.533400264848315,0.82476042078216,1,121,regulation of tube size,BP,ADM
5806,GO:0016311,0.534844043510046,0.691879160117774,3,412,dephosphorylation,BP,SPOCD1;ELFN2;PTPRT
7735,GO:0031225,0.535237776660165,0.823371993058291,1,121,anchored component of membrane,CC,MDGA2
12292,GO:0045995,0.536006800276045,0.82292409260437,1,108,regulation of embryonic development,BP,COL5A2
2755,GO:0005777,0.536691703550799,0.822259044252251,1,122,peroxisome,CC,VIM
10798,GO:0042579,0.536691703550799,0.822259044252251,1,122,microbody,CC,VIM
7546,GO:0030863,0.537457610577467,0.821908806261636,1,101,cortical cytoskeleton,CC,RIMS2
4554,GO:0009636,0.53997599928987,0.687024405154153,3,442,response to toxic substance,BP,COL1A1;ANXA1;GRIN1
9662,GO:0035270,0.541486893706436,0.818635002090286,1,117,endocrine system development,BP,ANXA1
9263,GO:0034248,0.543814104898946,0.683428780175881,3,429,regulation of cellular amide metabolic process,BP,VIM;IGF2BP2;IGF2BP3
3402,GO:0006766,0.545850369638415,0.815201121393386,1,122,vitamin metabolic process,BP,RBP1
4187,GO:0008584,0.545953493197575,0.815180273050783,1,116,male gonad development,BP,MMP14
9677,GO:0035304,0.54595949706019,0.815155022794562,1,118,regulation of protein dephosphorylation,BP,ELFN2
16233,GO:0071322,0.546837262540703,0.814458844646651,1,119,cellular response to carbohydrate stimulus,BP,KCNB1
7261,GO:0030260,0.54791299230821,0.813595952985228,1,121,entry into host cell,BP,PTX3
11626,GO:0044409,0.54791299230821,0.813595952985228,1,121,entry into host,BP,PTX3
14084,GO:0051806,0.54791299230821,0.813595952985228,1,121,entry into cell of other organism involved in symbiotic interaction,BP,PTX3
14091,GO:0051828,0.54791299230821,0.813595952985228,1,121,entry into other organism involved in symbiotic interaction,BP,PTX3
13965,GO:0051592,0.548058266732443,0.813576006044631,1,112,response to calcium ion,BP,KCNIP2
6286,GO:0018107,0.548130805369314,0.813519049548164,1,112,peptidyl-threonine phosphorylation,BP,CHI3L1
4000,GO:0008277,0.548871840317412,0.812823046656734,1,123,regulation of G-protein coupled receptor protein signaling pathway,BP,ADM
12526,GO:0046546,0.549442902215846,0.812432461742181,1,117,development of primary male sexual characteristics,BP,MMP14
6513,GO:0019359,0.550123637779092,0.811874791619837,1,119,nicotinamide nucleotide biosynthetic process,BP,NNMT
6515,GO:0019363,0.550123637779092,0.811874791619837,1,119,pyridine nucleotide biosynthetic process,BP,NNMT
18946,GO:1901568,0.550987270317417,0.811073335695487,1,132,fatty acid derivative metabolic process,BP,ANXA1
5884,GO:0016491,0.551055431202212,0.64869659874563,4,642,oxidoreductase activity,MF,CP;MOXD1;STEAP3;IFI30
7609,GO:0030968,0.551406360513203,0.810820550363914,1,123,endoplasmic reticulum unfolded protein response,BP,CCL2
7908,GO:0031514,0.551702018689583,0.810615184554319,1,120,motile cilium,CC,ANXA1
939,GO:0002224,0.552085900947551,0.810262547571446,1,125,toll-like receptor signaling pathway,BP,LTF
20037,GO:1904064,0.552466673434546,0.810049147928107,1,116,positive regulation of cation transmembrane transport,BP,CXCL10
10780,GO:0042552,0.552666098571726,0.809946461684807,1,111,myelination,BP,TYMP
2603,GO:0005506,0.556913963284367,0.806364569829199,1,129,iron ion binding,MF,LTF
576,GO:0001678,0.557394983447413,0.806051819846525,1,121,cellular glucose homeostasis,BP,KCNB1
12607,GO:0046700,0.55744185004408,0.642475698257012,4,615,heterocycle catabolic process,BP,TYMP;VIM;IGF2BP2;IGF2BP3
752,GO:0001935,0.557646887442632,0.805868981306001,1,119,endothelial cell proliferation,BP,MMP14
17425,GO:0090407,0.557804776965076,0.642124198642179,4,610,organophosphate biosynthetic process,BP,PLEKHA4;ADM;NNMT;PLA2G2A
4007,GO:0008286,0.557902816156481,0.805672873160636,1,118,insulin receptor signaling pathway,BP,SOCS3
72,GO:0000149,0.558045383517324,0.805526974403669,1,121,SNARE binding,MF,CPLX2
3706,GO:0007272,0.558101577064499,0.805567336670472,1,113,ensheathment of neurons,BP,TYMP
4056,GO:0008366,0.558101577064499,0.805567336670472,1,113,axon ensheathment,BP,TYMP
12374,GO:0046165,0.558232458384054,0.805327762119491,1,126,alcohol biosynthetic process,BP,MOXD1
11283,GO:0043492,0.559595895519961,0.804405944675358,1,109,ATPase activity, coupled to movement of substances,MF,ABCC3
11549,GO:0044270,0.559637576318332,0.64031394462005,4,617,cellular nitrogen compound catabolic process,BP,TYMP;VIM;IGF2BP2;IGF2BP3
16920,GO:0072525,0.559858505921986,0.804048836577748,1,122,pyridine-containing compound biosynthetic process,BP,NNMT
13654,GO:0051053,0.560937490056994,0.803223389273349,1,117,negative regulation of DNA metabolic process,BP,S100A11
18989,GO:1901657,0.56144663252582,0.802647980502728,1,134,glycosyl compound metabolic process,BP,TYMP
7143,GO:0030098,0.56354291839142,0.709762482533507,2,286,lymphocyte differentiation,BP,ANXA1;MMP14
9427,GO:0034605,0.563726931249704,0.8009014864838,1,121,cellular response to heat,BP,CXCL10
5997,GO:0016705,0.563759329123694,0.800798404683155,1,129,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,MOXD1
18944,GO:1901566,0.56411260841149,0.562702060781397,11,1757,organonitrogen compound biosynthetic process,BP,TYMP;VIM;IGF2BP2;MOXD1;IGF2BP3;MDGA2;GALNT13;ADM;NNMT;FUT9;ST8SIA3
12595,GO:0046683,0.565134063219283,0.799724399642526,1,123,response to organophosphorus,BP,COL1A1
686,GO:0001838,0.566015138035466,0.799049418327,1,118,embryonic epithelial tube formation,BP,ADM
12476,GO:0046467,0.56734398835965,0.797797337440507,1,134,membrane lipid biosynthetic process,BP,ST8SIA3
7202,GO:0030176,0.567662122706254,0.797508708911499,1,137,integral component of endoplasmic reticulum membrane,CC,HLA-DQB1
8116,GO:0031965,0.567720124002396,0.705854268302532,2,278,nuclear membrane,CC,HOXA7;INA
17334,GO:0090263,0.567761988719256,0.797522124905138,1,126,positive regulation of canonical Wnt signaling pathway,BP,COL1A1
9265,GO:0034250,0.569518193737453,0.796014843555108,1,131,positive regulation of cellular amide metabolic process,BP,VIM
13791,GO:0051260,0.570598081577623,0.703075865695586,2,294,protein homooligomerization,BP,GBP1;KCNB1
18073,GO:0098862,0.570690453805666,0.795163687365521,1,118,cluster of actin-based cell projections,CC,SHANK2
3178,GO:0006470,0.571296926737008,0.702451540202015,2,281,protein dephosphorylation,BP,ELFN2;PTPRT
4239,GO:0008757,0.573416955138822,0.792735873964655,1,132,S-adenosylmethionine-dependent methyltransferase activity,MF,NNMT
11623,GO:0044403,0.573505133037269,0.607041497073411,5,786,symbiont process,BP,LTF;VIM;CCL2;PTX3;ANXA2
8776,GO:0032993,0.574170678037361,0.792056929399525,1,137,protein-DNA complex,CC,KCNIP3
13674,GO:0051092,0.575210437843513,0.791193576705327,1,135,positive regulation of NF-kappaB transcription factor activity,BP,LTF
8081,GO:0031901,0.575215567202323,0.791261457663084,1,127,early endosome membrane,CC,ANXA1
10997,GO:0043010,0.575637057320506,0.698327430649608,2,274,camera-type eye development,BP,VIM;COL4A1
3197,GO:0006497,0.575969303576428,0.790558260744168,1,134,protein lipidation,BP,MDGA2
13101,GO:0048565,0.576340463008457,0.790356892898265,1,122,digestive tract development,BP,COL3A1
11541,GO:0044255,0.577544799558333,0.588472308066574,6,951,cellular lipid metabolic process,BP,PLEKHA4;RBP1;ANXA1;FABP5;ST8SIA3;PLA2G2A
5068,GO:0010942,0.578032906230282,0.621976878392793,4,614,positive regulation of cell death,BP,TNFRSF12A;ANXA1;ADM;GRIN1
7737,GO:0031227,0.579237086731789,0.787712084740529,1,141,intrinsic component of endoplasmic reticulum membrane,CC,HLA-DQB1
3420,GO:0006793,0.579295792196155,0.521773064309433,19,2937,phosphorus metabolic process,BP,LTF;SRPX2;PLEKHA4;CCL2;GBP1;GDF15;CHI3L1;SPOCD1;MMD2;ADM;NNMT;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT
2770,GO:0005795,0.579717834381761,0.787403251284952,1,129,Golgi stack,CC,FUT9
362,GO:0000977,0.579837610795045,0.620159928048453,4,608,RNA polymerase II regulatory region sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
4388,GO:0009165,0.580755411425607,0.693292789325663,2,306,nucleotide biosynthetic process,BP,ADM;NNMT
7803,GO:0031329,0.580840520449587,0.599615759619752,5,760,regulation of cellular catabolic process,BP,VIM;IGF2BP2;TIMP1;IGF2BP3;ANXA2
16183,GO:0071236,0.581074410081836,0.786246572295101,1,128,cellular response to antibiotic,BP,ANXA1
3571,GO:0007034,0.581170709066297,0.78621371810173,1,123,vacuolar transport,BP,CACNG2
7102,GO:0030010,0.582160763333291,0.785403022494555,1,119,establishment of cell polarity,BP,FERMT1
957,GO:0002262,0.583267539697013,0.784305336897007,1,133,myeloid cell homeostasis,BP,ANXA1
383,GO:0001012,0.584051224363608,0.61588312175177,4,611,RNA polymerase II regulatory region DNA binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
11713,GO:0044703,0.585015943155537,0.595336728295383,5,777,multi-organism reproductive process,BP,TIMP1;IGFBP2;SPP1;ADM;GRIN1
9287,GO:0034332,0.58620899882934,0.781865203877719,1,121,adherens junction organization,BP,MMP14
21737,GO:2001056,0.586382633789976,0.781558815231449,1,137,positive regulation of cysteine-type endopeptidase activity,BP,GRIN1
9529,GO:0034767,0.586683164267915,0.781388167535144,1,127,positive regulation of ion transmembrane transport,BP,CXCL10
18859,GO:1901293,0.586937367068187,0.687256849049451,2,310,nucleoside phosphate biosynthetic process,BP,ADM;NNMT
12692,GO:0046914,0.587833625059996,0.577940743406971,6,926,transition metal ion binding,MF,LTF;CP;MOXD1;TIMP1;AEBP1;MMP14
16741,GO:0072175,0.588696555095687,0.779632267964379,1,126,epithelial tube formation,BP,ADM
3922,GO:0008152,0.589282606064771,0.49335867412555,64,9943,metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;IGF2BP2;MOXD1;CHGB;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;COL6A2;GALNT13;ADAM12;ADM;SERPING1;MMP14;C1R;S100A11;PTX3;FABP5;NNMT;CACNG2;ELFN2;COL3A1;CXCL10;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;COL4A1;PLA2G2A;PTPRT;SERPINA3;COL5A2;CFI;IFI30
10590,GO:0042158,0.589310424876903,0.778980292248871,1,138,lipoprotein biosynthetic process,BP,MDGA2
721,GO:0001889,0.590818818855394,0.777710984817189,1,131,liver development,BP,ANXA1
14123,GO:0051897,0.593669157761314,0.775178955387508,1,131,positive regulation of protein kinase B signaling,BP,CHI3L1
12253,GO:0045931,0.593992793405271,0.774909615927454,1,129,positive regulation of mitotic cell cycle,BP,ANXA1
7578,GO:0030902,0.595725456705094,0.773359422475494,1,129,hindbrain development,BP,GRIN1
9434,GO:0034620,0.595725479643692,0.773258985293104,1,140,cellular response to unfolded protein,BP,CCL2
4671,GO:0010038,0.595911287889215,0.678403047836322,2,304,response to metal ion,BP,IGFBP2;KCNIP2
3174,GO:0006464,0.596722701701218,0.49563631440602,24,3680,cellular protein modification process,BP,LTF;CP;CHGB;TIMP1;CCL2;GBP1;SPP1;GDF15;CHI3L1;ANXA1;MMD2;MDGA2;GALNT13;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
10182,GO:0036211,0.596722701701218,0.49563631440602,24,3680,protein modification process,BP,LTF;CP;CHGB;TIMP1;CCL2;GBP1;SPP1;GDF15;CHI3L1;ANXA1;MMD2;MDGA2;GALNT13;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
11632,GO:0044419,0.596902606536242,0.583052908045774,5,809,interspecies interaction between organisms,BP,LTF;VIM;CCL2;PTX3;ANXA2
14449,GO:0055123,0.598597662361674,0.770763431472096,1,130,digestive system development,BP,COL3A1
1380,GO:0003018,0.598859247542431,0.770410512506845,1,143,vascular process in circulatory system,BP,ADM
15106,GO:0061008,0.600452369479613,0.769044146424519,1,134,hepaticobiliary system development,BP,ANXA1
14486,GO:0060041,0.600985255023951,0.768628448939789,1,127,retina development in camera-type eye,BP,COL4A1
586,GO:0001701,0.602031511457348,0.6723008383438,2,293,in utero embryonic development,BP,ADM;SOCS3
773,GO:0001959,0.603578273419637,0.766120422779481,1,142,regulation of cytokine-mediated signaling pathway,BP,SOCS3
16333,GO:0071466,0.604925884347645,0.764858016740123,1,145,cellular response to xenobiotic stimulus,BP,GRIN1
8689,GO:0032870,0.606981356394054,0.592196390537057,4,621,cellular response to hormone stimulus,BP,IGFBP2;SPP1;ANXA1;SOCS3
2853,GO:0005938,0.607779442217147,0.66651780380528,2,280,cell cortex,CC,RIMS2;ANXA2
13050,GO:0048469,0.608231740114772,0.761826919393093,1,142,cell maturation,BP,KCNIP2
1367,GO:0003002,0.608816408971739,0.665382258462924,2,304,regionalization,BP,HOXA7;DSCAML1
9430,GO:0034614,0.610268170610018,0.759889480462791,1,147,cellular response to reactive oxygen species,BP,ANXA1
3330,GO:0006661,0.610909631186542,0.759384743287511,1,136,phosphatidylinositol biosynthetic process,BP,PLEKHA4
3334,GO:0006665,0.611455087490921,0.758755753157747,1,150,sphingolipid metabolic process,BP,ST8SIA3
13771,GO:0051235,0.611693300646384,0.662493792634708,2,286,maintenance of location,BP,JPH3;CXCL10
4804,GO:0010565,0.612433815209552,0.757861006808637,1,147,regulation of cellular ketone metabolic process,BP,ANXA1
9923,GO:0035725,0.612693844625927,0.757781110427424,1,129,sodium ion transmembrane transport,BP,SLC8A2
9657,GO:0035264,0.612840077503043,0.757623154752867,1,131,multicellular organism growth,BP,SLITRK1
12588,GO:0046661,0.612881291049923,0.757508233923033,1,139,male sex differentiation,BP,MMP14
11244,GO:0043409,0.613332067828579,0.757049129624649,1,143,negative regulation of MAPK cascade,BP,GBP1
14425,GO:0055086,0.614003750442189,0.584753635338213,4,670,nucleobase-containing small molecule metabolic process,BP,TYMP;ADM;NNMT;CXCL10
8903,GO:0033209,0.614955139018846,0.755381034380773,1,161,tumor necrosis factor-mediated signaling pathway,BP,TNFRSF12A
13112,GO:0048592,0.615396831520053,0.755201046999447,1,132,eye morphogenesis,BP,COL5A2
11481,GO:0044089,0.615842916030247,0.611429067277628,3,464,positive regulation of cellular component biogenesis,BP,SRPX2;CUX2;SLITRK1
2748,GO:0005769,0.615981705394654,0.658006655939141,2,307,early endosome,CC,ANXA1;ANXA2
12215,GO:0045862,0.617257801673239,0.656647259394777,2,320,positive regulation of proteolysis,BP,MMP14;GRIN1
21165,GO:2000045,0.62017079873634,0.750531447934146,1,145,regulation of G1/S transition of mitotic cell cycle,BP,ANXA1
13682,GO:0051100,0.620497585054247,0.750201121237698,1,147,negative regulation of binding,BP,CRTAC1
14980,GO:0060759,0.620733695399879,0.749958091924205,1,149,regulation of response to cytokine stimulus,BP,SOCS3
1063,GO:0002440,0.620815391245186,0.74984846355673,1,153,production of molecular mediator of immune response,BP,HLA-DQB1
13443,GO:0050731,0.622404528226913,0.748356605854673,1,148,positive regulation of peptidyl-tyrosine phosphorylation,BP,SOCS3
5172,GO:0014074,0.622751384955933,0.748099535605401,1,139,response to purine-containing compound,BP,COL1A1
19909,GO:1903827,0.622948887152629,0.603876192522479,3,476,regulation of cellular protein localization,BP,GBP1;KCNB1;SHISA7
623,GO:0001764,0.623125314248607,0.747826957500866,1,130,neuron migration,BP,COL3A1
12681,GO:0046890,0.623500453545428,0.747272909647027,1,151,regulation of lipid biosynthetic process,BP,ANXA1
10341,GO:0038023,0.623921414999856,0.554527536113372,5,817,signaling receptor activity,MF,GPR17;GABRG1;GABRB3;GRIN1;HLA-DQB1
14529,GO:0060089,0.623921414999856,0.554527536113372,5,817,molecular transducer activity,MF,GPR17;GABRG1;GABRB3;GRIN1;HLA-DQB1
12213,GO:0045860,0.624375952910751,0.602350202649294,3,478,positive regulation of protein kinase activity,BP,LTF;CHI3L1;MMD2
557,GO:0001655,0.62468143460864,0.64896897549023,2,294,urogenital system development,BP,ANXA1;COL4A1
3266,GO:0006575,0.625650526819118,0.745124589603103,1,159,cellular modified amino acid metabolic process,BP,PLA2G2A
6211,GO:0017111,0.62620932836467,0.552108843890495,5,764,nucleoside-triphosphatase activity,MF,ABCC3;GBP1;ANXA1;GNAL;TUBA1C
5679,GO:0016055,0.62747433393339,0.599043331960179,3,471,Wnt signaling pathway,BP,FERMT1;COL1A1;IGFBP2
9614,GO:0035148,0.627627666392463,0.743347081127399,1,140,tube formation,BP,ADM
11328,GO:0043549,0.627643556527756,0.550537488702536,5,801,regulation of kinase activity,BP,LTF;CHI3L1;MMD2;CXCL10;SOCS3
1211,GO:0002699,0.627892103451383,0.742940921541937,1,158,positive regulation of immune effector process,BP,ANXA1
2747,GO:0005768,0.628045948245497,0.550097550667316,5,810,endosome,CC,STEAP3;ANXA1;MMP14;HLA-DQB1;ANXA2
5072,GO:0010950,0.62996423173854,0.740933593106347,1,154,positive regulation of endopeptidase activity,BP,GRIN1
18540,GO:0198738,0.63028672428097,0.596014876454088,3,473,cell-cell signaling by wnt,BP,FERMT1;COL1A1;IGFBP2
7382,GO:0030509,0.634134686917403,0.736927394115383,1,139,BMP signaling pathway,BP,GDF15
5817,GO:0016331,0.634738696809133,0.736287711512585,1,143,morphogenesis of embryonic epithelium,BP,ADM
5301,GO:0015081,0.636296343542229,0.734766157909866,1,139,sodium ion transmembrane transporter activity,MF,SLC8A2
10056,GO:0035967,0.636643966724283,0.734272233800874,1,156,cellular response to topologically incorrect protein,BP,CCL2
6464,GO:0019216,0.637446606659886,0.635291676789421,2,322,regulation of lipid metabolic process,BP,ANXA1;SERPINA3
11061,GO:0043123,0.638711960290754,0.732159993745172,1,160,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,LTF
21813,GO:2001235,0.640885133450612,0.729930200417627,1,164,positive regulation of apoptotic signaling pathway,BP,TNFRSF12A
16590,GO:0071902,0.641170931743039,0.631249857096025,2,327,positive regulation of protein serine/threonine kinase activity,BP,LTF;CHI3L1
3570,GO:0007033,0.641867122757608,0.729021500168545,1,152,vacuole organization,BP,ANXA2
5805,GO:0016310,0.642261331637806,0.472280413553825,13,2076,phosphorylation,BP,LTF;SRPX2;CCL2;GBP1;GDF15;CHI3L1;MMD2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
2851,GO:0005929,0.642276896627429,0.582958500853375,3,480,cilium,CC,ANXA1;CDHR1;SHANK2
6514,GO:0019362,0.643868615854921,0.726937794127671,1,157,pyridine nucleotide metabolic process,BP,NNMT
12496,GO:0046496,0.643868615854921,0.726937794127671,1,157,nicotinamide nucleotide metabolic process,BP,NNMT
1946,GO:0004386,0.64479784690977,0.72610283162777,1,143,helicase activity,MF,ANXA1
3359,GO:0006694,0.644932296959679,0.725816803508746,1,161,steroid biosynthetic process,BP,ADM
13391,GO:0050673,0.647296840341858,0.624573432776718,2,323,epithelial cell proliferation,BP,FERMT1;MMP14
3509,GO:0006936,0.647574296810248,0.624285900048672,2,317,muscle contraction,BP,VIM;KCNIP2
19407,GO:1902806,0.648476299476057,0.722196315809503,1,156,regulation of cell cycle G1/S phase transition,BP,ANXA1
4841,GO:0010629,0.648632960142253,0.479294406661827,10,1630,negative regulation of gene expression,BP,VIM;IGF2BP2;FERMT1;SERPINE1;AEBP1;CUX2;KCNIP3;HOXA7;IGF2BP3;SERPING1
4827,GO:0010608,0.648908980459915,0.575596975117697,3,508,posttranscriptional regulation of gene expression,BP,VIM;IGF2BP2;IGF2BP3
3321,GO:0006650,0.649164485153417,0.622497122094138,2,331,glycerophospholipid metabolic process,BP,PLEKHA4;PLA2G2A
937,GO:0002221,0.649968078667869,0.720615082314729,1,160,pattern recognition receptor signaling pathway,BP,LTF
13680,GO:0051098,0.652872021976588,0.618391943526235,2,333,regulation of binding,BP,CRTAC1;ANXA2
4508,GO:0009408,0.655313927069348,0.715013558847271,1,159,response to heat,BP,CXCL10
13485,GO:0050796,0.655362145763669,0.714986107857698,1,156,regulation of insulin secretion,BP,KCNB1
10603,GO:0042176,0.655726690712745,0.615215501281633,2,333,regulation of protein catabolic process,BP,TIMP1;ANXA2
11479,GO:0044087,0.655878152867116,0.519594007367488,5,806,regulation of cellular component biogenesis,BP,SRPX2;CUX2;MMP14;GRIN1;SLITRK1
16919,GO:0072524,0.656180223503227,0.714074136810235,1,162,pyridine-containing compound metabolic process,BP,NNMT
11089,GO:0043170,0.657203456647296,0.419138184978028,52,8159,macromolecule metabolic process,BP,LTF;VIM;CP;CHI3L2;IGF2BP2;CHGB;APOL4;FERMT1;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;ADAM12;ADM;SERPING1;MMP14;C1R;S100A11;PTX3;CACNG2;ELFN2;COL3A1;CXCL10;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;CFI
10811,GO:0042594,0.658270497480669,0.711853043592455,1,162,response to starvation,BP,ADM
2773,GO:0005798,0.658686666516777,0.711409303327822,1,162,Golgi-associated vesicle,CC,HLA-DQB1
7452,GO:0030662,0.659132444858608,0.710933428597851,1,162,coated vesicle membrane,CC,HLA-DQB1
16512,GO:0071772,0.659282785811486,0.710869794821565,1,150,response to BMP,BP,GDF15
16513,GO:0071773,0.659282785811486,0.710869794821565,1,150,cellular response to BMP stimulus,BP,GDF15
14376,GO:0055001,0.659709633616052,0.710431214707242,1,148,muscle cell development,BP,ADM
7203,GO:0030177,0.661972207239417,0.707903462373113,1,160,positive regulation of Wnt signaling pathway,BP,COL1A1
6962,GO:0021915,0.662021873778014,0.707941246085792,1,149,neural tube development,BP,ADM
3538,GO:0006986,0.662271207991017,0.707508721001323,1,170,response to unfolded protein,BP,CCL2
5676,GO:0016052,0.66569795280585,0.703849082004626,1,163,carbohydrate catabolic process,BP,FUT9
13681,GO:0051099,0.665778938154168,0.703760987482482,1,163,positive regulation of binding,BP,ANXA2
9429,GO:0034613,0.667136985478181,0.458969931402994,10,1643,cellular protein localization,BP,COL1A1;KCNIP3;GBP1;KCNB1;CACNG2;RIMS2;GRIN1;ANXA2;SHISA7;RTP5
7373,GO:0030496,0.667233295246783,0.702198653578285,1,160,midbody,CC,ANXA2
3815,GO:0007601,0.667404948465357,0.701980579362373,1,164,visual perception,BP,COL1A1
11087,GO:0043168,0.668571068232528,0.434271957328855,16,2524,anion binding,MF,LTF;SNAP91;PLEKHA4;ABCC3;GBP1;POSTN;ANXA1;GNAL;FABP5;TUBA1C;CXCL10;KSR2;GRIN1;ST8SIA3;ANXA2;PLA2G2A
5872,GO:0016462,0.668586653382385,0.505318800458501,5,806,pyrophosphatase activity,MF,ABCC3;GBP1;ANXA1;GNAL;TUBA1C
6067,GO:0016817,0.670242249565823,0.503441275594726,5,808,hydrolase activity, acting on acid anhydrides,MF,ABCC3;GBP1;ANXA1;GNAL;TUBA1C
6068,GO:0016818,0.670242249565823,0.503441275594726,5,808,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,ABCC3;GBP1;ANXA1;GNAL;TUBA1C
7461,GO:0030674,0.672849823134037,0.695993087734655,1,163,protein binding, bridging,MF,ANXA1
3383,GO:0006733,0.67340537371567,0.69531105980864,1,172,oxidoreduction coenzyme metabolic process,BP,NNMT
361,GO:0000976,0.674380156702016,0.518222326746344,4,679,transcription regulatory region sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
15939,GO:0070727,0.674465791341766,0.45082567050945,10,1653,cellular macromolecule localization,BP,COL1A1;KCNIP3;GBP1;KCNB1;CACNG2;RIMS2;GRIN1;ANXA2;SHISA7;RTP5
13590,GO:0050953,0.674616146353793,0.693998911238104,1,167,sensory perception of light stimulus,BP,COL1A1
2697,GO:0005681,0.675731338912768,0.692665344317009,1,180,spliceosomal complex,CC,LGALS3
18299,GO:0101002,0.676123111991648,0.692239691198069,1,178,ficolin-1-rich granule,CC,LGALS3
18986,GO:1901654,0.677191447019566,0.691081962804808,1,172,response to ketone,BP,SPP1
5604,GO:0015893,0.677218291406118,0.691031370787159,1,175,drug transport,BP,ABCC3
20621,GO:1905330,0.679750443242274,0.688205378297062,1,171,regulation of morphogenesis of an epithelium,BP,CXCL10
6981,GO:0021953,0.68028192250325,0.687679008697913,1,161,central nervous system neuron differentiation,BP,MDGA2
4628,GO:0009898,0.680859157967585,0.686956809458421,1,170,cytoplasmic side of plasma membrane,CC,GNAL
2176,GO:0004721,0.681532520659383,0.686221697286503,1,166,phosphoprotein phosphatase activity,MF,PTPRT
11246,GO:0043412,0.681632367580093,0.405401938828925,24,3845,macromolecule modification,BP,LTF;CP;CHGB;TIMP1;CCL2;GBP1;SPP1;GDF15;CHI3L1;ANXA1;MMD2;MDGA2;GALNT13;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
17693,GO:0097305,0.682764697219328,0.684782521948126,1,171,response to alcohol,BP,GRIN1
11654,GO:0044448,0.683301508107473,0.684278511092389,1,157,cell cortex part,CC,RIMS2
4624,GO:0009894,0.683603917773019,0.488129134354305,5,852,regulation of catabolic process,BP,VIM;IGF2BP2;TIMP1;IGF2BP3;ANXA2
3928,GO:0008168,0.685162120956057,0.681972090703092,1,181,methyltransferase activity,MF,NNMT
13242,GO:0048839,0.686491272292816,0.680555671068216,1,165,inner ear development,BP,GABRB3
4621,GO:0009891,0.688673425444199,0.43488245105243,10,1673,positive regulation of biosynthetic process,BP,VIM;SERPINE1;CCL2;COL1A1;SPP1;HOXA7;ANXA1;PTX3;CXCL10;GRIN1
11536,GO:0044242,0.688904778110048,0.677627707206645,1,185,cellular lipid catabolic process,BP,FABP5
7480,GO:0030705,0.68904032782153,0.677656887622932,1,159,cytoskeleton-dependent intracellular transport,BP,TUBA1C
17634,GO:0097190,0.689445898521848,0.529114332932496,3,552,apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1;LGALS3
6470,GO:0019222,0.689863931850912,0.386455801608137,37,5893,regulation of metabolic process,BP,LTF;VIM;IGF2BP2;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;HOXA7;GDF15;CHI3L1;SPOCD1;ANXA1;IGF2BP3;MMD2;ADM;SERPING1;MMP14;C1R;S100A11;PTX3;ELFN2;CXCL10;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI
11358,GO:0043604,0.691325891065994,0.498492892844622,4,749,amide biosynthetic process,BP,VIM;IGF2BP2;IGF2BP3;ST8SIA3
18509,GO:0140097,0.693999185978226,0.671707605901181,1,180,catalytic activity, acting on DNA,MF,ANXA1
7841,GO:0031400,0.694284405374287,0.523392505614044,3,536,negative regulation of protein modification process,BP,GBP1;ELFN2;SOCS3
11556,GO:0044282,0.694816628319668,0.569793180009268,2,389,small molecule catabolic process,BP,TYMP;FUT9
12446,GO:0046394,0.695619666128409,0.568858568765974,2,374,carboxylic acid biosynthetic process,BP,RBP1;ANXA1
13198,GO:0048736,0.696608722384233,0.668742373836617,1,164,appendage development,BP,SMOC1
14579,GO:0060173,0.696608722384233,0.668742373836617,1,164,limb development,BP,SMOC1
9526,GO:0034764,0.696763120693775,0.668520649154489,1,169,positive regulation of transmembrane transport,BP,CXCL10
5677,GO:0016053,0.696889440872416,0.567324603619664,2,375,organic acid biosynthetic process,BP,RBP1;ANXA1
10279,GO:0036464,0.697459490623205,0.667629959906459,1,178,cytoplasmic ribonucleoprotein granule,CC,INA
6162,GO:0017016,0.697497502885689,0.519627190527419,3,486,Ras GTPase binding,MF,RIMS2;GRIN1;ANXA2
14122,GO:0051896,0.69808424657002,0.6669149272415,1,174,regulation of protein kinase B signaling,BP,CHI3L1
10055,GO:0035966,0.699999294628845,0.664537430759116,1,188,response to topologically incorrect protein,BP,CCL2
5662,GO:0016032,0.702898918536195,0.484800185624668,4,736,viral process,BP,LTF;VIM;CCL2;PTX3
17382,GO:0090316,0.703655382321939,0.660198515850154,1,179,positive regulation of intracellular protein transport,BP,KCNB1
3833,GO:0007623,0.705316341045465,0.658193033477142,1,178,circadian rhythm,BP,SERPINE1
17345,GO:0090276,0.7063502735529,0.656915226460251,1,181,regulation of peptide hormone secretion,BP,KCNB1
3289,GO:0006605,0.708411106485504,0.553209844453753,2,394,protein targeting,BP,KCNB1;RTP5
14022,GO:0051701,0.709347847091967,0.653203584089772,1,188,interaction with host,BP,PTX3
6018,GO:0016741,0.709543408565011,0.652932894965695,1,193,transferase activity, transferring one-carbon groups,MF,NNMT
4301,GO:0009057,0.709603111235217,0.432741737424035,7,1229,macromolecule catabolic process,BP,VIM;CHI3L2;IGF2BP2;TIMP1;CHI3L1;IGF2BP3;ANXA2
4080,GO:0008406,0.713255475653883,0.648409573351785,1,183,gonad development,BP,MMP14
21094,GO:1990837,0.713449887815299,0.472128765875476,4,715,sequence-specific double-stranded DNA binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
9071,GO:0033674,0.714684504552432,0.498679105717069,3,541,positive regulation of kinase activity,BP,LTF;CHI3L1;MMD2
9953,GO:0035770,0.715399288554223,0.645713102230567,1,187,ribonucleoprotein granule,CC,INA
14530,GO:0060090,0.71543374700028,0.645702877375774,1,182,molecular adaptor activity,MF,ANXA1
2765,GO:0005789,0.716780507491337,0.44901258092363,5,930,endoplasmic reticulum membrane,CC,LTF;MOXD1;JPH3;HLA-DQB1;PLA2G2A
5674,GO:0016050,0.717023725863578,0.542530752485847,2,370,vesicle organization,BP,ANXA1;ANXA2
13833,GO:0051338,0.717957378263313,0.447615209293596,5,896,regulation of transferase activity,BP,LTF;CHI3L1;MMD2;CXCL10;SOCS3
4640,GO:0009952,0.718279074053623,0.642126596773326,1,183,anterior/posterior pattern specification,BP,HOXA7
12737,GO:0046983,0.719093595147303,0.43229212149049,6,1103,protein dimerization activity,MF,TYMP;GBP1;ANXA1;KCNB1;S100A11;DSCAML1
3317,GO:0006643,0.719440103302108,0.6405350396734,1,204,membrane lipid metabolic process,BP,ST8SIA3
18072,GO:0098858,0.719747287355451,0.640337141772643,1,174,actin-based cell projection,CC,PDPN
18051,GO:0098827,0.720161902053202,0.444934664602398,5,934,endoplasmic reticulum subcompartment,CC,LTF;MOXD1;JPH3;HLA-DQB1;PLA2G2A
17926,GO:0098562,0.720362513441184,0.639442890916332,1,191,cytoplasmic side of membrane,CC,GNAL
4344,GO:0009117,0.720528454634033,0.491393936189237,3,587,nucleotide metabolic process,BP,ADM;NNMT;CXCL10
3850,GO:0008022,0.721175968888143,0.638462686794739,1,183,protein C-terminus binding,MF,VIM
11880,GO:0045137,0.721850801839577,0.637571938465252,1,188,development of primary sexual characteristics,BP,MMP14
849,GO:0002064,0.722271436116004,0.637096991022327,1,179,epithelial cell development,BP,VIM
5685,GO:0016071,0.722612394751788,0.460910646456889,4,771,mRNA metabolic process,BP,VIM;IGF2BP2;LGALS3;IGF2BP3
11357,GO:0043603,0.725187592771796,0.438828704132559,5,963,cellular amide metabolic process,BP,VIM;IGF2BP2;AEBP1;IGF2BP3;ST8SIA3
8688,GO:0032869,0.725427896284997,0.633003478827209,1,187,cellular response to insulin stimulus,BP,SOCS3
9344,GO:0034404,0.726865274658564,0.631084058544901,1,198,nucleobase-containing small molecule biosynthetic process,BP,TYMP
7112,GO:0030027,0.727091841364317,0.630935969944697,1,176,lamellipodium,CC,PDPN
3397,GO:0006753,0.727232937117319,0.483005552335416,3,594,nucleoside phosphate metabolic process,BP,ADM;NNMT;CXCL10
8994,GO:0033500,0.727347552472023,0.630484911933042,1,194,carbohydrate homeostasis,BP,KCNB1
10810,GO:0042593,0.727347552472023,0.630484911933042,1,194,glucose homeostasis,BP,KCNB1
750,GO:0001933,0.728003858710392,0.528541848242877,2,387,negative regulation of protein phosphorylation,BP,GBP1;SOCS3
10824,GO:0042623,0.72810271010572,0.528508190119346,2,348,ATPase activity, coupled,MF,ABCC3;ANXA1
11649,GO:0044441,0.728445658204945,0.528014686642027,2,369,ciliary part,CC,CDHR1;SHANK2
5675,GO:0016051,0.729503420056001,0.627637136082137,1,203,carbohydrate biosynthetic process,BP,GALNT13
17666,GO:0097237,0.730351930880662,0.626526605125822,1,204,cellular response to toxic substance,BP,ANXA1
10566,GO:0042113,0.730426162264549,0.626469919226771,1,197,B cell activation,BP,MMP14
4659,GO:0010001,0.731170287639276,0.625541656166824,1,190,glial cell differentiation,BP,VIM
13442,GO:0050730,0.732892029952637,0.623213900346563,1,202,regulation of peptidyl-tyrosine phosphorylation,BP,SOCS3
10602,GO:0042175,0.735296685163683,0.426463262777642,5,947,nuclear outer membrane-endoplasmic reticulum membrane network,CC,LTF;MOXD1;JPH3;HLA-DQB1;PLA2G2A
11347,GO:0043583,0.73575403466712,0.619506039370445,1,191,ear development,BP,GABRB3
7233,GO:0030217,0.740206425197352,0.613494770120457,1,204,T cell differentiation,BP,ANXA1
11060,GO:0043122,0.741257967531881,0.612060088314813,1,208,regulation of I-kappaB kinase/NF-kappaB signaling,BP,LTF
18508,GO:0140096,0.743352459642519,0.362435592074852,12,2047,catalytic activity, acting on a protein,MF,LTF;AEBP1;CCL2;PLAU;MMD2;GALNT13;ADAM12;MMP14;C1R;KSR2;PTPRT;CFI
59,GO:0000122,0.743446244804255,0.434961390664871,4,746,negative regulation of transcription by RNA polymerase II,BP,AEBP1;CUX2;KCNIP3;HOXA7
3212,GO:0006518,0.74464880463264,0.433397187955674,4,803,peptide metabolic process,BP,VIM;IGF2BP2;AEBP1;IGF2BP3
3746,GO:0007389,0.746166989616173,0.50476768878862,2,390,pattern specification process,BP,HOXA7;DSCAML1
7760,GO:0031267,0.747429070656762,0.457267128980271,3,528,small GTPase binding,MF,RIMS2;GRIN1;ANXA2
18967,GO:1901617,0.748350564446944,0.602387214055665,1,214,organic hydroxy compound biosynthetic process,BP,MOXD1
6497,GO:0019318,0.750085749116392,0.600024839047666,1,209,hexose metabolic process,BP,FUT9
1374,GO:0003012,0.754781837406757,0.493180986840583,2,390,muscle system process,BP,VIM;KCNIP2
3433,GO:0006814,0.755088822125448,0.593138742845372,1,197,sodium ion transport,BP,SLC8A2
18943,GO:1901565,0.756397219693499,0.386715230378213,6,1129,organonitrogen compound catabolic process,BP,TYMP;CHI3L2;MOXD1;TIMP1;CHI3L1;ANXA2
17070,GO:0080090,0.75649459518753,0.314412245827651,33,5408,regulation of primary metabolic process,BP,LTF;VIM;IGF2BP2;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;HOXA7;GDF15;CHI3L1;ANXA1;IGF2BP3;MMD2;ADM;SERPING1;MMP14;C1R;S100A11;PTX3;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI
3630,GO:0007163,0.757793911718351,0.589341459491079,1,196,establishment or maintenance of cell polarity,BP,FERMT1
3318,GO:0006644,0.759906254728102,0.486140574672027,2,414,phospholipid metabolic process,BP,PLEKHA4;PLA2G2A
4336,GO:0009108,0.761053414171068,0.584577465137743,1,221,coenzyme biosynthetic process,BP,NNMT
13996,GO:0051649,0.762647317012214,0.343600382892445,11,1938,establishment of localization in cell,BP,KCNIP3;CPLX2;JPH3;KCNB1;CACNG2;TUBA1C;CXCL10;RIMS2;GRIN1;ANXA2;RTP5
13730,GO:0051171,0.765613365437595,0.304579841894914,32,5276,regulation of nitrogen compound metabolic process,BP,LTF;VIM;IGF2BP2;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;HOXA7;GDF15;CHI3L1;IGF2BP3;MMD2;ADM;SERPING1;MMP14;C1R;S100A11;PTX3;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI
21207,GO:2000113,0.76578654327145,0.36477122232804,7,1278,negative regulation of cellular macromolecule biosynthetic process,BP,IGF2BP2;AEBP1;CUX2;KCNIP3;HOXA7;IGF2BP3;S100A11
10669,GO:0042326,0.769062259334483,0.473447423489273,2,420,negative regulation of phosphorylation,BP,GBP1;SOCS3
16131,GO:0071103,0.770552105482892,0.570844199098096,1,221,DNA conformation change,BP,ANXA1
19666,GO:1903362,0.7707713247688,0.570527724628617,1,220,regulation of cellular protein catabolic process,BP,ANXA2
13268,GO:0048872,0.775071074435542,0.56415263448053,1,225,homeostasis of number of cells,BP,ANXA1
3138,GO:0006412,0.77696769686336,0.417717930531189,3,651,translation,BP,VIM;IGF2BP2;IGF2BP3
11635,GO:0044422,0.778305099727285,0.285768248947599,51,8301,organelle part,CC,LTF;VIM;CP;MOXD1;CHGB;FERMT1;TIMP1;SERPINE1;COL1A1;CUX2;RBP1;STEAP3;GBP1;SPP1;HOXA7;PLAU;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;COL6A2;GALNT13;CDHR1;INA;ADAM12;SERPING1;JPH3;MMP14;SHANK2;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;COL3A1;PCDH7;FUT9;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;COL5A2;IFI30
13673,GO:0051091,0.778461862939308,0.559081704590926,1,226,positive regulation of DNA binding transcription factor activity,BP,LTF
14627,GO:0060255,0.779428263255219,0.288166557303387,33,5463,regulation of macromolecule metabolic process,BP,LTF;VIM;IGF2BP2;FERMT1;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;HOXA7;GDF15;CHI3L1;IGF2BP3;MMD2;SERPING1;MMP14;C1R;S100A11;PTX3;ELFN2;CXCL10;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI
2668,GO:0005635,0.780435366257254,0.457345110626248,2,420,nuclear envelope,CC,HOXA7;INA
13260,GO:0048863,0.781129214605591,0.555026446503502,1,233,stem cell differentiation,BP,HOXA7
4376,GO:0009152,0.783874082002779,0.550844155547276,1,235,purine ribonucleotide biosynthetic process,BP,ADM
3476,GO:0006886,0.784744052553017,0.363408467624437,5,1001,intracellular protein transport,BP,KCNIP3;KCNB1;CACNG2;RIMS2;RTP5
1604,GO:0003690,0.784773593948614,0.380944288803303,4,793,double-stranded DNA binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
13842,GO:0051347,0.784785527806313,0.406974682729754,3,612,positive regulation of transferase activity,BP,LTF;CHI3L1;MMD2
2888,GO:0005996,0.785294884895005,0.548674884598473,1,234,monosaccharide metabolic process,BP,FUT9
7802,GO:0031328,0.785348479239796,0.32581143439655,9,1652,positive regulation of cellular biosynthetic process,BP,VIM;SERPINE1;COL1A1;SPP1;HOXA7;ANXA1;PTX3;CXCL10;GRIN1
4510,GO:0009410,0.78537645091408,0.548545205945701,1,235,response to xenobiotic stimulus,BP,GRIN1
14001,GO:0051656,0.786962535197146,0.447918720734236,2,422,establishment of organelle localization,BP,CPLX2;RIMS2
9401,GO:0034504,0.787295868059346,0.545635583794052,1,226,protein localization to nucleus,BP,COL1A1
4374,GO:0009150,0.787412045220117,0.447215801817241,2,450,purine ribonucleotide metabolic process,BP,ADM;CXCL10
3177,GO:0006469,0.788403732224942,0.543875967876369,1,236,negative regulation of protein kinase activity,BP,SOCS3
2988,GO:0006164,0.788852422604549,0.543167388751539,1,239,purine nucleotide biosynthetic process,BP,ADM
3687,GO:0007249,0.790868429260879,0.540023576594883,1,241,I-kappaB kinase/NF-kappaB signaling,BP,LTF
9284,GO:0034329,0.791806739645025,0.538685694549417,1,215,cell junction assembly,BP,MMP14
13988,GO:0051640,0.791948713875627,0.396959625978607,3,613,organelle localization,BP,CPLX2;KCNB1;RIMS2
14444,GO:0055114,0.792556008899239,0.37033414449092,4,870,oxidation-reduction process,BP,CP;MOXD1;STEAP3;IFI30
7902,GO:0031503,0.792863814872876,0.53693771559699,1,233,protein-containing complex localization,BP,CACNG2
11022,GO:0043043,0.79442355941623,0.393414995564098,3,671,peptide biosynthetic process,BP,VIM;IGF2BP2;IGF2BP3
40,GO:0000082,0.796534079489624,0.531112108592035,1,240,G1/S transition of mitotic cell cycle,BP,ANXA1
3795,GO:0007548,0.797007547137516,0.530401539700876,1,231,sex differentiation,BP,MMP14
17471,GO:0090596,0.797573171527781,0.529521061592969,1,227,sensory organ morphogenesis,BP,COL5A2
1253,GO:0002758,0.798074681720152,0.528638537880366,1,245,innate immune response-activating signal transduction,BP,LTF
6050,GO:0016791,0.798618226439209,0.52781071473969,1,236,phosphatase activity,MF,PTPRT
2141,GO:0004672,0.799098944361465,0.386847936725994,3,596,protein kinase activity,MF,CCL2;MMD2;KSR2
4461,GO:0009260,0.800434116141002,0.524847922414633,1,248,ribonucleotide biosynthetic process,BP,ADM
11925,GO:0045216,0.801527793849353,0.523198677265416,1,224,cell-cell junction organization,BP,MMP14
4460,GO:0009259,0.801551080852747,0.426285560220727,2,465,ribonucleotide metabolic process,BP,ADM;CXCL10
16275,GO:0071383,0.80249592872018,0.521567280094367,1,238,cellular response to steroid hormone stimulus,BP,ANXA1
16917,GO:0072522,0.80253965385021,0.521444452939825,1,250,purine-containing compound biosynthetic process,BP,ADM
11519,GO:0044212,0.802759680383187,0.356315226051463,4,810,transcription regulatory region DNA binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
17356,GO:0090287,0.802801290463909,0.521110868894387,1,230,regulation of cellular response to growth factor stimulus,BP,FERMT1
2987,GO:0006163,0.803177634014191,0.423834377810782,2,467,purine nucleotide metabolic process,BP,ADM;CXCL10
399,GO:0001067,0.803668935219112,0.355050562202743,4,811,regulatory region nucleic acid binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
8871,GO:0033157,0.803812353297257,0.51942438533799,1,240,regulation of intracellular protein transport,BP,KCNB1
12444,GO:0046390,0.803865795473563,0.519290331747289,1,251,ribose phosphate biosynthetic process,BP,ADM
6592,GO:0019637,0.80434071838216,0.337157616702787,5,1039,organophosphate metabolic process,BP,PLEKHA4;ADM;NNMT;CXCL10;PLA2G2A
4797,GO:0010558,0.804540911838435,0.315146284337532,7,1339,negative regulation of macromolecule biosynthetic process,BP,IGF2BP2;AEBP1;CUX2;KCNIP3;HOXA7;IGF2BP3;S100A11
7797,GO:0031323,0.804541680308846,0.258931956770706,33,5530,regulation of cellular metabolic process,BP,LTF;VIM;IGF2BP2;TIMP1;SRPX2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;HOXA7;GDF15;CHI3L1;SPOCD1;ANXA1;IGF2BP3;MMD2;ADM;SERPING1;MMP14;S100A11;PTX3;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3
4840,GO:0010628,0.806303808954603,0.299235226221296,9,1676,positive regulation of gene expression,BP,VIM;SERPINE1;COL1A1;CUX2;SPP1;HOXA7;CXCL10;RIMS2;GRIN1
9070,GO:0033673,0.807040038262904,0.51411137705522,1,250,negative regulation of kinase activity,BP,SOCS3
6111,GO:0016887,0.807308503558184,0.417680955898341,2,407,ATPase activity,MF,ABCC3;ANXA1
13119,GO:0048609,0.809972926948131,0.371124394709616,3,651,multicellular organismal reproductive process,BP,SPP1;ANXA1;GRIN1
19310,GO:1902532,0.810034269267814,0.413427451682228,2,458,negative regulation of intracellular signal transduction,BP,GBP1;SOCS3
16492,GO:0071704,0.810115469643602,0.250070652289302,58,9506,organic substance metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;IGF2BP2;MOXD1;CHGB;APOL4;FERMT1;TIMP1;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;IGFBP2;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;ADAM12;ADM;SERPING1;MMP14;C1R;S100A11;PTX3;FABP5;NNMT;CACNG2;ELFN2;COL3A1;CXCL10;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;CFI
9423,GO:0034599,0.810367194177649,0.508589723374258,1,258,cellular response to oxidative stress,BP,ANXA1
17199,GO:0090068,0.810870541208627,0.507812131078626,1,244,positive regulation of cell cycle process,BP,ANXA1
11769,GO:0044843,0.812902418672765,0.504391488880007,1,252,cell cycle G1/S phase transition,BP,ANXA1
6601,GO:0019693,0.814167396205938,0.407033509789235,2,479,ribose phosphate metabolic process,BP,ADM;CXCL10
11652,GO:0044446,0.814573308774965,0.243731964310651,49,8105,intracellular organelle part,CC,LTF;VIM;CP;MOXD1;CHGB;FERMT1;TIMP1;SERPINE1;COL1A1;CUX2;RBP1;STEAP3;GBP1;SPP1;HOXA7;PLAU;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;MMD2;COL6A2;GALNT13;INA;ADAM12;SERPING1;JPH3;MMP14;SHANK2;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;COL3A1;PCDH7;FUT9;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;COL5A2;IFI30
8460,GO:0032504,0.815649631819914,0.362805747378527,3,659,multicellular organism reproduction,BP,SPP1;ANXA1;GRIN1
16588,GO:0071900,0.815787660455763,0.404543468099652,2,465,regulation of protein serine/threonine kinase activity,BP,LTF;CHI3L1
17723,GO:0097367,0.817119640764336,0.276072372603471,11,1979,carbohydrate derivative binding,MF,LTF;CHI3L2;ABCC3;GBP1;CHI3L1;POSTN;GNAL;TUBA1C;CXCL10;KSR2;ST8SIA3
9547,GO:0034976,0.817428295151921,0.496735313637575,1,260,response to endoplasmic reticulum stress,BP,CCL2
935,GO:0002218,0.821808236027578,0.489241300215162,1,262,activation of innate immune response,BP,LTF
404,GO:0001077,0.824966262290882,0.483799846157409,1,256,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HOXA7
16916,GO:0072521,0.827204540630766,0.386532042442531,2,494,purine-containing compound metabolic process,BP,ADM;CXCL10
13989,GO:0051641,0.828537986735301,0.252123373578301,14,2541,cellular localization,BP,COL1A1;KCNIP3;GBP1;CPLX2;JPH3;KCNB1;CACNG2;TUBA1C;CXCL10;RIMS2;GRIN1;ANXA2;SHISA7;RTP5
21111,GO:1990904,0.828608552302955,0.343432385173742,3,717,ribonucleoprotein complex,CC,VIM;LGALS3;INA
2414,GO:0005088,0.829202432348985,0.476475892691749,1,234,Ras guanyl-nucleotide exchange factor activity,MF,GRIN1
13744,GO:0051188,0.82987073406379,0.475129960518339,1,274,cofactor biosynthetic process,BP,NNMT
3862,GO:0008047,0.829986025155551,0.382120395179882,2,465,enzyme activator activity,MF,LTF;MMP14
11427,GO:0043933,0.830136725705984,0.263383856358797,10,1932,protein-containing complex subunit organization,BP,SNAP91;COL1A1;GBP1;COL6A2;KCNB1;COL3A1;GRIN1;ANXA2;PLA2G2A;COL5A2
18261,GO:0099568,0.831853145732757,0.379155963879292,2,439,cytoplasmic region,CC,RIMS2;ANXA2
6698,GO:0019904,0.83204432967477,0.338273532550568,3,653,protein domain specific binding,MF,VIM;ADAM12;SHANK2
4796,GO:0010557,0.832405843136208,0.270886024405774,8,1558,positive regulation of macromolecule biosynthetic process,BP,VIM;SERPINE1;CCL2;COL1A1;SPP1;HOXA7;CXCL10;GRIN1
3755,GO:0007411,0.833102568446626,0.469540034460858,1,236,axon guidance,BP,TNR
13843,GO:0051348,0.8345349914735,0.466813164662437,1,275,negative regulation of transferase activity,BP,SOCS3
17784,GO:0097485,0.835323463500977,0.465545411758119,1,238,neuron projection guidance,BP,TNR
13627,GO:0051020,0.835444707003643,0.333109157846521,3,622,GTPase binding,MF,RIMS2;GRIN1;ANXA2
5469,GO:0015629,0.838975215465348,0.36753423420283,2,454,actin cytoskeleton,CC,FERMT1;ANXA1
7801,GO:0031327,0.839108916107179,0.268689595310189,7,1402,negative regulation of cellular biosynthetic process,BP,IGF2BP2;AEBP1;CUX2;KCNIP3;HOXA7;IGF2BP3;S100A11
8775,GO:0032991,0.83951696939479,0.22137842621625,26,4539,protein-containing complex,CC,LTF;VIM;FERMT1;COL1A1;KCNIP3;KCNIP2;LGALS3;EMILIN2;COL4A2;GNAL;COL6A2;CPLX2;INA;JPH3;KCNB1;SHANK2;GABRG1;GABRB3;CACNG2;COL3A1;GRIN1;HLA-DQB1;ANXA2;COL4A1;SHISA7;COL5A2
3038,GO:0006260,0.840136265478653,0.456657343035315,1,274,DNA replication,BP,S100A11
2936,GO:0006066,0.842326389712496,0.452607077708286,1,281,alcohol metabolic process,BP,MOXD1
4514,GO:0009416,0.842407809758729,0.4524775819034,1,275,response to light stimulus,BP,GRIN1
13840,GO:0051345,0.843590124148111,0.320468243170449,3,680,positive regulation of hydrolase activity,BP,CCL2;MMP14;GRIN1
9285,GO:0034330,0.846681250815794,0.4446030801728,1,256,cell junction organization,BP,MMP14
4620,GO:0009890,0.848391662989124,0.25581756836163,7,1422,negative regulation of biosynthetic process,BP,IGF2BP2;AEBP1;CUX2;KCNIP3;HOXA7;IGF2BP3;S100A11
16165,GO:0071214,0.85032123396931,0.437622866582468,1,288,cellular response to abiotic stimulus,BP,COL1A1
18381,GO:0104004,0.85032123396931,0.437622866582468,1,288,cellular response to environmental stimulus,BP,COL1A1
16628,GO:0072001,0.851291615136599,0.435870513338442,1,262,renal system development,BP,COL4A1
8639,GO:0032787,0.853341367964673,0.34339068677067,2,530,monocarboxylic acid metabolic process,BP,RBP1;ANXA1
12689,GO:0046907,0.85375035884085,0.241781060940335,8,1614,intracellular transport,BP,KCNIP3;CPLX2;KCNB1;CACNG2;TUBA1C;RIMS2;ANXA2;RTP5
16269,GO:0071375,0.855907877945041,0.426936364693223,1,281,cellular response to peptide hormone stimulus,BP,SOCS3
6316,GO:0018209,0.862469668917049,0.414062969624472,1,285,peptidyl-serine modification,BP,GALNT13
8272,GO:0032259,0.865823128400899,0.407307297593103,1,305,methylation,BP,NNMT
11040,GO:0043085,0.865942598377008,0.238828027219583,6,1274,positive regulation of catalytic activity,BP,LTF;CCL2;CHI3L1;MMD2;MMP14;GRIN1
7113,GO:0030029,0.866079698256507,0.284525590401645,3,674,actin filament-based process,BP,VIM;ANXA1;PDPN
11851,GO:0045089,0.866331193265069,0.406282921310677,1,306,positive regulation of innate immune response,BP,LTF
3993,GO:0008270,0.869047144504773,0.279613374393854,3,715,zinc ion binding,MF,TIMP1;AEBP1;MMP14
11539,GO:0044248,0.871953396860343,0.207159985372719,10,2055,cellular catabolic process,BP,TYMP;VIM;CHI3L2;IGF2BP2;MOXD1;TIMP1;CHI3L1;IGF2BP3;FABP5;ANXA2
8219,GO:0032147,0.872945877497946,0.392810978260271,1,303,activation of protein kinase activity,BP,CHI3L1
1613,GO:0003712,0.874256949396716,0.306702431340218,2,527,transcription cofactor activity,MF,AEBP1;KCNIP3
3308,GO:0006631,0.874397177313791,0.389744590114996,1,326,fatty acid metabolic process,BP,ANXA1
3780,GO:0007507,0.874916729217163,0.305554810947509,2,490,heart development,BP,ADM;COL3A1
11544,GO:0044260,0.87805915351171,0.167601724394068,43,7344,cellular macromolecule metabolic process,BP,LTF;VIM;CP;IGF2BP2;CHGB;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;GBP1;SPP1;HOXA7;GDF15;CHI3L1;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;ADM;SERPING1;MMP14;S100A11;PTX3;CACNG2;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
9895,GO:0035690,0.878979817242752,0.380181326519448,1,313,cellular response to drug,BP,ANXA1
2322,GO:0004930,0.88006103300986,0.377807579244654,1,347,G-protein coupled receptor activity,MF,GPR17
3426,GO:0006807,0.882368370522606,0.162123185123588,52,8813,nitrogen compound metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;IGF2BP2;MOXD1;CHGB;APOL4;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;ADAM12;ADM;SERPING1;MMP14;C1R;S100A11;PTX3;NNMT;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;CFI
8121,GO:0031974,0.886893225823807,0.162055817767548,26,4759,membrane-enclosed lumen,CC,LTF;CP;CHGB;TIMP1;SERPINE1;COL1A1;RBP1;SPP1;HOXA7;CHI3L1;COL4A2;ANXA1;COL6A2;INA;ADAM12;SERPING1;MMP14;S100A11;PTX3;FABP5;COL3A1;ANXA2;COL4A1;SERPINA3;COL5A2;IFI30
11135,GO:0043233,0.886893225823807,0.162055817767548,26,4759,organelle lumen,CC,LTF;CP;CHGB;TIMP1;SERPINE1;COL1A1;RBP1;SPP1;HOXA7;CHI3L1;COL4A2;ANXA1;COL6A2;INA;ADAM12;SERPING1;MMP14;S100A11;PTX3;FABP5;COL3A1;ANXA2;COL4A1;SERPINA3;COL5A2;IFI30
15532,GO:0070013,0.886893225823807,0.162055817767548,26,4759,intracellular organelle lumen,CC,LTF;CP;CHGB;TIMP1;SERPINE1;COL1A1;RBP1;SPP1;HOXA7;CHI3L1;COL4A2;ANXA1;COL6A2;INA;ADAM12;SERPING1;MMP14;S100A11;PTX3;FABP5;COL3A1;ANXA2;COL4A1;SERPINA3;COL5A2;IFI30
6035,GO:0016773,0.887423681112931,0.248578400950467,3,720,phosphotransferase activity, alcohol group as acceptor,MF,CCL2;MMD2;KSR2
10797,GO:0042578,0.888814154823754,0.358960261614157,1,321,phosphoric ester hydrolase activity,MF,PTPRT
8117,GO:0031966,0.890013896008016,0.277483999723678,2,618,mitochondrial membrane,CC,LGALS3;ANXA1
18985,GO:1901653,0.891561115982066,0.352884058976515,1,321,cellular response to peptide,BP,SOCS3
3382,GO:0006732,0.891755318256813,0.352387558761633,1,348,coenzyme metabolic process,BP,NNMT
19911,GO:1903829,0.89279187700455,0.350126123408818,1,326,positive regulation of cellular protein localization,BP,KCNB1
12225,GO:0045893,0.89414719776363,0.196361111395878,6,1329,positive regulation of transcription, DNA-templated,BP,SERPINE1;COL1A1;SPP1;HOXA7;CXCL10;GRIN1
19735,GO:1903508,0.89414719776363,0.196361111395878,6,1329,positive regulation of nucleic acid-templated transcription,BP,SERPINE1;COL1A1;SPP1;HOXA7;CXCL10;GRIN1
19365,GO:1902680,0.894496981913819,0.195819742713417,6,1330,positive regulation of RNA biosynthetic process,BP,SERPINE1;COL1A1;SPP1;HOXA7;CXCL10;GRIN1
6287,GO:0018108,0.895909104780551,0.343089032555844,1,334,peptidyl-tyrosine phosphorylation,BP,SOCS3
6319,GO:0018212,0.897896201273527,0.338559248155681,1,337,peptidyl-tyrosine modification,BP,SOCS3
12176,GO:0045787,0.898036347018481,0.338241127443658,1,336,positive regulation of cell cycle,BP,ANXA1
2411,GO:0005085,0.899453687138421,0.335069010892945,1,305,guanyl-nucleotide exchange factor activity,MF,GRIN1
8118,GO:0031967,0.904437896646602,0.200580514245919,4,1053,organelle envelope,CC,HOXA7;LGALS3;ANXA1;INA
8122,GO:0031975,0.904437896646602,0.200580514245919,4,1053,envelope,CC,HOXA7;LGALS3;ANXA1;INA
12946,GO:0048193,0.904782031171276,0.322582096184016,1,335,Golgi vesicle transport,BP,CUX2
11534,GO:0044238,0.904927652050894,0.13390566620275,54,9218,primary metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;IGF2BP2;CHGB;APOL4;TIMP1;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;IGFBP2;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;ADAM12;ADM;SERPING1;MMP14;C1R;S100A11;PTX3;FABP5;NNMT;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;CFI
366,GO:0000981,0.905958462850906,0.197998948378359,4,1002,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
2724,GO:0005740,0.907025124427978,0.24435102759742,2,654,mitochondrial envelope,CC,LGALS3;ANXA1
4849,GO:0010638,0.908289219808533,0.241865513142797,2,587,positive regulation of organelle organization,BP,ANXA1;ANXA2
2803,GO:0005856,0.909040424888198,0.157687449440797,9,1846,cytoskeleton,CC,VIM;IGF2BP2;FERMT1;ANXA1;INA;MMP14;SHANK2;TUBA1C;RIMS2
11547,GO:0044265,0.910745322180535,0.189746525342332,4,1024,cellular macromolecule catabolic process,BP,VIM;IGF2BP2;IGF2BP3;ANXA2
17079,GO:0080135,0.912415965503277,0.233494459584324,2,602,regulation of cellular response to stress,BP,TNR;SPP1
13653,GO:0051052,0.912715531897176,0.303487902709804,1,358,regulation of DNA metabolic process,BP,S100A11
11555,GO:0044281,0.912815582745898,0.155935445193797,8,1868,small molecule metabolic process,BP,TYMP;MOXD1;RBP1;ANXA1;ADM;NNMT;CXCL10;FUT9
1638,GO:0003824,0.913975872214738,0.125751193352837,28,5189,catalytic activity,MF,LTF;TYMP;CP;CHI3L2;MOXD1;AEBP1;CCL2;ABCC3;STEAP3;GBP1;PLAU;CHI3L1;ANXA1;MMD2;GNAL;GALNT13;ADAM12;MMP14;C1R;NNMT;TUBA1C;KSR2;FUT9;ST8SIA3;PLA2G2A;PTPRT;CFI;IFI30
11339,GO:0043565,0.914001256779679,0.184079089855167,4,1019,sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3;HOXA7
7034,GO:0022607,0.914071911344614,0.13977861964222,13,2621,cellular component assembly,BP,SNAP91;SRPX2;COL1A1;CUX2;GBP1;COL6A2;EMP3;MMP14;KCNB1;SHANK2;GRIN1;SLITRK1;ANXA2
11485,GO:0044093,0.914989328279855,0.157364679076776,7,1577,positive regulation of molecular function,BP,LTF;CCL2;CHI3L1;MMD2;MMP14;GRIN1;ANXA2
14837,GO:0060537,0.915729203115308,0.296096016513419,1,343,muscle tissue development,BP,COL3A1
5800,GO:0016301,0.916166598337579,0.196853569983282,3,784,kinase activity,MF,CCL2;MMD2;KSR2
11129,GO:0043227,0.916379613355022,0.12177039261315,66,11041,membrane-bounded organelle,CC,LTF;VIM;CP;SNAP91;IGF2BP2;MOXD1;CHGB;CRTAC1;APOL4;TIMP1;SERPINE1;AEBP1;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;GNAL;COL6A2;GALNT13;CPLX2;CDHR1;INA;ADAM12;SERPING1;SPHKAP;JPH3;MMP14;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;COL3A1;PCDH7;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;COL5A2;CFI;IFI30
8760,GO:0032970,0.916391475639826,0.29444362317493,1,346,regulation of actin filament-based process,BP,PDPN
371,GO:0000989,0.91734132366154,0.223356461108408,2,599,transcription factor activity, transcription factor binding,MF,AEBP1;KCNIP3
19101,GO:1901990,0.917940694426916,0.290513670949411,1,376,regulation of mitotic cell cycle phase transition,BP,ANXA1
13672,GO:0051090,0.91892718244006,0.288033295116865,1,376,regulation of DNA binding transcription factor activity,BP,LTF
12257,GO:0045935,0.918955078287554,0.151090424956784,7,1589,positive regulation of nucleobase-containing compound metabolic process,BP,SERPINE1;COL1A1;SPP1;HOXA7;ADM;CXCL10;GRIN1
370,GO:0000988,0.919139822568652,0.219604303630184,2,603,transcription factor activity, protein binding,MF,AEBP1;KCNIP3
13785,GO:0051254,0.920055593982598,0.155136398279561,6,1398,positive regulation of RNA metabolic process,BP,SERPINE1;COL1A1;SPP1;HOXA7;CXCL10;GRIN1
2727,GO:0005743,0.922635425759805,0.278507965384429,1,435,mitochondrial inner membrane,CC,LGALS3
461,GO:0001228,0.92293036475478,0.277835414019606,1,379,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,HOXA7
12264,GO:0045944,0.923375750607136,0.167462697462948,4,1028,positive regulation of transcription by RNA polymerase II,BP,SERPINE1;HOXA7;CXCL10;GRIN1
11326,GO:0043547,0.924464005925391,0.273906044665833,1,362,positive regulation of GTPase activity,BP,CCL2
12224,GO:0045892,0.924515542160343,0.165407187368731,4,1044,negative regulation of transcription, DNA-templated,BP,AEBP1;CUX2;KCNIP3;HOXA7
11641,GO:0044430,0.925591037046629,0.146006313107507,6,1378,cytoskeletal part,CC,VIM;FERMT1;ANXA1;INA;SHANK2;TUBA1C
4063,GO:0008380,0.926241700278401,0.26920237195844,1,405,RNA splicing,BP,LGALS3
15517,GO:0065003,0.927149173606907,0.137937149206766,7,1652,protein-containing complex assembly,BP,SNAP91;COL1A1;GBP1;COL6A2;KCNB1;GRIN1;ANXA2
12736,GO:0046982,0.928124492674799,0.26425376320485,1,403,protein heterodimerization activity,MF,KCNB1
3554,GO:0007010,0.929650240981729,0.146272308592116,5,1179,cytoskeleton organization,BP,VIM;CCL2;ANXA1;INA;TUBA1C
19098,GO:1901987,0.929959619051608,0.259383608002853,1,400,regulation of cell cycle phase transition,BP,ANXA1
6048,GO:0016788,0.93278938035621,0.190236927461051,2,660,hydrolase activity, acting on ester bonds,MF,PLA2G2A;PTPRT
19734,GO:1903507,0.935853966857934,0.144594278097194,4,1081,negative regulation of nucleic acid-templated transcription,BP,AEBP1;CUX2;KCNIP3;HOXA7
19364,GO:1902679,0.936336883587945,0.143690656779034,4,1083,negative regulation of RNA biosynthetic process,BP,AEBP1;CUX2;KCNIP3;HOXA7
4302,GO:0009058,0.936787215751612,0.0941766814838163,31,5810,biosynthetic process,BP,LTF;TYMP;VIM;IGF2BP2;MOXD1;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;ANXA1;IGF2BP3;MDGA2;GALNT13;ADM;S100A11;PTX3;NNMT;CXCL10;FUT9;GRIN1;ST8SIA3;PLA2G2A
12256,GO:0045934,0.936913848311963,0.133449990199864,5,1282,negative regulation of nucleobase-containing compound metabolic process,BP,AEBP1;CUX2;KCNIP3;HOXA7;S100A11
13196,GO:0048732,0.937007468739624,0.240199603792121,1,396,gland development,BP,ANXA1
2814,GO:0005874,0.938449621934442,0.236203243726641,1,379,microtubule,CC,TUBA1C
1618,GO:0003723,0.939231473671123,0.122894365658553,6,1531,RNA binding,MF,VIM;IGF2BP2;LGALS3;ANXA1;IGF2BP3;ANXA2
11540,GO:0044249,0.940929948856028,0.088808822494794,30,5674,cellular biosynthetic process,BP,LTF;TYMP;VIM;IGF2BP2;MOXD1;PLEKHA4;SERPINE1;AEBP1;COL1A1;CUX2;RBP1;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;ANXA1;IGF2BP3;MDGA2;GALNT13;ADM;S100A11;PTX3;NNMT;CXCL10;FUT9;GRIN1;ST8SIA3;PLA2G2A
18965,GO:1901615,0.94321269641879,0.222588060162081,1,433,organic hydroxy compound metabolic process,BP,MOXD1
1633,GO:0003779,0.945120373224165,0.217127548859239,1,380,actin binding,MF,GBP1
6676,GO:0019866,0.945163178529941,0.216871716599775,1,485,organelle inner membrane,CC,LGALS3
3125,GO:0006397,0.946756541372356,0.212227280211429,1,455,mRNA processing,BP,LGALS3
18951,GO:1901576,0.952018944090687,0.0734584447594397,30,5750,organic substance biosynthetic process,BP,LTF;TYMP;VIM;IGF2BP2;MOXD1;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;ANXA1;IGF2BP3;MDGA2;GALNT13;ADM;S100A11;NNMT;CXCL10;FUT9;GRIN1;ST8SIA3;PLA2G2A
13784,GO:0051253,0.954454104146783,0.108618262936819,4,1156,negative regulation of RNA metabolic process,BP,AEBP1;CUX2;KCNIP3;HOXA7
11042,GO:0043087,0.956634509824375,0.182109487809283,1,435,regulation of GTPase activity,BP,CCL2
16969,GO:0072594,0.958635493116464,0.175681529250676,1,493,establishment of protein localization to organelle,BP,CACNG2
6034,GO:0016772,0.959492916468034,0.108813087789262,3,934,transferase activity, transferring phosphorus-containing groups,MF,CCL2;MMD2;KSR2
11478,GO:0044085,0.959927791803904,0.0709935846763519,13,2879,cellular component biogenesis,BP,SNAP91;SRPX2;COL1A1;CUX2;GBP1;COL6A2;EMP3;MMP14;KCNB1;SHANK2;GRIN1;SLITRK1;ANXA2
13742,GO:0051186,0.961013546806344,0.16796543722996,1,512,cofactor metabolic process,BP,NNMT
3549,GO:0007005,0.961362628240996,0.166821971979224,1,513,mitochondrion organization,BP,TYMP
6693,GO:0019899,0.964992243074849,0.0684339883137859,9,2123,enzyme binding,MF,SNAP91;TIMP1;SERPINE1;COL1A1;GBP1;COL3A1;RIMS2;GRIN1;ANXA2
8966,GO:0033365,0.966282765940518,0.109747471266808,2,778,protein localization to organelle,BP,COL1A1;CACNG2
3101,GO:0006357,0.967810326277974,0.0655021244083222,8,2015,regulation of transcription by RNA polymerase II,BP,SERPINE1;AEBP1;CUX2;KCNIP3;HOXA7;GDF15;CXCL10;GRIN1
11736,GO:0044772,0.967956745401394,0.144590244529701,1,515,mitotic cell cycle phase transition,BP,ANXA1
2143,GO:0004674,0.969876004760596,0.137899938533065,1,474,protein serine/threonine kinase activity,MF,KSR2
11550,GO:0044271,0.970104125859219,0.0495518973174207,22,4581,cellular nitrogen compound biosynthetic process,BP,LTF;TYMP;VIM;IGF2BP2;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;IGF2BP3;ADM;PTX3;NNMT;CXCL10;GRIN1;ST8SIA3
111,GO:0000226,0.970114978081201,0.137043995988106,1,487,microtubule cytoskeleton organization,BP,TUBA1C
18446,GO:0120031,0.971819813130665,0.130939612761445,1,506,plasma membrane bounded cell projection assembly,BP,EMP3
4759,GO:0010467,0.972407055589084,0.0454618808515389,24,4917,gene expression,BP,LTF;VIM;IGF2BP2;FERMT1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;PLAU;GDF15;LGALS3;SPOCD1;COL4A2;IGF2BP3;SERPING1;MMP14;C1R;CXCL10;RIMS2;GRIN1;CFI
7190,GO:0030163,0.973140057605688,0.0911596696733547,2,806,protein catabolic process,BP,TIMP1;ANXA2
11533,GO:0044237,0.973414939573849,0.0416526478401801,52,9385,cellular metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;IGF2BP2;MOXD1;CHGB;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;IGFBP2;GBP1;SPP1;HOXA7;GDF15;LGALS3;CHI3L1;SPOCD1;COL4A2;ANXA1;IGF2BP3;MMD2;MDGA2;GALNT13;ADM;SERPING1;MMP14;S100A11;PTX3;FABP5;NNMT;CACNG2;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
11734,GO:0044770,0.97377948217842,0.123782671537083,1,545,cell cycle phase transition,BP,ANXA1
7115,GO:0030031,0.974343069641969,0.121719224181798,1,520,cell projection assembly,BP,EMP3
11640,GO:0044429,0.975629441285414,0.0841368664657642,2,909,mitochondrial part,CC,LGALS3;ANXA1
10133,GO:0036094,0.97621986164812,0.0485300035080796,9,2242,small molecule binding,MF,ABCC3;RBP1;GBP1;GNAL;FABP5;TUBA1C;KSR2;GRIN1;ST8SIA3
13819,GO:0051301,0.978451656533143,0.106137601272385,1,561,cell division,BP,TUBA1C
4760,GO:0010468,0.98065970807053,0.034073471290831,19,4126,regulation of gene expression,BP,LTF;VIM;IGF2BP2;FERMT1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;IGF2BP3;SERPING1;C1R;CXCL10;RIMS2;GRIN1;CFI
9008,GO:0033554,0.980927356005054,0.0449249547085733,6,1782,cellular response to stress,BP,CCL2;TNR;SPP1;ANXA1;ADM;CXCL10
6618,GO:0019752,0.981906256897771,0.0657476726285744,2,928,carboxylic acid metabolic process,BP,RBP1;ANXA1
3037,GO:0006259,0.983128828913313,0.0620282325567523,2,896,DNA metabolic process,BP,ANXA1;S100A11
3910,GO:0008134,0.983612750846558,0.0854045553698784,1,593,transcription factor binding,MF,HOXA7
3108,GO:0006366,0.983728963477605,0.0357285720078509,8,2184,transcription by RNA polymerase II,BP,SERPINE1;AEBP1;CUX2;KCNIP3;HOXA7;GDF15;CXCL10;GRIN1
4619,GO:0009889,0.983832634271458,0.0292016868182981,18,4015,regulation of biosynthetic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;ANXA1;IGF2BP3;S100A11;PTX3;CXCL10;GRIN1
6303,GO:0018193,0.984593563853136,0.0481349165188118,3,1143,peptidyl-amino acid modification,BP,CHI3L1;GALNT13;SOCS3
3732,GO:0007346,0.984780887902219,0.0804909921056725,1,612,regulation of mitotic cell cycle,BP,ANXA1
6017,GO:0016740,0.984904864589012,0.0334093948517781,8,2201,transferase activity,MF,TYMP;CCL2;MMD2;GALNT13;NNMT;KSR2;FUT9;ST8SIA3
4303,GO:0009059,0.985279912240339,0.0258459096595236,22,4765,macromolecule biosynthetic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;IGF2BP3;MDGA2;GALNT13;S100A11;CXCL10;FUT9;GRIN1;ST8SIA3
3887,GO:0008092,0.985329136015201,0.055194164373517,2,839,cytoskeletal protein binding,MF,GBP1;ANXA2
6713,GO:0019953,0.985949704400632,0.0754813649292906,1,634,sexual reproduction,BP,GRIN1
1609,GO:0003700,0.98651478107482,0.0382470292896163,4,1401,DNA binding transcription factor activity,MF,AEBP1;CUX2;KCNIP3;HOXA7
7119,GO:0030036,0.986890425204409,0.0713950468330418,1,595,actin cytoskeleton organization,BP,ANXA1
11128,GO:0043226,0.986893729241624,0.0226757669429312,68,11807,organelle,CC,LTF;VIM;CP;SNAP91;IGF2BP2;MOXD1;CHGB;CRTAC1;APOL4;FERMT1;TIMP1;SERPINE1;AEBP1;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;GNAL;COL6A2;GALNT13;CPLX2;CDHR1;INA;ADAM12;SERPING1;SPHKAP;JPH3;MMP14;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;COL3A1;PCDH7;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;SHISA7;PLA2G2A;SERPINA3;COL5A2;CFI;IFI30
6695,GO:0019901,0.987329257532374,0.0694508712348011,1,620,protein kinase binding,MF,SNAP91
9451,GO:0034645,0.988187163890371,0.0212638354975835,21,4656,cellular macromolecule biosynthetic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;IGF2BP3;MDGA2;GALNT13;S100A11;CXCL10;FUT9;GRIN1;ST8SIA3
11260,GO:0043436,0.989285972100667,0.0423326945312994,2,1015,oxoacid metabolic process,BP,RBP1;ANXA1
7800,GO:0031326,0.989430849546322,0.0199862806832406,17,3955,regulation of cellular biosynthetic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;ANXA1;IGF2BP3;S100A11;PTX3;CXCL10;GRIN1
3918,GO:0008144,0.989771865108027,0.0275927884769514,5,1585,drug binding,MF,CHI3L2;ABCC3;CHI3L1;KSR2;GRIN1
2944,GO:0006082,0.989925361225856,0.0401810245442522,2,1026,organic acid metabolic process,BP,RBP1;ANXA1
4803,GO:0010564,0.989960386511539,0.0574779112398949,1,670,regulation of cell cycle process,BP,ANXA1
11542,GO:0044257,0.98997120914666,0.0574259571965136,1,676,cellular protein catabolic process,BP,ANXA2
11131,GO:0043229,0.990259263065321,0.0167962959971989,62,11050,intracellular organelle,CC,LTF;VIM;CP;SNAP91;IGF2BP2;MOXD1;CHGB;APOL4;FERMT1;TIMP1;SERPINE1;AEBP1;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;COL6A2;GALNT13;CPLX2;INA;ADAM12;SERPING1;SPHKAP;JPH3;MMP14;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;CACNG2;TUBA1C;COL3A1;PCDH7;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;COL5A2;IFI30
135,GO:0000278,0.990281045565109,0.0389791723740282,2,971,mitotic cell cycle,BP,ANXA1;TUBA1C
6547,GO:0019438,0.991166174383078,0.01694230392479,17,4031,aromatic compound biosynthetic process,BP,LTF;TYMP;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;ADM;NNMT;CXCL10;GRIN1
4795,GO:0010556,0.991176351938504,0.0171474703224874,16,3815,regulation of macromolecule biosynthetic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;IGF2BP3;S100A11;CXCL10;GRIN1
6467,GO:0019219,0.991914816281685,0.0158210020851405,16,3836,regulation of nucleobase-containing compound metabolic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;IGF2BP3;ADM;S100A11;CXCL10;GRIN1
6694,GO:0019900,0.992682068045904,0.0443351518419093,1,695,kinase binding,MF,SNAP91
9868,GO:0035639,0.99316522240618,0.0192895186620944,5,1677,purine ribonucleoside triphosphate binding,MF,ABCC3;GBP1;GNAL;TUBA1C;KSR2
2665,GO:0005622,0.993460071934597,0.0124875058002988,74,12743,intracellular,CC,LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;CHGB;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;GNAL;COL6A2;GALNT13;CPLX2;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;MMP14;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;CACNG2;TUBA1C;COL3A1;PCDH7;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;RTP5;PLA2G2A;SERPINA3;COL5A2;IFI30
13783,GO:0051252,0.993957768242611,0.0124815157704524,14,3546,regulation of RNA metabolic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;IGF2BP3;CXCL10;GRIN1
21206,GO:2000112,0.994164358276373,0.0118870837125845,15,3735,regulation of cellular macromolecule biosynthetic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;IGF2BP3;S100A11;CXCL10;GRIN1
3558,GO:0007017,0.994265947597377,0.0362198102080328,1,701,microtubule-based process,BP,TUBA1C
18890,GO:1901362,0.994387842909205,0.0111408675876901,17,4153,organic cyclic compound biosynthetic process,BP,LTF;TYMP;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;ADM;NNMT;CXCL10;GRIN1
8488,GO:0032555,0.994457980034592,0.0159977470025072,5,1716,purine ribonucleotide binding,MF,ABCC3;GBP1;GNAL;TUBA1C;KSR2
9458,GO:0034654,0.994476722620519,0.0111285625772882,16,3968,nucleobase-containing compound biosynthetic process,BP,LTF;TYMP;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;ADM;NNMT;CXCL10;GRIN1
5925,GO:0016567,0.994539314740244,0.0347676524296858,1,762,protein ubiquitination,BP,SOCS3
8486,GO:0032553,0.994780800353306,0.0151617750058389,5,1728,ribonucleotide binding,MF,ABCC3;GBP1;GNAL;TUBA1C;KSR2
6192,GO:0017076,0.994810261186233,0.0150851628909089,5,1730,purine nucleotide binding,MF,ABCC3;GBP1;GNAL;TUBA1C;KSR2
16038,GO:0070925,0.994983069735754,0.0323953587399671,1,747,organelle assembly,BP,SHANK2
11636,GO:0044424,0.995128091013101,0.00935986727208602,72,12539,intracellular part,CC,LTF;TYMP;VIM;CP;CHI3L2;SNAP91;IGF2BP2;MOXD1;CHGB;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;COL1A1;CUX2;RBP1;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;KCNIP2;HOXA7;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;GNAL;COL6A2;GALNT13;CPLX2;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;MMP14;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;CACNG2;TUBA1C;COL3A1;PCDH7;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;PLA2G2A;SERPINA3;COL5A2;IFI30
1597,GO:0003677,0.995148533108107,0.012543039367348,7,2234,DNA binding,MF,LTF;AEBP1;CUX2;KCNIP3;HOXA7;ANXA1;SERPINA3
6293,GO:0018130,0.995551068713917,0.00910913069632729,16,4024,heterocycle biosynthetic process,BP,LTF;TYMP;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;ADM;NNMT;CXCL10;GRIN1
19529,GO:1903047,0.995989111458068,0.0268478948022093,1,802,mitotic cell cycle process,BP,ANXA1
3095,GO:0006351,0.996063645583041,0.00856813456591404,13,3476,transcription, DNA-templated,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;CXCL10;GRIN1
17859,GO:0097659,0.996278615338729,0.0081351118949631,13,3490,nucleic acid-templated transcription,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;CXCL10;GRIN1
2786,GO:0005829,0.996333761425978,0.00732414794349132,19,4599,cytosol,CC,TYMP;VIM;IGF2BP2;FERMT1;RBP1;KCNIP3;GBP1;ANXA1;IGF2BP3;CPLX2;MMP14;SHANK2;PDPN;FABP5;NNMT;KSR2;ANXA2;SOCS3;IFI30
8628,GO:0032774,0.996462828718036,0.00776235214274193,13,3503,RNA biosynthetic process,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;SPOCD1;COL4A2;CXCL10;GRIN1
3124,GO:0006396,0.996855476544716,0.0218574838251222,1,891,RNA processing,BP,LGALS3
5684,GO:0016070,0.996929725366938,0.00636467367176429,17,4304,RNA metabolic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;LGALS3;SPOCD1;COL4A2;IGF2BP3;CXCL10;GRIN1
8409,GO:0032446,0.996939514120307,0.0213649190171985,1,844,protein modification by small protein conjugation,BP,SOCS3
2723,GO:0005739,0.997029229661642,0.0114477850803433,3,1555,mitochondrion,CC,LGALS3;ANXA1;SPHKAP
8811,GO:0033043,0.997470648899279,0.0121972260284699,2,1156,regulation of organelle organization,BP,ANXA1;ANXA2
3378,GO:0006725,0.997647342908313,0.00465825538889602,23,5463,cellular aromatic compound metabolic process,BP,LTF;TYMP;VIM;IGF2BP2;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;IGF2BP3;ADM;S100A11;NNMT;CXCL10;GRIN1
2978,GO:0006139,0.99766706446065,0.00466106536480636,22,5285,nucleobase-containing compound metabolic process,BP,LTF;TYMP;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;IGF2BP3;ADM;S100A11;NNMT;CXCL10;GRIN1
17370,GO:0090304,0.997803612583246,0.00454162674373457,19,4746,nucleic acid metabolic process,BP,LTF;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;IGF2BP3;S100A11;CXCL10;GRIN1
18515,GO:0140110,0.997994205908981,0.00705863085874216,4,1741,transcription regulator activity,MF,AEBP1;CUX2;KCNIP3;HOXA7
83,GO:0000166,0.998267387976584,0.00561253462293413,5,1948,nucleotide binding,MF,ABCC3;GBP1;GNAL;TUBA1C;KSR2
18854,GO:1901265,0.998275153079242,0.00558971090637371,5,1949,nucleoside phosphate binding,MF,ABCC3;GBP1;GNAL;TUBA1C;KSR2
9448,GO:0034641,0.998360567764465,0.00326952876493359,25,5915,cellular nitrogen compound metabolic process,BP,LTF;TYMP;VIM;IGF2BP2;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;IGF2BP3;ADM;S100A11;PTX3;NNMT;CXCL10;GRIN1;ST8SIA3
9435,GO:0034622,0.998553169452309,0.0112567240224256,1,968,cellular protein-containing complex assembly,BP,SNAP91
12487,GO:0046483,0.99867441853544,0.00274341528649468,22,5424,heterocycle metabolic process,BP,LTF;TYMP;VIM;IGF2BP2;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;IGF2BP3;ADM;S100A11;NNMT;CXCL10;GRIN1
3099,GO:0006355,0.998714648791738,0.0031916057891334,11,3325,regulation of transcription, DNA-templated,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;CXCL10;GRIN1
19733,GO:1903506,0.99882182605497,0.00294384034609614,11,3344,regulation of nucleic acid-templated transcription,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;CXCL10;GRIN1
18888,GO:1901360,0.998843769035336,0.00239146284656559,23,5637,organic cyclic compound metabolic process,BP,LTF;TYMP;VIM;IGF2BP2;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;IGF2BP3;ADM;S100A11;NNMT;CXCL10;GRIN1
21755,GO:2001141,0.998846078045925,0.00288753472431033,11,3349,regulation of RNA biosynthetic process,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;HOXA7;GDF15;CXCL10;GRIN1
1596,GO:0003676,0.999096531424459,0.00223821145110209,12,3624,nucleic acid binding,MF,LTF;VIM;IGF2BP2;AEBP1;CUX2;KCNIP3;HOXA7;LGALS3;ANXA1;IGF2BP3;ANXA2;SERPINA3
15901,GO:0070647,0.999129859586023,0.00724584198882362,1,1010,protein modification by small protein conjugation or removal,BP,SOCS3
3580,GO:0007049,0.999456812395534,0.00249746331796664,3,1708,cell cycle,BP,STEAP3;ANXA1;TUBA1C
14041,GO:0051726,0.999474301140561,0.00466356223449377,1,1088,regulation of cell cycle,BP,ANXA1
13800,GO:0051276,0.999519432600527,0.00431009151538496,1,1085,chromosome organization,BP,ANXA1
5470,GO:0015630,0.999548167877326,0.00408284536600749,1,1069,microtubule cytoskeleton,CC,TUBA1C
2615,GO:0005524,0.99960647843752,0.00233896426809015,2,1372,ATP binding,MF,ABCC3;KSR2
8492,GO:0032559,0.999689638022892,0.00188916871574049,2,1407,adenyl ribonucleotide binding,MF,ABCC3;KSR2
7412,GO:0030554,0.999711203387697,0.00177045735690368,2,1419,adenyl nucleotide binding,MF,ABCC3;KSR2
11133,GO:0043231,0.999725045339773,0.000569069629121137,46,9620,intracellular membrane-bounded organelle,CC,LTF;VIM;CP;IGF2BP2;MOXD1;CHGB;APOL4;TIMP1;AEBP1;COL1A1;CUX2;RBP1;KCNIP3;GBP1;SPP1;HOXA7;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;IGF2BP3;MMD2;COL6A2;GALNT13;CPLX2;INA;ADAM12;SPHKAP;JPH3;MMP14;S100A11;FABP5;TUBA1C;COL3A1;FUT9;GRIN1;ST8SIA3;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;COL5A2;IFI30
11130,GO:0043228,0.999807473641389,0.000542638091552108,11,3648,non-membrane-bounded organelle,CC,VIM;IGF2BP2;FERMT1;RBP1;ANXA1;INA;MMP14;SHANK2;TUBA1C;RIMS2;ANXA2
11134,GO:0043232,0.999807473641389,0.000542638091552108,11,3648,intracellular non-membrane-bounded organelle,CC,VIM;IGF2BP2;FERMT1;RBP1;ANXA1;INA;MMP14;SHANK2;TUBA1C;RIMS2;ANXA2
7017,GO:0022402,0.999844666216144,0.00158426153130816,1,1257,cell cycle process,BP,ANXA1
19293,GO:1902494,0.999885489304146,0.00120617994074134,1,1316,catalytic complex,CC,GNAL
3543,GO:0006996,0.999986435032748,5.06889932257184e-05,8,3463,organelle organization,BP,TYMP;VIM;CCL2;ANXA1;INA;SHANK2;TUBA1C;ANXA2
18891,GO:1901363,0.999986870732352,3.71088461976138e-05,17,5338,heterocyclic compound binding,MF,LTF;VIM;IGF2BP2;AEBP1;ABCC3;CUX2;KCNIP3;GBP1;HOXA7;LGALS3;ANXA1;IGF2BP3;GNAL;TUBA1C;KSR2;ANXA2;SERPINA3
17615,GO:0097159,0.999990798238774,2.64491316242842e-05,17,5402,organic cyclic compound binding,MF,LTF;VIM;IGF2BP2;AEBP1;ABCC3;CUX2;KCNIP3;GBP1;HOXA7;LGALS3;ANXA1;IGF2BP3;GNAL;TUBA1C;KSR2;ANXA2;SERPINA3
2677,GO:0005654,0.999995652113925,1.98376071672032e-05,6,3238,nucleoplasm,CC,RBP1;HOXA7;ANXA1;INA;ADAM12;FABP5
2667,GO:0005634,0.999999805665226,6.36114299592035e-07,19,6455,nucleus,CC,LTF;IGF2BP2;AEBP1;CUX2;RBP1;KCNIP3;HOXA7;GDF15;LGALS3;ANXA1;IGF2BP3;INA;ADAM12;MMP14;S100A11;FABP5;TUBA1C;ANXA2;SERPINA3
8123,GO:0031981,0.999999873039563,6.98877864428491e-07,6,3766,nuclear lumen,CC,RBP1;HOXA7;ANXA1;INA;ADAM12;FABP5
11639,GO:0044428,0.999999924934215,3.91338049983125e-07,7,4087,nuclear part,CC,RBP1;HOXA7;LGALS3;ANXA1;INA;ADAM12;FABP5
2900,GO:0006012,0.999999999999991,0.914232771914099,0,14,galactose metabolic process,BP,
11336,GO:0043560,0.999999999999991,0.916968683704382,0,11,insulin receptor substrate binding,MF,
8549,GO:0032648,0.999999999999991,0.745235686032831,0,45,regulation of interferon-beta production,BP,
2946,GO:0006084,0.999999999999993,0.798352990304188,0,34,acetyl-CoA metabolic process,BP,
5974,GO:0016645,0.999999999999994,0.860919595654181,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
4768,GO:0010494,0.999999999999998,0.750634467371767,0,40,cytoplasmic stress granule,CC,
13603,GO:0050982,0.999999999999999,0.742857928563323,0,37,detection of mechanical stimulus,BP,
9162,GO:0034062,0.999999999999999,0.770629840711464,0,43,5'-3' RNA polymerase activity,MF,
17893,GO:0097747,0.999999999999999,0.770629840711464,0,43,RNA polymerase activity,MF,
13990,GO:0051642,0.999999999999999,0.832712974759145,0,22,centrosome localization,BP,
12322,GO:0046068,1,0.742323711783691,0,42,cGMP metabolic process,BP,
3,GO:0000009,1,0.994362291629,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.988273623232569,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.994184768585909,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.951198234462438,0,8,single strand break repair,BP,
7,GO:0000014,1,0.953476303975092,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.977808894795731,0,4,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.642640066751405,0,66,regulation of DNA recombination,BP,
10,GO:0000019,1,0.974706261096933,0,4,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.936371286485596,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.977569324019802,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.979852279257066,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.851676584476843,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.911701200847513,0,17,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.866175871938946,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.994529222266585,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.983328256684546,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.983450304758578,0,3,acyl binding,MF,
20,GO:0000036,1,0.989344272260938,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.83852848293476,0,29,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.55456336450996,0,87,autophagosome assembly,BP,
24,GO:0000048,1,0.988712552611516,0,2,peptidyltransferase activity,MF,
25,GO:0000049,1,0.712082027992807,0,55,tRNA binding,MF,
26,GO:0000050,1,0.928380726345119,0,12,urea cycle,BP,
27,GO:0000052,1,0.943178255614089,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.994518222134149,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.927103767420662,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.954522181564624,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.960028544666222,0,7,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.746411093799868,0,43,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.901384248758816,0,18,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.957792843037059,0,6,L-ornithine transmembrane transporter activity,MF,
35,GO:0000070,1,0.37017713504438,0,143,mitotic sister chromatid segregation,BP,
36,GO:0000075,1,0.246786453260953,0,211,cell cycle checkpoint,BP,
37,GO:0000076,1,0.906949495433204,0,16,DNA replication checkpoint,BP,
38,GO:0000077,1,0.376482367709945,0,147,DNA damage checkpoint,BP,
39,GO:0000079,1,0.587640354119992,0,83,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
41,GO:0000083,1,0.838925418587944,0,28,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
42,GO:0000086,1,0.207756851945338,0,237,G2/M transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.994412527970298,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.791376761126769,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.904887729630985,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.941429431586331,0,10,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.957378701598088,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.968819901864574,0,5,sulfur amino acid transport,BP,
49,GO:0000103,1,0.982451090603485,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.977974226500333,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.98814702001415,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.939193977470109,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.97931715471188,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.993632775438302,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.985912993904172,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
56,GO:0000118,1,0.63673423326073,0,60,histone deacetylase complex,CC,
57,GO:0000120,1,0.971210745703795,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.993982155737606,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.609514885302897,0,75,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.937409919740199,0,11,SAGA complex,CC,
62,GO:0000125,1,0.973189105741207,0,3,PCAF complex,CC,
63,GO:0000126,1,0.980690981650812,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.960968952700515,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.869445810251526,0,20,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.903718162757569,0,16,Golgi cis cisterna,CC,
67,GO:0000138,1,0.959812990523021,0,7,Golgi trans cisterna,CC,
69,GO:0000145,1,0.887813969030119,0,18,exocyst,CC,
70,GO:0000146,1,0.848658723130257,0,17,microfilament motor activity,MF,
71,GO:0000147,1,0.966507823179785,0,5,actin cortical patch assembly,BP,
73,GO:0000150,1,0.955366320661606,0,8,recombinase activity,MF,
74,GO:0000151,1,0.145361498851301,0,289,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.785333639809004,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.931111973176361,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.834993496293149,0,31,rRNA modification,BP,
78,GO:0000155,1,0.957429804673658,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.888177123917409,0,19,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.951260925936039,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.93148105993402,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.994592054250129,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.987061621420218,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.965064244564225,0,6,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.994552930170632,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.821445302182603,0,30,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.927202253739198,0,13,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.911330507974623,0,15,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.872363722254822,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.977690882750993,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.924620553745316,0,10,rDNA binding,MF,
94,GO:0000183,1,0.890583456910407,0,18,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.500471827736344,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.885736071700992,0,18,activation of MAPKKK activity,BP,
97,GO:0000186,1,0.683431920737558,0,53,activation of MAPKK activity,BP,
98,GO:0000187,1,0.414414327271667,0,133,activation of MAPK activity,BP,
99,GO:0000188,1,0.864619944128704,0,24,inactivation of MAPK activity,BP,
100,GO:0000209,1,0.143324922318056,0,290,protein polyubiquitination,BP,
101,GO:0000210,1,0.99373205913677,0,1,NAD+ diphosphatase activity,MF,
102,GO:0000212,1,0.923021174793156,0,10,meiotic spindle organization,BP,
103,GO:0000213,1,0.978003572820582,0,4,tRNA-intron endonuclease activity,MF,
104,GO:0000214,1,0.97804871961878,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000215,1,0.988850758119292,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000217,1,0.859402667341029,0,24,DNA secondary structure binding,MF,
107,GO:0000220,1,0.962274294693452,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000221,1,0.980276144447687,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
109,GO:0000224,1,0.994299134989657,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
110,GO:0000225,1,0.99462166853175,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000228,1,0.0300167742629309,0,511,nuclear chromosome,CC,
113,GO:0000229,1,0.989218118942197,0,2,cytoplasmic chromosome,CC,
114,GO:0000235,1,0.943969024634402,0,8,astral microtubule,CC,
115,GO:0000242,1,0.85504731627677,0,20,pericentriolar material,CC,
116,GO:0000243,1,0.956011026616404,0,8,commitment complex,CC,
117,GO:0000244,1,0.926202707680143,0,12,spliceosomal tri-snRNP complex assembly,BP,
118,GO:0000245,1,0.69994601091002,0,57,spliceosomal complex assembly,BP,
119,GO:0000246,1,0.99306586030518,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000247,1,0.99462146648342,0,1,C-8 sterol isomerase activity,MF,
121,GO:0000248,1,0.987174170237301,0,2,C-5 sterol desaturase activity,MF,
122,GO:0000250,1,0.993093756396154,0,1,lanosterol synthase activity,MF,
123,GO:0000252,1,0.994561789191343,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
124,GO:0000253,1,0.983894887115613,0,3,3-keto sterol reductase activity,MF,
125,GO:0000254,1,0.983061294410338,0,3,C-4 methylsterol oxidase activity,MF,
126,GO:0000255,1,0.973214943295128,0,4,allantoin metabolic process,BP,
127,GO:0000256,1,0.994585572603382,0,1,allantoin catabolic process,BP,
128,GO:0000257,1,0.994597284963999,0,1,nitrilase activity,MF,
129,GO:0000262,1,0.994562640879259,0,1,mitochondrial chromosome,CC,
130,GO:0000266,1,0.786147512203468,0,34,mitochondrial fission,BP,
131,GO:0000268,1,0.976037698412683,0,4,peroxisome targeting sequence binding,MF,
132,GO:0000270,1,0.989304444792726,0,2,peptidoglycan metabolic process,BP,
133,GO:0000271,1,0.616946008107808,0,69,polysaccharide biosynthetic process,BP,
134,GO:0000272,1,0.834394167896481,0,26,polysaccharide catabolic process,BP,
136,GO:0000280,1,0.0807536532388375,0,367,nuclear division,BP,
137,GO:0000281,1,0.636048209424315,0,64,mitotic cytokinesis,BP,
138,GO:0000285,1,0.974106647519793,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
139,GO:0000287,1,0.285862444573484,0,185,magnesium ion binding,MF,
140,GO:0000288,1,0.60179275831636,0,74,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
141,GO:0000289,1,0.769916912101127,0,36,nuclear-transcribed mRNA poly(A) tail shortening,BP,
142,GO:0000290,1,0.947570260168835,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
143,GO:0000291,1,0.805713577492537,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000293,1,0.981517116293582,0,3,ferric-chelate reductase activity,MF,
145,GO:0000294,1,0.986337417780763,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
146,GO:0000295,1,0.93701130918219,0,11,adenine nucleotide transmembrane transporter activity,MF,
147,GO:0000296,1,0.994392305664854,0,1,spermine transport,BP,
148,GO:0000298,1,0.976242838261684,0,4,endopolyphosphatase activity,MF,
149,GO:0000301,1,0.977111258850413,0,4,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000303,1,0.849514923187436,0,27,response to superoxide,BP,
152,GO:0000305,1,0.83437739309478,0,30,response to oxygen radical,BP,
153,GO:0000306,1,0.973590065281829,0,4,extrinsic component of vacuolar membrane,CC,
154,GO:0000307,1,0.776553008933725,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000308,1,0.985862608875053,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
156,GO:0000309,1,0.980036921918616,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000313,1,0.634979324215321,0,82,organellar ribosome,CC,
158,GO:0000314,1,0.863236847437804,0,27,organellar small ribosomal subunit,CC,
159,GO:0000315,1,0.756609671734872,0,50,organellar large ribosomal subunit,CC,
160,GO:0000320,1,0.986173153630563,0,2,re-entry into mitotic cell cycle,BP,
161,GO:0000322,1,0.981189628674022,0,3,storage vacuole,CC,
163,GO:0000333,1,0.984686465016785,0,2,telomerase catalytic core complex,CC,
164,GO:0000334,1,0.994606807078538,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
165,GO:0000338,1,0.94514833116577,0,10,protein deneddylation,BP,
166,GO:0000339,1,0.903649977078564,0,15,RNA cap binding,MF,
167,GO:0000340,1,0.951802684717005,0,7,RNA 7-methylguanosine cap binding,MF,
168,GO:0000346,1,0.924501891462554,0,13,transcription export complex,CC,
169,GO:0000347,1,0.964804229368999,0,6,THO complex,CC,
170,GO:0000349,1,0.988645416524332,0,2,generation of catalytic spliceosome for first transesterification step,BP,
171,GO:0000350,1,0.983604467007512,0,3,generation of catalytic spliceosome for second transesterification step,BP,
172,GO:0000354,1,0.984257229191613,0,2,cis assembly of pre-catalytic spliceosome,BP,
173,GO:0000375,1,0.137953820172547,0,314,RNA splicing, via transesterification reactions,BP,
174,GO:0000377,1,0.140394142655972,0,311,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
175,GO:0000379,1,0.983424364899542,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.700428596461539,0,54,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.756131200924158,0,42,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000384,1,0.989134255668703,0,2,first spliceosomal transesterification activity,MF,
179,GO:0000386,1,0.978597344968447,0,3,second spliceosomal transesterification activity,MF,
180,GO:0000387,1,0.798160684951099,0,38,spliceosomal snRNP assembly,BP,
181,GO:0000389,1,0.963914964142235,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.98877220092352,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.972434210011863,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.90708612546172,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.965616760897815,0,6,mRNA 5'-splice site recognition,BP,
186,GO:0000398,1,0.140394142655972,0,311,mRNA splicing, via spliceosome,BP,
187,GO:0000400,1,0.906462829396968,0,16,four-way junction DNA binding,MF,
188,GO:0000403,1,0.957887629643517,0,6,Y-form DNA binding,MF,
189,GO:0000404,1,0.980478315041769,0,3,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.953895210936765,0,7,bubble DNA binding,MF,
191,GO:0000406,1,0.986762085526098,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.802292205016711,0,33,phagophore assembly site,CC,
193,GO:0000408,1,0.972255890901455,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.990624553873387,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.990624553873387,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000412,1,0.994129564026399,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000413,1,0.828599907943201,0,31,protein peptidyl-prolyl isomerization,BP,
198,GO:0000414,1,0.964953759475439,0,4,regulation of histone H3-K36 methylation,BP,
199,GO:0000415,1,0.991120138482995,0,1,negative regulation of histone H3-K36 methylation,BP,
200,GO:0000416,1,0.993545914845996,0,1,positive regulation of histone H3-K36 methylation,BP,
201,GO:0000417,1,0.993290311076195,0,1,HIR complex,CC,
202,GO:0000421,1,0.829330398101206,0,30,autophagosome membrane,CC,
203,GO:0000422,1,0.58665910034824,0,80,autophagy of mitochondrion,BP,
204,GO:0000423,1,0.881512745918928,0,18,mitophagy,BP,
205,GO:0000428,1,0.420554233872729,0,132,DNA-directed RNA polymerase complex,CC,
206,GO:0000429,1,0.974302725683584,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
207,GO:0000430,1,0.983525237713326,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000431,1,0.990624553873387,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000432,1,0.983525237713326,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
210,GO:0000435,1,0.990624553873387,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
211,GO:0000436,1,0.974302725683584,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
212,GO:0000438,1,0.983691259350425,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
213,GO:0000439,1,0.951607581778789,0,8,core TFIIH complex,CC,
214,GO:0000444,1,0.969022763475562,0,4,MIS12/MIND type complex,CC,
215,GO:0000445,1,0.964804229368999,0,6,THO complex part of transcription export complex,CC,
216,GO:0000447,1,0.945233768395701,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000448,1,0.990800487377279,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
218,GO:0000451,1,0.992270475651402,0,1,rRNA 2'-O-methylation,BP,
219,GO:0000453,1,0.992270475651402,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
220,GO:0000454,1,0.983902688183534,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
221,GO:0000455,1,0.989010471749194,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
222,GO:0000459,1,0.960576974154457,0,7,exonucleolytic trimming involved in rRNA processing,BP,
223,GO:0000460,1,0.81845171044972,0,32,maturation of 5.8S rRNA,BP,
224,GO:0000461,1,0.989321967211898,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000462,1,0.795965607161074,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000463,1,0.947379327786747,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000466,1,0.875963364710079,0,21,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000467,1,0.960576974154457,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000469,1,0.85378856987541,0,25,cleavage involved in rRNA processing,BP,
230,GO:0000470,1,0.873725020290599,0,22,maturation of LSU-rRNA,BP,
231,GO:0000472,1,0.977370620036605,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000478,1,0.908744351357661,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
233,GO:0000479,1,0.913925031138483,0,13,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000480,1,0.960224779390054,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
235,GO:0000481,1,0.993635129337653,0,1,maturation of 5S rRNA,BP,
236,GO:0000491,1,0.953053284644075,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
237,GO:0000492,1,0.963939577297525,0,6,box C/D snoRNP assembly,BP,
238,GO:0000493,1,0.988710584011162,0,2,box H/ACA snoRNP assembly,BP,
239,GO:0000494,1,0.994620140326158,0,1,box C/D snoRNA 3'-end processing,BP,
240,GO:0000495,1,0.994281914990069,0,1,box H/ACA snoRNA 3'-end processing,BP,
241,GO:0000502,1,0.694971558902083,0,62,proteasome complex,CC,
242,GO:0000506,1,0.95089121259953,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.804383553708269,0,31,embryonic axis specification,BP,
244,GO:0000700,1,0.977536092297322,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.989144562680424,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.973147373781099,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.989225665301262,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.981296894996067,0,3,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.955189639436028,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.973870170020832,0,4,meiotic mismatch repair,BP,
251,GO:0000711,1,0.994589908436575,0,1,meiotic DNA repair synthesis,BP,
252,GO:0000712,1,0.915638153128675,0,13,resolution of meiotic recombination intermediates,BP,
253,GO:0000715,1,0.872633669564406,0,23,nucleotide-excision repair, DNA damage recognition,BP,
254,GO:0000717,1,0.873369320588959,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
255,GO:0000718,1,0.99453859512126,0,1,nucleotide-excision repair, DNA damage removal,BP,
256,GO:0000720,1,0.982023078745999,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
257,GO:0000722,1,0.899863502336658,0,14,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.375776282713208,0,144,telomere maintenance,BP,
259,GO:0000724,1,0.495667254350584,0,104,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.49276458625763,0,105,recombinational repair,BP,
261,GO:0000726,1,0.642303517271242,0,64,non-recombinational repair,BP,
262,GO:0000727,1,0.971172959919277,0,5,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.861610254925966,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.944156035074767,0,10,DNA recombinase assembly,BP,
265,GO:0000731,1,0.631431342349232,0,68,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.836759190586908,0,25,strand displacement,BP,
268,GO:0000737,1,0.847328046461711,0,26,DNA catabolic process, endonucleolytic,BP,
269,GO:0000738,1,0.97570177597148,0,4,DNA catabolic process, exonucleolytic,BP,
270,GO:0000741,1,0.994534660292313,0,1,karyogamy,BP,
272,GO:0000773,1,0.994636210809392,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
273,GO:0000774,1,0.936123439452971,0,11,adenyl-nucleotide exchange factor activity,MF,
274,GO:0000775,1,0.292682082165079,0,181,chromosome, centromeric region,CC,
275,GO:0000776,1,0.432855915140299,0,125,kinetochore,CC,
276,GO:0000777,1,0.53583527885494,0,96,condensed chromosome kinetochore,CC,
277,GO:0000778,1,0.933222320810498,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000779,1,0.496658521049946,0,107,condensed chromosome, centromeric region,CC,
279,GO:0000780,1,0.88370005707703,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000781,1,0.400745658125739,0,135,chromosome, telomeric region,CC,
281,GO:0000782,1,0.936616023680659,0,11,telomere cap complex,CC,
282,GO:0000783,1,0.936616023680659,0,11,nuclear telomere cap complex,CC,
283,GO:0000784,1,0.495517005896187,0,105,nuclear chromosome, telomeric region,CC,
284,GO:0000785,1,0.0455857498275007,0,450,chromatin,CC,
285,GO:0000786,1,0.764650554778986,0,47,nucleosome,CC,
286,GO:0000788,1,0.923172937331582,0,14,nuclear nucleosome,CC,
287,GO:0000789,1,0.994626551686144,0,1,cytoplasmic chromatin,CC,
288,GO:0000790,1,0.123563492456294,0,304,nuclear chromatin,CC,
289,GO:0000791,1,0.835796967000851,0,29,euchromatin,CC,
290,GO:0000792,1,0.631042245572538,0,68,heterochromatin,CC,
291,GO:0000793,1,0.269692712766138,0,194,condensed chromosome,CC,
292,GO:0000794,1,0.57179854513645,0,82,condensed nuclear chromosome,CC,
293,GO:0000795,1,0.818437377152762,0,31,synaptonemal complex,CC,
294,GO:0000796,1,0.948184518328241,0,7,condensin complex,CC,
295,GO:0000797,1,0.992571438769333,0,1,condensin core heterodimer,CC,
296,GO:0000798,1,0.969102824121034,0,5,nuclear cohesin complex,CC,
297,GO:0000799,1,0.977426085391314,0,3,nuclear condensin complex,CC,
298,GO:0000800,1,0.911834264163707,0,13,lateral element,CC,
299,GO:0000801,1,0.965303538816607,0,6,central element,CC,
300,GO:0000803,1,0.842723794854531,0,25,sex chromosome,CC,
301,GO:0000805,1,0.947991446265826,0,7,X chromosome,CC,
302,GO:0000806,1,0.986730557195034,0,2,Y chromosome,CC,
303,GO:0000808,1,0.948525732383987,0,9,origin recognition complex,CC,
304,GO:0000811,1,0.982053596587777,0,3,GINS complex,CC,
305,GO:0000812,1,0.929088434882994,0,10,Swr1 complex,CC,
306,GO:0000813,1,0.943250295001785,0,10,ESCRT I complex,CC,
307,GO:0000814,1,0.982286346278029,0,3,ESCRT II complex,CC,
308,GO:0000815,1,0.932322588495896,0,12,ESCRT III complex,CC,
309,GO:0000818,1,0.988751649334589,0,2,nuclear MIS12/MIND complex,CC,
310,GO:0000819,1,0.215880952520243,0,223,sister chromatid segregation,BP,
311,GO:0000820,1,0.965212082334594,0,5,regulation of glutamine family amino acid metabolic process,BP,
312,GO:0000821,1,0.983363371169605,0,2,regulation of arginine metabolic process,BP,
313,GO:0000822,1,0.972385731162816,0,3,inositol hexakisphosphate binding,MF,
314,GO:0000823,1,0.994525099131322,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
315,GO:0000824,1,0.994525099131322,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
316,GO:0000825,1,0.994525099131322,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
317,GO:0000827,1,0.966255224426478,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
318,GO:0000828,1,0.966255224426478,0,5,inositol hexakisphosphate kinase activity,MF,
319,GO:0000829,1,0.966255224426478,0,5,inositol heptakisphosphate kinase activity,MF,
320,GO:0000831,1,0.994197192684425,0,1,inositol hexakisphosphate 6-kinase activity,MF,
321,GO:0000832,1,0.966255224426478,0,5,inositol hexakisphosphate 5-kinase activity,MF,
322,GO:0000835,1,0.959039080264471,0,6,ER ubiquitin ligase complex,CC,
323,GO:0000836,1,0.96603841380273,0,5,Hrd1p ubiquitin ligase complex,CC,
324,GO:0000839,1,0.979638360487273,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
325,GO:0000900,1,0.912509124599711,0,13,translation repressor activity, mRNA regulatory element binding,MF,
328,GO:0000910,1,0.333641988330568,0,157,cytokinesis,BP,
329,GO:0000912,1,0.958062759460935,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
330,GO:0000915,1,0.958062759460935,0,6,actomyosin contractile ring assembly,BP,
331,GO:0000916,1,0.994427101077596,0,1,actomyosin contractile ring contraction,BP,
332,GO:0000917,1,0.994513329699592,0,1,division septum assembly,BP,
333,GO:0000920,1,0.905231654376635,0,17,cell separation after cytokinesis,BP,
334,GO:0000921,1,0.920120126654014,0,13,septin ring assembly,BP,
335,GO:0000922,1,0.382872501709196,0,141,spindle pole,CC,
336,GO:0000923,1,0.967388240925496,0,5,equatorial microtubule organizing center,CC,
337,GO:0000928,1,0.994184768585909,0,1,gamma-tubulin small complex, spindle pole body,CC,
338,GO:0000930,1,0.873861261310234,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.95080959326632,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.582516518466934,0,79,P-body,CC,
341,GO:0000938,1,0.972867175943333,0,4,GARP complex,CC,
342,GO:0000939,1,0.983276303651462,0,3,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.914916780135422,0,13,condensed chromosome outer kinetochore,CC,
344,GO:0000941,1,0.994404188207799,0,1,condensed nuclear chromosome inner kinetochore,CC,
345,GO:0000942,1,0.977212724386118,0,4,condensed nuclear chromosome outer kinetochore,CC,
346,GO:0000956,1,0.280181221991921,0,200,nuclear-transcribed mRNA catabolic process,BP,
347,GO:0000957,1,0.965943182320823,0,5,mitochondrial RNA catabolic process,BP,
348,GO:0000958,1,0.980558349906162,0,3,mitochondrial mRNA catabolic process,BP,
349,GO:0000959,1,0.771673643775329,0,41,mitochondrial RNA metabolic process,BP,
350,GO:0000960,1,0.972433937554632,0,4,regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000961,1,0.985097958777629,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000962,1,0.9871463210892,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000963,1,0.909426311659473,0,16,mitochondrial RNA processing,BP,
354,GO:0000964,1,0.976090801762877,0,4,mitochondrial RNA 5'-end processing,BP,
355,GO:0000965,1,0.970672679984523,0,5,mitochondrial RNA 3'-end processing,BP,
356,GO:0000966,1,0.87869474206978,0,21,RNA 5'-end processing,BP,
357,GO:0000967,1,0.977370620036605,0,3,rRNA 5'-end processing,BP,
358,GO:0000972,1,0.956661884579122,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000973,1,0.980824892789154,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000974,1,0.924770996030532,0,13,Prp19 complex,CC,
364,GO:0000979,1,0.784338354152407,0,36,RNA polymerase II core promoter sequence-specific DNA binding,MF,
365,GO:0000980,1,0.641345467043737,0,66,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
368,GO:0000983,1,0.863237042527987,0,21,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
372,GO:0000990,1,0.940621289151535,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.986186015720516,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.984807949856722,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.833510414664266,0,28,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.994528404170187,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.965552725884882,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0001002,1,0.984807949856722,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
379,GO:0001003,1,0.984807949856722,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
380,GO:0001007,1,0.965928825510792,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
381,GO:0001010,1,0.881324925985345,0,18,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001011,1,0.989333638287441,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
384,GO:0001013,1,0.945537154332016,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001016,1,0.949342694420069,0,7,RNA polymerase III regulatory region DNA binding,MF,
386,GO:0001018,1,0.988514491153799,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
387,GO:0001025,1,0.967157808234597,0,3,RNA polymerase III transcription factor binding,MF,
388,GO:0001026,1,0.980690981650812,0,2,TFIIIB-type transcription factor activity,MF,
389,GO:0001030,1,0.959744923135832,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
390,GO:0001031,1,0.959744923135832,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
391,GO:0001032,1,0.969176994286996,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001034,1,0.994522901519976,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
393,GO:0001042,1,0.964246843773262,0,5,RNA polymerase I core binding,MF,
394,GO:0001046,1,0.548887087067099,0,85,core promoter sequence-specific DNA binding,MF,
395,GO:0001047,1,0.38146486707872,0,138,core promoter binding,MF,
396,GO:0001054,1,0.934656772203023,0,11,RNA polymerase I activity,MF,
397,GO:0001055,1,0.937039951288159,0,11,RNA polymerase II activity,MF,
398,GO:0001056,1,0.915169376650486,0,15,RNA polymerase III activity,MF,
400,GO:0001069,1,0.984989908113512,0,2,regulatory region RNA binding,MF,
401,GO:0001074,1,0.994277353274586,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
402,GO:0001075,1,0.948675009882676,0,7,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
403,GO:0001076,1,0.273035679899418,0,183,transcription factor activity, RNA polymerase II transcription factor binding,MF,
406,GO:0001079,1,0.994436661814452,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
407,GO:0001080,1,0.994436661814452,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
408,GO:0001083,1,0.952634606912663,0,6,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
409,GO:0001084,1,0.994277353274586,0,1,transcription factor activity, TFIID-class binding,MF,
410,GO:0001085,1,0.385403118738492,0,138,RNA polymerase II transcription factor binding,MF,
411,GO:0001087,1,0.989333638287441,0,1,transcription factor activity, TFIIB-class binding,MF,
412,GO:0001091,1,0.89323559712163,0,16,RNA polymerase II basal transcription factor binding,MF,
413,GO:0001093,1,0.975202104690798,0,3,TFIIB-class transcription factor binding,MF,
414,GO:0001094,1,0.941236892975313,0,9,TFIID-class transcription factor binding,MF,
415,GO:0001096,1,0.993586872388492,0,1,TFIIF-class transcription factor binding,MF,
416,GO:0001097,1,0.979453696562837,0,3,TFIIH-class transcription factor binding,MF,
417,GO:0001098,1,0.751807746023759,0,43,basal transcription machinery binding,MF,
418,GO:0001099,1,0.751807746023759,0,43,basal RNA polymerase II transcription machinery binding,MF,
419,GO:0001100,1,0.994184768585909,0,1,negative regulation of exit from mitosis,BP,
421,GO:0001102,1,0.721470146922279,0,47,RNA polymerase II activating transcription factor binding,MF,
422,GO:0001103,1,0.811387684531494,0,32,RNA polymerase II repressing transcription factor binding,MF,
423,GO:0001104,1,0.486846128136817,0,101,RNA polymerase II transcription cofactor activity,MF,
424,GO:0001105,1,0.72551024653677,0,43,RNA polymerase II transcription coactivator activity,MF,
425,GO:0001106,1,0.833438100406216,0,28,RNA polymerase II transcription corepressor activity,MF,
426,GO:0001112,1,0.994045632471575,0,1,DNA-templated transcriptional open complex formation,BP,
427,GO:0001113,1,0.994045632471575,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
428,GO:0001120,1,0.994045632471575,0,1,protein-DNA complex remodeling,BP,
429,GO:0001128,1,0.994599619239508,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
430,GO:0001129,1,0.96845308664213,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
431,GO:0001132,1,0.96845308664213,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
432,GO:0001133,1,0.886557152736232,0,17,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
433,GO:0001134,1,0.827481335117588,0,27,transcription factor activity, transcription factor recruiting,MF,
434,GO:0001135,1,0.955348311216787,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
435,GO:0001147,1,0.980875571736273,0,2,transcription termination site sequence-specific DNA binding,MF,
436,GO:0001156,1,0.967157808234597,0,3,TFIIIC-class transcription factor binding,MF,
437,GO:0001158,1,0.566774904063961,0,85,enhancer sequence-specific DNA binding,MF,
438,GO:0001160,1,0.980875571736273,0,2,transcription termination site DNA binding,MF,
439,GO:0001161,1,0.92105190068899,0,12,intronic transcription regulatory region sequence-specific DNA binding,MF,
440,GO:0001162,1,0.932117348504645,0,10,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
441,GO:0001163,1,0.945537154332016,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
442,GO:0001164,1,0.945537154332016,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
443,GO:0001165,1,0.992799191825183,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
444,GO:0001172,1,0.984278661854357,0,2,transcription, RNA-templated,BP,
445,GO:0001179,1,0.994510675493164,0,1,RNA polymerase I transcription factor binding,MF,
446,GO:0001181,1,0.993521575890071,0,1,transcription factor activity, core RNA polymerase I binding,MF,
447,GO:0001188,1,0.945537154332016,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
448,GO:0001190,1,0.62334265824098,0,64,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
449,GO:0001191,1,0.738877035733799,0,46,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
450,GO:0001192,1,0.994645262762867,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
451,GO:0001193,1,0.994645262762867,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
452,GO:0001205,1,0.819189968139948,0,30,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
453,GO:0001206,1,0.927970789051591,0,9,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
454,GO:0001221,1,0.747747031238007,0,40,transcription cofactor binding,MF,
455,GO:0001222,1,0.908744893013675,0,14,transcription corepressor binding,MF,
456,GO:0001223,1,0.855914847541765,0,20,transcription coactivator binding,MF,
457,GO:0001224,1,0.975232797603773,0,3,RNA polymerase II transcription cofactor binding,MF,
458,GO:0001225,1,0.98124247416004,0,2,RNA polymerase II transcription coactivator binding,MF,
459,GO:0001226,1,0.99387659705545,0,1,RNA polymerase II transcription corepressor binding,MF,
463,GO:0001302,1,0.961641289342286,0,6,replicative cell aging,BP,
464,GO:0001306,1,0.994633718411125,0,1,age-dependent response to oxidative stress,BP,
465,GO:0001315,1,0.994633718411125,0,1,age-dependent response to reactive oxygen species,BP,
466,GO:0001325,1,0.913074374321036,0,14,formation of extrachromosomal circular DNA,BP,
467,GO:0001401,1,0.988431062918381,0,2,mitochondrial sorting and assembly machinery complex,CC,
468,GO:0001405,1,0.971107717957912,0,5,presequence translocase-associated import motor,CC,
470,GO:0001502,1,0.894233846824472,0,16,cartilage condensation,BP,
472,GO:0001504,1,0.815352817104949,0,30,neurotransmitter uptake,BP,
474,GO:0001507,1,0.988370487875647,0,2,acetylcholine catabolic process in synaptic cleft,BP,
476,GO:0001510,1,0.708191320945191,0,57,RNA methylation,BP,
477,GO:0001512,1,0.994622869842464,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
478,GO:0001514,1,0.946634038461049,0,8,selenocysteine incorporation,BP,
479,GO:0001515,1,0.978181046860516,0,4,opioid peptide activity,MF,
481,GO:0001517,1,0.958490904141077,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
482,GO:0001518,1,0.87792138870956,0,14,voltage-gated sodium channel complex,CC,
483,GO:0001519,1,0.99354389341953,0,1,peptide amidation,BP,
484,GO:0001520,1,0.980034089094982,0,3,outer dense fiber,CC,
485,GO:0001522,1,0.90261061324162,0,18,pseudouridine synthesis,BP,
488,GO:0001527,1,0.922324381476426,0,10,microfibril,CC,
490,GO:0001532,1,0.993892555891127,0,1,interleukin-21 receptor activity,MF,
492,GO:0001534,1,0.976283782237601,0,4,radial spoke,CC,
493,GO:0001536,1,0.981989306383522,0,3,radial spoke stalk,CC,
494,GO:0001537,1,0.969850579065735,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
495,GO:0001539,1,0.785961109524274,0,31,cilium or flagellum-dependent cell motility,BP,
496,GO:0001540,1,0.691006305155355,0,55,amyloid-beta binding,MF,
498,GO:0001542,1,0.930572161078978,0,9,ovulation from ovarian follicle,BP,
499,GO:0001543,1,0.990035385288247,0,1,ovarian follicle rupture,BP,
500,GO:0001544,1,0.990242720548869,0,1,initiation of primordial ovarian follicle growth,BP,
501,GO:0001545,1,0.993270962511823,0,1,primary ovarian follicle growth,BP,
502,GO:0001546,1,0.983498180421263,0,3,preantral ovarian follicle growth,BP,
503,GO:0001547,1,0.955831682953583,0,6,antral ovarian follicle growth,BP,
504,GO:0001550,1,0.984705511864492,0,2,ovarian cumulus expansion,BP,
505,GO:0001552,1,0.994492153968498,0,1,ovarian follicle atresia,BP,
506,GO:0001553,1,0.937601545948883,0,9,luteinization,BP,
507,GO:0001554,1,0.963748525667288,0,5,luteolysis,BP,
508,GO:0001555,1,0.982871772962438,0,3,oocyte growth,BP,
509,GO:0001556,1,0.878236261746473,0,20,oocyte maturation,BP,
511,GO:0001560,1,0.974948152857339,0,3,regulation of cell growth by extracellular stimulus,BP,
512,GO:0001561,1,0.954157856833974,0,8,fatty acid alpha-oxidation,BP,
513,GO:0001562,1,0.891914616957129,0,18,response to protozoan,BP,
514,GO:0001567,1,0.994596231431731,0,1,cholesterol 25-hydroxylase activity,MF,
518,GO:0001572,1,0.992586309730429,0,1,lactosylceramide biosynthetic process,BP,
521,GO:0001575,1,0.988984806682151,0,2,globoside metabolic process,BP,
522,GO:0001576,1,0.994453824998501,0,1,globoside biosynthetic process,BP,
523,GO:0001578,1,0.570610376849635,0,77,microtubule bundle formation,BP,
524,GO:0001579,1,0.987811003428464,0,2,medium-chain fatty acid transport,BP,
526,GO:0001581,1,0.994027159713676,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
527,GO:0001582,1,0.99429028007077,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
528,GO:0001587,1,0.99264656713459,0,1,Gq/11-coupled serotonin receptor activity,MF,
529,GO:0001588,1,0.977588023138715,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
530,GO:0001591,1,0.983182966016384,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
531,GO:0001595,1,0.983711198802958,0,3,angiotensin receptor activity,MF,
532,GO:0001596,1,0.994380025312847,0,1,angiotensin type I receptor activity,MF,
533,GO:0001601,1,0.982446893755838,0,3,peptide YY receptor activity,MF,
534,GO:0001602,1,0.97770748481463,0,4,pancreatic polypeptide receptor activity,MF,
535,GO:0001604,1,0.989228518359997,0,2,urotensin II receptor activity,MF,
536,GO:0001605,1,0.981771979121929,0,3,adrenomedullin receptor activity,MF,
537,GO:0001607,1,0.988384262270815,0,2,neuromedin U receptor activity,MF,
538,GO:0001608,1,0.933760455831869,0,12,G-protein coupled nucleotide receptor activity,MF,
539,GO:0001609,1,0.966490028326024,0,6,G-protein coupled adenosine receptor activity,MF,
540,GO:0001614,1,0.897373394087603,0,19,purinergic nucleotide receptor activity,MF,
541,GO:0001618,1,0.655434528873058,0,64,virus receptor activity,MF,
542,GO:0001621,1,0.994580182308155,0,1,ADP receptor activity,MF,
543,GO:0001626,1,0.993884943826343,0,1,nociceptin receptor activity,MF,
544,GO:0001631,1,0.966600258823513,0,6,cysteinyl leukotriene receptor activity,MF,
545,GO:0001632,1,0.988330752450836,0,2,leukotriene B4 receptor activity,MF,
546,GO:0001635,1,0.981395235434595,0,3,calcitonin gene-related peptide receptor activity,MF,
548,GO:0001640,1,0.954857422739705,0,6,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
549,GO:0001641,1,0.987385885892003,0,2,group II metabotropic glutamate receptor activity,MF,
550,GO:0001642,1,0.978255519334094,0,3,group III metabotropic glutamate receptor activity,MF,
552,GO:0001650,1,0.434273564901347,0,126,fibrillar center,CC,
553,GO:0001651,1,0.994620140326158,0,1,dense fibrillar component,CC,
554,GO:0001652,1,0.970683836863735,0,5,granular component,CC,
558,GO:0001656,1,0.555969058855298,0,81,metanephros development,BP,
559,GO:0001657,1,0.525997445501934,0,92,ureteric bud development,BP,
560,GO:0001658,1,0.683753302296342,0,54,branching involved in ureteric bud morphogenesis,BP,
561,GO:0001659,1,0.800231081121,0,35,temperature homeostasis,BP,
562,GO:0001660,1,0.938755345916056,0,10,fever generation,BP,
564,GO:0001662,1,0.794346353040983,0,35,behavioral fear response,BP,
566,GO:0001665,1,0.967000188444215,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
569,GO:0001669,1,0.598434548063243,0,80,acrosomal vesicle,CC,
570,GO:0001671,1,0.862803583849247,0,25,ATPase activator activity,MF,
571,GO:0001672,1,0.933560149265506,0,9,regulation of chromatin assembly or disassembly,BP,
572,GO:0001673,1,0.932403422537137,0,11,male germ cell nucleus,CC,
573,GO:0001674,1,0.994409983251703,0,1,female germ cell nucleus,CC,
574,GO:0001675,1,0.941263219475349,0,8,acrosome assembly,BP,
575,GO:0001676,1,0.585280075031741,0,86,long-chain fatty acid metabolic process,BP,
577,GO:0001680,1,0.994396973404851,0,1,tRNA 3'-terminal CCA addition,BP,
578,GO:0001681,1,0.994154109412701,0,1,sialate O-acetylesterase activity,MF,
579,GO:0001682,1,0.93318887093066,0,12,tRNA 5'-leader removal,BP,
580,GO:0001692,1,0.983558672655804,0,3,histamine metabolic process,BP,
581,GO:0001694,1,0.994349397078446,0,1,histamine biosynthetic process,BP,
582,GO:0001695,1,0.99464301845219,0,1,histamine catabolic process,BP,
583,GO:0001696,1,0.907728430516453,0,16,gastric acid secretion,BP,
584,GO:0001697,1,0.99416606875801,0,1,histamine-induced gastric acid secretion,BP,
585,GO:0001698,1,0.988861225915905,0,2,gastrin-induced gastric acid secretion,BP,
587,GO:0001702,1,0.826945735647744,0,25,gastrulation with mouth forming second,BP,
589,GO:0001705,1,0.987077600117949,0,2,ectoderm formation,BP,
591,GO:0001707,1,0.658389499559058,0,62,mesoderm formation,BP,
592,GO:0001708,1,0.610824240424723,0,74,cell fate specification,BP,
594,GO:0001710,1,0.903886057033996,0,17,mesodermal cell fate commitment,BP,
595,GO:0001711,1,0.912424925688569,0,15,endodermal cell fate commitment,BP,
596,GO:0001712,1,0.987077600117949,0,2,ectodermal cell fate commitment,BP,
597,GO:0001714,1,0.956215256081258,0,8,endodermal cell fate specification,BP,
598,GO:0001715,1,0.993447538755277,0,1,ectodermal cell fate specification,BP,
599,GO:0001716,1,0.994462987974902,0,1,L-amino-acid oxidase activity,MF,
600,GO:0001725,1,0.682975748879393,0,52,stress fiber,CC,
602,GO:0001727,1,0.966042785554209,0,5,lipid kinase activity,MF,
603,GO:0001729,1,0.98706468770413,0,2,ceramide kinase activity,MF,
604,GO:0001730,1,0.973928818727346,0,4,2'-5'-oligoadenylate synthetase activity,MF,
605,GO:0001731,1,0.947730741941322,0,8,formation of translation preinitiation complex,BP,
606,GO:0001732,1,0.98664355621097,0,2,formation of cytoplasmic translation initiation complex,BP,
607,GO:0001733,1,0.97745940981757,0,4,galactosylceramide sulfotransferase activity,MF,
608,GO:0001735,1,0.986397496251184,0,2,prenylcysteine oxidase activity,MF,
609,GO:0001736,1,0.460067067284419,0,117,establishment of planar polarity,BP,
610,GO:0001738,1,0.410794212642126,0,132,morphogenesis of a polarized epithelium,BP,
611,GO:0001739,1,0.970377368808895,0,5,sex chromatin,CC,
612,GO:0001740,1,0.978080034137693,0,3,Barr body,CC,
613,GO:0001741,1,0.927678496512634,0,12,XY body,CC,
614,GO:0001743,1,0.978634719940007,0,3,optic placode formation,BP,
616,GO:0001754,1,0.767395927046275,0,38,eye photoreceptor cell differentiation,BP,
617,GO:0001755,1,0.72986147050537,0,46,neural crest cell migration,BP,
618,GO:0001756,1,0.658968443212107,0,57,somitogenesis,BP,
619,GO:0001757,1,0.969767858917911,0,5,somite specification,BP,
620,GO:0001758,1,0.96084904146766,0,7,retinal dehydrogenase activity,MF,
621,GO:0001759,1,0.896558702232768,0,18,organ induction,BP,
625,GO:0001766,1,0.947333305716387,0,9,membrane raft polarization,BP,
626,GO:0001767,1,0.92929305133451,0,10,establishment of lymphocyte polarity,BP,
627,GO:0001768,1,0.938253478325223,0,9,establishment of T cell polarity,BP,
628,GO:0001770,1,0.990455934964258,0,1,establishment of natural killer cell polarity,BP,
631,GO:0001773,1,0.866359056944088,0,24,myeloid dendritic cell activation,BP,
632,GO:0001774,1,0.840218884867373,0,25,microglial cell activation,BP,
635,GO:0001777,1,0.983276231616027,0,3,T cell homeostatic proliferation,BP,
636,GO:0001778,1,0.961391714733672,0,5,plasma membrane repair,BP,
637,GO:0001779,1,0.894631372464909,0,17,natural killer cell differentiation,BP,
640,GO:0001782,1,0.825275707985095,0,28,B cell homeostasis,BP,
641,GO:0001783,1,0.868986878319532,0,22,B cell apoptotic process,BP,
643,GO:0001785,1,0.988320062730126,0,2,prostaglandin J receptor activity,MF,
644,GO:0001786,1,0.783969513202708,0,37,phosphatidylserine binding,MF,
645,GO:0001787,1,0.957918678647894,0,7,natural killer cell proliferation,BP,
646,GO:0001788,1,0.994560847088753,0,1,antibody-dependent cellular cytotoxicity,BP,
647,GO:0001791,1,0.994538009917527,0,1,IgM binding,MF,
648,GO:0001792,1,0.993075613281789,0,1,polymeric immunoglobulin receptor activity,MF,
649,GO:0001794,1,0.981620159031878,0,3,type IIa hypersensitivity,BP,
650,GO:0001796,1,0.981620159031878,0,3,regulation of type IIa hypersensitivity,BP,
651,GO:0001797,1,0.994560847088753,0,1,negative regulation of type IIa hypersensitivity,BP,
652,GO:0001798,1,0.986989246099525,0,2,positive regulation of type IIa hypersensitivity,BP,
653,GO:0001802,1,0.988952755139182,0,2,type III hypersensitivity,BP,
654,GO:0001803,1,0.988952755139182,0,2,regulation of type III hypersensitivity,BP,
655,GO:0001805,1,0.988952755139182,0,2,positive regulation of type III hypersensitivity,BP,
656,GO:0001806,1,0.983178196363735,0,3,type IV hypersensitivity,BP,
657,GO:0001807,1,0.989089904372687,0,2,regulation of type IV hypersensitivity,BP,
658,GO:0001808,1,0.994466597769599,0,1,negative regulation of type IV hypersensitivity,BP,
659,GO:0001809,1,0.994593689207107,0,1,positive regulation of type IV hypersensitivity,BP,
660,GO:0001810,1,0.983573093202474,0,3,regulation of type I hypersensitivity,BP,
661,GO:0001811,1,0.994560847088753,0,1,negative regulation of type I hypersensitivity,BP,
662,GO:0001812,1,0.988952755139182,0,2,positive regulation of type I hypersensitivity,BP,
663,GO:0001813,1,0.994560847088753,0,1,regulation of antibody-dependent cellular cytotoxicity,BP,
664,GO:0001814,1,0.994560847088753,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
669,GO:0001820,1,0.942063440409614,0,10,serotonin secretion,BP,
670,GO:0001821,1,0.950399155305622,0,9,histamine secretion,BP,
671,GO:0001822,1,0.168099945049081,0,246,kidney development,BP,
672,GO:0001823,1,0.509313434223658,0,96,mesonephros development,BP,
673,GO:0001824,1,0.702658615395905,0,54,blastocyst development,BP,
674,GO:0001825,1,0.848558874699208,0,25,blastocyst formation,BP,
675,GO:0001826,1,0.95528177647575,0,6,inner cell mass cell differentiation,BP,
676,GO:0001827,1,0.984601811850911,0,2,inner cell mass cell fate commitment,BP,
677,GO:0001828,1,0.979060627152699,0,3,inner cell mass cellular morphogenesis,BP,
678,GO:0001829,1,0.925425140057564,0,12,trophectodermal cell differentiation,BP,
679,GO:0001831,1,0.985234638933093,0,2,trophectodermal cellular morphogenesis,BP,
680,GO:0001832,1,0.893575748796875,0,16,blastocyst growth,BP,
681,GO:0001833,1,0.927396005317407,0,11,inner cell mass cell proliferation,BP,
682,GO:0001834,1,0.984541963706032,0,2,trophectodermal cell proliferation,BP,
683,GO:0001835,1,0.99390356047142,0,1,blastocyst hatching,BP,
684,GO:0001836,1,0.724115643329785,0,54,release of cytochrome c from mitochondria,BP,
687,GO:0001839,1,0.960961874271387,0,6,neural plate morphogenesis,BP,
688,GO:0001840,1,0.93688011086551,0,9,neural plate development,BP,
690,GO:0001842,1,0.954786113983227,0,7,neural fold formation,BP,
692,GO:0001844,1,0.825295270736101,0,32,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
693,GO:0001845,1,0.924074201543173,0,12,phagolysosome assembly,BP,
695,GO:0001847,1,0.971883481383423,0,4,opsonin receptor activity,MF,
698,GO:0001850,1,0.994517899353661,0,1,complement component C3a binding,MF,
699,GO:0001851,1,0.970048954306654,0,4,complement component C3b binding,MF,
700,GO:0001855,1,0.983100357057152,0,2,complement component C4b binding,MF,
701,GO:0001856,1,0.994375841828217,0,1,complement component C5a binding,MF,
702,GO:0001861,1,0.988473912080574,0,1,complement component C4b receptor activity,MF,
703,GO:0001865,1,0.948498879813951,0,8,NK T cell differentiation,BP,
704,GO:0001866,1,0.971195506177401,0,5,NK T cell proliferation,BP,
710,GO:0001875,1,0.968102622836946,0,5,lipopolysaccharide receptor activity,MF,
712,GO:0001880,1,0.978775189500993,0,3,Mullerian duct regression,BP,
716,GO:0001884,1,0.986168194071878,0,2,pyrimidine nucleoside binding,MF,
717,GO:0001885,1,0.691891491421175,0,53,endothelial cell development,BP,
718,GO:0001886,1,0.927993310158385,0,10,endothelial cell morphogenesis,BP,
719,GO:0001887,1,0.97062715388972,0,5,selenium compound metabolic process,BP,
720,GO:0001888,1,0.985496156274138,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
728,GO:0001897,1,0.988663882122091,0,2,cytolysis by symbiont of host cells,BP,
729,GO:0001905,1,0.976019749557517,0,3,activation of membrane attack complex,BP,
731,GO:0001907,1,0.970698634689607,0,5,killing by symbiont of host cells,BP,
732,GO:0001909,1,0.629537955146647,0,76,leukocyte mediated cytotoxicity,BP,
733,GO:0001910,1,0.732262804545692,0,52,regulation of leukocyte mediated cytotoxicity,BP,
734,GO:0001911,1,0.920929393045084,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,
735,GO:0001912,1,0.823387826441631,0,32,positive regulation of leukocyte mediated cytotoxicity,BP,
736,GO:0001913,1,0.850062264180427,0,27,T cell mediated cytotoxicity,BP,
737,GO:0001914,1,0.888524618411289,0,20,regulation of T cell mediated cytotoxicity,BP,
738,GO:0001915,1,0.963863072807569,0,6,negative regulation of T cell mediated cytotoxicity,BP,
739,GO:0001916,1,0.932006676979125,0,12,positive regulation of T cell mediated cytotoxicity,BP,
742,GO:0001920,1,0.976188843555374,0,4,negative regulation of receptor recycling,BP,
744,GO:0001922,1,0.978223076484873,0,3,B-1 B cell homeostasis,BP,
745,GO:0001923,1,0.980398627812504,0,3,B-1 B cell differentiation,BP,
746,GO:0001927,1,0.979777208291281,0,3,exocyst assembly,BP,
747,GO:0001928,1,0.994402887276554,0,1,regulation of exocyst assembly,BP,
748,GO:0001931,1,0.918748484698789,0,13,uropod,CC,
753,GO:0001936,1,0.483106463139587,0,105,regulation of endothelial cell proliferation,BP,
754,GO:0001937,1,0.80406330969207,0,31,negative regulation of endothelial cell proliferation,BP,
755,GO:0001938,1,0.580876315473781,0,78,positive regulation of endothelial cell proliferation,BP,
756,GO:0001939,1,0.960292023379333,0,6,female pronucleus,CC,
757,GO:0001940,1,0.960057214924648,0,5,male pronucleus,CC,
763,GO:0001947,1,0.689740632598977,0,55,heart looping,BP,
764,GO:0001949,1,0.994343367723908,0,1,sebaceous gland cell differentiation,BP,
765,GO:0001951,1,0.974456163265335,0,4,intestinal D-glucose absorption,BP,
769,GO:0001955,1,0.946320729303474,0,8,blood vessel maturation,BP,
770,GO:0001956,1,0.912605242505498,0,13,positive regulation of neurotransmitter secretion,BP,
774,GO:0001960,1,0.750091498541047,0,44,negative regulation of cytokine-mediated signaling pathway,BP,
775,GO:0001961,1,0.756041585208144,0,43,positive regulation of cytokine-mediated signaling pathway,BP,
776,GO:0001963,1,0.855849021934253,0,26,synaptic transmission, dopaminergic,BP,
778,GO:0001965,1,0.879490810066999,0,21,G-protein alpha-subunit binding,MF,
779,GO:0001966,1,0.994597808007503,0,1,thigmotaxis,BP,
781,GO:0001968,1,0.841066840509907,0,25,fibronectin binding,MF,
782,GO:0001969,1,0.976019749557517,0,3,regulation of activation of membrane attack complex,BP,
783,GO:0001970,1,0.985946564220963,0,2,positive regulation of activation of membrane attack complex,BP,
784,GO:0001971,1,0.989933106778457,0,1,negative regulation of activation of membrane attack complex,BP,
785,GO:0001972,1,0.921568066942186,0,12,retinoic acid binding,MF,
786,GO:0001973,1,0.929611702067564,0,12,adenosine receptor signaling pathway,BP,
787,GO:0001974,1,0.756139408767868,0,39,blood vessel remodeling,BP,
789,GO:0001976,1,0.929570561635418,0,11,neurological system process involved in regulation of systemic arterial blood pressure,BP,
790,GO:0001977,1,0.930364367134585,0,12,renal system process involved in regulation of blood volume,BP,
791,GO:0001978,1,0.994426645811938,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
792,GO:0001979,1,0.994543877670426,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
793,GO:0001980,1,0.994647274403834,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
794,GO:0001983,1,0.994426645811938,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
795,GO:0001985,1,0.994426645811938,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
796,GO:0001990,1,0.837403523503706,0,29,regulation of systemic arterial blood pressure by hormone,BP,
797,GO:0001991,1,0.922280110613509,0,13,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
798,GO:0001992,1,0.975344484045736,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
799,GO:0001993,1,0.945689020037046,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
800,GO:0001994,1,0.977628203014291,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
801,GO:0001996,1,0.972888635092688,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
802,GO:0001997,1,0.988606045231761,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
803,GO:0001998,1,0.994497393747748,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
804,GO:0001999,1,0.975844322015771,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
805,GO:0002001,1,0.975844322015771,0,4,renin secretion into blood stream,BP,
806,GO:0002002,1,0.945122933835124,0,9,regulation of angiotensin levels in blood,BP,
807,GO:0002003,1,0.945122933835124,0,9,angiotensin maturation,BP,
808,GO:0002007,1,0.994543877670426,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
811,GO:0002016,1,0.965260152197846,0,6,regulation of blood volume by renin-angiotensin,BP,
812,GO:0002017,1,0.994506408044933,0,1,regulation of blood volume by renal aldosterone,BP,
813,GO:0002018,1,0.988693540835202,0,2,renin-angiotensin regulation of aldosterone production,BP,
814,GO:0002019,1,0.982860235457327,0,3,regulation of renal output by angiotensin,BP,
816,GO:0002021,1,0.882087434412965,0,19,response to dietary excess,BP,
817,GO:0002023,1,0.99446096213131,0,1,reduction of food intake in response to dietary excess,BP,
818,GO:0002024,1,0.951973867462781,0,8,diet induced thermogenesis,BP,
819,GO:0002025,1,0.982965828016709,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
822,GO:0002028,1,0.569327482318386,0,80,regulation of sodium ion transport,BP,
824,GO:0002030,1,0.994120638582788,0,1,inhibitory G-protein coupled receptor phosphorylation,BP,
826,GO:0002032,1,0.988998712228271,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
827,GO:0002034,1,0.977745332893957,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
828,GO:0002035,1,0.98199894098245,0,3,brain renin-angiotensin system,BP,
829,GO:0002036,1,0.966164264557324,0,5,regulation of L-glutamate import across plasma membrane,BP,
830,GO:0002037,1,0.994443932436071,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
831,GO:0002038,1,0.99440059907078,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
832,GO:0002039,1,0.620031665970666,0,68,p53 binding,MF,
834,GO:0002041,1,0.994391969959294,0,1,intussusceptive angiogenesis,BP,
836,GO:0002043,1,0.903166652147436,0,15,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
837,GO:0002046,1,0.994637657247556,0,1,opsin binding,MF,
838,GO:0002051,1,0.966746097756327,0,4,osteoblast fate commitment,BP,
839,GO:0002052,1,0.868011266408572,0,20,positive regulation of neuroblast proliferation,BP,
840,GO:0002053,1,0.837270274625899,0,27,positive regulation of mesenchymal cell proliferation,BP,
841,GO:0002054,1,0.977802563774727,0,4,nucleobase binding,MF,
842,GO:0002055,1,0.994653599427905,0,1,adenine binding,MF,
843,GO:0002058,1,0.994443069044359,0,1,uracil binding,MF,
844,GO:0002059,1,0.994443069044359,0,1,thymine binding,MF,
845,GO:0002060,1,0.983267433525912,0,3,purine nucleobase binding,MF,
846,GO:0002061,1,0.994443069044359,0,1,pyrimidine nucleobase binding,MF,
847,GO:0002062,1,0.534285619235642,0,89,chondrocyte differentiation,BP,
848,GO:0002063,1,0.843757005450019,0,23,chondrocyte development,BP,
851,GO:0002066,1,0.704581960080038,0,51,columnar/cuboidal epithelial cell development,BP,
852,GO:0002067,1,0.756514469529966,0,42,glandular epithelial cell differentiation,BP,
853,GO:0002068,1,0.853360982214388,0,23,glandular epithelial cell development,BP,
854,GO:0002069,1,0.965998784298569,0,6,columnar/cuboidal epithelial cell maturation,BP,
855,GO:0002070,1,0.909028302705574,0,14,epithelial cell maturation,BP,
856,GO:0002071,1,0.988643532445578,0,2,glandular epithelial cell maturation,BP,
857,GO:0002072,1,0.937900072160513,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
858,GO:0002074,1,0.963592161574702,0,5,extraocular skeletal muscle development,BP,
859,GO:0002076,1,0.886710340721708,0,17,osteoblast development,BP,
860,GO:0002077,1,0.994596627672202,0,1,acrosome matrix dispersal,BP,
861,GO:0002079,1,0.977795398509946,0,3,inner acrosomal membrane,CC,
862,GO:0002080,1,0.898619336672146,0,17,acrosomal membrane,CC,
863,GO:0002081,1,0.98378859899215,0,2,outer acrosomal membrane,CC,
864,GO:0002082,1,0.911476515357162,0,15,regulation of oxidative phosphorylation,BP,
865,GO:0002083,1,0.994554632768503,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
866,GO:0002084,1,0.948151178139442,0,9,protein depalmitoylation,BP,
867,GO:0002085,1,0.971668483574888,0,4,inhibition of neuroepithelial cell differentiation,BP,
868,GO:0002086,1,0.988332484217337,0,2,diaphragm contraction,BP,
869,GO:0002087,1,0.922552340939384,0,12,regulation of respiratory gaseous exchange by neurological system process,BP,
871,GO:0002089,1,0.88410280543374,0,16,lens morphogenesis in camera-type eye,BP,
872,GO:0002090,1,0.796749690719874,0,35,regulation of receptor internalization,BP,
873,GO:0002091,1,0.943767768976825,0,9,negative regulation of receptor internalization,BP,
874,GO:0002092,1,0.86339835712847,0,22,positive regulation of receptor internalization,BP,
875,GO:0002093,1,0.919797164877164,0,12,auditory receptor cell morphogenesis,BP,
876,GO:0002094,1,0.98845763879829,0,2,polyprenyltransferase activity,MF,
877,GO:0002097,1,0.908782852801325,0,16,tRNA wobble base modification,BP,
878,GO:0002098,1,0.933335658827086,0,12,tRNA wobble uridine modification,BP,
879,GO:0002100,1,0.991231720385043,0,1,tRNA wobble adenosine to inosine editing,BP,
880,GO:0002101,1,0.982326238503904,0,3,tRNA wobble cytosine modification,BP,
881,GO:0002102,1,0.801768606820944,0,32,podosome,CC,
882,GO:0002113,1,0.994393645419597,0,1,interleukin-33 binding,MF,
883,GO:0002114,1,0.987908410293115,0,2,interleukin-33 receptor activity,MF,
884,GO:0002115,1,0.899356560418286,0,16,store-operated calcium entry,BP,
885,GO:0002116,1,0.905906991680217,0,11,semaphorin receptor complex,CC,
886,GO:0002118,1,0.958593310817098,0,7,aggressive behavior,BP,
887,GO:0002121,1,0.987773515261914,0,2,inter-male aggressive behavior,BP,
888,GO:0002125,1,0.987740675858107,0,2,maternal aggressive behavior,BP,
889,GO:0002127,1,0.994587439197288,0,1,tRNA wobble base cytosine methylation,BP,
890,GO:0002133,1,0.977056276461382,0,2,polycystin complex,CC,
891,GO:0002134,1,0.986168194071878,0,2,UTP binding,MF,
892,GO:0002135,1,0.994296200941556,0,1,CTP binding,MF,
894,GO:0002139,1,0.965056003501942,0,4,stereocilia coupling link,CC,
895,GO:0002140,1,0.990190990905559,0,1,stereocilia tip link,CC,
896,GO:0002141,1,0.974618486700701,0,3,stereocilia ankle link,CC,
897,GO:0002142,1,0.974618486700701,0,3,stereocilia ankle link complex,CC,
898,GO:0002143,1,0.97799364867754,0,4,tRNA wobble position uridine thiolation,BP,
899,GO:0002144,1,0.994449625774454,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
900,GO:0002148,1,0.993923299380449,0,1,hypochlorous acid metabolic process,BP,
901,GO:0002149,1,0.993923299380449,0,1,hypochlorous acid biosynthetic process,BP,
902,GO:0002151,1,0.949185353613432,0,6,G-quadruplex RNA binding,MF,
903,GO:0002152,1,0.993779383629816,0,1,bile acid conjugation,BP,
904,GO:0002153,1,0.994345827435354,0,1,steroid receptor RNA activator RNA binding,MF,
905,GO:0002154,1,0.959656257122871,0,5,thyroid hormone mediated signaling pathway,BP,
906,GO:0002155,1,0.979533501837813,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
907,GO:0002158,1,0.96973996943456,0,5,osteoclast proliferation,BP,
908,GO:0002159,1,0.970247393246685,0,4,desmosome assembly,BP,
909,GO:0002161,1,0.932503497455977,0,11,aminoacyl-tRNA editing activity,MF,
910,GO:0002162,1,0.932638731695984,0,8,dystroglycan binding,MF,
911,GO:0002169,1,0.987912894644403,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
912,GO:0002174,1,0.994102481539163,0,1,mammary stem cell proliferation,BP,
913,GO:0002175,1,0.967252966823436,0,4,protein localization to paranode region of axon,BP,
914,GO:0002176,1,0.967166836873869,0,6,male germ cell proliferation,BP,
915,GO:0002177,1,0.961109646900098,0,7,manchette,CC,
916,GO:0002178,1,0.934858505101104,0,11,palmitoyltransferase complex,CC,
917,GO:0002181,1,0.603604483853051,0,84,cytoplasmic translation,BP,
918,GO:0002182,1,0.93830815971915,0,10,cytoplasmic translational elongation,BP,
919,GO:0002183,1,0.887576766059914,0,18,cytoplasmic translational initiation,BP,
920,GO:0002184,1,0.984604227528067,0,2,cytoplasmic translational termination,BP,
921,GO:0002188,1,0.974509561821362,0,3,translation reinitiation,BP,
922,GO:0002189,1,0.994299343894086,0,1,ribose phosphate diphosphokinase complex,CC,
923,GO:0002190,1,0.97265141594213,0,5,cap-independent translational initiation,BP,
924,GO:0002191,1,0.981296831956331,0,3,cap-dependent translational initiation,BP,
925,GO:0002192,1,0.989229486441169,0,2,IRES-dependent translational initiation of linear mRNA,BP,
926,GO:0002193,1,0.974783772648207,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
927,GO:0002194,1,0.994022802320081,0,1,hepatocyte cell migration,BP,
928,GO:0002196,1,0.9945021752321,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
929,GO:0002199,1,0.955644978098905,0,8,zona pellucida receptor complex,CC,
930,GO:0002200,1,0.675069303185801,0,57,somatic diversification of immune receptors,BP,
931,GO:0002204,1,0.777208933921275,0,39,somatic recombination of immunoglobulin genes involved in immune response,BP,
932,GO:0002208,1,0.777208933921275,0,39,somatic diversification of immunoglobulins involved in immune response,BP,
933,GO:0002209,1,0.794346353040983,0,35,behavioral defense response,BP,
934,GO:0002215,1,0.988410811821072,0,2,defense response to nematode,BP,
936,GO:0002220,1,0.503472251260571,0,108,innate immune response activating cell surface receptor signaling pathway,BP,
938,GO:0002223,1,0.51187177662625,0,105,stimulatory C-type lectin receptor signaling pathway,BP,
940,GO:0002225,1,0.989113566180237,0,2,positive regulation of antimicrobial peptide production,BP,
942,GO:0002228,1,0.72589159566872,0,52,natural killer cell mediated immunity,BP,
943,GO:0002230,1,0.870097990773492,0,21,positive regulation of defense response to virus by host,BP,
944,GO:0002232,1,0.989012132003515,0,2,leukocyte chemotaxis involved in inflammatory response,BP,
946,GO:0002238,1,0.98668770822577,0,2,response to molecule of fungal origin,BP,
947,GO:0002244,1,0.364063016432459,0,158,hematopoietic progenitor cell differentiation,BP,
948,GO:0002246,1,0.96500888165445,0,6,wound healing involved in inflammatory response,BP,
949,GO:0002248,1,0.970278982567561,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
950,GO:0002249,1,0.966243906358988,0,5,lymphocyte anergy,BP,
955,GO:0002254,1,0.98338579941327,0,3,kinin cascade,BP,
956,GO:0002260,1,0.675370156141708,0,60,lymphocyte homeostasis,BP,
959,GO:0002265,1,0.969415396879459,0,3,astrocyte activation involved in immune response,BP,
960,GO:0002266,1,0.983188908824234,0,3,follicular dendritic cell activation,BP,
961,GO:0002268,1,0.988566490472146,0,2,follicular dendritic cell differentiation,BP,
964,GO:0002276,1,0.987640353554567,0,2,basophil activation involved in immune response,BP,
965,GO:0002277,1,0.980578806292288,0,3,myeloid dendritic cell activation involved in immune response,BP,
966,GO:0002278,1,0.977665455338287,0,4,eosinophil activation involved in immune response,BP,
968,GO:0002281,1,0.944316299282735,0,9,macrophage activation involved in immune response,BP,
969,GO:0002282,1,0.988237702541078,0,2,microglial cell activation involved in immune response,BP,
974,GO:0002290,1,0.994142758058285,0,1,gamma-delta T cell activation involved in immune response,BP,
979,GO:0002295,1,0.920798948047096,0,13,T-helper cell lineage commitment,BP,
980,GO:0002296,1,0.984034736008384,0,2,T-helper 1 cell lineage commitment,BP,
981,GO:0002298,1,0.994549014331626,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
982,GO:0002299,1,0.994568231100213,0,1,alpha-beta intraepithelial T cell differentiation,BP,
983,GO:0002300,1,0.994568231100213,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
984,GO:0002302,1,0.994209621620465,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
985,GO:0002304,1,0.994568231100213,0,1,gamma-delta intraepithelial T cell differentiation,BP,
986,GO:0002305,1,0.994568231100213,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
987,GO:0002309,1,0.977077076185587,0,4,T cell proliferation involved in immune response,BP,
988,GO:0002312,1,0.6694787083833,0,61,B cell activation involved in immune response,BP,
989,GO:0002313,1,0.892085726145869,0,17,mature B cell differentiation involved in immune response,BP,
990,GO:0002314,1,0.982596278841954,0,3,germinal center B cell differentiation,BP,
991,GO:0002315,1,0.933465841520422,0,9,marginal zone B cell differentiation,BP,
992,GO:0002316,1,0.987683436908958,0,2,follicular B cell differentiation,BP,
993,GO:0002317,1,0.983803176177364,0,3,plasma cell differentiation,BP,
994,GO:0002318,1,0.968174364991912,0,5,myeloid progenitor cell differentiation,BP,
995,GO:0002320,1,0.875646152038259,0,18,lymphoid progenitor cell differentiation,BP,
996,GO:0002322,1,0.965990364912593,0,5,B cell proliferation involved in immune response,BP,
997,GO:0002323,1,0.951210191101043,0,8,natural killer cell activation involved in immune response,BP,
998,GO:0002325,1,0.989221085826123,0,2,natural killer cell differentiation involved in immune response,BP,
999,GO:0002326,1,0.971836598057979,0,3,B cell lineage commitment,BP,
1000,GO:0002327,1,0.938923578772985,0,7,immature B cell differentiation,BP,
1001,GO:0002328,1,0.919458121328402,0,10,pro-B cell differentiation,BP,
1002,GO:0002329,1,0.962827053600544,0,4,pre-B cell differentiation,BP,
1003,GO:0002331,1,0.978032339529909,0,2,pre-B cell allelic exclusion,BP,
1004,GO:0002332,1,0.991812068390637,0,1,transitional stage B cell differentiation,BP,
1005,GO:0002333,1,0.991812068390637,0,1,transitional one stage B cell differentiation,BP,
1006,GO:0002335,1,0.868343079375968,0,21,mature B cell differentiation,BP,
1007,GO:0002337,1,0.987914712254529,0,2,B-1a B cell differentiation,BP,
1008,GO:0002339,1,0.983425627990272,0,3,B cell selection,BP,
1009,GO:0002343,1,0.994261404124983,0,1,peripheral B cell selection,BP,
1010,GO:0002344,1,0.994261404124983,0,1,B cell affinity maturation,BP,
1011,GO:0002347,1,0.904604178930587,0,17,response to tumor cell,BP,
1012,GO:0002349,1,0.966765733358507,0,6,histamine production involved in inflammatory response,BP,
1013,GO:0002351,1,0.981300351259249,0,3,serotonin production involved in inflammatory response,BP,
1014,GO:0002352,1,0.989102307278357,0,2,B cell negative selection,BP,
1015,GO:0002353,1,0.98338579941327,0,3,plasma kallikrein-kinin cascade,BP,
1016,GO:0002355,1,0.994344126061647,0,1,detection of tumor cell,BP,
1017,GO:0002357,1,0.982785596759977,0,3,defense response to tumor cell,BP,
1018,GO:0002358,1,0.994649325112124,0,1,B cell homeostatic proliferation,BP,
1019,GO:0002360,1,0.866537742469416,0,21,T cell lineage commitment,BP,
1020,GO:0002361,1,0.977725547913452,0,4,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1021,GO:0002362,1,0.994376891960695,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1022,GO:0002363,1,0.904602519086971,0,16,alpha-beta T cell lineage commitment,BP,
1024,GO:0002367,1,0.624928780037608,0,76,cytokine production involved in immune response,BP,
1025,GO:0002368,1,0.988676791251111,0,2,B cell cytokine production,BP,
1026,GO:0002369,1,0.834316964704469,0,30,T cell cytokine production,BP,
1027,GO:0002370,1,0.987204989032537,0,2,natural killer cell cytokine production,BP,
1028,GO:0002371,1,0.958332442738588,0,6,dendritic cell cytokine production,BP,
1029,GO:0002373,1,0.994640518331712,0,1,plasmacytoid dendritic cell cytokine production,BP,
1030,GO:0002374,1,0.90418446014996,0,16,cytokine secretion involved in immune response,BP,
1033,GO:0002378,1,0.979602897311328,0,3,immunoglobulin biosynthetic process,BP,
1034,GO:0002380,1,0.992878361887491,0,1,immunoglobulin secretion involved in immune response,BP,
1036,GO:0002384,1,0.987858318124822,0,2,hepatic immune response,BP,
1038,GO:0002386,1,0.987609675089213,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1039,GO:0002396,1,0.973243280265181,0,5,MHC protein complex assembly,BP,
1040,GO:0002397,1,0.994498334316267,0,1,MHC class I protein complex assembly,BP,
1041,GO:0002399,1,0.978628528805286,0,4,MHC class II protein complex assembly,BP,
1042,GO:0002407,1,0.873425447579552,0,22,dendritic cell chemotaxis,BP,
1043,GO:0002408,1,0.975894123311437,0,4,myeloid dendritic cell chemotaxis,BP,
1044,GO:0002414,1,0.98220831510695,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1045,GO:0002415,1,0.987609675089213,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1046,GO:0002416,1,0.994531556294423,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1047,GO:0002418,1,0.920165907571657,0,14,immune response to tumor cell,BP,
1048,GO:0002420,1,0.947163485194608,0,9,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1049,GO:0002423,1,0.947163485194608,0,9,natural killer cell mediated immune response to tumor cell,BP,
1050,GO:0002424,1,0.988198549922319,0,2,T cell mediated immune response to tumor cell,BP,
1051,GO:0002426,1,0.994614608811986,0,1,immunoglobulin production in mucosal tissue,BP,
1052,GO:0002428,1,0.98257974108643,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1054,GO:0002430,1,0.95040174227343,0,8,complement receptor mediated signaling pathway,BP,
1055,GO:0002431,1,0.615612715171507,0,75,Fc receptor mediated stimulatory signaling pathway,BP,
1056,GO:0002432,1,0.992953302098973,0,1,granuloma formation,BP,
1057,GO:0002433,1,0.634652735334656,0,70,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1058,GO:0002434,1,0.988906221245587,0,2,immune complex clearance,BP,
1059,GO:0002436,1,0.988906221245587,0,2,immune complex clearance by monocytes and macrophages,BP,
1061,GO:0002438,1,0.893855922424575,0,19,acute inflammatory response to antigenic stimulus,BP,
1062,GO:0002439,1,0.978265607218358,0,4,chronic inflammatory response to antigenic stimulus,BP,
1064,GO:0002441,1,0.966765733358507,0,6,histamine secretion involved in inflammatory response,BP,
1065,GO:0002442,1,0.981300351259249,0,3,serotonin secretion involved in inflammatory response,BP,
1068,GO:0002445,1,0.981620159031878,0,3,type II hypersensitivity,BP,
1070,GO:0002447,1,0.977665455338287,0,4,eosinophil mediated immunity,BP,
1073,GO:0002450,1,0.994560847088753,0,1,B cell antigen processing and presentation,BP,
1075,GO:0002456,1,0.634650868370459,0,74,T cell mediated immunity,BP,
1076,GO:0002457,1,0.969287622038288,0,5,T cell antigen processing and presentation,BP,
1077,GO:0002458,1,0.98885445848026,0,2,peripheral T cell tolerance induction,BP,
1079,GO:0002461,1,0.983297868781781,0,3,tolerance induction dependent upon immune response,BP,
1080,GO:0002465,1,0.98885445848026,0,2,peripheral tolerance induction,BP,
1081,GO:0002467,1,0.902618580537198,0,15,germinal center formation,BP,
1082,GO:0002468,1,0.945112162512527,0,9,dendritic cell antigen processing and presentation,BP,
1084,GO:0002475,1,0.956951227809724,0,7,antigen processing and presentation via MHC class Ib,BP,
1085,GO:0002476,1,0.987878518758326,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1086,GO:0002477,1,0.994636858150569,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1088,GO:0002479,1,0.673286841849215,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1089,GO:0002480,1,0.955919374406443,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1090,GO:0002481,1,0.994636858150569,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1091,GO:0002483,1,0.949948632577971,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1092,GO:0002488,1,0.993294602112599,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1093,GO:0002489,1,0.993294602112599,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1095,GO:0002501,1,0.978505780883162,0,4,peptide antigen assembly with MHC protein complex,BP,
1096,GO:0002502,1,0.994498334316267,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1097,GO:0002503,1,0.983919855288857,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1099,GO:0002505,1,0.989263002615058,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1100,GO:0002506,1,0.989263002615058,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1101,GO:0002507,1,0.864425254913112,0,23,tolerance induction,BP,
1102,GO:0002508,1,0.988734663192922,0,2,central tolerance induction,BP,
1103,GO:0002509,1,0.994446650305785,0,1,central tolerance induction to self antigen,BP,
1104,GO:0002510,1,0.994256434345611,0,1,central B cell tolerance induction,BP,
1105,GO:0002513,1,0.970349385273144,0,5,tolerance induction to self antigen,BP,
1106,GO:0002514,1,0.987023677110137,0,2,B cell tolerance induction,BP,
1107,GO:0002517,1,0.926912311519941,0,12,T cell tolerance induction,BP,
1108,GO:0002518,1,0.994616672573995,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1109,GO:0002519,1,0.988960745986574,0,2,natural killer cell tolerance induction,BP,
1112,GO:0002522,1,0.988814241917195,0,2,leukocyte migration involved in immune response,BP,
1113,GO:0002523,1,0.937586055102367,0,11,leukocyte migration involved in inflammatory response,BP,
1114,GO:0002524,1,0.954217905865776,0,8,hypersensitivity,BP,
1115,GO:0002525,1,0.983068279286114,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1117,GO:0002528,1,0.983771181601385,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1119,GO:0002534,1,0.826750310908697,0,30,cytokine production involved in inflammatory response,BP,
1120,GO:0002536,1,0.983660654403416,0,3,respiratory burst involved in inflammatory response,BP,
1121,GO:0002537,1,0.981905882891184,0,2,nitric oxide production involved in inflammatory response,BP,
1124,GO:0002541,1,0.983329320988605,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1125,GO:0002542,1,0.988896535566567,0,2,Factor XII activation,BP,
1126,GO:0002543,1,0.98702714054699,0,2,activation of blood coagulation via clotting cascade,BP,
1127,GO:0002544,1,0.902089074383142,0,17,chronic inflammatory response,BP,
1128,GO:0002545,1,0.994505954161315,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1130,GO:0002551,1,0.939251403793275,0,10,mast cell chemotaxis,BP,
1131,GO:0002553,1,0.966765733358507,0,6,histamine secretion by mast cell,BP,
1132,GO:0002554,1,0.981300351259249,0,3,serotonin secretion by platelet,BP,
1133,GO:0002560,1,0.993154938853001,0,1,basophil mediated immunity,BP,
1134,GO:0002561,1,0.993154938853001,0,1,basophil degranulation,BP,
1135,GO:0002562,1,0.704904023442831,0,51,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1136,GO:0002566,1,0.923847680845234,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1137,GO:0002568,1,0.956840946264534,0,5,somatic diversification of T cell receptor genes,BP,
1138,GO:0002572,1,0.987403028405364,0,2,pro-T cell differentiation,BP,
1141,GO:0002577,1,0.903597844683907,0,17,regulation of antigen processing and presentation,BP,
1142,GO:0002578,1,0.958412604628981,0,7,negative regulation of antigen processing and presentation,BP,
1143,GO:0002579,1,0.948031731904985,0,9,positive regulation of antigen processing and presentation,BP,
1144,GO:0002580,1,0.969629628374142,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1145,GO:0002581,1,0.980115531601188,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1146,GO:0002582,1,0.989303498470618,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1147,GO:0002583,1,0.967075606130816,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1148,GO:0002584,1,0.977534168117171,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1149,GO:0002585,1,0.989303498470618,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1150,GO:0002586,1,0.977793763308988,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1151,GO:0002587,1,0.988367064984783,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1152,GO:0002588,1,0.989303498470618,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1153,GO:0002589,1,0.989040878193631,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1154,GO:0002590,1,0.989040878193631,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1155,GO:0002604,1,0.945112162512527,0,9,regulation of dendritic cell antigen processing and presentation,BP,
1156,GO:0002605,1,0.986258120223114,0,2,negative regulation of dendritic cell antigen processing and presentation,BP,
1157,GO:0002606,1,0.958286392998634,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1158,GO:0002622,1,0.994560847088753,0,1,regulation of B cell antigen processing and presentation,BP,
1159,GO:0002625,1,0.989037242630743,0,2,regulation of T cell antigen processing and presentation,BP,
1160,GO:0002626,1,0.994490947237411,0,1,negative regulation of T cell antigen processing and presentation,BP,
1161,GO:0002634,1,0.938718761953662,0,9,regulation of germinal center formation,BP,
1162,GO:0002635,1,0.98139454272058,0,2,negative regulation of germinal center formation,BP,
1163,GO:0002636,1,0.983918528246353,0,3,positive regulation of germinal center formation,BP,
1164,GO:0002637,1,0.721515876477068,0,52,regulation of immunoglobulin production,BP,
1165,GO:0002638,1,0.934651818077445,0,10,negative regulation of immunoglobulin production,BP,
1166,GO:0002639,1,0.81108291400164,0,34,positive regulation of immunoglobulin production,BP,
1167,GO:0002640,1,0.994184768585909,0,1,regulation of immunoglobulin biosynthetic process,BP,
1168,GO:0002642,1,0.994184768585909,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1169,GO:0002643,1,0.900587890205301,0,16,regulation of tolerance induction,BP,
1170,GO:0002644,1,0.994447645442063,0,1,negative regulation of tolerance induction,BP,
1171,GO:0002645,1,0.94124519210509,0,9,positive regulation of tolerance induction,BP,
1172,GO:0002646,1,0.994256434345611,0,1,regulation of central tolerance induction,BP,
1173,GO:0002648,1,0.994256434345611,0,1,positive regulation of central tolerance induction,BP,
1174,GO:0002649,1,0.99272587850566,0,1,regulation of tolerance induction to self antigen,BP,
1175,GO:0002651,1,0.99272587850566,0,1,positive regulation of tolerance induction to self antigen,BP,
1176,GO:0002652,1,0.988789581136055,0,2,regulation of tolerance induction dependent upon immune response,BP,
1177,GO:0002654,1,0.994376891960695,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1178,GO:0002658,1,0.994376891960695,0,1,regulation of peripheral tolerance induction,BP,
1179,GO:0002660,1,0.994376891960695,0,1,positive regulation of peripheral tolerance induction,BP,
1180,GO:0002661,1,0.987023677110137,0,2,regulation of B cell tolerance induction,BP,
1181,GO:0002663,1,0.987023677110137,0,2,positive regulation of B cell tolerance induction,BP,
1182,GO:0002664,1,0.937482272086586,0,10,regulation of T cell tolerance induction,BP,
1183,GO:0002666,1,0.956817885961952,0,7,positive regulation of T cell tolerance induction,BP,
1184,GO:0002667,1,0.966243906358988,0,5,regulation of T cell anergy,BP,
1185,GO:0002669,1,0.980175174137862,0,3,positive regulation of T cell anergy,BP,
1187,GO:0002674,1,0.941819565130307,0,9,negative regulation of acute inflammatory response,BP,
1188,GO:0002675,1,0.861084116272948,0,25,positive regulation of acute inflammatory response,BP,
1189,GO:0002676,1,0.953938895095261,0,8,regulation of chronic inflammatory response,BP,
1190,GO:0002677,1,0.97501654704568,0,4,negative regulation of chronic inflammatory response,BP,
1191,GO:0002678,1,0.978387676106344,0,4,positive regulation of chronic inflammatory response,BP,
1192,GO:0002679,1,0.956806481561579,0,7,respiratory burst involved in defense response,BP,
1193,GO:0002681,1,0.956840946264534,0,5,somatic recombination of T cell receptor gene segments,BP,
1203,GO:0002691,1,0.868395921793856,0,22,regulation of cellular extravasation,BP,
1204,GO:0002692,1,0.94701776050346,0,8,negative regulation of cellular extravasation,BP,
1205,GO:0002693,1,0.927130533474343,0,12,positive regulation of cellular extravasation,BP,
1212,GO:0002700,1,0.519279848177111,0,104,regulation of production of molecular mediator of immune response,BP,
1213,GO:0002701,1,0.824553541120675,0,30,negative regulation of production of molecular mediator of immune response,BP,
1214,GO:0002702,1,0.656256685919958,0,68,positive regulation of production of molecular mediator of immune response,BP,
1215,GO:0002703,1,0.387464793505581,0,152,regulation of leukocyte mediated immunity,BP,
1216,GO:0002704,1,0.777758180512971,0,41,negative regulation of leukocyte mediated immunity,BP,
1217,GO:0002705,1,0.571289898484539,0,90,positive regulation of leukocyte mediated immunity,BP,
1218,GO:0002706,1,0.506438863675089,0,110,regulation of lymphocyte mediated immunity,BP,
1219,GO:0002707,1,0.829778545746851,0,31,negative regulation of lymphocyte mediated immunity,BP,
1220,GO:0002708,1,0.642897198849811,0,71,positive regulation of lymphocyte mediated immunity,BP,
1221,GO:0002709,1,0.750861258572303,0,48,regulation of T cell mediated immunity,BP,
1222,GO:0002710,1,0.916708684627797,0,15,negative regulation of T cell mediated immunity,BP,
1223,GO:0002711,1,0.838956110076595,0,29,positive regulation of T cell mediated immunity,BP,
1224,GO:0002712,1,0.769582655626779,0,41,regulation of B cell mediated immunity,BP,
1225,GO:0002713,1,0.943698017060582,0,9,negative regulation of B cell mediated immunity,BP,
1226,GO:0002714,1,0.837656565298043,0,28,positive regulation of B cell mediated immunity,BP,
1227,GO:0002715,1,0.817428339237038,0,33,regulation of natural killer cell mediated immunity,BP,
1228,GO:0002716,1,0.937230790431947,0,11,negative regulation of natural killer cell mediated immunity,BP,
1229,GO:0002717,1,0.877648488447384,0,21,positive regulation of natural killer cell mediated immunity,BP,
1230,GO:0002718,1,0.688435802957476,0,60,regulation of cytokine production involved in immune response,BP,
1231,GO:0002719,1,0.877403168458413,0,21,negative regulation of cytokine production involved in immune response,BP,
1232,GO:0002720,1,0.804441831400074,0,35,positive regulation of cytokine production involved in immune response,BP,
1233,GO:0002721,1,0.994261404124983,0,1,regulation of B cell cytokine production,BP,
1234,GO:0002724,1,0.880248654995524,0,21,regulation of T cell cytokine production,BP,
1235,GO:0002725,1,0.96682810328583,0,6,negative regulation of T cell cytokine production,BP,
1236,GO:0002726,1,0.91662510874875,0,14,positive regulation of T cell cytokine production,BP,
1237,GO:0002727,1,0.987204989032537,0,2,regulation of natural killer cell cytokine production,BP,
1238,GO:0002728,1,0.99290868086761,0,1,negative regulation of natural killer cell cytokine production,BP,
1239,GO:0002729,1,0.994255980289904,0,1,positive regulation of natural killer cell cytokine production,BP,
1240,GO:0002730,1,0.965827787441066,0,5,regulation of dendritic cell cytokine production,BP,
1241,GO:0002731,1,0.986672177267534,0,2,negative regulation of dendritic cell cytokine production,BP,
1242,GO:0002732,1,0.992884705063123,0,1,positive regulation of dendritic cell cytokine production,BP,
1243,GO:0002736,1,0.994640518331712,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1244,GO:0002737,1,0.994640518331712,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1245,GO:0002739,1,0.922758182355784,0,13,regulation of cytokine secretion involved in immune response,BP,
1246,GO:0002740,1,0.971245944556673,0,5,negative regulation of cytokine secretion involved in immune response,BP,
1247,GO:0002741,1,0.955917331471229,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1248,GO:0002752,1,0.989102337180252,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1249,GO:0002753,1,0.708379243334368,0,51,cytoplasmic pattern recognition receptor signaling pathway,BP,
1250,GO:0002755,1,0.796840687587499,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1251,GO:0002756,1,0.830487454955303,0,30,MyD88-independent toll-like receptor signaling pathway,BP,
1254,GO:0002759,1,0.977385271230283,0,4,regulation of antimicrobial humoral response,BP,
1255,GO:0002760,1,0.989113566180237,0,2,positive regulation of antimicrobial humoral response,BP,
1258,GO:0002763,1,0.760933707979145,0,42,positive regulation of myeloid leukocyte differentiation,BP,
1260,GO:0002765,1,0.966220676740099,0,6,immune response-inhibiting signal transduction,BP,
1261,GO:0002767,1,0.971598468418497,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1263,GO:0002769,1,0.994435186910565,0,1,natural killer cell inhibitory signaling pathway,BP,
1264,GO:0002774,1,0.982376921062204,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1265,GO:0002775,1,0.9775097399369,0,4,antimicrobial peptide production,BP,
1266,GO:0002777,1,0.994641709959346,0,1,antimicrobial peptide biosynthetic process,BP,
1267,GO:0002778,1,0.9775097399369,0,4,antibacterial peptide production,BP,
1268,GO:0002780,1,0.994641709959346,0,1,antibacterial peptide biosynthetic process,BP,
1269,GO:0002784,1,0.982776655839199,0,3,regulation of antimicrobial peptide production,BP,
1270,GO:0002785,1,0.993594043504133,0,1,negative regulation of antimicrobial peptide production,BP,
1271,GO:0002786,1,0.982776655839199,0,3,regulation of antibacterial peptide production,BP,
1272,GO:0002787,1,0.993594043504133,0,1,negative regulation of antibacterial peptide production,BP,
1277,GO:0002803,1,0.989113566180237,0,2,positive regulation of antibacterial peptide production,BP,
1278,GO:0002812,1,0.994641709959346,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1279,GO:0002818,1,0.994645706095718,0,1,intracellular defense response,BP,
1281,GO:0002820,1,0.807613019714317,0,34,negative regulation of adaptive immune response,BP,
1284,GO:0002823,1,0.821677512346737,0,31,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1287,GO:0002826,1,0.958468225359593,0,7,negative regulation of T-helper 1 type immune response,BP,
1291,GO:0002830,1,0.915098538704993,0,15,positive regulation of type 2 immune response,BP,
1295,GO:0002834,1,0.935979545283074,0,11,regulation of response to tumor cell,BP,
1296,GO:0002835,1,0.988160293597428,0,2,negative regulation of response to tumor cell,BP,
1297,GO:0002836,1,0.953131017971858,0,8,positive regulation of response to tumor cell,BP,
1298,GO:0002837,1,0.935979545283074,0,11,regulation of immune response to tumor cell,BP,
1299,GO:0002838,1,0.988160293597428,0,2,negative regulation of immune response to tumor cell,BP,
1300,GO:0002839,1,0.953131017971858,0,8,positive regulation of immune response to tumor cell,BP,
1301,GO:0002840,1,0.988198549922319,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1302,GO:0002842,1,0.99438347696915,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1303,GO:0002849,1,0.994376891960695,0,1,regulation of peripheral T cell tolerance induction,BP,
1304,GO:0002851,1,0.994376891960695,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1305,GO:0002855,1,0.947163485194608,0,9,regulation of natural killer cell mediated immune response to tumor cell,BP,
1306,GO:0002856,1,0.988160293597428,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1307,GO:0002857,1,0.958516826570223,0,7,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1308,GO:0002858,1,0.947163485194608,0,9,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1309,GO:0002859,1,0.988160293597428,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1310,GO:0002860,1,0.958516826570223,0,7,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1313,GO:0002863,1,0.940761743720597,0,10,positive regulation of inflammatory response to antigenic stimulus,BP,
1314,GO:0002864,1,0.935941154657501,0,11,regulation of acute inflammatory response to antigenic stimulus,BP,
1315,GO:0002865,1,0.977687565352809,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1316,GO:0002866,1,0.957310301359248,0,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1317,GO:0002870,1,0.966243906358988,0,5,T cell anergy,BP,
1318,GO:0002874,1,0.983783928249348,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1319,GO:0002875,1,0.994556759398708,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1320,GO:0002876,1,0.989168797565106,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1321,GO:0002877,1,0.983068279286114,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1322,GO:0002878,1,0.993957679579771,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1323,GO:0002879,1,0.989045063378497,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1324,GO:0002880,1,0.994505954161315,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1325,GO:0002882,1,0.994505954161315,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1326,GO:0002883,1,0.959957201637326,0,7,regulation of hypersensitivity,BP,
1327,GO:0002884,1,0.989057242185271,0,2,negative regulation of hypersensitivity,BP,
1328,GO:0002885,1,0.970581194047978,0,5,positive regulation of hypersensitivity,BP,
1329,GO:0002886,1,0.766135286560759,0,43,regulation of myeloid leukocyte mediated immunity,BP,
1330,GO:0002887,1,0.939766432451605,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1331,GO:0002888,1,0.878717983927423,0,21,positive regulation of myeloid leukocyte mediated immunity,BP,
1332,GO:0002889,1,0.769582655626779,0,41,regulation of immunoglobulin mediated immune response,BP,
1333,GO:0002890,1,0.943698017060582,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1334,GO:0002891,1,0.837656565298043,0,28,positive regulation of immunoglobulin mediated immune response,BP,
1335,GO:0002892,1,0.981620159031878,0,3,regulation of type II hypersensitivity,BP,
1336,GO:0002893,1,0.994560847088753,0,1,negative regulation of type II hypersensitivity,BP,
1337,GO:0002894,1,0.986989246099525,0,2,positive regulation of type II hypersensitivity,BP,
1338,GO:0002895,1,0.994256434345611,0,1,regulation of central B cell tolerance induction,BP,
1339,GO:0002897,1,0.994256434345611,0,1,positive regulation of central B cell tolerance induction,BP,
1340,GO:0002901,1,0.978022394299884,0,4,mature B cell apoptotic process,BP,
1341,GO:0002902,1,0.896627220347331,0,17,regulation of B cell apoptotic process,BP,
1342,GO:0002903,1,0.933089550500159,0,11,negative regulation of B cell apoptotic process,BP,
1343,GO:0002904,1,0.980254741330205,0,3,positive regulation of B cell apoptotic process,BP,
1344,GO:0002905,1,0.978022394299884,0,4,regulation of mature B cell apoptotic process,BP,
1345,GO:0002906,1,0.978022394299884,0,4,negative regulation of mature B cell apoptotic process,BP,
1346,GO:0002911,1,0.966243906358988,0,5,regulation of lymphocyte anergy,BP,
1347,GO:0002913,1,0.980175174137862,0,3,positive regulation of lymphocyte anergy,BP,
1350,GO:0002922,1,0.933436995962158,0,12,positive regulation of humoral immune response,BP,
1351,GO:0002923,1,0.945685433656406,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1352,GO:0002924,1,0.966541101543866,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1353,GO:0002925,1,0.97842963493894,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1354,GO:0002930,1,0.986799088722859,0,2,trabecular meshwork development,BP,
1355,GO:0002931,1,0.804814225113483,0,32,response to ischemia,BP,
1356,GO:0002933,1,0.983396956846813,0,3,lipid hydroxylation,BP,
1357,GO:0002934,1,0.933739312487181,0,9,desmosome organization,BP,
1358,GO:0002940,1,0.988641837009903,0,2,tRNA N2-guanine methylation,BP,
1359,GO:0002943,1,0.977816556722841,0,4,tRNA dihydrouridine synthesis,BP,
1360,GO:0002944,1,0.983840259812542,0,2,cyclin K-CDK12 complex,CC,
1361,GO:0002945,1,0.985088977664637,0,2,cyclin K-CDK13 complex,CC,
1362,GO:0002946,1,0.994587439197288,0,1,tRNA C5-cytosine methylation,BP,
1363,GO:0002947,1,0.993209945334547,0,1,tumor necrosis factor receptor superfamily complex,CC,
1364,GO:0002949,1,0.98355807289507,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1365,GO:0002950,1,0.979566847883675,0,3,ceramide phosphoethanolamine synthase activity,MF,
1366,GO:0002951,1,0.988712552611516,0,2,leukotriene-C(4) hydrolase,MF,
1369,GO:0003007,1,0.196906397434541,0,223,heart morphogenesis,BP,
1371,GO:0003009,1,0.794394669669132,0,36,skeletal muscle contraction,BP,
1372,GO:0003010,1,0.965485763457749,0,5,voluntary skeletal muscle contraction,BP,
1373,GO:0003011,1,0.980801180714834,0,3,involuntary skeletal muscle contraction,BP,
1378,GO:0003016,1,0.82556627394419,0,29,respiratory system process,BP,
1379,GO:0003017,1,0.988612532818545,0,1,lymph circulation,BP,
1381,GO:0003025,1,0.975970345266993,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1382,GO:0003026,1,0.994184768585909,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1383,GO:0003027,1,0.994543877670426,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1384,GO:0003029,1,0.994543877670426,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1385,GO:0003032,1,0.988385158923844,0,2,detection of oxygen,BP,
1386,GO:0003044,1,0.78759956986095,0,39,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1387,GO:0003050,1,0.992455723007578,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1388,GO:0003051,1,0.98199894098245,0,3,angiotensin-mediated drinking behavior,BP,
1389,GO:0003056,1,0.951500863312348,0,7,regulation of vascular smooth muscle contraction,BP,
1390,GO:0003057,1,0.97206904864454,0,5,regulation of the force of heart contraction by chemical signal,BP,
1391,GO:0003058,1,0.994612382336904,0,1,hormonal regulation of the force of heart contraction,BP,
1392,GO:0003062,1,0.958571760111732,0,6,regulation of heart rate by chemical signal,BP,
1393,GO:0003064,1,0.988490307077007,0,2,regulation of heart rate by hormone,BP,
1394,GO:0003065,1,0.994525930314966,0,1,positive regulation of heart rate by epinephrine,BP,
1395,GO:0003068,1,0.994633718411125,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1396,GO:0003069,1,0.994633718411125,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1397,GO:0003070,1,0.994633718411125,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1398,GO:0003071,1,0.89875896305583,0,18,renal system process involved in regulation of systemic arterial blood pressure,BP,
1399,GO:0003072,1,0.977745332893957,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1401,GO:0003081,1,0.896571726892535,0,18,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1402,GO:0003083,1,0.994656308629671,0,1,negative regulation of renal output by angiotensin,BP,
1403,GO:0003084,1,0.942518118082893,0,9,positive regulation of systemic arterial blood pressure,BP,
1404,GO:0003085,1,0.920763310155002,0,13,negative regulation of systemic arterial blood pressure,BP,
1405,GO:0003091,1,0.811393115371568,0,29,renal water homeostasis,BP,
1406,GO:0003093,1,0.940648586562164,0,10,regulation of glomerular filtration,BP,
1407,GO:0003094,1,0.908157126238493,0,15,glomerular filtration,BP,
1408,GO:0003095,1,0.994537422946554,0,1,pressure natriuresis,BP,
1409,GO:0003096,1,0.967518971252908,0,5,renal sodium ion transport,BP,
1410,GO:0003097,1,0.971283240457643,0,5,renal water transport,BP,
1411,GO:0003099,1,0.983279204404019,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1412,GO:0003100,1,0.964972360399783,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1413,GO:0003104,1,0.976770988792917,0,4,positive regulation of glomerular filtration,BP,
1414,GO:0003105,1,0.976262006758759,0,4,negative regulation of glomerular filtration,BP,
1415,GO:0003106,1,0.994656308629671,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1416,GO:0003127,1,0.981150874546019,0,2,detection of nodal flow,BP,
1417,GO:0003128,1,0.93109059293768,0,10,heart field specification,BP,
1418,GO:0003129,1,0.977829026204289,0,4,heart induction,BP,
1419,GO:0003130,1,0.988532458065961,0,2,BMP signaling pathway involved in heart induction,BP,
1420,GO:0003131,1,0.99416184066975,0,1,mesodermal-endodermal cell signaling,BP,
1421,GO:0003133,1,0.988532458065961,0,2,endodermal-mesodermal cell signaling,BP,
1422,GO:0003134,1,0.988532458065961,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1423,GO:0003137,1,0.994621263909854,0,1,Notch signaling pathway involved in heart induction,BP,
1424,GO:0003138,1,0.991187324387002,0,1,primary heart field specification,BP,
1425,GO:0003139,1,0.936221446732452,0,9,secondary heart field specification,BP,
1426,GO:0003140,1,0.949318803687981,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1427,GO:0003142,1,0.994373027526835,0,1,cardiogenic plate morphogenesis,BP,
1428,GO:0003143,1,0.652646766909922,0,61,embryonic heart tube morphogenesis,BP,
1429,GO:0003147,1,0.994631736805621,0,1,neural crest cell migration involved in heart formation,BP,
1430,GO:0003148,1,0.835308607071717,0,25,outflow tract septum morphogenesis,BP,
1431,GO:0003149,1,0.942890237431585,0,9,membranous septum morphogenesis,BP,
1432,GO:0003150,1,0.965376060016993,0,5,muscular septum morphogenesis,BP,
1433,GO:0003151,1,0.610182721299691,0,71,outflow tract morphogenesis,BP,
1434,GO:0003156,1,0.816863987838491,0,32,regulation of animal organ formation,BP,
1435,GO:0003157,1,0.925656893257685,0,11,endocardium development,BP,
1438,GO:0003160,1,0.960984541201036,0,6,endocardium morphogenesis,BP,
1439,GO:0003161,1,0.919442857948091,0,12,cardiac conduction system development,BP,
1440,GO:0003162,1,0.974909602674131,0,3,atrioventricular node development,BP,
1441,GO:0003163,1,0.979373934771071,0,3,sinoatrial node development,BP,
1442,GO:0003164,1,0.967556597547009,0,5,His-Purkinje system development,BP,
1443,GO:0003165,1,0.986330476546732,0,2,Purkinje myocyte development,BP,
1444,GO:0003166,1,0.975569147428118,0,4,bundle of His development,BP,
1445,GO:0003167,1,0.992643329103543,0,1,atrioventricular bundle cell differentiation,BP,
1446,GO:0003168,1,0.994496922073288,0,1,Purkinje myocyte differentiation,BP,
1447,GO:0003169,1,0.982258175494444,0,2,coronary vein morphogenesis,BP,
1448,GO:0003170,1,0.75223092808029,0,38,heart valve development,BP,
1449,GO:0003171,1,0.843585119689081,0,23,atrioventricular valve development,BP,
1450,GO:0003172,1,0.991187324387002,0,1,sinoatrial valve development,BP,
1451,GO:0003174,1,0.922156599389989,0,10,mitral valve development,BP,
1452,GO:0003175,1,0.956060340200866,0,6,tricuspid valve development,BP,
1453,GO:0003176,1,0.961332204674815,0,6,aortic valve development,BP,
1454,GO:0003177,1,0.921021189972588,0,11,pulmonary valve development,BP,
1455,GO:0003179,1,0.771342145877656,0,34,heart valve morphogenesis,BP,
1456,GO:0003180,1,0.961332204674815,0,6,aortic valve morphogenesis,BP,
1457,GO:0003181,1,0.852980820402613,0,21,atrioventricular valve morphogenesis,BP,
1458,GO:0003183,1,0.922156599389989,0,10,mitral valve morphogenesis,BP,
1459,GO:0003184,1,0.921021189972588,0,11,pulmonary valve morphogenesis,BP,
1460,GO:0003185,1,0.991187324387002,0,1,sinoatrial valve morphogenesis,BP,
1461,GO:0003186,1,0.961290014689601,0,5,tricuspid valve morphogenesis,BP,
1462,GO:0003188,1,0.91465067454121,0,12,heart valve formation,BP,
1463,GO:0003190,1,0.943094181794167,0,7,atrioventricular valve formation,BP,
1464,GO:0003192,1,0.969940059310809,0,3,mitral valve formation,BP,
1465,GO:0003193,1,0.99456187456426,0,1,pulmonary valve formation,BP,
1466,GO:0003195,1,0.988182723909817,0,2,tricuspid valve formation,BP,
1467,GO:0003197,1,0.760158404334289,0,39,endocardial cushion development,BP,
1468,GO:0003198,1,0.896048714215851,0,16,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1469,GO:0003199,1,0.976003666305318,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1470,GO:0003203,1,0.819243187789042,0,29,endocardial cushion morphogenesis,BP,
1471,GO:0003205,1,0.348378237249826,0,145,cardiac chamber development,BP,
1472,GO:0003206,1,0.451676141438369,0,112,cardiac chamber morphogenesis,BP,
1473,GO:0003207,1,0.923929600362562,0,11,cardiac chamber formation,BP,
1474,GO:0003208,1,0.612906454681064,0,67,cardiac ventricle morphogenesis,BP,
1475,GO:0003209,1,0.814369791356241,0,28,cardiac atrium morphogenesis,BP,
1476,GO:0003210,1,0.994621263909854,0,1,cardiac atrium formation,BP,
1477,GO:0003211,1,0.934772939433271,0,9,cardiac ventricle formation,BP,
1478,GO:0003213,1,0.980196759322232,0,2,cardiac right atrium morphogenesis,BP,
1479,GO:0003214,1,0.905284766844397,0,13,cardiac left ventricle morphogenesis,BP,
1480,GO:0003215,1,0.880799172623566,0,18,cardiac right ventricle morphogenesis,BP,
1481,GO:0003218,1,0.993607541176219,0,1,cardiac left ventricle formation,BP,
1482,GO:0003219,1,0.977546705428614,0,3,cardiac right ventricle formation,BP,
1483,GO:0003220,1,0.972074665569429,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1484,GO:0003221,1,0.975090216342934,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1485,GO:0003222,1,0.883443939046275,0,16,ventricular trabecula myocardium morphogenesis,BP,
1486,GO:0003223,1,0.926037878348242,0,8,ventricular compact myocardium morphogenesis,BP,
1487,GO:0003226,1,0.987504400141169,0,1,right ventricular compact myocardium morphogenesis,BP,
1488,GO:0003228,1,0.963119498481798,0,6,atrial cardiac muscle tissue development,BP,
1489,GO:0003229,1,0.683081760466557,0,50,ventricular cardiac muscle tissue development,BP,
1490,GO:0003230,1,0.787218007669172,0,32,cardiac atrium development,BP,
1491,GO:0003231,1,0.446296834677233,0,110,cardiac ventricle development,BP,
1492,GO:0003235,1,0.994621263909854,0,1,sinus venosus development,BP,
1493,GO:0003236,1,0.994621263909854,0,1,sinus venosus morphogenesis,BP,
1494,GO:0003241,1,0.971974259964886,0,4,growth involved in heart morphogenesis,BP,
1495,GO:0003245,1,0.98862375156298,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1496,GO:0003247,1,0.994555166933378,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1497,GO:0003249,1,0.975305220108409,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003250,1,0.975305220108409,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1499,GO:0003251,1,0.988951803627041,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1500,GO:0003252,1,0.986202479797742,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1501,GO:0003253,1,0.958755506545965,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1502,GO:0003254,1,0.759161347161817,0,39,regulation of membrane depolarization,BP,
1503,GO:0003256,1,0.954482719570519,0,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1504,GO:0003257,1,0.977129600244821,0,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1505,GO:0003259,1,0.994621263909854,0,1,cardioblast anterior-lateral migration,BP,
1506,GO:0003260,1,0.994621263909854,0,1,cardioblast migration,BP,
1507,GO:0003263,1,0.948260750744501,0,9,cardioblast proliferation,BP,
1508,GO:0003264,1,0.937329320804392,0,10,regulation of cardioblast proliferation,BP,
1509,GO:0003266,1,0.942779178794832,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1510,GO:0003270,1,0.9884782076295,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1511,GO:0003272,1,0.863478126849666,0,21,endocardial cushion formation,BP,
1512,GO:0003273,1,0.964627184643464,0,4,cell migration involved in endocardial cushion formation,BP,
1513,GO:0003274,1,0.979187271988121,0,3,endocardial cushion fusion,BP,
1514,GO:0003275,1,0.980667585975433,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1515,GO:0003278,1,0.964333868290258,0,6,apoptotic process involved in heart morphogenesis,BP,
1516,GO:0003279,1,0.5030346539143,0,93,cardiac septum development,BP,
1517,GO:0003281,1,0.631886219920072,0,61,ventricular septum development,BP,
1518,GO:0003283,1,0.872989528901694,0,18,atrial septum development,BP,
1519,GO:0003284,1,0.972918983052654,0,4,septum primum development,BP,
1520,GO:0003285,1,0.988321521961104,0,2,septum secundum development,BP,
1521,GO:0003289,1,0.972918983052654,0,4,atrial septum primum morphogenesis,BP,
1522,GO:0003290,1,0.993790769979693,0,1,atrial septum secundum morphogenesis,BP,
1523,GO:0003292,1,0.986274815437435,0,2,cardiac septum cell differentiation,BP,
1524,GO:0003294,1,0.993986671338394,0,1,atrial ventricular junction remodeling,BP,
1525,GO:0003298,1,0.887680435052754,0,17,physiological muscle hypertrophy,BP,
1526,GO:0003299,1,0.850193928982145,0,22,muscle hypertrophy in response to stress,BP,
1527,GO:0003300,1,0.58821965099139,0,68,cardiac muscle hypertrophy,BP,
1528,GO:0003301,1,0.887680435052754,0,17,physiological cardiac muscle hypertrophy,BP,
1529,GO:0003306,1,0.950440561673547,0,8,Wnt signaling pathway involved in heart development,BP,
1530,GO:0003307,1,0.972170299805033,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1531,GO:0003308,1,0.977677242693316,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1532,GO:0003309,1,0.853423596221636,0,23,type B pancreatic cell differentiation,BP,
1533,GO:0003310,1,0.962422517289922,0,6,pancreatic A cell differentiation,BP,
1534,GO:0003312,1,0.988750680202742,0,2,pancreatic PP cell differentiation,BP,
1535,GO:0003318,1,0.994621263909854,0,1,cell migration to the midline involved in heart development,BP,
1536,GO:0003321,1,0.956450455847787,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1537,GO:0003322,1,0.990635580277061,0,1,pancreatic A cell development,BP,
1538,GO:0003323,1,0.877040516065583,0,19,type B pancreatic cell development,BP,
1539,GO:0003326,1,0.988750680202742,0,2,pancreatic A cell fate commitment,BP,
1540,GO:0003327,1,0.994458238154445,0,1,type B pancreatic cell fate commitment,BP,
1541,GO:0003329,1,0.988750680202742,0,2,pancreatic PP cell fate commitment,BP,
1542,GO:0003330,1,0.988499389605576,0,2,regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003331,1,0.988499389605576,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1544,GO:0003333,1,0.62117036725214,0,71,amino acid transmembrane transport,BP,
1545,GO:0003334,1,0.931592388103538,0,9,keratinocyte development,BP,
1546,GO:0003335,1,0.994602029458109,0,1,corneocyte development,BP,
1547,GO:0003337,1,0.922210018862189,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003338,1,0.800226267980433,0,31,metanephros morphogenesis,BP,
1549,GO:0003339,1,0.952379877991449,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003340,1,0.9821952163403,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1551,GO:0003341,1,0.644239500277805,0,60,cilium movement,BP,
1552,GO:0003342,1,0.988582854849619,0,2,proepicardium development,BP,
1553,GO:0003343,1,0.988582854849619,0,2,septum transversum development,BP,
1554,GO:0003344,1,0.92906445120654,0,9,pericardium morphogenesis,BP,
1555,GO:0003345,1,0.993426300576519,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1556,GO:0003348,1,0.955609928201569,0,6,cardiac endothelial cell differentiation,BP,
1557,GO:0003350,1,0.981262925528394,0,3,pulmonary myocardium development,BP,
1558,GO:0003351,1,0.886765728074747,0,19,epithelial cilium movement,BP,
1559,GO:0003352,1,0.916089875678726,0,13,regulation of cilium movement,BP,
1560,GO:0003353,1,0.994062274268454,0,1,positive regulation of cilium movement,BP,
1561,GO:0003356,1,0.932072016457887,0,10,regulation of cilium beat frequency,BP,
1562,GO:0003357,1,0.964886025005457,0,5,noradrenergic neuron differentiation,BP,
1563,GO:0003358,1,0.988523217556245,0,2,noradrenergic neuron development,BP,
1564,GO:0003359,1,0.994325157917915,0,1,noradrenergic neuron fate commitment,BP,
1565,GO:0003360,1,0.953523283963231,0,6,brainstem development,BP,
1566,GO:0003365,1,0.972216736655973,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1567,GO:0003366,1,0.985614114036137,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1568,GO:0003373,1,0.950503532164888,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1569,GO:0003374,1,0.950503532164888,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1570,GO:0003376,1,0.931117887910944,0,12,sphingosine-1-phosphate signaling pathway,BP,
1571,GO:0003382,1,0.824438852035097,0,26,epithelial cell morphogenesis,BP,
1572,GO:0003383,1,0.974477208235977,0,3,apical constriction,BP,
1573,GO:0003400,1,0.994431019935691,0,1,regulation of COPII vesicle coating,BP,
1574,GO:0003401,1,0.813167836963863,0,29,axis elongation,BP,
1575,GO:0003402,1,0.957007825347499,0,6,planar cell polarity pathway involved in axis elongation,BP,
1576,GO:0003404,1,0.988210474897621,0,2,optic vesicle morphogenesis,BP,
1577,GO:0003406,1,0.965645803120512,0,5,retinal pigment epithelium development,BP,
1578,GO:0003407,1,0.686570000877325,0,53,neural retina development,BP,
1579,GO:0003408,1,0.975283504535559,0,3,optic cup formation involved in camera-type eye development,BP,
1580,GO:0003409,1,0.993868907053491,0,1,optic cup structural organization,BP,
1581,GO:0003413,1,0.933739451696371,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1582,GO:0003414,1,0.993460807808773,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1583,GO:0003415,1,0.973727954299337,0,4,chondrocyte hypertrophy,BP,
1584,GO:0003416,1,0.86859591702234,0,21,endochondral bone growth,BP,
1585,GO:0003417,1,0.91715665029409,0,14,growth plate cartilage development,BP,
1586,GO:0003418,1,0.961858823106744,0,6,growth plate cartilage chondrocyte differentiation,BP,
1587,GO:0003419,1,0.977859453981494,0,4,growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003420,1,0.988422501071726,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1589,GO:0003421,1,0.993423377024051,0,1,growth plate cartilage axis specification,BP,
1590,GO:0003422,1,0.986926763392983,0,2,growth plate cartilage morphogenesis,BP,
1591,GO:0003429,1,0.993460807808773,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1592,GO:0003430,1,0.98692686353259,0,2,growth plate cartilage chondrocyte growth,BP,
1593,GO:0003431,1,0.973382287316504,0,4,growth plate cartilage chondrocyte development,BP,
1594,GO:0003433,1,0.961618336568081,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003678,1,0.725822446285374,0,45,DNA helicase activity,MF,
1599,GO:0003680,1,0.939801391161615,0,10,AT DNA binding,MF,
1600,GO:0003682,1,0.0311729385277245,0,494,chromatin binding,MF,
1601,GO:0003684,1,0.642641837213005,0,66,damaged DNA binding,MF,
1602,GO:0003688,1,0.91857079636705,0,14,DNA replication origin binding,MF,
1603,GO:0003689,1,0.95402757784798,0,8,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.94649702583771,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994426037792768,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.955433034043319,0,7,satellite DNA binding,MF,
1610,GO:0003705,1,0.543562813378775,0,91,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1611,GO:0003707,1,0.685114865904284,0,54,steroid hormone receptor activity,MF,
1612,GO:0003708,1,0.955763162373025,0,7,retinoic acid receptor activity,MF,
1614,GO:0003713,1,0.12226095386833,0,303,transcription coactivator activity,MF,
1616,GO:0003720,1,0.947314846408339,0,8,telomerase activity,MF,
1617,GO:0003721,1,0.993313444145808,0,1,telomerase RNA reverse transcriptase activity,MF,
1619,GO:0003724,1,0.655193109633221,0,65,RNA helicase activity,MF,
1621,GO:0003726,1,0.978012134830873,0,3,double-stranded RNA adenosine deaminase activity,MF,
1625,GO:0003735,1,0.43140646965722,0,153,structural constituent of ribosome,MF,
1626,GO:0003743,1,0.732301386373382,0,50,translation initiation factor activity,MF,
1627,GO:0003746,1,0.894176105404844,0,18,translation elongation factor activity,MF,
1628,GO:0003747,1,0.961217679649298,0,6,translation release factor activity,MF,
1629,GO:0003755,1,0.828599907943201,0,31,peptidyl-prolyl cis-trans isomerase activity,MF,
1630,GO:0003756,1,0.898753110945441,0,17,protein disulfide isomerase activity,MF,
1631,GO:0003774,1,0.341833072693562,0,125,motor activity,MF,
1632,GO:0003777,1,0.380896603239163,0,109,microtubule motor activity,MF,
1634,GO:0003785,1,0.848515089880418,0,25,actin monomer binding,MF,
1635,GO:0003796,1,0.983952051986515,0,3,lysozyme activity,MF,
1636,GO:0003810,1,0.965044267685897,0,6,protein-glutamine gamma-glutamyltransferase activity,MF,
1639,GO:0003826,1,0.988816235171628,0,2,alpha-ketoacid dehydrogenase activity,MF,
1640,GO:0003827,1,0.98829415344144,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003829,1,0.985679842414845,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003830,1,0.992393830819426,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1644,GO:0003831,1,0.950110854100658,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1645,GO:0003834,1,0.994184768585909,0,1,beta-carotene 15,15'-monooxygenase activity,MF,
1646,GO:0003835,1,0.983874187789834,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1647,GO:0003836,1,0.961966726914795,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1648,GO:0003837,1,0.994458785047521,0,1,beta-ureidopropionase activity,MF,
1649,GO:0003839,1,0.978172548959754,0,4,gamma-glutamylcyclotransferase activity,MF,
1650,GO:0003841,1,0.886497634384512,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1651,GO:0003842,1,0.99390356047142,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1652,GO:0003844,1,0.993996928868153,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1653,GO:0003845,1,0.989126847618159,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1654,GO:0003846,1,0.987922766401229,0,2,2-acylglycerol O-acyltransferase activity,MF,
1655,GO:0003847,1,0.972250945751422,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.983265082840411,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.94987111830635,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.987947212283128,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.994494907073519,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.988816235171628,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.988678909867638,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.992492201901996,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.98910379394863,0,2,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.98887657525347,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.982247657797246,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.973623655784252,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.994640893629188,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.988329949777265,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.986593857053435,0,2,AMP deaminase activity,MF,
1670,GO:0003877,1,0.994447787333467,0,1,ATP adenylyltransferase activity,MF,
1671,GO:0003878,1,0.993003961948249,0,1,ATP citrate synthase activity,MF,
1672,GO:0003880,1,0.981426358112072,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1673,GO:0003881,1,0.994507764327808,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1674,GO:0003882,1,0.994334162790485,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1675,GO:0003883,1,0.987585783503965,0,2,CTP synthase activity,MF,
1676,GO:0003884,1,0.989149427734643,0,2,D-amino-acid oxidase activity,MF,
1677,GO:0003886,1,0.978606831725792,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1678,GO:0003887,1,0.831480195140753,0,26,DNA-directed DNA polymerase activity,MF,
1679,GO:0003896,1,0.983253498228371,0,3,DNA primase activity,MF,
1680,GO:0003899,1,0.780213013539092,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1681,GO:0003905,1,0.994628139820451,0,1,alkylbase DNA N-glycosylase activity,MF,
1682,GO:0003906,1,0.929488564449226,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1683,GO:0003908,1,0.994609519864942,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1684,GO:0003909,1,0.958462052232615,0,7,DNA ligase activity,MF,
1685,GO:0003910,1,0.963816292904509,0,6,DNA ligase (ATP) activity,MF,
1686,GO:0003916,1,0.959842045579471,0,6,DNA topoisomerase activity,MF,
1687,GO:0003917,1,0.97545216829952,0,4,DNA topoisomerase type I activity,MF,
1688,GO:0003918,1,0.984000982745603,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1689,GO:0003919,1,0.99448445191223,0,1,FMN adenylyltransferase activity,MF,
1690,GO:0003920,1,0.989110810578272,0,2,GMP reductase activity,MF,
1691,GO:0003921,1,0.994328703111093,0,1,GMP synthase activity,MF,
1692,GO:0003922,1,0.994328703111093,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1693,GO:0003923,1,0.970624853845606,0,5,GPI-anchor transamidase activity,MF,
1695,GO:0003933,1,0.994489126009256,0,1,GTP cyclohydrolase activity,MF,
1696,GO:0003934,1,0.994489126009256,0,1,GTP cyclohydrolase I activity,MF,
1697,GO:0003937,1,0.994451312696892,0,1,IMP cyclohydrolase activity,MF,
1698,GO:0003938,1,0.988884933830412,0,2,IMP dehydrogenase activity,MF,
1699,GO:0003939,1,0.99430288163403,0,1,L-iditol 2-dehydrogenase activity,MF,
1700,GO:0003940,1,0.994423134073305,0,1,L-iduronidase activity,MF,
1701,GO:0003941,1,0.983565929638479,0,3,L-serine ammonia-lyase activity,MF,
1702,GO:0003943,1,0.987614527675578,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1703,GO:0003944,1,0.994419118478056,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1704,GO:0003945,1,0.976678040650794,0,4,N-acetyllactosamine synthase activity,MF,
1705,GO:0003947,1,0.994055349240198,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1706,GO:0003948,1,0.994453824998501,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1707,GO:0003950,1,0.879072589453981,0,19,NAD+ ADP-ribosyltransferase activity,MF,
1708,GO:0003951,1,0.894647413570187,0,16,NAD+ kinase activity,MF,
1709,GO:0003952,1,0.994336867640233,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1710,GO:0003953,1,0.989188540351826,0,2,NAD+ nucleosidase activity,MF,
1711,GO:0003954,1,0.803188744149876,0,40,NADH dehydrogenase activity,MF,
1712,GO:0003955,1,0.982799856805264,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1713,GO:0003956,1,0.983810146657291,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1714,GO:0003957,1,0.992715761880479,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1715,GO:0003958,1,0.959292221832661,0,6,NADPH-hemoprotein reductase activity,MF,
1716,GO:0003960,1,0.978205760451752,0,4,NADPH:quinone reductase activity,MF,
1717,GO:0003962,1,0.994535156464788,0,1,cystathionine gamma-synthase activity,MF,
1718,GO:0003963,1,0.988646358170158,0,2,RNA-3'-phosphate cyclase activity,MF,
1719,GO:0003964,1,0.947314846408339,0,8,RNA-directed DNA polymerase activity,MF,
1720,GO:0003968,1,0.984278661854357,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1721,GO:0003972,1,0.994184768585909,0,1,RNA ligase (ATP) activity,MF,
1722,GO:0003973,1,0.985957915666211,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1723,GO:0003974,1,0.994559553513666,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1724,GO:0003975,1,0.994437836724958,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1725,GO:0003976,1,0.980986406494881,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1726,GO:0003977,1,0.988233962653492,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1727,GO:0003978,1,0.994559553513666,0,1,UDP-glucose 4-epimerase activity,MF,
1728,GO:0003979,1,0.993940765532477,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1729,GO:0003980,1,0.979709681795492,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1730,GO:0003983,1,0.994438129758075,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1731,GO:0003985,1,0.983137818160845,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1732,GO:0003986,1,0.978447930190528,0,4,acetyl-CoA hydrolase activity,MF,
1733,GO:0003987,1,0.98112110851014,0,3,acetate-CoA ligase activity,MF,
1734,GO:0003988,1,0.966936640226045,0,6,acetyl-CoA C-acyltransferase activity,MF,
1735,GO:0003989,1,0.988503133742174,0,1,acetyl-CoA carboxylase activity,MF,
1736,GO:0003990,1,0.988650412323543,0,2,acetylcholinesterase activity,MF,
1737,GO:0003991,1,0.994458238154445,0,1,acetylglutamate kinase activity,MF,
1738,GO:0003993,1,0.967148441112465,0,6,acid phosphatase activity,MF,
1739,GO:0003994,1,0.987913376383972,0,2,aconitate hydratase activity,MF,
1740,GO:0003995,1,0.909179879927773,0,15,acyl-CoA dehydrogenase activity,MF,
1741,GO:0003996,1,0.972117609256526,0,5,acyl-CoA ligase activity,MF,
1742,GO:0003997,1,0.967843431206684,0,5,acyl-CoA oxidase activity,MF,
1743,GO:0003998,1,0.989301776028748,0,2,acylphosphatase activity,MF,
1744,GO:0003999,1,0.994653599427905,0,1,adenine phosphoribosyltransferase activity,MF,
1745,GO:0004000,1,0.941723304565382,0,9,adenosine deaminase activity,MF,
1746,GO:0004001,1,0.994463122511233,0,1,adenosine kinase activity,MF,
1747,GO:0004003,1,0.802108334536902,0,32,ATP-dependent DNA helicase activity,MF,
1748,GO:0004004,1,0.659141540194465,0,64,ATP-dependent RNA helicase activity,MF,
1749,GO:0004008,1,0.980430159534642,0,2,copper-exporting ATPase activity,MF,
1750,GO:0004012,1,0.836967556961999,0,20,phospholipid-translocating ATPase activity,MF,
1751,GO:0004013,1,0.980168839953909,0,3,adenosylhomocysteinase activity,MF,
1752,GO:0004014,1,0.993894280649677,0,1,adenosylmethionine decarboxylase activity,MF,
1753,GO:0004016,1,0.900708369486453,0,13,adenylate cyclase activity,MF,
1754,GO:0004017,1,0.951883382715796,0,8,adenylate kinase activity,MF,
1755,GO:0004018,1,0.994581008791467,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1756,GO:0004019,1,0.988752673890787,0,2,adenylosuccinate synthase activity,MF,
1757,GO:0004020,1,0.987772046369248,0,2,adenylylsulfate kinase activity,MF,
1758,GO:0004021,1,0.987924666120691,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1759,GO:0004022,1,0.972295731376051,0,5,alcohol dehydrogenase (NAD) activity,MF,
1760,GO:0004024,1,0.988747570579576,0,2,alcohol dehydrogenase activity, zinc-dependent,MF,
1761,GO:0004027,1,0.994613835901305,0,1,alcohol sulfotransferase activity,MF,
1762,GO:0004028,1,0.959300757663935,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1763,GO:0004029,1,0.910783712716081,0,15,aldehyde dehydrogenase (NAD) activity,MF,
1764,GO:0004030,1,0.965272397403773,0,6,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1765,GO:0004031,1,0.992451977500062,0,1,aldehyde oxidase activity,MF,
1766,GO:0004032,1,0.941913534521828,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1767,GO:0004033,1,0.8699680062478,0,25,aldo-keto reductase (NADP) activity,MF,
1768,GO:0004034,1,0.994321186110909,0,1,aldose 1-epimerase activity,MF,
1769,GO:0004035,1,0.98845209084127,0,2,alkaline phosphatase activity,MF,
1770,GO:0004037,1,0.994585572603382,0,1,allantoicase activity,MF,
1771,GO:0004040,1,0.98236249131405,0,3,amidase activity,MF,
1772,GO:0004042,1,0.994458238154445,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1773,GO:0004043,1,0.99367482626026,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1774,GO:0004044,1,0.99352808359903,0,1,amidophosphoribosyltransferase activity,MF,
1775,GO:0004045,1,0.97822095179423,0,4,aminoacyl-tRNA hydrolase activity,MF,
1776,GO:0004046,1,0.972849610123218,0,5,aminoacylase activity,MF,
1777,GO:0004047,1,0.989065397001027,0,2,aminomethyltransferase activity,MF,
1778,GO:0004051,1,0.99429028007077,0,1,arachidonate 5-lipoxygenase activity,MF,
1779,GO:0004052,1,0.983005262291205,0,3,arachidonate 12-lipoxygenase activity,MF,
1780,GO:0004053,1,0.989097338762491,0,2,arginase activity,MF,
1781,GO:0004055,1,0.994518222134149,0,1,argininosuccinate synthase activity,MF,
1782,GO:0004056,1,0.994479310515241,0,1,argininosuccinate lyase activity,MF,
1783,GO:0004057,1,0.99441662299809,0,1,arginyltransferase activity,MF,
1784,GO:0004058,1,0.994472250304577,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1785,GO:0004059,1,0.994582646523443,0,1,aralkylamine N-acetyltransferase activity,MF,
1786,GO:0004060,1,0.983747409560794,0,3,arylamine N-acetyltransferase activity,MF,
1787,GO:0004061,1,0.994544350632709,0,1,arylformamidase activity,MF,
1788,GO:0004062,1,0.95681485219465,0,8,aryl sulfotransferase activity,MF,
1789,GO:0004063,1,0.989179922665767,0,2,aryldialkylphosphatase activity,MF,
1790,GO:0004064,1,0.967494203049777,0,6,arylesterase activity,MF,
1791,GO:0004065,1,0.931953443089691,0,11,arylsulfatase activity,MF,
1792,GO:0004066,1,0.988737246279911,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1793,GO:0004067,1,0.988903303299718,0,2,asparaginase activity,MF,
1794,GO:0004069,1,0.988807156452216,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1795,GO:0004070,1,0.982187002100417,0,2,aspartate carbamoyltransferase activity,MF,
1796,GO:0004074,1,0.989303599125088,0,2,biliverdin reductase activity,MF,
1797,GO:0004075,1,0.982863429006284,0,2,biotin carboxylase activity,MF,
1798,GO:0004077,1,0.991454089454464,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1799,GO:0004078,1,0.991454089454464,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1800,GO:0004079,1,0.991454089454464,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1801,GO:0004080,1,0.991454089454464,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1802,GO:0004081,1,0.988865121063588,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1803,GO:0004082,1,0.978402982207297,0,4,bisphosphoglycerate mutase activity,MF,
1804,GO:0004084,1,0.984011780924779,0,2,branched-chain-amino-acid transaminase activity,MF,
1805,GO:0004085,1,0.994496922073288,0,1,butyryl-CoA dehydrogenase activity,MF,
1806,GO:0004087,1,0.982187002100417,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1807,GO:0004088,1,0.982187002100417,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1808,GO:0004089,1,0.926417859416271,0,13,carbonate dehydratase activity,MF,
1809,GO:0004090,1,0.973327175615538,0,5,carbonyl reductase (NADPH) activity,MF,
1810,GO:0004092,1,0.994164750333053,0,1,carnitine O-acetyltransferase activity,MF,
1811,GO:0004095,1,0.975997930007995,0,4,carnitine O-palmitoyltransferase activity,MF,
1812,GO:0004096,1,0.977752248880039,0,4,catalase activity,MF,
1813,GO:0004098,1,0.994500901859156,0,1,cerebroside-sulfatase activity,MF,
1814,GO:0004102,1,0.994327524468545,0,1,choline O-acetyltransferase activity,MF,
1815,GO:0004103,1,0.988816035847212,0,2,choline kinase activity,MF,
1816,GO:0004104,1,0.982944489582076,0,3,cholinesterase activity,MF,
1817,GO:0004105,1,0.986556318854888,0,2,choline-phosphate cytidylyltransferase activity,MF,
1818,GO:0004108,1,0.994075679219768,0,1,citrate (Si)-synthase activity,MF,
1819,GO:0004109,1,0.988568356471983,0,2,coproporphyrinogen oxidase activity,MF,
1820,GO:0004111,1,0.968997336526752,0,5,creatine kinase activity,MF,
1821,GO:0004112,1,0.845093363969595,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1822,GO:0004113,1,0.992207171521825,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1823,GO:0004114,1,0.851741448263376,0,22,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1824,GO:0004115,1,0.891779901203297,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1825,GO:0004117,1,0.982595647132786,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1826,GO:0004118,1,0.972375389840411,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1827,GO:0004119,1,0.984636208750887,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1828,GO:0004122,1,0.994271649284811,0,1,cystathionine beta-synthase activity,MF,
1829,GO:0004123,1,0.994535156464788,0,1,cystathionine gamma-lyase activity,MF,
1830,GO:0004126,1,0.945440418803697,0,10,cytidine deaminase activity,MF,
1831,GO:0004127,1,0.976851211807652,0,4,cytidylate kinase activity,MF,
1832,GO:0004128,1,0.960631108687404,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1833,GO:0004129,1,0.884398506659984,0,22,cytochrome-c oxidase activity,MF,
1834,GO:0004132,1,0.994469635853322,0,1,dCMP deaminase activity,MF,
1835,GO:0004133,1,0.990348245443201,0,1,glycogen debranching enzyme activity,MF,
1836,GO:0004134,1,0.990348245443201,0,1,4-alpha-glucanotransferase activity,MF,
1837,GO:0004135,1,0.990348245443201,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1838,GO:0004137,1,0.98667973686468,0,2,deoxycytidine kinase activity,MF,
1839,GO:0004138,1,0.994634727767316,0,1,deoxyguanosine kinase activity,MF,
1840,GO:0004139,1,0.99453859512126,0,1,deoxyribose-phosphate aldolase activity,MF,
1841,GO:0004140,1,0.988886680343958,0,2,dephospho-CoA kinase activity,MF,
1842,GO:0004142,1,0.981921429152919,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1843,GO:0004143,1,0.9279596590634,0,10,diacylglycerol kinase activity,MF,
1844,GO:0004144,1,0.987922766401229,0,2,diacylglycerol O-acyltransferase activity,MF,
1845,GO:0004145,1,0.983787184884968,0,3,diamine N-acetyltransferase activity,MF,
1846,GO:0004146,1,0.988052716842742,0,2,dihydrofolate reductase activity,MF,
1847,GO:0004148,1,0.99365699921152,0,1,dihydrolipoyl dehydrogenase activity,MF,
1848,GO:0004149,1,0.994149266808764,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1849,GO:0004151,1,0.982187002100417,0,2,dihydroorotase activity,MF,
1850,GO:0004152,1,0.994459330890128,0,1,dihydroorotate dehydrogenase activity,MF,
1851,GO:0004155,1,0.994552840092642,0,1,6,7-dihydropteridine reductase activity,MF,
1852,GO:0004157,1,0.9873154359223,0,2,dihydropyrimidinase activity,MF,
1853,GO:0004161,1,0.988782289853063,0,2,dimethylallyltranstransferase activity,MF,
1854,GO:0004163,1,0.994523846156393,0,1,diphosphomevalonate decarboxylase activity,MF,
1855,GO:0004164,1,0.994525515135357,0,1,diphthine synthase activity,MF,
1856,GO:0004165,1,0.981872483684565,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1857,GO:0004167,1,0.983780371366803,0,3,dopachrome isomerase activity,MF,
1858,GO:0004168,1,0.99442159538829,0,1,dolichol kinase activity,MF,
1859,GO:0004169,1,0.970774090863154,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1860,GO:0004170,1,0.994507989594251,0,1,dUTP diphosphatase activity,MF,
1861,GO:0004174,1,0.988312496062548,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1863,GO:0004176,1,0.974961039871845,0,4,ATP-dependent peptidase activity,MF,
1868,GO:0004190,1,0.896829064565581,0,18,aspartic-type endopeptidase activity,MF,
1869,GO:0004197,1,0.586896597992511,0,81,cysteine-type endopeptidase activity,MF,
1870,GO:0004198,1,0.892698204233087,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1873,GO:0004298,1,0.907301720434293,0,18,threonine-type endopeptidase activity,MF,
1874,GO:0004300,1,0.95515969941322,0,8,enoyl-CoA hydratase activity,MF,
1875,GO:0004301,1,0.961680263330181,0,7,epoxide hydrolase activity,MF,
1876,GO:0004303,1,0.951815886966273,0,9,estradiol 17-beta-dehydrogenase activity,MF,
1877,GO:0004304,1,0.99452758282143,0,1,estrone sulfotransferase activity,MF,
1878,GO:0004305,1,0.976573014970932,0,4,ethanolamine kinase activity,MF,
1879,GO:0004306,1,0.99451134200227,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1880,GO:0004307,1,0.989068310574841,0,2,ethanolaminephosphotransferase activity,MF,
1881,GO:0004308,1,0.972066578855169,0,5,exo-alpha-sialidase activity,MF,
1882,GO:0004309,1,0.967247792362522,0,4,exopolyphosphatase activity,MF,
1883,GO:0004310,1,0.994448495776194,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1884,GO:0004311,1,0.982783243747641,0,3,farnesyltranstransferase activity,MF,
1885,GO:0004312,1,0.937874151278572,0,10,fatty acid synthase activity,MF,
1886,GO:0004313,1,0.989197930064612,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1887,GO:0004314,1,0.983747197497845,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1888,GO:0004315,1,0.9838638269477,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1889,GO:0004316,1,0.989197930064612,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1890,GO:0004317,1,0.989197930064612,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1891,GO:0004319,1,0.989197930064612,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1892,GO:0004320,1,0.983788867725699,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1893,GO:0004321,1,0.977587978146422,0,4,fatty-acyl-CoA synthase activity,MF,
1895,GO:0004324,1,0.994502290651241,0,1,ferredoxin-NADP+ reductase activity,MF,
1896,GO:0004325,1,0.990289983241082,0,1,ferrochelatase activity,MF,
1897,GO:0004326,1,0.994318385259016,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1898,GO:0004329,1,0.987416296427957,0,2,formate-tetrahydrofolate ligase activity,MF,
1899,GO:0004331,1,0.973623655784252,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1900,GO:0004332,1,0.983556750406446,0,3,fructose-bisphosphate aldolase activity,MF,
1901,GO:0004333,1,0.994525515135357,0,1,fumarate hydratase activity,MF,
1902,GO:0004334,1,0.994584556009909,0,1,fumarylacetoacetase activity,MF,
1903,GO:0004335,1,0.988588070147922,0,2,galactokinase activity,MF,
1904,GO:0004336,1,0.994117265092799,0,1,galactosylceramidase activity,MF,
1905,GO:0004337,1,0.988782289853063,0,2,geranyltranstransferase activity,MF,
1906,GO:0004339,1,0.990977340097145,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1907,GO:0004340,1,0.966237421369263,0,5,glucokinase activity,MF,
1908,GO:0004341,1,0.994495382707259,0,1,gluconolactonase activity,MF,
1909,GO:0004342,1,0.988918576696211,0,2,glucosamine-6-phosphate deaminase activity,MF,
1910,GO:0004343,1,0.993379708870825,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1911,GO:0004344,1,0.988659167440128,0,1,glucose dehydrogenase activity,MF,
1912,GO:0004345,1,0.983097292558188,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1913,GO:0004346,1,0.982712679120752,0,3,glucose-6-phosphatase activity,MF,
1914,GO:0004347,1,0.994454102809107,0,1,glucose-6-phosphate isomerase activity,MF,
1915,GO:0004348,1,0.982628658361197,0,3,glucosylceramidase activity,MF,
1916,GO:0004349,1,0.993744833423491,0,1,glutamate 5-kinase activity,MF,
1917,GO:0004350,1,0.993744833423491,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1918,GO:0004351,1,0.981731981652871,0,3,glutamate decarboxylase activity,MF,
1919,GO:0004352,1,0.988149668561995,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1920,GO:0004353,1,0.988149668561995,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1921,GO:0004356,1,0.98507106034725,0,2,glutamate-ammonia ligase activity,MF,
1922,GO:0004357,1,0.987602563914689,0,2,glutamate-cysteine ligase activity,MF,
1923,GO:0004359,1,0.981716212450513,0,3,glutaminase activity,MF,
1924,GO:0004360,1,0.983171909162831,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1925,GO:0004361,1,0.994541494738355,0,1,glutaryl-CoA dehydrogenase activity,MF,
1926,GO:0004362,1,0.994398955585378,0,1,glutathione-disulfide reductase activity,MF,
1927,GO:0004363,1,0.994500204377091,0,1,glutathione synthase activity,MF,
1928,GO:0004364,1,0.875970288821007,0,24,glutathione transferase activity,MF,
1929,GO:0004365,1,0.994603647147335,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1930,GO:0004366,1,0.979628129850478,0,3,glycerol-3-phosphate O-acyltransferase activity,MF,
1931,GO:0004367,1,0.987566354049708,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1932,GO:0004368,1,0.985722736618344,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1933,GO:0004370,1,0.98125978342873,0,2,glycerol kinase activity,MF,
1934,GO:0004372,1,0.988770817401512,0,2,glycine hydroxymethyltransferase activity,MF,
1935,GO:0004373,1,0.987779120273922,0,2,glycogen (starch) synthase activity,MF,
1936,GO:0004375,1,0.993464118074765,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1937,GO:0004376,1,0.977399376285871,0,4,glycolipid mannosyltransferase activity,MF,
1938,GO:0004377,1,0.994300387077942,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1939,GO:0004378,1,0.99411951568328,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1940,GO:0004379,1,0.984980628410901,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1941,GO:0004380,1,0.994565001565448,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1942,GO:0004381,1,0.994565001565448,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1943,GO:0004382,1,0.988236488181834,0,2,guanosine-diphosphatase activity,MF,
1944,GO:0004383,1,0.907788563566296,0,12,guanylate cyclase activity,MF,
1945,GO:0004385,1,0.906853427514242,0,13,guanylate kinase activity,MF,
1947,GO:0004392,1,0.989135130806115,0,2,heme oxygenase (decyclizing) activity,MF,
1948,GO:0004394,1,0.993173323385711,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1949,GO:0004395,1,0.994609403508997,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1950,GO:0004396,1,0.966237421369263,0,5,hexokinase activity,MF,
1951,GO:0004397,1,0.993967854321148,0,1,histidine ammonia-lyase activity,MF,
1952,GO:0004398,1,0.994349397078446,0,1,histidine decarboxylase activity,MF,
1953,GO:0004402,1,0.702303619011986,0,50,histone acetyltransferase activity,MF,
1954,GO:0004407,1,0.741743571553247,0,43,histone deacetylase activity,MF,
1955,GO:0004408,1,0.994392976155323,0,1,holocytochrome-c synthase activity,MF,
1956,GO:0004411,1,0.994495263886467,0,1,homogentisate 1,2-dioxygenase activity,MF,
1957,GO:0004415,1,0.970222536910018,0,5,hyalurononglucosaminidase activity,MF,
1958,GO:0004416,1,0.988670561288252,0,2,hydroxyacylglutathione hydrolase activity,MF,
1959,GO:0004418,1,0.994582646523443,0,1,hydroxymethylbilane synthase activity,MF,
1960,GO:0004419,1,0.988915220145027,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1961,GO:0004420,1,0.992863847841579,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1962,GO:0004421,1,0.9881211871942,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1963,GO:0004422,1,0.989114391765378,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1964,GO:0004423,1,0.991646640706399,0,1,iduronate-2-sulfatase activity,MF,
1965,GO:0004427,1,0.983809886905628,0,3,inorganic diphosphatase activity,MF,
1966,GO:0004430,1,0.973303551683684,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1967,GO:0004435,1,0.851028900495108,0,23,phosphatidylinositol phospholipase C activity,MF,
1968,GO:0004438,1,0.890761719350434,0,15,phosphatidylinositol-3-phosphatase activity,MF,
1969,GO:0004439,1,0.944198006440395,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1970,GO:0004441,1,0.994453129306627,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1971,GO:0004445,1,0.969179536949814,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1972,GO:0004446,1,0.994151961280623,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1973,GO:0004447,1,0.99408918264334,0,1,iodide peroxidase activity,MF,
1974,GO:0004448,1,0.972593273609075,0,5,isocitrate dehydrogenase activity,MF,
1975,GO:0004449,1,0.983467279233992,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1976,GO:0004450,1,0.988945030361313,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1977,GO:0004452,1,0.994441044865754,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1978,GO:0004454,1,0.994346769724911,0,1,ketohexokinase activity,MF,
1979,GO:0004457,1,0.97269654482088,0,5,lactate dehydrogenase activity,MF,
1980,GO:0004458,1,0.988775618924874,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1981,GO:0004459,1,0.983740222178148,0,3,L-lactate dehydrogenase activity,MF,
1982,GO:0004461,1,0.982352587070852,0,3,lactose synthase activity,MF,
1983,GO:0004462,1,0.99446579965428,0,1,lactoylglutathione lyase activity,MF,
1984,GO:0004463,1,0.994457964313476,0,1,leukotriene-A4 hydrolase activity,MF,
1985,GO:0004464,1,0.978779706411384,0,4,leukotriene-C4 synthase activity,MF,
1986,GO:0004465,1,0.964843805719698,0,6,lipoprotein lipase activity,MF,
1987,GO:0004466,1,0.971610195543927,0,5,long-chain-acyl-CoA dehydrogenase activity,MF,
1988,GO:0004467,1,0.928275681840778,0,12,long-chain fatty acid-CoA ligase activity,MF,
1989,GO:0004468,1,0.969857786009689,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1990,GO:0004470,1,0.975893060618297,0,4,malic enzyme activity,MF,
1991,GO:0004471,1,0.981183918175224,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1992,GO:0004473,1,0.981183918175224,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1993,GO:0004474,1,0.991683568212354,0,1,malate synthase activity,MF,
1994,GO:0004475,1,0.994560932962015,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1995,GO:0004476,1,0.994529222266585,0,1,mannose-6-phosphate isomerase activity,MF,
1996,GO:0004477,1,0.976364460904012,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1997,GO:0004478,1,0.987994624278484,0,2,methionine adenosyltransferase activity,MF,
1998,GO:0004479,1,0.994202692183443,0,1,methionyl-tRNA formyltransferase activity,MF,
1999,GO:0004482,1,0.991271959824451,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2000,GO:0004483,1,0.988403017609477,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2001,GO:0004484,1,0.99290099705519,0,1,mRNA guanylyltransferase activity,MF,
2002,GO:0004485,1,0.987912894644403,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2003,GO:0004486,1,0.993744084084168,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2004,GO:0004487,1,0.982622130604615,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2005,GO:0004488,1,0.976364460904012,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2006,GO:0004489,1,0.990396571355032,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2007,GO:0004490,1,0.994563318969277,0,1,methylglutaconyl-CoA hydratase activity,MF,
2008,GO:0004491,1,0.994425885609532,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2009,GO:0004492,1,0.994446222801475,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2010,GO:0004493,1,0.994645536077495,0,1,methylmalonyl-CoA epimerase activity,MF,
2011,GO:0004494,1,0.994086848831115,0,1,methylmalonyl-CoA mutase activity,MF,
2012,GO:0004496,1,0.994458101266859,0,1,mevalonate kinase activity,MF,
2014,GO:0004498,1,0.994318385259016,0,1,calcidiol 1-monooxygenase activity,MF,
2015,GO:0004499,1,0.970247025901226,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2017,GO:0004502,1,0.99239289162095,0,1,kynurenine 3-monooxygenase activity,MF,
2018,GO:0004504,1,0.99354389341953,0,1,peptidylglycine monooxygenase activity,MF,
2019,GO:0004505,1,0.983321969693564,0,3,phenylalanine 4-monooxygenase activity,MF,
2020,GO:0004506,1,0.994069149619843,0,1,squalene monooxygenase activity,MF,
2021,GO:0004509,1,0.994470291843378,0,1,steroid 21-monooxygenase activity,MF,
2022,GO:0004510,1,0.994519615317823,0,1,tryptophan 5-monooxygenase activity,MF,
2023,GO:0004511,1,0.994500437100244,0,1,tyrosine 3-monooxygenase activity,MF,
2024,GO:0004512,1,0.994401254350279,0,1,inositol-3-phosphate synthase activity,MF,
2025,GO:0004513,1,0.99438553296374,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2026,GO:0004514,1,0.981666497299886,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2027,GO:0004515,1,0.97201083612846,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2028,GO:0004516,1,0.994184768585909,0,1,nicotinate phosphoribosyltransferase activity,MF,
2029,GO:0004517,1,0.978010717681676,0,3,nitric-oxide synthase activity,MF,
2030,GO:0004518,1,0.288871262229701,0,193,nuclease activity,MF,
2031,GO:0004519,1,0.480088154961437,0,118,endonuclease activity,MF,
2032,GO:0004520,1,0.748288893663296,0,47,endodeoxyribonuclease activity,MF,
2033,GO:0004521,1,0.736688676613056,0,51,endoribonuclease activity,MF,
2034,GO:0004522,1,0.983951637894639,0,3,ribonuclease A activity,MF,
2035,GO:0004523,1,0.967123338606585,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2036,GO:0004525,1,0.969651364386121,0,4,ribonuclease III activity,MF,
2037,GO:0004526,1,0.938302022573212,0,11,ribonuclease P activity,MF,
2038,GO:0004527,1,0.615628351495885,0,73,exonuclease activity,MF,
2039,GO:0004528,1,0.961852883705043,0,6,phosphodiesterase I activity,MF,
2040,GO:0004529,1,0.889330115079198,0,19,exodeoxyribonuclease activity,MF,
2041,GO:0004530,1,0.98174996369425,0,2,deoxyribonuclease I activity,MF,
2042,GO:0004531,1,0.989128195506352,0,2,deoxyribonuclease II activity,MF,
2043,GO:0004532,1,0.793325987383303,0,34,exoribonuclease activity,MF,
2044,GO:0004534,1,0.970643453172786,0,3,5'-3' exoribonuclease activity,MF,
2045,GO:0004535,1,0.91700043245683,0,12,poly(A)-specific ribonuclease activity,MF,
2046,GO:0004536,1,0.669722931247948,0,65,deoxyribonuclease activity,MF,
2047,GO:0004540,1,0.55314777141439,0,94,ribonuclease activity,MF,
2048,GO:0004549,1,0.911652994610859,0,16,tRNA-specific ribonuclease activity,MF,
2049,GO:0004550,1,0.907991323024345,0,17,nucleoside diphosphate kinase activity,MF,
2050,GO:0004551,1,0.90659090166803,0,16,nucleotide diphosphatase activity,MF,
2052,GO:0004556,1,0.989012811572331,0,2,alpha-amylase activity,MF,
2053,GO:0004557,1,0.988168576372977,0,2,alpha-galactosidase activity,MF,
2054,GO:0004558,1,0.977569324019802,0,3,alpha-1,4-glucosidase activity,MF,
2055,GO:0004559,1,0.9110815646264,0,13,alpha-mannosidase activity,MF,
2056,GO:0004560,1,0.988928034123857,0,2,alpha-L-fucosidase activity,MF,
2057,GO:0004561,1,0.994186558343167,0,1,alpha-N-acetylglucosaminidase activity,MF,
2058,GO:0004563,1,0.9695734159054,0,5,beta-N-acetylhexosaminidase activity,MF,
2059,GO:0004565,1,0.965866725940101,0,6,beta-galactosidase activity,MF,
2060,GO:0004566,1,0.981443119855296,0,3,beta-glucuronidase activity,MF,
2061,GO:0004567,1,0.993854124286646,0,1,beta-mannosidase activity,MF,
2063,GO:0004569,1,0.992810147531021,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2064,GO:0004571,1,0.951112600905792,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2065,GO:0004572,1,0.983548032783572,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2066,GO:0004573,1,0.99421183238997,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2067,GO:0004574,1,0.993642960808039,0,1,oligo-1,6-glucosidase activity,MF,
2068,GO:0004576,1,0.944797007445997,0,10,oligosaccharyl transferase activity,MF,
2069,GO:0004577,1,0.988698380730404,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2070,GO:0004578,1,0.993369571814659,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2071,GO:0004579,1,0.94991025891441,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2072,GO:0004581,1,0.994619882730967,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2073,GO:0004582,1,0.983954850253025,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2074,GO:0004583,1,0.970498506402308,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2075,GO:0004584,1,0.99436697937206,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2076,GO:0004585,1,0.994552840092642,0,1,ornithine carbamoyltransferase activity,MF,
2077,GO:0004586,1,0.981827056191279,0,3,ornithine decarboxylase activity,MF,
2078,GO:0004587,1,0.994481956762006,0,1,ornithine-oxo-acid transaminase activity,MF,
2079,GO:0004588,1,0.99424681970748,0,1,orotate phosphoribosyltransferase activity,MF,
2080,GO:0004590,1,0.99424681970748,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2081,GO:0004591,1,0.973772564331403,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2082,GO:0004594,1,0.977027992841186,0,4,pantothenate kinase activity,MF,
2083,GO:0004595,1,0.994389611408741,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2084,GO:0004596,1,0.932815869262702,0,11,peptide alpha-N-acetyltransferase activity,MF,
2085,GO:0004597,1,0.993621369531904,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2086,GO:0004598,1,0.99354389341953,0,1,peptidylamidoglycolate lyase activity,MF,
2087,GO:0004601,1,0.794791205468716,0,38,peroxidase activity,MF,
2088,GO:0004602,1,0.915924007413605,0,16,glutathione peroxidase activity,MF,
2089,GO:0004603,1,0.99462146648342,0,1,phenylethanolamine N-methyltransferase activity,MF,
2090,GO:0004605,1,0.981358405482932,0,3,phosphatidate cytidylyltransferase activity,MF,
2091,GO:0004607,1,0.994598458336349,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2092,GO:0004608,1,0.994636210809392,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2093,GO:0004609,1,0.988708609474979,0,2,phosphatidylserine decarboxylase activity,MF,
2094,GO:0004610,1,0.994477531247325,0,1,phosphoacetylglucosamine mutase activity,MF,
2095,GO:0004611,1,0.988751379001487,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2096,GO:0004613,1,0.988751379001487,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2097,GO:0004614,1,0.966184409201446,0,5,phosphoglucomutase activity,MF,
2098,GO:0004615,1,0.989017422546522,0,2,phosphomannomutase activity,MF,
2099,GO:0004616,1,0.982608515279145,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2100,GO:0004617,1,0.994472120183136,0,1,phosphoglycerate dehydrogenase activity,MF,
2101,GO:0004618,1,0.994343367723908,0,1,phosphoglycerate kinase activity,MF,
2102,GO:0004619,1,0.978402982207297,0,4,phosphoglycerate mutase activity,MF,
2104,GO:0004621,1,0.994392473402516,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2105,GO:0004622,1,0.89523634205279,0,18,lysophospholipase activity,MF,
2107,GO:0004629,1,0.836280515735688,0,26,phospholipase C activity,MF,
2108,GO:0004630,1,0.964009933735261,0,6,phospholipase D activity,MF,
2109,GO:0004631,1,0.994605603537762,0,1,phosphomevalonate kinase activity,MF,
2110,GO:0004632,1,0.994609694129362,0,1,phosphopantothenate--cysteine ligase activity,MF,
2111,GO:0004633,1,0.994415368262063,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2112,GO:0004634,1,0.977808894795731,0,4,phosphopyruvate hydratase activity,MF,
2113,GO:0004637,1,0.993763852178591,0,1,phosphoribosylamine-glycine ligase activity,MF,
2114,GO:0004638,1,0.993838496252753,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2115,GO:0004639,1,0.993838496252753,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2116,GO:0004641,1,0.993763852178591,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2117,GO:0004642,1,0.99203091643859,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2118,GO:0004643,1,0.994451312696892,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2119,GO:0004644,1,0.993763852178591,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2121,GO:0004647,1,0.983566597857675,0,3,phosphoserine phosphatase activity,MF,
2122,GO:0004648,1,0.994444936617446,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2123,GO:0004649,1,0.987671695740976,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2124,GO:0004651,1,0.987493725026292,0,2,polynucleotide 5'-phosphatase activity,MF,
2125,GO:0004652,1,0.938079469423872,0,9,polynucleotide adenylyltransferase activity,MF,
2127,GO:0004654,1,0.992784567072978,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2128,GO:0004655,1,0.993945430097724,0,1,porphobilinogen synthase activity,MF,
2129,GO:0004656,1,0.977423829864099,0,4,procollagen-proline 4-dioxygenase activity,MF,
2130,GO:0004657,1,0.994415368262063,0,1,proline dehydrogenase activity,MF,
2131,GO:0004658,1,0.988876086956093,0,2,propionyl-CoA carboxylase activity,MF,
2132,GO:0004659,1,0.908965398603483,0,15,prenyltransferase activity,MF,
2133,GO:0004660,1,0.98875639582086,0,2,protein farnesyltransferase activity,MF,
2134,GO:0004661,1,0.971332585994855,0,5,protein geranylgeranyltransferase activity,MF,
2135,GO:0004662,1,0.988804519085754,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2136,GO:0004663,1,0.976988634307076,0,4,Rab geranylgeranyltransferase activity,MF,
2137,GO:0004666,1,0.985308496972618,0,2,prostaglandin-endoperoxide synthase activity,MF,
2138,GO:0004667,1,0.989236994032048,0,2,prostaglandin-D synthase activity,MF,
2139,GO:0004668,1,0.981443263621124,0,3,protein-arginine deiminase activity,MF,
2140,GO:0004671,1,0.992590025168258,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2142,GO:0004673,1,0.952309207556367,0,7,protein histidine kinase activity,MF,
2144,GO:0004675,1,0.882351903192076,0,15,transmembrane receptor protein serine/threonine kinase activity,MF,
2145,GO:0004676,1,0.990492519017293,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2146,GO:0004677,1,0.966563107402367,0,3,DNA-dependent protein kinase activity,MF,
2147,GO:0004679,1,0.951011663571722,0,7,AMP-activated protein kinase activity,MF,
2148,GO:0004683,1,0.827862032763532,0,28,calmodulin-dependent protein kinase activity,MF,
2149,GO:0004686,1,0.990153831969821,0,1,elongation factor-2 kinase activity,MF,
2150,GO:0004687,1,0.965945668891026,0,4,myosin light chain kinase activity,MF,
2151,GO:0004689,1,0.96377762280332,0,5,phosphorylase kinase activity,MF,
2152,GO:0004690,1,0.939563635067811,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2153,GO:0004691,1,0.951607843193509,0,6,cAMP-dependent protein kinase activity,MF,
2154,GO:0004692,1,0.987349540459352,0,2,cGMP-dependent protein kinase activity,MF,
2155,GO:0004693,1,0.80164664156269,0,34,cyclin-dependent protein serine/threonine kinase activity,MF,
2156,GO:0004694,1,0.972051611877626,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2157,GO:0004697,1,0.898907400291337,0,15,protein kinase C activity,MF,
2158,GO:0004698,1,0.975186780178322,0,3,calcium-dependent protein kinase C activity,MF,
2159,GO:0004699,1,0.979944238662016,0,3,calcium-independent protein kinase C activity,MF,
2160,GO:0004702,1,0.422472409006062,0,117,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
2161,GO:0004703,1,0.977430763187962,0,4,G-protein coupled receptor kinase activity,MF,
2162,GO:0004704,1,0.967393243767175,0,5,NF-kappaB-inducing kinase activity,MF,
2163,GO:0004705,1,0.981078672911666,0,3,JUN kinase activity,MF,
2164,GO:0004706,1,0.979415682096235,0,3,JUN kinase kinase kinase activity,MF,
2165,GO:0004707,1,0.91691290362072,0,14,MAP kinase activity,MF,
2166,GO:0004708,1,0.907256722538917,0,15,MAP kinase kinase activity,MF,
2167,GO:0004709,1,0.563797830777157,0,77,MAP kinase kinase kinase activity,MF,
2168,GO:0004711,1,0.94678631472548,0,7,ribosomal protein S6 kinase activity,MF,
2169,GO:0004712,1,0.759255767754042,0,41,protein serine/threonine/tyrosine kinase activity,MF,
2170,GO:0004713,1,0.306765747957887,0,169,protein tyrosine kinase activity,MF,
2171,GO:0004714,1,0.619773785494191,0,64,transmembrane receptor protein tyrosine kinase activity,MF,
2172,GO:0004715,1,0.728874704620114,0,49,non-membrane spanning protein tyrosine kinase activity,MF,
2173,GO:0004716,1,0.927752699390915,0,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
2174,GO:0004719,1,0.981238388298047,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2175,GO:0004720,1,0.963558709204074,0,6,protein-lysine 6-oxidase activity,MF,
2177,GO:0004722,1,0.647645460271356,0,66,protein serine/threonine phosphatase activity,MF,
2178,GO:0004723,1,0.951604790395716,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2180,GO:0004726,1,0.950295888226559,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2181,GO:0004727,1,0.98909877726287,0,2,prenylated protein tyrosine phosphatase activity,MF,
2182,GO:0004728,1,0.994276479790622,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2183,GO:0004729,1,0.994534958144399,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2184,GO:0004730,1,0.994549932779899,0,1,pseudouridylate synthase activity,MF,
2185,GO:0004731,1,0.986878768301145,0,2,purine-nucleoside phosphorylase activity,MF,
2186,GO:0004733,1,0.993749323936045,0,1,pyridoxamine-phosphate oxidase activity,MF,
2187,GO:0004735,1,0.989078728126096,0,2,pyrroline-5-carboxylate reductase activity,MF,
2188,GO:0004736,1,0.993300604165974,0,1,pyruvate carboxylase activity,MF,
2189,GO:0004738,1,0.969661924647328,0,5,pyruvate dehydrogenase activity,MF,
2190,GO:0004739,1,0.988414322410144,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2191,GO:0004740,1,0.971337467480426,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2192,GO:0004741,1,0.976389550860085,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2193,GO:0004742,1,0.993009770887461,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2194,GO:0004743,1,0.988261035532729,0,2,pyruvate kinase activity,MF,
2195,GO:0004744,1,0.994264990016345,0,1,retinal isomerase activity,MF,
2196,GO:0004745,1,0.934398762647207,0,12,retinol dehydrogenase activity,MF,
2197,GO:0004747,1,0.994616886931831,0,1,ribokinase activity,MF,
2198,GO:0004748,1,0.980385461654514,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2199,GO:0004749,1,0.977788333440333,0,4,ribose phosphate diphosphokinase activity,MF,
2200,GO:0004750,1,0.994389273240291,0,1,ribulose-phosphate 3-epimerase activity,MF,
2201,GO:0004751,1,0.994515952563576,0,1,ribose-5-phosphate isomerase activity,MF,
2202,GO:0004753,1,0.991574782178595,0,1,saccharopine dehydrogenase activity,MF,
2203,GO:0004756,1,0.988705419861271,0,2,selenide, water dikinase activity,MF,
2204,GO:0004757,1,0.994584410121704,0,1,sepiapterin reductase activity,MF,
2205,GO:0004758,1,0.967073315850824,0,5,serine C-palmitoyltransferase activity,MF,
2206,GO:0004760,1,0.994561275999617,0,1,serine-pyruvate transaminase activity,MF,
2207,GO:0004766,1,0.994608232017952,0,1,spermidine synthase activity,MF,
2208,GO:0004767,1,0.968667514959257,0,5,sphingomyelin phosphodiesterase activity,MF,
2209,GO:0004768,1,0.980344254175702,0,3,stearoyl-CoA 9-desaturase activity,MF,
2210,GO:0004769,1,0.99462146648342,0,1,steroid delta-isomerase activity,MF,
2211,GO:0004771,1,0.952330607435854,0,8,sterol esterase activity,MF,
2212,GO:0004772,1,0.993795890395374,0,1,sterol O-acyltransferase activity,MF,
2213,GO:0004773,1,0.991113147505727,0,1,steryl-sulfatase activity,MF,
2214,GO:0004774,1,0.9834749631327,0,3,succinate-CoA ligase activity,MF,
2215,GO:0004775,1,0.989044408933363,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2216,GO:0004776,1,0.9889834981427,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2217,GO:0004777,1,0.992269531760999,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2218,GO:0004778,1,0.994556935413119,0,1,succinyl-CoA hydrolase activity,MF,
2219,GO:0004779,1,0.987772046369248,0,2,sulfate adenylyltransferase activity,MF,
2220,GO:0004781,1,0.987772046369248,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2221,GO:0004782,1,0.994223728588005,0,1,sulfinoalanine decarboxylase activity,MF,
2222,GO:0004784,1,0.973090202095568,0,5,superoxide dismutase activity,MF,
2223,GO:0004788,1,0.994368053421367,0,1,thiamine diphosphokinase activity,MF,
2224,GO:0004790,1,0.994291130232951,0,1,thioether S-methyltransferase activity,MF,
2225,GO:0004791,1,0.955432149190612,0,8,thioredoxin-disulfide reductase activity,MF,
2226,GO:0004792,1,0.983628505723312,0,3,thiosulfate sulfurtransferase activity,MF,
2227,GO:0004793,1,0.988770817401512,0,2,threonine aldolase activity,MF,
2228,GO:0004794,1,0.989182346251114,0,2,L-threonine ammonia-lyase activity,MF,
2229,GO:0004795,1,0.994446507872243,0,1,threonine synthase activity,MF,
2230,GO:0004796,1,0.994447219361674,0,1,thromboxane-A synthase activity,MF,
2231,GO:0004797,1,0.986969506579903,0,2,thymidine kinase activity,MF,
2232,GO:0004798,1,0.988727535234231,0,2,thymidylate kinase activity,MF,
2233,GO:0004799,1,0.994564330687402,0,1,thymidylate synthase activity,MF,
2234,GO:0004800,1,0.985609573685923,0,2,thyroxine 5'-deiodinase activity,MF,
2235,GO:0004801,1,0.994611816945497,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2236,GO:0004802,1,0.988733673220698,0,2,transketolase activity,MF,
2237,GO:0004803,1,0.99328601686113,0,1,transposase activity,MF,
2238,GO:0004806,1,0.897347292564736,0,18,triglyceride lipase activity,MF,
2239,GO:0004807,1,0.99458397146376,0,1,triose-phosphate isomerase activity,MF,
2240,GO:0004809,1,0.983192090188467,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2241,GO:0004810,1,0.994396973404851,0,1,tRNA adenylyltransferase activity,MF,
2242,GO:0004812,1,0.768549811915563,0,44,aminoacyl-tRNA ligase activity,MF,
2243,GO:0004813,1,0.981051065589973,0,3,alanine-tRNA ligase activity,MF,
2244,GO:0004814,1,0.983449432850164,0,3,arginine-tRNA ligase activity,MF,
2245,GO:0004815,1,0.988238993119681,0,2,aspartate-tRNA ligase activity,MF,
2246,GO:0004816,1,0.988566290078889,0,2,asparagine-tRNA ligase activity,MF,
2247,GO:0004817,1,0.988789064145486,0,2,cysteine-tRNA ligase activity,MF,
2248,GO:0004818,1,0.985813191426609,0,2,glutamate-tRNA ligase activity,MF,
2249,GO:0004819,1,0.986908613093263,0,2,glutamine-tRNA ligase activity,MF,
2250,GO:0004820,1,0.98879157068439,0,2,glycine-tRNA ligase activity,MF,
2251,GO:0004821,1,0.988831831409508,0,2,histidine-tRNA ligase activity,MF,
2252,GO:0004822,1,0.986611655498549,0,2,isoleucine-tRNA ligase activity,MF,
2253,GO:0004823,1,0.985709931453409,0,2,leucine-tRNA ligase activity,MF,
2254,GO:0004824,1,0.994447787333467,0,1,lysine-tRNA ligase activity,MF,
2255,GO:0004825,1,0.988257015454977,0,2,methionine-tRNA ligase activity,MF,
2256,GO:0004826,1,0.972040414757054,0,5,phenylalanine-tRNA ligase activity,MF,
2257,GO:0004827,1,0.981487132428845,0,3,proline-tRNA ligase activity,MF,
2258,GO:0004828,1,0.988989866740843,0,2,serine-tRNA ligase activity,MF,
2259,GO:0004829,1,0.982470265092881,0,3,threonine-tRNA ligase activity,MF,
2260,GO:0004830,1,0.988430573854269,0,2,tryptophan-tRNA ligase activity,MF,
2261,GO:0004831,1,0.988454155406749,0,2,tyrosine-tRNA ligase activity,MF,
2262,GO:0004832,1,0.979340577739761,0,3,valine-tRNA ligase activity,MF,
2263,GO:0004833,1,0.989139634601092,0,2,tryptophan 2,3-dioxygenase activity,MF,
2264,GO:0004835,1,0.99226386778166,0,1,tubulin-tyrosine ligase activity,MF,
2265,GO:0004838,1,0.994195180820788,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2266,GO:0004839,1,0.965770680118045,0,5,ubiquitin activating enzyme activity,MF,
2267,GO:0004842,1,0.0528986036961061,0,422,ubiquitin-protein transferase activity,MF,
2268,GO:0004843,1,0.598639413616806,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2269,GO:0004844,1,0.97241091478928,0,5,uracil DNA N-glycosylase activity,MF,
2270,GO:0004849,1,0.972322246164336,0,5,uridine kinase activity,MF,
2271,GO:0004850,1,0.988901016535469,0,2,uridine phosphorylase activity,MF,
2272,GO:0004852,1,0.994598068601771,0,1,uroporphyrinogen-III synthase activity,MF,
2273,GO:0004853,1,0.994594094383405,0,1,uroporphyrinogen decarboxylase activity,MF,
2274,GO:0004854,1,0.984221206665505,0,2,xanthine dehydrogenase activity,MF,
2275,GO:0004855,1,0.991707255659884,0,1,xanthine oxidase activity,MF,
2276,GO:0004856,1,0.993570072890914,0,1,xylulokinase activity,MF,
2280,GO:0004861,1,0.931373718542716,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2281,GO:0004862,1,0.949125105312434,0,9,cAMP-dependent protein kinase inhibitor activity,MF,
2283,GO:0004865,1,0.945540918015568,0,10,protein serine/threonine phosphatase inhibitor activity,MF,
2288,GO:0004873,1,0.989195524283831,0,2,asialoglycoprotein receptor activity,MF,
2289,GO:0004874,1,0.983902637369992,0,2,aryl hydrocarbon receptor activity,MF,
2290,GO:0004875,1,0.955763632262423,0,7,complement receptor activity,MF,
2291,GO:0004876,1,0.99448949132686,0,1,complement component C3a receptor activity,MF,
2292,GO:0004877,1,0.988473912080574,0,1,complement component C3b receptor activity,MF,
2293,GO:0004878,1,0.988592990701521,0,2,complement component C5a receptor activity,MF,
2294,GO:0004879,1,0.732183937199706,0,45,nuclear receptor activity,MF,
2295,GO:0004882,1,0.987960925830096,0,2,androgen receptor activity,MF,
2296,GO:0004883,1,0.99089296560572,0,1,glucocorticoid receptor activity,MF,
2297,GO:0004886,1,0.980785776682837,0,3,9-cis retinoic acid receptor activity,MF,
2298,GO:0004887,1,0.960117851026067,0,6,thyroid hormone receptor activity,MF,
2302,GO:0004897,1,0.969700015934559,0,4,ciliary neurotrophic factor receptor activity,MF,
2303,GO:0004900,1,0.994512889517858,0,1,erythropoietin receptor activity,MF,
2304,GO:0004904,1,0.969377816915751,0,5,interferon receptor activity,MF,
2305,GO:0004905,1,0.986013708132113,0,2,type I interferon receptor activity,MF,
2306,GO:0004906,1,0.988889652503069,0,2,interferon-gamma receptor activity,MF,
2307,GO:0004908,1,0.957986266644211,0,7,interleukin-1 receptor activity,MF,
2308,GO:0004909,1,0.987023842270647,0,2,interleukin-1, Type I, activating receptor activity,MF,
2309,GO:0004910,1,0.988690120064843,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2310,GO:0004911,1,0.98188392477902,0,3,interleukin-2 receptor activity,MF,
2311,GO:0004912,1,0.992552829735561,0,1,interleukin-3 receptor activity,MF,
2312,GO:0004913,1,0.988960063532247,0,2,interleukin-4 receptor activity,MF,
2313,GO:0004914,1,0.987065449378199,0,2,interleukin-5 receptor activity,MF,
2314,GO:0004915,1,0.987184295453488,0,2,interleukin-6 receptor activity,MF,
2315,GO:0004917,1,0.989124422704675,0,2,interleukin-7 receptor activity,MF,
2316,GO:0004918,1,0.988550442086148,0,2,interleukin-8 receptor activity,MF,
2317,GO:0004920,1,0.968693472373344,0,5,interleukin-10 receptor activity,MF,
2318,GO:0004921,1,0.993940097846777,0,1,interleukin-11 receptor activity,MF,
2319,GO:0004923,1,0.981756834791508,0,2,leukemia inhibitory factor receptor activity,MF,
2320,GO:0004924,1,0.975482953279562,0,3,oncostatin-M receptor activity,MF,
2321,GO:0004925,1,0.986428904666488,0,1,prolactin receptor activity,MF,
2323,GO:0004931,1,0.961057896663504,0,7,extracellularly ATP-gated cation channel activity,MF,
2324,GO:0004935,1,0.944128098788568,0,10,adrenergic receptor activity,MF,
2325,GO:0004936,1,0.971327105859863,0,5,alpha-adrenergic receptor activity,MF,
2326,GO:0004937,1,0.983170189700288,0,3,alpha1-adrenergic receptor activity,MF,
2327,GO:0004938,1,0.987956221058162,0,2,alpha2-adrenergic receptor activity,MF,
2328,GO:0004939,1,0.982965828016709,0,3,beta-adrenergic receptor activity,MF,
2329,GO:0004940,1,0.99414710380472,0,1,beta1-adrenergic receptor activity,MF,
2330,GO:0004941,1,0.994467922829578,0,1,beta2-adrenergic receptor activity,MF,
2331,GO:0004945,1,0.983711198802958,0,3,angiotensin type II receptor activity,MF,
2332,GO:0004947,1,0.987793417842751,0,2,bradykinin receptor activity,MF,
2333,GO:0004948,1,0.986092280092446,0,2,calcitonin receptor activity,MF,
2334,GO:0004949,1,0.979776506748137,0,3,cannabinoid receptor activity,MF,
2336,GO:0004951,1,0.989022516068793,0,2,cholecystokinin receptor activity,MF,
2337,GO:0004952,1,0.961144192797739,0,7,dopamine neurotransmitter receptor activity,MF,
2338,GO:0004953,1,0.905625238487632,0,17,icosanoid receptor activity,MF,
2339,GO:0004954,1,0.936938818212309,0,11,prostanoid receptor activity,MF,
2340,GO:0004955,1,0.942219210380946,0,10,prostaglandin receptor activity,MF,
2341,GO:0004956,1,0.988320062730126,0,2,prostaglandin D receptor activity,MF,
2342,GO:0004957,1,0.965969543823714,0,6,prostaglandin E receptor activity,MF,
2343,GO:0004958,1,0.986274775541901,0,2,prostaglandin F receptor activity,MF,
2344,GO:0004960,1,0.994399120274267,0,1,thromboxane receptor activity,MF,
2345,GO:0004961,1,0.994399120274267,0,1,thromboxane A2 receptor activity,MF,
2346,GO:0004962,1,0.986581718823353,0,2,endothelin receptor activity,MF,
2347,GO:0004965,1,0.97796990917461,0,3,G-protein coupled GABA receptor activity,MF,
2348,GO:0004966,1,0.945688622843503,0,10,galanin receptor activity,MF,
2349,GO:0004967,1,0.988565939424568,0,2,glucagon receptor activity,MF,
2350,GO:0004968,1,0.993104798016431,0,1,gonadotropin-releasing hormone receptor activity,MF,
2351,GO:0004969,1,0.970336207347438,0,5,histamine receptor activity,MF,
2353,GO:0004971,1,0.968947033738688,0,4,AMPA glutamate receptor activity,MF,
2355,GO:0004974,1,0.966600258823513,0,6,leukotriene receptor activity,MF,
2356,GO:0004977,1,0.977925631555311,0,4,melanocortin receptor activity,MF,
2357,GO:0004979,1,0.994509783732194,0,1,beta-endorphin receptor activity,MF,
2358,GO:0004980,1,0.988626933107591,0,2,melanocyte-stimulating hormone receptor activity,MF,
2359,GO:0004982,1,0.983491844833253,0,3,N-formyl peptide receptor activity,MF,
2360,GO:0004983,1,0.954022279082375,0,8,neuropeptide Y receptor activity,MF,
2361,GO:0004984,1,0.91067129229085,0,17,olfactory receptor activity,MF,
2362,GO:0004985,1,0.954480163843176,0,8,opioid receptor activity,MF,
2363,GO:0004990,1,0.99300619663214,0,1,oxytocin receptor activity,MF,
2364,GO:0004991,1,0.988692149116596,0,2,parathyroid hormone receptor activity,MF,
2365,GO:0004992,1,0.979633756296216,0,3,platelet activating factor receptor activity,MF,
2366,GO:0004993,1,0.927297189606918,0,13,G-protein coupled serotonin receptor activity,MF,
2367,GO:0004994,1,0.976480267806635,0,4,somatostatin receptor activity,MF,
2368,GO:0004995,1,0.98288003328742,0,3,tachykinin receptor activity,MF,
2369,GO:0004996,1,0.988074318374586,0,2,thyroid-stimulating hormone receptor activity,MF,
2370,GO:0004998,1,0.986426043953855,0,2,transferrin receptor activity,MF,
2371,GO:0004999,1,0.98219566013847,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2372,GO:0005000,1,0.969292166090059,0,5,vasopressin receptor activity,MF,
2373,GO:0005001,1,0.87573340361712,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2374,GO:0005003,1,0.877326235240789,0,19,ephrin receptor activity,MF,
2375,GO:0005004,1,0.948207982230071,0,7,GPI-linked ephrin receptor activity,MF,
2376,GO:0005005,1,0.887615577036545,0,17,transmembrane-ephrin receptor activity,MF,
2377,GO:0005006,1,0.988534292744369,0,2,epidermal growth factor-activated receptor activity,MF,
2378,GO:0005007,1,0.96659541744111,0,5,fibroblast growth factor-activated receptor activity,MF,
2379,GO:0005008,1,0.990849469430641,0,1,hepatocyte growth factor-activated receptor activity,MF,
2380,GO:0005009,1,0.988707171226776,0,1,insulin-activated receptor activity,MF,
2381,GO:0005010,1,0.961096598090095,0,4,insulin-like growth factor-activated receptor activity,MF,
2382,GO:0005011,1,0.985980104032922,0,2,macrophage colony-stimulating factor receptor activity,MF,
2383,GO:0005017,1,0.977385173222582,0,3,platelet-derived growth factor-activated receptor activity,MF,
2384,GO:0005018,1,0.990917051265988,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2385,GO:0005019,1,0.986345322160385,0,2,platelet-derived growth factor beta-receptor activity,MF,
2386,GO:0005020,1,0.99224214601651,0,1,stem cell factor receptor activity,MF,
2387,GO:0005021,1,0.94817817599167,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2388,GO:0005024,1,0.940247509494484,0,8,transforming growth factor beta-activated receptor activity,MF,
2389,GO:0005025,1,0.970578151757465,0,4,transforming growth factor beta receptor activity, type I,MF,
2390,GO:0005026,1,0.99272587850566,0,1,transforming growth factor beta receptor activity, type II,MF,
2391,GO:0005030,1,0.969670171425425,0,4,neurotrophin receptor activity,MF,
2392,GO:0005031,1,0.869776924194414,0,24,tumor necrosis factor-activated receptor activity,MF,
2393,GO:0005034,1,0.993966218722892,0,1,osmosensor activity,MF,
2394,GO:0005035,1,0.869776924194414,0,24,death receptor activity,MF,
2395,GO:0005041,1,0.887670431374546,0,13,low-density lipoprotein particle receptor activity,MF,
2396,GO:0005042,1,0.952526563792691,0,6,netrin receptor activity,MF,
2398,GO:0005046,1,0.988811189884636,0,2,KDEL sequence binding,MF,
2401,GO:0005049,1,0.938765689276241,0,8,nuclear export signal receptor activity,MF,
2402,GO:0005052,1,0.987645729355209,0,2,peroxisome matrix targeting signal-1 binding,MF,
2403,GO:0005053,1,0.994580106920531,0,1,peroxisome matrix targeting signal-2 binding,MF,
2404,GO:0005055,1,0.988993079611534,0,2,laminin receptor activity,MF,
2405,GO:0005057,1,0.310445582434051,0,162,signal transducer activity, downstream of receptor,MF,
2406,GO:0005068,1,0.919663165155157,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2407,GO:0005070,1,0.688534860310829,0,57,SH3/SH2 adaptor activity,MF,
2408,GO:0005072,1,0.923729937580503,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2409,GO:0005078,1,0.94088340744835,0,7,MAP-kinase scaffold activity,MF,
2410,GO:0005080,1,0.749161311280653,0,43,protein kinase C binding,MF,
2412,GO:0005086,1,0.852520419403251,0,20,ARF guanyl-nucleotide exchange factor activity,MF,
2413,GO:0005087,1,0.977679803887426,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2415,GO:0005089,1,0.542754129552326,0,76,Rho guanyl-nucleotide exchange factor activity,MF,
2416,GO:0005090,1,0.994431019935691,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2417,GO:0005092,1,0.917366626116093,0,14,GDP-dissociation inhibitor activity,MF,
2418,GO:0005093,1,0.988724398598367,0,2,Rab GDP-dissociation inhibitor activity,MF,
2419,GO:0005094,1,0.983852350502024,0,3,Rho GDP-dissociation inhibitor activity,MF,
2420,GO:0005095,1,0.908605281930275,0,14,GTPase inhibitor activity,MF,
2421,GO:0005096,1,0.1509584210524,0,262,GTPase activator activity,MF,
2423,GO:0005104,1,0.881621360810329,0,19,fibroblast growth factor receptor binding,MF,
2424,GO:0005105,1,0.983675960630953,0,3,type 1 fibroblast growth factor receptor binding,MF,
2425,GO:0005109,1,0.809959187586353,0,33,frizzled binding,MF,
2426,GO:0005111,1,0.983935794159817,0,3,type 2 fibroblast growth factor receptor binding,MF,
2427,GO:0005112,1,0.847139620864744,0,21,Notch binding,MF,
2428,GO:0005113,1,0.955730038398787,0,7,patched binding,MF,
2429,GO:0005114,1,0.952305675491864,0,7,type II transforming growth factor beta receptor binding,MF,
2430,GO:0005115,1,0.99162298711725,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2431,GO:0005119,1,0.977040265215824,0,3,smoothened binding,MF,
2432,GO:0005123,1,0.905806209514472,0,16,death receptor binding,MF,
2433,GO:0005124,1,0.978072212352922,0,4,scavenger receptor binding,MF,
2436,GO:0005127,1,0.965693016335015,0,5,ciliary neurotrophic factor receptor binding,MF,
2437,GO:0005128,1,0.988525039126735,0,2,erythropoietin receptor binding,MF,
2438,GO:0005130,1,0.994575349928849,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2439,GO:0005131,1,0.972269056283811,0,4,growth hormone receptor binding,MF,
2440,GO:0005134,1,0.982890876066259,0,3,interleukin-2 receptor binding,MF,
2441,GO:0005135,1,0.993890483605859,0,1,interleukin-3 receptor binding,MF,
2442,GO:0005136,1,0.988552564905442,0,2,interleukin-4 receptor binding,MF,
2443,GO:0005137,1,0.994431319404835,0,1,interleukin-5 receptor binding,MF,
2444,GO:0005138,1,0.95745800131471,0,7,interleukin-6 receptor binding,MF,
2445,GO:0005139,1,0.988798379922334,0,2,interleukin-7 receptor binding,MF,
2446,GO:0005141,1,0.994556759398708,0,1,interleukin-10 receptor binding,MF,
2447,GO:0005142,1,0.994370192855279,0,1,interleukin-11 receptor binding,MF,
2448,GO:0005143,1,0.98131124462978,0,3,interleukin-12 receptor binding,MF,
2449,GO:0005144,1,0.994607640841943,0,1,interleukin-13 receptor binding,MF,
2450,GO:0005146,1,0.987975946655069,0,2,leukemia inhibitory factor receptor binding,MF,
2451,GO:0005147,1,0.994510897882685,0,1,oncostatin-M receptor binding,MF,
2452,GO:0005149,1,0.93378689666786,0,11,interleukin-1 receptor binding,MF,
2453,GO:0005150,1,0.988205763564736,0,2,interleukin-1, Type I receptor binding,MF,
2454,GO:0005151,1,0.986657815778026,0,2,interleukin-1, Type II receptor binding,MF,
2455,GO:0005152,1,0.985266956863922,0,2,interleukin-1 receptor antagonist activity,MF,
2456,GO:0005153,1,0.988206700953324,0,2,interleukin-8 receptor binding,MF,
2457,GO:0005154,1,0.814732897776443,0,29,epidermal growth factor receptor binding,MF,
2458,GO:0005157,1,0.983536770021945,0,3,macrophage colony-stimulating factor receptor binding,MF,
2459,GO:0005158,1,0.838320387139205,0,21,insulin receptor binding,MF,
2460,GO:0005159,1,0.910077025804657,0,13,insulin-like growth factor receptor binding,MF,
2462,GO:0005161,1,0.905643874567968,0,14,platelet-derived growth factor receptor binding,MF,
2463,GO:0005163,1,0.994631649231132,0,1,nerve growth factor receptor binding,MF,
2464,GO:0005164,1,0.846759894671802,0,29,tumor necrosis factor receptor binding,MF,
2465,GO:0005165,1,0.928224394837092,0,11,neurotrophin receptor binding,MF,
2466,GO:0005166,1,0.9835884458064,0,3,neurotrophin p75 receptor binding,MF,
2467,GO:0005167,1,0.943725482980344,0,8,neurotrophin TRK receptor binding,MF,
2468,GO:0005168,1,0.955216505242854,0,6,neurotrophin TRKA receptor binding,MF,
2469,GO:0005169,1,0.980169931254706,0,3,neurotrophin TRKB receptor binding,MF,
2470,GO:0005170,1,0.992100162087756,0,1,neurotrophin TRKC receptor binding,MF,
2471,GO:0005171,1,0.988971176909607,0,2,hepatocyte growth factor receptor binding,MF,
2472,GO:0005172,1,0.937468048458936,0,10,vascular endothelial growth factor receptor binding,MF,
2473,GO:0005173,1,0.975633358225642,0,3,stem cell factor receptor binding,MF,
2474,GO:0005174,1,0.988942442676313,0,2,CD40 receptor binding,MF,
2475,GO:0005175,1,0.994657184370711,0,1,CD27 receptor binding,MF,
2476,GO:0005176,1,0.982041592644466,0,3,ErbB-2 class receptor binding,MF,
2479,GO:0005183,1,0.989238804938096,0,2,gonadotropin hormone-releasing hormone activity,MF,
2480,GO:0005184,1,0.896252296504782,0,20,neuropeptide hormone activity,MF,
2482,GO:0005199,1,0.993820564805382,0,1,structural constituent of cell wall,MF,
2489,GO:0005219,1,0.94578878566885,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2490,GO:0005220,1,0.962708947263986,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2491,GO:0005221,1,0.947359977255438,0,8,intracellular cyclic nucleotide activated cation channel activity,MF,
2492,GO:0005222,1,0.952888727066976,0,7,intracellular cAMP activated cation channel activity,MF,
2493,GO:0005223,1,0.97029455033915,0,5,intracellular cGMP activated cation channel activity,MF,
2494,GO:0005225,1,0.931259447104922,0,10,volume-sensitive anion channel activity,MF,
2495,GO:0005227,1,0.851608469331875,0,25,calcium activated cation channel activity,MF,
2496,GO:0005228,1,0.98420379628502,0,2,intracellular sodium activated potassium channel activity,MF,
2497,GO:0005229,1,0.887771818277237,0,18,intracellular calcium activated chloride channel activity,MF,
2502,GO:0005242,1,0.882911363766106,0,20,inward rectifier potassium channel activity,MF,
2503,GO:0005243,1,0.938622950460995,0,10,gap junction channel activity,MF,
2506,GO:0005246,1,0.820584346163038,0,30,calcium channel regulator activity,MF,
2507,GO:0005247,1,0.935743337148104,0,9,voltage-gated chloride channel activity,MF,
2508,GO:0005248,1,0.813342034628129,0,23,voltage-gated sodium channel activity,MF,
2512,GO:0005252,1,0.993339883885943,0,1,open rectifier potassium channel activity,MF,
2515,GO:0005260,1,0.991327248497623,0,1,intracellularly ATP-gated chloride channel activity,MF,
2519,GO:0005272,1,0.709113494447695,0,43,sodium channel activity,MF,
2520,GO:0005275,1,0.988568526586257,0,2,amine transmembrane transporter activity,MF,
2521,GO:0005277,1,0.988688398225009,0,2,acetylcholine transmembrane transporter activity,MF,
2522,GO:0005280,1,0.974850164876108,0,4,amino acid:proton symporter activity,MF,
2523,GO:0005283,1,0.890151677525573,0,17,amino acid:sodium symporter activity,MF,
2524,GO:0005287,1,0.984443056688094,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2525,GO:0005289,1,0.984443056688094,0,2,high-affinity arginine transmembrane transporter activity,MF,
2526,GO:0005290,1,0.982796078867569,0,3,L-histidine transmembrane transporter activity,MF,
2527,GO:0005292,1,0.984443056688094,0,2,high-affinity lysine transmembrane transporter activity,MF,
2528,GO:0005294,1,0.98819429412571,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2529,GO:0005295,1,0.988098293972332,0,2,neutral amino acid:sodium symporter activity,MF,
2530,GO:0005298,1,0.986580707744909,0,2,proline:sodium symporter activity,MF,
2531,GO:0005302,1,0.993967854321148,0,1,L-tyrosine transmembrane transporter activity,MF,
2532,GO:0005308,1,0.986499704117638,0,2,creatine transmembrane transporter activity,MF,
2533,GO:0005309,1,0.993690992147529,0,1,creatine:sodium symporter activity,MF,
2534,GO:0005310,1,0.789396353418758,0,35,dicarboxylic acid transmembrane transporter activity,MF,
2535,GO:0005313,1,0.905625513299128,0,14,L-glutamate transmembrane transporter activity,MF,
2536,GO:0005314,1,0.951816775283688,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2537,GO:0005315,1,0.971303758257437,0,4,inorganic phosphate transmembrane transporter activity,MF,
2538,GO:0005316,1,0.993877991261232,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2540,GO:0005324,1,0.969729410359235,0,5,long-chain fatty acid transporter activity,MF,
2541,GO:0005326,1,0.73822062506441,0,46,neurotransmitter transporter activity,MF,
2542,GO:0005328,1,0.854159073625013,0,23,neurotransmitter:sodium symporter activity,MF,
2543,GO:0005329,1,0.966610902590954,0,5,dopamine transmembrane transporter activity,MF,
2544,GO:0005330,1,0.980164488606315,0,3,dopamine:sodium symporter activity,MF,
2545,GO:0005332,1,0.975886068618705,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2546,GO:0005333,1,0.988170476594166,0,2,norepinephrine transmembrane transporter activity,MF,
2547,GO:0005334,1,0.993827041024114,0,1,norepinephrine:sodium symporter activity,MF,
2548,GO:0005335,1,0.99284021766627,0,1,serotonin:sodium symporter activity,MF,
2549,GO:0005337,1,0.966575751444044,0,6,nucleoside transmembrane transporter activity,MF,
2550,GO:0005338,1,0.927717366662897,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2552,GO:0005343,1,0.836464159500639,0,26,organic acid:sodium symporter activity,MF,
2553,GO:0005344,1,0.92869039714459,0,13,oxygen carrier activity,MF,
2554,GO:0005345,1,0.970825318506459,0,5,purine nucleobase transmembrane transporter activity,MF,
2555,GO:0005346,1,0.93701130918219,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2556,GO:0005347,1,0.9529178969253,0,8,ATP transmembrane transporter activity,MF,
2557,GO:0005350,1,0.983028197219453,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2558,GO:0005351,1,0.936538928239273,0,10,carbohydrate:proton symporter activity,MF,
2559,GO:0005353,1,0.994381755056307,0,1,fructose transmembrane transporter activity,MF,
2560,GO:0005355,1,0.892375503309501,0,18,glucose transmembrane transporter activity,MF,
2561,GO:0005362,1,0.988335443583655,0,2,low-affinity glucose:sodium symporter activity,MF,
2562,GO:0005365,1,0.977266564495948,0,2,myo-inositol transmembrane transporter activity,MF,
2563,GO:0005366,1,0.990534640262238,0,1,myo-inositol:proton symporter activity,MF,
2564,GO:0005367,1,0.986606399018177,0,1,myo-inositol:sodium symporter activity,MF,
2565,GO:0005368,1,0.990990339355326,0,1,taurine transmembrane transporter activity,MF,
2566,GO:0005369,1,0.990990339355326,0,1,taurine:sodium symporter activity,MF,
2567,GO:0005372,1,0.937091582614167,0,11,water transmembrane transporter activity,MF,
2568,GO:0005375,1,0.95612762224075,0,6,copper ion transmembrane transporter activity,MF,
2569,GO:0005381,1,0.939927286558767,0,10,iron ion transmembrane transporter activity,MF,
2570,GO:0005384,1,0.962289241458779,0,6,manganese ion transmembrane transporter activity,MF,
2571,GO:0005385,1,0.888377415631053,0,19,zinc ion transmembrane transporter activity,MF,
2572,GO:0005388,1,0.89195835806901,0,14,calcium-transporting ATPase activity,MF,
2573,GO:0005391,1,0.933107272877798,0,11,sodium:potassium-exchanging ATPase activity,MF,
2574,GO:0005395,1,0.990204596110977,0,1,eye pigment precursor transporter activity,MF,
2575,GO:0005402,1,0.899842501320051,0,16,carbohydrate:cation symporter activity,MF,
2576,GO:0005412,1,0.969989765703365,0,5,glucose:sodium symporter activity,MF,
2577,GO:0005415,1,0.988911175747731,0,2,nucleoside:sodium symporter activity,MF,
2578,GO:0005416,1,0.87768462996014,0,19,amino acid:cation symporter activity,MF,
2579,GO:0005427,1,0.993558419502883,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2581,GO:0005436,1,0.969551354268173,0,5,sodium:phosphate symporter activity,MF,
2582,GO:0005451,1,0.917405766890777,0,13,monovalent cation:proton antiporter activity,MF,
2583,GO:0005452,1,0.850567793508048,0,24,inorganic anion exchanger activity,MF,
2584,GO:0005456,1,0.994520893390471,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2585,GO:0005457,1,0.984692981002002,0,2,GDP-fucose transmembrane transporter activity,MF,
2586,GO:0005459,1,0.989186121648947,0,2,UDP-galactose transmembrane transporter activity,MF,
2587,GO:0005461,1,0.991032156245626,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2588,GO:0005462,1,0.985193395330265,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2589,GO:0005464,1,0.990706419162221,0,1,UDP-xylose transmembrane transporter activity,MF,
2590,GO:0005471,1,0.987588553690074,0,2,ATP:ADP antiporter activity,MF,
2591,GO:0005476,1,0.982500526893359,0,3,carnitine:acyl carnitine antiporter activity,MF,
2592,GO:0005477,1,0.993693292775689,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2593,GO:0005483,1,0.98160260113149,0,3,soluble NSF attachment protein activity,MF,
2594,GO:0005484,1,0.802422776504041,0,36,SNAP receptor activity,MF,
2596,GO:0005496,1,0.595978740819306,0,77,steroid binding,MF,
2597,GO:0005497,1,0.977941071024933,0,4,androgen binding,MF,
2598,GO:0005499,1,0.974102150247891,0,4,vitamin D binding,MF,
2600,GO:0005502,1,0.976004554039955,0,4,11-cis retinal binding,MF,
2601,GO:0005503,1,0.987227817319356,0,2,all-trans retinal binding,MF,
2609,GO:0005518,1,0.666594522893764,0,58,collagen binding,MF,
2610,GO:0005519,1,0.993337331014503,0,1,cytoskeletal regulatory protein binding,MF,
2612,GO:0005521,1,0.896596728436648,0,15,lamin binding,MF,
2613,GO:0005522,1,0.91975393602789,0,10,profilin binding,MF,
2614,GO:0005523,1,0.918032902879168,0,13,tropomyosin binding,MF,
2617,GO:0005527,1,0.926664432195142,0,13,macrolide binding,MF,
2618,GO:0005528,1,0.926664432195142,0,13,FK506 binding,MF,
2619,GO:0005534,1,0.971393087083024,0,5,galactose binding,MF,
2620,GO:0005536,1,0.932482887624742,0,11,glucose binding,MF,
2621,GO:0005537,1,0.916247853991141,0,14,mannose binding,MF,
2623,GO:0005540,1,0.874863264921821,0,19,hyaluronic acid binding,MF,
2624,GO:0005542,1,0.942333219186679,0,10,folic acid binding,MF,
2629,GO:0005547,1,0.787398094327205,0,33,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2630,GO:0005548,1,0.680253506692266,0,52,phospholipid transporter activity,MF,
2631,GO:0005549,1,0.989310295553002,0,2,odorant binding,MF,
2634,GO:0005577,1,0.952805680838525,0,7,fibrinogen complex,CC,
2636,GO:0005579,1,0.973348245088964,0,4,membrane attack complex,CC,
2638,GO:0005582,1,0.992122910748252,0,1,collagen type XV trimer,CC,
2641,GO:0005585,1,0.99238631608569,0,1,collagen type II trimer,CC,
2645,GO:0005589,1,0.97678170318957,0,3,collagen type VI trimer,CC,
2646,GO:0005590,1,0.988513453949461,0,1,collagen type VII trimer,CC,
2647,GO:0005591,1,0.994260729103642,0,1,collagen type VIII trimer,CC,
2648,GO:0005592,1,0.981673267472083,0,2,collagen type XI trimer,CC,
2649,GO:0005593,1,0.953912986166896,0,6,FACIT collagen trimer,CC,
2650,GO:0005594,1,0.982325308035742,0,3,collagen type IX trimer,CC,
2651,GO:0005595,1,0.987998740534052,0,1,collagen type XII trimer,CC,
2652,GO:0005596,1,0.991006130829394,0,1,collagen type XIV trimer,CC,
2653,GO:0005597,1,0.991800204434427,0,1,collagen type XVI trimer,CC,
2654,GO:0005598,1,0.994260729103642,0,1,short-chain collagen trimer,CC,
2655,GO:0005600,1,0.994028401431377,0,1,collagen type XIII trimer,CC,
2656,GO:0005602,1,0.989288028871609,0,2,complement component C1 complex,CC,
2658,GO:0005605,1,0.83522857330562,0,20,basal lamina,CC,
2659,GO:0005606,1,0.9698713417149,0,3,laminin-1 complex,CC,
2660,GO:0005607,1,0.983985497390024,0,2,laminin-2 complex,CC,
2661,GO:0005608,1,0.979989840173901,0,2,laminin-3 complex,CC,
2662,GO:0005610,1,0.969825450694436,0,3,laminin-5 complex,CC,
2663,GO:0005614,1,0.917562381486555,0,12,interstitial matrix,CC,
2669,GO:0005637,1,0.715024977984408,0,50,nuclear inner membrane,CC,
2670,GO:0005638,1,0.975623097857538,0,4,lamin filament,CC,
2671,GO:0005639,1,0.918253221044032,0,14,integral component of nuclear inner membrane,CC,
2672,GO:0005640,1,0.857053237936218,0,20,nuclear outer membrane,CC,
2673,GO:0005641,1,0.942498077885314,0,8,nuclear envelope lumen,CC,
2674,GO:0005642,1,0.960041470266361,0,5,annulate lamellae,CC,
2675,GO:0005643,1,0.580715968687299,0,76,nuclear pore,CC,
2676,GO:0005652,1,0.941059436609101,0,9,nuclear lamina,CC,
2678,GO:0005655,1,0.954965099880356,0,8,nucleolar ribonuclease P complex,CC,
2679,GO:0005656,1,0.983342723850041,0,3,nuclear pre-replicative complex,CC,
2680,GO:0005657,1,0.653946990939775,0,67,replication fork,CC,
2681,GO:0005658,1,0.963627978180707,0,6,alpha DNA polymerase:primase complex,CC,
2682,GO:0005662,1,0.915808577658407,0,14,DNA replication factor A complex,CC,
2683,GO:0005663,1,0.965660189016413,0,6,DNA replication factor C complex,CC,
2684,GO:0005664,1,0.948525732383987,0,9,nuclear origin of replication recognition complex,CC,
2685,GO:0005665,1,0.891982473649269,0,18,DNA-directed RNA polymerase II, core complex,CC,
2686,GO:0005666,1,0.904665067025888,0,17,DNA-directed RNA polymerase III complex,CC,
2687,GO:0005667,1,0.119061452907997,0,318,transcription factor complex,CC,
2688,GO:0005668,1,0.989025338077329,0,2,RNA polymerase transcription factor SL1 complex,CC,
2689,GO:0005669,1,0.798595195457318,0,36,transcription factor TFIID complex,CC,
2690,GO:0005671,1,0.916691441042792,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2691,GO:0005672,1,0.973103062117578,0,5,transcription factor TFIIA complex,CC,
2692,GO:0005673,1,0.988649664495639,0,2,transcription factor TFIIE complex,CC,
2693,GO:0005674,1,0.988905738541724,0,2,transcription factor TFIIF complex,CC,
2694,GO:0005675,1,0.933130377412764,0,12,holo TFIIH complex,CC,
2695,GO:0005677,1,0.940742224215008,0,8,chromatin silencing complex,CC,
2696,GO:0005680,1,0.880010322495208,0,21,anaphase-promoting complex,CC,
2698,GO:0005682,1,0.853247485408994,0,22,U5 snRNP,CC,
2699,GO:0005683,1,0.962649051211004,0,7,U7 snRNP,CC,
2700,GO:0005684,1,0.70297112819596,0,57,U2-type spliceosomal complex,CC,
2701,GO:0005685,1,0.882960901104688,0,20,U1 snRNP,CC,
2702,GO:0005686,1,0.885371921005084,0,20,U2 snRNP,CC,
2703,GO:0005687,1,0.933390159804011,0,11,U4 snRNP,CC,
2704,GO:0005688,1,0.956815086710987,0,8,U6 snRNP,CC,
2705,GO:0005689,1,0.858912345726015,0,26,U12-type spliceosomal complex,CC,
2706,GO:0005690,1,0.994423747533249,0,1,U4atac snRNP,CC,
2707,GO:0005691,1,0.992982030804003,0,1,U6atac snRNP,CC,
2708,GO:0005694,1,0.00192183798790114,0,898,chromosome,CC,
2709,GO:0005697,1,0.862667828761991,0,22,telomerase holoenzyme complex,CC,
2710,GO:0005712,1,0.984139228887912,0,2,chiasma,CC,
2711,GO:0005713,1,0.994327130902036,0,1,recombination nodule,CC,
2712,GO:0005715,1,0.994327130902036,0,1,late recombination nodule,CC,
2713,GO:0005719,1,0.867777411563881,0,23,nuclear euchromatin,CC,
2714,GO:0005720,1,0.810299891970366,0,31,nuclear heterochromatin,CC,
2715,GO:0005721,1,0.870821714713707,0,19,pericentric heterochromatin,CC,
2716,GO:0005724,1,0.994555166933378,0,1,nuclear telomeric heterochromatin,CC,
2717,GO:0005726,1,0.971045187995191,0,4,perichromatin fibrils,CC,
2718,GO:0005730,1,0.00275327275480685,0,876,nucleolus,CC,
2719,GO:0005731,1,0.994540340159623,0,1,nucleolus organizer region,CC,
2720,GO:0005732,1,0.89390338753601,0,20,small nucleolar ribonucleoprotein complex,CC,
2721,GO:0005736,1,0.928071977040252,0,12,DNA-directed RNA polymerase I complex,CC,
2725,GO:0005741,1,0.345528125418077,0,163,mitochondrial outer membrane,CC,
2726,GO:0005742,1,0.956230419153805,0,8,mitochondrial outer membrane translocase complex,CC,
2728,GO:0005744,1,0.939006677105911,0,11,mitochondrial inner membrane presequence translocase complex,CC,
2729,GO:0005745,1,0.98834049375181,0,2,m-AAA complex,CC,
2730,GO:0005746,1,0.654100697307398,0,76,mitochondrial respiratory chain,CC,
2731,GO:0005747,1,0.789834625050682,0,43,mitochondrial respiratory chain complex I,CC,
2732,GO:0005749,1,0.977974226500333,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2733,GO:0005750,1,0.939033580546447,0,11,mitochondrial respiratory chain complex III,CC,
2734,GO:0005751,1,0.932536446675068,0,13,mitochondrial respiratory chain complex IV,CC,
2735,GO:0005753,1,0.994422519463272,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2736,GO:0005757,1,0.978002361826216,0,4,mitochondrial permeability transition pore complex,CC,
2737,GO:0005758,1,0.676617513379098,0,68,mitochondrial intermembrane space,CC,
2738,GO:0005759,1,0.0793988154425164,0,420,mitochondrial matrix,CC,
2739,GO:0005760,1,0.985903884150202,0,2,gamma DNA polymerase complex,CC,
2740,GO:0005761,1,0.634979324215321,0,82,mitochondrial ribosome,CC,
2741,GO:0005762,1,0.756609671734872,0,50,mitochondrial large ribosomal subunit,CC,
2742,GO:0005763,1,0.863236847437804,0,27,mitochondrial small ribosomal subunit,CC,
2746,GO:0005767,1,0.922973501108011,0,13,secondary lysosome,CC,
2754,GO:0005776,1,0.567820766268465,0,86,autophagosome,CC,
2756,GO:0005778,1,0.69099495948464,0,57,peroxisomal membrane,CC,
2757,GO:0005779,1,0.904180462364467,0,17,integral component of peroxisomal membrane,CC,
2758,GO:0005782,1,0.781810440873451,0,41,peroxisomal matrix,CC,
2760,GO:0005784,1,0.978469264994493,0,4,Sec61 translocon complex,CC,
2762,GO:0005786,1,0.966436319751638,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2763,GO:0005787,1,0.971221510407717,0,5,signal peptidase complex,CC,
2766,GO:0005790,1,0.785338604298407,0,31,smooth endoplasmic reticulum,CC,
2768,GO:0005793,1,0.474668020623858,0,113,endoplasmic reticulum-Golgi intermediate compartment,CC,
2772,GO:0005797,1,0.952137395276297,0,8,Golgi medial cisterna,CC,
2774,GO:0005801,1,0.694310021636914,0,53,cis-Golgi network,CC,
2777,GO:0005813,1,0.0401965122296777,0,464,centrosome,CC,
2778,GO:0005814,1,0.436198073481818,0,117,centriole,CC,
2779,GO:0005815,1,0.0102772038517623,0,655,microtubule organizing center,CC,
2780,GO:0005816,1,0.96176079370862,0,6,spindle pole body,CC,
2781,GO:0005818,1,0.943969024634402,0,8,aster,CC,
2782,GO:0005819,1,0.123239197866141,0,304,spindle,CC,
2783,GO:0005826,1,0.962941768777198,0,5,actomyosin contractile ring,CC,
2784,GO:0005827,1,0.966247251513813,0,5,polar microtubule,CC,
2785,GO:0005828,1,0.943165330744173,0,7,kinetochore microtubule,CC,
2787,GO:0005832,1,0.934357907437204,0,11,chaperonin-containing T-complex,CC,
2788,GO:0005833,1,0.942236504038358,0,11,hemoglobin complex,CC,
2790,GO:0005838,1,0.889898492735007,0,21,proteasome regulatory particle,CC,
2791,GO:0005839,1,0.897284575613132,0,19,proteasome core complex,CC,
2792,GO:0005840,1,0.267390293660222,0,228,ribosome,CC,
2794,GO:0005845,1,0.929561876218638,0,11,mRNA cap binding complex,CC,
2795,GO:0005846,1,0.986538743606365,0,2,nuclear cap binding complex,CC,
2796,GO:0005847,1,0.902262868837467,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2797,GO:0005849,1,0.889730317328358,0,18,mRNA cleavage factor complex,CC,
2798,GO:0005850,1,0.974847891110463,0,4,eukaryotic translation initiation factor 2 complex,CC,
2799,GO:0005851,1,0.965918209768211,0,6,eukaryotic translation initiation factor 2B complex,CC,
2800,GO:0005852,1,0.904028871671408,0,17,eukaryotic translation initiation factor 3 complex,CC,
2801,GO:0005853,1,0.97764894280267,0,4,eukaryotic translation elongation factor 1 complex,CC,
2802,GO:0005854,1,0.98730258165245,0,2,nascent polypeptide-associated complex,CC,
2804,GO:0005858,1,0.834429444124597,0,17,axonemal dynein complex,CC,
2805,GO:0005859,1,0.841889259186297,0,21,muscle myosin complex,CC,
2806,GO:0005861,1,0.963080881375705,0,7,troponin complex,CC,
2807,GO:0005862,1,0.976445483056903,0,4,muscle thin filament tropomyosin,CC,
2808,GO:0005863,1,0.978534709156812,0,3,striated muscle myosin thick filament,CC,
2809,GO:0005865,1,0.80918587731386,0,29,striated muscle thin filament,CC,
2810,GO:0005868,1,0.854755432157762,0,22,cytoplasmic dynein complex,CC,
2811,GO:0005869,1,0.954064193422053,0,8,dynactin complex,CC,
2812,GO:0005871,1,0.684885832770538,0,50,kinesin complex,CC,
2813,GO:0005873,1,0.983978591079141,0,2,plus-end kinesin complex,CC,
2815,GO:0005875,1,0.333654957447091,0,141,microtubule associated complex,CC,
2816,GO:0005876,1,0.671161926735481,0,57,spindle microtubule,CC,
2817,GO:0005879,1,0.969247762872698,0,4,axonemal microtubule,CC,
2818,GO:0005880,1,0.994584190979098,0,1,nuclear microtubule,CC,
2819,GO:0005881,1,0.688234234365721,0,54,cytoplasmic microtubule,CC,
2823,GO:0005885,1,0.940377172940276,0,11,Arp2/3 protein complex,CC,
2826,GO:0005889,1,0.987363098687563,0,2,potassium:proton exchanging ATPase complex,CC,
2827,GO:0005890,1,0.940007553849164,0,10,sodium:potassium-exchanging ATPase complex,CC,
2829,GO:0005892,1,0.905123003711638,0,16,acetylcholine-gated channel complex,CC,
2830,GO:0005895,1,0.994431319404835,0,1,interleukin-5 receptor complex,CC,
2831,GO:0005896,1,0.981871263907156,0,3,interleukin-6 receptor complex,CC,
2832,GO:0005898,1,0.993309167453853,0,1,interleukin-13 receptor complex,CC,
2833,GO:0005899,1,0.969493578157232,0,3,insulin receptor complex,CC,
2834,GO:0005900,1,0.987589139340092,0,2,oncostatin-M receptor complex,CC,
2835,GO:0005901,1,0.586906112545506,0,73,caveola,CC,
2842,GO:0005914,1,0.993839209719658,0,1,spot adherens junction,CC,
2843,GO:0005915,1,0.951981648220049,0,7,zonula adherens,CC,
2844,GO:0005916,1,0.931487639885791,0,10,fascia adherens,CC,
2845,GO:0005921,1,0.86796399294923,0,23,gap junction,CC,
2846,GO:0005922,1,0.917834511500106,0,14,connexin complex,CC,
2847,GO:0005923,1,0.461830957429467,0,107,bicellular tight junction,CC,
2850,GO:0005927,1,0.981280471154547,0,3,muscle tendon junction,CC,
2852,GO:0005930,1,0.473305716678384,0,99,axoneme,CC,
2854,GO:0005940,1,0.926971772021431,0,12,septin ring,CC,
2855,GO:0005942,1,0.873850751105238,0,18,phosphatidylinositol 3-kinase complex,CC,
2856,GO:0005943,1,0.985251019801861,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2857,GO:0005944,1,0.985014351042731,0,2,phosphatidylinositol 3-kinase complex, class IB,CC,
2858,GO:0005945,1,0.987920742774917,0,2,6-phosphofructokinase complex,CC,
2859,GO:0005947,1,0.965507922265515,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2860,GO:0005952,1,0.963602730178042,0,6,cAMP-dependent protein kinase complex,CC,
2861,GO:0005953,1,0.988804519085754,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2862,GO:0005954,1,0.994323969998905,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2863,GO:0005955,1,0.968891156906121,0,4,calcineurin complex,CC,
2864,GO:0005956,1,0.98886829950182,0,2,protein kinase CK2 complex,CC,
2865,GO:0005958,1,0.973103516450684,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2866,GO:0005960,1,0.988076342489068,0,2,glycine cleavage complex,CC,
2867,GO:0005964,1,0.96377762280332,0,5,phosphorylase kinase complex,CC,
2868,GO:0005965,1,0.98875639582086,0,2,protein farnesyltransferase complex,CC,
2869,GO:0005967,1,0.980333371283789,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2870,GO:0005968,1,0.972983866106125,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2871,GO:0005969,1,0.989613039684879,0,1,serine-pyruvate aminotransferase complex,CC,
2872,GO:0005971,1,0.980385461654514,0,3,ribonucleoside-diphosphate reductase complex,CC,
2874,GO:0005976,1,0.505901326379242,0,99,polysaccharide metabolic process,BP,
2875,GO:0005977,1,0.620406264719492,0,68,glycogen metabolic process,BP,
2876,GO:0005978,1,0.727670249179375,0,44,glycogen biosynthetic process,BP,
2877,GO:0005979,1,0.832744689708216,0,23,regulation of glycogen biosynthetic process,BP,
2878,GO:0005980,1,0.852011928249337,0,23,glycogen catabolic process,BP,
2879,GO:0005981,1,0.973865133112999,0,4,regulation of glycogen catabolic process,BP,
2880,GO:0005982,1,0.990977340097145,0,1,starch metabolic process,BP,
2881,GO:0005983,1,0.990977340097145,0,1,starch catabolic process,BP,
2882,GO:0005984,1,0.943335260095549,0,9,disaccharide metabolic process,BP,
2883,GO:0005985,1,0.988248839083783,0,2,sucrose metabolic process,BP,
2884,GO:0005986,1,0.99457171375683,0,1,sucrose biosynthetic process,BP,
2885,GO:0005988,1,0.98150073458807,0,3,lactose metabolic process,BP,
2886,GO:0005989,1,0.98150073458807,0,3,lactose biosynthetic process,BP,
2887,GO:0005991,1,0.994090347230627,0,1,trehalose metabolic process,BP,
2889,GO:0005997,1,0.977468405668943,0,4,xylulose metabolic process,BP,
2890,GO:0005998,1,0.993570072890914,0,1,xylulose catabolic process,BP,
2891,GO:0005999,1,0.98908936377773,0,2,xylulose biosynthetic process,BP,
2892,GO:0006000,1,0.925654326325594,0,13,fructose metabolic process,BP,
2893,GO:0006001,1,0.977246056371919,0,4,fructose catabolic process,BP,
2894,GO:0006002,1,0.950065499526497,0,8,fructose 6-phosphate metabolic process,BP,
2895,GO:0006003,1,0.973623655784252,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2897,GO:0006006,1,0.319777073013926,0,171,glucose metabolic process,BP,
2898,GO:0006007,1,0.84132008663938,0,28,glucose catabolic process,BP,
2899,GO:0006011,1,0.95775399811812,0,6,UDP-glucose metabolic process,BP,
2901,GO:0006013,1,0.94904815559256,0,8,mannose metabolic process,BP,
2902,GO:0006014,1,0.983835757491966,0,3,D-ribose metabolic process,BP,
2903,GO:0006015,1,0.983002239488952,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2904,GO:0006020,1,0.919585011900585,0,11,inositol metabolic process,BP,
2905,GO:0006021,1,0.973373770620388,0,4,inositol biosynthetic process,BP,
2907,GO:0006023,1,0.480455122767214,0,107,aminoglycan biosynthetic process,BP,
2908,GO:0006024,1,0.491998616187353,0,103,glycosaminoglycan biosynthetic process,BP,
2910,GO:0006027,1,0.696189488093498,0,53,glycosaminoglycan catabolic process,BP,
2911,GO:0006029,1,0.555935478681207,0,83,proteoglycan metabolic process,BP,
2915,GO:0006041,1,0.976944844322182,0,4,glucosamine metabolic process,BP,
2916,GO:0006043,1,0.988918576696211,0,2,glucosamine catabolic process,BP,
2917,GO:0006044,1,0.907552233121547,0,15,N-acetylglucosamine metabolic process,BP,
2918,GO:0006045,1,0.985673463019092,0,2,N-acetylglucosamine biosynthetic process,BP,
2919,GO:0006046,1,0.983495018993466,0,3,N-acetylglucosamine catabolic process,BP,
2920,GO:0006047,1,0.910724918518427,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2921,GO:0006048,1,0.933764098148865,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2922,GO:0006049,1,0.994111043140962,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2923,GO:0006050,1,0.989176428339817,0,2,mannosamine metabolic process,BP,
2924,GO:0006051,1,0.989176428339817,0,2,N-acetylmannosamine metabolic process,BP,
2925,GO:0006054,1,0.933103194513368,0,11,N-acetylneuraminate metabolic process,BP,
2926,GO:0006055,1,0.994612382336904,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2927,GO:0006056,1,0.994529222266585,0,1,mannoprotein metabolic process,BP,
2928,GO:0006057,1,0.994529222266585,0,1,mannoprotein biosynthetic process,BP,
2929,GO:0006059,1,0.983582091905924,0,3,hexitol metabolic process,BP,
2930,GO:0006060,1,0.988925438847536,0,2,sorbitol metabolic process,BP,
2931,GO:0006061,1,0.994592054250129,0,1,sorbitol biosynthetic process,BP,
2932,GO:0006062,1,0.99430288163403,0,1,sorbitol catabolic process,BP,
2933,GO:0006063,1,0.953278300702478,0,8,uronic acid metabolic process,BP,
2934,GO:0006064,1,0.971996053182398,0,5,glucuronate catabolic process,BP,
2935,GO:0006065,1,0.9795473058497,0,3,UDP-glucuronate biosynthetic process,BP,
2937,GO:0006067,1,0.917742540186892,0,15,ethanol metabolic process,BP,
2938,GO:0006068,1,0.951143010287578,0,9,ethanol catabolic process,BP,
2939,GO:0006069,1,0.953741050909729,0,8,ethanol oxidation,BP,
2940,GO:0006071,1,0.924424336966997,0,12,glycerol metabolic process,BP,
2941,GO:0006072,1,0.941271969382452,0,8,glycerol-3-phosphate metabolic process,BP,
2942,GO:0006073,1,0.614781914365399,0,69,cellular glucan metabolic process,BP,
2943,GO:0006081,1,0.659434559551664,0,69,cellular aldehyde metabolic process,BP,
2945,GO:0006083,1,0.979375114291066,0,3,acetate metabolic process,BP,
2947,GO:0006085,1,0.880925982637404,0,19,acetyl-CoA biosynthetic process,BP,
2948,GO:0006086,1,0.908936022285021,0,14,acetyl-CoA biosynthetic process from pyruvate,BP,
2949,GO:0006089,1,0.933674786834506,0,11,lactate metabolic process,BP,
2950,GO:0006090,1,0.428702885828908,0,126,pyruvate metabolic process,BP,
2951,GO:0006091,1,0.063738577566232,0,433,generation of precursor metabolites and energy,BP,
2952,GO:0006094,1,0.662071534844348,0,67,gluconeogenesis,BP,
2953,GO:0006096,1,0.53158564724049,0,92,glycolytic process,BP,
2954,GO:0006097,1,0.988945030361313,0,2,glyoxylate cycle,BP,
2955,GO:0006098,1,0.904011924215057,0,17,pentose-phosphate shunt,BP,
2956,GO:0006099,1,0.842250349694018,0,29,tricarboxylic acid cycle,BP,
2957,GO:0006101,1,0.818346431878488,0,33,citrate metabolic process,BP,
2958,GO:0006102,1,0.972554052091034,0,5,isocitrate metabolic process,BP,
2959,GO:0006103,1,0.893859664955802,0,18,2-oxoglutarate metabolic process,BP,
2960,GO:0006104,1,0.965637664064166,0,6,succinyl-CoA metabolic process,BP,
2961,GO:0006105,1,0.933675592898271,0,11,succinate metabolic process,BP,
2962,GO:0006106,1,0.983393338270018,0,3,fumarate metabolic process,BP,
2963,GO:0006107,1,0.929421615178681,0,12,oxaloacetate metabolic process,BP,
2964,GO:0006108,1,0.959880794279033,0,7,malate metabolic process,BP,
2965,GO:0006109,1,0.336766854476943,0,155,regulation of carbohydrate metabolic process,BP,
2966,GO:0006110,1,0.643612641878903,0,61,regulation of glycolytic process,BP,
2967,GO:0006111,1,0.840238916085723,0,26,regulation of gluconeogenesis,BP,
2968,GO:0006112,1,0.574281771490201,0,80,energy reserve metabolic process,BP,
2969,GO:0006114,1,0.971256732404819,0,5,glycerol biosynthetic process,BP,
2970,GO:0006116,1,0.974739037591277,0,4,NADH oxidation,BP,
2971,GO:0006117,1,0.994281914990069,0,1,acetaldehyde metabolic process,BP,
2972,GO:0006119,1,0.567559995195769,0,98,oxidative phosphorylation,BP,
2973,GO:0006120,1,0.784787952301148,0,44,mitochondrial electron transport, NADH to ubiquinone,BP,
2974,GO:0006121,1,0.977968092579247,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2975,GO:0006122,1,0.923568299670133,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2976,GO:0006123,1,0.910932308051993,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2977,GO:0006127,1,0.985722736618344,0,2,glycerophosphate shuttle,BP,
2980,GO:0006144,1,0.874487337023626,0,22,purine nucleobase metabolic process,BP,
2981,GO:0006145,1,0.970475160253339,0,4,purine nucleobase catabolic process,BP,
2982,GO:0006147,1,0.9920014927361,0,1,guanine catabolic process,BP,
2983,GO:0006148,1,0.994348273062443,0,1,inosine catabolic process,BP,
2984,GO:0006152,1,0.965405535740421,0,6,purine nucleoside catabolic process,BP,
2985,GO:0006154,1,0.988888320783881,0,2,adenosine catabolic process,BP,
2986,GO:0006157,1,0.994572033598167,0,1,deoxyadenosine catabolic process,BP,
2989,GO:0006165,1,0.482379686205366,0,109,nucleoside diphosphate phosphorylation,BP,
2990,GO:0006166,1,0.971026684881294,0,5,purine ribonucleoside salvage,BP,
2991,GO:0006167,1,0.967171851960826,0,6,AMP biosynthetic process,BP,
2992,GO:0006168,1,0.983825611947328,0,3,adenine salvage,BP,
2993,GO:0006169,1,0.994463122511233,0,1,adenosine salvage,BP,
2995,GO:0006172,1,0.98807804958915,0,2,ADP biosynthetic process,BP,
2996,GO:0006173,1,0.993648819298809,0,1,dADP biosynthetic process,BP,
2997,GO:0006174,1,0.994184768585909,0,1,dADP phosphorylation,BP,
2998,GO:0006175,1,0.994463122511233,0,1,dATP biosynthetic process,BP,
2999,GO:0006177,1,0.972570692551876,0,5,GMP biosynthetic process,BP,
3000,GO:0006178,1,0.989114391765378,0,2,guanine salvage,BP,
3001,GO:0006182,1,0.808940711962059,0,31,cGMP biosynthetic process,BP,
3002,GO:0006183,1,0.946707882215309,0,10,GTP biosynthetic process,BP,
3003,GO:0006185,1,0.994636454406539,0,1,dGDP biosynthetic process,BP,
3004,GO:0006186,1,0.994184768585909,0,1,dGDP phosphorylation,BP,
3005,GO:0006188,1,0.939519317694349,0,10,IMP biosynthetic process,BP,
3006,GO:0006189,1,0.962776447792972,0,6,'de novo' IMP biosynthetic process,BP,
3007,GO:0006193,1,0.994626787495288,0,1,ITP catabolic process,BP,
3008,GO:0006195,1,0.743108237087612,0,44,purine nucleotide catabolic process,BP,
3009,GO:0006196,1,0.986332292282555,0,2,AMP catabolic process,BP,
3010,GO:0006198,1,0.879729591518586,0,17,cAMP catabolic process,BP,
3011,GO:0006203,1,0.983159782855914,0,3,dGTP catabolic process,BP,
3013,GO:0006207,1,0.954766890506268,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3014,GO:0006208,1,0.982952380432702,0,3,pyrimidine nucleobase catabolic process,BP,
3015,GO:0006210,1,0.982952380432702,0,3,thymine catabolic process,BP,
3016,GO:0006211,1,0.964137453519136,0,3,5-methylcytosine catabolic process,BP,
3017,GO:0006212,1,0.988462823522544,0,2,uracil catabolic process,BP,
3019,GO:0006214,1,0.993986671338394,0,1,thymidine catabolic process,BP,
3020,GO:0006216,1,0.956042343188224,0,8,cytidine catabolic process,BP,
3021,GO:0006218,1,0.994521529581414,0,1,uridine catabolic process,BP,
3022,GO:0006220,1,0.773589570806822,0,45,pyrimidine nucleotide metabolic process,BP,
3023,GO:0006221,1,0.836842453572772,0,31,pyrimidine nucleotide biosynthetic process,BP,
3024,GO:0006222,1,0.941569242151373,0,10,UMP biosynthetic process,BP,
3025,GO:0006226,1,0.983625943870512,0,3,dUMP biosynthetic process,BP,
3026,GO:0006227,1,0.988727535234231,0,2,dUDP biosynthetic process,BP,
3027,GO:0006228,1,0.948165299903585,0,9,UTP biosynthetic process,BP,
3028,GO:0006231,1,0.983456161221139,0,3,dTMP biosynthetic process,BP,
3029,GO:0006233,1,0.988727535234231,0,2,dTDP biosynthetic process,BP,
3030,GO:0006235,1,0.978044515160479,0,4,dTTP biosynthetic process,BP,
3031,GO:0006238,1,0.994611703443189,0,1,CMP salvage,BP,
3032,GO:0006241,1,0.930004221830607,0,13,CTP biosynthetic process,BP,
3033,GO:0006244,1,0.930114042164934,0,13,pyrimidine nucleotide catabolic process,BP,
3034,GO:0006253,1,0.994625312802153,0,1,dCTP catabolic process,BP,
3035,GO:0006256,1,0.994104773294902,0,1,UDP catabolic process,BP,
3036,GO:0006258,1,0.989056323317503,0,2,UDP-glucose catabolic process,BP,
3039,GO:0006261,1,0.402546927303832,0,141,DNA-dependent DNA replication,BP,
3040,GO:0006264,1,0.937822596492626,0,10,mitochondrial DNA replication,BP,
3041,GO:0006265,1,0.943192235833836,0,9,DNA topological change,BP,
3042,GO:0006266,1,0.872201213315373,0,23,DNA ligation,BP,
3043,GO:0006267,1,0.983342723850041,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3044,GO:0006268,1,0.959054524994436,0,7,DNA unwinding involved in DNA replication,BP,
3045,GO:0006269,1,0.969326486685185,0,5,DNA replication, synthesis of RNA primer,BP,
3046,GO:0006270,1,0.774243625645178,0,42,DNA replication initiation,BP,
3047,GO:0006271,1,0.883030444060847,0,20,DNA strand elongation involved in DNA replication,BP,
3048,GO:0006272,1,0.97649144363622,0,3,leading strand elongation,BP,
3049,GO:0006273,1,0.933816697382658,0,11,lagging strand elongation,BP,
3051,GO:0006278,1,0.631896700908025,0,67,RNA-dependent DNA biosynthetic process,BP,
3052,GO:0006281,1,0.0413658225403792,0,475,DNA repair,BP,
3053,GO:0006282,1,0.553643806236705,0,89,regulation of DNA repair,BP,
3054,GO:0006283,1,0.639345678588466,0,73,transcription-coupled nucleotide-excision repair,BP,
3055,GO:0006284,1,0.765110930428734,0,41,base-excision repair,BP,
3056,GO:0006285,1,0.945831362435102,0,10,base-excision repair, AP site formation,BP,
3057,GO:0006286,1,0.989217451848443,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3058,GO:0006287,1,0.965751745278566,0,5,base-excision repair, gap-filling,BP,
3059,GO:0006288,1,0.982955026279773,0,3,base-excision repair, DNA ligation,BP,
3060,GO:0006289,1,0.497653348376556,0,112,nucleotide-excision repair,BP,
3061,GO:0006290,1,0.951825567984435,0,7,pyrimidine dimer repair,BP,
3062,GO:0006293,1,0.873988624965275,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3063,GO:0006294,1,0.838213890780192,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3064,GO:0006295,1,0.873988624965275,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3065,GO:0006296,1,0.796112640342856,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3066,GO:0006297,1,0.868762846521961,0,23,nucleotide-excision repair, DNA gap filling,BP,
3067,GO:0006298,1,0.825120091632419,0,30,mismatch repair,BP,
3068,GO:0006301,1,0.733000656468729,0,48,postreplication repair,BP,
3069,GO:0006302,1,0.280136399973796,0,189,double-strand break repair,BP,
3070,GO:0006303,1,0.665402717836698,0,58,double-strand break repair via nonhomologous end joining,BP,
3071,GO:0006304,1,0.541041221702515,0,92,DNA modification,BP,
3072,GO:0006305,1,0.691395252262723,0,54,DNA alkylation,BP,
3073,GO:0006306,1,0.691395252262723,0,54,DNA methylation,BP,
3074,GO:0006307,1,0.941664322962786,0,10,DNA dealkylation involved in DNA repair,BP,
3075,GO:0006308,1,0.796399670942322,0,35,DNA catabolic process,BP,
3076,GO:0006309,1,0.877164507653415,0,20,apoptotic DNA fragmentation,BP,
3077,GO:0006310,1,0.211936443887936,0,232,DNA recombination,BP,
3078,GO:0006311,1,0.976030648263071,0,4,meiotic gene conversion,BP,
3079,GO:0006312,1,0.85148074241894,0,23,mitotic recombination,BP,
3080,GO:0006313,1,0.99328601686113,0,1,transposition, DNA-mediated,BP,
3081,GO:0006323,1,0.390380881666029,0,142,DNA packaging,BP,
3082,GO:0006325,1,0.00881376820726522,0,674,chromatin organization,BP,
3083,GO:0006333,1,0.426389410878751,0,133,chromatin assembly or disassembly,BP,
3084,GO:0006334,1,0.574647723468546,0,91,nucleosome assembly,BP,
3085,GO:0006335,1,0.919944859500165,0,14,DNA replication-dependent nucleosome assembly,BP,
3086,GO:0006336,1,0.77955799092252,0,40,DNA replication-independent nucleosome assembly,BP,
3087,GO:0006337,1,0.887102841400398,0,17,nucleosome disassembly,BP,
3088,GO:0006338,1,0.342262096308619,0,158,chromatin remodeling,BP,
3089,GO:0006342,1,0.604700858068106,0,75,chromatin silencing,BP,
3090,GO:0006343,1,0.993450445158367,0,1,establishment of chromatin silencing,BP,
3091,GO:0006344,1,0.968332875987359,0,4,maintenance of chromatin silencing,BP,
3092,GO:0006346,1,0.909994850746246,0,14,methylation-dependent chromatin silencing,BP,
3093,GO:0006348,1,0.947855362370635,0,8,chromatin silencing at telomere,BP,
3094,GO:0006349,1,0.891441560948698,0,16,regulation of gene expression by genetic imprinting,BP,
3096,GO:0006352,1,0.221159574852238,0,223,DNA-templated transcription, initiation,BP,
3097,GO:0006353,1,0.516829123123318,0,107,DNA-templated transcription, termination,BP,
3098,GO:0006354,1,0.456862862491048,0,122,DNA-templated transcription, elongation,BP,
3100,GO:0006356,1,0.81033331985585,0,30,regulation of transcription by RNA polymerase I,BP,
3102,GO:0006359,1,0.829590661051875,0,27,regulation of transcription by RNA polymerase III,BP,
3103,GO:0006360,1,0.673570625394496,0,59,transcription by RNA polymerase I,BP,
3104,GO:0006361,1,0.803479991999442,0,35,transcription initiation from RNA polymerase I promoter,BP,
3105,GO:0006362,1,0.830258664863948,0,30,transcription elongation from RNA polymerase I promoter,BP,
3106,GO:0006363,1,0.833038469955896,0,30,termination of RNA polymerase I transcription,BP,
3107,GO:0006364,1,0.223166284565972,0,249,rRNA processing,BP,
3109,GO:0006367,1,0.306970136551296,0,175,transcription initiation from RNA polymerase II promoter,BP,
3110,GO:0006368,1,0.533926756366938,0,97,transcription elongation from RNA polymerase II promoter,BP,
3111,GO:0006369,1,0.657062584295136,0,68,termination of RNA polymerase II transcription,BP,
3112,GO:0006370,1,0.827246308980417,0,31,7-methylguanosine mRNA capping,BP,
3113,GO:0006376,1,0.838668165336555,0,27,mRNA splice site selection,BP,
3114,GO:0006378,1,0.768121263999386,0,40,mRNA polyadenylation,BP,
3115,GO:0006379,1,0.843999054869517,0,27,mRNA cleavage,BP,
3116,GO:0006382,1,0.961196459087613,0,5,adenosine to inosine editing,BP,
3117,GO:0006383,1,0.710173653840925,0,53,transcription by RNA polymerase III,BP,
3118,GO:0006384,1,0.947501186356639,0,7,transcription initiation from RNA polymerase III promoter,BP,
3119,GO:0006386,1,0.994650314805895,0,1,termination of RNA polymerase III transcription,BP,
3120,GO:0006388,1,0.923938340488137,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3121,GO:0006390,1,0.916015335035396,0,13,mitochondrial transcription,BP,
3122,GO:0006391,1,0.982594089504207,0,3,transcription initiation from mitochondrial promoter,BP,
3123,GO:0006393,1,0.988403017609477,0,2,termination of mitochondrial transcription,BP,
3126,GO:0006398,1,0.968774083284883,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3127,GO:0006399,1,0.339245032298857,0,181,tRNA metabolic process,BP,
3128,GO:0006400,1,0.646976561884984,0,73,tRNA modification,BP,
3132,GO:0006404,1,0.977442926008989,0,3,RNA import into nucleus,BP,
3133,GO:0006405,1,0.409594597226006,0,135,RNA export from nucleus,BP,
3134,GO:0006406,1,0.500093097319719,0,104,mRNA export from nucleus,BP,
3135,GO:0006407,1,0.978445506298374,0,3,rRNA export from nucleus,BP,
3136,GO:0006408,1,0.989017564869847,0,2,snRNA export from nucleus,BP,
3137,GO:0006409,1,0.801756675380865,0,31,tRNA export from nucleus,BP,
3139,GO:0006413,1,0.316210946212322,0,191,translational initiation,BP,
3140,GO:0006414,1,0.475025322673714,0,126,translational elongation,BP,
3141,GO:0006415,1,0.566179067017807,0,99,translational termination,BP,
3143,GO:0006418,1,0.747746921589569,0,49,tRNA aminoacylation for protein translation,BP,
3144,GO:0006419,1,0.981051065589973,0,3,alanyl-tRNA aminoacylation,BP,
3145,GO:0006420,1,0.983449432850164,0,3,arginyl-tRNA aminoacylation,BP,
3146,GO:0006421,1,0.982463210860757,0,3,asparaginyl-tRNA aminoacylation,BP,
3147,GO:0006422,1,0.994377590468389,0,1,aspartyl-tRNA aminoacylation,BP,
3148,GO:0006423,1,0.988789064145486,0,2,cysteinyl-tRNA aminoacylation,BP,
3149,GO:0006424,1,0.985813191426609,0,2,glutamyl-tRNA aminoacylation,BP,
3150,GO:0006425,1,0.986908613093263,0,2,glutaminyl-tRNA aminoacylation,BP,
3151,GO:0006426,1,0.98879157068439,0,2,glycyl-tRNA aminoacylation,BP,
3152,GO:0006427,1,0.988831831409508,0,2,histidyl-tRNA aminoacylation,BP,
3153,GO:0006428,1,0.986611655498549,0,2,isoleucyl-tRNA aminoacylation,BP,
3154,GO:0006429,1,0.985709931453409,0,2,leucyl-tRNA aminoacylation,BP,
3155,GO:0006430,1,0.994447787333467,0,1,lysyl-tRNA aminoacylation,BP,
3156,GO:0006431,1,0.988257015454977,0,2,methionyl-tRNA aminoacylation,BP,
3157,GO:0006432,1,0.972040414757054,0,5,phenylalanyl-tRNA aminoacylation,BP,
3158,GO:0006433,1,0.981487132428845,0,3,prolyl-tRNA aminoacylation,BP,
3159,GO:0006434,1,0.988989866740843,0,2,seryl-tRNA aminoacylation,BP,
3160,GO:0006435,1,0.982470265092881,0,3,threonyl-tRNA aminoacylation,BP,
3161,GO:0006436,1,0.988430573854269,0,2,tryptophanyl-tRNA aminoacylation,BP,
3162,GO:0006437,1,0.988454155406749,0,2,tyrosyl-tRNA aminoacylation,BP,
3163,GO:0006438,1,0.979340577739761,0,3,valyl-tRNA aminoacylation,BP,
3164,GO:0006446,1,0.619544699690772,0,74,regulation of translational initiation,BP,
3165,GO:0006447,1,0.979508756673152,0,3,regulation of translational initiation by iron,BP,
3166,GO:0006448,1,0.889811992368673,0,18,regulation of translational elongation,BP,
3167,GO:0006449,1,0.949411914571785,0,8,regulation of translational termination,BP,
3168,GO:0006450,1,0.897699283792416,0,18,regulation of translational fidelity,BP,
3169,GO:0006451,1,0.946634038461049,0,8,translational readthrough,BP,
3170,GO:0006452,1,0.980104354032603,0,3,translational frameshifting,BP,
3171,GO:0006457,1,0.2515645873726,0,225,protein folding,BP,
3172,GO:0006458,1,0.742596433323949,0,48,'de novo' protein folding,BP,
3173,GO:0006463,1,0.993532144564751,0,1,steroid hormone receptor complex assembly,BP,
3175,GO:0006465,1,0.889482056347958,0,20,signal peptide processing,BP,
3179,GO:0006471,1,0.84469131174314,0,26,protein ADP-ribosylation,BP,
3180,GO:0006473,1,0.310825332525697,0,174,protein acetylation,BP,
3181,GO:0006474,1,0.8927960773432,0,16,N-terminal protein amino acid acetylation,BP,
3182,GO:0006475,1,0.371525489630388,0,146,internal protein amino acid acetylation,BP,
3183,GO:0006476,1,0.511117131267235,0,95,protein deacetylation,BP,
3184,GO:0006477,1,0.960301614064907,0,6,protein sulfation,BP,
3185,GO:0006478,1,0.98898485539263,0,2,peptidyl-tyrosine sulfation,BP,
3186,GO:0006479,1,0.324672568660348,0,163,protein methylation,BP,
3187,GO:0006480,1,0.98885621810885,0,2,N-terminal protein amino acid methylation,BP,
3188,GO:0006481,1,0.981426358112072,0,3,C-terminal protein methylation,BP,
3189,GO:0006482,1,0.797809507416628,0,29,protein demethylation,BP,
3191,GO:0006487,1,0.572958079725332,0,89,protein N-linked glycosylation,BP,
3192,GO:0006488,1,0.881262562952461,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3193,GO:0006489,1,0.959264059693831,0,7,dolichyl diphosphate biosynthetic process,BP,
3194,GO:0006490,1,0.876233368983353,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3198,GO:0006498,1,0.958445862097522,0,6,N-terminal protein lipidation,BP,
3199,GO:0006499,1,0.969117708389033,0,4,N-terminal protein myristoylation,BP,
3200,GO:0006500,1,0.988991515437081,0,2,N-terminal protein palmitoylation,BP,
3202,GO:0006505,1,0.8198794430373,0,33,GPI anchor metabolic process,BP,
3203,GO:0006506,1,0.829001168535763,0,31,GPI anchor biosynthetic process,BP,
3204,GO:0006507,1,0.994392473402516,0,1,GPI anchor release,BP,
3207,GO:0006511,1,0.0254812940401613,0,539,ubiquitin-dependent protein catabolic process,BP,
3208,GO:0006513,1,0.64362191685401,0,63,protein monoubiquitination,BP,
3209,GO:0006515,1,0.844647727371571,0,25,protein quality control for misfolded or incompletely synthesized proteins,BP,
3210,GO:0006516,1,0.894353700984669,0,17,glycoprotein catabolic process,BP,
3211,GO:0006517,1,0.791608406448111,0,34,protein deglycosylation,BP,
3213,GO:0006520,1,0.122733173888369,0,340,cellular amino acid metabolic process,BP,
3214,GO:0006521,1,0.728101395469457,0,55,regulation of cellular amino acid metabolic process,BP,
3215,GO:0006522,1,0.977206538644559,0,4,alanine metabolic process,BP,
3216,GO:0006524,1,0.977206538644559,0,4,alanine catabolic process,BP,
3217,GO:0006525,1,0.878280758402759,0,20,arginine metabolic process,BP,
3218,GO:0006526,1,0.960759256130845,0,6,arginine biosynthetic process,BP,
3219,GO:0006527,1,0.929526157500745,0,11,arginine catabolic process,BP,
3220,GO:0006528,1,0.972491344884028,0,5,asparagine metabolic process,BP,
3221,GO:0006529,1,0.988737246279911,0,2,asparagine biosynthetic process,BP,
3222,GO:0006530,1,0.988903303299718,0,2,asparagine catabolic process,BP,
3223,GO:0006531,1,0.942594459711546,0,10,aspartate metabolic process,BP,
3224,GO:0006532,1,0.988807156452216,0,2,aspartate biosynthetic process,BP,
3225,GO:0006533,1,0.983461556775215,0,3,aspartate catabolic process,BP,
3226,GO:0006534,1,0.924809206814848,0,13,cysteine metabolic process,BP,
3227,GO:0006535,1,0.994271649284811,0,1,cysteine biosynthetic process from serine,BP,
3228,GO:0006536,1,0.830019400909302,0,31,glutamate metabolic process,BP,
3229,GO:0006537,1,0.969364836951021,0,5,glutamate biosynthetic process,BP,
3230,GO:0006538,1,0.94657990864591,0,9,glutamate catabolic process,BP,
3231,GO:0006539,1,0.994501365702875,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3232,GO:0006540,1,0.981010665213559,0,3,glutamate decarboxylation to succinate,BP,
3233,GO:0006541,1,0.854808692795679,0,23,glutamine metabolic process,BP,
3234,GO:0006542,1,0.98507106034725,0,2,glutamine biosynthetic process,BP,
3235,GO:0006543,1,0.980917592283995,0,3,glutamine catabolic process,BP,
3236,GO:0006544,1,0.943435769153488,0,10,glycine metabolic process,BP,
3237,GO:0006545,1,0.983392559459989,0,3,glycine biosynthetic process,BP,
3238,GO:0006546,1,0.982600273448858,0,3,glycine catabolic process,BP,
3239,GO:0006547,1,0.948398112768391,0,9,histidine metabolic process,BP,
3240,GO:0006548,1,0.959779000792164,0,7,histidine catabolic process,BP,
3241,GO:0006549,1,0.967775409528629,0,5,isoleucine metabolic process,BP,
3242,GO:0006550,1,0.989027797473476,0,2,isoleucine catabolic process,BP,
3243,GO:0006551,1,0.949185476563474,0,8,leucine metabolic process,BP,
3244,GO:0006552,1,0.964613438848018,0,6,leucine catabolic process,BP,
3245,GO:0006553,1,0.92347228538455,0,13,lysine metabolic process,BP,
3246,GO:0006554,1,0.928916163844917,0,12,lysine catabolic process,BP,
3247,GO:0006555,1,0.878361131119166,0,20,methionine metabolic process,BP,
3248,GO:0006556,1,0.982515332235409,0,3,S-adenosylmethionine biosynthetic process,BP,
3249,GO:0006557,1,0.993894280649677,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3250,GO:0006558,1,0.946013098796364,0,10,L-phenylalanine metabolic process,BP,
3251,GO:0006559,1,0.946013098796364,0,10,L-phenylalanine catabolic process,BP,
3252,GO:0006560,1,0.960823418581321,0,7,proline metabolic process,BP,
3253,GO:0006561,1,0.977466627556512,0,4,proline biosynthetic process,BP,
3254,GO:0006562,1,0.982976968782574,0,3,proline catabolic process,BP,
3255,GO:0006563,1,0.940433117530448,0,11,L-serine metabolic process,BP,
3256,GO:0006564,1,0.967149058660467,0,6,L-serine biosynthetic process,BP,
3257,GO:0006565,1,0.977938924200969,0,4,L-serine catabolic process,BP,
3258,GO:0006566,1,0.978340615896865,0,4,threonine metabolic process,BP,
3259,GO:0006567,1,0.983805060295345,0,3,threonine catabolic process,BP,
3260,GO:0006568,1,0.944756391841484,0,9,tryptophan metabolic process,BP,
3261,GO:0006569,1,0.960330503545629,0,7,tryptophan catabolic process,BP,
3262,GO:0006570,1,0.9566583275156,0,8,tyrosine metabolic process,BP,
3263,GO:0006572,1,0.967397201876536,0,6,tyrosine catabolic process,BP,
3264,GO:0006573,1,0.941680230793973,0,9,valine metabolic process,BP,
3265,GO:0006574,1,0.978005292228785,0,4,valine catabolic process,BP,
3268,GO:0006577,1,0.904265225878024,0,17,amino-acid betaine metabolic process,BP,
3269,GO:0006578,1,0.959557601192283,0,7,amino-acid betaine biosynthetic process,BP,
3270,GO:0006579,1,0.982738109271468,0,3,amino-acid betaine catabolic process,BP,
3271,GO:0006580,1,0.994229231381529,0,1,ethanolamine metabolic process,BP,
3272,GO:0006581,1,0.988370487875647,0,2,acetylcholine catabolic process,BP,
3273,GO:0006582,1,0.890827325551187,0,16,melanin metabolic process,BP,
3274,GO:0006583,1,0.994371789870626,0,1,melanin biosynthetic process from tyrosine,BP,
3276,GO:0006585,1,0.994500437100244,0,1,dopamine biosynthetic process from tyrosine,BP,
3277,GO:0006586,1,0.92931356358771,0,12,indolalkylamine metabolic process,BP,
3279,GO:0006590,1,0.913708867729179,0,13,thyroid hormone generation,BP,
3280,GO:0006591,1,0.949308908967707,0,9,ornithine metabolic process,BP,
3281,GO:0006592,1,0.993744833423491,0,1,ornithine biosynthetic process,BP,
3282,GO:0006593,1,0.994552840092642,0,1,ornithine catabolic process,BP,
3283,GO:0006595,1,0.913914376906703,0,16,polyamine metabolic process,BP,
3284,GO:0006596,1,0.92899334973407,0,13,polyamine biosynthetic process,BP,
3285,GO:0006597,1,0.98847236014804,0,2,spermine biosynthetic process,BP,
3286,GO:0006598,1,0.967757693008016,0,6,polyamine catabolic process,BP,
3287,GO:0006600,1,0.940805359472081,0,10,creatine metabolic process,BP,
3288,GO:0006601,1,0.988943326090042,0,2,creatine biosynthetic process,BP,
3290,GO:0006606,1,0.413183405271022,0,128,protein import into nucleus,BP,
3291,GO:0006607,1,0.852820877318063,0,20,NLS-bearing protein import into nucleus,BP,
3292,GO:0006610,1,0.942519873367449,0,8,ribosomal protein import into nucleus,BP,
3293,GO:0006611,1,0.314628160312905,0,173,protein export from nucleus,BP,
3295,GO:0006613,1,0.586422626040417,0,95,cotranslational protein targeting to membrane,BP,
3296,GO:0006614,1,0.609346744356866,0,90,SRP-dependent cotranslational protein targeting to membrane,BP,
3297,GO:0006616,1,0.966767235626271,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3298,GO:0006617,1,0.989081596573604,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3299,GO:0006620,1,0.953132002335247,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3300,GO:0006621,1,0.94164703790518,0,10,protein retention in ER lumen,BP,
3301,GO:0006622,1,0.872299305698539,0,19,protein targeting to lysosome,BP,
3302,GO:0006623,1,0.785831310495593,0,31,protein targeting to vacuole,BP,
3303,GO:0006624,1,0.989134419814859,0,2,vacuolar protein processing,BP,
3304,GO:0006625,1,0.899647397880482,0,17,protein targeting to peroxisome,BP,
3305,GO:0006626,1,0.434181807846801,0,135,protein targeting to mitochondrion,BP,
3306,GO:0006627,1,0.95019533860052,0,8,protein processing involved in protein targeting to mitochondrion,BP,
3310,GO:0006635,1,0.640943585809813,0,70,fatty acid beta-oxidation,BP,
3312,GO:0006637,1,0.563583948992917,0,91,acyl-CoA metabolic process,BP,
3316,GO:0006642,1,0.964928650243003,0,4,triglyceride mobilization,BP,
3319,GO:0006646,1,0.915807115449571,0,14,phosphatidylethanolamine biosynthetic process,BP,
3320,GO:0006649,1,0.984238697418308,0,2,phospholipid transfer to membrane,BP,
3322,GO:0006651,1,0.985002113312258,0,2,diacylglycerol biosynthetic process,BP,
3324,GO:0006655,1,0.94164250279296,0,10,phosphatidylglycerol biosynthetic process,BP,
3325,GO:0006656,1,0.817406861609343,0,33,phosphatidylcholine biosynthetic process,BP,
3326,GO:0006657,1,0.957880859295281,0,7,CDP-choline pathway,BP,
3328,GO:0006659,1,0.976943699545502,0,4,phosphatidylserine biosynthetic process,BP,
3329,GO:0006660,1,0.99452758282143,0,1,phosphatidylserine catabolic process,BP,
3331,GO:0006662,1,0.928647987903904,0,12,glycerol ether metabolic process,BP,
3332,GO:0006663,1,0.975440874289228,0,4,platelet activating factor biosynthetic process,BP,
3335,GO:0006666,1,0.992225135950649,0,1,3-keto-sphinganine metabolic process,BP,
3336,GO:0006667,1,0.979554001014719,0,3,sphinganine metabolic process,BP,
3337,GO:0006668,1,0.987988977176551,0,2,sphinganine-1-phosphate metabolic process,BP,
3338,GO:0006669,1,0.994086264413301,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3339,GO:0006670,1,0.934415590418616,0,11,sphingosine metabolic process,BP,
3340,GO:0006671,1,0.992973960372734,0,1,phytosphingosine metabolic process,BP,
3342,GO:0006677,1,0.897853125495942,0,18,glycosylceramide metabolic process,BP,
3343,GO:0006678,1,0.956618276962623,0,7,glucosylceramide metabolic process,BP,
3344,GO:0006679,1,0.986908528870319,0,2,glucosylceramide biosynthetic process,BP,
3345,GO:0006680,1,0.982267980464474,0,3,glucosylceramide catabolic process,BP,
3346,GO:0006681,1,0.953125020487665,0,8,galactosylceramide metabolic process,BP,
3347,GO:0006682,1,0.971584093028169,0,5,galactosylceramide biosynthetic process,BP,
3348,GO:0006683,1,0.994117265092799,0,1,galactosylceramide catabolic process,BP,
3349,GO:0006684,1,0.919001182687442,0,13,sphingomyelin metabolic process,BP,
3350,GO:0006685,1,0.968311820049561,0,5,sphingomyelin catabolic process,BP,
3351,GO:0006686,1,0.959577148776951,0,6,sphingomyelin biosynthetic process,BP,
3354,GO:0006689,1,0.971524772668778,0,5,ganglioside catabolic process,BP,
3356,GO:0006691,1,0.888564736160042,0,20,leukotriene metabolic process,BP,
3360,GO:0006695,1,0.659667846268557,0,62,cholesterol biosynthetic process,BP,
3361,GO:0006696,1,0.988918647851967,0,2,ergosterol biosynthetic process,BP,
3362,GO:0006699,1,0.823377589452047,0,32,bile acid biosynthetic process,BP,
3365,GO:0006702,1,0.95581810653008,0,7,androgen biosynthetic process,BP,
3366,GO:0006703,1,0.944745189208842,0,10,estrogen biosynthetic process,BP,
3367,GO:0006704,1,0.921055273314946,0,13,glucocorticoid biosynthetic process,BP,
3368,GO:0006705,1,0.948781039720699,0,8,mineralocorticoid biosynthetic process,BP,
3370,GO:0006707,1,0.946282176744052,0,9,cholesterol catabolic process,BP,
3372,GO:0006711,1,0.99452758282143,0,1,estrogen catabolic process,BP,
3373,GO:0006713,1,0.994526137596102,0,1,glucocorticoid catabolic process,BP,
3374,GO:0006714,1,0.989204734704115,0,2,sesquiterpenoid metabolic process,BP,
3377,GO:0006722,1,0.99435107751118,0,1,triterpenoid metabolic process,BP,
3379,GO:0006726,1,0.981205620029818,0,3,eye pigment biosynthetic process,BP,
3380,GO:0006729,1,0.961303256159708,0,7,tetrahydrobiopterin biosynthetic process,BP,
3381,GO:0006730,1,0.815677487771382,0,33,one-carbon metabolic process,BP,
3384,GO:0006734,1,0.807112180612433,0,35,NADH metabolic process,BP,
3385,GO:0006735,1,0.864213620176196,0,24,NADH regeneration,BP,
3386,GO:0006738,1,0.994348273062443,0,1,nicotinamide riboside catabolic process,BP,
3387,GO:0006739,1,0.820541337749208,0,33,NADP metabolic process,BP,
3388,GO:0006740,1,0.981580519662429,0,3,NADPH regeneration,BP,
3389,GO:0006741,1,0.97666452541126,0,4,NADP biosynthetic process,BP,
3390,GO:0006742,1,0.983094398728271,0,3,NADP catabolic process,BP,
3391,GO:0006743,1,0.917878813915264,0,15,ubiquinone metabolic process,BP,
3392,GO:0006744,1,0.924481217791942,0,14,ubiquinone biosynthetic process,BP,
3393,GO:0006747,1,0.99448445191223,0,1,FAD biosynthetic process,BP,
3394,GO:0006749,1,0.768407841060244,0,46,glutathione metabolic process,BP,
3395,GO:0006750,1,0.920946686575986,0,14,glutathione biosynthetic process,BP,
3396,GO:0006751,1,0.972425389177424,0,5,glutathione catabolic process,BP,
3398,GO:0006754,1,0.463499865071077,0,115,ATP biosynthetic process,BP,
3399,GO:0006756,1,0.994184768585909,0,1,AMP phosphorylation,BP,
3400,GO:0006757,1,0.528474810582943,0,93,ATP generation from ADP,BP,
3401,GO:0006760,1,0.839961479651079,0,28,folic acid-containing compound metabolic process,BP,
3403,GO:0006767,1,0.57937968521458,0,83,water-soluble vitamin metabolic process,BP,
3404,GO:0006768,1,0.934873035273309,0,10,biotin metabolic process,BP,
3405,GO:0006771,1,0.956756252038841,0,7,riboflavin metabolic process,BP,
3406,GO:0006772,1,0.977638673168487,0,4,thiamine metabolic process,BP,
3409,GO:0006777,1,0.964291290958706,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3410,GO:0006778,1,0.822412155914592,0,31,porphyrin-containing compound metabolic process,BP,
3411,GO:0006779,1,0.861119602638725,0,23,porphyrin-containing compound biosynthetic process,BP,
3412,GO:0006780,1,0.989058574079793,0,2,uroporphyrinogen III biosynthetic process,BP,
3413,GO:0006781,1,0.994430720184273,0,1,succinyl-CoA pathway,BP,
3414,GO:0006782,1,0.956178248770354,0,8,protoporphyrinogen IX biosynthetic process,BP,
3415,GO:0006783,1,0.885344905129462,0,19,heme biosynthetic process,BP,
3416,GO:0006784,1,0.984595622303081,0,2,heme a biosynthetic process,BP,
3417,GO:0006787,1,0.978553793680587,0,4,porphyrin-containing compound catabolic process,BP,
3418,GO:0006788,1,0.989135130806115,0,2,heme oxidation,BP,
3419,GO:0006790,1,0.122176186723303,0,331,sulfur compound metabolic process,BP,
3422,GO:0006797,1,0.961589411954637,0,5,polyphosphate metabolic process,BP,
3423,GO:0006798,1,0.967247792362522,0,4,polyphosphate catabolic process,BP,
3424,GO:0006801,1,0.707591597771735,0,55,superoxide metabolic process,BP,
3427,GO:0006808,1,0.982634020788757,0,3,regulation of nitrogen utilization,BP,
3435,GO:0006817,1,0.887772783872775,0,17,phosphate ion transport,BP,
3438,GO:0006824,1,0.976860135193838,0,4,cobalt ion transport,BP,
3441,GO:0006828,1,0.935693181592216,0,10,manganese ion transport,BP,
3442,GO:0006829,1,0.863856882232596,0,23,zinc ion transport,BP,
3443,GO:0006833,1,0.912591323800082,0,15,water transport,BP,
3444,GO:0006835,1,0.563405846323774,0,83,dicarboxylic acid transport,BP,
3446,GO:0006837,1,0.911861900969437,0,15,serotonin transport,BP,
3447,GO:0006839,1,0.18038015713069,0,277,mitochondrial transport,BP,
3448,GO:0006842,1,0.975173602702215,0,4,tricarboxylic acid transport,BP,
3449,GO:0006843,1,0.994561275999617,0,1,mitochondrial citrate transmembrane transport,BP,
3450,GO:0006844,1,0.98890461617223,0,2,acyl carnitine transport,BP,
3451,GO:0006848,1,0.976788838934138,0,4,pyruvate transport,BP,
3452,GO:0006850,1,0.988403017609477,0,2,mitochondrial pyruvate transmembrane transport,BP,
3453,GO:0006851,1,0.873526791239276,0,22,mitochondrial calcium ion transmembrane transport,BP,
3454,GO:0006853,1,0.935409471439303,0,9,carnitine shuttle,BP,
3456,GO:0006857,1,0.948907203438127,0,8,oligopeptide transport,BP,
3457,GO:0006858,1,0.982819675756366,0,3,extracellular transport,BP,
3458,GO:0006862,1,0.886900332544016,0,20,nucleotide transport,BP,
3459,GO:0006863,1,0.965569321457829,0,6,purine nucleobase transport,BP,
3460,GO:0006864,1,0.987352678048917,0,2,pyrimidine nucleotide transport,BP,
3461,GO:0006865,1,0.429504551774624,0,126,amino acid transport,BP,
3462,GO:0006867,1,0.988549190219632,0,2,asparagine transport,BP,
3463,GO:0006868,1,0.962937615809893,0,6,glutamine transport,BP,
3468,GO:0006876,1,0.993435892171835,0,1,cellular cadmium ion homeostasis,BP,
3469,GO:0006878,1,0.918357165060521,0,13,cellular copper ion homeostasis,BP,
3471,GO:0006880,1,0.983823056398968,0,3,intracellular sequestering of iron ion,BP,
3472,GO:0006882,1,0.822870568510774,0,32,cellular zinc ion homeostasis,BP,
3473,GO:0006883,1,0.89712392369748,0,16,cellular sodium ion homeostasis,BP,
3474,GO:0006884,1,0.856423650473559,0,22,cell volume homeostasis,BP,
3475,GO:0006885,1,0.533213034354723,0,96,regulation of pH,BP,
3478,GO:0006888,1,0.280946559330221,0,186,ER to Golgi vesicle-mediated transport,BP,
3479,GO:0006890,1,0.59387973099789,0,79,retrograde vesicle-mediated transport, Golgi to ER,BP,
3480,GO:0006891,1,0.810023441126659,0,33,intra-Golgi vesicle-mediated transport,BP,
3481,GO:0006892,1,0.511547871232174,0,92,post-Golgi vesicle-mediated transport,BP,
3482,GO:0006893,1,0.718789177879996,0,47,Golgi to plasma membrane transport,BP,
3483,GO:0006895,1,0.854585973417316,0,19,Golgi to endosome transport,BP,
3484,GO:0006896,1,0.912433595379269,0,14,Golgi to vacuole transport,BP,
3488,GO:0006901,1,0.640943352577847,0,66,vesicle coating,BP,
3489,GO:0006903,1,0.563362825556879,0,85,vesicle targeting,BP,
3492,GO:0006907,1,0.893010392421603,0,18,pinocytosis,BP,
3494,GO:0006910,1,0.914804500587169,0,14,phagocytosis, recognition,BP,
3495,GO:0006911,1,0.749013707193539,0,44,phagocytosis, engulfment,BP,
3496,GO:0006913,1,0.110919574166827,0,324,nucleocytoplasmic transport,BP,
3497,GO:0006914,1,0.0478697670490749,0,456,autophagy,BP,
3499,GO:0006919,1,0.582522427408892,0,86,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3500,GO:0006921,1,0.821113843415297,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3501,GO:0006924,1,0.947194312173133,0,9,activation-induced cell death of T cells,BP,
3505,GO:0006930,1,0.946593790504667,0,8,substrate-dependent cell migration, cell extension,BP,
3507,GO:0006933,1,0.981454464734785,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3510,GO:0006937,1,0.376573812013991,0,142,regulation of muscle contraction,BP,
3511,GO:0006939,1,0.536081079057543,0,94,smooth muscle contraction,BP,
3512,GO:0006940,1,0.703171329240596,0,55,regulation of smooth muscle contraction,BP,
3513,GO:0006941,1,0.32685172388263,0,157,striated muscle contraction,BP,
3514,GO:0006942,1,0.565649232928806,0,79,regulation of striated muscle contraction,BP,
3515,GO:0006948,1,0.993998204777549,0,1,induction by virus of host cell-cell fusion,BP,
3523,GO:0006957,1,0.934268179570059,0,10,complement activation, alternative pathway,BP,
3526,GO:0006968,1,0.745924372332062,0,49,cellular defense response,BP,
3527,GO:0006970,1,0.647658753747035,0,66,response to osmotic stress,BP,
3528,GO:0006971,1,0.932141193386473,0,9,hypotonic response,BP,
3529,GO:0006972,1,0.88117691083132,0,20,hyperosmotic response,BP,
3530,GO:0006974,1,0.00640650173602051,0,745,cellular response to DNA damage stimulus,BP,
3531,GO:0006975,1,0.946250421752889,0,8,DNA damage induced protein phosphorylation,BP,
3532,GO:0006977,1,0.677779534716861,0,60,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3533,GO:0006978,1,0.871662197442118,0,19,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3535,GO:0006982,1,0.989203287234052,0,2,response to lipid hydroperoxide,BP,
3536,GO:0006983,1,0.934295625971615,0,10,ER overload response,BP,
3539,GO:0006987,1,0.951407859518376,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3540,GO:0006990,1,0.978127266446498,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3541,GO:0006991,1,0.938083797082425,0,10,response to sterol depletion,BP,
3542,GO:0006995,1,0.938807061808315,0,11,cellular response to nitrogen starvation,BP,
3544,GO:0006997,1,0.395215399979607,0,132,nucleus organization,BP,
3545,GO:0006998,1,0.57922292190454,0,81,nuclear envelope organization,BP,
3546,GO:0006999,1,0.895226141169861,0,15,nuclear pore organization,BP,
3547,GO:0007000,1,0.955376627877695,0,7,nucleolus organization,BP,
3548,GO:0007004,1,0.643695317204793,0,65,telomere maintenance via telomerase,BP,
3550,GO:0007006,1,0.536111770834098,0,103,mitochondrial membrane organization,BP,
3551,GO:0007007,1,0.878755240393391,0,22,inner mitochondrial membrane organization,BP,
3552,GO:0007008,1,0.993810444463696,0,1,outer mitochondrial membrane organization,BP,
3553,GO:0007009,1,0.579397326901421,0,73,plasma membrane organization,BP,
3555,GO:0007014,1,0.993556003057948,0,1,actin ubiquitination,BP,
3556,GO:0007015,1,0.0789227488540681,0,359,actin filament organization,BP,
3557,GO:0007016,1,0.910899276472164,0,10,cytoskeletal anchoring at plasma membrane,BP,
3559,GO:0007018,1,0.112511480206891,0,288,microtubule-based movement,BP,
3560,GO:0007019,1,0.753491465755328,0,38,microtubule depolymerization,BP,
3561,GO:0007020,1,0.832678629580493,0,25,microtubule nucleation,BP,
3562,GO:0007021,1,0.960979954329759,0,7,tubulin complex assembly,BP,
3563,GO:0007023,1,0.976812850050673,0,4,post-chaperonin tubulin folding pathway,BP,
3564,GO:0007026,1,0.847010928402869,0,22,negative regulation of microtubule depolymerization,BP,
3565,GO:0007028,1,0.929249114897111,0,9,cytoplasm organization,BP,
3566,GO:0007029,1,0.737215555288502,0,46,endoplasmic reticulum organization,BP,
3567,GO:0007030,1,0.40387400963054,0,127,Golgi organization,BP,
3568,GO:0007031,1,0.818541953060415,0,31,peroxisome organization,BP,
3569,GO:0007032,1,0.637032509045395,0,69,endosome organization,BP,
3572,GO:0007035,1,0.865181368016323,0,22,vacuolar acidification,BP,
3573,GO:0007039,1,0.900338024083241,0,14,protein catabolic process in the vacuole,BP,
3574,GO:0007040,1,0.676402595133043,0,58,lysosome organization,BP,
3576,GO:0007042,1,0.956692407547305,0,8,lysosomal lumen acidification,BP,
3577,GO:0007043,1,0.472057340961884,0,108,cell-cell junction assembly,BP,
3581,GO:0007050,1,0.211902206835527,0,234,cell cycle arrest,BP,
3582,GO:0007051,1,0.31551674375665,0,162,spindle organization,BP,
3583,GO:0007052,1,0.474054384878792,0,106,mitotic spindle organization,BP,
3584,GO:0007056,1,0.988870928841041,0,2,spindle assembly involved in female meiosis,BP,
3585,GO:0007057,1,0.988870928841041,0,2,spindle assembly involved in female meiosis I,BP,
3586,GO:0007059,1,0.106712359893297,0,328,chromosome segregation,BP,
3587,GO:0007060,1,0.976898543277897,0,4,male meiosis chromosome segregation,BP,
3588,GO:0007062,1,0.430062398598384,0,123,sister chromatid cohesion,BP,
3589,GO:0007063,1,0.868646636445886,0,19,regulation of sister chromatid cohesion,BP,
3590,GO:0007064,1,0.860506539360573,0,19,mitotic sister chromatid cohesion,BP,
3591,GO:0007066,1,0.994640668770155,0,1,female meiosis sister chromatid cohesion,BP,
3592,GO:0007072,1,0.994540340159623,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3593,GO:0007076,1,0.870017257856508,0,16,mitotic chromosome condensation,BP,
3594,GO:0007077,1,0.745433210733916,0,42,mitotic nuclear envelope disassembly,BP,
3595,GO:0007079,1,0.976399348726104,0,3,mitotic chromosome movement towards spindle pole,BP,
3596,GO:0007080,1,0.763631095850891,0,44,mitotic metaphase plate congression,BP,
3597,GO:0007084,1,0.944014780758535,0,10,mitotic nuclear envelope reassembly,BP,
3598,GO:0007088,1,0.349962332600202,0,151,regulation of mitotic nuclear division,BP,
3599,GO:0007089,1,0.973054373623172,0,4,traversing start control point of mitotic cell cycle,BP,
3600,GO:0007091,1,0.703471338409392,0,51,metaphase/anaphase transition of mitotic cell cycle,BP,
3601,GO:0007093,1,0.355379764743402,0,157,mitotic cell cycle checkpoint,BP,
3602,GO:0007094,1,0.808348032084949,0,31,mitotic spindle assembly checkpoint,BP,
3603,GO:0007095,1,0.874836149667984,0,19,mitotic G2 DNA damage checkpoint,BP,
3604,GO:0007096,1,0.905358654318658,0,16,regulation of exit from mitosis,BP,
3605,GO:0007097,1,0.851526870261066,0,19,nuclear migration,BP,
3606,GO:0007098,1,0.450568051968163,0,114,centrosome cycle,BP,
3607,GO:0007099,1,0.820098760583979,0,29,centriole replication,BP,
3608,GO:0007100,1,0.901609273962279,0,15,mitotic centrosome separation,BP,
3609,GO:0007113,1,0.983541230876292,0,3,endomitotic cell cycle,BP,
3610,GO:0007127,1,0.537138019432301,0,96,meiosis I,BP,
3611,GO:0007129,1,0.808410127466331,0,34,synapsis,BP,
3612,GO:0007130,1,0.899771006892327,0,16,synaptonemal complex assembly,BP,
3613,GO:0007131,1,0.750418863460931,0,44,reciprocal meiotic recombination,BP,
3614,GO:0007135,1,0.953894821793427,0,8,meiosis II,BP,
3615,GO:0007140,1,0.766774631317899,0,39,male meiotic nuclear division,BP,
3616,GO:0007141,1,0.889944200529391,0,18,male meiosis I,BP,
3617,GO:0007143,1,0.85657723336852,0,23,female meiotic nuclear division,BP,
3618,GO:0007144,1,0.956346144706644,0,7,female meiosis I,BP,
3619,GO:0007146,1,0.994184768585909,0,1,meiotic recombination nodule assembly,BP,
3620,GO:0007147,1,0.993623339445579,0,1,female meiosis II,BP,
3624,GO:0007157,1,0.743891511337382,0,43,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3628,GO:0007161,1,0.961996329373264,0,4,calcium-independent cell-matrix adhesion,BP,
3631,GO:0007164,1,0.460067067284419,0,117,establishment of tissue polarity,BP,
3635,GO:0007168,1,0.970963203683926,0,5,receptor guanylyl cyclase signaling pathway,BP,
3637,GO:0007171,1,0.912930792444272,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3638,GO:0007172,1,0.951107577815315,0,8,signal complex assembly,BP,
3639,GO:0007173,1,0.444237663019326,0,119,epidermal growth factor receptor signaling pathway,BP,
3640,GO:0007174,1,0.994410939735775,0,1,epidermal growth factor catabolic process,BP,
3641,GO:0007175,1,0.908286276355892,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3642,GO:0007176,1,0.836810652741898,0,27,regulation of epidermal growth factor-activated receptor activity,BP,
3645,GO:0007181,1,0.979869516973606,0,3,transforming growth factor beta receptor complex assembly,BP,
3646,GO:0007182,1,0.952419841315651,0,6,common-partner SMAD protein phosphorylation,BP,
3647,GO:0007183,1,0.901711283142379,0,14,SMAD protein complex assembly,BP,
3648,GO:0007185,1,0.945271776716019,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3656,GO:0007194,1,0.877794988330373,0,20,negative regulation of adenylate cyclase activity,BP,
3657,GO:0007195,1,0.960666790436004,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3658,GO:0007196,1,0.930021726680667,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3659,GO:0007197,1,0.9648333730601,0,6,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3660,GO:0007198,1,0.977676485750488,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3661,GO:0007199,1,0.994281698680658,0,1,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3663,GO:0007202,1,0.87604196714086,0,22,activation of phospholipase C activity,BP,
3665,GO:0007205,1,0.837252903586453,0,25,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
3666,GO:0007206,1,0.98293104839051,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3667,GO:0007207,1,0.966234004872669,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3668,GO:0007208,1,0.986633763608902,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3669,GO:0007210,1,0.927297189606918,0,13,serotonin receptor signaling pathway,BP,
3671,GO:0007213,1,0.904361838041112,0,16,G-protein coupled acetylcholine receptor signaling pathway,BP,
3674,GO:0007216,1,0.893499397164874,0,15,G-protein coupled glutamate receptor signaling pathway,BP,
3675,GO:0007217,1,0.96163991615349,0,7,tachykinin receptor signaling pathway,BP,
3676,GO:0007218,1,0.600609116879033,0,86,neuropeptide signaling pathway,BP,
3678,GO:0007220,1,0.889800416576711,0,17,Notch receptor processing,BP,
3679,GO:0007221,1,0.858220977273148,0,18,positive regulation of transcription of Notch receptor target,BP,
3680,GO:0007223,1,0.759232615288413,0,38,Wnt signaling pathway, calcium modulating pathway,BP,
3681,GO:0007224,1,0.426109538834858,0,123,smoothened signaling pathway,BP,
3682,GO:0007225,1,0.992652116242884,0,1,patched ligand maturation,BP,
3683,GO:0007227,1,0.97418005024108,0,4,signal transduction downstream of smoothened,BP,
3684,GO:0007228,1,0.980692024130734,0,3,positive regulation of hh target transcription factor activity,BP,
3686,GO:0007231,1,0.983117885291337,0,3,osmosensory signaling pathway,BP,
3689,GO:0007252,1,0.909830678868678,0,14,I-kappaB phosphorylation,BP,
3690,GO:0007253,1,0.96056680774687,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3691,GO:0007254,1,0.281749185847946,0,186,JNK cascade,BP,
3692,GO:0007256,1,0.952111965334072,0,6,activation of JNKK activity,BP,
3693,GO:0007257,1,0.803175143348564,0,32,activation of JUN kinase activity,BP,
3694,GO:0007258,1,0.975221381202552,0,4,JUN phosphorylation,BP,
3697,GO:0007263,1,0.873694219154137,0,21,nitric oxide mediated signal transduction,BP,
3704,GO:0007270,1,0.931935724972441,0,8,neuron-neuron synaptic transmission,BP,
3705,GO:0007271,1,0.824674245270337,0,31,synaptic transmission, cholinergic,BP,
3707,GO:0007274,1,0.848328577133585,0,25,neuromuscular synaptic transmission,BP,
3709,GO:0007276,1,0.0290301493895864,0,523,gamete generation,BP,
3710,GO:0007281,1,0.283645623730649,0,188,germ cell development,BP,
3711,GO:0007283,1,0.0712062364024343,0,394,spermatogenesis,BP,
3712,GO:0007284,1,0.986123245859241,0,2,spermatogonial cell division,BP,
3713,GO:0007286,1,0.524149795787092,0,97,spermatid development,BP,
3714,GO:0007288,1,0.934491009237023,0,10,sperm axoneme assembly,BP,
3715,GO:0007289,1,0.900396579979054,0,14,spermatid nucleus differentiation,BP,
3716,GO:0007290,1,0.992624811397372,0,1,spermatid nucleus elongation,BP,
3717,GO:0007291,1,0.99463733894636,0,1,sperm individualization,BP,
3718,GO:0007292,1,0.492164419173031,0,105,female gamete generation,BP,
3719,GO:0007296,1,0.965830296813031,0,4,vitellogenesis,BP,
3720,GO:0007308,1,0.988022825937695,0,2,oocyte construction,BP,
3721,GO:0007309,1,0.988022825937695,0,2,oocyte axis specification,BP,
3722,GO:0007314,1,0.988022825937695,0,2,oocyte anterior/posterior axis specification,BP,
3723,GO:0007315,1,0.988022825937695,0,2,pole plasm assembly,BP,
3724,GO:0007320,1,0.939175678957791,0,10,insemination,BP,
3725,GO:0007338,1,0.533262091403414,0,101,single fertilization,BP,
3726,GO:0007339,1,0.865688713104807,0,25,binding of sperm to zona pellucida,BP,
3727,GO:0007340,1,0.84305504152296,0,26,acrosome reaction,BP,
3728,GO:0007341,1,0.96649162481797,0,6,penetration of zona pellucida,BP,
3729,GO:0007342,1,0.951579165724706,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3730,GO:0007343,1,0.985168944089096,0,2,egg activation,BP,
3731,GO:0007344,1,0.994534660292313,0,1,pronuclear fusion,BP,
3733,GO:0007349,1,0.99463733894636,0,1,cellularization,BP,
3734,GO:0007350,1,0.904236363288346,0,15,blastoderm segmentation,BP,
3735,GO:0007351,1,0.922760753003544,0,12,tripartite regional subdivision,BP,
3736,GO:0007352,1,0.976486014119943,0,3,zygotic specification of dorsal/ventral axis,BP,
3737,GO:0007354,1,0.977260658248298,0,4,zygotic determination of anterior/posterior axis, embryo,BP,
3738,GO:0007356,1,0.98329170354028,0,3,thorax and anterior abdomen determination,BP,
3739,GO:0007368,1,0.474599490629402,0,108,determination of left/right symmetry,BP,
3741,GO:0007371,1,0.993533767574381,0,1,ventral midline determination,BP,
3742,GO:0007379,1,0.913894746699409,0,15,segment specification,BP,
3743,GO:0007386,1,0.96586411462512,0,5,compartment pattern specification,BP,
3744,GO:0007387,1,0.994221078552789,0,1,anterior compartment pattern formation,BP,
3745,GO:0007388,1,0.994221078552789,0,1,posterior compartment specification,BP,
3747,GO:0007398,1,0.886588431220042,0,18,ectoderm development,BP,
3749,GO:0007400,1,0.994325157917915,0,1,neuroblast fate determination,BP,
3750,GO:0007402,1,0.989062857431514,0,2,ganglion mother cell fate determination,BP,
3751,GO:0007403,1,0.993779015227969,0,1,glial cell fate determination,BP,
3752,GO:0007405,1,0.684223086448243,0,53,neuroblast proliferation,BP,
3753,GO:0007406,1,0.962367992768434,0,5,negative regulation of neuroblast proliferation,BP,
3756,GO:0007412,1,0.988047158680444,0,2,axon target recognition,BP,
3760,GO:0007418,1,0.972856357653954,0,4,ventral midline development,BP,
3762,GO:0007422,1,0.579855676238347,0,73,peripheral nervous system development,BP,
3764,GO:0007431,1,0.764645190203216,0,38,salivary gland development,BP,
3765,GO:0007435,1,0.786799932045803,0,34,salivary gland morphogenesis,BP,
3766,GO:0007439,1,0.988409815558979,0,2,ectodermal digestive tract development,BP,
3767,GO:0007440,1,0.919102761296679,0,10,foregut morphogenesis,BP,
3768,GO:0007442,1,0.949499090652208,0,7,hindgut morphogenesis,BP,
3769,GO:0007468,1,0.988781128839797,0,2,regulation of rhodopsin gene expression,BP,
3771,GO:0007493,1,0.988134753001631,0,2,endodermal cell fate determination,BP,
3772,GO:0007494,1,0.929984406111087,0,11,midgut development,BP,
3773,GO:0007495,1,0.993948088286499,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3774,GO:0007497,1,0.985630239811734,0,2,posterior midgut development,BP,
3775,GO:0007498,1,0.473944181285396,0,112,mesoderm development,BP,
3776,GO:0007499,1,0.99275113269794,0,1,ectoderm and mesoderm interaction,BP,
3777,GO:0007500,1,0.988664660370621,0,2,mesodermal cell fate determination,BP,
3778,GO:0007501,1,0.924747937852946,0,13,mesodermal cell fate specification,BP,
3779,GO:0007506,1,0.987406446043449,0,2,gonadal mesoderm development,BP,
3781,GO:0007509,1,0.990946718584714,0,1,mesoderm migration involved in gastrulation,BP,
3782,GO:0007512,1,0.919170855130872,0,12,adult heart development,BP,
3784,GO:0007518,1,0.988918415547015,0,2,myoblast fate determination,BP,
3785,GO:0007519,1,0.36586206694475,0,148,skeletal muscle tissue development,BP,
3787,GO:0007521,1,0.985053928745237,0,2,muscle cell fate determination,BP,
3788,GO:0007522,1,0.991492703376543,0,1,visceral muscle development,BP,
3789,GO:0007525,1,0.971444620897949,0,2,somatic muscle development,BP,
3791,GO:0007529,1,0.9866114299679,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3792,GO:0007530,1,0.873869226435159,0,21,sex determination,BP,
3793,GO:0007538,1,0.985444991897272,0,2,primary sex determination,BP,
3794,GO:0007542,1,0.985444991897272,0,2,primary sex determination, germ-line,BP,
3796,GO:0007549,1,0.907440556813701,0,12,dosage compensation,BP,
3799,GO:0007567,1,0.90179542022683,0,16,parturition,BP,
3802,GO:0007571,1,0.994633718411125,0,1,age-dependent general metabolic decline,BP,
3803,GO:0007576,1,0.994295780359295,0,1,nucleolar fragmentation,BP,
3807,GO:0007588,1,0.72548969539014,0,50,excretion,BP,
3809,GO:0007595,1,0.756390935114098,0,38,lactation,BP,
3812,GO:0007598,1,0.977442234690133,0,4,blood coagulation, extrinsic pathway,BP,
3816,GO:0007602,1,0.779016023390048,0,41,phototransduction,BP,
3817,GO:0007603,1,0.850608248506708,0,26,phototransduction, visible light,BP,
3829,GO:0007619,1,0.97909857179174,0,3,courtship behavior,BP,
3830,GO:0007620,1,0.902601761554915,0,16,copulation,BP,
3831,GO:0007621,1,0.978006997542827,0,3,negative regulation of female receptivity,BP,
3832,GO:0007622,1,0.777381012548276,0,39,rhythmic behavior,BP,
3834,GO:0007624,1,0.993192531031669,0,1,ultradian rhythm,BP,
3835,GO:0007625,1,0.908069051742197,0,15,grooming behavior,BP,
3837,GO:0007628,1,0.823981118000616,0,26,adult walking behavior,BP,
3840,GO:0007634,1,0.994338021785842,0,1,optokinetic behavior,BP,
3842,GO:0007638,1,0.894089699800252,0,13,mechanosensory behavior,BP,
3847,GO:0008017,1,0.153705086286447,0,243,microtubule binding,MF,
3848,GO:0008020,1,0.956076861551177,0,8,G-protein coupled photoreceptor activity,MF,
3851,GO:0008023,1,0.710934448841356,0,48,transcription elongation factor complex,CC,
3852,GO:0008024,1,0.944292398991218,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3853,GO:0008026,1,0.546594647784948,0,91,ATP-dependent helicase activity,MF,
3855,GO:0008033,1,0.495994297190541,0,118,tRNA processing,BP,
3856,GO:0008035,1,0.960378151809079,0,7,high-density lipoprotein particle binding,MF,
3859,GO:0008043,1,0.98928796717152,0,2,intracellular ferritin complex,CC,
3860,GO:0008045,1,0.853218889200848,0,21,motor neuron axon guidance,BP,
3861,GO:0008046,1,0.946657844769724,0,7,axon guidance receptor activity,MF,
3863,GO:0008048,1,0.983609823944865,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3864,GO:0008049,1,0.994499971424535,0,1,male courtship behavior,BP,
3865,GO:0008050,1,0.984514271320189,0,2,female courtship behavior,BP,
3866,GO:0008052,1,0.994636129384553,0,1,sensory organ boundary specification,BP,
3867,GO:0008053,1,0.881447254488493,0,21,mitochondrial fusion,BP,
3868,GO:0008057,1,0.990130289476123,0,1,eye pigment granule organization,BP,
3870,GO:0008063,1,0.962705877268938,0,6,Toll signaling pathway,BP,
3871,GO:0008064,1,0.326176375086515,0,166,regulation of actin polymerization or depolymerization,BP,
3872,GO:0008065,1,0.981664999650605,0,3,establishment of blood-nerve barrier,BP,
3874,GO:0008068,1,0.994075679219768,0,1,extracellularly glutamate-gated chloride channel activity,MF,
3875,GO:0008073,1,0.983852884961775,0,3,ornithine decarboxylase inhibitor activity,MF,
3876,GO:0008074,1,0.907788563566296,0,12,guanylate cyclase complex, soluble,CC,
3878,GO:0008078,1,0.980324511607034,0,3,mesodermal cell migration,BP,
3879,GO:0008079,1,0.961217679649298,0,6,translation termination factor activity,MF,
3880,GO:0008080,1,0.594438392731303,0,77,N-acetyltransferase activity,MF,
3881,GO:0008081,1,0.571320901182151,0,82,phosphoric diester hydrolase activity,MF,
3883,GO:0008088,1,0.681282418708774,0,54,axo-dendritic transport,BP,
3884,GO:0008089,1,0.780463264542572,0,37,anterograde axonal transport,BP,
3885,GO:0008090,1,0.940175083799825,0,8,retrograde axonal transport,BP,
3886,GO:0008091,1,0.921318105262582,0,8,spectrin,CC,
3888,GO:0008093,1,0.919583622805377,0,12,cytoskeletal adaptor activity,MF,
3890,GO:0008097,1,0.94261622861765,0,10,5S rRNA binding,MF,
3892,GO:0008106,1,0.900473781541463,0,19,alcohol dehydrogenase (NADP+) activity,MF,
3893,GO:0008107,1,0.993107445586671,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3894,GO:0008108,1,0.994600640752168,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3895,GO:0008109,1,0.986678642302012,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3896,GO:0008111,1,0.994483954830032,0,1,alpha-methylacyl-CoA racemase activity,MF,
3898,GO:0008113,1,0.989210547962748,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3899,GO:0008115,1,0.994347897726635,0,1,sarcosine oxidase activity,MF,
3900,GO:0008116,1,0.991841971179298,0,1,prostaglandin-I synthase activity,MF,
3901,GO:0008117,1,0.991679779323791,0,1,sphinganine-1-phosphate aldolase activity,MF,
3902,GO:0008118,1,0.99441363535372,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3903,GO:0008119,1,0.993904245581716,0,1,thiopurine S-methyltransferase activity,MF,
3904,GO:0008120,1,0.994556053490614,0,1,ceramide glucosyltransferase activity,MF,
3905,GO:0008121,1,0.961250471740472,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3906,GO:0008124,1,0.989027461723327,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3907,GO:0008126,1,0.994154109412701,0,1,acetylesterase activity,MF,
3908,GO:0008127,1,0.99460548237435,0,1,quercetin 2,3-dioxygenase activity,MF,
3909,GO:0008131,1,0.969540673825714,0,5,primary amine oxidase activity,MF,
3911,GO:0008135,1,0.582337069665798,0,84,translation factor activity, RNA binding,MF,
3912,GO:0008137,1,0.812118658266644,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3913,GO:0008138,1,0.774639998548259,0,40,protein tyrosine/serine/threonine phosphatase activity,MF,
3914,GO:0008139,1,0.850926434652147,0,22,nuclear localization sequence binding,MF,
3915,GO:0008140,1,0.948945510318285,0,8,cAMP response element binding protein binding,MF,
3916,GO:0008142,1,0.962167332381694,0,5,oxysterol binding,MF,
3917,GO:0008143,1,0.898528908789081,0,16,poly(A) binding,MF,
3919,GO:0008146,1,0.741169616611702,0,46,sulfotransferase activity,MF,
3920,GO:0008147,1,0.989349487768257,0,2,structural constituent of bone,MF,
3923,GO:0008154,1,0.283270018401913,0,187,actin polymerization or depolymerization,BP,
3925,GO:0008157,1,0.885052199089193,0,18,protein phosphatase 1 binding,MF,
3926,GO:0008158,1,0.97785641945026,0,3,hedgehog receptor activity,MF,
3927,GO:0008160,1,0.994265436571711,0,1,protein tyrosine phosphatase activator activity,MF,
3929,GO:0008169,1,0.981876260916,0,3,C-methyltransferase activity,MF,
3931,GO:0008171,1,0.896563515084942,0,18,O-methyltransferase activity,MF,
3932,GO:0008172,1,0.959678562489857,0,6,S-methyltransferase activity,MF,
3933,GO:0008173,1,0.731494321617136,0,51,RNA methyltransferase activity,MF,
3934,GO:0008174,1,0.946664385054348,0,9,mRNA methyltransferase activity,MF,
3935,GO:0008175,1,0.844082124887007,0,27,tRNA methyltransferase activity,MF,
3936,GO:0008176,1,0.989162605016039,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3937,GO:0008177,1,0.977974226500333,0,4,succinate dehydrogenase (ubiquinone) activity,MF,
3938,GO:0008179,1,0.9094978022316,0,13,adenylate cyclase binding,MF,
3939,GO:0008180,1,0.808580025615339,0,33,COP9 signalosome,CC,
3940,GO:0008184,1,0.981209295485712,0,3,glycogen phosphorylase activity,MF,
3941,GO:0008186,1,0.654750716546994,0,65,RNA-dependent ATPase activity,MF,
3942,GO:0008187,1,0.86180247586343,0,23,poly-pyrimidine tract binding,MF,
3943,GO:0008188,1,0.778855939550758,0,42,neuropeptide receptor activity,MF,
3944,GO:0008190,1,0.932954944115104,0,10,eukaryotic initiation factor 4E binding,MF,
3946,GO:0008192,1,0.980847654342786,0,3,RNA guanylyltransferase activity,MF,
3947,GO:0008193,1,0.987861338357573,0,2,tRNA guanylyltransferase activity,MF,
3949,GO:0008195,1,0.976480550030243,0,3,phosphatidate phosphatase activity,MF,
3950,GO:0008198,1,0.873180148245054,0,21,ferrous iron binding,MF,
3951,GO:0008199,1,0.963443702266956,0,6,ferric iron binding,MF,
3952,GO:0008200,1,0.809615741315161,0,31,ion channel inhibitor activity,MF,
3955,GO:0008203,1,0.454569145003813,0,118,cholesterol metabolic process,BP,
3956,GO:0008204,1,0.988918647851967,0,2,ergosterol metabolic process,BP,
3957,GO:0008206,1,0.770902993485458,0,42,bile acid metabolic process,BP,
3960,GO:0008210,1,0.897336641773203,0,18,estrogen metabolic process,BP,
3961,GO:0008211,1,0.888467396429639,0,19,glucocorticoid metabolic process,BP,
3962,GO:0008212,1,0.948781039720699,0,8,mineralocorticoid metabolic process,BP,
3963,GO:0008213,1,0.324672568660348,0,163,protein alkylation,BP,
3964,GO:0008214,1,0.797809507416628,0,29,protein dealkylation,BP,
3965,GO:0008215,1,0.961776230238689,0,7,spermine metabolic process,BP,
3966,GO:0008216,1,0.956623998181847,0,8,spermidine metabolic process,BP,
3968,GO:0008218,1,0.993735071616435,0,1,bioluminescence,BP,
3970,GO:0008227,1,0.829901922829641,0,32,G-protein coupled amine receptor activity,MF,
3973,GO:0008234,1,0.338523346964021,0,157,cysteine-type peptidase activity,MF,
3978,GO:0008239,1,0.937537528999167,0,11,dipeptidyl-peptidase activity,MF,
3979,GO:0008240,1,0.980311046309984,0,3,tripeptidyl-peptidase activity,MF,
3980,GO:0008241,1,0.993824525273096,0,1,peptidyl-dipeptidase activity,MF,
3981,GO:0008242,1,0.944277805333574,0,9,omega peptidase activity,MF,
3982,GO:0008250,1,0.934326450102229,0,12,oligosaccharyltransferase complex,CC,
3983,GO:0008251,1,0.985492584844276,0,2,tRNA-specific adenosine deaminase activity,MF,
3984,GO:0008252,1,0.913193385772999,0,14,nucleotidase activity,MF,
3985,GO:0008253,1,0.927374985410899,0,12,5'-nucleotidase activity,MF,
3986,GO:0008254,1,0.990335491838031,0,1,3'-nucleotidase activity,MF,
3987,GO:0008260,1,0.988224917348086,0,2,3-oxoacid CoA-transferase activity,MF,
3988,GO:0008263,1,0.988265406275701,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3989,GO:0008265,1,0.994209129247398,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3990,GO:0008266,1,0.885759272570264,0,19,poly(U) RNA binding,MF,
3991,GO:0008267,1,0.989613930568171,0,1,poly-glutamine tract binding,MF,
3992,GO:0008269,1,0.988952163988644,0,2,JAK pathway signal transduction adaptor activity,MF,
3994,GO:0008271,1,0.934629892963021,0,10,secondary active sulfate transmembrane transporter activity,MF,
3995,GO:0008272,1,0.923768516255942,0,12,sulfate transport,BP,
3996,GO:0008273,1,0.972722246827088,0,4,calcium, potassium:sodium antiporter activity,MF,
3997,GO:0008274,1,0.95080959326632,0,7,gamma-tubulin ring complex,CC,
3998,GO:0008275,1,0.974009501249647,0,4,gamma-tubulin small complex,CC,
3999,GO:0008276,1,0.598346508774619,0,77,protein methyltransferase activity,MF,
4001,GO:0008278,1,0.930059952039877,0,10,cohesin complex,CC,
4002,GO:0008281,1,0.985151869144418,0,2,sulfonylurea receptor activity,MF,
4003,GO:0008282,1,0.973734366992341,0,4,inward rectifying potassium channel,CC,
4008,GO:0008287,1,0.751406961055586,0,44,protein serine/threonine phosphatase complex,CC,
4010,GO:0008290,1,0.958679036657775,0,7,F-actin capping protein complex,CC,
4011,GO:0008291,1,0.982688096723563,0,3,acetylcholine metabolic process,BP,
4012,GO:0008292,1,0.994251418956767,0,1,acetylcholine biosynthetic process,BP,
4013,GO:0008294,1,0.979176213551046,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4014,GO:0008295,1,0.977656395675461,0,4,spermidine biosynthetic process,BP,
4015,GO:0008296,1,0.940510908183665,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4016,GO:0008297,1,0.955870951143622,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4017,GO:0008298,1,0.93259353041615,0,12,intracellular mRNA localization,BP,
4019,GO:0008300,1,0.960184617193447,0,7,isoprenoid catabolic process,BP,
4020,GO:0008301,1,0.892166572174204,0,18,DNA binding, bending,MF,
4021,GO:0008305,1,0.791529460329602,0,32,integrin complex,CC,
4023,GO:0008307,1,0.711453049666539,0,41,structural constituent of muscle,MF,
4024,GO:0008308,1,0.91037610052668,0,14,voltage-gated anion channel activity,MF,
4025,GO:0008309,1,0.97759652677325,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4026,GO:0008310,1,0.967330739536095,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4027,GO:0008311,1,0.98909228896943,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4028,GO:0008312,1,0.961043607380299,0,7,7S RNA binding,MF,
4029,GO:0008318,1,0.953932264409966,0,7,protein prenyltransferase activity,MF,
4030,GO:0008320,1,0.929502657139865,0,13,protein transmembrane transporter activity,MF,
4031,GO:0008321,1,0.977886166123424,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4033,GO:0008327,1,0.904569938303056,0,15,methyl-CpG binding,MF,
4035,GO:0008329,1,0.915923199553783,0,14,signaling pattern recognition receptor activity,MF,
4036,GO:0008330,1,0.977711300565745,0,4,protein tyrosine/threonine phosphatase activity,MF,
4037,GO:0008331,1,0.893978410785942,0,12,high voltage-gated calcium channel activity,MF,
4038,GO:0008332,1,0.962491577940104,0,4,low voltage-gated calcium channel activity,MF,
4040,GO:0008334,1,0.844356839033405,0,24,histone mRNA metabolic process,BP,
4041,GO:0008336,1,0.994504129637034,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4042,GO:0008340,1,0.913073413254467,0,11,determination of adult lifespan,BP,
4043,GO:0008343,1,0.956967293396862,0,7,adult feeding behavior,BP,
4046,GO:0008348,1,0.993594043504133,0,1,negative regulation of antimicrobial humoral response,BP,
4047,GO:0008349,1,0.922848267836776,0,11,MAP kinase kinase kinase kinase activity,MF,
4048,GO:0008352,1,0.994244969345962,0,1,katanin complex,CC,
4049,GO:0008353,1,0.905543195042792,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4050,GO:0008354,1,0.954708137850881,0,7,germ cell migration,BP,
4052,GO:0008356,1,0.882963768313384,0,18,asymmetric cell division,BP,
4053,GO:0008358,1,0.988022825937695,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4058,GO:0008374,1,0.782961251502325,0,37,O-acyltransferase activity,MF,
4059,GO:0008375,1,0.712803556884181,0,53,acetylglucosaminyltransferase activity,MF,
4061,GO:0008378,1,0.829538048193661,0,31,galactosyltransferase activity,MF,
4062,GO:0008379,1,0.973408895024249,0,5,thioredoxin peroxidase activity,MF,
4064,GO:0008381,1,0.947246293532677,0,9,mechanosensitive ion channel activity,MF,
4065,GO:0008384,1,0.987110905603968,0,2,IkappaB kinase activity,MF,
4066,GO:0008385,1,0.942059543992206,0,9,IkappaB kinase complex,CC,
4067,GO:0008386,1,0.994484700089226,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4068,GO:0008387,1,0.994395978211725,0,1,steroid 7-alpha-hydroxylase activity,MF,
4069,GO:0008389,1,0.989094306843063,0,2,coumarin 7-hydroxylase activity,MF,
4070,GO:0008391,1,0.956674317201304,0,8,arachidonic acid monooxygenase activity,MF,
4071,GO:0008392,1,0.956674317201304,0,8,arachidonic acid epoxygenase activity,MF,
4072,GO:0008395,1,0.880773129948495,0,22,steroid hydroxylase activity,MF,
4073,GO:0008396,1,0.988782270688364,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4074,GO:0008397,1,0.993365341659798,0,1,sterol 12-alpha-hydroxylase activity,MF,
4075,GO:0008398,1,0.994019053366889,0,1,sterol 14-demethylase activity,MF,
4076,GO:0008401,1,0.981650681421893,0,3,retinoic acid 4-hydroxylase activity,MF,
4077,GO:0008403,1,0.993955700937162,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4078,GO:0008404,1,0.994510897882685,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4079,GO:0008405,1,0.994510897882685,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4081,GO:0008408,1,0.731061328132271,0,48,3'-5' exonuclease activity,MF,
4082,GO:0008409,1,0.892941249377072,0,16,5'-3' exonuclease activity,MF,
4083,GO:0008410,1,0.977091124424421,0,4,CoA-transferase activity,MF,
4084,GO:0008413,1,0.98915661079766,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4086,GO:0008418,1,0.994625504789316,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4087,GO:0008419,1,0.994249124084277,0,1,RNA lariat debranching enzyme activity,MF,
4088,GO:0008420,1,0.951769203193916,0,8,CTD phosphatase activity,MF,
4089,GO:0008422,1,0.975257542003164,0,4,beta-glucosidase activity,MF,
4090,GO:0008424,1,0.99387659705545,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4091,GO:0008425,1,0.994609403508997,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4092,GO:0008426,1,0.982877177619087,0,3,protein kinase C inhibitor activity,MF,
4093,GO:0008427,1,0.983696784104718,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4094,GO:0008428,1,0.981773809396806,0,3,ribonuclease inhibitor activity,MF,
4095,GO:0008429,1,0.940706875073401,0,9,phosphatidylethanolamine binding,MF,
4096,GO:0008430,1,0.97323522637671,0,4,selenium binding,MF,
4097,GO:0008431,1,0.988325825751645,0,2,vitamin E binding,MF,
4098,GO:0008432,1,0.944717803567277,0,8,JUN kinase binding,MF,
4099,GO:0008434,1,0.992678442915743,0,1,calcitriol receptor activity,MF,
4100,GO:0008437,1,0.994476252898515,0,1,thyrotropin-releasing hormone activity,MF,
4101,GO:0008440,1,0.967703681697279,0,5,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4102,GO:0008441,1,0.984719238170157,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4103,GO:0008442,1,0.994482832837644,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4104,GO:0008443,1,0.956334974570654,0,7,phosphofructokinase activity,MF,
4105,GO:0008444,1,0.994423134073305,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4106,GO:0008445,1,0.994558511239247,0,1,D-aspartate oxidase activity,MF,
4107,GO:0008446,1,0.994548091138381,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4108,GO:0008448,1,0.994516278235246,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4109,GO:0008449,1,0.977366419099729,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4110,GO:0008452,1,0.994184768585909,0,1,RNA ligase activity,MF,
4111,GO:0008453,1,0.983026740358504,0,3,alanine-glyoxylate transaminase activity,MF,
4112,GO:0008454,1,0.980270287630882,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4113,GO:0008455,1,0.994223728588005,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4114,GO:0008456,1,0.993544297805147,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4115,GO:0008457,1,0.993216029596454,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4116,GO:0008458,1,0.993902875045104,0,1,carnitine O-octanoyltransferase activity,MF,
4117,GO:0008459,1,0.985006621230964,0,2,chondroitin 6-sulfotransferase activity,MF,
4118,GO:0008460,1,0.994499971424535,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4119,GO:0008465,1,0.994612494991953,0,1,glycerate dehydrogenase activity,MF,
4120,GO:0008466,1,0.988386460947843,0,2,glycogenin glucosyltransferase activity,MF,
4121,GO:0008467,1,0.966374943761317,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4122,GO:0008469,1,0.950001687784387,0,9,histone-arginine N-methyltransferase activity,MF,
4123,GO:0008470,1,0.992762135654288,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4124,GO:0008474,1,0.942964370001418,0,10,palmitoyl-(protein) hydrolase activity,MF,
4125,GO:0008475,1,0.98152190030938,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4126,GO:0008476,1,0.98898485539263,0,2,protein-tyrosine sulfotransferase activity,MF,
4127,GO:0008478,1,0.990188270537855,0,1,pyridoxal kinase activity,MF,
4128,GO:0008479,1,0.978188322767825,0,4,queuine tRNA-ribosyltransferase activity,MF,
4129,GO:0008480,1,0.993861532284992,0,1,sarcosine dehydrogenase activity,MF,
4130,GO:0008481,1,0.988628192692792,0,2,sphinganine kinase activity,MF,
4131,GO:0008482,1,0.994377241372463,0,1,sulfite oxidase activity,MF,
4132,GO:0008483,1,0.896473849638916,0,17,transaminase activity,MF,
4133,GO:0008484,1,0.89849325202535,0,16,sulfuric ester hydrolase activity,MF,
4134,GO:0008486,1,0.976242838261684,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4135,GO:0008488,1,0.993957350015513,0,1,gamma-glutamyl carboxylase activity,MF,
4136,GO:0008489,1,0.994121479707721,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4137,GO:0008493,1,0.99451011855604,0,1,tetracycline transmembrane transporter activity,MF,
4138,GO:0008494,1,0.933546726927642,0,11,translation activator activity,MF,
4139,GO:0008495,1,0.994064970559805,0,1,protoheme IX farnesyltransferase activity,MF,
4140,GO:0008496,1,0.993095966016136,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4141,GO:0008499,1,0.930964072158016,0,12,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4142,GO:0008502,1,0.97748301130895,0,4,melatonin receptor activity,MF,
4144,GO:0008504,1,0.950051260608054,0,8,monoamine transmembrane transporter activity,MF,
4145,GO:0008506,1,0.982140527221787,0,3,sucrose:proton symporter activity,MF,
4146,GO:0008507,1,0.993658554363341,0,1,sodium:iodide symporter activity,MF,
4147,GO:0008508,1,0.978308791543408,0,4,bile acid:sodium symporter activity,MF,
4149,GO:0008510,1,0.931633435283892,0,9,sodium:bicarbonate symporter activity,MF,
4150,GO:0008511,1,0.983385076020577,0,2,sodium:potassium:chloride symporter activity,MF,
4151,GO:0008513,1,0.988762905179463,0,2,secondary active organic cation transmembrane transporter activity,MF,
4153,GO:0008515,1,0.982140527221787,0,3,sucrose transmembrane transporter activity,MF,
4154,GO:0008517,1,0.962678109675392,0,6,folic acid transmembrane transporter activity,MF,
4155,GO:0008518,1,0.994156250909866,0,1,reduced folate carrier activity,MF,
4156,GO:0008519,1,0.847230432951028,0,27,ammonium transmembrane transporter activity,MF,
4157,GO:0008520,1,0.990572227848584,0,1,L-ascorbate:sodium symporter activity,MF,
4158,GO:0008521,1,0.994245432508821,0,1,acetyl-CoA transmembrane transporter activity,MF,
4159,GO:0008523,1,0.993866452506802,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4160,GO:0008525,1,0.942210172087433,0,8,phosphatidylcholine transporter activity,MF,
4161,GO:0008526,1,0.946025594688883,0,8,phosphatidylinositol transporter activity,MF,
4162,GO:0008527,1,0.92573225553341,0,14,taste receptor activity,MF,
4164,GO:0008531,1,0.994223728588005,0,1,riboflavin kinase activity,MF,
4165,GO:0008532,1,0.954037974786919,0,8,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4166,GO:0008534,1,0.978464530329993,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4167,GO:0008535,1,0.86681096124421,0,24,respiratory chain complex IV assembly,BP,
4168,GO:0008536,1,0.781745633423168,0,33,Ran GTPase binding,MF,
4169,GO:0008537,1,0.983308908610722,0,3,proteasome activator complex,CC,
4170,GO:0008540,1,0.93483378954731,0,12,proteasome regulatory particle, base subcomplex,CC,
4171,GO:0008541,1,0.962377018940364,0,7,proteasome regulatory particle, lid subcomplex,CC,
4173,GO:0008543,1,0.514824251801623,0,98,fibroblast growth factor receptor signaling pathway,BP,
4175,GO:0008545,1,0.987383312124967,0,2,JUN kinase kinase activity,MF,
4176,GO:0008553,1,0.919199450464384,0,13,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4177,GO:0008554,1,0.992603949722694,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4178,GO:0008555,1,0.992059381825674,0,1,chloride-transporting ATPase activity,MF,
4179,GO:0008556,1,0.933107272877798,0,11,potassium-transporting ATPase activity,MF,
4181,GO:0008565,1,0.595255081869595,0,77,protein transporter activity,MF,
4182,GO:0008568,1,0.936029177736847,0,10,microtubule-severing ATPase activity,MF,
4183,GO:0008569,1,0.796753960559687,0,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4184,GO:0008574,1,0.803072641713084,0,30,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4185,GO:0008579,1,0.992146596288932,0,1,JUN kinase phosphatase activity,MF,
4186,GO:0008582,1,0.970111597203683,0,4,regulation of synaptic growth at neuromuscular junction,BP,
4189,GO:0008589,1,0.599777499492629,0,72,regulation of smoothened signaling pathway,BP,
4190,GO:0008591,1,0.994523216867324,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4191,GO:0008592,1,0.993911760867851,0,1,regulation of Toll signaling pathway,BP,
4194,GO:0008595,1,0.922760753003544,0,12,anterior/posterior axis specification, embryo,BP,
4195,GO:0008597,1,0.982852229127961,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4197,GO:0008607,1,0.982561032409948,0,3,phosphorylase kinase regulator activity,MF,
4198,GO:0008608,1,0.824538631388424,0,30,attachment of spindle microtubules to kinetochore,BP,
4199,GO:0008609,1,0.989922761612425,0,1,alkylglycerone-phosphate synthase activity,MF,
4201,GO:0008611,1,0.965941866423032,0,5,ether lipid biosynthetic process,BP,
4202,GO:0008612,1,0.975852452515844,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4203,GO:0008614,1,0.988228638020617,0,2,pyridoxine metabolic process,BP,
4204,GO:0008615,1,0.988228638020617,0,2,pyridoxine biosynthetic process,BP,
4205,GO:0008616,1,0.983499472061217,0,3,queuosine biosynthetic process,BP,
4206,GO:0008617,1,0.994634727767316,0,1,guanosine metabolic process,BP,
4207,GO:0008622,1,0.968063082382967,0,5,epsilon DNA polymerase complex,CC,
4208,GO:0008623,1,0.98587200491783,0,2,CHRAC,CC,
4210,GO:0008626,1,0.965001271436945,0,6,granzyme-mediated apoptotic signaling pathway,BP,
4211,GO:0008627,1,0.947032790616583,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4212,GO:0008628,1,0.983542486685656,0,3,hormone-mediated apoptotic signaling pathway,BP,
4213,GO:0008630,1,0.524977708400982,0,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
4214,GO:0008631,1,0.773201117981742,0,42,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4215,GO:0008635,1,0.94464468206456,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4216,GO:0008637,1,0.497660148497341,0,114,apoptotic mitochondrial changes,BP,
4217,GO:0008641,1,0.938671103442137,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4218,GO:0008643,1,0.425699922372886,0,127,carbohydrate transport,BP,
4219,GO:0008645,1,0.517583940333213,0,96,hexose transmembrane transport,BP,
4220,GO:0008649,1,0.914972032938873,0,15,rRNA methyltransferase activity,MF,
4221,GO:0008650,1,0.993667865440463,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4222,GO:0008652,1,0.620662380580658,0,75,cellular amino acid biosynthetic process,BP,
4225,GO:0008656,1,0.911124193867804,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4226,GO:0008670,1,0.989203727477396,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4227,GO:0008689,1,0.994609403508997,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4228,GO:0008700,1,0.994184768585909,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4229,GO:0008705,1,0.98741307309311,0,1,methionine synthase activity,MF,
4230,GO:0008709,1,0.994639568381293,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4231,GO:0008721,1,0.994322778976815,0,1,D-serine ammonia-lyase activity,MF,
4232,GO:0008725,1,0.994628139820451,0,1,DNA-3-methyladenine glycosylase activity,MF,
4233,GO:0008732,1,0.988770817401512,0,2,L-allo-threonine aldolase activity,MF,
4234,GO:0008745,1,0.994639606702336,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4235,GO:0008746,1,0.987382917177016,0,2,NAD(P)+ transhydrogenase activity,MF,
4236,GO:0008747,1,0.99456864024971,0,1,N-acetylneuraminate lyase activity,MF,
4237,GO:0008750,1,0.992715761880479,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4238,GO:0008753,1,0.993759020698383,0,1,NADPH dehydrogenase (quinone) activity,MF,
4240,GO:0008761,1,0.992131438897862,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4241,GO:0008768,1,0.994645807810909,0,1,UDP-sugar diphosphatase activity,MF,
4242,GO:0008775,1,0.994518544435163,0,1,acetate CoA-transferase activity,MF,
4243,GO:0008781,1,0.98917698359506,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4244,GO:0008783,1,0.99442190370155,0,1,agmatinase activity,MF,
4245,GO:0008785,1,0.994567656428863,0,1,alkyl hydroperoxide reductase activity,MF,
4246,GO:0008792,1,0.994184768585909,0,1,arginine decarboxylase activity,MF,
4247,GO:0008794,1,0.994642586024967,0,1,arsenate reductase (glutaredoxin) activity,MF,
4248,GO:0008796,1,0.988865121063588,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4249,GO:0008798,1,0.986128822936329,0,2,beta-aspartyl-peptidase activity,MF,
4250,GO:0008802,1,0.99367482626026,0,1,betaine-aldehyde dehydrogenase activity,MF,
4251,GO:0008803,1,0.994636616241269,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4252,GO:0008808,1,0.993485153846078,0,1,cardiolipin synthase activity,MF,
4253,GO:0008812,1,0.993611499054393,0,1,choline dehydrogenase activity,MF,
4254,GO:0008817,1,0.993197760073766,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4255,GO:0008821,1,0.95277991295496,0,8,crossover junction endodeoxyribonuclease activity,MF,
4257,GO:0008829,1,0.994519401565665,0,1,dCTP deaminase activity,MF,
4258,GO:0008832,1,0.993938092816132,0,1,dGTPase activity,MF,
4259,GO:0008841,1,0.994318385259016,0,1,dihydrofolate synthase activity,MF,
4260,GO:0008843,1,0.99438450636867,0,1,endochitinase activity,MF,
4261,GO:0008852,1,0.994159450681341,0,1,exodeoxyribonuclease I activity,MF,
4262,GO:0008853,1,0.976596070922862,0,4,exodeoxyribonuclease III activity,MF,
4263,GO:0008859,1,0.994639222273376,0,1,exoribonuclease II activity,MF,
4264,GO:0008865,1,0.966237421369263,0,5,fructokinase activity,MF,
4265,GO:0008887,1,0.99391244216693,0,1,glycerate kinase activity,MF,
4266,GO:0008889,1,0.968205514871202,0,5,glycerophosphodiester phosphodiesterase activity,MF,
4267,GO:0008890,1,0.99456449867657,0,1,glycine C-acetyltransferase activity,MF,
4268,GO:0008891,1,0.99453426246216,0,1,glycolate oxidase activity,MF,
4269,GO:0008892,1,0.9920014927361,0,1,guanine deaminase activity,MF,
4270,GO:0008893,1,0.994632085914953,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4271,GO:0008894,1,0.994208636477193,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4272,GO:0008897,1,0.99414384695735,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4273,GO:0008900,1,0.98736618196309,0,2,potassium:proton exchanging ATPase activity,MF,
4274,GO:0008903,1,0.994625982542501,0,1,hydroxypyruvate isomerase activity,MF,
4275,GO:0008905,1,0.994560932962015,0,1,mannose-phosphate guanylyltransferase activity,MF,
4276,GO:0008934,1,0.972955192526233,0,4,inositol monophosphate 1-phosphatase activity,MF,
4277,GO:0008940,1,0.981567765917473,0,3,nitrate reductase activity,MF,
4278,GO:0008941,1,0.988832116163384,0,2,nitric oxide dioxygenase activity,MF,
4279,GO:0008948,1,0.975833032835794,0,4,oxaloacetate decarboxylase activity,MF,
4280,GO:0008955,1,0.993356870251602,0,1,peptidoglycan glycosyltransferase activity,MF,
4281,GO:0008962,1,0.988786749197624,0,2,phosphatidylglycerophosphatase activity,MF,
4282,GO:0008963,1,0.994437836724958,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4283,GO:0008967,1,0.988487210808381,0,2,phosphoglycolate phosphatase activity,MF,
4284,GO:0008970,1,0.948829631508635,0,9,phosphatidylcholine 1-acylhydrolase activity,MF,
4285,GO:0008973,1,0.993906299013992,0,1,phosphopentomutase activity,MF,
4286,GO:0008988,1,0.988403017609477,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4287,GO:0008995,1,0.994276479790622,0,1,ribonuclease E activity,MF,
4288,GO:0009000,1,0.994328310572873,0,1,selenocysteine lyase activity,MF,
4289,GO:0009007,1,0.993586074527996,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4290,GO:0009008,1,0.967085980995881,0,5,DNA-methyltransferase activity,MF,
4291,GO:0009013,1,0.992269531760999,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4292,GO:0009019,1,0.974941613486029,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4293,GO:0009020,1,0.994487781908864,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4295,GO:0009041,1,0.982939960885462,0,3,uridylate kinase activity,MF,
4296,GO:0009048,1,0.917585010959604,0,10,dosage compensation by inactivation of X chromosome,BP,
4297,GO:0009051,1,0.983589021201314,0,3,pentose-phosphate shunt, oxidative branch,BP,
4298,GO:0009052,1,0.971739593829174,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4299,GO:0009055,1,0.557640135509255,0,101,electron transfer activity,MF,
4304,GO:0009060,1,0.643797309160778,0,74,aerobic respiration,BP,
4305,GO:0009061,1,0.994354603133905,0,1,anaerobic respiration,BP,
4306,GO:0009062,1,0.518373402995332,0,104,fatty acid catabolic process,BP,
4307,GO:0009063,1,0.510738561251433,0,110,cellular amino acid catabolic process,BP,
4308,GO:0009064,1,0.648796304561781,0,69,glutamine family amino acid metabolic process,BP,
4309,GO:0009065,1,0.838883105152359,0,28,glutamine family amino acid catabolic process,BP,
4310,GO:0009066,1,0.713694192902952,0,55,aspartate family amino acid metabolic process,BP,
4311,GO:0009067,1,0.870532354550474,0,22,aspartate family amino acid biosynthetic process,BP,
4312,GO:0009068,1,0.88322746119501,0,21,aspartate family amino acid catabolic process,BP,
4313,GO:0009069,1,0.80928536615284,0,36,serine family amino acid metabolic process,BP,
4314,GO:0009070,1,0.918721554729537,0,15,serine family amino acid biosynthetic process,BP,
4315,GO:0009071,1,0.940064950163078,0,11,serine family amino acid catabolic process,BP,
4316,GO:0009072,1,0.874126614854377,0,23,aromatic amino acid family metabolic process,BP,
4317,GO:0009074,1,0.903485893911473,0,18,aromatic amino acid family catabolic process,BP,
4318,GO:0009078,1,0.977206538644559,0,4,pyruvate family amino acid metabolic process,BP,
4319,GO:0009080,1,0.977206538644559,0,4,pyruvate family amino acid catabolic process,BP,
4320,GO:0009081,1,0.853677350927094,0,24,branched-chain amino acid metabolic process,BP,
4321,GO:0009082,1,0.984011780924779,0,2,branched-chain amino acid biosynthetic process,BP,
4322,GO:0009083,1,0.872447918630822,0,21,branched-chain amino acid catabolic process,BP,
4323,GO:0009084,1,0.896711494359405,0,17,glutamine family amino acid biosynthetic process,BP,
4324,GO:0009085,1,0.985767478784131,0,2,lysine biosynthetic process,BP,
4325,GO:0009086,1,0.925472251209503,0,12,methionine biosynthetic process,BP,
4326,GO:0009087,1,0.993792966113969,0,1,methionine catabolic process,BP,
4327,GO:0009088,1,0.994446507872243,0,1,threonine biosynthetic process,BP,
4328,GO:0009092,1,0.977325919388453,0,4,homoserine metabolic process,BP,
4329,GO:0009093,1,0.983483479201494,0,3,cysteine catabolic process,BP,
4330,GO:0009098,1,0.984011780924779,0,2,leucine biosynthetic process,BP,
4331,GO:0009099,1,0.984011780924779,0,2,valine biosynthetic process,BP,
4334,GO:0009106,1,0.988239603489497,0,2,lipoate metabolic process,BP,
4335,GO:0009107,1,0.99454836859542,0,1,lipoate biosynthetic process,BP,
4337,GO:0009109,1,0.917757934302343,0,14,coenzyme catabolic process,BP,
4338,GO:0009110,1,0.877688331952421,0,21,vitamin biosynthetic process,BP,
4339,GO:0009111,1,0.942127376121137,0,10,vitamin catabolic process,BP,
4341,GO:0009113,1,0.926767922888425,0,13,purine nucleobase biosynthetic process,BP,
4342,GO:0009115,1,0.984221206665505,0,2,xanthine catabolic process,BP,
4345,GO:0009119,1,0.553705153798811,0,94,ribonucleoside metabolic process,BP,
4346,GO:0009120,1,0.965169775613157,0,6,deoxyribonucleoside metabolic process,BP,
4347,GO:0009123,1,0.144486955755769,0,304,nucleoside monophosphate metabolic process,BP,
4348,GO:0009124,1,0.356867537741797,0,159,nucleoside monophosphate biosynthetic process,BP,
4349,GO:0009125,1,0.936729525139577,0,11,nucleoside monophosphate catabolic process,BP,
4350,GO:0009126,1,0.16860686679317,0,278,purine nucleoside monophosphate metabolic process,BP,
4351,GO:0009127,1,0.406526523562696,0,137,purine nucleoside monophosphate biosynthetic process,BP,
4352,GO:0009128,1,0.947364460581984,0,9,purine nucleoside monophosphate catabolic process,BP,
4353,GO:0009129,1,0.910895737542614,0,16,pyrimidine nucleoside monophosphate metabolic process,BP,
4354,GO:0009130,1,0.915878674406977,0,15,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4355,GO:0009131,1,0.994564162518276,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4356,GO:0009132,1,0.406877808464525,0,134,nucleoside diphosphate metabolic process,BP,
4357,GO:0009133,1,0.966284070958587,0,6,nucleoside diphosphate biosynthetic process,BP,
4358,GO:0009134,1,0.963918970105786,0,6,nucleoside diphosphate catabolic process,BP,
4359,GO:0009135,1,0.458189510564463,0,113,purine nucleoside diphosphate metabolic process,BP,
4360,GO:0009136,1,0.982777813344703,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4361,GO:0009137,1,0.980597495899688,0,3,purine nucleoside diphosphate catabolic process,BP,
4362,GO:0009138,1,0.982898102840542,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4363,GO:0009139,1,0.988727535234231,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4364,GO:0009140,1,0.994104773294902,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4365,GO:0009141,1,0.160141436420307,0,289,nucleoside triphosphate metabolic process,BP,
4366,GO:0009142,1,0.393702298041563,0,143,nucleoside triphosphate biosynthetic process,BP,
4367,GO:0009143,1,0.927968037120853,0,12,nucleoside triphosphate catabolic process,BP,
4368,GO:0009144,1,0.18088032693476,0,269,purine nucleoside triphosphate metabolic process,BP,
4369,GO:0009145,1,0.436164763303822,0,126,purine nucleoside triphosphate biosynthetic process,BP,
4370,GO:0009146,1,0.964242793333879,0,6,purine nucleoside triphosphate catabolic process,BP,
4371,GO:0009147,1,0.885937588686719,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4372,GO:0009148,1,0.900836753021259,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4373,GO:0009149,1,0.989162526270223,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4375,GO:0009151,1,0.942189844281861,0,10,purine deoxyribonucleotide metabolic process,BP,
4377,GO:0009153,1,0.982846156567271,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4378,GO:0009154,1,0.805307172513328,0,31,purine ribonucleotide catabolic process,BP,
4379,GO:0009155,1,0.969453486239468,0,5,purine deoxyribonucleotide catabolic process,BP,
4380,GO:0009156,1,0.37819601871305,0,149,ribonucleoside monophosphate biosynthetic process,BP,
4381,GO:0009157,1,0.949425889764847,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4382,GO:0009158,1,0.952485531787041,0,8,ribonucleoside monophosphate catabolic process,BP,
4383,GO:0009159,1,0.988780227091857,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4384,GO:0009161,1,0.157619374127868,0,289,ribonucleoside monophosphate metabolic process,BP,
4385,GO:0009162,1,0.933729739996427,0,12,deoxyribonucleoside monophosphate metabolic process,BP,
4389,GO:0009166,1,0.350994819679715,0,156,nucleotide catabolic process,BP,
4390,GO:0009167,1,0.169534211963277,0,277,purine ribonucleoside monophosphate metabolic process,BP,
4391,GO:0009168,1,0.406526523562696,0,137,purine ribonucleoside monophosphate biosynthetic process,BP,
4392,GO:0009169,1,0.952485531787041,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4393,GO:0009170,1,0.994636454406539,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4394,GO:0009173,1,0.941569242151373,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4395,GO:0009174,1,0.941569242151373,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4396,GO:0009176,1,0.967442301331864,0,6,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4397,GO:0009177,1,0.972731370893476,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4398,GO:0009178,1,0.994564162518276,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4399,GO:0009179,1,0.458189510564463,0,113,purine ribonucleoside diphosphate metabolic process,BP,
4400,GO:0009180,1,0.982777813344703,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4401,GO:0009181,1,0.980597495899688,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4402,GO:0009182,1,0.982571022043489,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4403,GO:0009183,1,0.988318999621452,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4404,GO:0009185,1,0.452995681884996,0,115,ribonucleoside diphosphate metabolic process,BP,
4405,GO:0009186,1,0.971493086451143,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4407,GO:0009188,1,0.982777813344703,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4408,GO:0009189,1,0.977176905661963,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4410,GO:0009191,1,0.969565698515166,0,5,ribonucleoside diphosphate catabolic process,BP,
4411,GO:0009193,1,0.994104773294902,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4412,GO:0009195,1,0.994104773294902,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4413,GO:0009196,1,0.988727535234231,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4414,GO:0009197,1,0.988727535234231,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4415,GO:0009199,1,0.181496623711309,0,268,ribonucleoside triphosphate metabolic process,BP,
4416,GO:0009200,1,0.910435593465006,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4417,GO:0009201,1,0.421864938008543,0,131,ribonucleoside triphosphate biosynthetic process,BP,
4418,GO:0009202,1,0.966970378262821,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4419,GO:0009203,1,0.994626787495288,0,1,ribonucleoside triphosphate catabolic process,BP,
4420,GO:0009204,1,0.958943814607771,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4421,GO:0009205,1,0.188764450959041,0,262,purine ribonucleoside triphosphate metabolic process,BP,
4422,GO:0009206,1,0.438613364392024,0,125,purine ribonucleoside triphosphate biosynthetic process,BP,
4423,GO:0009207,1,0.994626787495288,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4424,GO:0009208,1,0.915778767655371,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4425,GO:0009209,1,0.921075886142559,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4426,GO:0009211,1,0.967442639908826,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4427,GO:0009212,1,0.978044515160479,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4428,GO:0009213,1,0.989162526270223,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4429,GO:0009214,1,0.85998489252924,0,20,cyclic nucleotide catabolic process,BP,
4430,GO:0009215,1,0.948215325509735,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4431,GO:0009216,1,0.988679768845665,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4432,GO:0009217,1,0.969453486239468,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4433,GO:0009218,1,0.874248890774163,0,23,pyrimidine ribonucleotide metabolic process,BP,
4434,GO:0009219,1,0.899920612456139,0,19,pyrimidine deoxyribonucleotide metabolic process,BP,
4435,GO:0009220,1,0.884529032142511,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4436,GO:0009221,1,0.956570641998676,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4437,GO:0009222,1,0.994104773294902,0,1,pyrimidine ribonucleotide catabolic process,BP,
4438,GO:0009223,1,0.935633477146467,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4439,GO:0009224,1,0.994611703443189,0,1,CMP biosynthetic process,BP,
4440,GO:0009225,1,0.796634821900087,0,36,nucleotide-sugar metabolic process,BP,
4441,GO:0009226,1,0.869585708139494,0,23,nucleotide-sugar biosynthetic process,BP,
4442,GO:0009227,1,0.9832311736074,0,3,nucleotide-sugar catabolic process,BP,
4443,GO:0009229,1,0.994368053421367,0,1,thiamine diphosphate biosynthetic process,BP,
4444,GO:0009231,1,0.994223728588005,0,1,riboflavin biosynthetic process,BP,
4445,GO:0009233,1,0.987589636572795,0,2,menaquinone metabolic process,BP,
4446,GO:0009234,1,0.993607541176219,0,1,menaquinone biosynthetic process,BP,
4447,GO:0009235,1,0.880909963761701,0,18,cobalamin metabolic process,BP,
4448,GO:0009236,1,0.979016892222469,0,3,cobalamin biosynthetic process,BP,
4449,GO:0009237,1,0.994109337919242,0,1,siderophore metabolic process,BP,
4450,GO:0009240,1,0.978207171142858,0,4,isopentenyl diphosphate biosynthetic process,BP,
4451,GO:0009245,1,0.989344272260938,0,2,lipid A biosynthetic process,BP,
4453,GO:0009249,1,0.957694147284099,0,8,protein lipoylation,BP,
4454,GO:0009250,1,0.727670249179375,0,44,glucan biosynthetic process,BP,
4455,GO:0009251,1,0.844312261608353,0,24,glucan catabolic process,BP,
4456,GO:0009253,1,0.989304444792726,0,2,peptidoglycan catabolic process,BP,
4457,GO:0009256,1,0.966232373682587,0,5,10-formyltetrahydrofolate metabolic process,BP,
4458,GO:0009257,1,0.987416296427957,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4459,GO:0009258,1,0.984092034885503,0,2,10-formyltetrahydrofolate catabolic process,BP,
4462,GO:0009261,1,0.800549442139489,0,32,ribonucleotide catabolic process,BP,
4463,GO:0009262,1,0.826637643916073,0,33,deoxyribonucleotide metabolic process,BP,
4464,GO:0009263,1,0.921702571768158,0,14,deoxyribonucleotide biosynthetic process,BP,
4465,GO:0009264,1,0.902075881999762,0,18,deoxyribonucleotide catabolic process,BP,
4466,GO:0009265,1,0.940154546817775,0,11,2'-deoxyribonucleotide biosynthetic process,BP,
4468,GO:0009267,1,0.425265734379622,0,130,cellular response to starvation,BP,
4469,GO:0009268,1,0.804450282380162,0,36,response to pH,BP,
4470,GO:0009295,1,0.771041996975447,0,41,nucleoid,CC,
4471,GO:0009298,1,0.978255348625845,0,4,GDP-mannose biosynthetic process,BP,
4472,GO:0009299,1,0.845552257938127,0,25,mRNA transcription,BP,
4473,GO:0009301,1,0.660494651693939,0,66,snRNA transcription,BP,
4474,GO:0009303,1,0.841313450583817,0,27,rRNA transcription,BP,
4475,GO:0009304,1,0.95484215282293,0,7,tRNA transcription,BP,
4476,GO:0009305,1,0.991454089454464,0,1,protein biotinylation,BP,
4480,GO:0009310,1,0.880147973245718,0,21,amine catabolic process,BP,
4483,GO:0009313,1,0.936391679108842,0,11,oligosaccharide catabolic process,BP,
4485,GO:0009328,1,0.977403040898845,0,4,phenylalanine-tRNA ligase complex,CC,
4486,GO:0009330,1,0.985311750927874,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4487,GO:0009331,1,0.97920849175668,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4488,GO:0009346,1,0.993003961948249,0,1,citrate lyase complex,CC,
4489,GO:0009353,1,0.994602154797216,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4490,GO:0009360,1,0.994226606044192,0,1,DNA polymerase III complex,CC,
4491,GO:0009368,1,0.989020166557043,0,2,endopeptidase Clp complex,CC,
4492,GO:0009372,1,0.993882861295582,0,1,quorum sensing,BP,
4493,GO:0009374,1,0.962439219010707,0,5,biotin binding,MF,
4494,GO:0009378,1,0.96560131966706,0,5,four-way junction helicase activity,MF,
4495,GO:0009383,1,0.987198534206015,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4496,GO:0009384,1,0.992131438897862,0,1,N-acylmannosamine kinase activity,MF,
4497,GO:0009386,1,0.988980422693774,0,2,translational attenuation,BP,
4498,GO:0009394,1,0.847842730482137,0,29,2'-deoxyribonucleotide metabolic process,BP,
4499,GO:0009395,1,0.822743464625661,0,31,phospholipid catabolic process,BP,
4500,GO:0009396,1,0.948277486992882,0,9,folic acid-containing compound biosynthetic process,BP,
4501,GO:0009397,1,0.971660614163137,0,4,folic acid-containing compound catabolic process,BP,
4502,GO:0009398,1,0.994223728588005,0,1,FMN biosynthetic process,BP,
4503,GO:0009400,1,0.994152498934816,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4504,GO:0009403,1,0.973616247445746,0,4,toxin biosynthetic process,BP,
4505,GO:0009404,1,0.885479833124638,0,20,toxin metabolic process,BP,
4506,GO:0009405,1,0.983598685230165,0,2,pathogenesis,BP,
4507,GO:0009407,1,0.972869735087743,0,5,toxin catabolic process,BP,
4511,GO:0009411,1,0.425657955730981,0,129,response to UV,BP,
4512,GO:0009414,1,0.9593537789822,0,7,response to water deprivation,BP,
4513,GO:0009415,1,0.92301548443835,0,12,response to water,BP,
4516,GO:0009436,1,0.988777357192983,0,2,glyoxylate catabolic process,BP,
4517,GO:0009437,1,0.926681974214428,0,13,carnitine metabolic process,BP,
4518,GO:0009438,1,0.972503781935248,0,5,methylglyoxal metabolic process,BP,
4519,GO:0009439,1,0.989235108354544,0,2,cyanate metabolic process,BP,
4520,GO:0009440,1,0.989235108354544,0,2,cyanate catabolic process,BP,
4521,GO:0009441,1,0.979609179444422,0,3,glycolate metabolic process,BP,
4522,GO:0009443,1,0.990188270537855,0,1,pyridoxal 5'-phosphate salvage,BP,
4523,GO:0009444,1,0.992122436919099,0,1,pyruvate oxidation,BP,
4524,GO:0009445,1,0.960620815402806,0,7,putrescine metabolic process,BP,
4525,GO:0009446,1,0.971021435444195,0,5,putrescine biosynthetic process,BP,
4526,GO:0009447,1,0.983894314841693,0,3,putrescine catabolic process,BP,
4527,GO:0009448,1,0.973003242364198,0,4,gamma-aminobutyric acid metabolic process,BP,
4528,GO:0009449,1,0.980585104240802,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4529,GO:0009450,1,0.984819196995456,0,2,gamma-aminobutyric acid catabolic process,BP,
4530,GO:0009451,1,0.457269303271586,0,130,RNA modification,BP,
4531,GO:0009452,1,0.821916442814653,0,32,7-methylguanosine RNA capping,BP,
4532,GO:0009566,1,0.43775082146356,0,129,fertilization,BP,
4533,GO:0009581,1,0.488503292220111,0,103,detection of external stimulus,BP,
4534,GO:0009582,1,0.479194346583448,0,106,detection of abiotic stimulus,BP,
4535,GO:0009583,1,0.716922038422067,0,53,detection of light stimulus,BP,
4536,GO:0009584,1,0.761621945173639,0,43,detection of visible light,BP,
4538,GO:0009595,1,0.879765896889685,0,19,detection of biotic stimulus,BP,
4539,GO:0009597,1,0.969740576403791,0,5,detection of virus,BP,
4542,GO:0009608,1,0.987865041633813,0,2,response to symbiont,BP,
4543,GO:0009609,1,0.987865041633813,0,2,response to symbiotic bacterium,BP,
4549,GO:0009624,1,0.994268552029504,0,1,response to nematode,BP,
4551,GO:0009629,1,0.949329822748751,0,9,response to gravity,BP,
4552,GO:0009631,1,0.992311032969159,0,1,cold acclimation,BP,
4553,GO:0009635,1,0.939551401725196,0,11,response to herbicide,BP,
4555,GO:0009637,1,0.987132385154387,0,2,response to blue light,BP,
4556,GO:0009642,1,0.931703423472883,0,11,response to light intensity,BP,
4557,GO:0009644,1,0.986657556870989,0,2,response to high light intensity,BP,
4558,GO:0009645,1,0.993735071616435,0,1,response to low light intensity stimulus,BP,
4559,GO:0009646,1,0.993874503447871,0,1,response to absence of light,BP,
4560,GO:0009648,1,0.855461999765422,0,24,photoperiodism,BP,
4561,GO:0009649,1,0.845449335272762,0,26,entrainment of circadian clock,BP,
4562,GO:0009650,1,0.924421548778142,0,13,UV protection,BP,
4563,GO:0009651,1,0.882093813599871,0,20,response to salt stress,BP,
4565,GO:0009669,1,0.982140527221787,0,3,sucrose:cation symporter activity,MF,
4566,GO:0009673,1,0.993595634721041,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4567,GO:0009674,1,0.983385076020577,0,2,potassium:sodium symporter activity,MF,
4568,GO:0009692,1,0.994268552029504,0,1,ethylene metabolic process,BP,
4569,GO:0009698,1,0.967381988006463,0,6,phenylpropanoid metabolic process,BP,
4573,GO:0009720,1,0.994073606605985,0,1,detection of hormone stimulus,BP,
4575,GO:0009726,1,0.975335085923925,0,3,detection of endogenous stimulus,BP,
4576,GO:0009730,1,0.977734310503826,0,4,detection of carbohydrate stimulus,BP,
4577,GO:0009732,1,0.977734310503826,0,4,detection of hexose stimulus,BP,
4578,GO:0009737,1,0.993007983950641,0,1,response to abscisic acid,BP,
4579,GO:0009738,1,0.993007983950641,0,1,abscisic acid-activated signaling pathway,BP,
4581,GO:0009744,1,0.973750641835583,0,4,response to sucrose,BP,
4584,GO:0009750,1,0.95125527332201,0,8,response to fructose,BP,
4585,GO:0009753,1,0.978577477300448,0,4,response to jasmonic acid,BP,
4586,GO:0009755,1,0.254995595100586,0,198,hormone-mediated signaling pathway,BP,
4587,GO:0009756,1,0.958801086226989,0,7,carbohydrate mediated signaling,BP,
4588,GO:0009757,1,0.970099229084522,0,5,hexose mediated signaling,BP,
4589,GO:0009758,1,0.988950931178037,0,1,carbohydrate utilization,BP,
4590,GO:0009785,1,0.987132385154387,0,2,blue light signaling pathway,BP,
4591,GO:0009786,1,0.967340913060374,0,4,regulation of asymmetric cell division,BP,
4592,GO:0009787,1,0.993007983950641,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4593,GO:0009789,1,0.993007983950641,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4595,GO:0009791,1,0.520051110423906,0,84,post-embryonic development,BP,
4597,GO:0009794,1,0.976249278016842,0,4,regulation of mitotic cell cycle, embryonic,BP,
4598,GO:0009798,1,0.575313890556253,0,80,axis specification,BP,
4599,GO:0009799,1,0.449500164968783,0,117,specification of symmetry,BP,
4600,GO:0009804,1,0.967381988006463,0,6,coumarin metabolic process,BP,
4601,GO:0009810,1,0.994418807560719,0,1,stilbene metabolic process,BP,
4602,GO:0009812,1,0.964075480746348,0,6,flavonoid metabolic process,BP,
4603,GO:0009814,1,0.994420977895971,0,1,defense response, incompatible interaction,BP,
4604,GO:0009817,1,0.994420977895971,0,1,defense response to fungus, incompatible interaction,BP,
4605,GO:0009820,1,0.972714698247915,0,5,alkaloid metabolic process,BP,
4606,GO:0009822,1,0.989134818565555,0,2,alkaloid catabolic process,BP,
4607,GO:0009826,1,0.985509227662763,0,2,unidimensional cell growth,BP,
4608,GO:0009838,1,0.972440754898532,0,5,abscission,BP,
4609,GO:0009841,1,0.9943684107953,0,1,mitochondrial endopeptidase Clp complex,CC,
4610,GO:0009850,1,0.989165281136018,0,2,auxin metabolic process,BP,
4611,GO:0009852,1,0.989165281136018,0,2,auxin catabolic process,BP,
4612,GO:0009855,1,0.451993430641296,0,116,determination of bilateral symmetry,BP,
4613,GO:0009880,1,0.671135825418859,0,56,embryonic pattern specification,BP,
4614,GO:0009881,1,0.943768937975408,0,10,photoreceptor activity,MF,
4615,GO:0009882,1,0.987132385154387,0,2,blue light photoreceptor activity,MF,
4616,GO:0009886,1,0.9167666254672,0,11,post-embryonic animal morphogenesis,BP,
4626,GO:0009896,1,0.0769798713511816,0,365,positive regulation of catabolic process,BP,
4629,GO:0009912,1,0.96489979510642,0,5,auditory receptor cell fate commitment,BP,
4632,GO:0009918,1,0.994247512019971,0,1,sterol delta7 reductase activity,MF,
4633,GO:0009922,1,0.963818630025933,0,6,fatty acid elongase activity,MF,
4634,GO:0009925,1,0.775090635946857,0,33,basal plasma membrane,CC,
4635,GO:0009931,1,0.934946342130745,0,10,calcium-dependent protein serine/threonine kinase activity,MF,
4636,GO:0009946,1,0.983512173898757,0,3,proximal/distal axis specification,BP,
4637,GO:0009948,1,0.75184510463014,0,43,anterior/posterior axis specification,BP,
4638,GO:0009949,1,0.994566168695361,0,1,polarity specification of anterior/posterior axis,BP,
4639,GO:0009950,1,0.884769508491741,0,16,dorsal/ventral axis specification,BP,
4642,GO:0009954,1,0.813640317952947,0,32,proximal/distal pattern formation,BP,
4643,GO:0009955,1,0.994420049489966,0,1,adaxial/abaxial pattern specification,BP,
4644,GO:0009956,1,0.993393611384894,0,1,radial pattern formation,BP,
4645,GO:0009957,1,0.977588371652936,0,3,epidermal cell fate specification,BP,
4649,GO:0009972,1,0.956042343188224,0,8,cytidine deamination,BP,
4650,GO:0009975,1,0.885639966817457,0,16,cyclase activity,MF,
4651,GO:0009982,1,0.927343079997096,0,13,pseudouridine synthase activity,MF,
4656,GO:0009992,1,0.994427555702255,0,1,cellular water homeostasis,BP,
4657,GO:0009994,1,0.755511301015325,0,43,oocyte differentiation,BP,
4658,GO:0009996,1,0.97176626738998,0,5,negative regulation of cell fate specification,BP,
4660,GO:0010002,1,0.896287086417455,0,16,cardioblast differentiation,BP,
4662,GO:0010009,1,0.971554425018602,0,5,cytoplasmic side of endosome membrane,CC,
4663,GO:0010015,1,0.994651281344248,0,1,root morphogenesis,BP,
4664,GO:0010021,1,0.993968507967003,0,1,amylopectin biosynthetic process,BP,
4665,GO:0010025,1,0.986644926129104,0,2,wax biosynthetic process,BP,
4666,GO:0010032,1,0.961535302885363,0,5,meiotic chromosome condensation,BP,
4668,GO:0010034,1,0.993694059159692,0,1,response to acetate,BP,
4670,GO:0010037,1,0.994006780387232,0,1,response to carbon dioxide,BP,
4672,GO:0010039,1,0.81458810832432,0,32,response to iron ion,BP,
4673,GO:0010040,1,0.976911917779092,0,4,response to iron(II) ion,BP,
4674,GO:0010041,1,0.967342537263803,0,5,response to iron(III) ion,BP,
4675,GO:0010042,1,0.896680033939879,0,16,response to manganese ion,BP,
4676,GO:0010043,1,0.74048851396732,0,49,response to zinc ion,BP,
4677,GO:0010044,1,0.971520626214841,0,5,response to aluminum ion,BP,
4678,GO:0010045,1,0.990015535362609,0,1,response to nickel cation,BP,
4679,GO:0010046,1,0.965087534037061,0,6,response to mycotoxin,BP,
4680,GO:0010053,1,0.994651281344248,0,1,root epidermal cell differentiation,BP,
4681,GO:0010054,1,0.994651281344248,0,1,trichoblast differentiation,BP,
4682,GO:0010070,1,0.994347897726635,0,1,zygote asymmetric cell division,BP,
4683,GO:0010085,1,0.994455211392974,0,1,polarity specification of proximal/distal axis,BP,
4684,GO:0010092,1,0.822712257665475,0,29,specification of animal organ identity,BP,
4685,GO:0010106,1,0.994490947237411,0,1,cellular response to iron ion starvation,BP,
4686,GO:0010107,1,0.768800447135568,0,39,potassium ion import,BP,
4687,GO:0010121,1,0.994481956762006,0,1,arginine catabolic process to proline via ornithine,BP,
4688,GO:0010124,1,0.989165281136018,0,2,phenylacetate catabolic process,BP,
4689,GO:0010133,1,0.988352636355852,0,2,proline catabolic process to glutamate,BP,
4690,GO:0010138,1,0.972738597418278,0,5,pyrimidine ribonucleotide salvage,BP,
4691,GO:0010139,1,0.994559033202051,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4692,GO:0010142,1,0.9881211871942,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4693,GO:0010155,1,0.914712138915927,0,15,regulation of proton transport,BP,
4694,GO:0010157,1,0.989784542454828,0,1,response to chlorate,BP,
4695,GO:0010159,1,0.98118929293212,0,3,specification of animal organ position,BP,
4696,GO:0010160,1,0.994636129384553,0,1,formation of animal organ boundary,BP,
4697,GO:0010164,1,0.994559033202051,0,1,response to cesium ion,BP,
4699,GO:0010166,1,0.986644926129104,0,2,wax metabolic process,BP,
4701,GO:0010172,1,0.916981063312684,0,11,embryonic body morphogenesis,BP,
4702,GO:0010181,1,0.931912866277087,0,11,FMN binding,MF,
4703,GO:0010182,1,0.970099229084522,0,5,sugar mediated signaling pathway,BP,
4704,GO:0010189,1,0.994547998557532,0,1,vitamin E biosynthetic process,BP,
4705,GO:0010193,1,0.97747938049269,0,4,response to ozone,BP,
4707,GO:0010216,1,0.965614605975964,0,5,maintenance of DNA methylation,BP,
4708,GO:0010224,1,0.901267194128407,0,17,response to UV-B,BP,
4709,GO:0010225,1,0.907388109032882,0,13,response to UV-C,BP,
4711,GO:0010232,1,0.993986671338394,0,1,vascular transport,BP,
4713,GO:0010248,1,0.929789151433526,0,12,establishment or maintenance of transmembrane electrochemical gradient,BP,
4714,GO:0010255,1,0.970099229084522,0,5,glucose mediated signaling pathway,BP,
4715,GO:0010256,1,0.0622081969875919,0,391,endomembrane system organization,BP,
4716,GO:0010257,1,0.73784205193256,0,55,NADH dehydrogenase complex assembly,BP,
4717,GO:0010259,1,0.828124347772638,0,25,multicellular organism aging,BP,
4718,GO:0010265,1,0.960910927167174,0,6,SCF complex assembly,BP,
4719,GO:0010266,1,0.978943914657496,0,3,response to vitamin B1,BP,
4720,GO:0010269,1,0.962573524523647,0,5,response to selenium ion,BP,
4721,GO:0010273,1,0.937642172011859,0,11,detoxification of copper ion,BP,
4722,GO:0010286,1,0.972583858733421,0,5,heat acclimation,BP,
4723,GO:0010288,1,0.8728824235703,0,21,response to lead ion,BP,
4724,GO:0010309,1,0.994548645624522,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4725,GO:0010310,1,0.920777811244597,0,14,regulation of hydrogen peroxide metabolic process,BP,
4726,GO:0010314,1,0.928831811338366,0,10,phosphatidylinositol-5-phosphate binding,MF,
4727,GO:0010324,1,0.67095280609707,0,61,membrane invagination,BP,
4729,GO:0010335,1,0.992880174643176,0,1,response to non-ionic osmotic stress,BP,
4730,GO:0010340,1,0.963009796808802,0,6,carboxyl-O-methyltransferase activity,MF,
4731,GO:0010348,1,0.994184768585909,0,1,lithium:proton antiporter activity,MF,
4732,GO:0010359,1,0.938018001022634,0,9,regulation of anion channel activity,BP,
4733,GO:0010360,1,0.981221781494255,0,3,negative regulation of anion channel activity,BP,
4734,GO:0010369,1,0.907475067406994,0,14,chromocenter,CC,
4735,GO:0010370,1,0.987967637621967,0,2,perinucleolar chromocenter,CC,
4736,GO:0010385,1,0.968444465706684,0,5,double-stranded methylated DNA binding,MF,
4737,GO:0010387,1,0.98860869189305,0,2,COP9 signalosome assembly,BP,
4738,GO:0010389,1,0.292344389585476,0,186,regulation of G2/M transition of mitotic cell cycle,BP,
4739,GO:0010390,1,0.830893256250407,0,27,histone monoubiquitination,BP,
4740,GO:0010412,1,0.993854124286646,0,1,mannan metabolic process,BP,
4741,GO:0010420,1,0.994609403508997,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4742,GO:0010421,1,0.9263628560725,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4743,GO:0010428,1,0.991561561061162,0,1,methyl-CpNpG binding,MF,
4744,GO:0010430,1,0.992686284442654,0,1,fatty acid omega-oxidation,BP,
4745,GO:0010446,1,0.987736227228855,0,2,response to alkaline pH,BP,
4746,GO:0010447,1,0.891169750504265,0,19,response to acidic pH,BP,
4747,GO:0010452,1,0.926061668230279,0,9,histone H3-K36 methylation,BP,
4748,GO:0010453,1,0.869030628317121,0,23,regulation of cell fate commitment,BP,
4749,GO:0010454,1,0.944768902987914,0,10,negative regulation of cell fate commitment,BP,
4750,GO:0010455,1,0.963912118034062,0,6,positive regulation of cell fate commitment,BP,
4751,GO:0010457,1,0.916429089565534,0,11,centriole-centriole cohesion,BP,
4752,GO:0010458,1,0.840208679515976,0,27,exit from mitosis,BP,
4753,GO:0010459,1,0.948996968723645,0,9,negative regulation of heart rate,BP,
4755,GO:0010463,1,0.728442820460469,0,46,mesenchymal cell proliferation,BP,
4756,GO:0010464,1,0.79306972635178,0,35,regulation of mesenchymal cell proliferation,BP,
4757,GO:0010465,1,0.984814888981353,0,2,nerve growth factor receptor activity,MF,
4763,GO:0010477,1,0.993905614853238,0,1,response to sulfur dioxide,BP,
4764,GO:0010481,1,0.987393875504957,0,2,epidermal cell division,BP,
4765,GO:0010482,1,0.987393875504957,0,2,regulation of epidermal cell division,BP,
4766,GO:0010484,1,0.967693770833248,0,4,H3 histone acetyltransferase activity,MF,
4767,GO:0010485,1,0.882267819314377,0,18,H4 histone acetyltransferase activity,MF,
4769,GO:0010496,1,0.994477020653939,0,1,intercellular transport,BP,
4770,GO:0010498,1,0.0564024507261249,0,436,proteasomal protein catabolic process,BP,
4771,GO:0010499,1,0.885183568041692,0,21,proteasomal ubiquitin-independent protein catabolic process,BP,
4772,GO:0010501,1,0.75955469321962,0,44,RNA secondary structure unwinding,BP,
4773,GO:0010506,1,0.138458744663026,0,292,regulation of autophagy,BP,
4774,GO:0010507,1,0.630864222328925,0,67,negative regulation of autophagy,BP,
4775,GO:0010508,1,0.500458980531009,0,97,positive regulation of autophagy,BP,
4776,GO:0010509,1,0.991908439698879,0,1,polyamine homeostasis,BP,
4777,GO:0010510,1,0.919609610104132,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4778,GO:0010511,1,0.959135390796621,0,7,regulation of phosphatidylinositol biosynthetic process,BP,
4779,GO:0010512,1,0.988359683480356,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4780,GO:0010513,1,0.970434933755895,0,5,positive regulation of phosphatidylinositol biosynthetic process,BP,
4782,GO:0010518,1,0.739145785654389,0,45,positive regulation of phospholipase activity,BP,
4784,GO:0010520,1,0.981906586816201,0,3,regulation of reciprocal meiotic recombination,BP,
4785,GO:0010521,1,0.982216783039017,0,3,telomerase inhibitor activity,MF,
4787,GO:0010523,1,0.899305409562191,0,17,negative regulation of calcium ion transport into cytosol,BP,
4789,GO:0010528,1,0.899114376771006,0,17,regulation of transposition,BP,
4790,GO:0010529,1,0.899114376771006,0,17,negative regulation of transposition,BP,
4791,GO:0010533,1,0.978212154392975,0,4,regulation of activation of Janus kinase activity,BP,
4792,GO:0010536,1,0.988944347191953,0,2,positive regulation of activation of Janus kinase activity,BP,
4794,GO:0010544,1,0.895154186720704,0,17,negative regulation of platelet activation,BP,
4798,GO:0010559,1,0.787198555454071,0,36,regulation of glycoprotein biosynthetic process,BP,
4799,GO:0010560,1,0.877303186973241,0,19,positive regulation of glycoprotein biosynthetic process,BP,
4800,GO:0010561,1,0.939692813921743,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4805,GO:0010566,1,0.922221216177772,0,13,regulation of ketone biosynthetic process,BP,
4806,GO:0010569,1,0.827142619555608,0,27,regulation of double-strand break repair via homologous recombination,BP,
4807,GO:0010571,1,0.952199903790318,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4809,GO:0010573,1,0.809860974621279,0,31,vascular endothelial growth factor production,BP,
4810,GO:0010574,1,0.816717195697382,0,30,regulation of vascular endothelial growth factor production,BP,
4811,GO:0010575,1,0.839561989024269,0,25,positive regulation of vascular endothelial growth factor production,BP,
4812,GO:0010578,1,0.994288575408358,0,1,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4813,GO:0010585,1,0.99449550146966,0,1,glutamine secretion,BP,
4814,GO:0010586,1,0.863992916593994,0,22,miRNA metabolic process,BP,
4815,GO:0010587,1,0.964762293326546,0,5,miRNA catabolic process,BP,
4816,GO:0010591,1,0.828373578958533,0,27,regulation of lamellipodium assembly,BP,
4817,GO:0010592,1,0.897817286283119,0,15,positive regulation of lamellipodium assembly,BP,
4818,GO:0010593,1,0.983662488580859,0,2,negative regulation of lamellipodium assembly,BP,
4821,GO:0010596,1,0.746019484107596,0,42,negative regulation of endothelial cell migration,BP,
4822,GO:0010603,1,0.938991069718142,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4825,GO:0010606,1,0.957411799253573,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4826,GO:0010607,1,0.994487291347339,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4828,GO:0010609,1,0.988608482724986,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4829,GO:0010611,1,0.727831817965668,0,44,regulation of cardiac muscle hypertrophy,BP,
4830,GO:0010612,1,0.94231159957524,0,8,regulation of cardiac muscle adaptation,BP,
4831,GO:0010613,1,0.830352472135123,0,26,positive regulation of cardiac muscle hypertrophy,BP,
4832,GO:0010614,1,0.894799150709645,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4833,GO:0010615,1,0.986546338192883,0,2,positive regulation of cardiac muscle adaptation,BP,
4834,GO:0010616,1,0.955167958984734,0,6,negative regulation of cardiac muscle adaptation,BP,
4835,GO:0010621,1,0.983490842261851,0,3,negative regulation of transcription by transcription factor localization,BP,
4836,GO:0010623,1,0.92027995104446,0,12,programmed cell death involved in cell development,BP,
4837,GO:0010624,1,0.95631254365624,0,6,regulation of Schwann cell proliferation,BP,
4838,GO:0010625,1,0.994333581017709,0,1,positive regulation of Schwann cell proliferation,BP,
4839,GO:0010626,1,0.961764422806282,0,5,negative regulation of Schwann cell proliferation,BP,
4844,GO:0010633,1,0.673978121670866,0,57,negative regulation of epithelial cell migration,BP,
4846,GO:0010635,1,0.951116063753866,0,8,regulation of mitochondrial fusion,BP,
4847,GO:0010636,1,0.985448153056383,0,2,positive regulation of mitochondrial fusion,BP,
4848,GO:0010637,1,0.970778844044185,0,5,negative regulation of mitochondrial fusion,BP,
4850,GO:0010639,1,0.103627042742357,0,327,negative regulation of organelle organization,BP,
4851,GO:0010640,1,0.854174848534002,0,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4852,GO:0010641,1,0.965305938632156,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4853,GO:0010642,1,0.890893635665373,0,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4854,GO:0010643,1,0.988081309049387,0,2,cell communication by chemical coupling,BP,
4855,GO:0010644,1,0.812801519731393,0,27,cell communication by electrical coupling,BP,
4856,GO:0010645,1,0.993986671338394,0,1,regulation of cell communication by chemical coupling,BP,
4860,GO:0010649,1,0.917607488248577,0,12,regulation of cell communication by electrical coupling,BP,
4861,GO:0010650,1,0.980898540142139,0,2,positive regulation of cell communication by electrical coupling,BP,
4862,GO:0010652,1,0.993986671338394,0,1,positive regulation of cell communication by chemical coupling,BP,
4863,GO:0010656,1,0.810750206071834,0,32,negative regulation of muscle cell apoptotic process,BP,
4864,GO:0010657,1,0.696624208427713,0,55,muscle cell apoptotic process,BP,
4865,GO:0010658,1,0.810425227737489,0,32,striated muscle cell apoptotic process,BP,
4866,GO:0010659,1,0.820607994555432,0,30,cardiac muscle cell apoptotic process,BP,
4867,GO:0010660,1,0.711808531894681,0,52,regulation of muscle cell apoptotic process,BP,
4868,GO:0010661,1,0.882618399468358,0,19,positive regulation of muscle cell apoptotic process,BP,
4869,GO:0010662,1,0.823202200555018,0,30,regulation of striated muscle cell apoptotic process,BP,
4870,GO:0010663,1,0.941378950492156,0,9,positive regulation of striated muscle cell apoptotic process,BP,
4871,GO:0010664,1,0.86828594468634,0,22,negative regulation of striated muscle cell apoptotic process,BP,
4872,GO:0010665,1,0.833543879212978,0,28,regulation of cardiac muscle cell apoptotic process,BP,
4873,GO:0010666,1,0.941378950492156,0,9,positive regulation of cardiac muscle cell apoptotic process,BP,
4874,GO:0010667,1,0.885514976385244,0,19,negative regulation of cardiac muscle cell apoptotic process,BP,
4875,GO:0010668,1,0.959942599519945,0,6,ectodermal cell differentiation,BP,
4877,GO:0010675,1,0.482970975255032,0,104,regulation of cellular carbohydrate metabolic process,BP,
4878,GO:0010676,1,0.727017295699442,0,44,positive regulation of cellular carbohydrate metabolic process,BP,
4879,GO:0010677,1,0.821315823232117,0,29,negative regulation of cellular carbohydrate metabolic process,BP,
4880,GO:0010692,1,0.929038512251525,0,9,regulation of alkaline phosphatase activity,BP,
4881,GO:0010693,1,0.97976629217412,0,3,negative regulation of alkaline phosphatase activity,BP,
4882,GO:0010694,1,0.948234908266897,0,6,positive regulation of alkaline phosphatase activity,BP,
4883,GO:0010698,1,0.988338981377175,0,2,acetyltransferase activator activity,MF,
4884,GO:0010700,1,0.971438967852692,0,5,negative regulation of norepinephrine secretion,BP,
4886,GO:0010705,1,0.987037493503188,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4887,GO:0010710,1,0.982445782868318,0,3,regulation of collagen catabolic process,BP,
4888,GO:0010711,1,0.99465157871212,0,1,negative regulation of collagen catabolic process,BP,
4890,GO:0010713,1,0.954140199157732,0,8,negative regulation of collagen metabolic process,BP,
4893,GO:0010716,1,0.976838075997421,0,4,negative regulation of extracellular matrix disassembly,BP,
4896,GO:0010719,1,0.860886803151298,0,25,negative regulation of epithelial to mesenchymal transition,BP,
4899,GO:0010722,1,0.990386535669663,0,1,regulation of ferrochelatase activity,BP,
4900,GO:0010724,1,0.975557234336069,0,4,regulation of definitive erythrocyte differentiation,BP,
4901,GO:0010725,1,0.988430716942467,0,2,regulation of primitive erythrocyte differentiation,BP,
4902,GO:0010726,1,0.988462881934942,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4903,GO:0010727,1,0.957719144546699,0,7,negative regulation of hydrogen peroxide metabolic process,BP,
4904,GO:0010728,1,0.974663332637519,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4905,GO:0010729,1,0.99447081549268,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4906,GO:0010730,1,0.980083482873139,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4907,GO:0010731,1,0.989068248307261,0,2,protein glutathionylation,BP,
4908,GO:0010732,1,0.989068248307261,0,2,regulation of protein glutathionylation,BP,
4909,GO:0010734,1,0.989068248307261,0,2,negative regulation of protein glutathionylation,BP,
4910,GO:0010735,1,0.974048932210083,0,4,positive regulation of transcription via serum response element binding,BP,
4911,GO:0010736,1,0.987574931999058,0,2,serum response element binding,MF,
4914,GO:0010739,1,0.961335675272882,0,6,positive regulation of protein kinase A signaling,BP,
4918,GO:0010745,1,0.917404592116988,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4919,GO:0010746,1,0.968864127599536,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4920,GO:0010748,1,0.968864127599536,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4921,GO:0010749,1,0.962961284911927,0,5,regulation of nitric oxide mediated signal transduction,BP,
4922,GO:0010750,1,0.98723463372028,0,2,positive regulation of nitric oxide mediated signal transduction,BP,
4923,GO:0010751,1,0.97541590430538,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4924,GO:0010752,1,0.984722521810175,0,2,regulation of cGMP-mediated signaling,BP,
4925,GO:0010754,1,0.991652319730146,0,1,negative regulation of cGMP-mediated signaling,BP,
4927,GO:0010756,1,0.972572447346165,0,5,positive regulation of plasminogen activation,BP,
4929,GO:0010758,1,0.892776233392175,0,18,regulation of macrophage chemotaxis,BP,
4930,GO:0010759,1,0.939264608859822,0,10,positive regulation of macrophage chemotaxis,BP,
4931,GO:0010760,1,0.969132361772815,0,5,negative regulation of macrophage chemotaxis,BP,
4932,GO:0010761,1,0.767671310665707,0,38,fibroblast migration,BP,
4933,GO:0010762,1,0.834578759560301,0,28,regulation of fibroblast migration,BP,
4934,GO:0010763,1,0.928655685784693,0,11,positive regulation of fibroblast migration,BP,
4935,GO:0010764,1,0.951663828144834,0,8,negative regulation of fibroblast migration,BP,
4936,GO:0010765,1,0.808739811322752,0,30,positive regulation of sodium ion transport,BP,
4937,GO:0010766,1,0.902068829412227,0,14,negative regulation of sodium ion transport,BP,
4938,GO:0010767,1,0.97543757760457,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4939,GO:0010768,1,0.981095909349767,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4943,GO:0010789,1,0.994184768585909,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4944,GO:0010792,1,0.970766385168627,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4945,GO:0010793,1,0.963704179768647,0,5,regulation of mRNA export from nucleus,BP,
4946,GO:0010795,1,0.994609403508997,0,1,regulation of ubiquinone biosynthetic process,BP,
4947,GO:0010796,1,0.983586925880858,0,3,regulation of multivesicular body size,BP,
4948,GO:0010797,1,0.994615265897457,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4951,GO:0010801,1,0.91295926125086,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
4952,GO:0010803,1,0.718031323068562,0,54,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4953,GO:0010804,1,0.906844584825303,0,17,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4954,GO:0010807,1,0.960358457060432,0,6,regulation of synaptic vesicle priming,BP,
4955,GO:0010808,1,0.991091717391996,0,1,positive regulation of synaptic vesicle priming,BP,
4959,GO:0010813,1,0.986916292131352,0,2,neuropeptide catabolic process,BP,
4960,GO:0010814,1,0.992293119671063,0,1,substance P catabolic process,BP,
4961,GO:0010815,1,0.973679901430386,0,4,bradykinin catabolic process,BP,
4962,GO:0010816,1,0.992293119671063,0,1,calcitonin catabolic process,BP,
4966,GO:0010820,1,0.94680231793365,0,9,positive regulation of T cell chemotaxis,BP,
4967,GO:0010821,1,0.256064387419777,0,209,regulation of mitochondrion organization,BP,
4968,GO:0010822,1,0.360983861106873,0,156,positive regulation of mitochondrion organization,BP,
4969,GO:0010823,1,0.748841419494557,0,45,negative regulation of mitochondrion organization,BP,
4970,GO:0010824,1,0.766520363314166,0,39,regulation of centrosome duplication,BP,
4971,GO:0010825,1,0.960004887208013,0,6,positive regulation of centrosome duplication,BP,
4972,GO:0010826,1,0.920492876227226,0,12,negative regulation of centrosome duplication,BP,
4973,GO:0010827,1,0.628932540824759,0,66,regulation of glucose transmembrane transport,BP,
4974,GO:0010828,1,0.749284324774768,0,39,positive regulation of glucose transmembrane transport,BP,
4975,GO:0010829,1,0.903816729553185,0,16,negative regulation of glucose transmembrane transport,BP,
4979,GO:0010833,1,0.60324853423143,0,75,telomere maintenance via telomere lengthening,BP,
4980,GO:0010835,1,0.963580568698082,0,6,regulation of protein ADP-ribosylation,BP,
4981,GO:0010836,1,0.983549449053476,0,3,negative regulation of protein ADP-ribosylation,BP,
4982,GO:0010837,1,0.834577755189925,0,25,regulation of keratinocyte proliferation,BP,
4983,GO:0010838,1,0.954250129066261,0,7,positive regulation of keratinocyte proliferation,BP,
4984,GO:0010839,1,0.916973899945925,0,11,negative regulation of keratinocyte proliferation,BP,
4985,GO:0010840,1,0.981827603496385,0,3,regulation of circadian sleep/wake cycle, wakefulness,BP,
4986,GO:0010841,1,0.981827603496385,0,3,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4987,GO:0010842,1,0.85862993397786,0,19,retina layer formation,BP,
4988,GO:0010845,1,0.987866915731331,0,2,positive regulation of reciprocal meiotic recombination,BP,
4989,GO:0010847,1,0.968459475273169,0,4,regulation of chromatin assembly,BP,
4990,GO:0010848,1,0.986919257515287,0,2,regulation of chromatin disassembly,BP,
4991,GO:0010849,1,0.994422519463272,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4992,GO:0010851,1,0.971503615976944,0,5,cyclase regulator activity,MF,
4993,GO:0010853,1,0.978209141220823,0,4,cyclase activator activity,MF,
4994,GO:0010854,1,0.993146606215443,0,1,adenylate cyclase regulator activity,MF,
4995,GO:0010855,1,0.993146606215443,0,1,adenylate cyclase inhibitor activity,MF,
4996,GO:0010856,1,0.993880080266148,0,1,adenylate cyclase activator activity,MF,
4997,GO:0010857,1,0.929561652190492,0,11,calcium-dependent protein kinase activity,MF,
4998,GO:0010858,1,0.983696784104718,0,3,calcium-dependent protein kinase regulator activity,MF,
4999,GO:0010859,1,0.992987406907347,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5001,GO:0010863,1,0.808921138498705,0,31,positive regulation of phospholipase C activity,BP,
5002,GO:0010866,1,0.910828378475316,0,15,regulation of triglyceride biosynthetic process,BP,
5003,GO:0010867,1,0.93572508568317,0,11,positive regulation of triglyceride biosynthetic process,BP,
5004,GO:0010868,1,0.986265735800942,0,2,negative regulation of triglyceride biosynthetic process,BP,
5005,GO:0010869,1,0.880210263596342,0,18,regulation of receptor biosynthetic process,BP,
5006,GO:0010870,1,0.938967723490575,0,10,positive regulation of receptor biosynthetic process,BP,
5007,GO:0010871,1,0.960316947934916,0,5,negative regulation of receptor biosynthetic process,BP,
5008,GO:0010872,1,0.95610757731067,0,8,regulation of cholesterol esterification,BP,
5009,GO:0010873,1,0.96743758885536,0,6,positive regulation of cholesterol esterification,BP,
5010,GO:0010874,1,0.872874078199592,0,18,regulation of cholesterol efflux,BP,
5011,GO:0010875,1,0.900619785073363,0,13,positive regulation of cholesterol efflux,BP,
5013,GO:0010877,1,0.989049533789802,0,2,lipid transport involved in lipid storage,BP,
5014,GO:0010878,1,0.894018128159909,0,15,cholesterol storage,BP,
5015,GO:0010879,1,0.99440059907078,0,1,cholesterol transport involved in cholesterol storage,BP,
5016,GO:0010880,1,0.819911708324713,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5017,GO:0010881,1,0.870412892947283,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5018,GO:0010882,1,0.836200762866376,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5019,GO:0010883,1,0.757750560256086,0,40,regulation of lipid storage,BP,
5020,GO:0010884,1,0.8726857171605,0,20,positive regulation of lipid storage,BP,
5021,GO:0010885,1,0.904675972745824,0,13,regulation of cholesterol storage,BP,
5022,GO:0010886,1,0.948422015318614,0,7,positive regulation of cholesterol storage,BP,
5023,GO:0010887,1,0.953898748311864,0,6,negative regulation of cholesterol storage,BP,
5024,GO:0010888,1,0.890939532030754,0,16,negative regulation of lipid storage,BP,
5025,GO:0010889,1,0.921366269761715,0,12,regulation of sequestering of triglyceride,BP,
5026,GO:0010890,1,0.959868781635662,0,7,positive regulation of sequestering of triglyceride,BP,
5027,GO:0010891,1,0.959903825072829,0,5,negative regulation of sequestering of triglyceride,BP,
5028,GO:0010893,1,0.920199802999758,0,13,positive regulation of steroid biosynthetic process,BP,
5029,GO:0010894,1,0.87804088907481,0,22,negative regulation of steroid biosynthetic process,BP,
5030,GO:0010896,1,0.957411563428229,0,7,regulation of triglyceride catabolic process,BP,
5031,GO:0010897,1,0.980908346725818,0,3,negative regulation of triglyceride catabolic process,BP,
5032,GO:0010898,1,0.976050456387145,0,4,positive regulation of triglyceride catabolic process,BP,
5033,GO:0010899,1,0.98117307732059,0,3,regulation of phosphatidylcholine catabolic process,BP,
5034,GO:0010900,1,0.994666389148399,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5035,GO:0010901,1,0.989326588868623,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5036,GO:0010902,1,0.994654652928796,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5037,GO:0010903,1,0.994643589263539,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5038,GO:0010904,1,0.994425885609532,0,1,regulation of UDP-glucose catabolic process,BP,
5039,GO:0010905,1,0.994425885609532,0,1,negative regulation of UDP-glucose catabolic process,BP,
5040,GO:0010906,1,0.559249357326902,0,81,regulation of glucose metabolic process,BP,
5041,GO:0010907,1,0.809042881583835,0,28,positive regulation of glucose metabolic process,BP,
5042,GO:0010908,1,0.981411045074174,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5043,GO:0010909,1,0.981411045074174,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5044,GO:0010911,1,0.951717286162462,0,7,regulation of isomerase activity,BP,
5045,GO:0010912,1,0.951717286162462,0,7,positive regulation of isomerase activity,BP,
5046,GO:0010915,1,0.983972900428598,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5047,GO:0010916,1,0.983972900428598,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5048,GO:0010917,1,0.953209186479534,0,8,negative regulation of mitochondrial membrane potential,BP,
5049,GO:0010918,1,0.952108845651718,0,8,positive regulation of mitochondrial membrane potential,BP,
5050,GO:0010919,1,0.929027465205361,0,12,regulation of inositol phosphate biosynthetic process,BP,
5051,GO:0010920,1,0.994147645173646,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5053,GO:0010922,1,0.808233733927916,0,28,positive regulation of phosphatase activity,BP,
5055,GO:0010924,1,0.994147645173646,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5056,GO:0010925,1,0.994147645173646,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5057,GO:0010927,1,0.476780955101618,0,95,cellular component assembly involved in morphogenesis,BP,
5058,GO:0010931,1,0.989414988668542,0,1,macrophage tolerance induction,BP,
5059,GO:0010932,1,0.989414988668542,0,1,regulation of macrophage tolerance induction,BP,
5060,GO:0010933,1,0.989414988668542,0,1,positive regulation of macrophage tolerance induction,BP,
5061,GO:0010934,1,0.911223408856026,0,14,macrophage cytokine production,BP,
5062,GO:0010935,1,0.922487479752514,0,12,regulation of macrophage cytokine production,BP,
5063,GO:0010936,1,0.965113045303307,0,5,negative regulation of macrophage cytokine production,BP,
5064,GO:0010938,1,0.99360199092993,0,1,cytoplasmic microtubule depolymerization,BP,
5065,GO:0010939,1,0.855349409288758,0,27,regulation of necrotic cell death,BP,
5066,GO:0010940,1,0.966882219007932,0,6,positive regulation of necrotic cell death,BP,
5069,GO:0010944,1,0.948950910800473,0,8,negative regulation of transcription by competitive promoter binding,BP,
5070,GO:0010948,1,0.136842899013845,0,304,negative regulation of cell cycle process,BP,
5071,GO:0010949,1,0.994239849298598,0,1,negative regulation of intestinal phytosterol absorption,BP,
5075,GO:0010954,1,0.887593326892794,0,18,positive regulation of protein processing,BP,
5077,GO:0010956,1,0.981884287081557,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5078,GO:0010957,1,0.971108968500934,0,5,negative regulation of vitamin D biosynthetic process,BP,
5079,GO:0010958,1,0.960637548992407,0,6,regulation of amino acid import across plasma membrane,BP,
5081,GO:0010960,1,0.921812700421936,0,10,magnesium ion homeostasis,BP,
5082,GO:0010961,1,0.969800112329257,0,4,cellular magnesium ion homeostasis,BP,
5083,GO:0010962,1,0.832744689708216,0,23,regulation of glucan biosynthetic process,BP,
5084,GO:0010963,1,0.988897780454473,0,2,regulation of L-arginine import,BP,
5085,GO:0010965,1,0.699698087529087,0,52,regulation of mitotic sister chromatid separation,BP,
5086,GO:0010966,1,0.969601148417359,0,4,regulation of phosphate transport,BP,
5087,GO:0010967,1,0.994544350632709,0,1,regulation of polyamine biosynthetic process,BP,
5088,GO:0010968,1,0.962830542908146,0,6,regulation of microtubule nucleation,BP,
5089,GO:0010970,1,0.376066061742937,0,137,transport along microtubule,BP,
5090,GO:0010971,1,0.873069058335484,0,21,positive regulation of G2/M transition of mitotic cell cycle,BP,
5091,GO:0010972,1,0.592861458222843,0,86,negative regulation of G2/M transition of mitotic cell cycle,BP,
5095,GO:0010979,1,0.987038013093913,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5096,GO:0010980,1,0.987038013093913,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5097,GO:0010982,1,0.987624531757443,0,2,regulation of high-density lipoprotein particle clearance,BP,
5098,GO:0010983,1,0.987624531757443,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5100,GO:0010985,1,0.958976943994207,0,7,negative regulation of lipoprotein particle clearance,BP,
5103,GO:0010989,1,0.974600960580407,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5104,GO:0010990,1,0.959304599102764,0,6,regulation of SMAD protein complex assembly,BP,
5105,GO:0010991,1,0.965761153992831,0,5,negative regulation of SMAD protein complex assembly,BP,
5106,GO:0010992,1,0.955227906455235,0,7,ubiquitin recycling,BP,
5107,GO:0010994,1,0.97004166374212,0,5,free ubiquitin chain polymerization,BP,
5109,GO:0010997,1,0.968011620329764,0,5,anaphase-promoting complex binding,MF,
5110,GO:0010998,1,0.934754107529698,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5111,GO:0010999,1,0.992903257645364,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5116,GO:0012510,1,0.911729617936591,0,14,trans-Golgi network transport vesicle membrane,CC,
5118,GO:0014003,1,0.788008356054646,0,38,oligodendrocyte development,BP,
5119,GO:0014004,1,0.981583813129763,0,3,microglia differentiation,BP,
5120,GO:0014005,1,0.981583813129763,0,3,microglia development,BP,
5121,GO:0014009,1,0.783534812201503,0,34,glial cell proliferation,BP,
5122,GO:0014010,1,0.948193133818713,0,7,Schwann cell proliferation,BP,
5123,GO:0014011,1,0.994184768585909,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5124,GO:0014012,1,0.968473476898773,0,5,peripheral nervous system axon regeneration,BP,
5125,GO:0014013,1,0.515584663410533,0,98,regulation of gliogenesis,BP,
5126,GO:0014014,1,0.783826309046587,0,36,negative regulation of gliogenesis,BP,
5127,GO:0014015,1,0.697871697257897,0,54,positive regulation of gliogenesis,BP,
5128,GO:0014016,1,0.983064580887315,0,3,neuroblast differentiation,BP,
5129,GO:0014017,1,0.994325157917915,0,1,neuroblast fate commitment,BP,
5131,GO:0014022,1,0.980367653858857,0,3,neural plate elongation,BP,
5132,GO:0014028,1,0.98641843164948,0,2,notochord formation,BP,
5133,GO:0014029,1,0.927321744105436,0,11,neural crest formation,BP,
5134,GO:0014031,1,0.612811985735001,0,72,mesenchymal cell development,BP,
5135,GO:0014032,1,0.632034129492859,0,68,neural crest cell development,BP,
5136,GO:0014033,1,0.597493325443731,0,75,neural crest cell differentiation,BP,
5137,GO:0014034,1,0.981029729512898,0,3,neural crest cell fate commitment,BP,
5138,GO:0014036,1,0.98803660631339,0,2,neural crest cell fate specification,BP,
5139,GO:0014037,1,0.751214139588283,0,36,Schwann cell differentiation,BP,
5140,GO:0014038,1,0.976657735760792,0,3,regulation of Schwann cell differentiation,BP,
5141,GO:0014040,1,0.982025811056387,0,2,positive regulation of Schwann cell differentiation,BP,
5142,GO:0014041,1,0.932216915819984,0,9,regulation of neuron maturation,BP,
5143,GO:0014042,1,0.966441312203277,0,4,positive regulation of neuron maturation,BP,
5144,GO:0014043,1,0.981067428906541,0,3,negative regulation of neuron maturation,BP,
5145,GO:0014044,1,0.793437387326227,0,28,Schwann cell development,BP,
5146,GO:0014045,1,0.97591237218193,0,4,establishment of endothelial blood-brain barrier,BP,
5147,GO:0014046,1,0.868675809557836,0,22,dopamine secretion,BP,
5148,GO:0014047,1,0.752757738781552,0,41,glutamate secretion,BP,
5149,GO:0014048,1,0.916270770847499,0,14,regulation of glutamate secretion,BP,
5150,GO:0014049,1,0.949515543914112,0,8,positive regulation of glutamate secretion,BP,
5151,GO:0014050,1,0.970872240437216,0,5,negative regulation of glutamate secretion,BP,
5152,GO:0014051,1,0.932873555721222,0,9,gamma-aminobutyric acid secretion,BP,
5153,GO:0014052,1,0.960629686024904,0,6,regulation of gamma-aminobutyric acid secretion,BP,
5154,GO:0014053,1,0.992492201901996,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5155,GO:0014054,1,0.974771257819828,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5156,GO:0014055,1,0.982971841139556,0,3,acetylcholine secretion, neurotransmission,BP,
5157,GO:0014056,1,0.982971841139556,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5158,GO:0014057,1,0.988668059848001,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5159,GO:0014059,1,0.868675809557836,0,22,regulation of dopamine secretion,BP,
5160,GO:0014060,1,0.977363262012479,0,4,regulation of epinephrine secretion,BP,
5162,GO:0014062,1,0.960022790410962,0,7,regulation of serotonin secretion,BP,
5163,GO:0014063,1,0.977461629867923,0,4,negative regulation of serotonin secretion,BP,
5164,GO:0014064,1,0.99284021766627,0,1,positive regulation of serotonin secretion,BP,
5165,GO:0014065,1,0.441025127307103,0,116,phosphatidylinositol 3-kinase signaling,BP,
5166,GO:0014066,1,0.544006192567562,0,88,regulation of phosphatidylinositol 3-kinase signaling,BP,
5167,GO:0014067,1,0.935944075872874,0,10,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5168,GO:0014068,1,0.656030334078501,0,60,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5175,GO:0014704,1,0.70569694357258,0,47,intercalated disc,CC,
5176,GO:0014705,1,0.993105680644238,0,1,C zone,CC,
5177,GO:0014706,1,0.0936750258010885,0,329,striated muscle tissue development,BP,
5178,GO:0014707,1,0.988854873263566,0,2,branchiomeric skeletal muscle development,BP,
5179,GO:0014717,1,0.98853396485909,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5180,GO:0014718,1,0.98853396485909,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5181,GO:0014719,1,0.966109772428695,0,5,skeletal muscle satellite cell activation,BP,
5182,GO:0014721,1,0.965485763457749,0,5,twitch skeletal muscle contraction,BP,
5183,GO:0014722,1,0.962864712211475,0,6,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5184,GO:0014724,1,0.985161566981485,0,2,regulation of twitch skeletal muscle contraction,BP,
5185,GO:0014728,1,0.991408937314801,0,1,regulation of the force of skeletal muscle contraction,BP,
5186,GO:0014731,1,0.932450396433401,0,7,spectrin-associated cytoskeleton,CC,
5187,GO:0014732,1,0.956361226972142,0,7,skeletal muscle atrophy,BP,
5188,GO:0014733,1,0.926233627154049,0,10,regulation of skeletal muscle adaptation,BP,
5189,GO:0014734,1,0.974868205826713,0,3,skeletal muscle hypertrophy,BP,
5190,GO:0014735,1,0.978229834798857,0,3,regulation of muscle atrophy,BP,
5191,GO:0014736,1,0.983605093368501,0,2,negative regulation of muscle atrophy,BP,
5192,GO:0014737,1,0.994536046457936,0,1,positive regulation of muscle atrophy,BP,
5193,GO:0014738,1,0.983186955259169,0,3,regulation of muscle hyperplasia,BP,
5194,GO:0014739,1,0.99465882170133,0,1,positive regulation of muscle hyperplasia,BP,
5195,GO:0014740,1,0.988467146042505,0,2,negative regulation of muscle hyperplasia,BP,
5196,GO:0014741,1,0.881779485788466,0,18,negative regulation of muscle hypertrophy,BP,
5197,GO:0014742,1,0.830352472135123,0,26,positive regulation of muscle hypertrophy,BP,
5198,GO:0014743,1,0.717219870576771,0,46,regulation of muscle hypertrophy,BP,
5199,GO:0014744,1,0.965128097298178,0,5,positive regulation of muscle adaptation,BP,
5200,GO:0014745,1,0.920524271880729,0,11,negative regulation of muscle adaptation,BP,
5201,GO:0014802,1,0.967540342471032,0,4,terminal cisterna,CC,
5202,GO:0014804,1,0.994487045706162,0,1,terminal cisterna lumen,CC,
5203,GO:0014805,1,0.978309956850216,0,4,smooth muscle adaptation,BP,
5204,GO:0014806,1,0.988929295109293,0,2,smooth muscle hyperplasia,BP,
5205,GO:0014807,1,0.955131169887501,0,7,regulation of somitogenesis,BP,
5206,GO:0014808,1,0.797028812063052,0,28,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5207,GO:0014809,1,0.968541352376711,0,5,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5208,GO:0014810,1,0.994651041855128,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5210,GO:0014813,1,0.994401581537699,0,1,skeletal muscle satellite cell commitment,BP,
5211,GO:0014816,1,0.947408882918736,0,7,skeletal muscle satellite cell differentiation,BP,
5212,GO:0014819,1,0.92867705413616,0,11,regulation of skeletal muscle contraction,BP,
5213,GO:0014820,1,0.945214540310964,0,9,tonic smooth muscle contraction,BP,
5214,GO:0014821,1,0.898787038864124,0,18,phasic smooth muscle contraction,BP,
5215,GO:0014822,1,0.994290705332452,0,1,detection of wounding,BP,
5217,GO:0014824,1,0.959890888973764,0,7,artery smooth muscle contraction,BP,
5218,GO:0014825,1,0.994649074016324,0,1,stomach fundus smooth muscle contraction,BP,
5219,GO:0014826,1,0.976613320833429,0,4,vein smooth muscle contraction,BP,
5220,GO:0014827,1,0.964815787445956,0,6,intestine smooth muscle contraction,BP,
5221,GO:0014828,1,0.99224214601651,0,1,distal stomach smooth muscle contraction,BP,
5222,GO:0014829,1,0.878835822016322,0,19,vascular smooth muscle contraction,BP,
5223,GO:0014831,1,0.933318204268259,0,11,gastro-intestinal system smooth muscle contraction,BP,
5224,GO:0014832,1,0.956200858405771,0,7,urinary bladder smooth muscle contraction,BP,
5225,GO:0014834,1,0.972820758466538,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5226,GO:0014835,1,0.987477640615099,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5228,GO:0014841,1,0.913717372461069,0,13,skeletal muscle satellite cell proliferation,BP,
5229,GO:0014842,1,0.923046471345825,0,12,regulation of skeletal muscle satellite cell proliferation,BP,
5230,GO:0014843,1,0.99074973177919,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5231,GO:0014846,1,0.984963203122639,0,2,esophagus smooth muscle contraction,BP,
5232,GO:0014847,1,0.994649074016324,0,1,proximal stomach smooth muscle contraction,BP,
5233,GO:0014848,1,0.956200858405771,0,7,urinary tract smooth muscle contraction,BP,
5235,GO:0014852,1,0.994140848543646,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5236,GO:0014853,1,0.994140848543646,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5237,GO:0014854,1,0.906960444380411,0,13,response to inactivity,BP,
5238,GO:0014855,1,0.66573433622783,0,59,striated muscle cell proliferation,BP,
5239,GO:0014856,1,0.908747914372301,0,14,skeletal muscle cell proliferation,BP,
5240,GO:0014857,1,0.918026783150192,0,13,regulation of skeletal muscle cell proliferation,BP,
5241,GO:0014858,1,0.979282661978368,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5242,GO:0014859,1,0.980849372705236,0,3,negative regulation of skeletal muscle cell proliferation,BP,
5243,GO:0014861,1,0.992055587041537,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5244,GO:0014862,1,0.991408937314801,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5245,GO:0014866,1,0.89647594045233,0,12,skeletal myofibril assembly,BP,
5246,GO:0014870,1,0.922392253030215,0,10,response to muscle inactivity,BP,
5247,GO:0014873,1,0.988848678627108,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5248,GO:0014874,1,0.897255248884576,0,14,response to stimulus involved in regulation of muscle adaptation,BP,
5249,GO:0014876,1,0.994595034281466,0,1,response to injury involved in regulation of muscle adaptation,BP,
5250,GO:0014877,1,0.927791608200356,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5251,GO:0014878,1,0.972617167709797,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5252,GO:0014883,1,0.963388042070874,0,5,transition between fast and slow fiber,BP,
5253,GO:0014886,1,0.993894625366939,0,1,transition between slow and fast fiber,BP,
5254,GO:0014887,1,0.850193928982145,0,22,cardiac muscle adaptation,BP,
5255,GO:0014888,1,0.756171790786938,0,40,striated muscle adaptation,BP,
5256,GO:0014889,1,0.924742874995368,0,12,muscle atrophy,BP,
5257,GO:0014891,1,0.950820832582168,0,8,striated muscle atrophy,BP,
5258,GO:0014894,1,0.927791608200356,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5259,GO:0014895,1,0.994656308629671,0,1,smooth muscle hypertrophy,BP,
5260,GO:0014896,1,0.573303432260674,0,72,muscle hypertrophy,BP,
5261,GO:0014897,1,0.579800078574033,0,70,striated muscle hypertrophy,BP,
5262,GO:0014898,1,0.850193928982145,0,22,cardiac muscle hypertrophy in response to stress,BP,
5263,GO:0014900,1,0.977847448503783,0,4,muscle hyperplasia,BP,
5264,GO:0014901,1,0.98853396485909,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5266,GO:0014904,1,0.814496252557303,0,30,myotube cell development,BP,
5267,GO:0014908,1,0.985778306256425,0,2,myotube differentiation involved in skeletal muscle regeneration,BP,
5272,GO:0014916,1,0.972483130843843,0,3,regulation of lung blood pressure,BP,
5273,GO:0015002,1,0.884398506659984,0,22,heme-copper terminal oxidase activity,MF,
5274,GO:0015012,1,0.836510947295251,0,25,heparan sulfate proteoglycan biosynthetic process,BP,
5275,GO:0015014,1,0.955837772976236,0,6,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5276,GO:0015015,1,0.958620703568841,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5277,GO:0015016,1,0.968630601705537,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5278,GO:0015018,1,0.982836117677788,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5279,GO:0015019,1,0.992202442511032,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5280,GO:0015020,1,0.91788133520444,0,14,glucuronosyltransferase activity,MF,
5281,GO:0015026,1,0.78658202280326,0,36,coreceptor activity,MF,
5282,GO:0015030,1,0.719278132699996,0,53,Cajal body,CC,
5284,GO:0015035,1,0.888710991823434,0,20,protein disulfide oxidoreductase activity,MF,
5285,GO:0015036,1,0.811264119796728,0,36,disulfide oxidoreductase activity,MF,
5286,GO:0015037,1,0.930259410050913,0,13,peptide disulfide oxidoreductase activity,MF,
5287,GO:0015038,1,0.973159068916404,0,5,glutathione disulfide oxidoreductase activity,MF,
5288,GO:0015039,1,0.994502290651241,0,1,NADPH-adrenodoxin reductase activity,MF,
5289,GO:0015052,1,0.994254160293653,0,1,beta3-adrenergic receptor activity,MF,
5290,GO:0015054,1,0.994445365957991,0,1,gastrin receptor activity,MF,
5291,GO:0015056,1,0.988863210878402,0,2,corticotrophin-releasing factor receptor activity,MF,
5292,GO:0015057,1,0.970295213828479,0,5,thrombin-activated receptor activity,MF,
5293,GO:0015065,1,0.983459985627439,0,3,uridine nucleotide receptor activity,MF,
5294,GO:0015067,1,0.994277789465325,0,1,amidinotransferase activity,MF,
5295,GO:0015068,1,0.994277789465325,0,1,glycine amidinotransferase activity,MF,
5296,GO:0015074,1,0.933862002901008,0,10,DNA integration,BP,
5299,GO:0015078,1,0.547412321440221,0,97,proton transmembrane transporter activity,MF,
5303,GO:0015086,1,0.993168950513005,0,1,cadmium ion transmembrane transporter activity,MF,
5304,GO:0015087,1,0.993168950513005,0,1,cobalt ion transmembrane transporter activity,MF,
5305,GO:0015091,1,0.980680063828563,0,3,ferric iron transmembrane transporter activity,MF,
5306,GO:0015093,1,0.979834368442531,0,3,ferrous iron transmembrane transporter activity,MF,
5307,GO:0015094,1,0.993168950513005,0,1,lead ion transmembrane transporter activity,MF,
5308,GO:0015095,1,0.899581347384085,0,16,magnesium ion transmembrane transporter activity,MF,
5309,GO:0015098,1,0.9945021752321,0,1,molybdate ion transmembrane transporter activity,MF,
5310,GO:0015101,1,0.866820799524236,0,24,organic cation transmembrane transporter activity,MF,
5312,GO:0015105,1,0.994607403353366,0,1,arsenite transmembrane transporter activity,MF,
5313,GO:0015106,1,0.857999388147876,0,21,bicarbonate transmembrane transporter activity,MF,
5315,GO:0015111,1,0.979398240264,0,3,iodide transmembrane transporter activity,MF,
5316,GO:0015112,1,0.994248663970059,0,1,nitrate transmembrane transporter activity,MF,
5317,GO:0015114,1,0.925696760508854,0,11,phosphate ion transmembrane transporter activity,MF,
5318,GO:0015116,1,0.92948982227976,0,11,sulfate transmembrane transporter activity,MF,
5319,GO:0015117,1,0.994504129637034,0,1,thiosulfate transmembrane transporter activity,MF,
5320,GO:0015119,1,0.981720146901599,0,3,hexose phosphate transmembrane transporter activity,MF,
5322,GO:0015126,1,0.992603949722694,0,1,canalicular bile acid transmembrane transporter activity,MF,
5323,GO:0015127,1,0.992342116015422,0,1,bilirubin transmembrane transporter activity,MF,
5324,GO:0015129,1,0.96750662603516,0,5,lactate transmembrane transporter activity,MF,
5325,GO:0015130,1,0.993196453193617,0,1,mevalonate transmembrane transporter activity,MF,
5326,GO:0015131,1,0.994504129637034,0,1,oxaloacetate transmembrane transporter activity,MF,
5327,GO:0015132,1,0.993118907491824,0,1,prostaglandin transmembrane transporter activity,MF,
5328,GO:0015136,1,0.993856244232088,0,1,sialic acid transmembrane transporter activity,MF,
5329,GO:0015137,1,0.975173602702215,0,4,citrate transmembrane transporter activity,MF,
5330,GO:0015139,1,0.994142758058285,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5331,GO:0015140,1,0.989061897515725,0,2,malate transmembrane transporter activity,MF,
5332,GO:0015141,1,0.981804096141052,0,3,succinate transmembrane transporter activity,MF,
5333,GO:0015142,1,0.975173602702215,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5334,GO:0015143,1,0.983432370970908,0,3,urate transmembrane transporter activity,MF,
5335,GO:0015144,1,0.819427859537266,0,32,carbohydrate transmembrane transporter activity,MF,
5336,GO:0015145,1,0.878936983708439,0,20,monosaccharide transmembrane transporter activity,MF,
5337,GO:0015149,1,0.887312313809904,0,19,hexose transmembrane transporter activity,MF,
5338,GO:0015152,1,0.994448778680426,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5339,GO:0015154,1,0.982140527221787,0,3,disaccharide transmembrane transporter activity,MF,
5340,GO:0015157,1,0.982140527221787,0,3,oligosaccharide transmembrane transporter activity,MF,
5341,GO:0015165,1,0.938849313200899,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5342,GO:0015166,1,0.944756840424032,0,8,polyol transmembrane transporter activity,MF,
5343,GO:0015168,1,0.972218564111629,0,5,glycerol transmembrane transporter activity,MF,
5344,GO:0015171,1,0.623300267522647,0,72,amino acid transmembrane transporter activity,MF,
5345,GO:0015172,1,0.905625513299128,0,14,acidic amino acid transmembrane transporter activity,MF,
5346,GO:0015173,1,0.982525166127587,0,3,aromatic amino acid transmembrane transporter activity,MF,
5347,GO:0015174,1,0.931557446791298,0,11,basic amino acid transmembrane transporter activity,MF,
5348,GO:0015175,1,0.828531102734518,0,29,neutral amino acid transmembrane transporter activity,MF,
5349,GO:0015179,1,0.703963020341227,0,53,L-amino acid transmembrane transporter activity,MF,
5350,GO:0015180,1,0.967986622989911,0,5,L-alanine transmembrane transporter activity,MF,
5351,GO:0015181,1,0.958599430214621,0,6,arginine transmembrane transporter activity,MF,
5352,GO:0015182,1,0.988549190219632,0,2,L-asparagine transmembrane transporter activity,MF,
5353,GO:0015183,1,0.976187995607932,0,4,L-aspartate transmembrane transporter activity,MF,
5354,GO:0015184,1,0.980819080918437,0,3,L-cystine transmembrane transporter activity,MF,
5355,GO:0015185,1,0.970307246587714,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5356,GO:0015186,1,0.968966724180729,0,5,L-glutamine transmembrane transporter activity,MF,
5357,GO:0015187,1,0.963506503273525,0,6,glycine transmembrane transporter activity,MF,
5358,GO:0015189,1,0.958599430214621,0,6,L-lysine transmembrane transporter activity,MF,
5359,GO:0015190,1,0.994187068787961,0,1,L-leucine transmembrane transporter activity,MF,
5360,GO:0015191,1,0.994187068787961,0,1,L-methionine transmembrane transporter activity,MF,
5361,GO:0015193,1,0.965133616916813,0,5,L-proline transmembrane transporter activity,MF,
5362,GO:0015194,1,0.94935200731752,0,9,L-serine transmembrane transporter activity,MF,
5363,GO:0015195,1,0.993052985508184,0,1,L-threonine transmembrane transporter activity,MF,
5364,GO:0015196,1,0.994327130902036,0,1,L-tryptophan transmembrane transporter activity,MF,
5365,GO:0015203,1,0.988861098243212,0,2,polyamine transmembrane transporter activity,MF,
5366,GO:0015204,1,0.964640356391112,0,6,urea transmembrane transporter activity,MF,
5367,GO:0015205,1,0.961669902711825,0,6,nucleobase transmembrane transporter activity,MF,
5368,GO:0015207,1,0.987588553690074,0,2,adenine transmembrane transporter activity,MF,
5369,GO:0015215,1,0.908026950822948,0,16,nucleotide transmembrane transporter activity,MF,
5370,GO:0015216,1,0.930246840089103,0,12,purine nucleotide transmembrane transporter activity,MF,
5371,GO:0015217,1,0.947479627421108,0,9,ADP transmembrane transporter activity,MF,
5372,GO:0015218,1,0.987352678048917,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5373,GO:0015220,1,0.964006541206556,0,6,choline transmembrane transporter activity,MF,
5374,GO:0015222,1,0.98160224176816,0,3,serotonin transmembrane transporter activity,MF,
5375,GO:0015226,1,0.965684511878434,0,6,carnitine transmembrane transporter activity,MF,
5376,GO:0015227,1,0.98890461617223,0,2,acyl carnitine transmembrane transporter activity,MF,
5377,GO:0015228,1,0.982776038722554,0,3,coenzyme A transmembrane transporter activity,MF,
5378,GO:0015229,1,0.990572227848584,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5379,GO:0015230,1,0.988483479794799,0,2,FAD transmembrane transporter activity,MF,
5380,GO:0015232,1,0.949483763126389,0,8,heme transporter activity,MF,
5381,GO:0015234,1,0.981797053575049,0,3,thiamine transmembrane transporter activity,MF,
5383,GO:0015245,1,0.953621019573825,0,8,fatty acid transmembrane transporter activity,MF,
5384,GO:0015247,1,0.977610405977108,0,3,aminophospholipid transmembrane transporter activity,MF,
5385,GO:0015248,1,0.843502200189418,0,25,sterol transporter activity,MF,
5386,GO:0015250,1,0.943479039713049,0,10,water channel activity,MF,
5387,GO:0015252,1,0.982904249124279,0,3,proton channel activity,MF,
5388,GO:0015254,1,0.97789091443714,0,4,glycerol channel activity,MF,
5389,GO:0015265,1,0.981919798287578,0,3,urea channel activity,MF,
5391,GO:0015269,1,0.904951933795216,0,16,calcium-activated potassium channel activity,MF,
5393,GO:0015272,1,0.968402271323357,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5394,GO:0015275,1,0.980834416639924,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5396,GO:0015277,1,0.963438629106694,0,5,kainate selective glutamate receptor activity,MF,
5398,GO:0015279,1,0.935467877860998,0,9,store-operated calcium channel activity,MF,
5399,GO:0015280,1,0.949905011195869,0,8,ligand-gated sodium channel activity,MF,
5400,GO:0015288,1,0.966975821440699,0,6,porin activity,MF,
5402,GO:0015292,1,0.994184768585909,0,1,uniporter activity,MF,
5403,GO:0015293,1,0.45369524723918,0,117,symporter activity,MF,
5404,GO:0015294,1,0.557736936673593,0,84,solute:cation symporter activity,MF,
5405,GO:0015295,1,0.874513253366732,0,21,solute:proton symporter activity,MF,
5406,GO:0015296,1,0.927435780844283,0,10,anion:cation symporter activity,MF,
5409,GO:0015299,1,0.888724961944447,0,18,solute:proton antiporter activity,MF,
5410,GO:0015301,1,0.827643464279575,0,28,anion:anion antiporter activity,MF,
5411,GO:0015307,1,0.982928543408139,0,3,drug:proton antiporter activity,MF,
5412,GO:0015315,1,0.981720146901599,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5413,GO:0015317,1,0.994546977023184,0,1,phosphate:proton symporter activity,MF,
5415,GO:0015319,1,0.981665296952263,0,3,sodium:inorganic phosphate symporter activity,MF,
5416,GO:0015321,1,0.969551354268173,0,5,sodium-dependent phosphate transmembrane transporter activity,MF,
5417,GO:0015322,1,0.993558419502883,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5418,GO:0015327,1,0.98819429412571,0,1,cystine:glutamate antiporter activity,MF,
5419,GO:0015328,1,0.98819429412571,0,1,cystine secondary active transmembrane transporter activity,MF,
5420,GO:0015333,1,0.980720990975984,0,3,peptide:proton symporter activity,MF,
5421,GO:0015343,1,0.994184768585909,0,1,siderophore transmembrane transporter activity,MF,
5423,GO:0015349,1,0.975407713175115,0,4,thyroid hormone transmembrane transporter activity,MF,
5424,GO:0015350,1,0.985220885074367,0,2,methotrexate transmembrane transporter activity,MF,
5425,GO:0015355,1,0.934979613616014,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5426,GO:0015362,1,0.993263636869474,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5427,GO:0015367,1,0.994527993903154,0,1,oxoglutarate:malate antiporter activity,MF,
5429,GO:0015369,1,0.991972061796252,0,1,calcium:proton antiporter activity,MF,
5430,GO:0015370,1,0.660927441009273,0,59,solute:sodium symporter activity,MF,
5431,GO:0015373,1,0.971404358800478,0,4,anion:sodium symporter activity,MF,
5432,GO:0015375,1,0.988098293972332,0,2,glycine:sodium symporter activity,MF,
5433,GO:0015377,1,0.938879546183051,0,8,cation:chloride symporter activity,MF,
5434,GO:0015378,1,0.983385076020577,0,2,sodium:chloride symporter activity,MF,
5435,GO:0015379,1,0.938879546183051,0,8,potassium:chloride symporter activity,MF,
5436,GO:0015382,1,0.994123438828563,0,1,sodium:sulfate symporter activity,MF,
5437,GO:0015385,1,0.923063213020748,0,12,sodium:proton antiporter activity,MF,
5438,GO:0015386,1,0.933901014560378,0,10,potassium:proton antiporter activity,MF,
5439,GO:0015389,1,0.988911175747731,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5440,GO:0015390,1,0.994414108844754,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5441,GO:0015391,1,0.988911175747731,0,2,nucleobase:cation symporter activity,MF,
5444,GO:0015410,1,0.98105464081835,0,3,manganese-transporting ATPase activity,MF,
5445,GO:0015420,1,0.991086129130538,0,1,cobalamin-transporting ATPase activity,MF,
5446,GO:0015421,1,0.9936963568322,0,1,oligopeptide-transporting ATPase activity,MF,
5447,GO:0015431,1,0.991086129130538,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5449,GO:0015433,1,0.987057014422807,0,2,peptide antigen-transporting ATPase activity,MF,
5450,GO:0015439,1,0.994073310137837,0,1,heme-transporting ATPase activity,MF,
5451,GO:0015440,1,0.975036642842152,0,4,peptide-transporting ATPase activity,MF,
5452,GO:0015450,1,0.966967953018416,0,6,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5454,GO:0015464,1,0.890908082454048,0,19,acetylcholine receptor activity,MF,
5455,GO:0015467,1,0.937564266823094,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5456,GO:0015485,1,0.779401974919464,0,37,cholesterol binding,MF,
5457,GO:0015489,1,0.988861098243212,0,2,putrescine transmembrane transporter activity,MF,
5459,GO:0015495,1,0.99428471871073,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5460,GO:0015499,1,0.994247512019971,0,1,formate transmembrane transporter activity,MF,
5461,GO:0015501,1,0.951816775283688,0,7,glutamate:sodium symporter activity,MF,
5462,GO:0015526,1,0.981720146901599,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5463,GO:0015538,1,0.993856244232088,0,1,sialic acid:proton symporter activity,MF,
5464,GO:0015556,1,0.953174418327464,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5465,GO:0015562,1,0.97775451232861,0,3,efflux transmembrane transporter activity,MF,
5466,GO:0015578,1,0.99433260969691,0,1,mannose transmembrane transporter activity,MF,
5467,GO:0015605,1,0.866415033497804,0,23,organophosphate ester transmembrane transporter activity,MF,
5468,GO:0015616,1,0.964616434408654,0,4,DNA translocase activity,MF,
5471,GO:0015631,1,0.091848466236851,0,319,tubulin binding,MF,
5472,GO:0015633,1,0.99445215253624,0,1,zinc-transporting ATPase activity,MF,
5473,GO:0015636,1,0.99438519107665,0,1,short-chain fatty acid transmembrane transporter activity,MF,
5474,GO:0015643,1,0.946627426562635,0,9,toxic substance binding,MF,
5475,GO:0015645,1,0.902362456026372,0,17,fatty acid ligase activity,MF,
5476,GO:0015651,1,0.946960703469411,0,9,quaternary ammonium group transmembrane transporter activity,MF,
5477,GO:0015658,1,0.994187068787961,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5478,GO:0015660,1,0.994247512019971,0,1,formate efflux transmembrane transporter activity,MF,
5479,GO:0015662,1,0.766859415588947,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5480,GO:0015665,1,0.988823644565567,0,2,alcohol transmembrane transporter activity,MF,
5481,GO:0015669,1,0.908079138130992,0,17,gas transport,BP,
5482,GO:0015670,1,0.983362225763399,0,3,carbon dioxide transport,BP,
5483,GO:0015671,1,0.92345553350542,0,14,oxygen transport,BP,
5486,GO:0015679,1,0.981891517737008,0,2,plasma membrane copper ion transport,BP,
5487,GO:0015680,1,0.980566305373606,0,3,intracellular copper ion transport,BP,
5489,GO:0015684,1,0.979834368442531,0,3,ferrous iron transport,BP,
5490,GO:0015688,1,0.983353611864633,0,3,iron chelate transport,BP,
5491,GO:0015689,1,0.9945021752321,0,1,molybdate ion transport,BP,
5492,GO:0015691,1,0.975224083525005,0,4,cadmium ion transport,BP,
5493,GO:0015692,1,0.993168950513005,0,1,lead ion transport,BP,
5494,GO:0015693,1,0.89242716928166,0,17,magnesium ion transport,BP,
5495,GO:0015694,1,0.992342116015422,0,1,mercury ion transport,BP,
5496,GO:0015695,1,0.791065522594237,0,38,organic cation transport,BP,
5497,GO:0015696,1,0.589148612322972,0,85,ammonium transport,BP,
5498,GO:0015697,1,0.927216290210688,0,12,quaternary ammonium group transport,BP,
5500,GO:0015700,1,0.994607403353366,0,1,arsenite transport,BP,
5501,GO:0015701,1,0.764247805640504,0,41,bicarbonate transport,BP,
5502,GO:0015705,1,0.958109489299513,0,5,iodide transport,BP,
5503,GO:0015706,1,0.994248663970059,0,1,nitrate transport,BP,
5504,GO:0015707,1,0.993435892171835,0,1,nitrite transport,BP,
5505,GO:0015709,1,0.994504129637034,0,1,thiosulfate transport,BP,
5507,GO:0015712,1,0.970520087287621,0,5,hexose phosphate transport,BP,
5511,GO:0015723,1,0.992342116015422,0,1,bilirubin transport,BP,
5512,GO:0015724,1,0.994247512019971,0,1,formate transport,BP,
5513,GO:0015727,1,0.960777538734178,0,6,lactate transport,BP,
5514,GO:0015728,1,0.993196453193617,0,1,mevalonate transport,BP,
5515,GO:0015729,1,0.994504129637034,0,1,oxaloacetate transport,BP,
5516,GO:0015732,1,0.922138131215981,0,13,prostaglandin transport,BP,
5517,GO:0015734,1,0.990990339355326,0,1,taurine transport,BP,
5518,GO:0015739,1,0.993856244232088,0,1,sialic acid transport,BP,
5519,GO:0015740,1,0.919818561558434,0,12,C4-dicarboxylate transport,BP,
5520,GO:0015742,1,0.983211250377799,0,3,alpha-ketoglutarate transport,BP,
5521,GO:0015743,1,0.994504129637034,0,1,malate transport,BP,
5522,GO:0015744,1,0.981804096141052,0,3,succinate transport,BP,
5523,GO:0015746,1,0.975173602702215,0,4,citrate transport,BP,
5524,GO:0015747,1,0.97781379393414,0,4,urate transport,BP,
5525,GO:0015748,1,0.56514134674299,0,83,organophosphate ester transport,BP,
5526,GO:0015749,1,0.512672223270469,0,97,monosaccharide transmembrane transport,BP,
5527,GO:0015755,1,0.994381755056307,0,1,fructose transmembrane transport,BP,
5528,GO:0015760,1,0.970520087287621,0,5,glucose-6-phosphate transport,BP,
5529,GO:0015761,1,0.99433260969691,0,1,mannose transmembrane transport,BP,
5530,GO:0015766,1,0.982140527221787,0,3,disaccharide transport,BP,
5531,GO:0015770,1,0.982140527221787,0,3,sucrose transport,BP,
5532,GO:0015772,1,0.982140527221787,0,3,oligosaccharide transport,BP,
5533,GO:0015780,1,0.922517288683204,0,13,nucleotide-sugar transmembrane transport,BP,
5534,GO:0015782,1,0.994520893390471,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5535,GO:0015783,1,0.984692981002002,0,2,GDP-fucose transmembrane transport,BP,
5536,GO:0015786,1,0.994398955585378,0,1,UDP-glucose transmembrane transport,BP,
5537,GO:0015787,1,0.991032156245626,0,1,UDP-glucuronic acid transmembrane transport,BP,
5538,GO:0015790,1,0.990706419162221,0,1,UDP-xylose transmembrane transport,BP,
5539,GO:0015791,1,0.927064185023243,0,10,polyol transport,BP,
5540,GO:0015793,1,0.972218564111629,0,5,glycerol transport,BP,
5541,GO:0015797,1,0.994247512019971,0,1,mannitol transport,BP,
5542,GO:0015798,1,0.959087529121113,0,4,myo-inositol transport,BP,
5543,GO:0015800,1,0.663752181621569,0,59,acidic amino acid transport,BP,
5544,GO:0015801,1,0.970873929859167,0,5,aromatic amino acid transport,BP,
5545,GO:0015802,1,0.926724760117254,0,12,basic amino acid transport,BP,
5546,GO:0015803,1,0.972954642255026,0,4,branched-chain amino acid transport,BP,
5547,GO:0015804,1,0.809666527364103,0,33,neutral amino acid transport,BP,
5548,GO:0015805,1,0.994412527970298,0,1,S-adenosyl-L-methionine transport,BP,
5549,GO:0015807,1,0.66879131531984,0,60,L-amino acid transport,BP,
5550,GO:0015808,1,0.967986622989911,0,5,L-alanine transport,BP,
5551,GO:0015809,1,0.948081878428534,0,8,arginine transport,BP,
5552,GO:0015810,1,0.981896734256344,0,3,aspartate transmembrane transport,BP,
5553,GO:0015811,1,0.980819080918437,0,3,L-cystine transport,BP,
5554,GO:0015812,1,0.911657623368745,0,13,gamma-aminobutyric acid transport,BP,
5555,GO:0015813,1,0.850790123943657,0,23,L-glutamate transmembrane transport,BP,
5556,GO:0015816,1,0.947326813058862,0,8,glycine transport,BP,
5557,GO:0015817,1,0.988543072566915,0,2,histidine transport,BP,
5558,GO:0015819,1,0.994504587119821,0,1,lysine transport,BP,
5559,GO:0015820,1,0.978644661065699,0,3,leucine transport,BP,
5560,GO:0015821,1,0.994187068787961,0,1,methionine transport,BP,
5561,GO:0015822,1,0.957655170299288,0,6,ornithine transport,BP,
5562,GO:0015824,1,0.94983656254894,0,7,proline transport,BP,
5563,GO:0015825,1,0.94935200731752,0,9,L-serine transport,BP,
5564,GO:0015826,1,0.993052985508184,0,1,threonine transport,BP,
5565,GO:0015827,1,0.982537341863924,0,3,tryptophan transport,BP,
5566,GO:0015828,1,0.993967854321148,0,1,tyrosine transport,BP,
5569,GO:0015838,1,0.945553601707316,0,9,amino-acid betaine transport,BP,
5570,GO:0015840,1,0.964674808186987,0,6,urea transport,BP,
5571,GO:0015842,1,0.977807812744821,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5573,GO:0015846,1,0.959445382531268,0,7,polyamine transport,BP,
5574,GO:0015847,1,0.988861098243212,0,2,putrescine transport,BP,
5577,GO:0015851,1,0.956462980750408,0,7,nucleobase transport,BP,
5578,GO:0015853,1,0.982242715196978,0,3,adenine transport,BP,
5579,GO:0015855,1,0.983028197219453,0,3,pyrimidine nucleobase transport,BP,
5580,GO:0015858,1,0.960924891611814,0,7,nucleoside transport,BP,
5581,GO:0015860,1,0.994414108844754,0,1,purine nucleoside transmembrane transport,BP,
5582,GO:0015862,1,0.994378287713463,0,1,uridine transport,BP,
5583,GO:0015864,1,0.988823486227044,0,2,pyrimidine nucleoside transport,BP,
5584,GO:0015865,1,0.914120309170891,0,15,purine nucleotide transport,BP,
5585,GO:0015866,1,0.947479627421108,0,9,ADP transport,BP,
5586,GO:0015867,1,0.941529768206967,0,10,ATP transport,BP,
5587,GO:0015868,1,0.920768677893667,0,14,purine ribonucleotide transport,BP,
5588,GO:0015870,1,0.977320179188708,0,4,acetylcholine transport,BP,
5589,GO:0015871,1,0.95342215670585,0,7,choline transport,BP,
5590,GO:0015872,1,0.807060125762789,0,34,dopamine transport,BP,
5592,GO:0015876,1,0.994245432508821,0,1,acetyl-CoA transport,BP,
5593,GO:0015878,1,0.993866452506802,0,1,biotin transport,BP,
5594,GO:0015879,1,0.960320545560343,0,7,carnitine transport,BP,
5595,GO:0015880,1,0.982776038722554,0,3,coenzyme A transport,BP,
5596,GO:0015881,1,0.986499704117638,0,2,creatine transmembrane transport,BP,
5597,GO:0015882,1,0.990572227848584,0,1,L-ascorbic acid transmembrane transport,BP,
5598,GO:0015884,1,0.941619467534962,0,8,folic acid transport,BP,
5599,GO:0015886,1,0.949483763126389,0,8,heme transport,BP,
5600,GO:0015887,1,0.993866452506802,0,1,pantothenate transmembrane transport,BP,
5601,GO:0015888,1,0.981374619564572,0,3,thiamine transport,BP,
5602,GO:0015889,1,0.95636669120909,0,6,cobalamin transport,BP,
5603,GO:0015891,1,0.983353611864633,0,3,siderophore transport,BP,
5605,GO:0015904,1,0.99451011855604,0,1,tetracycline transport,BP,
5608,GO:0015910,1,0.988016476698021,0,2,peroxisomal long-chain fatty acid import,BP,
5609,GO:0015911,1,0.963402334578436,0,5,plasma membrane long-chain fatty acid transport,BP,
5610,GO:0015912,1,0.99438519107665,0,1,short-chain fatty acid transport,BP,
5611,GO:0015913,1,0.99438519107665,0,1,short-chain fatty acid import,BP,
5612,GO:0015914,1,0.656820625445596,0,58,phospholipid transport,BP,
5613,GO:0015916,1,0.994245432508821,0,1,fatty-acyl-CoA transport,BP,
5614,GO:0015917,1,0.968054347185641,0,4,aminophospholipid transport,BP,
5616,GO:0015919,1,0.905115025458672,0,16,peroxisomal membrane transport,BP,
5617,GO:0015920,1,0.988782330862408,0,2,lipopolysaccharide transport,BP,
5618,GO:0015922,1,0.994558511239247,0,1,aspartate oxidase activity,MF,
5619,GO:0015923,1,0.90547697024883,0,14,mannosidase activity,MF,
5620,GO:0015924,1,0.935457154406404,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5621,GO:0015925,1,0.954435198615291,0,8,galactosidase activity,MF,
5622,GO:0015926,1,0.932501168926997,0,10,glucosidase activity,MF,
5623,GO:0015928,1,0.988928034123857,0,2,fucosidase activity,MF,
5624,GO:0015929,1,0.931174382508042,0,12,hexosaminidase activity,MF,
5626,GO:0015932,1,0.80255758747914,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5627,GO:0015934,1,0.533152812764673,0,113,large ribosomal subunit,CC,
5628,GO:0015935,1,0.676690654568649,0,69,small ribosomal subunit,CC,
5629,GO:0015936,1,0.915221003958079,0,15,coenzyme A metabolic process,BP,
5630,GO:0015937,1,0.945113579681302,0,10,coenzyme A biosynthetic process,BP,
5631,GO:0015938,1,0.994634727767316,0,1,coenzyme A catabolic process,BP,
5632,GO:0015939,1,0.949929205660104,0,8,pantothenate metabolic process,BP,
5633,GO:0015942,1,0.965507241186619,0,6,formate metabolic process,BP,
5634,GO:0015949,1,0.831859001778657,0,32,nucleobase-containing small molecule interconversion,BP,
5635,GO:0015950,1,0.989110810578272,0,2,purine nucleotide interconversion,BP,
5636,GO:0015951,1,0.989110810578272,0,2,purine ribonucleotide interconversion,BP,
5637,GO:0015959,1,0.958969759154919,0,7,diadenosine polyphosphate metabolic process,BP,
5638,GO:0015960,1,0.982310794033361,0,3,diadenosine polyphosphate biosynthetic process,BP,
5639,GO:0015961,1,0.976242838261684,0,4,diadenosine polyphosphate catabolic process,BP,
5640,GO:0015965,1,0.982310794033361,0,3,diadenosine tetraphosphate metabolic process,BP,
5641,GO:0015966,1,0.982310794033361,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5642,GO:0015980,1,0.214376525422106,0,244,energy derivation by oxidation of organic compounds,BP,
5643,GO:0015985,1,0.946384518916844,0,9,energy coupled proton transport, down electrochemical gradient,BP,
5644,GO:0015986,1,0.946384518916844,0,9,ATP synthesis coupled proton transport,BP,
5645,GO:0015988,1,0.84253117602348,0,28,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5646,GO:0015990,1,0.994650679946396,0,1,electron transport coupled proton transport,BP,
5647,GO:0015991,1,0.847069937839941,0,27,ATP hydrolysis coupled proton transport,BP,
5648,GO:0016004,1,0.944308338506646,0,9,phospholipase activator activity,MF,
5649,GO:0016005,1,0.986770731854833,0,2,phospholipase A2 activator activity,MF,
5650,GO:0016010,1,0.863778325094418,0,20,dystrophin-associated glycoprotein complex,CC,
5651,GO:0016011,1,0.952064840620582,0,7,dystroglycan complex,CC,
5652,GO:0016012,1,0.959985282580189,0,6,sarcoglycan complex,CC,
5653,GO:0016013,1,0.973815839863684,0,4,syntrophin complex,CC,
5654,GO:0016015,1,0.966326826333715,0,6,morphogen activity,MF,
5655,GO:0016018,1,0.94012744380802,0,10,cyclosporin A binding,MF,
5656,GO:0016019,1,0.989232114334091,0,2,peptidoglycan receptor activity,MF,
5660,GO:0016028,1,0.993615451412137,0,1,rhabdomere,CC,
5661,GO:0016031,1,0.993810444463696,0,1,tRNA import into mitochondrion,BP,
5663,GO:0016034,1,0.994600640752168,0,1,maleylacetoacetate isomerase activity,MF,
5664,GO:0016035,1,0.981986353845361,0,2,zeta DNA polymerase complex,CC,
5665,GO:0016036,1,0.994399120274267,0,1,cellular response to phosphate starvation,BP,
5666,GO:0016037,1,0.994193667694308,0,1,light absorption,BP,
5667,GO:0016038,1,0.994193667694308,0,1,absorption of visible light,BP,
5670,GO:0016045,1,0.931808497736317,0,10,detection of bacterium,BP,
5671,GO:0016046,1,0.991803051652618,0,1,detection of fungus,BP,
5672,GO:0016048,1,0.889852888983109,0,18,detection of temperature stimulus,BP,
5678,GO:0016054,1,0.211763034799164,0,250,organic acid catabolic process,BP,
5680,GO:0016056,1,0.868581855933838,0,23,rhodopsin mediated signaling pathway,BP,
5681,GO:0016062,1,0.994287293109373,0,1,adaptation of rhodopsin mediated signaling,BP,
5683,GO:0016068,1,0.983573093202474,0,3,type I hypersensitivity,BP,
5686,GO:0016072,1,0.182139176363695,0,279,rRNA metabolic process,BP,
5687,GO:0016073,1,0.597166646701846,0,84,snRNA metabolic process,BP,
5688,GO:0016074,1,0.93371485925998,0,12,snoRNA metabolic process,BP,
5689,GO:0016075,1,0.903659652739729,0,16,rRNA catabolic process,BP,
5690,GO:0016077,1,0.991443266410328,0,1,snoRNA catabolic process,BP,
5691,GO:0016078,1,0.965999707365979,0,6,tRNA catabolic process,BP,
5693,GO:0016080,1,0.970125774177222,0,4,synaptic vesicle targeting,BP,
5694,GO:0016081,1,0.93307394705829,0,9,synaptic vesicle docking,BP,
5695,GO:0016082,1,0.893074939776045,0,15,synaptic vesicle priming,BP,
5696,GO:0016093,1,0.954451859011245,0,8,polyprenol metabolic process,BP,
5697,GO:0016094,1,0.980834617572008,0,3,polyprenol biosynthetic process,BP,
5698,GO:0016095,1,0.983511672508817,0,3,polyprenol catabolic process,BP,
5699,GO:0016098,1,0.989142862781335,0,2,monoterpenoid metabolic process,BP,
5702,GO:0016103,1,0.982035629027852,0,3,diterpenoid catabolic process,BP,
5703,GO:0016107,1,0.989204734704115,0,2,sesquiterpenoid catabolic process,BP,
5704,GO:0016108,1,0.982695549648697,0,3,tetraterpenoid metabolic process,BP,
5705,GO:0016109,1,0.994264990016345,0,1,tetraterpenoid biosynthetic process,BP,
5707,GO:0016115,1,0.971432380500882,0,5,terpenoid catabolic process,BP,
5708,GO:0016116,1,0.982695549648697,0,3,carotenoid metabolic process,BP,
5709,GO:0016117,1,0.994264990016345,0,1,carotenoid biosynthetic process,BP,
5710,GO:0016119,1,0.988364491961622,0,2,carotene metabolic process,BP,
5711,GO:0016121,1,0.994146019832506,0,1,carotene catabolic process,BP,
5712,GO:0016122,1,0.988444248419629,0,2,xanthophyll metabolic process,BP,
5713,GO:0016123,1,0.994264990016345,0,1,xanthophyll biosynthetic process,BP,
5714,GO:0016125,1,0.41434735531474,0,133,sterol metabolic process,BP,
5715,GO:0016126,1,0.637683573074361,0,68,sterol biosynthetic process,BP,
5716,GO:0016127,1,0.946282176744052,0,9,sterol catabolic process,BP,
5717,GO:0016128,1,0.983229272466252,0,3,phytosteroid metabolic process,BP,
5718,GO:0016129,1,0.983229272466252,0,3,phytosteroid biosynthetic process,BP,
5719,GO:0016131,1,0.994247512019971,0,1,brassinosteroid metabolic process,BP,
5720,GO:0016132,1,0.994247512019971,0,1,brassinosteroid biosynthetic process,BP,
5721,GO:0016137,1,0.908385707387356,0,17,glycoside metabolic process,BP,
5722,GO:0016139,1,0.954726603149751,0,8,glycoside catabolic process,BP,
5723,GO:0016149,1,0.993574882216759,0,1,translation release factor activity, codon specific,MF,
5724,GO:0016150,1,0.994558511239247,0,1,translation release factor activity, codon nonspecific,MF,
5725,GO:0016151,1,0.988977259401242,0,2,nickel cation binding,MF,
5726,GO:0016153,1,0.993819483166719,0,1,urocanate hydratase activity,MF,
5728,GO:0016155,1,0.984092034885503,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5729,GO:0016160,1,0.980088304138896,0,3,amylase activity,MF,
5730,GO:0016165,1,0.988658421370997,0,2,linoleate 13S-lipoxygenase activity,MF,
5731,GO:0016167,1,0.982687420652553,0,2,glial cell-derived neurotrophic factor receptor activity,MF,
5732,GO:0016174,1,0.957896119061212,0,6,NAD(P)H oxidase activity,MF,
5733,GO:0016175,1,0.957905912509813,0,7,superoxide-generating NADPH oxidase activity,MF,
5734,GO:0016176,1,0.944879555620614,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5735,GO:0016180,1,0.8664705598628,0,23,snRNA processing,BP,
5736,GO:0016182,1,0.992577017095215,0,1,synaptic vesicle budding from endosome,BP,
5737,GO:0016185,1,0.977627625557075,0,3,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5738,GO:0016188,1,0.920887635780146,0,11,synaptic vesicle maturation,BP,
5739,GO:0016189,1,0.989613039684879,0,1,synaptic vesicle to endosome fusion,BP,
5740,GO:0016191,1,0.964041119218301,0,5,synaptic vesicle uncoating,BP,
5742,GO:0016197,1,0.283730544781191,0,183,endosomal transport,BP,
5743,GO:0016198,1,0.957439680296579,0,6,axon choice point recognition,BP,
5744,GO:0016199,1,0.968620594302954,0,4,axon midline choice point recognition,BP,
5745,GO:0016202,1,0.446741003390157,0,115,regulation of striated muscle tissue development,BP,
5746,GO:0016206,1,0.988463715868363,0,2,catechol O-methyltransferase activity,MF,
5747,GO:0016208,1,0.943378092045173,0,10,AMP binding,MF,
5748,GO:0016209,1,0.655673592079201,0,71,antioxidant activity,MF,
5749,GO:0016211,1,0.98507106034725,0,2,ammonia ligase activity,MF,
5750,GO:0016212,1,0.988778748889868,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5751,GO:0016213,1,0.993967200336064,0,1,linoleoyl-CoA desaturase activity,MF,
5752,GO:0016215,1,0.980344254175702,0,3,acyl-CoA desaturase activity,MF,
5753,GO:0016222,1,0.988460858711185,0,2,procollagen-proline 4-dioxygenase complex,CC,
5754,GO:0016226,1,0.889745853486446,0,20,iron-sulfur cluster assembly,BP,
5755,GO:0016229,1,0.871095956757961,0,25,steroid dehydrogenase activity,MF,
5756,GO:0016230,1,0.98830313918863,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5757,GO:0016231,1,0.992290290169091,0,1,beta-N-acetylglucosaminidase activity,MF,
5758,GO:0016232,1,0.994168435401095,0,1,HNK-1 sulfotransferase activity,MF,
5759,GO:0016233,1,0.749959124592523,0,42,telomere capping,BP,
5760,GO:0016234,1,0.575950770342637,0,77,inclusion body,CC,
5761,GO:0016235,1,0.754257216182414,0,41,aggresome,CC,
5762,GO:0016236,1,0.160772708194079,0,278,macroautophagy,BP,
5763,GO:0016237,1,0.992437925305889,0,1,lysosomal microautophagy,BP,
5764,GO:0016239,1,0.660035619224886,0,57,positive regulation of macroautophagy,BP,
5765,GO:0016240,1,0.97282800910443,0,4,autophagosome membrane docking,BP,
5766,GO:0016241,1,0.352755707819202,0,155,regulation of macroautophagy,BP,
5767,GO:0016242,1,0.828065307271441,0,27,negative regulation of macroautophagy,BP,
5768,GO:0016243,1,0.99331429908418,0,1,regulation of autophagosome size,BP,
5769,GO:0016246,1,0.902845388482169,0,15,RNA interference,BP,
5771,GO:0016248,1,0.804299925093488,0,32,channel inhibitor activity,MF,
5772,GO:0016250,1,0.994192656926603,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5773,GO:0016254,1,0.910702798537641,0,16,preassembly of GPI anchor in ER membrane,BP,
5774,GO:0016255,1,0.952777984010126,0,7,attachment of GPI anchor to protein,BP,
5775,GO:0016256,1,0.986474081924869,0,2,N-glycan processing to lysosome,BP,
5776,GO:0016259,1,0.975204547296172,0,4,selenocysteine metabolic process,BP,
5777,GO:0016260,1,0.988705419861271,0,2,selenocysteine biosynthetic process,BP,
5778,GO:0016262,1,0.980772423035575,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5779,GO:0016263,1,0.989045515962762,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5780,GO:0016264,1,0.937536574448532,0,10,gap junction assembly,BP,
5782,GO:0016267,1,0.989045515962762,0,2,O-glycan processing, core 1,BP,
5783,GO:0016272,1,0.962931819163893,0,7,prefoldin complex,CC,
5784,GO:0016273,1,0.933760919781502,0,12,arginine N-methyltransferase activity,MF,
5785,GO:0016274,1,0.933760919781502,0,12,protein-arginine N-methyltransferase activity,MF,
5786,GO:0016277,1,0.994352008191647,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5787,GO:0016278,1,0.699494921253188,0,51,lysine N-methyltransferase activity,MF,
5788,GO:0016279,1,0.703600892896031,0,50,protein-lysine N-methyltransferase activity,MF,
5789,GO:0016281,1,0.942283008001722,0,9,eukaryotic translation initiation factor 4F complex,CC,
5790,GO:0016282,1,0.992882893147426,0,1,eukaryotic 43S preinitiation complex,CC,
5791,GO:0016286,1,0.977632870636489,0,4,small conductance calcium-activated potassium channel activity,MF,
5792,GO:0016287,1,0.994231370636155,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5793,GO:0016289,1,0.908111509021788,0,17,CoA hydrolase activity,MF,
5794,GO:0016290,1,0.950746465394592,0,9,palmitoyl-CoA hydrolase activity,MF,
5795,GO:0016295,1,0.983788867725699,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5796,GO:0016296,1,0.983788867725699,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5797,GO:0016297,1,0.983788867725699,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5799,GO:0016300,1,0.981517247463865,0,3,tRNA (uracil) methyltransferase activity,MF,
5801,GO:0016303,1,0.75595546581877,0,37,1-phosphatidylinositol-3-kinase activity,MF,
5802,GO:0016307,1,0.896902598708572,0,15,phosphatidylinositol phosphate kinase activity,MF,
5803,GO:0016308,1,0.960340561564149,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5804,GO:0016309,1,0.987483067692418,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5807,GO:0016312,1,0.972704663690411,0,4,inositol bisphosphate phosphatase activity,MF,
5808,GO:0016314,1,0.97910982527095,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5809,GO:0016316,1,0.984111202662415,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5810,GO:0016320,1,0.984148248579819,0,2,endoplasmic reticulum membrane fusion,BP,
5811,GO:0016321,1,0.977182897098959,0,4,female meiosis chromosome segregation,BP,
5812,GO:0016322,1,0.938063382378848,0,10,neuron remodeling,BP,
5815,GO:0016327,1,0.90509230911211,0,16,apicolateral plasma membrane,CC,
5818,GO:0016332,1,0.993394032013683,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5819,GO:0016333,1,0.994099895814038,0,1,morphogenesis of follicular epithelium,BP,
5820,GO:0016334,1,0.994099895814038,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5821,GO:0016338,1,0.901853364780471,0,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5822,GO:0016339,1,0.803433927232635,0,33,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5823,GO:0016340,1,0.982116624704276,0,2,calcium-dependent cell-matrix adhesion,BP,
5824,GO:0016342,1,0.826635031371064,0,28,catenin complex,CC,
5825,GO:0016344,1,0.978804655246134,0,3,meiotic chromosome movement towards spindle pole,BP,
5827,GO:0016361,1,0.971085826883437,0,4,activin receptor activity, type I,MF,
5828,GO:0016362,1,0.97314726695781,0,2,activin receptor activity, type II,MF,
5829,GO:0016363,1,0.494116925133775,0,102,nuclear matrix,CC,
5830,GO:0016401,1,0.973540618370159,0,4,palmitoyl-CoA oxidase activity,MF,
5831,GO:0016402,1,0.988564862097267,0,2,pristanoyl-CoA oxidase activity,MF,
5832,GO:0016403,1,0.987953559362784,0,2,dimethylargininase activity,MF,
5833,GO:0016404,1,0.987139922523407,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5834,GO:0016405,1,0.874925066541843,0,22,CoA-ligase activity,MF,
5835,GO:0016406,1,0.964383529816375,0,6,carnitine O-acyltransferase activity,MF,
5836,GO:0016407,1,0.53028711520226,0,94,acetyltransferase activity,MF,
5837,GO:0016408,1,0.904220262538521,0,17,C-acyltransferase activity,MF,
5838,GO:0016409,1,0.784099861349593,0,38,palmitoyltransferase activity,MF,
5839,GO:0016410,1,0.542973271058318,0,92,N-acyltransferase activity,MF,
5840,GO:0016411,1,0.865835241089012,0,21,acylglycerol O-acyltransferase activity,MF,
5841,GO:0016413,1,0.956843036927211,0,7,O-acetyltransferase activity,MF,
5842,GO:0016414,1,0.993902875045104,0,1,O-octanoyltransferase activity,MF,
5843,GO:0016415,1,0.988574380612189,0,2,octanoyltransferase activity,MF,
5844,GO:0016416,1,0.968697726255009,0,5,O-palmitoyltransferase activity,MF,
5845,GO:0016417,1,0.818086836712367,0,31,S-acyltransferase activity,MF,
5846,GO:0016418,1,0.982282462595312,0,2,S-acetyltransferase activity,MF,
5847,GO:0016419,1,0.983747197497845,0,2,S-malonyltransferase activity,MF,
5848,GO:0016420,1,0.983747197497845,0,2,malonyltransferase activity,MF,
5849,GO:0016421,1,0.965687959547083,0,5,CoA carboxylase activity,MF,
5850,GO:0016422,1,0.983213784518352,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5851,GO:0016423,1,0.924259341065244,0,13,tRNA (guanine) methyltransferase activity,MF,
5852,GO:0016426,1,0.982711357009015,0,3,tRNA (adenine) methyltransferase activity,MF,
5853,GO:0016427,1,0.947262560524647,0,8,tRNA (cytosine) methyltransferase activity,MF,
5854,GO:0016428,1,0.973556156027194,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5855,GO:0016429,1,0.982711357009015,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5856,GO:0016433,1,0.966670804442508,0,6,rRNA (adenine) methyltransferase activity,MF,
5857,GO:0016434,1,0.981457008401358,0,3,rRNA (cytosine) methyltransferase activity,MF,
5858,GO:0016435,1,0.980722508502316,0,3,rRNA (guanine) methyltransferase activity,MF,
5859,GO:0016436,1,0.98774839821241,0,2,rRNA (uridine) methyltransferase activity,MF,
5860,GO:0016441,1,0.429943540245209,0,121,posttranscriptional gene silencing,BP,
5861,GO:0016442,1,0.919633365182305,0,11,RISC complex,CC,
5862,GO:0016444,1,0.704904023442831,0,51,somatic cell DNA recombination,BP,
5863,GO:0016445,1,0.725482033079134,0,48,somatic diversification of immunoglobulins,BP,
5864,GO:0016446,1,0.932280787972943,0,11,somatic hypermutation of immunoglobulin genes,BP,
5865,GO:0016447,1,0.750654736559,0,43,somatic recombination of immunoglobulin gene segments,BP,
5866,GO:0016453,1,0.977793063831309,0,4,C-acetyltransferase activity,MF,
5867,GO:0016454,1,0.967073315850824,0,5,C-palmitoyltransferase activity,MF,
5868,GO:0016458,1,0.230582712489685,0,212,gene silencing,BP,
5869,GO:0016459,1,0.596530999241125,0,61,myosin complex,CC,
5870,GO:0016460,1,0.799531231484522,0,27,myosin II complex,CC,
5871,GO:0016461,1,0.916607820272205,0,10,unconventional myosin complex,CC,
5873,GO:0016469,1,0.84793089238627,0,28,proton-transporting two-sector ATPase complex,CC,
5874,GO:0016471,1,0.912627745275558,0,15,vacuolar proton-transporting V-type ATPase complex,CC,
5875,GO:0016476,1,0.980368789803597,0,3,regulation of embryonic cell shape,BP,
5877,GO:0016479,1,0.971849914265623,0,4,negative regulation of transcription by RNA polymerase I,BP,
5878,GO:0016480,1,0.983492805119365,0,3,negative regulation of transcription by RNA polymerase III,BP,
5879,GO:0016482,1,0.376565139077177,0,136,cytosolic transport,BP,
5881,GO:0016486,1,0.845599425439331,0,26,peptide hormone processing,BP,
5882,GO:0016487,1,0.989204734704115,0,2,farnesol metabolic process,BP,
5883,GO:0016488,1,0.989204734704115,0,2,farnesol catabolic process,BP,
5885,GO:0016492,1,0.987803811466487,0,2,G-protein coupled neurotensin receptor activity,MF,
5886,GO:0016493,1,0.944279824925004,0,10,C-C chemokine receptor activity,MF,
5887,GO:0016494,1,0.955788257998954,0,8,C-X-C chemokine receptor activity,MF,
5888,GO:0016495,1,0.993951403550986,0,1,C-X3-C chemokine receptor activity,MF,
5889,GO:0016496,1,0.99390150324533,0,1,substance P receptor activity,MF,
5890,GO:0016497,1,0.994347522058573,0,1,substance K receptor activity,MF,
5891,GO:0016499,1,0.994476252898515,0,1,orexin receptor activity,MF,
5892,GO:0016500,1,0.934119829430491,0,10,protein-hormone receptor activity,MF,
5893,GO:0016501,1,0.988589200922873,0,2,prostacyclin receptor activity,MF,
5894,GO:0016502,1,0.897373394087603,0,19,nucleotide receptor activity,MF,
5895,GO:0016503,1,0.994604262603351,0,1,pheromone receptor activity,MF,
5897,GO:0016505,1,0.893538988362632,0,17,peptidase activator activity involved in apoptotic process,MF,
5898,GO:0016507,1,0.994033971203805,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5899,GO:0016508,1,0.981769090222903,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5900,GO:0016509,1,0.982851274915346,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5901,GO:0016514,1,0.899173683520645,0,15,SWI/SNF complex,CC,
5902,GO:0016517,1,0.994480951861777,0,1,interleukin-12 receptor activity,MF,
5903,GO:0016519,1,0.994468978273153,0,1,gastric inhibitory peptide receptor activity,MF,
5904,GO:0016520,1,0.987424080585469,0,2,growth hormone-releasing hormone receptor activity,MF,
5905,GO:0016521,1,0.993957679579771,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5909,GO:0016530,1,0.953294703182145,0,7,metallochaperone activity,MF,
5910,GO:0016531,1,0.96819249021281,0,5,copper chaperone activity,MF,
5911,GO:0016532,1,0.978605796520937,0,3,superoxide dismutase copper chaperone activity,MF,
5912,GO:0016533,1,0.982493585044162,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5913,GO:0016534,1,0.987806639166044,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5914,GO:0016538,1,0.843135571661881,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5915,GO:0016539,1,0.994566168695361,0,1,intein-mediated protein splicing,BP,
5916,GO:0016540,1,0.921372177260589,0,13,protein autoprocessing,BP,
5917,GO:0016553,1,0.912526371805425,0,14,base conversion or substitution editing,BP,
5918,GO:0016554,1,0.949384621237635,0,9,cytidine to uridine editing,BP,
5919,GO:0016556,1,0.91787469248187,0,15,mRNA modification,BP,
5920,GO:0016557,1,0.983415616981447,0,3,peroxisome membrane biogenesis,BP,
5921,GO:0016558,1,0.929106499425834,0,12,protein import into peroxisome matrix,BP,
5922,GO:0016559,1,0.948511814214859,0,9,peroxisome fission,BP,
5923,GO:0016560,1,0.975199667118176,0,4,protein import into peroxisome matrix, docking,BP,
5924,GO:0016561,1,0.988247195917499,0,2,protein import into peroxisome matrix, translocation,BP,
5926,GO:0016569,1,0.0488469688616746,0,426,covalent chromatin modification,BP,
5927,GO:0016570,1,0.0515054674809224,0,418,histone modification,BP,
5928,GO:0016571,1,0.418694122484483,0,122,histone methylation,BP,
5929,GO:0016572,1,0.79913923862045,0,34,histone phosphorylation,BP,
5930,GO:0016573,1,0.392480405311313,0,137,histone acetylation,BP,
5931,GO:0016574,1,0.736110184661626,0,43,histone ubiquitination,BP,
5932,GO:0016575,1,0.559884428542558,0,83,histone deacetylation,BP,
5933,GO:0016576,1,0.961224565198384,0,6,histone dephosphorylation,BP,
5934,GO:0016577,1,0.806845916834989,0,27,histone demethylation,BP,
5935,GO:0016578,1,0.859275756540506,0,22,histone deubiquitination,BP,
5936,GO:0016579,1,0.178083825248723,0,249,protein deubiquitination,BP,
5937,GO:0016580,1,0.91501476017167,0,12,Sin3 complex,CC,
5938,GO:0016581,1,0.875538842004124,0,17,NuRD complex,CC,
5939,GO:0016584,1,0.958350858379829,0,7,nucleosome positioning,BP,
5940,GO:0016586,1,0.982993876571744,0,2,RSC-type complex,CC,
5941,GO:0016589,1,0.947028532995044,0,7,NURF complex,CC,
5942,GO:0016590,1,0.991480926300759,0,1,ACF complex,CC,
5943,GO:0016591,1,0.493078301801459,0,107,DNA-directed RNA polymerase II, holoenzyme,CC,
5944,GO:0016592,1,0.776742334129834,0,36,mediator complex,CC,
5945,GO:0016593,1,0.94544057212258,0,8,Cdc73/Paf1 complex,CC,
5948,GO:0016596,1,0.994184768585909,0,1,thienylcyclohexylpiperidine binding,MF,
5950,GO:0016598,1,0.988963537465515,0,2,protein arginylation,BP,
5951,GO:0016600,1,0.933956333877292,0,9,flotillin complex,CC,
5952,GO:0016601,1,0.774179043005981,0,37,Rac protein signal transduction,BP,
5953,GO:0016602,1,0.974358928295778,0,4,CCAAT-binding factor complex,CC,
5954,GO:0016603,1,0.989005468561096,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5955,GO:0016604,1,0.00784547371900561,0,702,nuclear body,CC,
5956,GO:0016605,1,0.521151826982671,0,94,PML body,CC,
5957,GO:0016607,1,0.0885181037115594,0,361,nuclear speck,CC,
5958,GO:0016608,1,0.989349960601074,0,2,growth hormone-releasing hormone activity,MF,
5959,GO:0016614,1,0.496853138970917,0,117,oxidoreductase activity, acting on CH-OH group of donors,MF,
5960,GO:0016615,1,0.959829241140226,0,7,malate dehydrogenase activity,MF,
5961,GO:0016616,1,0.547559732248501,0,103,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5962,GO:0016618,1,0.982831912707496,0,3,hydroxypyruvate reductase activity,MF,
5963,GO:0016620,1,0.820923227214232,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5964,GO:0016623,1,0.987027085508152,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5965,GO:0016624,1,0.951719434056501,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5966,GO:0016627,1,0.724536057396776,0,53,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5967,GO:0016628,1,0.866255505314011,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5968,GO:0016634,1,0.951544666167008,0,8,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5969,GO:0016635,1,0.972554389916157,0,5,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5970,GO:0016638,1,0.881834887051351,0,21,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5971,GO:0016639,1,0.982809104628118,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5972,GO:0016641,1,0.908057536556836,0,16,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5973,GO:0016642,1,0.993464118074765,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5975,GO:0016646,1,0.901696832450852,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5976,GO:0016647,1,0.98344165784836,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5977,GO:0016649,1,0.988312496062548,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5978,GO:0016651,1,0.568183117726786,0,97,oxidoreductase activity, acting on NAD(P)H,MF,
5979,GO:0016652,1,0.987382917177016,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5980,GO:0016653,1,0.917952333644949,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5981,GO:0016655,1,0.751631514568562,0,52,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5982,GO:0016657,1,0.989110810578272,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5983,GO:0016661,1,0.970694904241326,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5984,GO:0016662,1,0.994271649284811,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5986,GO:0016668,1,0.9284257134529,0,13,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5987,GO:0016670,1,0.950306596966949,0,8,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5988,GO:0016671,1,0.938667281873662,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5989,GO:0016672,1,0.989258493826838,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5990,GO:0016675,1,0.879361082813255,0,23,oxidoreductase activity, acting on a heme group of donors,MF,
5991,GO:0016676,1,0.884398506659984,0,22,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5992,GO:0016679,1,0.955738941085747,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5993,GO:0016681,1,0.961250471740472,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5994,GO:0016684,1,0.776663243214485,0,42,oxidoreductase activity, acting on peroxide as acceptor,MF,
5995,GO:0016701,1,0.866378884639009,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5996,GO:0016702,1,0.866378884639009,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5998,GO:0016706,1,0.755043040886779,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
5999,GO:0016708,1,0.988832116163384,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6000,GO:0016709,1,0.799193464915237,0,36,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6001,GO:0016711,1,0.994268552029504,0,1,flavonoid 3'-monooxygenase activity,MF,
6002,GO:0016712,1,0.894606832483181,0,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6003,GO:0016713,1,0.989051950788621,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6004,GO:0016714,1,0.966895494582531,0,6,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6006,GO:0016717,1,0.967768045286261,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6007,GO:0016721,1,0.973090202095568,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6011,GO:0016725,1,0.954207374924278,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
6012,GO:0016726,1,0.984221206665505,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6013,GO:0016727,1,0.991707255659884,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6014,GO:0016728,1,0.980385461654514,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6015,GO:0016730,1,0.994502290651241,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6016,GO:0016731,1,0.994502290651241,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6019,GO:0016742,1,0.950767419580327,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6020,GO:0016743,1,0.976835913589473,0,3,carboxyl- or carbamoyltransferase activity,MF,
6021,GO:0016744,1,0.98340559246057,0,3,transferase activity, transferring aldehyde or ketonic groups,MF,
6022,GO:0016746,1,0.240131563429535,0,220,transferase activity, transferring acyl groups,MF,
6023,GO:0016747,1,0.283335161071622,0,193,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6024,GO:0016748,1,0.983090276346059,0,3,succinyltransferase activity,MF,
6025,GO:0016749,1,0.98887657525347,0,2,N-succinyltransferase activity,MF,
6026,GO:0016751,1,0.994149266808764,0,1,S-succinyltransferase activity,MF,
6027,GO:0016755,1,0.932981756990534,0,12,transferase activity, transferring amino-acyl groups,MF,
6031,GO:0016765,1,0.727305379276715,0,54,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6032,GO:0016768,1,0.994545104868961,0,1,spermine synthase activity,MF,
6033,GO:0016769,1,0.88652293936111,0,19,transferase activity, transferring nitrogenous groups,MF,
6036,GO:0016774,1,0.982646635677639,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6037,GO:0016775,1,0.922770880281086,0,12,phosphotransferase activity, nitrogenous group as acceptor,MF,
6038,GO:0016776,1,0.766964519631642,0,41,phosphotransferase activity, phosphate group as acceptor,MF,
6039,GO:0016778,1,0.972280246883543,0,5,diphosphotransferase activity,MF,
6040,GO:0016779,1,0.42798206894623,0,131,nucleotidyltransferase activity,MF,
6041,GO:0016780,1,0.893658013653255,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6042,GO:0016781,1,0.988705419861271,0,2,phosphotransferase activity, paired acceptors,MF,
6043,GO:0016782,1,0.666135035737118,0,65,transferase activity, transferring sulfur-containing groups,MF,
6044,GO:0016783,1,0.935998723555595,0,12,sulfurtransferase activity,MF,
6045,GO:0016784,1,0.994581830190299,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6046,GO:0016785,1,0.991800204434427,0,1,transferase activity, transferring selenium-containing groups,MF,
6049,GO:0016790,1,0.828308506403344,0,32,thiolester hydrolase activity,MF,
6051,GO:0016793,1,0.993938092816132,0,1,triphosphoric monoester hydrolase activity,MF,
6052,GO:0016794,1,0.994632085914953,0,1,diphosphoric monoester hydrolase activity,MF,
6053,GO:0016796,1,0.717187862060898,0,50,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6055,GO:0016799,1,0.879772862581051,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6056,GO:0016801,1,0.920904410565331,0,14,hydrolase activity, acting on ether bonds,MF,
6057,GO:0016802,1,0.980168839953909,0,3,trialkylsulfonium hydrolase activity,MF,
6058,GO:0016803,1,0.939548254238886,0,11,ether hydrolase activity,MF,
6059,GO:0016805,1,0.90781136231446,0,16,dipeptidase activity,MF,
6060,GO:0016807,1,0.994184768585909,0,1,cysteine-type carboxypeptidase activity,MF,
6061,GO:0016810,1,0.422454313000016,0,135,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6062,GO:0016811,1,0.582274224275452,0,84,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6063,GO:0016812,1,0.951808097073655,0,7,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6064,GO:0016813,1,0.948525488756052,0,9,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6065,GO:0016814,1,0.836648152883398,0,29,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6066,GO:0016815,1,0.994597284963999,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6069,GO:0016822,1,0.983799517712379,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6070,GO:0016823,1,0.983799517712379,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6071,GO:0016826,1,0.994192656926603,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6072,GO:0016829,1,0.378230946138922,0,160,lyase activity,MF,
6073,GO:0016830,1,0.756832308645307,0,47,carbon-carbon lyase activity,MF,
6074,GO:0016831,1,0.826845191290664,0,32,carboxy-lyase activity,MF,
6075,GO:0016832,1,0.953567679387416,0,8,aldehyde-lyase activity,MF,
6076,GO:0016833,1,0.963716053110914,0,6,oxo-acid-lyase activity,MF,
6077,GO:0016835,1,0.677092151410508,0,66,carbon-oxygen lyase activity,MF,
6078,GO:0016836,1,0.7543129277077,0,48,hydro-lyase activity,MF,
6079,GO:0016838,1,0.9833642951308,0,3,carbon-oxygen lyase activity, acting on phosphates,MF,
6080,GO:0016840,1,0.929131978700131,0,13,carbon-nitrogen lyase activity,MF,
6081,GO:0016841,1,0.972255759541358,0,5,ammonia-lyase activity,MF,
6082,GO:0016842,1,0.961249949371204,0,7,amidine-lyase activity,MF,
6083,GO:0016843,1,0.994184768585909,0,1,amine-lyase activity,MF,
6084,GO:0016844,1,0.994184768585909,0,1,strictosidine synthase activity,MF,
6085,GO:0016846,1,0.951998685375136,0,9,carbon-sulfur lyase activity,MF,
6086,GO:0016849,1,0.884874085972062,0,16,phosphorus-oxygen lyase activity,MF,
6087,GO:0016853,1,0.449374324147521,0,132,isomerase activity,MF,
6088,GO:0016854,1,0.904666017797981,0,16,racemase and epimerase activity,MF,
6089,GO:0016855,1,0.994322778976815,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6090,GO:0016857,1,0.929882343339269,0,11,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6091,GO:0016859,1,0.819382140204366,0,33,cis-trans isomerase activity,MF,
6092,GO:0016860,1,0.77542837114267,0,43,intramolecular oxidoreductase activity,MF,
6093,GO:0016861,1,0.956441073500137,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6094,GO:0016862,1,0.989349232066065,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6095,GO:0016863,1,0.945153150635424,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6096,GO:0016864,1,0.898753110945441,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6097,GO:0016866,1,0.851101837210554,0,27,intramolecular transferase activity,MF,
6098,GO:0016868,1,0.934922841989609,0,11,intramolecular transferase activity, phosphotransferases,MF,
6099,GO:0016872,1,0.994401254350279,0,1,intramolecular lyase activity,MF,
6100,GO:0016874,1,0.38924772689881,0,149,ligase activity,MF,
6101,GO:0016875,1,0.768549811915563,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6102,GO:0016877,1,0.802478224551164,0,36,ligase activity, forming carbon-sulfur bonds,MF,
6103,GO:0016878,1,0.854993734589012,0,26,acid-thiol ligase activity,MF,
6104,GO:0016879,1,0.732308464428287,0,47,ligase activity, forming carbon-nitrogen bonds,MF,
6105,GO:0016880,1,0.979341784990893,0,3,acid-ammonia (or amide) ligase activity,MF,
6106,GO:0016881,1,0.894188469879696,0,18,acid-amino acid ligase activity,MF,
6107,GO:0016882,1,0.988441489595541,0,2,cyclo-ligase activity,MF,
6108,GO:0016884,1,0.935499536318023,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6109,GO:0016885,1,0.953880332150224,0,7,ligase activity, forming carbon-carbon bonds,MF,
6110,GO:0016886,1,0.942062090611708,0,10,ligase activity, forming phosphoric ester bonds,MF,
6112,GO:0016888,1,0.934849033704087,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6113,GO:0016889,1,0.890778671524997,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6114,GO:0016890,1,0.987557044547745,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6115,GO:0016891,1,0.848570058454271,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6116,GO:0016892,1,0.957117137856092,0,8,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6117,GO:0016893,1,0.812377902163997,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6118,GO:0016894,1,0.852536234697256,0,28,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6119,GO:0016895,1,0.889330115079198,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6120,GO:0016896,1,0.802306153775768,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6121,GO:0016898,1,0.988775618924874,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6122,GO:0016899,1,0.979561120750367,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6123,GO:0016900,1,0.989291609391381,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6124,GO:0016901,1,0.985722736618344,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6125,GO:0016903,1,0.774831614243259,0,41,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6126,GO:0016907,1,0.9648333730601,0,6,G-protein coupled acetylcholine receptor activity,MF,
6127,GO:0016909,1,0.981078672911666,0,3,SAP kinase activity,MF,
6130,GO:0016920,1,0.990463248567483,0,1,pyroglutamyl-peptidase activity,MF,
6131,GO:0016922,1,0.849511175814481,0,21,ligand-dependent nuclear receptor binding,MF,
6132,GO:0016925,1,0.552078822213246,0,88,protein sumoylation,BP,
6133,GO:0016926,1,0.95190572028196,0,7,protein desumoylation,BP,
6134,GO:0016929,1,0.957125988343884,0,6,SUMO-specific protease activity,MF,
6135,GO:0016933,1,0.970920510724037,0,5,extracellularly glycine-gated ion channel activity,MF,
6136,GO:0016934,1,0.970920510724037,0,5,extracellularly glycine-gated chloride channel activity,MF,
6137,GO:0016935,1,0.987706637696576,0,2,glycine-gated chloride channel complex,CC,
6138,GO:0016936,1,0.978347442663155,0,4,galactoside binding,MF,
6139,GO:0016938,1,0.994092961887538,0,1,kinesin I complex,CC,
6140,GO:0016939,1,0.97682779561632,0,3,kinesin II complex,CC,
6141,GO:0016941,1,0.981277552796408,0,3,natriuretic peptide receptor activity,MF,
6142,GO:0016942,1,0.965384181113263,0,5,insulin-like growth factor binding protein complex,CC,
6143,GO:0016964,1,0.984000893882437,0,1,alpha-2 macroglobulin receptor activity,MF,
6144,GO:0016971,1,0.981404390483116,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6145,GO:0016972,1,0.974184533556116,0,4,thiol oxidase activity,MF,
6146,GO:0016973,1,0.929014227128048,0,12,poly(A)+ mRNA export from nucleus,BP,
6147,GO:0016979,1,0.994590674263444,0,1,lipoate-protein ligase activity,MF,
6148,GO:0016990,1,0.994396973404851,0,1,arginine deiminase activity,MF,
6149,GO:0016992,1,0.99454836859542,0,1,lipoate synthase activity,MF,
6150,GO:0016997,1,0.972066578855169,0,5,alpha-sialidase activity,MF,
6151,GO:0016998,1,0.977903828696478,0,4,cell wall macromolecule catabolic process,BP,
6152,GO:0016999,1,0.477588648805002,0,123,antibiotic metabolic process,BP,
6153,GO:0017000,1,0.905695415834871,0,15,antibiotic biosynthetic process,BP,
6154,GO:0017001,1,0.782764658812221,0,42,antibiotic catabolic process,BP,
6155,GO:0017002,1,0.937608554171172,0,7,activin-activated receptor activity,MF,
6156,GO:0017003,1,0.994392976155323,0,1,protein-heme linkage,BP,
6157,GO:0017004,1,0.815468253273014,0,34,cytochrome complex assembly,BP,
6158,GO:0017005,1,0.993611499054393,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6159,GO:0017006,1,0.994392976155323,0,1,protein-tetrapyrrole linkage,BP,
6160,GO:0017014,1,0.910615432251776,0,13,protein nitrosylation,BP,
6163,GO:0017017,1,0.937140756170542,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6164,GO:0017018,1,0.975633248456245,0,3,myosin phosphatase activity,MF,
6165,GO:0017020,1,0.994140848543646,0,1,myosin phosphatase regulator activity,MF,
6166,GO:0017022,1,0.673805791110441,0,57,myosin binding,MF,
6167,GO:0017024,1,0.994643730944152,0,1,myosin I binding,MF,
6168,GO:0017025,1,0.850682344979352,0,25,TBP-class protein binding,MF,
6169,GO:0017034,1,0.959527058374664,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6170,GO:0017038,1,0.304774794185599,0,179,protein import,BP,
6171,GO:0017040,1,0.970776642486265,0,5,N-acylsphingosine amidohydrolase activity,MF,
6172,GO:0017042,1,0.994546697420715,0,1,glycosylceramidase activity,MF,
6173,GO:0017045,1,0.994608232017952,0,1,corticotropin-releasing hormone activity,MF,
6174,GO:0017046,1,0.790142229991794,0,35,peptide hormone binding,MF,
6175,GO:0017048,1,0.288485188041358,0,163,Rho GTPase binding,MF,
6176,GO:0017049,1,0.876784416527683,0,20,GTP-Rho binding,MF,
6177,GO:0017050,1,0.988628192692792,0,2,D-erythro-sphingosine kinase activity,MF,
6178,GO:0017053,1,0.543974624739836,0,82,transcriptional repressor complex,CC,
6179,GO:0017055,1,0.988161132236097,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6180,GO:0017056,1,0.848850464949341,0,23,structural constituent of nuclear pore,MF,
6181,GO:0017057,1,0.983352381450695,0,2,6-phosphogluconolactonase activity,MF,
6182,GO:0017059,1,0.951191618043865,0,8,serine C-palmitoyltransferase complex,CC,
6183,GO:0017060,1,0.983016721697573,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6184,GO:0017061,1,0.992488463873692,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6185,GO:0017062,1,0.946074710971722,0,9,respiratory chain complex III assembly,BP,
6186,GO:0017064,1,0.988953132972297,0,2,fatty acid amide hydrolase activity,MF,
6187,GO:0017065,1,0.994566996995852,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6188,GO:0017069,1,0.793031138671007,0,38,snRNA binding,MF,
6189,GO:0017070,1,0.934870934746417,0,11,U6 snRNA binding,MF,
6190,GO:0017071,1,0.993602387731193,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6193,GO:0017077,1,0.988961630054731,0,2,oxidative phosphorylation uncoupler activity,MF,
6194,GO:0017080,1,0.808886050538954,0,32,sodium channel regulator activity,MF,
6195,GO:0017081,1,0.902204503815348,0,15,chloride channel regulator activity,MF,
6196,GO:0017082,1,0.994184768585909,0,1,mineralocorticoid receptor activity,MF,
6197,GO:0017084,1,0.993744833423491,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6198,GO:0017085,1,0.90294233280101,0,16,response to insecticide,BP,
6199,GO:0017087,1,0.993381396256666,0,1,mitochondrial processing peptidase complex,CC,
6200,GO:0017089,1,0.988882676673559,0,2,glycolipid transporter activity,MF,
6201,GO:0017090,1,0.994101333307166,0,1,meprin A complex,CC,
6202,GO:0017091,1,0.858635519481944,0,24,AU-rich element binding,MF,
6203,GO:0017095,1,0.976237652050622,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6204,GO:0017098,1,0.988689606919866,0,2,sulfonylurea receptor binding,MF,
6205,GO:0017099,1,0.977164526400561,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6206,GO:0017101,1,0.929456382304986,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
6207,GO:0017102,1,0.988300898782848,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6208,GO:0017108,1,0.970257818846223,0,5,5'-flap endonuclease activity,MF,
6209,GO:0017109,1,0.987602563914689,0,2,glutamate-cysteine ligase complex,CC,
6210,GO:0017110,1,0.917697151400513,0,13,nucleoside-diphosphatase activity,MF,
6212,GO:0017112,1,0.697974226837511,0,51,Rab guanyl-nucleotide exchange factor activity,MF,
6213,GO:0017113,1,0.993986671338394,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6214,GO:0017116,1,0.980943668839679,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6215,GO:0017119,1,0.921454666000473,0,13,Golgi transport complex,CC,
6216,GO:0017121,1,0.938687819379403,0,10,phospholipid scrambling,BP,
6218,GO:0017125,1,0.992648879540395,0,1,deoxycytidyl transferase activity,MF,
6219,GO:0017126,1,0.99209968805571,0,1,nucleologenesis,BP,
6220,GO:0017127,1,0.902081886694348,0,15,cholesterol transporter activity,MF,
6221,GO:0017128,1,0.949668333936817,0,8,phospholipid scramblase activity,MF,
6222,GO:0017129,1,0.988099862295747,0,2,triglyceride binding,MF,
6223,GO:0017130,1,0.990699512717009,0,1,poly(C) RNA binding,MF,
6224,GO:0017133,1,0.994370192855279,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6225,GO:0017134,1,0.861332848990632,0,21,fibroblast growth factor binding,MF,
6226,GO:0017136,1,0.899168266959845,0,16,NAD-dependent histone deacetylase activity,MF,
6228,GO:0017143,1,0.988541783733204,0,2,insecticide metabolic process,BP,
6230,GO:0017145,1,0.771882585177354,0,37,stem cell division,BP,
6232,GO:0017147,1,0.812129796809883,0,31,Wnt-protein binding,MF,
6234,GO:0017150,1,0.977816556722841,0,4,tRNA dihydrouridine synthase activity,MF,
6235,GO:0017151,1,0.947865371873682,0,8,DEAD/H-box RNA helicase binding,MF,
6236,GO:0017153,1,0.939656570278397,0,9,sodium:dicarboxylate symporter activity,MF,
6237,GO:0017154,1,0.905906991680217,0,11,semaphorin receptor activity,MF,
6241,GO:0017159,1,0.982569763937485,0,3,pantetheine hydrolase activity,MF,
6242,GO:0017160,1,0.891406588574526,0,16,Ral GTPase binding,MF,
6243,GO:0017161,1,0.984111202662415,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6244,GO:0017162,1,0.937593858940659,0,9,aryl hydrocarbon receptor binding,MF,
6245,GO:0017166,1,0.919665315523736,0,10,vinculin binding,MF,
6246,GO:0017168,1,0.993290311076195,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6247,GO:0017169,1,0.96038834211226,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6249,GO:0017172,1,0.994559726584472,0,1,cysteine dioxygenase activity,MF,
6250,GO:0017174,1,0.994629782483651,0,1,glycine N-methyltransferase activity,MF,
6251,GO:0017176,1,0.961678772773434,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6252,GO:0017177,1,0.993398236143511,0,1,glucosidase II complex,CC,
6253,GO:0017178,1,0.994184768585909,0,1,diphthine-ammonia ligase activity,MF,
6254,GO:0017182,1,0.954016176691753,0,8,peptidyl-diphthamide metabolic process,BP,
6255,GO:0017183,1,0.954016176691753,0,8,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6256,GO:0017185,1,0.952830782639838,0,8,peptidyl-lysine hydroxylation,BP,
6257,GO:0017186,1,0.989005468561096,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6258,GO:0017187,1,0.955526372458096,0,8,peptidyl-glutamic acid carboxylation,BP,
6259,GO:0017188,1,0.991593678166507,0,1,aspartate N-acetyltransferase activity,MF,
6260,GO:0017196,1,0.960390100335877,0,6,N-terminal peptidyl-methionine acetylation,BP,
6261,GO:0017198,1,0.989249250744038,0,2,N-terminal peptidyl-serine acetylation,BP,
6262,GO:0018002,1,0.989249250744038,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6263,GO:0018008,1,0.984980628410901,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6264,GO:0018009,1,0.994440464053689,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6265,GO:0018011,1,0.994184768585909,0,1,N-terminal peptidyl-alanine methylation,BP,
6266,GO:0018012,1,0.994184768585909,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6267,GO:0018013,1,0.994184768585909,0,1,N-terminal peptidyl-glycine methylation,BP,
6268,GO:0018016,1,0.994184768585909,0,1,N-terminal peptidyl-proline dimethylation,BP,
6269,GO:0018022,1,0.471599110903813,0,104,peptidyl-lysine methylation,BP,
6270,GO:0018023,1,0.779061575914656,0,35,peptidyl-lysine trimethylation,BP,
6271,GO:0018024,1,0.743052347934844,0,41,histone-lysine N-methyltransferase activity,MF,
6272,GO:0018025,1,0.994184768585909,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6273,GO:0018026,1,0.946159770135179,0,8,peptidyl-lysine monomethylation,BP,
6274,GO:0018027,1,0.89983788910163,0,15,peptidyl-lysine dimethylation,BP,
6275,GO:0018032,1,0.99354389341953,0,1,protein amidation,BP,
6276,GO:0018057,1,0.975460280769028,0,4,peptidyl-lysine oxidation,BP,
6277,GO:0018063,1,0.994392976155323,0,1,cytochrome c-heme linkage,BP,
6278,GO:0018065,1,0.936880130900821,0,12,protein-cofactor linkage,BP,
6279,GO:0018076,1,0.962342373297295,0,4,N-terminal peptidyl-lysine acetylation,BP,
6280,GO:0018094,1,0.99379150230237,0,1,protein polyglycylation,BP,
6281,GO:0018095,1,0.945371483581418,0,9,protein polyglutamylation,BP,
6282,GO:0018101,1,0.981443263621124,0,3,protein citrullination,BP,
6283,GO:0018103,1,0.963659503038517,0,5,protein C-linked glycosylation,BP,
6284,GO:0018105,1,0.167116343355936,0,254,peptidyl-serine phosphorylation,BP,
6285,GO:0018106,1,0.994654046663328,0,1,peptidyl-histidine phosphorylation,BP,
6288,GO:0018114,1,0.994322778976815,0,1,threonine racemase activity,MF,
6289,GO:0018117,1,0.994553200123597,0,1,protein adenylylation,BP,
6290,GO:0018119,1,0.910615432251776,0,13,peptidyl-cysteine S-nitrosylation,BP,
6291,GO:0018125,1,0.982969055865874,0,3,peptidyl-cysteine methylation,BP,
6292,GO:0018126,1,0.869084454998119,0,22,protein hydroxylation,BP,
6294,GO:0018146,1,0.843281134449057,0,26,keratan sulfate biosynthetic process,BP,
6296,GO:0018153,1,0.988594626347888,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6297,GO:0018158,1,0.93153055460464,0,12,protein oxidation,BP,
6298,GO:0018160,1,0.994582646523443,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6299,GO:0018166,1,0.99226386778166,0,1,C-terminal protein-tyrosinylation,BP,
6300,GO:0018171,1,0.976632783647423,0,4,peptidyl-cysteine oxidation,BP,
6301,GO:0018175,1,0.994553200123597,0,1,protein nucleotidylation,BP,
6302,GO:0018192,1,0.994332998480301,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6304,GO:0018194,1,0.994184768585909,0,1,peptidyl-alanine modification,BP,
6305,GO:0018195,1,0.885011604336452,0,21,peptidyl-arginine modification,BP,
6306,GO:0018196,1,0.762486367126653,0,43,peptidyl-asparagine modification,BP,
6307,GO:0018197,1,0.977717885615387,0,3,peptidyl-aspartic acid modification,BP,
6308,GO:0018198,1,0.747365000508528,0,45,peptidyl-cysteine modification,BP,
6309,GO:0018199,1,0.977724250327377,0,4,peptidyl-glutamine modification,BP,
6310,GO:0018200,1,0.850829307588561,0,27,peptidyl-glutamic acid modification,BP,
6311,GO:0018201,1,0.979251873786745,0,3,peptidyl-glycine modification,BP,
6312,GO:0018202,1,0.940007289556813,0,10,peptidyl-histidine modification,BP,
6313,GO:0018205,1,0.0867144007773568,0,357,peptidyl-lysine modification,BP,
6314,GO:0018206,1,0.933180943099046,0,11,peptidyl-methionine modification,BP,
6315,GO:0018208,1,0.758833835300557,0,45,peptidyl-proline modification,BP,
6318,GO:0018211,1,0.963659503038517,0,5,peptidyl-tryptophan modification,BP,
6320,GO:0018214,1,0.955526372458096,0,8,protein carboxylation,BP,
6321,GO:0018216,1,0.916831378151822,0,15,peptidyl-arginine methylation,BP,
6322,GO:0018217,1,0.99331429908418,0,1,peptidyl-aspartic acid phosphorylation,BP,
6323,GO:0018230,1,0.869552014830217,0,22,peptidyl-L-cysteine S-palmitoylation,BP,
6324,GO:0018231,1,0.869552014830217,0,22,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6327,GO:0018262,1,0.988594626347888,0,2,isopeptide cross-linking,BP,
6328,GO:0018271,1,0.991454089454464,0,1,biotin-protein ligase activity,MF,
6329,GO:0018272,1,0.994535156464788,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6330,GO:0018277,1,0.99436697937206,0,1,protein deamination,BP,
6331,GO:0018279,1,0.769725952778873,0,42,protein N-linked glycosylation via asparagine,BP,
6332,GO:0018282,1,0.984801408435138,0,2,metal incorporation into metallo-sulfur cluster,BP,
6333,GO:0018283,1,0.984801408435138,0,2,iron incorporation into metallo-sulfur cluster,BP,
6334,GO:0018293,1,0.994616134288439,0,1,protein-FAD linkage,BP,
6335,GO:0018298,1,0.954598197382928,0,8,protein-chromophore linkage,BP,
6336,GO:0018307,1,0.989003959778342,0,2,enzyme active site formation,BP,
6337,GO:0018312,1,0.987860182800814,0,2,peptidyl-serine ADP-ribosylation,BP,
6338,GO:0018315,1,0.993085353964708,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6339,GO:0018317,1,0.963659503038517,0,5,protein C-linked glycosylation via tryptophan,BP,
6340,GO:0018322,1,0.99226386778166,0,1,protein tyrosinylation,BP,
6341,GO:0018323,1,0.994640893629188,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6342,GO:0018335,1,0.975077978693834,0,4,protein succinylation,BP,
6343,GO:0018342,1,0.944851532067315,0,8,protein prenylation,BP,
6344,GO:0018343,1,0.98875639582086,0,2,protein farnesylation,BP,
6345,GO:0018344,1,0.962087875566618,0,6,protein geranylgeranylation,BP,
6346,GO:0018345,1,0.817803605502304,0,32,protein palmitoylation,BP,
6347,GO:0018350,1,0.994357181974626,0,1,protein esterification,BP,
6348,GO:0018352,1,0.988930109164346,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6349,GO:0018364,1,0.989310216489753,0,2,peptidyl-glutamine methylation,BP,
6350,GO:0018377,1,0.969117708389033,0,4,protein myristoylation,BP,
6351,GO:0018393,1,0.385658696608831,0,140,internal peptidyl-lysine acetylation,BP,
6352,GO:0018394,1,0.368224298606055,0,147,peptidyl-lysine acetylation,BP,
6353,GO:0018395,1,0.993628847729139,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6354,GO:0018400,1,0.990860569539704,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6355,GO:0018401,1,0.96795084986014,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6356,GO:0018406,1,0.963659503038517,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6358,GO:0018423,1,0.988753824786103,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6359,GO:0018444,1,0.978277051369401,0,3,translation release factor complex,CC,
6360,GO:0018455,1,0.994607877748261,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6361,GO:0018467,1,0.994252334250217,0,1,formaldehyde dehydrogenase activity,MF,
6362,GO:0018478,1,0.994425885609532,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6363,GO:0018479,1,0.989007560424513,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6364,GO:0018549,1,0.994541686487349,0,1,methanethiol oxidase activity,MF,
6365,GO:0018585,1,0.994432663528536,0,1,fluorene oxygenase activity,MF,
6366,GO:0018636,1,0.983874328599682,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6367,GO:0018685,1,0.994537422946554,0,1,alkane 1-monooxygenase activity,MF,
6368,GO:0018733,1,0.994617526738012,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6369,GO:0018738,1,0.994617207446698,0,1,S-formylglutathione hydrolase activity,MF,
6370,GO:0018773,1,0.994547534938947,0,1,acetylpyruvate hydrolase activity,MF,
6371,GO:0018812,1,0.976939194758801,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6372,GO:0018872,1,0.994326736992354,0,1,arsonoacetate metabolic process,BP,
6373,GO:0018874,1,0.994462044402771,0,1,benzoate metabolic process,BP,
6374,GO:0018879,1,0.988704959385849,0,2,biphenyl metabolic process,BP,
6375,GO:0018885,1,0.994549198400433,0,1,carbon tetrachloride metabolic process,BP,
6376,GO:0018894,1,0.988541783733204,0,2,dibenzo-p-dioxin metabolic process,BP,
6377,GO:0018904,1,0.908226973104622,0,16,ether metabolic process,BP,
6378,GO:0018910,1,0.994549198400433,0,1,benzene metabolic process,BP,
6379,GO:0018916,1,0.977252812414093,0,4,nitrobenzene metabolic process,BP,
6380,GO:0018917,1,0.994432663528536,0,1,fluorene metabolic process,BP,
6381,GO:0018931,1,0.994592054250129,0,1,naphthalene metabolic process,BP,
6383,GO:0018963,1,0.988772346478989,0,2,phthalate metabolic process,BP,
6385,GO:0018969,1,0.994124556120584,0,1,thiocyanate metabolic process,BP,
6386,GO:0018992,1,0.985444991897272,0,2,germ-line sex determination,BP,
6387,GO:0018993,1,0.988190065464968,0,2,somatic sex determination,BP,
6388,GO:0018995,1,0.646473982090881,0,65,host,CC,
6390,GO:0019002,1,0.986675793923414,0,2,GMP binding,MF,
6392,GO:0019005,1,0.706899362326219,0,55,SCF ubiquitin ligase complex,CC,
6393,GO:0019008,1,0.987802509577677,0,2,molybdopterin synthase complex,CC,
6394,GO:0019034,1,0.985539969046493,0,2,viral replication complex,CC,
6395,GO:0019035,1,0.991729057835543,0,1,viral integration complex,CC,
6396,GO:0019042,1,0.930379687413851,0,11,viral latency,BP,
6397,GO:0019043,1,0.94900825961741,0,9,establishment of viral latency,BP,
6398,GO:0019045,1,0.980380648014629,0,2,latent virus replication,BP,
6399,GO:0019046,1,0.980380648014629,0,2,release from viral latency,BP,
6400,GO:0019048,1,0.796618622966447,0,32,modulation by virus of host morphology or physiology,BP,
6401,GO:0019049,1,0.972693084647571,0,4,evasion or tolerance of host defenses by virus,BP,
6402,GO:0019050,1,0.983247934862559,0,3,suppression by virus of host apoptotic process,BP,
6403,GO:0019054,1,0.870176580337934,0,21,modulation by virus of host process,BP,
6404,GO:0019056,1,0.994137289025417,0,1,modulation by virus of host transcription,BP,
6406,GO:0019060,1,0.989196984078889,0,2,intracellular transport of viral protein in host cell,BP,
6407,GO:0019061,1,0.994397304527389,0,1,uncoating of virus,BP,
6408,GO:0019062,1,0.956308425039758,0,7,virion attachment to host cell,BP,
6409,GO:0019064,1,0.965842853743896,0,6,fusion of virus membrane with host plasma membrane,BP,
6410,GO:0019065,1,0.980899321874487,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6411,GO:0019068,1,0.800619731661494,0,37,virion assembly,BP,
6412,GO:0019072,1,0.984607211354655,0,2,viral genome packaging,BP,
6413,GO:0019074,1,0.984607211354655,0,2,viral RNA genome packaging,BP,
6414,GO:0019075,1,0.988403017609477,0,2,virus maturation,BP,
6415,GO:0019076,1,0.809948371882078,0,33,viral release from host cell,BP,
6417,GO:0019080,1,0.322873873663371,0,184,viral gene expression,BP,
6418,GO:0019081,1,0.911603739121322,0,14,viral translation,BP,
6419,GO:0019082,1,0.993153185428097,0,1,viral protein processing,BP,
6420,GO:0019083,1,0.354383474072599,0,170,viral transcription,BP,
6421,GO:0019085,1,0.986741994781981,0,2,early viral transcription,BP,
6422,GO:0019086,1,0.976000561792933,0,4,late viral transcription,BP,
6423,GO:0019087,1,0.977843038206681,0,3,transformation of host cell by virus,BP,
6424,GO:0019088,1,0.994564330687402,0,1,immortalization of host cell by virus,BP,
6425,GO:0019089,1,0.991095443406033,0,1,transmission of virus,BP,
6427,GO:0019100,1,0.985444991897272,0,2,male germ-line sex determination,BP,
6428,GO:0019101,1,0.994116137405723,0,1,female somatic sex determination,BP,
6429,GO:0019102,1,0.994039204446332,0,1,male somatic sex determination,BP,
6430,GO:0019103,1,0.964851605853421,0,6,pyrimidine nucleotide binding,MF,
6431,GO:0019104,1,0.920335734901959,0,15,DNA N-glycosylase activity,MF,
6432,GO:0019107,1,0.984980628410901,0,2,myristoyltransferase activity,MF,
6433,GO:0019115,1,0.994482332589535,0,1,benzaldehyde dehydrogenase activity,MF,
6434,GO:0019118,1,0.994597284963999,0,1,phenanthrene-epoxide hydrolase activity,MF,
6435,GO:0019119,1,0.994597284963999,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6436,GO:0019135,1,0.994504929639732,0,1,deoxyhypusine monooxygenase activity,MF,
6437,GO:0019136,1,0.976047744412341,0,4,deoxynucleoside kinase activity,MF,
6438,GO:0019144,1,0.98921744023375,0,2,ADP-sugar diphosphatase activity,MF,
6439,GO:0019145,1,0.994312325987516,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6440,GO:0019150,1,0.994461909346776,0,1,D-ribulokinase activity,MF,
6441,GO:0019153,1,0.994562130410682,0,1,protein-disulfide reductase (glutathione) activity,MF,
6442,GO:0019158,1,0.966237421369263,0,5,mannokinase activity,MF,
6443,GO:0019166,1,0.983524118280044,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6444,GO:0019171,1,0.989197930064612,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6445,GO:0019184,1,0.909717794638473,0,16,nonribosomal peptide biosynthetic process,BP,
6446,GO:0019185,1,0.987011840406162,0,2,snRNA-activating protein complex,CC,
6447,GO:0019187,1,0.993369571814659,0,1,beta-1,4-mannosyltransferase activity,MF,
6448,GO:0019198,1,0.87573340361712,0,16,transmembrane receptor protein phosphatase activity,MF,
6449,GO:0019199,1,0.546530600009994,0,79,transmembrane receptor protein kinase activity,MF,
6450,GO:0019200,1,0.870791784021844,0,22,carbohydrate kinase activity,MF,
6451,GO:0019201,1,0.84378850672675,0,25,nucleotide kinase activity,MF,
6452,GO:0019202,1,0.987965615487822,0,2,amino acid kinase activity,MF,
6453,GO:0019203,1,0.951591840236699,0,8,carbohydrate phosphatase activity,MF,
6454,GO:0019205,1,0.729658826876915,0,49,nucleobase-containing compound kinase activity,MF,
6455,GO:0019206,1,0.92155097934753,0,14,nucleoside kinase activity,MF,
6460,GO:0019211,1,0.93733956403327,0,10,phosphatase activator activity,MF,
6462,GO:0019213,1,0.687021291208962,0,55,deacetylase activity,MF,
6466,GO:0019218,1,0.533948260744622,0,97,regulation of steroid metabolic process,BP,
6472,GO:0019227,1,0.956620823838718,0,6,neuronal action potential propagation,BP,
6473,GO:0019228,1,0.759871645728069,0,34,neuronal action potential,BP,
6475,GO:0019230,1,0.970201358932221,0,4,proprioception,BP,
6477,GO:0019236,1,0.977379793274201,0,4,response to pheromone,BP,
6478,GO:0019237,1,0.960954783042902,0,6,centromeric DNA binding,MF,
6479,GO:0019238,1,0.965593292251765,0,6,cyclohydrolase activity,MF,
6480,GO:0019239,1,0.833535388508255,0,30,deaminase activity,MF,
6481,GO:0019240,1,0.959948472007394,0,5,citrulline biosynthetic process,BP,
6482,GO:0019242,1,0.994454102809107,0,1,methylglyoxal biosynthetic process,BP,
6483,GO:0019243,1,0.988670561288252,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6484,GO:0019244,1,0.994610214985716,0,1,lactate biosynthetic process from pyruvate,BP,
6485,GO:0019249,1,0.980506549773275,0,3,lactate biosynthetic process,BP,
6486,GO:0019254,1,0.982846288391186,0,3,carnitine metabolic process, CoA-linked,BP,
6487,GO:0019255,1,0.988946070450769,0,2,glucose 1-phosphate metabolic process,BP,
6488,GO:0019262,1,0.967562984005781,0,6,N-acetylneuraminate catabolic process,BP,
6489,GO:0019264,1,0.988770817401512,0,2,glycine biosynthetic process from serine,BP,
6490,GO:0019265,1,0.994561275999617,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6491,GO:0019276,1,0.987535440462424,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6492,GO:0019285,1,0.98732633209369,0,2,glycine betaine biosynthetic process from choline,BP,
6493,GO:0019287,1,0.98367628207679,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6494,GO:0019290,1,0.994109337919242,0,1,siderophore biosynthetic process,BP,
6495,GO:0019303,1,0.989261499395662,0,2,D-ribose catabolic process,BP,
6498,GO:0019319,1,0.649918189301826,0,70,hexose biosynthetic process,BP,
6500,GO:0019321,1,0.92449594357858,0,14,pentose metabolic process,BP,
6501,GO:0019322,1,0.978106376802005,0,4,pentose biosynthetic process,BP,
6502,GO:0019323,1,0.972132902205735,0,5,pentose catabolic process,BP,
6504,GO:0019341,1,0.994268552029504,0,1,dibenzo-p-dioxin catabolic process,BP,
6505,GO:0019343,1,0.988837798652254,0,2,cysteine biosynthetic process via cystathionine,BP,
6506,GO:0019344,1,0.983266143425104,0,3,cysteine biosynthetic process,BP,
6507,GO:0019346,1,0.977325919388453,0,4,transsulfuration,BP,
6508,GO:0019348,1,0.970824566529454,0,5,dolichol metabolic process,BP,
6509,GO:0019353,1,0.994222284582967,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6510,GO:0019355,1,0.980036921918616,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6511,GO:0019357,1,0.994184768585909,0,1,nicotinate nucleotide biosynthetic process,BP,
6512,GO:0019358,1,0.994184768585909,0,1,nicotinate nucleotide salvage,BP,
6516,GO:0019364,1,0.983094398728271,0,3,pyridine nucleotide catabolic process,BP,
6517,GO:0019365,1,0.994184768585909,0,1,pyridine nucleotide salvage,BP,
6518,GO:0019367,1,0.963818630025933,0,6,fatty acid elongation, saturated fatty acid,BP,
6519,GO:0019368,1,0.963818630025933,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6520,GO:0019369,1,0.782676219080321,0,41,arachidonic acid metabolic process,BP,
6521,GO:0019370,1,0.938921142990216,0,11,leukotriene biosynthetic process,BP,
6522,GO:0019371,1,0.935513020067766,0,11,cyclooxygenase pathway,BP,
6523,GO:0019372,1,0.912701198216597,0,16,lipoxygenase pathway,BP,
6524,GO:0019373,1,0.938564786995605,0,11,epoxygenase P450 pathway,BP,
6525,GO:0019374,1,0.953125020487665,0,8,galactolipid metabolic process,BP,
6526,GO:0019375,1,0.971584093028169,0,5,galactolipid biosynthetic process,BP,
6527,GO:0019376,1,0.994117265092799,0,1,galactolipid catabolic process,BP,
6528,GO:0019377,1,0.927148603815227,0,13,glycolipid catabolic process,BP,
6529,GO:0019388,1,0.945010033281056,0,9,galactose catabolic process,BP,
6530,GO:0019389,1,0.994253704350216,0,1,glucuronoside metabolic process,BP,
6531,GO:0019391,1,0.994253704350216,0,1,glucuronoside catabolic process,BP,
6532,GO:0019395,1,0.544656475913003,0,95,fatty acid oxidation,BP,
6533,GO:0019400,1,0.909235382416789,0,15,alditol metabolic process,BP,
6534,GO:0019401,1,0.966002699122722,0,6,alditol biosynthetic process,BP,
6535,GO:0019402,1,0.99459741595704,0,1,galactitol metabolic process,BP,
6536,GO:0019405,1,0.962168960178926,0,5,alditol catabolic process,BP,
6537,GO:0019406,1,0.994592054250129,0,1,hexitol biosynthetic process,BP,
6538,GO:0019407,1,0.99430288163403,0,1,hexitol catabolic process,BP,
6539,GO:0019408,1,0.986885060987992,0,2,dolichol biosynthetic process,BP,
6540,GO:0019413,1,0.98700612746245,0,2,acetate biosynthetic process,BP,
6541,GO:0019417,1,0.987121720100747,0,2,sulfur oxidation,BP,
6542,GO:0019418,1,0.978357359865606,0,4,sulfide oxidation,BP,
6543,GO:0019427,1,0.98700612746245,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6544,GO:0019430,1,0.876709660849976,0,22,removal of superoxide radicals,BP,
6545,GO:0019432,1,0.835052029773327,0,28,triglyceride biosynthetic process,BP,
6549,GO:0019441,1,0.965539668699823,0,6,tryptophan catabolic process to kynurenine,BP,
6550,GO:0019442,1,0.989153092443555,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6551,GO:0019448,1,0.983483479201494,0,3,L-cysteine catabolic process,BP,
6552,GO:0019464,1,0.982600273448858,0,3,glycine decarboxylation via glycine cleavage system,BP,
6553,GO:0019470,1,0.977035831920756,0,4,4-hydroxyproline catabolic process,BP,
6554,GO:0019471,1,0.94064526021068,0,10,4-hydroxyproline metabolic process,BP,
6555,GO:0019474,1,0.974723518753772,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6556,GO:0019477,1,0.974723518753772,0,4,L-lysine catabolic process,BP,
6557,GO:0019478,1,0.989149427734643,0,2,D-amino acid catabolic process,BP,
6558,GO:0019482,1,0.976762489779501,0,4,beta-alanine metabolic process,BP,
6559,GO:0019483,1,0.988478445954467,0,2,beta-alanine biosynthetic process,BP,
6560,GO:0019493,1,0.994481956762006,0,1,arginine catabolic process to proline,BP,
6561,GO:0019509,1,0.97047026004299,0,5,L-methionine salvage from methylthioadenosine,BP,
6562,GO:0019510,1,0.994391633946583,0,1,S-adenosylhomocysteine catabolic process,BP,
6563,GO:0019511,1,0.921315949851925,0,13,peptidyl-proline hydroxylation,BP,
6564,GO:0019516,1,0.988917236191917,0,2,lactate oxidation,BP,
6565,GO:0019518,1,0.99456449867657,0,1,L-threonine catabolic process to glycine,BP,
6566,GO:0019519,1,0.99430288163403,0,1,pentitol metabolic process,BP,
6567,GO:0019520,1,0.988707913984206,0,2,aldonic acid metabolic process,BP,
6568,GO:0019521,1,0.988707913984206,0,2,D-gluconate metabolic process,BP,
6569,GO:0019527,1,0.99430288163403,0,1,pentitol catabolic process,BP,
6570,GO:0019530,1,0.961545875420646,0,6,taurine metabolic process,BP,
6571,GO:0019531,1,0.940158191092309,0,9,oxalate transmembrane transporter activity,MF,
6572,GO:0019532,1,0.935041780965582,0,10,oxalate transport,BP,
6573,GO:0019534,1,0.967684406358766,0,4,toxin transmembrane transporter activity,MF,
6575,GO:0019541,1,0.975902224835043,0,4,propionate metabolic process,BP,
6576,GO:0019542,1,0.98700612746245,0,2,propionate biosynthetic process,BP,
6577,GO:0019543,1,0.988751379001487,0,2,propionate catabolic process,BP,
6578,GO:0019544,1,0.994481956762006,0,1,arginine catabolic process to glutamate,BP,
6579,GO:0019546,1,0.994396973404851,0,1,arginine deiminase pathway,BP,
6580,GO:0019547,1,0.989097338762491,0,2,arginine catabolic process to ornithine,BP,
6581,GO:0019550,1,0.988807156452216,0,2,glutamate catabolic process to aspartate,BP,
6582,GO:0019551,1,0.988807156452216,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6583,GO:0019556,1,0.976929112336658,0,4,histidine catabolic process to glutamate and formamide,BP,
6584,GO:0019557,1,0.976929112336658,0,4,histidine catabolic process to glutamate and formate,BP,
6585,GO:0019563,1,0.967683775014148,0,4,glycerol catabolic process,BP,
6586,GO:0019566,1,0.988403017609477,0,2,arabinose metabolic process,BP,
6587,GO:0019585,1,0.953278300702478,0,8,glucuronate metabolic process,BP,
6588,GO:0019605,1,0.988989138836514,0,2,butyrate metabolic process,BP,
6590,GO:0019626,1,0.953286297594402,0,8,short-chain fatty acid catabolic process,BP,
6591,GO:0019627,1,0.923211998603998,0,13,urea metabolic process,BP,
6593,GO:0019640,1,0.971996053182398,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6594,GO:0019646,1,0.910932308051993,0,16,aerobic electron transport chain,BP,
6595,GO:0019673,1,0.962471155154618,0,7,GDP-mannose metabolic process,BP,
6597,GO:0019676,1,0.987474266871365,0,2,ammonia assimilation cycle,BP,
6598,GO:0019677,1,0.988392888874223,0,2,NAD catabolic process,BP,
6599,GO:0019682,1,0.883421540253475,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6600,GO:0019692,1,0.838057693911133,0,31,deoxyribose phosphate metabolic process,BP,
6602,GO:0019694,1,0.961545875420646,0,6,alkanesulfonate metabolic process,BP,
6603,GO:0019695,1,0.945587823073035,0,9,choline metabolic process,BP,
6604,GO:0019706,1,0.842429734080824,0,27,protein-cysteine S-palmitoyltransferase activity,MF,
6605,GO:0019707,1,0.842429734080824,0,27,protein-cysteine S-acyltransferase activity,MF,
6606,GO:0019720,1,0.964291290958706,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6613,GO:0019740,1,0.967961785867508,0,5,nitrogen utilization,BP,
6614,GO:0019742,1,0.99435107751118,0,1,pentacyclic triterpenoid metabolic process,BP,
6615,GO:0019747,1,0.989286098556009,0,2,regulation of isoprenoid metabolic process,BP,
6616,GO:0019748,1,0.702914191587836,0,56,secondary metabolic process,BP,
6617,GO:0019751,1,0.510300808750403,0,101,polyol metabolic process,BP,
6619,GO:0019755,1,0.94861903631945,0,9,one-carbon compound transport,BP,
6620,GO:0019763,1,0.971785858424053,0,5,immunoglobulin receptor activity,MF,
6621,GO:0019767,1,0.994661017801081,0,1,IgE receptor activity,MF,
6622,GO:0019770,1,0.989121850886028,0,2,IgG receptor activity,MF,
6623,GO:0019772,1,0.994560847088753,0,1,low-affinity IgG receptor activity,MF,
6624,GO:0019773,1,0.962962514860184,0,7,proteasome core complex, alpha-subunit complex,CC,
6625,GO:0019774,1,0.95270642599686,0,9,proteasome core complex, beta-subunit complex,CC,
6626,GO:0019776,1,0.981559892212746,0,3,Atg8 ligase activity,MF,
6627,GO:0019777,1,0.989010640583051,0,2,Atg12 transferase activity,MF,
6628,GO:0019778,1,0.992437925305889,0,1,Atg12 activating enzyme activity,MF,
6629,GO:0019779,1,0.992437925305889,0,1,Atg8 activating enzyme activity,MF,
6630,GO:0019780,1,0.991025648032757,0,1,FAT10 activating enzyme activity,MF,
6631,GO:0019781,1,0.988996317508782,0,2,NEDD8 activating enzyme activity,MF,
6632,GO:0019782,1,0.993847748337627,0,1,ISG15 activating enzyme activity,MF,
6633,GO:0019783,1,0.487136173912469,0,98,ubiquitin-like protein-specific protease activity,MF,
6634,GO:0019784,1,0.961137103872873,0,7,NEDD8-specific protease activity,MF,
6635,GO:0019785,1,0.987757629439371,0,2,ISG15-specific protease activity,MF,
6636,GO:0019787,1,0.0452785956773827,0,446,ubiquitin-like protein transferase activity,MF,
6637,GO:0019788,1,0.963603092631186,0,6,NEDD8 transferase activity,MF,
6638,GO:0019789,1,0.898582550173829,0,16,SUMO transferase activity,MF,
6639,GO:0019797,1,0.982654556248871,0,3,procollagen-proline 3-dioxygenase activity,MF,
6640,GO:0019798,1,0.960466138168161,0,7,procollagen-proline dioxygenase activity,MF,
6641,GO:0019799,1,0.994184768585909,0,1,tubulin N-acetyltransferase activity,MF,
6642,GO:0019800,1,0.965166317451176,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6643,GO:0019805,1,0.981689893699397,0,3,quinolinate biosynthetic process,BP,
6644,GO:0019807,1,0.994594498140637,0,1,aspartoacylase activity,MF,
6645,GO:0019808,1,0.977779476656726,0,4,polyamine binding,MF,
6646,GO:0019809,1,0.983787184884968,0,3,spermidine binding,MF,
6647,GO:0019810,1,0.993894280649677,0,1,putrescine binding,MF,
6648,GO:0019811,1,0.99284021766627,0,1,cocaine binding,MF,
6649,GO:0019814,1,0.970784166322975,0,5,immunoglobulin complex,CC,
6650,GO:0019815,1,0.981719433110481,0,3,B cell receptor complex,CC,
6651,GO:0019825,1,0.823729252318946,0,33,oxygen binding,MF,
6652,GO:0019826,1,0.97819936509609,0,3,oxygen sensor activity,MF,
6653,GO:0019827,1,0.352353528609433,0,147,stem cell population maintenance,BP,
6654,GO:0019828,1,0.981182433798788,0,3,aspartic-type endopeptidase inhibitor activity,MF,
6655,GO:0019829,1,0.701956285900321,0,51,cation-transporting ATPase activity,MF,
6657,GO:0019835,1,0.841682871325511,0,30,cytolysis,BP,
6658,GO:0019836,1,0.988663882122091,0,2,hemolysis by symbiont of host erythrocytes,BP,
6663,GO:0019843,1,0.723703767282972,0,55,rRNA binding,MF,
6664,GO:0019852,1,0.939775194352384,0,10,L-ascorbic acid metabolic process,BP,
6665,GO:0019853,1,0.98910674084631,0,2,L-ascorbic acid biosynthetic process,BP,
6666,GO:0019855,1,0.944224360155108,0,9,calcium channel inhibitor activity,MF,
6667,GO:0019856,1,0.954766890506268,0,6,pyrimidine nucleobase biosynthetic process,BP,
6668,GO:0019857,1,0.964137453519136,0,3,5-methylcytosine metabolic process,BP,
6669,GO:0019858,1,0.988234555295635,0,2,cytosine metabolic process,BP,
6670,GO:0019859,1,0.982952380432702,0,3,thymine metabolic process,BP,
6671,GO:0019860,1,0.983089243994654,0,3,uracil metabolic process,BP,
6672,GO:0019862,1,0.994567162121042,0,1,IgA binding,MF,
6674,GO:0019864,1,0.951622671974739,0,9,IgG binding,MF,
6677,GO:0019867,1,0.293460007074588,0,183,outer membrane,CC,
6678,GO:0019869,1,0.935342057341109,0,9,chloride channel inhibitor activity,MF,
6679,GO:0019870,1,0.954042553834446,0,6,potassium channel inhibitor activity,MF,
6680,GO:0019871,1,0.957066014933915,0,6,sodium channel inhibitor activity,MF,
6681,GO:0019878,1,0.985767478784131,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6683,GO:0019883,1,0.932953047140365,0,11,antigen processing and presentation of endogenous antigen,BP,
6685,GO:0019885,1,0.95515881010126,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6689,GO:0019894,1,0.768185688730343,0,37,kinesin binding,MF,
6690,GO:0019896,1,0.925435613266934,0,11,axonal transport of mitochondrion,BP,
6696,GO:0019902,1,0.318706701034553,0,164,phosphatase binding,MF,
6697,GO:0019903,1,0.452757635595797,0,116,protein phosphatase binding,MF,
6700,GO:0019907,1,0.954997214506152,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6701,GO:0019908,1,0.896885572338552,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6702,GO:0019911,1,0.944166234960402,0,10,structural constituent of myelin sheath,MF,
6703,GO:0019912,1,0.988830201975004,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6704,GO:0019915,1,0.668259227870292,0,59,lipid storage,BP,
6705,GO:0019918,1,0.977254774340434,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6706,GO:0019919,1,0.955413128928563,0,8,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6709,GO:0019934,1,0.93683181597571,0,10,cGMP-mediated signaling,BP,
6711,GO:0019941,1,0.0239613857921921,0,549,modification-dependent protein catabolic process,BP,
6712,GO:0019948,1,0.98859942194881,0,2,SUMO activating enzyme activity,MF,
6716,GO:0019957,1,0.943934296607306,0,10,C-C chemokine binding,MF,
6717,GO:0019958,1,0.964221166774166,0,6,C-X-C chemokine binding,MF,
6718,GO:0019959,1,0.981342409746306,0,3,interleukin-8 binding,MF,
6719,GO:0019960,1,0.962505805954013,0,5,C-X3-C chemokine binding,MF,
6720,GO:0019961,1,0.98517745402864,0,2,interferon binding,MF,
6721,GO:0019962,1,0.991376990031585,0,1,type I interferon binding,MF,
6722,GO:0019964,1,0.993747079864795,0,1,interferon-gamma binding,MF,
6723,GO:0019966,1,0.95464999421456,0,7,interleukin-1 binding,MF,
6724,GO:0019969,1,0.993550357556631,0,1,interleukin-10 binding,MF,
6725,GO:0019970,1,0.993940097846777,0,1,interleukin-11 binding,MF,
6726,GO:0019972,1,0.994587153829369,0,1,interleukin-12 binding,MF,
6727,GO:0019975,1,0.994587153829369,0,1,interleukin-17 binding,MF,
6728,GO:0019976,1,0.98188392477902,0,3,interleukin-2 binding,MF,
6729,GO:0019981,1,0.987184295453488,0,2,interleukin-6 binding,MF,
6730,GO:0019985,1,0.781414065477083,0,38,translesion synthesis,BP,
6731,GO:0019988,1,0.994202692183443,0,1,charged-tRNA amino acid modification,BP,
6732,GO:0019992,1,0.911412586949211,0,12,diacylglycerol binding,MF,
6733,GO:0020003,1,0.983145880158852,0,3,symbiont-containing vacuole,CC,
6734,GO:0020005,1,0.988897186980019,0,2,symbiont-containing vacuole membrane,CC,
6735,GO:0020012,1,0.986482973643855,0,2,evasion or tolerance of host immune response,BP,
6736,GO:0020016,1,0.980375967782619,0,3,ciliary pocket,CC,
6737,GO:0020018,1,0.980375967782619,0,3,ciliary pocket membrane,CC,
6738,GO:0020021,1,0.994564330687402,0,1,immortalization of host cell,BP,
6739,GO:0020027,1,0.921625270697112,0,14,hemoglobin metabolic process,BP,
6740,GO:0020037,1,0.539023045746359,0,99,heme binding,MF,
6741,GO:0021501,1,0.99445465763235,0,1,prechordal plate formation,BP,
6742,GO:0021502,1,0.981153066136352,0,3,neural fold elevation formation,BP,
6743,GO:0021503,1,0.989234443512697,0,1,neural fold bending,BP,
6744,GO:0021508,1,0.990746043434484,0,1,floor plate formation,BP,
6745,GO:0021509,1,0.994479816653063,0,1,roof plate formation,BP,
6747,GO:0021511,1,0.848879221780495,0,24,spinal cord patterning,BP,
6748,GO:0021512,1,0.993095082245681,0,1,spinal cord anterior/posterior patterning,BP,
6749,GO:0021513,1,0.86644947495941,0,22,spinal cord dorsal/ventral patterning,BP,
6750,GO:0021514,1,0.896673566239814,0,16,ventral spinal cord interneuron differentiation,BP,
6752,GO:0021516,1,0.891711520119452,0,18,dorsal spinal cord development,BP,
6754,GO:0021519,1,0.994607640841943,0,1,spinal cord association neuron specification,BP,
6755,GO:0021520,1,0.922083897441437,0,12,spinal cord motor neuron cell fate specification,BP,
6756,GO:0021521,1,0.931293545339302,0,10,ventral spinal cord interneuron specification,BP,
6758,GO:0021523,1,0.974226550466661,0,4,somatic motor neuron differentiation,BP,
6759,GO:0021524,1,0.983398528769481,0,3,visceral motor neuron differentiation,BP,
6760,GO:0021526,1,0.988898668144313,0,2,medial motor column neuron differentiation,BP,
6761,GO:0021527,1,0.93136946512032,0,11,spinal cord association neuron differentiation,BP,
6762,GO:0021528,1,0.994184768585909,0,1,commissural neuron differentiation in spinal cord,BP,
6763,GO:0021529,1,0.983198212761941,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6764,GO:0021530,1,0.983198212761941,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6765,GO:0021532,1,0.787214477878468,0,35,neural tube patterning,BP,
6766,GO:0021533,1,0.876267818991916,0,17,cell differentiation in hindbrain,BP,
6767,GO:0021534,1,0.926124255689328,0,11,cell proliferation in hindbrain,BP,
6768,GO:0021535,1,0.90614210658422,0,13,cell migration in hindbrain,BP,
6769,GO:0021536,1,0.625287389012276,0,70,diencephalon development,BP,
6771,GO:0021538,1,0.977973157529106,0,3,epithalamus development,BP,
6772,GO:0021539,1,0.989005048220515,0,2,subthalamus development,BP,
6773,GO:0021540,1,0.964018075789405,0,5,corpus callosum morphogenesis,BP,
6774,GO:0021541,1,0.993122870926,0,1,ammon gyrus development,BP,
6775,GO:0021542,1,0.90525209116847,0,15,dentate gyrus development,BP,
6777,GO:0021544,1,0.851177340202787,0,23,subpallium development,BP,
6778,GO:0021545,1,0.754780332733271,0,41,cranial nerve development,BP,
6779,GO:0021546,1,0.971110555072291,0,5,rhombomere development,BP,
6780,GO:0021547,1,0.99445465763235,0,1,midbrain-hindbrain boundary initiation,BP,
6782,GO:0021549,1,0.546571737713196,0,85,cerebellum development,BP,
6783,GO:0021550,1,0.994325157917915,0,1,medulla oblongata development,BP,
6784,GO:0021551,1,0.986326223511314,0,1,central nervous system morphogenesis,BP,
6785,GO:0021553,1,0.974197096252874,0,3,olfactory nerve development,BP,
6786,GO:0021554,1,0.92180822793436,0,11,optic nerve development,BP,
6787,GO:0021555,1,0.981449680310235,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6788,GO:0021557,1,0.988486913615085,0,2,oculomotor nerve development,BP,
6789,GO:0021558,1,0.994585137910175,0,1,trochlear nerve development,BP,
6790,GO:0021559,1,0.937011530194847,0,10,trigeminal nerve development,BP,
6791,GO:0021560,1,0.988203946602503,0,2,abducens nerve development,BP,
6792,GO:0021561,1,0.941325340146274,0,9,facial nerve development,BP,
6793,GO:0021562,1,0.959370648710316,0,6,vestibulocochlear nerve development,BP,
6794,GO:0021563,1,0.96342475753302,0,5,glossopharyngeal nerve development,BP,
6795,GO:0021564,1,0.975728467196417,0,3,vagus nerve development,BP,
6796,GO:0021566,1,0.99246695504308,0,1,hypoglossal nerve development,BP,
6797,GO:0021568,1,0.99460140049878,0,1,rhombomere 2 development,BP,
6798,GO:0021569,1,0.988739026232771,0,2,rhombomere 3 development,BP,
6799,GO:0021570,1,0.994562300748155,0,1,rhombomere 4 development,BP,
6800,GO:0021571,1,0.988012308252463,0,2,rhombomere 5 development,BP,
6801,GO:0021572,1,0.993831345478473,0,1,rhombomere 6 development,BP,
6802,GO:0021575,1,0.758911725581831,0,37,hindbrain morphogenesis,BP,
6803,GO:0021577,1,0.987659587600188,0,2,hindbrain structural organization,BP,
6806,GO:0021587,1,0.773758489962365,0,34,cerebellum morphogenesis,BP,
6807,GO:0021589,1,0.987659587600188,0,2,cerebellum structural organization,BP,
6808,GO:0021590,1,0.977742486829519,0,3,cerebellum maturation,BP,
6809,GO:0021591,1,0.839237972689731,0,24,ventricular system development,BP,
6810,GO:0021592,1,0.992150384852603,0,1,fourth ventricle development,BP,
6811,GO:0021593,1,0.994145205774216,0,1,rhombomere morphogenesis,BP,
6812,GO:0021594,1,0.994145205774216,0,1,rhombomere formation,BP,
6813,GO:0021598,1,0.988203946602503,0,2,abducens nerve morphogenesis,BP,
6814,GO:0021599,1,0.988203946602503,0,2,abducens nerve formation,BP,
6815,GO:0021602,1,0.850370616913423,0,24,cranial nerve morphogenesis,BP,
6816,GO:0021603,1,0.962096366074435,0,6,cranial nerve formation,BP,
6817,GO:0021604,1,0.942241146194404,0,9,cranial nerve structural organization,BP,
6818,GO:0021610,1,0.941325340146274,0,9,facial nerve morphogenesis,BP,
6819,GO:0021612,1,0.95397656512441,0,7,facial nerve structural organization,BP,
6820,GO:0021615,1,0.975936634108868,0,4,glossopharyngeal nerve morphogenesis,BP,
6821,GO:0021618,1,0.99246695504308,0,1,hypoglossal nerve morphogenesis,BP,
6822,GO:0021622,1,0.993868907053491,0,1,oculomotor nerve morphogenesis,BP,
6823,GO:0021623,1,0.993868907053491,0,1,oculomotor nerve formation,BP,
6825,GO:0021631,1,0.954936138940225,0,6,optic nerve morphogenesis,BP,
6826,GO:0021633,1,0.98770417981549,0,2,optic nerve structural organization,BP,
6827,GO:0021634,1,0.993222108242155,0,1,optic nerve formation,BP,
6828,GO:0021636,1,0.964845533414243,0,5,trigeminal nerve morphogenesis,BP,
6829,GO:0021637,1,0.964845533414243,0,5,trigeminal nerve structural organization,BP,
6830,GO:0021644,1,0.988398514720232,0,2,vagus nerve morphogenesis,BP,
6831,GO:0021648,1,0.974026619088705,0,4,vestibulocochlear nerve morphogenesis,BP,
6832,GO:0021649,1,0.994320787029434,0,1,vestibulocochlear nerve structural organization,BP,
6833,GO:0021650,1,0.979591069792565,0,3,vestibulocochlear nerve formation,BP,
6834,GO:0021658,1,0.994145205774216,0,1,rhombomere 3 morphogenesis,BP,
6835,GO:0021660,1,0.994145205774216,0,1,rhombomere 3 formation,BP,
6836,GO:0021664,1,0.994145205774216,0,1,rhombomere 5 morphogenesis,BP,
6837,GO:0021666,1,0.994145205774216,0,1,rhombomere 5 formation,BP,
6838,GO:0021670,1,0.93085084241472,0,10,lateral ventricle development,BP,
6840,GO:0021678,1,0.981574728676026,0,3,third ventricle development,BP,
6841,GO:0021679,1,0.987926323797839,0,2,cerebellar molecular layer development,BP,
6842,GO:0021680,1,0.848466538872157,0,21,cerebellar Purkinje cell layer development,BP,
6843,GO:0021681,1,0.913097501519047,0,13,cerebellar granular layer development,BP,
6844,GO:0021682,1,0.991752765240912,0,1,nerve maturation,BP,
6845,GO:0021683,1,0.937535342926517,0,9,cerebellar granular layer morphogenesis,BP,
6846,GO:0021684,1,0.952090144241583,0,7,cerebellar granular layer formation,BP,
6847,GO:0021685,1,0.990264525709011,0,1,cerebellar granular layer structural organization,BP,
6848,GO:0021686,1,0.9945542757273,0,1,cerebellar granular layer maturation,BP,
6849,GO:0021687,1,0.987926323797839,0,2,cerebellar molecular layer morphogenesis,BP,
6850,GO:0021688,1,0.993859771479433,0,1,cerebellar molecular layer formation,BP,
6851,GO:0021691,1,0.983097072579629,0,2,cerebellar Purkinje cell layer maturation,BP,
6852,GO:0021692,1,0.907089518657067,0,11,cerebellar Purkinje cell layer morphogenesis,BP,
6853,GO:0021693,1,0.984183482670387,0,2,cerebellar Purkinje cell layer structural organization,BP,
6854,GO:0021694,1,0.931252322165035,0,8,cerebellar Purkinje cell layer formation,BP,
6855,GO:0021695,1,0.728391766192635,0,44,cerebellar cortex development,BP,
6856,GO:0021696,1,0.808847363242969,0,28,cerebellar cortex morphogenesis,BP,
6857,GO:0021697,1,0.863703452208819,0,19,cerebellar cortex formation,BP,
6858,GO:0021698,1,0.984183482670387,0,2,cerebellar cortex structural organization,BP,
6859,GO:0021699,1,0.977742486829519,0,3,cerebellar cortex maturation,BP,
6861,GO:0021702,1,0.931252322165035,0,8,cerebellar Purkinje cell differentiation,BP,
6862,GO:0021707,1,0.952090144241583,0,7,cerebellar granule cell differentiation,BP,
6863,GO:0021718,1,0.987806639166044,0,2,superior olivary nucleus development,BP,
6864,GO:0021722,1,0.987806639166044,0,2,superior olivary nucleus maturation,BP,
6865,GO:0021730,1,0.983515908724806,0,2,trigeminal sensory nucleus development,BP,
6866,GO:0021740,1,0.983515908724806,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6867,GO:0021747,1,0.978592641502284,0,3,cochlear nucleus development,BP,
6868,GO:0021750,1,0.994325157917915,0,1,vestibular nucleus development,BP,
6869,GO:0021756,1,0.884488659060631,0,17,striatum development,BP,
6870,GO:0021757,1,0.993611499054393,0,1,caudate nucleus development,BP,
6871,GO:0021758,1,0.993611499054393,0,1,putamen development,BP,
6872,GO:0021759,1,0.975067050251766,0,4,globus pallidus development,BP,
6873,GO:0021761,1,0.508427367824729,0,96,limbic system development,BP,
6875,GO:0021763,1,0.994410302375483,0,1,subthalamic nucleus development,BP,
6876,GO:0021764,1,0.965242619009271,0,4,amygdala development,BP,
6877,GO:0021766,1,0.600189827969872,0,72,hippocampus development,BP,
6878,GO:0021767,1,0.988605630001894,0,1,mammillary body development,BP,
6879,GO:0021768,1,0.99372299694308,0,1,nucleus accumbens development,BP,
6880,GO:0021769,1,0.974023596559281,0,4,orbitofrontal cortex development,BP,
6881,GO:0021771,1,0.991736643198097,0,1,lateral geniculate nucleus development,BP,
6883,GO:0021773,1,0.974925749882242,0,3,striatal medium spiny neuron differentiation,BP,
6884,GO:0021775,1,0.972932403183199,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6885,GO:0021776,1,0.972932403183199,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6886,GO:0021778,1,0.963080510938264,0,5,oligodendrocyte cell fate specification,BP,
6887,GO:0021779,1,0.963080510938264,0,5,oligodendrocyte cell fate commitment,BP,
6888,GO:0021780,1,0.963080510938264,0,5,glial cell fate specification,BP,
6889,GO:0021781,1,0.922302491679923,0,12,glial cell fate commitment,BP,
6891,GO:0021783,1,0.913556573234188,0,13,preganglionic parasympathetic fiber development,BP,
6892,GO:0021784,1,0.988482627816693,0,2,postganglionic parasympathetic fiber development,BP,
6893,GO:0021785,1,0.941214747689022,0,7,branchiomotor neuron axon guidance,BP,
6894,GO:0021793,1,0.993792966113969,0,1,chemorepulsion of branchiomotor axon,BP,
6895,GO:0021794,1,0.911689408073126,0,13,thalamus development,BP,
6896,GO:0021795,1,0.763027894162931,0,38,cerebral cortex cell migration,BP,
6897,GO:0021796,1,0.961151123108576,0,6,cerebral cortex regionalization,BP,
6898,GO:0021797,1,0.982675502158978,0,3,forebrain anterior/posterior pattern specification,BP,
6899,GO:0021798,1,0.95153823329918,0,7,forebrain dorsal/ventral pattern formation,BP,
6900,GO:0021799,1,0.839555454535059,0,24,cerebral cortex radially oriented cell migration,BP,
6901,GO:0021800,1,0.936752487886722,0,8,cerebral cortex tangential migration,BP,
6902,GO:0021801,1,0.879948084049538,0,17,cerebral cortex radial glia guided migration,BP,
6903,GO:0021812,1,0.985910783157718,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6904,GO:0021813,1,0.994276042496976,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6905,GO:0021814,1,0.960878181966426,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6906,GO:0021815,1,0.973173770121007,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6907,GO:0021817,1,0.973173770121007,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6908,GO:0021819,1,0.922389885834876,0,11,layer formation in cerebral cortex,BP,
6909,GO:0021822,1,0.994439153190802,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6910,GO:0021823,1,0.98264957176644,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6911,GO:0021824,1,0.986152942757343,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6912,GO:0021825,1,0.969040403961766,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6913,GO:0021826,1,0.948940022402764,0,8,substrate-independent telencephalic tangential migration,BP,
6914,GO:0021827,1,0.98264957176644,0,2,postnatal olfactory bulb interneuron migration,BP,
6915,GO:0021828,1,0.986152942757343,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6916,GO:0021830,1,0.948940022402764,0,8,interneuron migration from the subpallium to the cortex,BP,
6917,GO:0021831,1,0.994138386097205,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6918,GO:0021836,1,0.98264957176644,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6919,GO:0021840,1,0.987969637214906,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6920,GO:0021842,1,0.987969637214906,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6921,GO:0021843,1,0.948940022402764,0,8,substrate-independent telencephalic tangential interneuron migration,BP,
6922,GO:0021846,1,0.825621862990178,0,25,cell proliferation in forebrain,BP,
6923,GO:0021847,1,0.979551759684196,0,3,ventricular zone neuroblast division,BP,
6924,GO:0021849,1,0.987391948235463,0,2,neuroblast division in subventricular zone,BP,
6925,GO:0021853,1,0.966462925537687,0,5,cerebral cortex GABAergic interneuron migration,BP,
6926,GO:0021854,1,0.895796569637532,0,18,hypothalamus development,BP,
6927,GO:0021855,1,0.980639879201394,0,3,hypothalamus cell migration,BP,
6928,GO:0021856,1,0.986152942757343,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6929,GO:0021859,1,0.938244783906255,0,8,pyramidal neuron differentiation,BP,
6930,GO:0021860,1,0.947472967569,0,7,pyramidal neuron development,BP,
6931,GO:0021861,1,0.956593800856447,0,7,forebrain radial glial cell differentiation,BP,
6932,GO:0021869,1,0.959701790527927,0,6,forebrain ventricular zone progenitor cell division,BP,
6933,GO:0021870,1,0.991384504393222,0,1,Cajal-Retzius cell differentiation,BP,
6934,GO:0021871,1,0.869581974615003,0,21,forebrain regionalization,BP,
6935,GO:0021872,1,0.651018467912162,0,61,forebrain generation of neurons,BP,
6936,GO:0021873,1,0.948764196090942,0,7,forebrain neuroblast division,BP,
6937,GO:0021877,1,0.933742665972384,0,10,forebrain neuron fate commitment,BP,
6938,GO:0021879,1,0.70041315986636,0,51,forebrain neuron differentiation,BP,
6939,GO:0021881,1,0.993798445476456,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6940,GO:0021882,1,0.988816202750704,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6941,GO:0021884,1,0.824596050561169,0,27,forebrain neuron development,BP,
6943,GO:0021886,1,0.980864739494667,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6944,GO:0021888,1,0.980864739494667,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6945,GO:0021889,1,0.917865523561034,0,11,olfactory bulb interneuron differentiation,BP,
6946,GO:0021891,1,0.948103073614904,0,7,olfactory bulb interneuron development,BP,
6947,GO:0021892,1,0.939828383515683,0,10,cerebral cortex GABAergic interneuron differentiation,BP,
6948,GO:0021893,1,0.988816202750704,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6949,GO:0021894,1,0.961271735968982,0,6,cerebral cortex GABAergic interneuron development,BP,
6950,GO:0021895,1,0.860091738379736,0,22,cerebral cortex neuron differentiation,BP,
6951,GO:0021896,1,0.978123325236126,0,2,forebrain astrocyte differentiation,BP,
6952,GO:0021897,1,0.978123325236126,0,2,forebrain astrocyte development,BP,
6953,GO:0021898,1,0.98268331709848,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6954,GO:0021902,1,0.955554936675647,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
6955,GO:0021903,1,0.933820982109248,0,10,rostrocaudal neural tube patterning,BP,
6956,GO:0021904,1,0.867257258935926,0,21,dorsal/ventral neural tube patterning,BP,
6957,GO:0021905,1,0.990635580277061,0,1,forebrain-midbrain boundary formation,BP,
6958,GO:0021910,1,0.94364246057098,0,8,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6959,GO:0021912,1,0.980023177551198,0,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
6960,GO:0021913,1,0.974643516842307,0,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
6961,GO:0021914,1,0.970058342189792,0,5,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6963,GO:0021917,1,0.990635580277061,0,1,somatic motor neuron fate commitment,BP,
6964,GO:0021918,1,0.990635580277061,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6965,GO:0021919,1,0.993692526145496,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6966,GO:0021920,1,0.994607640841943,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6967,GO:0021924,1,0.931366122371879,0,10,cell proliferation in external granule layer,BP,
6968,GO:0021930,1,0.931366122371879,0,10,cerebellar granule cell precursor proliferation,BP,
6969,GO:0021932,1,0.93797765158128,0,9,hindbrain radial glia guided cell migration,BP,
6970,GO:0021933,1,0.9945542757273,0,1,radial glia guided migration of cerebellar granule cell,BP,
6971,GO:0021934,1,0.978612633170421,0,2,hindbrain tangential cell migration,BP,
6972,GO:0021935,1,0.978612633170421,0,2,cerebellar granule cell precursor tangential migration,BP,
6973,GO:0021936,1,0.942767327128524,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6974,GO:0021937,1,0.967460593658624,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6975,GO:0021938,1,0.972856357653954,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6976,GO:0021940,1,0.954771367474824,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6977,GO:0021941,1,0.987433095997838,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6978,GO:0021942,1,0.97174598071925,0,4,radial glia guided migration of Purkinje cell,BP,
6979,GO:0021943,1,0.970546524048565,0,4,formation of radial glial scaffolds,BP,
6980,GO:0021952,1,0.834795944523379,0,23,central nervous system projection neuron axonogenesis,BP,
6982,GO:0021954,1,0.616007435537092,0,67,central nervous system neuron development,BP,
6983,GO:0021955,1,0.8082213146257,0,28,central nervous system neuron axonogenesis,BP,
6984,GO:0021956,1,0.994478040847751,0,1,central nervous system interneuron axonogenesis,BP,
6985,GO:0021957,1,0.953034052517878,0,6,corticospinal tract morphogenesis,BP,
6986,GO:0021960,1,0.963657392551616,0,5,anterior commissure morphogenesis,BP,
6987,GO:0021965,1,0.971191031525214,0,3,spinal cord ventral commissure morphogenesis,BP,
6988,GO:0021966,1,0.987080579756413,0,2,corticospinal neuron axon guidance,BP,
6989,GO:0021972,1,0.992432301579021,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6990,GO:0021978,1,0.929228698667767,0,12,telencephalon regionalization,BP,
6991,GO:0021979,1,0.962244115210878,0,6,hypothalamus cell differentiation,BP,
6992,GO:0021983,1,0.7694147888158,0,41,pituitary gland development,BP,
6993,GO:0021984,1,0.930263038861381,0,12,adenohypophysis development,BP,
6994,GO:0021985,1,0.987525054923705,0,2,neurohypophysis development,BP,
6995,GO:0021986,1,0.977973157529106,0,3,habenula development,BP,
6998,GO:0021993,1,0.992150384852603,0,1,initiation of neural tube closure,BP,
6999,GO:0021997,1,0.981054068581298,0,2,neural plate axis specification,BP,
7000,GO:0021998,1,0.993628847729139,0,1,neural plate mediolateral regionalization,BP,
7001,GO:0021999,1,0.958694158815582,0,6,neural plate anterior/posterior regionalization,BP,
7002,GO:0022007,1,0.980367653858857,0,3,convergent extension involved in neural plate elongation,BP,
7004,GO:0022009,1,0.97591237218193,0,4,central nervous system vasculogenesis,BP,
7005,GO:0022010,1,0.897796027707108,0,17,central nervous system myelination,BP,
7006,GO:0022011,1,0.8121939060845,0,25,myelination in peripheral nervous system,BP,
7007,GO:0022012,1,0.989438902750882,0,1,subpallium cell proliferation in forebrain,BP,
7008,GO:0022018,1,0.989438902750882,0,1,lateral ganglionic eminence cell proliferation,BP,
7009,GO:0022027,1,0.941314335558676,0,6,interkinetic nuclear migration,BP,
7010,GO:0022028,1,0.95228660701964,0,6,tangential migration from the subventricular zone to the olfactory bulb,BP,
7012,GO:0022030,1,0.879948084049538,0,17,telencephalon glial cell migration,BP,
7014,GO:0022038,1,0.90191655069782,0,15,corpus callosum development,BP,
7015,GO:0022400,1,0.883869726264328,0,20,regulation of rhodopsin mediated signaling pathway,BP,
7024,GO:0022410,1,0.877713780742469,0,21,circadian sleep/wake cycle process,BP,
7026,GO:0022412,1,0.173687697006388,0,261,cellular process involved in reproduction in multicellular organism,BP,
7028,GO:0022417,1,0.961824729935663,0,7,protein maturation by protein folding,BP,
7030,GO:0022602,1,0.760105357869756,0,39,ovulation cycle process,BP,
7033,GO:0022605,1,0.963268825722595,0,6,mammalian oogenesis stage,BP,
7036,GO:0022612,1,0.456491453152814,0,110,gland morphogenesis,BP,
7037,GO:0022613,1,0.0615662723012378,0,442,ribonucleoprotein complex biogenesis,BP,
7038,GO:0022614,1,0.966594571999648,0,5,membrane to membrane docking,BP,
7039,GO:0022615,1,0.978009000284796,0,4,protein to membrane docking,BP,
7040,GO:0022616,1,0.844460453477935,0,26,DNA strand elongation,BP,
7042,GO:0022618,1,0.282833933544293,0,195,ribonucleoprotein complex assembly,BP,
7043,GO:0022622,1,0.994651281344248,0,1,root system development,BP,
7044,GO:0022624,1,0.875027904826479,0,24,proteasome accessory complex,CC,
7045,GO:0022625,1,0.709218559906499,0,62,cytosolic large ribosomal subunit,CC,
7046,GO:0022626,1,0.522504734961568,0,114,cytosolic ribosome,CC,
7047,GO:0022627,1,0.771495106974235,0,45,cytosolic small ribosomal subunit,CC,
7050,GO:0022821,1,0.908409109694958,0,14,potassium ion antiporter activity,MF,
7052,GO:0022829,1,0.902434750053617,0,17,wide pore channel activity,MF,
7059,GO:0022840,1,0.904943459375292,0,16,leak channel activity,MF,
7060,GO:0022841,1,0.918901025662092,0,14,potassium ion leak channel activity,MF,
7061,GO:0022842,1,0.904943459375292,0,16,narrow pore channel activity,MF,
7063,GO:0022848,1,0.918632908626486,0,14,acetylcholine-gated cation-selective channel activity,MF,
7065,GO:0022850,1,0.977932356740699,0,4,serotonin-gated cation-selective channel activity,MF,
7067,GO:0022852,1,0.987528021452416,0,2,glycine-gated chloride ion channel activity,MF,
7068,GO:0022853,1,0.696955819260222,0,52,active ion transmembrane transporter activity,MF,
7070,GO:0022858,1,0.967986622989911,0,5,alanine transmembrane transporter activity,MF,
7071,GO:0022884,1,0.916308271491934,0,15,macromolecule transmembrane transporter activity,MF,
7072,GO:0022889,1,0.94935200731752,0,9,serine transmembrane transporter activity,MF,
7074,GO:0022894,1,0.994408062285494,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7076,GO:0022900,1,0.400186940259685,0,158,electron transport chain,BP,
7077,GO:0022904,1,0.571426448932401,0,97,respiratory electron transport chain,BP,
7079,GO:0023016,1,0.976177139339533,0,3,signal transduction by trans-phosphorylation,BP,
7080,GO:0023019,1,0.889477667145197,0,18,signal transduction involved in regulation of gene expression,BP,
7081,GO:0023021,1,0.983009876813939,0,3,termination of signal transduction,BP,
7082,GO:0023023,1,0.892961710669032,0,20,MHC protein complex binding,MF,
7083,GO:0023024,1,0.983229228907933,0,3,MHC class I protein complex binding,MF,
7084,GO:0023025,1,0.988394288837878,0,2,MHC class Ib protein complex binding,MF,
7085,GO:0023026,1,0.913308448108783,0,16,MHC class II protein complex binding,MF,
7086,GO:0023029,1,0.970208338931423,0,5,MHC class Ib protein binding,MF,
7087,GO:0023030,1,0.988394288837878,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7088,GO:0023035,1,0.951690536547714,0,8,CD40 signaling pathway,BP,
7089,GO:0023041,1,0.960406156292754,0,6,neuronal signal transduction,BP,
7097,GO:0030002,1,0.9286682695907,0,10,cellular anion homeostasis,BP,
7099,GO:0030004,1,0.493269890033611,0,106,cellular monovalent inorganic cation homeostasis,BP,
7100,GO:0030007,1,0.916075308111563,0,13,cellular potassium ion homeostasis,BP,
7101,GO:0030008,1,0.919261585925949,0,14,TRAPP complex,CC,
7103,GO:0030011,1,0.880714240246659,0,17,maintenance of cell polarity,BP,
7104,GO:0030014,1,0.900508141417802,0,15,CCR4-NOT complex,CC,
7105,GO:0030015,1,0.967911261118312,0,5,CCR4-NOT core complex,CC,
7106,GO:0030016,1,0.21374610429105,0,201,myofibril,CC,
7107,GO:0030017,1,0.249731025303873,0,181,sarcomere,CC,
7108,GO:0030018,1,0.377787855626752,0,119,Z disc,CC,
7109,GO:0030020,1,0.954776385473306,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7110,GO:0030021,1,0.99401591937602,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
7116,GO:0030032,1,0.689816703290384,0,53,lamellipodium assembly,BP,
7117,GO:0030033,1,0.891567502134738,0,16,microvillus assembly,BP,
7118,GO:0030035,1,0.97154324887856,0,4,microspike assembly,BP,
7120,GO:0030037,1,0.992438862436745,0,1,actin filament reorganization involved in cell cycle,BP,
7121,GO:0030038,1,0.547067261884131,0,86,contractile actin filament bundle assembly,BP,
7122,GO:0030041,1,0.340713037434579,0,161,actin filament polymerization,BP,
7123,GO:0030042,1,0.710484451328036,0,47,actin filament depolymerization,BP,
7124,GO:0030043,1,0.977438446486967,0,4,actin filament fragmentation,BP,
7125,GO:0030046,1,0.965362422354338,0,5,parallel actin filament bundle assembly,BP,
7126,GO:0030047,1,0.980371680174788,0,3,actin modification,BP,
7129,GO:0030050,1,0.940006209031609,0,8,vesicle transport along actin filament,BP,
7132,GO:0030056,1,0.942722536164569,0,5,hemidesmosome,CC,
7133,GO:0030057,1,0.85915802530455,0,20,desmosome,CC,
7134,GO:0030060,1,0.978239897911236,0,4,L-malate dehydrogenase activity,MF,
7135,GO:0030061,1,0.973819025833716,0,4,mitochondrial crista,CC,
7136,GO:0030062,1,0.960069707832936,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7137,GO:0030070,1,0.971305100709605,0,4,insulin processing,BP,
7138,GO:0030071,1,0.719845990883895,0,48,regulation of mitotic metaphase/anaphase transition,BP,
7141,GO:0030091,1,0.960866326117839,0,7,protein repair,BP,
7146,GO:0030101,1,0.738056331450319,0,49,natural killer cell activation,BP,
7147,GO:0030103,1,0.988659174935397,0,2,vasopressin secretion,BP,
7148,GO:0030104,1,0.679361356552642,0,56,water homeostasis,BP,
7149,GO:0030107,1,0.994142758058285,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7150,GO:0030108,1,0.994581830190299,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7151,GO:0030109,1,0.988675548878236,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7153,GO:0030117,1,0.529239234134651,0,96,membrane coat,CC,
7154,GO:0030118,1,0.717260210864602,0,48,clathrin coat,CC,
7155,GO:0030119,1,0.739924337302848,0,45,AP-type membrane coat adaptor complex,CC,
7156,GO:0030120,1,0.699974166980695,0,54,vesicle coat,CC,
7157,GO:0030121,1,0.961772988957725,0,6,AP-1 adaptor complex,CC,
7158,GO:0030122,1,0.907106319039346,0,14,AP-2 adaptor complex,CC,
7159,GO:0030123,1,0.934514730262254,0,10,AP-3 adaptor complex,CC,
7160,GO:0030124,1,0.97446318698083,0,4,AP-4 adaptor complex,CC,
7161,GO:0030125,1,0.835446372464461,0,26,clathrin vesicle coat,CC,
7162,GO:0030126,1,0.913026932416201,0,15,COPI vesicle coat,CC,
7163,GO:0030127,1,0.911832303233303,0,14,COPII vesicle coat,CC,
7164,GO:0030128,1,0.900499838367285,0,15,clathrin coat of endocytic vesicle,CC,
7165,GO:0030130,1,0.921720321839521,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7166,GO:0030131,1,0.821730583010145,0,29,clathrin adaptor complex,CC,
7167,GO:0030132,1,0.873971467609472,0,19,clathrin coat of coated pit,CC,
7172,GO:0030137,1,0.859203391655015,0,25,COPI-coated vesicle,CC,
7174,GO:0030140,1,0.809534719910765,0,30,trans-Golgi network transport vesicle,CC,
7176,GO:0030144,1,0.981956641058935,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7177,GO:0030145,1,0.726626777099973,0,48,manganese ion binding,MF,
7179,GO:0030149,1,0.875926051271413,0,22,sphingolipid catabolic process,BP,
7180,GO:0030150,1,0.907790620276421,0,17,protein import into mitochondrial matrix,BP,
7181,GO:0030151,1,0.977152308692095,0,4,molybdenum ion binding,MF,
7184,GO:0030156,1,0.99465365562554,0,1,benzodiazepine receptor binding,MF,
7185,GO:0030157,1,0.915458732423094,0,13,pancreatic juice secretion,BP,
7186,GO:0030158,1,0.976490945650259,0,3,protein xylosyltransferase activity,MF,
7191,GO:0030165,1,0.554642236607851,0,82,PDZ domain binding,MF,
7192,GO:0030166,1,0.648599161328771,0,60,proteoglycan biosynthetic process,BP,
7193,GO:0030167,1,0.974975593097877,0,4,proteoglycan catabolic process,BP,
7195,GO:0030169,1,0.910735827126889,0,13,low-density lipoprotein particle binding,MF,
7196,GO:0030170,1,0.760822345723898,0,45,pyridoxal phosphate binding,MF,
7197,GO:0030171,1,0.994538692483619,0,1,voltage-gated proton channel activity,MF,
7198,GO:0030172,1,0.983973111960014,0,3,troponin C binding,MF,
7199,GO:0030173,1,0.774222752207436,0,41,integral component of Golgi membrane,CC,
7200,GO:0030174,1,0.964938236950853,0,6,regulation of DNA-dependent DNA replication initiation,BP,
7207,GO:0030184,1,0.99420069797662,0,1,nitric oxide transmembrane transporter activity,MF,
7208,GO:0030185,1,0.983403333479905,0,3,nitric oxide transport,BP,
7209,GO:0030186,1,0.994582646523443,0,1,melatonin metabolic process,BP,
7210,GO:0030187,1,0.994582646523443,0,1,melatonin biosynthetic process,BP,
7214,GO:0030197,1,0.987177747537592,0,2,extracellular matrix constituent, lubricant activity,MF,
7217,GO:0030200,1,0.982403150746323,0,3,heparan sulfate proteoglycan catabolic process,BP,
7218,GO:0030201,1,0.804467899663997,0,31,heparan sulfate proteoglycan metabolic process,BP,
7219,GO:0030202,1,0.942180331921496,0,8,heparin metabolic process,BP,
7220,GO:0030203,1,0.374514701311146,0,146,glycosaminoglycan metabolic process,BP,
7221,GO:0030204,1,0.755743835813835,0,40,chondroitin sulfate metabolic process,BP,
7222,GO:0030205,1,0.909192606578714,0,13,dermatan sulfate metabolic process,BP,
7223,GO:0030206,1,0.835772688423099,0,25,chondroitin sulfate biosynthetic process,BP,
7224,GO:0030207,1,0.91333383786542,0,13,chondroitin sulfate catabolic process,BP,
7225,GO:0030208,1,0.914296071847009,0,12,dermatan sulfate biosynthetic process,BP,
7226,GO:0030209,1,0.994423134073305,0,1,dermatan sulfate catabolic process,BP,
7227,GO:0030210,1,0.942180331921496,0,8,heparin biosynthetic process,BP,
7228,GO:0030212,1,0.806955451969422,0,34,hyaluronan metabolic process,BP,
7229,GO:0030213,1,0.919459829774299,0,13,hyaluronan biosynthetic process,BP,
7230,GO:0030214,1,0.917025334789518,0,14,hyaluronan catabolic process,BP,
7231,GO:0030215,1,0.861180511255169,0,20,semaphorin receptor binding,MF,
7234,GO:0030218,1,0.509266759970162,0,101,erythrocyte differentiation,BP,
7235,GO:0030219,1,0.623667227580444,0,70,megakaryocyte differentiation,BP,
7236,GO:0030220,1,0.880196651110785,0,18,platelet formation,BP,
7237,GO:0030221,1,0.987036485813292,0,2,basophil differentiation,BP,
7238,GO:0030222,1,0.982128655153327,0,3,eosinophil differentiation,BP,
7239,GO:0030223,1,0.964051496990607,0,6,neutrophil differentiation,BP,
7241,GO:0030225,1,0.799067762481038,0,36,macrophage differentiation,BP,
7242,GO:0030226,1,0.962651400887296,0,3,apolipoprotein receptor activity,MF,
7243,GO:0030228,1,0.872351936254466,0,16,lipoprotein particle receptor activity,MF,
7244,GO:0030229,1,0.973371005569072,0,4,very-low-density lipoprotein particle receptor activity,MF,
7245,GO:0030233,1,0.994554096926973,0,1,deoxynucleotide transmembrane transporter activity,MF,
7247,GO:0030235,1,0.952046262245986,0,7,nitric-oxide synthase regulator activity,MF,
7248,GO:0030237,1,0.987555337173036,0,2,female sex determination,BP,
7249,GO:0030238,1,0.910191629882151,0,14,male sex determination,BP,
7250,GO:0030239,1,0.622176562476584,0,62,myofibril assembly,BP,
7251,GO:0030240,1,0.910022777330638,0,10,skeletal muscle thin filament assembly,BP,
7252,GO:0030241,1,0.923983576931888,0,7,skeletal muscle myosin thick filament assembly,BP,
7253,GO:0030242,1,0.965311091714983,0,5,autophagy of peroxisome,BP,
7256,GO:0030249,1,0.978209141220823,0,4,guanylate cyclase regulator activity,MF,
7257,GO:0030250,1,0.978209141220823,0,4,guanylate cyclase activator activity,MF,
7258,GO:0030252,1,0.907580233479619,0,14,growth hormone secretion,BP,
7259,GO:0030258,1,0.193953471400016,0,243,lipid modification,BP,
7260,GO:0030259,1,0.959636657072927,0,7,lipid glycosylation,BP,
7262,GO:0030261,1,0.81224237891686,0,27,chromosome condensation,BP,
7263,GO:0030262,1,0.830397335405192,0,28,apoptotic nuclear changes,BP,
7264,GO:0030263,1,0.972814073788253,0,4,apoptotic chromosome condensation,BP,
7265,GO:0030264,1,0.994184768585909,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7266,GO:0030267,1,0.982831912707496,0,3,glyoxylate reductase (NADP) activity,MF,
7267,GO:0030272,1,0.994644572510851,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7268,GO:0030273,1,0.994346393058899,0,1,melanin-concentrating hormone receptor activity,MF,
7269,GO:0030274,1,0.959952812726912,0,6,LIM domain binding,MF,
7270,GO:0030275,1,0.901859063807166,0,15,LRR domain binding,MF,
7274,GO:0030279,1,0.665568792241289,0,59,negative regulation of ossification,BP,
7275,GO:0030280,1,0.970418070087497,0,5,structural constituent of epidermis,MF,
7277,GO:0030283,1,0.994639568381293,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
7278,GO:0030284,1,0.967688230629797,0,5,estrogen receptor activity,MF,
7279,GO:0030285,1,0.897232465256668,0,17,integral component of synaptic vesicle membrane,CC,
7280,GO:0030286,1,0.657137501553206,0,48,dynein complex,CC,
7281,GO:0030289,1,0.982641336649368,0,3,protein phosphatase 4 complex,CC,
7282,GO:0030290,1,0.99366243812071,0,1,sphingolipid activator protein activity,MF,
7283,GO:0030291,1,0.812865287756925,0,33,protein serine/threonine kinase inhibitor activity,MF,
7284,GO:0030292,1,0.98070967295766,0,3,protein tyrosine kinase inhibitor activity,MF,
7285,GO:0030294,1,0.99441865199318,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7287,GO:0030296,1,0.899393616481569,0,15,protein tyrosine kinase activator activity,MF,
7288,GO:0030297,1,0.953912655643223,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7289,GO:0030299,1,0.95166641263297,0,8,intestinal cholesterol absorption,BP,
7290,GO:0030300,1,0.982762010701331,0,3,regulation of intestinal cholesterol absorption,BP,
7292,GO:0030302,1,0.994554096926973,0,1,deoxynucleotide transport,BP,
7293,GO:0030305,1,0.98765428504117,0,2,heparanase activity,MF,
7294,GO:0030306,1,0.939255219262659,0,8,ADP-ribosylation factor binding,MF,
7297,GO:0030309,1,0.953723942544929,0,8,poly-N-acetyllactosamine metabolic process,BP,
7298,GO:0030311,1,0.959620686757761,0,7,poly-N-acetyllactosamine biosynthetic process,BP,
7299,GO:0030312,1,0.994406453308164,0,1,external encapsulating structure,CC,
7301,GO:0030315,1,0.695455948594998,0,44,T-tubule,CC,
7303,GO:0030317,1,0.674438417183066,0,58,flagellated sperm motility,BP,
7304,GO:0030318,1,0.844482580093048,0,22,melanocyte differentiation,BP,
7305,GO:0030320,1,0.9286682695907,0,10,cellular monovalent inorganic anion homeostasis,BP,
7306,GO:0030321,1,0.968573866159219,0,5,transepithelial chloride transport,BP,
7307,GO:0030322,1,0.918789368712468,0,14,stabilization of membrane potential,BP,
7310,GO:0030325,1,0.876286147778518,0,19,adrenal gland development,BP,
7311,GO:0030326,1,0.414451084549465,0,122,embryonic limb morphogenesis,BP,
7312,GO:0030327,1,0.98044465370722,0,3,prenylated protein catabolic process,BP,
7313,GO:0030328,1,0.986397496251184,0,2,prenylcysteine catabolic process,BP,
7314,GO:0030329,1,0.986397496251184,0,2,prenylcysteine metabolic process,BP,
7315,GO:0030330,1,0.48422020702969,0,107,DNA damage response, signal transduction by p53 class mediator,BP,
7316,GO:0030331,1,0.768395022205862,0,37,estrogen receptor binding,MF,
7317,GO:0030332,1,0.818159226200634,0,30,cyclin binding,MF,
7321,GO:0030337,1,0.988816558449328,0,2,DNA polymerase processivity factor activity,MF,
7322,GO:0030342,1,0.993955700937162,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7323,GO:0030343,1,0.994559033202051,0,1,vitamin D3 25-hydroxylase activity,MF,
7324,GO:0030345,1,0.99401591937602,0,1,structural constituent of tooth enamel,MF,
7325,GO:0030346,1,0.95126243707397,0,7,protein phosphatase 2B binding,MF,
7326,GO:0030348,1,0.980455418933216,0,3,syntaxin-3 binding,MF,
7327,GO:0030350,1,0.98484145323833,0,2,iron-responsive element binding,MF,
7328,GO:0030351,1,0.994151961280623,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7329,GO:0030366,1,0.989171247726948,0,2,molybdopterin synthase activity,MF,
7330,GO:0030368,1,0.948425618323352,0,8,interleukin-17 receptor activity,MF,
7331,GO:0030369,1,0.986456157992285,0,2,ICAM-3 receptor activity,MF,
7332,GO:0030371,1,0.844466574096605,0,24,translation repressor activity,MF,
7333,GO:0030372,1,0.992601165872745,0,1,high molecular weight B cell growth factor receptor binding,MF,
7334,GO:0030374,1,0.618235015320871,0,67,ligand-dependent nuclear receptor transcription coactivator activity,MF,
7335,GO:0030375,1,0.968119512985318,0,4,thyroid hormone receptor coactivator activity,MF,
7336,GO:0030377,1,0.994587010900467,0,1,urokinase plasminogen activator receptor activity,MF,
7337,GO:0030378,1,0.994322778976815,0,1,serine racemase activity,MF,
7338,GO:0030379,1,0.990509910490986,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7339,GO:0030382,1,0.99453545357415,0,1,sperm mitochondrion organization,BP,
7340,GO:0030387,1,0.994587723912786,0,1,fructosamine-3-kinase activity,MF,
7341,GO:0030388,1,0.972302258225371,0,5,fructose 1,6-bisphosphate metabolic process,BP,
7342,GO:0030389,1,0.989272975986488,0,2,fructosamine metabolic process,BP,
7343,GO:0030393,1,0.994587723912786,0,1,fructoselysine metabolic process,BP,
7344,GO:0030395,1,0.989227517812425,0,2,lactose binding,MF,
7345,GO:0030397,1,0.725945088795184,0,46,membrane disassembly,BP,
7346,GO:0030407,1,0.994502059756027,0,1,formimidoyltransferase activity,MF,
7347,GO:0030409,1,0.994502059756027,0,1,glutamate formimidoyltransferase activity,MF,
7348,GO:0030412,1,0.994502059756027,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7350,GO:0030421,1,0.994643589263539,0,1,defecation,BP,
7351,GO:0030422,1,0.942528807705855,0,9,production of siRNA involved in RNA interference,BP,
7352,GO:0030423,1,0.969883794925115,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7357,GO:0030429,1,0.994580031490716,0,1,kynureninase activity,MF,
7358,GO:0030430,1,0.964449478970431,0,6,host cell cytoplasm,CC,
7359,GO:0030431,1,0.824047352158417,0,29,sleep,BP,
7360,GO:0030432,1,0.953906146980072,0,8,peristalsis,BP,
7361,GO:0030433,1,0.640648702095735,0,70,ubiquitin-dependent ERAD pathway,BP,
7363,GO:0030450,1,0.982946106273393,0,2,regulation of complement activation, classical pathway,BP,
7364,GO:0030451,1,0.988473912080574,0,1,regulation of complement activation, alternative pathway,BP,
7365,GO:0030473,1,0.959290477771613,0,5,nuclear migration along microtubule,BP,
7366,GO:0030474,1,0.994184768585909,0,1,spindle pole body duplication,BP,
7367,GO:0030478,1,0.973694783348923,0,4,actin cap,CC,
7368,GO:0030479,1,0.950307592574019,0,7,actin cortical patch,CC,
7369,GO:0030485,1,0.987400794328366,0,2,smooth muscle contractile fiber,CC,
7370,GO:0030488,1,0.827124530464653,0,31,tRNA methylation,BP,
7371,GO:0030490,1,0.731169910809148,0,51,maturation of SSU-rRNA,BP,
7372,GO:0030492,1,0.978706622633065,0,4,hemoglobin binding,MF,
7374,GO:0030497,1,0.936515264327365,0,11,fatty acid elongation,BP,
7377,GO:0030502,1,0.931950144750958,0,11,negative regulation of bone mineralization,BP,
7378,GO:0030504,1,0.989446878098921,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7379,GO:0030505,1,0.979671339478955,0,2,inorganic diphosphate transport,BP,
7380,GO:0030506,1,0.850041697127944,0,17,ankyrin binding,MF,
7383,GO:0030510,1,0.561751549876235,0,79,regulation of BMP signaling pathway,BP,
7385,GO:0030512,1,0.620605870482373,0,66,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7386,GO:0030513,1,0.794894215965338,0,31,positive regulation of BMP signaling pathway,BP,
7387,GO:0030514,1,0.731869542731324,0,43,negative regulation of BMP signaling pathway,BP,
7388,GO:0030515,1,0.83571442799648,0,29,snoRNA binding,MF,
7391,GO:0030518,1,0.421076816843054,0,125,intracellular steroid hormone receptor signaling pathway,BP,
7392,GO:0030520,1,0.706002141659797,0,51,intracellular estrogen receptor signaling pathway,BP,
7393,GO:0030521,1,0.652401204100512,0,61,androgen receptor signaling pathway,BP,
7394,GO:0030522,1,0.173524819563006,0,256,intracellular receptor signaling pathway,BP,
7395,GO:0030523,1,0.993009770887461,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7396,GO:0030526,1,0.992552829735561,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7397,GO:0030532,1,0.643835019213603,0,68,small nuclear ribonucleoprotein complex,CC,
7399,GO:0030538,1,0.982157068048808,0,3,embryonic genitalia morphogenesis,BP,
7400,GO:0030539,1,0.880892715428942,0,19,male genitalia development,BP,
7401,GO:0030540,1,0.8850837737937,0,16,female genitalia development,BP,
7402,GO:0030544,1,0.793718199591687,0,36,Hsp70 protein binding,MF,
7404,GO:0030546,1,0.924777665888071,0,11,receptor activator activity,MF,
7405,GO:0030547,1,0.892067077039895,0,19,receptor inhibitor activity,MF,
7406,GO:0030548,1,0.959976055760053,0,7,acetylcholine receptor regulator activity,MF,
7407,GO:0030549,1,0.994622020855198,0,1,acetylcholine receptor activator activity,MF,
7408,GO:0030550,1,0.975751661172414,0,4,acetylcholine receptor inhibitor activity,MF,
7409,GO:0030551,1,0.786563840498574,0,34,cyclic nucleotide binding,MF,
7410,GO:0030552,1,0.847607337227308,0,23,cAMP binding,MF,
7411,GO:0030553,1,0.91811363240638,0,12,cGMP binding,MF,
7413,GO:0030572,1,0.993485153846078,0,1,phosphatidyltransferase activity,MF,
7414,GO:0030573,1,0.994395978211725,0,1,bile acid catabolic process,BP,
7416,GO:0030575,1,0.914915606028738,0,11,nuclear body organization,BP,
7417,GO:0030576,1,0.982139775623134,0,3,Cajal body organization,BP,
7418,GO:0030578,1,0.965226482025362,0,4,PML body organization,BP,
7419,GO:0030579,1,0.966593227811721,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7420,GO:0030580,1,0.994609403508997,0,1,quinone cofactor methyltransferase activity,MF,
7421,GO:0030581,1,0.989196984078889,0,2,symbiont intracellular protein transport in host,BP,
7422,GO:0030586,1,0.993874503447871,0,1,[methionine synthase] reductase activity,MF,
7426,GO:0030611,1,0.994642586024967,0,1,arsenate reductase activity,MF,
7427,GO:0030613,1,0.983958054893233,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7428,GO:0030614,1,0.983958054893233,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7429,GO:0030616,1,0.988951803627041,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7430,GO:0030617,1,0.98818427177174,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7431,GO:0030618,1,0.956365613432229,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7432,GO:0030619,1,0.955481525669267,0,7,U1 snRNA binding,MF,
7433,GO:0030620,1,0.963643746129655,0,6,U2 snRNA binding,MF,
7434,GO:0030621,1,0.968214378926678,0,5,U4 snRNA binding,MF,
7435,GO:0030622,1,0.986479782948091,0,2,U4atac snRNA binding,MF,
7436,GO:0030623,1,0.990237271505502,0,1,U5 snRNA binding,MF,
7437,GO:0030624,1,0.992982030804003,0,1,U6atac snRNA binding,MF,
7438,GO:0030626,1,0.988000658409754,0,2,U12 snRNA binding,MF,
7439,GO:0030627,1,0.988785299814283,0,2,pre-mRNA 5'-splice site binding,MF,
7440,GO:0030628,1,0.966125365923789,0,6,pre-mRNA 3'-splice site binding,MF,
7441,GO:0030629,1,0.994184768585909,0,1,U6 snRNA 3'-end binding,MF,
7442,GO:0030638,1,0.956747578721904,0,8,polyketide metabolic process,BP,
7443,GO:0030641,1,0.556251696417094,0,89,regulation of cellular pH,BP,
7444,GO:0030643,1,0.954339568374166,0,6,cellular phosphate ion homeostasis,BP,
7445,GO:0030644,1,0.973112848219256,0,4,cellular chloride ion homeostasis,BP,
7446,GO:0030647,1,0.956747578721904,0,8,aminoglycoside antibiotic metabolic process,BP,
7447,GO:0030653,1,0.992342116015422,0,1,beta-lactam antibiotic metabolic process,BP,
7448,GO:0030656,1,0.93544619078554,0,11,regulation of vitamin metabolic process,BP,
7453,GO:0030663,1,0.89812089591298,0,18,COPI-coated vesicle membrane,CC,
7458,GO:0030670,1,0.652870364325852,0,67,phagocytic vesicle membrane,CC,
7460,GO:0030673,1,0.875288355140224,0,16,axolemma,CC,
7462,GO:0030676,1,0.888580065796647,0,16,Rac guanyl-nucleotide exchange factor activity,MF,
7463,GO:0030677,1,0.927838202114405,0,13,ribonuclease P complex,CC,
7464,GO:0030678,1,0.983186114170821,0,3,mitochondrial ribonuclease P complex,CC,
7465,GO:0030681,1,0.943714841892394,0,10,multimeric ribonuclease P complex,CC,
7466,GO:0030682,1,0.986482973643855,0,2,evasion or tolerance of host defense response,BP,
7467,GO:0030683,1,0.986482973643855,0,2,evasion or tolerance by virus of host immune response,BP,
7468,GO:0030684,1,0.630850221563182,0,72,preribosome,CC,
7469,GO:0030686,1,0.822721771316218,0,30,90S preribosome,CC,
7470,GO:0030687,1,0.855689183476727,0,24,preribosome, large subunit precursor,CC,
7471,GO:0030688,1,0.924689287982775,0,12,preribosome, small subunit precursor,CC,
7472,GO:0030689,1,0.982926861975226,0,3,Noc complex,CC,
7473,GO:0030690,1,0.994170008512245,0,1,Noc1p-Noc2p complex,CC,
7474,GO:0030691,1,0.994170008512245,0,1,Noc2p-Noc3p complex,CC,
7475,GO:0030692,1,0.988691579703672,0,2,Noc4p-Nop14p complex,CC,
7476,GO:0030695,1,0.123708849665007,0,292,GTPase regulator activity,MF,
7477,GO:0030696,1,0.993962941180746,0,1,tRNA (m5U54) methyltransferase activity,MF,
7478,GO:0030697,1,0.993962941180746,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7479,GO:0030702,1,0.993290311076195,0,1,chromatin silencing at centromere,BP,
7481,GO:0030718,1,0.988061890571827,0,2,germ-line stem cell population maintenance,BP,
7482,GO:0030719,1,0.988022825937695,0,2,P granule organization,BP,
7483,GO:0030728,1,0.876427931266273,0,19,ovulation,BP,
7484,GO:0030729,1,0.993844906858072,0,1,acetoacetate-CoA ligase activity,MF,
7485,GO:0030730,1,0.902356576645029,0,15,sequestering of triglyceride,BP,
7486,GO:0030731,1,0.994635143433145,0,1,guanidinoacetate N-methyltransferase activity,MF,
7487,GO:0030742,1,0.858262896202779,0,23,GTP-dependent protein binding,MF,
7488,GO:0030748,1,0.994291130232951,0,1,amine N-methyltransferase activity,MF,
7490,GO:0030791,1,0.994326736992354,0,1,arsenite methyltransferase activity,MF,
7491,GO:0030792,1,0.994326736992354,0,1,methylarsonite methyltransferase activity,MF,
7493,GO:0030800,1,0.845264376567446,0,26,negative regulation of cyclic nucleotide metabolic process,BP,
7495,GO:0030802,1,0.695457588429521,0,58,regulation of cyclic nucleotide biosynthetic process,BP,
7496,GO:0030803,1,0.86794443976181,0,22,negative regulation of cyclic nucleotide biosynthetic process,BP,
7497,GO:0030804,1,0.821581052654651,0,32,positive regulation of cyclic nucleotide biosynthetic process,BP,
7498,GO:0030805,1,0.976228199078179,0,3,regulation of cyclic nucleotide catabolic process,BP,
7499,GO:0030806,1,0.984632019779509,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7500,GO:0030807,1,0.991466328256244,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7501,GO:0030808,1,0.42619293357779,0,127,regulation of nucleotide biosynthetic process,BP,
7502,GO:0030809,1,0.791185795411416,0,35,negative regulation of nucleotide biosynthetic process,BP,
7503,GO:0030810,1,0.694268180220996,0,56,positive regulation of nucleotide biosynthetic process,BP,
7504,GO:0030811,1,0.628246107402832,0,64,regulation of nucleotide catabolic process,BP,
7505,GO:0030812,1,0.914254262296308,0,12,negative regulation of nucleotide catabolic process,BP,
7506,GO:0030813,1,0.881989452534476,0,17,positive regulation of nucleotide catabolic process,BP,
7508,GO:0030815,1,0.849868001011206,0,25,negative regulation of cAMP metabolic process,BP,
7510,GO:0030817,1,0.767549881829973,0,42,regulation of cAMP biosynthetic process,BP,
7511,GO:0030818,1,0.872670332633263,0,21,negative regulation of cAMP biosynthetic process,BP,
7512,GO:0030819,1,0.90025753482104,0,17,positive regulation of cAMP biosynthetic process,BP,
7513,GO:0030820,1,0.976228199078179,0,3,regulation of cAMP catabolic process,BP,
7514,GO:0030821,1,0.984632019779509,0,2,negative regulation of cAMP catabolic process,BP,
7515,GO:0030822,1,0.991466328256244,0,1,positive regulation of cAMP catabolic process,BP,
7516,GO:0030823,1,0.867763528696804,0,22,regulation of cGMP metabolic process,BP,
7517,GO:0030824,1,0.994591916970503,0,1,negative regulation of cGMP metabolic process,BP,
7518,GO:0030825,1,0.900043572008952,0,17,positive regulation of cGMP metabolic process,BP,
7519,GO:0030826,1,0.901404894755591,0,17,regulation of cGMP biosynthetic process,BP,
7520,GO:0030827,1,0.994591916970503,0,1,negative regulation of cGMP biosynthetic process,BP,
7521,GO:0030828,1,0.912694421670089,0,15,positive regulation of cGMP biosynthetic process,BP,
7522,GO:0030832,1,0.318603517358054,0,167,regulation of actin filament length,BP,
7523,GO:0030833,1,0.374049006585469,0,147,regulation of actin filament polymerization,BP,
7524,GO:0030834,1,0.727406036597496,0,44,regulation of actin filament depolymerization,BP,
7525,GO:0030835,1,0.777745109969816,0,34,negative regulation of actin filament depolymerization,BP,
7526,GO:0030836,1,0.935361086428826,0,10,positive regulation of actin filament depolymerization,BP,
7527,GO:0030837,1,0.700418288982451,0,51,negative regulation of actin filament polymerization,BP,
7528,GO:0030838,1,0.570298613270195,0,88,positive regulation of actin filament polymerization,BP,
7529,GO:0030842,1,0.991890396883822,0,1,regulation of intermediate filament depolymerization,BP,
7530,GO:0030844,1,0.991890396883822,0,1,positive regulation of intermediate filament depolymerization,BP,
7531,GO:0030845,1,0.994147645173646,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7532,GO:0030846,1,0.98704162678125,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7533,GO:0030849,1,0.986858113660452,0,2,autosome,CC,
7535,GO:0030851,1,0.854251597286037,0,25,granulocyte differentiation,BP,
7536,GO:0030852,1,0.921300026119325,0,13,regulation of granulocyte differentiation,BP,
7537,GO:0030853,1,0.955751393240185,0,7,negative regulation of granulocyte differentiation,BP,
7538,GO:0030854,1,0.957822012666387,0,7,positive regulation of granulocyte differentiation,BP,
7543,GO:0030859,1,0.881778883488242,0,18,polarized epithelial cell differentiation,BP,
7544,GO:0030860,1,0.986254366020421,0,2,regulation of polarized epithelial cell differentiation,BP,
7545,GO:0030862,1,0.991892770910328,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7547,GO:0030864,1,0.579439041734202,0,72,cortical actin cytoskeleton,CC,
7548,GO:0030865,1,0.714838640740046,0,49,cortical cytoskeleton organization,BP,
7549,GO:0030866,1,0.762936698562564,0,39,cortical actin cytoskeleton organization,BP,
7551,GO:0030868,1,0.969072154478986,0,5,smooth endoplasmic reticulum membrane,CC,
7552,GO:0030870,1,0.966199103068703,0,5,Mre11 complex,CC,
7553,GO:0030874,1,0.994540340159623,0,1,nucleolar chromatin,CC,
7554,GO:0030877,1,0.914096625736186,0,12,beta-catenin destruction complex,CC,
7555,GO:0030878,1,0.851152354933926,0,25,thyroid gland development,BP,
7556,GO:0030879,1,0.409270157841626,0,124,mammary gland development,BP,
7557,GO:0030880,1,0.415136696565763,0,134,RNA polymerase complex,CC,
7558,GO:0030881,1,0.966391805745874,0,6,beta-2-microglobulin binding,MF,
7559,GO:0030882,1,0.987813217151904,0,2,lipid antigen binding,MF,
7560,GO:0030883,1,0.987813217151904,0,2,endogenous lipid antigen binding,MF,
7561,GO:0030884,1,0.987813217151904,0,2,exogenous lipid antigen binding,MF,
7562,GO:0030885,1,0.973031576651987,0,5,regulation of myeloid dendritic cell activation,BP,
7563,GO:0030886,1,0.983622515290437,0,3,negative regulation of myeloid dendritic cell activation,BP,
7564,GO:0030887,1,0.994573305986838,0,1,positive regulation of myeloid dendritic cell activation,BP,
7565,GO:0030888,1,0.697825892259755,0,55,regulation of B cell proliferation,BP,
7566,GO:0030889,1,0.896377308973947,0,16,negative regulation of B cell proliferation,BP,
7567,GO:0030890,1,0.794687808465794,0,36,positive regulation of B cell proliferation,BP,
7568,GO:0030891,1,0.976153409992725,0,4,VCB complex,CC,
7569,GO:0030893,1,0.957194935835569,0,6,meiotic cohesin complex,CC,
7570,GO:0030894,1,0.852933869032883,0,26,replisome,CC,
7571,GO:0030895,1,0.988755033561007,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7572,GO:0030896,1,0.970815600594023,0,5,checkpoint clamp complex,CC,
7573,GO:0030897,1,0.901636025139766,0,14,HOPS complex,CC,
7574,GO:0030898,1,0.899006452815871,0,12,actin-dependent ATPase activity,MF,
7575,GO:0030899,1,0.983960945723265,0,3,calcium-dependent ATPase activity,MF,
7579,GO:0030903,1,0.894716673840933,0,16,notochord development,BP,
7580,GO:0030904,1,0.867174290914489,0,21,retromer complex,CC,
7581,GO:0030905,1,0.972780496825866,0,4,retromer, tubulation complex,CC,
7582,GO:0030906,1,0.976559012083337,0,4,retromer, cargo-selective complex,CC,
7583,GO:0030908,1,0.994566168695361,0,1,protein splicing,BP,
7584,GO:0030910,1,0.973585294671056,0,4,olfactory placode formation,BP,
7585,GO:0030911,1,0.946352576724326,0,8,TPR domain binding,MF,
7586,GO:0030913,1,0.946467768455708,0,7,paranodal junction assembly,BP,
7587,GO:0030914,1,0.928881842664081,0,11,STAGA complex,CC,
7588,GO:0030915,1,0.962683679538244,0,6,Smc5-Smc6 complex,CC,
7589,GO:0030916,1,0.94993449922591,0,8,otic vesicle formation,BP,
7590,GO:0030917,1,0.953267049688204,0,7,midbrain-hindbrain boundary development,BP,
7591,GO:0030920,1,0.989249250744038,0,2,peptidyl-serine acetylation,BP,
7592,GO:0030934,1,0.967862776800426,0,3,anchoring collagen complex,CC,
7593,GO:0030935,1,0.994260729103642,0,1,sheet-forming collagen trimer,CC,
7594,GO:0030936,1,0.994028401431377,0,1,transmembrane collagen trimer,CC,
7595,GO:0030942,1,0.983427497991145,0,3,endoplasmic reticulum signal peptide binding,MF,
7596,GO:0030943,1,0.98269509551302,0,3,mitochondrion targeting sequence binding,MF,
7597,GO:0030947,1,0.8285351580552,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7598,GO:0030948,1,0.941963219710736,0,9,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7599,GO:0030949,1,0.906626510829672,0,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7600,GO:0030950,1,0.913723825476335,0,14,establishment or maintenance of actin cytoskeleton polarity,BP,
7601,GO:0030951,1,0.97341620881368,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7602,GO:0030952,1,0.889411948553925,0,18,establishment or maintenance of cytoskeleton polarity,BP,
7603,GO:0030953,1,0.947791138705949,0,7,astral microtubule organization,BP,
7604,GO:0030955,1,0.905403409641019,0,14,potassium ion binding,MF,
7605,GO:0030956,1,0.982171803819661,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7606,GO:0030957,1,0.939638643890338,0,10,Tat protein binding,MF,
7607,GO:0030961,1,0.994184768585909,0,1,peptidyl-arginine hydroxylation,BP,
7608,GO:0030964,1,0.789834625050682,0,43,NADH dehydrogenase complex,CC,
7610,GO:0030969,1,0.981774757683272,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7611,GO:0030970,1,0.847554055321554,0,26,retrograde protein transport, ER to cytosol,BP,
7612,GO:0030971,1,0.680161758297646,0,55,receptor tyrosine kinase binding,MF,
7613,GO:0030974,1,0.988836510444566,0,2,thiamine pyrophosphate transmembrane transport,BP,
7614,GO:0030975,1,0.994368053421367,0,1,thiamine binding,MF,
7615,GO:0030976,1,0.968173664540189,0,5,thiamine pyrophosphate binding,MF,
7616,GO:0030977,1,0.994521317727986,0,1,taurine binding,MF,
7617,GO:0030981,1,0.974510454338743,0,3,cortical microtubule cytoskeleton,CC,
7618,GO:0030983,1,0.920224299531051,0,13,mismatched DNA binding,MF,
7619,GO:0030984,1,0.988836290658779,0,2,kininogen binding,MF,
7620,GO:0030990,1,0.819119598866442,0,31,intraciliary transport particle,CC,
7621,GO:0030991,1,0.944406474334851,0,8,intraciliary transport particle A,CC,
7622,GO:0030992,1,0.884994355780522,0,20,intraciliary transport particle B,CC,
7623,GO:0030997,1,0.977701795447453,0,3,regulation of centriole-centriole cohesion,BP,
7624,GO:0031000,1,0.856505309909305,0,18,response to caffeine,BP,
7625,GO:0031001,1,0.994184768585909,0,1,response to brefeldin A,BP,
7626,GO:0031005,1,0.927220221630526,0,11,filamin binding,MF,
7627,GO:0031010,1,0.918827543946826,0,11,ISWI-type complex,CC,
7628,GO:0031011,1,0.914810500260332,0,15,Ino80 complex,CC,
7630,GO:0031013,1,0.97270746314817,0,5,troponin I binding,MF,
7631,GO:0031014,1,0.97876157703429,0,4,troponin T binding,MF,
7633,GO:0031017,1,0.966940106604198,0,5,exocrine pancreas development,BP,
7635,GO:0031021,1,0.982438072528834,0,3,interphase microtubule organizing center,CC,
7636,GO:0031022,1,0.979498424523272,0,2,nuclear migration along microfilament,BP,
7637,GO:0031023,1,0.423675165897539,0,122,microtubule organizing center organization,BP,
7638,GO:0031032,1,0.268844783859406,0,178,actomyosin structure organization,BP,
7639,GO:0031033,1,0.877798265997845,0,15,myosin filament organization,BP,
7640,GO:0031034,1,0.882704703844524,0,14,myosin filament assembly,BP,
7641,GO:0031038,1,0.994448495776194,0,1,myosin II filament organization,BP,
7642,GO:0031045,1,0.914048086183974,0,13,dense core granule,CC,
7643,GO:0031047,1,0.381075096243666,0,140,gene silencing by RNA,BP,
7644,GO:0031048,1,0.98708970244236,0,2,chromatin silencing by small RNA,BP,
7645,GO:0031049,1,0.99416184066975,0,1,programmed DNA elimination,BP,
7646,GO:0031050,1,0.73972376722072,0,43,dsRNA fragmentation,BP,
7647,GO:0031052,1,0.99416184066975,0,1,chromosome breakage,BP,
7648,GO:0031053,1,0.931157043817181,0,10,primary miRNA processing,BP,
7649,GO:0031054,1,0.914188485652257,0,13,pre-miRNA processing,BP,
7650,GO:0031055,1,0.828855242897487,0,32,chromatin remodeling at centromere,BP,
7651,GO:0031056,1,0.398135733295686,0,132,regulation of histone modification,BP,
7652,GO:0031057,1,0.770055572345178,0,37,negative regulation of histone modification,BP,
7653,GO:0031058,1,0.577289618398431,0,81,positive regulation of histone modification,BP,
7654,GO:0031060,1,0.66299891184025,0,57,regulation of histone methylation,BP,
7655,GO:0031061,1,0.885035023921859,0,17,negative regulation of histone methylation,BP,
7656,GO:0031062,1,0.793000772701626,0,33,positive regulation of histone methylation,BP,
7657,GO:0031063,1,0.840138965720851,0,25,regulation of histone deacetylation,BP,
7658,GO:0031064,1,0.968291651209097,0,4,negative regulation of histone deacetylation,BP,
7659,GO:0031065,1,0.888178998229507,0,17,positive regulation of histone deacetylation,BP,
7660,GO:0031069,1,0.85333887118395,0,24,hair follicle morphogenesis,BP,
7661,GO:0031071,1,0.994361202073826,0,1,cysteine desulfurase activity,MF,
7663,GO:0031074,1,0.979817009602437,0,3,nucleocytoplasmic transport complex,CC,
7664,GO:0031076,1,0.755830574773805,0,37,embryonic camera-type eye development,BP,
7665,GO:0031077,1,0.95328117429438,0,7,post-embryonic camera-type eye development,BP,
7666,GO:0031078,1,0.925544223788268,0,11,histone deacetylase activity (H3-K14 specific),MF,
7667,GO:0031080,1,0.933679699151314,0,10,nuclear pore outer ring,CC,
7668,GO:0031081,1,0.987378245795369,0,2,nuclear pore distribution,BP,
7669,GO:0031082,1,0.892874854186561,0,19,BLOC complex,CC,
7670,GO:0031083,1,0.922861738191242,0,14,BLOC-1 complex,CC,
7671,GO:0031084,1,0.97995565365154,0,3,BLOC-2 complex,CC,
7672,GO:0031085,1,0.987325080059504,0,2,BLOC-3 complex,CC,
7673,GO:0031086,1,0.95866431259439,0,7,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7674,GO:0031087,1,0.964401164911595,0,6,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7675,GO:0031088,1,0.957851734146871,0,6,platelet dense granule membrane,CC,
7676,GO:0031089,1,0.937950833271621,0,11,platelet dense granule lumen,CC,
7681,GO:0031094,1,0.909018755817864,0,11,platelet dense tubular network,CC,
7682,GO:0031095,1,0.920159872438155,0,9,platelet dense tubular network membrane,CC,
7683,GO:0031098,1,0.164953478461203,0,268,stress-activated protein kinase signaling cascade,BP,
7688,GO:0031104,1,0.993239877419023,0,1,dendrite regeneration,BP,
7689,GO:0031105,1,0.926971772021431,0,12,septin complex,CC,
7690,GO:0031106,1,0.906618891041923,0,15,septin ring organization,BP,
7691,GO:0031109,1,0.505025311771538,0,97,microtubule polymerization or depolymerization,BP,
7692,GO:0031110,1,0.62197583770538,0,66,regulation of microtubule polymerization or depolymerization,BP,
7693,GO:0031111,1,0.796044926207997,0,32,negative regulation of microtubule polymerization or depolymerization,BP,
7694,GO:0031112,1,0.821520026377918,0,27,positive regulation of microtubule polymerization or depolymerization,BP,
7695,GO:0031113,1,0.747815975167926,0,41,regulation of microtubule polymerization,BP,
7696,GO:0031114,1,0.815040538219913,0,26,regulation of microtubule depolymerization,BP,
7697,GO:0031115,1,0.934898499171072,0,11,negative regulation of microtubule polymerization,BP,
7698,GO:0031116,1,0.835784533769961,0,24,positive regulation of microtubule polymerization,BP,
7699,GO:0031117,1,0.982963123563199,0,3,positive regulation of microtubule depolymerization,BP,
7700,GO:0031118,1,0.957143481440127,0,8,rRNA pseudouridine synthesis,BP,
7701,GO:0031119,1,0.961208094006706,0,7,tRNA pseudouridine synthesis,BP,
7702,GO:0031120,1,0.978368753272409,0,4,snRNA pseudouridine synthesis,BP,
7703,GO:0031122,1,0.680542788867108,0,52,cytoplasmic microtubule organization,BP,
7704,GO:0031123,1,0.469828050030091,0,120,RNA 3'-end processing,BP,
7705,GO:0031124,1,0.574936783277792,0,88,mRNA 3'-end processing,BP,
7706,GO:0031125,1,0.935018320315715,0,12,rRNA 3'-end processing,BP,
7707,GO:0031126,1,0.962385818654877,0,7,snoRNA 3'-end processing,BP,
7708,GO:0031127,1,0.993107445586671,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7709,GO:0031128,1,0.828691152580526,0,28,developmental induction,BP,
7710,GO:0031129,1,0.99223080695549,0,1,inductive cell-cell signaling,BP,
7711,GO:0031133,1,0.971418618226014,0,4,regulation of axon diameter,BP,
7712,GO:0031134,1,0.981424901585444,0,3,sister chromatid biorientation,BP,
7713,GO:0031143,1,0.915607993489297,0,14,pseudopodium,CC,
7714,GO:0031145,1,0.641501609056943,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7715,GO:0031146,1,0.659136410968367,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7716,GO:0031151,1,0.990123049020363,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7717,GO:0031161,1,0.993973724892221,0,1,phosphatidylinositol catabolic process,BP,
7718,GO:0031163,1,0.889745853486446,0,20,metallo-sulfur cluster assembly,BP,
7719,GO:0031166,1,0.98079429995622,0,3,integral component of vacuolar membrane,CC,
7720,GO:0031167,1,0.899611904693779,0,18,rRNA methylation,BP,
7722,GO:0031177,1,0.978656168105494,0,3,phosphopantetheine binding,MF,
7723,GO:0031179,1,0.99354389341953,0,1,peptide modification,BP,
7725,GO:0031204,1,0.978622133319048,0,3,posttranslational protein targeting to membrane, translocation,BP,
7726,GO:0031205,1,0.9780080234052,0,3,endoplasmic reticulum Sec complex,CC,
7727,GO:0031208,1,0.985067837925831,0,2,POZ domain binding,MF,
7728,GO:0031209,1,0.944330134353466,0,8,SCAR complex,CC,
7729,GO:0031210,1,0.893735277244437,0,17,phosphatidylcholine binding,MF,
7730,GO:0031211,1,0.951191618043865,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7731,GO:0031213,1,0.985759358531376,0,2,RSF complex,CC,
7733,GO:0031223,1,0.910160711254571,0,11,auditory behavior,BP,
7738,GO:0031228,1,0.756187694650623,0,45,intrinsic component of Golgi membrane,CC,
7739,GO:0031229,1,0.918253221044032,0,14,intrinsic component of nuclear inner membrane,CC,
7740,GO:0031231,1,0.904180462364467,0,17,intrinsic component of peroxisomal membrane,CC,
7742,GO:0031233,1,0.889300630369419,0,18,intrinsic component of external side of plasma membrane,CC,
7744,GO:0031235,1,0.89130225230979,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7745,GO:0031247,1,0.988689243523872,0,2,actin rod assembly,BP,
7746,GO:0031248,1,0.567091595046892,0,85,protein acetyltransferase complex,CC,
7747,GO:0031249,1,0.994344883062311,0,1,denatured protein binding,MF,
7748,GO:0031251,1,0.983982372054091,0,2,PAN complex,CC,
7751,GO:0031254,1,0.918748484698789,0,13,cell trailing edge,CC,
7753,GO:0031257,1,0.994184768585909,0,1,cell trailing edge membrane,CC,
7755,GO:0031259,1,0.994184768585909,0,1,uropod membrane,CC,
7756,GO:0031261,1,0.970967065536839,0,5,DNA replication preinitiation complex,CC,
7757,GO:0031262,1,0.978356117935261,0,4,Ndc80 complex,CC,
7758,GO:0031264,1,0.946992664244561,0,9,death-inducing signaling complex,CC,
7759,GO:0031265,1,0.963972967677877,0,6,CD95 death-inducing signaling complex,CC,
7761,GO:0031268,1,0.919581442830455,0,13,pseudopodium organization,BP,
7762,GO:0031269,1,0.919581442830455,0,13,pseudopodium assembly,BP,
7763,GO:0031271,1,0.994184768585909,0,1,lateral pseudopodium assembly,BP,
7764,GO:0031272,1,0.919581442830455,0,13,regulation of pseudopodium assembly,BP,
7765,GO:0031274,1,0.924964512224941,0,12,positive regulation of pseudopodium assembly,BP,
7766,GO:0031275,1,0.994184768585909,0,1,regulation of lateral pseudopodium assembly,BP,
7767,GO:0031279,1,0.766972770639535,0,41,regulation of cyclase activity,BP,
7768,GO:0031280,1,0.873041621065348,0,21,negative regulation of cyclase activity,BP,
7769,GO:0031281,1,0.900509114050266,0,16,positive regulation of cyclase activity,BP,
7770,GO:0031282,1,0.946287888696573,0,9,regulation of guanylate cyclase activity,BP,
7771,GO:0031283,1,0.994591916970503,0,1,negative regulation of guanylate cyclase activity,BP,
7772,GO:0031284,1,0.951435890384274,0,8,positive regulation of guanylate cyclase activity,BP,
7773,GO:0031289,1,0.994036437194702,0,1,actin phosphorylation,BP,
7774,GO:0031290,1,0.868503376065427,0,19,retinal ganglion cell axon guidance,BP,
7775,GO:0031291,1,0.981925484922908,0,3,Ran protein signal transduction,BP,
7776,GO:0031293,1,0.852541902778696,0,24,membrane protein intracellular domain proteolysis,BP,
7779,GO:0031296,1,0.983964114939947,0,3,B cell costimulation,BP,
7780,GO:0031297,1,0.830222076694534,0,27,replication fork processing,BP,
7781,GO:0031298,1,0.944406524403762,0,9,replication fork protection complex,CC,
7782,GO:0031300,1,0.329948479103103,0,181,intrinsic component of organelle membrane,CC,
7783,GO:0031301,1,0.36120026331627,0,166,integral component of organelle membrane,CC,
7784,GO:0031302,1,0.992293119671063,0,1,intrinsic component of endosome membrane,CC,
7785,GO:0031304,1,0.816262786880144,0,35,intrinsic component of mitochondrial inner membrane,CC,
7786,GO:0031305,1,0.816262786880144,0,35,integral component of mitochondrial inner membrane,CC,
7787,GO:0031306,1,0.869261978293038,0,23,intrinsic component of mitochondrial outer membrane,CC,
7788,GO:0031307,1,0.875600217150764,0,22,integral component of mitochondrial outer membrane,CC,
7789,GO:0031308,1,0.994184768585909,0,1,intrinsic component of nuclear outer membrane,CC,
7790,GO:0031309,1,0.994184768585909,0,1,integral component of nuclear outer membrane,CC,
7791,GO:0031310,1,0.98079429995622,0,3,intrinsic component of vacuolar membrane,CC,
7794,GO:0031314,1,0.968255264354197,0,5,extrinsic component of mitochondrial inner membrane,CC,
7795,GO:0031315,1,0.984735728751622,0,2,extrinsic component of mitochondrial outer membrane,CC,
7796,GO:0031320,1,0.99430288163403,0,1,hexitol dehydrogenase activity,MF,
7805,GO:0031331,1,0.111637821832186,0,312,positive regulation of cellular catabolic process,BP,
7806,GO:0031332,1,0.919633365182305,0,11,RNAi effector complex,CC,
7807,GO:0031333,1,0.450371767158936,0,118,negative regulation of protein complex assembly,BP,
7808,GO:0031334,1,0.209728101684096,0,232,positive regulation of protein complex assembly,BP,
7809,GO:0031335,1,0.988744599637742,0,2,regulation of sulfur amino acid metabolic process,BP,
7810,GO:0031337,1,0.994399120274267,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7812,GO:0031339,1,0.959533761510304,0,6,negative regulation of vesicle fusion,BP,
7814,GO:0031341,1,0.699232904698439,0,60,regulation of cell killing,BP,
7815,GO:0031342,1,0.910730298588132,0,16,negative regulation of cell killing,BP,
7816,GO:0031343,1,0.79510871043452,0,38,positive regulation of cell killing,BP,
7823,GO:0031362,1,0.910161831396223,0,14,anchored component of external side of plasma membrane,CC,
7824,GO:0031365,1,0.826539904926638,0,28,N-terminal protein amino acid modification,BP,
7825,GO:0031369,1,0.8323550288551,0,29,translation initiation factor binding,MF,
7826,GO:0031370,1,0.992647492144353,0,1,eukaryotic initiation factor 4G binding,MF,
7827,GO:0031371,1,0.954002668070204,0,8,ubiquitin conjugating enzyme complex,CC,
7828,GO:0031372,1,0.988899886248297,0,2,UBC13-MMS2 complex,CC,
7829,GO:0031379,1,0.987228499037598,0,2,RNA-directed RNA polymerase complex,CC,
7830,GO:0031380,1,0.993874503447871,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7831,GO:0031386,1,0.914499047237939,0,16,protein tag,MF,
7832,GO:0031389,1,0.994123997675265,0,1,Rad17 RFC-like complex,CC,
7833,GO:0031390,1,0.954860420441441,0,8,Ctf18 RFC-like complex,CC,
7835,GO:0031393,1,0.987477388345208,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7837,GO:0031396,1,0.329651813687182,0,170,regulation of protein ubiquitination,BP,
7838,GO:0031397,1,0.668104439761343,0,61,negative regulation of protein ubiquitination,BP,
7839,GO:0031398,1,0.53906594811122,0,97,positive regulation of protein ubiquitination,BP,
7843,GO:0031402,1,0.915151494629468,0,12,sodium ion binding,MF,
7844,GO:0031403,1,0.984046599643144,0,2,lithium ion binding,MF,
7845,GO:0031404,1,0.949889479436256,0,8,chloride ion binding,MF,
7846,GO:0031405,1,0.987218925996793,0,1,lipoic acid binding,MF,
7848,GO:0031407,1,0.994365902427248,0,1,oxylipin metabolic process,BP,
7850,GO:0031414,1,0.930729832343372,0,10,N-terminal protein acetyltransferase complex,CC,
7851,GO:0031415,1,0.969649178418959,0,5,NatA complex,CC,
7852,GO:0031416,1,0.986297576894699,0,2,NatB complex,CC,
7853,GO:0031417,1,0.973213536736258,0,3,NatC complex,CC,
7854,GO:0031418,1,0.88652804895082,0,20,L-ascorbic acid binding,MF,
7855,GO:0031419,1,0.935058628244386,0,9,cobalamin binding,MF,
7856,GO:0031420,1,0.872247632461952,0,19,alkali metal ion binding,MF,
7857,GO:0031424,1,0.671480130165968,0,63,keratinization,BP,
7858,GO:0031427,1,0.97479415621444,0,4,response to methotrexate,BP,
7859,GO:0031428,1,0.978319787258572,0,4,box C/D snoRNP complex,CC,
7860,GO:0031429,1,0.973107127549804,0,5,box H/ACA snoRNP complex,CC,
7861,GO:0031430,1,0.781219225111837,0,29,M band,CC,
7862,GO:0031431,1,0.987600440621572,0,2,Dbf4-dependent protein kinase complex,CC,
7863,GO:0031432,1,0.904672811238869,0,14,titin binding,MF,
7864,GO:0031433,1,0.945025862765011,0,5,telethonin binding,MF,
7865,GO:0031434,1,0.606444156799207,0,68,mitogen-activated protein kinase kinase binding,MF,
7866,GO:0031435,1,0.905262021997571,0,15,mitogen-activated protein kinase kinase kinase binding,MF,
7867,GO:0031436,1,0.984748520157955,0,2,BRCA1-BARD1 complex,CC,
7868,GO:0031437,1,0.981439400884374,0,3,regulation of mRNA cleavage,BP,
7869,GO:0031438,1,0.994019679090279,0,1,negative regulation of mRNA cleavage,BP,
7870,GO:0031439,1,0.987344789676977,0,2,positive regulation of mRNA cleavage,BP,
7871,GO:0031440,1,0.867627998411264,0,22,regulation of mRNA 3'-end processing,BP,
7872,GO:0031441,1,0.944844616208354,0,9,negative regulation of mRNA 3'-end processing,BP,
7873,GO:0031442,1,0.941885941295012,0,9,positive regulation of mRNA 3'-end processing,BP,
7874,GO:0031443,1,0.984403539265673,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7875,GO:0031444,1,0.98078548935913,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7876,GO:0031445,1,0.982732788173921,0,2,regulation of heterochromatin assembly,BP,
7877,GO:0031446,1,0.993699034638344,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7878,GO:0031448,1,0.993699034638344,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7879,GO:0031449,1,0.991408937314801,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7880,GO:0031453,1,0.982732788173921,0,2,positive regulation of heterochromatin assembly,BP,
7881,GO:0031455,1,0.98732633209369,0,2,glycine betaine metabolic process,BP,
7882,GO:0031456,1,0.98732633209369,0,2,glycine betaine biosynthetic process,BP,
7883,GO:0031460,1,0.992514613194794,0,1,glycine betaine transport,BP,
7884,GO:0031461,1,0.303774550062001,0,180,cullin-RING ubiquitin ligase complex,CC,
7885,GO:0031462,1,0.909602794624822,0,14,Cul2-RING ubiquitin ligase complex,CC,
7886,GO:0031463,1,0.63793294713703,0,66,Cul3-RING ubiquitin ligase complex,CC,
7887,GO:0031464,1,0.929045081769739,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7888,GO:0031465,1,0.96770049864506,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7889,GO:0031466,1,0.962956754731072,0,6,Cul5-RING ubiquitin ligase complex,CC,
7890,GO:0031467,1,0.968550808562488,0,5,Cul7-RING ubiquitin ligase complex,CC,
7891,GO:0031468,1,0.897973400220534,0,18,nuclear envelope reassembly,BP,
7892,GO:0031475,1,0.994574880842985,0,1,myosin V complex,CC,
7893,GO:0031477,1,0.990190990905559,0,1,myosin VII complex,CC,
7894,GO:0031489,1,0.905439823114337,0,16,myosin V binding,MF,
7895,GO:0031490,1,0.537069926917921,0,90,chromatin DNA binding,MF,
7896,GO:0031491,1,0.697230654226871,0,55,nucleosome binding,MF,
7897,GO:0031492,1,0.816680997476762,0,32,nucleosomal DNA binding,MF,
7898,GO:0031493,1,0.988758070923608,0,2,nucleosomal histone binding,MF,
7899,GO:0031497,1,0.51168712022494,0,108,chromatin assembly,BP,
7900,GO:0031498,1,0.875485062595856,0,19,chromatin disassembly,BP,
7901,GO:0031501,1,0.978411317127615,0,4,mannosyltransferase complex,CC,
7903,GO:0031506,1,0.994529222266585,0,1,cell wall glycoprotein biosynthetic process,BP,
7904,GO:0031507,1,0.936620794180994,0,9,heterochromatin assembly,BP,
7905,GO:0031508,1,0.988646374215567,0,2,pericentric heterochromatin assembly,BP,
7906,GO:0031509,1,0.994555166933378,0,1,telomeric heterochromatin assembly,BP,
7907,GO:0031510,1,0.983245822991088,0,3,SUMO activating enzyme complex,CC,
7909,GO:0031515,1,0.982907455102539,0,3,tRNA (m1A) methyltransferase complex,CC,
7910,GO:0031519,1,0.726991338546464,0,46,PcG protein complex,CC,
7911,GO:0031523,1,0.983436021385486,0,2,Myb complex,CC,
7915,GO:0031529,1,0.759392579939183,0,44,ruffle organization,BP,
7916,GO:0031530,1,0.989238804938096,0,2,gonadotropin-releasing hormone receptor binding,MF,
7917,GO:0031531,1,0.994602154797216,0,1,thyrotropin-releasing hormone receptor binding,MF,
7919,GO:0031533,1,0.991271959824451,0,1,mRNA cap methyltransferase complex,CC,
7920,GO:0031536,1,0.978122462443472,0,4,positive regulation of exit from mitosis,BP,
7921,GO:0031543,1,0.929820129713233,0,12,peptidyl-proline dioxygenase activity,MF,
7922,GO:0031544,1,0.976805442661551,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7923,GO:0031545,1,0.951910025656545,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7924,GO:0031547,1,0.959826770124926,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
7925,GO:0031548,1,0.985400975888011,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7926,GO:0031549,1,0.99204420154366,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7927,GO:0031550,1,0.993304031055145,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7928,GO:0031554,1,0.98704162678125,0,1,regulation of DNA-templated transcription, termination,BP,
7929,GO:0031559,1,0.993093756396154,0,1,oxidosqualene cyclase activity,MF,
7930,GO:0031570,1,0.352494059739035,0,157,DNA integrity checkpoint,BP,
7931,GO:0031571,1,0.631664914204128,0,69,mitotic G1 DNA damage checkpoint,BP,
7932,GO:0031572,1,0.80113825589518,0,32,G2 DNA damage checkpoint,BP,
7933,GO:0031573,1,0.919674165540375,0,14,intra-S DNA damage checkpoint,BP,
7934,GO:0031577,1,0.794392611991796,0,34,spindle checkpoint,BP,
7936,GO:0031580,1,0.947333305716387,0,9,membrane raft distribution,BP,
7937,GO:0031581,1,0.911473495087871,0,11,hemidesmosome assembly,BP,
7938,GO:0031583,1,0.994451452837518,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7939,GO:0031584,1,0.969078654181792,0,5,activation of phospholipase D activity,BP,
7940,GO:0031585,1,0.957583082038018,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7941,GO:0031587,1,0.971095746878467,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7942,GO:0031588,1,0.939026000964387,0,9,nucleotide-activated protein kinase complex,CC,
7944,GO:0031590,1,0.988334781590364,0,2,wybutosine metabolic process,BP,
7945,GO:0031591,1,0.988334781590364,0,2,wybutosine biosynthetic process,BP,
7946,GO:0031592,1,0.989683495567633,0,1,centrosomal corona,CC,
7947,GO:0031593,1,0.792944842914063,0,35,polyubiquitin modification-dependent protein binding,MF,
7949,GO:0031595,1,0.956542454822035,0,8,nuclear proteasome complex,CC,
7950,GO:0031597,1,0.932635139896104,0,12,cytosolic proteasome complex,CC,
7951,GO:0031616,1,0.941211189787461,0,10,spindle pole centrosome,CC,
7952,GO:0031618,1,0.930162255825635,0,9,nuclear pericentric heterochromatin,CC,
7953,GO:0031620,1,0.956026738058714,0,7,regulation of fever generation,BP,
7954,GO:0031622,1,0.962700495935857,0,6,positive regulation of fever generation,BP,
7956,GO:0031624,1,0.787674299822067,0,33,ubiquitin conjugating enzyme binding,MF,
7957,GO:0031625,1,0.147147846158826,0,292,ubiquitin protein ligase binding,MF,
7958,GO:0031626,1,0.992224190689415,0,1,beta-endorphin binding,MF,
7959,GO:0031627,1,0.981944490987812,0,3,telomeric loop formation,BP,
7960,GO:0031628,1,0.949732740574645,0,8,opioid receptor binding,MF,
7961,GO:0031629,1,0.907471927724441,0,16,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7962,GO:0031630,1,0.981767741707224,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7963,GO:0031635,1,0.987005583649578,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7968,GO:0031642,1,0.959633874569743,0,6,negative regulation of myelination,BP,
7969,GO:0031643,1,0.916525377005219,0,13,positive regulation of myelination,BP,
7971,GO:0031645,1,0.926212770531161,0,12,negative regulation of neurological system process,BP,
7973,GO:0031647,1,0.209032324924402,0,234,regulation of protein stability,BP,
7974,GO:0031648,1,0.748218702534744,0,41,protein destabilization,BP,
7975,GO:0031649,1,0.893506599192913,0,18,heat generation,BP,
7976,GO:0031650,1,0.925734900217022,0,12,regulation of heat generation,BP,
7977,GO:0031651,1,0.993176819693024,0,1,negative regulation of heat generation,BP,
7978,GO:0031652,1,0.938607621050296,0,10,positive regulation of heat generation,BP,
7979,GO:0031657,1,0.902653040365065,0,14,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7980,GO:0031658,1,0.951196926886755,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7981,GO:0031659,1,0.94899032682779,0,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7985,GO:0031666,1,0.946579965232321,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7990,GO:0031672,1,0.71789279275376,0,39,A band,CC,
7991,GO:0031673,1,0.982074942706843,0,1,H zone,CC,
7992,GO:0031674,1,0.352517965167866,0,130,I band,CC,
7993,GO:0031681,1,0.94800186613701,0,9,G-protein beta-subunit binding,MF,
7994,GO:0031682,1,0.994041657996762,0,1,G-protein gamma-subunit binding,MF,
7996,GO:0031685,1,0.981932060840011,0,3,adenosine receptor binding,MF,
7997,GO:0031686,1,0.994002024083546,0,1,A1 adenosine receptor binding,MF,
7998,GO:0031687,1,0.994559726584472,0,1,A2A adenosine receptor binding,MF,
7999,GO:0031690,1,0.887070309784359,0,18,adrenergic receptor binding,MF,
8000,GO:0031691,1,0.988951561554918,0,2,alpha-1A adrenergic receptor binding,MF,
8001,GO:0031692,1,0.982454310747072,0,3,alpha-1B adrenergic receptor binding,MF,
8002,GO:0031694,1,0.977777380212493,0,4,alpha-2A adrenergic receptor binding,MF,
8003,GO:0031695,1,0.994330855957059,0,1,alpha-2B adrenergic receptor binding,MF,
8004,GO:0031696,1,0.987798617485984,0,2,alpha-2C adrenergic receptor binding,MF,
8005,GO:0031697,1,0.969414764428919,0,4,beta-1 adrenergic receptor binding,MF,
8006,GO:0031698,1,0.969928407149608,0,4,beta-2 adrenergic receptor binding,MF,
8007,GO:0031699,1,0.987469795171462,0,2,beta-3 adrenergic receptor binding,MF,
8009,GO:0031701,1,0.929235361877429,0,11,angiotensin receptor binding,MF,
8010,GO:0031702,1,0.93445265487702,0,10,type 1 angiotensin receptor binding,MF,
8011,GO:0031703,1,0.994281698680658,0,1,type 2 angiotensin receptor binding,MF,
8012,GO:0031704,1,0.993924650737727,0,1,apelin receptor binding,MF,
8013,GO:0031705,1,0.983429331306709,0,3,bombesin receptor binding,MF,
8014,GO:0031707,1,0.994451452837518,0,1,endothelin A receptor binding,MF,
8015,GO:0031708,1,0.983429331306709,0,3,endothelin B receptor binding,MF,
8016,GO:0031711,1,0.988238911330193,0,2,bradykinin receptor binding,MF,
8017,GO:0031714,1,0.99228746037689,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8018,GO:0031715,1,0.99228746037689,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8019,GO:0031717,1,0.9945542757273,0,1,cannabinoid receptor binding,MF,
8020,GO:0031718,1,0.9945542757273,0,1,type 1 cannabinoid receptor binding,MF,
8021,GO:0031720,1,0.984066312652421,0,3,haptoglobin binding,MF,
8022,GO:0031724,1,0.994616672573995,0,1,CXCR5 chemokine receptor binding,MF,
8023,GO:0031726,1,0.994649822882411,0,1,CCR1 chemokine receptor binding,MF,
8025,GO:0031728,1,0.989357501373982,0,2,CCR3 chemokine receptor binding,MF,
8026,GO:0031730,1,0.973386832627009,0,4,CCR5 chemokine receptor binding,MF,
8027,GO:0031731,1,0.994647438103144,0,1,CCR6 chemokine receptor binding,MF,
8028,GO:0031732,1,0.989330056882933,0,2,CCR7 chemokine receptor binding,MF,
8029,GO:0031735,1,0.984002566050246,0,3,CCR10 chemokine receptor binding,MF,
8030,GO:0031737,1,0.993891174679371,0,1,CX3C chemokine receptor binding,MF,
8031,GO:0031739,1,0.994445365957991,0,1,cholecystokinin receptor binding,MF,
8032,GO:0031741,1,0.994445365957991,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8033,GO:0031748,1,0.956518997098831,0,7,D1 dopamine receptor binding,MF,
8034,GO:0031749,1,0.982172709965904,0,3,D2 dopamine receptor binding,MF,
8035,GO:0031750,1,0.988751541075635,0,2,D3 dopamine receptor binding,MF,
8036,GO:0031751,1,0.994549290363696,0,1,D4 dopamine receptor binding,MF,
8037,GO:0031752,1,0.978860715794795,0,3,D5 dopamine receptor binding,MF,
8038,GO:0031753,1,0.994180916594065,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8039,GO:0031755,1,0.994180916594065,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8040,GO:0031762,1,0.988951561554918,0,2,follicle-stimulating hormone receptor binding,MF,
8041,GO:0031763,1,0.994651281344248,0,1,galanin receptor binding,MF,
8042,GO:0031764,1,0.994651281344248,0,1,type 1 galanin receptor binding,MF,
8043,GO:0031765,1,0.994651281344248,0,1,type 2 galanin receptor binding,MF,
8044,GO:0031766,1,0.994651281344248,0,1,type 3 galanin receptor binding,MF,
8045,GO:0031768,1,0.994654979429419,0,1,ghrelin receptor binding,MF,
8046,GO:0031770,1,0.994666758843356,0,1,growth hormone-releasing hormone receptor binding,MF,
8047,GO:0031773,1,0.994655087611488,0,1,kisspeptin receptor binding,MF,
8048,GO:0031775,1,0.989418530363553,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8049,GO:0031779,1,0.978511621152073,0,4,melanocortin receptor binding,MF,
8050,GO:0031780,1,0.98909707903161,0,2,corticotropin hormone receptor binding,MF,
8051,GO:0031781,1,0.978511621152073,0,4,type 3 melanocortin receptor binding,MF,
8052,GO:0031782,1,0.978511621152073,0,4,type 4 melanocortin receptor binding,MF,
8053,GO:0031783,1,0.98909707903161,0,2,type 5 melanocortin receptor binding,MF,
8054,GO:0031798,1,0.989947505515292,0,1,type 1 metabotropic glutamate receptor binding,MF,
8055,GO:0031802,1,0.967873407170987,0,5,type 5 metabotropic glutamate receptor binding,MF,
8056,GO:0031811,1,0.993405374094566,0,1,G-protein coupled nucleotide receptor binding,MF,
8057,GO:0031812,1,0.993405374094566,0,1,P2Y1 nucleotide receptor binding,MF,
8058,GO:0031821,1,0.957363877933623,0,7,G-protein coupled serotonin receptor binding,MF,
8059,GO:0031826,1,0.983585172355647,0,3,type 2A serotonin receptor binding,MF,
8060,GO:0031834,1,0.99462321669727,0,1,neurokinin receptor binding,MF,
8061,GO:0031835,1,0.99462321669727,0,1,substance P receptor binding,MF,
8062,GO:0031838,1,0.978751190456355,0,4,haptoglobin-hemoglobin complex,CC,
8063,GO:0031839,1,0.994649074016324,0,1,type 1 neuromedin U receptor binding,MF,
8064,GO:0031840,1,0.994649074016324,0,1,type 2 neuromedin U receptor binding,MF,
8065,GO:0031841,1,0.994662427018319,0,1,neuropeptide Y receptor binding,MF,
8066,GO:0031848,1,0.938030454181154,0,10,protection from non-homologous end joining at telomere,BP,
8068,GO:0031852,1,0.970942408268477,0,4,mu-type opioid receptor binding,MF,
8069,GO:0031858,1,0.993957679579771,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8070,GO:0031859,1,0.994500669594196,0,1,platelet activating factor receptor binding,MF,
8071,GO:0031860,1,0.978135141659309,0,3,telomeric 3' overhang formation,BP,
8072,GO:0031862,1,0.984906543159508,0,2,prostanoid receptor binding,MF,
8073,GO:0031867,1,0.993455008080408,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8074,GO:0031870,1,0.991395778988745,0,1,thromboxane A2 receptor binding,MF,
8075,GO:0031871,1,0.980242731256705,0,3,proteinase activated receptor binding,MF,
8076,GO:0031877,1,0.990852244117435,0,1,somatostatin receptor binding,MF,
8077,GO:0031883,1,0.99445047044479,0,1,taste receptor binding,MF,
8078,GO:0031893,1,0.987646313050839,0,2,vasopressin receptor binding,MF,
8079,GO:0031894,1,0.993188170404299,0,1,V1A vasopressin receptor binding,MF,
8080,GO:0031896,1,0.994420514018365,0,1,V2 vasopressin receptor binding,MF,
8083,GO:0031903,1,0.69099495948464,0,57,microbody membrane,CC,
8084,GO:0031904,1,0.832409675154781,0,26,endosome lumen,CC,
8085,GO:0031905,1,0.982139043786141,0,3,early endosome lumen,CC,
8086,GO:0031906,1,0.96801991837119,0,6,late endosome lumen,CC,
8087,GO:0031907,1,0.781810440873451,0,41,microbody lumen,CC,
8088,GO:0031914,1,0.969884377115734,0,4,negative regulation of synaptic plasticity,BP,
8090,GO:0031929,1,0.502026891677376,0,99,TOR signaling,BP,
8091,GO:0031930,1,0.994583678196224,0,1,mitochondria-nucleus signaling pathway,BP,
8092,GO:0031931,1,0.948903402637985,0,7,TORC1 complex,CC,
8093,GO:0031932,1,0.916420252613849,0,13,TORC2 complex,CC,
8094,GO:0031933,1,0.976092439700627,0,3,telomeric heterochromatin,CC,
8095,GO:0031935,1,0.869758807169044,0,19,regulation of chromatin silencing,BP,
8096,GO:0031936,1,0.937855830797521,0,8,negative regulation of chromatin silencing,BP,
8097,GO:0031937,1,0.944903841159269,0,8,positive regulation of chromatin silencing,BP,
8098,GO:0031938,1,0.989081283920198,0,2,regulation of chromatin silencing at telomere,BP,
8099,GO:0031940,1,0.994555166933378,0,1,positive regulation of chromatin silencing at telomere,BP,
8101,GO:0031943,1,0.946385472421859,0,9,regulation of glucocorticoid metabolic process,BP,
8102,GO:0031944,1,0.970087418007484,0,5,negative regulation of glucocorticoid metabolic process,BP,
8103,GO:0031945,1,0.993400756729801,0,1,positive regulation of glucocorticoid metabolic process,BP,
8104,GO:0031946,1,0.95668261642535,0,7,regulation of glucocorticoid biosynthetic process,BP,
8105,GO:0031947,1,0.970087418007484,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8106,GO:0031948,1,0.993400756729801,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8107,GO:0031952,1,0.766874090927097,0,39,regulation of protein autophosphorylation,BP,
8108,GO:0031953,1,0.938042135950203,0,10,negative regulation of protein autophosphorylation,BP,
8109,GO:0031954,1,0.843175249602403,0,25,positive regulation of protein autophosphorylation,BP,
8110,GO:0031956,1,0.955977924966647,0,7,medium-chain fatty acid-CoA ligase activity,MF,
8111,GO:0031957,1,0.947136823263033,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8112,GO:0031958,1,0.884179576941225,0,17,corticosteroid receptor signaling pathway,BP,
8113,GO:0031959,1,0.986358684410224,0,2,mineralocorticoid receptor signaling pathway,BP,
8115,GO:0031962,1,0.991555424385236,0,1,mineralocorticoid receptor binding,MF,
8119,GO:0031968,1,0.299145980852167,0,181,organelle outer membrane,CC,
8120,GO:0031970,1,0.637562847835937,0,76,organelle envelope lumen,CC,
8128,GO:0031987,1,0.941554436991323,0,8,locomotion involved in locomotory behavior,BP,
8129,GO:0031990,1,0.982560734443401,0,2,mRNA export from nucleus in response to heat stress,BP,
8132,GO:0031996,1,0.935450664426809,0,11,thioesterase binding,MF,
8133,GO:0031997,1,0.982219711347604,0,3,N-terminal myristoylation domain binding,MF,
8134,GO:0031998,1,0.880076420532839,0,16,regulation of fatty acid beta-oxidation,BP,
8135,GO:0031999,1,0.96898132802098,0,4,negative regulation of fatty acid beta-oxidation,BP,
8136,GO:0032000,1,0.930769065992914,0,9,positive regulation of fatty acid beta-oxidation,BP,
8137,GO:0032002,1,0.988709588744126,0,2,interleukin-28 receptor complex,CC,
8138,GO:0032006,1,0.566959106335026,0,82,regulation of TOR signaling,BP,
8139,GO:0032007,1,0.768484309998197,0,38,negative regulation of TOR signaling,BP,
8140,GO:0032008,1,0.802076484692471,0,33,positive regulation of TOR signaling,BP,
8141,GO:0032009,1,0.944701673312098,0,8,early phagosome,CC,
8142,GO:0032010,1,0.972123766534532,0,5,phagolysosome,CC,
8143,GO:0032011,1,0.7230848743346,0,44,ARF protein signal transduction,BP,
8144,GO:0032012,1,0.7230848743346,0,44,regulation of ARF protein signal transduction,BP,
8145,GO:0032020,1,0.966416115216498,0,6,ISG15-protein conjugation,BP,
8146,GO:0032021,1,0.976939194758801,0,4,NELF complex,CC,
8147,GO:0032023,1,0.994395978211725,0,1,trypsinogen activation,BP,
8148,GO:0032024,1,0.692474540577914,0,59,positive regulation of insulin secretion,BP,
8149,GO:0032025,1,0.945251931852238,0,9,response to cobalt ion,BP,
8150,GO:0032026,1,0.882557807267057,0,16,response to magnesium ion,BP,
8151,GO:0032027,1,0.975148668442806,0,4,myosin light chain binding,MF,
8152,GO:0032028,1,0.994448778680426,0,1,myosin head/neck binding,MF,
8153,GO:0032029,1,0.986435309959398,0,1,myosin tail binding,MF,
8154,GO:0032036,1,0.941204865385466,0,9,myosin heavy chain binding,MF,
8155,GO:0032038,1,0.98931395994675,0,2,myosin II heavy chain binding,MF,
8156,GO:0032039,1,0.894313679814084,0,15,integrator complex,CC,
8157,GO:0032040,1,0.816594553062803,0,32,small-subunit processome,CC,
8158,GO:0032041,1,0.925544223788268,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8159,GO:0032042,1,0.901588434857987,0,16,mitochondrial DNA metabolic process,BP,
8160,GO:0032044,1,0.988158997724018,0,2,DSIF complex,CC,
8161,GO:0032045,1,0.909903702902366,0,13,guanyl-nucleotide exchange factor complex,CC,
8162,GO:0032048,1,0.917439123926467,0,14,cardiolipin metabolic process,BP,
8163,GO:0032049,1,0.953954898737228,0,8,cardiolipin biosynthetic process,BP,
8164,GO:0032050,1,0.944896443839278,0,7,clathrin heavy chain binding,MF,
8165,GO:0032051,1,0.959557315211787,0,5,clathrin light chain binding,MF,
8166,GO:0032052,1,0.945013372878575,0,10,bile acid binding,MF,
8167,GO:0032053,1,0.985064861022343,0,2,ciliary basal body organization,BP,
8168,GO:0032055,1,0.961264356715059,0,6,negative regulation of translation in response to stress,BP,
8169,GO:0032056,1,0.961158524857004,0,6,positive regulation of translation in response to stress,BP,
8170,GO:0032057,1,0.97262765809469,0,4,negative regulation of translational initiation in response to stress,BP,
8171,GO:0032058,1,0.971932341163171,0,4,positive regulation of translational initiation in response to stress,BP,
8172,GO:0032059,1,0.948549622979502,0,8,bleb,CC,
8174,GO:0032069,1,0.83357096165304,0,30,regulation of nuclease activity,BP,
8175,GO:0032070,1,0.943123683261592,0,10,regulation of deoxyribonuclease activity,BP,
8176,GO:0032071,1,0.953761733811929,0,8,regulation of endodeoxyribonuclease activity,BP,
8177,GO:0032072,1,0.993780488424455,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8178,GO:0032074,1,0.959468565325786,0,7,negative regulation of nuclease activity,BP,
8179,GO:0032075,1,0.908546736333588,0,16,positive regulation of nuclease activity,BP,
8180,GO:0032076,1,0.988894182332627,0,2,negative regulation of deoxyribonuclease activity,BP,
8181,GO:0032077,1,0.971270257939986,0,5,positive regulation of deoxyribonuclease activity,BP,
8182,GO:0032078,1,0.99464366015479,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8183,GO:0032079,1,0.976544158144071,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8184,GO:0032088,1,0.600063525085949,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8185,GO:0032089,1,0.986358125092985,0,2,NACHT domain binding,MF,
8186,GO:0032090,1,0.988376559701326,0,2,Pyrin domain binding,MF,
8189,GO:0032093,1,0.994184768585909,0,1,SAM domain binding,MF,
8190,GO:0032094,1,0.819443362533961,0,31,response to food,BP,
8191,GO:0032095,1,0.898374679894152,0,17,regulation of response to food,BP,
8192,GO:0032096,1,0.933873477879395,0,11,negative regulation of response to food,BP,
8193,GO:0032097,1,0.983913349087889,0,3,positive regulation of response to food,BP,
8194,GO:0032098,1,0.890037347056556,0,19,regulation of appetite,BP,
8195,GO:0032099,1,0.933873477879395,0,11,negative regulation of appetite,BP,
8196,GO:0032100,1,0.983913349087889,0,3,positive regulation of appetite,BP,
8200,GO:0032104,1,0.861583734991202,0,23,regulation of response to extracellular stimulus,BP,
8201,GO:0032105,1,0.921565533688861,0,13,negative regulation of response to extracellular stimulus,BP,
8202,GO:0032106,1,0.972883155132388,0,5,positive regulation of response to extracellular stimulus,BP,
8203,GO:0032107,1,0.861583734991202,0,23,regulation of response to nutrient levels,BP,
8204,GO:0032108,1,0.921565533688861,0,13,negative regulation of response to nutrient levels,BP,
8205,GO:0032109,1,0.972883155132388,0,5,positive regulation of response to nutrient levels,BP,
8206,GO:0032116,1,0.982026472845047,0,2,SMC loading complex,CC,
8207,GO:0032119,1,0.932866444062724,0,11,sequestering of zinc ion,BP,
8208,GO:0032127,1,0.987250056738537,0,2,dense core granule membrane,CC,
8209,GO:0032129,1,0.988040918615773,0,2,histone deacetylase activity (H3-K9 specific),MF,
8210,GO:0032133,1,0.972596342411307,0,5,chromosome passenger complex,CC,
8211,GO:0032135,1,0.962726629214932,0,6,DNA insertion or deletion binding,MF,
8212,GO:0032137,1,0.981443452945352,0,3,guanine/thymine mispair binding,MF,
8213,GO:0032138,1,0.974158909037661,0,4,single base insertion or deletion binding,MF,
8214,GO:0032139,1,0.981433556644853,0,3,dinucleotide insertion or deletion binding,MF,
8215,GO:0032142,1,0.979888125941566,0,3,single guanine insertion binding,MF,
8216,GO:0032143,1,0.987043550360205,0,2,single thymine insertion binding,MF,
8217,GO:0032144,1,0.992492201901996,0,1,4-aminobutyrate transaminase complex,CC,
8218,GO:0032145,1,0.992492201901996,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8220,GO:0032148,1,0.815107294144938,0,29,activation of protein kinase B activity,BP,
8221,GO:0032153,1,0.596336713896883,0,76,cell division site,CC,
8222,GO:0032154,1,0.702330860659797,0,51,cleavage furrow,CC,
8223,GO:0032155,1,0.660677434007915,0,60,cell division site part,CC,
8224,GO:0032156,1,0.920592456689147,0,13,septin cytoskeleton,CC,
8225,GO:0032160,1,0.926971772021431,0,12,septin filament array,CC,
8226,GO:0032173,1,0.994064671348188,0,1,septin collar,CC,
8227,GO:0032181,1,0.986762085526098,0,2,dinucleotide repeat insertion binding,MF,
8228,GO:0032182,1,0.574508706079952,0,83,ubiquitin-like protein binding,MF,
8229,GO:0032183,1,0.899526221190689,0,14,SUMO binding,MF,
8230,GO:0032184,1,0.962782236948051,0,5,SUMO polymer binding,MF,
8231,GO:0032185,1,0.901341534323579,0,16,septin cytoskeleton organization,BP,
8232,GO:0032190,1,0.983654453215909,0,3,acrosin binding,MF,
8233,GO:0032194,1,0.993607541176219,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8234,GO:0032196,1,0.887495395301912,0,19,transposition,BP,
8235,GO:0032200,1,0.363893176069533,0,149,telomere organization,BP,
8236,GO:0032201,1,0.845642473259545,0,27,telomere maintenance via semi-conservative replication,BP,
8237,GO:0032202,1,0.976883709473408,0,4,telomere assembly,BP,
8238,GO:0032203,1,0.994511452894922,0,1,telomere formation via telomerase,BP,
8239,GO:0032204,1,0.588543133142863,0,76,regulation of telomere maintenance,BP,
8240,GO:0032205,1,0.7764736817089,0,34,negative regulation of telomere maintenance,BP,
8241,GO:0032206,1,0.723360698615156,0,49,positive regulation of telomere maintenance,BP,
8242,GO:0032207,1,0.994123438828563,0,1,regulation of telomere maintenance via recombination,BP,
8243,GO:0032208,1,0.994123438828563,0,1,negative regulation of telomere maintenance via recombination,BP,
8244,GO:0032210,1,0.700557291615301,0,52,regulation of telomere maintenance via telomerase,BP,
8245,GO:0032211,1,0.87272873133079,0,19,negative regulation of telomere maintenance via telomerase,BP,
8246,GO:0032212,1,0.801432474944147,0,34,positive regulation of telomere maintenance via telomerase,BP,
8247,GO:0032213,1,0.988261087851807,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8248,GO:0032214,1,0.988261087851807,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8249,GO:0032217,1,0.977365196124024,0,4,riboflavin transmembrane transporter activity,MF,
8250,GO:0032218,1,0.982654556248871,0,3,riboflavin transport,BP,
8251,GO:0032222,1,0.954680697039498,0,7,regulation of synaptic transmission, cholinergic,BP,
8252,GO:0032223,1,0.994281482279886,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8253,GO:0032224,1,0.96573910894026,0,5,positive regulation of synaptic transmission, cholinergic,BP,
8254,GO:0032225,1,0.911681898426344,0,15,regulation of synaptic transmission, dopaminergic,BP,
8255,GO:0032226,1,0.959136985601403,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8256,GO:0032227,1,0.979814967193698,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8257,GO:0032228,1,0.808153781640282,0,30,regulation of synaptic transmission, GABAergic,BP,
8258,GO:0032229,1,0.964609216478841,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8259,GO:0032230,1,0.924206962304718,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8260,GO:0032231,1,0.543273825203884,0,86,regulation of actin filament bundle assembly,BP,
8261,GO:0032232,1,0.849051450078988,0,22,negative regulation of actin filament bundle assembly,BP,
8262,GO:0032233,1,0.686324812347099,0,56,positive regulation of actin filament bundle assembly,BP,
8263,GO:0032237,1,0.973063105283406,0,4,activation of store-operated calcium channel activity,BP,
8264,GO:0032239,1,0.881234556449844,0,17,regulation of nucleobase-containing compound transport,BP,
8265,GO:0032240,1,0.979959620632606,0,2,negative regulation of nucleobase-containing compound transport,BP,
8266,GO:0032241,1,0.94635615326524,0,8,positive regulation of nucleobase-containing compound transport,BP,
8267,GO:0032242,1,0.994155716158444,0,1,regulation of nucleoside transport,BP,
8268,GO:0032244,1,0.994155716158444,0,1,positive regulation of nucleoside transport,BP,
8269,GO:0032252,1,0.965203914987156,0,4,secretory granule localization,BP,
8270,GO:0032253,1,0.994184768585909,0,1,dense core granule localization,BP,
8271,GO:0032258,1,0.988653167774531,0,2,protein localization by the Cvt pathway,BP,
8273,GO:0032261,1,0.960017046567591,0,7,purine nucleotide salvage,BP,
8274,GO:0032262,1,0.96744449810242,0,6,pyrimidine nucleotide salvage,BP,
8275,GO:0032263,1,0.989114391765378,0,2,GMP salvage,BP,
8276,GO:0032264,1,0.975852740327457,0,4,IMP salvage,BP,
8281,GO:0032271,1,0.269330092297153,0,193,regulation of protein polymerization,BP,
8282,GO:0032272,1,0.651097492679072,0,63,negative regulation of protein polymerization,BP,
8283,GO:0032273,1,0.462411652061818,0,116,positive regulation of protein polymerization,BP,
8284,GO:0032274,1,0.910850342992616,0,14,gonadotropin secretion,BP,
8285,GO:0032275,1,0.932691987722092,0,10,luteinizing hormone secretion,BP,
8286,GO:0032276,1,0.937660033095484,0,10,regulation of gonadotropin secretion,BP,
8287,GO:0032277,1,0.964886504513923,0,6,negative regulation of gonadotropin secretion,BP,
8288,GO:0032278,1,0.955319473733239,0,7,positive regulation of gonadotropin secretion,BP,
8290,GO:0032280,1,0.942423754849334,0,8,symmetric synapse,CC,
8292,GO:0032286,1,0.974812767417264,0,4,central nervous system myelin maintenance,BP,
8293,GO:0032287,1,0.915262996725117,0,9,peripheral nervous system myelin maintenance,BP,
8294,GO:0032288,1,0.85289535564099,0,20,myelin assembly,BP,
8295,GO:0032289,1,0.982518557725705,0,3,central nervous system myelin formation,BP,
8296,GO:0032290,1,0.956461140988484,0,4,peripheral nervous system myelin formation,BP,
8297,GO:0032291,1,0.897796027707108,0,17,axon ensheathment in central nervous system,BP,
8298,GO:0032292,1,0.8121939060845,0,25,peripheral nervous system axon ensheathment,BP,
8299,GO:0032296,1,0.969651364386121,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8300,GO:0032298,1,0.994407901722561,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8301,GO:0032299,1,0.983465519039796,0,3,ribonuclease H2 complex,CC,
8302,GO:0032300,1,0.939396055370487,0,9,mismatch repair complex,CC,
8303,GO:0032301,1,0.987043550360205,0,2,MutSalpha complex,CC,
8304,GO:0032302,1,0.986762085526098,0,2,MutSbeta complex,CC,
8305,GO:0032303,1,0.934572251616596,0,11,regulation of icosanoid secretion,BP,
8306,GO:0032304,1,0.992376919026555,0,1,negative regulation of icosanoid secretion,BP,
8307,GO:0032305,1,0.941749823331706,0,10,positive regulation of icosanoid secretion,BP,
8308,GO:0032306,1,0.961281788526851,0,7,regulation of prostaglandin secretion,BP,
8309,GO:0032308,1,0.961281788526851,0,7,positive regulation of prostaglandin secretion,BP,
8311,GO:0032310,1,0.94198792839066,0,10,prostaglandin secretion,BP,
8312,GO:0032311,1,0.98916920628461,0,2,angiogenin-PRI complex,CC,
8313,GO:0032324,1,0.959036822178512,0,7,molybdopterin cofactor biosynthetic process,BP,
8314,GO:0032328,1,0.946923475692788,0,8,alanine transport,BP,
8315,GO:0032329,1,0.943919275152245,0,10,serine transport,BP,
8316,GO:0032330,1,0.748088191937381,0,42,regulation of chondrocyte differentiation,BP,
8317,GO:0032331,1,0.895753448146908,0,17,negative regulation of chondrocyte differentiation,BP,
8318,GO:0032332,1,0.876504506691959,0,19,positive regulation of chondrocyte differentiation,BP,
8319,GO:0032341,1,0.954059184657268,0,7,aldosterone metabolic process,BP,
8320,GO:0032342,1,0.954059184657268,0,7,aldosterone biosynthetic process,BP,
8321,GO:0032344,1,0.964147328399523,0,6,regulation of aldosterone metabolic process,BP,
8322,GO:0032345,1,0.976414551179982,0,4,negative regulation of aldosterone metabolic process,BP,
8323,GO:0032346,1,0.987439441304203,0,2,positive regulation of aldosterone metabolic process,BP,
8324,GO:0032347,1,0.964147328399523,0,6,regulation of aldosterone biosynthetic process,BP,
8325,GO:0032348,1,0.976414551179982,0,4,negative regulation of aldosterone biosynthetic process,BP,
8326,GO:0032349,1,0.987439441304203,0,2,positive regulation of aldosterone biosynthetic process,BP,
8327,GO:0032350,1,0.821062411647267,0,31,regulation of hormone metabolic process,BP,
8328,GO:0032351,1,0.936066358143705,0,11,negative regulation of hormone metabolic process,BP,
8329,GO:0032352,1,0.926389290266279,0,12,positive regulation of hormone metabolic process,BP,
8330,GO:0032353,1,0.941138450615426,0,10,negative regulation of hormone biosynthetic process,BP,
8331,GO:0032354,1,0.901464635977622,0,14,response to follicle-stimulating hormone,BP,
8333,GO:0032356,1,0.93809793269792,0,10,oxidized DNA binding,MF,
8334,GO:0032357,1,0.943339542585106,0,9,oxidized purine DNA binding,MF,
8335,GO:0032358,1,0.994647405411136,0,1,oxidized pyrimidine DNA binding,MF,
8336,GO:0032361,1,0.994477020653939,0,1,pyridoxal phosphate catabolic process,BP,
8337,GO:0032364,1,0.961341049859529,0,6,oxygen homeostasis,BP,
8342,GO:0032369,1,0.876392659442811,0,19,negative regulation of lipid transport,BP,
8345,GO:0032372,1,0.951571156991165,0,8,negative regulation of sterol transport,BP,
8348,GO:0032375,1,0.951571156991165,0,8,negative regulation of cholesterol transport,BP,
8351,GO:0032378,1,0.993613080661637,0,1,negative regulation of intracellular lipid transport,BP,
8354,GO:0032381,1,0.993613080661637,0,1,negative regulation of intracellular sterol transport,BP,
8357,GO:0032384,1,0.993613080661637,0,1,negative regulation of intracellular cholesterol transport,BP,
8360,GO:0032387,1,0.700314492362847,0,56,negative regulation of intracellular transport,BP,
8362,GO:0032389,1,0.974202551198944,0,4,MutLalpha complex,CC,
8363,GO:0032391,1,0.796570272702481,0,32,photoreceptor connecting cilium,CC,
8365,GO:0032393,1,0.961756480320373,0,7,MHC class I receptor activity,MF,
8366,GO:0032394,1,0.994565502838772,0,1,MHC class Ib receptor activity,MF,
8368,GO:0032396,1,0.982846702763703,0,3,inhibitory MHC class I receptor activity,MF,
8369,GO:0032397,1,0.994581830190299,0,1,activating MHC class I receptor activity,MF,
8370,GO:0032398,1,0.99454772052931,0,1,MHC class Ib protein complex,CC,
8371,GO:0032400,1,0.848563714261897,0,26,melanosome localization,BP,
8372,GO:0032401,1,0.858409142810616,0,24,establishment of melanosome localization,BP,
8373,GO:0032402,1,0.866978117335759,0,23,melanosome transport,BP,
8374,GO:0032404,1,0.949651150853405,0,8,mismatch repair complex binding,MF,
8375,GO:0032405,1,0.965990444288441,0,5,MutLalpha complex binding,MF,
8376,GO:0032407,1,0.967346334370492,0,5,MutSalpha complex binding,MF,
8378,GO:0032410,1,0.645456569846739,0,67,negative regulation of transporter activity,BP,
8379,GO:0032411,1,0.514744389868847,0,93,positive regulation of transporter activity,BP,
8381,GO:0032413,1,0.675733478389166,0,60,negative regulation of ion transmembrane transporter activity,BP,
8382,GO:0032414,1,0.543012159838174,0,84,positive regulation of ion transmembrane transporter activity,BP,
8383,GO:0032415,1,0.971613006941315,0,5,regulation of sodium:proton antiporter activity,BP,
8384,GO:0032416,1,0.994476509065974,0,1,negative regulation of sodium:proton antiporter activity,BP,
8385,GO:0032417,1,0.977010770090482,0,4,positive regulation of sodium:proton antiporter activity,BP,
8387,GO:0032419,1,0.994410939735775,0,1,extrinsic component of lysosome membrane,CC,
8388,GO:0032420,1,0.756702857933175,0,39,stereocilium,CC,
8389,GO:0032421,1,0.734336766281013,0,44,stereocilium bundle,CC,
8390,GO:0032422,1,0.972070994874326,0,4,purine-rich negative regulatory element binding,MF,
8391,GO:0032423,1,0.980991388979205,0,3,regulation of mismatch repair,BP,
8392,GO:0032425,1,0.98779455060185,0,2,positive regulation of mismatch repair,BP,
8393,GO:0032426,1,0.907038356717961,0,15,stereocilium tip,CC,
8394,GO:0032427,1,0.987311618825234,0,2,GBD domain binding,MF,
8395,GO:0032428,1,0.99366243812071,0,1,beta-N-acetylgalactosaminidase activity,MF,
8397,GO:0032430,1,0.970566154493869,0,5,positive regulation of phospholipase A2 activity,BP,
8398,GO:0032431,1,0.983478344129029,0,3,activation of phospholipase A2 activity,BP,
8399,GO:0032432,1,0.666834641742612,0,56,actin filament bundle,CC,
8400,GO:0032433,1,0.882217572536876,0,16,filopodium tip,CC,
8401,GO:0032434,1,0.479335279068672,0,113,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8402,GO:0032435,1,0.838464945749665,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8403,GO:0032436,1,0.602498003508081,0,78,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8404,GO:0032437,1,0.959968621662458,0,5,cuticular plate,CC,
8405,GO:0032438,1,0.838238375968486,0,26,melanosome organization,BP,
8406,GO:0032440,1,0.994611019451608,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8407,GO:0032444,1,0.971171843342121,0,3,activin responsive factor complex,CC,
8408,GO:0032445,1,0.994381755056307,0,1,fructose import,BP,
8410,GO:0032447,1,0.994332998480301,0,1,protein urmylation,BP,
8411,GO:0032448,1,0.994565001565448,0,1,DNA hairpin binding,MF,
8412,GO:0032449,1,0.967798451228041,0,5,CBM complex,CC,
8413,GO:0032450,1,0.977569324019802,0,3,maltose alpha-glucosidase activity,MF,
8414,GO:0032451,1,0.774016440117563,0,34,demethylase activity,MF,
8415,GO:0032452,1,0.816187923935412,0,25,histone demethylase activity,MF,
8416,GO:0032453,1,0.949665602924998,0,6,histone demethylase activity (H3-K4 specific),MF,
8417,GO:0032454,1,0.91172266179128,0,12,histone demethylase activity (H3-K9 specific),MF,
8418,GO:0032455,1,0.975696945789372,0,4,nerve growth factor processing,BP,
8419,GO:0032456,1,0.791160011334825,0,34,endocytic recycling,BP,
8420,GO:0032458,1,0.993424212531507,0,1,slow endocytic recycling,BP,
8421,GO:0032459,1,0.7932189076758,0,36,regulation of protein oligomerization,BP,
8422,GO:0032460,1,0.90845490063039,0,14,negative regulation of protein oligomerization,BP,
8423,GO:0032461,1,0.879163514703484,0,21,positive regulation of protein oligomerization,BP,
8424,GO:0032462,1,0.903406644849666,0,17,regulation of protein homooligomerization,BP,
8425,GO:0032463,1,0.942415140354274,0,10,negative regulation of protein homooligomerization,BP,
8426,GO:0032464,1,0.958182106947795,0,7,positive regulation of protein homooligomerization,BP,
8427,GO:0032465,1,0.593146704227845,0,73,regulation of cytokinesis,BP,
8428,GO:0032466,1,0.956541911851556,0,7,negative regulation of cytokinesis,BP,
8429,GO:0032467,1,0.817902601457826,0,29,positive regulation of cytokinesis,BP,
8430,GO:0032468,1,0.993723753537484,0,1,Golgi calcium ion homeostasis,BP,
8431,GO:0032469,1,0.867116259668611,0,21,endoplasmic reticulum calcium ion homeostasis,BP,
8432,GO:0032470,1,0.983183578073952,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8433,GO:0032471,1,0.95195086941573,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8434,GO:0032472,1,0.988244076825629,0,2,Golgi calcium ion transport,BP,
8435,GO:0032473,1,0.988525498597407,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8436,GO:0032474,1,0.980444506569601,0,3,otolith morphogenesis,BP,
8437,GO:0032475,1,0.994251418956767,0,1,otolith formation,BP,
8438,GO:0032479,1,0.468960562567851,0,115,regulation of type I interferon production,BP,
8439,GO:0032480,1,0.742404061283802,0,45,negative regulation of type I interferon production,BP,
8440,GO:0032481,1,0.63247656598338,0,69,positive regulation of type I interferon production,BP,
8441,GO:0032482,1,0.666968415684915,0,67,Rab protein signal transduction,BP,
8442,GO:0032483,1,0.971372098946208,0,4,regulation of Rab protein signal transduction,BP,
8443,GO:0032484,1,0.976825875698937,0,3,Ral protein signal transduction,BP,
8444,GO:0032485,1,0.976825875698937,0,3,regulation of Ral protein signal transduction,BP,
8445,GO:0032486,1,0.90907813710628,0,13,Rap protein signal transduction,BP,
8446,GO:0032487,1,0.976926338997695,0,3,regulation of Rap protein signal transduction,BP,
8447,GO:0032488,1,0.908837006837968,0,14,Cdc42 protein signal transduction,BP,
8448,GO:0032489,1,0.958261080704784,0,6,regulation of Cdc42 protein signal transduction,BP,
8449,GO:0032490,1,0.919712131807951,0,12,detection of molecule of bacterial origin,BP,
8450,GO:0032493,1,0.946741407005677,0,8,response to bacterial lipoprotein,BP,
8451,GO:0032494,1,0.937967228415247,0,10,response to peptidoglycan,BP,
8452,GO:0032495,1,0.906833216722193,0,14,response to muramyl dipeptide,BP,
8454,GO:0032497,1,0.975551936642792,0,4,detection of lipopolysaccharide,BP,
8455,GO:0032498,1,0.992884705063123,0,1,detection of muramyl dipeptide,BP,
8456,GO:0032499,1,0.987553822913397,0,2,detection of peptidoglycan,BP,
8457,GO:0032500,1,0.992884705063123,0,1,muramyl dipeptide binding,MF,
8461,GO:0032506,1,0.855541935724725,0,23,cytokinetic process,BP,
8462,GO:0032507,1,0.59122700983107,0,72,maintenance of protein location in cell,BP,
8464,GO:0032509,1,0.871820765753772,0,21,endosome transport via multivesicular body sorting pathway,BP,
8465,GO:0032510,1,0.956054832694726,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8466,GO:0032511,1,0.953819833770716,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8468,GO:0032516,1,0.885920657969042,0,16,positive regulation of phosphoprotein phosphatase activity,BP,
8469,GO:0032525,1,0.940306951161526,0,9,somite rostral/caudal axis specification,BP,
8471,GO:0032527,1,0.770337996233,0,39,protein exit from endoplasmic reticulum,BP,
8472,GO:0032528,1,0.850561739961126,0,23,microvillus organization,BP,
8473,GO:0032530,1,0.923291426115418,0,12,regulation of microvillus organization,BP,
8474,GO:0032532,1,0.964132144942938,0,6,regulation of microvillus length,BP,
8475,GO:0032534,1,0.95765505570697,0,6,regulation of microvillus assembly,BP,
8477,GO:0032536,1,0.930375026150364,0,11,regulation of cell projection size,BP,
8478,GO:0032541,1,0.970277434437156,0,5,cortical endoplasmic reticulum,CC,
8479,GO:0032542,1,0.98805734845068,0,2,sulfiredoxin activity,MF,
8480,GO:0032543,1,0.483875291147972,0,127,mitochondrial translation,BP,
8481,GO:0032545,1,0.987800572209234,0,2,CURI complex,CC,
8484,GO:0032551,1,0.986168194071878,0,2,pyrimidine ribonucleoside binding,MF,
8485,GO:0032552,1,0.966431797945672,0,6,deoxyribonucleotide binding,MF,
8487,GO:0032554,1,0.977022706751504,0,4,purine deoxyribonucleotide binding,MF,
8489,GO:0032556,1,0.989162526270223,0,2,pyrimidine deoxyribonucleotide binding,MF,
8490,GO:0032557,1,0.980682492369743,0,3,pyrimidine ribonucleotide binding,MF,
8491,GO:0032558,1,0.982982475756022,0,3,adenyl deoxyribonucleotide binding,MF,
8493,GO:0032560,1,0.993938092816132,0,1,guanyl deoxyribonucleotide binding,MF,
8495,GO:0032564,1,0.982982475756022,0,3,dATP binding,MF,
8496,GO:0032567,1,0.993938092816132,0,1,dGTP binding,MF,
8497,GO:0032570,1,0.777819443823766,0,40,response to progesterone,BP,
8499,GO:0032574,1,0.993349233497017,0,1,5'-3' RNA helicase activity,MF,
8500,GO:0032575,1,0.993349233497017,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8502,GO:0032581,1,0.994514097923653,0,1,ER-dependent peroxisome organization,BP,
8503,GO:0032584,1,0.964253346472429,0,6,growth cone membrane,CC,
8504,GO:0032585,1,0.948021897098204,0,9,multivesicular body membrane,CC,
8510,GO:0032592,1,0.681264675115454,0,65,integral component of mitochondrial membrane,CC,
8511,GO:0032593,1,0.948925864291709,0,7,insulin-responsive compartment,CC,
8513,GO:0032596,1,0.96900962910527,0,5,protein transport into membrane raft,BP,
8514,GO:0032601,1,0.994607640841943,0,1,connective tissue growth factor production,BP,
8516,GO:0032603,1,0.994642441055126,0,1,fractalkine production,BP,
8517,GO:0032604,1,0.928500083604362,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8518,GO:0032605,1,0.993938092816132,0,1,hepatocyte growth factor production,BP,
8519,GO:0032606,1,0.466402285743755,0,116,type I interferon production,BP,
8520,GO:0032607,1,0.835608212632575,0,26,interferon-alpha production,BP,
8521,GO:0032608,1,0.73648038567709,0,47,interferon-beta production,BP,
8522,GO:0032609,1,0.575640548291238,0,91,interferon-gamma production,BP,
8523,GO:0032610,1,0.961558022228268,0,7,interleukin-1 alpha production,BP,
8524,GO:0032611,1,0.688185306932151,0,59,interleukin-1 beta production,BP,
8526,GO:0032613,1,0.778187403584168,0,42,interleukin-10 production,BP,
8527,GO:0032615,1,0.736042235413893,0,49,interleukin-12 production,BP,
8528,GO:0032616,1,0.901863210253655,0,17,interleukin-13 production,BP,
8529,GO:0032618,1,0.98910424911626,0,2,interleukin-15 production,BP,
8530,GO:0032620,1,0.888457386840138,0,20,interleukin-17 production,BP,
8531,GO:0032621,1,0.949865069377829,0,8,interleukin-18 production,BP,
8533,GO:0032625,1,0.99367444005724,0,1,interleukin-21 production,BP,
8534,GO:0032627,1,0.968979842089233,0,5,interleukin-23 production,BP,
8535,GO:0032632,1,0.980328445020143,0,3,interleukin-3 production,BP,
8536,GO:0032633,1,0.826586471761884,0,31,interleukin-4 production,BP,
8537,GO:0032634,1,0.909771649400933,0,15,interleukin-5 production,BP,
8538,GO:0032635,1,0.51617430554286,0,105,interleukin-6 production,BP,
8540,GO:0032639,1,0.988628827518782,0,2,TRAIL production,BP,
8542,GO:0032641,1,0.988256128063181,0,2,lymphotoxin A production,BP,
8544,GO:0032643,1,0.994607640841943,0,1,regulation of connective tissue growth factor production,BP,
8545,GO:0032644,1,0.994642441055126,0,1,regulation of fractalkine production,BP,
8546,GO:0032645,1,0.933602911264102,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8547,GO:0032646,1,0.993938092816132,0,1,regulation of hepatocyte growth factor production,BP,
8548,GO:0032647,1,0.840164892797622,0,25,regulation of interferon-alpha production,BP,
8550,GO:0032649,1,0.617215374465297,0,80,regulation of interferon-gamma production,BP,
8551,GO:0032650,1,0.966721738569764,0,6,regulation of interleukin-1 alpha production,BP,
8552,GO:0032651,1,0.728101901780878,0,51,regulation of interleukin-1 beta production,BP,
8554,GO:0032653,1,0.78738223503588,0,40,regulation of interleukin-10 production,BP,
8555,GO:0032655,1,0.745010608412486,0,47,regulation of interleukin-12 production,BP,
8556,GO:0032656,1,0.906744110491955,0,16,regulation of interleukin-13 production,BP,
8557,GO:0032658,1,0.994527170923359,0,1,regulation of interleukin-15 production,BP,
8558,GO:0032660,1,0.903652582494778,0,17,regulation of interleukin-17 production,BP,
8559,GO:0032661,1,0.962935394006573,0,6,regulation of interleukin-18 production,BP,
8561,GO:0032667,1,0.968979842089233,0,5,regulation of interleukin-23 production,BP,
8562,GO:0032672,1,0.986806808777468,0,2,regulation of interleukin-3 production,BP,
8563,GO:0032673,1,0.862031172748913,0,25,regulation of interleukin-4 production,BP,
8564,GO:0032674,1,0.909771649400933,0,15,regulation of interleukin-5 production,BP,
8565,GO:0032675,1,0.54549291850919,0,97,regulation of interleukin-6 production,BP,
8567,GO:0032679,1,0.988628827518782,0,2,regulation of TRAIL production,BP,
8569,GO:0032681,1,0.994219143804611,0,1,regulation of lymphotoxin A production,BP,
8570,GO:0032682,1,0.912068807168263,0,16,negative regulation of chemokine production,BP,
8571,GO:0032685,1,0.993893246028882,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8572,GO:0032686,1,0.993938092816132,0,1,negative regulation of hepatocyte growth factor production,BP,
8573,GO:0032687,1,0.960651628075674,0,6,negative regulation of interferon-alpha production,BP,
8574,GO:0032688,1,0.916184639230974,0,14,negative regulation of interferon-beta production,BP,
8576,GO:0032690,1,0.994588007976772,0,1,negative regulation of interleukin-1 alpha production,BP,
8577,GO:0032691,1,0.914325770225029,0,15,negative regulation of interleukin-1 beta production,BP,
8578,GO:0032692,1,0.883243174135319,0,21,negative regulation of interleukin-1 production,BP,
8579,GO:0032693,1,0.921064582552089,0,14,negative regulation of interleukin-10 production,BP,
8580,GO:0032695,1,0.899653530387622,0,16,negative regulation of interleukin-12 production,BP,
8581,GO:0032696,1,0.981932595318688,0,3,negative regulation of interleukin-13 production,BP,
8582,GO:0032700,1,0.946832632414037,0,9,negative regulation of interleukin-17 production,BP,
8583,GO:0032701,1,0.988482915177174,0,2,negative regulation of interleukin-18 production,BP,
8585,GO:0032707,1,0.986213249155056,0,2,negative regulation of interleukin-23 production,BP,
8586,GO:0032712,1,0.99438140973488,0,1,negative regulation of interleukin-3 production,BP,
8587,GO:0032713,1,0.970334408503642,0,5,negative regulation of interleukin-4 production,BP,
8588,GO:0032714,1,0.981828472103479,0,3,negative regulation of interleukin-5 production,BP,
8589,GO:0032715,1,0.812456497321322,0,33,negative regulation of interleukin-6 production,BP,
8591,GO:0032720,1,0.771753591760549,0,43,negative regulation of tumor necrosis factor production,BP,
8593,GO:0032723,1,0.994607640841943,0,1,positive regulation of connective tissue growth factor production,BP,
8594,GO:0032724,1,0.994642441055126,0,1,positive regulation of fractalkine production,BP,
8595,GO:0032725,1,0.939342827797469,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8596,GO:0032727,1,0.87462517651344,0,19,positive regulation of interferon-alpha production,BP,
8597,GO:0032728,1,0.825064686948194,0,29,positive regulation of interferon-beta production,BP,
8598,GO:0032729,1,0.713535683504862,0,55,positive regulation of interferon-gamma production,BP,
8599,GO:0032730,1,0.971983598742039,0,5,positive regulation of interleukin-1 alpha production,BP,
8600,GO:0032731,1,0.813913773584628,0,32,positive regulation of interleukin-1 beta production,BP,
8601,GO:0032732,1,0.784015353776735,0,38,positive regulation of interleukin-1 production,BP,
8602,GO:0032733,1,0.845751392800654,0,28,positive regulation of interleukin-10 production,BP,
8603,GO:0032735,1,0.840550431433721,0,29,positive regulation of interleukin-12 production,BP,
8604,GO:0032736,1,0.923441481529113,0,13,positive regulation of interleukin-13 production,BP,
8605,GO:0032738,1,0.994527170923359,0,1,positive regulation of interleukin-15 production,BP,
8606,GO:0032740,1,0.949092411068344,0,9,positive regulation of interleukin-17 production,BP,
8607,GO:0032741,1,0.980126211212314,0,3,positive regulation of interleukin-18 production,BP,
8609,GO:0032747,1,0.988041048622222,0,2,positive regulation of interleukin-23 production,BP,
8610,GO:0032752,1,0.992383027571753,0,1,positive regulation of interleukin-3 production,BP,
8611,GO:0032753,1,0.883415785551693,0,21,positive regulation of interleukin-4 production,BP,
8612,GO:0032754,1,0.931777149207207,0,11,positive regulation of interleukin-5 production,BP,
8613,GO:0032755,1,0.670667738353268,0,64,positive regulation of interleukin-6 production,BP,
8615,GO:0032759,1,0.988628827518782,0,2,positive regulation of TRAIL production,BP,
8616,GO:0032760,1,0.655268860365856,0,64,positive regulation of tumor necrosis factor production,BP,
8617,GO:0032761,1,0.994219143804611,0,1,positive regulation of lymphotoxin A production,BP,
8618,GO:0032762,1,0.956580818473929,0,7,mast cell cytokine production,BP,
8619,GO:0032763,1,0.969429020594503,0,5,regulation of mast cell cytokine production,BP,
8620,GO:0032764,1,0.98830187077166,0,2,negative regulation of mast cell cytokine production,BP,
8621,GO:0032765,1,0.980905985992345,0,3,positive regulation of mast cell cytokine production,BP,
8622,GO:0032767,1,0.977546776243059,0,3,copper-dependent protein binding,MF,
8623,GO:0032768,1,0.734804872210583,0,49,regulation of monooxygenase activity,BP,
8624,GO:0032769,1,0.936146933395993,0,10,negative regulation of monooxygenase activity,BP,
8625,GO:0032770,1,0.867829344560773,0,23,positive regulation of monooxygenase activity,BP,
8626,GO:0032771,1,0.993068521420915,0,1,regulation of monophenol monooxygenase activity,BP,
8627,GO:0032773,1,0.993068521420915,0,1,positive regulation of monophenol monooxygenase activity,BP,
8629,GO:0032775,1,0.993586074527996,0,1,DNA methylation on adenine,BP,
8630,GO:0032776,1,0.978606831725792,0,3,DNA methylation on cytosine,BP,
8631,GO:0032777,1,0.97687483293937,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8633,GO:0032781,1,0.739425400943663,0,50,positive regulation of ATPase activity,BP,
8634,GO:0032782,1,0.976673061719009,0,4,bile acid secretion,BP,
8635,GO:0032783,1,0.940211499562106,0,6,ELL-EAF complex,CC,
8636,GO:0032784,1,0.771211677519588,0,41,regulation of DNA-templated transcription, elongation,BP,
8637,GO:0032785,1,0.920774652899621,0,13,negative regulation of DNA-templated transcription, elongation,BP,
8638,GO:0032786,1,0.862817141614255,0,23,positive regulation of DNA-templated transcription, elongation,BP,
8640,GO:0032788,1,0.994556935413119,0,1,saturated monocarboxylic acid metabolic process,BP,
8641,GO:0032789,1,0.994556935413119,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8642,GO:0032790,1,0.949065127140326,0,8,ribosome disassembly,BP,
8643,GO:0032792,1,0.968421608443428,0,5,negative regulation of CREB transcription factor activity,BP,
8644,GO:0032793,1,0.903835263258263,0,14,positive regulation of CREB transcription factor activity,BP,
8645,GO:0032794,1,0.898576271918551,0,14,GTPase activating protein binding,MF,
8646,GO:0032795,1,0.982319301961337,0,3,heterotrimeric G-protein binding,MF,
8647,GO:0032796,1,0.98466001047545,0,2,uropod organization,BP,
8648,GO:0032797,1,0.929779208446852,0,12,SMN complex,CC,
8649,GO:0032798,1,0.988403017609477,0,2,Swi5-Sfr1 complex,CC,
8651,GO:0032800,1,0.860195425014408,0,22,receptor biosynthetic process,BP,
8656,GO:0032805,1,0.988266211031581,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8657,GO:0032806,1,0.85538381775348,0,24,carboxy-terminal domain protein kinase complex,CC,
8658,GO:0032807,1,0.976287037084782,0,4,DNA ligase IV complex,CC,
8659,GO:0032808,1,0.951187431731819,0,7,lacrimal gland development,BP,
8661,GO:0032810,1,0.987054057032133,0,2,sterol response element binding,MF,
8662,GO:0032811,1,0.982628745989083,0,3,negative regulation of epinephrine secretion,BP,
8663,GO:0032812,1,0.994642368414548,0,1,positive regulation of epinephrine secretion,BP,
8664,GO:0032813,1,0.775739100263258,0,43,tumor necrosis factor receptor superfamily binding,MF,
8665,GO:0032814,1,0.872643821083094,0,22,regulation of natural killer cell activation,BP,
8666,GO:0032815,1,0.972447053990034,0,5,negative regulation of natural killer cell activation,BP,
8667,GO:0032816,1,0.920315502964938,0,13,positive regulation of natural killer cell activation,BP,
8668,GO:0032817,1,0.96448167976835,0,6,regulation of natural killer cell proliferation,BP,
8669,GO:0032819,1,0.976320628783791,0,4,positive regulation of natural killer cell proliferation,BP,
8670,GO:0032823,1,0.93771151573053,0,10,regulation of natural killer cell differentiation,BP,
8671,GO:0032824,1,0.994639606702336,0,1,negative regulation of natural killer cell differentiation,BP,
8672,GO:0032825,1,0.955109154448676,0,7,positive regulation of natural killer cell differentiation,BP,
8673,GO:0032826,1,0.989221085826123,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8674,GO:0032827,1,0.994639606702336,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8675,GO:0032829,1,0.988956252595132,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8676,GO:0032831,1,0.988956252595132,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8677,GO:0032832,1,0.994549014331626,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8678,GO:0032834,1,0.994549014331626,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8679,GO:0032835,1,0.67407159946662,0,54,glomerulus development,BP,
8680,GO:0032836,1,0.922049299660093,0,10,glomerular basement membrane development,BP,
8681,GO:0032838,1,0.295089296732987,0,167,plasma membrane bounded cell projection cytoplasm,CC,
8682,GO:0032839,1,0.831369987272163,0,27,dendrite cytoplasm,CC,
8683,GO:0032841,1,0.993632775438302,0,1,calcitonin binding,MF,
8684,GO:0032847,1,0.975959986979303,0,4,regulation of cellular pH reduction,BP,
8685,GO:0032848,1,0.993447954084981,0,1,negative regulation of cellular pH reduction,BP,
8686,GO:0032849,1,0.982397842575547,0,3,positive regulation of cellular pH reduction,BP,
8690,GO:0032872,1,0.269394807790267,0,193,regulation of stress-activated MAPK cascade,BP,
8691,GO:0032873,1,0.773471677419532,0,39,negative regulation of stress-activated MAPK cascade,BP,
8692,GO:0032874,1,0.398014826367681,0,136,positive regulation of stress-activated MAPK cascade,BP,
8693,GO:0032875,1,0.946617333054939,0,7,regulation of DNA endoreduplication,BP,
8694,GO:0032876,1,0.966599218364486,0,4,negative regulation of DNA endoreduplication,BP,
8695,GO:0032877,1,0.985310968128143,0,2,positive regulation of DNA endoreduplication,BP,
8696,GO:0032878,1,0.85495316278152,0,21,regulation of establishment or maintenance of cell polarity,BP,
8699,GO:0032881,1,0.778996947727086,0,33,regulation of polysaccharide metabolic process,BP,
8700,GO:0032885,1,0.792723005547572,0,30,regulation of polysaccharide biosynthetic process,BP,
8701,GO:0032886,1,0.256388945920169,0,189,regulation of microtubule-based process,BP,
8702,GO:0032887,1,0.990353712774273,0,1,regulation of spindle elongation,BP,
8703,GO:0032888,1,0.990353712774273,0,1,regulation of mitotic spindle elongation,BP,
8704,GO:0032889,1,0.994304124112745,0,1,regulation of vacuole fusion, non-autophagic,BP,
8705,GO:0032890,1,0.759201953104529,0,42,regulation of organic acid transport,BP,
8706,GO:0032891,1,0.904945245926256,0,15,negative regulation of organic acid transport,BP,
8707,GO:0032892,1,0.872594981752107,0,22,positive regulation of organic acid transport,BP,
8708,GO:0032897,1,0.881205802940818,0,20,negative regulation of viral transcription,BP,
8709,GO:0032898,1,0.974828178890844,0,4,neurotrophin production,BP,
8710,GO:0032899,1,0.987607165913594,0,2,regulation of neurotrophin production,BP,
8711,GO:0032900,1,0.994155716158444,0,1,negative regulation of neurotrophin production,BP,
8712,GO:0032901,1,0.99341333813081,0,1,positive regulation of neurotrophin production,BP,
8713,GO:0032902,1,0.987062261200103,0,2,nerve growth factor production,BP,
8714,GO:0032905,1,0.938348821795816,0,10,transforming growth factor beta1 production,BP,
8715,GO:0032906,1,0.943223578362273,0,8,transforming growth factor beta2 production,BP,
8716,GO:0032907,1,0.97976035578548,0,2,transforming growth factor beta3 production,BP,
8717,GO:0032908,1,0.938348821795816,0,10,regulation of transforming growth factor beta1 production,BP,
8718,GO:0032909,1,0.943223578362273,0,8,regulation of transforming growth factor beta2 production,BP,
8719,GO:0032910,1,0.97976035578548,0,2,regulation of transforming growth factor beta3 production,BP,
8720,GO:0032911,1,0.973569440880339,0,4,negative regulation of transforming growth factor beta1 production,BP,
8721,GO:0032912,1,0.986838349535234,0,2,negative regulation of transforming growth factor beta2 production,BP,
8722,GO:0032914,1,0.96383272267683,0,6,positive regulation of transforming growth factor beta1 production,BP,
8723,GO:0032915,1,0.988971658848808,0,2,positive regulation of transforming growth factor beta2 production,BP,
8724,GO:0032916,1,0.97976035578548,0,2,positive regulation of transforming growth factor beta3 production,BP,
8725,GO:0032917,1,0.983787184884968,0,3,polyamine acetylation,BP,
8726,GO:0032918,1,0.983787184884968,0,3,spermidine acetylation,BP,
8727,GO:0032919,1,0.994638523445285,0,1,spermine acetylation,BP,
8728,GO:0032920,1,0.994638523445285,0,1,putrescine acetylation,BP,
8729,GO:0032922,1,0.688644115829242,0,50,circadian regulation of gene expression,BP,
8730,GO:0032924,1,0.777198920362425,0,36,activin receptor signaling pathway,BP,
8731,GO:0032925,1,0.855399768551348,0,23,regulation of activin receptor signaling pathway,BP,
8732,GO:0032926,1,0.942736303685497,0,9,negative regulation of activin receptor signaling pathway,BP,
8733,GO:0032927,1,0.93847994502801,0,8,positive regulation of activin receptor signaling pathway,BP,
8734,GO:0032928,1,0.908228644918974,0,16,regulation of superoxide anion generation,BP,
8735,GO:0032929,1,0.989211324128438,0,2,negative regulation of superoxide anion generation,BP,
8736,GO:0032930,1,0.92519525962404,0,13,positive regulation of superoxide anion generation,BP,
8737,GO:0032933,1,0.950959342106123,0,8,SREBP signaling pathway,BP,
8738,GO:0032934,1,0.754710558951895,0,41,sterol binding,MF,
8739,GO:0032937,1,0.98165255950914,0,3,SREBP-SCAP-Insig complex,CC,
8741,GO:0032941,1,0.811049722517161,0,33,secretion by tissue,BP,
8744,GO:0032945,1,0.663728777576784,0,64,negative regulation of mononuclear cell proliferation,BP,
8747,GO:0032954,1,0.985062728365624,0,2,regulation of cytokinetic process,BP,
8748,GO:0032956,1,0.116423071933163,0,305,regulation of actin cytoskeleton organization,BP,
8749,GO:0032957,1,0.94695392240258,0,8,inositol trisphosphate metabolic process,BP,
8750,GO:0032958,1,0.854499841499719,0,24,inositol phosphate biosynthetic process,BP,
8751,GO:0032959,1,0.961119046732964,0,6,inositol trisphosphate biosynthetic process,BP,
8752,GO:0032960,1,0.974444705680118,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8753,GO:0032962,1,0.981302897857899,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8757,GO:0032966,1,0.959272925122111,0,7,negative regulation of collagen biosynthetic process,BP,
8759,GO:0032968,1,0.912010146250458,0,14,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8761,GO:0032971,1,0.976763519161389,0,4,regulation of muscle filament sliding,BP,
8762,GO:0032972,1,0.989307602480418,0,2,regulation of muscle filament sliding speed,BP,
8763,GO:0032976,1,0.994649325112124,0,1,release of matrix enzymes from mitochondria,BP,
8764,GO:0032977,1,0.992855674397724,0,1,membrane insertase activity,MF,
8765,GO:0032978,1,0.992855674397724,0,1,protein insertion into membrane from inner side,BP,
8766,GO:0032979,1,0.992855674397724,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8767,GO:0032981,1,0.73784205193256,0,55,mitochondrial respiratory chain complex I assembly,BP,
8768,GO:0032982,1,0.872178066844292,0,17,myosin filament,CC,
8769,GO:0032983,1,0.963438629106694,0,5,kainate selective glutamate receptor complex,CC,
8770,GO:0032984,1,0.141835776388674,0,294,protein-containing complex disassembly,BP,
8771,GO:0032986,1,0.877385252389358,0,19,protein-DNA complex disassembly,BP,
8772,GO:0032988,1,0.92000357025411,0,13,ribonucleoprotein complex disassembly,BP,
8777,GO:0032994,1,0.797455040800948,0,34,protein-lipid complex,CC,
8778,GO:0032996,1,0.994509336527139,0,1,Bcl3-Bcl10 complex,CC,
8779,GO:0032997,1,0.989231746425174,0,2,Fc receptor complex,CC,
8780,GO:0032998,1,0.989231746425174,0,2,Fc-epsilon receptor I complex,CC,
8781,GO:0033002,1,0.32600497506634,0,167,muscle cell proliferation,BP,
8782,GO:0033003,1,0.806566877820018,0,35,regulation of mast cell activation,BP,
8783,GO:0033004,1,0.937224627828396,0,11,negative regulation of mast cell activation,BP,
8784,GO:0033005,1,0.911554331406691,0,15,positive regulation of mast cell activation,BP,
8785,GO:0033006,1,0.848138514191688,0,27,regulation of mast cell activation involved in immune response,BP,
8786,GO:0033007,1,0.961144785329554,0,7,negative regulation of mast cell activation involved in immune response,BP,
8787,GO:0033008,1,0.929402517729102,0,12,positive regulation of mast cell activation involved in immune response,BP,
8788,GO:0033010,1,0.9461701202115,0,7,paranodal junction,CC,
8789,GO:0033011,1,0.988907555257652,0,2,perinuclear theca,CC,
8790,GO:0033013,1,0.724291212415672,0,49,tetrapyrrole metabolic process,BP,
8791,GO:0033014,1,0.843023889451321,0,26,tetrapyrrole biosynthetic process,BP,
8792,GO:0033015,1,0.978553793680587,0,4,tetrapyrrole catabolic process,BP,
8794,GO:0033018,1,0.958123702530099,0,7,sarcoplasmic reticulum lumen,CC,
8795,GO:0033023,1,0.980502925881937,0,3,mast cell homeostasis,BP,
8796,GO:0033024,1,0.980502925881937,0,3,mast cell apoptotic process,BP,
8797,GO:0033025,1,0.980502925881937,0,3,regulation of mast cell apoptotic process,BP,
8798,GO:0033026,1,0.986745857421942,0,2,negative regulation of mast cell apoptotic process,BP,
8801,GO:0033030,1,0.985560403340416,0,2,negative regulation of neutrophil apoptotic process,BP,
8804,GO:0033033,1,0.921706969297385,0,13,negative regulation of myeloid cell apoptotic process,BP,
8807,GO:0033037,1,0.991705834090908,0,1,polysaccharide localization,BP,
8808,GO:0033038,1,0.947405912274451,0,10,bitter taste receptor activity,MF,
8809,GO:0033040,1,0.994027159713676,0,1,sour taste receptor activity,MF,
8810,GO:0033041,1,0.99429028007077,0,1,sweet taste receptor activity,MF,
8812,GO:0033044,1,0.12729776607136,0,295,regulation of chromosome organization,BP,
8813,GO:0033045,1,0.610151330188391,0,70,regulation of sister chromatid segregation,BP,
8814,GO:0033046,1,0.767760758002991,0,37,negative regulation of sister chromatid segregation,BP,
8815,GO:0033047,1,0.644826173979164,0,61,regulation of mitotic sister chromatid segregation,BP,
8816,GO:0033048,1,0.774858349096001,0,36,negative regulation of mitotic sister chromatid segregation,BP,
8817,GO:0033058,1,0.971883241559657,0,3,directional locomotion,BP,
8818,GO:0033059,1,0.704539438379626,0,52,cellular pigmentation,BP,
8819,GO:0033061,1,0.94963244874351,0,9,DNA recombinase mediator complex,CC,
8820,GO:0033063,1,0.960779023129619,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8821,GO:0033065,1,0.988940954268174,0,2,Rad51C-XRCC3 complex,CC,
8822,GO:0033076,1,0.983626299206346,0,3,isoquinoline alkaloid metabolic process,BP,
8823,GO:0033077,1,0.66788159746849,0,60,T cell differentiation in thymus,BP,
8824,GO:0033078,1,0.981696659314013,0,3,extrathymic T cell differentiation,BP,
8825,GO:0033079,1,0.959072510007848,0,7,immature T cell proliferation,BP,
8826,GO:0033080,1,0.969890722705227,0,5,immature T cell proliferation in thymus,BP,
8827,GO:0033081,1,0.879497444889208,0,20,regulation of T cell differentiation in thymus,BP,
8828,GO:0033082,1,0.987084798560463,0,2,regulation of extrathymic T cell differentiation,BP,
8829,GO:0033083,1,0.965445956956948,0,6,regulation of immature T cell proliferation,BP,
8830,GO:0033084,1,0.976335335666603,0,4,regulation of immature T cell proliferation in thymus,BP,
8831,GO:0033085,1,0.965556167540326,0,6,negative regulation of T cell differentiation in thymus,BP,
8832,GO:0033087,1,0.981833073184454,0,3,negative regulation of immature T cell proliferation,BP,
8833,GO:0033088,1,0.98722252414055,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8834,GO:0033089,1,0.944232027292117,0,9,positive regulation of T cell differentiation in thymus,BP,
8835,GO:0033091,1,0.983312708364604,0,3,positive regulation of immature T cell proliferation,BP,
8836,GO:0033092,1,0.988973311452113,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8837,GO:0033093,1,0.963270790476112,0,5,Weibel-Palade body,CC,
8838,GO:0033106,1,0.983162229900869,0,3,cis-Golgi network membrane,CC,
8839,GO:0033108,1,0.610331178616356,0,87,mitochondrial respiratory chain complex assembly,BP,
8840,GO:0033116,1,0.670311269942532,0,62,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8841,GO:0033119,1,0.866436854091082,0,24,negative regulation of RNA splicing,BP,
8842,GO:0033120,1,0.822195589986667,0,29,positive regulation of RNA splicing,BP,
8843,GO:0033121,1,0.976228199078179,0,3,regulation of purine nucleotide catabolic process,BP,
8844,GO:0033122,1,0.984632019779509,0,2,negative regulation of purine nucleotide catabolic process,BP,
8845,GO:0033123,1,0.991466328256244,0,1,positive regulation of purine nucleotide catabolic process,BP,
8846,GO:0033127,1,0.920303701496851,0,13,regulation of histone phosphorylation,BP,
8847,GO:0033128,1,0.983398189678279,0,3,negative regulation of histone phosphorylation,BP,
8848,GO:0033129,1,0.947054036105112,0,8,positive regulation of histone phosphorylation,BP,
8849,GO:0033130,1,0.937939952601349,0,9,acetylcholine receptor binding,MF,
8850,GO:0033131,1,0.940832531607661,0,9,regulation of glucokinase activity,BP,
8851,GO:0033132,1,0.977084789327339,0,4,negative regulation of glucokinase activity,BP,
8852,GO:0033133,1,0.962905971222107,0,5,positive regulation of glucokinase activity,BP,
8853,GO:0033135,1,0.495933274011976,0,105,regulation of peptidyl-serine phosphorylation,BP,
8854,GO:0033137,1,0.862509564938658,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8855,GO:0033138,1,0.609861257228697,0,76,positive regulation of peptidyl-serine phosphorylation,BP,
8856,GO:0033139,1,0.974701922372975,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8857,GO:0033140,1,0.994510230053668,0,1,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8858,GO:0033141,1,0.980083435084786,0,3,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8859,GO:0033142,1,0.994424053832446,0,1,progesterone receptor binding,MF,
8860,GO:0033143,1,0.633838658123351,0,69,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8861,GO:0033144,1,0.821635768970572,0,30,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8862,GO:0033145,1,0.911690445647166,0,14,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8863,GO:0033146,1,0.795975560445063,0,34,regulation of intracellular estrogen receptor signaling pathway,BP,
8864,GO:0033147,1,0.922151071111192,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8865,GO:0033148,1,0.947226230861823,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8866,GO:0033149,1,0.98425519618807,0,2,FFAT motif binding,MF,
8867,GO:0033150,1,0.994493115098907,0,1,cytoskeletal calyx,CC,
8868,GO:0033151,1,0.907666874690518,0,12,V(D)J recombination,BP,
8869,GO:0033152,1,0.966424264626088,0,4,immunoglobulin V(D)J recombination,BP,
8870,GO:0033153,1,0.956840946264534,0,5,T cell receptor V(D)J recombination,BP,
8872,GO:0033158,1,0.870323489540227,0,18,regulation of protein import into nucleus, translocation,BP,
8873,GO:0033159,1,0.981275678601645,0,3,negative regulation of protein import into nucleus, translocation,BP,
8874,GO:0033160,1,0.907638793003975,0,11,positive regulation of protein import into nucleus, translocation,BP,
8875,GO:0033162,1,0.939994745178766,0,11,melanosome membrane,CC,
8876,GO:0033165,1,0.987562432484495,0,2,interphotoreceptor matrix,CC,
8877,GO:0033167,1,0.987674113341626,0,1,ARC complex,CC,
8878,GO:0033168,1,0.987674113341626,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8879,GO:0033169,1,0.906508282372654,0,13,histone H3-K9 demethylation,BP,
8880,GO:0033170,1,0.95402757784798,0,8,protein-DNA loading ATPase activity,MF,
8881,GO:0033173,1,0.841769297394784,0,24,calcineurin-NFAT signaling cascade,BP,
8882,GO:0033176,1,0.866786392023801,0,24,proton-transporting V-type ATPase complex,CC,
8883,GO:0033177,1,0.935996976961487,0,11,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8884,GO:0033178,1,0.936243850661391,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8885,GO:0033179,1,0.941088260110468,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8886,GO:0033180,1,0.946553957550918,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8887,GO:0033181,1,0.988942628603478,0,2,plasma membrane proton-transporting V-type ATPase complex,CC,
8888,GO:0033182,1,0.932434488516922,0,10,regulation of histone ubiquitination,BP,
8889,GO:0033183,1,0.973977406065055,0,3,negative regulation of histone ubiquitination,BP,
8890,GO:0033184,1,0.968237604955428,0,5,positive regulation of histone ubiquitination,BP,
8891,GO:0033185,1,0.983954850253025,0,3,dolichol-phosphate-mannose synthase complex,CC,
8892,GO:0033186,1,0.978065498684867,0,3,CAF-1 complex,CC,
8893,GO:0033188,1,0.979566847883675,0,3,sphingomyelin synthase activity,MF,
8894,GO:0033189,1,0.914563165592532,0,15,response to vitamin A,BP,
8895,GO:0033192,1,0.963505707331719,0,5,calmodulin-dependent protein phosphatase activity,MF,
8896,GO:0033193,1,0.992414482626439,0,1,Lsd1/2 complex,CC,
8897,GO:0033194,1,0.904614485676661,0,16,response to hydroperoxide,BP,
8899,GO:0033198,1,0.826316087214677,0,29,response to ATP,BP,
8900,GO:0033202,1,0.914810500260332,0,15,DNA helicase complex,CC,
8901,GO:0033204,1,0.99432138552181,0,1,ribonuclease P RNA binding,MF,
8902,GO:0033206,1,0.965074803729593,0,5,meiotic cytokinesis,BP,
8904,GO:0033210,1,0.945948190411342,0,9,leptin-mediated signaling pathway,BP,
8905,GO:0033211,1,0.96992775594899,0,5,adiponectin-activated signaling pathway,BP,
8910,GO:0033220,1,0.975036642842152,0,4,amide-transporting ATPase activity,MF,
8911,GO:0033227,1,0.968729213798239,0,5,dsRNA transport,BP,
8912,GO:0033229,1,0.993544297805147,0,1,cysteine transmembrane transporter activity,MF,
8913,GO:0033231,1,0.993327106956322,0,1,carbohydrate export,BP,
8914,GO:0033233,1,0.875961027809783,0,21,regulation of protein sumoylation,BP,
8915,GO:0033234,1,0.939725378486697,0,10,negative regulation of protein sumoylation,BP,
8916,GO:0033235,1,0.932312753243106,0,11,positive regulation of protein sumoylation,BP,
8917,GO:0033238,1,0.65488829811269,0,72,regulation of cellular amine metabolic process,BP,
8918,GO:0033239,1,0.962820355838547,0,5,negative regulation of cellular amine metabolic process,BP,
8919,GO:0033240,1,0.948542219953648,0,9,positive regulation of cellular amine metabolic process,BP,
8920,GO:0033241,1,0.988902548506595,0,1,regulation of cellular amine catabolic process,BP,
8921,GO:0033242,1,0.988902548506595,0,1,negative regulation of cellular amine catabolic process,BP,
8922,GO:0033256,1,0.959982265468042,0,7,I-kappaB/NF-kappaB complex,CC,
8923,GO:0033257,1,0.988566490472146,0,2,Bcl3/NF-kappaB2 complex,CC,
8924,GO:0033260,1,0.72962110280693,0,49,nuclear DNA replication,BP,
8925,GO:0033262,1,0.919591456732626,0,12,regulation of nuclear cell cycle DNA replication,BP,
8926,GO:0033263,1,0.972635481942386,0,4,CORVET complex,CC,
8927,GO:0033265,1,0.988598454403158,0,2,choline binding,MF,
8929,GO:0033268,1,0.881522322798814,0,15,node of Ranvier,CC,
8930,GO:0033269,1,0.975587806820364,0,4,internode region of axon,CC,
8931,GO:0033270,1,0.907210477529588,0,12,paranode region of axon,CC,
8933,GO:0033274,1,0.990396571355032,0,1,response to vitamin B2,BP,
8935,GO:0033276,1,0.916747879954783,0,13,transcription factor TFTC complex,CC,
8936,GO:0033277,1,0.985646337732375,0,2,abortive mitotic cell cycle,BP,
8937,GO:0033278,1,0.96719594837201,0,5,cell proliferation in midbrain,BP,
8942,GO:0033290,1,0.993174197628683,0,1,eukaryotic 48S preinitiation complex,CC,
8943,GO:0033291,1,0.99466945796494,0,1,eukaryotic 80S initiation complex,CC,
8944,GO:0033292,1,0.979055879361833,0,2,T-tubule organization,BP,
8946,GO:0033299,1,0.969959336356507,0,5,secretion of lysosomal enzymes,BP,
8947,GO:0033300,1,0.980842887578453,0,3,dehydroascorbic acid transmembrane transporter activity,MF,
8948,GO:0033301,1,0.993550761136509,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8949,GO:0033306,1,0.988055380928383,0,2,phytol metabolic process,BP,
8950,GO:0033313,1,0.969959239262564,0,5,meiotic cell cycle checkpoint,BP,
8951,GO:0033314,1,0.952178345317022,0,8,mitotic DNA replication checkpoint,BP,
8952,GO:0033316,1,0.994045937555551,0,1,meiotic spindle assembly checkpoint,BP,
8953,GO:0033319,1,0.994452711091407,0,1,UDP-D-xylose metabolic process,BP,
8954,GO:0033320,1,0.994452711091407,0,1,UDP-D-xylose biosynthetic process,BP,
8955,GO:0033326,1,0.986732755403835,0,2,cerebrospinal fluid secretion,BP,
8956,GO:0033327,1,0.936988849635195,0,10,Leydig cell differentiation,BP,
8957,GO:0033328,1,0.993633952644134,0,1,peroxisome membrane targeting sequence binding,MF,
8958,GO:0033341,1,0.984094184298331,0,2,regulation of collagen binding,BP,
8959,GO:0033342,1,0.994304537562654,0,1,negative regulation of collagen binding,BP,
8960,GO:0033343,1,0.989731744046093,0,1,positive regulation of collagen binding,BP,
8961,GO:0033344,1,0.791076097614561,0,32,cholesterol efflux,BP,
8962,GO:0033345,1,0.994360656199831,0,1,asparagine catabolic process via L-aspartate,BP,
8963,GO:0033353,1,0.97416361985547,0,4,S-adenosylmethionine cycle,BP,
8964,GO:0033363,1,0.831661396249513,0,25,secretory granule organization,BP,
8965,GO:0033364,1,0.9797685113501,0,2,mast cell secretory granule organization,BP,
8967,GO:0033366,1,0.994611248016744,0,1,protein localization to secretory granule,BP,
8968,GO:0033367,1,0.994611248016744,0,1,protein localization to mast cell secretory granule,BP,
8969,GO:0033368,1,0.994611248016744,0,1,protease localization to mast cell secretory granule,BP,
8970,GO:0033370,1,0.994611248016744,0,1,maintenance of protein location in mast cell secretory granule,BP,
8971,GO:0033371,1,0.994611248016744,0,1,T cell secretory granule organization,BP,
8972,GO:0033373,1,0.994611248016744,0,1,maintenance of protease location in mast cell secretory granule,BP,
8973,GO:0033374,1,0.994611248016744,0,1,protein localization to T cell secretory granule,BP,
8974,GO:0033375,1,0.994611248016744,0,1,protease localization to T cell secretory granule,BP,
8975,GO:0033377,1,0.994611248016744,0,1,maintenance of protein location in T cell secretory granule,BP,
8976,GO:0033379,1,0.994611248016744,0,1,maintenance of protease location in T cell secretory granule,BP,
8977,GO:0033380,1,0.994611248016744,0,1,granzyme B localization to T cell secretory granule,BP,
8978,GO:0033382,1,0.994611248016744,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8979,GO:0033383,1,0.988782289853063,0,2,geranyl diphosphate metabolic process,BP,
8980,GO:0033384,1,0.988782289853063,0,2,geranyl diphosphate biosynthetic process,BP,
8981,GO:0033385,1,0.994171055189162,0,1,geranylgeranyl diphosphate metabolic process,BP,
8982,GO:0033386,1,0.994171055189162,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8983,GO:0033387,1,0.981827056191279,0,3,putrescine biosynthetic process from ornithine,BP,
8984,GO:0033388,1,0.99442190370155,0,1,putrescine biosynthetic process from arginine,BP,
8985,GO:0033391,1,0.926419471197236,0,11,chromatoid body,CC,
8986,GO:0033396,1,0.994458785047521,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8987,GO:0033477,1,0.994479057076195,0,1,S-methylmethionine metabolic process,BP,
8988,GO:0033483,1,0.943792160156095,0,9,gas homeostasis,BP,
8989,GO:0033484,1,0.981752538430585,0,3,nitric oxide homeostasis,BP,
8990,GO:0033488,1,0.994019053366889,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8991,GO:0033489,1,0.976329846999711,0,4,cholesterol biosynthetic process via desmosterol,BP,
8992,GO:0033490,1,0.976329846999711,0,4,cholesterol biosynthetic process via lathosterol,BP,
8993,GO:0033499,1,0.988952183537104,0,2,galactose catabolic process via UDP-galactose,BP,
8995,GO:0033503,1,0.975472861578427,0,4,HULC complex,CC,
8996,GO:0033504,1,0.96392053199608,0,5,floor plate development,BP,
8997,GO:0033505,1,0.985252056915092,0,2,floor plate morphogenesis,BP,
8998,GO:0033512,1,0.980265179643741,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8999,GO:0033514,1,0.994347897726635,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9000,GO:0033522,1,0.842434335887247,0,24,histone H2A ubiquitination,BP,
9001,GO:0033523,1,0.923417257711101,0,12,histone H2B ubiquitination,BP,
9002,GO:0033526,1,0.994222284582967,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
9003,GO:0033539,1,0.917225711045958,0,14,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9004,GO:0033540,1,0.918091123340234,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9005,GO:0033549,1,0.930779105300149,0,12,MAP kinase phosphatase activity,MF,
9006,GO:0033552,1,0.994277353274586,0,1,response to vitamin B3,BP,
9007,GO:0033553,1,0.971305698619313,0,4,rDNA heterochromatin,CC,
9009,GO:0033555,1,0.640219148987454,0,66,multicellular organismal response to stress,BP,
9010,GO:0033557,1,0.988403017609477,0,2,Slx1-Slx4 complex,CC,
9011,GO:0033558,1,0.737257862168502,0,44,protein deacetylase activity,MF,
9013,GO:0033560,1,0.993388139661984,0,1,folate reductase activity,MF,
9014,GO:0033561,1,0.89012222800495,0,18,regulation of water loss via skin,BP,
9015,GO:0033563,1,0.972251926045079,0,3,dorsal/ventral axon guidance,BP,
9016,GO:0033564,1,0.95403185227347,0,6,anterior/posterior axon guidance,BP,
9017,GO:0033565,1,0.980063603955379,0,3,ESCRT-0 complex,CC,
9018,GO:0033566,1,0.988563711490462,0,2,gamma-tubulin complex localization,BP,
9019,GO:0033567,1,0.970866148155787,0,5,DNA replication, Okazaki fragment processing,BP,
9020,GO:0033570,1,0.986426043953855,0,2,transferrin transmembrane transporter activity,MF,
9023,GO:0033577,1,0.988453085736738,0,2,protein glycosylation in endoplasmic reticulum,BP,
9024,GO:0033578,1,0.96757133475038,0,5,protein glycosylation in Golgi,BP,
9025,GO:0033588,1,0.971493847615072,0,5,Elongator holoenzyme complex,CC,
9026,GO:0033590,1,0.983228330023987,0,3,response to cobalamin,BP,
9027,GO:0033591,1,0.966950920406367,0,5,response to L-ascorbic acid,BP,
9028,GO:0033592,1,0.967241360766467,0,5,RNA strand annealing activity,MF,
9029,GO:0033593,1,0.986738850995929,0,1,BRCA2-MAGE-D1 complex,CC,
9030,GO:0033594,1,0.97754387126082,0,4,response to hydroxyisoflavone,BP,
9031,GO:0033595,1,0.988435018520693,0,2,response to genistein,BP,
9032,GO:0033596,1,0.98101626823342,0,2,TSC1-TSC2 complex,CC,
9033,GO:0033597,1,0.99443533471489,0,1,mitotic checkpoint complex,CC,
9034,GO:0033598,1,0.828706209090664,0,26,mammary gland epithelial cell proliferation,BP,
9035,GO:0033599,1,0.881870511711052,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9036,GO:0033600,1,0.965913884030499,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9037,GO:0033601,1,0.938989543142844,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
9038,GO:0033602,1,0.978536817878796,0,3,negative regulation of dopamine secretion,BP,
9039,GO:0033603,1,0.961829788160967,0,6,positive regulation of dopamine secretion,BP,
9040,GO:0033604,1,0.938924406422417,0,10,negative regulation of catecholamine secretion,BP,
9042,GO:0033608,1,0.994184768585909,0,1,formyl-CoA transferase activity,MF,
9043,GO:0033609,1,0.994184768585909,0,1,oxalate metabolic process,BP,
9044,GO:0033612,1,0.891126462650758,0,18,receptor serine/threonine kinase binding,MF,
9045,GO:0033613,1,0.606822827892916,0,70,activating transcription factor binding,MF,
9046,GO:0033615,1,0.982390191304459,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9047,GO:0033617,1,0.890336540402762,0,20,mitochondrial respiratory chain complex IV assembly,BP,
9049,GO:0033622,1,0.878296946156013,0,19,integrin activation,BP,
9050,GO:0033623,1,0.937101951517839,0,10,regulation of integrin activation,BP,
9051,GO:0033624,1,0.984113694966223,0,2,negative regulation of integrin activation,BP,
9052,GO:0033625,1,0.970137474387179,0,5,positive regulation of integrin activation,BP,
9053,GO:0033626,1,0.993558419502883,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9058,GO:0033631,1,0.930148089872365,0,11,cell-cell adhesion mediated by integrin,BP,
9059,GO:0033632,1,0.95597542704662,0,7,regulation of cell-cell adhesion mediated by integrin,BP,
9060,GO:0033633,1,0.992553760714798,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9061,GO:0033634,1,0.980454167580896,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
9062,GO:0033643,1,0.926503661872363,0,12,host cell part,CC,
9063,GO:0033644,1,0.993154938853001,0,1,host cell membrane,CC,
9064,GO:0033646,1,0.945163931944093,0,9,host intracellular part,CC,
9065,GO:0033647,1,0.968577097978527,0,5,host intracellular organelle,CC,
9066,GO:0033648,1,0.968577097978527,0,5,host intracellular membrane-bounded organelle,CC,
9067,GO:0033650,1,0.994533464418864,0,1,host cell mitochondrion,CC,
9068,GO:0033655,1,0.964449478970431,0,6,host cell cytoplasm part,CC,
9069,GO:0033668,1,0.976554234909907,0,4,negative regulation by symbiont of host apoptotic process,BP,
9073,GO:0033677,1,0.981335654590704,0,3,DNA/RNA helicase activity,MF,
9074,GO:0033678,1,0.994243577564622,0,1,5'-3' DNA/RNA helicase activity,MF,
9075,GO:0033679,1,0.992762593882542,0,1,3'-5' DNA/RNA helicase activity,MF,
9076,GO:0033680,1,0.987047419041746,0,2,ATP-dependent DNA/RNA helicase activity,MF,
9077,GO:0033681,1,0.992762593882542,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
9078,GO:0033682,1,0.994243577564622,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9079,GO:0033683,1,0.787108017970795,0,39,nucleotide-excision repair, DNA incision,BP,
9080,GO:0033684,1,0.953831754634402,0,7,regulation of luteinizing hormone secretion,BP,
9081,GO:0033685,1,0.981522994203174,0,3,negative regulation of luteinizing hormone secretion,BP,
9082,GO:0033686,1,0.971792663785629,0,4,positive regulation of luteinizing hormone secretion,BP,
9085,GO:0033689,1,0.937926646926274,0,9,negative regulation of osteoblast proliferation,BP,
9088,GO:0033692,1,0.651399017786249,0,61,cellular polysaccharide biosynthetic process,BP,
9089,GO:0033693,1,0.987720991072691,0,2,neurofilament bundle assembly,BP,
9090,GO:0033695,1,0.99449550146966,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9091,GO:0033699,1,0.994472120183136,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9092,GO:0033700,1,0.941435272291335,0,8,phospholipid efflux,BP,
9093,GO:0033735,1,0.994639912298859,0,1,aspartate dehydrogenase activity,MF,
9094,GO:0033737,1,0.994312325987516,0,1,1-pyrroline dehydrogenase activity,MF,
9095,GO:0033743,1,0.976585210505439,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9096,GO:0033745,1,0.981887366818381,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9097,GO:0033746,1,0.993628847729139,0,1,histone demethylase activity (H3-R2 specific),MF,
9098,GO:0033749,1,0.993628847729139,0,1,histone demethylase activity (H4-R3 specific),MF,
9099,GO:0033750,1,0.927103767420662,0,13,ribosome localization,BP,
9100,GO:0033754,1,0.99456650055091,0,1,indoleamine 2,3-dioxygenase activity,MF,
9101,GO:0033762,1,0.730621817152515,0,46,response to glucagon,BP,
9102,GO:0033764,1,0.88607420444145,0,22,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9103,GO:0033765,1,0.988678909867638,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9104,GO:0033768,1,0.994096146901523,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9105,GO:0033778,1,0.993365341659798,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9106,GO:0033781,1,0.99445465763235,0,1,cholesterol 24-hydroxylase activity,MF,
9107,GO:0033787,1,0.994151961280623,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9108,GO:0033791,1,0.994382789142064,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9109,GO:0033798,1,0.994451312696892,0,1,thyroxine 5-deiodinase activity,MF,
9110,GO:0033814,1,0.994589558723342,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9111,GO:0033819,1,0.994639145062024,0,1,lipoyl(octanoyl) transferase activity,MF,
9112,GO:0033823,1,0.994070934974276,0,1,procollagen glucosyltransferase activity,MF,
9113,GO:0033829,1,0.983495570393156,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9114,GO:0033842,1,0.987545480640074,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9115,GO:0033857,1,0.984000234984658,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9116,GO:0033858,1,0.993958338456657,0,1,N-acetylgalactosamine kinase activity,MF,
9117,GO:0033860,1,0.961788797218634,0,7,regulation of NAD(P)H oxidase activity,BP,
9118,GO:0033861,1,0.989001830103032,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9119,GO:0033862,1,0.994072716916501,0,1,UMP kinase activity,MF,
9120,GO:0033864,1,0.972487349639617,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9121,GO:0033865,1,0.797684228724816,0,37,nucleoside bisphosphate metabolic process,BP,
9122,GO:0033866,1,0.907930561464981,0,16,nucleoside bisphosphate biosynthetic process,BP,
9123,GO:0033867,1,0.994553917940019,0,1,Fas-activated serine/threonine kinase activity,MF,
9124,GO:0033869,1,0.994634727767316,0,1,nucleoside bisphosphate catabolic process,BP,
9125,GO:0033871,1,0.994490705180086,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9126,GO:0033872,1,0.98880616024419,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9127,GO:0033875,1,0.797684228724816,0,37,ribonucleoside bisphosphate metabolic process,BP,
9128,GO:0033878,1,0.993478154947979,0,1,hormone-sensitive lipase activity,MF,
9129,GO:0033882,1,0.994621162425816,0,1,choloyl-CoA hydrolase activity,MF,
9130,GO:0033883,1,0.989131146287166,0,2,pyridoxal phosphatase activity,MF,
9131,GO:0033885,1,0.994418807560719,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9132,GO:0033897,1,0.994611248016744,0,1,ribonuclease T2 activity,MF,
9133,GO:0033906,1,0.988941241101204,0,2,hyaluronoglucuronidase activity,MF,
9134,GO:0033919,1,0.993398236143511,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9135,GO:0033925,1,0.992880174643176,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9136,GO:0033961,1,0.994534361994104,0,1,cis-stilbene-oxide hydrolase activity,MF,
9137,GO:0033962,1,0.864446188005721,0,18,cytoplasmic mRNA processing body assembly,BP,
9138,GO:0033967,1,0.994620140326158,0,1,box C/D snoRNA metabolic process,BP,
9139,GO:0033979,1,0.994281914990069,0,1,box H/ACA snoRNA metabolic process,BP,
9140,GO:0033981,1,0.994658578816756,0,1,D-dopachrome decarboxylase activity,MF,
9141,GO:0033989,1,0.994230895925626,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9143,GO:0034014,1,0.994392473402516,0,1,response to triglyceride,BP,
9144,GO:0034030,1,0.907930561464981,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9145,GO:0034031,1,0.994634727767316,0,1,ribonucleoside bisphosphate catabolic process,BP,
9146,GO:0034032,1,0.797684228724816,0,37,purine nucleoside bisphosphate metabolic process,BP,
9147,GO:0034033,1,0.907930561464981,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9148,GO:0034034,1,0.994634727767316,0,1,purine nucleoside bisphosphate catabolic process,BP,
9149,GO:0034035,1,0.871681741980657,0,22,purine ribonucleoside bisphosphate metabolic process,BP,
9150,GO:0034036,1,0.960679393224186,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9151,GO:0034038,1,0.99461816166225,0,1,deoxyhypusine synthase activity,MF,
9152,GO:0034039,1,0.989042865388961,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9154,GO:0034041,1,0.981964432668268,0,3,sterol-transporting ATPase activity,MF,
9155,GO:0034045,1,0.892021503693795,0,16,phagophore assembly site membrane,CC,
9156,GO:0034046,1,0.94718941996494,0,7,poly(G) binding,MF,
9157,GO:0034056,1,0.973084361257121,0,4,estrogen response element binding,MF,
9158,GO:0034057,1,0.987632336788619,0,2,RNA strand-exchange activity,MF,
9159,GO:0034058,1,0.929891157442594,0,10,endosomal vesicle fusion,BP,
9160,GO:0034059,1,0.977696409760855,0,3,response to anoxia,BP,
9161,GO:0034061,1,0.787594796475818,0,34,DNA polymerase activity,MF,
9163,GO:0034063,1,0.907233412211188,0,13,stress granule assembly,BP,
9164,GO:0034066,1,0.988821188427093,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9165,GO:0034067,1,0.842374961258036,0,21,protein localization to Golgi apparatus,BP,
9166,GO:0034080,1,0.838390729966046,0,30,CENP-A containing nucleosome assembly,BP,
9167,GO:0034085,1,0.957758764901289,0,6,establishment of sister chromatid cohesion,BP,
9168,GO:0034086,1,0.922167906689086,0,10,maintenance of sister chromatid cohesion,BP,
9169,GO:0034087,1,0.981513532182504,0,2,establishment of mitotic sister chromatid cohesion,BP,
9170,GO:0034088,1,0.922167906689086,0,10,maintenance of mitotic sister chromatid cohesion,BP,
9171,GO:0034091,1,0.951384237577456,0,6,regulation of maintenance of sister chromatid cohesion,BP,
9172,GO:0034092,1,0.970097182738633,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9173,GO:0034093,1,0.980716029064338,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9175,GO:0034098,1,0.94212548680833,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9176,GO:0034101,1,0.485750018623731,0,109,erythrocyte homeostasis,BP,
9178,GO:0034104,1,0.900031968312272,0,16,negative regulation of tissue remodeling,BP,
9182,GO:0034111,1,0.913328148507342,0,14,negative regulation of homotypic cell-cell adhesion,BP,
9184,GO:0034113,1,0.736491465041849,0,46,heterotypic cell-cell adhesion,BP,
9185,GO:0034114,1,0.90459074207662,0,17,regulation of heterotypic cell-cell adhesion,BP,
9186,GO:0034115,1,0.955601605444668,0,8,negative regulation of heterotypic cell-cell adhesion,BP,
9187,GO:0034116,1,0.941487087610996,0,10,positive regulation of heterotypic cell-cell adhesion,BP,
9188,GO:0034117,1,0.994662598497264,0,1,erythrocyte aggregation,BP,
9189,GO:0034118,1,0.994662598497264,0,1,regulation of erythrocyte aggregation,BP,
9190,GO:0034120,1,0.994662598497264,0,1,positive regulation of erythrocyte aggregation,BP,
9192,GO:0034122,1,0.798194107335378,0,33,negative regulation of toll-like receptor signaling pathway,BP,
9194,GO:0034124,1,0.977390491848186,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9195,GO:0034125,1,0.989066169279996,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9196,GO:0034127,1,0.949520871941964,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9197,GO:0034128,1,0.954790566410615,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9198,GO:0034130,1,0.994151423212716,0,1,toll-like receptor 1 signaling pathway,BP,
9199,GO:0034134,1,0.927428965045927,0,12,toll-like receptor 2 signaling pathway,BP,
9200,GO:0034135,1,0.95682898419905,0,7,regulation of toll-like receptor 2 signaling pathway,BP,
9201,GO:0034136,1,0.978700640340688,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
9202,GO:0034137,1,0.977657111481918,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,
9203,GO:0034138,1,0.891571433195189,0,19,toll-like receptor 3 signaling pathway,BP,
9204,GO:0034139,1,0.945274317177905,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9205,GO:0034140,1,0.980407155420671,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9206,GO:0034141,1,0.958514645307478,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9209,GO:0034144,1,0.963336500717991,0,6,negative regulation of toll-like receptor 4 signaling pathway,BP,
9211,GO:0034146,1,0.986072597141894,0,2,toll-like receptor 5 signaling pathway,BP,
9212,GO:0034147,1,0.992938902842734,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9213,GO:0034148,1,0.992938902842734,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9214,GO:0034150,1,0.99158611854615,0,1,toll-like receptor 6 signaling pathway,BP,
9215,GO:0034154,1,0.957279209528331,0,7,toll-like receptor 7 signaling pathway,BP,
9216,GO:0034155,1,0.982813044987009,0,3,regulation of toll-like receptor 7 signaling pathway,BP,
9217,GO:0034156,1,0.994541878042146,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9218,GO:0034157,1,0.988207440466034,0,2,positive regulation of toll-like receptor 7 signaling pathway,BP,
9219,GO:0034158,1,0.993135627359409,0,1,toll-like receptor 8 signaling pathway,BP,
9220,GO:0034162,1,0.879200102626104,0,20,toll-like receptor 9 signaling pathway,BP,
9221,GO:0034163,1,0.961016380439514,0,6,regulation of toll-like receptor 9 signaling pathway,BP,
9222,GO:0034164,1,0.985452756802785,0,2,negative regulation of toll-like receptor 9 signaling pathway,BP,
9223,GO:0034165,1,0.987533094206846,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9224,GO:0034166,1,0.993862587864356,0,1,toll-like receptor 10 signaling pathway,BP,
9225,GO:0034182,1,0.951384237577456,0,6,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9226,GO:0034183,1,0.970097182738633,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9227,GO:0034184,1,0.980716029064338,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9228,GO:0034185,1,0.877634315053957,0,16,apolipoprotein binding,MF,
9229,GO:0034186,1,0.971036180435203,0,4,apolipoprotein A-I binding,MF,
9230,GO:0034188,1,0.978306830527145,0,2,apolipoprotein A-I receptor activity,MF,
9231,GO:0034189,1,0.987294296507436,0,2,very-low-density lipoprotein particle binding,MF,
9232,GO:0034190,1,0.966659119105496,0,5,apolipoprotein receptor binding,MF,
9233,GO:0034191,1,0.972874493433488,0,4,apolipoprotein A-I receptor binding,MF,
9234,GO:0034196,1,0.977040985357274,0,4,acylglycerol transport,BP,
9235,GO:0034197,1,0.977040985357274,0,4,triglyceride transport,BP,
9236,GO:0034198,1,0.767241624807099,0,42,cellular response to amino acid starvation,BP,
9237,GO:0034199,1,0.886803842361965,0,16,activation of protein kinase A activity,BP,
9238,GO:0034201,1,0.968376560348648,0,5,response to oleic acid,BP,
9239,GO:0034203,1,0.992317629537908,0,1,glycolipid translocation,BP,
9240,GO:0034204,1,0.81503660968344,0,24,lipid translocation,BP,
9241,GO:0034205,1,0.850061051916124,0,23,amyloid-beta formation,BP,
9242,GO:0034211,1,0.988525498597407,0,1,GTP-dependent protein kinase activity,MF,
9243,GO:0034212,1,0.658504448014683,0,60,peptide N-acetyltransferase activity,MF,
9244,GO:0034213,1,0.994570427387633,0,1,quinolinate catabolic process,BP,
9245,GO:0034214,1,0.949061950921894,0,8,protein hexamerization,BP,
9246,GO:0034219,1,0.503478019036291,0,100,carbohydrate transmembrane transport,BP,
9248,GO:0034224,1,0.994405969162152,0,1,cellular response to zinc ion starvation,BP,
9249,GO:0034227,1,0.972682460148704,0,5,tRNA thio-modification,BP,
9250,GO:0034230,1,0.99264934197407,0,1,enkephalin processing,BP,
9251,GO:0034231,1,0.99264934197407,0,1,islet amyloid polypeptide processing,BP,
9252,GO:0034235,1,0.965312043068964,0,6,GPI anchor binding,MF,
9253,GO:0034236,1,0.905271241720451,0,14,protein kinase A catalytic subunit binding,MF,
9254,GO:0034237,1,0.867163080173819,0,17,protein kinase A regulatory subunit binding,MF,
9255,GO:0034238,1,0.993328812352498,0,1,macrophage fusion,BP,
9256,GO:0034239,1,0.993328812352498,0,1,regulation of macrophage fusion,BP,
9257,GO:0034241,1,0.993328812352498,0,1,positive regulation of macrophage fusion,BP,
9259,GO:0034243,1,0.849386770567321,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9260,GO:0034244,1,0.932849058690353,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9261,GO:0034245,1,0.993473206668361,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9262,GO:0034247,1,0.994606447558221,0,1,snoRNA splicing,BP,
9266,GO:0034255,1,0.994436661814452,0,1,regulation of urea metabolic process,BP,
9267,GO:0034260,1,0.736454075288734,0,44,negative regulation of GTPase activity,BP,
9268,GO:0034271,1,0.980934821141329,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9269,GO:0034272,1,0.980934821141329,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9270,GO:0034274,1,0.979706956751157,0,3,Atg12-Atg5-Atg16 complex,CC,
9271,GO:0034275,1,0.99456650055091,0,1,kynurenic acid metabolic process,BP,
9272,GO:0034276,1,0.99456650055091,0,1,kynurenic acid biosynthetic process,BP,
9274,GO:0034285,1,0.973750641835583,0,4,response to disaccharide,BP,
9275,GO:0034287,1,0.977734310503826,0,4,detection of monosaccharide stimulus,BP,
9276,GO:0034308,1,0.740570552082065,0,50,primary alcohol metabolic process,BP,
9277,GO:0034309,1,0.994640893629188,0,1,primary alcohol biosynthetic process,BP,
9278,GO:0034310,1,0.935724366739428,0,12,primary alcohol catabolic process,BP,
9279,GO:0034311,1,0.893369872313921,0,19,diol metabolic process,BP,
9280,GO:0034312,1,0.908677530685243,0,16,diol biosynthetic process,BP,
9281,GO:0034314,1,0.822422902180007,0,31,Arp2/3 complex-mediated actin nucleation,BP,
9282,GO:0034315,1,0.910035656109615,0,15,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9283,GO:0034316,1,0.970049743379126,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9286,GO:0034331,1,0.931917494374257,0,11,cell junction maintenance,BP,
9289,GO:0034334,1,0.972732083311319,0,4,adherens junction maintenance,BP,
9290,GO:0034338,1,0.972284832615429,0,4,short-chain carboxylesterase activity,MF,
9291,GO:0034340,1,0.621099686833705,0,75,response to type I interferon,BP,
9293,GO:0034342,1,0.988660117253548,0,2,response to type III interferon,BP,
9294,GO:0034343,1,0.980573772206801,0,3,type III interferon production,BP,
9295,GO:0034344,1,0.980573772206801,0,3,regulation of type III interferon production,BP,
9296,GO:0034346,1,0.994041351624122,0,1,positive regulation of type III interferon production,BP,
9300,GO:0034353,1,0.994184768585909,0,1,RNA pyrophosphohydrolase activity,MF,
9301,GO:0034354,1,0.994606807078538,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9302,GO:0034355,1,0.994184768585909,0,1,NAD salvage,BP,
9304,GO:0034358,1,0.806668570896641,0,32,plasma lipoprotein particle,CC,
9305,GO:0034359,1,0.984610241887998,0,1,mature chylomicron,CC,
9306,GO:0034360,1,0.984610241887998,0,1,chylomicron remnant,CC,
9307,GO:0034361,1,0.907838584538531,0,15,very-low-density lipoprotein particle,CC,
9308,GO:0034362,1,0.917086249418281,0,12,low-density lipoprotein particle,CC,
9309,GO:0034363,1,0.968856573665302,0,4,intermediate-density lipoprotein particle,CC,
9310,GO:0034364,1,0.882374653496459,0,21,high-density lipoprotein particle,CC,
9311,GO:0034365,1,0.984000211418937,0,3,discoidal high-density lipoprotein particle,CC,
9312,GO:0034366,1,0.96768781134532,0,6,spherical high-density lipoprotein particle,CC,
9316,GO:0034370,1,0.946968478326413,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9317,GO:0034371,1,0.962582662579821,0,5,chylomicron remodeling,BP,
9318,GO:0034372,1,0.961775691723397,0,7,very-low-density lipoprotein particle remodeling,BP,
9319,GO:0034373,1,0.994560589195528,0,1,intermediate-density lipoprotein particle remodeling,BP,
9321,GO:0034375,1,0.919492533307681,0,14,high-density lipoprotein particle remodeling,BP,
9322,GO:0034377,1,0.859143528959576,0,22,plasma lipoprotein particle assembly,BP,
9323,GO:0034378,1,0.948935823354078,0,7,chylomicron assembly,BP,
9324,GO:0034379,1,0.938037722952904,0,9,very-low-density lipoprotein particle assembly,BP,
9325,GO:0034380,1,0.928494943872747,0,11,high-density lipoprotein particle assembly,BP,
9327,GO:0034382,1,0.950562906123663,0,7,chylomicron remnant clearance,BP,
9329,GO:0034384,1,0.934237072095938,0,10,high-density lipoprotein particle clearance,BP,
9330,GO:0034385,1,0.907838584538531,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9331,GO:0034386,1,0.992492201901996,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9332,GO:0034388,1,0.962022480517106,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9333,GO:0034389,1,0.900326019073211,0,17,lipid particle organization,BP,
9334,GO:0034390,1,0.891270632142848,0,17,smooth muscle cell apoptotic process,BP,
9335,GO:0034391,1,0.891270632142848,0,17,regulation of smooth muscle cell apoptotic process,BP,
9336,GO:0034392,1,0.962246764749229,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9337,GO:0034393,1,0.937616848225372,0,10,positive regulation of smooth muscle cell apoptotic process,BP,
9338,GO:0034394,1,0.700403865365364,0,51,protein localization to cell surface,BP,
9339,GO:0034395,1,0.988433185423144,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9340,GO:0034397,1,0.926516267701751,0,11,telomere localization,BP,
9341,GO:0034398,1,0.961645387514271,0,6,telomere tethering at nuclear periphery,BP,
9342,GO:0034399,1,0.411189038844866,0,127,nuclear periphery,CC,
9343,GO:0034402,1,0.985945467594191,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9345,GO:0034405,1,0.798342548463408,0,33,response to fluid shear stress,BP,
9346,GO:0034414,1,0.987918431464433,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9347,GO:0034416,1,0.994151961280623,0,1,bisphosphoglycerate phosphatase activity,MF,
9348,GO:0034417,1,0.994151961280623,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9349,GO:0034418,1,0.98881371436994,0,2,urate biosynthetic process,BP,
9350,GO:0034421,1,0.981213024223358,0,3,post-translational protein acetylation,BP,
9351,GO:0034423,1,0.994257341326422,0,1,autophagosome lumen,CC,
9352,GO:0034427,1,0.944902219009479,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9353,GO:0034431,1,0.976242838261684,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9354,GO:0034432,1,0.976242838261684,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9355,GO:0034433,1,0.945038104847938,0,10,steroid esterification,BP,
9356,GO:0034434,1,0.945038104847938,0,10,sterol esterification,BP,
9357,GO:0034435,1,0.945038104847938,0,10,cholesterol esterification,BP,
9358,GO:0034436,1,0.98245341865159,0,3,glycoprotein transport,BP,
9359,GO:0034437,1,0.987751922891605,0,2,glycoprotein transporter activity,MF,
9360,GO:0034439,1,0.988436814170517,0,2,lipoprotein lipid oxidation,BP,
9361,GO:0034440,1,0.538725929841947,0,97,lipid oxidation,BP,
9362,GO:0034441,1,0.989205226998861,0,2,plasma lipoprotein particle oxidation,BP,
9363,GO:0034442,1,0.988436814170517,0,2,regulation of lipoprotein oxidation,BP,
9364,GO:0034443,1,0.994623954628972,0,1,negative regulation of lipoprotein oxidation,BP,
9365,GO:0034444,1,0.994652283438407,0,1,regulation of plasma lipoprotein oxidation,BP,
9366,GO:0034445,1,0.994652283438407,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9368,GO:0034447,1,0.946826682767607,0,8,very-low-density lipoprotein particle clearance,BP,
9369,GO:0034448,1,0.970916398124428,0,5,EGO complex,CC,
9370,GO:0034450,1,0.911889778777336,0,13,ubiquitin-ubiquitin ligase activity,MF,
9371,GO:0034451,1,0.820887596891704,0,27,centriolar satellite,CC,
9372,GO:0034452,1,0.917142192683294,0,10,dynactin binding,MF,
9373,GO:0034453,1,0.83668915519981,0,22,microtubule anchoring,BP,
9374,GO:0034454,1,0.926120957059478,0,9,microtubule anchoring at centrosome,BP,
9375,GO:0034455,1,0.985075540262632,0,2,t-UTP complex,CC,
9376,GO:0034456,1,0.987800572209234,0,2,UTP-C complex,CC,
9377,GO:0034457,1,0.983652221746715,0,3,Mpp10 complex,CC,
9378,GO:0034458,1,0.987124471448492,0,2,3'-5' RNA helicase activity,MF,
9379,GO:0034459,1,0.992762593882542,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9380,GO:0034462,1,0.994405484344401,0,1,small-subunit processome assembly,BP,
9381,GO:0034463,1,0.99466945796494,0,1,90S preribosome assembly,BP,
9382,GO:0034464,1,0.947988783600614,0,9,BBSome,CC,
9383,GO:0034465,1,0.974267150835425,0,4,response to carbon monoxide,BP,
9384,GO:0034466,1,0.994193162512267,0,1,chromaffin granule lumen,CC,
9385,GO:0034470,1,0.0923825706730797,0,389,ncRNA processing,BP,
9386,GO:0034471,1,0.89092403394916,0,19,ncRNA 5'-end processing,BP,
9387,GO:0034472,1,0.909464680906337,0,15,snRNA 3'-end processing,BP,
9388,GO:0034473,1,0.983857249815349,0,3,U1 snRNA 3'-end processing,BP,
9389,GO:0034474,1,0.990524562963214,0,1,U2 snRNA 3'-end processing,BP,
9390,GO:0034475,1,0.957445453452141,0,8,U4 snRNA 3'-end processing,BP,
9391,GO:0034476,1,0.983857249815349,0,3,U5 snRNA 3'-end processing,BP,
9392,GO:0034477,1,0.994184768585909,0,1,U6 snRNA 3'-end processing,BP,
9393,GO:0034481,1,0.960709500317679,0,6,chondroitin sulfotransferase activity,MF,
9394,GO:0034483,1,0.907549093593837,0,14,heparan sulfate sulfotransferase activity,MF,
9395,GO:0034485,1,0.97380570977674,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9396,GO:0034497,1,0.916549343317895,0,13,protein localization to phagophore assembly site,BP,
9397,GO:0034498,1,0.946330912811558,0,8,early endosome to Golgi transport,BP,
9398,GO:0034499,1,0.983241410464209,0,2,late endosome to Golgi transport,BP,
9399,GO:0034501,1,0.910986861210572,0,16,protein localization to kinetochore,BP,
9400,GO:0034502,1,0.629652896389433,0,70,protein localization to chromosome,BP,
9403,GO:0034506,1,0.993294602112599,0,1,chromosome, centromeric core domain,CC,
9404,GO:0034508,1,0.775417151008234,0,40,centromere complex assembly,BP,
9405,GO:0034511,1,0.965959719144058,0,5,U3 snoRNA binding,MF,
9406,GO:0034513,1,0.973107127549804,0,5,box H/ACA snoRNA binding,MF,
9407,GO:0034515,1,0.988043219523742,0,2,proteasome storage granule,CC,
9408,GO:0034516,1,0.994580031490716,0,1,response to vitamin B6,BP,
9409,GO:0034518,1,0.929561876218638,0,11,RNA cap binding complex,CC,
9410,GO:0034545,1,0.994547534938947,0,1,fumarylpyruvate hydrolase activity,MF,
9411,GO:0034551,1,0.946074710971722,0,9,mitochondrial respiratory chain complex III assembly,BP,
9412,GO:0034552,1,0.989268939054881,0,2,respiratory chain complex II assembly,BP,
9413,GO:0034553,1,0.989268939054881,0,2,mitochondrial respiratory chain complex II assembly,BP,
9414,GO:0034584,1,0.98742659916448,0,2,piRNA binding,MF,
9415,GO:0034587,1,0.916242425986522,0,14,piRNA metabolic process,BP,
9416,GO:0034589,1,0.993052985508184,0,1,hydroxyproline transport,BP,
9417,GO:0034590,1,0.993052985508184,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9418,GO:0034593,1,0.83161911078133,0,25,phosphatidylinositol bisphosphate phosphatase activity,MF,
9419,GO:0034594,1,0.960612763757503,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9420,GO:0034595,1,0.911271269117378,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9421,GO:0034596,1,0.940621212439247,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9422,GO:0034597,1,0.984111202662415,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9424,GO:0034602,1,0.993050763593737,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9425,GO:0034603,1,0.969661924647328,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9426,GO:0034604,1,0.969661924647328,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9431,GO:0034616,1,0.9122888720235,0,14,response to laminar fluid shear stress,BP,
9432,GO:0034617,1,0.972630893188359,0,4,tetrahydrobiopterin binding,MF,
9433,GO:0034618,1,0.961757196043298,0,6,arginine binding,MF,
9436,GO:0034625,1,0.963818630025933,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9437,GO:0034626,1,0.963818630025933,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9438,GO:0034627,1,0.974750330035967,0,4,'de novo' NAD biosynthetic process,BP,
9439,GO:0034628,1,0.980036921918616,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9440,GO:0034629,1,0.867065167802487,0,23,cellular protein-containing complex localization,BP,
9441,GO:0034632,1,0.988823644565567,0,2,retinol transmembrane transporter activity,MF,
9442,GO:0034633,1,0.988823644565567,0,2,retinol transport,BP,
9443,GO:0034634,1,0.991086129130538,0,1,glutathione transmembrane transporter activity,MF,
9444,GO:0034635,1,0.985611385193292,0,2,glutathione transport,BP,
9445,GO:0034637,1,0.59766921042719,0,75,cellular carbohydrate biosynthetic process,BP,
9446,GO:0034638,1,0.953064145788624,0,8,phosphatidylcholine catabolic process,BP,
9447,GO:0034640,1,0.993919915338298,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9449,GO:0034643,1,0.86878666214475,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
9450,GO:0034644,1,0.603698402652583,0,74,cellular response to UV,BP,
9452,GO:0034647,1,0.978351544213141,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9453,GO:0034648,1,0.966084786040771,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9454,GO:0034649,1,0.99341333813081,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9455,GO:0034650,1,0.947589955315412,0,8,cortisol metabolic process,BP,
9456,GO:0034651,1,0.952847729293324,0,7,cortisol biosynthetic process,BP,
9457,GO:0034653,1,0.982035629027852,0,3,retinoic acid catabolic process,BP,
9461,GO:0034657,1,0.974421848064549,0,4,GID complex,CC,
9462,GO:0034660,1,0.0339536774097562,0,546,ncRNA metabolic process,BP,
9463,GO:0034661,1,0.84905387037551,0,24,ncRNA catabolic process,BP,
9464,GO:0034663,1,0.946885700878501,0,9,endoplasmic reticulum chaperone complex,CC,
9465,GO:0034665,1,0.986147119463548,0,2,integrin alpha1-beta1 complex,CC,
9466,GO:0034666,1,0.977437045856409,0,3,integrin alpha2-beta1 complex,CC,
9467,GO:0034667,1,0.986001999512501,0,2,integrin alpha3-beta1 complex,CC,
9468,GO:0034668,1,0.993375487741975,0,1,integrin alpha4-beta1 complex,CC,
9469,GO:0034669,1,0.985614114036137,0,2,integrin alpha4-beta7 complex,CC,
9470,GO:0034670,1,0.988105479342562,0,1,chemotaxis to arachidonic acid,BP,
9471,GO:0034673,1,0.977997326715197,0,3,inhibin-betaglycan-ActRII complex,CC,
9472,GO:0034676,1,0.991690673218904,0,1,integrin alpha6-beta4 complex,CC,
9473,GO:0034677,1,0.993515055779981,0,1,integrin alpha7-beta1 complex,CC,
9474,GO:0034678,1,0.980318911708518,0,3,integrin alpha8-beta1 complex,CC,
9475,GO:0034679,1,0.993333073423649,0,1,integrin alpha9-beta1 complex,CC,
9476,GO:0034680,1,0.985797623489595,0,2,integrin alpha10-beta1 complex,CC,
9477,GO:0034681,1,0.985954922968256,0,2,integrin alpha11-beta1 complex,CC,
9478,GO:0034683,1,0.983165693972715,0,2,integrin alphav-beta3 complex,CC,
9479,GO:0034684,1,0.984459209283926,0,2,integrin alphav-beta5 complex,CC,
9480,GO:0034685,1,0.984993184585206,0,2,integrin alphav-beta6 complex,CC,
9481,GO:0034686,1,0.979639219403927,0,2,integrin alphav-beta8 complex,CC,
9482,GO:0034687,1,0.986456157992285,0,2,integrin alphaL-beta2 complex,CC,
9483,GO:0034688,1,0.986772641960785,0,2,integrin alphaM-beta2 complex,CC,
9484,GO:0034693,1,0.994329487160654,0,1,U11/U12 snRNP,CC,
9485,GO:0034694,1,0.818041364097943,0,29,response to prostaglandin,BP,
9486,GO:0034695,1,0.86499110205658,0,22,response to prostaglandin E,BP,
9487,GO:0034696,1,0.988758938844262,0,2,response to prostaglandin F,BP,
9488,GO:0034698,1,0.842599693816342,0,25,response to gonadotropin,BP,
9489,GO:0034699,1,0.979621110620343,0,3,response to luteinizing hormone,BP,
9494,GO:0034706,1,0.824873245604933,0,23,sodium channel complex,CC,
9496,GO:0034708,1,0.550798509889051,0,88,methyltransferase complex,CC,
9497,GO:0034709,1,0.936733024884649,0,12,methylosome,CC,
9498,GO:0034711,1,0.96893007913856,0,5,inhibin binding,MF,
9499,GO:0034713,1,0.940865647497639,0,9,type I transforming growth factor beta receptor binding,MF,
9500,GO:0034714,1,0.980721110559423,0,3,type III transforming growth factor beta receptor binding,MF,
9501,GO:0034715,1,0.968052854075695,0,6,pICln-Sm protein complex,CC,
9502,GO:0034718,1,0.992011934357864,0,1,SMN-Gemin2 complex,CC,
9503,GO:0034719,1,0.90687920646688,0,17,SMN-Sm protein complex,CC,
9504,GO:0034720,1,0.949665602924998,0,6,histone H3-K4 demethylation,BP,
9505,GO:0034721,1,0.978351544213141,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9506,GO:0034722,1,0.994579198974191,0,1,gamma-glutamyl-peptidase activity,MF,
9507,GO:0034723,1,0.919944859500165,0,14,DNA replication-dependent nucleosome organization,BP,
9508,GO:0034724,1,0.773845246578124,0,41,DNA replication-independent nucleosome organization,BP,
9509,GO:0034727,1,0.992437925305889,0,1,piecemeal microautophagy of the nucleus,BP,
9510,GO:0034728,1,0.474238189520573,0,117,nucleosome organization,BP,
9511,GO:0034729,1,0.977928338675542,0,3,histone H3-K79 methylation,BP,
9512,GO:0034736,1,0.993795890395374,0,1,cholesterol O-acyltransferase activity,MF,
9513,GO:0034739,1,0.989060824700976,0,2,histone deacetylase activity (H4-K16 specific),MF,
9514,GO:0034750,1,0.986042642786511,0,2,Scrib-APC-beta-catenin complex,CC,
9515,GO:0034751,1,0.980267527824278,0,3,aryl hydrocarbon receptor complex,CC,
9516,GO:0034752,1,0.991231720385043,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9517,GO:0034753,1,0.991231720385043,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9520,GO:0034756,1,0.967573781969269,0,5,regulation of iron ion transport,BP,
9521,GO:0034757,1,0.983913979421589,0,2,negative regulation of iron ion transport,BP,
9522,GO:0034759,1,0.983913979421589,0,2,regulation of iron ion transmembrane transport,BP,
9523,GO:0034760,1,0.983913979421589,0,2,negative regulation of iron ion transmembrane transport,BP,
9525,GO:0034763,1,0.517059939303594,0,100,negative regulation of transmembrane transport,BP,
9528,GO:0034766,1,0.586831961147212,0,80,negative regulation of ion transmembrane transport,BP,
9530,GO:0034769,1,0.987725564258963,0,2,basement membrane disassembly,BP,
9531,GO:0034770,1,0.946121274459942,0,6,histone H4-K20 methylation,BP,
9532,GO:0034773,1,0.969055629838764,0,4,histone H4-K20 trimethylation,BP,
9534,GO:0034775,1,0.991086129130538,0,1,glutathione transmembrane transport,BP,
9536,GO:0034777,1,0.994410142850578,0,1,recycling endosome lumen,CC,
9537,GO:0034875,1,0.99449550146966,0,1,caffeine oxidase activity,MF,
9538,GO:0034899,1,0.994456177922003,0,1,trimethylamine monooxygenase activity,MF,
9539,GO:0034959,1,0.992293119671063,0,1,endothelin maturation,BP,
9540,GO:0034963,1,0.994620140326158,0,1,box C/D snoRNA processing,BP,
9541,GO:0034964,1,0.994281914990069,0,1,box H/ACA snoRNA processing,BP,
9542,GO:0034968,1,0.495189856102412,0,96,histone lysine methylation,BP,
9543,GO:0034969,1,0.932780637982086,0,12,histone arginine methylation,BP,
9544,GO:0034970,1,0.988367699891604,0,2,histone H3-R2 methylation,BP,
9545,GO:0034971,1,0.988547322005313,0,2,histone H3-R17 methylation,BP,
9546,GO:0034975,1,0.924079573309853,0,13,protein folding in endoplasmic reticulum,BP,
9548,GO:0034979,1,0.893740952840514,0,17,NAD-dependent protein deacetylase activity,MF,
9549,GO:0034982,1,0.928089819457703,0,12,mitochondrial protein processing,BP,
9550,GO:0034983,1,0.952763153583235,0,7,peptidyl-lysine deacetylation,BP,
9551,GO:0034986,1,0.984617716530335,0,2,iron chaperone activity,MF,
9552,GO:0034987,1,0.961739246110376,0,6,immunoglobulin receptor binding,MF,
9553,GO:0034988,1,0.983554077881424,0,2,Fc-gamma receptor I complex binding,MF,
9554,GO:0034991,1,0.975424399382376,0,4,nuclear meiotic cohesin complex,CC,
9555,GO:0034992,1,0.938575766854313,0,7,microtubule organizing center attachment site,CC,
9556,GO:0034993,1,0.938575766854313,0,7,meiotic nuclear membrane microtubule tethering complex,CC,
9557,GO:0034998,1,0.994184768585909,0,1,oligosaccharyltransferase I complex,CC,
9558,GO:0035004,1,0.607448830750465,0,69,phosphatidylinositol 3-kinase activity,MF,
9559,GO:0035005,1,0.944729791269532,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9560,GO:0035014,1,0.946190256745004,0,8,phosphatidylinositol 3-kinase regulator activity,MF,
9561,GO:0035019,1,0.637958550114124,0,67,somatic stem cell population maintenance,BP,
9562,GO:0035020,1,0.887833009413077,0,16,regulation of Rac protein signal transduction,BP,
9563,GO:0035021,1,0.967055820666404,0,4,negative regulation of Rac protein signal transduction,BP,
9564,GO:0035022,1,0.97105720892563,0,4,positive regulation of Rac protein signal transduction,BP,
9566,GO:0035024,1,0.878447617532794,0,18,negative regulation of Rho protein signal transduction,BP,
9568,GO:0035026,1,0.986680855475866,0,2,leading edge cell differentiation,BP,
9569,GO:0035032,1,0.964044669254631,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9570,GO:0035033,1,0.981111232775915,0,3,histone deacetylase regulator activity,MF,
9571,GO:0035034,1,0.988440967608578,0,2,histone acetyltransferase regulator activity,MF,
9572,GO:0035035,1,0.814543076824654,0,29,histone acetyltransferase binding,MF,
9573,GO:0035036,1,0.817898705691376,0,35,sperm-egg recognition,BP,
9574,GO:0035037,1,0.992858399617087,0,1,sperm entry,BP,
9575,GO:0035038,1,0.988440477820961,0,2,female pronucleus assembly,BP,
9576,GO:0035039,1,0.994383820414269,0,1,male pronucleus assembly,BP,
9577,GO:0035050,1,0.618852716212359,0,69,embryonic heart tube development,BP,
9578,GO:0035051,1,0.422605647565882,0,118,cardiocyte differentiation,BP,
9579,GO:0035054,1,0.982295260527995,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9580,GO:0035061,1,0.969107996618706,0,4,interchromatin granule,CC,
9581,GO:0035063,1,0.978647428614741,0,2,nuclear speck organization,BP,
9582,GO:0035064,1,0.670788096592327,0,56,methylated histone binding,MF,
9583,GO:0035065,1,0.712745008127481,0,52,regulation of histone acetylation,BP,
9584,GO:0035066,1,0.833484849116059,0,28,positive regulation of histone acetylation,BP,
9585,GO:0035067,1,0.895482943986285,0,17,negative regulation of histone acetylation,BP,
9586,GO:0035068,1,0.93497018172594,0,9,micro-ribonucleoprotein complex,CC,
9587,GO:0035082,1,0.692181117020556,0,51,axoneme assembly,BP,
9588,GO:0035087,1,0.971273517771821,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9589,GO:0035088,1,0.735711413757827,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9590,GO:0035089,1,0.891264212879026,0,17,establishment of apical/basal cell polarity,BP,
9591,GO:0035090,1,0.923546499956443,0,12,maintenance of apical/basal cell polarity,BP,
9593,GO:0035092,1,0.953599448377462,0,6,sperm chromatin condensation,BP,
9594,GO:0035093,1,0.965558658236073,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9595,GO:0035094,1,0.758054780352561,0,42,response to nicotine,BP,
9596,GO:0035095,1,0.949919702195351,0,7,behavioral response to nicotine,BP,
9597,GO:0035097,1,0.617149633362547,0,68,histone methyltransferase complex,CC,
9598,GO:0035098,1,0.895996058100105,0,16,ESC/E(Z) complex,CC,
9599,GO:0035101,1,0.981176924953241,0,3,FACT complex,CC,
9600,GO:0035102,1,0.927123353911982,0,11,PRC1 complex,CC,
9601,GO:0035106,1,0.982175404285505,0,3,operant conditioning,BP,
9602,GO:0035107,1,0.352549441905404,0,142,appendage morphogenesis,BP,
9603,GO:0035108,1,0.352549441905404,0,142,limb morphogenesis,BP,
9604,GO:0035112,1,0.922218834115659,0,11,genitalia morphogenesis,BP,
9605,GO:0035113,1,0.414451084549465,0,122,embryonic appendage morphogenesis,BP,
9606,GO:0035115,1,0.808460392682026,0,32,embryonic forelimb morphogenesis,BP,
9607,GO:0035116,1,0.827677548501522,0,28,embryonic hindlimb morphogenesis,BP,
9608,GO:0035120,1,0.986945640841821,0,1,post-embryonic appendage morphogenesis,BP,
9609,GO:0035127,1,0.986945640841821,0,1,post-embryonic limb morphogenesis,BP,
9610,GO:0035128,1,0.986945640841821,0,1,post-embryonic forelimb morphogenesis,BP,
9611,GO:0035136,1,0.755434887945229,0,40,forelimb morphogenesis,BP,
9612,GO:0035137,1,0.77689040102079,0,36,hindlimb morphogenesis,BP,
9613,GO:0035145,1,0.887766925944067,0,19,exon-exon junction complex,CC,
9616,GO:0035162,1,0.867986172664534,0,20,embryonic hemopoiesis,BP,
9617,GO:0035166,1,0.980748582531536,0,3,post-embryonic hemopoiesis,BP,
9618,GO:0035173,1,0.894916753699787,0,16,histone kinase activity,MF,
9619,GO:0035174,1,0.954186339377517,0,7,histone serine kinase activity,MF,
9620,GO:0035175,1,0.994541878042146,0,1,histone kinase activity (H3-S10 specific),MF,
9622,GO:0035184,1,0.964336674507209,0,5,histone threonine kinase activity,MF,
9623,GO:0035188,1,0.99390356047142,0,1,hatching,BP,
9624,GO:0035189,1,0.981374387776135,0,3,Rb-E2F complex,CC,
9625,GO:0035194,1,0.434445755145355,0,120,posttranscriptional gene silencing by RNA,BP,
9626,GO:0035195,1,0.451117990018128,0,114,gene silencing by miRNA,BP,
9627,GO:0035196,1,0.753727745355686,0,40,production of miRNAs involved in gene silencing by miRNA,BP,
9628,GO:0035197,1,0.929224337232897,0,10,siRNA binding,MF,
9629,GO:0035198,1,0.868471160023875,0,22,miRNA binding,MF,
9630,GO:0035226,1,0.99401842728491,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9631,GO:0035227,1,0.99401842728491,0,1,regulation of glutamate-cysteine ligase activity,BP,
9632,GO:0035229,1,0.99401842728491,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9633,GO:0035234,1,0.947173157653316,0,7,ectopic germ cell programmed cell death,BP,
9635,GO:0035238,1,0.994184768585909,0,1,vitamin A biosynthetic process,BP,
9637,GO:0035240,1,0.954602172177328,0,8,dopamine binding,MF,
9638,GO:0035241,1,0.977358978805471,0,4,protein-arginine omega-N monomethyltransferase activity,MF,
9639,GO:0035242,1,0.955413128928563,0,8,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9640,GO:0035243,1,0.977254774340434,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9641,GO:0035246,1,0.933760919781502,0,12,peptidyl-arginine N-methylation,BP,
9642,GO:0035247,1,0.94447437958183,0,10,peptidyl-arginine omega-N-methylation,BP,
9643,GO:0035248,1,0.994140028646777,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9645,GO:0035250,1,0.84986123206894,0,27,UDP-galactosyltransferase activity,MF,
9646,GO:0035251,1,0.940656693948481,0,9,UDP-glucosyltransferase activity,MF,
9647,GO:0035252,1,0.956013138950541,0,6,UDP-xylosyltransferase activity,MF,
9648,GO:0035253,1,0.922683863443959,0,11,ciliary rootlet,CC,
9651,GO:0035256,1,0.950740531582258,0,8,G-protein coupled glutamate receptor binding,MF,
9652,GO:0035257,1,0.371490907125465,0,143,nuclear hormone receptor binding,MF,
9653,GO:0035258,1,0.55731988414824,0,84,steroid hormone receptor binding,MF,
9654,GO:0035259,1,0.907187739026699,0,14,glucocorticoid receptor binding,MF,
9655,GO:0035261,1,0.97573753549565,0,2,external genitalia morphogenesis,BP,
9656,GO:0035262,1,0.983403119646929,0,2,gonad morphogenesis,BP,
9658,GO:0035265,1,0.367378019705318,0,141,organ growth,BP,
9659,GO:0035267,1,0.887914796281093,0,18,NuA4 histone acetyltransferase complex,CC,
9660,GO:0035268,1,0.890957512769789,0,17,protein mannosylation,BP,
9661,GO:0035269,1,0.92651222466084,0,12,protein O-linked mannosylation,BP,
9663,GO:0035272,1,0.718501163513793,0,47,exocrine system development,BP,
9664,GO:0035276,1,0.986441586499542,0,2,ethanol binding,MF,
9665,GO:0035278,1,0.90288237376073,0,13,miRNA mediated inhibition of translation,BP,
9666,GO:0035279,1,0.987873255423423,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9667,GO:0035280,1,0.950990200709497,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9668,GO:0035281,1,0.986718846436001,0,2,pre-miRNA export from nucleus,BP,
9669,GO:0035282,1,0.559472543428357,0,83,segmentation,BP,
9670,GO:0035283,1,0.988012308252463,0,2,central nervous system segmentation,BP,
9671,GO:0035284,1,0.988012308252463,0,2,brain segmentation,BP,
9672,GO:0035290,1,0.979941001625813,0,3,trunk segmentation,BP,
9675,GO:0035299,1,0.992959594511044,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9679,GO:0035306,1,0.713699581643187,0,48,positive regulation of dephosphorylation,BP,
9680,GO:0035307,1,0.782389241273841,0,36,positive regulation of protein dephosphorylation,BP,
9682,GO:0035312,1,0.963204097619392,0,6,5'-3' exodeoxyribonuclease activity,MF,
9683,GO:0035313,1,0.89360725178492,0,14,wound healing, spreading of epidermal cells,BP,
9684,GO:0035315,1,0.777352386148459,0,36,hair cell differentiation,BP,
9685,GO:0035325,1,0.939927851378878,0,10,Toll-like receptor binding,MF,
9686,GO:0035326,1,0.511269153546568,0,99,enhancer binding,MF,
9687,GO:0035327,1,0.871078183201201,0,21,transcriptionally active chromatin,CC,
9688,GO:0035329,1,0.737794233533878,0,38,hippo signaling,BP,
9689,GO:0035330,1,0.912620329587018,0,11,regulation of hippo signaling,BP,
9690,GO:0035331,1,0.936165318290997,0,8,negative regulation of hippo signaling,BP,
9691,GO:0035332,1,0.979195359077144,0,2,positive regulation of hippo signaling,BP,
9692,GO:0035333,1,0.914703464164546,0,13,Notch receptor processing, ligand-dependent,BP,
9694,GO:0035336,1,0.873399705604419,0,22,long-chain fatty-acyl-CoA metabolic process,BP,
9695,GO:0035337,1,0.803983002814871,0,35,fatty-acyl-CoA metabolic process,BP,
9696,GO:0035338,1,0.906026126831652,0,16,long-chain fatty-acyl-CoA biosynthetic process,BP,
9697,GO:0035339,1,0.978178835787244,0,4,SPOTS complex,CC,
9698,GO:0035349,1,0.982776038722554,0,3,coenzyme A transmembrane transport,BP,
9699,GO:0035350,1,0.988483479794799,0,2,FAD transmembrane transport,BP,
9700,GO:0035352,1,0.99440059907078,0,1,NAD transmembrane transport,BP,
9701,GO:0035354,1,0.987986865881369,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9702,GO:0035355,1,0.99158611854615,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9703,GO:0035356,1,0.959770614085374,0,7,cellular triglyceride homeostasis,BP,
9704,GO:0035357,1,0.872984649177271,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9705,GO:0035358,1,0.925405636232321,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9706,GO:0035359,1,0.982263573164981,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9707,GO:0035360,1,0.95384309686396,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9708,GO:0035363,1,0.976429811425716,0,4,histone locus body,CC,
9709,GO:0035368,1,0.973680263550241,0,4,selenocysteine insertion sequence binding,MF,
9710,GO:0035370,1,0.988709035506685,0,2,UBC13-UEV1A complex,CC,
9711,GO:0035371,1,0.859727881039776,0,18,microtubule plus-end,CC,
9712,GO:0035372,1,0.910396914664754,0,13,protein localization to microtubule,BP,
9713,GO:0035373,1,0.971099306765408,0,3,chondroitin sulfate proteoglycan binding,MF,
9714,GO:0035374,1,0.957242558172502,0,6,chondroitin sulfate binding,MF,
9715,GO:0035375,1,0.989902081128648,0,1,zymogen binding,MF,
9716,GO:0035376,1,0.959397114139139,0,7,sterol import,BP,
9717,GO:0035377,1,0.985577743234314,0,2,transepithelial water transport,BP,
9718,GO:0035378,1,0.99420069797662,0,1,carbon dioxide transmembrane transport,BP,
9719,GO:0035379,1,0.99420069797662,0,1,carbon dioxide transmembrane transporter activity,MF,
9720,GO:0035381,1,0.952719584302592,0,8,ATP-gated ion channel activity,MF,
9721,GO:0035383,1,0.563583948992917,0,91,thioester metabolic process,BP,
9722,GO:0035384,1,0.739509735828735,0,46,thioester biosynthetic process,BP,
9723,GO:0035385,1,0.944750326804463,0,7,Roundabout signaling pathway,BP,
9724,GO:0035397,1,0.993998204777549,0,1,helper T cell enhancement of adaptive immune response,BP,
9725,GO:0035400,1,0.99212859634608,0,1,histone tyrosine kinase activity,MF,
9726,GO:0035401,1,0.99212859634608,0,1,histone kinase activity (H3-Y41 specific),MF,
9727,GO:0035402,1,0.988314879486203,0,2,histone kinase activity (H3-T11 specific),MF,
9728,GO:0035403,1,0.981097076584597,0,2,histone kinase activity (H3-T6 specific),MF,
9729,GO:0035404,1,0.926478153639181,0,12,histone-serine phosphorylation,BP,
9730,GO:0035405,1,0.964336674507209,0,5,histone-threonine phosphorylation,BP,
9731,GO:0035406,1,0.99212859634608,0,1,histone-tyrosine phosphorylation,BP,
9732,GO:0035407,1,0.988314879486203,0,2,histone H3-T11 phosphorylation,BP,
9733,GO:0035408,1,0.981097076584597,0,2,histone H3-T6 phosphorylation,BP,
9734,GO:0035409,1,0.99212859634608,0,1,histone H3-Y41 phosphorylation,BP,
9735,GO:0035410,1,0.994613946734573,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9737,GO:0035425,1,0.987241888073927,0,2,autocrine signaling,BP,
9738,GO:0035426,1,0.965156608238168,0,5,extracellular matrix-cell signaling,BP,
9739,GO:0035434,1,0.95612762224075,0,6,copper ion transmembrane transport,BP,
9740,GO:0035435,1,0.937672356361928,0,9,phosphate ion transmembrane transport,BP,
9741,GO:0035437,1,0.923256482227719,0,13,maintenance of protein localization in endoplasmic reticulum,BP,
9742,GO:0035438,1,0.994545668527907,0,1,cyclic-di-GMP binding,MF,
9743,GO:0035441,1,0.974779183010948,0,3,cell migration involved in vasculogenesis,BP,
9744,GO:0035442,1,0.988828301877708,0,2,dipeptide transmembrane transport,BP,
9745,GO:0035443,1,0.991086129130538,0,1,tripeptide transmembrane transport,BP,
9746,GO:0035445,1,0.993993092744862,0,1,borate transmembrane transport,BP,
9747,GO:0035455,1,0.878185970976767,0,20,response to interferon-alpha,BP,
9748,GO:0035456,1,0.889096039380262,0,20,response to interferon-beta,BP,
9749,GO:0035457,1,0.932669702528725,0,10,cellular response to interferon-alpha,BP,
9750,GO:0035458,1,0.924344195725586,0,13,cellular response to interferon-beta,BP,
9751,GO:0035459,1,0.873438233293243,0,20,cargo loading into vesicle,BP,
9752,GO:0035461,1,0.920101164775628,0,11,vitamin transmembrane transport,BP,
9753,GO:0035469,1,0.966535884986268,0,5,determination of pancreatic left/right asymmetry,BP,
9754,GO:0035470,1,0.989100504866481,0,2,positive regulation of vascular wound healing,BP,
9755,GO:0035473,1,0.966758462442778,0,4,lipase binding,MF,
9756,GO:0035480,1,0.994621263909854,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9757,GO:0035481,1,0.994621263909854,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9759,GO:0035483,1,0.984048823683778,0,3,gastric emptying,BP,
9760,GO:0035485,1,0.994514535715055,0,1,adenine/guanine mispair binding,MF,
9763,GO:0035493,1,0.910279176372294,0,15,SNARE complex assembly,BP,
9764,GO:0035494,1,0.982223369345342,0,3,SNARE complex disassembly,BP,
9765,GO:0035497,1,0.917076635239122,0,13,cAMP response element binding,MF,
9766,GO:0035498,1,0.993354325971769,0,1,carnosine metabolic process,BP,
9767,GO:0035499,1,0.993354325971769,0,1,carnosine biosynthetic process,BP,
9768,GO:0035500,1,0.987712757637241,0,2,MH2 domain binding,MF,
9769,GO:0035501,1,0.99416184066975,0,1,MH1 domain binding,MF,
9770,GO:0035502,1,0.969864668263146,0,5,metanephric part of ureteric bud development,BP,
9771,GO:0035504,1,0.99457797888621,0,1,regulation of myosin light chain kinase activity,BP,
9772,GO:0035505,1,0.99457797888621,0,1,positive regulation of myosin light chain kinase activity,BP,
9773,GO:0035507,1,0.946995622896766,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9774,GO:0035508,1,0.99184576884256,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9775,GO:0035509,1,0.963748254683713,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9776,GO:0035510,1,0.821572549464053,0,28,DNA dealkylation,BP,
9777,GO:0035511,1,0.970794963996605,0,5,oxidative DNA demethylation,BP,
9778,GO:0035513,1,0.975900360228511,0,4,oxidative RNA demethylation,BP,
9779,GO:0035514,1,0.982370518727636,0,3,DNA demethylase activity,MF,
9780,GO:0035515,1,0.975900360228511,0,4,oxidative RNA demethylase activity,MF,
9781,GO:0035516,1,0.993061423099223,0,1,oxidative DNA demethylase activity,MF,
9782,GO:0035517,1,0.967638200490102,0,4,PR-DUB complex,CC,
9783,GO:0035518,1,0.896377648847753,0,16,histone H2A monoubiquitination,BP,
9784,GO:0035519,1,0.975175908188489,0,4,protein K29-linked ubiquitination,BP,
9785,GO:0035520,1,0.936220444049842,0,9,monoubiquitinated protein deubiquitination,BP,
9786,GO:0035521,1,0.975493242077081,0,4,monoubiquitinated histone deubiquitination,BP,
9787,GO:0035522,1,0.975493242077081,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9788,GO:0035523,1,0.973605148479907,0,3,protein K29-linked deubiquitination,BP,
9789,GO:0035524,1,0.965133616916813,0,5,proline transmembrane transport,BP,
9790,GO:0035525,1,0.994281914990069,0,1,NF-kappaB p50/p65 complex,CC,
9791,GO:0035526,1,0.98573226824499,0,2,retrograde transport, plasma membrane to Golgi,BP,
9792,GO:0035529,1,0.9569542951275,0,7,NADH pyrophosphatase activity,MF,
9793,GO:0035538,1,0.993898412087486,0,1,carbohydrate response element binding,MF,
9794,GO:0035539,1,0.98915661079766,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9795,GO:0035542,1,0.943427465323938,0,9,regulation of SNARE complex assembly,BP,
9796,GO:0035544,1,0.980066715775835,0,3,negative regulation of SNARE complex assembly,BP,
9797,GO:0035545,1,0.993373798229804,0,1,determination of left/right asymmetry in nervous system,BP,
9798,GO:0035546,1,0.960383876650462,0,5,interferon-beta secretion,BP,
9799,GO:0035547,1,0.960383876650462,0,5,regulation of interferon-beta secretion,BP,
9800,GO:0035548,1,0.994142758058285,0,1,negative regulation of interferon-beta secretion,BP,
9801,GO:0035549,1,0.966044179671801,0,4,positive regulation of interferon-beta secretion,BP,
9802,GO:0035552,1,0.982013454051554,0,3,oxidative single-stranded DNA demethylation,BP,
9803,GO:0035553,1,0.981516997349004,0,3,oxidative single-stranded RNA demethylation,BP,
9805,GO:0035561,1,0.873191882458662,0,21,regulation of chromatin binding,BP,
9806,GO:0035562,1,0.951374776331644,0,7,negative regulation of chromatin binding,BP,
9807,GO:0035563,1,0.923610702332714,0,13,positive regulation of chromatin binding,BP,
9808,GO:0035564,1,0.981824610254549,0,2,regulation of kidney size,BP,
9809,GO:0035566,1,0.993222108242155,0,1,regulation of metanephros size,BP,
9810,GO:0035567,1,0.36236074419294,0,150,non-canonical Wnt signaling pathway,BP,
9811,GO:0035568,1,0.994184768585909,0,1,N-terminal peptidyl-proline methylation,BP,
9812,GO:0035570,1,0.994184768585909,0,1,N-terminal peptidyl-serine methylation,BP,
9813,GO:0035572,1,0.994184768585909,0,1,N-terminal peptidyl-serine dimethylation,BP,
9814,GO:0035573,1,0.994184768585909,0,1,N-terminal peptidyl-serine trimethylation,BP,
9815,GO:0035574,1,0.98563382390062,0,2,histone H4-K20 demethylation,BP,
9816,GO:0035575,1,0.98563382390062,0,2,histone demethylase activity (H4-K20 specific),MF,
9817,GO:0035577,1,0.70451031862534,0,53,azurophil granule membrane,CC,
9821,GO:0035581,1,0.938319010328945,0,8,sequestering of extracellular ligand from receptor,BP,
9822,GO:0035582,1,0.970389118919375,0,4,sequestering of BMP in extracellular matrix,BP,
9823,GO:0035583,1,0.966318817223095,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9824,GO:0035584,1,0.886942761558281,0,17,calcium-mediated signaling using intracellular calcium source,BP,
9825,GO:0035585,1,0.979311292825021,0,2,calcium-mediated signaling using extracellular calcium source,BP,
9826,GO:0035586,1,0.882142939755219,0,22,purinergic receptor activity,MF,
9827,GO:0035587,1,0.842176841090002,0,29,purinergic receptor signaling pathway,BP,
9828,GO:0035588,1,0.882875963667731,0,21,G-protein coupled purinergic receptor signaling pathway,BP,
9829,GO:0035589,1,0.933760455831869,0,12,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9830,GO:0035590,1,0.890739209030896,0,20,purinergic nucleotide receptor signaling pathway,BP,
9831,GO:0035591,1,0.576742552144239,0,80,signaling adaptor activity,MF,
9832,GO:0035594,1,0.977033395911096,0,4,ganglioside binding,MF,
9833,GO:0035596,1,0.988388113584464,0,2,methylthiotransferase activity,MF,
9834,GO:0035597,1,0.994471076936969,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9835,GO:0035598,1,0.993883555781604,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9836,GO:0035600,1,0.988388113584464,0,2,tRNA methylthiolation,BP,
9837,GO:0035601,1,0.481717002002213,0,105,protein deacylation,BP,
9838,GO:0035602,1,0.993234248573307,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9839,GO:0035603,1,0.993234248573307,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9840,GO:0035604,1,0.993234248573307,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9841,GO:0035605,1,0.994603647147335,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9842,GO:0035606,1,0.989293941978156,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9843,GO:0035607,1,0.985096922462462,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9844,GO:0035608,1,0.95815830620411,0,7,protein deglutamylation,BP,
9845,GO:0035609,1,0.975970233575345,0,4,C-terminal protein deglutamylation,BP,
9846,GO:0035610,1,0.974728792931414,0,4,protein side chain deglutamylation,BP,
9847,GO:0035611,1,0.994153841258718,0,1,protein branching point deglutamylation,BP,
9848,GO:0035612,1,0.932710896582873,0,8,AP-2 adaptor complex binding,MF,
9849,GO:0035613,1,0.898996580140083,0,15,RNA stem-loop binding,MF,
9850,GO:0035614,1,0.983334182721814,0,3,snRNA stem-loop binding,MF,
9851,GO:0035615,1,0.927751948136304,0,11,clathrin adaptor activity,MF,
9852,GO:0035616,1,0.978864105746002,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9853,GO:0035617,1,0.980404467141765,0,3,stress granule disassembly,BP,
9854,GO:0035620,1,0.973538188477179,0,4,ceramide transporter activity,MF,
9855,GO:0035621,1,0.986556534504173,0,2,ER to Golgi ceramide transport,BP,
9856,GO:0035622,1,0.993383083030628,0,1,intrahepatic bile duct development,BP,
9857,GO:0035623,1,0.993910397313129,0,1,renal glucose absorption,BP,
9858,GO:0035624,1,0.97152483554004,0,4,receptor transactivation,BP,
9859,GO:0035625,1,0.981705707948264,0,3,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9860,GO:0035627,1,0.951987119289452,0,7,ceramide transport,BP,
9862,GO:0035631,1,0.935896112094368,0,11,CD40 receptor complex,CC,
9863,GO:0035633,1,0.973281765244229,0,4,maintenance of permeability of blood-brain barrier,BP,
9864,GO:0035634,1,0.980368654929156,0,3,response to stilbenoid,BP,
9865,GO:0035635,1,0.87989969561819,0,18,entry of bacterium into host cell,BP,
9867,GO:0035638,1,0.992652116242884,0,1,signal maturation,BP,
9871,GO:0035642,1,0.994078042204579,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9872,GO:0035643,1,0.994543972359281,0,1,L-DOPA receptor activity,MF,
9873,GO:0035644,1,0.994060472513707,0,1,phosphoanandamide dephosphorylation,BP,
9874,GO:0035645,1,0.993070294993462,0,1,enteric smooth muscle cell differentiation,BP,
9875,GO:0035646,1,0.938724071474145,0,10,endosome to melanosome transport,BP,
9876,GO:0035650,1,0.976922187724699,0,4,AP-1 adaptor complex binding,MF,
9877,GO:0035651,1,0.982465020118662,0,3,AP-3 adaptor complex binding,MF,
9878,GO:0035655,1,0.954712117061484,0,8,interleukin-18-mediated signaling pathway,BP,
9879,GO:0035658,1,0.982628067615933,0,3,Mon1-Ccz1 complex,CC,
9880,GO:0035659,1,0.994541302795038,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9881,GO:0035662,1,0.983943145702218,0,3,Toll-like receptor 4 binding,MF,
9882,GO:0035663,1,0.980390452288563,0,3,Toll-like receptor 2 binding,MF,
9883,GO:0035664,1,0.994527170923359,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9884,GO:0035665,1,0.994527170923359,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9885,GO:0035666,1,0.850094662712974,0,27,TRIF-dependent toll-like receptor signaling pathway,BP,
9886,GO:0035668,1,0.986035838336429,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9887,GO:0035669,1,0.986035838336429,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9888,GO:0035671,1,0.983353227195619,0,3,enone reductase activity,MF,
9889,GO:0035672,1,0.959767329366052,0,6,oligopeptide transmembrane transport,BP,
9890,GO:0035673,1,0.970613952545103,0,4,oligopeptide transmembrane transporter activity,MF,
9891,GO:0035674,1,0.988520318355077,0,2,tricarboxylic acid transmembrane transport,BP,
9892,GO:0035675,1,0.994251418956767,0,1,neuromast hair cell development,BP,
9894,GO:0035686,1,0.976737956435034,0,4,sperm fibrous sheath,CC,
9896,GO:0035691,1,0.987661543572818,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9897,GO:0035692,1,0.987069975348138,0,2,macrophage migration inhibitory factor receptor complex,CC,
9898,GO:0035693,1,0.994603770536692,0,1,NOS2-CD74 complex,CC,
9899,GO:0035694,1,0.974939948990648,0,4,mitochondrial protein catabolic process,BP,
9900,GO:0035695,1,0.993050763593737,0,1,mitophagy by induced vacuole formation,BP,
9901,GO:0035696,1,0.978530262534636,0,3,monocyte extravasation,BP,
9902,GO:0035697,1,0.983415441380407,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9903,GO:0035698,1,0.98903898491731,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9904,GO:0035700,1,0.988873348708464,0,2,astrocyte chemotaxis,BP,
9905,GO:0035701,1,0.958266409054066,0,6,hematopoietic stem cell migration,BP,
9906,GO:0035704,1,0.994314759125492,0,1,helper T cell chemotaxis,BP,
9907,GO:0035705,1,0.994314759125492,0,1,T-helper 17 cell chemotaxis,BP,
9908,GO:0035708,1,0.993731305369998,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9909,GO:0035709,1,0.98818598590003,0,2,memory T cell activation,BP,
9911,GO:0035711,1,0.988428258446508,0,2,T-helper 1 cell activation,BP,
9912,GO:0035712,1,0.987657644695339,0,2,T-helper 2 cell activation,BP,
9913,GO:0035713,1,0.993731305369998,0,1,response to nitrogen dioxide,BP,
9914,GO:0035715,1,0.994314759125492,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9915,GO:0035716,1,0.994314759125492,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9916,GO:0035717,1,0.988586565231547,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9917,GO:0035718,1,0.989212382368732,0,2,macrophage migration inhibitory factor binding,MF,
9918,GO:0035720,1,0.979336728803456,0,3,intraciliary anterograde transport,BP,
9919,GO:0035721,1,0.912459382436932,0,12,intraciliary retrograde transport,BP,
9921,GO:0035723,1,0.915043323332307,0,13,interleukin-15-mediated signaling pathway,BP,
9922,GO:0035724,1,0.990733598244629,0,1,CD24 biosynthetic process,BP,
9924,GO:0035726,1,0.960472522291227,0,6,common myeloid progenitor cell proliferation,BP,
9925,GO:0035727,1,0.971456335527448,0,5,lysophosphatidic acid binding,MF,
9926,GO:0035728,1,0.901233611366675,0,15,response to hepatocyte growth factor,BP,
9927,GO:0035729,1,0.915718321970581,0,13,cellular response to hepatocyte growth factor stimulus,BP,
9928,GO:0035730,1,0.994638912774767,0,1,S-nitrosoglutathione binding,MF,
9929,GO:0035731,1,0.994638912774767,0,1,dinitrosyl-iron complex binding,MF,
9930,GO:0035732,1,0.994638912774767,0,1,nitric oxide storage,BP,
9931,GO:0035733,1,0.956203492397779,0,7,hepatic stellate cell activation,BP,
9932,GO:0035735,1,0.755991616506951,0,40,intraciliary transport involved in cilium assembly,BP,
9933,GO:0035739,1,0.964568699485603,0,6,CD4-positive, alpha-beta T cell proliferation,BP,
9934,GO:0035740,1,0.982937731171114,0,3,CD8-positive, alpha-beta T cell proliferation,BP,
9935,GO:0035743,1,0.922508071924671,0,14,CD4-positive, alpha-beta T cell cytokine production,BP,
9936,GO:0035744,1,0.97824194309633,0,4,T-helper 1 cell cytokine production,BP,
9937,GO:0035745,1,0.943483670546066,0,10,T-helper 2 cell cytokine production,BP,
9938,GO:0035746,1,0.994614608811986,0,1,granzyme A production,BP,
9940,GO:0035748,1,0.959586186121325,0,6,myelin sheath abaxonal region,CC,
9942,GO:0035750,1,0.992069816437491,0,1,protein localization to myelin sheath abaxonal region,BP,
9943,GO:0035751,1,0.929979303871761,0,12,regulation of lysosomal lumen pH,BP,
9944,GO:0035752,1,0.994500785755289,0,1,lysosomal lumen pH elevation,BP,
9945,GO:0035754,1,0.952927769097281,0,8,B cell chemotaxis,BP,
9946,GO:0035755,1,0.99428471871073,0,1,cardiolipin hydrolase activity,MF,
9947,GO:0035757,1,0.994430720184273,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9948,GO:0035758,1,0.994430720184273,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9949,GO:0035759,1,0.988894366404656,0,2,mesangial cell-matrix adhesion,BP,
9950,GO:0035766,1,0.965692012951657,0,5,cell chemotaxis to fibroblast growth factor,BP,
9951,GO:0035767,1,0.848630429854824,0,23,endothelial cell chemotaxis,BP,
9952,GO:0035768,1,0.965692012951657,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9954,GO:0035771,1,0.954116883542374,0,7,interleukin-4-mediated signaling pathway,BP,
9955,GO:0035772,1,0.994532060178788,0,1,interleukin-13-mediated signaling pathway,BP,
9956,GO:0035773,1,0.696895843762365,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
9957,GO:0035774,1,0.859722958149924,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9958,GO:0035782,1,0.994614608811986,0,1,mature natural killer cell chemotaxis,BP,
9959,GO:0035783,1,0.993731305369998,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
9960,GO:0035787,1,0.972420633969171,0,4,cell migration involved in kidney development,BP,
9961,GO:0035788,1,0.980178441941452,0,3,cell migration involved in metanephros development,BP,
9962,GO:0035789,1,0.980178441941452,0,3,metanephric mesenchymal cell migration,BP,
9963,GO:0035790,1,0.984425161822557,0,2,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9964,GO:0035791,1,0.9022431466714,0,13,platelet-derived growth factor receptor-beta signaling pathway,BP,
9965,GO:0035793,1,0.980178441941452,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9966,GO:0035794,1,0.703152465587019,0,59,positive regulation of mitochondrial membrane permeability,BP,
9967,GO:0035795,1,0.969143243035323,0,5,negative regulation of mitochondrial membrane permeability,BP,
9968,GO:0035799,1,0.973897549535318,0,4,ureter maturation,BP,
9969,GO:0035800,1,0.988057757687456,0,2,deubiquitinase activator activity,MF,
9970,GO:0035801,1,0.988621187258969,0,2,adrenal cortex development,BP,
9971,GO:0035802,1,0.988621187258969,0,2,adrenal cortex formation,BP,
9972,GO:0035803,1,0.989209957118416,0,2,egg coat formation,BP,
9973,GO:0035805,1,0.994406453308164,0,1,egg coat,CC,
9975,GO:0035810,1,0.928298966059868,0,12,positive regulation of urine volume,BP,
9976,GO:0035811,1,0.980547643133557,0,3,negative regulation of urine volume,BP,
9977,GO:0035812,1,0.908113093026167,0,16,renal sodium excretion,BP,
9978,GO:0035813,1,0.908113093026167,0,16,regulation of renal sodium excretion,BP,
9979,GO:0035814,1,0.972228538357687,0,5,negative regulation of renal sodium excretion,BP,
9980,GO:0035815,1,0.946498071644123,0,9,positive regulation of renal sodium excretion,BP,
9982,GO:0035822,1,0.967286539846461,0,5,gene conversion,BP,
9983,GO:0035825,1,0.750418863460931,0,44,homologous recombination,BP,
9984,GO:0035838,1,0.9766750939201,0,3,growing cell tip,CC,
9985,GO:0035841,1,0.983407701337359,0,2,new growing cell tip,CC,
9986,GO:0035844,1,0.973920841896782,0,4,cloaca development,BP,
9988,GO:0035850,1,0.746444944967355,0,41,epithelial cell differentiation involved in kidney development,BP,
9989,GO:0035851,1,0.99408216271031,0,1,Krueppel-associated box domain binding,MF,
9990,GO:0035853,1,0.992891044108827,0,1,chromosome passenger complex localization to spindle midzone,BP,
9991,GO:0035854,1,0.988430716942467,0,2,eosinophil fate commitment,BP,
9992,GO:0035855,1,0.896993553987482,0,15,megakaryocyte development,BP,
9993,GO:0035859,1,0.924851452866356,0,13,Seh1-associated complex,CC,
9994,GO:0035860,1,0.962122035844351,0,5,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9995,GO:0035861,1,0.814939779332173,0,30,site of double-strand break,CC,
9996,GO:0035862,1,0.991443266410328,0,1,dITP metabolic process,BP,
9997,GO:0035863,1,0.991443266410328,0,1,dITP catabolic process,BP,
9998,GO:0035864,1,0.934304765225123,0,10,response to potassium ion,BP,
9999,GO:0035865,1,0.959170957509356,0,6,cellular response to potassium ion,BP,
10000,GO:0035866,1,0.97229650887928,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
10001,GO:0035867,1,0.960833164985786,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10002,GO:0035868,1,0.977049849143819,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
10003,GO:0035869,1,0.676118632297568,0,58,ciliary transition zone,CC,
10004,GO:0035870,1,0.986115574498681,0,2,dITP diphosphatase activity,MF,
10005,GO:0035871,1,0.936995623721668,0,8,protein K11-linked deubiquitination,BP,
10006,GO:0035872,1,0.799833510859118,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10007,GO:0035873,1,0.960777538734178,0,6,lactate transmembrane transport,BP,
10008,GO:0035877,1,0.975210372370105,0,4,death effector domain binding,MF,
10009,GO:0035878,1,0.949922507585323,0,8,nail development,BP,
10010,GO:0035879,1,0.980834289046168,0,3,plasma membrane lactate transport,BP,
10011,GO:0035880,1,0.982528392081515,0,3,embryonic nail plate morphogenesis,BP,
10012,GO:0035881,1,0.958602105862604,0,7,amacrine cell differentiation,BP,
10013,GO:0035883,1,0.843915865082862,0,25,enteroendocrine cell differentiation,BP,
10015,GO:0035887,1,0.994535156464788,0,1,aortic smooth muscle cell differentiation,BP,
10016,GO:0035890,1,0.809948371882078,0,33,exit from host,BP,
10017,GO:0035891,1,0.809948371882078,0,33,exit from host cell,BP,
10018,GO:0035897,1,0.96558892811694,0,6,proteolysis in other organism,BP,
10019,GO:0035898,1,0.980460404981548,0,3,parathyroid hormone secretion,BP,
10020,GO:0035900,1,0.962854946704621,0,6,response to isolation stress,BP,
10021,GO:0035902,1,0.884155425570144,0,19,response to immobilization stress,BP,
10023,GO:0035905,1,0.973845753228402,0,4,ascending aorta development,BP,
10024,GO:0035907,1,0.945822312812688,0,9,dorsal aorta development,BP,
10026,GO:0035910,1,0.973845753228402,0,4,ascending aorta morphogenesis,BP,
10027,GO:0035912,1,0.951643885660986,0,8,dorsal aorta morphogenesis,BP,
10028,GO:0035914,1,0.660562672744541,0,61,skeletal muscle cell differentiation,BP,
10029,GO:0035915,1,0.994466199001112,0,1,pore formation in membrane of other organism,BP,
10030,GO:0035921,1,0.994451872857536,0,1,desmosome disassembly,BP,
10031,GO:0035922,1,0.99456187456426,0,1,foramen ovale closure,BP,
10033,GO:0035925,1,0.923421383235179,0,12,mRNA 3'-UTR AU-rich region binding,MF,
10035,GO:0035927,1,0.976071537291638,0,4,RNA import into mitochondrion,BP,
10036,GO:0035928,1,0.982151711891042,0,3,rRNA import into mitochondrion,BP,
10037,GO:0035929,1,0.896588352946846,0,18,steroid hormone secretion,BP,
10038,GO:0035930,1,0.926198849578505,0,13,corticosteroid hormone secretion,BP,
10039,GO:0035931,1,0.97707872414095,0,4,mineralocorticoid secretion,BP,
10040,GO:0035932,1,0.97707872414095,0,4,aldosterone secretion,BP,
10041,GO:0035933,1,0.9479383003765,0,9,glucocorticoid secretion,BP,
10042,GO:0035934,1,0.97830605293471,0,4,corticosterone secretion,BP,
10043,GO:0035935,1,0.993885637384576,0,1,androgen secretion,BP,
10044,GO:0035936,1,0.984554131550098,0,2,testosterone secretion,BP,
10046,GO:0035939,1,0.98195925691516,0,3,microsatellite binding,MF,
10047,GO:0035945,1,0.994321186110909,0,1,mitochondrial ncRNA surveillance,BP,
10048,GO:0035946,1,0.994321186110909,0,1,mitochondrial mRNA surveillance,BP,
10049,GO:0035947,1,0.966900855347345,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10050,GO:0035948,1,0.980671377884682,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10051,GO:0035962,1,0.982322511248381,0,3,response to interleukin-13,BP,
10052,GO:0035963,1,0.982322511248381,0,3,cellular response to interleukin-13,BP,
10053,GO:0035964,1,0.962293745894193,0,6,COPI-coated vesicle budding,BP,
10054,GO:0035965,1,0.969889577299064,0,5,cardiolipin acyl-chain remodeling,BP,
10057,GO:0035970,1,0.902668263629534,0,16,peptidyl-threonine dephosphorylation,BP,
10058,GO:0035971,1,0.994614608811986,0,1,peptidyl-histidine dephosphorylation,BP,
10059,GO:0035973,1,0.948452295811554,0,7,aggrephagy,BP,
10060,GO:0035976,1,0.972275010443814,0,5,transcription factor AP-1 complex,CC,
10061,GO:0035977,1,0.971199669184398,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10062,GO:0035978,1,0.99416184066975,0,1,histone H2A-S139 phosphorylation,BP,
10063,GO:0035981,1,0.987461740926244,0,2,tongue muscle cell differentiation,BP,
10064,GO:0035983,1,0.973589421086084,0,4,response to trichostatin A,BP,
10065,GO:0035984,1,0.973589421086084,0,4,cellular response to trichostatin A,BP,
10066,GO:0035985,1,0.977966546093583,0,4,senescence-associated heterochromatin focus,CC,
10067,GO:0035986,1,0.98335874502378,0,3,senescence-associated heterochromatin focus assembly,BP,
10070,GO:0035989,1,0.963597809259766,0,5,tendon development,BP,
10071,GO:0035990,1,0.983695083669786,0,3,tendon cell differentiation,BP,
10072,GO:0035992,1,0.983695083669786,0,3,tendon formation,BP,
10073,GO:0035993,1,0.988967965084518,0,2,deltoid tuberosity development,BP,
10074,GO:0035994,1,0.864114777266552,0,17,response to muscle stretch,BP,
10075,GO:0035995,1,0.962525380033179,0,2,detection of muscle stretch,BP,
10076,GO:0035998,1,0.994489126009256,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10077,GO:0035999,1,0.945917110692408,0,9,tetrahydrofolate interconversion,BP,
10078,GO:0036002,1,0.795664993072626,0,35,pre-mRNA binding,MF,
10079,GO:0036003,1,0.853308358853263,0,25,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10080,GO:0036004,1,0.99461316796907,0,1,GAF domain binding,MF,
10081,GO:0036005,1,0.951522392957872,0,8,response to macrophage colony-stimulating factor,BP,
10082,GO:0036006,1,0.951522392957872,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,
10083,GO:0036009,1,0.994620140326158,0,1,protein-glutamine N-methyltransferase activity,MF,
10084,GO:0036010,1,0.878849219634746,0,18,protein localization to endosome,BP,
10085,GO:0036015,1,0.972374782648387,0,4,response to interleukin-3,BP,
10086,GO:0036016,1,0.972374782648387,0,4,cellular response to interleukin-3,BP,
10087,GO:0036017,1,0.960597694255126,0,7,response to erythropoietin,BP,
10088,GO:0036018,1,0.965749085699399,0,6,cellular response to erythropoietin,BP,
10089,GO:0036019,1,0.87790625698988,0,19,endolysosome,CC,
10090,GO:0036020,1,0.904901258920327,0,14,endolysosome membrane,CC,
10091,GO:0036021,1,0.970197365073813,0,5,endolysosome lumen,CC,
10092,GO:0036022,1,0.982898291875903,0,3,limb joint morphogenesis,BP,
10093,GO:0036023,1,0.982898291875903,0,3,embryonic skeletal limb joint morphogenesis,BP,
10094,GO:0036024,1,0.99438450636867,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10095,GO:0036025,1,0.99438450636867,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10096,GO:0036026,1,0.99438450636867,0,1,protein C inhibitor-PLAT complex,CC,
10097,GO:0036027,1,0.99438450636867,0,1,protein C inhibitor-PLAU complex,CC,
10098,GO:0036028,1,0.99438450636867,0,1,protein C inhibitor-thrombin complex,CC,
10099,GO:0036029,1,0.99438450636867,0,1,protein C inhibitor-KLK3 complex,CC,
10100,GO:0036030,1,0.99438450636867,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10101,GO:0036033,1,0.959212872323267,0,4,mediator complex binding,MF,
10102,GO:0036034,1,0.988641702330571,0,2,mediator complex assembly,BP,
10104,GO:0036037,1,0.924798467768488,0,13,CD8-positive, alpha-beta T cell activation,BP,
10105,GO:0036038,1,0.921669629541771,0,13,MKS complex,CC,
10106,GO:0036041,1,0.951128960819722,0,9,long-chain fatty acid binding,MF,
10107,GO:0036042,1,0.978167704701818,0,4,long-chain fatty acyl-CoA binding,MF,
10108,GO:0036046,1,0.993970466866716,0,1,protein demalonylation,BP,
10109,GO:0036047,1,0.993970466866716,0,1,peptidyl-lysine demalonylation,BP,
10110,GO:0036048,1,0.993970466866716,0,1,protein desuccinylation,BP,
10111,GO:0036049,1,0.993970466866716,0,1,peptidyl-lysine desuccinylation,BP,
10112,GO:0036053,1,0.99421865913556,0,1,glomerular endothelium fenestra,CC,
10113,GO:0036054,1,0.993970466866716,0,1,protein-malonyllysine demalonylase activity,MF,
10114,GO:0036055,1,0.993970466866716,0,1,protein-succinyllysine desuccinylase activity,MF,
10115,GO:0036056,1,0.945691411901591,0,7,filtration diaphragm,CC,
10116,GO:0036057,1,0.945691411901591,0,7,slit diaphragm,CC,
10117,GO:0036058,1,0.99329245699361,0,1,filtration diaphragm assembly,BP,
10118,GO:0036060,1,0.99329245699361,0,1,slit diaphragm assembly,BP,
10119,GO:0036064,1,0.499901956799384,0,101,ciliary basal body,CC,
10121,GO:0036066,1,0.90883108782905,0,14,protein O-linked fucosylation,BP,
10122,GO:0036071,1,0.99387659705545,0,1,N-glycan fucosylation,BP,
10125,GO:0036080,1,0.984692981002002,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
10126,GO:0036085,1,0.993930715803111,0,1,GDP-fucose import into Golgi lumen,BP,
10127,GO:0036088,1,0.994561618309242,0,1,D-serine catabolic process,BP,
10128,GO:0036089,1,0.955177035865381,0,7,cleavage furrow formation,BP,
10129,GO:0036090,1,0.988976179795198,0,2,cleavage furrow ingression,BP,
10130,GO:0036091,1,0.96516347724514,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10131,GO:0036092,1,0.713775639449066,0,44,phosphatidylinositol-3-phosphate biosynthetic process,BP,
10132,GO:0036093,1,0.967166836873869,0,6,germ cell proliferation,BP,
10134,GO:0036100,1,0.988637462164201,0,2,leukotriene catabolic process,BP,
10135,GO:0036101,1,0.988637462164201,0,2,leukotriene B4 catabolic process,BP,
10136,GO:0036102,1,0.988637462164201,0,2,leukotriene B4 metabolic process,BP,
10137,GO:0036105,1,0.993633952644134,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10138,GO:0036109,1,0.926486615536668,0,12,alpha-linolenic acid metabolic process,BP,
10139,GO:0036111,1,0.994230895925626,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10140,GO:0036112,1,0.982982116649237,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10141,GO:0036114,1,0.994573226788901,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10142,GO:0036115,1,0.994573226788901,0,1,fatty-acyl-CoA catabolic process,BP,
10143,GO:0036116,1,0.994573226788901,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10144,GO:0036117,1,0.988745492305656,0,2,hyaluranon cable,CC,
10145,GO:0036118,1,0.982110568912909,0,3,hyaluranon cable assembly,BP,
10146,GO:0036119,1,0.85778217821932,0,21,response to platelet-derived growth factor,BP,
10147,GO:0036120,1,0.86289311336651,0,20,cellular response to platelet-derived growth factor stimulus,BP,
10148,GO:0036122,1,0.940724002193718,0,9,BMP binding,MF,
10149,GO:0036123,1,0.964850823311247,0,6,histone H3-K9 dimethylation,BP,
10150,GO:0036124,1,0.901356560592715,0,14,histone H3-K9 trimethylation,BP,
10151,GO:0036125,1,0.994033971203805,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10152,GO:0036126,1,0.68220900386537,0,61,sperm flagellum,CC,
10153,GO:0036128,1,0.965215153113033,0,6,CatSper complex,CC,
10154,GO:0036130,1,0.994613946734573,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10155,GO:0036131,1,0.994613946734573,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10156,GO:0036132,1,0.980972815315488,0,3,13-prostaglandin reductase activity,MF,
10157,GO:0036134,1,0.994447219361674,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10158,GO:0036135,1,0.984577715603563,0,2,Schwann cell migration,BP,
10159,GO:0036137,1,0.988778748889868,0,2,kynurenine aminotransferase activity,MF,
10160,GO:0036138,1,0.990619042028229,0,1,peptidyl-histidine hydroxylation,BP,
10161,GO:0036139,1,0.990619042028229,0,1,peptidyl-histidine dioxygenase activity,MF,
10162,GO:0036140,1,0.990619042028229,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10163,GO:0036143,1,0.994646812851981,0,1,kringle domain binding,MF,
10164,GO:0036145,1,0.994527788464228,0,1,dendritic cell homeostasis,BP,
10165,GO:0036146,1,0.970501208948201,0,5,cellular response to mycotoxin,BP,
10171,GO:0036153,1,0.994172100216872,0,1,triglyceride acyl-chain remodeling,BP,
10172,GO:0036155,1,0.969847432015166,0,5,acylglycerol acyl-chain remodeling,BP,
10173,GO:0036156,1,0.946966126940445,0,4,inner dynein arm,CC,
10174,GO:0036157,1,0.927086654983024,0,9,outer dynein arm,CC,
10175,GO:0036158,1,0.890304401408937,0,16,outer dynein arm assembly,BP,
10176,GO:0036159,1,0.893018790422997,0,14,inner dynein arm assembly,BP,
10177,GO:0036164,1,0.994626928605241,0,1,cell-abiotic substrate adhesion,BP,
10178,GO:0036166,1,0.969668855338595,0,4,phenotypic switching,BP,
10179,GO:0036179,1,0.994199198116083,0,1,osteoclast maturation,BP,
10180,GO:0036194,1,0.983797927281522,0,3,muscle cell projection,CC,
10181,GO:0036195,1,0.983797927281522,0,3,muscle cell projection membrane,CC,
10183,GO:0036213,1,0.994427101077596,0,1,contractile ring contraction,BP,
10184,GO:0036215,1,0.98637325243499,0,2,response to stem cell factor,BP,
10185,GO:0036216,1,0.98637325243499,0,2,cellular response to stem cell factor stimulus,BP,
10186,GO:0036219,1,0.994654979429419,0,1,GTP diphosphatase activity,MF,
10187,GO:0036220,1,0.994626787495288,0,1,ITP diphosphatase activity,MF,
10188,GO:0036222,1,0.994626787495288,0,1,XTP diphosphatase activity,MF,
10189,GO:0036228,1,0.987457123711854,0,2,protein localization to nuclear inner membrane,BP,
10191,GO:0036245,1,0.987179034445779,0,2,cellular response to menadione,BP,
10192,GO:0036250,1,0.994495263886467,0,1,peroxisome transport along microtubule,BP,
10193,GO:0036255,1,0.993464118074765,0,1,response to methylamine,BP,
10194,GO:0036257,1,0.83139813840752,0,31,multivesicular body organization,BP,
10195,GO:0036258,1,0.836277748003897,0,30,multivesicular body assembly,BP,
10196,GO:0036260,1,0.821916442814653,0,32,RNA capping,BP,
10197,GO:0036261,1,0.993569270606298,0,1,7-methylguanosine cap hypermethylation,BP,
10198,GO:0036265,1,0.975292780089671,0,4,RNA (guanine-N7)-methylation,BP,
10199,GO:0036266,1,0.994293883296756,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10200,GO:0036269,1,0.985854693897786,0,2,swimming behavior,BP,
10201,GO:0036270,1,0.856505309909305,0,18,response to diuretic,BP,
10202,GO:0036284,1,0.984578992880145,0,2,tubulobulbar complex,CC,
10203,GO:0036289,1,0.949638675502052,0,7,peptidyl-serine autophosphorylation,BP,
10204,GO:0036290,1,0.993299747117968,0,1,protein trans-autophosphorylation,BP,
10207,GO:0036294,1,0.28700880129668,0,189,cellular response to decreased oxygen levels,BP,
10208,GO:0036295,1,0.919826552102889,0,13,cellular response to increased oxygen levels,BP,
10210,GO:0036297,1,0.75354977138961,0,44,interstrand cross-link repair,BP,
10211,GO:0036301,1,0.971141087899361,0,5,macrophage colony-stimulating factor production,BP,
10212,GO:0036302,1,0.944862010485896,0,7,atrioventricular canal development,BP,
10214,GO:0036304,1,0.988661920524162,0,2,umbilical cord morphogenesis,BP,
10215,GO:0036306,1,0.99456187456426,0,1,embryonic heart tube elongation,BP,
10216,GO:0036309,1,0.968971128213705,0,2,protein localization to M-band,BP,
10218,GO:0036312,1,0.933898272842217,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10219,GO:0036313,1,0.994341084672099,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10220,GO:0036314,1,0.834484512730221,0,23,response to sterol,BP,
10221,GO:0036315,1,0.888556610044259,0,15,cellular response to sterol,BP,
10222,GO:0036316,1,0.994219870071372,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10223,GO:0036317,1,0.994184768585909,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10224,GO:0036323,1,0.992655352165659,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10225,GO:0036324,1,0.98755180098144,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10226,GO:0036326,1,0.992655352165659,0,1,VEGF-A-activated receptor activity,MF,
10227,GO:0036327,1,0.992655352165659,0,1,VEGF-B-activated receptor activity,MF,
10228,GO:0036328,1,0.992222772747765,0,1,VEGF-C-activated receptor activity,MF,
10229,GO:0036332,1,0.992655352165659,0,1,placental growth factor-activated receptor activity,MF,
10230,GO:0036333,1,0.994257567836224,0,1,hepatocyte homeostasis,BP,
10231,GO:0036335,1,0.99217216264654,0,1,intestinal stem cell homeostasis,BP,
10232,GO:0036336,1,0.848900655834897,0,26,dendritic cell migration,BP,
10233,GO:0036337,1,0.972523248000724,0,4,Fas signaling pathway,BP,
10234,GO:0036342,1,0.898197896159831,0,15,post-anal tail morphogenesis,BP,
10235,GO:0036343,1,0.977132233671626,0,4,psychomotor behavior,BP,
10236,GO:0036344,1,0.875368842909519,0,19,platelet morphogenesis,BP,
10237,GO:0036345,1,0.988706157693647,0,2,platelet maturation,BP,
10238,GO:0036351,1,0.99438347696915,0,1,histone H2A-K13 ubiquitination,BP,
10239,GO:0036352,1,0.99438347696915,0,1,histone H2A-K15 ubiquitination,BP,
10240,GO:0036353,1,0.952853540440208,0,7,histone H2A-K119 monoubiquitination,BP,
10241,GO:0036361,1,0.994322778976815,0,1,racemase activity, acting on amino acids and derivatives,MF,
10242,GO:0036363,1,0.987139689082134,0,2,transforming growth factor beta activation,BP,
10243,GO:0036367,1,0.994287293109373,0,1,light adaption,BP,
10244,GO:0036369,1,0.98021306302177,0,2,transcription factor catabolic process,BP,
10245,GO:0036371,1,0.989527629791075,0,1,protein localization to T-tubule,BP,
10246,GO:0036372,1,0.994637657247556,0,1,opsin transport,BP,
10247,GO:0036374,1,0.98302730783788,0,3,glutathione hydrolase activity,MF,
10248,GO:0036376,1,0.913543295463563,0,14,sodium ion export across plasma membrane,BP,
10249,GO:0036378,1,0.988908024168256,0,2,calcitriol biosynthetic process from calciol,BP,
10250,GO:0036379,1,0.803960472873453,0,30,myofilament,CC,
10251,GO:0036387,1,0.983342723850041,0,3,pre-replicative complex,CC,
10252,GO:0036388,1,0.983342723850041,0,3,pre-replicative complex assembly,BP,
10253,GO:0036392,1,0.993556003057948,0,1,chemokine (C-C motif) ligand 20 production,BP,
10254,GO:0036393,1,0.994124556120584,0,1,thiocyanate peroxidase activity,MF,
10255,GO:0036396,1,0.98356393780636,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
10256,GO:0036398,1,0.98825631775724,0,2,TCR signalosome,CC,
10257,GO:0036399,1,0.993882861295582,0,1,TCR signalosome assembly,BP,
10258,GO:0036402,1,0.96789134625698,0,6,proteasome-activating ATPase activity,MF,
10259,GO:0036403,1,0.99426050390905,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10260,GO:0036404,1,0.987674113341626,0,1,conversion of ds siRNA to ss siRNA,BP,
10261,GO:0036413,1,0.987427734158519,0,2,histone H3-R26 citrullination,BP,
10262,GO:0036414,1,0.981443263621124,0,3,histone citrullination,BP,
10263,GO:0036435,1,0.988069096692302,0,2,K48-linked polyubiquitin modification-dependent protein binding,MF,
10264,GO:0036438,1,0.975288006041768,0,4,maintenance of lens transparency,BP,
10265,GO:0036440,1,0.994075679219768,0,1,citrate synthase activity,MF,
10266,GO:0036442,1,0.844529116502488,0,27,proton-exporting ATPase activity,MF,
10267,GO:0036444,1,0.950938429096271,0,8,calcium import into the mitochondrion,BP,
10268,GO:0036445,1,0.910139447238502,0,13,neuronal stem cell division,BP,
10269,GO:0036446,1,0.978913755874709,0,3,myofibroblast differentiation,BP,
10270,GO:0036449,1,0.938373695182999,0,7,microtubule minus-end,CC,
10271,GO:0036451,1,0.988403017609477,0,2,cap mRNA methylation,BP,
10272,GO:0036452,1,0.846534977019118,0,28,ESCRT complex,CC,
10273,GO:0036454,1,0.965384181113263,0,5,growth factor complex,CC,
10274,GO:0036455,1,0.99462458832223,0,1,iron-sulfur transferase activity,MF,
10276,GO:0036459,1,0.520497556686326,0,88,thiol-dependent ubiquitinyl hydrolase activity,MF,
10277,GO:0036461,1,0.989237139490812,0,2,BLOC-2 complex binding,MF,
10278,GO:0036462,1,0.957002959384071,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10280,GO:0036465,1,0.708158875586272,0,48,synaptic vesicle recycling,BP,
10281,GO:0036466,1,0.985463529963913,0,2,synaptic vesicle recycling via endosome,BP,
10282,GO:0036468,1,0.994472250304577,0,1,L-dopa decarboxylase activity,MF,
10283,GO:0036470,1,0.994640893629188,0,1,tyrosine 3-monooxygenase activator activity,MF,
10284,GO:0036471,1,0.994640893629188,0,1,cellular response to glyoxal,BP,
10285,GO:0036473,1,0.624953228724987,0,73,cell death in response to oxidative stress,BP,
10286,GO:0036474,1,0.846872092218459,0,26,cell death in response to hydrogen peroxide,BP,
10287,GO:0036475,1,0.866729319482636,0,21,neuron death in response to oxidative stress,BP,
10288,GO:0036476,1,0.975783309819863,0,4,neuron death in response to hydrogen peroxide,BP,
10290,GO:0036478,1,0.994640893629188,0,1,L-dopa decarboxylase activator activity,MF,
10291,GO:0036479,1,0.988525498597407,0,1,peroxidase inhibitor activity,MF,
10292,GO:0036480,1,0.957290011870099,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10293,GO:0036481,1,0.966376577366271,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10294,GO:0036482,1,0.988915936649862,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10295,GO:0036483,1,0.992822003594547,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10296,GO:0036484,1,0.979941001625813,0,3,trunk neural crest cell migration,BP,
10297,GO:0036486,1,0.979941001625813,0,3,ventral trunk neural crest cell migration,BP,
10298,GO:0036487,1,0.988902548506595,0,1,nitric-oxide synthase inhibitor activity,MF,
10299,GO:0036488,1,0.989188632850635,0,2,CHOP-C/EBP complex,CC,
10300,GO:0036490,1,0.946892361635026,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10301,GO:0036491,1,0.952867755433934,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10302,GO:0036492,1,0.95827391484683,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10303,GO:0036493,1,0.980867517354148,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10304,GO:0036494,1,0.991860010856517,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10305,GO:0036496,1,0.988973287763761,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10306,GO:0036497,1,0.994360838239109,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10307,GO:0036498,1,0.644621708974553,0,67,IRE1-mediated unfolded protein response,BP,
10309,GO:0036500,1,0.940852579764524,0,10,ATF6-mediated unfolded protein response,BP,
10310,GO:0036501,1,0.992975754450315,0,1,UFD1-NPL4 complex,CC,
10311,GO:0036502,1,0.993981509271607,0,1,Derlin-1-VIMP complex,CC,
10312,GO:0036503,1,0.561287557520517,0,89,ERAD pathway,BP,
10313,GO:0036505,1,0.988458427449907,0,2,prosaposin receptor activity,MF,
10314,GO:0036506,1,0.978468923843233,0,3,maintenance of unfolded protein,BP,
10315,GO:0036507,1,0.846822710818785,0,24,protein demannosylation,BP,
10316,GO:0036508,1,0.846822710818785,0,24,protein alpha-1,2-demannosylation,BP,
10317,GO:0036509,1,0.988736599255315,0,2,trimming of terminal mannose on B branch,BP,
10318,GO:0036510,1,0.980153147253927,0,3,trimming of terminal mannose on C branch,BP,
10319,GO:0036511,1,0.988736599255315,0,2,trimming of first mannose on A branch,BP,
10320,GO:0036512,1,0.988736599255315,0,2,trimming of second mannose on A branch,BP,
10321,GO:0036513,1,0.931678807930638,0,11,Derlin-1 retrotranslocation complex,CC,
10322,GO:0036514,1,0.95816596574676,0,5,dopaminergic neuron axon guidance,BP,
10323,GO:0036515,1,0.963857692119183,0,4,serotonergic neuron axon guidance,BP,
10324,GO:0036517,1,0.99162298711725,0,1,chemoattraction of serotonergic neuron axon,BP,
10325,GO:0036518,1,0.985768959207248,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10326,GO:0036524,1,0.994640893629188,0,1,protein deglycase activity,MF,
10327,GO:0036525,1,0.994640893629188,0,1,protein deglycation,BP,
10328,GO:0036526,1,0.994640893629188,0,1,peptidyl-cysteine deglycation,BP,
10329,GO:0036527,1,0.994640893629188,0,1,peptidyl-arginine deglycation,BP,
10330,GO:0036528,1,0.994640893629188,0,1,peptidyl-lysine deglycation,BP,
10331,GO:0036529,1,0.994640893629188,0,1,protein deglycation, glyoxal removal,BP,
10332,GO:0036530,1,0.994640893629188,0,1,protein deglycation, methylglyoxal removal,BP,
10333,GO:0036531,1,0.994640893629188,0,1,glutathione deglycation,BP,
10334,GO:0038001,1,0.974002924423673,0,3,paracrine signaling,BP,
10335,GO:0038002,1,0.992075981591355,0,1,endocrine signaling,BP,
10336,GO:0038003,1,0.942688768001464,0,10,opioid receptor signaling pathway,BP,
10337,GO:0038007,1,0.945761730709298,0,7,netrin-activated signaling pathway,BP,
10338,GO:0038016,1,0.988161664460438,0,2,insulin receptor internalization,BP,
10339,GO:0038018,1,0.983846861339487,0,2,Wnt receptor catabolic process,BP,
10340,GO:0038021,1,0.993089777454543,0,1,leptin receptor activity,MF,
10343,GO:0038025,1,0.986807173241545,0,2,reelin receptor activity,MF,
10344,GO:0038026,1,0.966622837570249,0,4,reelin-mediated signaling pathway,BP,
10345,GO:0038027,1,0.956539491317509,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10346,GO:0038028,1,0.974351953917565,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10347,GO:0038030,1,0.954374003222925,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10348,GO:0038031,1,0.960716538062888,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10349,GO:0038033,1,0.967636626027941,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10350,GO:0038034,1,0.649649168010429,0,67,signal transduction in absence of ligand,BP,
10351,GO:0038036,1,0.953868081811865,0,8,sphingosine-1-phosphate receptor activity,MF,
10352,GO:0038037,1,0.946499523691788,0,8,G-protein coupled receptor dimeric complex,CC,
10353,GO:0038038,1,0.990630985502494,0,1,G-protein coupled receptor homodimeric complex,CC,
10354,GO:0038039,1,0.984713091617697,0,2,G-protein coupled receptor heterodimeric complex,CC,
10356,GO:0038043,1,0.987065449378199,0,2,interleukin-5-mediated signaling pathway,BP,
10358,GO:0038046,1,0.994529630099203,0,1,enkephalin receptor activity,MF,
10359,GO:0038047,1,0.994509783732194,0,1,morphine receptor activity,MF,
10360,GO:0038048,1,0.99245478670028,0,1,dynorphin receptor activity,MF,
10361,GO:0038049,1,0.977716118507412,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10362,GO:0038051,1,0.99089296560572,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10363,GO:0038052,1,0.985527845797474,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10364,GO:0038060,1,0.993838496252753,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10366,GO:0038062,1,0.987429036727356,0,2,protein tyrosine kinase collagen receptor activity,MF,
10368,GO:0038064,1,0.969850711288611,0,4,collagen receptor activity,MF,
10370,GO:0038066,1,0.786205359309855,0,37,p38MAPK cascade,BP,
10371,GO:0038083,1,0.69436083940434,0,52,peptidyl-tyrosine autophosphorylation,BP,
10372,GO:0038084,1,0.833369702998996,0,25,vascular endothelial growth factor signaling pathway,BP,
10373,GO:0038085,1,0.963461568403939,0,5,vascular endothelial growth factor binding,MF,
10374,GO:0038086,1,0.976530726161363,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10375,GO:0038089,1,0.9506642600255,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10376,GO:0038091,1,0.976530726161363,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10377,GO:0038092,1,0.910434852632617,0,14,nodal signaling pathway,BP,
10378,GO:0038093,1,0.324295979242361,0,178,Fc receptor signaling pathway,BP,
10379,GO:0038094,1,0.62081701833936,0,74,Fc-gamma receptor signaling pathway,BP,
10380,GO:0038095,1,0.477984190486451,0,118,Fc-epsilon receptor signaling pathway,BP,
10381,GO:0038096,1,0.634652735334656,0,70,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10382,GO:0038097,1,0.992122436919099,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10383,GO:0038098,1,0.987670067093946,0,2,sequestering of BMP from receptor via BMP binding,BP,
10384,GO:0038100,1,0.983563081167796,0,2,nodal binding,MF,
10385,GO:0038101,1,0.994538205181646,0,1,sequestering of nodal from receptor via nodal binding,BP,
10386,GO:0038107,1,0.955500093545621,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10387,GO:0038108,1,0.97673348036984,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10388,GO:0038109,1,0.98637325243499,0,2,Kit signaling pathway,BP,
10389,GO:0038110,1,0.927718679654316,0,11,interleukin-2-mediated signaling pathway,BP,
10390,GO:0038111,1,0.880622746067777,0,18,interleukin-7-mediated signaling pathway,BP,
10391,GO:0038112,1,0.988550442086148,0,2,interleukin-8-mediated signaling pathway,BP,
10392,GO:0038113,1,0.97905272134544,0,3,interleukin-9-mediated signaling pathway,BP,
10393,GO:0038114,1,0.954022866371072,0,7,interleukin-21-mediated signaling pathway,BP,
10394,GO:0038115,1,0.994430720184273,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10395,GO:0038116,1,0.994430720184273,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10396,GO:0038117,1,0.994430720184273,0,1,C-C motif chemokine 19 receptor activity,MF,
10397,GO:0038118,1,0.994631297741194,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10398,GO:0038121,1,0.994430720184273,0,1,C-C motif chemokine 21 receptor activity,MF,
10399,GO:0038123,1,0.982615182326496,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10400,GO:0038124,1,0.974647162308915,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10401,GO:0038127,1,0.375979549853283,0,141,ERBB signaling pathway,BP,
10402,GO:0038128,1,0.771284525592493,0,38,ERBB2 signaling pathway,BP,
10403,GO:0038129,1,0.983257950403177,0,3,ERBB3 signaling pathway,BP,
10404,GO:0038131,1,0.988408518215404,0,2,neuregulin receptor activity,MF,
10405,GO:0038132,1,0.96099021257629,0,5,neuregulin binding,MF,
10406,GO:0038133,1,0.994466863294272,0,1,ERBB2-ERBB3 signaling pathway,BP,
10407,GO:0038145,1,0.969759671235148,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10408,GO:0038154,1,0.993940097846777,0,1,interleukin-11-mediated signaling pathway,BP,
10409,GO:0038155,1,0.956079159885321,0,7,interleukin-23-mediated signaling pathway,BP,
10410,GO:0038156,1,0.992552829735561,0,1,interleukin-3-mediated signaling pathway,BP,
10411,GO:0038158,1,0.98833030355474,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10412,GO:0038161,1,0.980691811725905,0,2,prolactin signaling pathway,BP,
10413,GO:0038162,1,0.981469648315658,0,3,erythropoietin-mediated signaling pathway,BP,
10414,GO:0038163,1,0.982864265016414,0,3,thrombopoietin-mediated signaling pathway,BP,
10415,GO:0038164,1,0.993606748940786,0,1,thrombopoietin receptor activity,MF,
10416,GO:0038165,1,0.970127102168388,0,4,oncostatin-M-mediated signaling pathway,BP,
10417,GO:0038166,1,0.94566198044991,0,9,angiotensin-activated signaling pathway,BP,
10418,GO:0038167,1,0.992075033143782,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10419,GO:0038168,1,0.992075033143782,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10420,GO:0038169,1,0.976480267806635,0,4,somatostatin receptor signaling pathway,BP,
10421,GO:0038170,1,0.976480267806635,0,4,somatostatin signaling pathway,BP,
10422,GO:0038171,1,0.953795885354363,0,7,cannabinoid signaling pathway,BP,
10423,GO:0038172,1,0.982229101686353,0,3,interleukin-33-mediated signaling pathway,BP,
10424,GO:0038178,1,0.988592990701521,0,2,complement component C5a signaling pathway,BP,
10425,GO:0038179,1,0.787333645270607,0,35,neurotrophin signaling pathway,BP,
10426,GO:0038180,1,0.917127032464855,0,12,nerve growth factor signaling pathway,BP,
10427,GO:0038181,1,0.981803568611129,0,3,bile acid receptor activity,MF,
10428,GO:0038182,1,0.994579198974191,0,1,G-protein coupled bile acid receptor activity,MF,
10429,GO:0038183,1,0.981803568611129,0,3,bile acid signaling pathway,BP,
10430,GO:0038184,1,0.994579198974191,0,1,cell surface bile acid receptor signaling pathway,BP,
10431,GO:0038185,1,0.994436661814452,0,1,intracellular bile acid receptor signaling pathway,BP,
10432,GO:0038186,1,0.992678442915743,0,1,lithocholic acid receptor activity,MF,
10433,GO:0038187,1,0.915923199553783,0,14,pattern recognition receptor activity,MF,
10434,GO:0038188,1,0.989022516068793,0,2,cholecystokinin signaling pathway,BP,
10435,GO:0038189,1,0.974514633422696,0,4,neuropilin signaling pathway,BP,
10436,GO:0038190,1,0.988064356692548,0,2,VEGF-activated neuropilin signaling pathway,BP,
10437,GO:0038191,1,0.86666056158877,0,19,neuropilin binding,MF,
10438,GO:0038192,1,0.994468978273153,0,1,gastric inhibitory peptide signaling pathway,BP,
10439,GO:0038193,1,0.994399120274267,0,1,thromboxane A2 signaling pathway,BP,
10440,GO:0038194,1,0.988074318374586,0,2,thyroid-stimulating hormone signaling pathway,BP,
10441,GO:0038195,1,0.994587010900467,0,1,urokinase plasminogen activator signaling pathway,BP,
10442,GO:0038201,1,0.89479885641577,0,16,TOR complex,CC,
10443,GO:0038202,1,0.80312229104615,0,32,TORC1 signaling,BP,
10444,GO:0038203,1,0.958995877472722,0,7,TORC2 signaling,BP,
10445,GO:0039003,1,0.986693766028451,0,2,pronephric field specification,BP,
10446,GO:0039007,1,0.991892770910328,0,1,pronephric nephron morphogenesis,BP,
10447,GO:0039008,1,0.991892770910328,0,1,pronephric nephron tubule morphogenesis,BP,
10448,GO:0039017,1,0.986693766028451,0,2,pattern specification involved in pronephros development,BP,
10449,GO:0039019,1,0.985557902130638,0,2,pronephric nephron development,BP,
10450,GO:0039020,1,0.991892770910328,0,1,pronephric nephron tubule development,BP,
10451,GO:0039022,1,0.991892770910328,0,1,pronephric duct development,BP,
10452,GO:0039023,1,0.991892770910328,0,1,pronephric duct morphogenesis,BP,
10453,GO:0039502,1,0.992215682152264,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
10454,GO:0039503,1,0.992215682152264,0,1,suppression by virus of host innate immune response,BP,
10455,GO:0039506,1,0.986457098637473,0,2,modulation by virus of host molecular function,BP,
10456,GO:0039507,1,0.986457098637473,0,2,suppression by virus of host molecular function,BP,
10457,GO:0039513,1,0.994196690322018,0,1,suppression by virus of host catalytic activity,BP,
10458,GO:0039514,1,0.992215682152264,0,1,suppression by virus of host JAK-STAT cascade,BP,
10459,GO:0039516,1,0.994196690322018,0,1,modulation by virus of host catalytic activity,BP,
10460,GO:0039519,1,0.984397522335764,0,2,modulation by virus of host autophagy,BP,
10461,GO:0039520,1,0.991898943426997,0,1,induction by virus of host autophagy,BP,
10462,GO:0039521,1,0.992437925305889,0,1,suppression by virus of host autophagy,BP,
10463,GO:0039526,1,0.983247934862559,0,3,modulation by virus of host apoptotic process,BP,
10464,GO:0039528,1,0.869467120826779,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10465,GO:0039529,1,0.895554319497948,0,15,RIG-I signaling pathway,BP,
10466,GO:0039530,1,0.946363451890575,0,8,MDA-5 signaling pathway,BP,
10467,GO:0039531,1,0.896983781082031,0,15,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10468,GO:0039532,1,0.942845954526684,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10469,GO:0039533,1,0.962819639636155,0,5,regulation of MDA-5 signaling pathway,BP,
10470,GO:0039534,1,0.982270943533479,0,3,negative regulation of MDA-5 signaling pathway,BP,
10471,GO:0039535,1,0.908090824439792,0,13,regulation of RIG-I signaling pathway,BP,
10472,GO:0039536,1,0.954515040596662,0,7,negative regulation of RIG-I signaling pathway,BP,
10473,GO:0039552,1,0.991941676437859,0,1,RIG-I binding,MF,
10474,GO:0039562,1,0.992215682152264,0,1,suppression by virus of host STAT activity,BP,
10475,GO:0039563,1,0.992215682152264,0,1,suppression by virus of host STAT1 activity,BP,
10476,GO:0039564,1,0.992215682152264,0,1,suppression by virus of host STAT2 activity,BP,
10477,GO:0039650,1,0.994196690322018,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10478,GO:0039656,1,0.982779853895845,0,3,modulation by virus of host gene expression,BP,
10479,GO:0039663,1,0.965842853743896,0,6,membrane fusion involved in viral entry into host cell,BP,
10480,GO:0039689,1,0.982253923529721,0,3,negative stranded viral RNA replication,BP,
10481,GO:0039692,1,0.931336645829671,0,12,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10482,GO:0039694,1,0.847741175202201,0,26,viral RNA genome replication,BP,
10483,GO:0039695,1,0.992762593882542,0,1,DNA-templated viral transcription,BP,
10484,GO:0039702,1,0.884209729840484,0,21,viral budding via host ESCRT complex,BP,
10485,GO:0039706,1,0.929960800849282,0,11,co-receptor binding,MF,
10486,GO:0039713,1,0.993768301928894,0,1,viral factory,CC,
10487,GO:0039714,1,0.993768301928894,0,1,cytoplasmic viral factory,CC,
10488,GO:0040001,1,0.841927170343587,0,24,establishment of mitotic spindle localization,BP,
10491,GO:0040009,1,0.956649217190761,0,5,regulation of growth rate,BP,
10492,GO:0040010,1,0.994654979429419,0,1,positive regulation of growth rate,BP,
10496,GO:0040014,1,0.655032520833014,0,60,regulation of multicellular organism growth,BP,
10497,GO:0040015,1,0.925320086451152,0,11,negative regulation of multicellular organism growth,BP,
10498,GO:0040016,1,0.959541301959815,0,6,embryonic cleavage,BP,
10500,GO:0040018,1,0.815659738147742,0,29,positive regulation of multicellular organism growth,BP,
10501,GO:0040019,1,0.816846677045854,0,29,positive regulation of embryonic development,BP,
10502,GO:0040020,1,0.850605873543899,0,26,regulation of meiotic nuclear division,BP,
10503,GO:0040029,1,0.1561321160659,0,266,regulation of gene expression, epigenetic,BP,
10504,GO:0040030,1,0.988187957583059,0,2,regulation of molecular function, epigenetic,BP,
10505,GO:0040031,1,0.967039531084935,0,6,snRNA modification,BP,
10506,GO:0040032,1,0.994503556512332,0,1,post-embryonic body morphogenesis,BP,
10507,GO:0040033,1,0.90288237376073,0,13,negative regulation of translation, ncRNA-mediated,BP,
10508,GO:0040034,1,0.923206262079448,0,12,regulation of development, heterochronic,BP,
10509,GO:0040036,1,0.842241975470017,0,26,regulation of fibroblast growth factor receptor signaling pathway,BP,
10510,GO:0040037,1,0.916404331259192,0,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10511,GO:0040038,1,0.977160937686628,0,3,polar body extrusion after meiotic divisions,BP,
10512,GO:0040040,1,0.991402357528276,0,1,thermosensory behavior,BP,
10513,GO:0042000,1,0.994347709934147,0,1,translocation of peptides or proteins into host,BP,
10514,GO:0042007,1,0.994589838574551,0,1,interleukin-18 binding,MF,
10515,GO:0042008,1,0.993705525213526,0,1,interleukin-18 receptor activity,MF,
10516,GO:0042011,1,0.993998204777549,0,1,interleukin-16 binding,MF,
10517,GO:0042012,1,0.993998204777549,0,1,interleukin-16 receptor activity,MF,
10518,GO:0042015,1,0.982328533920217,0,3,interleukin-20 binding,MF,
10519,GO:0042019,1,0.994480951861777,0,1,interleukin-23 binding,MF,
10520,GO:0042020,1,0.994480951861777,0,1,interleukin-23 receptor activity,MF,
10521,GO:0042022,1,0.994480951861777,0,1,interleukin-12 receptor complex,CC,
10522,GO:0042023,1,0.94110952261072,0,8,DNA endoreduplication,BP,
10523,GO:0042025,1,0.980010735502656,0,3,host cell nucleus,CC,
10524,GO:0042026,1,0.855708484033303,0,26,protein refolding,BP,
10525,GO:0042030,1,0.977296318769274,0,3,ATPase inhibitor activity,MF,
10526,GO:0042033,1,0.932783686863631,0,12,chemokine biosynthetic process,BP,
10528,GO:0042036,1,0.845960719845707,0,28,negative regulation of cytokine biosynthetic process,BP,
10529,GO:0042040,1,0.993085353964708,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10530,GO:0042043,1,0.911855829492822,0,13,neurexin family protein binding,MF,
10531,GO:0042044,1,0.873839885161897,0,21,fluid transport,BP,
10532,GO:0042045,1,0.949464875208727,0,7,epithelial fluid transport,BP,
10534,GO:0042053,1,0.894791178765509,0,18,regulation of dopamine metabolic process,BP,
10535,GO:0042054,1,0.693639213578483,0,53,histone methyltransferase activity,MF,
10537,GO:0042058,1,0.607512557561455,0,77,regulation of epidermal growth factor receptor signaling pathway,BP,
10538,GO:0042059,1,0.763650230581853,0,41,negative regulation of epidermal growth factor receptor signaling pathway,BP,
10541,GO:0042069,1,0.894791178765509,0,18,regulation of catecholamine metabolic process,BP,
10542,GO:0042073,1,0.70816915314904,0,50,intraciliary transport,BP,
10543,GO:0042074,1,0.909869874056194,0,13,cell migration involved in gastrulation,BP,
10544,GO:0042078,1,0.982334135500385,0,3,germ-line stem cell division,BP,
10545,GO:0042083,1,0.994564330687402,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10546,GO:0042084,1,0.98741307309311,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10549,GO:0042090,1,0.954534050441612,0,7,interleukin-12 biosynthetic process,BP,
10550,GO:0042091,1,0.980384902529235,0,3,interleukin-10 biosynthetic process,BP,
10553,GO:0042094,1,0.886526830542981,0,20,interleukin-2 biosynthetic process,BP,
10554,GO:0042095,1,0.914161905269159,0,15,interferon-gamma biosynthetic process,BP,
10555,GO:0042097,1,0.980370361602395,0,3,interleukin-4 biosynthetic process,BP,
10557,GO:0042100,1,0.645273450176541,0,68,B cell proliferation,BP,
10558,GO:0042101,1,0.893371669453815,0,19,T cell receptor complex,CC,
10561,GO:0042105,1,0.973078447960892,0,5,alpha-beta T cell receptor complex,CC,
10563,GO:0042108,1,0.719798909474634,0,52,positive regulation of cytokine biosynthetic process,BP,
10564,GO:0042109,1,0.988256128063181,0,2,lymphotoxin A biosynthetic process,BP,
10567,GO:0042116,1,0.663583007586604,0,60,macrophage activation,BP,
10568,GO:0042117,1,0.959171526478997,0,7,monocyte activation,BP,
10571,GO:0042126,1,0.977252551922152,0,4,nitrate metabolic process,BP,
10573,GO:0042128,1,0.994377241372463,0,1,nitrate assimilation,BP,
10575,GO:0042130,1,0.726071111665568,0,51,negative regulation of T cell proliferation,BP,
10576,GO:0042131,1,0.994303503272759,0,1,thiamine phosphate phosphatase activity,MF,
10577,GO:0042132,1,0.99457171375683,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10579,GO:0042134,1,0.989143528563944,0,2,rRNA primary transcript binding,MF,
10580,GO:0042135,1,0.877974669640457,0,21,neurotransmitter catabolic process,BP,
10582,GO:0042137,1,0.988608604362838,0,2,sequestering of neurotransmitter,BP,
10583,GO:0042138,1,0.982810972349105,0,3,meiotic DNA double-strand break formation,BP,
10584,GO:0042140,1,0.994184768585909,0,1,late meiotic recombination nodule assembly,BP,
10585,GO:0042144,1,0.986874862667981,0,2,vacuole fusion, non-autophagic,BP,
10586,GO:0042147,1,0.60458079065424,0,72,retrograde transport, endosome to Golgi,BP,
10587,GO:0042148,1,0.952783765407931,0,8,strand invasion,BP,
10588,GO:0042149,1,0.786018830823017,0,37,cellular response to glucose starvation,BP,
10591,GO:0042159,1,0.904151829554211,0,14,lipoprotein catabolic process,BP,
10592,GO:0042160,1,0.988436814170517,0,2,lipoprotein modification,BP,
10593,GO:0042161,1,0.988436814170517,0,2,lipoprotein oxidation,BP,
10594,GO:0042162,1,0.783648160147109,0,36,telomeric DNA binding,MF,
10595,GO:0042163,1,0.994587153829369,0,1,interleukin-12 beta subunit binding,MF,
10597,GO:0042166,1,0.907633544082646,0,16,acetylcholine binding,MF,
10598,GO:0042167,1,0.978553793680587,0,4,heme catabolic process,BP,
10599,GO:0042168,1,0.856529421917566,0,25,heme metabolic process,BP,
10600,GO:0042169,1,0.797819305253221,0,32,SH2 domain binding,MF,
10601,GO:0042171,1,0.88132500419684,0,18,lysophosphatidic acid acyltransferase activity,MF,
10605,GO:0042178,1,0.944425648830436,0,10,xenobiotic catabolic process,BP,
10608,GO:0042182,1,0.965947585871225,0,6,ketone catabolic process,BP,
10609,GO:0042197,1,0.994549198400433,0,1,halogenated hydrocarbon metabolic process,BP,
10610,GO:0042214,1,0.982928284193457,0,3,terpene metabolic process,BP,
10611,GO:0042219,1,0.884824344568918,0,20,cellular modified amino acid catabolic process,BP,
10612,GO:0042220,1,0.756432560607334,0,41,response to cocaine,BP,
10614,GO:0042222,1,0.983364068808023,0,3,interleukin-1 biosynthetic process,BP,
10615,GO:0042223,1,0.992383027571753,0,1,interleukin-3 biosynthetic process,BP,
10616,GO:0042226,1,0.91683620993557,0,14,interleukin-6 biosynthetic process,BP,
10617,GO:0042228,1,0.938181284663763,0,10,interleukin-8 biosynthetic process,BP,
10618,GO:0042231,1,0.986780622830529,0,2,interleukin-13 biosynthetic process,BP,
10619,GO:0042241,1,0.993911760867851,0,1,interleukin-18 biosynthetic process,BP,
10620,GO:0042245,1,0.98737938721214,0,2,RNA repair,BP,
10622,GO:0042247,1,0.994099895814038,0,1,establishment of planar polarity of follicular epithelium,BP,
10623,GO:0042249,1,0.885529498065311,0,17,establishment of planar polarity of embryonic epithelium,BP,
10624,GO:0042253,1,0.981319056234773,0,3,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10625,GO:0042254,1,0.152509261314039,0,309,ribosome biogenesis,BP,
10626,GO:0042255,1,0.730529593094838,0,53,ribosome assembly,BP,
10627,GO:0042256,1,0.969156811254763,0,5,mature ribosome assembly,BP,
10628,GO:0042262,1,0.972961137946578,0,5,DNA protection,BP,
10629,GO:0042264,1,0.984299656071215,0,2,peptidyl-aspartic acid hydroxylation,BP,
10630,GO:0042265,1,0.990619042028229,0,1,peptidyl-asparagine hydroxylation,BP,
10631,GO:0042267,1,0.743808810835898,0,48,natural killer cell mediated cytotoxicity,BP,
10632,GO:0042268,1,0.944751010570344,0,10,regulation of cytolysis,BP,
10633,GO:0042269,1,0.828005650761261,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10634,GO:0042270,1,0.987777865781257,0,2,protection from natural killer cell mediated cytotoxicity,BP,
10635,GO:0042271,1,0.979552646357035,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10636,GO:0042272,1,0.974146812561481,0,3,nuclear RNA export factor complex,CC,
10637,GO:0042273,1,0.672811274179545,0,66,ribosomal large subunit biogenesis,BP,
10638,GO:0042274,1,0.668208323539115,0,67,ribosomal small subunit biogenesis,BP,
10639,GO:0042275,1,0.994574724135979,0,1,error-free postreplication DNA repair,BP,
10640,GO:0042276,1,0.885077759431773,0,19,error-prone translesion synthesis,BP,
10642,GO:0042278,1,0.625735713279798,0,73,purine nucleoside metabolic process,BP,
10643,GO:0042281,1,0.988387168633372,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10644,GO:0042282,1,0.992863847841579,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10645,GO:0042284,1,0.989133883562359,0,2,sphingolipid delta-4 desaturase activity,MF,
10646,GO:0042285,1,0.956013138950541,0,6,xylosyltransferase activity,MF,
10647,GO:0042287,1,0.851605189451982,0,27,MHC protein binding,MF,
10648,GO:0042288,1,0.911326805984397,0,16,MHC class I protein binding,MF,
10649,GO:0042289,1,0.965037363745964,0,6,MHC class II protein binding,MF,
10650,GO:0042292,1,0.994332998480301,0,1,URM1 activating enzyme activity,MF,
10651,GO:0042296,1,0.977624091163835,0,4,ISG15 transferase activity,MF,
10652,GO:0042297,1,0.932707382882002,0,7,vocal learning,BP,
10653,GO:0042301,1,0.935626746986302,0,11,phosphate ion binding,MF,
10656,GO:0042306,1,0.720354065383403,0,47,regulation of protein import into nucleus,BP,
10657,GO:0042307,1,0.797727987941387,0,30,positive regulation of protein import into nucleus,BP,
10658,GO:0042308,1,0.94041680284587,0,10,negative regulation of protein import into nucleus,BP,
10659,GO:0042309,1,0.994193162512267,0,1,homoiothermy,BP,
10661,GO:0042311,1,0.847729526030811,0,27,vasodilation,BP,
10662,GO:0042313,1,0.994451452837518,0,1,protein kinase C deactivation,BP,
10663,GO:0042316,1,0.992342116015422,0,1,penicillin metabolic process,BP,
10664,GO:0042320,1,0.970631382593974,0,5,regulation of circadian sleep/wake cycle, REM sleep,BP,
10665,GO:0042321,1,0.97254124912414,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10666,GO:0042322,1,0.989291743507274,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10667,GO:0042323,1,0.988759156560841,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10671,GO:0042328,1,0.968848560690212,0,4,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10673,GO:0042335,1,0.977539120461551,0,3,cuticle development,BP,
10674,GO:0042339,1,0.818072465559363,0,31,keratan sulfate metabolic process,BP,
10675,GO:0042340,1,0.929704906974959,0,11,keratan sulfate catabolic process,BP,
10676,GO:0042350,1,0.982627707275771,0,3,GDP-L-fucose biosynthetic process,BP,
10677,GO:0042351,1,0.989174537868809,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10678,GO:0042352,1,0.99338223972025,0,1,GDP-L-fucose salvage,BP,
10681,GO:0042356,1,0.994597284963999,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10682,GO:0042357,1,0.988923472764547,0,2,thiamine diphosphate metabolic process,BP,
10683,GO:0042359,1,0.877171042234398,0,19,vitamin D metabolic process,BP,
10684,GO:0042360,1,0.983435032728531,0,3,vitamin E metabolic process,BP,
10685,GO:0042361,1,0.993943766039235,0,1,menaquinone catabolic process,BP,
10686,GO:0042362,1,0.931690992451282,0,12,fat-soluble vitamin biosynthetic process,BP,
10687,GO:0042363,1,0.964672041152125,0,6,fat-soluble vitamin catabolic process,BP,
10688,GO:0042364,1,0.942077822420915,0,9,water-soluble vitamin biosynthetic process,BP,
10689,GO:0042365,1,0.98191572181859,0,3,water-soluble vitamin catabolic process,BP,
10690,GO:0042368,1,0.948350116985483,0,9,vitamin D biosynthetic process,BP,
10691,GO:0042369,1,0.988308085911699,0,2,vitamin D catabolic process,BP,
10692,GO:0042371,1,0.993607541176219,0,1,vitamin K biosynthetic process,BP,
10693,GO:0042373,1,0.97174750122316,0,5,vitamin K metabolic process,BP,
10694,GO:0042374,1,0.988602065571983,0,2,phylloquinone metabolic process,BP,
10695,GO:0042376,1,0.988602065571983,0,2,phylloquinone catabolic process,BP,
10696,GO:0042377,1,0.993943766039235,0,1,vitamin K catabolic process,BP,
10698,GO:0042382,1,0.961342173349022,0,6,paraspeckles,CC,
10701,GO:0042392,1,0.988516377447624,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10702,GO:0042393,1,0.302439411985588,0,170,histone binding,MF,
10703,GO:0042398,1,0.807730837380792,0,36,cellular modified amino acid biosynthetic process,BP,
10705,GO:0042402,1,0.8900365490987,0,20,cellular biogenic amine catabolic process,BP,
10706,GO:0042403,1,0.888514343897087,0,17,thyroid hormone metabolic process,BP,
10707,GO:0042404,1,0.994451312696892,0,1,thyroid hormone catabolic process,BP,
10708,GO:0042405,1,0.907696157935639,0,11,nuclear inclusion body,CC,
10709,GO:0042406,1,0.977518801825839,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10710,GO:0042407,1,0.916422769202738,0,15,cristae formation,BP,
10711,GO:0042412,1,0.988814566844118,0,2,taurine biosynthetic process,BP,
10712,GO:0042413,1,0.994317179683683,0,1,carnitine catabolic process,BP,
10713,GO:0042414,1,0.978456452049297,0,3,epinephrine metabolic process,BP,
10715,GO:0042416,1,0.93581453912013,0,11,dopamine biosynthetic process,BP,
10717,GO:0042418,1,0.989151188591993,0,2,epinephrine biosynthetic process,BP,
10722,GO:0042426,1,0.962883314735833,0,6,choline catabolic process,BP,
10723,GO:0042427,1,0.9890218581728,0,2,serotonin biosynthetic process,BP,
10724,GO:0042428,1,0.930559698998585,0,9,serotonin metabolic process,BP,
10725,GO:0042430,1,0.883915257528964,0,18,indole-containing compound metabolic process,BP,
10726,GO:0042435,1,0.983663386550155,0,3,indole-containing compound biosynthetic process,BP,
10727,GO:0042436,1,0.960330503545629,0,7,indole-containing compound catabolic process,BP,
10728,GO:0042438,1,0.896708989868724,0,15,melanin biosynthetic process,BP,
10730,GO:0042440,1,0.687594905082796,0,58,pigment metabolic process,BP,
10731,GO:0042441,1,0.981205620029818,0,3,eye pigment metabolic process,BP,
10736,GO:0042450,1,0.989061923239132,0,2,arginine biosynthetic process via ornithine,BP,
10737,GO:0042451,1,0.887510313885434,0,21,purine nucleoside biosynthetic process,BP,
10738,GO:0042454,1,0.91247770116799,0,16,ribonucleoside catabolic process,BP,
10739,GO:0042455,1,0.811558269670533,0,36,ribonucleoside biosynthetic process,BP,
10741,GO:0042462,1,0.825708051755298,0,28,eye photoreceptor cell development,BP,
10743,GO:0042471,1,0.48558079546411,0,106,ear morphogenesis,BP,
10744,GO:0042472,1,0.547218509835887,0,87,inner ear morphogenesis,BP,
10745,GO:0042473,1,0.94484579952091,0,9,outer ear morphogenesis,BP,
10746,GO:0042474,1,0.893278108223305,0,19,middle ear morphogenesis,BP,
10749,GO:0042481,1,0.886535834264318,0,20,regulation of odontogenesis,BP,
10750,GO:0042482,1,0.960497474054362,0,7,positive regulation of odontogenesis,BP,
10751,GO:0042483,1,0.974041982038039,0,4,negative regulation of odontogenesis,BP,
10752,GO:0042487,1,0.947738821720428,0,9,regulation of odontogenesis of dentin-containing tooth,BP,
10753,GO:0042488,1,0.994342608047487,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10754,GO:0042489,1,0.988378732592649,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10756,GO:0042491,1,0.817121868680641,0,29,inner ear auditory receptor cell differentiation,BP,
10757,GO:0042492,1,0.958991940118134,0,6,gamma-delta T cell differentiation,BP,
10759,GO:0042494,1,0.962495258757637,0,5,detection of bacterial lipoprotein,BP,
10760,GO:0042495,1,0.987986865881369,0,2,detection of triacyl bacterial lipopeptide,BP,
10761,GO:0042496,1,0.985437310323287,0,2,detection of diacyl bacterial lipopeptide,BP,
10762,GO:0042497,1,0.993799539461312,0,1,triacyl lipopeptide binding,MF,
10763,GO:0042500,1,0.962646269399287,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10764,GO:0042501,1,0.957024175960701,0,7,serine phosphorylation of STAT protein,BP,
10768,GO:0042533,1,0.892459610870933,0,18,tumor necrosis factor biosynthetic process,BP,
10769,GO:0042534,1,0.892459610870933,0,18,regulation of tumor necrosis factor biosynthetic process,BP,
10770,GO:0042535,1,0.929629860609883,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10771,GO:0042536,1,0.97216178783799,0,5,negative regulation of tumor necrosis factor biosynthetic process,BP,
10772,GO:0042537,1,0.902497573942325,0,18,benzene-containing compound metabolic process,BP,
10773,GO:0042538,1,0.959134716453854,0,7,hyperosmotic salinity response,BP,
10774,GO:0042539,1,0.984112310128388,0,2,hypotonic salinity response,BP,
10775,GO:0042541,1,0.948622489626049,0,9,hemoglobin biosynthetic process,BP,
10777,GO:0042543,1,0.994662980627241,0,1,protein N-linked glycosylation via arginine,BP,
10778,GO:0042546,1,0.994529222266585,0,1,cell wall biogenesis,BP,
10781,GO:0042554,1,0.863667679079438,0,24,superoxide anion generation,BP,
10782,GO:0042555,1,0.935819583004382,0,11,MCM complex,CC,
10783,GO:0042558,1,0.806992388349968,0,34,pteridine-containing compound metabolic process,BP,
10784,GO:0042559,1,0.922724689296091,0,14,pteridine-containing compound biosynthetic process,BP,
10785,GO:0042560,1,0.971660614163137,0,4,pteridine-containing compound catabolic process,BP,
10786,GO:0042562,1,0.589516950854706,0,82,hormone binding,MF,
10787,GO:0042564,1,0.99300619663214,0,1,NLS-dependent protein nuclear import complex,CC,
10788,GO:0042565,1,0.986718846436001,0,2,RNA nuclear export complex,CC,
10789,GO:0042567,1,0.970589600370788,0,4,insulin-like growth factor ternary complex,CC,
10790,GO:0042568,1,0.99463844525077,0,1,insulin-like growth factor binary complex,CC,
10791,GO:0042571,1,0.988863152976634,0,2,immunoglobulin complex, circulating,CC,
10794,GO:0042574,1,0.923558297206497,0,13,retinal metabolic process,BP,
10795,GO:0042575,1,0.896309539470052,0,16,DNA polymerase complex,CC,
10796,GO:0042577,1,0.988377028615308,0,2,lipid phosphatase activity,MF,
10801,GO:0042583,1,0.945020183212364,0,8,chromaffin granule,CC,
10802,GO:0042584,1,0.955873642712576,0,6,chromaffin granule membrane,CC,
10803,GO:0042585,1,0.994409983251703,0,1,germinal vesicle,CC,
10804,GO:0042586,1,0.99462146648342,0,1,peptide deformylase activity,MF,
10805,GO:0042587,1,0.964497005693885,0,5,glycogen granule,CC,
10806,GO:0042588,1,0.924660687549398,0,12,zymogen granule,CC,
10807,GO:0042589,1,0.936648239965232,0,10,zymogen granule membrane,CC,
10812,GO:0042595,1,0.988127482337021,0,2,behavioral response to starvation,BP,
10813,GO:0042596,1,0.785090043537419,0,37,fear response,BP,
10814,GO:0042599,1,0.910352000463201,0,15,lamellar body,CC,
10815,GO:0042602,1,0.994646346562996,0,1,riboflavin reductase (NADPH) activity,MF,
10817,GO:0042608,1,0.959043750180489,0,7,T cell receptor binding,MF,
10818,GO:0042609,1,0.956674086191835,0,7,CD4 receptor binding,MF,
10819,GO:0042610,1,0.988933983114299,0,2,CD8 receptor binding,MF,
10821,GO:0042612,1,0.957482503325442,0,8,MHC class I protein complex,CC,
10825,GO:0042624,1,0.994656308629671,0,1,ATPase activity, uncoupled,MF,
10826,GO:0042625,1,0.696955819260222,0,52,ATPase coupled ion transmembrane transporter activity,MF,
10828,GO:0042627,1,0.941458161882,0,9,chylomicron,CC,
10829,GO:0042628,1,0.994401745018416,0,1,mating plug formation,BP,
10831,GO:0042631,1,0.986896046852068,0,2,cellular response to water deprivation,BP,
10832,GO:0042632,1,0.713001735029754,0,52,cholesterol homeostasis,BP,
10835,GO:0042635,1,0.926398379046665,0,12,positive regulation of hair cycle,BP,
10837,GO:0042637,1,0.974610199317378,0,4,catagen,BP,
10839,GO:0042641,1,0.616147984462239,0,64,actomyosin,CC,
10840,GO:0042643,1,0.987709123324695,0,2,actomyosin, actin portion,CC,
10841,GO:0042645,1,0.771041996975447,0,41,mitochondrial nucleoid,CC,
10842,GO:0042658,1,0.994603770536692,0,1,MHC class II protein binding, via antigen binding groove,MF,
10843,GO:0042659,1,0.930262582636193,0,11,regulation of cell fate specification,BP,
10844,GO:0042660,1,0.99074973177919,0,1,positive regulation of cell fate specification,BP,
10845,GO:0042661,1,0.963979042358291,0,6,regulation of mesodermal cell fate specification,BP,
10846,GO:0042662,1,0.978177145800475,0,4,negative regulation of mesodermal cell fate specification,BP,
10847,GO:0042663,1,0.983509091150432,0,3,regulation of endodermal cell fate specification,BP,
10848,GO:0042664,1,0.994621263909854,0,1,negative regulation of endodermal cell fate specification,BP,
10849,GO:0042665,1,0.993447538755277,0,1,regulation of ectodermal cell fate specification,BP,
10850,GO:0042666,1,0.993447538755277,0,1,negative regulation of ectodermal cell fate specification,BP,
10851,GO:0042668,1,0.989219056404866,0,2,auditory receptor cell fate determination,BP,
10852,GO:0042670,1,0.950878828806934,0,8,retinal cone cell differentiation,BP,
10854,GO:0042693,1,0.929808943830256,0,12,muscle cell fate commitment,BP,
10855,GO:0042695,1,0.965219024390618,0,5,thelarche,BP,
10857,GO:0042699,1,0.988951561554918,0,2,follicle-stimulating hormone signaling pathway,BP,
10858,GO:0042700,1,0.992760760859541,0,1,luteinizing hormone signaling pathway,BP,
10859,GO:0042701,1,0.974011226578169,0,4,progesterone secretion,BP,
10860,GO:0042704,1,0.98622403771455,0,2,uterine wall breakdown,BP,
10861,GO:0042709,1,0.994369480992414,0,1,succinate-CoA ligase complex,CC,
10863,GO:0042711,1,0.924355932313656,0,12,maternal behavior,BP,
10864,GO:0042713,1,0.965594641569358,0,5,sperm ejaculation,BP,
10865,GO:0042719,1,0.972893601412186,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10866,GO:0042720,1,0.989253746460796,0,2,mitochondrial inner membrane peptidase complex,CC,
10867,GO:0042721,1,0.972428594805318,0,5,mitochondrial inner membrane protein insertion complex,CC,
10868,GO:0042723,1,0.959838777427468,0,7,thiamine-containing compound metabolic process,BP,
10869,GO:0042726,1,0.950465250626829,0,8,flavin-containing compound metabolic process,BP,
10870,GO:0042727,1,0.988739722679032,0,2,flavin-containing compound biosynthetic process,BP,
10871,GO:0042728,1,0.993427552906125,0,1,flavin-containing compound catabolic process,BP,
10873,GO:0042731,1,0.973851067597544,0,4,PH domain binding,MF,
10874,GO:0042732,1,0.982943028449454,0,3,D-xylose metabolic process,BP,
10875,GO:0042733,1,0.655596591531095,0,60,embryonic digit morphogenesis,BP,
10878,GO:0042738,1,0.919684054950727,0,14,exogenous drug catabolic process,BP,
10880,GO:0042743,1,0.786596222853518,0,40,hydrogen peroxide metabolic process,BP,
10881,GO:0042744,1,0.879561625220986,0,21,hydrogen peroxide catabolic process,BP,
10882,GO:0042745,1,0.867978371418675,0,23,circadian sleep/wake cycle,BP,
10883,GO:0042746,1,0.981827603496385,0,3,circadian sleep/wake cycle, wakefulness,BP,
10884,GO:0042747,1,0.954500160104038,0,8,circadian sleep/wake cycle, REM sleep,BP,
10885,GO:0042748,1,0.94801381247427,0,8,circadian sleep/wake cycle, non-REM sleep,BP,
10886,GO:0042749,1,0.90247285932335,0,17,regulation of circadian sleep/wake cycle,BP,
10887,GO:0042752,1,0.533346806809416,0,91,regulation of circadian rhythm,BP,
10888,GO:0042753,1,0.899919845474862,0,16,positive regulation of circadian rhythm,BP,
10889,GO:0042754,1,0.920733573549894,0,13,negative regulation of circadian rhythm,BP,
10890,GO:0042755,1,0.854155094844297,0,25,eating behavior,BP,
10891,GO:0042756,1,0.954458393922335,0,8,drinking behavior,BP,
10892,GO:0042758,1,0.954298699338855,0,8,long-chain fatty acid catabolic process,BP,
10893,GO:0042759,1,0.916080465623519,0,12,long-chain fatty acid biosynthetic process,BP,
10894,GO:0042760,1,0.957989351821261,0,7,very long-chain fatty acid catabolic process,BP,
10895,GO:0042761,1,0.936515264327365,0,11,very long-chain fatty acid biosynthetic process,BP,
10896,GO:0042762,1,0.889493046905562,0,17,regulation of sulfur metabolic process,BP,
10897,GO:0042765,1,0.970624853845606,0,5,GPI-anchor transamidase complex,CC,
10898,GO:0042766,1,0.989392419616187,0,1,nucleosome mobilization,BP,
10899,GO:0042769,1,0.797871476330277,0,37,DNA damage response, detection of DNA damage,BP,
10900,GO:0042770,1,0.423031081939278,0,127,signal transduction in response to DNA damage,BP,
10901,GO:0042771,1,0.759983325127225,0,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10902,GO:0042772,1,0.866968945369559,0,20,DNA damage response, signal transduction resulting in transcription,BP,
10903,GO:0042773,1,0.632328212133507,0,81,ATP synthesis coupled electron transport,BP,
10904,GO:0042774,1,0.994184768585909,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10905,GO:0042775,1,0.636043694033709,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10906,GO:0042776,1,0.978652915284874,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10907,GO:0042779,1,0.987918431464433,0,2,tRNA 3'-trailer cleavage,BP,
10908,GO:0042780,1,0.960359152796132,0,7,tRNA 3'-end processing,BP,
10909,GO:0042781,1,0.987918431464433,0,2,3'-tRNA processing endoribonuclease activity,MF,
10910,GO:0042788,1,0.836381669292372,0,30,polysomal ribosome,CC,
10911,GO:0042789,1,0.879015287053939,0,19,mRNA transcription by RNA polymerase II,BP,
10912,GO:0042790,1,0.925195255181825,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10913,GO:0042791,1,0.960968952700515,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10914,GO:0042795,1,0.660494651693939,0,66,snRNA transcription by RNA polymerase II,BP,
10915,GO:0042796,1,0.963744778516081,0,6,snRNA transcription by RNA polymerase III,BP,
10916,GO:0042797,1,0.960968952700515,0,6,tRNA transcription by RNA polymerase III,BP,
10917,GO:0042799,1,0.985784132517966,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10918,GO:0042800,1,0.896002094917695,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10921,GO:0042805,1,0.721153820755218,0,40,actinin binding,MF,
10922,GO:0042806,1,0.977400910014387,0,4,fucose binding,MF,
10923,GO:0042809,1,0.895221646435696,0,15,vitamin D receptor binding,MF,
10924,GO:0042813,1,0.856421182171515,0,22,Wnt-activated receptor activity,MF,
10925,GO:0042816,1,0.965778518991474,0,5,vitamin B6 metabolic process,BP,
10926,GO:0042819,1,0.978531264225683,0,3,vitamin B6 biosynthetic process,BP,
10927,GO:0042820,1,0.994477020653939,0,1,vitamin B6 catabolic process,BP,
10928,GO:0042822,1,0.978562839909114,0,3,pyridoxal phosphate metabolic process,BP,
10929,GO:0042823,1,0.983998316581763,0,2,pyridoxal phosphate biosynthetic process,BP,
10930,GO:0042824,1,0.975823709506878,0,4,MHC class I peptide loading complex,CC,
10931,GO:0042825,1,0.981223092217545,0,3,TAP complex,CC,
10932,GO:0042826,1,0.491450657241042,0,104,histone deacetylase binding,MF,
10933,GO:0042827,1,0.892140021004583,0,18,platelet dense granule,CC,
10934,GO:0042832,1,0.89706005384369,0,17,defense response to protozoan,BP,
10935,GO:0042834,1,0.951008462046321,0,8,peptidoglycan binding,MF,
10936,GO:0042835,1,0.986004262310772,0,2,BRE binding,MF,
10937,GO:0042839,1,0.994581830190299,0,1,D-glucuronate metabolic process,BP,
10938,GO:0042840,1,0.994581830190299,0,1,D-glucuronate catabolic process,BP,
10939,GO:0042843,1,0.994628416358595,0,1,D-xylose catabolic process,BP,
10940,GO:0042851,1,0.98255096491877,0,3,L-alanine metabolic process,BP,
10941,GO:0042853,1,0.98255096491877,0,3,L-alanine catabolic process,BP,
10942,GO:0042866,1,0.51971828118196,0,96,pyruvate biosynthetic process,BP,
10943,GO:0042883,1,0.993544297805147,0,1,cysteine transport,BP,
10945,GO:0042887,1,0.803309418754063,0,36,amide transmembrane transporter activity,MF,
10946,GO:0042891,1,0.951099091150452,0,8,antibiotic transport,BP,
10947,GO:0042895,1,0.96423809546455,0,6,antibiotic transmembrane transporter activity,MF,
10948,GO:0042903,1,0.987740280955228,0,2,tubulin deacetylase activity,MF,
10949,GO:0042904,1,0.977198095595904,0,4,9-cis-retinoic acid biosynthetic process,BP,
10950,GO:0042905,1,0.977198095595904,0,4,9-cis-retinoic acid metabolic process,BP,
10953,GO:0042921,1,0.896421222670198,0,15,glucocorticoid receptor signaling pathway,BP,
10954,GO:0042922,1,0.994649074016324,0,1,neuromedin U receptor binding,MF,
10955,GO:0042923,1,0.895637964757994,0,19,neuropeptide binding,MF,
10956,GO:0042924,1,0.988384262270815,0,2,neuromedin U binding,MF,
10957,GO:0042930,1,0.994184768585909,0,1,enterobactin transport,BP,
10958,GO:0042931,1,0.994184768585909,0,1,enterobactin transmembrane transporter activity,MF,
10959,GO:0042937,1,0.991086129130538,0,1,tripeptide transmembrane transporter activity,MF,
10960,GO:0042938,1,0.988828301877708,0,2,dipeptide transport,BP,
10961,GO:0042939,1,0.985611385193292,0,2,tripeptide transport,BP,
10962,GO:0042940,1,0.956169002547873,0,6,D-amino acid transport,BP,
10963,GO:0042941,1,0.99448949132686,0,1,D-alanine transport,BP,
10964,GO:0042942,1,0.988801094395355,0,2,D-serine transport,BP,
10965,GO:0042946,1,0.994184768585909,0,1,glucoside transport,BP,
10966,GO:0042947,1,0.994184768585909,0,1,glucoside transmembrane transporter activity,MF,
10967,GO:0042953,1,0.883512975815367,0,13,lipoprotein transport,BP,
10968,GO:0042954,1,0.941915797879804,0,6,lipoprotein transporter activity,MF,
10969,GO:0042974,1,0.849891389932807,0,23,retinoic acid receptor binding,MF,
10970,GO:0042975,1,0.922779395614767,0,10,peroxisome proliferator activated receptor binding,MF,
10971,GO:0042976,1,0.938306961887277,0,9,activation of Janus kinase activity,BP,
10972,GO:0042978,1,0.973897631322952,0,3,ornithine decarboxylase activator activity,MF,
10973,GO:0042979,1,0.958167868600332,0,6,ornithine decarboxylase regulator activity,MF,
10975,GO:0042982,1,0.736503240894566,0,46,amyloid precursor protein metabolic process,BP,
10976,GO:0042983,1,0.939626366386868,0,10,amyloid precursor protein biosynthetic process,BP,
10977,GO:0042984,1,0.939626366386868,0,10,regulation of amyloid precursor protein biosynthetic process,BP,
10978,GO:0042985,1,0.968733002977118,0,5,negative regulation of amyloid precursor protein biosynthetic process,BP,
10979,GO:0042986,1,0.988319471129006,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10980,GO:0042987,1,0.80146781732593,0,32,amyloid precursor protein catabolic process,BP,
10981,GO:0042988,1,0.992236949440937,0,1,X11-like protein binding,MF,
10982,GO:0042989,1,0.946099738382332,0,10,sequestering of actin monomers,BP,
10983,GO:0042994,1,0.889989698073801,0,18,cytoplasmic sequestering of transcription factor,BP,
10985,GO:0042996,1,0.962744157990166,0,6,regulation of Golgi to plasma membrane protein transport,BP,
10986,GO:0042997,1,0.975926713312733,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
10987,GO:0042998,1,0.986495538561359,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10988,GO:0042999,1,0.99279325286723,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10989,GO:0043000,1,0.987417959649903,0,2,Golgi to plasma membrane CFTR protein transport,BP,
10990,GO:0043001,1,0.805848407299875,0,31,Golgi to plasma membrane protein transport,BP,
10991,GO:0043002,1,0.99279325286723,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10992,GO:0043004,1,0.99279325286723,0,1,cytoplasmic sequestering of CFTR protein,BP,
10994,GO:0043006,1,0.988781282791341,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10995,GO:0043008,1,0.954455891668825,0,8,ATP-dependent protein binding,MF,
10998,GO:0043011,1,0.913739692628028,0,15,myeloid dendritic cell differentiation,BP,
10999,GO:0043012,1,0.994275166805352,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11000,GO:0043014,1,0.834591885370515,0,27,alpha-tubulin binding,MF,
11001,GO:0043015,1,0.84160923423815,0,26,gamma-tubulin binding,MF,
11002,GO:0043016,1,0.994219143804611,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11003,GO:0043017,1,0.994219143804611,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11004,GO:0043020,1,0.95431791281116,0,8,NADPH oxidase complex,CC,
11006,GO:0043022,1,0.73267630363177,0,47,ribosome binding,MF,
11007,GO:0043023,1,0.9332595313857,0,11,ribosomal large subunit binding,MF,
11008,GO:0043024,1,0.913212131102369,0,14,ribosomal small subunit binding,MF,
11010,GO:0043027,1,0.861420677385392,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
11011,GO:0043028,1,0.780123576514301,0,38,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
11012,GO:0043029,1,0.78978190327863,0,37,T cell homeostasis,BP,
11013,GO:0043030,1,0.777659980571907,0,36,regulation of macrophage activation,BP,
11014,GO:0043031,1,0.954329078802532,0,8,negative regulation of macrophage activation,BP,
11015,GO:0043032,1,0.869014069365975,0,21,positive regulation of macrophage activation,BP,
11016,GO:0043033,1,0.990348245443201,0,1,isoamylase complex,CC,
11017,GO:0043034,1,0.841329144576913,0,19,costamere,CC,
11018,GO:0043035,1,0.993492139520802,0,1,chromatin insulator sequence binding,MF,
11019,GO:0043038,1,0.729715220780896,0,53,amino acid activation,BP,
11020,GO:0043039,1,0.734377456401056,0,52,tRNA aminoacylation,BP,
11021,GO:0043041,1,0.993670961530716,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11023,GO:0043044,1,0.662821215994141,0,62,ATP-dependent chromatin remodeling,BP,
11024,GO:0043045,1,0.956292391238087,0,6,DNA methylation involved in embryo development,BP,
11025,GO:0043046,1,0.899616216121813,0,17,DNA methylation involved in gamete generation,BP,
11026,GO:0043047,1,0.933592962313816,0,11,single-stranded telomeric DNA binding,MF,
11027,GO:0043048,1,0.99442159538829,0,1,dolichyl monophosphate biosynthetic process,BP,
11028,GO:0043049,1,0.994022802320081,0,1,otic placode formation,BP,
11029,GO:0043060,1,0.994327130902036,0,1,meiotic metaphase I plate congression,BP,
11031,GO:0043063,1,0.992514146592329,0,1,intercellular bridge organization,BP,
11037,GO:0043073,1,0.927187630438455,0,12,germ cell nucleus,CC,
11039,GO:0043084,1,0.952642453238536,0,7,penile erection,BP,
11043,GO:0043090,1,0.85794881222556,0,22,amino acid import,BP,
11045,GO:0043095,1,0.994655087611488,0,1,regulation of GTP cyclohydrolase I activity,BP,
11046,GO:0043096,1,0.972891882302907,0,5,purine nucleobase salvage,BP,
11048,GO:0043101,1,0.921418328350301,0,14,purine-containing compound salvage,BP,
11049,GO:0043102,1,0.959621132240115,0,7,amino acid salvage,BP,
11050,GO:0043103,1,0.98353795452204,0,3,hypoxanthine salvage,BP,
11051,GO:0043105,1,0.994655087611488,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11052,GO:0043111,1,0.986911635386677,0,2,replication fork arrest,BP,
11057,GO:0043117,1,0.942270515888317,0,10,positive regulation of vascular permeability,BP,
11058,GO:0043120,1,0.970955504459121,0,5,tumor necrosis factor binding,MF,
11059,GO:0043121,1,0.93180760900118,0,10,neurotrophin binding,MF,
11062,GO:0043124,1,0.761657629465157,0,39,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11063,GO:0043125,1,0.973547236727546,0,4,ErbB-3 class receptor binding,MF,
11064,GO:0043126,1,0.99457797888621,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11065,GO:0043128,1,0.99457797888621,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11066,GO:0043129,1,0.947800707726627,0,8,surfactant homeostasis,BP,
11067,GO:0043130,1,0.660399714060201,0,65,ubiquitin binding,MF,
11068,GO:0043131,1,0.992269531760999,0,1,erythrocyte enucleation,BP,
11069,GO:0043132,1,0.988409671645195,0,2,NAD transport,BP,
11070,GO:0043136,1,0.993982155737606,0,1,glycerol-3-phosphatase activity,MF,
11071,GO:0043137,1,0.976728404127801,0,4,DNA replication, removal of RNA primer,BP,
11072,GO:0043138,1,0.923231752569506,0,12,3'-5' DNA helicase activity,MF,
11073,GO:0043139,1,0.958633687452954,0,7,5'-3' DNA helicase activity,MF,
11074,GO:0043140,1,0.950839588207734,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
11075,GO:0043141,1,0.970859199958322,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11076,GO:0043142,1,0.918456134884604,0,13,single-stranded DNA-dependent ATPase activity,MF,
11077,GO:0043144,1,0.957193152570191,0,8,snoRNA processing,BP,
11078,GO:0043149,1,0.547067261884131,0,86,stress fiber assembly,BP,
11079,GO:0043152,1,0.973932363434581,0,4,induction of bacterial agglutination,BP,
11080,GO:0043153,1,0.872062998882996,0,21,entrainment of circadian clock by photoperiod,BP,
11081,GO:0043154,1,0.575061134145079,0,86,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11082,GO:0043159,1,0.988287559484328,0,2,acrosomal matrix,CC,
11083,GO:0043161,1,0.0794747993871305,0,387,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11084,GO:0043162,1,0.892788290338725,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11085,GO:0043163,1,0.988451920485171,0,2,cell envelope organization,BP,
11090,GO:0043171,1,0.850811679516161,0,25,peptide catabolic process,BP,
11091,GO:0043173,1,0.917230422493545,0,15,nucleotide salvage,BP,
11093,GO:0043175,1,0.794591353291507,0,35,RNA polymerase core enzyme binding,MF,
11094,GO:0043176,1,0.937323288180629,0,11,amine binding,MF,
11097,GO:0043179,1,0.994451452837518,0,1,rhythmic excitation,BP,
11098,GO:0043181,1,0.993642960808039,0,1,vacuolar sequestering,BP,
11099,GO:0043183,1,0.988366698250934,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11100,GO:0043184,1,0.955507228577003,0,7,vascular endothelial growth factor receptor 2 binding,MF,
11101,GO:0043185,1,0.994456040045037,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11102,GO:0043186,1,0.914806591493227,0,14,P granule,CC,
11103,GO:0043189,1,0.887914796281093,0,18,H4/H2A histone acetyltransferase complex,CC,
11104,GO:0043190,1,0.950331752875336,0,7,ATP-binding cassette (ABC) transporter complex,CC,
11105,GO:0043194,1,0.900374733478653,0,12,axon initial segment,CC,
11107,GO:0043196,1,0.95828107675935,0,7,varicosity,CC,
11109,GO:0043198,1,0.784965366578031,0,35,dendritic shaft,CC,
11110,GO:0043199,1,0.972341447253466,0,4,sulfate binding,MF,
11112,GO:0043201,1,0.910335642629394,0,12,response to leucine,BP,
11114,GO:0043203,1,0.958615710260889,0,7,axon hillock,CC,
11117,GO:0043208,1,0.959890827264979,0,7,glycosphingolipid binding,MF,
11119,GO:0043210,1,0.994521317727986,0,1,alkanesulfonate binding,MF,
11120,GO:0043215,1,0.993327106956322,0,1,daunorubicin transport,BP,
11121,GO:0043217,1,0.886021802372617,0,14,myelin maintenance,BP,
11123,GO:0043219,1,0.973805911332563,0,4,lateral loop,CC,
11125,GO:0043221,1,0.993431724632106,0,1,SMC family protein binding,MF,
11126,GO:0043224,1,0.989255884064695,0,2,nuclear SCF ubiquitin ligase complex,CC,
11138,GO:0043237,1,0.964466589344141,0,5,laminin-1 binding,MF,
11139,GO:0043240,1,0.943964207629659,0,9,Fanconi anaemia nuclear complex,CC,
11140,GO:0043242,1,0.630817072259829,0,62,negative regulation of protein complex disassembly,BP,
11141,GO:0043243,1,0.800532952680676,0,30,positive regulation of protein complex disassembly,BP,
11142,GO:0043244,1,0.481802557284629,0,97,regulation of protein complex disassembly,BP,
11143,GO:0043247,1,0.916280411196431,0,13,telomere maintenance in response to DNA damage,BP,
11144,GO:0043248,1,0.93605591367525,0,12,proteasome assembly,BP,
11145,GO:0043249,1,0.924130869733257,0,13,erythrocyte maturation,BP,
11146,GO:0043250,1,0.994577518545636,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11147,GO:0043251,1,0.994577518545636,0,1,sodium-dependent organic anion transport,BP,
11149,GO:0043254,1,0.064684431180646,0,402,regulation of protein complex assembly,BP,
11150,GO:0043255,1,0.62193671357317,0,67,regulation of carbohydrate biosynthetic process,BP,
11151,GO:0043256,1,0.925560983759646,0,8,laminin complex,CC,
11152,GO:0043257,1,0.991587063409352,0,1,laminin-8 complex,CC,
11153,GO:0043259,1,0.968299405980024,0,3,laminin-10 complex,CC,
11154,GO:0043260,1,0.968337265961641,0,3,laminin-11 complex,CC,
11155,GO:0043262,1,0.98239612879696,0,3,adenosine-diphosphatase activity,MF,
11156,GO:0043265,1,0.993976974382358,0,1,ectoplasm,CC,
11158,GO:0043267,1,0.845178729524942,0,25,negative regulation of potassium ion transport,BP,
11159,GO:0043268,1,0.753794800174028,0,39,positive regulation of potassium ion transport,BP,
11162,GO:0043271,1,0.458742604769925,0,119,negative regulation of ion transport,BP,
11163,GO:0043273,1,0.992031865442565,0,1,CTPase activity,MF,
11164,GO:0043274,1,0.914821711308291,0,13,phospholipase binding,MF,
11165,GO:0043276,1,0.819073761861302,0,29,anoikis,BP,
11169,GO:0043280,1,0.461785644859396,0,122,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11170,GO:0043281,1,0.270414077468755,0,204,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11171,GO:0043291,1,0.974435078465361,0,2,RAVE complex,CC,
11172,GO:0043292,1,0.1995949392538,0,212,contractile fiber,CC,
11173,GO:0043293,1,0.985053414156891,0,2,apoptosome,CC,
11174,GO:0043295,1,0.93870276104786,0,11,glutathione binding,MF,
11175,GO:0043296,1,0.411385010855425,0,122,apical junction complex,CC,
11176,GO:0043297,1,0.680479285704475,0,56,apical junction assembly,BP,
11178,GO:0043300,1,0.773082714310472,0,41,regulation of leukocyte degranulation,BP,
11179,GO:0043301,1,0.933883689490722,0,11,negative regulation of leukocyte degranulation,BP,
11180,GO:0043302,1,0.882096009857947,0,20,positive regulation of leukocyte degranulation,BP,
11182,GO:0043304,1,0.848138514191688,0,27,regulation of mast cell degranulation,BP,
11183,GO:0043305,1,0.966865058225564,0,6,negative regulation of mast cell degranulation,BP,
11184,GO:0043306,1,0.929402517729102,0,12,positive regulation of mast cell degranulation,BP,
11185,GO:0043307,1,0.972291344709989,0,5,eosinophil activation,BP,
11186,GO:0043308,1,0.977665455338287,0,4,eosinophil degranulation,BP,
11187,GO:0043309,1,0.983137652365182,0,3,regulation of eosinophil degranulation,BP,
11188,GO:0043310,1,0.994314759125492,0,1,negative regulation of eosinophil degranulation,BP,
11189,GO:0043311,1,0.988759623282602,0,2,positive regulation of eosinophil degranulation,BP,
11191,GO:0043313,1,0.945259211871371,0,8,regulation of neutrophil degranulation,BP,
11192,GO:0043314,1,0.982887815118725,0,2,negative regulation of neutrophil degranulation,BP,
11193,GO:0043315,1,0.974534991541025,0,4,positive regulation of neutrophil degranulation,BP,
11194,GO:0043316,1,0.982581352740864,0,3,cytotoxic T cell degranulation,BP,
11195,GO:0043317,1,0.988338619500819,0,2,regulation of cytotoxic T cell degranulation,BP,
11196,GO:0043318,1,0.988338619500819,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11197,GO:0043320,1,0.967084068501089,0,5,natural killer cell degranulation,BP,
11198,GO:0043321,1,0.98501799445435,0,2,regulation of natural killer cell degranulation,BP,
11199,GO:0043323,1,0.98501799445435,0,2,positive regulation of natural killer cell degranulation,BP,
11200,GO:0043324,1,0.981205620029818,0,3,pigment metabolic process involved in developmental pigmentation,BP,
11201,GO:0043325,1,0.871028312114819,0,20,phosphatidylinositol-3,4-bisphosphate binding,MF,
11202,GO:0043328,1,0.977015458348993,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11203,GO:0043330,1,0.836536777149307,0,28,response to exogenous dsRNA,BP,
11204,GO:0043331,1,0.591889722626267,0,78,response to dsRNA,BP,
11205,GO:0043335,1,0.988250726894833,0,2,protein unfolding,BP,
11206,GO:0043337,1,0.993485153846078,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11207,GO:0043353,1,0.944108841858004,0,8,enucleate erythrocyte differentiation,BP,
11208,GO:0043354,1,0.992269531760999,0,1,enucleate erythrocyte maturation,BP,
11209,GO:0043363,1,0.994184768585909,0,1,nucleate erythrocyte differentiation,BP,
11210,GO:0043366,1,0.981484914273281,0,3,beta selection,BP,
11212,GO:0043368,1,0.830070393377943,0,28,positive T cell selection,BP,
11213,GO:0043369,1,0.889502682304477,0,18,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11217,GO:0043373,1,0.915616931346492,0,14,CD4-positive, alpha-beta T cell lineage commitment,BP,
11218,GO:0043374,1,0.945634425232074,0,9,CD8-positive, alpha-beta T cell differentiation,BP,
11219,GO:0043375,1,0.993447954084981,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11220,GO:0043376,1,0.987065713540254,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11221,GO:0043378,1,0.993388139661984,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11222,GO:0043379,1,0.960189248415452,0,6,memory T cell differentiation,BP,
11223,GO:0043380,1,0.970794841934444,0,5,regulation of memory T cell differentiation,BP,
11224,GO:0043382,1,0.976953142614417,0,4,positive regulation of memory T cell differentiation,BP,
11225,GO:0043383,1,0.930941906059875,0,11,negative T cell selection,BP,
11226,GO:0043385,1,0.994207649744507,0,1,mycotoxin metabolic process,BP,
11227,GO:0043387,1,0.994207649744507,0,1,mycotoxin catabolic process,BP,
11228,GO:0043388,1,0.716108351669429,0,51,positive regulation of DNA binding,BP,
11229,GO:0043392,1,0.711147473364528,0,51,negative regulation of DNA binding,BP,
11231,GO:0043394,1,0.772561725952041,0,34,proteoglycan binding,MF,
11232,GO:0043395,1,0.869262720150409,0,18,heparan sulfate proteoglycan binding,MF,
11233,GO:0043396,1,0.98661544883475,0,2,corticotropin-releasing hormone secretion,BP,
11234,GO:0043397,1,0.98661544883475,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11235,GO:0043398,1,0.980546442495337,0,3,HLH domain binding,MF,
11236,GO:0043400,1,0.969662105750119,0,5,cortisol secretion,BP,
11237,GO:0043401,1,0.29771627654119,0,174,steroid hormone mediated signaling pathway,BP,
11238,GO:0043402,1,0.970579412036867,0,3,glucocorticoid mediated signaling pathway,BP,
11240,GO:0043405,1,0.118260708262241,0,315,regulation of MAP kinase activity,BP,
11241,GO:0043406,1,0.183643902264276,0,249,positive regulation of MAP kinase activity,BP,
11242,GO:0043407,1,0.652347500293254,0,67,negative regulation of MAP kinase activity,BP,
11248,GO:0043414,1,0.184799492920827,0,253,macromolecule methylation,BP,
11249,GO:0043415,1,0.969828070705091,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11250,GO:0043416,1,0.969828070705091,0,5,regulation of skeletal muscle tissue regeneration,BP,
11251,GO:0043418,1,0.98259157713876,0,3,homocysteine catabolic process,BP,
11252,GO:0043420,1,0.994580031490716,0,1,anthranilate metabolic process,BP,
11253,GO:0043422,1,0.922208950343247,0,12,protein kinase B binding,MF,
11254,GO:0043423,1,0.993012450575616,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11255,GO:0043425,1,0.846935117377916,0,24,bHLH transcription factor binding,MF,
11256,GO:0043426,1,0.96431889386034,0,5,MRF binding,MF,
11257,GO:0043433,1,0.371957414503532,0,149,negative regulation of DNA binding transcription factor activity,BP,
11259,GO:0043435,1,0.969306862653002,0,5,response to corticotropin-releasing hormone,BP,
11261,GO:0043438,1,0.994135089997524,0,1,acetoacetic acid metabolic process,BP,
11263,GO:0043455,1,0.92371230346219,0,11,regulation of secondary metabolic process,BP,
11264,GO:0043456,1,0.978402982207297,0,4,regulation of pentose-phosphate shunt,BP,
11265,GO:0043457,1,0.872172422182351,0,21,regulation of cellular respiration,BP,
11266,GO:0043461,1,0.977054171299084,0,4,proton-transporting ATP synthase complex assembly,BP,
11268,GO:0043467,1,0.463165224773184,0,108,regulation of generation of precursor metabolites and energy,BP,
11269,GO:0043470,1,0.613049743666018,0,69,regulation of carbohydrate catabolic process,BP,
11270,GO:0043471,1,0.947513307692177,0,9,regulation of cellular carbohydrate catabolic process,BP,
11271,GO:0043473,1,0.525772286291429,0,93,pigmentation,BP,
11272,GO:0043474,1,0.981205620029818,0,3,pigment metabolic process involved in pigmentation,BP,
11273,GO:0043476,1,0.917410260970906,0,12,pigment accumulation,BP,
11274,GO:0043482,1,0.917410260970906,0,12,cellular pigment accumulation,BP,
11275,GO:0043484,1,0.470928016190328,0,111,regulation of RNA splicing,BP,
11276,GO:0043485,1,0.938724071474145,0,10,endosome to pigment granule transport,BP,
11277,GO:0043486,1,0.780664044588588,0,40,histone exchange,BP,
11280,GO:0043489,1,0.792653085641706,0,35,RNA stabilization,BP,
11281,GO:0043490,1,0.987288637931267,0,2,malate-aspartate shuttle,BP,
11284,GO:0043495,1,0.934534028631408,0,9,protein membrane anchor,MF,
11285,GO:0043496,1,0.872802426628814,0,21,regulation of protein homodimerization activity,BP,
11286,GO:0043497,1,0.93890480333233,0,10,regulation of protein heterodimerization activity,BP,
11287,GO:0043500,1,0.564514670641737,0,83,muscle adaptation,BP,
11288,GO:0043501,1,0.871290915681314,0,20,skeletal muscle adaptation,BP,
11289,GO:0043502,1,0.612213331056798,0,67,regulation of muscle adaptation,BP,
11290,GO:0043503,1,0.989131808740062,0,2,skeletal muscle fiber adaptation,BP,
11291,GO:0043504,1,0.980567010991482,0,3,mitochondrial DNA repair,BP,
11292,GO:0043506,1,0.58723791964242,0,77,regulation of JUN kinase activity,BP,
11293,GO:0043507,1,0.634850056611852,0,64,positive regulation of JUN kinase activity,BP,
11294,GO:0043508,1,0.923057945590757,0,13,negative regulation of JUN kinase activity,BP,
11295,GO:0043509,1,0.994430119833875,0,1,activin A complex,CC,
11296,GO:0043511,1,0.989049653226206,0,2,inhibin complex,CC,
11297,GO:0043512,1,0.989049653226206,0,2,inhibin A complex,CC,
11298,GO:0043513,1,0.994589698729595,0,1,inhibin B complex,CC,
11299,GO:0043514,1,0.994587153829369,0,1,interleukin-12 complex,CC,
11300,GO:0043515,1,0.962298881559095,0,5,kinetochore binding,MF,
11301,GO:0043516,1,0.82465684382045,0,29,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11302,GO:0043517,1,0.905602730673479,0,14,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11303,GO:0043518,1,0.915700366066264,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11304,GO:0043519,1,0.994448495776194,0,1,regulation of myosin II filament organization,BP,
11305,GO:0043522,1,0.944072095399533,0,9,leucine zipper domain binding,MF,
11308,GO:0043525,1,0.739621344126199,0,45,positive regulation of neuron apoptotic process,BP,
11309,GO:0043527,1,0.972253470084005,0,5,tRNA methyltransferase complex,CC,
11310,GO:0043531,1,0.795285528312544,0,33,ADP binding,MF,
11311,GO:0043532,1,0.990783868066783,0,1,angiostatin binding,MF,
11312,GO:0043533,1,0.96058742707594,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11316,GO:0043537,1,0.817956025553277,0,29,negative regulation of blood vessel endothelial cell migration,BP,
11317,GO:0043538,1,0.994036437194702,0,1,regulation of actin phosphorylation,BP,
11319,GO:0043540,1,0.99453565139976,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11320,GO:0043541,1,0.987625867680645,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11322,GO:0043543,1,0.238078348845397,0,215,protein acylation,BP,
11323,GO:0043544,1,0.99365699921152,0,1,lipoamide binding,MF,
11324,GO:0043545,1,0.959036822178512,0,7,molybdopterin cofactor metabolic process,BP,
11325,GO:0043546,1,0.960643065196567,0,6,molybdopterin cofactor binding,MF,
11327,GO:0043548,1,0.811567467784236,0,27,phosphatidylinositol 3-kinase binding,MF,
11329,GO:0043550,1,0.727165790008235,0,47,regulation of lipid kinase activity,BP,
11330,GO:0043551,1,0.759926696780044,0,40,regulation of phosphatidylinositol 3-kinase activity,BP,
11331,GO:0043552,1,0.813618470807379,0,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11332,GO:0043553,1,0.987271507816587,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11333,GO:0043555,1,0.887888272550457,0,18,regulation of translation in response to stress,BP,
11334,GO:0043558,1,0.913108099036445,0,14,regulation of translational initiation in response to stress,BP,
11335,GO:0043559,1,0.954115553377138,0,5,insulin binding,MF,
11337,GO:0043562,1,0.938807061808315,0,11,cellular response to nitrogen levels,BP,
11338,GO:0043564,1,0.988239038569764,0,2,Ku70:Ku80 complex,CC,
11341,GO:0043568,1,0.934778748077024,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11342,GO:0043569,1,0.952163793773453,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11343,GO:0043570,1,0.966648442255164,0,5,maintenance of DNA repeat elements,BP,
11344,GO:0043574,1,0.89387678226306,0,18,peroxisomal transport,BP,
11346,GO:0043578,1,0.968307167696946,0,3,nuclear matrix organization,BP,
11348,GO:0043584,1,0.888392821912312,0,16,nose development,BP,
11349,GO:0043585,1,0.975530281971021,0,3,nose morphogenesis,BP,
11350,GO:0043586,1,0.871435177794239,0,19,tongue development,BP,
11351,GO:0043587,1,0.947595117836108,0,8,tongue morphogenesis,BP,
11354,GO:0043596,1,0.771048634610876,0,41,nuclear replication fork,CC,
11355,GO:0043601,1,0.862382506096776,0,24,nuclear replisome,CC,
11356,GO:0043602,1,0.994311104687468,0,1,nitrate catabolic process,BP,
11359,GO:0043605,1,0.983643069739799,0,3,cellular amide catabolic process,BP,
11360,GO:0043606,1,0.976929112336658,0,4,formamide metabolic process,BP,
11361,GO:0043610,1,0.988950931178037,0,1,regulation of carbohydrate utilization,BP,
11362,GO:0043614,1,0.9853399876576,0,2,multi-eIF complex,CC,
11365,GO:0043618,1,0.509820145386029,0,108,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11366,GO:0043619,1,0.92544628669486,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11367,GO:0043620,1,0.491053649083421,0,113,regulation of DNA-templated transcription in response to stress,BP,
11368,GO:0043621,1,0.68648614950011,0,51,protein self-association,MF,
11369,GO:0043622,1,0.972454001017201,0,4,cortical microtubule organization,BP,
11370,GO:0043624,1,0.273411717478373,0,199,cellular protein complex disassembly,BP,
11371,GO:0043625,1,0.976903731539385,0,4,delta DNA polymerase complex,CC,
11372,GO:0043626,1,0.994600704273074,0,1,PCNA complex,CC,
11374,GO:0043628,1,0.843448150050307,0,28,ncRNA 3'-end processing,BP,
11375,GO:0043629,1,0.989593891665526,0,1,ncRNA polyadenylation,BP,
11376,GO:0043630,1,0.989593891665526,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11377,GO:0043631,1,0.755438347048855,0,42,RNA polyadenylation,BP,
11378,GO:0043632,1,0.0225819996193199,0,558,modification-dependent macromolecule catabolic process,BP,
11379,GO:0043633,1,0.950462966294084,0,8,polyadenylation-dependent RNA catabolic process,BP,
11380,GO:0043634,1,0.957373831509522,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
11381,GO:0043647,1,0.656585834671027,0,62,inositol phosphate metabolic process,BP,
11382,GO:0043648,1,0.549570423152987,0,98,dicarboxylic acid metabolic process,BP,
11383,GO:0043649,1,0.89491259231676,0,18,dicarboxylic acid catabolic process,BP,
11384,GO:0043650,1,0.929105858028875,0,12,dicarboxylic acid biosynthetic process,BP,
11385,GO:0043651,1,0.913766997017129,0,15,linoleic acid metabolic process,BP,
11386,GO:0043652,1,0.930262131056513,0,11,engulfment of apoptotic cell,BP,
11387,GO:0043653,1,0.941701907413721,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11388,GO:0043654,1,0.960191718745741,0,6,recognition of apoptotic cell,BP,
11389,GO:0043656,1,0.945163931944093,0,9,intracellular region of host,CC,
11390,GO:0043657,1,0.646473982090881,0,65,host cell,CC,
11393,GO:0043682,1,0.980430159534642,0,2,copper-transporting ATPase activity,MF,
11394,GO:0043686,1,0.983202621456735,0,3,co-translational protein modification,BP,
11396,GO:0043691,1,0.917658457946677,0,13,reverse cholesterol transport,BP,
11397,GO:0043696,1,0.948880981876339,0,7,dedifferentiation,BP,
11398,GO:0043697,1,0.948880981876339,0,7,cell dedifferentiation,BP,
11399,GO:0043733,1,0.994628139820451,0,1,DNA-3-methylbase glycosylase activity,MF,
11400,GO:0043734,1,0.976749046001457,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11401,GO:0043739,1,0.993905614853238,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11402,GO:0043754,1,0.987218925996793,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11403,GO:0043783,1,0.994370192855279,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11404,GO:0043795,1,0.994592054250129,0,1,glyceraldehyde oxidoreductase activity,MF,
11405,GO:0043812,1,0.978148467718365,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11406,GO:0043813,1,0.959607881205198,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11407,GO:0043843,1,0.99429028007077,0,1,ADP-specific glucokinase activity,MF,
11408,GO:0043849,1,0.994112461438073,0,1,Ras palmitoyltransferase activity,MF,
11409,GO:0043855,1,0.947359977255438,0,8,cyclic nucleotide-gated ion channel activity,MF,
11410,GO:0043865,1,0.994187068787961,0,1,methionine transmembrane transporter activity,MF,
11411,GO:0043874,1,0.994473936150735,0,1,acireductone synthase activity,MF,
11412,GO:0043890,1,0.994364101069896,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11413,GO:0043891,1,0.994603647147335,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11416,GO:0043902,1,0.356900899316367,0,158,positive regulation of multi-organism process,BP,
11418,GO:0043914,1,0.993381396256666,0,1,NADPH:sulfur oxidoreductase activity,MF,
11419,GO:0043916,1,0.994628139820451,0,1,DNA-7-methylguanine glycosylase activity,MF,
11420,GO:0043921,1,0.851394349398094,0,24,modulation by host of viral transcription,BP,
11421,GO:0043922,1,0.946978353741359,0,9,negative regulation by host of viral transcription,BP,
11422,GO:0043923,1,0.888157928631887,0,17,positive regulation by host of viral transcription,BP,
11423,GO:0043924,1,0.982936190394119,0,1,suramin binding,MF,
11424,GO:0043928,1,0.815195851044214,0,32,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11426,GO:0043932,1,0.977534577896771,0,4,ossification involved in bone remodeling,BP,
11428,GO:0043946,1,0.994534759625888,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11429,GO:0043947,1,0.994534759625888,0,1,positive regulation by host of symbiont catalytic activity,BP,
11432,GO:0043951,1,0.893929809410181,0,17,negative regulation of cAMP-mediated signaling,BP,
11433,GO:0043954,1,0.781865609226164,0,35,cellular component maintenance,BP,
11434,GO:0043966,1,0.694761245611185,0,56,histone H3 acetylation,BP,
11435,GO:0043967,1,0.653782404131545,0,62,histone H4 acetylation,BP,
11436,GO:0043968,1,0.903302724669983,0,15,histone H2A acetylation,BP,
11437,GO:0043969,1,0.988943080235015,0,1,histone H2B acetylation,BP,
11438,GO:0043970,1,0.915744041782352,0,13,histone H3-K9 acetylation,BP,
11439,GO:0043972,1,0.992670596622893,0,1,histone H3-K23 acetylation,BP,
11440,GO:0043973,1,0.994419894502428,0,1,histone H3-K4 acetylation,BP,
11441,GO:0043974,1,0.978545213248593,0,3,histone H3-K27 acetylation,BP,
11442,GO:0043981,1,0.90791580143676,0,15,histone H4-K5 acetylation,BP,
11443,GO:0043982,1,0.90791580143676,0,15,histone H4-K8 acetylation,BP,
11444,GO:0043983,1,0.960430576142656,0,7,histone H4-K12 acetylation,BP,
11445,GO:0043984,1,0.883819816991,0,18,histone H4-K16 acetylation,BP,
11446,GO:0043985,1,0.965376265962291,0,6,histone H4-R3 methylation,BP,
11447,GO:0043987,1,0.965841047776052,0,6,histone H3-S10 phosphorylation,BP,
11448,GO:0043988,1,0.982696862526086,0,3,histone H3-S28 phosphorylation,BP,
11449,GO:0043990,1,0.994006463918456,0,1,histone H2A-S1 phosphorylation,BP,
11450,GO:0043994,1,0.992670596622893,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
11451,GO:0043995,1,0.934188154877888,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
11452,GO:0043996,1,0.934188154877888,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
11453,GO:0043997,1,0.993987315041155,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11454,GO:0043998,1,0.993843484342972,0,1,H2A histone acetyltransferase activity,MF,
11455,GO:0044003,1,0.765898446972367,0,38,modification by symbiont of host morphology or physiology,BP,
11456,GO:0044004,1,0.970698634689607,0,5,disruption by symbiont of host cell,BP,
11457,GO:0044007,1,0.991095443406033,0,1,dissemination or transmission of symbiont from host,BP,
11459,GO:0044020,1,0.97772215731077,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11460,GO:0044026,1,0.988122640770378,0,2,DNA hypermethylation,BP,
11461,GO:0044027,1,0.994591573073426,0,1,hypermethylation of CpG island,BP,
11462,GO:0044028,1,0.987025720235563,0,2,DNA hypomethylation,BP,
11463,GO:0044029,1,0.987025720235563,0,2,hypomethylation of CpG island,BP,
11464,GO:0044030,1,0.90404340104706,0,15,regulation of DNA methylation,BP,
11467,GO:0044036,1,0.972552740563038,0,5,cell wall macromolecule metabolic process,BP,
11468,GO:0044038,1,0.994529222266585,0,1,cell wall macromolecule biosynthetic process,BP,
11469,GO:0044042,1,0.614781914365399,0,69,glucan metabolic process,BP,
11470,GO:0044053,1,0.994347709934147,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11473,GO:0044060,1,0.778847324035209,0,40,regulation of endocrine process,BP,
11474,GO:0044062,1,0.890294643321915,0,19,regulation of excretion,BP,
11475,GO:0044065,1,0.905852936060758,0,15,regulation of respiratory system process,BP,
11476,GO:0044068,1,0.846258031358829,0,25,modulation by symbiont of host cellular process,BP,
11477,GO:0044070,1,0.610936169399387,0,73,regulation of anion transport,BP,
11486,GO:0044094,1,0.980010735502656,0,3,host cell nuclear part,CC,
11487,GO:0044105,1,0.99464799022202,0,1,L-xylulose reductase (NAD+) activity,MF,
11489,GO:0044107,1,0.97794836913717,0,4,cellular alcohol metabolic process,BP,
11490,GO:0044108,1,0.97794836913717,0,4,cellular alcohol biosynthetic process,BP,
11491,GO:0044110,1,0.928218419057838,0,13,growth involved in symbiotic interaction,BP,
11494,GO:0044116,1,0.928218419057838,0,13,growth of symbiont involved in interaction with host,BP,
11495,GO:0044117,1,0.933209889026612,0,12,growth of symbiont in host,BP,
11496,GO:0044126,1,0.938242439568225,0,11,regulation of growth of symbiont in host,BP,
11497,GO:0044128,1,0.992328933981718,0,1,positive regulation of growth of symbiont in host,BP,
11498,GO:0044130,1,0.945499479016548,0,10,negative regulation of growth of symbiont in host,BP,
11499,GO:0044133,1,0.994654979429419,0,1,growth of symbiont on or near host,BP,
11500,GO:0044139,1,0.994654979429419,0,1,modulation of growth of symbiont on or near host,BP,
11501,GO:0044140,1,0.994654979429419,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11502,GO:0044144,1,0.933224321494062,0,12,modulation of growth of symbiont involved in interaction with host,BP,
11504,GO:0044146,1,0.940442935888394,0,11,negative regulation of growth of symbiont involved in interaction with host,BP,
11506,GO:0044148,1,0.992328933981718,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11507,GO:0044154,1,0.953307725514578,0,8,histone H3-K14 acetylation,BP,
11508,GO:0044179,1,0.988663882122091,0,2,hemolysis in other organism,BP,
11509,GO:0044183,1,0.794028257574437,0,38,protein binding involved in protein folding,MF,
11510,GO:0044190,1,0.994533464418864,0,1,host cell mitochondrial envelope,CC,
11511,GO:0044194,1,0.972340552716252,0,5,cytolytic granule,CC,
11512,GO:0044205,1,0.979251294701474,0,3,'de novo' UMP biosynthetic process,BP,
11513,GO:0044206,1,0.972738597418278,0,5,UMP salvage,BP,
11514,GO:0044207,1,0.993174197628683,0,1,translation initiation ternary complex,CC,
11515,GO:0044208,1,0.983394026696065,0,3,'de novo' AMP biosynthetic process,BP,
11516,GO:0044209,1,0.989146029503619,0,2,AMP salvage,BP,
11517,GO:0044210,1,0.987585783503965,0,2,'de novo' CTP biosynthetic process,BP,
11518,GO:0044211,1,0.983657992392578,0,3,CTP salvage,BP,
11520,GO:0044213,1,0.92105190068899,0,12,intronic transcription regulatory region DNA binding,MF,
11521,GO:0044214,1,0.959914773949529,0,5,spanning component of plasma membrane,CC,
11526,GO:0044220,1,0.99256492814898,0,1,host cell perinuclear region of cytoplasm,CC,
11527,GO:0044221,1,0.993154938853001,0,1,host cell synapse,CC,
11528,GO:0044224,1,0.923148363601703,0,10,juxtaparanode region of axon,CC,
11529,GO:0044228,1,0.992660435603432,0,1,host cell surface,CC,
11530,GO:0044231,1,0.993154938853001,0,1,host cell presynaptic membrane,CC,
11531,GO:0044232,1,0.881789359171116,0,19,organelle membrane contact site,CC,
11532,GO:0044233,1,0.919208276699212,0,13,ER-mitochondrion membrane contact site,CC,
11535,GO:0044241,1,0.946085353926832,0,9,lipid digestion,BP,
11537,GO:0044245,1,0.980047215661012,0,3,polysaccharide digestion,BP,
11538,GO:0044247,1,0.839114461671415,0,25,cellular polysaccharide catabolic process,BP,
11543,GO:0044258,1,0.994357181974626,0,1,intestinal lipid catabolic process,BP,
11545,GO:0044262,1,0.212415867595681,0,227,cellular carbohydrate metabolic process,BP,
11546,GO:0044264,1,0.543459241308034,0,88,cellular polysaccharide metabolic process,BP,
11551,GO:0044272,1,0.334999882914873,0,167,sulfur compound biosynthetic process,BP,
11552,GO:0044273,1,0.764488355607674,0,42,sulfur compound catabolic process,BP,
11553,GO:0044275,1,0.767859207035866,0,39,cellular carbohydrate catabolic process,BP,
11558,GO:0044284,1,0.994643375977365,0,1,mitochondrial crista junction,CC,
11559,GO:0044291,1,0.633086771274762,0,62,cell-cell contact zone,CC,
11560,GO:0044292,1,0.935952791775533,0,10,dendrite terminus,CC,
11561,GO:0044294,1,0.957416944056173,0,6,dendritic growth cone,CC,
11562,GO:0044295,1,0.860025543699773,0,21,axonal growth cone,CC,
11565,GO:0044299,1,0.990981982120696,0,1,C-fiber,CC,
11566,GO:0044300,1,0.964460211249861,0,5,cerebellar mossy fiber,CC,
11567,GO:0044301,1,0.987507341583591,0,2,climbing fiber,CC,
11568,GO:0044302,1,0.966801902563745,0,4,dentate gyrus mossy fiber,CC,
11569,GO:0044304,1,0.621009448363467,0,62,main axon,CC,
11570,GO:0044305,1,0.962901514977989,0,4,calyx of Held,CC,
11572,GO:0044307,1,0.985872615304086,0,1,dendritic branch,CC,
11573,GO:0044308,1,0.97425296435294,0,3,axonal spine,CC,
11575,GO:0044313,1,0.974418347406409,0,3,protein K6-linked deubiquitination,BP,
11576,GO:0044314,1,0.977832689814207,0,4,protein K27-linked ubiquitination,BP,
11577,GO:0044316,1,0.987872774957738,0,2,cone cell pedicle,CC,
11578,GO:0044317,1,0.994596231431731,0,1,rod spherule,CC,
11580,GO:0044320,1,0.909292674996508,0,15,cellular response to leptin stimulus,BP,
11581,GO:0044321,1,0.887599835154238,0,19,response to leptin,BP,
11582,GO:0044322,1,0.826040656071929,0,28,endoplasmic reticulum quality control compartment,CC,
11583,GO:0044323,1,0.972480169994855,0,4,retinoic acid-responsive element binding,MF,
11584,GO:0044324,1,0.994642730580491,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11586,GO:0044326,1,0.969299729093668,0,4,dendritic spine neck,CC,
11587,GO:0044327,1,0.948033053810255,0,8,dendritic spine head,CC,
11588,GO:0044331,1,0.818057855692497,0,32,cell-cell adhesion mediated by cadherin,BP,
11589,GO:0044332,1,0.947270967334083,0,6,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11590,GO:0044333,1,0.994506634650739,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11591,GO:0044334,1,0.987152304682153,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11592,GO:0044335,1,0.987818746204725,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11593,GO:0044336,1,0.980848833590227,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11594,GO:0044338,1,0.987632986845118,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11595,GO:0044339,1,0.972924421956861,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11596,GO:0044340,1,0.963654387224121,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11597,GO:0044341,1,0.957251895758153,0,7,sodium-dependent phosphate transport,BP,
11598,GO:0044342,1,0.905283787948844,0,16,type B pancreatic cell proliferation,BP,
11599,GO:0044343,1,0.992909132662584,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11601,GO:0044345,1,0.992909132662584,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11602,GO:0044346,1,0.883534519589131,0,18,fibroblast apoptotic process,BP,
11603,GO:0044349,1,0.99453859512126,0,1,DNA excision,BP,
11604,GO:0044351,1,0.955374311980202,0,7,macropinocytosis,BP,
11607,GO:0044355,1,0.994586293802041,0,1,clearance of foreign intracellular DNA,BP,
11608,GO:0044356,1,0.994586293802041,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11612,GO:0044375,1,0.983898258529775,0,3,regulation of peroxisome size,BP,
11613,GO:0044378,1,0.985947378069438,0,2,non-sequence-specific DNA binding, bending,MF,
11614,GO:0044380,1,0.690696388629494,0,49,protein localization to cytoskeleton,BP,
11615,GO:0044381,1,0.859968295761305,0,21,glucose import in response to insulin stimulus,BP,
11616,GO:0044387,1,0.948417802083531,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11617,GO:0044388,1,0.972709681073578,0,5,small protein activating enzyme binding,MF,
11618,GO:0044389,1,0.135242882322745,0,305,ubiquitin-like protein ligase binding,MF,
11619,GO:0044390,1,0.761463833933448,0,39,ubiquitin-like protein conjugating enzyme binding,MF,
11620,GO:0044391,1,0.361910029661065,0,181,ribosomal subunit,CC,
11621,GO:0044393,1,0.981731522660603,0,3,microspike,CC,
11622,GO:0044396,1,0.966507823179785,0,5,actin cortical patch organization,BP,
11627,GO:0044413,1,0.972693084647571,0,4,avoidance of host defenses,BP,
11628,GO:0044414,1,0.992215682152264,0,1,suppression of host defenses,BP,
11629,GO:0044415,1,0.972693084647571,0,4,evasion or tolerance of host defenses,BP,
11630,GO:0044416,1,0.994420977895971,0,1,induction by symbiont of host defense response,BP,
11631,GO:0044417,1,0.948218778330173,0,9,translocation of molecules into host,BP,
11638,GO:0044427,1,0.00460913670701264,0,784,chromosomal part,CC,
11646,GO:0044438,1,0.574371278105699,0,89,microbody part,CC,
11647,GO:0044439,1,0.574371278105699,0,89,peroxisomal part,CC,
11651,GO:0044445,1,0.253110425831066,0,227,cytosolic part,CC,
11653,GO:0044447,1,0.763890279827088,0,29,axoneme part,CC,
11655,GO:0044449,1,0.221340617287933,0,196,contractile fiber part,CC,
11656,GO:0044450,1,0.323901049981469,0,159,microtubule organizing center part,CC,
11657,GO:0044451,1,0.000742502439996118,0,1030,nucleoplasm part,CC,
11658,GO:0044452,1,0.334540625451746,0,169,nucleolar part,CC,
11659,GO:0044453,1,0.912908820544874,0,15,nuclear membrane part,CC,
11660,GO:0044454,1,0.0386775404273363,0,479,nuclear chromosome part,CC,
11661,GO:0044455,1,0.370940719936504,0,170,mitochondrial membrane part,CC,
11663,GO:0044458,1,0.893774794811338,0,19,motile cilium assembly,BP,
11667,GO:0044467,1,0.988498408955292,0,2,glial cell-derived neurotrophic factor secretion,BP,
11668,GO:0044495,1,0.994649074016324,0,1,modulation of blood pressure in other organism,BP,
11669,GO:0044497,1,0.994649074016324,0,1,positive regulation of blood pressure in other organism,BP,
11670,GO:0044501,1,0.986147066416099,0,2,modulation of signal transduction in other organism,BP,
11671,GO:0044508,1,0.99398409306727,0,1,glucagon-like peptide 1 receptor activity,MF,
11672,GO:0044524,1,0.994535156464788,0,1,protein sulfhydration,BP,
11673,GO:0044528,1,0.976442891747168,0,4,regulation of mitochondrial mRNA stability,BP,
11674,GO:0044530,1,0.977656263762496,0,3,supraspliceosomal complex,CC,
11675,GO:0044531,1,0.963987932654882,0,6,modulation of programmed cell death in other organism,BP,
11676,GO:0044532,1,0.963987932654882,0,6,modulation of apoptotic process in other organism,BP,
11677,GO:0044533,1,0.981830815481985,0,3,positive regulation of apoptotic process in other organism,BP,
11678,GO:0044537,1,0.994527376974531,0,1,regulation of circulating fibrinogen levels,BP,
11679,GO:0044539,1,0.958987151244538,0,7,long-chain fatty acid import,BP,
11680,GO:0044540,1,0.994535156464788,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11681,GO:0044545,1,0.971576833966076,0,5,NSL complex,CC,
11682,GO:0044546,1,0.922262314680952,0,12,NLRP3 inflammasome complex assembly,BP,
11683,GO:0044547,1,0.96927774500869,0,5,DNA topoisomerase binding,MF,
11685,GO:0044549,1,0.994655087611488,0,1,GTP cyclohydrolase binding,MF,
11686,GO:0044550,1,0.856506768380617,0,22,secondary metabolite biosynthetic process,BP,
11687,GO:0044557,1,0.956045537166205,0,7,relaxation of smooth muscle,BP,
11688,GO:0044558,1,0.992405097966755,0,1,uterine smooth muscle relaxation,BP,
11689,GO:0044565,1,0.988683834868577,0,2,dendritic cell proliferation,BP,
11690,GO:0044571,1,0.978417346024628,0,4,[2Fe-2S] cluster assembly,BP,
11691,GO:0044594,1,0.994230895925626,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11692,GO:0044595,1,0.994609403508997,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11693,GO:0044596,1,0.994609403508997,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11694,GO:0044597,1,0.956747578721904,0,8,daunorubicin metabolic process,BP,
11695,GO:0044598,1,0.956747578721904,0,8,doxorubicin metabolic process,BP,
11696,GO:0044599,1,0.994184768585909,0,1,AP-5 adaptor complex,CC,
11697,GO:0044601,1,0.994553200123597,0,1,protein denucleotidylation,BP,
11698,GO:0044602,1,0.994553200123597,0,1,protein deadenylylation,BP,
11699,GO:0044603,1,0.994553200123597,0,1,protein adenylylhydrolase activity,MF,
11700,GO:0044609,1,0.988657240849429,0,2,DBIRD complex,CC,
11701,GO:0044610,1,0.99440059907078,0,1,FMN transmembrane transporter activity,MF,
11702,GO:0044611,1,0.976160026827144,0,3,nuclear pore inner ring,CC,
11703,GO:0044613,1,0.931299649915325,0,11,nuclear pore central transport channel,CC,
11704,GO:0044614,1,0.967269652651738,0,4,nuclear pore cytoplasmic filaments,CC,
11705,GO:0044615,1,0.931695632440245,0,8,nuclear pore nuclear basket,CC,
11706,GO:0044620,1,0.989344272260938,0,2,ACP phosphopantetheine attachment site binding,MF,
11707,GO:0044648,1,0.994184768585909,0,1,histone H3-K4 dimethylation,BP,
11708,GO:0044650,1,0.945380367714312,0,9,adhesion of symbiont to host cell,BP,
11709,GO:0044651,1,0.994607284390444,0,1,adhesion of symbiont to host epithelial cell,BP,
11710,GO:0044665,1,0.826362973847467,0,28,MLL1/2 complex,CC,
11711,GO:0044666,1,0.935263966015689,0,10,MLL3/4 complex,CC,
11715,GO:0044713,1,0.994654979429419,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11716,GO:0044714,1,0.994654979429419,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11717,GO:0044715,1,0.994615918015444,0,1,8-oxo-dGDP phosphatase activity,MF,
11718,GO:0044721,1,0.994495263886467,0,1,protein import into peroxisome matrix, substrate release,BP,
11719,GO:0044722,1,0.993423377024051,0,1,renal phosphate excretion,BP,
11720,GO:0044725,1,0.987084209388974,0,1,chromatin reprogramming in the zygote,BP,
11721,GO:0044727,1,0.987084209388974,0,1,DNA demethylation of male pronucleus,BP,
11722,GO:0044728,1,0.600191615254108,0,74,DNA methylation or demethylation,BP,
11723,GO:0044729,1,0.988080403165184,0,2,hemi-methylated DNA-binding,MF,
11725,GO:0044732,1,0.994184768585909,0,1,mitotic spindle pole body,CC,
11726,GO:0044736,1,0.982654556248871,0,3,acid-sensing ion channel activity,MF,
11727,GO:0044743,1,0.806944169375089,0,37,protein transmembrane import into intracellular organelle,BP,
11728,GO:0044752,1,0.982051228909213,0,3,response to human chorionic gonadotropin,BP,
11729,GO:0044753,1,0.982713486281718,0,2,amphisome,CC,
11730,GO:0044754,1,0.949245181965489,0,8,autolysosome,CC,
11732,GO:0044766,1,0.635430494898411,0,69,multi-organism transport,BP,
11733,GO:0044769,1,0.885939617794302,0,20,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11735,GO:0044771,1,0.988151823395855,0,2,meiotic cell cycle phase transition,BP,
11737,GO:0044773,1,0.516470105313197,0,100,mitotic DNA damage checkpoint,BP,
11738,GO:0044774,1,0.496618544267825,0,106,mitotic DNA integrity checkpoint,BP,
11739,GO:0044778,1,0.988773446381178,0,2,meiotic DNA integrity checkpoint,BP,
11740,GO:0044779,1,0.994045937555551,0,1,meiotic spindle checkpoint,BP,
11741,GO:0044782,1,0.0868762925200442,0,349,cilium organization,BP,
11742,GO:0044783,1,0.627718231809279,0,70,G1 DNA damage checkpoint,BP,
11743,GO:0044784,1,0.703471338409392,0,51,metaphase/anaphase transition of cell cycle,BP,
11744,GO:0044785,1,0.994045937555551,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11745,GO:0044786,1,0.686521807568876,0,57,cell cycle DNA replication,BP,
11747,GO:0044789,1,0.965451006312407,0,5,modulation by host of viral release from host cell,BP,
11748,GO:0044791,1,0.965451006312407,0,5,positive regulation by host of viral release from host cell,BP,
11750,GO:0044794,1,0.915982104736792,0,13,positive regulation by host of viral process,BP,
11751,GO:0044795,1,0.994621365262349,0,1,trans-Golgi network to recycling endosome transport,BP,
11752,GO:0044796,1,0.994600704273074,0,1,DNA polymerase processivity factor complex,CC,
11753,GO:0044798,1,0.307004950606294,0,175,nuclear transcription factor complex,CC,
11754,GO:0044800,1,0.965842853743896,0,6,multi-organism membrane fusion,BP,
11755,GO:0044803,1,0.958594405418665,0,7,multi-organism membrane organization,BP,
11756,GO:0044804,1,0.881852941530162,0,19,autophagy of nucleus,BP,
11757,GO:0044805,1,0.978912856736338,0,3,late nucleophagy,BP,
11758,GO:0044806,1,0.95239708566254,0,7,G-quadruplex DNA unwinding,BP,
11759,GO:0044815,1,0.724926144060987,0,54,DNA packaging complex,CC,
11760,GO:0044818,1,0.837458234452588,0,26,mitotic G2/M transition checkpoint,BP,
11761,GO:0044819,1,0.631664914204128,0,69,mitotic G1/S transition checkpoint,BP,
11762,GO:0044821,1,0.969218577709014,0,5,meiotic telomere tethering at nuclear periphery,BP,
11763,GO:0044827,1,0.91968933816767,0,12,modulation by host of viral genome replication,BP,
11764,GO:0044828,1,0.971426400134971,0,4,negative regulation by host of viral genome replication,BP,
11765,GO:0044829,1,0.950072244854478,0,7,positive regulation by host of viral genome replication,BP,
11766,GO:0044830,1,0.987150979146589,0,2,modulation by host of viral RNA genome replication,BP,
11767,GO:0044837,1,0.952721290363056,0,7,actomyosin contractile ring organization,BP,
11768,GO:0044839,1,0.189591185438187,0,252,cell cycle G2/M phase transition,BP,
11773,GO:0044853,1,0.515441543438212,0,93,plasma membrane raft,CC,
11774,GO:0044854,1,0.97733228920701,0,4,plasma membrane raft assembly,BP,
11775,GO:0044855,1,0.994209375483572,0,1,plasma membrane raft distribution,BP,
11776,GO:0044856,1,0.994209375483572,0,1,plasma membrane raft localization,BP,
11777,GO:0044857,1,0.97733228920701,0,4,plasma membrane raft organization,BP,
11778,GO:0044858,1,0.994209375483572,0,1,plasma membrane raft polarization,BP,
11779,GO:0044860,1,0.974851612650401,0,4,protein localization to plasma membrane raft,BP,
11780,GO:0044861,1,0.986165664732778,0,2,protein transport into plasma membrane raft,BP,
11787,GO:0044872,1,0.883512975815367,0,13,lipoprotein localization,BP,
11789,GO:0044878,1,0.97813006306672,0,4,mitotic cytokinesis checkpoint,BP,
11790,GO:0045002,1,0.965424085031284,0,6,double-strand break repair via single-strand annealing,BP,
11791,GO:0045003,1,0.944156035074767,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11792,GO:0045004,1,0.983551133638217,0,2,DNA replication proofreading,BP,
11793,GO:0045005,1,0.79695850545223,0,33,DNA-dependent DNA replication maintenance of fidelity,BP,
11794,GO:0045006,1,0.935285424763339,0,12,DNA deamination,BP,
11795,GO:0045007,1,0.983729280821282,0,3,depurination,BP,
11796,GO:0045008,1,0.956189749076889,0,8,depyrimidination,BP,
11797,GO:0045009,1,0.939994745178766,0,11,chitosome,CC,
11798,GO:0045010,1,0.745838333315979,0,45,actin nucleation,BP,
11799,GO:0045016,1,0.99383635409174,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11801,GO:0045019,1,0.923534807603918,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11802,GO:0045022,1,0.773878430153977,0,37,early endosome to late endosome transport,BP,
11803,GO:0045023,1,0.741220295130256,0,42,G0 to G1 transition,BP,
11804,GO:0045025,1,0.9871463210892,0,2,mitochondrial degradosome,CC,
11805,GO:0045026,1,0.846875770131361,0,28,plasma membrane fusion,BP,
11806,GO:0045027,1,0.99445047044479,0,1,DNA end binding,MF,
11807,GO:0045028,1,0.933760455831869,0,12,G-protein coupled purinergic nucleotide receptor activity,MF,
11808,GO:0045029,1,0.988844153477719,0,2,UDP-activated nucleotide receptor activity,MF,
11809,GO:0045030,1,0.994555699424682,0,1,UTP-activated nucleotide receptor activity,MF,
11810,GO:0045031,1,0.988519598869574,0,2,ATP-activated adenosine receptor activity,MF,
11811,GO:0045032,1,0.994002024083546,0,1,ADP-activated adenosine receptor activity,MF,
11812,GO:0045039,1,0.967533509379271,0,6,protein import into mitochondrial inner membrane,BP,
11813,GO:0045040,1,0.966343865148776,0,6,protein import into mitochondrial outer membrane,BP,
11814,GO:0045041,1,0.988989068805849,0,2,protein import into mitochondrial intermembrane space,BP,
11815,GO:0045046,1,0.963640468893656,0,6,protein import into peroxisome membrane,BP,
11816,GO:0045047,1,0.572536062732079,0,100,protein targeting to ER,BP,
11817,GO:0045048,1,0.96848048795826,0,5,protein insertion into ER membrane,BP,
11818,GO:0045053,1,0.939177162072124,0,5,protein retention in Golgi apparatus,BP,
11819,GO:0045054,1,0.976947703284678,0,4,constitutive secretory pathway,BP,
11821,GO:0045056,1,0.899444739269662,0,15,transcytosis,BP,
11822,GO:0045058,1,0.757154722657744,0,42,T cell selection,BP,
11823,GO:0045059,1,0.943864986149849,0,9,positive thymic T cell selection,BP,
11824,GO:0045060,1,0.937101030501137,0,10,negative thymic T cell selection,BP,
11825,GO:0045061,1,0.888359686017049,0,18,thymic T cell selection,BP,
11826,GO:0045062,1,0.994542069402828,0,1,extrathymic T cell selection,BP,
11829,GO:0045065,1,0.982435498972306,0,3,cytotoxic T cell differentiation,BP,
11830,GO:0045066,1,0.849576339646429,0,26,regulatory T cell differentiation,BP,
11832,GO:0045070,1,0.799698805178761,0,32,positive regulation of viral genome replication,BP,
11834,GO:0045072,1,0.919108694020232,0,14,regulation of interferon-gamma biosynthetic process,BP,
11835,GO:0045073,1,0.937830222256506,0,11,regulation of chemokine biosynthetic process,BP,
11836,GO:0045074,1,0.980384902529235,0,3,regulation of interleukin-10 biosynthetic process,BP,
11837,GO:0045075,1,0.954534050441612,0,7,regulation of interleukin-12 biosynthetic process,BP,
11838,GO:0045076,1,0.902159053428684,0,17,regulation of interleukin-2 biosynthetic process,BP,
11839,GO:0045077,1,0.977726027195081,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
11840,GO:0045078,1,0.94006038499298,0,10,positive regulation of interferon-gamma biosynthetic process,BP,
11841,GO:0045079,1,0.983895217170707,0,3,negative regulation of chemokine biosynthetic process,BP,
11842,GO:0045080,1,0.953188424127416,0,8,positive regulation of chemokine biosynthetic process,BP,
11843,GO:0045081,1,0.993632382922634,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11844,GO:0045082,1,0.986668470122018,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
11845,GO:0045083,1,0.993231215619269,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11846,GO:0045084,1,0.969094453771559,0,5,positive regulation of interleukin-12 biosynthetic process,BP,
11847,GO:0045085,1,0.978178186245374,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
11848,GO:0045086,1,0.927421473421068,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
11852,GO:0045091,1,0.936448133280125,0,11,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11853,GO:0045092,1,0.993643742691423,0,1,interleukin-18 receptor complex,CC,
11854,GO:0045095,1,0.889575243869578,0,20,keratin filament,CC,
11855,GO:0045098,1,0.983505899810285,0,3,type III intermediate filament,CC,
11858,GO:0045105,1,0.991890396883822,0,1,intermediate filament polymerization or depolymerization,BP,
11859,GO:0045106,1,0.991890396883822,0,1,intermediate filament depolymerization,BP,
11860,GO:0045108,1,0.991890396883822,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11862,GO:0045110,1,0.967664727549996,0,5,intermediate filament bundle assembly,BP,
11864,GO:0045112,1,0.965129100408169,0,5,integrin biosynthetic process,BP,
11865,GO:0045113,1,0.975672680375062,0,4,regulation of integrin biosynthetic process,BP,
11866,GO:0045116,1,0.9157127777279,0,14,protein neddylation,BP,
11867,GO:0045117,1,0.893898007800038,0,19,azole transport,BP,
11868,GO:0045120,1,0.915282255997548,0,12,pronucleus,CC,
11872,GO:0045125,1,0.917148781587995,0,15,bioactive lipid receptor activity,MF,
11873,GO:0045127,1,0.994565669571382,0,1,N-acetylglucosamine kinase activity,MF,
11874,GO:0045128,1,0.993967200336064,0,1,negative regulation of reciprocal meiotic recombination,BP,
11875,GO:0045130,1,0.994218416653593,0,1,keratan sulfotransferase activity,MF,
11876,GO:0045131,1,0.994075087520282,0,1,pre-mRNA branch point binding,MF,
11877,GO:0045132,1,0.632462167581454,0,70,meiotic chromosome segregation,BP,
11878,GO:0045134,1,0.976719421568362,0,4,uridine-diphosphatase activity,MF,
11879,GO:0045136,1,0.940632945375816,0,9,development of secondary sexual characteristics,BP,
11881,GO:0045141,1,0.933815531432566,0,10,meiotic telomere clustering,BP,
11882,GO:0045142,1,0.986176316832046,0,2,triplex DNA binding,MF,
11883,GO:0045143,1,0.741776602300622,0,46,homologous chromosome segregation,BP,
11884,GO:0045144,1,0.960019028784165,0,7,meiotic sister chromatid segregation,BP,
11885,GO:0045145,1,0.98815709698939,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11886,GO:0045153,1,0.994615592575856,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11887,GO:0045155,1,0.986597393678282,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11888,GO:0045159,1,0.96531303140827,0,6,myosin II binding,MF,
11890,GO:0045162,1,0.943346730902534,0,7,clustering of voltage-gated sodium channels,BP,
11893,GO:0045167,1,0.994541302795038,0,1,asymmetric protein localization involved in cell fate determination,BP,
11894,GO:0045168,1,0.988477827019839,0,2,cell-cell signaling involved in cell fate commitment,BP,
11895,GO:0045171,1,0.708513789689738,0,54,intercellular bridge,CC,
11896,GO:0045174,1,0.989258493826838,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11897,GO:0045176,1,0.911231788577167,0,11,apical protein localization,BP,
11899,GO:0045178,1,0.688533963911598,0,49,basal part of cell,CC,
11900,GO:0045179,1,0.954763665011232,0,7,apical cortex,CC,
11901,GO:0045180,1,0.956520035937836,0,5,basal cortex,CC,
11903,GO:0045183,1,0.994184768585909,0,1,translation factor activity, non-nucleic acid binding,MF,
11905,GO:0045185,1,0.476575172327072,0,102,maintenance of protein location,BP,
11906,GO:0045186,1,0.990081447331442,0,1,zonula adherens assembly,BP,
11907,GO:0045187,1,0.909307929249102,0,16,regulation of circadian sleep/wake cycle, sleep,BP,
11908,GO:0045188,1,0.958536329067987,0,7,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11909,GO:0045190,1,0.777208933921275,0,39,isotype switching,BP,
11910,GO:0045191,1,0.838719775620843,0,27,regulation of isotype switching,BP,
11911,GO:0045196,1,0.978514471625395,0,3,establishment or maintenance of neuroblast polarity,BP,
11912,GO:0045197,1,0.749622570629166,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11913,GO:0045198,1,0.915606298265038,0,13,establishment of epithelial cell apical/basal polarity,BP,
11914,GO:0045199,1,0.923546499956443,0,12,maintenance of epithelial cell apical/basal polarity,BP,
11915,GO:0045200,1,0.978514471625395,0,3,establishment of neuroblast polarity,BP,
11917,GO:0045204,1,0.97902366349026,0,3,MAPK export from nucleus,BP,
11918,GO:0045208,1,0.993671734955949,0,1,MAPK phosphatase export from nucleus,BP,
11919,GO:0045209,1,0.993671734955949,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11920,GO:0045210,1,0.983611085748488,0,2,FasL biosynthetic process,BP,
11922,GO:0045212,1,0.994281482279886,0,1,neurotransmitter receptor biosynthetic process,BP,
11923,GO:0045213,1,0.983296149165067,0,3,neurotransmitter receptor metabolic process,BP,
11924,GO:0045214,1,0.714914584998306,0,43,sarcomere organization,BP,
11926,GO:0045217,1,0.939559084436101,0,10,cell-cell junction maintenance,BP,
11927,GO:0045218,1,0.980704916571539,0,3,zonula adherens maintenance,BP,
11928,GO:0045219,1,0.991989151471223,0,1,regulation of FasL biosynthetic process,BP,
11929,GO:0045221,1,0.991989151471223,0,1,negative regulation of FasL biosynthetic process,BP,
11930,GO:0045222,1,0.994621162425816,0,1,CD4 biosynthetic process,BP,
11931,GO:0045223,1,0.994621162425816,0,1,regulation of CD4 biosynthetic process,BP,
11932,GO:0045225,1,0.994621162425816,0,1,negative regulation of CD4 biosynthetic process,BP,
11933,GO:0045226,1,0.982675056898366,0,3,extracellular polysaccharide biosynthetic process,BP,
11934,GO:0045229,1,0.988451920485171,0,2,external encapsulating structure organization,BP,
11935,GO:0045234,1,0.994526758207341,0,1,protein palmitoleylation,BP,
11937,GO:0045239,1,0.917878531630444,0,13,tricarboxylic acid cycle enzyme complex,CC,
11938,GO:0045240,1,0.928165110154347,0,11,dihydrolipoyl dehydrogenase complex,CC,
11939,GO:0045244,1,0.994369480992414,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11940,GO:0045251,1,0.994370192855279,0,1,electron transfer flavoprotein complex,CC,
11941,GO:0045252,1,0.956145262047827,0,7,oxoglutarate dehydrogenase complex,CC,
11942,GO:0045254,1,0.957280647207865,0,7,pyruvate dehydrogenase complex,CC,
11943,GO:0045257,1,0.977974226500333,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11944,GO:0045259,1,0.989045657656934,0,2,proton-transporting ATP synthase complex,CC,
11945,GO:0045263,1,0.994593282608679,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11946,GO:0045271,1,0.789834625050682,0,43,respiratory chain complex I,CC,
11947,GO:0045272,1,0.983161907230002,0,3,plasma membrane respiratory chain complex I,CC,
11948,GO:0045273,1,0.977974226500333,0,4,respiratory chain complex II,CC,
11949,GO:0045274,1,0.994354603133905,0,1,plasma membrane respiratory chain complex II,CC,
11950,GO:0045275,1,0.939033580546447,0,11,respiratory chain complex III,CC,
11951,GO:0045277,1,0.927559396818442,0,14,respiratory chain complex IV,CC,
11952,GO:0045281,1,0.977974226500333,0,4,succinate dehydrogenase complex,CC,
11953,GO:0045282,1,0.994354603133905,0,1,plasma membrane succinate dehydrogenase complex,CC,
11954,GO:0045283,1,0.977974226500333,0,4,fumarate reductase complex,CC,
11955,GO:0045292,1,0.901050818045689,0,17,mRNA cis splicing, via spliceosome,BP,
11956,GO:0045293,1,0.98356393780636,0,3,mRNA editing complex,CC,
11960,GO:0045297,1,0.994401745018416,0,1,post-mating behavior,BP,
11961,GO:0045298,1,0.964469084154715,0,5,tubulin complex,CC,
11964,GO:0045322,1,0.98181137052294,0,3,unmethylated CpG binding,MF,
11965,GO:0045323,1,0.982016670023162,0,3,interleukin-1 receptor complex,CC,
11966,GO:0045324,1,0.935413330315724,0,11,late endosome to vacuole transport,BP,
11967,GO:0045329,1,0.971878358443334,0,5,carnitine biosynthetic process,BP,
11968,GO:0045332,1,0.8213589603496,0,23,phospholipid translocation,BP,
11969,GO:0045333,1,0.379602830469701,0,162,cellular respiration,BP,
11972,GO:0045337,1,0.977035411789323,0,4,farnesyl diphosphate biosynthetic process,BP,
11973,GO:0045338,1,0.971610137571865,0,5,farnesyl diphosphate metabolic process,BP,
11974,GO:0045340,1,0.994640893629188,0,1,mercury ion binding,MF,
11975,GO:0045341,1,0.965468395100456,0,5,MHC class I biosynthetic process,BP,
11976,GO:0045342,1,0.931156423335613,0,11,MHC class II biosynthetic process,BP,
11977,GO:0045343,1,0.965468395100456,0,5,regulation of MHC class I biosynthetic process,BP,
11978,GO:0045345,1,0.965468395100456,0,5,positive regulation of MHC class I biosynthetic process,BP,
11979,GO:0045346,1,0.937313018435729,0,10,regulation of MHC class II biosynthetic process,BP,
11980,GO:0045347,1,0.968744600867928,0,5,negative regulation of MHC class II biosynthetic process,BP,
11981,GO:0045348,1,0.962296029988868,0,6,positive regulation of MHC class II biosynthetic process,BP,
11982,GO:0045349,1,0.962756428330164,0,6,interferon-alpha biosynthetic process,BP,
11983,GO:0045350,1,0.943712875600005,0,9,interferon-beta biosynthetic process,BP,
11984,GO:0045351,1,0.933391976078548,0,11,type I interferon biosynthetic process,BP,
11985,GO:0045352,1,0.99452758282143,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11986,GO:0045353,1,0.99452758282143,0,1,interleukin-1 Type II receptor antagonist activity,MF,
11987,GO:0045354,1,0.962756428330164,0,6,regulation of interferon-alpha biosynthetic process,BP,
11988,GO:0045355,1,0.989166672972844,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11989,GO:0045356,1,0.973303381854237,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
11990,GO:0045357,1,0.943712875600005,0,9,regulation of interferon-beta biosynthetic process,BP,
11991,GO:0045358,1,0.989168934575699,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11992,GO:0045359,1,0.954051103761671,0,7,positive regulation of interferon-beta biosynthetic process,BP,
11993,GO:0045360,1,0.983364068808023,0,3,regulation of interleukin-1 biosynthetic process,BP,
11994,GO:0045362,1,0.983364068808023,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
11995,GO:0045366,1,0.992116276737533,0,1,regulation of interleukin-13 biosynthetic process,BP,
11996,GO:0045368,1,0.992116276737533,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
11997,GO:0045381,1,0.993911760867851,0,1,regulation of interleukin-18 biosynthetic process,BP,
11998,GO:0045399,1,0.992383027571753,0,1,regulation of interleukin-3 biosynthetic process,BP,
11999,GO:0045401,1,0.992383027571753,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
12000,GO:0045402,1,0.980370361602395,0,3,regulation of interleukin-4 biosynthetic process,BP,
12001,GO:0045403,1,0.993907666384269,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12002,GO:0045404,1,0.986380542623994,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12003,GO:0045408,1,0.922372452142724,0,13,regulation of interleukin-6 biosynthetic process,BP,
12004,GO:0045409,1,0.975600367373597,0,4,negative regulation of interleukin-6 biosynthetic process,BP,
12005,GO:0045410,1,0.955945178864856,0,7,positive regulation of interleukin-6 biosynthetic process,BP,
12006,GO:0045414,1,0.944918739621207,0,9,regulation of interleukin-8 biosynthetic process,BP,
12007,GO:0045415,1,0.977807984202256,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12008,GO:0045416,1,0.96119186721492,0,6,positive regulation of interleukin-8 biosynthetic process,BP,
12009,GO:0045423,1,0.986625474383476,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12010,GO:0045425,1,0.986625474383476,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12013,GO:0045444,1,0.275556452989268,0,193,fat cell differentiation,BP,
12016,GO:0045448,1,0.976249278016842,0,4,mitotic cell cycle, embryonic,BP,
12018,GO:0045454,1,0.68583509542817,0,63,cell redox homeostasis,BP,
12020,GO:0045472,1,0.932204662911181,0,10,response to ether,BP,
12021,GO:0045475,1,0.926977381501199,0,10,locomotor rhythm,BP,
12022,GO:0045485,1,0.992948804803441,0,1,omega-6 fatty acid desaturase activity,MF,
12024,GO:0045495,1,0.914806591493227,0,14,pole plasm,CC,
12025,GO:0045499,1,0.860041940600926,0,21,chemorepellent activity,MF,
12026,GO:0045503,1,0.767865149126868,0,24,dynein light chain binding,MF,
12027,GO:0045504,1,0.915919670790389,0,14,dynein heavy chain binding,MF,
12028,GO:0045505,1,0.737278031241999,0,28,dynein intermediate chain binding,MF,
12029,GO:0045509,1,0.987869982209366,0,2,interleukin-27 receptor activity,MF,
12030,GO:0045513,1,0.994587153829369,0,1,interleukin-27 binding,MF,
12031,GO:0045519,1,0.994632259758038,0,1,interleukin-23 receptor binding,MF,
12032,GO:0045523,1,0.989284524620793,0,2,interleukin-27 receptor binding,MF,
12033,GO:0045540,1,0.753758991330565,0,41,regulation of cholesterol biosynthetic process,BP,
12034,GO:0045541,1,0.971062608422538,0,5,negative regulation of cholesterol biosynthetic process,BP,
12035,GO:0045542,1,0.96704961336862,0,5,positive regulation of cholesterol biosynthetic process,BP,
12036,GO:0045545,1,0.954100520223581,0,6,syndecan binding,MF,
12037,GO:0045550,1,0.989204734704115,0,2,geranylgeranyl reductase activity,MF,
12038,GO:0045553,1,0.994048983315089,0,1,TRAIL biosynthetic process,BP,
12039,GO:0045554,1,0.994048983315089,0,1,regulation of TRAIL biosynthetic process,BP,
12040,GO:0045556,1,0.994048983315089,0,1,positive regulation of TRAIL biosynthetic process,BP,
12041,GO:0045569,1,0.976293508533821,0,4,TRAIL binding,MF,
12042,GO:0045575,1,0.987640353554567,0,2,basophil activation,BP,
12045,GO:0045578,1,0.970557656947838,0,5,negative regulation of B cell differentiation,BP,
12050,GO:0045583,1,0.988220132733468,0,2,regulation of cytotoxic T cell differentiation,BP,
12051,GO:0045585,1,0.988220132733468,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12052,GO:0045586,1,0.971638959201469,0,4,regulation of gamma-delta T cell differentiation,BP,
12053,GO:0045588,1,0.978243723573361,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12054,GO:0045589,1,0.859348855519012,0,24,regulation of regulatory T cell differentiation,BP,
12055,GO:0045590,1,0.982014644410795,0,3,negative regulation of regulatory T cell differentiation,BP,
12056,GO:0045591,1,0.944521984900752,0,10,positive regulation of regulatory T cell differentiation,BP,
12060,GO:0045598,1,0.478417465385608,0,111,regulation of fat cell differentiation,BP,
12061,GO:0045599,1,0.746105349791261,0,43,negative regulation of fat cell differentiation,BP,
12062,GO:0045600,1,0.706005448936622,0,54,positive regulation of fat cell differentiation,BP,
12063,GO:0045601,1,0.809492314376249,0,30,regulation of endothelial cell differentiation,BP,
12064,GO:0045602,1,0.939892037598921,0,8,negative regulation of endothelial cell differentiation,BP,
12065,GO:0045603,1,0.903780363581605,0,15,positive regulation of endothelial cell differentiation,BP,
12068,GO:0045606,1,0.868679053249245,0,20,positive regulation of epidermal cell differentiation,BP,
12069,GO:0045607,1,0.955090399082362,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
12070,GO:0045608,1,0.977087479648038,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
12073,GO:0045618,1,0.903497271433669,0,14,positive regulation of keratinocyte differentiation,BP,
12081,GO:0045626,1,0.980207221017241,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12085,GO:0045630,1,0.959029179674674,0,7,positive regulation of T-helper 2 cell differentiation,BP,
12086,GO:0045631,1,0.955090399082362,0,7,regulation of mechanoreceptor differentiation,BP,
12087,GO:0045632,1,0.971814870093555,0,4,negative regulation of mechanoreceptor differentiation,BP,
12088,GO:0045634,1,0.946259809268818,0,7,regulation of melanocyte differentiation,BP,
12089,GO:0045636,1,0.956765165976625,0,5,positive regulation of melanocyte differentiation,BP,
12092,GO:0045639,1,0.61449270036976,0,74,positive regulation of myeloid cell differentiation,BP,
12093,GO:0045643,1,0.993624914366704,0,1,regulation of eosinophil differentiation,BP,
12094,GO:0045645,1,0.993624914366704,0,1,positive regulation of eosinophil differentiation,BP,
12095,GO:0045646,1,0.754797461497517,0,42,regulation of erythrocyte differentiation,BP,
12096,GO:0045647,1,0.949751604901338,0,8,negative regulation of erythrocyte differentiation,BP,
12097,GO:0045648,1,0.833605325195266,0,27,positive regulation of erythrocyte differentiation,BP,
12098,GO:0045649,1,0.887881300001927,0,19,regulation of macrophage differentiation,BP,
12099,GO:0045650,1,0.965488375576732,0,6,negative regulation of macrophage differentiation,BP,
12100,GO:0045651,1,0.919645922722889,0,13,positive regulation of macrophage differentiation,BP,
12101,GO:0045652,1,0.698322163732762,0,54,regulation of megakaryocyte differentiation,BP,
12102,GO:0045653,1,0.955683707490501,0,8,negative regulation of megakaryocyte differentiation,BP,
12103,GO:0045654,1,0.966430028564237,0,6,positive regulation of megakaryocyte differentiation,BP,
12106,GO:0045657,1,0.953020758520802,0,8,positive regulation of monocyte differentiation,BP,
12107,GO:0045658,1,0.980780984783913,0,3,regulation of neutrophil differentiation,BP,
12108,GO:0045659,1,0.986226136733404,0,2,negative regulation of neutrophil differentiation,BP,
12109,GO:0045660,1,0.994479563707462,0,1,positive regulation of neutrophil differentiation,BP,
12112,GO:0045663,1,0.887693128710194,0,17,positive regulation of myoblast differentiation,BP,
12117,GO:0045668,1,0.76514698814917,0,38,negative regulation of osteoblast differentiation,BP,
12121,GO:0045672,1,0.89366007701589,0,17,positive regulation of osteoclast differentiation,BP,
12124,GO:0045684,1,0.808289044400879,0,32,positive regulation of epidermis development,BP,
12125,GO:0045685,1,0.669647313878298,0,61,regulation of glial cell differentiation,BP,
12126,GO:0045686,1,0.869252774271108,0,21,negative regulation of glial cell differentiation,BP,
12127,GO:0045687,1,0.787191194483542,0,37,positive regulation of glial cell differentiation,BP,
12128,GO:0045703,1,0.994613946734573,0,1,ketoreductase activity,MF,
12129,GO:0045713,1,0.944989576887609,0,8,low-density lipoprotein particle receptor biosynthetic process,BP,
12130,GO:0045714,1,0.950207493272482,0,7,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12131,GO:0045715,1,0.983165693972715,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12132,GO:0045716,1,0.981897354970326,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12133,GO:0045717,1,0.921740203940041,0,13,negative regulation of fatty acid biosynthetic process,BP,
12134,GO:0045719,1,0.962323406937456,0,5,negative regulation of glycogen biosynthetic process,BP,
12135,GO:0045720,1,0.98859285446427,0,2,negative regulation of integrin biosynthetic process,BP,
12136,GO:0045721,1,0.946387682696174,0,9,negative regulation of gluconeogenesis,BP,
12137,GO:0045722,1,0.934422159877828,0,9,positive regulation of gluconeogenesis,BP,
12139,GO:0045724,1,0.877510208690236,0,18,positive regulation of cilium assembly,BP,
12140,GO:0045725,1,0.897930443031087,0,13,positive regulation of glycogen biosynthetic process,BP,
12141,GO:0045726,1,0.986314452830635,0,2,positive regulation of integrin biosynthetic process,BP,
12143,GO:0045728,1,0.994433705021114,0,1,respiratory burst after phagocytosis,BP,
12144,GO:0045730,1,0.86537187748283,0,23,respiratory burst,BP,
12145,GO:0045732,1,0.261969952745271,0,198,positive regulation of protein catabolic process,BP,
12146,GO:0045736,1,0.81301428994683,0,30,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12147,GO:0045737,1,0.817102998667344,0,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12148,GO:0045738,1,0.854126832611941,0,22,negative regulation of DNA repair,BP,
12149,GO:0045739,1,0.76385789934266,0,42,positive regulation of DNA repair,BP,
12150,GO:0045740,1,0.710387289737435,0,51,positive regulation of DNA replication,BP,
12151,GO:0045741,1,0.938197548421077,0,10,positive regulation of epidermal growth factor-activated receptor activity,BP,
12152,GO:0045742,1,0.810237683162473,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12153,GO:0045743,1,0.966574162160473,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12155,GO:0045745,1,0.834190166651599,0,27,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
12157,GO:0045747,1,0.727496801080125,0,44,positive regulation of Notch signaling pathway,BP,
12158,GO:0045751,1,0.993911760867851,0,1,negative regulation of Toll signaling pathway,BP,
12159,GO:0045759,1,0.961646878364068,0,6,negative regulation of action potential,BP,
12160,GO:0045760,1,0.929075838135615,0,10,positive regulation of action potential,BP,
12161,GO:0045761,1,0.8264884463397,0,29,regulation of adenylate cyclase activity,BP,
12162,GO:0045762,1,0.963619032682581,0,5,positive regulation of adenylate cyclase activity,BP,
12163,GO:0045763,1,0.981362298107075,0,2,negative regulation of cellular amino acid metabolic process,BP,
12164,GO:0045764,1,0.983566597511839,0,3,positive regulation of cellular amino acid metabolic process,BP,
12167,GO:0045769,1,0.987144917583477,0,1,negative regulation of asymmetric cell division,BP,
12169,GO:0045776,1,0.793228740454585,0,36,negative regulation of blood pressure,BP,
12170,GO:0045777,1,0.823243273844836,0,31,positive regulation of blood pressure,BP,
12172,GO:0045779,1,0.94404382634386,0,9,negative regulation of bone resorption,BP,
12175,GO:0045786,1,0.0224840748250115,0,570,negative regulation of cell cycle,BP,
12177,GO:0045792,1,0.936584744789196,0,9,negative regulation of cell size,BP,
12178,GO:0045793,1,0.934305724323859,0,10,positive regulation of cell size,BP,
12179,GO:0045794,1,0.96207395637629,0,5,negative regulation of cell volume,BP,
12180,GO:0045795,1,0.990649368370044,0,1,positive regulation of cell volume,BP,
12181,GO:0045796,1,0.994239849298598,0,1,negative regulation of intestinal cholesterol absorption,BP,
12182,GO:0045799,1,0.975276959520775,0,3,positive regulation of chromatin assembly or disassembly,BP,
12185,GO:0045813,1,0.994523216867324,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12186,GO:0045814,1,0.54540066521362,0,90,negative regulation of gene expression, epigenetic,BP,
12187,GO:0045815,1,0.685106597864448,0,57,positive regulation of gene expression, epigenetic,BP,
12188,GO:0045819,1,0.993374643061405,0,1,positive regulation of glycogen catabolic process,BP,
12189,GO:0045820,1,0.928534455648419,0,10,negative regulation of glycolytic process,BP,
12190,GO:0045821,1,0.889589758779159,0,16,positive regulation of glycolytic process,BP,
12191,GO:0045822,1,0.877188251761482,0,19,negative regulation of heart contraction,BP,
12194,GO:0045827,1,0.994613946734573,0,1,negative regulation of isoprenoid metabolic process,BP,
12195,GO:0045829,1,0.976374101097332,0,4,negative regulation of isotype switching,BP,
12196,GO:0045830,1,0.88227262314823,0,19,positive regulation of isotype switching,BP,
12197,GO:0045833,1,0.662576717093966,0,66,negative regulation of lipid metabolic process,BP,
12199,GO:0045835,1,0.946429785040601,0,9,negative regulation of meiotic nuclear division,BP,
12200,GO:0045836,1,0.931680125507544,0,11,positive regulation of meiotic nuclear division,BP,
12201,GO:0045837,1,0.948031652911793,0,9,negative regulation of membrane potential,BP,
12202,GO:0045838,1,0.930034191286907,0,11,positive regulation of membrane potential,BP,
12203,GO:0045839,1,0.729615080100115,0,46,negative regulation of mitotic nuclear division,BP,
12204,GO:0045840,1,0.726220703785473,0,45,positive regulation of mitotic nuclear division,BP,
12205,GO:0045841,1,0.80309943470983,0,32,negative regulation of mitotic metaphase/anaphase transition,BP,
12206,GO:0045842,1,0.947280867880651,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
12207,GO:0045843,1,0.757454310681542,0,42,negative regulation of striated muscle tissue development,BP,
12208,GO:0045844,1,0.652303615620634,0,60,positive regulation of striated muscle tissue development,BP,
12209,GO:0045848,1,0.994436661814452,0,1,positive regulation of nitrogen utilization,BP,
12210,GO:0045851,1,0.742610118262694,0,48,pH reduction,BP,
12211,GO:0045852,1,0.973779597432299,0,4,pH elevation,BP,
12216,GO:0045869,1,0.949788615789237,0,9,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12217,GO:0045870,1,0.991729057835543,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12218,GO:0045872,1,0.994484824086778,0,1,positive regulation of rhodopsin gene expression,BP,
12219,GO:0045875,1,0.961231066108284,0,4,negative regulation of sister chromatid cohesion,BP,
12220,GO:0045876,1,0.945016677507492,0,8,positive regulation of sister chromatid cohesion,BP,
12221,GO:0045879,1,0.815773193006605,0,29,negative regulation of smoothened signaling pathway,BP,
12222,GO:0045880,1,0.819852949405363,0,29,positive regulation of smoothened signaling pathway,BP,
12223,GO:0045887,1,0.990220929766105,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12226,GO:0045898,1,0.911568999048561,0,14,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12227,GO:0045899,1,0.929267070020875,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12228,GO:0045900,1,0.972854542116786,0,4,negative regulation of translational elongation,BP,
12229,GO:0045901,1,0.974295577145852,0,4,positive regulation of translational elongation,BP,
12230,GO:0045903,1,0.983826206152277,0,3,positive regulation of translational fidelity,BP,
12231,GO:0045905,1,0.980104354032603,0,3,positive regulation of translational termination,BP,
12233,GO:0045907,1,0.854653277575109,0,26,positive regulation of vasoconstriction,BP,
12234,GO:0045910,1,0.853773278610313,0,23,negative regulation of DNA recombination,BP,
12235,GO:0045911,1,0.858720317415219,0,23,positive regulation of DNA recombination,BP,
12236,GO:0045912,1,0.802737604152708,0,32,negative regulation of carbohydrate metabolic process,BP,
12237,GO:0045913,1,0.655747705611736,0,59,positive regulation of carbohydrate metabolic process,BP,
12238,GO:0045914,1,0.981109433107862,0,3,negative regulation of catecholamine metabolic process,BP,
12239,GO:0045915,1,0.964489880951195,0,6,positive regulation of catecholamine metabolic process,BP,
12241,GO:0045917,1,0.98054074269736,0,3,positive regulation of complement activation,BP,
12242,GO:0045918,1,0.982615353407302,0,3,negative regulation of cytolysis,BP,
12243,GO:0045919,1,0.961472385647065,0,7,positive regulation of cytolysis,BP,
12246,GO:0045922,1,0.883275318217631,0,19,negative regulation of fatty acid metabolic process,BP,
12248,GO:0045924,1,0.966993648424478,0,5,regulation of female receptivity,BP,
12249,GO:0045925,1,0.994345827435354,0,1,positive regulation of female receptivity,BP,
12252,GO:0045930,1,0.16154098550306,0,281,negative regulation of mitotic cell cycle,BP,
12254,GO:0045932,1,0.878644267035466,0,19,negative regulation of muscle contraction,BP,
12255,GO:0045933,1,0.759996182820185,0,44,positive regulation of muscle contraction,BP,
12260,GO:0045938,1,0.966917890780062,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12261,GO:0045939,1,0.87804088907481,0,22,negative regulation of steroid metabolic process,BP,
12262,GO:0045940,1,0.889943648582741,0,19,positive regulation of steroid metabolic process,BP,
12263,GO:0045943,1,0.863035654835925,0,21,positive regulation of transcription by RNA polymerase I,BP,
12265,GO:0045945,1,0.923153306262573,0,11,positive regulation of transcription by RNA polymerase III,BP,
12266,GO:0045947,1,0.878834177297464,0,19,negative regulation of translational initiation,BP,
12267,GO:0045948,1,0.842604284123129,0,26,positive regulation of translational initiation,BP,
12268,GO:0045950,1,0.982954443753226,0,3,negative regulation of mitotic recombination,BP,
12269,GO:0045953,1,0.943928338224165,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12270,GO:0045954,1,0.887530181319612,0,19,positive regulation of natural killer cell mediated cytotoxicity,BP,
12271,GO:0045955,1,0.939082765305746,0,9,negative regulation of calcium ion-dependent exocytosis,BP,
12273,GO:0045957,1,0.988473912080574,0,1,negative regulation of complement activation, alternative pathway,BP,
12274,GO:0045959,1,0.982946106273393,0,2,negative regulation of complement activation, classical pathway,BP,
12275,GO:0045963,1,0.981109433107862,0,3,negative regulation of dopamine metabolic process,BP,
12276,GO:0045964,1,0.964489880951195,0,6,positive regulation of dopamine metabolic process,BP,
12277,GO:0045967,1,0.975333154815187,0,2,negative regulation of growth rate,BP,
12278,GO:0045974,1,0.90288237376073,0,13,regulation of translation, ncRNA-mediated,BP,
12279,GO:0045976,1,0.987212062098174,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12280,GO:0045977,1,0.994585137910175,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12281,GO:0045980,1,0.739662228459188,0,46,negative regulation of nucleotide metabolic process,BP,
12283,GO:0045986,1,0.921982609996262,0,12,negative regulation of smooth muscle contraction,BP,
12284,GO:0045987,1,0.826694453757063,0,30,positive regulation of smooth muscle contraction,BP,
12285,GO:0045988,1,0.952572247151707,0,7,negative regulation of striated muscle contraction,BP,
12286,GO:0045989,1,0.91938027462769,0,14,positive regulation of striated muscle contraction,BP,
12287,GO:0045990,1,0.967519907089752,0,5,carbon catabolite regulation of transcription,BP,
12288,GO:0045991,1,0.967519907089752,0,5,carbon catabolite activation of transcription,BP,
12290,GO:0045993,1,0.992903257645364,0,1,negative regulation of translational initiation by iron,BP,
12291,GO:0045994,1,0.98651071621045,0,2,positive regulation of translational initiation by iron,BP,
12293,GO:0046005,1,0.989315611857004,0,2,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12295,GO:0046007,1,0.930726705292029,0,11,negative regulation of activated T cell proliferation,BP,
12296,GO:0046010,1,0.982977962210293,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12297,GO:0046013,1,0.988566336060137,0,2,regulation of T cell homeostatic proliferation,BP,
12298,GO:0046015,1,0.971353379757548,0,5,regulation of transcription by glucose,BP,
12299,GO:0046016,1,0.976678856655637,0,4,positive regulation of transcription by glucose,BP,
12300,GO:0046030,1,0.925532849918941,0,11,inositol trisphosphate phosphatase activity,MF,
12301,GO:0046031,1,0.512843857163754,0,98,ADP metabolic process,BP,
12302,GO:0046032,1,0.994572591640109,0,1,ADP catabolic process,BP,
12303,GO:0046033,1,0.937459080840353,0,11,AMP metabolic process,BP,
12304,GO:0046034,1,0.225110469240832,0,234,ATP metabolic process,BP,
12305,GO:0046035,1,0.994611703443189,0,1,CMP metabolic process,BP,
12306,GO:0046036,1,0.930004221830607,0,13,CTP metabolic process,BP,
12307,GO:0046037,1,0.864482635264223,0,21,GMP metabolic process,BP,
12308,GO:0046038,1,0.994590117781034,0,1,GMP catabolic process,BP,
12309,GO:0046039,1,0.829880201519208,0,30,GTP metabolic process,BP,
12310,GO:0046040,1,0.92160925859708,0,13,IMP metabolic process,BP,
12311,GO:0046041,1,0.988911060512979,0,2,ITP metabolic process,BP,
12312,GO:0046048,1,0.994104773294902,0,1,UDP metabolic process,BP,
12313,GO:0046049,1,0.941569242151373,0,10,UMP metabolic process,BP,
12314,GO:0046051,1,0.942713967055568,0,10,UTP metabolic process,BP,
12315,GO:0046054,1,0.994636454406539,0,1,dGMP metabolic process,BP,
12316,GO:0046056,1,0.98787015419085,0,2,dADP metabolic process,BP,
12318,GO:0046060,1,0.972567494313813,0,5,dATP metabolic process,BP,
12319,GO:0046061,1,0.983258313729375,0,3,dATP catabolic process,BP,
12320,GO:0046065,1,0.994625312802153,0,1,dCTP metabolic process,BP,
12321,GO:0046066,1,0.988852102743475,0,2,dGDP metabolic process,BP,
12323,GO:0046069,1,0.95680111248068,0,6,cGMP catabolic process,BP,
12324,GO:0046070,1,0.977883968354973,0,4,dGTP metabolic process,BP,
12325,GO:0046072,1,0.988727535234231,0,2,dTDP metabolic process,BP,
12326,GO:0046073,1,0.983456161221139,0,3,dTMP metabolic process,BP,
12327,GO:0046075,1,0.978044515160479,0,4,dTTP metabolic process,BP,
12328,GO:0046077,1,0.988727535234231,0,2,dUDP metabolic process,BP,
12329,GO:0046078,1,0.972959468380926,0,5,dUMP metabolic process,BP,
12330,GO:0046079,1,0.994564162518276,0,1,dUMP catabolic process,BP,
12331,GO:0046080,1,0.994507989594251,0,1,dUTP metabolic process,BP,
12332,GO:0046081,1,0.994507989594251,0,1,dUTP catabolic process,BP,
12333,GO:0046083,1,0.983825611947328,0,3,adenine metabolic process,BP,
12334,GO:0046084,1,0.983825611947328,0,3,adenine biosynthetic process,BP,
12335,GO:0046085,1,0.947179812133015,0,9,adenosine metabolic process,BP,
12336,GO:0046086,1,0.987767973541661,0,2,adenosine biosynthetic process,BP,
12337,GO:0046087,1,0.956042343188224,0,8,cytidine metabolic process,BP,
12338,GO:0046090,1,0.994572033598167,0,1,deoxyadenosine metabolic process,BP,
12339,GO:0046092,1,0.992366107504535,0,1,deoxycytidine metabolic process,BP,
12340,GO:0046098,1,0.975325684322555,0,4,guanine metabolic process,BP,
12341,GO:0046099,1,0.989114391765378,0,2,guanine biosynthetic process,BP,
12342,GO:0046100,1,0.972677332180082,0,5,hypoxanthine metabolic process,BP,
12343,GO:0046101,1,0.978062968738169,0,4,hypoxanthine biosynthetic process,BP,
12344,GO:0046102,1,0.983298770598343,0,3,inosine metabolic process,BP,
12345,GO:0046103,1,0.988888320783881,0,2,inosine biosynthetic process,BP,
12346,GO:0046104,1,0.981033758197872,0,3,thymidine metabolic process,BP,
12347,GO:0046108,1,0.988901016535469,0,2,uridine metabolic process,BP,
12348,GO:0046110,1,0.978878039516124,0,3,xanthine metabolic process,BP,
12349,GO:0046111,1,0.994572033598167,0,1,xanthine biosynthetic process,BP,
12350,GO:0046112,1,0.884816163972458,0,19,nucleobase biosynthetic process,BP,
12351,GO:0046113,1,0.959699306813272,0,6,nucleobase catabolic process,BP,
12352,GO:0046116,1,0.983499472061217,0,3,queuosine metabolic process,BP,
12353,GO:0046121,1,0.983191305881024,0,3,deoxyribonucleoside catabolic process,BP,
12354,GO:0046122,1,0.98923559382996,0,2,purine deoxyribonucleoside metabolic process,BP,
12355,GO:0046124,1,0.994572033598167,0,1,purine deoxyribonucleoside catabolic process,BP,
12356,GO:0046125,1,0.981033758197872,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12357,GO:0046127,1,0.993986671338394,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12358,GO:0046128,1,0.637489022448285,0,70,purine ribonucleoside metabolic process,BP,
12359,GO:0046129,1,0.887510313885434,0,21,purine ribonucleoside biosynthetic process,BP,
12360,GO:0046130,1,0.965405535740421,0,6,purine ribonucleoside catabolic process,BP,
12361,GO:0046131,1,0.841119704472793,0,30,pyrimidine ribonucleoside metabolic process,BP,
12362,GO:0046132,1,0.890189348236731,0,20,pyrimidine ribonucleoside biosynthetic process,BP,
12363,GO:0046133,1,0.945194324228819,0,10,pyrimidine ribonucleoside catabolic process,BP,
12366,GO:0046136,1,0.989157349897981,0,2,positive regulation of vitamin metabolic process,BP,
12367,GO:0046137,1,0.965876992770249,0,6,negative regulation of vitamin metabolic process,BP,
12368,GO:0046144,1,0.994561618309242,0,1,D-alanine family amino acid metabolic process,BP,
12369,GO:0046146,1,0.961303256159708,0,7,tetrahydrobiopterin metabolic process,BP,
12370,GO:0046148,1,0.721881285208683,0,50,pigment biosynthetic process,BP,
12371,GO:0046149,1,0.978553793680587,0,4,pigment catabolic process,BP,
12372,GO:0046160,1,0.984595622303081,0,2,heme a metabolic process,BP,
12373,GO:0046164,1,0.776894202559822,0,40,alcohol catabolic process,BP,
12375,GO:0046166,1,0.98906167136673,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12376,GO:0046167,1,0.98125978342873,0,2,glycerol-3-phosphate biosynthetic process,BP,
12377,GO:0046168,1,0.987566354049708,0,2,glycerol-3-phosphate catabolic process,BP,
12378,GO:0046173,1,0.721743658707545,0,52,polyol biosynthetic process,BP,
12379,GO:0046174,1,0.887551749888352,0,17,polyol catabolic process,BP,
12380,GO:0046176,1,0.994184768585909,0,1,aldonic acid catabolic process,BP,
12381,GO:0046177,1,0.994184768585909,0,1,D-gluconate catabolic process,BP,
12382,GO:0046184,1,0.916541734616057,0,13,aldehyde biosynthetic process,BP,
12383,GO:0046185,1,0.945314512181397,0,10,aldehyde catabolic process,BP,
12385,GO:0046203,1,0.989191581301232,0,2,spermidine catabolic process,BP,
12386,GO:0046204,1,0.994638523445285,0,1,nor-spermidine metabolic process,BP,
12387,GO:0046208,1,0.978241601682048,0,4,spermine catabolic process,BP,
12389,GO:0046210,1,0.994311104687468,0,1,nitric oxide catabolic process,BP,
12390,GO:0046218,1,0.960330503545629,0,7,indolalkylamine catabolic process,BP,
12391,GO:0046219,1,0.983663386550155,0,3,indolalkylamine biosynthetic process,BP,
12392,GO:0046222,1,0.994207649744507,0,1,aflatoxin metabolic process,BP,
12393,GO:0046223,1,0.994207649744507,0,1,aflatoxin catabolic process,BP,
12394,GO:0046226,1,0.989177318356436,0,2,coumarin catabolic process,BP,
12395,GO:0046247,1,0.994146019832506,0,1,terpene catabolic process,BP,
12396,GO:0046271,1,0.989177318356436,0,2,phenylpropanoid catabolic process,BP,
12397,GO:0046272,1,0.994418807560719,0,1,stilbene catabolic process,BP,
12398,GO:0046292,1,0.981606035621732,0,3,formaldehyde metabolic process,BP,
12399,GO:0046293,1,0.992624811397372,0,1,formaldehyde biosynthetic process,BP,
12400,GO:0046294,1,0.988900172171727,0,2,formaldehyde catabolic process,BP,
12401,GO:0046295,1,0.994640893629188,0,1,glycolate biosynthetic process,BP,
12402,GO:0046296,1,0.99453426246216,0,1,glycolate catabolic process,BP,
12403,GO:0046305,1,0.988814566844118,0,2,alkanesulfonate biosynthetic process,BP,
12404,GO:0046316,1,0.994184768585909,0,1,gluconokinase activity,MF,
12405,GO:0046317,1,0.992311032969159,0,1,regulation of glucosylceramide biosynthetic process,BP,
12406,GO:0046318,1,0.992311032969159,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12407,GO:0046320,1,0.811609472573343,0,28,regulation of fatty acid oxidation,BP,
12408,GO:0046321,1,0.888735550783325,0,15,positive regulation of fatty acid oxidation,BP,
12409,GO:0046322,1,0.947515297932589,0,8,negative regulation of fatty acid oxidation,BP,
12410,GO:0046323,1,0.619094148966675,0,67,glucose import,BP,
12411,GO:0046324,1,0.675221573213533,0,55,regulation of glucose import,BP,
12412,GO:0046325,1,0.926717167617143,0,12,negative regulation of glucose import,BP,
12413,GO:0046326,1,0.770440863266199,0,35,positive regulation of glucose import,BP,
12414,GO:0046327,1,0.988751379001487,0,2,glycerol biosynthetic process from pyruvate,BP,
12415,GO:0046328,1,0.339091743838691,0,157,regulation of JNK cascade,BP,
12416,GO:0046329,1,0.818967264050618,0,30,negative regulation of JNK cascade,BP,
12417,GO:0046330,1,0.453455321547192,0,116,positive regulation of JNK cascade,BP,
12418,GO:0046331,1,0.988477827019839,0,2,lateral inhibition,BP,
12421,GO:0046337,1,0.892329033451558,0,18,phosphatidylethanolamine metabolic process,BP,
12422,GO:0046338,1,0.987947679748504,0,2,phosphatidylethanolamine catabolic process,BP,
12423,GO:0046339,1,0.921361033603024,0,12,diacylglycerol metabolic process,BP,
12424,GO:0046340,1,0.979521427591245,0,3,diacylglycerol catabolic process,BP,
12425,GO:0046341,1,0.918337557898315,0,12,CDP-diacylglycerol metabolic process,BP,
12427,GO:0046349,1,0.920377388062103,0,13,amino sugar biosynthetic process,BP,
12428,GO:0046351,1,0.976171874601152,0,4,disaccharide biosynthetic process,BP,
12429,GO:0046355,1,0.993854124286646,0,1,mannan catabolic process,BP,
12430,GO:0046356,1,0.989103854560055,0,2,acetyl-CoA catabolic process,BP,
12431,GO:0046359,1,0.994496922073288,0,1,butyrate catabolic process,BP,
12432,GO:0046360,1,0.994446507872243,0,1,2-oxobutyrate biosynthetic process,BP,
12433,GO:0046361,1,0.994446507872243,0,1,2-oxobutyrate metabolic process,BP,
12434,GO:0046364,1,0.628672938760371,0,76,monosaccharide biosynthetic process,BP,
12436,GO:0046368,1,0.97660962990145,0,4,GDP-L-fucose metabolic process,BP,
12437,GO:0046370,1,0.988925438847536,0,2,fructose biosynthetic process,BP,
12438,GO:0046373,1,0.988403017609477,0,2,L-arabinose metabolic process,BP,
12439,GO:0046379,1,0.982675056898366,0,3,extracellular polysaccharide metabolic process,BP,
12440,GO:0046380,1,0.99349131836788,0,1,N-acetylneuraminate biosynthetic process,BP,
12441,GO:0046381,1,0.994612382336904,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12442,GO:0046385,1,0.940154546817775,0,11,deoxyribose phosphate biosynthetic process,BP,
12443,GO:0046386,1,0.896573246743071,0,19,deoxyribose phosphate catabolic process,BP,
12445,GO:0046391,1,0.983002239488952,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
12447,GO:0046395,1,0.211763034799164,0,250,carboxylic acid catabolic process,BP,
12448,GO:0046398,1,0.973038705906195,0,4,UDP-glucuronate metabolic process,BP,
12449,GO:0046403,1,0.99453859512126,0,1,polynucleotide 3'-phosphatase activity,MF,
12450,GO:0046404,1,0.979904942698287,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12451,GO:0046415,1,0.958719228531987,0,7,urate metabolic process,BP,
12452,GO:0046416,1,0.983533196169355,0,3,D-amino acid metabolic process,BP,
12456,GO:0046434,1,0.250735766249698,0,208,organophosphate catabolic process,BP,
12457,GO:0046436,1,0.994561618309242,0,1,D-alanine metabolic process,BP,
12458,GO:0046437,1,0.994322778976815,0,1,D-amino acid biosynthetic process,BP,
12459,GO:0046439,1,0.958069646265017,0,7,L-cysteine metabolic process,BP,
12460,GO:0046440,1,0.974723518753772,0,4,L-lysine metabolic process,BP,
12461,GO:0046443,1,0.99448445191223,0,1,FAD metabolic process,BP,
12462,GO:0046444,1,0.994223728588005,0,1,FMN metabolic process,BP,
12463,GO:0046448,1,0.994336867640233,0,1,tropane alkaloid metabolic process,BP,
12464,GO:0046449,1,0.970468402441911,0,4,creatinine metabolic process,BP,
12465,GO:0046452,1,0.982569663562827,0,3,dihydrofolate metabolic process,BP,
12468,GO:0046459,1,0.907935819690712,0,16,short-chain fatty acid metabolic process,BP,
12469,GO:0046460,1,0.822505595487871,0,30,neutral lipid biosynthetic process,BP,
12471,GO:0046462,1,0.988743858010874,0,2,monoacylglycerol metabolic process,BP,
12472,GO:0046463,1,0.822505595487871,0,30,acylglycerol biosynthetic process,BP,
12474,GO:0046465,1,0.959264059693831,0,7,dolichyl diphosphate metabolic process,BP,
12475,GO:0046466,1,0.859684026297522,0,25,membrane lipid catabolic process,BP,
12477,GO:0046469,1,0.96216953052712,0,6,platelet activating factor metabolic process,BP,
12482,GO:0046475,1,0.888531520236324,0,19,glycerophospholipid catabolic process,BP,
12483,GO:0046476,1,0.958860983138619,0,7,glycosylceramide biosynthetic process,BP,
12484,GO:0046477,1,0.959668598154996,0,7,glycosylceramide catabolic process,BP,
12485,GO:0046478,1,0.992586309730429,0,1,lactosylceramide metabolic process,BP,
12486,GO:0046479,1,0.932330716302986,0,12,glycosphingolipid catabolic process,BP,
12488,GO:0046485,1,0.943900469553319,0,9,ether lipid metabolic process,BP,
12490,GO:0046487,1,0.96116592205144,0,7,glyoxylate metabolic process,BP,
12492,GO:0046490,1,0.978207171142858,0,4,isopentenyl diphosphate metabolic process,BP,
12493,GO:0046491,1,0.994645536077495,0,1,L-methylmalonyl-CoA metabolic process,BP,
12494,GO:0046493,1,0.989344272260938,0,2,lipid A metabolic process,BP,
12495,GO:0046495,1,0.994348273062443,0,1,nicotinamide riboside metabolic process,BP,
12497,GO:0046497,1,0.994184768585909,0,1,nicotinate nucleotide metabolic process,BP,
12498,GO:0046498,1,0.963737200545853,0,6,S-adenosylhomocysteine metabolic process,BP,
12499,GO:0046499,1,0.993894280649677,0,1,S-adenosylmethioninamine metabolic process,BP,
12500,GO:0046500,1,0.927589642614394,0,12,S-adenosylmethionine metabolic process,BP,
12501,GO:0046501,1,0.940166116101884,0,10,protoporphyrinogen IX metabolic process,BP,
12502,GO:0046502,1,0.989058574079793,0,2,uroporphyrinogen III metabolic process,BP,
12504,GO:0046504,1,0.965941866423032,0,5,glycerol ether biosynthetic process,BP,
12505,GO:0046511,1,0.984880993454442,0,2,sphinganine biosynthetic process,BP,
12506,GO:0046512,1,0.945276872489306,0,9,sphingosine biosynthetic process,BP,
12508,GO:0046514,1,0.922115073528173,0,14,ceramide catabolic process,BP,
12509,GO:0046519,1,0.916077058246028,0,14,sphingoid metabolic process,BP,
12510,GO:0046520,1,0.939075576171059,0,10,sphingoid biosynthetic process,BP,
12511,GO:0046521,1,0.994509783732194,0,1,sphingoid catabolic process,BP,
12512,GO:0046523,1,0.993999160789366,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12513,GO:0046525,1,0.994538789796979,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12514,GO:0046526,1,0.99430288163403,0,1,D-xylulose reductase activity,MF,
12515,GO:0046527,1,0.896144978794862,0,16,glucosyltransferase activity,MF,
12517,GO:0046532,1,0.959855721998745,0,6,regulation of photoreceptor cell differentiation,BP,
12518,GO:0046533,1,0.959855721998745,0,6,negative regulation of photoreceptor cell differentiation,BP,
12519,GO:0046538,1,0.978402982207297,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12520,GO:0046539,1,0.99464301845219,0,1,histamine N-methyltransferase activity,MF,
12521,GO:0046540,1,0.863446443013758,0,23,U4/U6 x U5 tri-snRNP complex,CC,
12522,GO:0046541,1,0.943236161447152,0,10,saliva secretion,BP,
12523,GO:0046543,1,0.952226295887264,0,7,development of secondary female sexual characteristics,BP,
12524,GO:0046544,1,0.992314802642986,0,1,development of secondary male sexual characteristics,BP,
12527,GO:0046548,1,0.953206876264316,0,7,retinal rod cell development,BP,
12528,GO:0046549,1,0.950878828806934,0,8,retinal cone cell development,BP,
12529,GO:0046554,1,0.994604507743816,0,1,malate dehydrogenase (NADP+) activity,MF,
12530,GO:0046556,1,0.988403017609477,0,2,alpha-L-arabinofuranosidase activity,MF,
12531,GO:0046570,1,0.994610099490611,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12532,GO:0046573,1,0.983793242021221,0,3,lactonohydrolase activity,MF,
12533,GO:0046577,1,0.993513015721929,0,1,long-chain-alcohol oxidase activity,MF,
12536,GO:0046580,1,0.717931574044376,0,46,negative regulation of Ras protein signal transduction,BP,
12537,GO:0046581,1,0.956852701467149,0,6,intercellular canaliculus,CC,
12538,GO:0046586,1,0.988733353242793,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12539,GO:0046587,1,0.994058968473674,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12540,GO:0046588,1,0.99464287472259,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12541,GO:0046592,1,0.989032385500447,0,2,polyamine oxidase activity,MF,
12544,GO:0046598,1,0.949771990343729,0,9,positive regulation of viral entry into host cell,BP,
12545,GO:0046599,1,0.891279987702693,0,17,regulation of centriole replication,BP,
12546,GO:0046600,1,0.943905167895298,0,8,negative regulation of centriole replication,BP,
12547,GO:0046601,1,0.981252354012953,0,3,positive regulation of centriole replication,BP,
12548,GO:0046602,1,0.93136921989993,0,10,regulation of mitotic centrosome separation,BP,
12549,GO:0046603,1,0.994587510437295,0,1,negative regulation of mitotic centrosome separation,BP,
12550,GO:0046604,1,0.969527795907448,0,4,positive regulation of mitotic centrosome separation,BP,
12551,GO:0046605,1,0.689426825542395,0,54,regulation of centrosome cycle,BP,
12552,GO:0046606,1,0.910413119492139,0,14,negative regulation of centrosome cycle,BP,
12553,GO:0046607,1,0.930739669131864,0,10,positive regulation of centrosome cycle,BP,
12554,GO:0046618,1,0.976368440225621,0,4,drug export,BP,
12555,GO:0046619,1,0.984742590623179,0,2,optic placode formation involved in camera-type eye formation,BP,
12556,GO:0046620,1,0.562952204138038,0,82,regulation of organ growth,BP,
12557,GO:0046621,1,0.844435997456039,0,24,negative regulation of organ growth,BP,
12558,GO:0046622,1,0.731057404439154,0,44,positive regulation of organ growth,BP,
12559,GO:0046623,1,0.991086129130538,0,1,sphingolipid-translocating ATPase activity,MF,
12560,GO:0046624,1,0.942415003953445,0,9,sphingolipid transporter activity,MF,
12561,GO:0046625,1,0.90978769774676,0,16,sphingolipid binding,MF,
12564,GO:0046628,1,0.919799863712792,0,11,positive regulation of insulin receptor signaling pathway,BP,
12565,GO:0046629,1,0.93080487782773,0,11,gamma-delta T cell activation,BP,
12568,GO:0046633,1,0.866655479301729,0,23,alpha-beta T cell proliferation,BP,
12575,GO:0046640,1,0.8850720485251,0,20,regulation of alpha-beta T cell proliferation,BP,
12576,GO:0046641,1,0.909608554418242,0,16,positive regulation of alpha-beta T cell proliferation,BP,
12577,GO:0046642,1,0.968656616037095,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12578,GO:0046643,1,0.95907083746397,0,6,regulation of gamma-delta T cell activation,BP,
12579,GO:0046645,1,0.96559102098741,0,5,positive regulation of gamma-delta T cell activation,BP,
12582,GO:0046653,1,0.893757810740636,0,18,tetrahydrofolate metabolic process,BP,
12583,GO:0046654,1,0.958835729770858,0,7,tetrahydrofolate biosynthetic process,BP,
12584,GO:0046655,1,0.878820776846099,0,20,folic acid metabolic process,BP,
12585,GO:0046657,1,0.987369635673596,0,2,folic acid catabolic process,BP,
12586,GO:0046658,1,0.789197247167331,0,37,anchored component of plasma membrane,CC,
12589,GO:0046666,1,0.977306933372292,0,4,retinal cell programmed cell death,BP,
12590,GO:0046668,1,0.987988189284958,0,2,regulation of retinal cell programmed cell death,BP,
12591,GO:0046671,1,0.993447954084981,0,1,negative regulation of retinal cell programmed cell death,BP,
12594,GO:0046680,1,0.994453268578291,0,1,response to DDT,BP,
12596,GO:0046684,1,0.976280211153281,0,4,response to pyrethroid,BP,
12597,GO:0046685,1,0.837247474532295,0,29,response to arsenic-containing substance,BP,
12598,GO:0046686,1,0.716242774651014,0,56,response to cadmium ion,BP,
12599,GO:0046687,1,0.994627350249509,0,1,response to chromate,BP,
12600,GO:0046688,1,0.837812841953676,0,30,response to copper ion,BP,
12601,GO:0046689,1,0.953535041931488,0,8,response to mercury ion,BP,
12602,GO:0046690,1,0.993735071616435,0,1,response to tellurium ion,BP,
12603,GO:0046691,1,0.99414493421607,0,1,intracellular canaliculus,CC,
12604,GO:0046695,1,0.983455338079949,0,3,SLIK (SAGA-like) complex,CC,
12605,GO:0046696,1,0.969779421990327,0,5,lipopolysaccharide receptor complex,CC,
12608,GO:0046703,1,0.96197101204704,0,7,natural killer cell lectin-like receptor binding,MF,
12609,GO:0046707,1,0.986061837808516,0,2,IDP metabolic process,BP,
12610,GO:0046709,1,0.986061837808516,0,2,IDP catabolic process,BP,
12611,GO:0046710,1,0.906853427514242,0,13,GDP metabolic process,BP,
12612,GO:0046711,1,0.994636454406539,0,1,GDP biosynthetic process,BP,
12613,GO:0046713,1,0.993993092744862,0,1,borate transport,BP,
12614,GO:0046715,1,0.993993092744862,0,1,active borate transmembrane transporter activity,MF,
12615,GO:0046716,1,0.908925707202341,0,15,muscle cell cellular homeostasis,BP,
12618,GO:0046719,1,0.957434997716376,0,7,regulation by virus of viral protein levels in host cell,BP,
12619,GO:0046724,1,0.988839762757681,0,2,oxalic acid secretion,BP,
12620,GO:0046725,1,0.993668639820947,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12621,GO:0046726,1,0.974063336438771,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12622,GO:0046730,1,0.994420977895971,0,1,induction of host immune response by virus,BP,
12623,GO:0046732,1,0.994420977895971,0,1,active induction of host immune response by virus,BP,
12624,GO:0046745,1,0.994184768585909,0,1,viral capsid secondary envelopment,BP,
12625,GO:0046755,1,0.868772624910066,0,24,viral budding,BP,
12626,GO:0046777,1,0.198778152059723,0,225,protein autophosphorylation,BP,
12627,GO:0046778,1,0.988576255285238,0,2,modification by virus of host mRNA processing,BP,
12628,GO:0046782,1,0.680939852250828,0,60,regulation of viral transcription,BP,
12629,GO:0046784,1,0.953611422426411,0,8,viral mRNA export from host cell nucleus,BP,
12630,GO:0046785,1,0.630195608519966,0,66,microtubule polymerization,BP,
12631,GO:0046786,1,0.992497807452188,0,1,viral replication complex formation and maintenance,BP,
12632,GO:0046789,1,0.993938092816132,0,1,host cell surface receptor binding,MF,
12634,GO:0046794,1,0.685532254014805,0,56,transport of virus,BP,
12635,GO:0046811,1,0.986448876013879,0,2,histone deacetylase inhibitor activity,MF,
12636,GO:0046812,1,0.993938092816132,0,1,host cell surface binding,MF,
12637,GO:0046813,1,0.968457935665518,0,5,receptor-mediated virion attachment to host cell,BP,
12638,GO:0046822,1,0.505327916944524,0,97,regulation of nucleocytoplasmic transport,BP,
12639,GO:0046823,1,0.883133663879987,0,19,negative regulation of nucleocytoplasmic transport,BP,
12640,GO:0046824,1,0.666726272263112,0,55,positive regulation of nucleocytoplasmic transport,BP,
12641,GO:0046825,1,0.760376986877078,0,39,regulation of protein export from nucleus,BP,
12642,GO:0046826,1,0.958337284901165,0,7,negative regulation of protein export from nucleus,BP,
12643,GO:0046827,1,0.865594574570228,0,20,positive regulation of protein export from nucleus,BP,
12644,GO:0046831,1,0.892289491136688,0,15,regulation of RNA export from nucleus,BP,
12645,GO:0046832,1,0.979959620632606,0,2,negative regulation of RNA export from nucleus,BP,
12646,GO:0046833,1,0.951922190974165,0,7,positive regulation of RNA export from nucleus,BP,
12647,GO:0046834,1,0.477981837287679,0,103,lipid phosphorylation,BP,
12648,GO:0046835,1,0.847177366471141,0,26,carbohydrate phosphorylation,BP,
12649,GO:0046836,1,0.97032423311423,0,5,glycolipid transport,BP,
12650,GO:0046838,1,0.928237567020482,0,11,phosphorylated carbohydrate dephosphorylation,BP,
12651,GO:0046839,1,0.839239625113047,0,24,phospholipid dephosphorylation,BP,
12652,GO:0046847,1,0.67946417535961,0,54,filopodium assembly,BP,
12653,GO:0046848,1,0.994663523694347,0,1,hydroxyapatite binding,MF,
12656,GO:0046851,1,0.930973081010466,0,11,negative regulation of bone remodeling,BP,
12658,GO:0046854,1,0.52142728687152,0,91,phosphatidylinositol phosphorylation,BP,
12659,GO:0046855,1,0.93383897794502,0,10,inositol phosphate dephosphorylation,BP,
12660,GO:0046856,1,0.843957893582606,0,23,phosphatidylinositol dephosphorylation,BP,
12661,GO:0046864,1,0.988823644565567,0,2,isoprenoid transport,BP,
12662,GO:0046865,1,0.988823644565567,0,2,terpenoid transport,BP,
12663,GO:0046870,1,0.967398376254803,0,5,cadmium ion binding,MF,
12666,GO:0046874,1,0.976358753881093,0,4,quinolinate metabolic process,BP,
12667,GO:0046875,1,0.830488714493414,0,27,ephrin receptor binding,MF,
12668,GO:0046877,1,0.964964439514675,0,6,regulation of saliva secretion,BP,
12669,GO:0046878,1,0.982823583756124,0,3,positive regulation of saliva secretion,BP,
12671,GO:0046880,1,0.960455089503824,0,6,regulation of follicle-stimulating hormone secretion,BP,
12672,GO:0046881,1,0.960455089503824,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12673,GO:0046882,1,0.983053467276655,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12675,GO:0046884,1,0.953386497780571,0,7,follicle-stimulating hormone secretion,BP,
12676,GO:0046885,1,0.855627137798528,0,24,regulation of hormone biosynthetic process,BP,
12677,GO:0046886,1,0.94336576946907,0,9,positive regulation of hormone biosynthetic process,BP,
12682,GO:0046898,1,0.971101144727098,0,4,response to cycloheximide,BP,
12683,GO:0046899,1,0.988471556459255,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12684,GO:0046900,1,0.988928076499436,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12685,GO:0046901,1,0.994318385259016,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12686,GO:0046902,1,0.653295518405795,0,70,regulation of mitochondrial membrane permeability,BP,
12688,GO:0046906,1,0.503808379389808,0,108,tetrapyrrole binding,MF,
12690,GO:0046911,1,0.994619104948451,0,1,metal chelating activity,MF,
12691,GO:0046912,1,0.967279538734662,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12693,GO:0046915,1,0.789080821324667,0,37,transition metal ion transmembrane transporter activity,MF,
12696,GO:0046921,1,0.99387659705545,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12697,GO:0046922,1,0.987878012858011,0,2,peptide-O-fucosyltransferase activity,MF,
12700,GO:0046929,1,0.926013708825668,0,10,negative regulation of neurotransmitter secretion,BP,
12701,GO:0046930,1,0.914506387414801,0,15,pore complex,CC,
12702,GO:0046931,1,0.895451957194068,0,16,pore complex assembly,BP,
12703,GO:0046933,1,0.983817160878495,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12704,GO:0046934,1,0.651480198851141,0,61,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
12705,GO:0046935,1,0.964862030247857,0,5,1-phosphatidylinositol-3-kinase regulator activity,MF,
12706,GO:0046939,1,0.465139286327388,0,115,nucleotide phosphorylation,BP,
12707,GO:0046940,1,0.971648408220332,0,5,nucleoside monophosphate phosphorylation,BP,
12710,GO:0046946,1,0.98152190030938,0,3,hydroxylysine metabolic process,BP,
12711,GO:0046947,1,0.98152190030938,0,3,hydroxylysine biosynthetic process,BP,
12712,GO:0046949,1,0.843892773846495,0,27,fatty-acyl-CoA biosynthetic process,BP,
12713,GO:0046950,1,0.937834898079909,0,11,cellular ketone body metabolic process,BP,
12714,GO:0046951,1,0.949015452724974,0,9,ketone body biosynthetic process,BP,
12715,GO:0046952,1,0.976637047975462,0,4,ketone body catabolic process,BP,
12716,GO:0046958,1,0.957602156822179,0,6,nonassociative learning,BP,
12717,GO:0046959,1,0.968952769782438,0,4,habituation,BP,
12718,GO:0046960,1,0.988219146087564,0,2,sensitization,BP,
12719,GO:0046961,1,0.885939617794302,0,20,proton-transporting ATPase activity, rotational mechanism,MF,
12720,GO:0046963,1,0.98895733690234,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12721,GO:0046964,1,0.98895733690234,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12722,GO:0046965,1,0.904370778595134,0,14,retinoid X receptor binding,MF,
12724,GO:0046967,1,0.987424182036895,0,2,cytosol to ER transport,BP,
12725,GO:0046968,1,0.986464003640197,0,2,peptide antigen transport,BP,
12726,GO:0046969,1,0.988040918615773,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12727,GO:0046970,1,0.994490705180086,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12728,GO:0046972,1,0.934188154877888,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12729,GO:0046974,1,0.967006054682178,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12730,GO:0046975,1,0.946060786386602,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12731,GO:0046976,1,0.968758372350429,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12732,GO:0046977,1,0.975930517034455,0,4,TAP binding,MF,
12733,GO:0046978,1,0.975930517034455,0,4,TAP1 binding,MF,
12734,GO:0046979,1,0.982519861984528,0,3,TAP2 binding,MF,
12735,GO:0046980,1,0.993294602112599,0,1,tapasin binding,MF,
12738,GO:0046984,1,0.976229279902012,0,4,regulation of hemoglobin biosynthetic process,BP,
12739,GO:0046985,1,0.983208031817923,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12740,GO:0046986,1,0.992903257645364,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12741,GO:0046996,1,0.994184768585909,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
12742,GO:0046997,1,0.987905679113162,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12743,GO:0047006,1,0.989211728285613,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12744,GO:0047012,1,0.994561789191343,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12745,GO:0047015,1,0.994639568381293,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12746,GO:0047016,1,0.994425276162126,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12747,GO:0047017,1,0.988829724664419,0,2,prostaglandin-F synthase activity,MF,
12748,GO:0047020,1,0.994613946734573,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12749,GO:0047021,1,0.994612043525747,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12750,GO:0047023,1,0.978577477300448,0,4,androsterone dehydrogenase activity,MF,
12751,GO:0047025,1,0.988428373702046,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12752,GO:0047035,1,0.967985260728992,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12753,GO:0047042,1,0.994594900481862,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12754,GO:0047045,1,0.983935117526881,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12755,GO:0047057,1,0.989291609391381,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12756,GO:0047066,1,0.994640367466263,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12757,GO:0047086,1,0.978577477300448,0,4,ketosteroid monooxygenase activity,MF,
12758,GO:0047105,1,0.994312325987516,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12759,GO:0047115,1,0.978588507239947,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12760,GO:0047117,1,0.989197930064612,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12761,GO:0047127,1,0.994596032785648,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12762,GO:0047130,1,0.991574782178595,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12763,GO:0047131,1,0.991574782178595,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12764,GO:0047134,1,0.967076994148792,0,6,protein-disulfide reductase activity,MF,
12765,GO:0047144,1,0.940887354390549,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12766,GO:0047150,1,0.988824086409864,0,2,betaine-homocysteine S-methyltransferase activity,MF,
12767,GO:0047159,1,0.993358565708716,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12768,GO:0047166,1,0.994498099521183,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12769,GO:0047173,1,0.992522077071725,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12770,GO:0047179,1,0.989275310657014,0,2,platelet-activating factor acetyltransferase activity,MF,
12771,GO:0047184,1,0.969176622755608,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12772,GO:0047186,1,0.993411662700702,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12773,GO:0047191,1,0.993358565708716,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12774,GO:0047192,1,0.980029600187474,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12775,GO:0047220,1,0.994184000021534,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12776,GO:0047223,1,0.994148996793878,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12777,GO:0047237,1,0.981163399720287,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12778,GO:0047238,1,0.967957679640417,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12779,GO:0047256,1,0.993216029596454,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12780,GO:0047263,1,0.994121479707721,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12781,GO:0047273,1,0.993858361481204,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12782,GO:0047275,1,0.988156926135241,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12783,GO:0047277,1,0.994490220352734,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12784,GO:0047280,1,0.992800105224156,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12785,GO:0047288,1,0.987493837217169,0,2,monosialoganglioside sialyltransferase activity,MF,
12786,GO:0047290,1,0.994553559405743,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12787,GO:0047291,1,0.99438553296374,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12788,GO:0047293,1,0.994554632768503,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12789,GO:0047298,1,0.992492201901996,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12790,GO:0047322,1,0.980849683645135,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12791,GO:0047323,1,0.994441624576333,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12792,GO:0047325,1,0.993900130184356,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12793,GO:0047326,1,0.994525099131322,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12794,GO:0047341,1,0.993779751963204,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12795,GO:0047349,1,0.991986778020044,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12796,GO:0047369,1,0.994184768585909,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12797,GO:0047372,1,0.930833392211058,0,11,acylglycerol lipase activity,MF,
12798,GO:0047374,1,0.982578607542301,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12799,GO:0047389,1,0.985964476995709,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12800,GO:0047390,1,0.993371262831178,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12801,GO:0047391,1,0.982538200876203,0,3,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12802,GO:0047394,1,0.994409184146715,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12803,GO:0047395,1,0.994102481539163,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12804,GO:0047408,1,0.988231193187992,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12805,GO:0047409,1,0.988231193187992,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12806,GO:0047429,1,0.94265349655336,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12807,GO:0047444,1,0.994612382336904,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12808,GO:0047451,1,0.989197930064612,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12809,GO:0047464,1,0.992375039135627,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12810,GO:0047484,1,0.943997271986164,0,9,regulation of response to osmotic stress,BP,
12812,GO:0047493,1,0.979566847883675,0,3,ceramide cholinephosphotransferase activity,MF,
12813,GO:0047496,1,0.760760664671028,0,38,vesicle transport along microtubule,BP,
12814,GO:0047497,1,0.86878666214475,0,19,mitochondrion transport along microtubule,BP,
12816,GO:0047499,1,0.965748141828016,0,6,calcium-independent phospholipase A2 activity,MF,
12817,GO:0047522,1,0.980972815315488,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12818,GO:0047536,1,0.99441363535372,0,1,2-aminoadipate transaminase activity,MF,
12819,GO:0047545,1,0.991376990031585,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12820,GO:0047555,1,0.913943917149888,0,12,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12821,GO:0047560,1,0.992225135950649,0,1,3-dehydrosphinganine reductase activity,MF,
12822,GO:0047578,1,0.994333775026887,0,1,4-hydroxyglutamate transaminase activity,MF,
12823,GO:0047598,1,0.994247512019971,0,1,7-dehydrocholesterol reductase activity,MF,
12824,GO:0047617,1,0.918072925255262,0,15,acyl-CoA hydrolase activity,MF,
12825,GO:0047620,1,0.994102481539163,0,1,acylglycerol kinase activity,MF,
12826,GO:0047621,1,0.994547534938947,0,1,acylpyruvate hydrolase activity,MF,
12827,GO:0047623,1,0.986593857053435,0,2,adenosine-phosphate deaminase activity,MF,
12828,GO:0047631,1,0.972939653371732,0,5,ADP-ribose diphosphatase activity,MF,
12829,GO:0047635,1,0.987924666120691,0,2,alanine-oxo-acid transaminase activity,MF,
12830,GO:0047658,1,0.994544350632709,0,1,alpha-amino-acid esterase activity,MF,
12831,GO:0047661,1,0.994322778976815,0,1,amino-acid racemase activity,MF,
12832,GO:0047676,1,0.992236004518701,0,1,arachidonate-CoA ligase activity,MF,
12833,GO:0047685,1,0.994576979539892,0,1,amine sulfotransferase activity,MF,
12834,GO:0047693,1,0.994654979429419,0,1,ATP diphosphatase activity,MF,
12835,GO:0047696,1,0.988409054870724,0,2,beta-adrenergic receptor kinase activity,MF,
12836,GO:0047708,1,0.989110502581849,0,2,biotinidase activity,MF,
12837,GO:0047710,1,0.987381589731578,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12838,GO:0047718,1,0.983857405101417,0,3,indanol dehydrogenase activity,MF,
12839,GO:0047726,1,0.994311104687468,0,1,iron-cytochrome-c reductase activity,MF,
12840,GO:0047730,1,0.993354325971769,0,1,carnosine synthase activity,MF,
12841,GO:0047734,1,0.994184768585909,0,1,CDP-glycerol diphosphatase activity,MF,
12842,GO:0047743,1,0.994617207446698,0,1,chlordecone reductase activity,MF,
12843,GO:0047747,1,0.994364461987243,0,1,cholate-CoA ligase activity,MF,
12844,GO:0047750,1,0.989287599012666,0,2,cholestenol delta-isomerase activity,MF,
12845,GO:0047751,1,0.988678909867638,0,2,cholestenone 5-alpha-reductase activity,MF,
12846,GO:0047756,1,0.975336717167387,0,4,chondroitin 4-sulfotransferase activity,MF,
12847,GO:0047757,1,0.981893667601238,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12848,GO:0047760,1,0.971569472278073,0,5,butyrate-CoA ligase activity,MF,
12849,GO:0047777,1,0.991683568212354,0,1,(3S)-citramalyl-CoA lyase activity,MF,
12850,GO:0047787,1,0.994613946734573,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12851,GO:0047800,1,0.993552374949571,0,1,cysteamine dioxygenase activity,MF,
12852,GO:0047801,1,0.994442203187033,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12853,GO:0047837,1,0.994628416358595,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12854,GO:0047840,1,0.994625312802153,0,1,dCTP diphosphatase activity,MF,
12855,GO:0047844,1,0.961640430997254,0,7,deoxycytidine deaminase activity,MF,
12856,GO:0047856,1,0.994617526738012,0,1,dihydrocoumarin hydrolase activity,MF,
12857,GO:0047860,1,0.994608702348059,0,1,diiodophenylpyruvate reductase activity,MF,
12858,GO:0047865,1,0.994007729262637,0,1,dimethylglycine dehydrogenase activity,MF,
12859,GO:0047874,1,0.994447077199391,0,1,dolichyldiphosphatase activity,MF,
12860,GO:0047888,1,0.994489977582292,0,1,fatty acid peroxidase activity,MF,
12861,GO:0047894,1,0.983843068597925,0,3,flavonol 3-sulfotransferase activity,MF,
12862,GO:0047915,1,0.994547163185992,0,1,ganglioside galactosyltransferase activity,MF,
12863,GO:0047933,1,0.989184742820394,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12864,GO:0047936,1,0.988659167440128,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12865,GO:0047939,1,0.994581830190299,0,1,L-glucuronate reductase activity,MF,
12866,GO:0047946,1,0.99445905810003,0,1,glutamine N-acyltransferase activity,MF,
12867,GO:0047961,1,0.989084273459924,0,2,glycine N-acyltransferase activity,MF,
12868,GO:0047963,1,0.993779383629816,0,1,glycine N-choloyltransferase activity,MF,
12869,GO:0047969,1,0.99453426246216,0,1,glyoxylate oxidase activity,MF,
12870,GO:0047977,1,0.988631335009537,0,2,hepoxilin-epoxide hydrolase activity,MF,
12871,GO:0047982,1,0.994535156464788,0,1,homocysteine desulfhydrase activity,MF,
12872,GO:0047988,1,0.994501365702875,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12873,GO:0047992,1,0.994184768585909,0,1,hydroxylysine kinase activity,MF,
12875,GO:0048003,1,0.97392164127093,0,4,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12876,GO:0048006,1,0.993500340831078,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12877,GO:0048007,1,0.97392164127093,0,4,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12878,GO:0048008,1,0.700037416822793,0,48,platelet-derived growth factor receptor signaling pathway,BP,
12880,GO:0048010,1,0.542527976237893,0,91,vascular endothelial growth factor receptor signaling pathway,BP,
12881,GO:0048011,1,0.854141092826517,0,24,neurotrophin TRK receptor signaling pathway,BP,
12882,GO:0048012,1,0.903258871743194,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12884,GO:0048014,1,0.977971361032548,0,3,Tie signaling pathway,BP,
12885,GO:0048015,1,0.370320054589161,0,141,phosphatidylinositol-mediated signaling,BP,
12886,GO:0048016,1,0.765585037632899,0,36,inositol phosphate-mediated signaling,BP,
12887,GO:0048017,1,0.362898914591546,0,144,inositol lipid-mediated signaling,BP,
12889,GO:0048019,1,0.930404172075495,0,12,receptor antagonist activity,MF,
12891,GO:0048021,1,0.953681288565,0,6,regulation of melanin biosynthetic process,BP,
12892,GO:0048022,1,0.982390052701331,0,2,negative regulation of melanin biosynthetic process,BP,
12893,GO:0048023,1,0.970781722992663,0,4,positive regulation of melanin biosynthetic process,BP,
12894,GO:0048024,1,0.618931665349446,0,74,regulation of mRNA splicing, via spliceosome,BP,
12895,GO:0048025,1,0.89180893548618,0,19,negative regulation of mRNA splicing, via spliceosome,BP,
12896,GO:0048026,1,0.909980005403709,0,15,positive regulation of mRNA splicing, via spliceosome,BP,
12898,GO:0048029,1,0.678546431317266,0,64,monosaccharide binding,MF,
12899,GO:0048030,1,0.983834669556571,0,3,disaccharide binding,MF,
12900,GO:0048033,1,0.994064970559805,0,1,heme o metabolic process,BP,
12901,GO:0048034,1,0.994064970559805,0,1,heme O biosynthetic process,BP,
12902,GO:0048037,1,0.0663429212143036,0,433,cofactor binding,MF,
12903,GO:0048038,1,0.924168778878594,0,14,quinone binding,MF,
12904,GO:0048039,1,0.967549820488328,0,6,ubiquinone binding,MF,
12905,GO:0048040,1,0.994452711091407,0,1,UDP-glucuronate decarboxylase activity,MF,
12907,GO:0048048,1,0.763653418935393,0,34,embryonic eye morphogenesis,BP,
12908,GO:0048050,1,0.959639554884944,0,6,post-embryonic eye morphogenesis,BP,
12909,GO:0048066,1,0.74632400734663,0,42,developmental pigmentation,BP,
12910,GO:0048069,1,0.956167565180512,0,7,eye pigmentation,BP,
12911,GO:0048070,1,0.898187219565342,0,15,regulation of developmental pigmentation,BP,
12912,GO:0048073,1,0.986101547642261,0,2,regulation of eye pigmentation,BP,
12913,GO:0048075,1,0.993047207239945,0,1,positive regulation of eye pigmentation,BP,
12914,GO:0048087,1,0.934058138191517,0,9,positive regulation of developmental pigmentation,BP,
12915,GO:0048096,1,0.938705417030378,0,9,chromatin-mediated maintenance of transcription,BP,
12916,GO:0048101,1,0.98830503544679,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12917,GO:0048102,1,0.955793220073297,0,7,autophagic cell death,BP,
12918,GO:0048103,1,0.852730298642938,0,22,somatic stem cell division,BP,
12919,GO:0048104,1,0.965480641003469,0,4,establishment of body hair or bristle planar orientation,BP,
12920,GO:0048105,1,0.965480641003469,0,4,establishment of body hair planar orientation,BP,
12921,GO:0048133,1,0.982334135500385,0,3,male germ-line stem cell asymmetric division,BP,
12922,GO:0048143,1,0.912703443427198,0,12,astrocyte activation,BP,
12926,GO:0048147,1,0.837660779297519,0,27,negative regulation of fibroblast proliferation,BP,
12927,GO:0048148,1,0.907352486107061,0,15,behavioral response to cocaine,BP,
12928,GO:0048149,1,0.936100832883104,0,10,behavioral response to ethanol,BP,
12929,GO:0048156,1,0.935706167832661,0,11,tau protein binding,MF,
12930,GO:0048160,1,0.992760760859541,0,1,primary follicle stage,BP,
12931,GO:0048162,1,0.983498180421263,0,3,multi-layer follicle stage,BP,
12932,GO:0048165,1,0.984705511864492,0,2,fused antrum stage,BP,
12936,GO:0048170,1,0.964256537668252,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12938,GO:0048174,1,0.993238578892015,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12939,GO:0048175,1,0.993938092816132,0,1,hepatocyte growth factor biosynthetic process,BP,
12940,GO:0048176,1,0.993938092816132,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12941,GO:0048178,1,0.993938092816132,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12942,GO:0048179,1,0.977788063788616,0,3,activin receptor complex,CC,
12943,GO:0048180,1,0.994430119833875,0,1,activin complex,CC,
12944,GO:0048185,1,0.91821721867712,0,12,activin binding,MF,
12945,GO:0048188,1,0.913128185099267,0,12,Set1C/COMPASS complex,CC,
12947,GO:0048194,1,0.584499737608339,0,78,Golgi vesicle budding,BP,
12948,GO:0048199,1,0.625018267543113,0,70,vesicle targeting, to, from or within Golgi,BP,
12949,GO:0048200,1,0.962293745894193,0,6,Golgi transport vesicle coating,BP,
12950,GO:0048203,1,0.988670857424845,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12951,GO:0048205,1,0.962293745894193,0,6,COPI coating of Golgi vesicle,BP,
12952,GO:0048207,1,0.657920037475546,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
12953,GO:0048208,1,0.657920037475546,0,62,COPII vesicle coating,BP,
12954,GO:0048209,1,0.986683979913869,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12955,GO:0048210,1,0.97631370276113,0,4,Golgi vesicle fusion to target membrane,BP,
12956,GO:0048211,1,0.987667542990915,0,2,Golgi vesicle docking,BP,
12957,GO:0048213,1,0.988722768865767,0,2,Golgi vesicle prefusion complex stabilization,BP,
12958,GO:0048227,1,0.950001740590298,0,8,plasma membrane to endosome transport,BP,
12959,GO:0048232,1,0.0621874559798722,0,413,male gamete generation,BP,
12960,GO:0048237,1,0.983654662536005,0,3,rough endoplasmic reticulum lumen,CC,
12961,GO:0048239,1,0.988602540480664,0,2,negative regulation of DNA recombination at telomere,BP,
12962,GO:0048240,1,0.899574841772364,0,17,sperm capacitation,BP,
12963,GO:0048241,1,0.977363262012479,0,4,epinephrine transport,BP,
12964,GO:0048242,1,0.977363262012479,0,4,epinephrine secretion,BP,
12966,GO:0048244,1,0.994550298833769,0,1,phytanoyl-CoA dioxygenase activity,MF,
12971,GO:0048250,1,0.989109422479566,0,2,iron import into the mitochondrion,BP,
12972,GO:0048251,1,0.935295753492135,0,9,elastic fiber assembly,BP,
12973,GO:0048254,1,0.97527678407915,0,4,snoRNA localization,BP,
12974,GO:0048255,1,0.811611873074689,0,31,mRNA stabilization,BP,
12975,GO:0048256,1,0.95892323993515,0,7,flap endonuclease activity,MF,
12976,GO:0048257,1,0.988567441595152,0,2,3'-flap endonuclease activity,MF,
12979,GO:0048261,1,0.898388750456148,0,17,negative regulation of receptor-mediated endocytosis,BP,
12980,GO:0048262,1,0.947774272787014,0,9,determination of dorsal/ventral asymmetry,BP,
12981,GO:0048263,1,0.953440815597406,0,8,determination of dorsal identity,BP,
12982,GO:0048264,1,0.994059570370626,0,1,determination of ventral identity,BP,
12983,GO:0048265,1,0.835221886638358,0,26,response to pain,BP,
12984,GO:0048266,1,0.919849865302058,0,12,behavioral response to pain,BP,
12986,GO:0048269,1,0.988652631257236,0,2,methionine adenosyltransferase complex,CC,
12987,GO:0048270,1,0.99445479617206,0,1,methionine adenosyltransferase regulator activity,MF,
12988,GO:0048273,1,0.959436626134269,0,6,mitogen-activated protein kinase p38 binding,MF,
12990,GO:0048280,1,0.953336302586872,0,8,vesicle fusion with Golgi apparatus,BP,
12992,GO:0048285,1,0.060881055083165,0,407,organelle fission,BP,
12993,GO:0048286,1,0.769531031431761,0,35,lung alveolus development,BP,
12994,GO:0048289,1,0.963854837042343,0,6,isotype switching to IgE isotypes,BP,
12995,GO:0048290,1,0.965897496263552,0,6,isotype switching to IgA isotypes,BP,
12996,GO:0048291,1,0.93375531316892,0,11,isotype switching to IgG isotypes,BP,
12997,GO:0048293,1,0.963854837042343,0,6,regulation of isotype switching to IgE isotypes,BP,
12998,GO:0048294,1,0.981833065820906,0,3,negative regulation of isotype switching to IgE isotypes,BP,
12999,GO:0048295,1,0.981692446205786,0,3,positive regulation of isotype switching to IgE isotypes,BP,
13000,GO:0048296,1,0.971887139392259,0,5,regulation of isotype switching to IgA isotypes,BP,
13001,GO:0048297,1,0.994441044865754,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13002,GO:0048298,1,0.977321268714381,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13003,GO:0048302,1,0.939032723644356,0,10,regulation of isotype switching to IgG isotypes,BP,
13004,GO:0048304,1,0.956227474442079,0,7,positive regulation of isotype switching to IgG isotypes,BP,
13005,GO:0048305,1,0.902793448259625,0,18,immunoglobulin secretion,BP,
13007,GO:0048308,1,0.909757152561142,0,15,organelle inheritance,BP,
13008,GO:0048311,1,0.885841256035802,0,16,mitochondrion distribution,BP,
13009,GO:0048312,1,0.939129604569678,0,8,intracellular distribution of mitochondria,BP,
13010,GO:0048313,1,0.915083286592575,0,14,Golgi inheritance,BP,
13011,GO:0048318,1,0.95775911676148,0,7,axial mesoderm development,BP,
13012,GO:0048319,1,0.979339405548581,0,3,axial mesoderm morphogenesis,BP,
13013,GO:0048320,1,0.988287701070598,0,2,axial mesoderm formation,BP,
13014,GO:0048321,1,0.994455211392974,0,1,axial mesodermal cell differentiation,BP,
13015,GO:0048322,1,0.994455211392974,0,1,axial mesodermal cell fate commitment,BP,
13016,GO:0048327,1,0.994455211392974,0,1,axial mesodermal cell fate specification,BP,
13017,GO:0048332,1,0.646464140953636,0,64,mesoderm morphogenesis,BP,
13018,GO:0048333,1,0.821374428230591,0,30,mesodermal cell differentiation,BP,
13019,GO:0048338,1,0.993628847729139,0,1,mesoderm structural organization,BP,
13020,GO:0048339,1,0.887063186067556,0,17,paraxial mesoderm development,BP,
13021,GO:0048340,1,0.936796297752046,0,9,paraxial mesoderm morphogenesis,BP,
13022,GO:0048341,1,0.962854385823984,0,6,paraxial mesoderm formation,BP,
13023,GO:0048342,1,0.994548460985986,0,1,paraxial mesodermal cell differentiation,BP,
13024,GO:0048343,1,0.994548460985986,0,1,paraxial mesodermal cell fate commitment,BP,
13025,GO:0048352,1,0.993628847729139,0,1,paraxial mesoderm structural organization,BP,
13026,GO:0048364,1,0.994651281344248,0,1,root development,BP,
13027,GO:0048365,1,0.650534574573051,0,60,Rac GTPase binding,MF,
13028,GO:0048368,1,0.907818723543975,0,15,lateral mesoderm development,BP,
13029,GO:0048369,1,0.974531368179366,0,4,lateral mesoderm morphogenesis,BP,
13030,GO:0048370,1,0.974531368179366,0,4,lateral mesoderm formation,BP,
13031,GO:0048371,1,0.979861057336606,0,3,lateral mesodermal cell differentiation,BP,
13032,GO:0048372,1,0.985488320841739,0,2,lateral mesodermal cell fate commitment,BP,
13033,GO:0048377,1,0.985488320841739,0,2,lateral mesodermal cell fate specification,BP,
13034,GO:0048378,1,0.985488320841739,0,2,regulation of lateral mesodermal cell fate specification,BP,
13035,GO:0048382,1,0.976968767302468,0,4,mesendoderm development,BP,
13036,GO:0048384,1,0.840840822396534,0,28,retinoic acid receptor signaling pathway,BP,
13037,GO:0048385,1,0.911367074073348,0,15,regulation of retinoic acid receptor signaling pathway,BP,
13038,GO:0048386,1,0.975820253307127,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13039,GO:0048387,1,0.949370293697221,0,8,negative regulation of retinoic acid receptor signaling pathway,BP,
13040,GO:0048388,1,0.982501065127673,0,3,endosomal lumen acidification,BP,
13041,GO:0048389,1,0.989061056105154,0,2,intermediate mesoderm development,BP,
13042,GO:0048390,1,0.994527376974531,0,1,intermediate mesoderm morphogenesis,BP,
13043,GO:0048391,1,0.994527376974531,0,1,intermediate mesoderm formation,BP,
13044,GO:0048392,1,0.994527376974531,0,1,intermediate mesodermal cell differentiation,BP,
13045,GO:0048403,1,0.976077973682971,0,3,brain-derived neurotrophic factor binding,MF,
13046,GO:0048406,1,0.960287530276151,0,6,nerve growth factor binding,MF,
13048,GO:0048408,1,0.982897131488616,0,3,epidermal growth factor binding,MF,
13052,GO:0048475,1,0.529239234134651,0,96,coated membrane,CC,
13053,GO:0048476,1,0.97245739064717,0,5,Holliday junction resolvase complex,CC,
13054,GO:0048477,1,0.644132550564811,0,67,oogenesis,BP,
13055,GO:0048478,1,0.950058813396784,0,7,replication fork protection,BP,
13056,GO:0048483,1,0.765537117121124,0,38,autonomic nervous system development,BP,
13057,GO:0048484,1,0.934808805464514,0,10,enteric nervous system development,BP,
13058,GO:0048485,1,0.873205281313182,0,19,sympathetic nervous system development,BP,
13059,GO:0048486,1,0.908670876260898,0,14,parasympathetic nervous system development,BP,
13060,GO:0048487,1,0.7938422065581,0,36,beta-tubulin binding,MF,
13061,GO:0048488,1,0.750687712615605,0,39,synaptic vesicle endocytosis,BP,
13063,GO:0048490,1,0.900093209303852,0,17,anterograde synaptic vesicle transport,BP,
13064,GO:0048495,1,0.959266060363622,0,5,Roundabout binding,MF,
13065,GO:0048496,1,0.965570116840123,0,4,maintenance of animal organ identity,BP,
13066,GO:0048499,1,0.976273986101029,0,4,synaptic vesicle membrane organization,BP,
13067,GO:0048500,1,0.949719659056317,0,9,signal recognition particle,CC,
13068,GO:0048505,1,0.928217269843448,0,11,regulation of timing of cell differentiation,BP,
13070,GO:0048512,1,0.781970534270711,0,38,circadian behavior,BP,
13073,GO:0048515,1,0.507078142076235,0,102,spermatid differentiation,BP,
13076,GO:0048520,1,0.89003423301362,0,18,positive regulation of behavior,BP,
13077,GO:0048521,1,0.9268600955161,0,13,negative regulation of behavior,BP,
13080,GO:0048524,1,0.525381356516199,0,100,positive regulation of viral process,BP,
13082,GO:0048531,1,0.920758576412799,0,14,beta-1,3-galactosyltransferase activity,MF,
13083,GO:0048532,1,0.904452094377524,0,15,anatomical structure arrangement,BP,
13087,GO:0048537,1,0.963040281545176,0,6,mucosal-associated lymphoid tissue development,BP,
13088,GO:0048538,1,0.739641978819712,0,43,thymus development,BP,
13089,GO:0048539,1,0.956378715701256,0,7,bone marrow development,BP,
13090,GO:0048541,1,0.963040281545176,0,6,Peyer's patch development,BP,
13092,GO:0048546,1,0.723864829528815,0,45,digestive tract morphogenesis,BP,
13093,GO:0048548,1,0.943881409504197,0,9,regulation of pinocytosis,BP,
13094,GO:0048549,1,0.973164500145438,0,4,positive regulation of pinocytosis,BP,
13095,GO:0048550,1,0.969917475200636,0,5,negative regulation of pinocytosis,BP,
13096,GO:0048557,1,0.894413511723338,0,16,embryonic digestive tract morphogenesis,BP,
13097,GO:0048560,1,0.988872656438497,0,2,establishment of anatomical structure orientation,BP,
13098,GO:0048561,1,0.994414739139378,0,1,establishment of animal organ orientation,BP,
13100,GO:0048563,1,0.943083991889206,0,8,post-embryonic animal organ morphogenesis,BP,
13102,GO:0048566,1,0.808489173914764,0,32,embryonic digestive tract development,BP,
13103,GO:0048567,1,0.994290705332452,0,1,ectodermal digestive tract morphogenesis,BP,
13105,GO:0048569,1,0.896553619945634,0,15,post-embryonic animal organ development,BP,
13106,GO:0048570,1,0.944518322138875,0,8,notochord morphogenesis,BP,
13113,GO:0048593,1,0.495746206307992,0,98,camera-type eye morphogenesis,BP,
13114,GO:0048596,1,0.816641582986698,0,25,embryonic camera-type eye morphogenesis,BP,
13115,GO:0048597,1,0.983765993570563,0,3,post-embryonic camera-type eye morphogenesis,BP,
13117,GO:0048599,1,0.777157121019249,0,38,oocyte development,BP,
13120,GO:0048611,1,0.988409815558979,0,2,embryonic ectodermal digestive tract development,BP,
13121,GO:0048613,1,0.994290705332452,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13122,GO:0048617,1,0.929823734698765,0,9,embryonic foregut morphogenesis,BP,
13123,GO:0048619,1,0.982126492981098,0,3,embryonic hindgut morphogenesis,BP,
13124,GO:0048625,1,0.969210270072428,0,5,myoblast fate commitment,BP,
13125,GO:0048627,1,0.988532264598271,0,2,myoblast development,BP,
13126,GO:0048630,1,0.954556005218365,0,7,skeletal muscle tissue growth,BP,
13127,GO:0048631,1,0.965141384185734,0,5,regulation of skeletal muscle tissue growth,BP,
13128,GO:0048632,1,0.98497432617569,0,2,negative regulation of skeletal muscle tissue growth,BP,
13129,GO:0048633,1,0.979867524616157,0,3,positive regulation of skeletal muscle tissue growth,BP,
13130,GO:0048634,1,0.441457023019876,0,117,regulation of muscle organ development,BP,
13131,GO:0048635,1,0.752610887845982,0,43,negative regulation of muscle organ development,BP,
13132,GO:0048636,1,0.652303615620634,0,60,positive regulation of muscle organ development,BP,
13136,GO:0048641,1,0.732796738085055,0,46,regulation of skeletal muscle tissue development,BP,
13137,GO:0048642,1,0.916605850798389,0,13,negative regulation of skeletal muscle tissue development,BP,
13138,GO:0048643,1,0.869935839020484,0,21,positive regulation of skeletal muscle tissue development,BP,
13140,GO:0048645,1,0.686122926308928,0,58,animal organ formation,BP,
13142,GO:0048659,1,0.45941775788875,0,117,smooth muscle cell proliferation,BP,
13143,GO:0048660,1,0.468882226966963,0,114,regulation of smooth muscle cell proliferation,BP,
13144,GO:0048661,1,0.613195735800392,0,72,positive regulation of smooth muscle cell proliferation,BP,
13145,GO:0048662,1,0.784680953985274,0,39,negative regulation of smooth muscle cell proliferation,BP,
13146,GO:0048663,1,0.682203898029379,0,58,neuron fate commitment,BP,
13147,GO:0048664,1,0.966450268917637,0,6,neuron fate determination,BP,
13148,GO:0048665,1,0.830622227893799,0,29,neuron fate specification,BP,
13152,GO:0048669,1,0.980561196669972,0,3,collateral sprouting in absence of injury,BP,
13155,GO:0048672,1,0.934972430004113,0,11,positive regulation of collateral sprouting,BP,
13157,GO:0048674,1,0.994337252693284,0,1,collateral sprouting of injured axon,BP,
13162,GO:0048680,1,0.960532291317708,0,7,positive regulation of axon regeneration,BP,
13168,GO:0048687,1,0.988507410398742,0,2,positive regulation of sprouting of injured axon,BP,
13170,GO:0048689,1,0.994337252693284,0,1,formation of growth cone in injured axon,BP,
13172,GO:0048691,1,0.994137289025417,0,1,positive regulation of axon extension involved in regeneration,BP,
13174,GO:0048693,1,0.994337252693284,0,1,regulation of collateral sprouting of injured axon,BP,
13175,GO:0048694,1,0.994337252693284,0,1,positive regulation of collateral sprouting of injured axon,BP,
13176,GO:0048696,1,0.994578590289335,0,1,regulation of collateral sprouting in absence of injury,BP,
13177,GO:0048697,1,0.994578590289335,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13180,GO:0048702,1,0.95112104853773,0,7,embryonic neurocranium morphogenesis,BP,
13181,GO:0048703,1,0.932533539284227,0,9,embryonic viscerocranium morphogenesis,BP,
13186,GO:0048709,1,0.560416411175754,0,87,oligodendrocyte differentiation,BP,
13187,GO:0048710,1,0.831370045785978,0,27,regulation of astrocyte differentiation,BP,
13188,GO:0048711,1,0.91337975094836,0,14,positive regulation of astrocyte differentiation,BP,
13189,GO:0048712,1,0.927775270968174,0,11,negative regulation of astrocyte differentiation,BP,
13190,GO:0048713,1,0.804599495577033,0,33,regulation of oligodendrocyte differentiation,BP,
13191,GO:0048714,1,0.897797542916831,0,17,positive regulation of oligodendrocyte differentiation,BP,
13192,GO:0048715,1,0.923522183152319,0,11,negative regulation of oligodendrocyte differentiation,BP,
13194,GO:0048730,1,0.838721326275319,0,27,epidermis morphogenesis,BP,
13197,GO:0048733,1,0.95328693548357,0,6,sebaceous gland development,BP,
13199,GO:0048738,1,0.254669016320267,0,184,cardiac muscle tissue development,BP,
13200,GO:0048739,1,0.887249876191532,0,13,cardiac muscle fiber development,BP,
13201,GO:0048741,1,0.832024892345932,0,27,skeletal muscle fiber development,BP,
13202,GO:0048742,1,0.940974847419592,0,9,regulation of skeletal muscle fiber development,BP,
13203,GO:0048743,1,0.96370305312878,0,6,positive regulation of skeletal muscle fiber development,BP,
13205,GO:0048747,1,0.683115174033556,0,51,muscle fiber development,BP,
13206,GO:0048749,1,0.99329588879917,0,1,compound eye development,BP,
13207,GO:0048752,1,0.949164685830611,0,7,semicircular canal morphogenesis,BP,
13208,GO:0048753,1,0.832736532983384,0,27,pigment granule organization,BP,
13210,GO:0048755,1,0.934483255386763,0,9,branching morphogenesis of a nerve,BP,
13211,GO:0048757,1,0.938724071474145,0,10,pigment granule maturation,BP,
13213,GO:0048763,1,0.943616192138009,0,4,calcium-induced calcium release activity,MF,
13214,GO:0048764,1,0.994651281344248,0,1,trichoblast maturation,BP,
13215,GO:0048765,1,0.994651281344248,0,1,root hair cell differentiation,BP,
13216,GO:0048767,1,0.994651281344248,0,1,root hair elongation,BP,
13217,GO:0048769,1,0.946992714169088,0,4,sarcomerogenesis,BP,
13221,GO:0048787,1,0.966296190959463,0,5,presynaptic active zone membrane,CC,
13223,GO:0048789,1,0.992490332986896,0,1,cytoskeletal matrix organization at active zone,BP,
13224,GO:0048790,1,0.994577825609846,0,1,maintenance of presynaptic active zone structure,BP,
13226,GO:0048792,1,0.993773111512133,0,1,spontaneous exocytosis of neurotransmitter,BP,
13227,GO:0048793,1,0.95706711876209,0,6,pronephros development,BP,
13229,GO:0048806,1,0.739295468086625,0,40,genitalia development,BP,
13230,GO:0048807,1,0.982156689248424,0,3,female genitalia morphogenesis,BP,
13231,GO:0048808,1,0.980745796057172,0,3,male genitalia morphogenesis,BP,
13236,GO:0048818,1,0.96773890276163,0,5,positive regulation of hair follicle maturation,BP,
13239,GO:0048821,1,0.834230091544588,0,28,erythrocyte development,BP,
13240,GO:0048822,1,0.976387696582685,0,3,enucleate erythrocyte development,BP,
13241,GO:0048823,1,0.994184768585909,0,1,nucleate erythrocyte development,BP,
13243,GO:0048840,1,0.974470135109345,0,4,otolith development,BP,
13244,GO:0048841,1,0.800942225051907,0,27,regulation of axon extension involved in axon guidance,BP,
13245,GO:0048842,1,0.934469273703347,0,7,positive regulation of axon extension involved in axon guidance,BP,
13246,GO:0048843,1,0.867237448343941,0,19,negative regulation of axon extension involved in axon guidance,BP,
13248,GO:0048845,1,0.928886837352017,0,10,venous blood vessel morphogenesis,BP,
13249,GO:0048846,1,0.768431539666481,0,32,axon extension involved in axon guidance,BP,
13250,GO:0048850,1,0.982815389267432,0,2,hypophysis morphogenesis,BP,
13251,GO:0048852,1,0.977342046288112,0,3,diencephalon morphogenesis,BP,
13252,GO:0048853,1,0.909558066211837,0,13,forebrain morphogenesis,BP,
13254,GO:0048855,1,0.99111874017356,0,1,adenohypophysis morphogenesis,BP,
13258,GO:0048859,1,0.967634349103475,0,5,formation of anatomical boundary,BP,
13259,GO:0048861,1,0.969949979073521,0,4,leukemia inhibitory factor signaling pathway,BP,
13261,GO:0048864,1,0.613606107568674,0,72,stem cell development,BP,
13262,GO:0048865,1,0.954122646456151,0,8,stem cell fate commitment,BP,
13263,GO:0048866,1,0.977114733698129,0,4,stem cell fate specification,BP,
13264,GO:0048867,1,0.983449465689643,0,3,stem cell fate determination,BP,
13269,GO:0048873,1,0.839188087828358,0,27,homeostasis of number of cells within a tissue,BP,
13270,GO:0048874,1,0.993882861295582,0,1,homeostasis of number of cells in a free-living population,BP,
13271,GO:0048875,1,0.936110935959826,0,10,chemical homeostasis within a tissue,BP,
13273,GO:0048880,1,0.973990230416378,0,4,sensory system development,BP,
13274,GO:0048882,1,0.994251418956767,0,1,lateral line development,BP,
13275,GO:0048884,1,0.994251418956767,0,1,neuromast development,BP,
13276,GO:0048886,1,0.994251418956767,0,1,neuromast hair cell differentiation,BP,
13277,GO:0048925,1,0.994251418956767,0,1,lateral line system development,BP,
13278,GO:0048934,1,0.907153504573105,0,13,peripheral nervous system neuron differentiation,BP,
13279,GO:0048935,1,0.907153504573105,0,13,peripheral nervous system neuron development,BP,
13280,GO:0048936,1,0.982369931428051,0,3,peripheral nervous system neuron axonogenesis,BP,
13281,GO:0050000,1,0.627098562859501,0,71,chromosome localization,BP,
13282,GO:0050011,1,0.994563318969277,0,1,itaconyl-CoA hydratase activity,MF,
13283,GO:0050023,1,0.994510452883552,0,1,L-fuconate dehydratase activity,MF,
13284,GO:0050031,1,0.994347897726635,0,1,L-pipecolate oxidase activity,MF,
13285,GO:0050038,1,0.99464799022202,0,1,L-xylulose reductase (NADP+) activity,MF,
13286,GO:0050046,1,0.994184768585909,0,1,lathosterol oxidase activity,MF,
13287,GO:0050051,1,0.988637462164201,0,2,leukotriene-B4 20-monooxygenase activity,MF,
13288,GO:0050072,1,0.951853875600734,0,7,m7G(5')pppN diphosphatase activity,MF,
13289,GO:0050080,1,0.994423440946932,0,1,malonyl-CoA decarboxylase activity,MF,
13290,GO:0050104,1,0.994577825609846,0,1,L-gulonate 3-dehydrogenase activity,MF,
13291,GO:0050115,1,0.992522077071725,0,1,myosin-light-chain-phosphatase activity,MF,
13292,GO:0050119,1,0.982983746488401,0,2,N-acetylglucosamine deacetylase activity,MF,
13293,GO:0050121,1,0.994581606675608,0,1,N-acylglucosamine 2-epimerase activity,MF,
13294,GO:0050124,1,0.99349131836788,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13295,GO:0050129,1,0.993937423815543,0,1,N-formylglutamate deformylase activity,MF,
13296,GO:0050135,1,0.989188540351826,0,2,NAD(P)+ nucleosidase activity,MF,
13297,GO:0050136,1,0.812118658266644,0,38,NADH dehydrogenase (quinone) activity,MF,
13298,GO:0050144,1,0.994184768585909,0,1,nucleoside deoxyribosyltransferase activity,MF,
13299,GO:0050145,1,0.971648408220332,0,5,nucleoside phosphate kinase activity,MF,
13300,GO:0050146,1,0.992108220013928,0,1,nucleoside phosphotransferase activity,MF,
13301,GO:0050152,1,0.994608349817702,0,1,omega-amidase activity,MF,
13302,GO:0050178,1,0.989349232066065,0,2,phenylpyruvate tautomerase activity,MF,
13303,GO:0050185,1,0.981626092715081,0,2,phosphatidylinositol deacylase activity,MF,
13304,GO:0050197,1,0.994383820414269,0,1,phytanate-CoA ligase activity,MF,
13305,GO:0050201,1,0.99338223972025,0,1,fucokinase activity,MF,
13306,GO:0050211,1,0.982542029752326,0,3,procollagen galactosyltransferase activity,MF,
13307,GO:0050220,1,0.978406390783658,0,4,prostaglandin-E synthase activity,MF,
13308,GO:0050221,1,0.994612043525747,0,1,prostaglandin-E2 9-reductase activity,MF,
13309,GO:0050252,1,0.987922766401229,0,2,retinol O-fatty-acyltransferase activity,MF,
13310,GO:0050253,1,0.986489709456949,0,2,retinyl-palmitate esterase activity,MF,
13311,GO:0050254,1,0.98889425621504,0,2,rhodopsin kinase activity,MF,
13312,GO:0050262,1,0.988403017609477,0,2,ribosylnicotinamide kinase activity,MF,
13313,GO:0050265,1,0.977716860554058,0,3,RNA uridylyltransferase activity,MF,
13314,GO:0050277,1,0.993453349443659,0,1,sedoheptulokinase activity,MF,
13315,GO:0050290,1,0.992650266793855,0,1,sphingomyelin phosphodiesterase D activity,MF,
13316,GO:0050291,1,0.960292033374754,0,7,sphingosine N-acyltransferase activity,MF,
13317,GO:0050294,1,0.98383894581118,0,3,steroid sulfotransferase activity,MF,
13318,GO:0050308,1,0.951591840236699,0,8,sugar-phosphatase activity,MF,
13319,GO:0050309,1,0.982712679120752,0,3,sugar-terminal-phosphatase activity,MF,
13320,GO:0050313,1,0.994638523445285,0,1,sulfur dioxygenase activity,MF,
13321,GO:0050321,1,0.914750607583592,0,13,tau-protein kinase activity,MF,
13322,GO:0050333,1,0.994524890819631,0,1,thiamin-triphosphatase activity,MF,
13323,GO:0050337,1,0.99466137643777,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13324,GO:0050346,1,0.994184768585909,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13325,GO:0050347,1,0.988273623232569,0,2,trans-octaprenyltranstransferase activity,MF,
13326,GO:0050353,1,0.994146019832506,0,1,trimethyllysine dioxygenase activity,MF,
13327,GO:0050355,1,0.99290099705519,0,1,triphosphatase activity,MF,
13328,GO:0050379,1,0.992375039135627,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13329,GO:0050405,1,0.980849683645135,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13330,GO:0050421,1,0.994271649284811,0,1,nitrite reductase (NO-forming) activity,MF,
13331,GO:0050427,1,0.871681741980657,0,22,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13332,GO:0050428,1,0.960679393224186,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13333,GO:0050429,1,0.991035875780876,0,1,calcium-dependent phospholipase C activity,MF,
13334,GO:0050431,1,0.871186294410355,0,19,transforming growth factor beta binding,MF,
13337,GO:0050434,1,0.767721058068623,0,41,positive regulation of viral transcription,BP,
13338,GO:0050435,1,0.796042223237395,0,32,amyloid-beta metabolic process,BP,
13339,GO:0050436,1,0.985683997772891,0,2,microfibril binding,MF,
13340,GO:0050444,1,0.993874503447871,0,1,aquacobalamin reductase (NADPH) activity,MF,
13341,GO:0050459,1,0.994184768585909,0,1,ethanolamine-phosphate phospho-lyase activity,MF,
13342,GO:0050462,1,0.994612382336904,0,1,N-acetylneuraminate synthase activity,MF,
13343,GO:0050473,1,0.981487592495713,0,3,arachidonate 15-lipoxygenase activity,MF,
13344,GO:0050479,1,0.994184768585909,0,1,glyceryl-ether monooxygenase activity,MF,
13345,GO:0050480,1,0.994439590766747,0,1,imidazolonepropionase activity,MF,
13347,GO:0050497,1,0.988388113584464,0,2,transferase activity, transferring alkylthio groups,MF,
13348,GO:0050501,1,0.97725067971459,0,4,hyaluronan synthase activity,MF,
13349,GO:0050508,1,0.980798624836287,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13350,GO:0050509,1,0.987411985513519,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13351,GO:0050510,1,0.974233154015869,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13352,GO:0050512,1,0.994453824998501,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13353,GO:0050528,1,0.994356446801965,0,1,acyloxyacyl hydrolase activity,MF,
13354,GO:0050542,1,0.967559509764474,0,6,icosanoid binding,MF,
13355,GO:0050543,1,0.967651517539449,0,6,icosatetraenoic acid binding,MF,
13356,GO:0050544,1,0.972880033035727,0,5,arachidonic acid binding,MF,
13357,GO:0050560,1,0.993827041024114,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13358,GO:0050561,1,0.993387297275929,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13359,GO:0050567,1,0.982171803819661,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13360,GO:0050571,1,0.994560072177133,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13361,GO:0050577,1,0.994597284963999,0,1,GDP-L-fucose synthase activity,MF,
13362,GO:0050610,1,0.989258493826838,0,2,methylarsonate reductase activity,MF,
13363,GO:0050613,1,0.988091880445917,0,2,delta14-sterol reductase activity,MF,
13364,GO:0050614,1,0.99306586030518,0,1,delta24-sterol reductase activity,MF,
13365,GO:0050632,1,0.994589558723342,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13366,GO:0050646,1,0.994532663192208,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13367,GO:0050647,1,0.994532663192208,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13368,GO:0050648,1,0.994532663192208,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13369,GO:0050650,1,0.812226732923535,0,30,chondroitin sulfate proteoglycan biosynthetic process,BP,
13370,GO:0050651,1,0.897462041177045,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13371,GO:0050652,1,0.993548338899064,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13372,GO:0050653,1,0.986947642577799,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13373,GO:0050654,1,0.747294948190195,0,42,chondroitin sulfate proteoglycan metabolic process,BP,
13374,GO:0050655,1,0.892451611857784,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13375,GO:0050656,1,0.960317638642215,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13378,GO:0050659,1,0.984478675905134,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13379,GO:0050660,1,0.612108538822401,0,77,flavin adenine dinucleotide binding,MF,
13380,GO:0050661,1,0.75596583795663,0,44,NADP binding,MF,
13381,GO:0050662,1,0.201797337975452,0,258,coenzyme binding,MF,
13383,GO:0050664,1,0.924049921994686,0,12,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13384,GO:0050665,1,0.930513271100857,0,11,hydrogen peroxide biosynthetic process,BP,
13385,GO:0050666,1,0.988744599637742,0,2,regulation of homocysteine metabolic process,BP,
13386,GO:0050667,1,0.915616529646312,0,14,homocysteine metabolic process,BP,
13387,GO:0050668,1,0.994399120274267,0,1,positive regulation of homocysteine metabolic process,BP,
13390,GO:0050672,1,0.663728777576784,0,64,negative regulation of lymphocyte proliferation,BP,
13392,GO:0050674,1,0.994659444719884,0,1,urothelial cell proliferation,BP,
13393,GO:0050675,1,0.994659444719884,0,1,regulation of urothelial cell proliferation,BP,
13394,GO:0050677,1,0.994659444719884,0,1,positive regulation of urothelial cell proliferation,BP,
13395,GO:0050678,1,0.147002313640496,0,277,regulation of epithelial cell proliferation,BP,
13396,GO:0050679,1,0.338815111376089,0,158,positive regulation of epithelial cell proliferation,BP,
13397,GO:0050680,1,0.465828634110177,0,109,negative regulation of epithelial cell proliferation,BP,
13398,GO:0050681,1,0.752824140839628,0,41,androgen receptor binding,MF,
13399,GO:0050682,1,0.974181924561316,0,3,AF-2 domain binding,MF,
13400,GO:0050683,1,0.993221240209097,0,1,AF-1 domain binding,MF,
13401,GO:0050684,1,0.488255138450815,0,111,regulation of mRNA processing,BP,
13402,GO:0050685,1,0.859041909656484,0,24,positive regulation of mRNA processing,BP,
13403,GO:0050686,1,0.837518632690364,0,29,negative regulation of mRNA processing,BP,
13404,GO:0050687,1,0.876592400035631,0,21,negative regulation of defense response to virus,BP,
13405,GO:0050688,1,0.681505677113727,0,58,regulation of defense response to virus,BP,
13406,GO:0050689,1,0.972613923878661,0,5,negative regulation of defense response to virus by host,BP,
13407,GO:0050690,1,0.831910135535138,0,29,regulation of defense response to virus by virus,BP,
13408,GO:0050691,1,0.81350513775144,0,32,regulation of defense response to virus by host,BP,
13409,GO:0050692,1,0.980575221443319,0,3,DBD domain binding,MF,
13410,GO:0050693,1,0.959788261452275,0,6,LBD domain binding,MF,
13411,GO:0050694,1,0.97745940981757,0,4,galactose 3-O-sulfotransferase activity,MF,
13412,GO:0050698,1,0.988191459357373,0,2,proteoglycan sulfotransferase activity,MF,
13413,GO:0050699,1,0.823052853069967,0,30,WW domain binding,MF,
13414,GO:0050700,1,0.926717198366594,0,11,CARD domain binding,MF,
13415,GO:0050701,1,0.756790679525312,0,44,interleukin-1 secretion,BP,
13416,GO:0050702,1,0.77839953030153,0,39,interleukin-1 beta secretion,BP,
13417,GO:0050703,1,0.972355247579242,0,5,interleukin-1 alpha secretion,BP,
13418,GO:0050704,1,0.796252279490782,0,37,regulation of interleukin-1 secretion,BP,
13419,GO:0050705,1,0.97757636138601,0,4,regulation of interleukin-1 alpha secretion,BP,
13420,GO:0050706,1,0.814594385126679,0,33,regulation of interleukin-1 beta secretion,BP,
13425,GO:0050711,1,0.936438276429678,0,11,negative regulation of interleukin-1 secretion,BP,
13426,GO:0050712,1,0.994588007976772,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13427,GO:0050713,1,0.95272930193527,0,8,negative regulation of interleukin-1 beta secretion,BP,
13430,GO:0050716,1,0.847466508319337,0,26,positive regulation of interleukin-1 secretion,BP,
13431,GO:0050717,1,0.982896706801207,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13432,GO:0050718,1,0.857365331410959,0,24,positive regulation of interleukin-1 beta secretion,BP,
13433,GO:0050719,1,0.994647438103144,0,1,interleukin-1 alpha biosynthetic process,BP,
13434,GO:0050720,1,0.988656516849403,0,2,interleukin-1 beta biosynthetic process,BP,
13435,GO:0050721,1,0.994647438103144,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13436,GO:0050722,1,0.988656516849403,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13437,GO:0050725,1,0.988656516849403,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13438,GO:0050726,1,0.994647438103144,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13445,GO:0050733,1,0.967184433613718,0,5,RS domain binding,MF,
13446,GO:0050746,1,0.922652237304974,0,12,regulation of lipoprotein metabolic process,BP,
13447,GO:0050747,1,0.966702920611897,0,5,positive regulation of lipoprotein metabolic process,BP,
13448,GO:0050748,1,0.972520155287656,0,4,negative regulation of lipoprotein metabolic process,BP,
13449,GO:0050750,1,0.876267353415168,0,18,low-density lipoprotein particle receptor binding,MF,
13450,GO:0050751,1,0.994642441055126,0,1,fractalkine biosynthetic process,BP,
13451,GO:0050752,1,0.994642441055126,0,1,regulation of fractalkine biosynthetic process,BP,
13452,GO:0050754,1,0.994642441055126,0,1,positive regulation of fractalkine biosynthetic process,BP,
13453,GO:0050755,1,0.932783686863631,0,12,chemokine metabolic process,BP,
13454,GO:0050756,1,0.994642441055126,0,1,fractalkine metabolic process,BP,
13455,GO:0050757,1,0.988910247850311,0,2,thymidylate synthase biosynthetic process,BP,
13456,GO:0050758,1,0.988910247850311,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13457,GO:0050760,1,0.994254843500199,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13459,GO:0050765,1,0.924473853599383,0,13,negative regulation of phagocytosis,BP,
13468,GO:0050774,1,0.89902786678684,0,15,negative regulation of dendrite morphogenesis,BP,
13473,GO:0050779,1,0.836658061731247,0,24,RNA destabilization,BP,
13474,GO:0050780,1,0.919170001418075,0,13,dopamine receptor binding,MF,
13475,GO:0050783,1,0.994336867640233,0,1,cocaine metabolic process,BP,
13476,GO:0050785,1,0.994600258828157,0,1,advanced glycation end-product receptor activity,MF,
13477,GO:0050786,1,0.946876301475773,0,10,RAGE receptor binding,MF,
13478,GO:0050787,1,0.987023641228649,0,2,detoxification of mercury ion,BP,
13484,GO:0050795,1,0.689295060093831,0,54,regulation of behavior,BP,
13488,GO:0050802,1,0.88436318775465,0,20,circadian sleep/wake cycle, sleep,BP,
13495,GO:0050810,1,0.606204134927988,0,77,regulation of steroid biosynthetic process,BP,
13497,GO:0050812,1,0.914049601802541,0,13,regulation of acyl-CoA biosynthetic process,BP,
13498,GO:0050815,1,0.961709945669021,0,6,phosphoserine residue binding,MF,
13499,GO:0050816,1,0.979405115044221,0,3,phosphothreonine residue binding,MF,
13504,GO:0050821,1,0.379593351137126,0,145,protein stabilization,BP,
13505,GO:0050822,1,0.9937207256272,0,1,peptide stabilization,BP,
13506,GO:0050823,1,0.9937207256272,0,1,peptide antigen stabilization,BP,
13510,GO:0050833,1,0.976788838934138,0,4,pyruvate transmembrane transporter activity,MF,
13513,GO:0050847,1,0.934115445486133,0,8,progesterone receptor signaling pathway,BP,
13515,GO:0050849,1,0.8933690562267,0,17,negative regulation of calcium-mediated signaling,BP,
13516,GO:0050850,1,0.805229361497715,0,33,positive regulation of calcium-mediated signaling,BP,
13519,GO:0050853,1,0.717411944583856,0,52,B cell receptor signaling pathway,BP,
13521,GO:0050855,1,0.880019893780578,0,20,regulation of B cell receptor signaling pathway,BP,
13523,GO:0050857,1,0.879495957791087,0,20,positive regulation of antigen receptor-mediated signaling pathway,BP,
13525,GO:0050859,1,0.971070944382189,0,5,negative regulation of B cell receptor signaling pathway,BP,
13527,GO:0050861,1,0.953706672431248,0,7,positive regulation of B cell receptor signaling pathway,BP,
13528,GO:0050862,1,0.929313197902939,0,12,positive regulation of T cell receptor signaling pathway,BP,
13535,GO:0050869,1,0.819603837733187,0,31,negative regulation of B cell activation,BP,
13538,GO:0050872,1,0.921949897366899,0,12,white fat cell differentiation,BP,
13539,GO:0050873,1,0.806996064371064,0,33,brown fat cell differentiation,BP,
13542,GO:0050879,1,0.732290440293611,0,45,multicellular organismal movement,BP,
13544,GO:0050881,1,0.732290440293611,0,45,musculoskeletal movement,BP,
13545,GO:0050882,1,0.943195669439151,0,6,voluntary musculoskeletal movement,BP,
13546,GO:0050883,1,0.994325157917915,0,1,musculoskeletal movement, spinal reflex action,BP,
13547,GO:0050884,1,0.906136841624964,0,14,neuromuscular process controlling posture,BP,
13549,GO:0050886,1,0.636926299569776,0,71,endocrine process,BP,
13551,GO:0050891,1,0.698557040943499,0,52,multicellular organismal water homeostasis,BP,
13552,GO:0050892,1,0.846774580496789,0,26,intestinal absorption,BP,
13553,GO:0050893,1,0.974271506293754,0,4,sensory processing,BP,
13554,GO:0050894,1,0.990852244117435,0,1,determination of affect,BP,
13556,GO:0050897,1,0.991443266410328,0,1,cobalt ion binding,MF,
13558,GO:0050901,1,0.858672436295859,0,24,leukocyte tethering or rolling,BP,
13559,GO:0050902,1,0.988228100430929,0,2,leukocyte adhesive activation,BP,
13560,GO:0050904,1,0.985514096511212,0,2,diapedesis,BP,
13564,GO:0050908,1,0.909652900732385,0,14,detection of light stimulus involved in visual perception,BP,
13566,GO:0050910,1,0.93114827129408,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13567,GO:0050911,1,0.91067129229085,0,17,detection of chemical stimulus involved in sensory perception of smell,BP,
13570,GO:0050915,1,0.976784292816296,0,4,sensory perception of sour taste,BP,
13571,GO:0050916,1,0.971753302433955,0,4,sensory perception of sweet taste,BP,
13572,GO:0050917,1,0.965949537254979,0,5,sensory perception of umami taste,BP,
13574,GO:0050919,1,0.759861797979066,0,36,negative chemotaxis,BP,
13578,GO:0050923,1,0.968304367829887,0,4,regulation of negative chemotaxis,BP,
13579,GO:0050924,1,0.992432301579021,0,1,positive regulation of negative chemotaxis,BP,
13580,GO:0050925,1,0.981784992066588,0,2,negative regulation of negative chemotaxis,BP,
13581,GO:0050926,1,0.857143285112124,0,24,regulation of positive chemotaxis,BP,
13582,GO:0050927,1,0.863922337190617,0,23,positive regulation of positive chemotaxis,BP,
13583,GO:0050928,1,0.992164589038325,0,1,negative regulation of positive chemotaxis,BP,
13584,GO:0050929,1,0.992432301579021,0,1,induction of negative chemotaxis,BP,
13585,GO:0050930,1,0.925585839830021,0,13,induction of positive chemotaxis,BP,
13586,GO:0050931,1,0.792651332922645,0,32,pigment cell differentiation,BP,
13587,GO:0050932,1,0.935280023569641,0,9,regulation of pigment cell differentiation,BP,
13588,GO:0050942,1,0.945664702689227,0,7,positive regulation of pigment cell differentiation,BP,
13589,GO:0050951,1,0.880803552872829,0,19,sensory perception of temperature stimulus,BP,
13592,GO:0050955,1,0.985063832591016,0,2,thermoception,BP,
13593,GO:0050957,1,0.956220659514655,0,6,equilibrioception,BP,
13594,GO:0050960,1,0.99319993764267,0,1,detection of temperature stimulus involved in thermoception,BP,
13595,GO:0050961,1,0.917561392576686,0,14,detection of temperature stimulus involved in sensory perception,BP,
13596,GO:0050962,1,0.909652900732385,0,14,detection of light stimulus involved in sensory perception,BP,
13597,GO:0050965,1,0.917561392576686,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13598,GO:0050966,1,0.94175270078946,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13599,GO:0050968,1,0.987423857101206,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13600,GO:0050974,1,0.857104038237974,0,23,detection of mechanical stimulus involved in sensory perception,BP,
13601,GO:0050975,1,0.978895936366531,0,3,sensory perception of touch,BP,
13602,GO:0050976,1,0.984233467828045,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13604,GO:0050992,1,0.994441044865754,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13605,GO:0050993,1,0.994441044865754,0,1,dimethylallyl diphosphate metabolic process,BP,
13606,GO:0050994,1,0.747711713465473,0,42,regulation of lipid catabolic process,BP,
13607,GO:0050995,1,0.891546233141698,0,17,negative regulation of lipid catabolic process,BP,
13608,GO:0050996,1,0.890998820171535,0,16,positive regulation of lipid catabolic process,BP,
13609,GO:0050997,1,0.893735277244437,0,17,quaternary ammonium group binding,MF,
13610,GO:0050998,1,0.91285859036027,0,12,nitric-oxide synthase binding,MF,
13611,GO:0050999,1,0.780798161386033,0,39,regulation of nitric-oxide synthase activity,BP,
13612,GO:0051000,1,0.898143815974864,0,17,positive regulation of nitric-oxide synthase activity,BP,
13613,GO:0051001,1,0.959224192977017,0,6,negative regulation of nitric-oxide synthase activity,BP,
13614,GO:0051004,1,0.91172013668664,0,15,regulation of lipoprotein lipase activity,BP,
13615,GO:0051005,1,0.979820323438896,0,3,negative regulation of lipoprotein lipase activity,BP,
13616,GO:0051006,1,0.959984819788618,0,7,positive regulation of lipoprotein lipase activity,BP,
13617,GO:0051010,1,0.887391749776659,0,13,microtubule plus-end binding,MF,
13618,GO:0051011,1,0.925441731336842,0,9,microtubule minus-end binding,MF,
13619,GO:0051012,1,0.986847346596073,0,2,microtubule sliding,BP,
13620,GO:0051013,1,0.954520214617729,0,7,microtubule severing,BP,
13621,GO:0051014,1,0.949409869046427,0,8,actin filament severing,BP,
13622,GO:0051015,1,0.288306978287677,0,164,actin filament binding,MF,
13623,GO:0051016,1,0.917046405291321,0,14,barbed-end actin filament capping,BP,
13624,GO:0051017,1,0.385266057610513,0,139,actin filament bundle assembly,BP,
13626,GO:0051019,1,0.835990113464,0,26,mitogen-activated protein kinase binding,MF,
13628,GO:0051021,1,0.969407850223917,0,5,GDP-dissociation inhibitor binding,MF,
13629,GO:0051022,1,0.974694164057061,0,4,Rho GDP-dissociation inhibitor binding,MF,
13630,GO:0051023,1,0.919496749958489,0,15,regulation of immunoglobulin secretion,BP,
13631,GO:0051024,1,0.951077003387552,0,9,positive regulation of immunoglobulin secretion,BP,
13632,GO:0051025,1,0.988305589503187,0,2,negative regulation of immunoglobulin secretion,BP,
13633,GO:0051026,1,0.964696932131343,0,6,chiasma assembly,BP,
13635,GO:0051029,1,0.960978157254858,0,6,rRNA transport,BP,
13636,GO:0051030,1,0.978337280457465,0,4,snRNA transport,BP,
13637,GO:0051031,1,0.796783216036215,0,32,tRNA transport,BP,
13638,GO:0051032,1,0.985815200235503,0,2,nucleic acid transmembrane transporter activity,MF,
13639,GO:0051033,1,0.985815200235503,0,2,RNA transmembrane transporter activity,MF,
13640,GO:0051036,1,0.970639531803011,0,5,regulation of endosome size,BP,
13641,GO:0051040,1,0.987900052629835,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13642,GO:0051041,1,0.993891174679371,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13643,GO:0051042,1,0.993972422704564,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13645,GO:0051044,1,0.922297532490908,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13655,GO:0051054,1,0.266754659836183,0,201,positive regulation of DNA metabolic process,BP,
13656,GO:0051055,1,0.764300985106632,0,44,negative regulation of lipid biosynthetic process,BP,
13659,GO:0051058,1,0.68703039545411,0,52,negative regulation of small GTPase mediated signal transduction,BP,
13660,GO:0051059,1,0.837707119849995,0,28,NF-kappaB binding,MF,
13661,GO:0051066,1,0.989071685795491,0,2,dihydrobiopterin metabolic process,BP,
13662,GO:0051068,1,0.99365699921152,0,1,dihydrolipoamide metabolic process,BP,
13663,GO:0051081,1,0.725945088795184,0,46,nuclear envelope disassembly,BP,
13664,GO:0051082,1,0.516752167754122,0,108,unfolded protein binding,MF,
13665,GO:0051083,1,0.988989841557804,0,2,'de novo' cotranslational protein folding,BP,
13666,GO:0051084,1,0.819776046963406,0,32,'de novo' posttranslational protein folding,BP,
13667,GO:0051085,1,0.85074758310382,0,27,chaperone cofactor-dependent protein refolding,BP,
13668,GO:0051086,1,0.994486307338562,0,1,chaperone mediated protein folding independent of cofactor,BP,
13670,GO:0051088,1,0.98050093848063,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13671,GO:0051089,1,0.993371262831178,0,1,constitutive protein ectodomain proteolysis,BP,
13677,GO:0051095,1,0.945429264763173,0,9,regulation of helicase activity,BP,
13678,GO:0051096,1,0.962428948464711,0,6,positive regulation of helicase activity,BP,
13679,GO:0051097,1,0.982343393096309,0,3,negative regulation of helicase activity,BP,
13683,GO:0051101,1,0.480382952621593,0,110,regulation of DNA binding,BP,
13684,GO:0051102,1,0.99327139315954,0,1,DNA ligation involved in DNA recombination,BP,
13685,GO:0051103,1,0.937089729772724,0,11,DNA ligation involved in DNA repair,BP,
13686,GO:0051105,1,0.96508334959657,0,6,regulation of DNA ligation,BP,
13687,GO:0051106,1,0.970789397904858,0,5,positive regulation of DNA ligation,BP,
13688,GO:0051107,1,0.994123997675265,0,1,negative regulation of DNA ligation,BP,
13689,GO:0051117,1,0.617590257209597,0,73,ATPase binding,MF,
13690,GO:0051119,1,0.863512448417771,0,23,sugar transmembrane transporter activity,MF,
13691,GO:0051120,1,0.982552537871785,0,3,hepoxilin A3 synthase activity,MF,
13692,GO:0051121,1,0.971352147376557,0,5,hepoxilin metabolic process,BP,
13693,GO:0051122,1,0.971352147376557,0,5,hepoxilin biosynthetic process,BP,
13694,GO:0051123,1,0.818235730486482,0,31,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13696,GO:0051125,1,0.836407704336543,0,27,regulation of actin nucleation,BP,
13697,GO:0051126,1,0.9591562475333,0,7,negative regulation of actin nucleation,BP,
13698,GO:0051127,1,0.897680906712875,0,15,positive regulation of actin nucleation,BP,
13702,GO:0051131,1,0.900134097433425,0,18,chaperone-mediated protein complex assembly,BP,
13703,GO:0051132,1,0.954462135369972,0,8,NK T cell activation,BP,
13704,GO:0051133,1,0.966277373771785,0,6,regulation of NK T cell activation,BP,
13705,GO:0051134,1,0.994504358491303,0,1,negative regulation of NK T cell activation,BP,
13706,GO:0051135,1,0.971618576143121,0,5,positive regulation of NK T cell activation,BP,
13707,GO:0051136,1,0.960690297647621,0,6,regulation of NK T cell differentiation,BP,
13708,GO:0051138,1,0.973263577510422,0,4,positive regulation of NK T cell differentiation,BP,
13709,GO:0051139,1,0.98546012740338,0,2,metal ion:proton antiporter activity,MF,
13710,GO:0051140,1,0.983215782821465,0,3,regulation of NK T cell proliferation,BP,
13711,GO:0051142,1,0.983215782821465,0,3,positive regulation of NK T cell proliferation,BP,
13717,GO:0051150,1,0.843174889237535,0,26,regulation of smooth muscle cell differentiation,BP,
13718,GO:0051151,1,0.928961561825834,0,11,negative regulation of smooth muscle cell differentiation,BP,
13719,GO:0051152,1,0.933604134106007,0,11,positive regulation of smooth muscle cell differentiation,BP,
13723,GO:0051156,1,0.853572264892011,0,26,glucose 6-phosphate metabolic process,BP,
13724,GO:0051160,1,0.99430288163403,0,1,L-xylitol catabolic process,BP,
13725,GO:0051164,1,0.99430288163403,0,1,L-xylitol metabolic process,BP,
13726,GO:0051167,1,0.971996053182398,0,5,xylulose 5-phosphate metabolic process,BP,
13727,GO:0051168,1,0.275139127915001,0,191,nuclear export,BP,
13728,GO:0051169,1,0.108994031558556,0,327,nuclear transport,BP,
13729,GO:0051170,1,0.363880018062241,0,149,import into nucleus,BP,
13734,GO:0051176,1,0.978724402671902,0,3,positive regulation of sulfur metabolic process,BP,
13735,GO:0051177,1,0.965423253357689,0,6,meiotic sister chromatid cohesion,BP,
13737,GO:0051180,1,0.815647450246269,0,30,vitamin transport,BP,
13738,GO:0051181,1,0.766759484814026,0,41,cofactor transport,BP,
13739,GO:0051182,1,0.95082439851238,0,8,coenzyme transport,BP,
13740,GO:0051184,1,0.877791940906691,0,20,cofactor transmembrane transporter activity,MF,
13741,GO:0051185,1,0.962495519732837,0,6,coenzyme transmembrane transporter activity,MF,
13743,GO:0051187,1,0.763641596978561,0,45,cofactor catabolic process,BP,
13745,GO:0051189,1,0.959036822178512,0,7,prosthetic group metabolic process,BP,
13746,GO:0051192,1,0.989344272260938,0,2,prosthetic group binding,MF,
13747,GO:0051193,1,0.522153992319351,0,94,regulation of cofactor metabolic process,BP,
13748,GO:0051194,1,0.874214676041428,0,19,positive regulation of cofactor metabolic process,BP,
13749,GO:0051195,1,0.896022363217082,0,16,negative regulation of cofactor metabolic process,BP,
13750,GO:0051196,1,0.567641519567513,0,80,regulation of coenzyme metabolic process,BP,
13751,GO:0051197,1,0.889589758779159,0,16,positive regulation of coenzyme metabolic process,BP,
13752,GO:0051198,1,0.928534455648419,0,10,negative regulation of coenzyme metabolic process,BP,
13753,GO:0051204,1,0.814950878750442,0,34,protein insertion into mitochondrial membrane,BP,
13757,GO:0051213,1,0.562308553870626,0,85,dioxygenase activity,MF,
13760,GO:0051220,1,0.849062231002674,0,24,cytoplasmic sequestering of protein,BP,
13764,GO:0051225,1,0.476888364176202,0,105,spindle assembly,BP,
13765,GO:0051228,1,0.992250175410291,0,1,mitotic spindle disassembly,BP,
13766,GO:0051230,1,0.992250175410291,0,1,spindle disassembly,BP,
13767,GO:0051231,1,0.931089174290403,0,11,spindle elongation,BP,
13768,GO:0051232,1,0.99436265416508,0,1,meiotic spindle elongation,BP,
13769,GO:0051233,1,0.807858586326915,0,31,spindle midzone,CC,
13773,GO:0051238,1,0.917765102077046,0,14,sequestering of metal ion,BP,
13786,GO:0051255,1,0.939919141868869,0,10,spindle midzone assembly,BP,
13787,GO:0051256,1,0.95118815568013,0,8,mitotic spindle midzone assembly,BP,
13788,GO:0051257,1,0.994327130902036,0,1,meiotic spindle midzone assembly,BP,
13789,GO:0051258,1,0.184217434459734,0,250,protein polymerization,BP,
13792,GO:0051261,1,0.496503523021017,0,96,protein depolymerization,BP,
13794,GO:0051264,1,0.994172100216872,0,1,mono-olein transacylation activity,MF,
13795,GO:0051265,1,0.994172100216872,0,1,diolein transacylation activity,MF,
13796,GO:0051267,1,0.993907666384269,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13802,GO:0051280,1,0.924520469756216,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13806,GO:0051284,1,0.908732369416046,0,14,positive regulation of sequestering of calcium ion,BP,
13807,GO:0051286,1,0.951206662635547,0,7,cell tip,CC,
13808,GO:0051287,1,0.719311353605619,0,56,NAD binding,MF,
13809,GO:0051289,1,0.612737309527489,0,75,protein homotetramerization,BP,
13812,GO:0051292,1,0.927813406851292,0,10,nuclear pore complex assembly,BP,
13813,GO:0051293,1,0.77567298436492,0,34,establishment of spindle localization,BP,
13814,GO:0051294,1,0.832506684913961,0,26,establishment of spindle orientation,BP,
13815,GO:0051295,1,0.967434904985541,0,4,establishment of meiotic spindle localization,BP,
13816,GO:0051298,1,0.647474697575094,0,62,centrosome duplication,BP,
13817,GO:0051299,1,0.89576664039184,0,16,centrosome separation,BP,
13818,GO:0051300,1,0.994184768585909,0,1,spindle pole body organization,BP,
13820,GO:0051302,1,0.388376205279869,0,138,regulation of cell division,BP,
13821,GO:0051303,1,0.632058346116071,0,70,establishment of chromosome localization,BP,
13822,GO:0051304,1,0.597809161177819,0,75,chromosome separation,BP,
13823,GO:0051305,1,0.955699341034813,0,6,chromosome movement towards spindle pole,BP,
13824,GO:0051306,1,0.691348113119144,0,54,mitotic sister chromatid separation,BP,
13825,GO:0051307,1,0.896607873683398,0,16,meiotic chromosome separation,BP,
13826,GO:0051308,1,0.994184768585909,0,1,male meiosis chromosome separation,BP,
13827,GO:0051310,1,0.700351413581934,0,55,metaphase plate congression,BP,
13828,GO:0051311,1,0.994327130902036,0,1,meiotic metaphase plate congression,BP,
13829,GO:0051315,1,0.920179216809296,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
13830,GO:0051316,1,0.988621173870166,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13831,GO:0051321,1,0.263670071258376,0,202,meiotic cell cycle,BP,
13834,GO:0051339,1,0.765602891980734,0,41,regulation of lyase activity,BP,
13835,GO:0051340,1,0.950774218361198,0,9,regulation of ligase activity,BP,
13836,GO:0051341,1,0.610437131638605,0,77,regulation of oxidoreductase activity,BP,
13837,GO:0051342,1,0.950912934526976,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13838,GO:0051343,1,0.976367766380677,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13839,GO:0051344,1,0.968132131493431,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13844,GO:0051349,1,0.903112860609688,0,15,positive regulation of lyase activity,BP,
13845,GO:0051350,1,0.863007107143352,0,23,negative regulation of lyase activity,BP,
13846,GO:0051351,1,0.961692320458503,0,7,positive regulation of ligase activity,BP,
13847,GO:0051352,1,0.988651403598272,0,2,negative regulation of ligase activity,BP,
13848,GO:0051353,1,0.766434376901675,0,41,positive regulation of oxidoreductase activity,BP,
13849,GO:0051354,1,0.878822631151841,0,20,negative regulation of oxidoreductase activity,BP,
13850,GO:0051355,1,0.993478979029256,0,1,proprioception involved in equilibrioception,BP,
13851,GO:0051365,1,0.982522377825779,0,3,cellular response to potassium ion starvation,BP,
13852,GO:0051371,1,0.854174403017927,0,18,muscle alpha-actinin binding,MF,
13853,GO:0051373,1,0.970280975006137,0,5,FATZ binding,MF,
13854,GO:0051377,1,0.98047823269376,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13855,GO:0051378,1,0.937323288180629,0,11,serotonin binding,MF,
13856,GO:0051379,1,0.96045641521651,0,7,epinephrine binding,MF,
13857,GO:0051380,1,0.97123110581681,0,5,norepinephrine binding,MF,
13858,GO:0051382,1,0.906312173819553,0,14,kinetochore assembly,BP,
13859,GO:0051383,1,0.876617943672642,0,19,kinetochore organization,BP,
13861,GO:0051385,1,0.840098299838062,0,28,response to mineralocorticoid,BP,
13862,GO:0051386,1,0.944298590055074,0,9,regulation of neurotrophin TRK receptor signaling pathway,BP,
13863,GO:0051387,1,0.983174176974395,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13864,GO:0051388,1,0.972861749128215,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13865,GO:0051389,1,0.97948854023634,0,2,inactivation of MAPKK activity,BP,
13866,GO:0051391,1,0.993356446296021,0,1,tRNA acetylation,BP,
13867,GO:0051392,1,0.993356446296021,0,1,tRNA N-acetyltransferase activity,MF,
13868,GO:0051393,1,0.757586723122412,0,33,alpha-actinin binding,MF,
13869,GO:0051400,1,0.952086761055335,0,8,BH domain binding,MF,
13871,GO:0051403,1,0.197614030850344,0,242,stress-activated MAPK cascade,BP,
13872,GO:0051409,1,0.936671387628938,0,10,response to nitrosative stress,BP,
13873,GO:0051410,1,0.971166914234209,0,5,detoxification of nitrogen compound,BP,
13874,GO:0051412,1,0.903403977668908,0,16,response to corticosterone,BP,
13875,GO:0051413,1,0.994310288731472,0,1,response to cortisone,BP,
13876,GO:0051414,1,0.962288931299318,0,5,response to cortisol,BP,
13877,GO:0051415,1,0.967388240925496,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13878,GO:0051417,1,0.994184768585909,0,1,microtubule nucleation by spindle pole body,BP,
13879,GO:0051418,1,0.948575494850747,0,7,microtubule nucleation by microtubule organizing center,BP,
13880,GO:0051424,1,0.994515517581278,0,1,corticotropin-releasing hormone binding,MF,
13881,GO:0051425,1,0.96920952211755,0,4,PTB domain binding,MF,
13882,GO:0051427,1,0.328457996662627,0,163,hormone receptor binding,MF,
13883,GO:0051428,1,0.903334493781238,0,17,peptide hormone receptor binding,MF,
13884,GO:0051429,1,0.971308897234189,0,5,corticotropin-releasing hormone receptor binding,MF,
13885,GO:0051430,1,0.976602642321426,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13886,GO:0051431,1,0.983934929132051,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13887,GO:0051433,1,0.992833846361643,0,1,BH2 domain binding,MF,
13888,GO:0051434,1,0.976070727054724,0,4,BH3 domain binding,MF,
13889,GO:0051438,1,0.719736087704827,0,51,regulation of ubiquitin-protein transferase activity,BP,
13890,GO:0051443,1,0.816230735755442,0,32,positive regulation of ubiquitin-protein transferase activity,BP,
13891,GO:0051444,1,0.915060419927345,0,14,negative regulation of ubiquitin-protein transferase activity,BP,
13892,GO:0051445,1,0.783024404033829,0,38,regulation of meiotic cell cycle,BP,
13893,GO:0051446,1,0.910582015053658,0,14,positive regulation of meiotic cell cycle,BP,
13894,GO:0051447,1,0.918232853147986,0,14,negative regulation of meiotic cell cycle,BP,
13895,GO:0051450,1,0.890814326203677,0,18,myoblast proliferation,BP,
13897,GO:0051452,1,0.746767050851198,0,47,intracellular pH reduction,BP,
13898,GO:0051453,1,0.570567073986657,0,85,regulation of intracellular pH,BP,
13899,GO:0051454,1,0.973779597432299,0,4,intracellular pH elevation,BP,
13900,GO:0051455,1,0.994184768585909,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13901,GO:0051456,1,0.994404188207799,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13902,GO:0051457,1,0.859479100639772,0,22,maintenance of protein location in nucleus,BP,
13903,GO:0051458,1,0.959881904576378,0,7,corticotropin secretion,BP,
13904,GO:0051459,1,0.965397638491072,0,6,regulation of corticotropin secretion,BP,
13905,GO:0051460,1,0.994515517581278,0,1,negative regulation of corticotropin secretion,BP,
13906,GO:0051461,1,0.970723131766278,0,5,positive regulation of corticotropin secretion,BP,
13907,GO:0051462,1,0.969662105750119,0,5,regulation of cortisol secretion,BP,
13908,GO:0051463,1,0.991194330476438,0,1,negative regulation of cortisol secretion,BP,
13909,GO:0051464,1,0.978278385207017,0,4,positive regulation of cortisol secretion,BP,
13910,GO:0051466,1,0.993924650737727,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13912,GO:0051481,1,0.930944953982347,0,9,negative regulation of cytosolic calcium ion concentration,BP,
13914,GO:0051489,1,0.759689514344483,0,39,regulation of filopodium assembly,BP,
13915,GO:0051490,1,0.988754244844817,0,2,negative regulation of filopodium assembly,BP,
13916,GO:0051491,1,0.825932675137796,0,28,positive regulation of filopodium assembly,BP,
13917,GO:0051492,1,0.589119997585671,0,75,regulation of stress fiber assembly,BP,
13918,GO:0051493,1,0.0340710370299827,0,473,regulation of cytoskeleton organization,BP,
13919,GO:0051494,1,0.411066957187555,0,126,negative regulation of cytoskeleton organization,BP,
13920,GO:0051495,1,0.261038260516418,0,199,positive regulation of cytoskeleton organization,BP,
13921,GO:0051496,1,0.728866430069866,0,47,positive regulation of stress fiber assembly,BP,
13922,GO:0051497,1,0.865228089523738,0,20,negative regulation of stress fiber assembly,BP,
13923,GO:0051499,1,0.988812897887761,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13924,GO:0051500,1,0.988812897887761,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13925,GO:0051503,1,0.925811401393341,0,13,adenine nucleotide transport,BP,
13926,GO:0051525,1,0.964195956957567,0,5,NFAT protein binding,MF,
13927,GO:0051536,1,0.680410588543915,0,61,iron-sulfur cluster binding,MF,
13928,GO:0051537,1,0.883020937530586,0,20,2 iron, 2 sulfur cluster binding,MF,
13929,GO:0051538,1,0.982600100397946,0,3,3 iron, 4 sulfur cluster binding,MF,
13930,GO:0051539,1,0.776657723283999,0,40,4 iron, 4 sulfur cluster binding,MF,
13931,GO:0051540,1,0.680410588543915,0,61,metal cluster binding,MF,
13932,GO:0051541,1,0.971814084716913,0,4,elastin metabolic process,BP,
13933,GO:0051542,1,0.98361818092974,0,2,elastin biosynthetic process,BP,
13934,GO:0051543,1,0.994368767848314,0,1,regulation of elastin biosynthetic process,BP,
13935,GO:0051545,1,0.994368767848314,0,1,negative regulation of elastin biosynthetic process,BP,
13937,GO:0051547,1,0.939216587109457,0,9,regulation of keratinocyte migration,BP,
13938,GO:0051548,1,0.991895144947715,0,1,negative regulation of keratinocyte migration,BP,
13939,GO:0051549,1,0.946895204229585,0,8,positive regulation of keratinocyte migration,BP,
13940,GO:0051552,1,0.991164447768179,0,1,flavone metabolic process,BP,
13941,GO:0051560,1,0.879174913039136,0,21,mitochondrial calcium ion homeostasis,BP,
13942,GO:0051561,1,0.943409870480352,0,10,positive regulation of mitochondrial calcium ion concentration,BP,
13943,GO:0051562,1,0.982998865770697,0,3,negative regulation of mitochondrial calcium ion concentration,BP,
13944,GO:0051563,1,0.985179721240781,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13945,GO:0051567,1,0.805939991068016,0,29,histone H3-K9 methylation,BP,
13946,GO:0051568,1,0.708069155961712,0,48,histone H3-K4 methylation,BP,
13947,GO:0051569,1,0.84939183622676,0,24,regulation of histone H3-K4 methylation,BP,
13948,GO:0051570,1,0.860311349252546,0,20,regulation of histone H3-K9 methylation,BP,
13949,GO:0051571,1,0.899204880358464,0,15,positive regulation of histone H3-K4 methylation,BP,
13950,GO:0051572,1,0.976222830171309,0,3,negative regulation of histone H3-K4 methylation,BP,
13951,GO:0051573,1,0.932446458165772,0,10,negative regulation of histone H3-K9 methylation,BP,
13952,GO:0051574,1,0.934093672950707,0,9,positive regulation of histone H3-K9 methylation,BP,
13953,GO:0051575,1,0.966023388465337,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13954,GO:0051580,1,0.909307242972788,0,15,regulation of neurotransmitter uptake,BP,
13955,GO:0051581,1,0.973602474399207,0,4,negative regulation of neurotransmitter uptake,BP,
13956,GO:0051582,1,0.977997957723624,0,4,positive regulation of neurotransmitter uptake,BP,
13957,GO:0051583,1,0.936843861497983,0,11,dopamine uptake involved in synaptic transmission,BP,
13958,GO:0051584,1,0.960963310433912,0,7,regulation of dopamine uptake involved in synaptic transmission,BP,
13959,GO:0051585,1,0.993958996997799,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13960,GO:0051586,1,0.983505916105877,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13962,GO:0051589,1,0.874586097455274,0,19,negative regulation of neurotransmitter transport,BP,
13963,GO:0051590,1,0.8444506852601,0,26,positive regulation of neurotransmitter transport,BP,
13966,GO:0051593,1,0.936345552129341,0,11,response to folic acid,BP,
13967,GO:0051594,1,0.977734310503826,0,4,detection of glucose,BP,
13968,GO:0051595,1,0.98018004565451,0,3,response to methylglyoxal,BP,
13969,GO:0051596,1,0.988670561288252,0,2,methylglyoxal catabolic process,BP,
13970,GO:0051597,1,0.951425684122387,0,7,response to methylmercury,BP,
13971,GO:0051598,1,0.992784109736932,0,1,meiotic recombination checkpoint,BP,
13972,GO:0051599,1,0.962137525762362,0,5,response to hydrostatic pressure,BP,
13973,GO:0051601,1,0.951751391635751,0,8,exocyst localization,BP,
13974,GO:0051602,1,0.778416858541845,0,39,response to electrical stimulus,BP,
13975,GO:0051603,1,0.0141043613099235,0,627,proteolysis involved in cellular protein catabolic process,BP,
13979,GO:0051608,1,0.942621080854803,0,10,histamine transport,BP,
13980,GO:0051610,1,0.972032038950507,0,4,serotonin uptake,BP,
13981,GO:0051611,1,0.979043254252027,0,3,regulation of serotonin uptake,BP,
13982,GO:0051612,1,0.979043254252027,0,3,negative regulation of serotonin uptake,BP,
13983,GO:0051615,1,0.991820136659896,0,1,histamine uptake,BP,
13984,GO:0051620,1,0.993958996997799,0,1,norepinephrine uptake,BP,
13985,GO:0051621,1,0.993958996997799,0,1,regulation of norepinephrine uptake,BP,
13986,GO:0051622,1,0.993958996997799,0,1,negative regulation of norepinephrine uptake,BP,
13987,GO:0051639,1,0.947190538419428,0,8,actin filament network formation,BP,
13991,GO:0051643,1,0.958504259374242,0,5,endoplasmic reticulum localization,BP,
13992,GO:0051645,1,0.912548252594911,0,13,Golgi localization,BP,
13993,GO:0051646,1,0.757050009875982,0,39,mitochondrion localization,BP,
13994,GO:0051647,1,0.837453859384015,0,22,nucleus localization,BP,
13998,GO:0051651,1,0.526147555033949,0,88,maintenance of location in cell,BP,
13999,GO:0051653,1,0.75083425485751,0,38,spindle localization,BP,
14000,GO:0051654,1,0.86878666214475,0,19,establishment of mitochondrion localization,BP,
14002,GO:0051657,1,0.920820279371248,0,10,maintenance of organelle location,BP,
14003,GO:0051659,1,0.988137808372786,0,2,maintenance of mitochondrion location,BP,
14004,GO:0051660,1,0.971928511978283,0,4,establishment of centrosome localization,BP,
14005,GO:0051661,1,0.953852738267791,0,5,maintenance of centrosome location,BP,
14006,GO:0051664,1,0.987378245795369,0,2,nuclear pore localization,BP,
14007,GO:0051665,1,0.941817717490917,0,10,membrane raft localization,BP,
14008,GO:0051666,1,0.966507823179785,0,5,actin cortical patch localization,BP,
14012,GO:0051683,1,0.957347855223947,0,7,establishment of Golgi localization,BP,
14013,GO:0051684,1,0.976922187647524,0,3,maintenance of Golgi location,BP,
14014,GO:0051685,1,0.994184768585909,0,1,maintenance of ER location,BP,
14015,GO:0051686,1,0.986089177528569,0,1,establishment of ER localization,BP,
14016,GO:0051691,1,0.994546697420715,0,1,cellular oligosaccharide metabolic process,BP,
14017,GO:0051692,1,0.994546697420715,0,1,cellular oligosaccharide catabolic process,BP,
14018,GO:0051693,1,0.796239454629042,0,31,actin filament capping,BP,
14019,GO:0051694,1,0.958846144478547,0,6,pointed-end actin filament capping,BP,
14020,GO:0051695,1,0.992837487587332,0,1,actin filament uncapping,BP,
14021,GO:0051697,1,0.977768701797241,0,4,protein delipidation,BP,
14028,GO:0051708,1,0.989196984078889,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14029,GO:0051709,1,0.942567241721653,0,10,regulation of killing of cells of other organism,BP,
14030,GO:0051710,1,0.994639606702336,0,1,regulation of cytolysis in other organism,BP,
14031,GO:0051712,1,0.948283033482907,0,9,positive regulation of killing of cells of other organism,BP,
14032,GO:0051714,1,0.994639606702336,0,1,positive regulation of cytolysis in other organism,BP,
14033,GO:0051715,1,0.978117966898271,0,4,cytolysis in other organism,BP,
14035,GO:0051717,1,0.986094033165542,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14036,GO:0051721,1,0.831590816649212,0,27,protein phosphatase 2A binding,MF,
14037,GO:0051722,1,0.994330269842402,0,1,protein C-terminal methylesterase activity,MF,
14038,GO:0051723,1,0.994330269842402,0,1,protein methylesterase activity,MF,
14039,GO:0051724,1,0.99440059907078,0,1,NAD transmembrane transporter activity,MF,
14040,GO:0051725,1,0.975863496559322,0,4,protein de-ADP-ribosylation,BP,
14042,GO:0051728,1,0.994070934974276,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14043,GO:0051729,1,0.994070934974276,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14044,GO:0051731,1,0.970888474973325,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14045,GO:0051732,1,0.994534660292313,0,1,polyribonucleotide kinase activity,MF,
14046,GO:0051733,1,0.979904942698287,0,3,polydeoxyribonucleotide kinase activity,MF,
14047,GO:0051734,1,0.979904942698287,0,3,ATP-dependent polynucleotide kinase activity,MF,
14048,GO:0051736,1,0.994534660292313,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14049,GO:0051747,1,0.989235143560639,0,2,cytosine C-5 DNA demethylase activity,MF,
14050,GO:0051748,1,0.994438129758075,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14051,GO:0051750,1,0.994609403508997,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14052,GO:0051754,1,0.975993516934878,0,4,meiotic sister chromatid cohesion, centromeric,BP,
14053,GO:0051758,1,0.99106099323147,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14054,GO:0051764,1,0.92813376137963,0,11,actin crosslink formation,BP,
14055,GO:0051765,1,0.988458293177986,0,2,inositol tetrakisphosphate kinase activity,MF,
14056,GO:0051766,1,0.961798882518025,0,6,inositol trisphosphate kinase activity,MF,
14060,GO:0051771,1,0.983394241660124,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14061,GO:0051775,1,0.925956371680512,0,11,response to redox state,BP,
14062,GO:0051780,1,0.993196453193617,0,1,behavioral response to nutrient,BP,
14063,GO:0051781,1,0.627797422621586,0,71,positive regulation of cell division,BP,
14064,GO:0051782,1,0.906167657847413,0,14,negative regulation of cell division,BP,
14065,GO:0051783,1,0.307628462771268,0,171,regulation of nuclear division,BP,
14066,GO:0051784,1,0.694559883076793,0,54,negative regulation of nuclear division,BP,
14067,GO:0051785,1,0.68026585445837,0,55,positive regulation of nuclear division,BP,
14068,GO:0051786,1,0.993858361481204,0,1,all-trans-retinol 13,14-reductase activity,MF,
14069,GO:0051787,1,0.851741181518755,0,26,misfolded protein binding,MF,
14070,GO:0051788,1,0.855720088876569,0,23,response to misfolded protein,BP,
14071,GO:0051790,1,0.976230946034645,0,4,short-chain fatty acid biosynthetic process,BP,
14072,GO:0051791,1,0.940192498115382,0,10,medium-chain fatty acid metabolic process,BP,
14073,GO:0051792,1,0.967448827419406,0,5,medium-chain fatty acid biosynthetic process,BP,
14074,GO:0051793,1,0.967137898855733,0,5,medium-chain fatty acid catabolic process,BP,
14075,GO:0051794,1,0.974610199317378,0,4,regulation of timing of catagen,BP,
14076,GO:0051795,1,0.981414122165632,0,3,positive regulation of timing of catagen,BP,
14077,GO:0051796,1,0.993068521420915,0,1,negative regulation of timing of catagen,BP,
14079,GO:0051798,1,0.932638856872622,0,11,positive regulation of hair follicle development,BP,
14081,GO:0051800,1,0.986455749092122,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14082,GO:0051801,1,0.988663882122091,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14083,GO:0051805,1,0.986482973643855,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14085,GO:0051807,1,0.986482973643855,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14086,GO:0051808,1,0.994347709934147,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14088,GO:0051818,1,0.93427101950759,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14089,GO:0051821,1,0.991095443406033,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14090,GO:0051823,1,0.93341815578812,0,9,regulation of synapse structural plasticity,BP,
14092,GO:0051832,1,0.972693084647571,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14093,GO:0051833,1,0.992215682152264,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
14094,GO:0051834,1,0.972693084647571,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14095,GO:0051835,1,0.968973564200188,0,4,positive regulation of synapse structural plasticity,BP,
14096,GO:0051836,1,0.948218778330173,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
14098,GO:0051852,1,0.957287859703292,0,8,disruption by host of symbiont cells,BP,
14099,GO:0051861,1,0.9057297881212,0,17,glycolipid binding,MF,
14100,GO:0051864,1,0.941639822158804,0,8,histone demethylase activity (H3-K36 specific),MF,
14101,GO:0051865,1,0.686913333055082,0,54,protein autoubiquitination,BP,
14102,GO:0051866,1,0.988342272697944,0,2,general adaptation syndrome,BP,
14103,GO:0051867,1,0.99460922870528,0,1,general adaptation syndrome, behavioral process,BP,
14104,GO:0051870,1,0.982743417372062,0,3,methotrexate binding,MF,
14105,GO:0051873,1,0.957287859703292,0,8,killing by host of symbiont cells,BP,
14106,GO:0051875,1,0.84022654581507,0,27,pigment granule localization,BP,
14107,GO:0051877,1,0.988268183347174,0,2,pigment granule aggregation in cell center,BP,
14109,GO:0051880,1,0.946194234420813,0,7,G-quadruplex DNA binding,MF,
14110,GO:0051881,1,0.700841354470876,0,59,regulation of mitochondrial membrane potential,BP,
14111,GO:0051882,1,0.88017813910061,0,20,mitochondrial depolarization,BP,
14112,GO:0051883,1,0.93427101950759,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14114,GO:0051885,1,0.986068396866844,0,2,positive regulation of timing of anagen,BP,
14116,GO:0051890,1,0.961570207468633,0,6,regulation of cardioblast differentiation,BP,
14117,GO:0051891,1,0.968256806445667,0,5,positive regulation of cardioblast differentiation,BP,
14118,GO:0051892,1,0.99309640786257,0,1,negative regulation of cardioblast differentiation,BP,
14120,GO:0051894,1,0.839616420036254,0,23,positive regulation of focal adhesion assembly,BP,
14124,GO:0051898,1,0.764088062970756,0,39,negative regulation of protein kinase B signaling,BP,
14126,GO:0051900,1,0.892250463110868,0,18,regulation of mitochondrial depolarization,BP,
14127,GO:0051901,1,0.952450815905099,0,8,positive regulation of mitochondrial depolarization,BP,
14128,GO:0051902,1,0.964900127590921,0,6,negative regulation of mitochondrial depolarization,BP,
14129,GO:0051903,1,0.994252334250217,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14130,GO:0051904,1,0.858461843829247,0,24,pigment granule transport,BP,
14131,GO:0051905,1,0.849976210144014,0,25,establishment of pigment granule localization,BP,
14132,GO:0051908,1,0.993937423815543,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14133,GO:0051916,1,0.994084215917333,0,1,granulocyte colony-stimulating factor binding,MF,
14136,GO:0051919,1,0.983321878546484,0,3,positive regulation of fibrinolysis,BP,
14137,GO:0051920,1,0.957321277693636,0,8,peroxiredoxin activity,MF,
14138,GO:0051923,1,0.917433551318167,0,14,sulfation,BP,
14140,GO:0051926,1,0.729946182435494,0,50,negative regulation of calcium ion transport,BP,
14142,GO:0051930,1,0.811173893021286,0,31,regulation of sensory perception of pain,BP,
14143,GO:0051931,1,0.811173893021286,0,31,regulation of sensory perception,BP,
14145,GO:0051933,1,0.976223632167023,0,3,amino acid neurotransmitter reuptake,BP,
14146,GO:0051934,1,0.936843861497983,0,11,catecholamine uptake involved in synaptic transmission,BP,
14147,GO:0051935,1,0.976223632167023,0,3,glutamate reuptake,BP,
14149,GO:0051938,1,0.917126720241884,0,12,L-glutamate import,BP,
14150,GO:0051939,1,0.992873828534662,0,1,gamma-aminobutyric acid import,BP,
14151,GO:0051940,1,0.960963310433912,0,7,regulation of catecholamine uptake involved in synaptic transmission,BP,
14152,GO:0051941,1,0.98317150410206,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14153,GO:0051944,1,0.983505916105877,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14154,GO:0051945,1,0.993958996997799,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14155,GO:0051946,1,0.98317150410206,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14157,GO:0051953,1,0.885014326850398,0,20,negative regulation of amine transport,BP,
14159,GO:0051955,1,0.836540543642725,0,28,regulation of amino acid transport,BP,
14160,GO:0051956,1,0.941226526866087,0,10,negative regulation of amino acid transport,BP,
14161,GO:0051957,1,0.914761563356073,0,14,positive regulation of amino acid transport,BP,
14162,GO:0051958,1,0.985220885074367,0,2,methotrexate transport,BP,
14163,GO:0051959,1,0.728057115537632,0,29,dynein light intermediate chain binding,MF,
14168,GO:0051964,1,0.951411327566186,0,6,negative regulation of synapse assembly,BP,
14171,GO:0051967,1,0.936000096885306,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14174,GO:0051970,1,0.982321500013836,0,3,negative regulation of transmission of nerve impulse,BP,
14176,GO:0051972,1,0.755808163485693,0,45,regulation of telomerase activity,BP,
14177,GO:0051973,1,0.805506544211562,0,35,positive regulation of telomerase activity,BP,
14178,GO:0051974,1,0.947885036966029,0,9,negative regulation of telomerase activity,BP,
14179,GO:0051977,1,0.994424512743338,0,1,lysophospholipid transport,BP,
14180,GO:0051978,1,0.994424512743338,0,1,lysophospholipid transporter activity,MF,
14181,GO:0051983,1,0.526216776406613,0,90,regulation of chromosome segregation,BP,
14182,GO:0051984,1,0.843658138442527,0,24,positive regulation of chromosome segregation,BP,
14183,GO:0051985,1,0.767760758002991,0,37,negative regulation of chromosome segregation,BP,
14184,GO:0051987,1,0.967788132625645,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14185,GO:0051988,1,0.921257579161853,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
14186,GO:0051990,1,0.988685929938793,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14187,GO:0051996,1,0.994448495776194,0,1,squalene synthase activity,MF,
14188,GO:0051998,1,0.963009796808802,0,6,protein carboxyl O-methyltransferase activity,MF,
14189,GO:0052026,1,0.994137289025417,0,1,modulation by symbiont of host transcription,BP,
14190,GO:0052027,1,0.986147066416099,0,2,modulation by symbiont of host signal transduction pathway,BP,
14191,GO:0052029,1,0.992215682152264,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
14192,GO:0052031,1,0.986679657513878,0,2,modulation by symbiont of host defense response,BP,
14193,GO:0052037,1,0.992215682152264,0,1,negative regulation by symbiont of host defense response,BP,
14194,GO:0052040,1,0.963987932654882,0,6,modulation by symbiont of host programmed cell death,BP,
14195,GO:0052041,1,0.976554234909907,0,4,negative regulation by symbiont of host programmed cell death,BP,
14196,GO:0052042,1,0.981830815481985,0,3,positive regulation by symbiont of host programmed cell death,BP,
14197,GO:0052047,1,0.983707402898587,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14198,GO:0052053,1,0.994196690322018,0,1,negative regulation by symbiont of host catalytic activity,BP,
14199,GO:0052055,1,0.986457098637473,0,2,modulation by symbiont of host molecular function,BP,
14200,GO:0052056,1,0.986457098637473,0,2,negative regulation by symbiont of host molecular function,BP,
14201,GO:0052066,1,0.990589660791941,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14202,GO:0052097,1,0.993882861295582,0,1,interspecies quorum sensing,BP,
14203,GO:0052106,1,0.993882861295582,0,1,quorum sensing involved in interaction with host,BP,
14204,GO:0052126,1,0.809948371882078,0,33,movement in host environment,BP,
14205,GO:0052148,1,0.994196690322018,0,1,modulation by symbiont of host catalytic activity,BP,
14206,GO:0052150,1,0.96921981714817,0,5,modulation by symbiont of host apoptotic process,BP,
14207,GO:0052151,1,0.987158558565514,0,2,positive regulation by symbiont of host apoptotic process,BP,
14208,GO:0052167,1,0.992215682152264,0,1,modulation by symbiont of host innate immune response,BP,
14209,GO:0052170,1,0.992215682152264,0,1,negative regulation by symbiont of host innate immune response,BP,
14210,GO:0052173,1,0.967388044330101,0,5,response to defenses of other organism involved in symbiotic interaction,BP,
14211,GO:0052182,1,0.994363378264981,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14212,GO:0052190,1,0.990589660791941,0,1,modulation by symbiont of host phagocytosis,BP,
14213,GO:0052191,1,0.990589660791941,0,1,positive regulation by symbiont of host phagocytosis,BP,
14214,GO:0052192,1,0.809948371882078,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
14216,GO:0052200,1,0.967388044330101,0,5,response to host defenses,BP,
14220,GO:0052212,1,0.994363378264981,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14221,GO:0052213,1,0.994363378264981,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14225,GO:0052231,1,0.990589660791941,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14226,GO:0052248,1,0.963987932654882,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14227,GO:0052250,1,0.986147066416099,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14228,GO:0052251,1,0.994420977895971,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14229,GO:0052255,1,0.986679657513878,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14230,GO:0052261,1,0.992215682152264,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
14231,GO:0052306,1,0.992215682152264,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14232,GO:0052309,1,0.992215682152264,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14233,GO:0052312,1,0.846394854892867,0,25,modulation of transcription in other organism involved in symbiotic interaction,BP,
14234,GO:0052314,1,0.989002784918968,0,2,phytoalexin metabolic process,BP,
14235,GO:0052330,1,0.981830815481985,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14236,GO:0052331,1,0.988663882122091,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14242,GO:0052370,1,0.990589660791941,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14243,GO:0052381,1,0.994441624576333,0,1,tRNA dimethylallyltransferase activity,MF,
14252,GO:0052433,1,0.963987932654882,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14253,GO:0052472,1,0.851394349398094,0,24,modulation by host of symbiont transcription,BP,
14254,GO:0052490,1,0.976554234909907,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14255,GO:0052493,1,0.992215682152264,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
14256,GO:0052501,1,0.981830815481985,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14257,GO:0052509,1,0.994420977895971,0,1,positive regulation by symbiont of host defense response,BP,
14258,GO:0052510,1,0.994420977895971,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14259,GO:0052522,1,0.990589660791941,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14262,GO:0052550,1,0.994547534938947,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14263,GO:0052552,1,0.986679657513878,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14264,GO:0052553,1,0.986679657513878,0,2,modulation by symbiont of host immune response,BP,
14265,GO:0052561,1,0.992215682152264,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14266,GO:0052562,1,0.992215682152264,0,1,negative regulation by symbiont of host immune response,BP,
14267,GO:0052564,1,0.975628839190569,0,4,response to immune response of other organism involved in symbiotic interaction,BP,
14268,GO:0052567,1,0.994547534938947,0,1,response to defense-related host reactive oxygen species production,BP,
14269,GO:0052572,1,0.975628839190569,0,4,response to host immune response,BP,
14270,GO:0052590,1,0.991537964360869,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14271,GO:0052591,1,0.991537964360869,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14272,GO:0052593,1,0.9876007803714,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14273,GO:0052594,1,0.9876007803714,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14274,GO:0052595,1,0.9876007803714,0,2,aliphatic-amine oxidase activity,MF,
14275,GO:0052596,1,0.9876007803714,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14276,GO:0052629,1,0.909355704950771,0,12,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14277,GO:0052642,1,0.988855508733174,0,2,lysophosphatidic acid phosphatase activity,MF,
14278,GO:0052646,1,0.936111725501862,0,9,alditol phosphate metabolic process,BP,
14279,GO:0052650,1,0.95611353820079,0,8,NADP-retinol dehydrogenase activity,MF,
14280,GO:0052651,1,0.988743858010874,0,2,monoacylglycerol catabolic process,BP,
14282,GO:0052654,1,0.984011780924779,0,2,L-leucine transaminase activity,MF,
14283,GO:0052655,1,0.984011780924779,0,2,L-valine transaminase activity,MF,
14284,GO:0052656,1,0.984011780924779,0,2,L-isoleucine transaminase activity,MF,
14285,GO:0052657,1,0.994590117781034,0,1,guanine phosphoribosyltransferase activity,MF,
14286,GO:0052658,1,0.958764540335873,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14287,GO:0052659,1,0.938870308464512,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14288,GO:0052666,1,0.994487781908864,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14290,GO:0052692,1,0.994589698729595,0,1,raffinose alpha-galactosidase activity,MF,
14291,GO:0052695,1,0.980748393974186,0,3,cellular glucuronidation,BP,
14292,GO:0052717,1,0.991231720385043,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
14293,GO:0052718,1,0.991231720385043,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14294,GO:0052723,1,0.966255224426478,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14295,GO:0052724,1,0.966255224426478,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14296,GO:0052725,1,0.993900130184356,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14297,GO:0052726,1,0.993900130184356,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14298,GO:0052731,1,0.994448637262067,0,1,phosphocholine phosphatase activity,MF,
14299,GO:0052732,1,0.994448637262067,0,1,phosphoethanolamine phosphatase activity,MF,
14300,GO:0052735,1,0.978393647000768,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14301,GO:0052739,1,0.983692915867119,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14302,GO:0052740,1,0.989101257341559,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14303,GO:0052742,1,0.726729251418079,0,43,phosphatidylinositol kinase activity,MF,
14304,GO:0052743,1,0.925806231724134,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14305,GO:0052744,1,0.890761719350434,0,15,phosphatidylinositol monophosphate phosphatase activity,MF,
14306,GO:0052745,1,0.876040377195649,0,19,inositol phosphate phosphatase activity,MF,
14307,GO:0052746,1,0.986902243605702,0,2,inositol phosphorylation,BP,
14308,GO:0052794,1,0.983130707870294,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14309,GO:0052795,1,0.983130707870294,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14310,GO:0052796,1,0.983130707870294,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14311,GO:0052798,1,0.994451312696892,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14312,GO:0052803,1,0.943156630238003,0,10,imidazole-containing compound metabolic process,BP,
14313,GO:0052805,1,0.959779000792164,0,7,imidazole-containing compound catabolic process,BP,
14314,GO:0052810,1,0.987819033931388,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14315,GO:0052811,1,0.973853918126432,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14316,GO:0052812,1,0.980270240433327,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14317,GO:0052813,1,0.638572014864977,0,64,phosphatidylinositol bisphosphate kinase activity,MF,
14318,GO:0052815,1,0.988433672792096,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14319,GO:0052816,1,0.993779383629816,0,1,long-chain acyl-CoA hydrolase activity,MF,
14320,GO:0052817,1,0.993779383629816,0,1,very long chain acyl-CoA hydrolase activity,MF,
14321,GO:0052821,1,0.994628139820451,0,1,DNA-7-methyladenine glycosylase activity,MF,
14322,GO:0052822,1,0.994628139820451,0,1,DNA-3-methylguanine glycosylase activity,MF,
14323,GO:0052825,1,0.993900130184356,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14324,GO:0052826,1,0.994151961280623,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14325,GO:0052827,1,0.98808740892347,0,2,inositol pentakisphosphate phosphatase activity,MF,
14326,GO:0052828,1,0.984111202662415,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14327,GO:0052829,1,0.994453129306627,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14328,GO:0052830,1,0.993900130184356,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14329,GO:0052831,1,0.993900130184356,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14330,GO:0052832,1,0.972955192526233,0,4,inositol monophosphate 3-phosphatase activity,MF,
14331,GO:0052833,1,0.972955192526233,0,4,inositol monophosphate 4-phosphatase activity,MF,
14332,GO:0052834,1,0.972955192526233,0,4,inositol monophosphate phosphatase activity,MF,
14333,GO:0052835,1,0.993900130184356,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14334,GO:0052836,1,0.981969338227263,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14335,GO:0052839,1,0.981969338227263,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14336,GO:0052840,1,0.976242838261684,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14337,GO:0052841,1,0.976242838261684,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14338,GO:0052842,1,0.976242838261684,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14339,GO:0052843,1,0.976242838261684,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14340,GO:0052844,1,0.976242838261684,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14341,GO:0052845,1,0.976242838261684,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14342,GO:0052846,1,0.976242838261684,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14343,GO:0052847,1,0.976242838261684,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14344,GO:0052848,1,0.976242838261684,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14346,GO:0052852,1,0.99453426246216,0,1,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14347,GO:0052853,1,0.99453426246216,0,1,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14348,GO:0052854,1,0.99453426246216,0,1,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14349,GO:0052856,1,0.99463693856271,0,1,NADHX epimerase activity,MF,
14350,GO:0052857,1,0.99463693856271,0,1,NADPHX epimerase activity,MF,
14351,GO:0052858,1,0.993665540870709,0,1,peptidyl-lysine acetyltransferase activity,MF,
14352,GO:0052866,1,0.814399249678853,0,28,phosphatidylinositol phosphate phosphatase activity,MF,
14353,GO:0052870,1,0.994067957491109,0,1,tocopherol omega-hydroxylase activity,MF,
14354,GO:0052871,1,0.994067957491109,0,1,alpha-tocopherol omega-hydroxylase activity,MF,
14355,GO:0052884,1,0.994264990016345,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14356,GO:0052885,1,0.994264990016345,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14357,GO:0052890,1,0.994496922073288,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14358,GO:0052894,1,0.994458101266859,0,1,norspermine:oxygen oxidoreductase activity,MF,
14359,GO:0052895,1,0.994458101266859,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14360,GO:0052899,1,0.994544350632709,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14361,GO:0052901,1,0.989032385500447,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14362,GO:0052902,1,0.994544350632709,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14363,GO:0052903,1,0.994544350632709,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14364,GO:0052904,1,0.994544350632709,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14365,GO:0052905,1,0.982654556248871,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14366,GO:0052906,1,0.992152279013264,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14367,GO:0052907,1,0.994184768585909,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14368,GO:0052909,1,0.994184768585909,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14369,GO:0052917,1,0.994362291629,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14370,GO:0052918,1,0.991191994954788,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14371,GO:0052925,1,0.994575115579907,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14372,GO:0052926,1,0.991191994954788,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14373,GO:0052927,1,0.994396973404851,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14374,GO:0052928,1,0.994396973404851,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14375,GO:0052929,1,0.994396973404851,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14377,GO:0055002,1,0.381735677094437,0,133,striated muscle cell development,BP,
14378,GO:0055003,1,0.841188357971234,0,19,cardiac myofibril assembly,BP,
14379,GO:0055005,1,0.980615343358844,0,3,ventricular cardiac myofibril assembly,BP,
14380,GO:0055006,1,0.615186377286874,0,63,cardiac cell development,BP,
14381,GO:0055007,1,0.495090385752364,0,94,cardiac muscle cell differentiation,BP,
14382,GO:0055008,1,0.609814901642797,0,63,cardiac muscle tissue morphogenesis,BP,
14383,GO:0055009,1,0.963119498481798,0,6,atrial cardiac muscle tissue morphogenesis,BP,
14384,GO:0055010,1,0.713428992820963,0,44,ventricular cardiac muscle tissue morphogenesis,BP,
14385,GO:0055011,1,0.989070620396919,0,2,atrial cardiac muscle cell differentiation,BP,
14386,GO:0055012,1,0.906620820511229,0,15,ventricular cardiac muscle cell differentiation,BP,
14387,GO:0055013,1,0.641177707197098,0,58,cardiac muscle cell development,BP,
14388,GO:0055014,1,0.989070620396919,0,2,atrial cardiac muscle cell development,BP,
14389,GO:0055015,1,0.942106349355723,0,10,ventricular cardiac muscle cell development,BP,
14390,GO:0055017,1,0.625888779209086,0,67,cardiac muscle tissue growth,BP,
14391,GO:0055018,1,0.994527376974531,0,1,regulation of cardiac muscle fiber development,BP,
14392,GO:0055020,1,0.994527376974531,0,1,positive regulation of cardiac muscle fiber development,BP,
14393,GO:0055021,1,0.718803607167214,0,47,regulation of cardiac muscle tissue growth,BP,
14394,GO:0055022,1,0.904069211835994,0,16,negative regulation of cardiac muscle tissue growth,BP,
14395,GO:0055023,1,0.80600603475149,0,29,positive regulation of cardiac muscle tissue growth,BP,
14396,GO:0055024,1,0.626618820552557,0,66,regulation of cardiac muscle tissue development,BP,
14397,GO:0055025,1,0.75630418810651,0,38,positive regulation of cardiac muscle tissue development,BP,
14398,GO:0055026,1,0.845536986750721,0,25,negative regulation of cardiac muscle tissue development,BP,
14399,GO:0055028,1,0.990353712774273,0,1,cortical microtubule,CC,
14400,GO:0055029,1,0.423341068258096,0,131,nuclear DNA-directed RNA polymerase complex,CC,
14401,GO:0055037,1,0.352509318764889,0,152,recycling endosome,CC,
14402,GO:0055038,1,0.652649617209686,0,67,recycling endosome membrane,CC,
14403,GO:0055048,1,0.990353712774273,0,1,anastral spindle assembly,BP,
14404,GO:0055056,1,0.944266640411841,0,9,D-glucose transmembrane transporter activity,MF,
14405,GO:0055057,1,0.910139447238502,0,13,neuroblast division,BP,
14406,GO:0055059,1,0.959310367568164,0,6,asymmetric neuroblast division,BP,
14407,GO:0055062,1,0.935188594772829,0,9,phosphate ion homeostasis,BP,
14408,GO:0055064,1,0.915416424382795,0,12,chloride ion homeostasis,BP,
14410,GO:0055067,1,0.389298581362056,0,142,monovalent inorganic cation homeostasis,BP,
14411,GO:0055069,1,0.817050385792079,0,33,zinc ion homeostasis,BP,
14412,GO:0055070,1,0.898745877541369,0,16,copper ion homeostasis,BP,
14414,GO:0055073,1,0.988132139869815,0,2,cadmium ion homeostasis,BP,
14416,GO:0055075,1,0.832276786277819,0,26,potassium ion homeostasis,BP,
14418,GO:0055077,1,0.988283090927841,0,2,gap junction hemi-channel activity,MF,
14419,GO:0055078,1,0.76955335474308,0,40,sodium ion homeostasis,BP,
14421,GO:0055081,1,0.733091663412008,0,44,anion homeostasis,BP,
14423,GO:0055083,1,0.856036304440716,0,21,monovalent inorganic anion homeostasis,BP,
14426,GO:0055087,1,0.980134628237419,0,3,Ski complex,CC,
14428,GO:0055089,1,0.92177584440385,0,12,fatty acid homeostasis,BP,
14429,GO:0055090,1,0.854624382003215,0,25,acylglycerol homeostasis,BP,
14430,GO:0055091,1,0.945588644233883,0,8,phospholipid homeostasis,BP,
14431,GO:0055092,1,0.713001735029754,0,52,sterol homeostasis,BP,
14433,GO:0055094,1,0.867266245933906,0,21,response to lipoprotein particle,BP,
14434,GO:0055095,1,0.981557217073224,0,3,lipoprotein particle mediated signaling,BP,
14435,GO:0055096,1,0.981557217073224,0,3,low-density lipoprotein particle mediated signaling,BP,
14436,GO:0055100,1,0.981362778648702,0,3,adiponectin binding,MF,
14438,GO:0055103,1,0.993907666384269,0,1,ligase regulator activity,MF,
14439,GO:0055105,1,0.967937524258934,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14440,GO:0055106,1,0.912495261582556,0,16,ubiquitin-protein transferase regulator activity,MF,
14441,GO:0055108,1,0.994483082595611,0,1,Golgi to transport vesicle transport,BP,
14442,GO:0055111,1,0.99180115349764,0,1,ingression involved in gastrulation with mouth forming second,BP,
14443,GO:0055113,1,0.987070281144135,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14445,GO:0055117,1,0.602480277165962,0,69,regulation of cardiac muscle contraction,BP,
14446,GO:0055118,1,0.960288139389226,0,6,negative regulation of cardiac muscle contraction,BP,
14447,GO:0055119,1,0.886450299502129,0,17,relaxation of cardiac muscle,BP,
14448,GO:0055120,1,0.994631736805621,0,1,striated muscle dense body,CC,
14450,GO:0055129,1,0.977466627556512,0,4,L-proline biosynthetic process,BP,
14451,GO:0055130,1,0.994561618309242,0,1,D-alanine catabolic process,BP,
14452,GO:0055131,1,0.966356670733413,0,6,C3HC4-type RING finger domain binding,MF,
14453,GO:0060001,1,0.98902517649828,0,1,minus-end directed microfilament motor activity,MF,
14454,GO:0060002,1,0.978447580613944,0,2,plus-end directed microfilament motor activity,MF,
14455,GO:0060003,1,0.980430159534642,0,2,copper ion export,BP,
14456,GO:0060004,1,0.88456729141357,0,18,reflex,BP,
14457,GO:0060005,1,0.973425614495073,0,4,vestibular reflex,BP,
14458,GO:0060007,1,0.993164574884721,0,1,linear vestibuloocular reflex,BP,
14459,GO:0060008,1,0.891381475788027,0,17,Sertoli cell differentiation,BP,
14460,GO:0060009,1,0.912706109378032,0,13,Sertoli cell development,BP,
14461,GO:0060010,1,0.99385589109491,0,1,Sertoli cell fate commitment,BP,
14462,GO:0060011,1,0.980630759448647,0,3,Sertoli cell proliferation,BP,
14463,GO:0060012,1,0.95936150762778,0,7,synaptic transmission, glycinergic,BP,
14464,GO:0060013,1,0.943402628181306,0,8,righting reflex,BP,
14465,GO:0060014,1,0.994116137405723,0,1,granulosa cell differentiation,BP,
14466,GO:0060017,1,0.960549785686344,0,6,parathyroid gland development,BP,
14467,GO:0060018,1,0.979967869557742,0,3,astrocyte fate commitment,BP,
14468,GO:0060019,1,0.927417693153927,0,12,radial glial cell differentiation,BP,
14471,GO:0060022,1,0.95711759474252,0,6,hard palate development,BP,
14472,GO:0060023,1,0.96169459073869,0,5,soft palate development,BP,
14473,GO:0060024,1,0.972083959033403,0,4,rhythmic synaptic transmission,BP,
14474,GO:0060025,1,0.97835921073614,0,3,regulation of synaptic activity,BP,
14475,GO:0060026,1,0.903150396632985,0,15,convergent extension,BP,
14476,GO:0060027,1,0.946847380099759,0,8,convergent extension involved in gastrulation,BP,
14477,GO:0060028,1,0.954839823045869,0,7,convergent extension involved in axis elongation,BP,
14478,GO:0060029,1,0.961572417438253,0,6,convergent extension involved in organogenesis,BP,
14479,GO:0060031,1,0.986164377343908,0,2,mediolateral intercalation,BP,
14480,GO:0060032,1,0.984540006508728,0,2,notochord regression,BP,
14481,GO:0060033,1,0.93458503432849,0,10,anatomical structure regression,BP,
14482,GO:0060037,1,0.843760647272531,0,24,pharyngeal system development,BP,
14483,GO:0060038,1,0.726002895007435,0,46,cardiac muscle cell proliferation,BP,
14484,GO:0060039,1,0.856267152387421,0,19,pericardium development,BP,
14485,GO:0060040,1,0.977120226823755,0,4,retinal bipolar neuron differentiation,BP,
14487,GO:0060042,1,0.740934136640837,0,41,retina morphogenesis in camera-type eye,BP,
14488,GO:0060043,1,0.778394573739313,0,36,regulation of cardiac muscle cell proliferation,BP,
14489,GO:0060044,1,0.925986522080592,0,12,negative regulation of cardiac muscle cell proliferation,BP,
14490,GO:0060045,1,0.852077588944621,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14491,GO:0060046,1,0.925172017362628,0,12,regulation of acrosome reaction,BP,
14493,GO:0060048,1,0.423908817758342,0,118,cardiac muscle contraction,BP,
14494,GO:0060049,1,0.912507278391349,0,13,regulation of protein glycosylation,BP,
14495,GO:0060050,1,0.937103720728304,0,9,positive regulation of protein glycosylation,BP,
14496,GO:0060051,1,0.988724682055188,0,2,negative regulation of protein glycosylation,BP,
14498,GO:0060053,1,0.98505668116098,0,2,neurofilament cytoskeleton,CC,
14499,GO:0060054,1,0.976009405892551,0,4,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14501,GO:0060056,1,0.949671894806146,0,8,mammary gland involution,BP,
14502,GO:0060057,1,0.980597584579315,0,3,apoptotic process involved in mammary gland involution,BP,
14503,GO:0060058,1,0.980597584579315,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14504,GO:0060059,1,0.934876410750719,0,7,embryonic retina morphogenesis in camera-type eye,BP,
14505,GO:0060060,1,0.9904148258142,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14506,GO:0060061,1,0.985573903255539,0,2,Spemann organizer formation,BP,
14507,GO:0060064,1,0.994578590289335,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14508,GO:0060065,1,0.864636556795673,0,19,uterus development,BP,
14509,GO:0060066,1,0.988353938616178,0,2,oviduct development,BP,
14510,GO:0060067,1,0.99162298711725,0,1,cervix development,BP,
14511,GO:0060068,1,0.931608849106197,0,9,vagina development,BP,
14513,GO:0060071,1,0.495951294868031,0,106,Wnt signaling pathway, planar cell polarity pathway,BP,
14514,GO:0060072,1,0.991212552986038,0,1,large conductance calcium-activated potassium channel activity,MF,
14515,GO:0060073,1,0.953971470692468,0,7,micturition,BP,
14516,GO:0060074,1,0.877425429204236,0,17,synapse maturation,BP,
14517,GO:0060075,1,0.950378460942996,0,7,regulation of resting membrane potential,BP,
14519,GO:0060077,1,0.903484063419328,0,15,inhibitory synapse,CC,
14524,GO:0060083,1,0.978466919742012,0,3,smooth muscle contraction involved in micturition,BP,
14525,GO:0060084,1,0.980436256122016,0,3,synaptic transmission involved in micturition,BP,
14526,GO:0060086,1,0.988211980262053,0,2,circadian temperature homeostasis,BP,
14527,GO:0060087,1,0.971690942012896,0,5,relaxation of vascular smooth muscle,BP,
14528,GO:0060088,1,0.931553546933426,0,10,auditory receptor cell stereocilium organization,BP,
14531,GO:0060091,1,0.957253508083548,0,7,kinocilium,CC,
14532,GO:0060092,1,0.993924650737727,0,1,regulation of synaptic transmission, glycinergic,BP,
14533,GO:0060099,1,0.929001435985252,0,11,regulation of phagocytosis, engulfment,BP,
14534,GO:0060100,1,0.939560181857454,0,9,positive regulation of phagocytosis, engulfment,BP,
14535,GO:0060101,1,0.994504358491303,0,1,negative regulation of phagocytosis, engulfment,BP,
14536,GO:0060112,1,0.989199410660697,0,2,generation of ovulation cycle rhythm,BP,
14538,GO:0060117,1,0.884824442771665,0,17,auditory receptor cell development,BP,
14540,GO:0060120,1,0.96489979510642,0,5,inner ear receptor cell fate commitment,BP,
14541,GO:0060122,1,0.848631096737915,0,23,inner ear receptor cell stereocilium organization,BP,
14542,GO:0060123,1,0.925410617416384,0,11,regulation of growth hormone secretion,BP,
14543,GO:0060124,1,0.953737187611277,0,8,positive regulation of growth hormone secretion,BP,
14544,GO:0060125,1,0.982593474056202,0,2,negative regulation of growth hormone secretion,BP,
14545,GO:0060126,1,0.982508959450821,0,3,somatotropin secreting cell differentiation,BP,
14546,GO:0060127,1,0.994410302375483,0,1,prolactin secreting cell differentiation,BP,
14547,GO:0060128,1,0.988636325435322,0,2,corticotropin hormone secreting cell differentiation,BP,
14548,GO:0060129,1,0.982111330272338,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14549,GO:0060133,1,0.994596363667603,0,1,somatotropin secreting cell development,BP,
14552,GO:0060136,1,0.961877436979403,0,6,embryonic process involved in female pregnancy,BP,
14553,GO:0060137,1,0.950558976509445,0,8,maternal process involved in parturition,BP,
14554,GO:0060139,1,0.987158558565514,0,2,positive regulation of apoptotic process by virus,BP,
14557,GO:0060147,1,0.559349815848241,0,86,regulation of posttranscriptional gene silencing,BP,
14558,GO:0060148,1,0.870932307179914,0,21,positive regulation of posttranscriptional gene silencing,BP,
14559,GO:0060149,1,0.903502614106863,0,14,negative regulation of posttranscriptional gene silencing,BP,
14560,GO:0060151,1,0.985883014481353,0,2,peroxisome localization,BP,
14561,GO:0060152,1,0.985883014481353,0,2,microtubule-based peroxisome localization,BP,
14562,GO:0060154,1,0.981561107129007,0,3,cellular process regulating host cell cycle in response to virus,BP,
14563,GO:0060155,1,0.948955852770039,0,8,platelet dense granule organization,BP,
14564,GO:0060156,1,0.993986671338394,0,1,milk ejection reflex,BP,
14565,GO:0060157,1,0.964865308151366,0,5,urinary bladder development,BP,
14566,GO:0060158,1,0.950039593098998,0,9,phospholipase C-activating dopamine receptor signaling pathway,BP,
14567,GO:0060159,1,0.941131669722649,0,9,regulation of dopamine receptor signaling pathway,BP,
14568,GO:0060160,1,0.988450816150582,0,2,negative regulation of dopamine receptor signaling pathway,BP,
14569,GO:0060161,1,0.970979506631722,0,4,positive regulation of dopamine receptor signaling pathway,BP,
14570,GO:0060163,1,0.988971217802089,0,2,subpallium neuron fate commitment,BP,
14571,GO:0060164,1,0.982904238846454,0,3,regulation of timing of neuron differentiation,BP,
14572,GO:0060165,1,0.994325157917915,0,1,regulation of timing of subpallium neuron differentiation,BP,
14573,GO:0060166,1,0.982736952776019,0,3,olfactory pit development,BP,
14574,GO:0060167,1,0.973636668228813,0,4,regulation of adenosine receptor signaling pathway,BP,
14575,GO:0060168,1,0.9789515120502,0,3,positive regulation of adenosine receptor signaling pathway,BP,
14576,GO:0060169,1,0.994572033598167,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14578,GO:0060171,1,0.978501170891998,0,2,stereocilium membrane,CC,
14580,GO:0060174,1,0.920352316359111,0,11,limb bud formation,BP,
14581,GO:0060175,1,0.990431263388985,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14582,GO:0060177,1,0.993824525273096,0,1,regulation of angiotensin metabolic process,BP,
14583,GO:0060178,1,0.994402887276554,0,1,regulation of exocyst localization,BP,
14585,GO:0060180,1,0.9613684737951,0,6,female mating behavior,BP,
14586,GO:0060183,1,0.993924650737727,0,1,apelin receptor signaling pathway,BP,
14587,GO:0060184,1,0.994070934974276,0,1,cell cycle switching,BP,
14588,GO:0060187,1,0.984857893180427,0,2,cell pole,CC,
14591,GO:0060193,1,0.701517172132015,0,54,positive regulation of lipase activity,BP,
14592,GO:0060197,1,0.981882638493433,0,3,cloacal septation,BP,
14593,GO:0060198,1,0.932143762873732,0,12,clathrin-sculpted vesicle,CC,
14594,GO:0060199,1,0.975894125472429,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14595,GO:0060200,1,0.981625277042959,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14596,GO:0060201,1,0.981625277042959,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14597,GO:0060203,1,0.975894125472429,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14599,GO:0060211,1,0.916321418665976,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14600,GO:0060212,1,0.994519401565665,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14601,GO:0060213,1,0.916321418665976,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14602,GO:0060214,1,0.977696088308529,0,4,endocardium formation,BP,
14603,GO:0060215,1,0.949181569096248,0,8,primitive hemopoiesis,BP,
14604,GO:0060216,1,0.865018593208159,0,21,definitive hemopoiesis,BP,
14605,GO:0060217,1,0.992414482626439,0,1,hemangioblast cell differentiation,BP,
14606,GO:0060218,1,0.589225885562685,0,89,hematopoietic stem cell differentiation,BP,
14607,GO:0060219,1,0.902066937604569,0,15,camera-type eye photoreceptor cell differentiation,BP,
14608,GO:0060221,1,0.982097520857496,0,3,retinal rod cell differentiation,BP,
14609,GO:0060228,1,0.984014167564839,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14610,GO:0060229,1,0.939221706247951,0,10,lipase activator activity,MF,
14611,GO:0060230,1,0.989299600867921,0,2,lipoprotein lipase activator activity,MF,
14612,GO:0060231,1,0.88429908717731,0,20,mesenchymal to epithelial transition,BP,
14613,GO:0060232,1,0.982716384852968,0,3,delamination,BP,
14614,GO:0060235,1,0.963760121789314,0,4,lens induction in camera-type eye,BP,
14615,GO:0060236,1,0.767256356187844,0,36,regulation of mitotic spindle organization,BP,
14616,GO:0060242,1,0.948966704015326,0,8,contact inhibition,BP,
14617,GO:0060243,1,0.993112737902662,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14618,GO:0060244,1,0.982549607246836,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14619,GO:0060245,1,0.993533767574381,0,1,detection of cell density,BP,
14620,GO:0060246,1,0.993533767574381,0,1,detection of cell density by contact stimulus,BP,
14621,GO:0060248,1,0.993533767574381,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14623,GO:0060251,1,0.829936943880121,0,25,regulation of glial cell proliferation,BP,
14624,GO:0060252,1,0.92687972986361,0,11,positive regulation of glial cell proliferation,BP,
14625,GO:0060253,1,0.901423735128987,0,14,negative regulation of glial cell proliferation,BP,
14626,GO:0060254,1,0.994520893390471,0,1,regulation of N-terminal protein palmitoylation,BP,
14628,GO:0060259,1,0.891028479147739,0,17,regulation of feeding behavior,BP,
14629,GO:0060260,1,0.838609486060085,0,27,regulation of transcription initiation from RNA polymerase II promoter,BP,
14630,GO:0060261,1,0.876685279550994,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14631,GO:0060262,1,0.994520893390471,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14632,GO:0060263,1,0.937338763688086,0,10,regulation of respiratory burst,BP,
14633,GO:0060264,1,0.983660654403416,0,3,regulation of respiratory burst involved in inflammatory response,BP,
14634,GO:0060265,1,0.989192758825321,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14635,GO:0060266,1,0.989084577596814,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14636,GO:0060267,1,0.972622319771643,0,4,positive regulation of respiratory burst,BP,
14637,GO:0060268,1,0.979838185282434,0,3,negative regulation of respiratory burst,BP,
14638,GO:0060271,1,0.0932691848414017,0,338,cilium assembly,BP,
14639,GO:0060272,1,0.930754165785079,0,12,embryonic skeletal joint morphogenesis,BP,
14640,GO:0060278,1,0.982847911629279,0,3,regulation of ovulation,BP,
14641,GO:0060279,1,0.988401640789572,0,2,positive regulation of ovulation,BP,
14642,GO:0060280,1,0.994381755056307,0,1,negative regulation of ovulation,BP,
14643,GO:0060281,1,0.935971841638252,0,10,regulation of oocyte development,BP,
14644,GO:0060282,1,0.973064365985576,0,4,positive regulation of oocyte development,BP,
14645,GO:0060283,1,0.973026932539981,0,4,negative regulation of oocyte development,BP,
14647,GO:0060285,1,0.797483445107705,0,30,cilium-dependent cell motility,BP,
14648,GO:0060287,1,0.945024396258413,0,9,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14649,GO:0060290,1,0.967468599707553,0,5,transdifferentiation,BP,
14652,GO:0060293,1,0.914806591493227,0,14,germ plasm,CC,
14653,GO:0060294,1,0.913612667081761,0,16,cilium movement involved in cell motility,BP,
14654,GO:0060295,1,0.971448060042142,0,5,regulation of cilium movement involved in cell motility,BP,
14655,GO:0060296,1,0.971448060042142,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14656,GO:0060297,1,0.95531062377127,0,5,regulation of sarcomere organization,BP,
14657,GO:0060298,1,0.978257708117719,0,3,positive regulation of sarcomere organization,BP,
14658,GO:0060300,1,0.976749514473457,0,4,regulation of cytokine activity,BP,
14659,GO:0060301,1,0.994320787029434,0,1,positive regulation of cytokine activity,BP,
14660,GO:0060302,1,0.989090961500972,0,2,negative regulation of cytokine activity,BP,
14661,GO:0060304,1,0.952468734495678,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14662,GO:0060305,1,0.994147645173646,0,1,regulation of cell diameter,BP,
14663,GO:0060306,1,0.805869538832413,0,29,regulation of membrane repolarization,BP,
14664,GO:0060307,1,0.878779670648871,0,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14665,GO:0060309,1,0.99465157871212,0,1,elastin catabolic process,BP,
14666,GO:0060310,1,0.99465157871212,0,1,regulation of elastin catabolic process,BP,
14667,GO:0060311,1,0.99465157871212,0,1,negative regulation of elastin catabolic process,BP,
14668,GO:0060312,1,0.945950530155008,0,8,regulation of blood vessel remodeling,BP,
14669,GO:0060313,1,0.977630012057054,0,3,negative regulation of blood vessel remodeling,BP,
14671,GO:0060315,1,0.93607456580443,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14672,GO:0060316,1,0.946708203957367,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14673,GO:0060317,1,0.81711960994421,0,31,cardiac epithelial to mesenchymal transition,BP,
14674,GO:0060318,1,0.966841839957694,0,5,definitive erythrocyte differentiation,BP,
14675,GO:0060319,1,0.976225950936865,0,4,primitive erythrocyte differentiation,BP,
14681,GO:0060327,1,0.994201695880389,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14683,GO:0060331,1,0.963119879887004,0,6,negative regulation of response to interferon-gamma,BP,
14684,GO:0060332,1,0.963271938523951,0,5,positive regulation of response to interferon-gamma,BP,
14687,GO:0060335,1,0.963271938523951,0,5,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14688,GO:0060336,1,0.963119879887004,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14689,GO:0060337,1,0.639018097427886,0,71,type I interferon signaling pathway,BP,
14690,GO:0060338,1,0.813078457883038,0,30,regulation of type I interferon-mediated signaling pathway,BP,
14691,GO:0060339,1,0.952277239147575,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
14692,GO:0060340,1,0.928757888031139,0,10,positive regulation of type I interferon-mediated signaling pathway,BP,
14694,GO:0060342,1,0.988731430331043,0,2,photoreceptor inner segment membrane,CC,
14696,GO:0060345,1,0.993829911822307,0,1,spleen trabecula formation,BP,
14698,GO:0060347,1,0.924145592622123,0,12,heart trabecula formation,BP,
14703,GO:0060352,1,0.958786191429504,0,7,cell adhesion molecule production,BP,
14704,GO:0060353,1,0.972266322378099,0,5,regulation of cell adhesion molecule production,BP,
14705,GO:0060354,1,0.994643589263539,0,1,negative regulation of cell adhesion molecule production,BP,
14706,GO:0060355,1,0.977503421911578,0,4,positive regulation of cell adhesion molecule production,BP,
14708,GO:0060363,1,0.950874058656977,0,8,cranial suture morphogenesis,BP,
14709,GO:0060364,1,0.97250447252592,0,4,frontal suture morphogenesis,BP,
14710,GO:0060366,1,0.989438902750882,0,1,lambdoid suture morphogenesis,BP,
14711,GO:0060367,1,0.989438902750882,0,1,sagittal suture morphogenesis,BP,
14712,GO:0060368,1,0.963419955686735,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14713,GO:0060369,1,0.97436703514656,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14714,GO:0060370,1,0.986374445262884,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14715,GO:0060371,1,0.944785349109395,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14716,GO:0060372,1,0.94640855821021,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14717,GO:0060373,1,0.962735638634152,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14718,GO:0060374,1,0.965089168133498,0,5,mast cell differentiation,BP,
14719,GO:0060375,1,0.986367903620669,0,2,regulation of mast cell differentiation,BP,
14720,GO:0060377,1,0.993907666384269,0,1,negative regulation of mast cell differentiation,BP,
14721,GO:0060378,1,0.98441211892767,0,2,regulation of brood size,BP,
14722,GO:0060379,1,0.931089097425919,0,10,cardiac muscle cell myoblast differentiation,BP,
14723,GO:0060380,1,0.99446096213131,0,1,regulation of single-stranded telomeric DNA binding,BP,
14724,GO:0060381,1,0.99446096213131,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14725,GO:0060382,1,0.984340138172689,0,2,regulation of DNA strand elongation,BP,
14726,GO:0060383,1,0.993236847114163,0,1,positive regulation of DNA strand elongation,BP,
14728,GO:0060385,1,0.967038110814818,0,5,axonogenesis involved in innervation,BP,
14729,GO:0060386,1,0.991725265528508,0,1,synapse assembly involved in innervation,BP,
14731,GO:0060390,1,0.89249644462151,0,17,regulation of SMAD protein signal transduction,BP,
14732,GO:0060391,1,0.914502153431674,0,13,positive regulation of SMAD protein signal transduction,BP,
14733,GO:0060392,1,0.983448955815432,0,3,negative regulation of SMAD protein signal transduction,BP,
14735,GO:0060394,1,0.941891211260085,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14737,GO:0060396,1,0.87636815792912,0,18,growth hormone receptor signaling pathway,BP,
14738,GO:0060397,1,0.920291677300102,0,11,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14739,GO:0060398,1,0.971287407183699,0,4,regulation of growth hormone receptor signaling pathway,BP,
14740,GO:0060399,1,0.978383366343042,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14741,GO:0060400,1,0.992748839098802,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14744,GO:0060404,1,0.99360199092993,0,1,axonemal microtubule depolymerization,BP,
14745,GO:0060405,1,0.966740729858266,0,5,regulation of penile erection,BP,
14746,GO:0060406,1,0.980208900564527,0,3,positive regulation of penile erection,BP,
14747,GO:0060407,1,0.994572033598167,0,1,negative regulation of penile erection,BP,
14748,GO:0060411,1,0.634389253458903,0,63,cardiac septum morphogenesis,BP,
14749,GO:0060412,1,0.776720730706165,0,35,ventricular septum morphogenesis,BP,
14750,GO:0060413,1,0.90306802857172,0,14,atrial septum morphogenesis,BP,
14753,GO:0060416,1,0.812354895253255,0,29,response to growth hormone,BP,
14754,GO:0060419,1,0.596007356194831,0,74,heart growth,BP,
14755,GO:0060420,1,0.68824825149773,0,53,regulation of heart growth,BP,
14756,GO:0060421,1,0.782914834869687,0,33,positive regulation of heart growth,BP,
14757,GO:0060422,1,0.994390624063498,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14758,GO:0060423,1,0.982428102321502,0,3,foregut regionalization,BP,
14759,GO:0060424,1,0.982428102321502,0,3,lung field specification,BP,
14760,GO:0060425,1,0.720913688967764,0,49,lung morphogenesis,BP,
14761,GO:0060426,1,0.97078760708216,0,5,lung vasculature development,BP,
14762,GO:0060428,1,0.801803618467109,0,33,lung epithelium development,BP,
14764,GO:0060430,1,0.959013332575712,0,6,lung saccule development,BP,
14765,GO:0060431,1,0.970900128998332,0,5,primary lung bud formation,BP,
14766,GO:0060432,1,0.994659444719884,0,1,lung pattern specification process,BP,
14767,GO:0060433,1,0.940125359018617,0,10,bronchus development,BP,
14768,GO:0060434,1,0.987056856510205,0,2,bronchus morphogenesis,BP,
14769,GO:0060435,1,0.989289765394946,0,2,bronchiole development,BP,
14770,GO:0060436,1,0.994659444719884,0,1,bronchiole morphogenesis,BP,
14771,GO:0060437,1,0.968574397327475,0,5,lung growth,BP,
14772,GO:0060438,1,0.880205001264218,0,19,trachea development,BP,
14773,GO:0060439,1,0.930016958036667,0,11,trachea morphogenesis,BP,
14774,GO:0060440,1,0.963924368146766,0,6,trachea formation,BP,
14775,GO:0060441,1,0.828353163464604,0,28,epithelial tube branching involved in lung morphogenesis,BP,
14776,GO:0060442,1,0.921773427773593,0,12,branching involved in prostate gland morphogenesis,BP,
14777,GO:0060443,1,0.729341009537384,0,43,mammary gland morphogenesis,BP,
14778,GO:0060444,1,0.845382298373389,0,22,branching involved in mammary gland duct morphogenesis,BP,
14779,GO:0060445,1,0.853382853581044,0,22,branching involved in salivary gland morphogenesis,BP,
14780,GO:0060447,1,0.979336865923477,0,3,bud outgrowth involved in lung branching,BP,
14781,GO:0060448,1,0.973615720200192,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14782,GO:0060449,1,0.957828638825791,0,7,bud elongation involved in lung branching,BP,
14783,GO:0060452,1,0.936263197470147,0,11,positive regulation of cardiac muscle contraction,BP,
14784,GO:0060453,1,0.941286068964651,0,10,regulation of gastric acid secretion,BP,
14785,GO:0060454,1,0.987126051037963,0,2,positive regulation of gastric acid secretion,BP,
14786,GO:0060455,1,0.971777510569873,0,5,negative regulation of gastric acid secretion,BP,
14787,GO:0060456,1,0.943550718454059,0,10,positive regulation of digestive system process,BP,
14788,GO:0060457,1,0.917387963869146,0,13,negative regulation of digestive system process,BP,
14789,GO:0060458,1,0.988887588515246,0,2,right lung development,BP,
14790,GO:0060459,1,0.983522104651654,0,3,left lung development,BP,
14791,GO:0060460,1,0.988896198896944,0,2,left lung morphogenesis,BP,
14792,GO:0060461,1,0.994290705332452,0,1,right lung morphogenesis,BP,
14793,GO:0060462,1,0.961603594239763,0,6,lung lobe development,BP,
14794,GO:0060463,1,0.961603594239763,0,6,lung lobe morphogenesis,BP,
14795,GO:0060465,1,0.987615040739607,0,2,pharynx development,BP,
14796,GO:0060466,1,0.990733598244629,0,1,activation of meiosis involved in egg activation,BP,
14797,GO:0060467,1,0.989030081854295,0,2,negative regulation of fertilization,BP,
14798,GO:0060474,1,0.993838853022917,0,1,positive regulation of flagellated sperm motility involved in capacitation,BP,
14799,GO:0060478,1,0.976470968869409,0,4,acrosomal vesicle exocytosis,BP,
14800,GO:0060479,1,0.87592506467438,0,20,lung cell differentiation,BP,
14801,GO:0060480,1,0.983799790422114,0,3,lung goblet cell differentiation,BP,
14802,GO:0060481,1,0.977300609452475,0,4,lobar bronchus epithelium development,BP,
14803,GO:0060482,1,0.970843114659775,0,5,lobar bronchus development,BP,
14804,GO:0060484,1,0.949681700672702,0,8,lung-associated mesenchyme development,BP,
14806,GO:0060486,1,0.972273434138587,0,4,Clara cell differentiation,BP,
14807,GO:0060487,1,0.881415240403208,0,19,lung epithelial cell differentiation,BP,
14808,GO:0060488,1,0.978920805745453,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14809,GO:0060489,1,0.978920805745453,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14810,GO:0060490,1,0.978920805745453,0,2,lateral sprouting involved in lung morphogenesis,BP,
14811,GO:0060491,1,0.37170014867453,0,143,regulation of cell projection assembly,BP,
14812,GO:0060492,1,0.982428102321502,0,3,lung induction,BP,
14813,GO:0060495,1,0.994659444719884,0,1,cell-cell signaling involved in lung development,BP,
14814,GO:0060496,1,0.994659444719884,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14815,GO:0060501,1,0.963534971394477,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14816,GO:0060502,1,0.936514741482569,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14817,GO:0060503,1,0.994527376974531,0,1,bud dilation involved in lung branching,BP,
14818,GO:0060509,1,0.957332967716311,0,5,Type I pneumocyte differentiation,BP,
14819,GO:0060510,1,0.967319151430403,0,5,Type II pneumocyte differentiation,BP,
14820,GO:0060512,1,0.833219643883024,0,26,prostate gland morphogenesis,BP,
14821,GO:0060513,1,0.934493183170625,0,10,prostatic bud formation,BP,
14822,GO:0060514,1,0.994039204446332,0,1,prostate induction,BP,
14823,GO:0060515,1,0.994039204446332,0,1,prostate field specification,BP,
14824,GO:0060516,1,0.987984849322668,0,2,primary prostatic bud elongation,BP,
14825,GO:0060517,1,0.993383083030628,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14826,GO:0060520,1,0.994039204446332,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14827,GO:0060523,1,0.979090151980453,0,3,prostate epithelial cord elongation,BP,
14828,GO:0060525,1,0.926393219117563,0,10,prostate glandular acinus development,BP,
14829,GO:0060526,1,0.957153512947056,0,6,prostate glandular acinus morphogenesis,BP,
14830,GO:0060527,1,0.957153512947056,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14831,GO:0060528,1,0.974945604191507,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14832,GO:0060529,1,0.986033938492622,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14833,GO:0060532,1,0.986468768651993,0,2,bronchus cartilage development,BP,
14834,GO:0060534,1,0.945537982932789,0,8,trachea cartilage development,BP,
14835,GO:0060535,1,0.97010927806422,0,4,trachea cartilage morphogenesis,BP,
14836,GO:0060536,1,0.928131281550103,0,11,cartilage morphogenesis,BP,
14838,GO:0060538,1,0.352712108594311,0,154,skeletal muscle organ development,BP,
14839,GO:0060539,1,0.958074628751048,0,7,diaphragm development,BP,
14841,GO:0060542,1,0.991681673728574,0,1,regulation of strand invasion,BP,
14842,GO:0060544,1,0.888462109787227,0,20,regulation of necroptotic process,BP,
14843,GO:0060545,1,0.987962663489947,0,2,positive regulation of necroptotic process,BP,
14844,GO:0060546,1,0.940451565922616,0,10,negative regulation of necroptotic process,BP,
14845,GO:0060547,1,0.925396914673719,0,13,negative regulation of necrotic cell death,BP,
14847,GO:0060556,1,0.953540765061925,0,8,regulation of vitamin D biosynthetic process,BP,
14848,GO:0060557,1,0.989157349897981,0,2,positive regulation of vitamin D biosynthetic process,BP,
14849,GO:0060558,1,0.964123092742635,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14850,GO:0060559,1,0.989157349897981,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14852,GO:0060561,1,0.854822982170884,0,23,apoptotic process involved in morphogenesis,BP,
14855,GO:0060566,1,0.98704162678125,0,1,positive regulation of DNA-templated transcription, termination,BP,
14856,GO:0060571,1,0.846953617033809,0,26,morphogenesis of an epithelial fold,BP,
14857,GO:0060572,1,0.896184613288967,0,17,morphogenesis of an epithelial bud,BP,
14858,GO:0060573,1,0.931293545339302,0,10,cell fate specification involved in pattern specification,BP,
14859,GO:0060574,1,0.977097721754949,0,4,intestinal epithelial cell maturation,BP,
14860,GO:0060575,1,0.905892816186131,0,16,intestinal epithelial cell differentiation,BP,
14861,GO:0060576,1,0.942763688837221,0,10,intestinal epithelial cell development,BP,
14862,GO:0060577,1,0.989002271750509,0,2,pulmonary vein morphogenesis,BP,
14863,GO:0060578,1,0.994410302375483,0,1,superior vena cava morphogenesis,BP,
14864,GO:0060579,1,0.909509126713259,0,14,ventral spinal cord interneuron fate commitment,BP,
14865,GO:0060580,1,0.994458238154445,0,1,ventral spinal cord interneuron fate determination,BP,
14866,GO:0060581,1,0.909509126713259,0,14,cell fate commitment involved in pattern specification,BP,
14867,GO:0060582,1,0.994458238154445,0,1,cell fate determination involved in pattern specification,BP,
14868,GO:0060584,1,0.982054970102057,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
14869,GO:0060585,1,0.982054970102057,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14870,GO:0060586,1,0.948226612057904,0,8,multicellular organismal iron ion homeostasis,BP,
14871,GO:0060587,1,0.988436814170517,0,2,regulation of lipoprotein lipid oxidation,BP,
14872,GO:0060588,1,0.994623954628972,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14873,GO:0060589,1,0.0965230614805598,0,332,nucleoside-triphosphatase regulator activity,MF,
14874,GO:0060590,1,0.784263169767853,0,40,ATPase regulator activity,MF,
14875,GO:0060591,1,0.973616344657949,0,4,chondroblast differentiation,BP,
14876,GO:0060592,1,0.952851368426933,0,7,mammary gland formation,BP,
14877,GO:0060594,1,0.977494588397261,0,3,mammary gland specification,BP,
14878,GO:0060595,1,0.98792946679262,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14879,GO:0060596,1,0.980160188678002,0,3,mammary placode formation,BP,
14880,GO:0060598,1,0.994612832112658,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14881,GO:0060599,1,0.985711629647295,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14882,GO:0060600,1,0.92273435059566,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14883,GO:0060601,1,0.908586949043228,0,13,lateral sprouting from an epithelium,BP,
14884,GO:0060602,1,0.877289165009559,0,19,branch elongation of an epithelium,BP,
14885,GO:0060603,1,0.795849855554745,0,30,mammary gland duct morphogenesis,BP,
14886,GO:0060605,1,0.966375241252933,0,5,tube lumen cavitation,BP,
14888,GO:0060611,1,0.994342608047487,0,1,mammary gland fat development,BP,
14889,GO:0060612,1,0.793326184309185,0,35,adipose tissue development,BP,
14890,GO:0060613,1,0.958211454030243,0,6,fat pad development,BP,
14891,GO:0060615,1,0.98792946679262,0,2,mammary gland bud formation,BP,
14892,GO:0060620,1,0.994184768585909,0,1,regulation of cholesterol import,BP,
14893,GO:0060623,1,0.988111625820962,0,2,regulation of chromosome condensation,BP,
14895,GO:0060628,1,0.923522220186871,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14896,GO:0060629,1,0.994150884731329,0,1,regulation of homologous chromosome segregation,BP,
14897,GO:0060631,1,0.958591142212696,0,7,regulation of meiosis I,BP,
14898,GO:0060632,1,0.861671807325799,0,23,regulation of microtubule-based movement,BP,
14899,GO:0060633,1,0.96907609237864,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14900,GO:0060638,1,0.946211460314191,0,8,mesenchymal-epithelial cell signaling,BP,
14901,GO:0060644,1,0.889908765312052,0,16,mammary gland epithelial cell differentiation,BP,
14902,GO:0060648,1,0.982505083485973,0,3,mammary gland bud morphogenesis,BP,
14903,GO:0060661,1,0.989119909924972,0,2,submandibular salivary gland formation,BP,
14904,GO:0060662,1,0.966375241252933,0,5,salivary gland cavitation,BP,
14905,GO:0060664,1,0.971228433083421,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14906,GO:0060665,1,0.974558462728843,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14907,GO:0060666,1,0.958256213715731,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14908,GO:0060667,1,0.98792946679262,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14909,GO:0060668,1,0.993631990350183,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14912,GO:0060671,1,0.988434194101916,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14913,GO:0060672,1,0.988434194101916,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14915,GO:0060675,1,0.656279900614997,0,59,ureteric bud morphogenesis,BP,
14916,GO:0060676,1,0.962484719196246,0,6,ureteric bud formation,BP,
14917,GO:0060677,1,0.943360504614917,0,7,ureteric bud elongation,BP,
14918,GO:0060678,1,0.994401581537699,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14919,GO:0060681,1,0.973759534537956,0,4,branch elongation involved in ureteric bud branching,BP,
14920,GO:0060683,1,0.994191137745906,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14921,GO:0060684,1,0.966272160298803,0,6,epithelial-mesenchymal cell signaling,BP,
14922,GO:0060685,1,0.960501849010953,0,6,regulation of prostatic bud formation,BP,
14923,GO:0060686,1,0.971544247900669,0,4,negative regulation of prostatic bud formation,BP,
14924,GO:0060687,1,0.952391905913934,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
14925,GO:0060688,1,0.717810726959974,0,51,regulation of morphogenesis of a branching structure,BP,
14926,GO:0060689,1,0.978113474293455,0,3,cell differentiation involved in salivary gland development,BP,
14927,GO:0060690,1,0.994522480326503,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14928,GO:0060691,1,0.994522480326503,0,1,epithelial cell maturation involved in salivary gland development,BP,
14929,GO:0060693,1,0.944477475247148,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14930,GO:0060694,1,0.994511452894922,0,1,regulation of cholesterol transporter activity,BP,
14931,GO:0060696,1,0.964790967116064,0,6,regulation of phospholipid catabolic process,BP,
14932,GO:0060697,1,0.988867133025174,0,2,positive regulation of phospholipid catabolic process,BP,
14933,GO:0060698,1,0.987201626942155,0,2,endoribonuclease inhibitor activity,MF,
14934,GO:0060699,1,0.976313525657625,0,4,regulation of endoribonuclease activity,BP,
14935,GO:0060700,1,0.945338689803721,0,9,regulation of ribonuclease activity,BP,
14936,GO:0060701,1,0.987201626942155,0,2,negative regulation of ribonuclease activity,BP,
14937,GO:0060702,1,0.987201626942155,0,2,negative regulation of endoribonuclease activity,BP,
14938,GO:0060703,1,0.994219870071372,0,1,deoxyribonuclease inhibitor activity,MF,
14942,GO:0060709,1,0.994142212994221,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14943,GO:0060710,1,0.958503131109673,0,7,chorio-allantoic fusion,BP,
14947,GO:0060715,1,0.979748702690066,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14948,GO:0060716,1,0.887594242372774,0,19,labyrinthine layer blood vessel development,BP,
14949,GO:0060717,1,0.95169128340335,0,7,chorion development,BP,
14950,GO:0060718,1,0.963202483229037,0,5,chorionic trophoblast cell differentiation,BP,
14951,GO:0060720,1,0.984262401118232,0,2,spongiotrophoblast cell proliferation,BP,
14952,GO:0060721,1,0.984262401118232,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14953,GO:0060722,1,0.984262401118232,0,2,cell proliferation involved in embryonic placenta development,BP,
14954,GO:0060723,1,0.984262401118232,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14955,GO:0060729,1,0.968286449189825,0,5,intestinal epithelial structure maintenance,BP,
14956,GO:0060730,1,0.988178572813576,0,2,regulation of intestinal epithelial structure maintenance,BP,
14957,GO:0060731,1,0.993882861295582,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14958,GO:0060732,1,0.941080013189701,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14959,GO:0060733,1,0.98546843974442,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14960,GO:0060734,1,0.992733230726232,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14961,GO:0060735,1,0.994597022512958,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14962,GO:0060736,1,0.918106323307109,0,11,prostate gland growth,BP,
14963,GO:0060737,1,0.972610229469248,0,4,prostate gland morphogenetic growth,BP,
14964,GO:0060738,1,0.994566168695361,0,1,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14965,GO:0060739,1,0.989975871609228,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14966,GO:0060740,1,0.837696028474267,0,25,prostate gland epithelium morphogenesis,BP,
14967,GO:0060741,1,0.989070244865068,0,2,prostate gland stromal morphogenesis,BP,
14968,GO:0060742,1,0.933110903355702,0,10,epithelial cell differentiation involved in prostate gland development,BP,
14969,GO:0060743,1,0.988371867539193,0,2,epithelial cell maturation involved in prostate gland development,BP,
14970,GO:0060744,1,0.965219024390618,0,5,mammary gland branching involved in thelarche,BP,
14971,GO:0060745,1,0.947364750590415,0,6,mammary gland branching involved in pregnancy,BP,
14972,GO:0060746,1,0.917341323959327,0,13,parental behavior,BP,
14973,GO:0060748,1,0.973107872034645,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14974,GO:0060749,1,0.886089879085538,0,17,mammary gland alveolus development,BP,
14975,GO:0060750,1,0.967276672020082,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14976,GO:0060751,1,0.96187842360168,0,5,branch elongation involved in mammary gland duct branching,BP,
14977,GO:0060752,1,0.994239849298598,0,1,intestinal phytosterol absorption,BP,
14978,GO:0060753,1,0.964979117744475,0,6,regulation of mast cell chemotaxis,BP,
14979,GO:0060754,1,0.970236674800065,0,5,positive regulation of mast cell chemotaxis,BP,
14981,GO:0060760,1,0.740357382905854,0,46,positive regulation of response to cytokine stimulus,BP,
14982,GO:0060761,1,0.733044471929274,0,48,negative regulation of response to cytokine stimulus,BP,
14983,GO:0060762,1,0.97410738970517,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14984,GO:0060763,1,0.985483296718347,0,2,mammary duct terminal end bud growth,BP,
14985,GO:0060764,1,0.986924828810951,0,2,cell-cell signaling involved in mammary gland development,BP,
14986,GO:0060765,1,0.848443017295471,0,25,regulation of androgen receptor signaling pathway,BP,
14987,GO:0060766,1,0.932548151407866,0,11,negative regulation of androgen receptor signaling pathway,BP,
14988,GO:0060767,1,0.932072661537156,0,11,epithelial cell proliferation involved in prostate gland development,BP,
14989,GO:0060768,1,0.938285159827636,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14990,GO:0060769,1,0.982486441136997,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14991,GO:0060770,1,0.966154204826055,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14992,GO:0060775,1,0.986164377343908,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14993,GO:0060781,1,0.994566168695361,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
14994,GO:0060782,1,0.994566168695361,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
14995,GO:0060783,1,0.994566168695361,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
14996,GO:0060784,1,0.993383083030628,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14997,GO:0060788,1,0.910551612799682,0,14,ectodermal placode formation,BP,
14998,GO:0060789,1,0.96320842499057,0,6,hair follicle placode formation,BP,
14999,GO:0060795,1,0.827566579623378,0,31,cell fate commitment involved in formation of primary germ layer,BP,
15000,GO:0060796,1,0.988982877692922,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15001,GO:0060800,1,0.979992750592412,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15002,GO:0060802,1,0.994455211392974,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15003,GO:0060803,1,0.994579653708309,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15004,GO:0060804,1,0.993972422704564,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15005,GO:0060806,1,0.99454604334118,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15006,GO:0060807,1,0.994373027526835,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15007,GO:0060809,1,0.985880633312054,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15008,GO:0060816,1,0.981304844455264,0,2,random inactivation of X chromosome,BP,
15009,GO:0060819,1,0.982280423568276,0,2,inactivation of X chromosome by genetic imprinting,BP,
15010,GO:0060821,1,0.989005943138727,0,1,inactivation of X chromosome by DNA methylation,BP,
15011,GO:0060823,1,0.987095724866354,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15012,GO:0060825,1,0.989084899398519,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15013,GO:0060827,1,0.993255870882139,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15015,GO:0060829,1,0.993255870882139,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15016,GO:0060830,1,0.980952806444091,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15017,GO:0060831,1,0.910050542631525,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15019,GO:0060837,1,0.942120074997652,0,9,blood vessel endothelial cell differentiation,BP,
15023,GO:0060841,1,0.880779984574347,0,16,venous blood vessel development,BP,
15024,GO:0060842,1,0.960460811523229,0,6,arterial endothelial cell differentiation,BP,
15025,GO:0060843,1,0.9884782076295,0,1,venous endothelial cell differentiation,BP,
15026,GO:0060844,1,0.988262594985988,0,2,arterial endothelial cell fate commitment,BP,
15027,GO:0060846,1,0.982649379866352,0,3,blood vessel endothelial cell fate commitment,BP,
15028,GO:0060847,1,0.982649379866352,0,3,endothelial cell fate specification,BP,
15029,GO:0060849,1,0.98745550888778,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15030,GO:0060850,1,0.897705711012882,0,16,regulation of transcription involved in cell fate commitment,BP,
15031,GO:0060853,1,0.993859771479433,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15032,GO:0060856,1,0.941307597862584,0,10,establishment of blood-brain barrier,BP,
15033,GO:0060857,1,0.994396641978191,0,1,establishment of glial blood-brain barrier,BP,
15034,GO:0060872,1,0.933324242222543,0,9,semicircular canal development,BP,
15035,GO:0060873,1,0.989438902750882,0,1,anterior semicircular canal development,BP,
15036,GO:0060875,1,0.989438902750882,0,1,lateral semicircular canal development,BP,
15037,GO:0060876,1,0.989027403523545,0,2,semicircular canal formation,BP,
15038,GO:0060879,1,0.994659444719884,0,1,semicircular canal fusion,BP,
15039,GO:0060896,1,0.934527344404609,0,9,neural plate pattern specification,BP,
15040,GO:0060897,1,0.952583603832333,0,7,neural plate regionalization,BP,
15041,GO:0060900,1,0.913167760259429,0,12,embryonic camera-type eye formation,BP,
15042,GO:0060901,1,0.993068521420915,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15043,GO:0060903,1,0.975921301872897,0,4,positive regulation of meiosis I,BP,
15044,GO:0060904,1,0.993345835634699,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15045,GO:0060907,1,0.955848932749944,0,7,positive regulation of macrophage cytokine production,BP,
15046,GO:0060911,1,0.943079156948397,0,10,cardiac cell fate commitment,BP,
15047,GO:0060912,1,0.988590192604142,0,2,cardiac cell fate specification,BP,
15048,GO:0060913,1,0.983307894072375,0,3,cardiac cell fate determination,BP,
15049,GO:0060914,1,0.867644006068853,0,22,heart formation,BP,
15050,GO:0060915,1,0.98792946679262,0,2,mesenchymal cell differentiation involved in lung development,BP,
15051,GO:0060916,1,0.965008239833877,0,5,mesenchymal cell proliferation involved in lung development,BP,
15052,GO:0060920,1,0.965929065074402,0,5,cardiac pacemaker cell differentiation,BP,
15053,GO:0060921,1,0.979373934771071,0,3,sinoatrial node cell differentiation,BP,
15054,GO:0060922,1,0.986274815437435,0,2,atrioventricular node cell differentiation,BP,
15055,GO:0060923,1,0.964707118491474,0,6,cardiac muscle cell fate commitment,BP,
15056,GO:0060926,1,0.971154172660366,0,4,cardiac pacemaker cell development,BP,
15057,GO:0060927,1,0.994496922073288,0,1,cardiac pacemaker cell fate commitment,BP,
15058,GO:0060928,1,0.986274815437435,0,2,atrioventricular node cell development,BP,
15059,GO:0060929,1,0.994496922073288,0,1,atrioventricular node cell fate commitment,BP,
15060,GO:0060931,1,0.984671036589266,0,2,sinoatrial node cell development,BP,
15061,GO:0060932,1,0.987180333159786,0,2,His-Purkinje system cell differentiation,BP,
15062,GO:0060935,1,0.979190479735525,0,3,cardiac fibroblast cell differentiation,BP,
15063,GO:0060936,1,0.979190479735525,0,3,cardiac fibroblast cell development,BP,
15064,GO:0060938,1,0.979190479735525,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15065,GO:0060939,1,0.979190479735525,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15066,GO:0060940,1,0.988016064108242,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15067,GO:0060947,1,0.944097269704128,0,8,cardiac vascular smooth muscle cell differentiation,BP,
15068,GO:0060948,1,0.976599669969248,0,3,cardiac vascular smooth muscle cell development,BP,
15069,GO:0060956,1,0.955609928201569,0,6,endocardial cell differentiation,BP,
15070,GO:0060957,1,0.994088308187862,0,1,endocardial cell fate commitment,BP,
15071,GO:0060964,1,0.572884375188011,0,83,regulation of gene silencing by miRNA,BP,
15072,GO:0060965,1,0.917894642264578,0,12,negative regulation of gene silencing by miRNA,BP,
15073,GO:0060966,1,0.559349815848241,0,86,regulation of gene silencing by RNA,BP,
15074,GO:0060967,1,0.903502614106863,0,14,negative regulation of gene silencing by RNA,BP,
15075,GO:0060968,1,0.483365971229854,0,106,regulation of gene silencing,BP,
15076,GO:0060969,1,0.847300033679423,0,22,negative regulation of gene silencing,BP,
15077,GO:0060971,1,0.969780451922708,0,4,embryonic heart tube left/right pattern formation,BP,
15078,GO:0060972,1,0.859580062767931,0,21,left/right pattern formation,BP,
15079,GO:0060973,1,0.887642410195513,0,17,cell migration involved in heart development,BP,
15080,GO:0060974,1,0.989281587587808,0,2,cell migration involved in heart formation,BP,
15081,GO:0060975,1,0.994621263909854,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15082,GO:0060976,1,0.732750499661223,0,41,coronary vasculature development,BP,
15083,GO:0060977,1,0.879375170137574,0,15,coronary vasculature morphogenesis,BP,
15084,GO:0060978,1,0.977344620169693,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15085,GO:0060979,1,0.963946720659512,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
15086,GO:0060980,1,0.993607541176219,0,1,cell migration involved in coronary vasculogenesis,BP,
15087,GO:0060981,1,0.991723369470809,0,1,cell migration involved in coronary angiogenesis,BP,
15088,GO:0060982,1,0.924536301562792,0,9,coronary artery morphogenesis,BP,
15089,GO:0060986,1,0.758364944531796,0,43,endocrine hormone secretion,BP,
15090,GO:0060987,1,0.994381755056307,0,1,lipid tube,CC,
15091,GO:0060988,1,0.98755381634528,0,2,lipid tube assembly,BP,
15092,GO:0060992,1,0.924889585667126,0,11,response to fungicide,BP,
15093,GO:0060993,1,0.53472720326091,0,86,kidney morphogenesis,BP,
15094,GO:0060994,1,0.988125099530687,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15095,GO:0060995,1,0.98624221690062,0,2,cell-cell signaling involved in kidney development,BP,
15100,GO:0061000,1,0.918818581827547,0,11,negative regulation of dendritic spine development,BP,
15102,GO:0061002,1,0.957121044190291,0,6,negative regulation of dendritic spine morphogenesis,BP,
15104,GO:0061004,1,0.949004314209258,0,9,pattern specification involved in kidney development,BP,
15105,GO:0061005,1,0.700046405302294,0,50,cell differentiation involved in kidney development,BP,
15107,GO:0061009,1,0.971551137738007,0,5,common bile duct development,BP,
15108,GO:0061010,1,0.976841602024846,0,3,gall bladder development,BP,
15109,GO:0061011,1,0.994532863797711,0,1,hepatic duct development,BP,
15111,GO:0061014,1,0.746200378537681,0,39,positive regulation of mRNA catabolic process,BP,
15112,GO:0061015,1,0.98920230510758,0,2,snRNA import into nucleus,BP,
15113,GO:0061017,1,0.994532863797711,0,1,hepatoblast differentiation,BP,
15116,GO:0061026,1,0.986326223511314,0,1,cardiac muscle tissue regeneration,BP,
15117,GO:0061027,1,0.988661920524162,0,2,umbilical cord development,BP,
15118,GO:0061028,1,0.76884114019284,0,38,establishment of endothelial barrier,BP,
15119,GO:0061029,1,0.914125933595699,0,13,eyelid development in camera-type eye,BP,
15120,GO:0061030,1,0.982306697327308,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15121,GO:0061031,1,0.983472104259059,0,3,endodermal digestive tract morphogenesis,BP,
15122,GO:0061032,1,0.988462251212648,0,2,visceral serous pericardium development,BP,
15123,GO:0061033,1,0.988069118905568,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15124,GO:0061034,1,0.985335024938472,0,2,olfactory bulb mitral cell layer development,BP,
15125,GO:0061035,1,0.680984255512892,0,56,regulation of cartilage development,BP,
15126,GO:0061036,1,0.826506186953779,0,27,positive regulation of cartilage development,BP,
15127,GO:0061037,1,0.870136383719342,0,22,negative regulation of cartilage development,BP,
15128,GO:0061038,1,0.949612699100431,0,6,uterus morphogenesis,BP,
15129,GO:0061040,1,0.988951803627041,0,1,female gonad morphogenesis,BP,
15135,GO:0061046,1,0.965292984315225,0,6,regulation of branching involved in lung morphogenesis,BP,
15136,GO:0061047,1,0.977050692127094,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15137,GO:0061048,1,0.994550115901387,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15138,GO:0061049,1,0.887680435052754,0,17,cell growth involved in cardiac muscle cell development,BP,
15139,GO:0061050,1,0.923627774939246,0,11,regulation of cell growth involved in cardiac muscle cell development,BP,
15140,GO:0061051,1,0.946014383922925,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15141,GO:0061052,1,0.976348839086927,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15142,GO:0061053,1,0.587102934458268,0,73,somite development,BP,
15143,GO:0061054,1,0.98791739253083,0,2,dermatome development,BP,
15144,GO:0061055,1,0.973013868830919,0,4,myotome development,BP,
15145,GO:0061056,1,0.977822469712784,0,4,sclerotome development,BP,
15147,GO:0061072,1,0.932510497948899,0,9,iris morphogenesis,BP,
15148,GO:0061073,1,0.980295677732977,0,3,ciliary body morphogenesis,BP,
15149,GO:0061074,1,0.971211556592317,0,5,regulation of neural retina development,BP,
15150,GO:0061075,1,0.988816202750704,0,2,positive regulation of neural retina development,BP,
15151,GO:0061076,1,0.993979567808698,0,1,negative regulation of neural retina development,BP,
15152,GO:0061077,1,0.653283592606089,0,71,chaperone-mediated protein folding,BP,
15153,GO:0061078,1,0.994662427018319,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15154,GO:0061081,1,0.932582100646083,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15155,GO:0061082,1,0.866964102456365,0,22,myeloid leukocyte cytokine production,BP,
15156,GO:0061083,1,0.975427952048351,0,4,regulation of protein refolding,BP,
15157,GO:0061084,1,0.975427952048351,0,4,negative regulation of protein refolding,BP,
15158,GO:0061085,1,0.942851451111403,0,9,regulation of histone H3-K27 methylation,BP,
15159,GO:0061086,1,0.974005411718316,0,4,negative regulation of histone H3-K27 methylation,BP,
15160,GO:0061087,1,0.961899985378065,0,6,positive regulation of histone H3-K27 methylation,BP,
15161,GO:0061088,1,0.942906432586541,0,9,regulation of sequestering of zinc ion,BP,
15162,GO:0061090,1,0.994352751250786,0,1,positive regulation of sequestering of zinc ion,BP,
15163,GO:0061091,1,0.975297944711081,0,3,regulation of phospholipid translocation,BP,
15164,GO:0061092,1,0.975297944711081,0,3,positive regulation of phospholipid translocation,BP,
15165,GO:0061097,1,0.640245801138833,0,67,regulation of protein tyrosine kinase activity,BP,
15166,GO:0061098,1,0.774331746073397,0,38,positive regulation of protein tyrosine kinase activity,BP,
15167,GO:0061099,1,0.85547313968027,0,24,negative regulation of protein tyrosine kinase activity,BP,
15168,GO:0061100,1,0.994325157917915,0,1,lung neuroendocrine cell differentiation,BP,
15169,GO:0061101,1,0.955061700343342,0,8,neuroendocrine cell differentiation,BP,
15170,GO:0061102,1,0.988940718375049,0,2,stomach neuroendocrine cell differentiation,BP,
15171,GO:0061103,1,0.994325157917915,0,1,carotid body glomus cell differentiation,BP,
15172,GO:0061104,1,0.988523217556245,0,2,adrenal chromaffin cell differentiation,BP,
15173,GO:0061105,1,0.994585137910175,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15174,GO:0061106,1,0.994585137910175,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15175,GO:0061107,1,0.983254444431834,0,3,seminal vesicle development,BP,
15176,GO:0061108,1,0.994401745018416,0,1,seminal vesicle epithelium development,BP,
15177,GO:0061110,1,0.977176758495083,0,3,dense core granule biogenesis,BP,
15178,GO:0061113,1,0.980126103991064,0,3,pancreas morphogenesis,BP,
15179,GO:0061114,1,0.994022802320081,0,1,branching involved in pancreas morphogenesis,BP,
15180,GO:0061115,1,0.994659444719884,0,1,lung proximal/distal axis specification,BP,
15181,GO:0061117,1,0.904069211835994,0,16,negative regulation of heart growth,BP,
15182,GO:0061133,1,0.967278544316675,0,6,endopeptidase activator activity,MF,
15185,GO:0061136,1,0.338516863874927,0,165,regulation of proteasomal protein catabolic process,BP,
15187,GO:0061140,1,0.946240113178608,0,9,lung secretory cell differentiation,BP,
15188,GO:0061141,1,0.978502386865533,0,3,lung ciliated cell differentiation,BP,
15189,GO:0061143,1,0.994151423212716,0,1,alveolar primary septum development,BP,
15190,GO:0061145,1,0.986468768651993,0,2,lung smooth muscle development,BP,
15191,GO:0061146,1,0.981099996868993,0,3,Peyer's patch morphogenesis,BP,
15192,GO:0061149,1,0.994527376974531,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15193,GO:0061150,1,0.994527376974531,0,1,renal system segmentation,BP,
15194,GO:0061151,1,0.994527376974531,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15195,GO:0061152,1,0.988373464239055,0,2,trachea submucosa development,BP,
15196,GO:0061153,1,0.988373464239055,0,2,trachea gland development,BP,
15198,GO:0061155,1,0.994527376974531,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15199,GO:0061156,1,0.951509369876879,0,6,pulmonary artery morphogenesis,BP,
15200,GO:0061157,1,0.847003320949225,0,22,mRNA destabilization,BP,
15201,GO:0061158,1,0.909939171951355,0,12,3'-UTR-mediated mRNA destabilization,BP,
15202,GO:0061162,1,0.871174573045883,0,19,establishment of monopolar cell polarity,BP,
15203,GO:0061178,1,0.726201536777373,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15204,GO:0061179,1,0.945457703560408,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15205,GO:0061180,1,0.62518610540434,0,64,mammary gland epithelium development,BP,
15206,GO:0061181,1,0.993113619588249,0,1,regulation of chondrocyte development,BP,
15207,GO:0061183,1,0.98791739253083,0,2,regulation of dermatome development,BP,
15208,GO:0061184,1,0.993400756729801,0,1,positive regulation of dermatome development,BP,
15209,GO:0061185,1,0.994480574012177,0,1,negative regulation of dermatome development,BP,
15210,GO:0061187,1,0.983538763037729,0,2,regulation of chromatin silencing at rDNA,BP,
15211,GO:0061188,1,0.983538763037729,0,2,negative regulation of chromatin silencing at rDNA,BP,
15212,GO:0061189,1,0.994566168695361,0,1,positive regulation of sclerotome development,BP,
15213,GO:0061190,1,0.994566168695361,0,1,regulation of sclerotome development,BP,
15214,GO:0061193,1,0.994636129384553,0,1,taste bud development,BP,
15215,GO:0061196,1,0.959673201072598,0,6,fungiform papilla development,BP,
15216,GO:0061197,1,0.965080577041685,0,5,fungiform papilla morphogenesis,BP,
15217,GO:0061198,1,0.979229800152966,0,3,fungiform papilla formation,BP,
15218,GO:0061200,1,0.953836637229187,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15219,GO:0061202,1,0.953836637229187,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15220,GO:0061205,1,0.987590392420255,0,2,paramesonephric duct development,BP,
15221,GO:0061209,1,0.977111176639958,0,4,cell proliferation involved in mesonephros development,BP,
15222,GO:0061213,1,0.882860428261843,0,20,positive regulation of mesonephros development,BP,
15223,GO:0061216,1,0.994527376974531,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15224,GO:0061217,1,0.86828793886544,0,23,regulation of mesonephros development,BP,
15225,GO:0061218,1,0.970794761620299,0,5,negative regulation of mesonephros development,BP,
15226,GO:0061227,1,0.989061056105154,0,2,pattern specification involved in mesonephros development,BP,
15227,GO:0061245,1,0.735711413757827,0,45,establishment or maintenance of bipolar cell polarity,BP,
15228,GO:0061289,1,0.98624221690062,0,2,Wnt signaling pathway involved in kidney development,BP,
15229,GO:0061290,1,0.98624221690062,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15232,GO:0061300,1,0.98482216691472,0,2,cerebellum vasculature development,BP,
15233,GO:0061301,1,0.990194618411626,0,1,cerebellum vasculature morphogenesis,BP,
15235,GO:0061303,1,0.947071054750513,0,8,cornea development in camera-type eye,BP,
15237,GO:0061307,1,0.934162067890838,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15238,GO:0061308,1,0.934162067890838,0,11,cardiac neural crest cell development involved in heart development,BP,
15239,GO:0061309,1,0.945416067717006,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15240,GO:0061311,1,0.852947450994082,0,24,cell surface receptor signaling pathway involved in heart development,BP,
15241,GO:0061312,1,0.96614590945678,0,6,BMP signaling pathway involved in heart development,BP,
15242,GO:0061314,1,0.934161400341412,0,9,Notch signaling involved in heart development,BP,
15243,GO:0061316,1,0.982769586646075,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15244,GO:0061317,1,0.988922341180946,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15245,GO:0061318,1,0.898519921532419,0,15,renal filtration cell differentiation,BP,
15246,GO:0061323,1,0.903441934412636,0,15,cell proliferation involved in heart morphogenesis,BP,
15247,GO:0061324,1,0.993779015227969,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15248,GO:0061325,1,0.977277049360855,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15252,GO:0061339,1,0.871174573045883,0,19,establishment or maintenance of monopolar cell polarity,BP,
15253,GO:0061341,1,0.983775506401568,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15254,GO:0061343,1,0.969765668785306,0,4,cell adhesion involved in heart morphogenesis,BP,
15255,GO:0061346,1,0.983775506401568,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15256,GO:0061347,1,0.99162298711725,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15257,GO:0061348,1,0.99162298711725,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15258,GO:0061349,1,0.99162298711725,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15259,GO:0061350,1,0.99162298711725,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15260,GO:0061351,1,0.403813067202376,0,127,neural precursor cell proliferation,BP,
15261,GO:0061354,1,0.99162298711725,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15262,GO:0061355,1,0.975108120841289,0,4,Wnt protein secretion,BP,
15263,GO:0061356,1,0.975108120841289,0,4,regulation of Wnt protein secretion,BP,
15264,GO:0061357,1,0.980492293910215,0,3,positive regulation of Wnt protein secretion,BP,
15265,GO:0061358,1,0.994509783732194,0,1,negative regulation of Wnt protein secretion,BP,
15266,GO:0061360,1,0.993222108242155,0,1,optic chiasma development,BP,
15267,GO:0061364,1,0.976208675988921,0,3,apoptotic process involved in luteolysis,BP,
15268,GO:0061365,1,0.959984819788618,0,7,positive regulation of triglyceride lipase activity,BP,
15269,GO:0061366,1,0.980299187114676,0,3,behavioral response to chemical pain,BP,
15270,GO:0061368,1,0.980299187114676,0,3,behavioral response to formalin induced pain,BP,
15271,GO:0061369,1,0.993400756729801,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15272,GO:0061370,1,0.964938294883342,0,6,testosterone biosynthetic process,BP,
15273,GO:0061371,1,0.67339798033756,0,58,determination of heart left/right asymmetry,BP,
15274,GO:0061373,1,0.988605630001894,0,1,mammillary axonal complex development,BP,
15275,GO:0061377,1,0.886089879085538,0,17,mammary gland lobule development,BP,
15277,GO:0061384,1,0.797564939810881,0,31,heart trabecula morphogenesis,BP,
15278,GO:0061386,1,0.980372911382726,0,2,closure of optic fissure,BP,
15280,GO:0061394,1,0.989036149759764,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15281,GO:0061395,1,0.994540436642298,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15282,GO:0061400,1,0.994184768585909,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15283,GO:0061402,1,0.988596067516969,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15284,GO:0061408,1,0.983052654006244,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15285,GO:0061418,1,0.632375550832512,0,74,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15286,GO:0061419,1,0.96457266186902,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15287,GO:0061428,1,0.974015728715127,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15289,GO:0061433,1,0.994490705180086,0,1,cellular response to caloric restriction,BP,
15290,GO:0061436,1,0.901464406696576,0,16,establishment of skin barrier,BP,
15291,GO:0061437,1,0.854872277741446,0,23,renal system vasculature development,BP,
15292,GO:0061438,1,0.954269968089678,0,6,renal system vasculature morphogenesis,BP,
15293,GO:0061439,1,0.954269968089678,0,6,kidney vasculature morphogenesis,BP,
15294,GO:0061440,1,0.854872277741446,0,23,kidney vasculature development,BP,
15295,GO:0061441,1,0.986718127000699,0,2,renal artery morphogenesis,BP,
15296,GO:0061443,1,0.985599904045884,0,2,endocardial cushion cell differentiation,BP,
15297,GO:0061444,1,0.991461620515323,0,1,endocardial cushion cell development,BP,
15298,GO:0061445,1,0.994088308187862,0,1,endocardial cushion cell fate commitment,BP,
15302,GO:0061459,1,0.990021849942505,0,1,L-arginine transmembrane transporter activity,MF,
15304,GO:0061469,1,0.950806183341514,0,8,regulation of type B pancreatic cell proliferation,BP,
15305,GO:0061470,1,0.969102837554724,0,4,T follicular helper cell differentiation,BP,
15306,GO:0061474,1,0.994296621165289,0,1,phagolysosome membrane,CC,
15307,GO:0061476,1,0.967148488180267,0,5,response to anticoagulant,BP,
15308,GO:0061478,1,0.909793860205743,0,12,response to platelet aggregation inhibitor,BP,
15309,GO:0061481,1,0.994647405411136,0,1,response to TNF agonist,BP,
15310,GO:0061484,1,0.973300753837285,0,4,hematopoietic stem cell homeostasis,BP,
15311,GO:0061485,1,0.990089582646646,0,1,memory T cell proliferation,BP,
15312,GO:0061495,1,0.994184768585909,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
15313,GO:0061502,1,0.964347822720877,0,4,early endosome to recycling endosome transport,BP,
15314,GO:0061505,1,0.984000982745603,0,2,DNA topoisomerase II activity,MF,
15315,GO:0061507,1,0.994545668527907,0,1,cyclic-GMP-AMP binding,MF,
15316,GO:0061508,1,0.994184768585909,0,1,CDP phosphorylation,BP,
15317,GO:0061511,1,0.972166350066734,0,4,centriole elongation,BP,
15318,GO:0061512,1,0.800825772163225,0,33,protein localization to cilium,BP,
15319,GO:0061513,1,0.981720146901599,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15321,GO:0061517,1,0.988437653429742,0,2,macrophage proliferation,BP,
15322,GO:0061518,1,0.988437653429742,0,2,microglial cell proliferation,BP,
15323,GO:0061519,1,0.993651548795761,0,1,macrophage homeostasis,BP,
15324,GO:0061523,1,0.99360199092993,0,1,cilium disassembly,BP,
15325,GO:0061525,1,0.941933057896743,0,8,hindgut development,BP,
15326,GO:0061526,1,0.977320179188708,0,4,acetylcholine secretion,BP,
15327,GO:0061528,1,0.992492201901996,0,1,aspartate secretion,BP,
15328,GO:0061534,1,0.985937007888714,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15329,GO:0061535,1,0.972037278997014,0,3,glutamate secretion, neurotransmission,BP,
15330,GO:0061536,1,0.993924650737727,0,1,glycine secretion,BP,
15331,GO:0061537,1,0.993924650737727,0,1,glycine secretion, neurotransmission,BP,
15332,GO:0061542,1,0.994609403508997,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15333,GO:0061547,1,0.987779120273922,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15334,GO:0061548,1,0.924045980134867,0,12,ganglion development,BP,
15335,GO:0061549,1,0.948701861057315,0,8,sympathetic ganglion development,BP,
15336,GO:0061550,1,0.965856758918606,0,5,cranial ganglion development,BP,
15337,GO:0061551,1,0.9719046808713,0,4,trigeminal ganglion development,BP,
15338,GO:0061552,1,0.994320787029434,0,1,ganglion morphogenesis,BP,
15340,GO:0061565,1,0.994184768585909,0,1,dAMP phosphorylation,BP,
15341,GO:0061566,1,0.994184768585909,0,1,CMP phosphorylation,BP,
15342,GO:0061567,1,0.994184768585909,0,1,dCMP phosphorylation,BP,
15343,GO:0061568,1,0.994184768585909,0,1,GDP phosphorylation,BP,
15344,GO:0061569,1,0.994184768585909,0,1,UDP phosphorylation,BP,
15345,GO:0061570,1,0.994184768585909,0,1,dCDP phosphorylation,BP,
15346,GO:0061571,1,0.994184768585909,0,1,TDP phosphorylation,BP,
15347,GO:0061572,1,0.385266057610513,0,139,actin filament bundle organization,BP,
15348,GO:0061574,1,0.981560532612125,0,3,ASAP complex,CC,
15349,GO:0061575,1,0.978528431195623,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15350,GO:0061577,1,0.91666395479767,0,11,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15351,GO:0061578,1,0.928667611286745,0,10,Lys63-specific deubiquitinase activity,MF,
15352,GO:0061580,1,0.99321255356127,0,1,colon epithelial cell migration,BP,
15353,GO:0061582,1,0.984466059566375,0,2,intestinal epithelial cell migration,BP,
15354,GO:0061588,1,0.966213140513399,0,5,calcium activated phospholipid scrambling,BP,
15355,GO:0061589,1,0.974489002165898,0,4,calcium activated phosphatidylserine scrambling,BP,
15356,GO:0061590,1,0.966213140513399,0,5,calcium activated phosphatidylcholine scrambling,BP,
15357,GO:0061591,1,0.966213140513399,0,5,calcium activated galactosylceramide scrambling,BP,
15358,GO:0061598,1,0.993085353964708,0,1,molybdopterin adenylyltransferase activity,MF,
15359,GO:0061599,1,0.993085353964708,0,1,molybdopterin molybdotransferase activity,MF,
15360,GO:0061604,1,0.994332998480301,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15361,GO:0061605,1,0.994332998480301,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15362,GO:0061608,1,0.941303130785186,0,9,nuclear import signal receptor activity,MF,
15363,GO:0061609,1,0.994342227706761,0,1,fructose-1-phosphate aldolase activity,MF,
15364,GO:0061611,1,0.994529222266585,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15365,GO:0061614,1,0.769834899110247,0,37,pri-miRNA transcription by RNA polymerase II,BP,
15366,GO:0061615,1,0.859537826970015,0,25,glycolytic process through fructose-6-phosphate,BP,
15367,GO:0061617,1,0.95546783555971,0,8,MICOS complex,CC,
15368,GO:0061618,1,0.986686683591878,0,1,sublamina densa,CC,
15369,GO:0061620,1,0.859537826970015,0,25,glycolytic process through glucose-6-phosphate,BP,
15370,GO:0061621,1,0.864213620176196,0,24,canonical glycolysis,BP,
15371,GO:0061622,1,0.988559256931314,0,2,glycolytic process through glucose-1-phosphate,BP,
15372,GO:0061623,1,0.99459741595704,0,1,glycolytic process from galactose,BP,
15373,GO:0061624,1,0.977246056371919,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15374,GO:0061626,1,0.951317907792616,0,7,pharyngeal arch artery morphogenesis,BP,
15375,GO:0061627,1,0.994479057076195,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15376,GO:0061628,1,0.972713503943878,0,3,H3K27me3 modified histone binding,MF,
15377,GO:0061629,1,0.968198064836164,0,5,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15378,GO:0061630,1,0.227620763405712,0,212,ubiquitin protein ligase activity,MF,
15379,GO:0061631,1,0.840249309265151,0,27,ubiquitin conjugating enzyme activity,MF,
15380,GO:0061635,1,0.960468674033356,0,7,regulation of protein complex stability,BP,
15381,GO:0061640,1,0.585359267510356,0,77,cytoskeleton-dependent cytokinesis,BP,
15382,GO:0061641,1,0.838390729966046,0,30,CENP-A containing chromatin organization,BP,
15383,GO:0061642,1,0.99162298711725,0,1,chemoattraction of axon,BP,
15384,GO:0061643,1,0.979649383618497,0,3,chemorepulsion of axon,BP,
15385,GO:0061645,1,0.950307592574019,0,7,endocytic patch,CC,
15386,GO:0061646,1,0.99246695504308,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15387,GO:0061647,1,0.749107615257318,0,40,histone H3-K9 modification,BP,
15388,GO:0061649,1,0.978596452659447,0,3,ubiquitin modification-dependent histone binding,MF,
15389,GO:0061650,1,0.835718107532386,0,28,ubiquitin-like protein conjugating enzyme activity,MF,
15390,GO:0061656,1,0.994616672573995,0,1,SUMO conjugating enzyme activity,MF,
15391,GO:0061659,1,0.22071529911134,0,217,ubiquitin-like protein ligase activity,MF,
15392,GO:0061663,1,0.990203688922681,0,1,NEDD8 ligase activity,MF,
15393,GO:0061665,1,0.970101484716145,0,5,SUMO ligase activity,MF,
15394,GO:0061668,1,0.961678834614268,0,6,mitochondrial ribosome assembly,BP,
15396,GO:0061670,1,0.994577825609846,0,1,evoked neurotransmitter secretion,BP,
15397,GO:0061673,1,0.967358741771933,0,5,mitotic spindle astral microtubule,CC,
15398,GO:0061676,1,0.961097258089484,0,6,importin-alpha family protein binding,MF,
15399,GO:0061682,1,0.994374788845745,0,1,seminal vesicle morphogenesis,BP,
15400,GO:0061684,1,0.930867534351588,0,12,chaperone-mediated autophagy,BP,
15401,GO:0061685,1,0.994184768585909,0,1,diphthine methylesterase activity,MF,
15402,GO:0061687,1,0.925311503197396,0,13,detoxification of inorganic compound,BP,
15403,GO:0061689,1,0.972997590947956,0,4,tricellular tight junction,CC,
15404,GO:0061690,1,0.994620037387759,0,1,lipoamidase activity,MF,
15405,GO:0061695,1,0.180424990039214,0,251,transferase complex, transferring phosphorus-containing groups,CC,
15406,GO:0061697,1,0.993970466866716,0,1,protein-glutaryllysine deglutarylase activity,MF,
15407,GO:0061698,1,0.993970466866716,0,1,protein deglutarylation,BP,
15408,GO:0061699,1,0.993970466866716,0,1,peptidyl-lysine deglutarylation,BP,
15409,GO:0061700,1,0.948024833004416,0,9,GATOR2 complex,CC,
15410,GO:0061702,1,0.928494285004124,0,12,inflammasome complex,CC,
15411,GO:0061709,1,0.990834212709851,0,1,reticulophagy,BP,
15412,GO:0061711,1,0.988982082741409,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15413,GO:0061712,1,0.993883555781604,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15414,GO:0061713,1,0.994631736805621,0,1,anterior neural tube closure,BP,
15415,GO:0061714,1,0.989285135332006,0,2,folic acid receptor activity,MF,
15416,GO:0061718,1,0.864213620176196,0,24,glucose catabolic process to pyruvate,BP,
15417,GO:0061723,1,0.985220559574108,0,2,glycophagy,BP,
15418,GO:0061724,1,0.953394063706866,0,6,lipophagy,BP,
15419,GO:0061726,1,0.58665910034824,0,80,mitochondrion disassembly,BP,
15420,GO:0061727,1,0.988670561288252,0,2,methylglyoxal catabolic process to lactate,BP,
15421,GO:0061731,1,0.980385461654514,0,3,ribonucleoside-diphosphate reductase activity,MF,
15422,GO:0061732,1,0.965162416579844,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15423,GO:0061733,1,0.693210508461197,0,52,peptide-lysine-N-acetyltransferase activity,MF,
15424,GO:0061734,1,0.958130467304455,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15425,GO:0061736,1,0.991741858696238,0,1,engulfment of target by autophagosome,BP,
15426,GO:0061737,1,0.972075756829438,0,5,leukotriene signaling pathway,BP,
15427,GO:0061738,1,0.982805356556144,0,3,late endosomal microautophagy,BP,
15428,GO:0061739,1,0.980768359188961,0,3,protein lipidation involved in autophagosome assembly,BP,
15429,GO:0061740,1,0.98198145646908,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15430,GO:0061741,1,0.988653236007286,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15431,GO:0061743,1,0.977141014104297,0,4,motor learning,BP,
15432,GO:0061744,1,0.969769756054223,0,5,motor behavior,BP,
15433,GO:0061749,1,0.984579053402406,0,2,forked DNA-dependent helicase activity,MF,
15434,GO:0061750,1,0.994380025312847,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15435,GO:0061752,1,0.988557674820876,0,2,telomeric repeat-containing RNA binding,MF,
15436,GO:0061753,1,0.991741858696238,0,1,substrate localization to autophagosome,BP,
15437,GO:0061756,1,0.841829149833608,0,27,leukocyte adhesion to vascular endothelial cell,BP,
15438,GO:0061757,1,0.988687266584695,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15439,GO:0061760,1,0.988791682470169,0,2,antifungal innate immune response,BP,
15440,GO:0061762,1,0.973074594024216,0,3,CAMKK-AMPK signaling cascade,BP,
15441,GO:0061763,1,0.98847786879228,0,2,multivesicular body-lysosome fusion,BP,
15442,GO:0061767,1,0.991555424385236,0,1,negative regulation of lung blood pressure,BP,
15443,GO:0061768,1,0.992546311346437,0,1,magnesium:sodium antiporter activity,MF,
15444,GO:0061769,1,0.988403017609477,0,2,ribosylnicotinate kinase activity,MF,
15445,GO:0061770,1,0.994433705021114,0,1,translation elongation factor binding,MF,
15446,GO:0061771,1,0.981379574549112,0,3,response to caloric restriction,BP,
15447,GO:0061772,1,0.99378490142507,0,1,drug transport across blood-nerve barrier,BP,
15448,GO:0061778,1,0.887771818277237,0,18,intracellular chloride channel activity,MF,
15449,GO:0061780,1,0.987771295481469,0,1,mitotic cohesin loading,BP,
15450,GO:0061782,1,0.993238578892015,0,1,vesicle fusion with vesicle,BP,
15451,GO:0061783,1,0.978676829744541,0,4,peptidoglycan muralytic activity,MF,
15452,GO:0061789,1,0.968911811004767,0,3,dense core granule priming,BP,
15453,GO:0061792,1,0.97839331003267,0,3,secretory granule maturation,BP,
15454,GO:0061798,1,0.993176819693024,0,1,GTP 3',8'-cyclase activity,MF,
15455,GO:0061799,1,0.993176819693024,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15456,GO:0061809,1,0.989188540351826,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15457,GO:0061811,1,0.994580558613897,0,1,ADP-ribosyl cyclase activity,MF,
15458,GO:0061812,1,0.994580558613897,0,1,cyclic ADP-ribose hydrolase,MF,
15459,GO:0061817,1,0.977716722378986,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
15460,GO:0061819,1,0.979201400799308,0,3,telomeric DNA-containing double minutes formation,BP,
15461,GO:0061820,1,0.948974513270096,0,8,telomeric D-loop disassembly,BP,
15462,GO:0061821,1,0.97152131980922,0,4,telomeric D-loop binding,MF,
15463,GO:0061825,1,0.993378864949064,0,1,podosome core,CC,
15464,GO:0061827,1,0.97182096862755,0,5,sperm head,CC,
15465,GO:0061828,1,0.989947505515292,0,1,apical tubulobulbar complex,CC,
15466,GO:0061829,1,0.989947505515292,0,1,basal tubulobulbar complex,CC,
15467,GO:0061832,1,0.989786333741576,0,1,basal ectoplasmic specialization,CC,
15468,GO:0061833,1,0.987474079790729,0,2,protein localization to tricellular tight junction,BP,
15469,GO:0061842,1,0.823285440658154,0,24,microtubule organizing center localization,BP,
15471,GO:0061845,1,0.993900130184356,0,1,neuron projection branch point,CC,
15472,GO:0061846,1,0.993900130184356,0,1,dendritic spine cytoplasm,CC,
15473,GO:0061847,1,0.994386215805125,0,1,response to cholecystokinin,BP,
15474,GO:0061849,1,0.984579053402406,0,2,telomeric G-quadruplex DNA binding,MF,
15475,GO:0061850,1,0.99464436348237,0,1,growth cone leading edge,CC,
15477,GO:0061853,1,0.992405097966755,0,1,regulation of neuroblast migration,BP,
15478,GO:0061855,1,0.992405097966755,0,1,negative regulation of neuroblast migration,BP,
15479,GO:0061857,1,0.987650161802223,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15480,GO:0061880,1,0.994543403502452,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15481,GO:0061881,1,0.994543403502452,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15482,GO:0061884,1,0.994467922829578,0,1,regulation of mini excitatory postsynaptic potential,BP,
15483,GO:0061885,1,0.994467922829578,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
15484,GO:0061888,1,0.971219739248548,0,4,regulation of astrocyte activation,BP,
15485,GO:0061889,1,0.992156067088974,0,1,negative regulation of astrocyte activation,BP,
15486,GO:0061890,1,0.978899793520944,0,3,positive regulation of astrocyte activation,BP,
15487,GO:0061896,1,0.992705636875583,0,1,all-trans retinol 3,4-desaturase activity,MF,
15488,GO:0061897,1,0.992705636875583,0,1,all-trans retinal 3,4-desaturase activity,MF,
15489,GO:0061898,1,0.992705636875583,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15490,GO:0061899,1,0.992705636875583,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15491,GO:0061900,1,0.800578747625878,0,31,glial cell activation,BP,
15492,GO:0061901,1,0.994488271510653,0,1,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15493,GO:0061903,1,0.994488271510653,0,1,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15494,GO:0061912,1,0.758271641550874,0,40,selective autophagy,BP,
15495,GO:0061919,1,0.0478697670490749,0,456,process utilizing autophagic mechanism,BP,
15496,GO:0061920,1,0.988943080235015,0,1,protein propionyltransferase activity,MF,
15497,GO:0061921,1,0.988943080235015,0,1,peptidyl-lysine propionylation,BP,
15498,GO:0061930,1,0.992269531760999,0,1,regulation of erythrocyte enucleation,BP,
15499,GO:0061931,1,0.992269531760999,0,1,positive regulation of erythrocyte enucleation,BP,
15500,GO:0061944,1,0.993024052563394,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15501,GO:0061945,1,0.981256676853788,0,3,regulation of protein K48-linked ubiquitination,BP,
15502,GO:0061951,1,0.767914153343099,0,39,establishment of protein localization to plasma membrane,BP,
15503,GO:0061953,1,0.982711357009015,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15505,GO:0061980,1,0.817392073382873,0,30,regulatory RNA binding,MF,
15506,GO:0061981,1,0.994580031490716,0,1,3-hydroxykynureninase activity,MF,
15507,GO:0061982,1,0.530077852295986,0,98,meiosis I cell cycle process,BP,
15508,GO:0061983,1,0.953894821793427,0,8,meiosis II cell cycle process,BP,
15509,GO:0061986,1,0.994348648066218,0,1,negative regulation of transcription by glucose,BP,
15510,GO:0061987,1,0.994348648066218,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15511,GO:0062009,1,0.929379531917893,0,10,secondary palate development,BP,
15514,GO:0062014,1,0.526718123287198,0,99,negative regulation of small molecule metabolic process,BP,
15515,GO:0065001,1,0.972318778695516,0,4,specification of axis polarity,BP,
15516,GO:0065002,1,0.745725304183915,0,49,intracellular protein transmembrane transport,BP,
15518,GO:0065004,1,0.296350910193258,0,192,protein-DNA complex assembly,BP,
15519,GO:0065005,1,0.848434325641791,0,24,protein-lipid complex assembly,BP,
15520,GO:0065006,1,0.989263002615058,0,2,protein-carbohydrate complex assembly,BP,
15524,GO:0065010,1,0.972093490021317,0,5,extracellular membrane-bounded organelle,CC,
15525,GO:0070001,1,0.896829064565581,0,18,aspartic-type peptidase activity,MF,
15526,GO:0070003,1,0.907301720434293,0,18,threonine-type peptidase activity,MF,
15527,GO:0070004,1,0.994184768585909,0,1,cysteine-type exopeptidase activity,MF,
15531,GO:0070012,1,0.98853699995152,0,2,oligopeptidase activity,MF,
15533,GO:0070016,1,0.932530520681052,0,10,armadillo repeat domain binding,MF,
15534,GO:0070022,1,0.970934558042003,0,4,transforming growth factor beta receptor complex,CC,
15535,GO:0070025,1,0.994271649284811,0,1,carbon monoxide binding,MF,
15536,GO:0070026,1,0.988940966487943,0,2,nitric oxide binding,MF,
15537,GO:0070032,1,0.977968940362073,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15539,GO:0070034,1,0.851579156047478,0,22,telomerase RNA binding,MF,
15540,GO:0070035,1,0.546594647784948,0,91,purine NTP-dependent helicase activity,MF,
15541,GO:0070037,1,0.994631385792714,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15542,GO:0070039,1,0.992270475651402,0,1,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15543,GO:0070042,1,0.994043188481586,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15544,GO:0070044,1,0.977018918312627,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15545,GO:0070050,1,0.943993655732244,0,10,neuron cellular homeostasis,BP,
15546,GO:0070051,1,0.97989278565707,0,3,fibrinogen binding,MF,
15547,GO:0070052,1,0.985661571058134,0,2,collagen V binding,MF,
15548,GO:0070053,1,0.980961156819384,0,3,thrombospondin receptor activity,MF,
15549,GO:0070054,1,0.981774757683272,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15550,GO:0070055,1,0.981774757683272,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15551,GO:0070059,1,0.710024625128485,0,54,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
15552,GO:0070060,1,0.988641887108238,0,1,'de novo' actin filament nucleation,BP,
15553,GO:0070061,1,0.971507496519683,0,5,fructose binding,MF,
15555,GO:0070063,1,0.694887907309285,0,54,RNA polymerase binding,MF,
15556,GO:0070064,1,0.873513046117505,0,18,proline-rich region binding,MF,
15557,GO:0070069,1,0.866916924479363,0,25,cytochrome complex,CC,
15558,GO:0070070,1,0.924253013402268,0,10,proton-transporting V-type ATPase complex assembly,BP,
15559,GO:0070071,1,0.903028744229414,0,14,proton-transporting two-sector ATPase complex assembly,BP,
15560,GO:0070072,1,0.924253013402268,0,10,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15561,GO:0070075,1,0.994659444719884,0,1,tear secretion,BP,
15562,GO:0070076,1,0.820187275544487,0,25,histone lysine demethylation,BP,
15563,GO:0070077,1,0.993628847729139,0,1,histone arginine demethylation,BP,
15564,GO:0070078,1,0.993628847729139,0,1,histone H3-R2 demethylation,BP,
15565,GO:0070079,1,0.993628847729139,0,1,histone H4-R3 demethylation,BP,
15566,GO:0070080,1,0.987514417459798,0,2,titin Z domain binding,MF,
15567,GO:0070081,1,0.970597915507219,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15568,GO:0070083,1,0.970597915507219,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15570,GO:0070086,1,0.974516499181266,0,4,ubiquitin-dependent endocytosis,BP,
15571,GO:0070087,1,0.949966684068896,0,6,chromo shadow domain binding,MF,
15572,GO:0070091,1,0.958367355185436,0,7,glucagon secretion,BP,
15573,GO:0070092,1,0.963554465221658,0,6,regulation of glucagon secretion,BP,
15574,GO:0070093,1,0.983124976006191,0,3,negative regulation of glucagon secretion,BP,
15575,GO:0070094,1,0.994279530557931,0,1,positive regulation of glucagon secretion,BP,
15576,GO:0070095,1,0.983008071198533,0,3,fructose-6-phosphate binding,MF,
15577,GO:0070096,1,0.993810444463696,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15580,GO:0070099,1,0.951034765485277,0,7,regulation of chemokine-mediated signaling pathway,BP,
15581,GO:0070100,1,0.967981245287319,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
15582,GO:0070101,1,0.982498611842317,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15584,GO:0070103,1,0.983450800640942,0,3,regulation of interleukin-6-mediated signaling pathway,BP,
15585,GO:0070104,1,0.994543023298783,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15586,GO:0070105,1,0.988847522804559,0,2,positive regulation of interleukin-6-mediated signaling pathway,BP,
15587,GO:0070106,1,0.930066951111408,0,11,interleukin-27-mediated signaling pathway,BP,
15588,GO:0070110,1,0.981735152208874,0,3,ciliary neurotrophic factor receptor complex,CC,
15589,GO:0070119,1,0.99320342028195,0,1,ciliary neurotrophic factor binding,MF,
15590,GO:0070120,1,0.964369478400203,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15591,GO:0070121,1,0.991892770910328,0,1,Kupffer's vesicle development,BP,
15592,GO:0070122,1,0.969057615738981,0,5,isopeptidase activity,MF,
15593,GO:0070123,1,0.991068438981621,0,1,transforming growth factor beta receptor activity, type III,MF,
15594,GO:0070124,1,0.988865123549604,0,2,mitochondrial translational initiation,BP,
15595,GO:0070125,1,0.625409209407694,0,84,mitochondrial translational elongation,BP,
15596,GO:0070126,1,0.618133549268751,0,86,mitochondrial translational termination,BP,
15597,GO:0070127,1,0.952541241416415,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
15598,GO:0070129,1,0.89866456881526,0,18,regulation of mitochondrial translation,BP,
15599,GO:0070130,1,0.994184768585909,0,1,negative regulation of mitochondrial translation,BP,
15600,GO:0070131,1,0.938186788736944,0,11,positive regulation of mitochondrial translation,BP,
15601,GO:0070137,1,0.968997124304102,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
15602,GO:0070138,1,0.980122911353274,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15603,GO:0070139,1,0.968997124304102,0,4,SUMO-specific endopeptidase activity,MF,
15604,GO:0070140,1,0.980122911353274,0,3,SUMO-specific isopeptidase activity,MF,
15605,GO:0070141,1,0.962567452079915,0,6,response to UV-A,BP,
15606,GO:0070142,1,0.965014025271558,0,5,synaptic vesicle budding,BP,
15607,GO:0070143,1,0.992603021832032,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15608,GO:0070145,1,0.993827041024114,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15609,GO:0070150,1,0.98879157068439,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15610,GO:0070159,1,0.994359379646613,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15611,GO:0070160,1,0.451800049092547,0,110,occluding junction,CC,
15613,GO:0070162,1,0.960211695449744,0,6,adiponectin secretion,BP,
15614,GO:0070163,1,0.960211695449744,0,6,regulation of adiponectin secretion,BP,
15615,GO:0070164,1,0.972055392889523,0,4,negative regulation of adiponectin secretion,BP,
15616,GO:0070165,1,0.987819252198774,0,2,positive regulation of adiponectin secretion,BP,
15617,GO:0070166,1,0.934222615192798,0,9,enamel mineralization,BP,
15619,GO:0070168,1,0.921383942091101,0,13,negative regulation of biomineral tissue development,BP,
15621,GO:0070170,1,0.974108281351086,0,4,regulation of tooth mineralization,BP,
15622,GO:0070171,1,0.98549636252903,0,2,negative regulation of tooth mineralization,BP,
15623,GO:0070172,1,0.988445997958984,0,2,positive regulation of tooth mineralization,BP,
15624,GO:0070176,1,0.994524055503688,0,1,DRM complex,CC,
15625,GO:0070178,1,0.98891496479255,0,2,D-serine metabolic process,BP,
15626,GO:0070179,1,0.994322778976815,0,1,D-serine biosynthetic process,BP,
15627,GO:0070180,1,0.994661642616348,0,1,large ribosomal subunit rRNA binding,MF,
15628,GO:0070181,1,0.95466050336773,0,8,small ribosomal subunit rRNA binding,MF,
15629,GO:0070182,1,0.901687660479332,0,16,DNA polymerase binding,MF,
15630,GO:0070183,1,0.994166595402938,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15631,GO:0070184,1,0.994433705021114,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15632,GO:0070187,1,0.965350701925826,0,6,shelterin complex,CC,
15633,GO:0070189,1,0.960066788576736,0,7,kynurenine metabolic process,BP,
15634,GO:0070191,1,0.988708991936116,0,2,methionine-R-sulfoxide reductase activity,MF,
15635,GO:0070192,1,0.693958642440228,0,55,chromosome organization involved in meiotic cell cycle,BP,
15636,GO:0070193,1,0.884440934424909,0,19,synaptonemal complex organization,BP,
15637,GO:0070194,1,0.988656914334673,0,2,synaptonemal complex disassembly,BP,
15638,GO:0070195,1,0.992999938021006,0,1,growth hormone receptor complex,CC,
15639,GO:0070197,1,0.969218577709014,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15640,GO:0070198,1,0.827822138235137,0,27,protein localization to chromosome, telomeric region,BP,
15641,GO:0070199,1,0.863851385659002,0,23,establishment of protein localization to chromosome,BP,
15642,GO:0070200,1,0.909144193666718,0,15,establishment of protein localization to telomere,BP,
15644,GO:0070202,1,0.93910496438132,0,11,regulation of establishment of protein localization to chromosome,BP,
15645,GO:0070203,1,0.944601163897959,0,10,regulation of establishment of protein localization to telomere,BP,
15647,GO:0070207,1,0.83198841057846,0,28,protein homotrimerization,BP,
15649,GO:0070209,1,0.993839209719658,0,1,ASTRA complex,CC,
15650,GO:0070212,1,0.969955393142365,0,4,protein poly-ADP-ribosylation,BP,
15651,GO:0070213,1,0.967804346686067,0,4,protein auto-ADP-ribosylation,BP,
15652,GO:0070221,1,0.978357359865606,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15655,GO:0070229,1,0.840841660087995,0,27,negative regulation of lymphocyte apoptotic process,BP,
15656,GO:0070230,1,0.918979112395644,0,14,positive regulation of lymphocyte apoptotic process,BP,
15659,GO:0070233,1,0.896305363175613,0,17,negative regulation of T cell apoptotic process,BP,
15660,GO:0070234,1,0.943187555875997,0,10,positive regulation of T cell apoptotic process,BP,
15661,GO:0070235,1,0.969341835289259,0,5,regulation of activation-induced cell death of T cells,BP,
15662,GO:0070236,1,0.974708023339684,0,4,negative regulation of activation-induced cell death of T cells,BP,
15663,GO:0070238,1,0.994549014331626,0,1,activated T cell autonomous cell death,BP,
15664,GO:0070239,1,0.994549014331626,0,1,regulation of activated T cell autonomous cell death,BP,
15665,GO:0070241,1,0.994549014331626,0,1,positive regulation of activated T cell autonomous cell death,BP,
15666,GO:0070242,1,0.894278249966497,0,17,thymocyte apoptotic process,BP,
15667,GO:0070243,1,0.926076645522396,0,12,regulation of thymocyte apoptotic process,BP,
15668,GO:0070244,1,0.955398025914118,0,7,negative regulation of thymocyte apoptotic process,BP,
15669,GO:0070245,1,0.969323562237311,0,5,positive regulation of thymocyte apoptotic process,BP,
15670,GO:0070246,1,0.994605845422229,0,1,natural killer cell apoptotic process,BP,
15671,GO:0070247,1,0.994605845422229,0,1,regulation of natural killer cell apoptotic process,BP,
15672,GO:0070251,1,0.994383820414269,0,1,pristanate-CoA ligase activity,MF,
15674,GO:0070253,1,0.978105532062367,0,4,somatostatin secretion,BP,
15675,GO:0070254,1,0.941526046258935,0,10,mucus secretion,BP,
15676,GO:0070255,1,0.946589721226017,0,9,regulation of mucus secretion,BP,
15677,GO:0070256,1,0.988759156560841,0,2,negative regulation of mucus secretion,BP,
15678,GO:0070257,1,0.962908535228924,0,6,positive regulation of mucus secretion,BP,
15679,GO:0070259,1,0.987833048828126,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15680,GO:0070260,1,0.994184768585909,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15681,GO:0070262,1,0.906796591983663,0,16,peptidyl-serine dephosphorylation,BP,
15682,GO:0070265,1,0.747525647800025,0,48,necrotic cell death,BP,
15683,GO:0070266,1,0.800358257940077,0,36,necroptotic process,BP,
15684,GO:0070267,1,0.993656221283248,0,1,oncosis,BP,
15685,GO:0070268,1,0.714437442288609,0,53,cornification,BP,
15686,GO:0070269,1,0.949250371632168,0,9,pyroptosis,BP,
15687,GO:0070273,1,0.862523967874957,0,22,phosphatidylinositol-4-phosphate binding,MF,
15688,GO:0070274,1,0.989078784842649,0,2,RES complex,CC,
15689,GO:0070278,1,0.971388901048695,0,5,extracellular matrix constituent secretion,BP,
15690,GO:0070279,1,0.760822345723898,0,45,vitamin B6 binding,MF,
15691,GO:0070280,1,0.993464118074765,0,1,pyridoxal binding,MF,
15692,GO:0070283,1,0.99454836859542,0,1,radical SAM enzyme activity,MF,
15693,GO:0070286,1,0.798388066022184,0,29,axonemal dynein complex assembly,BP,
15694,GO:0070287,1,0.993623339445579,0,1,ferritin receptor activity,MF,
15695,GO:0070288,1,0.98928796717152,0,2,ferritin complex,CC,
15696,GO:0070290,1,0.967151364618542,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15697,GO:0070291,1,0.98096374202912,0,3,N-acylethanolamine metabolic process,BP,
15698,GO:0070292,1,0.986274286815529,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15699,GO:0070293,1,0.913759161303487,0,15,renal absorption,BP,
15700,GO:0070294,1,0.972894217113069,0,4,renal sodium ion absorption,BP,
15701,GO:0070295,1,0.982922813896106,0,3,renal water absorption,BP,
15702,GO:0070296,1,0.780112928906672,0,31,sarcoplasmic reticulum calcium ion transport,BP,
15703,GO:0070300,1,0.881069611563973,0,18,phosphatidic acid binding,MF,
15705,GO:0070302,1,0.267764148446867,0,194,regulation of stress-activated protein kinase signaling cascade,BP,
15706,GO:0070303,1,0.773471677419532,0,39,negative regulation of stress-activated protein kinase signaling cascade,BP,
15707,GO:0070304,1,0.395614982613444,0,137,positive regulation of stress-activated protein kinase signaling cascade,BP,
15708,GO:0070305,1,0.954853990089459,0,6,response to cGMP,BP,
15711,GO:0070309,1,0.975055542791425,0,4,lens fiber cell morphogenesis,BP,
15712,GO:0070314,1,0.960802464509259,0,6,G1 to G0 transition,BP,
15713,GO:0070315,1,0.987898183801952,0,2,G1 to G0 transition involved in cell differentiation,BP,
15714,GO:0070316,1,0.754462635308572,0,40,regulation of G0 to G1 transition,BP,
15715,GO:0070317,1,0.775519042731608,0,36,negative regulation of G0 to G1 transition,BP,
15716,GO:0070318,1,0.972916603491397,0,4,positive regulation of G0 to G1 transition,BP,
15717,GO:0070320,1,0.994240083034553,0,1,inward rectifier potassium channel inhibitor activity,MF,
15718,GO:0070324,1,0.956984616758791,0,7,thyroid hormone binding,MF,
15719,GO:0070325,1,0.846063322857517,0,21,lipoprotein particle receptor binding,MF,
15720,GO:0070326,1,0.969686561582718,0,4,very-low-density lipoprotein particle receptor binding,MF,
15721,GO:0070327,1,0.957543286787127,0,7,thyroid hormone transport,BP,
15722,GO:0070328,1,0.854624382003215,0,25,triglyceride homeostasis,BP,
15723,GO:0070329,1,0.988705419861271,0,2,tRNA seleno-modification,BP,
15724,GO:0070330,1,0.909419722006983,0,16,aromatase activity,MF,
15725,GO:0070335,1,0.990406610068576,0,1,aspartate binding,MF,
15726,GO:0070336,1,0.985914335118657,0,2,flap-structured DNA binding,MF,
15727,GO:0070337,1,0.991681673728574,0,1,3'-flap-structured DNA binding,MF,
15728,GO:0070339,1,0.963640860773101,0,6,response to bacterial lipopeptide,BP,
15729,GO:0070340,1,0.979673061452212,0,3,detection of bacterial lipopeptide,BP,
15730,GO:0070341,1,0.943860069931539,0,9,fat cell proliferation,BP,
15731,GO:0070343,1,0.982430086942349,0,3,white fat cell proliferation,BP,
15732,GO:0070344,1,0.943860069931539,0,9,regulation of fat cell proliferation,BP,
15733,GO:0070345,1,0.966334461811362,0,5,negative regulation of fat cell proliferation,BP,
15734,GO:0070346,1,0.983576255141055,0,3,positive regulation of fat cell proliferation,BP,
15735,GO:0070350,1,0.982430086942349,0,3,regulation of white fat cell proliferation,BP,
15736,GO:0070352,1,0.989295123864398,0,2,positive regulation of white fat cell proliferation,BP,
15737,GO:0070358,1,0.959399135630944,0,6,actin polymerization-dependent cell motility,BP,
15739,GO:0070366,1,0.989118908843042,0,2,regulation of hepatocyte differentiation,BP,
15740,GO:0070367,1,0.994468187073568,0,1,negative regulation of hepatocyte differentiation,BP,
15741,GO:0070368,1,0.994621263909854,0,1,positive regulation of hepatocyte differentiation,BP,
15742,GO:0070369,1,0.976621628391648,0,3,beta-catenin-TCF7L2 complex,CC,
15743,GO:0070370,1,0.972583858733421,0,5,cellular heat acclimation,BP,
15748,GO:0070375,1,0.980587598228409,0,3,ERK5 cascade,BP,
15749,GO:0070376,1,0.994125114164287,0,1,regulation of ERK5 cascade,BP,
15750,GO:0070377,1,0.994125114164287,0,1,negative regulation of ERK5 cascade,BP,
15751,GO:0070381,1,0.987321561571312,0,2,endosome to plasma membrane transport vesicle,CC,
15753,GO:0070383,1,0.955728863506002,0,8,DNA cytosine deamination,BP,
15754,GO:0070384,1,0.976138350333356,0,4,Harderian gland development,BP,
15755,GO:0070390,1,0.994541302795038,0,1,transcription export complex 2,CC,
15756,GO:0070391,1,0.936437374813443,0,11,response to lipoteichoic acid,BP,
15757,GO:0070392,1,0.994631297741194,0,1,detection of lipoteichoic acid,BP,
15758,GO:0070401,1,0.988992036645984,0,2,NADP+ binding,MF,
15759,GO:0070402,1,0.921308272426121,0,13,NADPH binding,MF,
15760,GO:0070403,1,0.922275107842029,0,14,NAD+ binding,MF,
15761,GO:0070404,1,0.983667144812859,0,3,NADH binding,MF,
15762,GO:0070405,1,0.696225761786631,0,59,ammonium ion binding,MF,
15763,GO:0070407,1,0.993988601406961,0,1,oxidation-dependent protein catabolic process,BP,
15764,GO:0070408,1,0.991701569623798,0,1,carbamoyl phosphate metabolic process,BP,
15765,GO:0070409,1,0.991701569623798,0,1,carbamoyl phosphate biosynthetic process,BP,
15766,GO:0070410,1,0.902996405437949,0,12,co-SMAD binding,MF,
15767,GO:0070411,1,0.919822012865024,0,11,I-SMAD binding,MF,
15768,GO:0070412,1,0.837949791486377,0,23,R-SMAD binding,MF,
15769,GO:0070413,1,0.994090347230627,0,1,trehalose metabolism in response to stress,BP,
15770,GO:0070417,1,0.951094867225373,0,7,cellular response to cold,BP,
15771,GO:0070418,1,0.992250647663248,0,1,DNA-dependent protein kinase complex,CC,
15772,GO:0070419,1,0.950124228074516,0,7,nonhomologous end joining complex,CC,
15773,GO:0070423,1,0.804293996250724,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15774,GO:0070424,1,0.944967141826146,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15775,GO:0070425,1,0.98704089822028,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15776,GO:0070426,1,0.980579470113624,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15777,GO:0070427,1,0.973841724675119,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15778,GO:0070428,1,0.984799260054596,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15779,GO:0070429,1,0.992938902842734,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15780,GO:0070430,1,0.991803051652618,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15781,GO:0070431,1,0.939351322812006,0,10,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15782,GO:0070432,1,0.967869564656003,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15783,GO:0070433,1,0.98704089822028,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15784,GO:0070434,1,0.980579470113624,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15785,GO:0070435,1,0.988172242054805,0,2,Shc-EGFR complex,CC,
15786,GO:0070436,1,0.986956644651125,0,2,Grb2-EGFR complex,CC,
15787,GO:0070442,1,0.994595034281466,0,1,integrin alphaIIb-beta3 complex,CC,
15788,GO:0070444,1,0.938801973389316,0,8,oligodendrocyte progenitor proliferation,BP,
15789,GO:0070445,1,0.938801973389316,0,8,regulation of oligodendrocyte progenitor proliferation,BP,
15790,GO:0070446,1,0.994490705180086,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15791,GO:0070447,1,0.972055675388417,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,
15792,GO:0070458,1,0.982563682422364,0,3,cellular detoxification of nitrogen compound,BP,
15794,GO:0070460,1,0.993427552906125,0,1,thyroid-stimulating hormone secretion,BP,
15795,GO:0070461,1,0.855791093915402,0,23,SAGA-type complex,CC,
15796,GO:0070462,1,0.99360199092993,0,1,plus-end specific microtubule depolymerization,BP,
15797,GO:0070463,1,0.99374258461866,0,1,tubulin-dependent ATPase activity,MF,
15798,GO:0070469,1,0.634348093867935,0,81,respiratory chain,CC,
15799,GO:0070470,1,0.977610627185282,0,4,plasma membrane respiratory chain,CC,
15800,GO:0070471,1,0.952252703813616,0,8,uterine smooth muscle contraction,BP,
15801,GO:0070472,1,0.957731662543705,0,7,regulation of uterine smooth muscle contraction,BP,
15802,GO:0070473,1,0.99448949132686,0,1,negative regulation of uterine smooth muscle contraction,BP,
15803,GO:0070474,1,0.963040500450842,0,6,positive regulation of uterine smooth muscle contraction,BP,
15804,GO:0070475,1,0.960953590241297,0,7,rRNA base methylation,BP,
15805,GO:0070476,1,0.994661642616348,0,1,rRNA (guanine-N7)-methylation,BP,
15806,GO:0070478,1,0.99315143156814,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15807,GO:0070481,1,0.994113877257533,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15809,GO:0070483,1,0.993948088286499,0,1,detection of hypoxia,BP,
15810,GO:0070486,1,0.925010106115684,0,12,leukocyte aggregation,BP,
15811,GO:0070487,1,0.966748874255387,0,5,monocyte aggregation,BP,
15812,GO:0070488,1,0.98935831315704,0,2,neutrophil aggregation,BP,
15813,GO:0070489,1,0.987866184648803,0,2,T cell aggregation,BP,
15814,GO:0070491,1,0.662565789651358,0,62,repressing transcription factor binding,MF,
15815,GO:0070492,1,0.948448031054575,0,9,oligosaccharide binding,MF,
15816,GO:0070493,1,0.924742549914208,0,12,thrombin-activated receptor signaling pathway,BP,
15817,GO:0070494,1,0.979503430717595,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15818,GO:0070495,1,0.979503430717595,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15819,GO:0070498,1,0.556584165736731,0,96,interleukin-1-mediated signaling pathway,BP,
15820,GO:0070506,1,0.988512492714997,0,2,high-density lipoprotein particle receptor activity,MF,
15821,GO:0070507,1,0.310069610378374,0,162,regulation of microtubule cytoskeleton organization,BP,
15822,GO:0070508,1,0.959397114139139,0,7,cholesterol import,BP,
15824,GO:0070510,1,0.990421673817856,0,1,regulation of histone H4-K20 methylation,BP,
15825,GO:0070512,1,0.990421673817856,0,1,positive regulation of histone H4-K20 methylation,BP,
15826,GO:0070513,1,0.948718636691109,0,9,death domain binding,MF,
15827,GO:0070522,1,0.973505924365896,0,4,ERCC4-ERCC1 complex,CC,
15828,GO:0070524,1,0.994591020760409,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15829,GO:0070525,1,0.927319115408624,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15831,GO:0070528,1,0.840385693823525,0,27,protein kinase C signaling,BP,
15832,GO:0070530,1,0.892208259007502,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15833,GO:0070531,1,0.967693905621523,0,5,BRCA1-A complex,CC,
15834,GO:0070534,1,0.755088921037342,0,42,protein K63-linked ubiquitination,BP,
15835,GO:0070535,1,0.960671904964293,0,5,histone H2A K63-linked ubiquitination,BP,
15836,GO:0070536,1,0.843402349221197,0,24,protein K63-linked deubiquitination,BP,
15837,GO:0070537,1,0.982574877051236,0,3,histone H2A K63-linked deubiquitination,BP,
15838,GO:0070538,1,0.989245548345144,0,2,oleic acid binding,MF,
15839,GO:0070539,1,0.993711617489603,0,1,linoleic acid binding,MF,
15840,GO:0070541,1,0.978975694236499,0,3,response to platinum ion,BP,
15841,GO:0070542,1,0.610788582051495,0,75,response to fatty acid,BP,
15842,GO:0070543,1,0.994458511732395,0,1,response to linoleic acid,BP,
15843,GO:0070544,1,0.941639822158804,0,8,histone H3-K36 demethylation,BP,
15844,GO:0070545,1,0.981670163261523,0,3,PeBoW complex,CC,
15845,GO:0070547,1,0.994195180820788,0,1,L-tyrosine aminotransferase activity,MF,
15846,GO:0070548,1,0.983171909162831,0,2,L-glutamine aminotransferase activity,MF,
15847,GO:0070550,1,0.987771295481469,0,1,rDNA condensation,BP,
15848,GO:0070551,1,0.994184768585909,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15849,GO:0070552,1,0.982824303390716,0,3,BRISC complex,CC,
15850,GO:0070553,1,0.994184768585909,0,1,nicotinic acid receptor activity,MF,
15853,GO:0070557,1,0.989051043612571,0,2,PCNA-p21 complex,CC,
15854,GO:0070560,1,0.988366107944456,0,2,protein secretion by platelet,BP,
15855,GO:0070561,1,0.940837783196073,0,9,vitamin D receptor signaling pathway,BP,
15856,GO:0070562,1,0.959090175520954,0,6,regulation of vitamin D receptor signaling pathway,BP,
15857,GO:0070563,1,0.986829499738363,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15858,GO:0070564,1,0.988791276015889,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15859,GO:0070566,1,0.837182767199193,0,27,adenylyltransferase activity,MF,
15860,GO:0070567,1,0.944786722374542,0,9,cytidylyltransferase activity,MF,
15861,GO:0070568,1,0.969442303158865,0,5,guanylyltransferase activity,MF,
15862,GO:0070569,1,0.955644689708414,0,7,uridylyltransferase activity,MF,
15865,GO:0070572,1,0.955223433619776,0,8,positive regulation of neuron projection regeneration,BP,
15866,GO:0070573,1,0.982653775057058,0,3,metallodipeptidase activity,MF,
15867,GO:0070574,1,0.975224083525005,0,4,cadmium ion transmembrane transport,BP,
15868,GO:0070576,1,0.988258550912075,0,2,vitamin D 24-hydroxylase activity,MF,
15869,GO:0070577,1,0.87051726691179,0,17,lysine-acetylated histone binding,MF,
15870,GO:0070578,1,0.942314527706235,0,9,RISC-loading complex,CC,
15871,GO:0070579,1,0.958619288950126,0,4,methylcytosine dioxygenase activity,MF,
15872,GO:0070584,1,0.875676020159856,0,21,mitochondrion morphogenesis,BP,
15873,GO:0070585,1,0.333722272702336,0,177,protein localization to mitochondrion,BP,
15874,GO:0070586,1,0.950081124275417,0,9,cell-cell adhesion involved in gastrulation,BP,
15875,GO:0070587,1,0.955601605444668,0,8,regulation of cell-cell adhesion involved in gastrulation,BP,
15877,GO:0070589,1,0.994529222266585,0,1,cellular component macromolecule biosynthetic process,BP,
15878,GO:0070593,1,0.982881771569286,0,2,dendrite self-avoidance,BP,
15879,GO:0070601,1,0.940619247630606,0,10,centromeric sister chromatid cohesion,BP,
15880,GO:0070602,1,0.975259077635575,0,4,regulation of centromeric sister chromatid cohesion,BP,
15881,GO:0070603,1,0.590408491643479,0,73,SWI/SNF superfamily-type complex,CC,
15882,GO:0070611,1,0.994255980289904,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15883,GO:0070612,1,0.994255980289904,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15885,GO:0070615,1,0.993245068895093,0,1,nucleosome-dependent ATPase activity,MF,
15886,GO:0070618,1,0.99423231889384,0,1,Grb2-Sos complex,CC,
15887,GO:0070625,1,0.994456040045037,0,1,zymogen granule exocytosis,BP,
15888,GO:0070626,1,0.994581008791467,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15889,GO:0070627,1,0.993168950513005,0,1,ferrous iron import,BP,
15890,GO:0070628,1,0.870495315407968,0,21,proteasome binding,MF,
15891,GO:0070631,1,0.994184768585909,0,1,spindle pole body localization,BP,
15892,GO:0070632,1,0.994184768585909,0,1,establishment of spindle pole body localization,BP,
15893,GO:0070633,1,0.900898323948538,0,15,transepithelial transport,BP,
15894,GO:0070634,1,0.985192035635827,0,2,transepithelial ammonium transport,BP,
15895,GO:0070637,1,0.994348273062443,0,1,pyridine nucleoside metabolic process,BP,
15896,GO:0070638,1,0.994348273062443,0,1,pyridine nucleoside catabolic process,BP,
15897,GO:0070640,1,0.980805789199006,0,3,vitamin D3 metabolic process,BP,
15898,GO:0070643,1,0.994559033202051,0,1,vitamin D 25-hydroxylase activity,MF,
15899,GO:0070644,1,0.977839645313812,0,3,vitamin D response element binding,MF,
15900,GO:0070646,1,0.161706870180546,0,264,protein modification by small protein removal,BP,
15902,GO:0070649,1,0.977160937686628,0,3,formin-nucleated actin cable assembly,BP,
15903,GO:0070651,1,0.994113877257533,0,1,nonfunctional rRNA decay,BP,
15904,GO:0070652,1,0.948879731407698,0,8,HAUS complex,CC,
15905,GO:0070653,1,0.994643589263539,0,1,high-density lipoprotein particle receptor binding,MF,
15907,GO:0070662,1,0.978464246899956,0,3,mast cell proliferation,BP,
15909,GO:0070664,1,0.647479926459024,0,68,negative regulation of leukocyte proliferation,BP,
15911,GO:0070666,1,0.986115451382712,0,2,regulation of mast cell proliferation,BP,
15912,GO:0070667,1,0.99402560553207,0,1,negative regulation of mast cell proliferation,BP,
15913,GO:0070668,1,0.986115451382712,0,2,positive regulation of mast cell proliferation,BP,
15914,GO:0070669,1,0.917257961946756,0,13,response to interleukin-2,BP,
15915,GO:0070670,1,0.828064681269312,0,30,response to interleukin-4,BP,
15917,GO:0070672,1,0.907932649285632,0,14,response to interleukin-15,BP,
15918,GO:0070673,1,0.937919517346198,0,11,response to interleukin-18,BP,
15919,GO:0070676,1,0.983616442829876,0,3,intralumenal vesicle formation,BP,
15920,GO:0070678,1,0.994235625601745,0,1,preprotein binding,MF,
15921,GO:0070679,1,0.89675892023514,0,13,inositol 1,4,5 trisphosphate binding,MF,
15922,GO:0070681,1,0.982171803819661,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15923,GO:0070682,1,0.982854932428935,0,3,proteasome regulatory particle assembly,BP,
15924,GO:0070684,1,0.994623463480445,0,1,seminal clot liquefaction,BP,
15925,GO:0070685,1,0.994447503482982,0,1,macropinocytic cup,CC,
15926,GO:0070694,1,0.994184768585909,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15927,GO:0070695,1,0.959033126958849,0,5,FHF complex,CC,
15928,GO:0070696,1,0.896048369837703,0,17,transmembrane receptor protein serine/threonine kinase binding,MF,
15929,GO:0070697,1,0.968537378638396,0,5,activin receptor binding,MF,
15930,GO:0070698,1,0.988624138245944,0,2,type I activin receptor binding,MF,
15931,GO:0070699,1,0.985117341310023,0,2,type II activin receptor binding,MF,
15932,GO:0070700,1,0.925179224618176,0,12,BMP receptor binding,MF,
15933,GO:0070704,1,0.987174170237301,0,2,sterol desaturase activity,MF,
15934,GO:0070715,1,0.993882861295582,0,1,sodium-dependent organic cation transport,BP,
15935,GO:0070717,1,0.853063476857719,0,23,poly-purine tract binding,MF,
15936,GO:0070722,1,0.993725265958504,0,1,Tle3-Aes complex,CC,
15937,GO:0070723,1,0.855402833682019,0,20,response to cholesterol,BP,
15938,GO:0070724,1,0.993972422704564,0,1,BMP receptor complex,CC,
15940,GO:0070728,1,0.953418048371922,0,7,leucine binding,MF,
15941,GO:0070733,1,0.994553200123597,0,1,protein adenylyltransferase activity,MF,
15942,GO:0070734,1,0.878515340877526,0,19,histone H3-K27 methylation,BP,
15943,GO:0070735,1,0.99379150230237,0,1,protein-glycine ligase activity,MF,
15944,GO:0070736,1,0.99379150230237,0,1,protein-glycine ligase activity, initiating,MF,
15945,GO:0070739,1,0.956468544198551,0,7,protein-glutamic acid ligase activity,MF,
15946,GO:0070740,1,0.956468544198551,0,7,tubulin-glutamic acid ligase activity,MF,
15948,GO:0070742,1,0.906902576641858,0,14,C2H2 zinc finger domain binding,MF,
15949,GO:0070743,1,0.994632259758038,0,1,interleukin-23 complex,CC,
15950,GO:0070757,1,0.929888506814203,0,11,interleukin-35-mediated signaling pathway,BP,
15951,GO:0070761,1,0.969012743312165,0,5,pre-snoRNP complex,CC,
15952,GO:0070762,1,0.994184768585909,0,1,nuclear pore transmembrane ring,CC,
15953,GO:0070765,1,0.961628916863513,0,6,gamma-secretase complex,CC,
15954,GO:0070772,1,0.993998204777549,0,1,PAS complex,CC,
15955,GO:0070773,1,0.994599233652156,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15956,GO:0070774,1,0.992973960372734,0,1,phytoceramidase activity,MF,
15957,GO:0070775,1,0.952888801810438,0,7,H3 histone acetyltransferase complex,CC,
15958,GO:0070776,1,0.952888801810438,0,7,MOZ/MORF histone acetyltransferase complex,CC,
15959,GO:0070777,1,0.967001979845725,0,4,D-aspartate transport,BP,
15960,GO:0070778,1,0.96367881953425,0,6,L-aspartate transmembrane transport,BP,
15961,GO:0070779,1,0.967001979845725,0,4,D-aspartate import across plasma membrane,BP,
15962,GO:0070780,1,0.988516377447624,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15963,GO:0070781,1,0.986053018273405,0,2,response to biotin,BP,
15964,GO:0070782,1,0.994434594994479,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15965,GO:0070813,1,0.968394833703004,0,5,hydrogen sulfide metabolic process,BP,
15966,GO:0070814,1,0.973616247445746,0,4,hydrogen sulfide biosynthetic process,BP,
15967,GO:0070815,1,0.975267311816,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15968,GO:0070816,1,0.907471337290881,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
15969,GO:0070818,1,0.994534958144399,0,1,protoporphyrinogen oxidase activity,MF,
15972,GO:0070822,1,0.898691826179283,0,15,Sin3-type complex,CC,
15973,GO:0070826,1,0.993168950513005,0,1,paraferritin complex,CC,
15974,GO:0070827,1,0.969312661482357,0,4,chromatin maintenance,BP,
15975,GO:0070828,1,0.895220844843822,0,15,heterochromatin organization,BP,
15976,GO:0070829,1,0.983153310486588,0,2,heterochromatin maintenance,BP,
15977,GO:0070830,1,0.724678026025762,0,47,bicellular tight junction assembly,BP,
15978,GO:0070831,1,0.937934753546298,0,8,basement membrane assembly,BP,
15979,GO:0070836,1,0.982722309260996,0,3,caveola assembly,BP,
15980,GO:0070837,1,0.980842887578453,0,3,dehydroascorbic acid transport,BP,
15982,GO:0070839,1,0.987305902603058,0,2,divalent metal ion export,BP,
15983,GO:0070840,1,0.857194321922954,0,20,dynein complex binding,MF,
15984,GO:0070841,1,0.869560618264751,0,20,inclusion body assembly,BP,
15985,GO:0070842,1,0.974761707972982,0,4,aggresome assembly,BP,
15986,GO:0070843,1,0.99321255356127,0,1,misfolded protein transport,BP,
15987,GO:0070844,1,0.99321255356127,0,1,polyubiquitinated protein transport,BP,
15988,GO:0070845,1,0.99321255356127,0,1,polyubiquitinated misfolded protein transport,BP,
15989,GO:0070846,1,0.99321255356127,0,1,Hsp90 deacetylation,BP,
15990,GO:0070847,1,0.952814107444298,0,8,core mediator complex,CC,
15993,GO:0070851,1,0.495220798187481,0,107,growth factor receptor binding,MF,
15994,GO:0070852,1,0.953244115056562,0,6,cell body fiber,CC,
15995,GO:0070853,1,0.980284258610916,0,2,myosin VI binding,MF,
15996,GO:0070856,1,0.991390141232994,0,1,myosin VI light chain binding,MF,
15997,GO:0070857,1,0.953918369784718,0,8,regulation of bile acid biosynthetic process,BP,
15998,GO:0070858,1,0.982743410447409,0,3,negative regulation of bile acid biosynthetic process,BP,
15999,GO:0070859,1,0.982930861259615,0,3,positive regulation of bile acid biosynthetic process,BP,
16000,GO:0070860,1,0.99438655675982,0,1,RNA polymerase I core factor complex,CC,
16001,GO:0070861,1,0.851265067932361,0,23,regulation of protein exit from endoplasmic reticulum,BP,
16002,GO:0070862,1,0.939899392748652,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
16003,GO:0070863,1,0.920160483599543,0,11,positive regulation of protein exit from endoplasmic reticulum,BP,
16004,GO:0070873,1,0.81833269353967,0,26,regulation of glycogen metabolic process,BP,
16005,GO:0070874,1,0.962323406937456,0,5,negative regulation of glycogen metabolic process,BP,
16006,GO:0070875,1,0.891974950753019,0,14,positive regulation of glycogen metabolic process,BP,
16007,GO:0070876,1,0.975646312671504,0,4,SOSS complex,CC,
16008,GO:0070877,1,0.987149986248601,0,2,microprocessor complex,CC,
16009,GO:0070878,1,0.942553288327305,0,8,primary miRNA binding,MF,
16010,GO:0070883,1,0.963961705943512,0,5,pre-miRNA binding,MF,
16011,GO:0070884,1,0.8871968840967,0,16,regulation of calcineurin-NFAT signaling cascade,BP,
16012,GO:0070885,1,0.977459362921709,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
16013,GO:0070886,1,0.937985602095814,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16015,GO:0070888,1,0.815672159026104,0,31,E-box binding,MF,
16016,GO:0070889,1,0.988654347608763,0,2,platelet alpha granule organization,BP,
16017,GO:0070890,1,0.990572227848584,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16018,GO:0070891,1,0.977771242843275,0,4,lipoteichoic acid binding,MF,
16019,GO:0070892,1,0.994458511732395,0,1,lipoteichoic acid receptor activity,MF,
16020,GO:0070893,1,0.986269499221307,0,2,transposon integration,BP,
16021,GO:0070894,1,0.986269499221307,0,2,regulation of transposon integration,BP,
16022,GO:0070895,1,0.986269499221307,0,2,negative regulation of transposon integration,BP,
16023,GO:0070897,1,0.754413948331581,0,42,DNA-templated transcriptional preinitiation complex assembly,BP,
16024,GO:0070898,1,0.986981954760422,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16025,GO:0070899,1,0.994061974210582,0,1,mitochondrial tRNA wobble uridine modification,BP,
16026,GO:0070900,1,0.948695605390323,0,9,mitochondrial tRNA modification,BP,
16027,GO:0070901,1,0.975711398286442,0,4,mitochondrial tRNA methylation,BP,
16028,GO:0070902,1,0.994549932779899,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16029,GO:0070903,1,0.994485319471347,0,1,mitochondrial tRNA thio-modification,BP,
16030,GO:0070904,1,0.990572227848584,0,1,transepithelial L-ascorbic acid transport,BP,
16031,GO:0070905,1,0.982031272115579,0,3,serine binding,MF,
16032,GO:0070911,1,0.818001007499948,0,32,global genome nucleotide-excision repair,BP,
16033,GO:0070914,1,0.931595546469349,0,11,UV-damage excision repair,BP,
16034,GO:0070915,1,0.971943602078199,0,5,lysophosphatidic acid receptor activity,MF,
16035,GO:0070918,1,0.73972376722072,0,43,production of small RNA involved in gene silencing by RNA,BP,
16036,GO:0070920,1,0.902957720251117,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
16037,GO:0070922,1,0.938941242451242,0,9,small RNA loading onto RISC,BP,
16039,GO:0070926,1,0.993430890620848,0,1,regulation of ATP:ADP antiporter activity,BP,
16040,GO:0070931,1,0.991721947469998,0,1,Golgi-associated vesicle lumen,CC,
16041,GO:0070932,1,0.872492491823477,0,20,histone H3 deacetylation,BP,
16042,GO:0070933,1,0.935904151793256,0,9,histone H4 deacetylation,BP,
16043,GO:0070934,1,0.96912853667549,0,4,CRD-mediated mRNA stabilization,BP,
16044,GO:0070935,1,0.907934752589007,0,15,3'-UTR-mediated mRNA stabilization,BP,
16045,GO:0070936,1,0.720033285145034,0,49,protein K48-linked ubiquitination,BP,
16046,GO:0070937,1,0.96254267259261,0,5,CRD-mediated mRNA stability complex,CC,
16047,GO:0070938,1,0.917338948496054,0,11,contractile ring,CC,
16048,GO:0070939,1,0.978588249920599,0,3,Dsl1/NZR complex,CC,
16049,GO:0070940,1,0.969080533312088,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16050,GO:0070942,1,0.961771962207409,0,7,neutrophil mediated cytotoxicity,BP,
16051,GO:0070943,1,0.972848326757682,0,5,neutrophil mediated killing of symbiont cell,BP,
16052,GO:0070944,1,0.978145736116431,0,4,neutrophil mediated killing of bacterium,BP,
16053,GO:0070945,1,0.983415321617778,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16054,GO:0070947,1,0.989255861709809,0,2,neutrophil mediated killing of fungus,BP,
16055,GO:0070948,1,0.977495797746567,0,4,regulation of neutrophil mediated cytotoxicity,BP,
16056,GO:0070949,1,0.988751409923247,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
16057,GO:0070950,1,0.994134539224412,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16058,GO:0070951,1,0.994134539224412,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16059,GO:0070953,1,0.994585427870367,0,1,regulation of neutrophil mediated killing of fungus,BP,
16060,GO:0070960,1,0.988751409923247,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
16061,GO:0070961,1,0.988751409923247,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16062,GO:0070962,1,0.994134539224412,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16063,GO:0070963,1,0.994134539224412,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16064,GO:0070965,1,0.994585427870367,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
16065,GO:0070966,1,0.978767024986631,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16067,GO:0070971,1,0.880925820501968,0,17,endoplasmic reticulum exit site,CC,
16068,GO:0070972,1,0.463422102128368,0,129,protein localization to endoplasmic reticulum,BP,
16069,GO:0070973,1,0.954448155607279,0,6,protein localization to endoplasmic reticulum exit site,BP,
16070,GO:0070974,1,0.994039204446332,0,1,POU domain binding,MF,
16071,GO:0070975,1,0.990196432314307,0,1,FHA domain binding,MF,
16072,GO:0070976,1,0.994221319954819,0,1,TIR domain binding,MF,
16074,GO:0070979,1,0.85282525534799,0,27,protein K11-linked ubiquitination,BP,
16075,GO:0070981,1,0.994379331217224,0,1,L-asparagine biosynthetic process,BP,
16076,GO:0070982,1,0.994379331217224,0,1,L-asparagine metabolic process,BP,
16077,GO:0070984,1,0.993171574567941,0,1,SET domain binding,MF,
16078,GO:0070985,1,0.989198477554441,0,2,TFIIK complex,CC,
16079,GO:0070986,1,0.907064375639317,0,13,left/right axis specification,BP,
16080,GO:0070987,1,0.893601138535321,0,18,error-free translesion synthesis,BP,
16081,GO:0070988,1,0.648986620296145,0,59,demethylation,BP,
16082,GO:0070989,1,0.914958479694584,0,12,oxidative demethylation,BP,
16083,GO:0070990,1,0.967689239068345,0,6,snRNP binding,MF,
16084,GO:0070991,1,0.982319575076669,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16085,GO:0070992,1,0.988727521114159,0,2,translation initiation complex,CC,
16086,GO:0070993,1,0.986105188504401,0,2,translation preinitiation complex,CC,
16087,GO:0070995,1,0.980769311020207,0,3,NADPH oxidation,BP,
16088,GO:0070996,1,0.983764383682304,0,3,type 1 melanocortin receptor binding,MF,
16090,GO:0071000,1,0.988891902753679,0,2,response to magnetism,BP,
16091,GO:0071001,1,0.981945807238693,0,3,U4/U6 snRNP,CC,
16092,GO:0071004,1,0.894684323955371,0,17,U2-type prespliceosome,CC,
16093,GO:0071005,1,0.994423747533249,0,1,U2-type precatalytic spliceosome,CC,
16094,GO:0071006,1,0.982716130282261,0,3,U2-type catalytic step 1 spliceosome,CC,
16095,GO:0071007,1,0.836791420493434,0,29,U2-type catalytic step 2 spliceosome,CC,
16096,GO:0071008,1,0.977172726879265,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16097,GO:0071010,1,0.868979316022306,0,22,prespliceosome,CC,
16098,GO:0071011,1,0.820408182039785,0,31,precatalytic spliceosome,CC,
16099,GO:0071012,1,0.964863430707289,0,6,catalytic step 1 spliceosome,CC,
16100,GO:0071013,1,0.534769088463767,0,97,catalytic step 2 spliceosome,CC,
16101,GO:0071014,1,0.948873753450447,0,9,post-mRNA release spliceosomal complex,CC,
16102,GO:0071020,1,0.989102873575155,0,2,post-spliceosomal complex,CC,
16103,GO:0071021,1,0.994542069402828,0,1,U2-type post-spliceosomal complex,CC,
16104,GO:0071025,1,0.913940837042807,0,15,RNA surveillance,BP,
16105,GO:0071026,1,0.994321186110909,0,1,cytoplasmic RNA surveillance,BP,
16106,GO:0071027,1,0.924611631571182,0,13,nuclear RNA surveillance,BP,
16107,GO:0071028,1,0.924611631571182,0,13,nuclear mRNA surveillance,BP,
16108,GO:0071029,1,0.967444476806385,0,6,nuclear ncRNA surveillance,BP,
16109,GO:0071030,1,0.988756986657753,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16110,GO:0071031,1,0.989074221665062,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16111,GO:0071033,1,0.972613293955652,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16112,GO:0071034,1,0.973469135804036,0,4,CUT catabolic process,BP,
16113,GO:0071035,1,0.967444476806385,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16114,GO:0071038,1,0.97310610134592,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16115,GO:0071042,1,0.976757142160121,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16116,GO:0071043,1,0.973469135804036,0,4,CUT metabolic process,BP,
16117,GO:0071044,1,0.9125836273024,0,11,histone mRNA catabolic process,BP,
16118,GO:0071045,1,0.994554096926973,0,1,nuclear histone mRNA catabolic process,BP,
16119,GO:0071046,1,0.967444476806385,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16120,GO:0071047,1,0.976757142160121,0,4,polyadenylation-dependent mRNA catabolic process,BP,
16121,GO:0071048,1,0.988756986657753,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16122,GO:0071049,1,0.989074221665062,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16123,GO:0071051,1,0.97315916463662,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16124,GO:0071062,1,0.980263906637667,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16125,GO:0071065,1,0.988091810033674,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16126,GO:0071071,1,0.924656699847324,0,13,regulation of phospholipid biosynthetic process,BP,
16127,GO:0071072,1,0.975591203201331,0,4,negative regulation of phospholipid biosynthetic process,BP,
16128,GO:0071073,1,0.953165360198326,0,8,positive regulation of phospholipid biosynthetic process,BP,
16129,GO:0071074,1,0.994499037316187,0,1,eukaryotic initiation factor eIF2 binding,MF,
16130,GO:0071077,1,0.982776038722554,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16132,GO:0071104,1,0.973806031176842,0,4,response to interleukin-9,BP,
16133,GO:0071105,1,0.987298745214573,0,2,response to interleukin-11,BP,
16134,GO:0071106,1,0.982776038722554,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16135,GO:0071107,1,0.948009534615306,0,7,response to parathyroid hormone,BP,
16136,GO:0071108,1,0.822197507481286,0,24,protein K48-linked deubiquitination,BP,
16137,GO:0071109,1,0.978538474302661,0,2,superior temporal gyrus development,BP,
16138,GO:0071110,1,0.991454089454464,0,1,histone biotinylation,BP,
16139,GO:0071133,1,0.993971119153192,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16140,GO:0071139,1,0.985502559139931,0,2,resolution of recombination intermediates,BP,
16141,GO:0071140,1,0.985502559139931,0,2,resolution of mitotic recombination intermediates,BP,
16142,GO:0071141,1,0.934167175579676,0,8,SMAD protein complex,CC,
16143,GO:0071144,1,0.979186575454757,0,2,heteromeric SMAD protein complex,CC,
16144,GO:0071148,1,0.980606216919904,0,2,TEAD-1-YAP complex,CC,
16145,GO:0071149,1,0.986611148506113,0,2,TEAD-2-YAP complex,CC,
16146,GO:0071156,1,0.50903924889916,0,107,regulation of cell cycle arrest,BP,
16147,GO:0071157,1,0.87607929512317,0,21,negative regulation of cell cycle arrest,BP,
16148,GO:0071158,1,0.58349903238751,0,84,positive regulation of cell cycle arrest,BP,
16149,GO:0071159,1,0.988959622257307,0,2,NF-kappaB complex,CC,
16150,GO:0071163,1,0.983439477802667,0,3,DNA replication preinitiation complex assembly,BP,
16151,GO:0071164,1,0.993569270606298,0,1,RNA trimethylguanosine synthase activity,MF,
16152,GO:0071166,1,0.444752583860777,0,123,ribonucleoprotein complex localization,BP,
16153,GO:0071168,1,0.876800527868925,0,20,protein localization to chromatin,BP,
16154,GO:0071169,1,0.955787715534661,0,7,establishment of protein localization to chromatin,BP,
16155,GO:0071173,1,0.808348032084949,0,31,spindle assembly checkpoint,BP,
16156,GO:0071174,1,0.808348032084949,0,31,mitotic spindle checkpoint,BP,
16157,GO:0071203,1,0.96321528182694,0,5,WASH complex,CC,
16158,GO:0071204,1,0.962138104064118,0,6,histone pre-mRNA 3'end processing complex,CC,
16159,GO:0071205,1,0.951607323123957,0,5,protein localization to juxtaparanode region of axon,BP,
16160,GO:0071206,1,0.989947055458545,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16161,GO:0071207,1,0.987348329417086,0,2,histone pre-mRNA stem-loop binding,MF,
16162,GO:0071208,1,0.978580954543645,0,4,histone pre-mRNA DCP binding,MF,
16163,GO:0071209,1,0.983620739295081,0,3,U7 snRNA binding,MF,
16164,GO:0071211,1,0.973870646892211,0,4,protein targeting to vacuole involved in autophagy,BP,
16166,GO:0071215,1,0.993007983950641,0,1,cellular response to abscisic acid stimulus,BP,
16168,GO:0071217,1,0.993327106956322,0,1,cellular response to external biotic stimulus,BP,
16169,GO:0071218,1,0.86556103556487,0,21,cellular response to misfolded protein,BP,
16171,GO:0071220,1,0.963640860773101,0,6,cellular response to bacterial lipoprotein,BP,
16172,GO:0071221,1,0.963640860773101,0,6,cellular response to bacterial lipopeptide,BP,
16174,GO:0071223,1,0.936437374813443,0,11,cellular response to lipoteichoic acid,BP,
16175,GO:0071224,1,0.969516923698939,0,5,cellular response to peptidoglycan,BP,
16176,GO:0071225,1,0.967666029778547,0,5,cellular response to muramyl dipeptide,BP,
16177,GO:0071226,1,0.98668770822577,0,2,cellular response to molecule of fungal origin,BP,
16178,GO:0071228,1,0.99462758340661,0,1,cellular response to tumor cell,BP,
16181,GO:0071231,1,0.989285135332006,0,2,cellular response to folic acid,BP,
16182,GO:0071233,1,0.931349760453358,0,9,cellular response to leucine,BP,
16184,GO:0071241,1,0.334267309104783,0,163,cellular response to inorganic substance,BP,
16186,GO:0071243,1,0.910443750852688,0,16,cellular response to arsenic-containing substance,BP,
16187,GO:0071245,1,0.993613475925209,0,1,cellular response to carbon monoxide,BP,
16188,GO:0071247,1,0.994627350249509,0,1,cellular response to chromate,BP,
16189,GO:0071248,1,0.389109863289276,0,141,cellular response to metal ion,BP,
16190,GO:0071250,1,0.991164447768179,0,1,cellular response to nitrite,BP,
16191,GO:0071253,1,0.975223604879484,0,4,connexin binding,MF,
16192,GO:0071256,1,0.978469264994493,0,4,translocon complex,CC,
16193,GO:0071257,1,0.925586711229425,0,12,cellular response to electrical stimulus,BP,
16194,GO:0071258,1,0.993196453193617,0,1,cellular response to gravity,BP,
16195,GO:0071259,1,0.988891902753679,0,2,cellular response to magnetism,BP,
16197,GO:0071262,1,0.98546843974442,0,2,regulation of translational initiation in response to starvation,BP,
16198,GO:0071264,1,0.98546843974442,0,2,positive regulation of translational initiation in response to starvation,BP,
16199,GO:0071265,1,0.954374794756231,0,8,L-methionine biosynthetic process,BP,
16200,GO:0071266,1,0.994535156464788,0,1,'de novo' L-methionine biosynthetic process,BP,
16201,GO:0071267,1,0.959621132240115,0,7,L-methionine salvage,BP,
16202,GO:0071268,1,0.994391633946583,0,1,homocysteine biosynthetic process,BP,
16203,GO:0071275,1,0.994436367391314,0,1,cellular response to aluminum ion,BP,
16204,GO:0071276,1,0.82951838687719,0,32,cellular response to cadmium ion,BP,
16205,GO:0071277,1,0.654377500945087,0,59,cellular response to calcium ion,BP,
16206,GO:0071279,1,0.978477788599543,0,3,cellular response to cobalt ion,BP,
16207,GO:0071280,1,0.900552895971681,0,18,cellular response to copper ion,BP,
16208,GO:0071281,1,0.939046581996201,0,10,cellular response to iron ion,BP,
16209,GO:0071283,1,0.989119578395913,0,2,cellular response to iron(III) ion,BP,
16210,GO:0071284,1,0.970129362869534,0,4,cellular response to lead ion,BP,
16211,GO:0071285,1,0.935926455893823,0,11,cellular response to lithium ion,BP,
16212,GO:0071286,1,0.943669427000163,0,6,cellular response to magnesium ion,BP,
16213,GO:0071287,1,0.940046667043457,0,9,cellular response to manganese ion,BP,
16214,GO:0071288,1,0.99420069797662,0,1,cellular response to mercury ion,BP,
16215,GO:0071294,1,0.902370687265432,0,17,cellular response to zinc ion,BP,
16217,GO:0071298,1,0.993779751963204,0,1,cellular response to L-ascorbic acid,BP,
16219,GO:0071301,1,0.990203688922681,0,1,cellular response to vitamin B1,BP,
16220,GO:0071305,1,0.885408637619012,0,18,cellular response to vitamin D,BP,
16224,GO:0071312,1,0.795010801102496,0,31,cellular response to alkaloid,BP,
16225,GO:0071313,1,0.915918178113911,0,8,cellular response to caffeine,BP,
16226,GO:0071314,1,0.983392345871159,0,3,cellular response to cocaine,BP,
16227,GO:0071315,1,0.975112179028378,0,4,cellular response to morphine,BP,
16228,GO:0071316,1,0.954860889529137,0,8,cellular response to nicotine,BP,
16229,GO:0071317,1,0.975112179028378,0,4,cellular response to isoquinoline alkaloid,BP,
16230,GO:0071318,1,0.912167105266953,0,13,cellular response to ATP,BP,
16231,GO:0071320,1,0.705594405783874,0,48,cellular response to cAMP,BP,
16232,GO:0071321,1,0.954853990089459,0,6,cellular response to cGMP,BP,
16234,GO:0071324,1,0.992411667675857,0,1,cellular response to disaccharide stimulus,BP,
16236,GO:0071329,1,0.992411667675857,0,1,cellular response to sucrose stimulus,BP,
16238,GO:0071332,1,0.968935729567066,0,5,cellular response to fructose stimulus,BP,
16240,GO:0071335,1,0.989119909924972,0,2,hair follicle cell proliferation,BP,
16241,GO:0071336,1,0.989119909924972,0,2,regulation of hair follicle cell proliferation,BP,
16242,GO:0071338,1,0.989119909924972,0,2,positive regulation of hair follicle cell proliferation,BP,
16243,GO:0071339,1,0.826362973847467,0,28,MLL1 complex,CC,
16244,GO:0071340,1,0.944179630337026,0,9,skeletal muscle acetylcholine-gated channel clustering,BP,
16245,GO:0071344,1,0.989196746305866,0,2,diphosphate metabolic process,BP,
16249,GO:0071348,1,0.992617397417962,0,1,cellular response to interleukin-11,BP,
16251,GO:0071350,1,0.915043323332307,0,13,cellular response to interleukin-15,BP,
16252,GO:0071351,1,0.954712117061484,0,8,cellular response to interleukin-18,BP,
16253,GO:0071352,1,0.922202948508163,0,12,cellular response to interleukin-2,BP,
16254,GO:0071353,1,0.838992512742021,0,28,cellular response to interleukin-4,BP,
16256,GO:0071355,1,0.97905272134544,0,3,cellular response to interleukin-9,BP,
16258,GO:0071357,1,0.639018097427886,0,71,cellular response to type I interferon,BP,
16259,GO:0071359,1,0.654071280385015,0,62,cellular response to dsRNA,BP,
16260,GO:0071360,1,0.918042285014828,0,13,cellular response to exogenous dsRNA,BP,
16261,GO:0071361,1,0.907721533026216,0,13,cellular response to ethanol,BP,
16262,GO:0071362,1,0.963537557333318,0,5,cellular response to ether,BP,
16265,GO:0071371,1,0.898174543531945,0,16,cellular response to gonadotropin stimulus,BP,
16266,GO:0071372,1,0.931943433981374,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16267,GO:0071373,1,0.988450537496504,0,2,cellular response to luteinizing hormone stimulus,BP,
16268,GO:0071374,1,0.963010756457942,0,5,cellular response to parathyroid hormone stimulus,BP,
16270,GO:0071376,1,0.969306862653002,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16271,GO:0071377,1,0.78817353267509,0,35,cellular response to glucagon stimulus,BP,
16272,GO:0071378,1,0.871314112769266,0,19,cellular response to growth hormone stimulus,BP,
16273,GO:0071379,1,0.857901304165768,0,21,cellular response to prostaglandin stimulus,BP,
16274,GO:0071380,1,0.896907828304991,0,16,cellular response to prostaglandin E stimulus,BP,
16278,GO:0071386,1,0.974974435151288,0,3,cellular response to corticosterone stimulus,BP,
16279,GO:0071387,1,0.992224190689415,0,1,cellular response to cortisol stimulus,BP,
16280,GO:0071389,1,0.953390680896412,0,7,cellular response to mineralocorticoid stimulus,BP,
16281,GO:0071391,1,0.92235881515664,0,12,cellular response to estrogen stimulus,BP,
16282,GO:0071392,1,0.808231275814945,0,33,cellular response to estradiol stimulus,BP,
16283,GO:0071393,1,0.987454364249679,0,2,cellular response to progesterone stimulus,BP,
16285,GO:0071395,1,0.978577477300448,0,4,cellular response to jasmonic acid stimulus,BP,
16287,GO:0071397,1,0.910816240769175,0,12,cellular response to cholesterol,BP,
16288,GO:0071398,1,0.711954077275928,0,49,cellular response to fatty acid,BP,
16289,GO:0071400,1,0.986080742817713,0,2,cellular response to oleic acid,BP,
16290,GO:0071401,1,0.994392473402516,0,1,cellular response to triglyceride,BP,
16291,GO:0071402,1,0.856657389149738,0,23,cellular response to lipoprotein particle stimulus,BP,
16292,GO:0071403,1,0.98778477766924,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16293,GO:0071404,1,0.896992800978099,0,16,cellular response to low-density lipoprotein particle stimulus,BP,
16295,GO:0071409,1,0.976639541708016,0,3,cellular response to cycloheximide,BP,
16296,GO:0071412,1,0.994394980276072,0,1,cellular response to genistein,BP,
16297,GO:0071413,1,0.994394980276072,0,1,cellular response to hydroxyisoflavone,BP,
16298,GO:0071415,1,0.908181644138714,0,9,cellular response to purine-containing compound,BP,
16300,GO:0071418,1,0.994598068601771,0,1,cellular response to amine stimulus,BP,
16302,GO:0071421,1,0.974418007159225,0,4,manganese ion transmembrane transport,BP,
16303,GO:0071422,1,0.981804096141052,0,3,succinate transmembrane transport,BP,
16304,GO:0071423,1,0.994504129637034,0,1,malate transmembrane transport,BP,
16305,GO:0071424,1,0.994184768585909,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16306,GO:0071425,1,0.883103417873994,0,19,hematopoietic stem cell proliferation,BP,
16307,GO:0071426,1,0.447266758770622,0,122,ribonucleoprotein complex export from nucleus,BP,
16308,GO:0071427,1,0.500093097319719,0,104,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16309,GO:0071428,1,0.912037796554085,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16310,GO:0071431,1,0.801756675380865,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16313,GO:0071438,1,0.968503598370995,0,5,invadopodium membrane,CC,
16314,GO:0071439,1,0.938499601192473,0,9,clathrin complex,CC,
16315,GO:0071440,1,0.964444510177669,0,6,regulation of histone H3-K14 acetylation,BP,
16316,GO:0071441,1,0.993450445158367,0,1,negative regulation of histone H3-K14 acetylation,BP,
16317,GO:0071442,1,0.976484559837905,0,4,positive regulation of histone H3-K14 acetylation,BP,
16318,GO:0071444,1,0.99467437419784,0,1,cellular response to pheromone,BP,
16319,GO:0071447,1,0.948878502213349,0,8,cellular response to hydroperoxide,BP,
16320,GO:0071449,1,0.994642222821521,0,1,cellular response to lipid hydroperoxide,BP,
16321,GO:0071450,1,0.867243706596575,0,24,cellular response to oxygen radical,BP,
16322,GO:0071451,1,0.867243706596575,0,24,cellular response to superoxide,BP,
16323,GO:0071453,1,0.260659218746145,0,204,cellular response to oxygen levels,BP,
16324,GO:0071454,1,0.990153831969821,0,1,cellular response to anoxia,BP,
16325,GO:0071455,1,0.960906373843571,0,6,cellular response to hyperoxia,BP,
16326,GO:0071456,1,0.305800660153469,0,182,cellular response to hypoxia,BP,
16327,GO:0071458,1,0.969028748459833,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16328,GO:0071459,1,0.888590926538695,0,20,protein localization to chromosome, centromeric region,BP,
16329,GO:0071460,1,0.989242198467425,0,2,cellular response to cell-matrix adhesion,BP,
16330,GO:0071461,1,0.988821217917007,0,2,cellular response to redox state,BP,
16331,GO:0071462,1,0.979349594063986,0,3,cellular response to water stimulus,BP,
16332,GO:0071464,1,0.992354350037758,0,1,cellular response to hydrostatic pressure,BP,
16334,GO:0071467,1,0.892201543939478,0,19,cellular response to pH,BP,
16335,GO:0071468,1,0.945242173437441,0,9,cellular response to acidic pH,BP,
16336,GO:0071469,1,0.987736227228855,0,2,cellular response to alkaline pH,BP,
16337,GO:0071470,1,0.810629449825805,0,32,cellular response to osmotic stress,BP,
16338,GO:0071471,1,0.992880174643176,0,1,cellular response to non-ionic osmotic stress,BP,
16339,GO:0071472,1,0.943773553187563,0,9,cellular response to salt stress,BP,
16340,GO:0071474,1,0.935834079814327,0,11,cellular hyperosmotic response,BP,
16341,GO:0071475,1,0.97633418887234,0,4,cellular hyperosmotic salinity response,BP,
16342,GO:0071476,1,0.949989619206646,0,7,cellular hypotonic response,BP,
16343,GO:0071477,1,0.984112310128388,0,2,cellular hypotonic salinity response,BP,
16344,GO:0071478,1,0.336501206628596,0,164,cellular response to radiation,BP,
16345,GO:0071479,1,0.643009305089536,0,66,cellular response to ionizing radiation,BP,
16346,GO:0071480,1,0.831236247703897,0,27,cellular response to gamma radiation,BP,
16347,GO:0071481,1,0.904489222270567,0,13,cellular response to X-ray,BP,
16348,GO:0071482,1,0.494758037160723,0,106,cellular response to light stimulus,BP,
16349,GO:0071483,1,0.987132385154387,0,2,cellular response to blue light,BP,
16350,GO:0071484,1,0.98608190630511,0,2,cellular response to light intensity,BP,
16351,GO:0071485,1,0.993874503447871,0,1,cellular response to absence of light,BP,
16352,GO:0071486,1,0.992159854832894,0,1,cellular response to high light intensity,BP,
16353,GO:0071492,1,0.980603118917235,0,3,cellular response to UV-A,BP,
16354,GO:0071493,1,0.953617925955058,0,8,cellular response to UV-B,BP,
16355,GO:0071494,1,0.968019053858291,0,4,cellular response to UV-C,BP,
16358,GO:0071498,1,0.890508385703551,0,18,cellular response to fluid shear stress,BP,
16359,GO:0071499,1,0.959626212793826,0,7,cellular response to laminar fluid shear stress,BP,
16360,GO:0071500,1,0.959416973348928,0,6,cellular response to nitrosative stress,BP,
16361,GO:0071501,1,0.943725241940114,0,9,cellular response to sterol depletion,BP,
16362,GO:0071502,1,0.968706142093851,0,5,cellular response to temperature stimulus,BP,
16363,GO:0071503,1,0.972981372099308,0,4,response to heparin,BP,
16364,GO:0071504,1,0.972981372099308,0,4,cellular response to heparin,BP,
16365,GO:0071505,1,0.988151915075647,0,2,response to mycophenolic acid,BP,
16366,GO:0071506,1,0.988151915075647,0,2,cellular response to mycophenolic acid,BP,
16367,GO:0071514,1,0.860073427997241,0,22,genetic imprinting,BP,
16368,GO:0071526,1,0.780166073361566,0,32,semaphorin-plexin signaling pathway,BP,
16369,GO:0071527,1,0.994366261730916,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16370,GO:0071528,1,0.993415850059303,0,1,tRNA re-export from nucleus,BP,
16371,GO:0071529,1,0.994279964914517,0,1,cementum mineralization,BP,
16372,GO:0071532,1,0.962066779152667,0,5,ankyrin repeat binding,MF,
16373,GO:0071535,1,0.976021921173638,0,4,RING-like zinc finger domain binding,MF,
16374,GO:0071538,1,0.994386215805125,0,1,SH2 domain-mediated complex assembly,BP,
16375,GO:0071539,1,0.809892257548828,0,27,protein localization to centrosome,BP,
16376,GO:0071540,1,0.992112485491152,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16377,GO:0071541,1,0.95974850239115,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16378,GO:0071542,1,0.822420464408545,0,30,dopaminergic neuron differentiation,BP,
16379,GO:0071543,1,0.976242838261684,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16380,GO:0071544,1,0.994599233652156,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16381,GO:0071545,1,0.922477659320924,0,12,inositol phosphate catabolic process,BP,
16382,GO:0071546,1,0.962460403633946,0,6,pi-body,CC,
16383,GO:0071547,1,0.969892421308282,0,5,piP-body,CC,
16384,GO:0071548,1,0.770237745926533,0,41,response to dexamethasone,BP,
16385,GO:0071549,1,0.817328124368931,0,32,cellular response to dexamethasone stimulus,BP,
16386,GO:0071550,1,0.949752856016043,0,9,death-inducing signaling complex assembly,BP,
16387,GO:0071553,1,0.983459985627439,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16388,GO:0071554,1,0.972552740563038,0,5,cell wall organization or biogenesis,BP,
16390,GO:0071557,1,0.961126667116582,0,5,histone H3-K27 demethylation,BP,
16391,GO:0071558,1,0.961126667116582,0,5,histone demethylase activity (H3-K27 specific),MF,
16394,GO:0071561,1,0.992365637321136,0,1,nucleus-vacuole junction,CC,
16395,GO:0071564,1,0.920025251367977,0,12,npBAF complex,CC,
16396,GO:0071565,1,0.904297093145326,0,14,nBAF complex,CC,
16397,GO:0071566,1,0.994095568683332,0,1,UFM1 activating enzyme activity,MF,
16398,GO:0071567,1,0.989029583974284,0,2,UFM1 hydrolase activity,MF,
16399,GO:0071568,1,0.9888404496125,0,2,UFM1 transferase activity,MF,
16400,GO:0071569,1,0.966757019671605,0,6,protein ufmylation,BP,
16401,GO:0071573,1,0.994103341683755,0,1,shelterin complex assembly,BP,
16402,GO:0071577,1,0.880871221685726,0,20,zinc ion transmembrane transport,BP,
16403,GO:0071578,1,0.956837449976841,0,7,zinc ion import across plasma membrane,BP,
16404,GO:0071579,1,0.988654955520484,0,2,regulation of zinc ion transport,BP,
16405,GO:0071580,1,0.994473677481634,0,1,regulation of zinc ion transmembrane transport,BP,
16406,GO:0071581,1,0.994473677481634,0,1,regulation of zinc ion transmembrane import,BP,
16407,GO:0071582,1,0.994473677481634,0,1,negative regulation of zinc ion transport,BP,
16408,GO:0071583,1,0.994473677481634,0,1,negative regulation of zinc ion transmembrane transport,BP,
16409,GO:0071584,1,0.994473677481634,0,1,negative regulation of zinc ion transmembrane import,BP,
16410,GO:0071585,1,0.994473677481634,0,1,detoxification of cadmium ion,BP,
16411,GO:0071586,1,0.98858045945514,0,2,CAAX-box protein processing,BP,
16412,GO:0071593,1,0.974100385502652,0,4,lymphocyte aggregation,BP,
16413,GO:0071595,1,0.988403017609477,0,2,Nem1-Spo7 phosphatase complex,CC,
16414,GO:0071596,1,0.971868942887977,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16415,GO:0071598,1,0.970360876131125,0,5,neuronal ribonucleoprotein granule,CC,
16416,GO:0071599,1,0.906454662211425,0,15,otic vesicle development,BP,
16417,GO:0071600,1,0.937972810382082,0,10,otic vesicle morphogenesis,BP,
16418,GO:0071602,1,0.992973960372734,0,1,phytosphingosine biosynthetic process,BP,
16419,GO:0071603,1,0.97452385987814,0,4,endothelial cell-cell adhesion,BP,
16420,GO:0071604,1,0.828661286885756,0,28,transforming growth factor beta production,BP,
16421,GO:0071605,1,0.932737055677226,0,12,monocyte chemotactic protein-1 production,BP,
16422,GO:0071606,1,0.994482332589535,0,1,chemokine (C-C motif) ligand 4 production,BP,
16423,GO:0071608,1,0.97641192214386,0,4,macrophage inflammatory protein-1 alpha production,BP,
16424,GO:0071609,1,0.93440809107224,0,10,chemokine (C-C motif) ligand 5 production,BP,
16425,GO:0071610,1,0.994310288731472,0,1,chemokine (C-C motif) ligand 1 production,BP,
16426,GO:0071611,1,0.971985267922244,0,5,granulocyte colony-stimulating factor production,BP,
16427,GO:0071612,1,0.986454534771948,0,1,IP-10 production,BP,
16428,GO:0071613,1,0.988954420781827,0,2,granzyme B production,BP,
16429,GO:0071614,1,0.994510897882685,0,1,linoleic acid epoxygenase activity,MF,
16430,GO:0071616,1,0.739509735828735,0,46,acyl-CoA biosynthetic process,BP,
16431,GO:0071617,1,0.88132500419684,0,18,lysophospholipid acyltransferase activity,MF,
16432,GO:0071619,1,0.994397800641409,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16434,GO:0071622,1,0.778926375895792,0,43,regulation of granulocyte chemotaxis,BP,
16435,GO:0071623,1,0.986660640952053,0,2,negative regulation of granulocyte chemotaxis,BP,
16436,GO:0071624,1,0.845896224632297,0,30,positive regulation of granulocyte chemotaxis,BP,
16438,GO:0071626,1,0.994609170365369,0,1,mastication,BP,
16439,GO:0071629,1,0.994554096926973,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16440,GO:0071630,1,0.976418586229189,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16441,GO:0071633,1,0.994148726675904,0,1,dihydroceramidase activity,MF,
16442,GO:0071634,1,0.834679426516587,0,27,regulation of transforming growth factor beta production,BP,
16443,GO:0071635,1,0.956117231303533,0,7,negative regulation of transforming growth factor beta production,BP,
16444,GO:0071636,1,0.89572423449502,0,17,positive regulation of transforming growth factor beta production,BP,
16445,GO:0071637,1,0.932737055677226,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16446,GO:0071638,1,0.970557287290975,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16447,GO:0071639,1,0.961043883262801,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16448,GO:0071640,1,0.97641192214386,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
16449,GO:0071641,1,0.988237360480266,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16450,GO:0071642,1,0.988035215886598,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16451,GO:0071643,1,0.994482332589535,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16452,GO:0071644,1,0.994482332589535,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16453,GO:0071649,1,0.939534056566334,0,9,regulation of chemokine (C-C motif) ligand 5 production,BP,
16454,GO:0071650,1,0.983462772750339,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16455,GO:0071651,1,0.955339890453209,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16456,GO:0071652,1,0.994310288731472,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16457,GO:0071654,1,0.994310288731472,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16458,GO:0071655,1,0.977324627843995,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16459,GO:0071656,1,0.99438140973488,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16460,GO:0071657,1,0.982847800637355,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16461,GO:0071658,1,0.986454534771948,0,1,regulation of IP-10 production,BP,
16462,GO:0071660,1,0.986454534771948,0,1,positive regulation of IP-10 production,BP,
16463,GO:0071661,1,0.988954420781827,0,2,regulation of granzyme B production,BP,
16464,GO:0071663,1,0.988954420781827,0,2,positive regulation of granzyme B production,BP,
16465,GO:0071664,1,0.970585235456408,0,4,catenin-TCF7L2 complex,CC,
16466,GO:0071665,1,0.993820564805382,0,1,gamma-catenin-TCF7L2 complex,CC,
16467,GO:0071670,1,0.950361594316701,0,8,smooth muscle cell chemotaxis,BP,
16468,GO:0071671,1,0.964088492355761,0,6,regulation of smooth muscle cell chemotaxis,BP,
16469,GO:0071672,1,0.976436087462878,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16470,GO:0071673,1,0.982083101192116,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16473,GO:0071676,1,0.960206116489709,0,6,negative regulation of mononuclear cell migration,BP,
16475,GO:0071678,1,0.989900283446145,0,1,olfactory bulb axon guidance,BP,
16476,GO:0071679,1,0.940649839137558,0,8,commissural neuron axon guidance,BP,
16477,GO:0071680,1,0.96461035558883,0,5,response to indole-3-methanol,BP,
16478,GO:0071681,1,0.96461035558883,0,5,cellular response to indole-3-methanol,BP,
16480,GO:0071684,1,0.99390356047142,0,1,organism emergence from protective structure,BP,
16481,GO:0071688,1,0.888421427609882,0,13,striated muscle myosin thick filament assembly,BP,
16482,GO:0071691,1,0.990595167814922,0,1,cardiac muscle thin filament assembly,BP,
16483,GO:0071692,1,0.950573479098418,0,6,protein localization to extracellular region,BP,
16484,GO:0071694,1,0.950573479098418,0,6,maintenance of protein location in extracellular region,BP,
16486,GO:0071696,1,0.905375560107312,0,15,ectodermal placode development,BP,
16487,GO:0071697,1,0.910551612799682,0,14,ectodermal placode morphogenesis,BP,
16488,GO:0071698,1,0.973585294671056,0,4,olfactory placode development,BP,
16489,GO:0071699,1,0.973585294671056,0,4,olfactory placode morphogenesis,BP,
16490,GO:0071701,1,0.992550967612268,0,1,regulation of MAPK export from nucleus,BP,
16495,GO:0071707,1,0.994609170365369,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16498,GO:0071712,1,0.922898150924155,0,12,ER-associated misfolded protein catabolic process,BP,
16499,GO:0071713,1,0.992686284442654,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
16500,GO:0071714,1,0.993118907491824,0,1,icosanoid transmembrane transporter activity,MF,
16502,GO:0071723,1,0.957189512716105,0,7,lipopeptide binding,MF,
16503,GO:0071724,1,0.974647162308915,0,4,response to diacyl bacterial lipopeptide,BP,
16504,GO:0071725,1,0.982615182326496,0,3,response to triacyl bacterial lipopeptide,BP,
16505,GO:0071726,1,0.974647162308915,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16506,GO:0071727,1,0.982615182326496,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16507,GO:0071731,1,0.890732192124953,0,18,response to nitric oxide,BP,
16508,GO:0071732,1,0.909233312952353,0,15,cellular response to nitric oxide,BP,
16509,GO:0071733,1,0.971136738303144,0,4,transcriptional activation by promoter-enhancer looping,BP,
16510,GO:0071763,1,0.963819294902656,0,6,nuclear membrane organization,BP,
16511,GO:0071765,1,0.993130351552928,0,1,nuclear inner membrane organization,BP,
16515,GO:0071782,1,0.895621658669004,0,18,endoplasmic reticulum tubular network,CC,
16516,GO:0071786,1,0.907011594919945,0,15,endoplasmic reticulum tubular network organization,BP,
16517,GO:0071787,1,0.977343706502866,0,4,endoplasmic reticulum tubular network formation,BP,
16518,GO:0071789,1,0.994184768585909,0,1,spindle pole body localization to nuclear envelope,BP,
16519,GO:0071790,1,0.994184768585909,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
16520,GO:0071791,1,0.987972831561859,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16521,GO:0071796,1,0.994606447558221,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16522,GO:0071797,1,0.97680520163347,0,4,LUBAC complex,CC,
16523,GO:0071798,1,0.965779546797583,0,5,response to prostaglandin D,BP,
16524,GO:0071799,1,0.965779546797583,0,5,cellular response to prostaglandin D stimulus,BP,
16525,GO:0071800,1,0.871768114117093,0,20,podosome assembly,BP,
16526,GO:0071801,1,0.918512577776855,0,13,regulation of podosome assembly,BP,
16527,GO:0071802,1,0.993148799963944,0,1,negative regulation of podosome assembly,BP,
16528,GO:0071803,1,0.941277048679749,0,9,positive regulation of podosome assembly,BP,
16531,GO:0071806,1,0.724521707244764,0,54,protein transmembrane transport,BP,
16532,GO:0071812,1,0.993984738153575,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16533,GO:0071813,1,0.866960837887529,0,21,lipoprotein particle binding,MF,
16534,GO:0071814,1,0.866960837887529,0,21,protein-lipid complex binding,MF,
16535,GO:0071816,1,0.9777869097873,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16536,GO:0071817,1,0.970877205711687,0,5,MMXD complex,CC,
16537,GO:0071818,1,0.983120903180175,0,3,BAT3 complex,CC,
16538,GO:0071819,1,0.988335091542341,0,2,DUBm complex,CC,
16539,GO:0071820,1,0.994585137910175,0,1,N-box binding,MF,
16540,GO:0071821,1,0.98509953525704,0,2,FANCM-MHF complex,CC,
16541,GO:0071823,1,0.989263002615058,0,2,protein-carbohydrate complex subunit organization,BP,
16542,GO:0071824,1,0.243376873690499,0,219,protein-DNA complex subunit organization,BP,
16544,GO:0071826,1,0.263028386307042,0,207,ribonucleoprotein complex subunit organization,BP,
16546,GO:0071830,1,0.950562906123663,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16547,GO:0071837,1,0.892432833218975,0,17,HMG box domain binding,MF,
16548,GO:0071838,1,0.960784889780704,0,6,cell proliferation in bone marrow,BP,
16549,GO:0071839,1,0.977062959690705,0,4,apoptotic process in bone marrow,BP,
16551,GO:0071846,1,0.994657839102691,0,1,actin filament debranching,BP,
16552,GO:0071847,1,0.986907314928133,0,2,TNFSF11-mediated signaling pathway,BP,
16553,GO:0071848,1,0.993984738153575,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16554,GO:0071850,1,0.9157637974262,0,14,mitotic cell cycle arrest,BP,
16555,GO:0071855,1,0.876270378421935,0,23,neuropeptide receptor binding,MF,
16556,GO:0071863,1,0.960214044523049,0,6,regulation of cell proliferation in bone marrow,BP,
16557,GO:0071864,1,0.960214044523049,0,6,positive regulation of cell proliferation in bone marrow,BP,
16558,GO:0071865,1,0.97598559174047,0,4,regulation of apoptotic process in bone marrow,BP,
16559,GO:0071866,1,0.97598559174047,0,4,negative regulation of apoptotic process in bone marrow,BP,
16560,GO:0071867,1,0.775504308125372,0,35,response to monoamine,BP,
16561,GO:0071868,1,0.791134665797134,0,32,cellular response to monoamine stimulus,BP,
16562,GO:0071869,1,0.775504308125372,0,35,response to catecholamine,BP,
16563,GO:0071870,1,0.791134665797134,0,32,cellular response to catecholamine stimulus,BP,
16564,GO:0071871,1,0.892474236633998,0,15,response to epinephrine,BP,
16565,GO:0071872,1,0.910436638344928,0,12,cellular response to epinephrine stimulus,BP,
16566,GO:0071873,1,0.979376298407254,0,3,response to norepinephrine,BP,
16567,GO:0071874,1,0.988107815990435,0,2,cellular response to norepinephrine stimulus,BP,
16568,GO:0071875,1,0.858811686343618,0,21,adrenergic receptor signaling pathway,BP,
16569,GO:0071877,1,0.994599233652156,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16570,GO:0071878,1,0.982405617869602,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16571,GO:0071879,1,0.978160763372141,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16572,GO:0071880,1,0.874302480794368,0,18,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16573,GO:0071881,1,0.988065249597395,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16574,GO:0071882,1,0.993430890620848,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16575,GO:0071885,1,0.98885621810885,0,2,N-terminal protein N-methyltransferase activity,MF,
16576,GO:0071886,1,0.986633763608902,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16578,GO:0071888,1,0.944800172189427,0,9,macrophage apoptotic process,BP,
16579,GO:0071889,1,0.836897988651064,0,25,14-3-3 protein binding,MF,
16580,GO:0071890,1,0.992208117248964,0,1,bicarbonate binding,MF,
16581,GO:0071893,1,0.994527376974531,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16582,GO:0071894,1,0.988256051520415,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16584,GO:0071896,1,0.963882766171886,0,4,protein localization to adherens junction,BP,
16585,GO:0071897,1,0.281616046224612,0,190,DNA biosynthetic process,BP,
16586,GO:0071898,1,0.982289732891522,0,3,regulation of estrogen receptor binding,BP,
16587,GO:0071899,1,0.982289732891522,0,3,negative regulation of estrogen receptor binding,BP,
16589,GO:0071901,1,0.440907204174165,0,125,negative regulation of protein serine/threonine kinase activity,BP,
16591,GO:0071907,1,0.948890831135907,0,7,determination of digestive tract left/right asymmetry,BP,
16592,GO:0071908,1,0.992045150398547,0,1,determination of intestine left/right asymmetry,BP,
16593,GO:0071909,1,0.992045150398547,0,1,determination of stomach left/right asymmetry,BP,
16594,GO:0071910,1,0.959143585345526,0,6,determination of liver left/right asymmetry,BP,
16595,GO:0071914,1,0.986875130048472,0,2,prominosome,CC,
16596,GO:0071918,1,0.975215330244279,0,4,urea transmembrane transport,BP,
16597,GO:0071920,1,0.98871730295108,0,2,cleavage body,CC,
16598,GO:0071921,1,0.963866578067158,0,5,cohesin loading,BP,
16599,GO:0071922,1,0.969506222090689,0,4,regulation of cohesin loading,BP,
16600,GO:0071926,1,0.973488458662894,0,4,endocannabinoid signaling pathway,BP,
16601,GO:0071929,1,0.988206700953324,0,2,alpha-tubulin acetylation,BP,
16602,GO:0071930,1,0.978692889145258,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16603,GO:0071931,1,0.982933670988657,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16604,GO:0071933,1,0.94469484390595,0,8,Arp2/3 complex binding,MF,
16605,GO:0071934,1,0.981797053575049,0,3,thiamine transmembrane transport,BP,
16606,GO:0071936,1,0.940392753050541,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16607,GO:0071938,1,0.994151423212716,0,1,vitamin A transport,BP,
16608,GO:0071939,1,0.994151423212716,0,1,vitamin A import,BP,
16609,GO:0071941,1,0.91801685994791,0,14,nitrogen cycle metabolic process,BP,
16610,GO:0071942,1,0.981577261357566,0,3,XPC complex,CC,
16612,GO:0071947,1,0.979580819639331,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16613,GO:0071949,1,0.850131967099976,0,25,FAD binding,MF,
16614,GO:0071951,1,0.994202692183443,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16615,GO:0071953,1,0.977023760376241,0,4,elastic fiber,CC,
16616,GO:0071954,1,0.993731305369998,0,1,chemokine (C-C motif) ligand 11 production,BP,
16617,GO:0071955,1,0.98316853750104,0,2,recycling endosome to Golgi transport,BP,
16618,GO:0071960,1,0.99464436348237,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16619,GO:0071962,1,0.98292337819031,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16620,GO:0071963,1,0.994534858909912,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
16621,GO:0071971,1,0.958067531065522,0,7,extracellular exosome assembly,BP,
16622,GO:0071976,1,0.9938724070874,0,1,cell gliding,BP,
16623,GO:0071985,1,0.829674004307403,0,28,multivesicular body sorting pathway,BP,
16624,GO:0071986,1,0.965715686744607,0,6,Ragulator complex,CC,
16625,GO:0071987,1,0.971452743222114,0,4,WD40-repeat domain binding,MF,
16626,GO:0071988,1,0.990353712774273,0,1,protein localization to spindle pole body,BP,
16627,GO:0071997,1,0.991086129130538,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16629,GO:0072003,1,0.981348655701141,0,3,kidney rudiment formation,BP,
16630,GO:0072004,1,0.986693766028451,0,2,kidney field specification,BP,
16631,GO:0072006,1,0.397488667664285,0,127,nephron development,BP,
16632,GO:0072007,1,0.955343815441196,0,7,mesangial cell differentiation,BP,
16633,GO:0072008,1,0.960625626014089,0,6,glomerular mesangial cell differentiation,BP,
16634,GO:0072009,1,0.491395099737725,0,99,nephron epithelium development,BP,
16635,GO:0072010,1,0.8826400259119,0,18,glomerular epithelium development,BP,
16636,GO:0072011,1,0.988798323585822,0,2,glomerular endothelium development,BP,
16637,GO:0072012,1,0.86639604203121,0,21,glomerulus vasculature development,BP,
16638,GO:0072014,1,0.961264589427406,0,5,proximal tubule development,BP,
16639,GO:0072015,1,0.931478943603375,0,9,glomerular visceral epithelial cell development,BP,
16640,GO:0072016,1,0.994256434345611,0,1,glomerular parietal epithelial cell development,BP,
16641,GO:0072017,1,0.911640333751955,0,11,distal tubule development,BP,
16642,GO:0072019,1,0.994439590766747,0,1,proximal convoluted tubule development,BP,
16643,GO:0072021,1,0.971757730262183,0,3,ascending thin limb development,BP,
16644,GO:0072023,1,0.994578284928014,0,1,thick ascending limb development,BP,
16645,GO:0072024,1,0.994578284928014,0,1,macula densa development,BP,
16646,GO:0072025,1,0.975748330410125,0,4,distal convoluted tubule development,BP,
16647,GO:0072027,1,0.99429955270927,0,1,connecting tubule development,BP,
16648,GO:0072028,1,0.596098218114521,0,72,nephron morphogenesis,BP,
16649,GO:0072033,1,0.938295695423046,0,8,renal vesicle formation,BP,
16650,GO:0072034,1,0.980941896661474,0,3,renal vesicle induction,BP,
16651,GO:0072036,1,0.993533767574381,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16652,GO:0072038,1,0.969338269812964,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16653,GO:0072039,1,0.980072474009355,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16654,GO:0072040,1,0.980072474009355,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16655,GO:0072044,1,0.910757831133227,0,12,collecting duct development,BP,
16656,GO:0072046,1,0.994583531313447,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16657,GO:0072047,1,0.972547895308333,0,5,proximal/distal pattern formation involved in nephron development,BP,
16658,GO:0072048,1,0.949004314209258,0,9,renal system pattern specification,BP,
16659,GO:0072049,1,0.96924687891337,0,5,comma-shaped body morphogenesis,BP,
16660,GO:0072050,1,0.956121304387564,0,7,S-shaped body morphogenesis,BP,
16661,GO:0072051,1,0.994578284928014,0,1,juxtaglomerular apparatus development,BP,
16662,GO:0072053,1,0.987213734482905,0,2,renal inner medulla development,BP,
16663,GO:0072054,1,0.987213734482905,0,2,renal outer medulla development,BP,
16664,GO:0072055,1,0.992354350037758,0,1,renal cortex development,BP,
16665,GO:0072059,1,0.992354350037758,0,1,cortical collecting duct development,BP,
16666,GO:0072060,1,0.993394032013683,0,1,outer medullary collecting duct development,BP,
16667,GO:0072061,1,0.982192177771975,0,3,inner medullary collecting duct development,BP,
16668,GO:0072069,1,0.981343478437903,0,3,DCT cell differentiation,BP,
16669,GO:0072070,1,0.930202395689676,0,10,loop of Henle development,BP,
16670,GO:0072071,1,0.989118502721439,0,2,kidney interstitial fibroblast differentiation,BP,
16671,GO:0072073,1,0.394907258746093,0,130,kidney epithelium development,BP,
16672,GO:0072074,1,0.887999582053555,0,18,kidney mesenchyme development,BP,
16673,GO:0072075,1,0.908239435665949,0,14,metanephric mesenchyme development,BP,
16674,GO:0072076,1,0.976815119373919,0,3,nephrogenic mesenchyme development,BP,
16675,GO:0072077,1,0.883229719325817,0,18,renal vesicle morphogenesis,BP,
16676,GO:0072078,1,0.613127934097952,0,68,nephron tubule morphogenesis,BP,
16677,GO:0072079,1,0.896481508581909,0,18,nephron tubule formation,BP,
16678,GO:0072080,1,0.54239748116755,0,85,nephron tubule development,BP,
16679,GO:0072081,1,0.972547895308333,0,5,specification of nephron tubule identity,BP,
16680,GO:0072086,1,0.977923860151311,0,4,specification of loop of Henle identity,BP,
16681,GO:0072087,1,0.878369383538543,0,19,renal vesicle development,BP,
16682,GO:0072088,1,0.605179481024699,0,70,nephron epithelium morphogenesis,BP,
16685,GO:0072092,1,0.968789949645159,0,3,ureteric bud invasion,BP,
16686,GO:0072093,1,0.962523550835681,0,4,metanephric renal vesicle formation,BP,
16687,GO:0072095,1,0.980159323526878,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16688,GO:0072096,1,0.994527376974531,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16689,GO:0072097,1,0.994527376974531,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16690,GO:0072098,1,0.989061056105154,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16691,GO:0072099,1,0.994527376974531,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16692,GO:0072100,1,0.994527376974531,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16693,GO:0072101,1,0.994527376974531,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16694,GO:0072102,1,0.945557834097609,0,7,glomerulus morphogenesis,BP,
16695,GO:0072103,1,0.967119388542346,0,4,glomerulus vasculature morphogenesis,BP,
16696,GO:0072104,1,0.967119388542346,0,4,glomerular capillary formation,BP,
16697,GO:0072106,1,0.974427306088359,0,4,regulation of ureteric bud formation,BP,
16698,GO:0072107,1,0.974427306088359,0,4,positive regulation of ureteric bud formation,BP,
16699,GO:0072108,1,0.974931580276684,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16700,GO:0072109,1,0.913466226450399,0,14,glomerular mesangium development,BP,
16701,GO:0072110,1,0.94534668656622,0,9,glomerular mesangial cell proliferation,BP,
16702,GO:0072111,1,0.893202774578846,0,18,cell proliferation involved in kidney development,BP,
16703,GO:0072112,1,0.898519921532419,0,15,glomerular visceral epithelial cell differentiation,BP,
16704,GO:0072114,1,0.991892770910328,0,1,pronephros morphogenesis,BP,
16705,GO:0072124,1,0.953240064463256,0,8,regulation of glomerular mesangial cell proliferation,BP,
16706,GO:0072125,1,0.981988313630096,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16707,GO:0072126,1,0.970729694494712,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16708,GO:0072127,1,0.994401581537699,0,1,renal capsule development,BP,
16709,GO:0072128,1,0.994401581537699,0,1,renal capsule morphogenesis,BP,
16710,GO:0072129,1,0.994401581537699,0,1,renal capsule formation,BP,
16711,GO:0072130,1,0.994401581537699,0,1,renal capsule specification,BP,
16712,GO:0072131,1,0.971411729102554,0,4,kidney mesenchyme morphogenesis,BP,
16713,GO:0072132,1,0.736107383982574,0,45,mesenchyme morphogenesis,BP,
16714,GO:0072133,1,0.971411729102554,0,4,metanephric mesenchyme morphogenesis,BP,
16715,GO:0072134,1,0.982315510938435,0,2,nephrogenic mesenchyme morphogenesis,BP,
16716,GO:0072135,1,0.981637112974341,0,3,kidney mesenchymal cell proliferation,BP,
16717,GO:0072136,1,0.981637112974341,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16718,GO:0072137,1,0.95786612296762,0,4,condensed mesenchymal cell proliferation,BP,
16719,GO:0072138,1,0.982986769471453,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16720,GO:0072139,1,0.987672950118143,0,2,glomerular parietal epithelial cell differentiation,BP,
16721,GO:0072141,1,0.989118502721439,0,2,renal interstitial fibroblast development,BP,
16722,GO:0072143,1,0.960901324031455,0,6,mesangial cell development,BP,
16723,GO:0072144,1,0.96621355111829,0,5,glomerular mesangial cell development,BP,
16725,GO:0072156,1,0.968760258450175,0,3,distal tubule morphogenesis,BP,
16726,GO:0072160,1,0.905018223463294,0,13,nephron tubule epithelial cell differentiation,BP,
16727,GO:0072161,1,0.958686197410676,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16728,GO:0072162,1,0.975029822952966,0,4,metanephric mesenchymal cell differentiation,BP,
16729,GO:0072163,1,0.517837569767508,0,93,mesonephric epithelium development,BP,
16730,GO:0072164,1,0.517837569767508,0,93,mesonephric tubule development,BP,
16731,GO:0072165,1,0.994503900556797,0,1,anterior mesonephric tubule development,BP,
16732,GO:0072166,1,0.988599080938424,0,2,posterior mesonephric tubule development,BP,
16733,GO:0072167,1,0.994503900556797,0,1,specification of mesonephric tubule identity,BP,
16734,GO:0072168,1,0.994503900556797,0,1,specification of anterior mesonephric tubule identity,BP,
16735,GO:0072169,1,0.994503900556797,0,1,specification of posterior mesonephric tubule identity,BP,
16736,GO:0072170,1,0.851908315649218,0,22,metanephric tubule development,BP,
16737,GO:0072171,1,0.652657734322943,0,60,mesonephric tubule morphogenesis,BP,
16738,GO:0072172,1,0.952005919288952,0,8,mesonephric tubule formation,BP,
16739,GO:0072173,1,0.924827035541894,0,11,metanephric tubule morphogenesis,BP,
16740,GO:0072174,1,0.962642522842878,0,6,metanephric tubule formation,BP,
16742,GO:0072176,1,0.907707128621952,0,13,nephric duct development,BP,
16743,GO:0072177,1,0.955705884466147,0,6,mesonephric duct development,BP,
16744,GO:0072178,1,0.934183701996051,0,10,nephric duct morphogenesis,BP,
16745,GO:0072179,1,0.976562910863289,0,4,nephric duct formation,BP,
16746,GO:0072180,1,0.983567970130958,0,3,mesonephric duct morphogenesis,BP,
16747,GO:0072181,1,0.994583531313447,0,1,mesonephric duct formation,BP,
16748,GO:0072182,1,0.920070072014361,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16749,GO:0072183,1,0.988206991987884,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16750,GO:0072184,1,0.994503900556797,0,1,renal vesicle progenitor cell differentiation,BP,
16751,GO:0072185,1,0.988901887731824,0,2,metanephric cap development,BP,
16752,GO:0072186,1,0.988901887731824,0,2,metanephric cap morphogenesis,BP,
16753,GO:0072189,1,0.916983677909153,0,13,ureter development,BP,
16754,GO:0072190,1,0.982515803303974,0,3,ureter urothelium development,BP,
16755,GO:0072191,1,0.97691146458442,0,4,ureter smooth muscle development,BP,
16756,GO:0072192,1,0.994527376974531,0,1,ureter epithelial cell differentiation,BP,
16757,GO:0072193,1,0.97691146458442,0,4,ureter smooth muscle cell differentiation,BP,
16758,GO:0072194,1,0.981536501278079,0,3,kidney smooth muscle tissue development,BP,
16759,GO:0072195,1,0.994566168695361,0,1,kidney smooth muscle cell differentiation,BP,
16760,GO:0072197,1,0.982054527314186,0,3,ureter morphogenesis,BP,
16761,GO:0072198,1,0.983419756470375,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16762,GO:0072199,1,0.983419756470375,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16763,GO:0072200,1,0.994527376974531,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16764,GO:0072201,1,0.947438866929578,0,8,negative regulation of mesenchymal cell proliferation,BP,
16765,GO:0072202,1,0.852914704207931,0,23,cell differentiation involved in metanephros development,BP,
16766,GO:0072203,1,0.9362181215671,0,10,cell proliferation involved in metanephros development,BP,
16767,GO:0072204,1,0.98624221690062,0,2,cell-cell signaling involved in metanephros development,BP,
16768,GO:0072205,1,0.944836223481849,0,7,metanephric collecting duct development,BP,
16769,GO:0072206,1,0.994578284928014,0,1,metanephric juxtaglomerular apparatus development,BP,
16770,GO:0072207,1,0.839738995961735,0,24,metanephric epithelium development,BP,
16771,GO:0072208,1,0.986899854324148,0,2,metanephric smooth muscle tissue development,BP,
16772,GO:0072209,1,0.988387045047551,0,2,metanephric mesangial cell differentiation,BP,
16773,GO:0072210,1,0.775605471279849,0,36,metanephric nephron development,BP,
16774,GO:0072213,1,0.994401581537699,0,1,metanephric capsule development,BP,
16775,GO:0072214,1,0.992354350037758,0,1,metanephric cortex development,BP,
16776,GO:0072215,1,0.871507980832617,0,20,regulation of metanephros development,BP,
16777,GO:0072216,1,0.926743227700362,0,12,positive regulation of metanephros development,BP,
16778,GO:0072217,1,0.958093841219661,0,7,negative regulation of metanephros development,BP,
16779,GO:0072218,1,0.971757730262183,0,3,metanephric ascending thin limb development,BP,
16780,GO:0072219,1,0.992354350037758,0,1,metanephric cortical collecting duct development,BP,
16781,GO:0072221,1,0.975748330410125,0,4,metanephric distal convoluted tubule development,BP,
16782,GO:0072223,1,0.96851960114253,0,5,metanephric glomerular mesangium development,BP,
16783,GO:0072224,1,0.925673308741358,0,11,metanephric glomerulus development,BP,
16784,GO:0072227,1,0.994578284928014,0,1,metanephric macula densa development,BP,
16785,GO:0072229,1,0.994439590766747,0,1,metanephric proximal convoluted tubule development,BP,
16786,GO:0072233,1,0.994578284928014,0,1,metanephric thick ascending limb development,BP,
16787,GO:0072234,1,0.867295044758006,0,19,metanephric nephron tubule development,BP,
16788,GO:0072235,1,0.953355603081418,0,6,metanephric distal tubule development,BP,
16789,GO:0072236,1,0.965336498457225,0,4,metanephric loop of Henle development,BP,
16790,GO:0072237,1,0.979109688946694,0,2,metanephric proximal tubule development,BP,
16791,GO:0072239,1,0.954442908516144,0,7,metanephric glomerulus vasculature development,BP,
16792,GO:0072240,1,0.981343478437903,0,3,metanephric DCT cell differentiation,BP,
16793,GO:0072243,1,0.860021870908872,0,20,metanephric nephron epithelium development,BP,
16794,GO:0072244,1,0.991625824755757,0,1,metanephric glomerular epithelium development,BP,
16795,GO:0072248,1,0.991625824755757,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16796,GO:0072249,1,0.991625824755757,0,1,metanephric glomerular visceral epithelial cell development,BP,
16797,GO:0072254,1,0.988387045047551,0,2,metanephric glomerular mesangial cell differentiation,BP,
16798,GO:0072255,1,0.994134814661725,0,1,metanephric glomerular mesangial cell development,BP,
16799,GO:0072257,1,0.942801200388352,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16800,GO:0072258,1,0.994503900556797,0,1,metanephric interstitial fibroblast differentiation,BP,
16801,GO:0072259,1,0.994503900556797,0,1,metanephric interstitial fibroblast development,BP,
16802,GO:0072262,1,0.979901450466381,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16803,GO:0072265,1,0.994401581537699,0,1,metanephric capsule morphogenesis,BP,
16804,GO:0072266,1,0.994401581537699,0,1,metanephric capsule formation,BP,
16805,GO:0072267,1,0.994401581537699,0,1,metanephric capsule specification,BP,
16806,GO:0072268,1,0.977839220241732,0,4,pattern specification involved in metanephros development,BP,
16807,GO:0072272,1,0.988780369363947,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16808,GO:0072273,1,0.834914109094826,0,25,metanephric nephron morphogenesis,BP,
16809,GO:0072274,1,0.991625824755757,0,1,metanephric glomerular basement membrane development,BP,
16810,GO:0072275,1,0.982714852851408,0,2,metanephric glomerulus morphogenesis,BP,
16811,GO:0072276,1,0.982714852851408,0,2,metanephric glomerulus vasculature morphogenesis,BP,
16812,GO:0072277,1,0.982714852851408,0,2,metanephric glomerular capillary formation,BP,
16813,GO:0072278,1,0.979812324430906,0,3,metanephric comma-shaped body morphogenesis,BP,
16814,GO:0072282,1,0.941516951793759,0,8,metanephric nephron tubule morphogenesis,BP,
16815,GO:0072283,1,0.90040761840502,0,15,metanephric renal vesicle morphogenesis,BP,
16816,GO:0072284,1,0.966545101805242,0,5,metanephric S-shaped body morphogenesis,BP,
16817,GO:0072285,1,0.993533767574381,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16818,GO:0072286,1,0.99429955270927,0,1,metanephric connecting tubule development,BP,
16819,GO:0072287,1,0.984585232849827,0,1,metanephric distal tubule morphogenesis,BP,
16820,GO:0072289,1,0.974318189410501,0,4,metanephric nephron tubule formation,BP,
16821,GO:0072298,1,0.974029142857146,0,4,regulation of metanephric glomerulus development,BP,
16822,GO:0072299,1,0.994062874102441,0,1,negative regulation of metanephric glomerulus development,BP,
16823,GO:0072300,1,0.979847803802915,0,3,positive regulation of metanephric glomerulus development,BP,
16824,GO:0072301,1,0.988080403165184,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16825,GO:0072302,1,0.994062874102441,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16826,GO:0072303,1,0.993982155737606,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16827,GO:0072304,1,0.986693766028451,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16828,GO:0072305,1,0.986693766028451,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16829,GO:0072307,1,0.942801200388352,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16830,GO:0072308,1,0.993668639820947,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16831,GO:0072309,1,0.986693766028451,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16832,GO:0072310,1,0.926125145573465,0,10,glomerular epithelial cell development,BP,
16833,GO:0072311,1,0.893353703033276,0,16,glomerular epithelial cell differentiation,BP,
16834,GO:0072312,1,0.991625824755757,0,1,metanephric glomerular epithelial cell differentiation,BP,
16835,GO:0072313,1,0.991625824755757,0,1,metanephric glomerular epithelial cell development,BP,
16836,GO:0072318,1,0.958706784626792,0,6,clathrin coat disassembly,BP,
16837,GO:0072319,1,0.953361760630332,0,7,vesicle uncoating,BP,
16838,GO:0072320,1,0.974433737335836,0,4,volume-sensitive chloride channel activity,MF,
16839,GO:0072321,1,0.944979093595302,0,10,chaperone-mediated protein transport,BP,
16840,GO:0072329,1,0.46555411744849,0,122,monocarboxylic acid catabolic process,BP,
16842,GO:0072331,1,0.179445768270721,0,259,signal transduction by p53 class mediator,BP,
16843,GO:0072332,1,0.597048813376294,0,79,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
16844,GO:0072334,1,0.989186121648947,0,2,UDP-galactose transmembrane transport,BP,
16845,GO:0072337,1,0.885747101391145,0,17,modified amino acid transport,BP,
16846,GO:0072338,1,0.957778497730134,0,6,cellular lactam metabolic process,BP,
16847,GO:0072340,1,0.994544350632709,0,1,cellular lactam catabolic process,BP,
16848,GO:0072341,1,0.64670230836897,0,68,modified amino acid binding,MF,
16849,GO:0072343,1,0.989148395214517,0,2,pancreatic stellate cell proliferation,BP,
16850,GO:0072344,1,0.97706135608391,0,4,rescue of stalled ribosome,BP,
16851,GO:0072345,1,0.96200777477196,0,6,NAADP-sensitive calcium-release channel activity,MF,
16853,GO:0072348,1,0.824220330869841,0,30,sulfur compound transport,BP,
16854,GO:0072349,1,0.912236049973521,0,13,modified amino acid transmembrane transporter activity,MF,
16855,GO:0072350,1,0.804382625642526,0,36,tricarboxylic acid metabolic process,BP,
16856,GO:0072354,1,0.994541878042146,0,1,histone kinase activity (H3-T3 specific),MF,
16857,GO:0072355,1,0.994541878042146,0,1,histone H3-T3 phosphorylation,BP,
16858,GO:0072356,1,0.993294602112599,0,1,chromosome passenger complex localization to kinetochore,BP,
16859,GO:0072357,1,0.95299542870345,0,7,PTW/PP1 phosphatase complex,CC,
16862,GO:0072361,1,0.977693332237469,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16863,GO:0072362,1,0.989676353777139,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16864,GO:0072363,1,0.987893225038007,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16865,GO:0072364,1,0.977079784802581,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16866,GO:0072365,1,0.989055361719207,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16867,GO:0072366,1,0.987893225038007,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16868,GO:0072367,1,0.965150410773487,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16869,GO:0072368,1,0.98278846478272,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
16870,GO:0072369,1,0.982056133927969,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
16873,GO:0072379,1,0.983120903180175,0,3,ER membrane insertion complex,CC,
16874,GO:0072382,1,0.98441013096479,0,1,minus-end-directed vesicle transport along microtubule,BP,
16875,GO:0072383,1,0.944077930001087,0,7,plus-end-directed vesicle transport along microtubule,BP,
16876,GO:0072384,1,0.606344111083006,0,69,organelle transport along microtubule,BP,
16877,GO:0072385,1,0.964346418000972,0,4,minus-end-directed organelle transport along microtubule,BP,
16878,GO:0072386,1,0.936226997302609,0,8,plus-end-directed organelle transport along microtubule,BP,
16879,GO:0072387,1,0.987947894933616,0,2,flavin adenine dinucleotide metabolic process,BP,
16880,GO:0072388,1,0.99448445191223,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16881,GO:0072389,1,0.993427552906125,0,1,flavin adenine dinucleotide catabolic process,BP,
16882,GO:0072393,1,0.912903427233888,0,11,microtubule anchoring at microtubule organizing center,BP,
16883,GO:0072395,1,0.610850310047311,0,74,signal transduction involved in cell cycle checkpoint,BP,
16884,GO:0072396,1,0.962067288523212,0,5,response to cell cycle checkpoint signaling,BP,
16885,GO:0072401,1,0.617673621104415,0,73,signal transduction involved in DNA integrity checkpoint,BP,
16886,GO:0072402,1,0.962067288523212,0,5,response to DNA integrity checkpoint signaling,BP,
16887,GO:0072413,1,0.663644881920468,0,62,signal transduction involved in mitotic cell cycle checkpoint,BP,
16888,GO:0072414,1,0.990470563774202,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16889,GO:0072422,1,0.617673621104415,0,73,signal transduction involved in DNA damage checkpoint,BP,
16890,GO:0072423,1,0.962067288523212,0,5,response to DNA damage checkpoint signaling,BP,
16891,GO:0072425,1,0.924094254584465,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16892,GO:0072428,1,0.994509112592768,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16893,GO:0072429,1,0.983006770476651,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16894,GO:0072431,1,0.66761762083613,0,61,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16895,GO:0072432,1,0.990470563774202,0,1,response to G1 DNA damage checkpoint signaling,BP,
16896,GO:0072434,1,0.981133279114541,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16897,GO:0072487,1,0.975328262707693,0,4,MSL complex,CC,
16898,GO:0072488,1,0.936038619311989,0,11,ammonium transmembrane transport,BP,
16899,GO:0072492,1,0.994533464418864,0,1,host cell mitochondrial intermembrane space,CC,
16900,GO:0072497,1,0.941653442789133,0,8,mesenchymal stem cell differentiation,BP,
16901,GO:0072498,1,0.920011198506377,0,14,embryonic skeletal joint development,BP,
16902,GO:0072501,1,0.954339568374166,0,6,cellular divalent inorganic anion homeostasis,BP,
16903,GO:0072502,1,0.954339568374166,0,6,cellular trivalent inorganic anion homeostasis,BP,
16905,GO:0072505,1,0.935188594772829,0,9,divalent inorganic anion homeostasis,BP,
16906,GO:0072506,1,0.935188594772829,0,9,trivalent inorganic anion homeostasis,BP,
16908,GO:0072509,1,0.864804958279806,0,23,divalent inorganic cation transmembrane transporter activity,MF,
16909,GO:0072510,1,0.980680063828563,0,3,trivalent inorganic cation transmembrane transporter activity,MF,
16912,GO:0072513,1,0.976084772879216,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
16913,GO:0072517,1,0.993768301928894,0,1,host cell viral assembly compartment,CC,
16914,GO:0072518,1,0.991067508174269,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
16915,GO:0072520,1,0.923852890785327,0,11,seminiferous tubule development,BP,
16918,GO:0072523,1,0.719435332507735,0,49,purine-containing compound catabolic process,BP,
16921,GO:0072526,1,0.966857350575768,0,6,pyridine-containing compound catabolic process,BP,
16925,GO:0072530,1,0.955421770354812,0,8,purine-containing compound transmembrane transport,BP,
16926,GO:0072531,1,0.947439940791326,0,9,pyrimidine-containing compound transmembrane transport,BP,
16929,GO:0072536,1,0.994480951861777,0,1,interleukin-23 receptor complex,CC,
16930,GO:0072537,1,0.944728456947727,0,9,fibroblast activation,BP,
16931,GO:0072538,1,0.895502386913584,0,17,T-helper 17 type immune response,BP,
16932,GO:0072539,1,0.901014747529347,0,16,T-helper 17 cell differentiation,BP,
16933,GO:0072540,1,0.941487565077975,0,10,T-helper 17 cell lineage commitment,BP,
16934,GO:0072542,1,0.957386791964734,0,7,protein phosphatase activator activity,MF,
16935,GO:0072544,1,0.994543972359281,0,1,L-DOPA binding,MF,
16936,GO:0072545,1,0.989007744846808,0,2,tyrosine binding,MF,
16937,GO:0072546,1,0.942785897930341,0,10,ER membrane protein complex,CC,
16938,GO:0072553,1,0.958811229395992,0,6,terminal button organization,BP,
16939,GO:0072554,1,0.988209212908983,0,2,blood vessel lumenization,BP,
16940,GO:0072556,1,0.993154938853001,0,1,other organism presynaptic membrane,CC,
16941,GO:0072557,1,0.977851345049603,0,4,IPAF inflammasome complex,CC,
16942,GO:0072558,1,0.976051887265109,0,4,NLRP1 inflammasome complex,CC,
16943,GO:0072559,1,0.952483848438216,0,8,NLRP3 inflammasome complex,CC,
16944,GO:0072560,1,0.988643532445578,0,2,type B pancreatic cell maturation,BP,
16946,GO:0072563,1,0.98857307169774,0,2,endothelial microparticle,CC,
16947,GO:0072564,1,0.989038527385328,0,2,blood microparticle formation,BP,
16948,GO:0072566,1,0.988526082880454,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
16950,GO:0072570,1,0.993910056225356,0,1,ADP-D-ribose binding,MF,
16951,GO:0072572,1,0.994439299118594,0,1,poly-ADP-D-ribose binding,MF,
16952,GO:0072573,1,0.992938902842734,0,1,tolerance induction to lipopolysaccharide,BP,
16953,GO:0072574,1,0.915033929735465,0,14,hepatocyte proliferation,BP,
16954,GO:0072575,1,0.915033929735465,0,14,epithelial cell proliferation involved in liver morphogenesis,BP,
16955,GO:0072576,1,0.906542724348803,0,15,liver morphogenesis,BP,
16958,GO:0072579,1,0.993085353964708,0,1,glycine receptor clustering,BP,
16960,GO:0072584,1,0.94232927893522,0,9,caveolin-mediated endocytosis,BP,
16961,GO:0072586,1,0.992870200352359,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
16962,GO:0072587,1,0.992870200352359,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
16963,GO:0072588,1,0.973107127549804,0,5,box H/ACA RNP complex,CC,
16964,GO:0072589,1,0.978394137191543,0,4,box H/ACA scaRNP complex,CC,
16965,GO:0072590,1,0.979158286674869,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16966,GO:0072591,1,0.991627716637489,0,1,citrate-L-glutamate ligase activity,MF,
16967,GO:0072592,1,0.970756172828981,0,5,oxygen metabolic process,BP,
16970,GO:0072595,1,0.767478786081077,0,40,maintenance of protein localization in organelle,BP,
16971,GO:0072599,1,0.549335396977309,0,104,establishment of protein localization to endoplasmic reticulum,BP,
16972,GO:0072602,1,0.959943240521633,0,6,interleukin-4 secretion,BP,
16973,GO:0072603,1,0.965159962512534,0,6,interleukin-5 secretion,BP,
16974,GO:0072604,1,0.835948637323158,0,28,interleukin-6 secretion,BP,
16976,GO:0072608,1,0.955493572675455,0,8,interleukin-10 secretion,BP,
16977,GO:0072610,1,0.947731558770477,0,9,interleukin-12 secretion,BP,
16978,GO:0072611,1,0.960063174402818,0,7,interleukin-13 secretion,BP,
16979,GO:0072615,1,0.988949385428558,0,2,interleukin-17 secretion,BP,
16980,GO:0072616,1,0.993317290312421,0,1,interleukin-18 secretion,BP,
16981,GO:0072619,1,0.99367444005724,0,1,interleukin-21 secretion,BP,
16982,GO:0072641,1,0.948252814819394,0,7,type I interferon secretion,BP,
16983,GO:0072642,1,0.953842332758032,0,6,interferon-alpha secretion,BP,
16984,GO:0072643,1,0.911969903356332,0,15,interferon-gamma secretion,BP,
16985,GO:0072655,1,0.340398107441239,0,174,establishment of protein localization to mitochondrion,BP,
16986,GO:0072656,1,0.96737451774441,0,5,maintenance of protein location in mitochondrion,BP,
16988,GO:0072658,1,0.987945935997587,0,1,maintenance of protein location in membrane,BP,
16990,GO:0072660,1,0.987945935997587,0,1,maintenance of protein location in plasma membrane,BP,
16991,GO:0072662,1,0.899647397880482,0,17,protein localization to peroxisome,BP,
16992,GO:0072663,1,0.899647397880482,0,17,establishment of protein localization to peroxisome,BP,
16995,GO:0072669,1,0.961747477220663,0,7,tRNA-splicing ligase complex,CC,
16996,GO:0072671,1,0.994293883296756,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
16997,GO:0072672,1,0.954543194264702,0,7,neutrophil extravasation,BP,
16999,GO:0072674,1,0.962811005678047,0,4,multinuclear osteoclast differentiation,BP,
17000,GO:0072675,1,0.962811005678047,0,4,osteoclast fusion,BP,
17004,GO:0072679,1,0.97183785242038,0,5,thymocyte migration,BP,
17005,GO:0072680,1,0.993971119153192,0,1,extracellular matrix-dependent thymocyte migration,BP,
17006,GO:0072681,1,0.993971119153192,0,1,fibronectin-dependent thymocyte migration,BP,
17007,GO:0072682,1,0.993789304501779,0,1,eosinophil extravasation,BP,
17009,GO:0072684,1,0.993470730101755,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17010,GO:0072686,1,0.543850204457119,0,85,mitotic spindle,CC,
17011,GO:0072687,1,0.965303675507479,0,5,meiotic spindle,CC,
17012,GO:0072695,1,0.988602540480664,0,2,regulation of DNA recombination at telomere,BP,
17013,GO:0072697,1,0.926835302539687,0,11,protein localization to cell cortex,BP,
17014,GO:0072698,1,0.721566590752347,0,43,protein localization to microtubule cytoskeleton,BP,
17015,GO:0072702,1,0.991817763577806,0,1,response to methyl methanesulfonate,BP,
17016,GO:0072703,1,0.991817763577806,0,1,cellular response to methyl methanesulfonate,BP,
17017,GO:0072706,1,0.99428579296682,0,1,response to sodium dodecyl sulfate,BP,
17018,GO:0072707,1,0.99428579296682,0,1,cellular response to sodium dodecyl sulfate,BP,
17019,GO:0072708,1,0.97129426325847,0,5,response to sorbitol,BP,
17020,GO:0072709,1,0.982641308068738,0,3,cellular response to sorbitol,BP,
17021,GO:0072710,1,0.942638937796222,0,8,response to hydroxyurea,BP,
17022,GO:0072711,1,0.948155609505008,0,7,cellular response to hydroxyurea,BP,
17023,GO:0072714,1,0.994536046457936,0,1,response to selenite ion,BP,
17024,GO:0072715,1,0.994536046457936,0,1,cellular response to selenite ion,BP,
17025,GO:0072716,1,0.973583993411679,0,4,response to actinomycin D,BP,
17026,GO:0072717,1,0.979279922018656,0,3,cellular response to actinomycin D,BP,
17027,GO:0072718,1,0.94161790590995,0,9,response to cisplatin,BP,
17028,GO:0072719,1,0.962022670453871,0,6,cellular response to cisplatin,BP,
17029,GO:0072720,1,0.988403017609477,0,2,response to dithiothreitol,BP,
17030,GO:0072721,1,0.994184768585909,0,1,cellular response to dithiothreitol,BP,
17031,GO:0072733,1,0.983205194499441,0,3,response to staurosporine,BP,
17032,GO:0072734,1,0.983205194499441,0,3,cellular response to staurosporine,BP,
17033,GO:0072737,1,0.98874583967244,0,2,response to diamide,BP,
17034,GO:0072738,1,0.98874583967244,0,2,cellular response to diamide,BP,
17035,GO:0072739,1,0.988719627468541,0,2,response to anisomycin,BP,
17036,GO:0072740,1,0.994503211958308,0,1,cellular response to anisomycin,BP,
17037,GO:0072741,1,0.978060145538437,0,3,protein localization to cell division site,BP,
17038,GO:0072749,1,0.994521952658588,0,1,cellular response to cytochalasin B,BP,
17039,GO:0072750,1,0.994607165281603,0,1,cellular response to leptomycin B,BP,
17040,GO:0072752,1,0.990905932687135,0,1,cellular response to rapamycin,BP,
17041,GO:0072755,1,0.99351750226667,0,1,cellular response to benomyl,BP,
17042,GO:0072757,1,0.975231334374916,0,4,cellular response to camptothecin,BP,
17043,GO:0075044,1,0.969836987312453,0,4,autophagy of host cells involved in interaction with symbiont,BP,
17044,GO:0075071,1,0.969836987312453,0,4,autophagy involved in symbiotic interaction,BP,
17045,GO:0075109,1,0.992215682152264,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
17046,GO:0075111,1,0.992215682152264,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
17047,GO:0075112,1,0.992215682152264,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17048,GO:0075114,1,0.992215682152264,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17049,GO:0075136,1,0.967388044330101,0,5,response to host,BP,
17050,GO:0075341,1,0.994390455480333,0,1,host cell PML body,CC,
17051,GO:0075509,1,0.980899321874487,0,3,endocytosis involved in viral entry into host cell,BP,
17052,GO:0075519,1,0.994655941472146,0,1,microtubule-dependent intracellular transport of viral material,BP,
17053,GO:0075521,1,0.994655941472146,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17054,GO:0075522,1,0.935929962931477,0,10,IRES-dependent viral translational initiation,BP,
17055,GO:0075525,1,0.970102213116639,0,5,viral translational termination-reinitiation,BP,
17056,GO:0075528,1,0.986679657513878,0,2,modulation by virus of host immune response,BP,
17057,GO:0075606,1,0.994655941472146,0,1,transport of viral material towards nucleus,BP,
17058,GO:0075713,1,0.954275138722755,0,8,establishment of integrated proviral latency,BP,
17059,GO:0075732,1,0.984697192287777,0,2,viral penetration into host nucleus,BP,
17060,GO:0075733,1,0.698929731839115,0,53,intracellular transport of virus,BP,
17061,GO:0080008,1,0.800025322314166,0,34,Cul4-RING E3 ubiquitin ligase complex,CC,
17062,GO:0080009,1,0.944448078165788,0,10,mRNA methylation,BP,
17063,GO:0080019,1,0.986644926129104,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17064,GO:0080023,1,0.988403017609477,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
17065,GO:0080025,1,0.855468836243495,0,22,phosphatidylinositol-3,5-bisphosphate binding,MF,
17066,GO:0080033,1,0.991164447768179,0,1,response to nitrite,BP,
17067,GO:0080048,1,0.994184768585909,0,1,GDP-D-glucose phosphorylase activity,MF,
17068,GO:0080058,1,0.994597808007503,0,1,protein deglutathionylation,BP,
17069,GO:0080084,1,0.959744923135832,0,5,5S rDNA binding,MF,
17071,GO:0080101,1,0.994636210809392,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17072,GO:0080111,1,0.852225411249251,0,22,DNA demethylation,BP,
17073,GO:0080120,1,0.98858045945514,0,2,CAAX-box protein maturation,BP,
17074,GO:0080121,1,0.988414829737875,0,2,AMP transport,BP,
17075,GO:0080122,1,0.982776038722554,0,3,AMP transmembrane transporter activity,MF,
17076,GO:0080129,1,0.99462758340661,0,1,proteasome core complex assembly,BP,
17077,GO:0080132,1,0.994343367723908,0,1,fatty acid alpha-hydroxylase activity,MF,
17080,GO:0080144,1,0.987608174523248,0,2,amino acid homeostasis,BP,
17081,GO:0080146,1,0.994535156464788,0,1,L-cysteine desulfhydrase activity,MF,
17082,GO:0080147,1,0.994651281344248,0,1,root hair cell development,BP,
17083,GO:0080154,1,0.902887458968293,0,16,regulation of fertilization,BP,
17084,GO:0080163,1,0.994355894562627,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17085,GO:0080171,1,0.676402595133043,0,58,lytic vacuole organization,BP,
17086,GO:0080182,1,0.888747042672237,0,16,histone H3-K4 trimethylation,BP,
17087,GO:0080184,1,0.972055240016687,0,5,response to phenylpropanoid,BP,
17088,GO:0085018,1,0.99420069797662,0,1,maintenance of symbiont-containing vacuole by host,BP,
17089,GO:0085020,1,0.957228918209489,0,7,protein K6-linked ubiquitination,BP,
17090,GO:0085029,1,0.806696616267559,0,30,extracellular matrix assembly,BP,
17091,GO:0085032,1,0.993884249958602,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17093,GO:0086002,1,0.700997127243322,0,46,cardiac muscle cell action potential involved in contraction,BP,
17094,GO:0086003,1,0.65417980790174,0,56,cardiac muscle cell contraction,BP,
17095,GO:0086004,1,0.760971692121638,0,33,regulation of cardiac muscle cell contraction,BP,
17096,GO:0086005,1,0.798825457038624,0,29,ventricular cardiac muscle cell action potential,BP,
17097,GO:0086006,1,0.961417993957756,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17098,GO:0086007,1,0.952405140486497,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17101,GO:0086010,1,0.67053964265357,0,45,membrane depolarization during action potential,BP,
17103,GO:0086012,1,0.843075269629599,0,20,membrane depolarization during cardiac muscle cell action potential,BP,
17105,GO:0086014,1,0.859328104761657,0,18,atrial cardiac muscle cell action potential,BP,
17106,GO:0086015,1,0.920453674708406,0,8,SA node cell action potential,BP,
17107,GO:0086016,1,0.915665587085364,0,9,AV node cell action potential,BP,
17108,GO:0086017,1,0.977225361495687,0,3,Purkinje myocyte action potential,BP,
17109,GO:0086018,1,0.920453674708406,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
17110,GO:0086019,1,0.792047351968625,0,29,cell-cell signaling involved in cardiac conduction,BP,
17111,GO:0086020,1,0.989959659394607,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17112,GO:0086021,1,0.989959659394607,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17113,GO:0086023,1,0.944356377245889,0,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17114,GO:0086024,1,0.989520522560469,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17115,GO:0086026,1,0.859328104761657,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17116,GO:0086027,1,0.915665587085364,0,9,AV node cell to bundle of His cell signaling,BP,
17117,GO:0086028,1,0.9570256228695,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
17118,GO:0086029,1,0.954996694833369,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17119,GO:0086030,1,0.994466065949798,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17120,GO:0086036,1,0.946811130339026,0,8,regulation of cardiac muscle cell membrane potential,BP,
17121,GO:0086037,1,0.993672508141756,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17122,GO:0086038,1,0.994184768585909,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17123,GO:0086039,1,0.989418530363553,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17124,GO:0086040,1,0.992806496864073,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17125,GO:0086041,1,0.990330027507323,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17126,GO:0086042,1,0.949054123909533,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17127,GO:0086043,1,0.9570256228695,0,6,bundle of His cell action potential,BP,
17128,GO:0086045,1,0.951589784305463,0,5,membrane depolarization during AV node cell action potential,BP,
17129,GO:0086046,1,0.949951551793453,0,5,membrane depolarization during SA node cell action potential,BP,
17130,GO:0086047,1,0.977225361495687,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17131,GO:0086048,1,0.976077747601135,0,3,membrane depolarization during bundle of His cell action potential,BP,
17132,GO:0086050,1,0.99414493421607,0,1,membrane repolarization during bundle of His cell action potential,BP,
17133,GO:0086052,1,0.99414493421607,0,1,membrane repolarization during SA node cell action potential,BP,
17134,GO:0086053,1,0.989959659394607,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
17135,GO:0086056,1,0.968520832944202,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17136,GO:0086057,1,0.993440055495113,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17137,GO:0086059,1,0.979975640987934,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17138,GO:0086060,1,0.989196171446771,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17139,GO:0086061,1,0.989196171446771,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17140,GO:0086062,1,0.983861727238696,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17141,GO:0086063,1,0.989196171446771,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17142,GO:0086064,1,0.845934591617042,0,22,cell communication by electrical coupling involved in cardiac conduction,BP,
17143,GO:0086065,1,0.67641005199055,0,52,cell communication involved in cardiac conduction,BP,
17144,GO:0086066,1,0.859328104761657,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17145,GO:0086067,1,0.906463947515936,0,10,AV node cell to bundle of His cell communication,BP,
17146,GO:0086068,1,0.954996694833369,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17147,GO:0086069,1,0.907920271659607,0,13,bundle of His cell to Purkinje myocyte communication,BP,
17148,GO:0086070,1,0.911204398878119,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
17149,GO:0086072,1,0.994325948142686,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17150,GO:0086073,1,0.954472366533189,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17151,GO:0086075,1,0.984006108169413,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17152,GO:0086077,1,0.989959659394607,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17153,GO:0086080,1,0.922704313492322,0,10,protein binding involved in heterotypic cell-cell adhesion,MF,
17154,GO:0086082,1,0.994325948142686,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17155,GO:0086083,1,0.960311547447855,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17156,GO:0086087,1,0.99414493421607,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17157,GO:0086089,1,0.976584476305328,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17158,GO:0086090,1,0.99414493421607,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17159,GO:0086091,1,0.76545434171438,0,35,regulation of heart rate by cardiac conduction,BP,
17160,GO:0086092,1,0.9873872476332,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17161,GO:0086096,1,0.994599233652156,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17162,GO:0086097,1,0.987257365971396,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17163,GO:0086098,1,0.987549418934945,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17164,GO:0086100,1,0.986581718823353,0,2,endothelin receptor signaling pathway,BP,
17165,GO:0086103,1,0.922539273125659,0,10,G-protein coupled receptor signaling pathway involved in heart process,BP,
17166,GO:0089700,1,0.973002339524408,0,4,protein kinase D signaling,BP,
17167,GO:0089701,1,0.972281450691873,0,5,U2AF,CC,
17168,GO:0089709,1,0.982978611797694,0,3,L-histidine transmembrane transport,BP,
17169,GO:0089717,1,0.924509716702636,0,10,spanning component of membrane,CC,
17170,GO:0089718,1,0.874136447860654,0,19,amino acid import across plasma membrane,BP,
17171,GO:0089720,1,0.950332402398974,0,9,caspase binding,MF,
17172,GO:0090009,1,0.940085586711449,0,9,primitive streak formation,BP,
17173,GO:0090010,1,0.994455211392974,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17174,GO:0090022,1,0.824599234653778,0,34,regulation of neutrophil chemotaxis,BP,
17175,GO:0090023,1,0.8504686348002,0,29,positive regulation of neutrophil chemotaxis,BP,
17176,GO:0090024,1,0.986660640952053,0,2,negative regulation of neutrophil chemotaxis,BP,
17179,GO:0090027,1,0.974619427802912,0,4,negative regulation of monocyte chemotaxis,BP,
17180,GO:0090030,1,0.945526975320811,0,9,regulation of steroid hormone biosynthetic process,BP,
17181,GO:0090031,1,0.981821293201318,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17182,GO:0090032,1,0.970087418007484,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17183,GO:0090034,1,0.987810377510927,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17184,GO:0090035,1,0.987810377510927,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17185,GO:0090036,1,0.901500424871995,0,15,regulation of protein kinase C signaling,BP,
17186,GO:0090037,1,0.950123906439967,0,8,positive regulation of protein kinase C signaling,BP,
17187,GO:0090038,1,0.987429184013759,0,2,negative regulation of protein kinase C signaling,BP,
17188,GO:0090042,1,0.935370995292963,0,9,tubulin deacetylation,BP,
17189,GO:0090043,1,0.9469870756754,0,7,regulation of tubulin deacetylation,BP,
17190,GO:0090044,1,0.994561275999617,0,1,positive regulation of tubulin deacetylation,BP,
17191,GO:0090045,1,0.945197711861196,0,8,positive regulation of deacetylase activity,BP,
17194,GO:0090051,1,0.900225048932693,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17195,GO:0090063,1,0.973463533719707,0,4,positive regulation of microtubule nucleation,BP,
17196,GO:0090065,1,0.993313444145808,0,1,regulation of production of siRNA involved in RNA interference,BP,
17198,GO:0090067,1,0.99284021766627,0,1,regulation of thalamus size,BP,
17200,GO:0090069,1,0.916720341653704,0,13,regulation of ribosome biogenesis,BP,
17201,GO:0090070,1,0.950611783080998,0,8,positive regulation of ribosome biogenesis,BP,
17202,GO:0090071,1,0.971965906927173,0,4,negative regulation of ribosome biogenesis,BP,
17203,GO:0090073,1,0.943201334240742,0,9,positive regulation of protein homodimerization activity,BP,
17204,GO:0090074,1,0.963493140636818,0,5,negative regulation of protein homodimerization activity,BP,
17205,GO:0090075,1,0.835118566924237,0,27,relaxation of muscle,BP,
17206,GO:0090076,1,0.985804182348124,0,2,relaxation of skeletal muscle,BP,
17208,GO:0090079,1,0.851816237695421,0,24,translation regulator activity, nucleic acid binding,MF,
17209,GO:0090080,1,0.984280083149817,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17210,GO:0090081,1,0.9891736455744,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17211,GO:0090082,1,0.9891736455744,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17212,GO:0090083,1,0.899585650140991,0,15,regulation of inclusion body assembly,BP,
17213,GO:0090084,1,0.927494570723692,0,10,negative regulation of inclusion body assembly,BP,
17214,GO:0090085,1,0.930258134983147,0,11,regulation of protein deubiquitination,BP,
17215,GO:0090086,1,0.983828961927726,0,3,negative regulation of protein deubiquitination,BP,
17217,GO:0090088,1,0.988828301877708,0,2,regulation of oligopeptide transport,BP,
17218,GO:0090089,1,0.988828301877708,0,2,regulation of dipeptide transport,BP,
17222,GO:0090094,1,0.988901887731824,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17223,GO:0090095,1,0.994367337709948,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17224,GO:0090096,1,0.994367337709948,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17226,GO:0090101,1,0.483433178713209,0,101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17228,GO:0090103,1,0.864352837376695,0,22,cochlea morphogenesis,BP,
17229,GO:0090107,1,0.976742752043891,0,3,regulation of high-density lipoprotein particle assembly,BP,
17230,GO:0090108,1,0.994458785047521,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17232,GO:0090110,1,0.912582983143227,0,13,cargo loading into COPII-coated vesicle,BP,
17233,GO:0090113,1,0.994431019935691,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17234,GO:0090114,1,0.624650888941165,0,69,COPII-coated vesicle budding,BP,
17235,GO:0090116,1,0.978606831725792,0,3,C-5 methylation of cytosine,BP,
17237,GO:0090119,1,0.987360048887864,0,2,vesicle-mediated cholesterol transport,BP,
17238,GO:0090122,1,0.99447341856126,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17239,GO:0090128,1,0.92593149421553,0,10,regulation of synapse maturation,BP,
17240,GO:0090129,1,0.93970715123378,0,8,positive regulation of synapse maturation,BP,
17242,GO:0090131,1,0.971924742459233,0,5,mesenchyme migration,BP,
17244,GO:0090133,1,0.994631867944308,0,1,mesendoderm migration,BP,
17245,GO:0090134,1,0.994631867944308,0,1,cell migration involved in mesendoderm migration,BP,
17246,GO:0090135,1,0.980861720837864,0,3,actin filament branching,BP,
17247,GO:0090136,1,0.904232652024677,0,15,epithelial cell-cell adhesion,BP,
17248,GO:0090138,1,0.993592451425202,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17249,GO:0090140,1,0.855938029109425,0,21,regulation of mitochondrial fission,BP,
17250,GO:0090141,1,0.909095990998793,0,14,positive regulation of mitochondrial fission,BP,
17251,GO:0090148,1,0.919072751611871,0,12,membrane fission,BP,
17252,GO:0090149,1,0.987253400577986,0,2,mitochondrial membrane fission,BP,
17254,GO:0090151,1,0.934959491657291,0,12,establishment of protein localization to mitochondrial membrane,BP,
17255,GO:0090153,1,0.92497359367927,0,13,regulation of sphingolipid biosynthetic process,BP,
17256,GO:0090154,1,0.952882203034509,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17257,GO:0090155,1,0.976019036464033,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17258,GO:0090156,1,0.983583021201446,0,3,cellular sphingolipid homeostasis,BP,
17259,GO:0090158,1,0.964930761669972,0,6,endoplasmic reticulum membrane organization,BP,
17260,GO:0090160,1,0.947934015877041,0,8,Golgi to lysosome transport,BP,
17261,GO:0090161,1,0.922832324725587,0,11,Golgi ribbon formation,BP,
17263,GO:0090164,1,0.984293003847094,0,2,asymmetric Golgi ribbon formation,BP,
17264,GO:0090166,1,0.962707323904332,0,6,Golgi disassembly,BP,
17265,GO:0090168,1,0.972853611596927,0,4,Golgi reassembly,BP,
17266,GO:0090169,1,0.831086438928845,0,25,regulation of spindle assembly,BP,
17267,GO:0090170,1,0.977079724002199,0,4,regulation of Golgi inheritance,BP,
17268,GO:0090171,1,0.993460807808773,0,1,chondrocyte morphogenesis,BP,
17270,GO:0090175,1,0.489460196079188,0,108,regulation of establishment of planar polarity,BP,
17271,GO:0090176,1,0.991829629471424,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17272,GO:0090177,1,0.897842012810863,0,15,establishment of planar polarity involved in neural tube closure,BP,
17273,GO:0090178,1,0.902708118546788,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17274,GO:0090179,1,0.90928269756719,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17275,GO:0090181,1,0.709425214602885,0,51,regulation of cholesterol metabolic process,BP,
17276,GO:0090182,1,0.989057059312218,0,2,regulation of secretion of lysosomal enzymes,BP,
17277,GO:0090183,1,0.731852826210651,0,48,regulation of kidney development,BP,
17278,GO:0090184,1,0.803962985018527,0,35,positive regulation of kidney development,BP,
17279,GO:0090185,1,0.913492610947919,0,15,negative regulation of kidney development,BP,
17280,GO:0090186,1,0.949371724859302,0,7,regulation of pancreatic juice secretion,BP,
17281,GO:0090187,1,0.98915239582034,0,2,positive regulation of pancreatic juice secretion,BP,
17282,GO:0090188,1,0.959787369255529,0,5,negative regulation of pancreatic juice secretion,BP,
17283,GO:0090189,1,0.883581291972717,0,20,regulation of branching involved in ureteric bud morphogenesis,BP,
17284,GO:0090190,1,0.898407837095793,0,17,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17285,GO:0090191,1,0.976632752248057,0,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17286,GO:0090192,1,0.934512293933936,0,11,regulation of glomerulus development,BP,
17287,GO:0090193,1,0.951661748936147,0,8,positive regulation of glomerulus development,BP,
17288,GO:0090194,1,0.981988313630096,0,3,negative regulation of glomerulus development,BP,
17292,GO:0090198,1,0.994134539224412,0,1,negative regulation of chemokine secretion,BP,
17293,GO:0090199,1,0.774852182931459,0,42,regulation of release of cytochrome c from mitochondria,BP,
17294,GO:0090200,1,0.847883738259302,0,28,positive regulation of release of cytochrome c from mitochondria,BP,
17295,GO:0090201,1,0.908899509686415,0,15,negative regulation of release of cytochrome c from mitochondria,BP,
17296,GO:0090202,1,0.971136738303144,0,4,gene looping,BP,
17297,GO:0090204,1,0.979685372243669,0,3,protein localization to nuclear pore,BP,
17298,GO:0090205,1,0.961343959144789,0,6,positive regulation of cholesterol metabolic process,BP,
17299,GO:0090206,1,0.971062608422538,0,5,negative regulation of cholesterol metabolic process,BP,
17300,GO:0090207,1,0.859499234228577,0,24,regulation of triglyceride metabolic process,BP,
17301,GO:0090208,1,0.913300174733335,0,15,positive regulation of triglyceride metabolic process,BP,
17302,GO:0090209,1,0.962226333706728,0,6,negative regulation of triglyceride metabolic process,BP,
17303,GO:0090210,1,0.987496840594318,0,2,regulation of establishment of blood-brain barrier,BP,
17304,GO:0090212,1,0.987496840594318,0,2,negative regulation of establishment of blood-brain barrier,BP,
17305,GO:0090214,1,0.984262401118232,0,2,spongiotrophoblast layer developmental growth,BP,
17306,GO:0090218,1,0.80474926946327,0,32,positive regulation of lipid kinase activity,BP,
17307,GO:0090219,1,0.981328225555124,0,3,negative regulation of lipid kinase activity,BP,
17308,GO:0090220,1,0.933815531432566,0,10,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17309,GO:0090222,1,0.980559431800819,0,2,centrosome-templated microtubule nucleation,BP,
17310,GO:0090224,1,0.750775261674198,0,39,regulation of spindle organization,BP,
17311,GO:0090226,1,0.994648183451414,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17312,GO:0090230,1,0.972045066638762,0,4,regulation of centromere complex assembly,BP,
17313,GO:0090231,1,0.906664682207727,0,15,regulation of spindle checkpoint,BP,
17314,GO:0090232,1,0.946576296025334,0,8,positive regulation of spindle checkpoint,BP,
17315,GO:0090233,1,0.994236566898091,0,1,negative regulation of spindle checkpoint,BP,
17316,GO:0090234,1,0.979283957988115,0,3,regulation of kinetochore assembly,BP,
17317,GO:0090235,1,0.941328129994885,0,7,regulation of metaphase plate congression,BP,
17318,GO:0090237,1,0.967034701684723,0,5,regulation of arachidonic acid secretion,BP,
17319,GO:0090238,1,0.974459041864972,0,4,positive regulation of arachidonic acid secretion,BP,
17320,GO:0090239,1,0.927216659630003,0,12,regulation of histone H4 acetylation,BP,
17321,GO:0090240,1,0.955205535468336,0,7,positive regulation of histone H4 acetylation,BP,
17322,GO:0090241,1,0.971250663670603,0,5,negative regulation of histone H4 acetylation,BP,
17323,GO:0090244,1,0.970055453134083,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17324,GO:0090245,1,0.965963914584885,0,4,axis elongation involved in somitogenesis,BP,
17325,GO:0090246,1,0.992909132662584,0,1,convergent extension involved in somitogenesis,BP,
17326,GO:0090247,1,0.994276479790622,0,1,cell motility involved in somitogenic axis elongation,BP,
17327,GO:0090249,1,0.994276479790622,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17328,GO:0090251,1,0.986729947345359,0,1,protein localization involved in establishment of planar polarity,BP,
17329,GO:0090257,1,0.24856926881367,0,199,regulation of muscle system process,BP,
17330,GO:0090258,1,0.977267737754555,0,3,negative regulation of mitochondrial fission,BP,
17331,GO:0090259,1,0.968141994430183,0,5,regulation of retinal ganglion cell axon guidance,BP,
17332,GO:0090260,1,0.985775015496612,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17333,GO:0090261,1,0.977957316893464,0,4,positive regulation of inclusion body assembly,BP,
17335,GO:0090264,1,0.988906221245587,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17336,GO:0090265,1,0.994314759125492,0,1,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17337,GO:0090266,1,0.912256230803898,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17338,GO:0090267,1,0.95241146310745,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17339,GO:0090269,1,0.956938787913989,0,6,fibroblast growth factor production,BP,
17340,GO:0090270,1,0.956938787913989,0,6,regulation of fibroblast growth factor production,BP,
17341,GO:0090271,1,0.975863850142388,0,3,positive regulation of fibroblast growth factor production,BP,
17342,GO:0090272,1,0.980611550904478,0,3,negative regulation of fibroblast growth factor production,BP,
17343,GO:0090273,1,0.988653937635473,0,2,regulation of somatostatin secretion,BP,
17344,GO:0090274,1,0.988653937635473,0,2,positive regulation of somatostatin secretion,BP,
17346,GO:0090277,1,0.623119815786254,0,77,positive regulation of peptide hormone secretion,BP,
17350,GO:0090281,1,0.972719003547621,0,5,negative regulation of calcium ion import,BP,
17351,GO:0090282,1,0.994054139843672,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17352,GO:0090283,1,0.979148258677389,0,3,regulation of protein glycosylation in Golgi,BP,
17353,GO:0090284,1,0.990315460358159,0,1,positive regulation of protein glycosylation in Golgi,BP,
17354,GO:0090285,1,0.988724682055188,0,2,negative regulation of protein glycosylation in Golgi,BP,
17355,GO:0090286,1,0.944068895517613,0,6,cytoskeletal anchoring at nuclear membrane,BP,
17357,GO:0090288,1,0.412663188438719,0,124,negative regulation of cellular response to growth factor stimulus,BP,
17358,GO:0090289,1,0.980897727115918,0,3,regulation of osteoclast proliferation,BP,
17359,GO:0090290,1,0.994632346502079,0,1,positive regulation of osteoclast proliferation,BP,
17360,GO:0090291,1,0.986191998520206,0,2,negative regulation of osteoclast proliferation,BP,
17361,GO:0090292,1,0.968307167696946,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17362,GO:0090293,1,0.994436661814452,0,1,nitrogen catabolite regulation of transcription,BP,
17363,GO:0090294,1,0.994436661814452,0,1,nitrogen catabolite activation of transcription,BP,
17364,GO:0090296,1,0.975296775464799,0,4,regulation of mitochondrial DNA replication,BP,
17365,GO:0090297,1,0.994607995983347,0,1,positive regulation of mitochondrial DNA replication,BP,
17366,GO:0090298,1,0.980585129054868,0,3,negative regulation of mitochondrial DNA replication,BP,
17367,GO:0090299,1,0.994550664131612,0,1,regulation of neural crest formation,BP,
17368,GO:0090301,1,0.994550664131612,0,1,negative regulation of neural crest formation,BP,
17371,GO:0090305,1,0.181116787533164,0,265,nucleic acid phosphodiester bond hydrolysis,BP,
17372,GO:0090306,1,0.969395717786839,0,4,spindle assembly involved in meiosis,BP,
17373,GO:0090307,1,0.652750225149859,0,62,mitotic spindle assembly,BP,
17374,GO:0090308,1,0.94915324765818,0,7,regulation of methylation-dependent chromatin silencing,BP,
17375,GO:0090309,1,0.972269426937233,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17376,GO:0090310,1,0.982497266900743,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
17377,GO:0090311,1,0.77188862316468,0,36,regulation of protein deacetylation,BP,
17378,GO:0090312,1,0.871708006731726,0,20,positive regulation of protein deacetylation,BP,
17381,GO:0090315,1,0.971183830177818,0,5,negative regulation of protein targeting to membrane,BP,
17383,GO:0090317,1,0.798813630570483,0,36,negative regulation of intracellular protein transport,BP,
17384,GO:0090322,1,0.852158454992471,0,27,regulation of superoxide metabolic process,BP,
17385,GO:0090323,1,0.994662427018319,0,1,prostaglandin secretion involved in immune response,BP,
17386,GO:0090324,1,0.970455871174575,0,5,negative regulation of oxidative phosphorylation,BP,
17387,GO:0090325,1,0.981411664975084,0,3,regulation of locomotion involved in locomotory behavior,BP,
17388,GO:0090326,1,0.993873106179705,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17389,GO:0090327,1,0.993176819693024,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17390,GO:0090329,1,0.739388301433254,0,45,regulation of DNA-dependent DNA replication,BP,
17392,GO:0090331,1,0.930454069267923,0,11,negative regulation of platelet aggregation,BP,
17393,GO:0090335,1,0.919083543527616,0,12,regulation of brown fat cell differentiation,BP,
17394,GO:0090336,1,0.959052710777975,0,6,positive regulation of brown fat cell differentiation,BP,
17395,GO:0090340,1,0.994458785047521,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17396,GO:0090341,1,0.994568476722784,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17397,GO:0090342,1,0.767583584671576,0,39,regulation of cell aging,BP,
17398,GO:0090343,1,0.942523382457155,0,10,positive regulation of cell aging,BP,
17399,GO:0090344,1,0.861587302001115,0,21,negative regulation of cell aging,BP,
17400,GO:0090345,1,0.988906050464825,0,2,cellular organohalogen metabolic process,BP,
17401,GO:0090346,1,0.988906050464825,0,2,cellular organofluorine metabolic process,BP,
17402,GO:0090347,1,0.994564330687402,0,1,regulation of cellular organohalogen metabolic process,BP,
17403,GO:0090348,1,0.994564330687402,0,1,regulation of cellular organofluorine metabolic process,BP,
17404,GO:0090349,1,0.994564330687402,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17405,GO:0090350,1,0.994564330687402,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17406,GO:0090360,1,0.981897656471586,0,3,platelet-derived growth factor production,BP,
17407,GO:0090361,1,0.981897656471586,0,3,regulation of platelet-derived growth factor production,BP,
17408,GO:0090362,1,0.987368224539625,0,2,positive regulation of platelet-derived growth factor production,BP,
17409,GO:0090365,1,0.994426797638421,0,1,regulation of mRNA modification,BP,
17410,GO:0090367,1,0.994426797638421,0,1,negative regulation of mRNA modification,BP,
17411,GO:0090370,1,0.980249847597219,0,3,negative regulation of cholesterol efflux,BP,
17412,GO:0090381,1,0.9891736455744,0,2,regulation of heart induction,BP,
17413,GO:0090382,1,0.776736006445243,0,40,phagosome maturation,BP,
17414,GO:0090383,1,0.856924830727599,0,26,phagosome acidification,BP,
17415,GO:0090385,1,0.955934613562516,0,7,phagosome-lysosome fusion,BP,
17416,GO:0090386,1,0.983017123170695,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17417,GO:0090387,1,0.983017123170695,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17418,GO:0090389,1,0.989948405647418,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17419,GO:0090394,1,0.93007611883513,0,10,negative regulation of excitatory postsynaptic potential,BP,
17420,GO:0090398,1,0.682259608805923,0,58,cellular senescence,BP,
17422,GO:0090400,1,0.951328102013391,0,8,stress-induced premature senescence,BP,
17423,GO:0090402,1,0.988677183346717,0,2,oncogene-induced cell senescence,BP,
17424,GO:0090403,1,0.975127870794828,0,4,oxidative stress-induced premature senescence,BP,
17426,GO:0090409,1,0.994392641063462,0,1,malonyl-CoA synthetase activity,MF,
17427,GO:0090410,1,0.994392641063462,0,1,malonate catabolic process,BP,
17428,GO:0090416,1,0.994287720904879,0,1,nicotinate transmembrane transporter activity,MF,
17429,GO:0090420,1,0.994592054250129,0,1,naphthalene-containing compound metabolic process,BP,
17430,GO:0090422,1,0.988836510444566,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17431,GO:0090425,1,0.994022802320081,0,1,acinar cell differentiation,BP,
17432,GO:0090427,1,0.979779802997139,0,3,activation of meiosis,BP,
17433,GO:0090435,1,0.956397993074867,0,7,protein localization to nuclear envelope,BP,
17434,GO:0090461,1,0.99306586030518,0,1,glutamate homeostasis,BP,
17435,GO:0090472,1,0.993153185428097,0,1,dibasic protein processing,BP,
17436,GO:0090480,1,0.978965882734684,0,3,purine nucleotide-sugar transmembrane transport,BP,
17437,GO:0090481,1,0.933587464432301,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17438,GO:0090482,1,0.869673163474868,0,22,vitamin transmembrane transporter activity,MF,
17439,GO:0090493,1,0.936843861497983,0,11,catecholamine uptake,BP,
17440,GO:0090494,1,0.936843861497983,0,11,dopamine uptake,BP,
17441,GO:0090498,1,0.979695018000512,0,3,extrinsic component of Golgi membrane,CC,
17442,GO:0090500,1,0.970036609494768,0,5,endocardial cushion to mesenchymal transition,BP,
17443,GO:0090501,1,0.439026273542555,0,129,RNA phosphodiester bond hydrolysis,BP,
17444,GO:0090502,1,0.681180197182951,0,62,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17445,GO:0090503,1,0.789024482352067,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17448,GO:0090520,1,0.931117887910944,0,12,sphingolipid mediated signaling pathway,BP,
17449,GO:0090521,1,0.972998598530334,0,4,glomerular visceral epithelial cell migration,BP,
17450,GO:0090527,1,0.919878387929782,0,11,actin filament reorganization,BP,
17451,GO:0090529,1,0.994513329699592,0,1,cell septum assembly,BP,
17452,GO:0090533,1,0.916406615317259,0,14,cation-transporting ATPase complex,CC,
17453,GO:0090534,1,0.994541878042146,0,1,calcium ion-transporting ATPase complex,CC,
17454,GO:0090537,1,0.985101055745739,0,2,CERF complex,CC,
17455,GO:0090541,1,0.987208096018548,0,2,MIT domain binding,MF,
17456,GO:0090543,1,0.84069263101578,0,26,Flemming body,CC,
17457,GO:0090545,1,0.875538842004124,0,17,CHD-type complex,CC,
17458,GO:0090554,1,0.964499253386934,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17459,GO:0090555,1,0.982789957460838,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17460,GO:0090556,1,0.978306830527145,0,2,phosphatidylserine-translocating ATPase activity,MF,
17461,GO:0090557,1,0.94015524886911,0,8,establishment of endothelial intestinal barrier,BP,
17462,GO:0090558,1,0.994651281344248,0,1,plant epidermis development,BP,
17463,GO:0090559,1,0.624500377416532,0,76,regulation of membrane permeability,BP,
17464,GO:0090560,1,0.994434446840627,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17465,GO:0090568,1,0.804369847053309,0,29,nuclear transcriptional repressor complex,CC,
17466,GO:0090571,1,0.97670828270389,0,4,RNA polymerase II transcription repressor complex,CC,
17467,GO:0090575,1,0.376315682120029,0,146,RNA polymerase II transcription factor complex,CC,
17468,GO:0090576,1,0.942406275915639,0,8,RNA polymerase III transcription factor complex,CC,
17469,GO:0090579,1,0.971136738303144,0,4,dsDNA loop formation,BP,
17470,GO:0090594,1,0.95929721952576,0,7,inflammatory response to wounding,BP,
17472,GO:0090598,1,0.980745796057172,0,3,male anatomical structure morphogenesis,BP,
17473,GO:0090599,1,0.961738496996572,0,5,alpha-glucosidase activity,MF,
17474,GO:0090600,1,0.993398236143511,0,1,alpha-1,3-glucosidase activity,MF,
17475,GO:0090601,1,0.992269531760999,0,1,enucleation,BP,
17476,GO:0090611,1,0.969507077231873,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17477,GO:0090615,1,0.987321035827887,0,2,mitochondrial mRNA processing,BP,
17478,GO:0090616,1,0.992784567072978,0,1,mitochondrial mRNA 3'-end processing,BP,
17479,GO:0090624,1,0.994184768585909,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17480,GO:0090625,1,0.994184768585909,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17481,GO:0090627,1,0.994651281344248,0,1,plant epidermal cell differentiation,BP,
17482,GO:0090630,1,0.569849033222797,0,79,activation of GTPase activity,BP,
17483,GO:0090634,1,0.994575505946109,0,1,microglial cell mediated cytotoxicity,BP,
17484,GO:0090646,1,0.931838193997298,0,12,mitochondrial tRNA processing,BP,
17485,GO:0090647,1,0.952648546679589,0,7,modulation of age-related behavioral decline,BP,
17486,GO:0090648,1,0.991241074205711,0,1,response to environmental enrichment,BP,
17487,GO:0090649,1,0.958406657973287,0,5,response to oxygen-glucose deprivation,BP,
17488,GO:0090650,1,0.958406657973287,0,5,cellular response to oxygen-glucose deprivation,BP,
17489,GO:0090651,1,0.990764489186394,0,1,apical cytoplasm,CC,
17490,GO:0090656,1,0.913074374321036,0,14,t-circle formation,BP,
17491,GO:0090657,1,0.936742259041648,0,10,telomeric loop disassembly,BP,
17492,GO:0090659,1,0.815682848194358,0,27,walking behavior,BP,
17493,GO:0090661,1,0.978394137191543,0,4,box H/ACA telomerase RNP complex,CC,
17494,GO:0090662,1,0.836549367380661,0,29,ATP hydrolysis coupled transmembrane transport,BP,
17495,GO:0090663,1,0.989256256209334,0,2,galanin-activated signaling pathway,BP,
17496,GO:0090665,1,0.863778325094418,0,20,glycoprotein complex,CC,
17497,GO:0090666,1,0.977903525629809,0,4,scaRNA localization to Cajal body,BP,
17498,GO:0090667,1,0.989752763595964,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17499,GO:0090668,1,0.989752763595964,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17500,GO:0090669,1,0.97668872743778,0,4,telomerase RNA stabilization,BP,
17501,GO:0090670,1,0.893362818236793,0,19,RNA localization to Cajal body,BP,
17502,GO:0090671,1,0.893362818236793,0,19,telomerase RNA localization to Cajal body,BP,
17503,GO:0090672,1,0.893362818236793,0,19,telomerase RNA localization,BP,
17504,GO:0090673,1,0.990225468327144,0,1,endothelial cell-matrix adhesion,BP,
17505,GO:0090675,1,0.993112737902662,0,1,intermicrovillar adhesion,BP,
17506,GO:0090677,1,0.988677365607901,0,2,reversible differentiation,BP,
17507,GO:0090678,1,0.988677365607901,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17508,GO:0090685,1,0.893362818236793,0,19,RNA localization to nucleus,BP,
17509,GO:0090694,1,0.982026472845047,0,2,Scc2-Scc4 cohesin loading complex,CC,
17510,GO:0090713,1,0.960189248415452,0,6,immunological memory process,BP,
17511,GO:0090715,1,0.960189248415452,0,6,immunological memory formation process,BP,
17512,GO:0090722,1,0.972089774246788,0,4,receptor-receptor interaction,MF,
17513,GO:0090723,1,0.911650713905584,0,14,growth cone part,CC,
17514,GO:0090724,1,0.980822959618109,0,3,central region of growth cone,CC,
17515,GO:0090725,1,0.99464436348237,0,1,peripheral region of growth cone,CC,
17516,GO:0090731,1,0.994619104948451,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17517,GO:0090734,1,0.799484212335313,0,33,site of DNA damage,CC,
17518,GO:0090735,1,0.944156035074767,0,10,DNA repair complex assembly,BP,
17519,GO:0090737,1,0.913074374321036,0,14,telomere maintenance via telomere trimming,BP,
17520,GO:0090741,1,0.939994745178766,0,11,pigment granule membrane,CC,
17521,GO:0093001,1,0.993929370284502,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17522,GO:0095500,1,0.874646701883533,0,21,acetylcholine receptor signaling pathway,BP,
17523,GO:0097001,1,0.942545492047378,0,10,ceramide binding,MF,
17524,GO:0097003,1,0.987824779886986,0,2,adipokinetic hormone receptor activity,MF,
17526,GO:0097009,1,0.884973437497073,0,18,energy homeostasis,BP,
17527,GO:0097010,1,0.979922787466407,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17528,GO:0097011,1,0.952963077655874,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17529,GO:0097012,1,0.952963077655874,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17531,GO:0097014,1,0.470232342836082,0,100,ciliary plasm,CC,
17532,GO:0097016,1,0.974464492649571,0,4,L27 domain binding,MF,
17533,GO:0097017,1,0.988553904476675,0,2,renal protein absorption,BP,
17534,GO:0097018,1,0.994311919238431,0,1,renal albumin absorption,BP,
17535,GO:0097020,1,0.99382272614122,0,1,COPII adaptor activity,MF,
17536,GO:0097021,1,0.981576451913519,0,3,lymphocyte migration into lymphoid organs,BP,
17537,GO:0097022,1,0.994430720184273,0,1,lymphocyte migration into lymph node,BP,
17538,GO:0097025,1,0.966869623837082,0,5,MPP7-DLG1-LIN7 complex,CC,
17539,GO:0097026,1,0.973517639397428,0,4,dendritic cell dendrite assembly,BP,
17540,GO:0097027,1,0.960316704288485,0,7,ubiquitin-protein transferase activator activity,MF,
17541,GO:0097028,1,0.802023299509078,0,37,dendritic cell differentiation,BP,
17542,GO:0097029,1,0.978038772296015,0,4,mature conventional dendritic cell differentiation,BP,
17543,GO:0097035,1,0.752781467025814,0,37,regulation of membrane lipid distribution,BP,
17544,GO:0097036,1,0.994587153829369,0,1,regulation of plasma membrane sterol distribution,BP,
17545,GO:0097037,1,0.993771632860367,0,1,heme export,BP,
17546,GO:0097038,1,0.926259654729224,0,11,perinuclear endoplasmic reticulum,CC,
17547,GO:0097039,1,0.963954997160666,0,5,protein linear polyubiquitination,BP,
17548,GO:0097045,1,0.992615079751999,0,1,phosphatidylserine exposure on blood platelet,BP,
17549,GO:0097048,1,0.940252659636349,0,10,dendritic cell apoptotic process,BP,
17551,GO:0097050,1,0.919492968577331,0,12,type B pancreatic cell apoptotic process,BP,
17552,GO:0097051,1,0.976362439450915,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17553,GO:0097052,1,0.983418995342367,0,3,L-kynurenine metabolic process,BP,
17554,GO:0097053,1,0.994580031490716,0,1,L-kynurenine catabolic process,BP,
17555,GO:0097055,1,0.98863878736283,0,2,agmatine biosynthetic process,BP,
17556,GO:0097056,1,0.975525603396762,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17557,GO:0097057,1,0.989063642831442,0,2,TRAF2-GSTP1 complex,CC,
17558,GO:0097058,1,0.983640667813217,0,3,CRLF-CLCF1 complex,CC,
17559,GO:0097059,1,0.989035115148633,0,2,CNTFR-CLCF1 complex,CC,
17562,GO:0097062,1,0.883386254622506,0,17,dendritic spine maintenance,BP,
17563,GO:0097064,1,0.775801558135554,0,36,ncRNA export from nucleus,BP,
17564,GO:0097065,1,0.961253774859576,0,6,anterior head development,BP,
17566,GO:0097067,1,0.897534914759005,0,16,cellular response to thyroid hormone stimulus,BP,
17567,GO:0097068,1,0.968776612269347,0,5,response to thyroxine,BP,
17568,GO:0097069,1,0.987602563914689,0,2,cellular response to thyroxine stimulus,BP,
17569,GO:0097070,1,0.965511606308453,0,5,ductus arteriosus closure,BP,
17571,GO:0097086,1,0.993598814561107,0,1,amniotic stem cell differentiation,BP,
17572,GO:0097089,1,0.98896442101485,0,2,methyl-branched fatty acid metabolic process,BP,
17573,GO:0097090,1,0.910491731237077,0,12,presynaptic membrane organization,BP,
17574,GO:0097091,1,0.933887967284474,0,9,synaptic vesicle clustering,BP,
17576,GO:0097100,1,0.970696593685494,0,5,supercoiled DNA binding,MF,
17577,GO:0097101,1,0.982649379866352,0,3,blood vessel endothelial cell fate specification,BP,
17578,GO:0097102,1,0.988215083269859,0,2,endothelial tip cell fate specification,BP,
17579,GO:0097104,1,0.913286518292224,0,11,postsynaptic membrane assembly,BP,
17580,GO:0097105,1,0.924725305365551,0,10,presynaptic membrane assembly,BP,
17583,GO:0097108,1,0.976925865266455,0,3,hedgehog family protein binding,MF,
17584,GO:0097109,1,0.960646182105564,0,5,neuroligin family protein binding,MF,
17586,GO:0097111,1,0.981789761499678,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17587,GO:0097112,1,0.987163228685481,0,2,gamma-aminobutyric acid receptor clustering,BP,
17589,GO:0097114,1,0.964523324167804,0,4,NMDA glutamate receptor clustering,BP,
17590,GO:0097115,1,0.992490332986896,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17591,GO:0097116,1,0.972526397953172,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17592,GO:0097117,1,0.990391096969467,0,1,guanylate kinase-associated protein clustering,BP,
17593,GO:0097118,1,0.963650993032602,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17594,GO:0097119,1,0.927575211763817,0,9,postsynaptic density protein 95 clustering,BP,
17596,GO:0097123,1,0.988938786725582,0,2,cyclin A1-CDK2 complex,CC,
17597,GO:0097124,1,0.988616924111092,0,2,cyclin A2-CDK2 complex,CC,
17598,GO:0097125,1,0.989017941794168,0,2,cyclin B1-CDK1 complex,CC,
17599,GO:0097129,1,0.980302495394003,0,3,cyclin D2-CDK4 complex,CC,
17600,GO:0097134,1,0.988946856483335,0,2,cyclin E1-CDK2 complex,CC,
17601,GO:0097135,1,0.988652023748936,0,2,cyclin E2-CDK2 complex,CC,
17602,GO:0097136,1,0.963558266577985,0,6,Bcl-2 family protein complex,CC,
17603,GO:0097144,1,0.994649325112124,0,1,BAX complex,CC,
17604,GO:0097145,1,0.994423440946932,0,1,BAK complex,CC,
17605,GO:0097149,1,0.981090185751092,0,3,centralspindlin complex,CC,
17606,GO:0097150,1,0.845649496819758,0,21,neuronal stem cell population maintenance,BP,
17608,GO:0097152,1,0.927606314068736,0,12,mesenchymal cell apoptotic process,BP,
17609,GO:0097153,1,0.927001555781326,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17610,GO:0097154,1,0.928807220850965,0,12,GABAergic neuron differentiation,BP,
17611,GO:0097155,1,0.97156374887383,0,3,fasciculation of sensory neuron axon,BP,
17612,GO:0097156,1,0.984292370262559,0,2,fasciculation of motor neuron axon,BP,
17613,GO:0097157,1,0.94450145109013,0,8,pre-mRNA intronic binding,MF,
17614,GO:0097158,1,0.9945542757273,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17616,GO:0097161,1,0.991132725832899,0,1,DH domain binding,MF,
17617,GO:0097162,1,0.993885637384576,0,1,MADS box domain binding,MF,
17619,GO:0097165,1,0.96807579961555,0,5,nuclear stress granule,CC,
17620,GO:0097166,1,0.983549571270326,0,2,lens epithelial cell proliferation,BP,
17621,GO:0097167,1,0.973061370054581,0,4,circadian regulation of translation,BP,
17622,GO:0097168,1,0.987278856692413,0,2,mesenchymal stem cell proliferation,BP,
17623,GO:0097169,1,0.973354767928323,0,5,AIM2 inflammasome complex,CC,
17624,GO:0097176,1,0.978026056950357,0,4,epoxide metabolic process,BP,
17625,GO:0097177,1,0.983435573600979,0,3,mitochondrial ribosome binding,MF,
17626,GO:0097178,1,0.809988631305091,0,34,ruffle assembly,BP,
17627,GO:0097179,1,0.978397339240516,0,4,protease inhibitor complex,CC,
17628,GO:0097180,1,0.98896834571135,0,2,serine protease inhibitor complex,CC,
17629,GO:0097181,1,0.99438450636867,0,1,protein C inhibitor-coagulation factor V complex,CC,
17630,GO:0097182,1,0.99438450636867,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17631,GO:0097183,1,0.99438450636867,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17632,GO:0097186,1,0.890718078638652,0,16,amelogenesis,BP,
17636,GO:0097192,1,0.649649168010429,0,67,extrinsic apoptotic signaling pathway in absence of ligand,BP,
17637,GO:0097193,1,0.175592764876532,0,269,intrinsic apoptotic signaling pathway,BP,
17638,GO:0097194,1,0.604042599912641,0,77,execution phase of apoptosis,BP,
17639,GO:0097195,1,0.981787760145961,0,3,pilomotor reflex,BP,
17640,GO:0097196,1,0.988708752802498,0,2,Shu complex,CC,
17642,GO:0097198,1,0.983363021443658,0,2,histone H3-K36 trimethylation,BP,
17643,GO:0097199,1,0.964727363191228,0,6,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17644,GO:0097200,1,0.937004604755738,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17645,GO:0097201,1,0.929450865474732,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17646,GO:0097202,1,0.915152330360834,0,13,activation of cysteine-type endopeptidase activity,BP,
17647,GO:0097205,1,0.901283408418666,0,16,renal filtration,BP,
17648,GO:0097208,1,0.963152406579042,0,6,alveolar lamellar body,CC,
17649,GO:0097209,1,0.972037599004491,0,4,epidermal lamellar body,CC,
17650,GO:0097210,1,0.968973218841512,0,5,response to gonadotropin-releasing hormone,BP,
17651,GO:0097211,1,0.968973218841512,0,5,cellular response to gonadotropin-releasing hormone,BP,
17652,GO:0097212,1,0.98364274729083,0,3,lysosomal membrane organization,BP,
17653,GO:0097213,1,0.989100128158417,0,2,regulation of lysosomal membrane permeability,BP,
17654,GO:0097214,1,0.994661554154907,0,1,positive regulation of lysosomal membrane permeability,BP,
17655,GO:0097222,1,0.992784567072978,0,1,mitochondrial mRNA polyadenylation,BP,
17656,GO:0097223,1,0.42438700409651,0,135,sperm part,CC,
17657,GO:0097224,1,0.989071469179875,0,2,sperm connecting piece,CC,
17658,GO:0097225,1,0.916176346801269,0,15,sperm midpiece,CC,
17659,GO:0097226,1,0.994393979592428,0,1,sperm mitochondrial sheath,CC,
17660,GO:0097227,1,0.968315622141091,0,5,sperm annulus,CC,
17661,GO:0097228,1,0.897436767097808,0,17,sperm principal piece,CC,
17662,GO:0097229,1,0.994601652535729,0,1,sperm end piece,CC,
17663,GO:0097231,1,0.994540725798002,0,1,cell motility in response to calcium ion,BP,
17664,GO:0097232,1,0.984757859679261,0,2,lamellar body membrane,CC,
17665,GO:0097233,1,0.984757859679261,0,2,alveolar lamellar body membrane,CC,
17667,GO:0097238,1,0.989261640975643,0,2,cellular response to methylglyoxal,BP,
17668,GO:0097240,1,0.969218577709014,0,5,chromosome attachment to the nuclear envelope,BP,
17669,GO:0097241,1,0.988735971217766,0,2,hematopoietic stem cell migration to bone marrow,BP,
17670,GO:0097242,1,0.855722445503458,0,19,amyloid-beta clearance,BP,
17671,GO:0097252,1,0.982313559137512,0,3,oligodendrocyte apoptotic process,BP,
17672,GO:0097254,1,0.994446650305785,0,1,renal tubular secretion,BP,
17673,GO:0097255,1,0.966870688110056,0,6,R2TP complex,CC,
17674,GO:0097258,1,0.994067957491109,0,1,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17675,GO:0097259,1,0.994067957491109,0,1,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17676,GO:0097260,1,0.994233265601744,0,1,eoxin A4 synthase activity,MF,
17677,GO:0097264,1,0.964040238631181,0,6,self proteolysis,BP,
17678,GO:0097267,1,0.9739399087306,0,4,omega-hydroxylase P450 pathway,BP,
17679,GO:0097272,1,0.986283143697167,0,2,ammonia homeostasis,BP,
17680,GO:0097273,1,0.991685462774464,0,1,creatinine homeostasis,BP,
17681,GO:0097274,1,0.985486983862403,0,2,urea homeostasis,BP,
17682,GO:0097275,1,0.991685462774464,0,1,cellular ammonia homeostasis,BP,
17683,GO:0097276,1,0.991685462774464,0,1,cellular creatinine homeostasis,BP,
17684,GO:0097277,1,0.991685462774464,0,1,cellular urea homeostasis,BP,
17685,GO:0097278,1,0.983173590333305,0,3,complement-dependent cytotoxicity,BP,
17686,GO:0097283,1,0.971737058586982,0,5,keratinocyte apoptotic process,BP,
17687,GO:0097284,1,0.925880925331735,0,12,hepatocyte apoptotic process,BP,
17689,GO:0097291,1,0.994476509065974,0,1,renal phosphate ion absorption,BP,
17690,GO:0097296,1,0.923381235641956,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17691,GO:0097298,1,0.993378864949064,0,1,regulation of nucleus size,BP,
17692,GO:0097300,1,0.777104316087952,0,41,programmed necrotic cell death,BP,
17694,GO:0097306,1,0.680671536918182,0,53,cellular response to alcohol,BP,
17695,GO:0097309,1,0.988403017609477,0,2,cap1 mRNA methylation,BP,
17696,GO:0097310,1,0.994184768585909,0,1,cap2 mRNA methylation,BP,
17697,GO:0097320,1,0.892200762660628,0,17,plasma membrane tubulation,BP,
17698,GO:0097322,1,0.954812384872944,0,7,7SK snRNA binding,MF,
17699,GO:0097323,1,0.987819269815997,0,2,B cell adhesion,BP,
17700,GO:0097324,1,0.980935297981077,0,2,melanocyte migration,BP,
17701,GO:0097325,1,0.985848066548584,0,2,melanocyte proliferation,BP,
17702,GO:0097326,1,0.99224214601651,0,1,melanocyte adhesion,BP,
17703,GO:0097327,1,0.573203293792554,0,84,response to antineoplastic agent,BP,
17704,GO:0097329,1,0.918865069304095,0,12,response to antimetabolite,BP,
17705,GO:0097332,1,0.98124016893975,0,3,response to antipsychotic drug,BP,
17706,GO:0097338,1,0.986530065562117,0,2,response to clozapine,BP,
17707,GO:0097340,1,0.90665108782702,0,13,inhibition of cysteine-type endopeptidase activity,BP,
17708,GO:0097341,1,0.90665108782702,0,13,zymogen inhibition,BP,
17709,GO:0097342,1,0.963103783158289,0,6,ripoptosome,CC,
17710,GO:0097343,1,0.976250736566149,0,3,ripoptosome assembly,BP,
17711,GO:0097344,1,0.988621896829166,0,2,Rix1 complex,CC,
17712,GO:0097345,1,0.728583944559477,0,53,mitochondrial outer membrane permeabilization,BP,
17713,GO:0097346,1,0.859232028987315,0,23,INO80-type complex,CC,
17715,GO:0097352,1,0.806992197774096,0,33,autophagosome maturation,BP,
17716,GO:0097354,1,0.944851532067315,0,8,prenylation,BP,
17717,GO:0097359,1,0.979709681795492,0,2,UDP-glucosylation,BP,
17718,GO:0097360,1,0.969043994598312,0,4,chorionic trophoblast cell proliferation,BP,
17719,GO:0097361,1,0.976169590915307,0,4,CIA complex,CC,
17720,GO:0097362,1,0.987924902377927,0,2,MCM8-MCM9 complex,CC,
17721,GO:0097363,1,0.98618889051498,0,2,protein O-GlcNAc transferase activity,MF,
17724,GO:0097368,1,0.972150237458632,0,4,establishment of Sertoli cell barrier,BP,
17725,GO:0097371,1,0.951038666342153,0,7,MDM2/MDM4 family protein binding,MF,
17726,GO:0097372,1,0.994540340159623,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17727,GO:0097374,1,0.994320787029434,0,1,sensory neuron axon guidance,BP,
17728,GO:0097376,1,0.989009697845926,0,2,interneuron axon guidance,BP,
17729,GO:0097377,1,0.994389949268636,0,1,spinal cord interneuron axon guidance,BP,
17730,GO:0097378,1,0.994389949268636,0,1,dorsal spinal cord interneuron axon guidance,BP,
17731,GO:0097380,1,0.994389949268636,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17732,GO:0097381,1,0.904578499604288,0,15,photoreceptor disc membrane,CC,
17733,GO:0097382,1,0.991443266410328,0,1,deoxynucleoside-diphosphatase activity,MF,
17734,GO:0097383,1,0.991443266410328,0,1,dIDP diphosphatase activity,MF,
17735,GO:0097384,1,0.955234233804369,0,7,cellular lipid biosynthetic process,BP,
17736,GO:0097386,1,0.898660817264043,0,16,glial cell projection,CC,
17737,GO:0097393,1,0.986945640841821,0,1,telomeric repeat-containing RNA transcription,BP,
17738,GO:0097394,1,0.986945640841821,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17739,GO:0097396,1,0.970707785587554,0,5,response to interleukin-17,BP,
17740,GO:0097398,1,0.970707785587554,0,5,cellular response to interleukin-17,BP,
17741,GO:0097400,1,0.970707785587554,0,5,interleukin-17-mediated signaling pathway,BP,
17742,GO:0097401,1,0.994075679219768,0,1,synaptic vesicle lumen acidification,BP,
17743,GO:0097402,1,0.986754916957342,0,2,neuroblast migration,BP,
17744,GO:0097403,1,0.994053534586749,0,1,cellular response to raffinose,BP,
17745,GO:0097409,1,0.994487904399225,0,1,glial cytoplasmic inclusion,CC,
17746,GO:0097411,1,0.964544829316529,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17747,GO:0097413,1,0.959343505642792,0,7,Lewy body,CC,
17748,GO:0097414,1,0.994487904399225,0,1,classical Lewy body,CC,
17749,GO:0097418,1,0.967437422335416,0,5,neurofibrillary tangle,CC,
17750,GO:0097421,1,0.81801047846895,0,32,liver regeneration,BP,
17751,GO:0097422,1,0.969885780594623,0,5,tubular endosome,CC,
17752,GO:0097425,1,0.969072154478986,0,5,smooth endoplasmic reticulum part,CC,
17753,GO:0097427,1,0.958375348316504,0,6,microtubule bundle,CC,
17754,GO:0097428,1,0.946308884637776,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17755,GO:0097431,1,0.827938786371221,0,25,mitotic spindle pole,CC,
17756,GO:0097433,1,0.97071111188014,0,5,dense body,CC,
17758,GO:0097440,1,0.891773325980901,0,15,apical dendrite,CC,
17759,GO:0097441,1,0.960904122403508,0,5,basal dendrite,CC,
17760,GO:0097442,1,0.976221188741952,0,3,CA3 pyramidal cell dendrite,CC,
17761,GO:0097443,1,0.958281459292093,0,6,sorting endosome,CC,
17762,GO:0097444,1,0.992286988716793,0,1,spine apparatus,CC,
17764,GO:0097449,1,0.940576181995403,0,10,astrocyte projection,CC,
17765,GO:0097450,1,0.975781360484628,0,4,astrocyte end-foot,CC,
17766,GO:0097451,1,0.986610783536424,0,2,glial limiting end-foot,CC,
17767,GO:0097452,1,0.972621855292056,0,4,GAIT complex,CC,
17768,GO:0097453,1,0.994350144764933,0,1,mesaxon,CC,
17769,GO:0097454,1,0.976596711205628,0,3,Schwann cell microvillus,CC,
17770,GO:0097457,1,0.972609129444853,0,3,hippocampal mossy fiber,CC,
17772,GO:0097462,1,0.994487904399225,0,1,Lewy neurite,CC,
17773,GO:0097466,1,0.971199669184398,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17774,GO:0097468,1,0.9263628560725,0,12,programmed cell death in response to reactive oxygen species,BP,
17775,GO:0097470,1,0.961359648826342,0,5,ribbon synapse,CC,
17776,GO:0097472,1,0.796968172509143,0,35,cyclin-dependent protein kinase activity,MF,
17777,GO:0097473,1,0.992159854832894,0,1,retinal rod cell apoptotic process,BP,
17778,GO:0097475,1,0.959812223364845,0,5,motor neuron migration,BP,
17779,GO:0097476,1,0.980915519070332,0,2,spinal cord motor neuron migration,BP,
17780,GO:0097477,1,0.980915519070332,0,2,lateral motor column neuron migration,BP,
17785,GO:0097486,1,0.973289609850029,0,5,multivesicular body lumen,CC,
17786,GO:0097487,1,0.972137648502748,0,4,multivesicular body, internal vesicle,CC,
17787,GO:0097489,1,0.994289002116722,0,1,multivesicular body, internal vesicle lumen,CC,
17788,GO:0097490,1,0.972156235039347,0,4,sympathetic neuron projection extension,BP,
17789,GO:0097491,1,0.972156235039347,0,4,sympathetic neuron projection guidance,BP,
17791,GO:0097494,1,0.971898570776055,0,4,regulation of vesicle size,BP,
17792,GO:0097497,1,0.993966218722892,0,1,blood vessel endothelial cell delamination,BP,
17793,GO:0097498,1,0.986134049677063,0,2,endothelial tube lumen extension,BP,
17794,GO:0097499,1,0.949169021770684,0,8,protein localization to non-motile cilium,BP,
17795,GO:0097500,1,0.97436320368628,0,4,receptor localization to non-motile cilium,BP,
17796,GO:0097501,1,0.92624807693407,0,13,stress response to metal ion,BP,
17797,GO:0097502,1,0.829427480511164,0,29,mannosylation,BP,
17799,GO:0097504,1,0.928148943655445,0,12,Gemini of coiled bodies,CC,
17800,GO:0097505,1,0.991710098916107,0,1,Rad6-Rad18 complex,CC,
17801,GO:0097506,1,0.97241091478928,0,5,deaminated base DNA N-glycosylase activity,MF,
17802,GO:0097510,1,0.99446406245136,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17803,GO:0097512,1,0.96296004858708,0,6,cardiac myofibril,CC,
17804,GO:0097513,1,0.970956644424796,0,3,myosin II filament,CC,
17805,GO:0097517,1,0.682975748879393,0,52,contractile actin filament bundle,CC,
17806,GO:0097524,1,0.977108260915717,0,3,sperm plasma membrane,CC,
17807,GO:0097525,1,0.678386058265296,0,61,spliceosomal snRNP complex,CC,
17808,GO:0097526,1,0.840436595020654,0,28,spliceosomal tri-snRNP complex,CC,
17809,GO:0097527,1,0.965819389089601,0,6,necroptotic signaling pathway,BP,
17812,GO:0097531,1,0.932028564999057,0,11,mast cell migration,BP,
17813,GO:0097532,1,0.988296035284342,0,2,stress response to acid chemical,BP,
17814,GO:0097533,1,0.988296035284342,0,2,cellular stress response to acid chemical,BP,
17815,GO:0097534,1,0.989900283446145,0,1,lymphoid lineage cell migration,BP,
17816,GO:0097535,1,0.989900283446145,0,1,lymphoid lineage cell migration into thymus,BP,
17817,GO:0097536,1,0.994446650305785,0,1,thymus epithelium morphogenesis,BP,
17818,GO:0097539,1,0.926721731646336,0,10,ciliary transition fiber,CC,
17819,GO:0097541,1,0.994184768585909,0,1,axonemal basal plate,CC,
17820,GO:0097542,1,0.741332398327364,0,43,ciliary tip,CC,
17821,GO:0097543,1,0.986232957348515,0,2,ciliary inversin compartment,CC,
17822,GO:0097546,1,0.836862811691253,0,27,ciliary base,CC,
17823,GO:0097550,1,0.96397261421192,0,6,transcriptional preinitiation complex,CC,
17825,GO:0097573,1,0.994597808007503,0,1,glutathione oxidoreductase activity,MF,
17826,GO:0097574,1,0.984450150733075,0,2,lateral part of cell,CC,
17827,GO:0097575,1,0.984450150733075,0,2,lateral cell cortex,CC,
17828,GO:0097576,1,0.986874862667981,0,2,vacuole fusion,BP,
17829,GO:0097577,1,0.983823056398968,0,3,sequestering of iron ion,BP,
17831,GO:0097598,1,0.986266284527984,0,2,sperm cytoplasmic droplet,CC,
17832,GO:0097602,1,0.896411009742168,0,17,cullin family protein binding,MF,
17833,GO:0097603,1,0.987758350718859,0,2,temperature-gated ion channel activity,MF,
17834,GO:0097604,1,0.994521529581414,0,1,temperature-gated cation channel activity,MF,
17836,GO:0097621,1,0.994389273240291,0,1,monoamine oxidase activity,MF,
17838,GO:0097625,1,0.990021849942505,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17839,GO:0097626,1,0.990021849942505,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17840,GO:0097627,1,0.990021849942505,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17841,GO:0097629,1,0.969138099517135,0,5,extrinsic component of omegasome membrane,CC,
17842,GO:0097630,1,0.994184768585909,0,1,intrinsic component of omegasome membrane,CC,
17843,GO:0097631,1,0.994184768585909,0,1,integral component of omegasome membrane,CC,
17844,GO:0097632,1,0.986415173951727,0,2,extrinsic component of phagophore assembly site membrane,CC,
17845,GO:0097635,1,0.984975779029659,0,2,extrinsic component of autophagosome membrane,CC,
17846,GO:0097636,1,0.987396572701399,0,2,intrinsic component of autophagosome membrane,CC,
17847,GO:0097637,1,0.987396572701399,0,2,integral component of autophagosome membrane,CC,
17848,GO:0097638,1,0.969280686296733,0,4,L-arginine import across plasma membrane,BP,
17849,GO:0097639,1,0.984360040935183,0,2,L-lysine import across plasma membrane,BP,
17850,GO:0097640,1,0.990021849942505,0,1,L-ornithine import across plasma membrane,BP,
17851,GO:0097642,1,0.964688899089914,0,6,calcitonin family receptor activity,MF,
17852,GO:0097643,1,0.977713345648645,0,4,amylin receptor activity,MF,
17853,GO:0097644,1,0.975561671856407,0,4,calcitonin family binding,MF,
17856,GO:0097648,1,0.946499523691788,0,8,G-protein coupled receptor complex,CC,
17857,GO:0097651,1,0.970484218038006,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17858,GO:0097655,1,0.994184768585909,0,1,serpin family protein binding,MF,
17860,GO:0097676,1,0.970379602775024,0,3,histone H3-K36 dimethylation,BP,
17861,GO:0097677,1,0.964033108062912,0,5,STAT family protein binding,MF,
17862,GO:0097679,1,0.989019413389243,0,2,other organism cytoplasm,CC,
17863,GO:0097680,1,0.98009210327531,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17864,GO:0097681,1,0.974155843859783,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
17865,GO:0097682,1,0.994449061314739,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17867,GO:0097689,1,0.993829911822307,0,1,iron channel activity,MF,
17868,GO:0097692,1,0.991232655652902,0,1,histone H3-K4 monomethylation,BP,
17869,GO:0097694,1,0.970738003926474,0,3,establishment of RNA localization to telomere,BP,
17870,GO:0097695,1,0.970738003926474,0,3,establishment of protein-containing complex localization to telomere,BP,
17872,GO:0097698,1,0.994579350721524,0,1,telomere maintenance via base-excision repair,BP,
17873,GO:0097699,1,0.992911842978017,0,1,vascular endothelial cell response to fluid shear stress,BP,
17874,GO:0097707,1,0.994640367466263,0,1,ferroptosis,BP,
17876,GO:0097709,1,0.963229635518073,0,6,connective tissue replacement,BP,
17877,GO:0097711,1,0.510966699137378,0,96,ciliary basal body-plasma membrane docking,BP,
17878,GO:0097712,1,0.994184768585909,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17879,GO:0097718,1,0.801864296116941,0,30,disordered domain specific binding,MF,
17880,GO:0097720,1,0.830854754758937,0,26,calcineurin-mediated signaling,BP,
17881,GO:0097722,1,0.661605715060231,0,60,sperm motility,BP,
17882,GO:0097724,1,0.994517576093017,0,1,sperm flagellum movement,BP,
17883,GO:0097726,1,0.994624878973799,0,1,LEM domain binding,MF,
17884,GO:0097729,1,0.68220900386537,0,61,9+2 motile cilium,CC,
17887,GO:0097732,1,0.957253508083548,0,7,9+2 non-motile cilium,CC,
17889,GO:0097734,1,0.89719624193359,0,18,extracellular exosome biogenesis,BP,
17890,GO:0097742,1,0.972726753727923,0,4,de novo centriole assembly,BP,
17891,GO:0097745,1,0.983186114170821,0,3,mitochondrial tRNA 5'-end processing,BP,
17894,GO:0097749,1,0.985376151068652,0,2,membrane tubulation,BP,
17895,GO:0097752,1,0.982649729252982,0,3,regulation of DNA stability,BP,
17896,GO:0097753,1,0.987735790542739,0,2,membrane bending,BP,
17899,GO:0098501,1,0.971508500212666,0,5,polynucleotide dephosphorylation,BP,
17900,GO:0098502,1,0.983814349948853,0,3,DNA dephosphorylation,BP,
17901,GO:0098503,1,0.99453859512126,0,1,DNA 3' dephosphorylation,BP,
17902,GO:0098504,1,0.99453859512126,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
17903,GO:0098505,1,0.941496652842468,0,10,G-rich strand telomeric DNA binding,MF,
17904,GO:0098506,1,0.99453859512126,0,1,polynucleotide 3' dephosphorylation,BP,
17905,GO:0098507,1,0.987493725026292,0,2,polynucleotide 5' dephosphorylation,BP,
17906,GO:0098508,1,0.988682556639899,0,2,endothelial to hematopoietic transition,BP,
17907,GO:0098518,1,0.982099944546625,0,3,polynucleotide phosphatase activity,MF,
17908,GO:0098519,1,0.969025430223066,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
17909,GO:0098528,1,0.967434240681104,0,5,skeletal muscle fiber differentiation,BP,
17910,GO:0098530,1,0.991681673728574,0,1,positive regulation of strand invasion,BP,
17911,GO:0098531,1,0.732183937199706,0,45,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
17912,GO:0098532,1,0.951217497340694,0,7,histone H3-K27 trimethylation,BP,
17913,GO:0098533,1,0.87085155619163,0,21,ATPase dependent transmembrane transport complex,CC,
17914,GO:0098534,1,0.811091111650918,0,31,centriole assembly,BP,
17915,GO:0098535,1,0.972726753727923,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17916,GO:0098536,1,0.973982616928458,0,4,deuterosome,CC,
17918,GO:0098543,1,0.924165142031325,0,11,detection of other organism,BP,
17919,GO:0098547,1,0.994405484344401,0,1,lumenal side of Golgi membrane,CC,
17922,GO:0098554,1,0.92425060275803,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
17923,GO:0098556,1,0.973480793567026,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17924,GO:0098559,1,0.982955695078387,0,3,cytoplasmic side of early endosome membrane,CC,
17925,GO:0098560,1,0.988512762295726,0,2,cytoplasmic side of late endosome membrane,CC,
17927,GO:0098563,1,0.852528741141498,0,26,intrinsic component of synaptic vesicle membrane,CC,
17928,GO:0098573,1,0.676320832187173,0,66,intrinsic component of mitochondrial membrane,CC,
17929,GO:0098574,1,0.971371431554006,0,5,cytoplasmic side of lysosomal membrane,CC,
17930,GO:0098575,1,0.98890547865596,0,2,lumenal side of lysosomal membrane,CC,
17931,GO:0098576,1,0.977276183470926,0,4,lumenal side of membrane,CC,
17932,GO:0098577,1,0.990699512717009,0,1,inactive sex chromosome,CC,
17933,GO:0098581,1,0.89676394976864,0,16,detection of external biotic stimulus,BP,
17934,GO:0098582,1,0.985184240342744,0,2,innate vocalization behavior,BP,
17935,GO:0098583,1,0.994609170365369,0,1,learned vocalization behavior,BP,
17936,GO:0098586,1,0.769638796777508,0,39,cellular response to virus,BP,
17940,GO:0098592,1,0.98169114346325,0,3,cytoplasmic side of apical plasma membrane,CC,
17941,GO:0098594,1,0.99465354314616,0,1,mucin granule,CC,
17942,GO:0098595,1,0.994406453308164,0,1,perivitelline space,CC,
17943,GO:0098596,1,0.932707382882002,0,7,imitative learning,BP,
17944,GO:0098597,1,0.919581675413972,0,8,observational learning,BP,
17945,GO:0098598,1,0.927675823242226,0,8,learned vocalization behavior or vocal learning,BP,
17946,GO:0098599,1,0.942964370001418,0,10,palmitoyl hydrolase activity,MF,
17947,GO:0098601,1,0.993792966113969,0,1,selenomethionine adenosyltransferase activity,MF,
17949,GO:0098619,1,0.994501597282049,0,1,selenocysteine-tRNA ligase activity,MF,
17950,GO:0098621,1,0.991800204434427,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
17951,GO:0098625,1,0.993484742510782,0,1,methylselenol reductase activity,MF,
17952,GO:0098626,1,0.993484742510782,0,1,methylseleninic acid reductase activity,MF,
17953,GO:0098629,1,0.994184768585909,0,1,trans-Golgi network membrane organization,BP,
17956,GO:0098633,1,0.994301220020547,0,1,collagen fibril binding,MF,
17957,GO:0098634,1,0.949530949856018,0,7,cell-matrix adhesion mediator activity,MF,
17958,GO:0098636,1,0.777472893688156,0,35,protein complex involved in cell adhesion,CC,
17959,GO:0098637,1,0.993375487741975,0,1,protein complex involved in cell-matrix adhesion,CC,
17960,GO:0098639,1,0.961065657673126,0,5,collagen binding involved in cell-matrix adhesion,MF,
17961,GO:0098640,1,0.988002737750792,0,2,integrin binding involved in cell-matrix adhesion,MF,
17967,GO:0098646,1,0.994260729103642,0,1,collagen sheet,CC,
17968,GO:0098647,1,0.97678170318957,0,3,collagen beaded filament,CC,
17969,GO:0098648,1,0.988513453949461,0,1,collagen anchoring fibril,CC,
17971,GO:0098652,1,0.988513453949461,0,1,collagen type VII anchoring fibril,CC,
17979,GO:0098664,1,0.927297189606918,0,13,G-protein coupled serotonin receptor signaling pathway,BP,
17980,GO:0098679,1,0.977693332237469,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17981,GO:0098680,1,0.993313444145808,0,1,template-free RNA nucleotidyltransferase,MF,
17982,GO:0098687,1,0.122105438588368,0,310,chromosomal region,CC,
17985,GO:0098700,1,0.95371047058505,0,8,neurotransmitter loading into synaptic vesicle,BP,
17986,GO:0098703,1,0.914851884255339,0,13,calcium ion import across plasma membrane,BP,
17987,GO:0098704,1,0.994381755056307,0,1,carbohydrate import across plasma membrane,BP,
17988,GO:0098705,1,0.992623421573599,0,1,copper ion import across plasma membrane,BP,
17991,GO:0098712,1,0.922596872105721,0,11,L-glutamate import across plasma membrane,BP,
17992,GO:0098713,1,0.994400926861373,0,1,leucine import across plasma membrane,BP,
17993,GO:0098719,1,0.905086489345199,0,14,sodium ion import across plasma membrane,BP,
17994,GO:0098722,1,0.942356340278473,0,9,asymmetric stem cell division,BP,
17995,GO:0098725,1,0.994184768585909,0,1,symmetric cell division,BP,
17996,GO:0098727,1,0.346875876009691,0,149,maintenance of cell number,BP,
17997,GO:0098728,1,0.982334135500385,0,3,germline stem cell asymmetric division,BP,
17998,GO:0098732,1,0.479063933016195,0,106,macromolecule deacylation,BP,
17999,GO:0098734,1,0.942964370001418,0,10,macromolecule depalmitoylation,BP,
18000,GO:0098735,1,0.958214594881289,0,4,positive regulation of the force of heart contraction,BP,
18001,GO:0098736,1,0.988902548506595,0,1,negative regulation of the force of heart contraction,BP,
18004,GO:0098743,1,0.889300228692794,0,17,cell aggregation,BP,
18005,GO:0098745,1,0.99453565139976,0,1,Dcp1-Dcp2 complex,CC,
18006,GO:0098746,1,0.992588167565446,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18007,GO:0098748,1,0.927751948136304,0,11,endocytic adaptor activity,MF,
18008,GO:0098749,1,0.992765342866359,0,1,cerebellar neuron development,BP,
18010,GO:0098754,1,0.550939451182974,0,100,detoxification,BP,
18011,GO:0098756,1,0.954022866371072,0,7,response to interleukin-21,BP,
18012,GO:0098757,1,0.954022866371072,0,7,cellular response to interleukin-21,BP,
18013,GO:0098758,1,0.982600815957015,0,3,response to interleukin-8,BP,
18014,GO:0098759,1,0.982600815957015,0,3,cellular response to interleukin-8,BP,
18015,GO:0098760,1,0.875562796682815,0,19,response to interleukin-7,BP,
18016,GO:0098761,1,0.875562796682815,0,19,cellular response to interleukin-7,BP,
18017,GO:0098770,1,0.980152766226566,0,2,FBXO family protein binding,MF,
18021,GO:0098779,1,0.942350784385287,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
18022,GO:0098780,1,0.889742306261866,0,17,response to mitochondrial depolarisation,BP,
18023,GO:0098781,1,0.550858549808611,0,94,ncRNA transcription,BP,
18024,GO:0098782,1,0.994521529581414,0,1,mechanosensitived potassium channel activity,MF,
18025,GO:0098787,1,0.912905681502974,0,14,mRNA cleavage involved in mRNA processing,BP,
18026,GO:0098789,1,0.929864912575516,0,11,pre-mRNA cleavage required for polyadenylation,BP,
18028,GO:0098792,1,0.939802738858322,0,10,xenophagy,BP,
18031,GO:0098795,1,0.987873255423423,0,2,mRNA cleavage involved in gene silencing,BP,
18034,GO:0098798,1,0.291845052787243,0,217,mitochondrial protein complex,CC,
18035,GO:0098799,1,0.933847670092776,0,12,outer mitochondrial membrane protein complex,CC,
18036,GO:0098800,1,0.572088607473784,0,100,inner mitochondrial membrane protein complex,CC,
18037,GO:0098801,1,0.847969869187217,0,27,regulation of renal system process,BP,
18039,GO:0098803,1,0.683541540718514,0,69,respiratory chain complex,CC,
18041,GO:0098808,1,0.988704529771716,0,2,mRNA cap binding,MF,
18042,GO:0098809,1,0.994271649284811,0,1,nitrite reductase activity,MF,
18043,GO:0098810,1,0.900819244484735,0,16,neurotransmitter reuptake,BP,
18044,GO:0098813,1,0.150006301520655,0,279,nuclear chromosome segregation,BP,
18047,GO:0098816,1,0.994467922829578,0,1,mini excitatory postsynaptic potential,BP,
18048,GO:0098821,1,0.960286909330314,0,5,BMP receptor activity,MF,
18049,GO:0098822,1,0.994332998480301,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18050,GO:0098826,1,0.977306704566153,0,4,endoplasmic reticulum tubular network membrane,CC,
18053,GO:0098829,1,0.991012635324777,0,1,intestinal folate absorption,BP,
18054,GO:0098830,1,0.992577017095215,0,1,presynaptic endosome,CC,
18056,GO:0098833,1,0.992461339871517,0,1,presynaptic endocytic zone,CC,
18057,GO:0098835,1,0.992461339871517,0,1,presynaptic endocytic zone membrane,CC,
18058,GO:0098837,1,0.982935767594832,0,3,postsynaptic recycling endosome,CC,
18059,GO:0098838,1,0.994156250909866,0,1,reduced folate transmembrane transport,BP,
18061,GO:0098840,1,0.968653740804396,0,4,protein transport along microtubule,BP,
18062,GO:0098842,1,0.988781254118574,0,2,postsynaptic early endosome,CC,
18063,GO:0098843,1,0.959099683078639,0,6,postsynaptic endocytic zone,CC,
18064,GO:0098844,1,0.977627625557075,0,3,postsynaptic endocytic zone membrane,CC,
18065,GO:0098845,1,0.96524680639304,0,6,postsynaptic endosome,CC,
18066,GO:0098847,1,0.923315550992673,0,13,sequence-specific single stranded DNA binding,MF,
18067,GO:0098850,1,0.994490705180086,0,1,extrinsic component of synaptic vesicle membrane,CC,
18069,GO:0098855,1,0.976370328181143,0,3,HCN channel complex,CC,
18070,GO:0098856,1,0.95166641263297,0,8,intestinal lipid absorption,BP,
18074,GO:0098868,1,0.857211888019717,0,23,bone growth,BP,
18075,GO:0098869,1,0.610375584056569,0,82,cellular oxidant detoxification,BP,
18076,GO:0098870,1,0.956620823838718,0,6,action potential propagation,BP,
18077,GO:0098871,1,0.994544916598442,0,1,postsynaptic actin cytoskeleton,CC,
18078,GO:0098875,1,0.992656738750151,0,1,epididymosome,CC,
18079,GO:0098876,1,0.626911238156646,0,68,vesicle-mediated transport to the plasma membrane,BP,
18080,GO:0098877,1,0.940425495037096,0,10,neurotransmitter receptor transport to plasma membrane,BP,
18082,GO:0098881,1,0.975975112234397,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18083,GO:0098883,1,0.994523216867324,0,1,synapse disassembly,BP,
18084,GO:0098884,1,0.977627625557075,0,3,postsynaptic neurotransmitter receptor internalization,BP,
18085,GO:0098885,1,0.990337313481602,0,1,modification of postsynaptic actin cytoskeleton,BP,
18086,GO:0098886,1,0.986516164779744,0,2,modification of dendritic spine,BP,
18087,GO:0098887,1,0.974959840032187,0,4,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18088,GO:0098888,1,0.990298170178154,0,1,extrinsic component of presynaptic membrane,CC,
18089,GO:0098889,1,0.975668780973587,0,4,intrinsic component of presynaptic membrane,CC,
18090,GO:0098890,1,0.990298170178154,0,1,extrinsic component of postsynaptic membrane,CC,
18091,GO:0098895,1,0.993149677273809,0,1,postsynaptic endosome membrane,CC,
18093,GO:0098901,1,0.804298649562888,0,25,regulation of cardiac muscle cell action potential,BP,
18094,GO:0098902,1,0.966841023647629,0,4,regulation of membrane depolarization during action potential,BP,
18095,GO:0098903,1,0.945070379755948,0,8,regulation of membrane repolarization during action potential,BP,
18096,GO:0098904,1,0.977358003658765,0,2,regulation of AV node cell action potential,BP,
18097,GO:0098905,1,0.994648183451414,0,1,regulation of bundle of His cell action potential,BP,
18098,GO:0098907,1,0.972640761819292,0,2,regulation of SA node cell action potential,BP,
18099,GO:0098908,1,0.975944672644883,0,4,regulation of neuronal action potential,BP,
18100,GO:0098909,1,0.943490661163236,0,7,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18101,GO:0098910,1,0.949233358354267,0,5,regulation of atrial cardiac muscle cell action potential,BP,
18102,GO:0098911,1,0.887888392573699,0,14,regulation of ventricular cardiac muscle cell action potential,BP,
18103,GO:0098912,1,0.967719083530523,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18104,GO:0098914,1,0.96066047283813,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18105,GO:0098915,1,0.928433231703014,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18107,GO:0098917,1,0.9510203089654,0,7,retrograde trans-synaptic signaling,BP,
18108,GO:0098918,1,0.994521952658588,0,1,structural constituent of synapse,MF,
18109,GO:0098920,1,0.985952564015087,0,2,retrograde trans-synaptic signaling by lipid,BP,
18110,GO:0098921,1,0.985952564015087,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18111,GO:0098923,1,0.990402959276893,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18112,GO:0098924,1,0.990402959276893,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18113,GO:0098926,1,0.990576814586614,0,1,postsynaptic signal transduction,BP,
18114,GO:0098927,1,0.753779391101193,0,40,vesicle-mediated transport between endosomal compartments,BP,
18115,GO:0098928,1,0.9650222645763,0,2,presynaptic signal transduction,BP,
18116,GO:0098930,1,0.72913124945662,0,45,axonal transport,BP,
18117,GO:0098935,1,0.960617273364301,0,5,dendritic transport,BP,
18118,GO:0098936,1,0.924594537339572,0,10,intrinsic component of postsynaptic membrane,CC,
18119,GO:0098937,1,0.960617273364301,0,5,anterograde dendritic transport,BP,
18120,GO:0098939,1,0.990967129869184,0,1,dendritic transport of mitochondrion,BP,
18121,GO:0098942,1,0.992490332986896,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18123,GO:0098945,1,0.992987406907347,0,1,intrinsic component of presynaptic active zone membrane,CC,
18124,GO:0098948,1,0.961435666166678,0,4,intrinsic component of postsynaptic specialization membrane,CC,
18126,GO:0098957,1,0.971755331241861,0,4,anterograde axonal transport of mitochondrion,BP,
18128,GO:0098961,1,0.990584154672841,0,1,dendritic transport of ribonucleoprotein complex,BP,
18129,GO:0098963,1,0.990584154672841,0,1,dendritic transport of messenger ribonucleoprotein complex,BP,
18130,GO:0098964,1,0.990584154672841,0,1,anterograde dendritic transport of messenger ribonucleoprotein complex,BP,
18131,GO:0098967,1,0.975975112234397,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18132,GO:0098968,1,0.992215682152264,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18133,GO:0098969,1,0.946226118872372,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
18135,GO:0098971,1,0.969376230717033,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18136,GO:0098972,1,0.990967129869184,0,1,anterograde dendritic transport of mitochondrion,BP,
18137,GO:0098973,1,0.994521952658588,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18138,GO:0098974,1,0.994521952658588,0,1,postsynaptic actin cytoskeleton organization,BP,
18141,GO:0098982,1,0.964632664526245,0,5,GABA-ergic synapse,CC,
18142,GO:0098983,1,0.970420965861203,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18145,GO:0098988,1,0.954857422739705,0,6,G-protein coupled glutamate receptor activity,MF,
18146,GO:0098989,1,0.984966174090539,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18147,GO:0098992,1,0.994326342739316,0,1,neuronal dense core vesicle,CC,
18148,GO:0098993,1,0.950228660971648,0,9,anchored component of synaptic vesicle membrane,CC,
18149,GO:0098999,1,0.993149677273809,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18151,GO:0099004,1,0.967879615012123,0,4,calmodulin dependent kinase signaling pathway,BP,
18152,GO:0099010,1,0.976982481902852,0,3,modification of postsynaptic structure,BP,
18153,GO:0099011,1,0.954847255553841,0,5,neuronal dense core vesicle exocytosis,BP,
18154,GO:0099022,1,0.988743407492446,0,2,vesicle tethering,BP,
18155,GO:0099023,1,0.630060709934389,0,69,tethering complex,CC,
18156,GO:0099024,1,0.707433552180507,0,53,plasma membrane invagination,BP,
18157,GO:0099038,1,0.992512746707578,0,1,ceramide-translocating ATPase activity,MF,
18158,GO:0099039,1,0.983664955125791,0,2,sphingolipid translocation,BP,
18159,GO:0099040,1,0.992512746707578,0,1,ceramide translocation,BP,
18160,GO:0099044,1,0.988743407492446,0,2,vesicle tethering to endoplasmic reticulum,BP,
18161,GO:0099046,1,0.994586293802041,0,1,clearance of foreign intracellular nucleic acids,BP,
18162,GO:0099050,1,0.994212077535645,0,1,vesicle scission,BP,
18163,GO:0099053,1,0.980668838985973,0,3,activating signal cointegrator 1 complex,CC,
18164,GO:0099054,1,0.873200319781365,0,18,presynapse assembly,BP,
18165,GO:0099055,1,0.924594537339572,0,10,integral component of postsynaptic membrane,CC,
18166,GO:0099056,1,0.975668780973587,0,4,integral component of presynaptic membrane,CC,
18167,GO:0099059,1,0.992987406907347,0,1,integral component of presynaptic active zone membrane,CC,
18168,GO:0099060,1,0.961435666166678,0,4,integral component of postsynaptic specialization membrane,CC,
18169,GO:0099061,1,0.968227634313337,0,3,integral component of postsynaptic density membrane,CC,
18172,GO:0099073,1,0.986750422675688,0,2,mitochondrion-derived vesicle,CC,
18173,GO:0099074,1,0.988152524507758,0,2,mitochondrion to lysosome transport,BP,
18174,GO:0099075,1,0.988152524507758,0,2,mitochondrion-derived vesicle mediated transport,BP,
18175,GO:0099077,1,0.991688778444706,0,1,histone-dependent DNA binding,MF,
18176,GO:0099078,1,0.978139119221463,0,4,BORC complex,CC,
18179,GO:0099082,1,0.981294794089104,0,3,retrograde trans-synaptic signaling by neuropeptide,BP,
18180,GO:0099083,1,0.987975719520783,0,2,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18182,GO:0099086,1,0.818437377152762,0,31,synaptonemal structure,CC,
18183,GO:0099089,1,0.986089177528569,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18184,GO:0099093,1,0.986203051165941,0,2,calcium export from the mitochondrion,BP,
18187,GO:0099098,1,0.993919915338298,0,1,microtubule polymerization based movement,BP,
18188,GO:0099103,1,0.975681604904061,0,4,channel activator activity,MF,
18189,GO:0099104,1,0.975681604904061,0,4,potassium channel activator activity,MF,
18191,GO:0099111,1,0.376066061742937,0,137,microtubule-based transport,BP,
18192,GO:0099116,1,0.911571216133161,0,16,tRNA 5'-end processing,BP,
18193,GO:0099118,1,0.968653740804396,0,4,microtubule-based protein transport,BP,
18194,GO:0099122,1,0.977682662263741,0,3,RNA polymerase II C-terminal domain binding,MF,
18195,GO:0099130,1,0.994413793257457,0,1,estrogen binding,MF,
18196,GO:0099131,1,0.841047016670199,0,28,ATP hydrolysis coupled ion transmembrane transport,BP,
18197,GO:0099132,1,0.727266515718437,0,45,ATP hydrolysis coupled cation transmembrane transport,BP,
18199,GO:0099142,1,0.991327248497623,0,1,intracellularly ATP-gated ion channel activity,MF,
18200,GO:0099146,1,0.968227634313337,0,3,intrinsic component of postsynaptic density membrane,CC,
18201,GO:0099159,1,0.990337313481602,0,1,regulation of modification of postsynaptic structure,BP,
18202,GO:0099163,1,0.990402959276893,0,1,synaptic signaling by nitric oxide,BP,
18203,GO:0099170,1,0.981364195242476,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
18204,GO:0099172,1,0.860656116827689,0,20,presynapse organization,BP,
18206,GO:0099174,1,0.966355751254352,0,5,regulation of presynapse organization,BP,
18209,GO:0099186,1,0.994521952658588,0,1,structural constituent of postsynapse,MF,
18210,GO:0099188,1,0.994521952658588,0,1,postsynaptic cytoskeleton organization,BP,
18211,GO:0099240,1,0.924594537339572,0,10,intrinsic component of synaptic membrane,CC,
18212,GO:0099243,1,0.990298170178154,0,1,extrinsic component of synaptic membrane,CC,
18213,GO:0099400,1,0.988525498597407,0,1,caveola neck,CC,
18214,GO:0099402,1,0.994651281344248,0,1,plant organ development,BP,
18215,GO:0099403,1,0.975321953424054,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18216,GO:0099404,1,0.975321953424054,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18217,GO:0099500,1,0.907471927724441,0,16,vesicle fusion to plasma membrane,BP,
18221,GO:0099509,1,0.983559519321654,0,3,regulation of presynaptic cytosolic calcium ion concentration,BP,
18224,GO:0099514,1,0.900093209303852,0,17,synaptic vesicle cytoskeletal transport,BP,
18225,GO:0099515,1,0.92072281597247,0,10,actin filament-based transport,BP,
18227,GO:0099517,1,0.900093209303852,0,17,synaptic vesicle transport along microtubule,BP,
18228,GO:0099518,1,0.714998674632131,0,46,vesicle cytoskeletal trafficking,BP,
18229,GO:0099519,1,0.994184768585909,0,1,dense core granule cytoskeletal transport,BP,
18230,GO:0099522,1,0.994468714795154,0,1,region of cytosol,CC,
18231,GO:0099523,1,0.994468714795154,0,1,presynaptic cytosol,CC,
18232,GO:0099524,1,0.994468714795154,0,1,postsynaptic cytosol,CC,
18233,GO:0099525,1,0.954847255553841,0,5,presynaptic dense core vesicle exocytosis,BP,
18234,GO:0099526,1,0.9650222645763,0,2,presynapse to nucleus signaling pathway,BP,
18235,GO:0099527,1,0.990576814586614,0,1,postsynapse to nucleus signaling pathway,BP,
18236,GO:0099528,1,0.85496145959412,0,26,G-protein coupled neurotransmitter receptor activity,MF,
18238,GO:0099530,1,0.980457096534242,0,2,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18240,GO:0099532,1,0.982266396020618,0,2,synaptic vesicle endosomal processing,BP,
18243,GO:0099538,1,0.971903279539205,0,4,synaptic signaling via neuropeptide,BP,
18244,GO:0099540,1,0.971903279539205,0,4,trans-synaptic signaling by neuropeptide,BP,
18245,GO:0099541,1,0.961362028341917,0,5,trans-synaptic signaling by lipid,BP,
18246,GO:0099542,1,0.961362028341917,0,5,trans-synaptic signaling by endocannabinoid,BP,
18247,GO:0099543,1,0.990402959276893,0,1,trans-synaptic signaling by soluble gas,BP,
18248,GO:0099545,1,0.985075877609421,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18249,GO:0099547,1,0.981364195242476,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18250,GO:0099548,1,0.990402959276893,0,1,trans-synaptic signaling by nitric oxide,BP,
18251,GO:0099550,1,0.946983337614747,0,7,trans-synaptic signaling, modulating synaptic transmission,BP,
18252,GO:0099551,1,0.978520902712353,0,3,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18253,GO:0099552,1,0.975062589583083,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18254,GO:0099553,1,0.975062589583083,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18255,GO:0099557,1,0.992530003773513,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18256,GO:0099558,1,0.989185518971035,0,2,maintenance of synapse structure,BP,
18257,GO:0099560,1,0.975144720842312,0,3,synaptic membrane adhesion,BP,
18258,GO:0099563,1,0.926443191110163,0,11,modification of synaptic structure,BP,
18260,GO:0099566,1,0.972332256732664,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18263,GO:0099571,1,0.994544916598442,0,1,postsynaptic cytoskeleton,CC,
18265,GO:0099578,1,0.981364195242476,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18266,GO:0099580,1,0.983674287728149,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18267,GO:0099583,1,0.972332256732664,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18269,GO:0099589,1,0.927297189606918,0,13,serotonin receptor activity,MF,
18272,GO:0099602,1,0.959976055760053,0,7,neurotransmitter receptor regulator activity,MF,
18274,GO:0099606,1,0.989056674780098,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18275,GO:0099607,1,0.989056674780098,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18276,GO:0099609,1,0.983314160683335,0,2,microtubule lateral binding,MF,
18277,GO:0099612,1,0.94030582581124,0,7,protein localization to axon,BP,
18278,GO:0099617,1,0.99380172553683,0,1,matrix side of mitochondrial inner membrane,CC,
18280,GO:0099623,1,0.850781694368549,0,22,regulation of cardiac muscle cell membrane repolarization,BP,
18281,GO:0099624,1,0.9301538204447,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18282,GO:0099625,1,0.858592082275691,0,22,ventricular cardiac muscle cell membrane repolarization,BP,
18284,GO:0099631,1,0.989271019066617,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18288,GO:0099638,1,0.968984853769606,0,5,endosome to plasma membrane protein transport,BP,
18289,GO:0099639,1,0.968984853769606,0,5,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18290,GO:0099640,1,0.985277818925412,0,2,axo-dendritic protein transport,BP,
18291,GO:0099641,1,0.994643730944152,0,1,anterograde axonal protein transport,BP,
18293,GO:0099699,1,0.924594537339572,0,10,integral component of synaptic membrane,CC,
18295,GO:0100001,1,0.992055587041537,0,1,regulation of skeletal muscle contraction by action potential,BP,
18296,GO:0100002,1,0.994142212994221,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18297,GO:0100012,1,0.9891736455744,0,2,regulation of heart induction by canonical Wnt signaling pathway,BP,
18298,GO:0100057,1,0.989972718603745,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18301,GO:0101005,1,0.520497556686326,0,88,ubiquitinyl hydrolase activity,MF,
18302,GO:0101006,1,0.983413042355581,0,3,protein histidine phosphatase activity,MF,
18303,GO:0101020,1,0.983396956846813,0,3,estrogen 16-alpha-hydroxylase activity,MF,
18304,GO:0101023,1,0.903233863514482,0,14,vascular endothelial cell proliferation,BP,
18305,GO:0101030,1,0.994600640752168,0,1,tRNA-guanine transglycosylation,BP,
18306,GO:0101031,1,0.929260938479771,0,12,chaperone complex,CC,
18307,GO:0102005,1,0.994576438438411,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18308,GO:0102007,1,0.983793242021221,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18309,GO:0102008,1,0.992402281743374,0,1,cytosolic dipeptidase activity,MF,
18310,GO:0102009,1,0.994502981972204,0,1,proline dipeptidase activity,MF,
18311,GO:0102076,1,0.994146019832506,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18312,GO:0102077,1,0.988953132972297,0,2,oleamide hydrolase activity,MF,
18313,GO:0102084,1,0.988463715868363,0,2,L-dopa O-methyltransferase activity,MF,
18314,GO:0102092,1,0.984000234984658,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18315,GO:0102102,1,0.993354325971769,0,1,homocarnosine synthase activity,MF,
18316,GO:0102113,1,0.990619042028229,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18317,GO:0102121,1,0.982897582577568,0,3,ceramidase activity,MF,
18318,GO:0102131,1,0.989197930064612,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18319,GO:0102132,1,0.989197930064612,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18320,GO:0102148,1,0.983341407198979,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
18321,GO:0102158,1,0.976939194758801,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18322,GO:0102166,1,0.992290290169091,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18323,GO:0102167,1,0.992290290169091,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18324,GO:0102200,1,0.992214736628953,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
18325,GO:0102250,1,0.981209295485712,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18326,GO:0102279,1,0.992522077071725,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18327,GO:0102336,1,0.963818630025933,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18328,GO:0102337,1,0.963818630025933,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18329,GO:0102338,1,0.963818630025933,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18330,GO:0102339,1,0.994297460537937,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18331,GO:0102340,1,0.994297460537937,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18332,GO:0102341,1,0.994297460537937,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18333,GO:0102342,1,0.994297460537937,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18334,GO:0102343,1,0.976939194758801,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18335,GO:0102344,1,0.976939194758801,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18336,GO:0102345,1,0.976939194758801,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18337,GO:0102389,1,0.994245432508821,0,1,polyprenol reductase activity,MF,
18338,GO:0102390,1,0.994253704350216,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18339,GO:0102391,1,0.955977924966647,0,7,decanoate-CoA ligase activity,MF,
18340,GO:0102420,1,0.985312873299686,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18341,GO:0102483,1,0.994546697420715,0,1,scopolin beta-glucosidase activity,MF,
18342,GO:0102485,1,0.974596740520611,0,3,dATP phosphohydrolase activity,MF,
18343,GO:0102486,1,0.974596740520611,0,3,dCTP phosphohydrolase activity,MF,
18344,GO:0102487,1,0.974596740520611,0,3,dUTP phosphohydrolase activity,MF,
18345,GO:0102488,1,0.974596740520611,0,3,dTTP phosphohydrolase activity,MF,
18346,GO:0102489,1,0.974596740520611,0,3,GTP phosphohydrolase activity,MF,
18347,GO:0102490,1,0.974596740520611,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18348,GO:0102491,1,0.974596740520611,0,3,dGTP phosphohydrolase activity,MF,
18349,GO:0102499,1,0.981209295485712,0,3,SHG alpha-glucan phosphorylase activity,MF,
18350,GO:0102500,1,0.990348245443201,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18351,GO:0102521,1,0.993842060646925,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18352,GO:0102522,1,0.994417248614663,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18353,GO:0102524,1,0.994184768585909,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18354,GO:0102555,1,0.994639145062024,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18357,GO:0102571,1,0.992290290169091,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18358,GO:0102704,1,0.99411951568328,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18359,GO:0102707,1,0.994291130232951,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18360,GO:0102751,1,0.988386460947843,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18361,GO:0102752,1,0.993996928868153,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18362,GO:0102756,1,0.963818630025933,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18363,GO:0102758,1,0.994619934316476,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18364,GO:0102769,1,0.994556053490614,0,1,dihydroceramide glucosyltransferase activity,MF,
18365,GO:0102773,1,0.992920871713537,0,1,dihydroceramide kinase activity,MF,
18366,GO:0102797,1,0.992451977500062,0,1,geranial:oxygen oxidoreductase activity,MF,
18367,GO:0102798,1,0.992451977500062,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18368,GO:0102867,1,0.994209129247398,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18369,GO:0102938,1,0.988463715868363,0,2,orcinol O-methyltransferase activity,MF,
18370,GO:0102953,1,0.98302730783788,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18371,GO:0102965,1,0.986644926129104,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18372,GO:0102991,1,0.966883230892848,0,6,myristoyl-CoA hydrolase activity,MF,
18373,GO:0103025,1,0.989012811572331,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18374,GO:0103045,1,0.994458238154445,0,1,methione N-acyltransferase activity,MF,
18375,GO:0103046,1,0.992402281743374,0,1,alanylglutamate dipeptidase activity,MF,
18376,GO:0103053,1,0.988949161367904,0,2,1-ethyladenine demethylase activity,MF,
18377,GO:0103066,1,0.994561789191343,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18378,GO:0103067,1,0.994561789191343,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18379,GO:0103068,1,0.98302730783788,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18380,GO:0103073,1,0.988953132972297,0,2,anandamide amidohydrolase activity,MF,
18382,GO:0104005,1,0.655434528873058,0,64,hijacked molecular function,MF,
18383,GO:0106001,1,0.96293649373913,0,6,intestinal hexose absorption,BP,
18384,GO:0106003,1,0.920725250946606,0,11,amyloid-beta complex,CC,
18385,GO:0106004,1,0.989162605016039,0,2,tRNA (guanine-N7)-methylation,BP,
18386,GO:0106005,1,0.991271959824451,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18387,GO:0106014,1,0.988715225821173,0,2,regulation of inflammatory response to wounding,BP,
18388,GO:0106015,1,0.988715225821173,0,2,negative regulation of inflammatory response to wounding,BP,
18389,GO:0106017,1,0.970780034552401,0,4,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18390,GO:0106018,1,0.889236797262403,0,15,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18391,GO:0106019,1,0.92918729482192,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18392,GO:0106020,1,0.987827247417853,0,2,regulation of vesicle docking,BP,
18393,GO:0106022,1,0.993387718488302,0,1,positive regulation of vesicle docking,BP,
18395,GO:0106028,1,0.992530003773513,0,1,neuron projection retraction,BP,
18397,GO:0106044,1,0.994640893629188,0,1,guanine deglycation,BP,
18398,GO:0106045,1,0.994640893629188,0,1,guanine deglycation, methylglyoxal removal,BP,
18399,GO:0106046,1,0.994640893629188,0,1,guanine deglycation, glyoxal removal,BP,
18400,GO:0106049,1,0.96316371499223,0,6,regulation of cellular response to osmotic stress,BP,
18401,GO:0106050,1,0.994487781908864,0,1,tRNA 2'-O-methyltransferase activity,MF,
18402,GO:0106056,1,0.8871968840967,0,16,regulation of calcineurin-mediated signaling,BP,
18403,GO:0106057,1,0.977459362921709,0,3,negative regulation of calcineurin-mediated signaling,BP,
18404,GO:0106058,1,0.937985602095814,0,9,positive regulation of calcineurin-mediated signaling,BP,
18405,GO:0106064,1,0.991683568212354,0,1,regulation of cobalamin metabolic process,BP,
18406,GO:0106068,1,0.962683679538244,0,6,SUMO ligase complex,CC,
18407,GO:0106070,1,0.930150764181565,0,10,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18408,GO:0106071,1,0.963371679253831,0,5,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18409,GO:0106072,1,0.954997871987851,0,7,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18410,GO:0106073,1,0.981903252755183,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18411,GO:0106074,1,0.932503497455977,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18412,GO:0106075,1,0.993987315041155,0,1,peptide N-succinyltransferase activity,MF,
18413,GO:0106077,1,0.975077978693834,0,4,histone succinylation,BP,
18414,GO:0106078,1,0.993987315041155,0,1,histone succinyltransferase activity,MF,
18415,GO:0106083,1,0.938575766854313,0,7,nuclear membrane protein complex,CC,
18416,GO:0106088,1,0.990656724331827,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18417,GO:0106089,1,0.990656724331827,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18418,GO:0106094,1,0.938575766854313,0,7,nuclear membrane microtubule tethering complex,CC,
18419,GO:0106101,1,0.994514097923653,0,1,ER-dependent peroxisome localization,BP,
18421,GO:0110008,1,0.994033044953299,0,1,ncRNA deadenylation,BP,
18422,GO:0110009,1,0.977160937686628,0,3,formin-nucleated actin cable organization,BP,
18423,GO:0110011,1,0.955939962256976,0,5,regulation of basement membrane organization,BP,
18424,GO:0110017,1,0.989229486441169,0,2,cap-independent translational initiation of linear mRNA,BP,
18425,GO:0110020,1,0.556404298003402,0,81,regulation of actomyosin structure organization,BP,
18426,GO:0110021,1,0.981929517309145,0,3,cardiac muscle myoblast proliferation,BP,
18427,GO:0110022,1,0.981929517309145,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18428,GO:0110024,1,0.981929517309145,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18429,GO:0110025,1,0.994030261290764,0,1,DNA strand resection involved in replication fork processing,BP,
18430,GO:0110026,1,0.994030261290764,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18431,GO:0110028,1,0.990353712774273,0,1,positive regulation of mitotic spindle organization,BP,
18432,GO:0110029,1,0.993967200336064,0,1,negative regulation of meiosis I,BP,
18433,GO:0110053,1,0.195997884753531,0,236,regulation of actin filament organization,BP,
18434,GO:0110057,1,0.991954970494667,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18435,GO:0110059,1,0.991954970494667,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18436,GO:0110075,1,0.994640367466263,0,1,regulation of ferroptosis,BP,
18437,GO:0110076,1,0.994640367466263,0,1,negative regulation of ferroptosis,BP,
18438,GO:0110095,1,0.983599960230884,0,3,cellular detoxification of aldehyde,BP,
18439,GO:0110096,1,0.972817747075054,0,5,cellular response to aldehyde,BP,
18440,GO:0120009,1,0.969694165471622,0,5,intermembrane lipid transfer,BP,
18441,GO:0120012,1,0.99203091643859,0,1,intermembrane sphingolipid transfer,BP,
18442,GO:0120013,1,0.969694165471622,0,5,intermembrane lipid transfer activity,MF,
18443,GO:0120016,1,0.99203091643859,0,1,intermembrane sphingolipid transfer activity,MF,
18444,GO:0120017,1,0.99203091643859,0,1,intermembrane ceramide transfer activity,MF,
18447,GO:0120032,1,0.376771601809446,0,141,regulation of plasma membrane bounded cell projection assembly,BP,
18448,GO:0120033,1,0.88201903866563,0,20,negative regulation of plasma membrane bounded cell projection assembly,BP,
18449,GO:0120034,1,0.570226270507618,0,81,positive regulation of plasma membrane bounded cell projection assembly,BP,
18454,GO:0120043,1,0.992651191550151,0,1,stereocilium shaft,CC,
18455,GO:0120044,1,0.992651191550151,0,1,stereocilium base,CC,
18456,GO:0120048,1,0.994184768585909,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18457,GO:0120049,1,0.994184768585909,0,1,snRNA (adenine-N6)-methylation,BP,
18458,GO:0120054,1,0.994654979429419,0,1,intestinal motility,BP,
18459,GO:0120055,1,0.994654979429419,0,1,small intestinal transit,BP,
18460,GO:0120057,1,0.994654979429419,0,1,regulation of small intestinal transit,BP,
18461,GO:0120058,1,0.994654979429419,0,1,positive regulation of small intestinal transit,BP,
18462,GO:0120060,1,0.994649074016324,0,1,regulation of gastric emptying,BP,
18463,GO:0120061,1,0.994649074016324,0,1,negative regulation of gastric emptying,BP,
18464,GO:0120063,1,0.986932319242146,0,2,stomach smooth muscle contraction,BP,
18465,GO:0120064,1,0.99224214601651,0,1,stomach pylorus smooth muscle contraction,BP,
18466,GO:0120065,1,0.99224214601651,0,1,pyloric antrum smooth muscle contraction,BP,
18467,GO:0120068,1,0.994649074016324,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18468,GO:0120069,1,0.994649074016324,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18469,GO:0120071,1,0.99224214601651,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18470,GO:0120072,1,0.99224214601651,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18471,GO:0120077,1,0.990656724331827,0,1,angiogenic sprout fusion,BP,
18472,GO:0120078,1,0.990656724331827,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18473,GO:0120092,1,0.99382344601035,0,1,crotonyl-CoA hydratase activity,MF,
18474,GO:0120093,1,0.99382344601035,0,1,regulation of peptidyl-lysine crotonylation,BP,
18475,GO:0120094,1,0.99382344601035,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18476,GO:0120103,1,0.939226875338932,0,9,centriolar subdistal appendage,CC,
18477,GO:0120108,1,0.994472120183136,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
18478,GO:0120111,1,0.629049753601824,0,67,neuron projection cytoplasm,CC,
18479,GO:0120114,1,0.603602594800647,0,79,Sm-like protein family complex,CC,
18480,GO:0140007,1,0.977558135601806,0,4,KICSTOR complex,CC,
18481,GO:0140009,1,0.987188758672189,0,2,L-aspartate import across plasma membrane,BP,
18482,GO:0140013,1,0.393651416045039,0,143,meiotic nuclear division,BP,
18483,GO:0140014,1,0.172815300262339,0,252,mitotic nuclear division,BP,
18485,GO:0140030,1,0.448519772665396,0,113,modification-dependent protein binding,MF,
18486,GO:0140031,1,0.988461923177767,0,2,phosphorylation-dependent protein binding,MF,
18487,GO:0140033,1,0.87051726691179,0,17,acetylation-dependent protein binding,MF,
18488,GO:0140034,1,0.670788096592327,0,56,methylation-dependent protein binding,MF,
18489,GO:0140035,1,0.965337271417365,0,5,ubiquitination-like modification-dependent protein binding,MF,
18490,GO:0140036,1,0.965337271417365,0,5,ubiquitin-dependent protein binding,MF,
18491,GO:0140041,1,0.994640893629188,0,1,cellular detoxification of methylglyoxal,BP,
18492,GO:0140049,1,0.994551028674317,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18493,GO:0140051,1,0.994551028674317,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18494,GO:0140052,1,0.966739002637884,0,5,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18495,GO:0140053,1,0.414230125389602,0,151,mitochondrial gene expression,BP,
18497,GO:0140058,1,0.877971534333505,0,16,neuron projection arborization,BP,
18498,GO:0140059,1,0.967612399168006,0,5,dendrite arborization,BP,
18499,GO:0140064,1,0.988943080235015,0,1,peptide crotonyltransferase activity,MF,
18500,GO:0140065,1,0.988943080235015,0,1,peptide butyryltransferase activity,MF,
18501,GO:0140066,1,0.982834143589289,0,2,peptidyl-lysine crotonylation,BP,
18502,GO:0140067,1,0.988943080235015,0,1,peptidyl-lysine butyrylation,BP,
18503,GO:0140068,1,0.988943080235015,0,1,histone crotonyltransferase activity,MF,
18504,GO:0140069,1,0.988943080235015,0,1,histone butyryltransferase activity,MF,
18505,GO:0140074,1,0.992240256450348,0,1,cardiac endothelial to mesenchymal transition,BP,
18506,GO:0140078,1,0.945238627894252,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18507,GO:0140080,1,0.945238627894252,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18510,GO:0140098,1,0.120398885416494,0,338,catalytic activity, acting on RNA,MF,
18511,GO:0140101,1,0.502202235958133,0,115,catalytic activity, acting on a tRNA,MF,
18512,GO:0140102,1,0.914972032938873,0,15,catalytic activity, acting on a rRNA,MF,
18513,GO:0140103,1,0.883132438819404,0,20,catalytic activity, acting on a glycoprotein,MF,
18514,GO:0140104,1,0.769624073666449,0,40,molecular carrier activity,MF,
18516,GO:0140112,1,0.886290192844787,0,20,extracellular vesicle biogenesis,BP,
18518,GO:0140131,1,0.929988906437957,0,12,positive regulation of lymphocyte chemotaxis,BP,
18519,GO:0140135,1,0.975459906507323,0,4,mechanosensitive cation channel activity,MF,
18520,GO:0140142,1,0.878877925592422,0,18,nucleocytoplasmic carrier activity,MF,
18521,GO:0140161,1,0.954712804447527,0,8,monocarboxylate:sodium symporter activity,MF,
18522,GO:0140192,1,0.979410958881191,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18523,GO:0140193,1,0.994599233652156,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18524,GO:0140194,1,0.994599233652156,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18525,GO:0140196,1,0.990402959276893,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18526,GO:0140199,1,0.988902548506595,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18527,GO:0140200,1,0.989520522560469,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18528,GO:0150003,1,0.969334552878035,0,4,regulation of spontaneous synaptic transmission,BP,
18529,GO:0150005,1,0.932676907972173,0,11,enzyme activator complex,CC,
18530,GO:0150011,1,0.949203049994416,0,7,regulation of neuron projection arborization,BP,
18531,GO:0150012,1,0.949203049994416,0,7,positive regulation of neuron projection arborization,BP,
18532,GO:0150018,1,0.978875213224496,0,3,basal dendrite development,BP,
18533,GO:0150019,1,0.978875213224496,0,3,basal dendrite morphogenesis,BP,
18534,GO:0150020,1,0.978875213224496,0,3,basal dendrite arborization,BP,
18535,GO:0150024,1,0.994458511732395,0,1,oxidised low-density lipoprotein particle clearance,BP,
18536,GO:0150025,1,0.994458511732395,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18537,GO:0150031,1,0.991067508174269,0,1,regulation of protein localization to lysosome,BP,
18538,GO:0150033,1,0.991067508174269,0,1,negative regulation of protein localization to lysosome,BP,
18541,GO:1900003,1,0.961345866502627,0,6,regulation of serine-type endopeptidase activity,BP,
18542,GO:1900004,1,0.961345866502627,0,6,negative regulation of serine-type endopeptidase activity,BP,
18543,GO:1900005,1,0.988473912080574,0,1,positive regulation of serine-type endopeptidase activity,BP,
18545,GO:1900010,1,0.994515517581278,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18546,GO:1900011,1,0.994515517581278,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18547,GO:1900015,1,0.842091372953128,0,27,regulation of cytokine production involved in inflammatory response,BP,
18548,GO:1900016,1,0.945676610401292,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18549,GO:1900017,1,0.921213269054163,0,13,positive regulation of cytokine production involved in inflammatory response,BP,
18550,GO:1900019,1,0.973594234169516,0,4,regulation of protein kinase C activity,BP,
18551,GO:1900020,1,0.973594234169516,0,4,positive regulation of protein kinase C activity,BP,
18554,GO:1900026,1,0.811889066674667,0,31,positive regulation of substrate adhesion-dependent cell spreading,BP,
18555,GO:1900027,1,0.862075473076182,0,24,regulation of ruffle assembly,BP,
18556,GO:1900028,1,0.970651841899744,0,5,negative regulation of ruffle assembly,BP,
18557,GO:1900029,1,0.932854199848186,0,11,positive regulation of ruffle assembly,BP,
18558,GO:1900034,1,0.593454331638241,0,75,regulation of cellular response to heat,BP,
18559,GO:1900035,1,0.99421865913556,0,1,negative regulation of cellular response to heat,BP,
18560,GO:1900036,1,0.994376542232862,0,1,positive regulation of cellular response to heat,BP,
18561,GO:1900037,1,0.930244919034719,0,12,regulation of cellular response to hypoxia,BP,
18562,GO:1900038,1,0.958485391811497,0,7,negative regulation of cellular response to hypoxia,BP,
18563,GO:1900039,1,0.988451157931619,0,2,positive regulation of cellular response to hypoxia,BP,
18566,GO:1900042,1,0.974468075684891,0,3,positive regulation of interleukin-2 secretion,BP,
18567,GO:1900044,1,0.932366202996111,0,9,regulation of protein K63-linked ubiquitination,BP,
18568,GO:1900045,1,0.960537256713002,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18572,GO:1900052,1,0.994613946734573,0,1,regulation of retinoic acid biosynthetic process,BP,
18573,GO:1900053,1,0.994613946734573,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18574,GO:1900060,1,0.976019036464033,0,4,negative regulation of ceramide biosynthetic process,BP,
18575,GO:1900062,1,0.993554794146471,0,1,regulation of replicative cell aging,BP,
18576,GO:1900063,1,0.973970972861208,0,3,regulation of peroxisome organization,BP,
18579,GO:1900078,1,0.827382988045557,0,26,positive regulation of cellular response to insulin stimulus,BP,
18580,GO:1900081,1,0.988902548506595,0,1,regulation of arginine catabolic process,BP,
18581,GO:1900082,1,0.988902548506595,0,1,negative regulation of arginine catabolic process,BP,
18582,GO:1900084,1,0.958406718199041,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18583,GO:1900085,1,0.994240083034553,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18584,GO:1900086,1,0.963961086635338,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18586,GO:1900094,1,0.955500093545621,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18587,GO:1900095,1,0.987404370521563,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18588,GO:1900098,1,0.994522480326503,0,1,regulation of plasma cell differentiation,BP,
18589,GO:1900100,1,0.994522480326503,0,1,positive regulation of plasma cell differentiation,BP,
18590,GO:1900101,1,0.854453783702238,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
18591,GO:1900102,1,0.934899626419381,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18592,GO:1900103,1,0.91834875824522,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18593,GO:1900104,1,0.982110568912909,0,3,regulation of hyaluranon cable assembly,BP,
18594,GO:1900106,1,0.982110568912909,0,3,positive regulation of hyaluranon cable assembly,BP,
18595,GO:1900107,1,0.955079086100079,0,7,regulation of nodal signaling pathway,BP,
18596,GO:1900108,1,0.983348025082244,0,3,negative regulation of nodal signaling pathway,BP,
18597,GO:1900109,1,0.983564370276978,0,3,regulation of histone H3-K9 dimethylation,BP,
18598,GO:1900110,1,0.989185548774345,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18599,GO:1900111,1,0.99431798374846,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18600,GO:1900112,1,0.93604060152504,0,9,regulation of histone H3-K9 trimethylation,BP,
18601,GO:1900113,1,0.968965241185706,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18602,GO:1900114,1,0.984517816280771,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18603,GO:1900115,1,0.901791343065241,0,15,extracellular regulation of signal transduction,BP,
18604,GO:1900116,1,0.901791343065241,0,15,extracellular negative regulation of signal transduction,BP,
18605,GO:1900117,1,0.874383967848776,0,21,regulation of execution phase of apoptosis,BP,
18606,GO:1900118,1,0.956395823527373,0,7,negative regulation of execution phase of apoptosis,BP,
18607,GO:1900119,1,0.928274721101931,0,12,positive regulation of execution phase of apoptosis,BP,
18611,GO:1900125,1,0.952025722840074,0,7,regulation of hyaluronan biosynthetic process,BP,
18612,GO:1900126,1,0.977423889563078,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18613,GO:1900127,1,0.974021050597608,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18614,GO:1900130,1,0.993633952644134,0,1,regulation of lipid binding,BP,
18615,GO:1900131,1,0.993633952644134,0,1,negative regulation of lipid binding,BP,
18616,GO:1900133,1,0.981910959311927,0,3,regulation of renin secretion into blood stream,BP,
18617,GO:1900134,1,0.993481450184868,0,1,negative regulation of renin secretion into blood stream,BP,
18618,GO:1900135,1,0.988354348934978,0,2,positive regulation of renin secretion into blood stream,BP,
18620,GO:1900139,1,0.992376919026555,0,1,negative regulation of arachidonic acid secretion,BP,
18621,GO:1900141,1,0.994311919238431,0,1,regulation of oligodendrocyte apoptotic process,BP,
18622,GO:1900142,1,0.994311919238431,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18623,GO:1900145,1,0.966146772325868,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18624,GO:1900146,1,0.98918409422828,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18625,GO:1900147,1,0.984577715603563,0,2,regulation of Schwann cell migration,BP,
18626,GO:1900148,1,0.994184768585909,0,1,negative regulation of Schwann cell migration,BP,
18627,GO:1900149,1,0.990337313481602,0,1,positive regulation of Schwann cell migration,BP,
18628,GO:1900150,1,0.988724076782426,0,2,regulation of defense response to fungus,BP,
18629,GO:1900151,1,0.888777773019314,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18630,GO:1900152,1,0.994519401565665,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18631,GO:1900153,1,0.888777773019314,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18632,GO:1900154,1,0.987787395083273,0,2,regulation of bone trabecula formation,BP,
18633,GO:1900155,1,0.987787395083273,0,2,negative regulation of bone trabecula formation,BP,
18635,GO:1900158,1,0.993205596010162,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
18637,GO:1900161,1,0.994181688827792,0,1,regulation of phospholipid scramblase activity,BP,
18638,GO:1900163,1,0.994181688827792,0,1,positive regulation of phospholipid scramblase activity,BP,
18639,GO:1900164,1,0.955500093545621,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18640,GO:1900165,1,0.957271755341729,0,7,negative regulation of interleukin-6 secretion,BP,
18641,GO:1900166,1,0.988498408955292,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18642,GO:1900168,1,0.988498408955292,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18643,GO:1900169,1,0.979501602289708,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18644,GO:1900170,1,0.994184768585909,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18645,GO:1900175,1,0.966146772325868,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18646,GO:1900176,1,0.98918409422828,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18647,GO:1900180,1,0.534949453649231,0,93,regulation of protein localization to nucleus,BP,
18648,GO:1900181,1,0.866800774189874,0,21,negative regulation of protein localization to nucleus,BP,
18649,GO:1900182,1,0.656126360778512,0,62,positive regulation of protein localization to nucleus,BP,
18650,GO:1900186,1,0.980668724603018,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18653,GO:1900193,1,0.960559656245984,0,7,regulation of oocyte maturation,BP,
18654,GO:1900194,1,0.982558082721523,0,3,negative regulation of oocyte maturation,BP,
18655,GO:1900195,1,0.9889311788638,0,2,positive regulation of oocyte maturation,BP,
18656,GO:1900200,1,0.986693766028451,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18657,GO:1900204,1,0.986693766028451,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18658,GO:1900205,1,0.986693766028451,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18659,GO:1900208,1,0.989147310253467,0,2,regulation of cardiolipin metabolic process,BP,
18660,GO:1900210,1,0.989147310253467,0,2,positive regulation of cardiolipin metabolic process,BP,
18661,GO:1900211,1,0.986693766028451,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18662,GO:1900212,1,0.986693766028451,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18663,GO:1900214,1,0.986693766028451,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18664,GO:1900215,1,0.986693766028451,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18665,GO:1900217,1,0.986693766028451,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18666,GO:1900218,1,0.986693766028451,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18667,GO:1900220,1,0.983223389974279,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18668,GO:1900221,1,0.921116655683798,0,10,regulation of amyloid-beta clearance,BP,
18669,GO:1900222,1,0.978468531848326,0,3,negative regulation of amyloid-beta clearance,BP,
18670,GO:1900223,1,0.946888414879716,0,6,positive regulation of amyloid-beta clearance,BP,
18671,GO:1900224,1,0.982050548258152,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18672,GO:1900225,1,0.928704354325362,0,11,regulation of NLRP3 inflammasome complex assembly,BP,
18673,GO:1900226,1,0.973735979975017,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18674,GO:1900227,1,0.959310236890203,0,6,positive regulation of NLRP3 inflammasome complex assembly,BP,
18677,GO:1900238,1,0.980178441941452,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18678,GO:1900239,1,0.969668855338595,0,4,regulation of phenotypic switching,BP,
18679,GO:1900241,1,0.994134814661725,0,1,positive regulation of phenotypic switching,BP,
18680,GO:1900242,1,0.93648595441511,0,8,regulation of synaptic vesicle endocytosis,BP,
18681,GO:1900243,1,0.992181627661619,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18682,GO:1900244,1,0.968660953463662,0,4,positive regulation of synaptic vesicle endocytosis,BP,
18683,GO:1900245,1,0.974574582497775,0,3,positive regulation of MDA-5 signaling pathway,BP,
18684,GO:1900246,1,0.95844846299152,0,5,positive regulation of RIG-I signaling pathway,BP,
18685,GO:1900247,1,0.93830815971915,0,10,regulation of cytoplasmic translational elongation,BP,
18686,GO:1900248,1,0.983542535617682,0,2,negative regulation of cytoplasmic translational elongation,BP,
18687,GO:1900259,1,0.994503211958308,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18688,GO:1900260,1,0.994503211958308,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18689,GO:1900262,1,0.966917212845905,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18690,GO:1900264,1,0.966917212845905,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18692,GO:1900272,1,0.94331041369015,0,8,negative regulation of long-term synaptic potentiation,BP,
18694,GO:1900274,1,0.797273174526767,0,33,regulation of phospholipase C activity,BP,
18695,GO:1900275,1,0.985630888700158,0,2,negative regulation of phospholipase C activity,BP,
18696,GO:1900276,1,0.993768301928894,0,1,regulation of proteinase activated receptor activity,BP,
18697,GO:1900279,1,0.993731305369998,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18698,GO:1900281,1,0.993731305369998,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18699,GO:1900363,1,0.925404675538723,0,12,regulation of mRNA polyadenylation,BP,
18700,GO:1900364,1,0.950290143052634,0,8,negative regulation of mRNA polyadenylation,BP,
18701,GO:1900365,1,0.979152740688422,0,3,positive regulation of mRNA polyadenylation,BP,
18702,GO:1900368,1,0.97650433103557,0,3,regulation of RNA interference,BP,
18703,GO:1900369,1,0.984333921298193,0,2,negative regulation of RNA interference,BP,
18704,GO:1900370,1,0.992047048074476,0,1,positive regulation of RNA interference,BP,
18705,GO:1900371,1,0.42619293357779,0,127,regulation of purine nucleotide biosynthetic process,BP,
18706,GO:1900372,1,0.791185795411416,0,35,negative regulation of purine nucleotide biosynthetic process,BP,
18707,GO:1900373,1,0.694268180220996,0,56,positive regulation of purine nucleotide biosynthetic process,BP,
18708,GO:1900376,1,0.944113951875233,0,7,regulation of secondary metabolite biosynthetic process,BP,
18709,GO:1900377,1,0.982390052701331,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18710,GO:1900378,1,0.961044553236572,0,5,positive regulation of secondary metabolite biosynthetic process,BP,
18711,GO:1900383,1,0.993894625366939,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18712,GO:1900387,1,0.994451872857536,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18713,GO:1900390,1,0.983395326956365,0,3,regulation of iron ion import,BP,
18714,GO:1900402,1,0.9378137844212,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18715,GO:1900407,1,0.655694839361591,0,66,regulation of cellular response to oxidative stress,BP,
18716,GO:1900408,1,0.777822649429908,0,39,negative regulation of cellular response to oxidative stress,BP,
18717,GO:1900409,1,0.907411721598754,0,15,positive regulation of cellular response to oxidative stress,BP,
18718,GO:1900424,1,0.92475580961858,0,12,regulation of defense response to bacterium,BP,
18719,GO:1900425,1,0.967662040385111,0,5,negative regulation of defense response to bacterium,BP,
18720,GO:1900426,1,0.963893183553747,0,6,positive regulation of defense response to bacterium,BP,
18722,GO:1900450,1,0.992530003773513,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18723,GO:1900451,1,0.930437672330617,0,9,positive regulation of glutamate receptor signaling pathway,BP,
18725,GO:1900453,1,0.981855133590237,0,3,negative regulation of long term synaptic depression,BP,
18727,GO:1900477,1,0.994456866315321,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18728,GO:1900533,1,0.994573226788901,0,1,palmitic acid metabolic process,BP,
18729,GO:1900535,1,0.994573226788901,0,1,palmitic acid biosynthetic process,BP,
18731,GO:1900543,1,0.743660686677242,0,45,negative regulation of purine nucleotide metabolic process,BP,
18733,GO:1900558,1,0.994484700089226,0,1,austinol metabolic process,BP,
18734,GO:1900560,1,0.994484700089226,0,1,austinol biosynthetic process,BP,
18735,GO:1900561,1,0.994484700089226,0,1,dehydroaustinol metabolic process,BP,
18736,GO:1900563,1,0.994484700089226,0,1,dehydroaustinol biosynthetic process,BP,
18737,GO:1900619,1,0.982688096723563,0,3,acetate ester metabolic process,BP,
18738,GO:1900620,1,0.994251418956767,0,1,acetate ester biosynthetic process,BP,
18739,GO:1900623,1,0.978588121211147,0,3,regulation of monocyte aggregation,BP,
18740,GO:1900625,1,0.978588121211147,0,3,positive regulation of monocyte aggregation,BP,
18742,GO:1900719,1,0.992405097966755,0,1,regulation of uterine smooth muscle relaxation,BP,
18743,GO:1900721,1,0.992405097966755,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18744,GO:1900736,1,0.977694333517591,0,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18745,GO:1900737,1,0.993768301928894,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18746,GO:1900738,1,0.983826239074577,0,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18747,GO:1900739,1,0.834467631306206,0,30,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18748,GO:1900740,1,0.834467631306206,0,30,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18749,GO:1900744,1,0.814805925348621,0,31,regulation of p38MAPK cascade,BP,
18750,GO:1900745,1,0.871985974552691,0,21,positive regulation of p38MAPK cascade,BP,
18751,GO:1900746,1,0.930163130400247,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18752,GO:1900747,1,0.979317396045355,0,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18753,GO:1900748,1,0.966058932610176,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18754,GO:1900750,1,0.933322560824139,0,12,oligopeptide binding,MF,
18755,GO:1900753,1,0.993005302829955,0,1,doxorubicin transport,BP,
18756,GO:1900756,1,0.984315353323881,0,2,protein processing in phagocytic vesicle,BP,
18757,GO:1900825,1,0.975714598075194,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18758,GO:1900827,1,0.987945935997587,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18759,GO:1900864,1,0.948695605390323,0,9,mitochondrial RNA modification,BP,
18760,GO:1901004,1,0.99460858498263,0,1,ubiquinone-6 metabolic process,BP,
18761,GO:1901006,1,0.99460858498263,0,1,ubiquinone-6 biosynthetic process,BP,
18762,GO:1901016,1,0.700951164591377,0,49,regulation of potassium ion transmembrane transporter activity,BP,
18763,GO:1901017,1,0.900627982707945,0,15,negative regulation of potassium ion transmembrane transporter activity,BP,
18764,GO:1901018,1,0.846416009511568,0,22,positive regulation of potassium ion transmembrane transporter activity,BP,
18766,GO:1901020,1,0.828016871167695,0,31,negative regulation of calcium ion transmembrane transporter activity,BP,
18767,GO:1901021,1,0.800541881981175,0,31,positive regulation of calcium ion transmembrane transporter activity,BP,
18768,GO:1901026,1,0.976250736566149,0,3,ripoptosome assembly involved in necroptotic process,BP,
18769,GO:1901028,1,0.758774624050637,0,46,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18770,GO:1901029,1,0.956159807090947,0,8,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18771,GO:1901030,1,0.79801043574406,0,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18772,GO:1901031,1,0.802524644799363,0,35,regulation of response to reactive oxygen species,BP,
18773,GO:1901032,1,0.896328767175987,0,17,negative regulation of response to reactive oxygen species,BP,
18774,GO:1901033,1,0.950760576988913,0,8,positive regulation of response to reactive oxygen species,BP,
18775,GO:1901052,1,0.993861532284992,0,1,sarcosine metabolic process,BP,
18776,GO:1901053,1,0.993861532284992,0,1,sarcosine catabolic process,BP,
18777,GO:1901068,1,0.721405606261619,0,50,guanosine-containing compound metabolic process,BP,
18778,GO:1901069,1,0.994590117781034,0,1,guanosine-containing compound catabolic process,BP,
18779,GO:1901070,1,0.926085233339968,0,14,guanosine-containing compound biosynthetic process,BP,
18782,GO:1901073,1,0.985673463019092,0,2,glucosamine-containing compound biosynthetic process,BP,
18783,GO:1901074,1,0.984957053645233,0,2,regulation of engulfment of apoptotic cell,BP,
18784,GO:1901076,1,0.990670521096357,0,1,positive regulation of engulfment of apoptotic cell,BP,
18785,GO:1901077,1,0.93109270297336,0,11,regulation of relaxation of muscle,BP,
18786,GO:1901078,1,0.977375329297865,0,3,negative regulation of relaxation of muscle,BP,
18787,GO:1901079,1,0.981345604425775,0,3,positive regulation of relaxation of muscle,BP,
18788,GO:1901080,1,0.992405097966755,0,1,regulation of relaxation of smooth muscle,BP,
18789,GO:1901082,1,0.992405097966755,0,1,positive regulation of relaxation of smooth muscle,BP,
18790,GO:1901086,1,0.992342116015422,0,1,benzylpenicillin metabolic process,BP,
18791,GO:1901090,1,0.988478973258552,0,2,regulation of protein tetramerization,BP,
18792,GO:1901091,1,0.988478973258552,0,2,negative regulation of protein tetramerization,BP,
18793,GO:1901093,1,0.988478973258552,0,2,regulation of protein homotetramerization,BP,
18794,GO:1901094,1,0.988478973258552,0,2,negative regulation of protein homotetramerization,BP,
18795,GO:1901096,1,0.933439668061995,0,9,regulation of autophagosome maturation,BP,
18796,GO:1901097,1,0.978952105982752,0,3,negative regulation of autophagosome maturation,BP,
18797,GO:1901098,1,0.950781982024038,0,6,positive regulation of autophagosome maturation,BP,
18798,GO:1901099,1,0.824623941565115,0,32,negative regulation of signal transduction in absence of ligand,BP,
18802,GO:1901142,1,0.951299148010464,0,7,insulin metabolic process,BP,
18803,GO:1901143,1,0.9860164367095,0,2,insulin catabolic process,BP,
18804,GO:1901145,1,0.980072474009355,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18805,GO:1901147,1,0.986693766028451,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18806,GO:1901159,1,0.971996053182398,0,5,xylulose 5-phosphate biosynthetic process,BP,
18807,GO:1901160,1,0.914666437200082,0,12,primary amino compound metabolic process,BP,
18808,GO:1901162,1,0.977784135805869,0,4,primary amino compound biosynthetic process,BP,
18811,GO:1901165,1,0.970990437525756,0,5,positive regulation of trophoblast cell migration,BP,
18812,GO:1901166,1,0.979941001625813,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
18813,GO:1901184,1,0.548248115843235,0,90,regulation of ERBB signaling pathway,BP,
18814,GO:1901185,1,0.704258439796987,0,53,negative regulation of ERBB signaling pathway,BP,
18816,GO:1901187,1,0.985542409584028,0,2,regulation of ephrin receptor signaling pathway,BP,
18817,GO:1901189,1,0.994368589361908,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18818,GO:1901193,1,0.994624247775424,0,1,regulation of formation of translation preinitiation complex,BP,
18819,GO:1901194,1,0.994624247775424,0,1,negative regulation of formation of translation preinitiation complex,BP,
18820,GO:1901201,1,0.904164243082947,0,13,regulation of extracellular matrix assembly,BP,
18821,GO:1901202,1,0.994370903438534,0,1,negative regulation of extracellular matrix assembly,BP,
18822,GO:1901203,1,0.930883699380924,0,9,positive regulation of extracellular matrix assembly,BP,
18823,GO:1901207,1,0.987192455283473,0,2,regulation of heart looping,BP,
18824,GO:1901208,1,0.993812617818958,0,1,negative regulation of heart looping,BP,
18825,GO:1901210,1,0.993812617818958,0,1,regulation of cardiac chamber formation,BP,
18826,GO:1901211,1,0.993812617818958,0,1,negative regulation of cardiac chamber formation,BP,
18827,GO:1901213,1,0.92215477477542,0,12,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18830,GO:1901216,1,0.601127032931119,0,75,positive regulation of neuron death,BP,
18831,GO:1901219,1,0.993812617818958,0,1,regulation of cardiac chamber morphogenesis,BP,
18832,GO:1901220,1,0.993812617818958,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18834,GO:1901223,1,0.943897176616643,0,9,negative regulation of NIK/NF-kappaB signaling,BP,
18836,GO:1901228,1,0.977129600244821,0,3,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18837,GO:1901229,1,0.994276479790622,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18838,GO:1901231,1,0.994276479790622,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18839,GO:1901232,1,0.994276479790622,0,1,regulation of convergent extension involved in axis elongation,BP,
18840,GO:1901233,1,0.994276479790622,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18841,GO:1901246,1,0.988894738213698,0,2,regulation of lung ciliated cell differentiation,BP,
18842,GO:1901247,1,0.994607640841943,0,1,negative regulation of lung ciliated cell differentiation,BP,
18843,GO:1901248,1,0.994256434345611,0,1,positive regulation of lung ciliated cell differentiation,BP,
18844,GO:1901249,1,0.994607640841943,0,1,regulation of lung goblet cell differentiation,BP,
18845,GO:1901251,1,0.994607640841943,0,1,positive regulation of lung goblet cell differentiation,BP,
18846,GO:1901252,1,0.987667807929729,0,2,regulation of intracellular transport of viral material,BP,
18847,GO:1901253,1,0.994640518331712,0,1,negative regulation of intracellular transport of viral material,BP,
18848,GO:1901254,1,0.992990093697166,0,1,positive regulation of intracellular transport of viral material,BP,
18849,GO:1901255,1,0.985368431053127,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18850,GO:1901256,1,0.971141087899361,0,5,regulation of macrophage colony-stimulating factor production,BP,
18851,GO:1901257,1,0.99438140973488,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18852,GO:1901258,1,0.982847800637355,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18853,GO:1901264,1,0.6812194750621,0,64,carbohydrate derivative transport,BP,
18855,GO:1901269,1,0.989344272260938,0,2,lipooligosaccharide metabolic process,BP,
18856,GO:1901271,1,0.989344272260938,0,2,lipooligosaccharide biosynthetic process,BP,
18857,GO:1901291,1,0.99449845162717,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18858,GO:1901292,1,0.337638886152265,0,162,nucleoside phosphate catabolic process,BP,
18860,GO:1901295,1,0.988922341180946,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18861,GO:1901296,1,0.994523216867324,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18862,GO:1901297,1,0.994368589361908,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18863,GO:1901298,1,0.936603191959117,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18864,GO:1901299,1,0.962761731599822,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18865,GO:1901300,1,0.972839853320739,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18866,GO:1901301,1,0.987037541079932,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18867,GO:1901303,1,0.994219870071372,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18868,GO:1901304,1,0.994544350632709,0,1,regulation of spermidine biosynthetic process,BP,
18869,GO:1901307,1,0.994544350632709,0,1,positive regulation of spermidine biosynthetic process,BP,
18870,GO:1901314,1,0.973977406065055,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18871,GO:1901315,1,0.973977406065055,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18872,GO:1901317,1,0.955851138817029,0,8,regulation of flagellated sperm motility,BP,
18873,GO:1901318,1,0.994495382707259,0,1,negative regulation of flagellated sperm motility,BP,
18874,GO:1901321,1,0.9891736455744,0,2,positive regulation of heart induction,BP,
18875,GO:1901328,1,0.994521952658588,0,1,response to cytochalasin B,BP,
18878,GO:1901337,1,0.994245432508821,0,1,thioester transport,BP,
18879,GO:1901338,1,0.921820351163302,0,14,catecholamine binding,MF,
18880,GO:1901339,1,0.955321565379051,0,7,regulation of store-operated calcium channel activity,BP,
18881,GO:1901340,1,0.993206031070605,0,1,negative regulation of store-operated calcium channel activity,BP,
18882,GO:1901341,1,0.96769719118794,0,5,positive regulation of store-operated calcium channel activity,BP,
18885,GO:1901344,1,0.994607165281603,0,1,response to leptomycin B,BP,
18886,GO:1901350,1,0.990481082193494,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18887,GO:1901355,1,0.985390049897158,0,2,response to rapamycin,BP,
18892,GO:1901373,1,0.994589558723342,0,1,lipid hydroperoxide transport,BP,
18893,GO:1901374,1,0.966262598029304,0,6,acetate ester transport,BP,
18894,GO:1901375,1,0.988688398225009,0,2,acetate ester transmembrane transporter activity,MF,
18895,GO:1901376,1,0.994207649744507,0,1,organic heteropentacyclic compound metabolic process,BP,
18896,GO:1901377,1,0.994207649744507,0,1,organic heteropentacyclic compound catabolic process,BP,
18898,GO:1901380,1,0.884868307607707,0,18,negative regulation of potassium ion transmembrane transport,BP,
18899,GO:1901381,1,0.78983327174669,0,32,positive regulation of potassium ion transmembrane transport,BP,
18900,GO:1901382,1,0.969043994598312,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18901,GO:1901383,1,0.983532811461402,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18902,GO:1901385,1,0.820721424958742,0,31,regulation of voltage-gated calcium channel activity,BP,
18903,GO:1901386,1,0.933017948944027,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18904,GO:1901387,1,0.953047486258487,0,8,positive regulation of voltage-gated calcium channel activity,BP,
18905,GO:1901388,1,0.994296200941556,0,1,regulation of transforming growth factor beta activation,BP,
18906,GO:1901389,1,0.994296200941556,0,1,negative regulation of transforming growth factor beta activation,BP,
18907,GO:1901401,1,0.991683568212354,0,1,regulation of tetrapyrrole metabolic process,BP,
18908,GO:1901407,1,0.9472980983208,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18909,GO:1901409,1,0.95992459203851,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18910,GO:1901419,1,0.993007983950641,0,1,regulation of response to alcohol,BP,
18911,GO:1901421,1,0.993007983950641,0,1,positive regulation of response to alcohol,BP,
18912,GO:1901474,1,0.959354413704027,0,7,azole transmembrane transporter activity,MF,
18913,GO:1901475,1,0.976788838934138,0,4,pyruvate transmembrane transport,BP,
18914,GO:1901490,1,0.971191415142296,0,4,regulation of lymphangiogenesis,BP,
18915,GO:1901491,1,0.985258317093616,0,2,negative regulation of lymphangiogenesis,BP,
18916,GO:1901492,1,0.985724729252854,0,2,positive regulation of lymphangiogenesis,BP,
18917,GO:1901503,1,0.965941866423032,0,5,ether biosynthetic process,BP,
18918,GO:1901505,1,0.814908152419827,0,34,carbohydrate derivative transmembrane transporter activity,MF,
18920,GO:1901522,1,0.845912671508835,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18921,GO:1901523,1,0.982887650854271,0,3,icosanoid catabolic process,BP,
18922,GO:1901524,1,0.909105202744872,0,13,regulation of mitophagy,BP,
18923,GO:1901525,1,0.964741145848635,0,5,negative regulation of mitophagy,BP,
18924,GO:1901526,1,0.942350784385287,0,8,positive regulation of mitophagy,BP,
18925,GO:1901529,1,0.971525162464811,0,4,positive regulation of anion channel activity,BP,
18926,GO:1901532,1,0.587685203844318,0,88,regulation of hematopoietic progenitor cell differentiation,BP,
18927,GO:1901533,1,0.955759012608097,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18928,GO:1901534,1,0.987147436567671,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18929,GO:1901535,1,0.957230644124513,0,5,regulation of DNA demethylation,BP,
18930,GO:1901536,1,0.988140914999368,0,2,negative regulation of DNA demethylation,BP,
18931,GO:1901537,1,0.968722432058314,0,3,positive regulation of DNA demethylation,BP,
18932,GO:1901538,1,0.956292391238087,0,6,changes to DNA methylation involved in embryo development,BP,
18933,GO:1901545,1,0.994053534586749,0,1,response to raffinose,BP,
18934,GO:1901550,1,0.92390262521118,0,12,regulation of endothelial cell development,BP,
18935,GO:1901551,1,0.993143533832264,0,1,negative regulation of endothelial cell development,BP,
18936,GO:1901552,1,0.969549089459728,0,5,positive regulation of endothelial cell development,BP,
18937,GO:1901555,1,0.99058782531848,0,1,response to paclitaxel,BP,
18938,GO:1901557,1,0.993327106956322,0,1,response to fenofibrate,BP,
18939,GO:1901558,1,0.985723913628766,0,2,response to metformin,BP,
18940,GO:1901561,1,0.99351750226667,0,1,response to benomyl,BP,
18941,GO:1901563,1,0.967730939756819,0,5,response to camptothecin,BP,
18945,GO:1901567,1,0.872112989527079,0,24,fatty acid derivative binding,MF,
18947,GO:1901569,1,0.954709174182963,0,8,fatty acid derivative catabolic process,BP,
18952,GO:1901580,1,0.986945640841821,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18953,GO:1901581,1,0.986945640841821,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18954,GO:1901582,1,0.986945640841821,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18955,GO:1901585,1,0.994164222237481,0,1,regulation of acid-sensing ion channel activity,BP,
18956,GO:1901588,1,0.992711160637842,0,1,dendritic microtubule,CC,
18957,GO:1901594,1,0.99319993764267,0,1,response to capsazepine,BP,
18958,GO:1901605,1,0.288367000842317,0,201,alpha-amino acid metabolic process,BP,
18959,GO:1901606,1,0.564458053785713,0,96,alpha-amino acid catabolic process,BP,
18960,GO:1901607,1,0.690338609694368,0,59,alpha-amino acid biosynthetic process,BP,
18961,GO:1901608,1,0.994601526592866,0,1,regulation of vesicle transport along microtubule,BP,
18962,GO:1901609,1,0.994601526592866,0,1,negative regulation of vesicle transport along microtubule,BP,
18963,GO:1901611,1,0.939222222852193,0,10,phosphatidylglycerol binding,MF,
18964,GO:1901612,1,0.955742865627209,0,7,cardiolipin binding,MF,
18969,GO:1901620,1,0.956616657837849,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18970,GO:1901621,1,0.967589424798355,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18971,GO:1901622,1,0.994279964914517,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18975,GO:1901627,1,0.994376192188773,0,1,negative regulation of postsynaptic membrane organization,BP,
18976,GO:1901628,1,0.973409310431252,0,4,positive regulation of postsynaptic membrane organization,BP,
18977,GO:1901629,1,0.984299889678434,0,2,regulation of presynaptic membrane organization,BP,
18978,GO:1901630,1,0.994619104948451,0,1,negative regulation of presynaptic membrane organization,BP,
18979,GO:1901631,1,0.989625514297932,0,1,positive regulation of presynaptic membrane organization,BP,
18980,GO:1901639,1,0.991443266410328,0,1,XDP catabolic process,BP,
18981,GO:1901640,1,0.991443266410328,0,1,XTP binding,MF,
18982,GO:1901641,1,0.991443266410328,0,1,ITP binding,MF,
18983,GO:1901642,1,0.966575751444044,0,6,nucleoside transmembrane transport,BP,
18988,GO:1901656,1,0.980641816604885,0,3,glycoside transport,BP,
18992,GO:1901660,1,0.939231434915281,0,8,calcium ion export,BP,
18993,GO:1901661,1,0.858606175118957,0,27,quinone metabolic process,BP,
18994,GO:1901662,1,0.988602065571983,0,2,quinone catabolic process,BP,
18995,GO:1901663,1,0.924481217791942,0,14,quinone biosynthetic process,BP,
18996,GO:1901664,1,0.980837433065299,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18997,GO:1901666,1,0.980837433065299,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18998,GO:1901668,1,0.978052250688145,0,4,regulation of superoxide dismutase activity,BP,
18999,GO:1901671,1,0.98377405870361,0,3,positive regulation of superoxide dismutase activity,BP,
19000,GO:1901673,1,0.876428307857226,0,19,regulation of mitotic spindle assembly,BP,
19001,GO:1901674,1,0.978545213248593,0,3,regulation of histone H3-K27 acetylation,BP,
19002,GO:1901675,1,0.990820810954847,0,1,negative regulation of histone H3-K27 acetylation,BP,
19003,GO:1901676,1,0.993388981893144,0,1,positive regulation of histone H3-K27 acetylation,BP,
19004,GO:1901678,1,0.933670156090708,0,11,iron coordination entity transport,BP,
19005,GO:1901679,1,0.953913785557727,0,8,nucleotide transmembrane transport,BP,
19006,GO:1901680,1,0.98819429412571,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19008,GO:1901682,1,0.834085911107645,0,27,sulfur compound transmembrane transporter activity,MF,
19009,GO:1901685,1,0.906056404421472,0,18,glutathione derivative metabolic process,BP,
19010,GO:1901687,1,0.906056404421472,0,18,glutathione derivative biosynthetic process,BP,
19015,GO:1901702,1,0.983432370970908,0,3,salt transmembrane transporter activity,MF,
19016,GO:1901706,1,0.994277353274586,0,1,mesenchymal cell differentiation involved in bone development,BP,
19017,GO:1901707,1,0.994607165281603,0,1,leptomycin B binding,MF,
19018,GO:1901722,1,0.936749377311416,0,11,regulation of cell proliferation involved in kidney development,BP,
19019,GO:1901723,1,0.970473283305095,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19020,GO:1901724,1,0.965260280594926,0,6,positive regulation of cell proliferation involved in kidney development,BP,
19021,GO:1901725,1,0.936834044058107,0,8,regulation of histone deacetylase activity,BP,
19022,GO:1901726,1,0.987147381450321,0,1,negative regulation of histone deacetylase activity,BP,
19023,GO:1901727,1,0.955541177364174,0,6,positive regulation of histone deacetylase activity,BP,
19028,GO:1901748,1,0.98302730783788,0,3,leukotriene D4 metabolic process,BP,
19029,GO:1901750,1,0.98302730783788,0,3,leukotriene D4 biosynthetic process,BP,
19030,GO:1901751,1,0.994365902427248,0,1,leukotriene A4 metabolic process,BP,
19031,GO:1901796,1,0.327979460220173,0,167,regulation of signal transduction by p53 class mediator,BP,
19032,GO:1901797,1,0.85207115364804,0,26,negative regulation of signal transduction by p53 class mediator,BP,
19033,GO:1901798,1,0.869263275294159,0,20,positive regulation of signal transduction by p53 class mediator,BP,
19034,GO:1901799,1,0.750158587479305,0,44,negative regulation of proteasomal protein catabolic process,BP,
19035,GO:1901800,1,0.524385109392864,0,99,positive regulation of proteasomal protein catabolic process,BP,
19036,GO:1901804,1,0.994352008191647,0,1,beta-glucoside metabolic process,BP,
19037,GO:1901805,1,0.994352008191647,0,1,beta-glucoside catabolic process,BP,
19038,GO:1901810,1,0.994184768585909,0,1,beta-carotene metabolic process,BP,
19039,GO:1901825,1,0.994264990016345,0,1,zeaxanthin metabolic process,BP,
19040,GO:1901827,1,0.994264990016345,0,1,zeaxanthin biosynthetic process,BP,
19041,GO:1901834,1,0.99453565139976,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19042,GO:1901835,1,0.99453565139976,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19043,GO:1901836,1,0.930421884944479,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19044,GO:1901837,1,0.98895384923706,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19045,GO:1901838,1,0.94082064117927,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19046,GO:1901841,1,0.935903066504065,0,11,regulation of high voltage-gated calcium channel activity,BP,
19047,GO:1901842,1,0.978267179841757,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19048,GO:1901843,1,0.980899612597178,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
19049,GO:1901844,1,0.942287213934784,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19050,GO:1901846,1,0.99286747834402,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19051,GO:1901856,1,0.988378788262353,0,2,negative regulation of cellular respiration,BP,
19052,GO:1901857,1,0.964191701620276,0,6,positive regulation of cellular respiration,BP,
19053,GO:1901858,1,0.960872350792045,0,6,regulation of mitochondrial DNA metabolic process,BP,
19054,GO:1901859,1,0.980585129054868,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
19055,GO:1901860,1,0.9858196121179,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
19056,GO:1901861,1,0.438854874307037,0,117,regulation of muscle tissue development,BP,
19057,GO:1901862,1,0.74671429266432,0,44,negative regulation of muscle tissue development,BP,
19058,GO:1901863,1,0.646515612437949,0,61,positive regulation of muscle tissue development,BP,
19059,GO:1901873,1,0.985097958777629,0,2,regulation of post-translational protein modification,BP,
19060,GO:1901874,1,0.985097958777629,0,2,negative regulation of post-translational protein modification,BP,
19061,GO:1901876,1,0.98922541594942,0,2,regulation of calcium ion binding,BP,
19062,GO:1901877,1,0.98922541594942,0,2,negative regulation of calcium ion binding,BP,
19063,GO:1901879,1,0.580742942061125,0,73,regulation of protein depolymerization,BP,
19064,GO:1901880,1,0.65848337709372,0,56,negative regulation of protein depolymerization,BP,
19065,GO:1901881,1,0.907073372582108,0,15,positive regulation of protein depolymerization,BP,
19068,GO:1901890,1,0.804231246065981,0,30,positive regulation of cell junction assembly,BP,
19069,GO:1901894,1,0.941552953376571,0,8,regulation of calcium-transporting ATPase activity,BP,
19070,GO:1901895,1,0.979346662839,0,3,negative regulation of calcium-transporting ATPase activity,BP,
19071,GO:1901896,1,0.966585641388085,0,4,positive regulation of calcium-transporting ATPase activity,BP,
19072,GO:1901897,1,0.95365324222588,0,7,regulation of relaxation of cardiac muscle,BP,
19073,GO:1901898,1,0.982673679049145,0,2,negative regulation of relaxation of cardiac muscle,BP,
19074,GO:1901899,1,0.988856712803112,0,2,positive regulation of relaxation of cardiac muscle,BP,
19075,GO:1901906,1,0.976242838261684,0,4,diadenosine pentaphosphate metabolic process,BP,
19076,GO:1901907,1,0.976242838261684,0,4,diadenosine pentaphosphate catabolic process,BP,
19077,GO:1901908,1,0.976242838261684,0,4,diadenosine hexaphosphate metabolic process,BP,
19078,GO:1901909,1,0.976242838261684,0,4,diadenosine hexaphosphate catabolic process,BP,
19079,GO:1901910,1,0.976242838261684,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19080,GO:1901911,1,0.976242838261684,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19081,GO:1901917,1,0.994202692183443,0,1,regulation of exoribonuclease activity,BP,
19082,GO:1901919,1,0.994202692183443,0,1,positive regulation of exoribonuclease activity,BP,
19083,GO:1901950,1,0.994184768585909,0,1,dense core granule transport,BP,
19084,GO:1901962,1,0.994412527970298,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19085,GO:1901963,1,0.988340098571693,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19086,GO:1901964,1,0.994527376974531,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19087,GO:1901970,1,0.947280867880651,0,8,positive regulation of mitotic sister chromatid separation,BP,
19088,GO:1901976,1,0.818023196689485,0,32,regulation of cell cycle checkpoint,BP,
19089,GO:1901977,1,0.965020219899803,0,6,negative regulation of cell cycle checkpoint,BP,
19090,GO:1901978,1,0.935440358990214,0,10,positive regulation of cell cycle checkpoint,BP,
19091,GO:1901979,1,0.976896199029018,0,3,regulation of inward rectifier potassium channel activity,BP,
19092,GO:1901980,1,0.987842289874961,0,1,positive regulation of inward rectifier potassium channel activity,BP,
19094,GO:1901983,1,0.656691833643409,0,65,regulation of protein acetylation,BP,
19095,GO:1901984,1,0.863224317361975,0,23,negative regulation of protein acetylation,BP,
19096,GO:1901985,1,0.796770190064612,0,35,positive regulation of protein acetylation,BP,
19097,GO:1901986,1,0.994591916970503,0,1,response to ketamine,BP,
19099,GO:1901988,1,0.245255313441274,0,219,negative regulation of cell cycle phase transition,BP,
19102,GO:1901991,1,0.265715420170817,0,206,negative regulation of mitotic cell cycle phase transition,BP,
19104,GO:1901993,1,0.988151823395855,0,2,regulation of meiotic cell cycle phase transition,BP,
19105,GO:1901994,1,0.988151823395855,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19106,GO:1901998,1,0.801441408313161,0,35,toxin transport,BP,
19107,GO:1902001,1,0.901153240179435,0,14,fatty acid transmembrane transport,BP,
19108,GO:1902003,1,0.878880406708983,0,18,regulation of amyloid-beta formation,BP,
19109,GO:1902004,1,0.934994017366382,0,10,positive regulation of amyloid-beta formation,BP,
19110,GO:1902010,1,0.99373205913677,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19111,GO:1902017,1,0.760320603209882,0,39,regulation of cilium assembly,BP,
19112,GO:1902018,1,0.94519900109553,0,9,negative regulation of cilium assembly,BP,
19113,GO:1902019,1,0.971448060042142,0,5,regulation of cilium-dependent cell motility,BP,
19114,GO:1902022,1,0.967988179569866,0,5,L-lysine transport,BP,
19115,GO:1902023,1,0.958597037323849,0,6,L-arginine transport,BP,
19116,GO:1902031,1,0.96539114562937,0,6,regulation of NADP metabolic process,BP,
19117,GO:1902033,1,0.95735917732797,0,7,regulation of hematopoietic stem cell proliferation,BP,
19118,GO:1902035,1,0.968909675384593,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19119,GO:1902036,1,0.627715307542104,0,79,regulation of hematopoietic stem cell differentiation,BP,
19120,GO:1902037,1,0.982695851263501,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19121,GO:1902038,1,0.993766449045507,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19124,GO:1902043,1,0.886994365507848,0,17,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19125,GO:1902044,1,0.987211992902895,0,2,regulation of Fas signaling pathway,BP,
19126,GO:1902045,1,0.994369480992414,0,1,negative regulation of Fas signaling pathway,BP,
19127,GO:1902047,1,0.964857943119883,0,6,polyamine transmembrane transport,BP,
19128,GO:1902065,1,0.92846625001581,0,11,response to L-glutamate,BP,
19129,GO:1902071,1,0.994619313091668,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19130,GO:1902073,1,0.994619313091668,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19131,GO:1902074,1,0.92845619509007,0,13,response to salt,BP,
19132,GO:1902075,1,0.961472735849086,0,7,cellular response to salt,BP,
19133,GO:1902076,1,0.986563326491222,0,1,regulation of lateral motor column neuron migration,BP,
19134,GO:1902078,1,0.986563326491222,0,1,positive regulation of lateral motor column neuron migration,BP,
19135,GO:1902080,1,0.994541878042146,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19136,GO:1902081,1,0.994541878042146,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19137,GO:1902083,1,0.958996672160943,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19138,GO:1902093,1,0.961143962212242,0,7,positive regulation of flagellated sperm motility,BP,
19139,GO:1902098,1,0.992678442915743,0,1,calcitriol binding,MF,
19140,GO:1902099,1,0.719845990883895,0,48,regulation of metaphase/anaphase transition of cell cycle,BP,
19141,GO:1902100,1,0.80309943470983,0,32,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19142,GO:1902101,1,0.947280867880651,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19143,GO:1902102,1,0.994045937555551,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19144,GO:1902103,1,0.994045937555551,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19148,GO:1902108,1,0.702627943089102,0,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19149,GO:1902109,1,0.983748369582868,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19150,GO:1902110,1,0.720297480081004,0,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19151,GO:1902115,1,0.345764830541972,0,149,regulation of organelle assembly,BP,
19152,GO:1902116,1,0.810040100364236,0,31,negative regulation of organelle assembly,BP,
19153,GO:1902117,1,0.653811053083656,0,58,positive regulation of organelle assembly,BP,
19154,GO:1902121,1,0.992678442915743,0,1,lithocholic acid binding,MF,
19155,GO:1902122,1,0.994436661814452,0,1,chenodeoxycholic acid binding,MF,
19156,GO:1902159,1,0.98602313387017,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19157,GO:1902161,1,0.991327248497623,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19158,GO:1902162,1,0.983602095714403,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19159,GO:1902164,1,0.983602095714403,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19160,GO:1902165,1,0.922274427372476,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19161,GO:1902166,1,0.932742590647824,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19162,GO:1902167,1,0.994661465429014,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19163,GO:1902170,1,0.888188877110716,0,18,cellular response to reactive nitrogen species,BP,
19164,GO:1902172,1,0.971737058586982,0,5,regulation of keratinocyte apoptotic process,BP,
19165,GO:1902174,1,0.982923310257039,0,3,positive regulation of keratinocyte apoptotic process,BP,
19166,GO:1902175,1,0.855529629979159,0,26,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19167,GO:1902176,1,0.898723623307601,0,18,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19168,GO:1902177,1,0.970608828616119,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19169,GO:1902178,1,0.993056983385791,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19170,GO:1902186,1,0.828460934510862,0,29,regulation of viral release from host cell,BP,
19171,GO:1902187,1,0.910126087039023,0,14,negative regulation of viral release from host cell,BP,
19172,GO:1902188,1,0.911021924180401,0,15,positive regulation of viral release from host cell,BP,
19173,GO:1902202,1,0.97553877282081,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19174,GO:1902203,1,0.992440736563162,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19175,GO:1902204,1,0.994474839516679,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19176,GO:1902205,1,0.994543023298783,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19177,GO:1902206,1,0.994543023298783,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19178,GO:1902211,1,0.994184768585909,0,1,regulation of prolactin signaling pathway,BP,
19179,GO:1902213,1,0.994184768585909,0,1,positive regulation of prolactin signaling pathway,BP,
19180,GO:1902214,1,0.979101414768051,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19181,GO:1902215,1,0.994543023298783,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19182,GO:1902216,1,0.984474507692885,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19183,GO:1902217,1,0.994601903968252,0,1,erythrocyte apoptotic process,BP,
19184,GO:1902218,1,0.96316371499223,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19185,GO:1902219,1,0.968368086886453,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19186,GO:1902220,1,0.994627350249509,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19187,GO:1902221,1,0.946013098796364,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19188,GO:1902222,1,0.946013098796364,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19189,GO:1902224,1,0.932331057182958,0,12,ketone body metabolic process,BP,
19190,GO:1902226,1,0.983551229180954,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19191,GO:1902227,1,0.989147835792323,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19192,GO:1902228,1,0.994342608047487,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19193,GO:1902229,1,0.815098912000654,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19194,GO:1902230,1,0.847962178366074,0,28,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19195,GO:1902231,1,0.967022087249669,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19196,GO:1902232,1,0.994543023298783,0,1,regulation of positive thymic T cell selection,BP,
19197,GO:1902233,1,0.994543023298783,0,1,negative regulation of positive thymic T cell selection,BP,
19198,GO:1902235,1,0.835627236248796,0,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19199,GO:1902236,1,0.897751890074285,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19200,GO:1902237,1,0.942791289132679,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19201,GO:1902238,1,0.993149677273809,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19202,GO:1902239,1,0.993149677273809,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19203,GO:1902250,1,0.994601903968252,0,1,regulation of erythrocyte apoptotic process,BP,
19204,GO:1902251,1,0.994601903968252,0,1,negative regulation of erythrocyte apoptotic process,BP,
19205,GO:1902253,1,0.870040145197727,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19206,GO:1902254,1,0.899228444366223,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19207,GO:1902255,1,0.978619997619236,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19208,GO:1902256,1,0.980667585975433,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19209,GO:1902257,1,0.98834855436167,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19210,GO:1902259,1,0.901953798419819,0,15,regulation of delayed rectifier potassium channel activity,BP,
19211,GO:1902260,1,0.954033013917997,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19212,GO:1902261,1,0.968815440701085,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19213,GO:1902262,1,0.970027897603029,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19214,GO:1902263,1,0.975804825566073,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19215,GO:1902267,1,0.971354007576001,0,5,regulation of polyamine transmembrane transport,BP,
19216,GO:1902268,1,0.983852884961775,0,3,negative regulation of polyamine transmembrane transport,BP,
19217,GO:1902269,1,0.987298045822507,0,2,positive regulation of polyamine transmembrane transport,BP,
19218,GO:1902271,1,0.992678442915743,0,1,D3 vitamins binding,MF,
19219,GO:1902275,1,0.327882779246356,0,157,regulation of chromatin organization,BP,
19220,GO:1902282,1,0.954267234216904,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19221,GO:1902283,1,0.993299747117968,0,1,negative regulation of primary amine oxidase activity,BP,
19222,GO:1902284,1,0.768431539666481,0,32,neuron projection extension involved in neuron projection guidance,BP,
19223,GO:1902285,1,0.892793737061778,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19224,GO:1902287,1,0.899949095396501,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19225,GO:1902292,1,0.994619000676033,0,1,cell cycle DNA replication initiation,BP,
19226,GO:1902296,1,0.993875899492539,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19227,GO:1902298,1,0.981220809925568,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19228,GO:1902299,1,0.983342723850041,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19229,GO:1902302,1,0.968035600450415,0,5,regulation of potassium ion export,BP,
19230,GO:1902303,1,0.988003272537507,0,2,negative regulation of potassium ion export,BP,
19231,GO:1902304,1,0.987300966671645,0,2,positive regulation of potassium ion export,BP,
19232,GO:1902305,1,0.670782293098603,0,55,regulation of sodium ion transmembrane transport,BP,
19233,GO:1902306,1,0.913408614821035,0,12,negative regulation of sodium ion transmembrane transport,BP,
19234,GO:1902307,1,0.878045369507697,0,18,positive regulation of sodium ion transmembrane transport,BP,
19235,GO:1902308,1,0.967690518284683,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19236,GO:1902309,1,0.97850977526871,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19237,GO:1902310,1,0.988945517535847,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19238,GO:1902311,1,0.994529630099203,0,1,regulation of copper ion transmembrane transport,BP,
19239,GO:1902315,1,0.994619000676033,0,1,nuclear cell cycle DNA replication initiation,BP,
19240,GO:1902319,1,0.993875899492539,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19241,GO:1902336,1,0.988064356692548,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19242,GO:1902337,1,0.942466126402528,0,9,regulation of apoptotic process involved in morphogenesis,BP,
19243,GO:1902338,1,0.968650926748831,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19244,GO:1902339,1,0.980597584579315,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19245,GO:1902356,1,0.994504129637034,0,1,oxaloacetate(2-) transmembrane transport,BP,
19246,GO:1902358,1,0.92948982227976,0,11,sulfate transmembrane transport,BP,
19247,GO:1902359,1,0.988728225461589,0,2,Notch signaling pathway involved in somitogenesis,BP,
19248,GO:1902362,1,0.99417678247596,0,1,melanocyte apoptotic process,BP,
19249,GO:1902363,1,0.990353712774273,0,1,regulation of protein localization to spindle pole body,BP,
19250,GO:1902365,1,0.990353712774273,0,1,positive regulation of protein localization to spindle pole body,BP,
19251,GO:1902366,1,0.988728225461589,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19252,GO:1902367,1,0.988728225461589,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19253,GO:1902369,1,0.742989024119637,0,44,negative regulation of RNA catabolic process,BP,
19254,GO:1902373,1,0.772310111378986,0,38,negative regulation of mRNA catabolic process,BP,
19255,GO:1902378,1,0.994320787029434,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19256,GO:1902379,1,0.99162298711725,0,1,chemoattractant activity involved in axon guidance,MF,
19257,GO:1902380,1,0.994344883062311,0,1,positive regulation of endoribonuclease activity,BP,
19258,GO:1902387,1,0.994184768585909,0,1,ceramide 1-phosphate binding,MF,
19259,GO:1902388,1,0.994184768585909,0,1,ceramide 1-phosphate transporter activity,MF,
19260,GO:1902389,1,0.994184768585909,0,1,ceramide 1-phosphate transport,BP,
19261,GO:1902396,1,0.993395714137065,0,1,protein localization to bicellular tight junction,BP,
19262,GO:1902400,1,0.66761762083613,0,61,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19263,GO:1902402,1,0.663644881920468,0,62,signal transduction involved in mitotic DNA damage checkpoint,BP,
19264,GO:1902403,1,0.663644881920468,0,62,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19265,GO:1902410,1,0.962614967961222,0,6,mitotic cytokinetic process,BP,
19266,GO:1902412,1,0.97003627138936,0,4,regulation of mitotic cytokinesis,BP,
19267,GO:1902414,1,0.940288584432987,0,8,protein localization to cell junction,BP,
19268,GO:1902415,1,0.947077305391138,0,9,regulation of mRNA binding,BP,
19269,GO:1902416,1,0.957958496746725,0,7,positive regulation of mRNA binding,BP,
19270,GO:1902423,1,0.985187111187452,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19271,GO:1902425,1,0.985187111187452,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19272,GO:1902426,1,0.994236566898091,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19273,GO:1902430,1,0.9356905994274,0,9,negative regulation of amyloid-beta formation,BP,
19274,GO:1902442,1,0.993535389794458,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19275,GO:1902443,1,0.993535389794458,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19276,GO:1902444,1,0.994618214353015,0,1,riboflavin binding,MF,
19277,GO:1902445,1,0.983785360813916,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19278,GO:1902455,1,0.962784236841812,0,6,negative regulation of stem cell population maintenance,BP,
19279,GO:1902459,1,0.950092894930876,0,7,positive regulation of stem cell population maintenance,BP,
19280,GO:1902460,1,0.992802844960391,0,1,regulation of mesenchymal stem cell proliferation,BP,
19281,GO:1902462,1,0.992802844960391,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19282,GO:1902463,1,0.989149462736543,0,2,protein localization to cell leading edge,BP,
19283,GO:1902464,1,0.992956898307576,0,1,regulation of histone H3-K27 trimethylation,BP,
19284,GO:1902466,1,0.992956898307576,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19285,GO:1902473,1,0.945989143086744,0,8,regulation of protein localization to synapse,BP,
19286,GO:1902474,1,0.951525225017015,0,7,positive regulation of protein localization to synapse,BP,
19287,GO:1902475,1,0.740192467217003,0,44,L-alpha-amino acid transmembrane transport,BP,
19289,GO:1902480,1,0.994343747060013,0,1,protein localization to mitotic spindle,BP,
19290,GO:1902488,1,0.988950931178037,0,1,cholangiocyte apoptotic process,BP,
19291,GO:1902490,1,0.994482332589535,0,1,regulation of sperm capacitation,BP,
19292,GO:1902493,1,0.567091595046892,0,85,acetyltransferase complex,CC,
19295,GO:1902498,1,0.962983206664452,0,4,regulation of protein autoubiquitination,BP,
19296,GO:1902499,1,0.982743898625707,0,2,positive regulation of protein autoubiquitination,BP,
19297,GO:1902504,1,0.994073310137837,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19298,GO:1902510,1,0.958189433540471,0,7,regulation of apoptotic DNA fragmentation,BP,
19299,GO:1902511,1,0.994219870071372,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19300,GO:1902512,1,0.983793250442458,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19301,GO:1902513,1,0.957388406082977,0,7,regulation of organelle transport along microtubule,BP,
19302,GO:1902514,1,0.936005405530781,0,9,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19303,GO:1902523,1,0.980605699693715,0,3,positive regulation of protein K63-linked ubiquitination,BP,
19304,GO:1902524,1,0.988150783734535,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19305,GO:1902525,1,0.971254652360238,0,5,regulation of protein monoubiquitination,BP,
19306,GO:1902527,1,0.977546337552494,0,4,positive regulation of protein monoubiquitination,BP,
19307,GO:1902528,1,0.989269236511746,0,1,regulation of protein linear polyubiquitination,BP,
19308,GO:1902530,1,0.989269236511746,0,1,positive regulation of protein linear polyubiquitination,BP,
19312,GO:1902544,1,0.988585316382927,0,2,regulation of DNA N-glycosylase activity,BP,
19313,GO:1902546,1,0.994647405411136,0,1,positive regulation of DNA N-glycosylase activity,BP,
19314,GO:1902547,1,0.92312671306937,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19315,GO:1902548,1,0.971912937343574,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19316,GO:1902554,1,0.584616354350026,0,80,serine/threonine protein kinase complex,CC,
19317,GO:1902555,1,0.838389855218208,0,29,endoribonuclease complex,CC,
19318,GO:1902559,1,0.98895733690234,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19319,GO:1902560,1,0.989110810578272,0,2,GMP reductase complex,CC,
19320,GO:1902562,1,0.775495784940179,0,39,H4 histone acetyltransferase complex,CC,
19321,GO:1902563,1,0.934945195198179,0,10,regulation of neutrophil activation,BP,
19322,GO:1902564,1,0.972167386603201,0,4,negative regulation of neutrophil activation,BP,
19323,GO:1902565,1,0.974534991541025,0,4,positive regulation of neutrophil activation,BP,
19324,GO:1902566,1,0.977733762873691,0,4,regulation of eosinophil activation,BP,
19325,GO:1902567,1,0.988850050623184,0,2,negative regulation of eosinophil activation,BP,
19326,GO:1902568,1,0.988759623282602,0,2,positive regulation of eosinophil activation,BP,
19327,GO:1902569,1,0.994504358491303,0,1,negative regulation of activation of Janus kinase activity,BP,
19328,GO:1902570,1,0.937779213265379,0,10,protein localization to nucleolus,BP,
19329,GO:1902571,1,0.961345866502627,0,6,regulation of serine-type peptidase activity,BP,
19330,GO:1902572,1,0.961345866502627,0,6,negative regulation of serine-type peptidase activity,BP,
19331,GO:1902573,1,0.988473912080574,0,1,positive regulation of serine-type peptidase activity,BP,
19332,GO:1902576,1,0.976639017377113,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19333,GO:1902579,1,0.635430494898411,0,69,multi-organism localization,BP,
19334,GO:1902581,1,0.968612364841024,0,5,multi-organism cellular localization,BP,
19335,GO:1902583,1,0.968612364841024,0,5,multi-organism intracellular transport,BP,
19336,GO:1902594,1,0.984697192287777,0,2,multi-organism nuclear import,BP,
19337,GO:1902595,1,0.988857206655599,0,2,regulation of DNA replication origin binding,BP,
19338,GO:1902600,1,0.509778506913294,0,110,proton transmembrane transport,BP,
19339,GO:1902603,1,0.977488954046444,0,4,carnitine transmembrane transport,BP,
19340,GO:1902605,1,0.994206166661807,0,1,heterotrimeric G-protein complex assembly,BP,
19341,GO:1902606,1,0.98928581128919,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19342,GO:1902608,1,0.98928581128919,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19343,GO:1902612,1,0.994203686887394,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19344,GO:1902613,1,0.994203686887394,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19345,GO:1902616,1,0.994508439459796,0,1,acyl carnitine transmembrane transport,BP,
19348,GO:1902622,1,0.808653110153597,0,37,regulation of neutrophil migration,BP,
19349,GO:1902623,1,0.986660640952053,0,2,negative regulation of neutrophil migration,BP,
19350,GO:1902624,1,0.834027278679595,0,32,positive regulation of neutrophil migration,BP,
19351,GO:1902626,1,0.9839593022918,0,3,assembly of large subunit precursor of preribosome,BP,
19352,GO:1902629,1,0.994597022512958,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19353,GO:1902630,1,0.982254518431285,0,2,regulation of membrane hyperpolarization,BP,
19354,GO:1902631,1,0.990561680732437,0,1,negative regulation of membrane hyperpolarization,BP,
19355,GO:1902636,1,0.98894103290378,0,2,kinociliary basal body,CC,
19356,GO:1902652,1,0.443276899290151,0,122,secondary alcohol metabolic process,BP,
19357,GO:1902653,1,0.655984566842605,0,63,secondary alcohol biosynthetic process,BP,
19358,GO:1902656,1,0.914851884255339,0,13,calcium ion import into cytosol,BP,
19359,GO:1902659,1,0.9813562264546,0,3,regulation of glucose mediated signaling pathway,BP,
19360,GO:1902661,1,0.9813562264546,0,3,positive regulation of glucose mediated signaling pathway,BP,
19361,GO:1902667,1,0.75317285157347,0,36,regulation of axon guidance,BP,
19362,GO:1902668,1,0.8548835611286,0,21,negative regulation of axon guidance,BP,
19363,GO:1902669,1,0.929301120635768,0,8,positive regulation of axon guidance,BP,
19366,GO:1902683,1,0.982182619230679,0,3,regulation of receptor localization to synapse,BP,
19367,GO:1902684,1,0.994601526592866,0,1,negative regulation of receptor localization to synapse,BP,
19368,GO:1902685,1,0.993079156776419,0,1,positive regulation of receptor localization to synapse,BP,
19369,GO:1902686,1,0.712117946058984,0,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
19370,GO:1902692,1,0.820989416536814,0,27,regulation of neuroblast proliferation,BP,
19373,GO:1902713,1,0.951441089935039,0,8,regulation of interferon-gamma secretion,BP,
19374,GO:1902714,1,0.98868788722433,0,2,negative regulation of interferon-gamma secretion,BP,
19375,GO:1902715,1,0.962331248931616,0,6,positive regulation of interferon-gamma secretion,BP,
19376,GO:1902722,1,0.981542535701815,0,3,positive regulation of prolactin secretion,BP,
19377,GO:1902723,1,0.980849372705236,0,3,negative regulation of skeletal muscle satellite cell proliferation,BP,
19378,GO:1902724,1,0.984633822529097,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19379,GO:1902725,1,0.978302071752008,0,3,negative regulation of satellite cell differentiation,BP,
19380,GO:1902728,1,0.984633822529097,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19381,GO:1902730,1,0.981411045074174,0,3,positive regulation of proteoglycan biosynthetic process,BP,
19382,GO:1902731,1,0.972595647043811,0,3,negative regulation of chondrocyte proliferation,BP,
19384,GO:1902737,1,0.992990093697166,0,1,dendritic filopodium,CC,
19385,GO:1902739,1,0.953842332758032,0,6,regulation of interferon-alpha secretion,BP,
19386,GO:1902741,1,0.953842332758032,0,6,positive regulation of interferon-alpha secretion,BP,
19387,GO:1902742,1,0.816515032163113,0,29,apoptotic process involved in development,BP,
19389,GO:1902744,1,0.970376469706832,0,4,negative regulation of lamellipodium organization,BP,
19390,GO:1902745,1,0.854299581301273,0,22,positive regulation of lamellipodium organization,BP,
19391,GO:1902746,1,0.977595105114443,0,3,regulation of lens fiber cell differentiation,BP,
19392,GO:1902747,1,0.994483581380404,0,1,negative regulation of lens fiber cell differentiation,BP,
19393,GO:1902748,1,0.988605630001894,0,1,positive regulation of lens fiber cell differentiation,BP,
19394,GO:1902749,1,0.26512181045284,0,202,regulation of cell cycle G2/M phase transition,BP,
19395,GO:1902750,1,0.55738039358735,0,96,negative regulation of cell cycle G2/M phase transition,BP,
19397,GO:1902766,1,0.989128705511032,0,2,skeletal muscle satellite cell migration,BP,
19398,GO:1902767,1,0.9881211871942,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19399,GO:1902769,1,0.987098144443813,0,1,regulation of choline O-acetyltransferase activity,BP,
19400,GO:1902771,1,0.987098144443813,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19401,GO:1902773,1,0.994041657996762,0,1,GTPase activator complex,CC,
19402,GO:1902774,1,0.951892308788775,0,7,late endosome to lysosome transport,BP,
19403,GO:1902775,1,0.97825072092855,0,3,mitochondrial large ribosomal subunit assembly,BP,
19405,GO:1902804,1,0.976401345353763,0,4,negative regulation of synaptic vesicle transport,BP,
19406,GO:1902805,1,0.976598154203279,0,3,positive regulation of synaptic vesicle transport,BP,
19408,GO:1902807,1,0.519446160194419,0,99,negative regulation of cell cycle G1/S phase transition,BP,
19410,GO:1902809,1,0.981666914015251,0,3,regulation of skeletal muscle fiber differentiation,BP,
19411,GO:1902811,1,0.987461740926244,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19412,GO:1902816,1,0.97460957830016,0,4,regulation of protein localization to microtubule,BP,
19413,GO:1902817,1,0.97460957830016,0,4,negative regulation of protein localization to microtubule,BP,
19414,GO:1902822,1,0.971801901144249,0,4,regulation of late endosome to lysosome transport,BP,
19415,GO:1902823,1,0.982468211769326,0,2,negative regulation of late endosome to lysosome transport,BP,
19416,GO:1902824,1,0.989145262251006,0,2,positive regulation of late endosome to lysosome transport,BP,
19417,GO:1902838,1,0.992269531760999,0,1,regulation of nuclear migration along microtubule,BP,
19418,GO:1902846,1,0.990353712774273,0,1,positive regulation of mitotic spindle elongation,BP,
19419,GO:1902847,1,0.994152498934816,0,1,regulation of neuronal signal transduction,BP,
19420,GO:1902850,1,0.41280213454824,0,125,microtubule cytoskeleton organization involved in mitosis,BP,
19421,GO:1902855,1,0.93629950391048,0,10,regulation of non-motile cilium assembly,BP,
19422,GO:1902856,1,0.985927198413588,0,2,negative regulation of non-motile cilium assembly,BP,
19423,GO:1902857,1,0.955104146926133,0,7,positive regulation of non-motile cilium assembly,BP,
19424,GO:1902858,1,0.994439590766747,0,1,propionyl-CoA metabolic process,BP,
19425,GO:1902860,1,0.994439590766747,0,1,propionyl-CoA biosynthetic process,BP,
19426,GO:1902866,1,0.964672660395102,0,6,regulation of retina development in camera-type eye,BP,
19427,GO:1902867,1,0.993979567808698,0,1,negative regulation of retina development in camera-type eye,BP,
19428,GO:1902868,1,0.988816202750704,0,2,positive regulation of retina development in camera-type eye,BP,
19429,GO:1902869,1,0.982862433762205,0,3,regulation of amacrine cell differentiation,BP,
19430,GO:1902870,1,0.993979567808698,0,1,negative regulation of amacrine cell differentiation,BP,
19431,GO:1902871,1,0.988816202750704,0,2,positive regulation of amacrine cell differentiation,BP,
19432,GO:1902882,1,0.625397046463566,0,74,regulation of response to oxidative stress,BP,
19433,GO:1902883,1,0.768303172479329,0,41,negative regulation of response to oxidative stress,BP,
19434,GO:1902884,1,0.902309655070395,0,16,positive regulation of response to oxidative stress,BP,
19435,GO:1902889,1,0.990699512717009,0,1,protein localization to spindle microtubule,BP,
19436,GO:1902890,1,0.994651281344248,0,1,regulation of root hair elongation,BP,
19437,GO:1902891,1,0.994651281344248,0,1,negative regulation of root hair elongation,BP,
19438,GO:1902893,1,0.803139226161572,0,31,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19439,GO:1902894,1,0.917813580821823,0,11,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19440,GO:1902895,1,0.863953721830487,0,22,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19441,GO:1902896,1,0.981833043482587,0,3,terminal web assembly,BP,
19442,GO:1902897,1,0.980412517594845,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19443,GO:1902902,1,0.929686219772273,0,11,negative regulation of autophagosome assembly,BP,
19444,GO:1902903,1,0.115401914740548,0,308,regulation of supramolecular fiber organization,BP,
19445,GO:1902904,1,0.441039096524768,0,116,negative regulation of supramolecular fiber organization,BP,
19446,GO:1902905,1,0.303703684518093,0,178,positive regulation of supramolecular fiber organization,BP,
19447,GO:1902908,1,0.987649936097519,0,2,regulation of melanosome transport,BP,
19448,GO:1902910,1,0.993068521420915,0,1,positive regulation of melanosome transport,BP,
19449,GO:1902911,1,0.528047981505856,0,93,protein kinase complex,CC,
19450,GO:1902912,1,0.994184768585909,0,1,pyruvate kinase complex,CC,
19452,GO:1902914,1,0.889694766200447,0,16,regulation of protein polyubiquitination,BP,
19453,GO:1902915,1,0.953833912479559,0,6,negative regulation of protein polyubiquitination,BP,
19454,GO:1902916,1,0.942326098715949,0,9,positive regulation of protein polyubiquitination,BP,
19455,GO:1902930,1,0.674910700370888,0,59,regulation of alcohol biosynthetic process,BP,
19456,GO:1902931,1,0.947883319259586,0,9,negative regulation of alcohol biosynthetic process,BP,
19457,GO:1902932,1,0.900175891555906,0,17,positive regulation of alcohol biosynthetic process,BP,
19459,GO:1902937,1,0.981396781549994,0,3,inward rectifier potassium channel complex,CC,
19460,GO:1902938,1,0.97822111044017,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19461,GO:1902939,1,0.994126785883217,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19462,GO:1902941,1,0.984582122188174,0,2,regulation of voltage-gated chloride channel activity,BP,
19463,GO:1902943,1,0.984582122188174,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19464,GO:1902946,1,0.938287033296338,0,8,protein localization to early endosome,BP,
19465,GO:1902947,1,0.959136975602568,0,6,regulation of tau-protein kinase activity,BP,
19466,GO:1902948,1,0.987098144443813,0,1,negative regulation of tau-protein kinase activity,BP,
19467,GO:1902949,1,0.977076363043878,0,4,positive regulation of tau-protein kinase activity,BP,
19468,GO:1902950,1,0.944342983317514,0,9,regulation of dendritic spine maintenance,BP,
19469,GO:1902951,1,0.980312608271411,0,3,negative regulation of dendritic spine maintenance,BP,
19470,GO:1902952,1,0.980259242329287,0,3,positive regulation of dendritic spine maintenance,BP,
19471,GO:1902953,1,0.969269334434315,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19472,GO:1902954,1,0.977223423297169,0,2,regulation of early endosome to recycling endosome transport,BP,
19473,GO:1902955,1,0.987098144443813,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19474,GO:1902956,1,0.982941228071887,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19475,GO:1902957,1,0.993958996997799,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19476,GO:1902958,1,0.988915936649862,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19477,GO:1902959,1,0.941793355718151,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19478,GO:1902960,1,0.98155166786929,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19479,GO:1902961,1,0.95950180760981,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19480,GO:1902962,1,0.980667738758704,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19481,GO:1902963,1,0.980667738758704,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19482,GO:1902965,1,0.951056340537055,0,6,regulation of protein localization to early endosome,BP,
19483,GO:1902966,1,0.951056340537055,0,6,positive regulation of protein localization to early endosome,BP,
19484,GO:1902969,1,0.939785423667288,0,9,mitotic DNA replication,BP,
19485,GO:1902975,1,0.994619000676033,0,1,mitotic DNA replication initiation,BP,
19486,GO:1902977,1,0.994496449469869,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19487,GO:1902983,1,0.993875899492539,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19488,GO:1902988,1,0.973167799462086,0,3,neurofibrillary tangle assembly,BP,
19489,GO:1902990,1,0.980472766068659,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19490,GO:1902991,1,0.848857916996998,0,23,regulation of amyloid precursor protein catabolic process,BP,
19491,GO:1902992,1,0.924248352731852,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
19492,GO:1902993,1,0.924315968933376,0,12,positive regulation of amyloid precursor protein catabolic process,BP,
19493,GO:1902994,1,0.985339328793143,0,2,regulation of phospholipid efflux,BP,
19494,GO:1902995,1,0.985339328793143,0,2,positive regulation of phospholipid efflux,BP,
19495,GO:1902996,1,0.981325340497565,0,2,regulation of neurofibrillary tangle assembly,BP,
19496,GO:1902997,1,0.987098144443813,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19497,GO:1902998,1,0.994152498934816,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19498,GO:1903000,1,0.994619104948451,0,1,regulation of lipid transport across blood brain barrier,BP,
19499,GO:1903002,1,0.994619104948451,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19500,GO:1903003,1,0.963242805983856,0,6,positive regulation of protein deubiquitination,BP,
19501,GO:1903004,1,0.993427552906125,0,1,regulation of protein K63-linked deubiquitination,BP,
19502,GO:1903006,1,0.993427552906125,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19503,GO:1903007,1,0.993427552906125,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19504,GO:1903008,1,0.514507809155731,0,100,organelle disassembly,BP,
19510,GO:1903017,1,0.994546697420715,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19513,GO:1903020,1,0.867485127761058,0,21,positive regulation of glycoprotein metabolic process,BP,
19514,GO:1903025,1,0.937554059262796,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19515,GO:1903026,1,0.968880884776373,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19516,GO:1903027,1,0.984461259107368,0,2,regulation of opsonization,BP,
19517,GO:1903028,1,0.989997500418501,0,1,positive regulation of opsonization,BP,
19518,GO:1903031,1,0.988801490825272,0,2,regulation of microtubule plus-end binding,BP,
19519,GO:1903033,1,0.988801490825272,0,2,positive regulation of microtubule plus-end binding,BP,
19526,GO:1903044,1,0.952635297883214,0,8,protein localization to membrane raft,BP,
19527,GO:1903045,1,0.991785969687603,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19528,GO:1903046,1,0.358701876994182,0,156,meiotic cell cycle process,BP,
19530,GO:1903050,1,0.282526827015489,0,190,regulation of proteolysis involved in cellular protein catabolic process,BP,
19531,GO:1903051,1,0.684970709539239,0,56,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19532,GO:1903052,1,0.477833139137355,0,112,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19534,GO:1903054,1,0.965801025120865,0,6,negative regulation of extracellular matrix organization,BP,
19536,GO:1903056,1,0.983211154344465,0,2,regulation of melanosome organization,BP,
19537,GO:1903059,1,0.966590809941125,0,5,regulation of protein lipidation,BP,
19538,GO:1903060,1,0.994520893390471,0,1,negative regulation of protein lipidation,BP,
19539,GO:1903061,1,0.971917563343198,0,4,positive regulation of protein lipidation,BP,
19540,GO:1903069,1,0.947875146926884,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19541,GO:1903070,1,0.982300012311834,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19542,GO:1903071,1,0.959537336869668,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19543,GO:1903072,1,0.994640893629188,0,1,regulation of death-inducing signaling complex assembly,BP,
19544,GO:1903073,1,0.994640893629188,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19547,GO:1903078,1,0.720277974065061,0,47,positive regulation of protein localization to plasma membrane,BP,
19548,GO:1903080,1,0.994631297741194,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19549,GO:1903082,1,0.994631297741194,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19550,GO:1903093,1,0.979844085465615,0,3,regulation of protein K48-linked deubiquitination,BP,
19551,GO:1903094,1,0.989275957911691,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19552,GO:1903095,1,0.987149986248601,0,2,ribonuclease III complex,CC,
19553,GO:1903096,1,0.994045937555551,0,1,protein localization to meiotic spindle midzone,BP,
19554,GO:1903108,1,0.992311032969159,0,1,regulation of mitochondrial transcription,BP,
19555,GO:1903109,1,0.992311032969159,0,1,positive regulation of mitochondrial transcription,BP,
19557,GO:1903116,1,0.979638746683551,0,3,positive regulation of actin filament-based movement,BP,
19558,GO:1903119,1,0.978060145538437,0,3,protein localization to actin cytoskeleton,BP,
19559,GO:1903121,1,0.973225619056801,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19560,GO:1903122,1,0.994640893629188,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19561,GO:1903123,1,0.988525498597407,0,1,regulation of thioredoxin peroxidase activity,BP,
19562,GO:1903124,1,0.988525498597407,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19563,GO:1903125,1,0.988525498597407,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19564,GO:1903126,1,0.99444133485863,0,1,negative regulation of centriole-centriole cohesion,BP,
19566,GO:1903135,1,0.982271078384826,0,3,cupric ion binding,MF,
19567,GO:1903136,1,0.961867219157899,0,6,cuprous ion binding,MF,
19568,GO:1903140,1,0.92390262521118,0,12,regulation of establishment of endothelial barrier,BP,
19569,GO:1903141,1,0.993143533832264,0,1,negative regulation of establishment of endothelial barrier,BP,
19570,GO:1903142,1,0.969549089459728,0,5,positive regulation of establishment of endothelial barrier,BP,
19571,GO:1903143,1,0.981771979121929,0,3,adrenomedullin receptor complex,CC,
19572,GO:1903146,1,0.740287015486341,0,44,regulation of autophagy of mitochondrion,BP,
19573,GO:1903147,1,0.954055171604925,0,7,negative regulation of autophagy of mitochondrion,BP,
19574,GO:1903165,1,0.994229231381529,0,1,response to polycyclic arene,BP,
19575,GO:1903167,1,0.994640893629188,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19576,GO:1903168,1,0.994640893629188,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19578,GO:1903170,1,0.807555855001135,0,34,negative regulation of calcium ion transmembrane transport,BP,
19579,GO:1903173,1,0.988055380928383,0,2,fatty alcohol metabolic process,BP,
19580,GO:1903176,1,0.994640893629188,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19581,GO:1903178,1,0.994640893629188,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19582,GO:1903179,1,0.988546507715232,0,2,regulation of dopamine biosynthetic process,BP,
19583,GO:1903181,1,0.988546507715232,0,2,positive regulation of dopamine biosynthetic process,BP,
19584,GO:1903182,1,0.994616672573995,0,1,regulation of SUMO transferase activity,BP,
19585,GO:1903184,1,0.994640893629188,0,1,L-dopa metabolic process,BP,
19586,GO:1903185,1,0.994640893629188,0,1,L-dopa biosynthetic process,BP,
19587,GO:1903189,1,0.994640893629188,0,1,glyoxal metabolic process,BP,
19588,GO:1903195,1,0.994640893629188,0,1,regulation of L-dopa biosynthetic process,BP,
19589,GO:1903197,1,0.994640893629188,0,1,positive regulation of L-dopa biosynthetic process,BP,
19590,GO:1903198,1,0.994640893629188,0,1,regulation of L-dopa decarboxylase activity,BP,
19591,GO:1903200,1,0.994640893629188,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19592,GO:1903201,1,0.691645704038333,0,57,regulation of oxidative stress-induced cell death,BP,
19593,GO:1903202,1,0.777822649429908,0,39,negative regulation of oxidative stress-induced cell death,BP,
19594,GO:1903203,1,0.871421593017295,0,20,regulation of oxidative stress-induced neuron death,BP,
19595,GO:1903204,1,0.9038226628212,0,15,negative regulation of oxidative stress-induced neuron death,BP,
19596,GO:1903205,1,0.856242163840429,0,24,regulation of hydrogen peroxide-induced cell death,BP,
19597,GO:1903206,1,0.896328767175987,0,17,negative regulation of hydrogen peroxide-induced cell death,BP,
19598,GO:1903207,1,0.975783309819863,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19599,GO:1903208,1,0.975783309819863,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19600,GO:1903209,1,0.917443203410053,0,13,positive regulation of oxidative stress-induced cell death,BP,
19601,GO:1903210,1,0.991164447768179,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19602,GO:1903214,1,0.591016282578295,0,82,regulation of protein targeting to mitochondrion,BP,
19603,GO:1903215,1,0.971201229566449,0,4,negative regulation of protein targeting to mitochondrion,BP,
19604,GO:1903216,1,0.983206656651672,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19605,GO:1903217,1,0.983206656651672,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19606,GO:1903223,1,0.970675725574158,0,4,positive regulation of oxidative stress-induced neuron death,BP,
19609,GO:1903232,1,0.971470975685316,0,5,melanosome assembly,BP,
19610,GO:1903233,1,0.981964407474361,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19611,GO:1903236,1,0.952947089083438,0,8,regulation of leukocyte tethering or rolling,BP,
19612,GO:1903237,1,0.978605067419528,0,4,negative regulation of leukocyte tethering or rolling,BP,
19613,GO:1903238,1,0.973786668392658,0,4,positive regulation of leukocyte tethering or rolling,BP,
19614,GO:1903242,1,0.94231159957524,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19615,GO:1903243,1,0.955167958984734,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19616,GO:1903244,1,0.986546338192883,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19617,GO:1903248,1,0.988902548506595,0,1,regulation of citrulline biosynthetic process,BP,
19618,GO:1903249,1,0.988902548506595,0,1,negative regulation of citrulline biosynthetic process,BP,
19619,GO:1903251,1,0.962089916713658,0,6,multi-ciliated epithelial cell differentiation,BP,
19620,GO:1903265,1,0.954871752926594,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19621,GO:1903276,1,0.977714319019919,0,4,regulation of sodium ion export across plasma membrane,BP,
19622,GO:1903278,1,0.977714319019919,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19623,GO:1903279,1,0.9794209860046,0,3,regulation of calcium:sodium antiporter activity,BP,
19624,GO:1903280,1,0.991968263853182,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19625,GO:1903281,1,0.987352142793599,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19626,GO:1903282,1,0.993958996997799,0,1,regulation of glutathione peroxidase activity,BP,
19627,GO:1903284,1,0.993958996997799,0,1,positive regulation of glutathione peroxidase activity,BP,
19628,GO:1903285,1,0.993958996997799,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19629,GO:1903286,1,0.97548472607354,0,4,regulation of potassium ion import,BP,
19630,GO:1903288,1,0.982960725228377,0,3,positive regulation of potassium ion import,BP,
19631,GO:1903292,1,0.987806643779731,0,2,protein localization to Golgi membrane,BP,
19632,GO:1903293,1,0.751406961055586,0,44,phosphatase complex,CC,
19633,GO:1903294,1,0.98590398977402,0,2,regulation of glutamate secretion, neurotransmission,BP,
19634,GO:1903296,1,0.98590398977402,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19635,GO:1903297,1,0.970549657010324,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19636,GO:1903298,1,0.970549657010324,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19637,GO:1903299,1,0.940832531607661,0,9,regulation of hexokinase activity,BP,
19638,GO:1903300,1,0.977084789327339,0,4,negative regulation of hexokinase activity,BP,
19639,GO:1903301,1,0.962905971222107,0,5,positive regulation of hexokinase activity,BP,
19641,GO:1903306,1,0.876956351262645,0,20,negative regulation of regulated secretory pathway,BP,
19644,GO:1903312,1,0.642908238189371,0,68,negative regulation of mRNA metabolic process,BP,
19645,GO:1903313,1,0.646173263636162,0,62,positive regulation of mRNA metabolic process,BP,
19646,GO:1903314,1,0.994436661814452,0,1,regulation of nitrogen cycle metabolic process,BP,
19649,GO:1903319,1,0.875775137608989,0,20,positive regulation of protein maturation,BP,
19650,GO:1903320,1,0.280014926315773,0,195,regulation of protein modification by small protein conjugation or removal,BP,
19651,GO:1903321,1,0.633509038411123,0,70,negative regulation of protein modification by small protein conjugation or removal,BP,
19652,GO:1903322,1,0.483769105702006,0,114,positive regulation of protein modification by small protein conjugation or removal,BP,
19653,GO:1903332,1,0.958259496784,0,7,regulation of protein folding,BP,
19654,GO:1903333,1,0.970220241012838,0,5,negative regulation of protein folding,BP,
19655,GO:1903335,1,0.971801901144249,0,4,regulation of vacuolar transport,BP,
19656,GO:1903336,1,0.982468211769326,0,2,negative regulation of vacuolar transport,BP,
19657,GO:1903337,1,0.989145262251006,0,2,positive regulation of vacuolar transport,BP,
19658,GO:1903347,1,0.970164784635451,0,4,negative regulation of bicellular tight junction assembly,BP,
19659,GO:1903348,1,0.98053768745564,0,3,positive regulation of bicellular tight junction assembly,BP,
19660,GO:1903349,1,0.963500574402306,0,6,omegasome membrane,CC,
19661,GO:1903350,1,0.910886136085463,0,13,response to dopamine,BP,
19662,GO:1903351,1,0.910886136085463,0,13,cellular response to dopamine,BP,
19663,GO:1903352,1,0.957655170299288,0,6,L-ornithine transmembrane transport,BP,
19664,GO:1903358,1,0.904492424108536,0,15,regulation of Golgi organization,BP,
19665,GO:1903361,1,0.959398311267255,0,7,protein localization to basolateral plasma membrane,BP,
19668,GO:1903364,1,0.415083211630893,0,131,positive regulation of cellular protein catabolic process,BP,
19669,GO:1903365,1,0.955459503524251,0,7,regulation of fear response,BP,
19670,GO:1903367,1,0.969424197611352,0,5,positive regulation of fear response,BP,
19671,GO:1903371,1,0.967364761402754,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19672,GO:1903373,1,0.977249256047558,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19673,GO:1903375,1,0.986152942757343,0,2,facioacoustic ganglion development,BP,
19674,GO:1903376,1,0.957290011870099,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19675,GO:1903377,1,0.976424374493998,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19676,GO:1903378,1,0.987005423564315,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19677,GO:1903381,1,0.992822003594547,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19678,GO:1903382,1,0.992822003594547,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19679,GO:1903383,1,0.988915936649862,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19680,GO:1903384,1,0.988915936649862,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19681,GO:1903385,1,0.985941205534569,0,2,regulation of homophilic cell adhesion,BP,
19682,GO:1903387,1,0.992148490610944,0,1,positive regulation of homophilic cell adhesion,BP,
19685,GO:1903393,1,0.827427556641867,0,25,positive regulation of adherens junction organization,BP,
19686,GO:1903394,1,0.994370903438534,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19687,GO:1903400,1,0.963817616296923,0,5,L-arginine transmembrane transport,BP,
19688,GO:1903401,1,0.967988179569866,0,5,L-lysine transmembrane transport,BP,
19689,GO:1903402,1,0.993423377024051,0,1,regulation of renal phosphate excretion,BP,
19690,GO:1903403,1,0.993423377024051,0,1,negative regulation of renal phosphate excretion,BP,
19691,GO:1903405,1,0.95036795435714,0,9,protein localization to nuclear body,BP,
19692,GO:1903406,1,0.993613475925209,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19693,GO:1903408,1,0.993613475925209,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19695,GO:1903412,1,0.982669893698365,0,3,response to bile acid,BP,
19696,GO:1903413,1,0.982669893698365,0,3,cellular response to bile acid,BP,
19697,GO:1903414,1,0.993829911822307,0,1,iron cation export,BP,
19698,GO:1903416,1,0.962014353077715,0,6,response to glycoside,BP,
19699,GO:1903420,1,0.991084266579247,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19700,GO:1903421,1,0.89232043786075,0,15,regulation of synaptic vesicle recycling,BP,
19701,GO:1903422,1,0.985070042573994,0,2,negative regulation of synaptic vesicle recycling,BP,
19702,GO:1903423,1,0.945874478710088,0,7,positive regulation of synaptic vesicle recycling,BP,
19704,GO:1903427,1,0.875334300468678,0,21,negative regulation of reactive oxygen species biosynthetic process,BP,
19706,GO:1903429,1,0.870287829010881,0,20,regulation of cell maturation,BP,
19707,GO:1903430,1,0.958794687286753,0,7,negative regulation of cell maturation,BP,
19708,GO:1903431,1,0.948348665345392,0,7,positive regulation of cell maturation,BP,
19709,GO:1903432,1,0.847180888101623,0,25,regulation of TORC1 signaling,BP,
19710,GO:1903433,1,0.987650886218351,0,2,regulation of constitutive secretory pathway,BP,
19711,GO:1903434,1,0.993437558008804,0,1,negative regulation of constitutive secretory pathway,BP,
19712,GO:1903435,1,0.994175485186617,0,1,positive regulation of constitutive secretory pathway,BP,
19713,GO:1903436,1,0.985062728365624,0,2,regulation of mitotic cytokinetic process,BP,
19714,GO:1903438,1,0.985062728365624,0,2,positive regulation of mitotic cytokinetic process,BP,
19715,GO:1903439,1,0.970292465697438,0,5,calcitonin family receptor complex,CC,
19716,GO:1903440,1,0.977713345648645,0,4,amylin receptor complex,CC,
19717,GO:1903441,1,0.951667049405965,0,8,protein localization to ciliary membrane,BP,
19718,GO:1903442,1,0.993464118074765,0,1,response to lipoic acid,BP,
19719,GO:1903444,1,0.993966218722892,0,1,negative regulation of brown fat cell differentiation,BP,
19720,GO:1903445,1,0.983534895859418,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19721,GO:1903450,1,0.989075063409054,0,1,regulation of G1 to G0 transition,BP,
19722,GO:1903452,1,0.989075063409054,0,1,positive regulation of G1 to G0 transition,BP,
19723,GO:1903461,1,0.993999479284538,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19724,GO:1903463,1,0.980144433629301,0,3,regulation of mitotic cell cycle DNA replication,BP,
19725,GO:1903464,1,0.988241259900554,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19726,GO:1903465,1,0.991807797202965,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19727,GO:1903487,1,0.988246923180837,0,2,regulation of lactation,BP,
19728,GO:1903489,1,0.994522480326503,0,1,positive regulation of lactation,BP,
19729,GO:1903490,1,0.985062728365624,0,2,positive regulation of mitotic cytokinesis,BP,
19730,GO:1903494,1,0.99463741868846,0,1,response to dehydroepiandrosterone,BP,
19731,GO:1903496,1,0.99463741868846,0,1,response to 11-deoxycorticosterone,BP,
19732,GO:1903504,1,0.912256230803898,0,14,regulation of mitotic spindle checkpoint,BP,
19737,GO:1903510,1,0.48267557324872,0,108,mucopolysaccharide metabolic process,BP,
19738,GO:1903513,1,0.847554055321554,0,26,endoplasmic reticulum to cytosol transport,BP,
19739,GO:1903514,1,0.792644639235221,0,29,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19740,GO:1903515,1,0.989418530363553,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19741,GO:1903516,1,0.981994819204024,0,3,regulation of single strand break repair,BP,
19742,GO:1903517,1,0.994123438828563,0,1,negative regulation of single strand break repair,BP,
19743,GO:1903518,1,0.987800399559875,0,2,positive regulation of single strand break repair,BP,
19744,GO:1903519,1,0.980597584579315,0,3,regulation of mammary gland involution,BP,
19745,GO:1903521,1,0.980597584579315,0,3,positive regulation of mammary gland involution,BP,
19749,GO:1903525,1,0.962842351603084,0,5,regulation of membrane tubulation,BP,
19750,GO:1903526,1,0.986604183724742,0,2,negative regulation of membrane tubulation,BP,
19751,GO:1903527,1,0.97591874332598,0,3,positive regulation of membrane tubulation,BP,
19756,GO:1903537,1,0.988558395768777,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19757,GO:1903538,1,0.988558395768777,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19759,GO:1903540,1,0.946226118872372,0,9,establishment of protein localization to postsynaptic membrane,BP,
19760,GO:1903541,1,0.917846676197455,0,14,regulation of exosomal secretion,BP,
19761,GO:1903542,1,0.988256354565602,0,2,negative regulation of exosomal secretion,BP,
19762,GO:1903543,1,0.917846676197455,0,14,positive regulation of exosomal secretion,BP,
19763,GO:1903544,1,0.99378490142507,0,1,response to butyrate,BP,
19764,GO:1903545,1,0.99378490142507,0,1,cellular response to butyrate,BP,
19765,GO:1903546,1,0.959913046871857,0,6,protein localization to photoreceptor outer segment,BP,
19766,GO:1903547,1,0.989267628968843,0,2,regulation of growth hormone activity,BP,
19767,GO:1903551,1,0.963640725612698,0,6,regulation of extracellular exosome assembly,BP,
19768,GO:1903553,1,0.974673119887032,0,4,positive regulation of extracellular exosome assembly,BP,
19771,GO:1903557,1,0.647520415103266,0,66,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19773,GO:1903564,1,0.967447458334946,0,4,regulation of protein localization to cilium,BP,
19774,GO:1903565,1,0.993795890395374,0,1,negative regulation of protein localization to cilium,BP,
19775,GO:1903566,1,0.973488705815192,0,3,positive regulation of protein localization to cilium,BP,
19776,GO:1903567,1,0.988195326445061,0,2,regulation of protein localization to ciliary membrane,BP,
19777,GO:1903568,1,0.993795890395374,0,1,negative regulation of protein localization to ciliary membrane,BP,
19778,GO:1903569,1,0.994364822581448,0,1,positive regulation of protein localization to ciliary membrane,BP,
19779,GO:1903570,1,0.993708192560737,0,1,regulation of protein kinase D signaling,BP,
19780,GO:1903572,1,0.993708192560737,0,1,positive regulation of protein kinase D signaling,BP,
19781,GO:1903573,1,0.77685651179179,0,40,negative regulation of response to endoplasmic reticulum stress,BP,
19782,GO:1903575,1,0.988417840868116,0,2,cornified envelope assembly,BP,
19783,GO:1903576,1,0.994459330890128,0,1,response to L-arginine,BP,
19784,GO:1903578,1,0.560567469205816,0,83,regulation of ATP metabolic process,BP,
19785,GO:1903579,1,0.879985931524527,0,19,negative regulation of ATP metabolic process,BP,
19786,GO:1903580,1,0.819401225965246,0,29,positive regulation of ATP metabolic process,BP,
19787,GO:1903584,1,0.992982030804003,0,1,regulation of histone deubiquitination,BP,
19788,GO:1903586,1,0.992982030804003,0,1,positive regulation of histone deubiquitination,BP,
19789,GO:1903587,1,0.943385462573982,0,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19790,GO:1903588,1,0.974110507837485,0,4,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19791,GO:1903589,1,0.968466499922306,0,5,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19792,GO:1903593,1,0.983690467002363,0,3,regulation of histamine secretion by mast cell,BP,
19793,GO:1903595,1,0.983690467002363,0,3,positive regulation of histamine secretion by mast cell,BP,
19794,GO:1903596,1,0.976266051923129,0,4,regulation of gap junction assembly,BP,
19795,GO:1903597,1,0.993824525273096,0,1,negative regulation of gap junction assembly,BP,
19796,GO:1903598,1,0.982333506270394,0,3,positive regulation of gap junction assembly,BP,
19797,GO:1903599,1,0.881166289509861,0,17,positive regulation of autophagy of mitochondrion,BP,
19798,GO:1903608,1,0.961503391501739,0,6,protein localization to cytoplasmic stress granule,BP,
19799,GO:1903609,1,0.994240083034553,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19800,GO:1903610,1,0.994495382707259,0,1,regulation of calcium-dependent ATPase activity,BP,
19801,GO:1903611,1,0.994495382707259,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19802,GO:1903613,1,0.99208451698471,0,1,regulation of protein tyrosine phosphatase activity,BP,
19803,GO:1903615,1,0.99208451698471,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19804,GO:1903618,1,0.993313444145808,0,1,regulation of transdifferentiation,BP,
19805,GO:1903620,1,0.993313444145808,0,1,positive regulation of transdifferentiation,BP,
19806,GO:1903621,1,0.994491068177062,0,1,protein localization to photoreceptor connecting cilium,BP,
19807,GO:1903624,1,0.940503276837313,0,9,regulation of DNA catabolic process,BP,
19808,GO:1903625,1,0.988746753472157,0,2,negative regulation of DNA catabolic process,BP,
19809,GO:1903626,1,0.970985715173072,0,4,positive regulation of DNA catabolic process,BP,
19810,GO:1903627,1,0.994495382707259,0,1,regulation of dUTP diphosphatase activity,BP,
19811,GO:1903629,1,0.994495382707259,0,1,positive regulation of dUTP diphosphatase activity,BP,
19812,GO:1903630,1,0.98913966819044,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19813,GO:1903631,1,0.994495382707259,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19814,GO:1903632,1,0.994614937977184,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19815,GO:1903633,1,0.994495382707259,0,1,regulation of leucine-tRNA ligase activity,BP,
19816,GO:1903634,1,0.994495382707259,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19817,GO:1903636,1,0.994662427018319,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19818,GO:1903638,1,0.994662427018319,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19819,GO:1903639,1,0.994664339170437,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19820,GO:1903640,1,0.994664339170437,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19821,GO:1903644,1,0.98898499117312,0,2,regulation of chaperone-mediated protein folding,BP,
19822,GO:1903645,1,0.994662427018319,0,1,negative regulation of chaperone-mediated protein folding,BP,
19823,GO:1903649,1,0.868248276203172,0,20,regulation of cytoplasmic transport,BP,
19824,GO:1903650,1,0.989277886579472,0,2,negative regulation of cytoplasmic transport,BP,
19825,GO:1903651,1,0.934981512200159,0,9,positive regulation of cytoplasmic transport,BP,
19826,GO:1903659,1,0.988934292494866,0,2,regulation of complement-dependent cytotoxicity,BP,
19827,GO:1903660,1,0.988934292494866,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19829,GO:1903671,1,0.846672835881895,0,23,negative regulation of sprouting angiogenesis,BP,
19831,GO:1903673,1,0.994497393747748,0,1,mitotic cleavage furrow formation,BP,
19832,GO:1903674,1,0.994499037316187,0,1,regulation of cap-dependent translational initiation,BP,
19833,GO:1903676,1,0.994499037316187,0,1,positive regulation of cap-dependent translational initiation,BP,
19834,GO:1903677,1,0.983243232755673,0,3,regulation of cap-independent translational initiation,BP,
19835,GO:1903679,1,0.983243232755673,0,3,positive regulation of cap-independent translational initiation,BP,
19836,GO:1903689,1,0.942831177069481,0,6,regulation of wound healing, spreading of epidermal cells,BP,
19837,GO:1903690,1,0.963836934816476,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19838,GO:1903691,1,0.978214029151117,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19839,GO:1903697,1,0.993832061869992,0,1,negative regulation of microvillus assembly,BP,
19840,GO:1903699,1,0.986426503065449,0,1,tarsal gland development,BP,
19841,GO:1903701,1,0.992229389295191,0,1,substantia propria of cornea development,BP,
19842,GO:1903704,1,0.993313444145808,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19846,GO:1903709,1,0.986426503065449,0,1,uterine gland development,BP,
19847,GO:1903712,1,0.993544297805147,0,1,cysteine transmembrane transport,BP,
19848,GO:1903715,1,0.961542641953959,0,6,regulation of aerobic respiration,BP,
19849,GO:1903717,1,0.991701569623798,0,1,response to ammonia,BP,
19850,GO:1903718,1,0.991701569623798,0,1,cellular response to ammonia,BP,
19851,GO:1903719,1,0.983241705132654,0,3,regulation of I-kappaB phosphorylation,BP,
19852,GO:1903721,1,0.983241705132654,0,3,positive regulation of I-kappaB phosphorylation,BP,
19853,GO:1903722,1,0.988487011183306,0,2,regulation of centriole elongation,BP,
19854,GO:1903723,1,0.99464301845219,0,1,negative regulation of centriole elongation,BP,
19855,GO:1903724,1,0.993811169199884,0,1,positive regulation of centriole elongation,BP,
19856,GO:1903725,1,0.642239422977823,0,66,regulation of phospholipid metabolic process,BP,
19857,GO:1903726,1,0.958031247423949,0,7,negative regulation of phospholipid metabolic process,BP,
19858,GO:1903727,1,0.758506350390082,0,42,positive regulation of phospholipid metabolic process,BP,
19859,GO:1903729,1,0.928529238393731,0,11,regulation of plasma membrane organization,BP,
19860,GO:1903742,1,0.994601526592866,0,1,regulation of anterograde synaptic vesicle transport,BP,
19861,GO:1903743,1,0.994601526592866,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19862,GO:1903747,1,0.482778079691905,0,115,regulation of establishment of protein localization to mitochondrion,BP,
19863,GO:1903748,1,0.951749339796416,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19864,GO:1903749,1,0.52019009555521,0,104,positive regulation of establishment of protein localization to mitochondrion,BP,
19865,GO:1903750,1,0.977054696020747,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19866,GO:1903751,1,0.977054696020747,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19867,GO:1903753,1,0.968818621808737,0,5,negative regulation of p38MAPK cascade,BP,
19868,GO:1903755,1,0.994616672573995,0,1,positive regulation of SUMO transferase activity,BP,
19869,GO:1903756,1,0.987197511129328,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19870,GO:1903758,1,0.987197511129328,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19871,GO:1903759,1,0.993966218722892,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19872,GO:1903760,1,0.978790260681586,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19873,GO:1903762,1,0.986291337700756,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19874,GO:1903763,1,0.978503984120827,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19875,GO:1903764,1,0.981183850611706,0,3,regulation of potassium ion export across plasma membrane,BP,
19876,GO:1903765,1,0.994024671939509,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19877,GO:1903766,1,0.994646746530207,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19878,GO:1903767,1,0.99429028007077,0,1,sweet taste receptor complex,CC,
19879,GO:1903768,1,0.99429028007077,0,1,taste receptor complex,CC,
19880,GO:1903770,1,0.994123438828563,0,1,negative regulation of beta-galactosidase activity,BP,
19881,GO:1903772,1,0.972313106001425,0,5,regulation of viral budding via host ESCRT complex,BP,
19882,GO:1903774,1,0.983297360246402,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19883,GO:1903775,1,0.988292319216075,0,2,regulation of DNA double-strand break processing,BP,
19884,GO:1903778,1,0.991116875849629,0,1,protein localization to vacuolar membrane,BP,
19886,GO:1903781,1,0.97960121056249,0,3,positive regulation of cardiac conduction,BP,
19887,GO:1903786,1,0.994207649744507,0,1,regulation of glutathione biosynthetic process,BP,
19888,GO:1903788,1,0.994207649744507,0,1,positive regulation of glutathione biosynthetic process,BP,
19889,GO:1903789,1,0.949505644900327,0,8,regulation of amino acid transmembrane transport,BP,
19890,GO:1903792,1,0.862284109626968,0,22,negative regulation of anion transport,BP,
19891,GO:1903793,1,0.801135888126571,0,34,positive regulation of anion transport,BP,
19892,GO:1903795,1,0.952490002016969,0,6,regulation of inorganic anion transmembrane transport,BP,
19893,GO:1903796,1,0.983141967748138,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19894,GO:1903797,1,0.984582122188174,0,2,positive regulation of inorganic anion transmembrane transport,BP,
19895,GO:1903798,1,0.909041858203991,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19896,GO:1903799,1,0.941149194673402,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19897,GO:1903800,1,0.960514624893105,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19898,GO:1903801,1,0.994400926861373,0,1,L-leucine import across plasma membrane,BP,
19899,GO:1903803,1,0.99449550146966,0,1,L-glutamine import across plasma membrane,BP,
19900,GO:1903804,1,0.994138386097205,0,1,glycine import across plasma membrane,BP,
19901,GO:1903814,1,0.994646746530207,0,1,regulation of collecting lymphatic vessel constriction,BP,
19902,GO:1903815,1,0.994646746530207,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19903,GO:1903817,1,0.948535283070973,0,8,negative regulation of voltage-gated potassium channel activity,BP,
19904,GO:1903818,1,0.904520117437146,0,13,positive regulation of voltage-gated potassium channel activity,BP,
19905,GO:1903823,1,0.994123438828563,0,1,telomere single strand break repair,BP,
19906,GO:1903824,1,0.994123438828563,0,1,negative regulation of telomere single strand break repair,BP,
19907,GO:1903825,1,0.47865004913819,0,107,organic acid transmembrane transport,BP,
19908,GO:1903826,1,0.958519093123457,0,6,arginine transmembrane transport,BP,
19912,GO:1903830,1,0.899581347384085,0,16,magnesium ion transmembrane transport,BP,
19913,GO:1903831,1,0.874646701883533,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19914,GO:1903837,1,0.994325157917915,0,1,regulation of mRNA 3'-UTR binding,BP,
19915,GO:1903839,1,0.994325157917915,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19917,GO:1903845,1,0.61369347843267,0,68,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19919,GO:1903847,1,0.981599454430245,0,2,regulation of aorta morphogenesis,BP,
19920,GO:1903849,1,0.981599454430245,0,2,positive regulation of aorta morphogenesis,BP,
19921,GO:1903850,1,0.994244505801108,0,1,regulation of cristae formation,BP,
19922,GO:1903852,1,0.994244505801108,0,1,positive regulation of cristae formation,BP,
19924,GO:1903860,1,0.982463050430831,0,3,negative regulation of dendrite extension,BP,
19926,GO:1903862,1,0.966314327024855,0,6,positive regulation of oxidative phosphorylation,BP,
19927,GO:1903867,1,0.940034686704535,0,9,extraembryonic membrane development,BP,
19928,GO:1903874,1,0.979834368442531,0,3,ferrous iron transmembrane transport,BP,
19929,GO:1903881,1,0.993556003057948,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19930,GO:1903883,1,0.993556003057948,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19931,GO:1903884,1,0.993556003057948,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19932,GO:1903886,1,0.993556003057948,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19933,GO:1903888,1,0.994651281344248,0,1,regulation of plant epidermal cell differentiation,BP,
19934,GO:1903889,1,0.994651281344248,0,1,negative regulation of plant epidermal cell differentiation,BP,
19935,GO:1903891,1,0.975760296979992,0,4,regulation of ATF6-mediated unfolded protein response,BP,
19936,GO:1903892,1,0.98791424558106,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19937,GO:1903893,1,0.994315567373823,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
19938,GO:1903894,1,0.920479706557633,0,13,regulation of IRE1-mediated unfolded protein response,BP,
19939,GO:1903895,1,0.975985588201981,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
19940,GO:1903896,1,0.953480450251895,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
19941,GO:1903897,1,0.942798990769442,0,9,regulation of PERK-mediated unfolded protein response,BP,
19942,GO:1903898,1,0.96963549601476,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19943,GO:1903899,1,0.978846305872466,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
19946,GO:1903902,1,0.698264496247225,0,55,positive regulation of viral life cycle,BP,
19947,GO:1903903,1,0.978700728691636,0,3,regulation of establishment of T cell polarity,BP,
19948,GO:1903905,1,0.984401924114958,0,2,positive regulation of establishment of T cell polarity,BP,
19949,GO:1903906,1,0.994209375483572,0,1,regulation of plasma membrane raft polarization,BP,
19951,GO:1903910,1,0.994376192188773,0,1,negative regulation of receptor clustering,BP,
19952,GO:1903911,1,0.97321536669771,0,4,positive regulation of receptor clustering,BP,
19953,GO:1903912,1,0.973176823391442,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19954,GO:1903916,1,0.994360838239109,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19955,GO:1903917,1,0.994360838239109,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19956,GO:1903918,1,0.990048926230235,0,1,regulation of actin filament severing,BP,
19957,GO:1903919,1,0.990048926230235,0,1,negative regulation of actin filament severing,BP,
19958,GO:1903921,1,0.984315353323881,0,2,regulation of protein processing in phagocytic vesicle,BP,
19959,GO:1903923,1,0.984315353323881,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19960,GO:1903924,1,0.994413793257457,0,1,estradiol binding,MF,
19961,GO:1903925,1,0.994509112592768,0,1,response to bisphenol A,BP,
19962,GO:1903926,1,0.994509112592768,0,1,cellular response to bisphenol A,BP,
19963,GO:1903929,1,0.988360916136999,0,2,primary palate development,BP,
19964,GO:1903935,1,0.972259765148481,0,5,response to sodium arsenite,BP,
19965,GO:1903936,1,0.972259765148481,0,5,cellular response to sodium arsenite,BP,
19966,GO:1903937,1,0.99245478670028,0,1,response to acrylamide,BP,
19967,GO:1903939,1,0.993839209719658,0,1,regulation of TORC2 signaling,BP,
19968,GO:1903943,1,0.99448753674817,0,1,regulation of hepatocyte apoptotic process,BP,
19969,GO:1903944,1,0.99448753674817,0,1,negative regulation of hepatocyte apoptotic process,BP,
19970,GO:1903946,1,0.994024671939509,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19971,GO:1903947,1,0.986291337700756,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19972,GO:1903949,1,0.98663938021675,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19973,GO:1903952,1,0.993339033069618,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19974,GO:1903954,1,0.993339033069618,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19975,GO:1903955,1,0.623913918553546,0,74,positive regulation of protein targeting to mitochondrion,BP,
19976,GO:1903959,1,0.847699707860919,0,23,regulation of anion transmembrane transport,BP,
19977,GO:1903960,1,0.92409195075814,0,11,negative regulation of anion transmembrane transport,BP,
19978,GO:1903961,1,0.960557376939738,0,6,positive regulation of anion transmembrane transport,BP,
19980,GO:1903964,1,0.980964094849366,0,3,monounsaturated fatty acid metabolic process,BP,
19981,GO:1903965,1,0.994595567912165,0,1,monounsaturated fatty acid catabolic process,BP,
19982,GO:1903966,1,0.986295194246699,0,2,monounsaturated fatty acid biosynthetic process,BP,
19983,GO:1903969,1,0.983551229180954,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19984,GO:1903970,1,0.989147835792323,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19985,GO:1903971,1,0.994342608047487,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19986,GO:1903972,1,0.983551229180954,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19987,GO:1903973,1,0.989147835792323,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19988,GO:1903974,1,0.994342608047487,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19989,GO:1903975,1,0.947105088564142,0,9,regulation of glial cell migration,BP,
19990,GO:1903976,1,0.977919768573332,0,4,negative regulation of glial cell migration,BP,
19991,GO:1903977,1,0.979134735831119,0,3,positive regulation of glial cell migration,BP,
19992,GO:1903978,1,0.930451252501664,0,9,regulation of microglial cell activation,BP,
19993,GO:1903979,1,0.986824909202917,0,2,negative regulation of microglial cell activation,BP,
19994,GO:1903980,1,0.950186373787619,0,7,positive regulation of microglial cell activation,BP,
19995,GO:1903984,1,0.978470485254855,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19996,GO:1903988,1,0.993829911822307,0,1,ferrous iron export across plasma membrane,BP,
19997,GO:1903995,1,0.989032083349305,0,2,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19998,GO:1903997,1,0.989032083349305,0,2,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19999,GO:1903998,1,0.970781245329908,0,4,regulation of eating behavior,BP,
20000,GO:1903999,1,0.986905055072431,0,2,negative regulation of eating behavior,BP,
20001,GO:1904000,1,0.983664382700291,0,2,positive regulation of eating behavior,BP,
20002,GO:1904008,1,0.994591916970503,0,1,response to monosodium glutamate,BP,
20003,GO:1904009,1,0.994591916970503,0,1,cellular response to monosodium glutamate,BP,
20004,GO:1904010,1,0.994591916970503,0,1,response to Aroclor 1254,BP,
20005,GO:1904016,1,0.970159025843131,0,4,response to Thyroglobulin triiodothyronine,BP,
20006,GO:1904017,1,0.982010016801992,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20009,GO:1904020,1,0.982376289130504,0,3,regulation of G-protein coupled receptor internalization,BP,
20010,GO:1904021,1,0.988381753569499,0,2,negative regulation of G-protein coupled receptor internalization,BP,
20011,GO:1904022,1,0.993924650737727,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20012,GO:1904026,1,0.988518798546646,0,2,regulation of collagen fibril organization,BP,
20013,GO:1904027,1,0.994301220020547,0,1,negative regulation of collagen fibril organization,BP,
20014,GO:1904028,1,0.994184768585909,0,1,positive regulation of collagen fibril organization,BP,
20015,GO:1904029,1,0.568795651120839,0,88,regulation of cyclin-dependent protein kinase activity,BP,
20016,GO:1904030,1,0.803999902090676,0,32,negative regulation of cyclin-dependent protein kinase activity,BP,
20017,GO:1904031,1,0.795381841198098,0,36,positive regulation of cyclin-dependent protein kinase activity,BP,
20020,GO:1904037,1,0.841300765764291,0,26,positive regulation of epithelial cell apoptotic process,BP,
20021,GO:1904041,1,0.993874503447871,0,1,regulation of cystathionine beta-synthase activity,BP,
20022,GO:1904042,1,0.993874503447871,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20023,GO:1904044,1,0.975647286466943,0,4,response to aldosterone,BP,
20024,GO:1904045,1,0.994417873065761,0,1,cellular response to aldosterone,BP,
20025,GO:1904046,1,0.98917511494302,0,2,negative regulation of vascular endothelial growth factor production,BP,
20026,GO:1904047,1,0.98287588086258,0,3,S-adenosyl-L-methionine binding,MF,
20027,GO:1904048,1,0.980737288249879,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20028,GO:1904049,1,0.987817905705933,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20029,GO:1904050,1,0.99283293585568,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20030,GO:1904054,1,0.988950931178037,0,1,regulation of cholangiocyte proliferation,BP,
20031,GO:1904056,1,0.988950931178037,0,1,positive regulation of cholangiocyte proliferation,BP,
20032,GO:1904057,1,0.988859717667377,0,2,negative regulation of sensory perception of pain,BP,
20033,GO:1904058,1,0.96574311193792,0,5,positive regulation of sensory perception of pain,BP,
20034,GO:1904059,1,0.978383207480761,0,2,regulation of locomotor rhythm,BP,
20036,GO:1904063,1,0.635056862400457,0,69,negative regulation of cation transmembrane transport,BP,
20038,GO:1904071,1,0.98219652385323,0,2,presynaptic active zone assembly,BP,
20039,GO:1904073,1,0.990301354533528,0,1,regulation of trophectodermal cell proliferation,BP,
20040,GO:1904075,1,0.990301354533528,0,1,positive regulation of trophectodermal cell proliferation,BP,
20041,GO:1904090,1,0.978397339240516,0,4,peptidase inhibitor complex,CC,
20042,GO:1904098,1,0.981184477643534,0,3,regulation of protein O-linked glycosylation,BP,
20043,GO:1904100,1,0.981184477643534,0,3,positive regulation of protein O-linked glycosylation,BP,
20044,GO:1904106,1,0.994197443714856,0,1,protein localization to microvillus,BP,
20045,GO:1904115,1,0.755545992296944,0,40,axon cytoplasm,CC,
20046,GO:1904116,1,0.979459580171324,0,3,response to vasopressin,BP,
20047,GO:1904117,1,0.979459580171324,0,3,cellular response to vasopressin,BP,
20048,GO:1904118,1,0.993996928868153,0,1,regulation of otic vesicle morphogenesis,BP,
20049,GO:1904120,1,0.993996928868153,0,1,positive regulation of otic vesicle morphogenesis,BP,
20050,GO:1904121,1,0.977430857622546,0,3,phosphatidylethanolamine transporter activity,MF,
20051,GO:1904124,1,0.983587981578552,0,3,microglial cell migration,BP,
20052,GO:1904139,1,0.983587981578552,0,3,regulation of microglial cell migration,BP,
20053,GO:1904140,1,0.994575505946109,0,1,negative regulation of microglial cell migration,BP,
20054,GO:1904141,1,0.994342608047487,0,1,positive regulation of microglial cell migration,BP,
20055,GO:1904149,1,0.994575505946109,0,1,regulation of microglial cell mediated cytotoxicity,BP,
20056,GO:1904151,1,0.994575505946109,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
20057,GO:1904152,1,0.921102057739253,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20058,GO:1904153,1,0.945366799416528,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20059,GO:1904154,1,0.980513529374199,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20060,GO:1904155,1,0.993838853022917,0,1,DN2 thymocyte differentiation,BP,
20061,GO:1904156,1,0.993838853022917,0,1,DN3 thymocyte differentiation,BP,
20062,GO:1904158,1,0.973262081329574,0,3,axonemal central apparatus assembly,BP,
20063,GO:1904167,1,0.987492760745113,0,1,regulation of thyroid hormone receptor activity,BP,
20064,GO:1904168,1,0.987492760745113,0,1,negative regulation of thyroid hormone receptor activity,BP,
20065,GO:1904170,1,0.986633880998135,0,2,regulation of bleb assembly,BP,
20066,GO:1904172,1,0.986633880998135,0,2,positive regulation of bleb assembly,BP,
20067,GO:1904177,1,0.960878673309237,0,6,regulation of adipose tissue development,BP,
20068,GO:1904179,1,0.966085638366106,0,5,positive regulation of adipose tissue development,BP,
20069,GO:1904180,1,0.964900127590921,0,6,negative regulation of membrane depolarization,BP,
20070,GO:1904181,1,0.934614524817579,0,10,positive regulation of membrane depolarization,BP,
20071,GO:1904182,1,0.994620037387759,0,1,regulation of pyruvate dehydrogenase activity,BP,
20072,GO:1904192,1,0.988950931178037,0,1,regulation of cholangiocyte apoptotic process,BP,
20073,GO:1904193,1,0.988950931178037,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20074,GO:1904195,1,0.988950931178037,0,1,regulation of granulosa cell proliferation,BP,
20075,GO:1904197,1,0.988950931178037,0,1,positive regulation of granulosa cell proliferation,BP,
20076,GO:1904199,1,0.993255870882139,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
20077,GO:1904200,1,0.988950931178037,0,1,iodide transmembrane transport,BP,
20078,GO:1904201,1,0.988950931178037,0,1,regulation of iodide transport,BP,
20079,GO:1904202,1,0.988950931178037,0,1,negative regulation of iodide transport,BP,
20080,GO:1904204,1,0.980293379244614,0,2,regulation of skeletal muscle hypertrophy,BP,
20081,GO:1904205,1,0.991246687716404,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20082,GO:1904206,1,0.988950931178037,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20085,GO:1904210,1,0.994594363712384,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20086,GO:1904211,1,0.98697811604448,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20087,GO:1904212,1,0.988950931178037,0,1,regulation of iodide transmembrane transport,BP,
20088,GO:1904213,1,0.988950931178037,0,1,negative regulation of iodide transmembrane transport,BP,
20089,GO:1904217,1,0.983047005157009,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20090,GO:1904219,1,0.983047005157009,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20091,GO:1904220,1,0.977329383786988,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20092,GO:1904222,1,0.983047005157009,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20093,GO:1904226,1,0.994425885609532,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20094,GO:1904227,1,0.994425885609532,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20095,GO:1904229,1,0.990386535669663,0,1,regulation of succinate dehydrogenase activity,BP,
20096,GO:1904231,1,0.990386535669663,0,1,positive regulation of succinate dehydrogenase activity,BP,
20097,GO:1904232,1,0.990386535669663,0,1,regulation of aconitate hydratase activity,BP,
20098,GO:1904234,1,0.990386535669663,0,1,positive regulation of aconitate hydratase activity,BP,
20099,GO:1904235,1,0.989284222498419,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20100,GO:1904237,1,0.989284222498419,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20101,GO:1904238,1,0.955343815441196,0,7,pericyte cell differentiation,BP,
20102,GO:1904239,1,0.994594363712384,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20103,GO:1904240,1,0.994594363712384,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20104,GO:1904245,1,0.988585815739263,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20105,GO:1904246,1,0.99453565139976,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20106,GO:1904247,1,0.994017800844593,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20107,GO:1904251,1,0.941335443408622,0,10,regulation of bile acid metabolic process,BP,
20108,GO:1904252,1,0.982743410447409,0,3,negative regulation of bile acid metabolic process,BP,
20109,GO:1904253,1,0.982930861259615,0,3,positive regulation of bile acid metabolic process,BP,
20110,GO:1904259,1,0.955939962256976,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20111,GO:1904261,1,0.955939962256976,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20112,GO:1904262,1,0.929879978411858,0,11,negative regulation of TORC1 signaling,BP,
20113,GO:1904263,1,0.943345679644224,0,9,positive regulation of TORC1 signaling,BP,
20114,GO:1904265,1,0.991223304116268,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20115,GO:1904266,1,0.990337313481602,0,1,regulation of Schwann cell chemotaxis,BP,
20116,GO:1904268,1,0.990337313481602,0,1,positive regulation of Schwann cell chemotaxis,BP,
20117,GO:1904271,1,0.994327130902036,0,1,L-proline import across plasma membrane,BP,
20118,GO:1904274,1,0.994414108844754,0,1,tricellular tight junction assembly,BP,
20119,GO:1904282,1,0.994490947237411,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20120,GO:1904283,1,0.994490947237411,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20121,GO:1904288,1,0.971439085550582,0,4,BAT3 complex binding,MF,
20122,GO:1904289,1,0.986962773988454,0,2,regulation of mitotic DNA damage checkpoint,BP,
20123,GO:1904290,1,0.992847494337506,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20124,GO:1904292,1,0.838347454602922,0,27,regulation of ERAD pathway,BP,
20125,GO:1904293,1,0.921598607810619,0,13,negative regulation of ERAD pathway,BP,
20126,GO:1904294,1,0.91682104467697,0,13,positive regulation of ERAD pathway,BP,
20127,GO:1904298,1,0.993196453193617,0,1,regulation of transcytosis,BP,
20128,GO:1904300,1,0.993196453193617,0,1,positive regulation of transcytosis,BP,
20129,GO:1904301,1,0.993196453193617,0,1,regulation of maternal process involved in parturition,BP,
20130,GO:1904303,1,0.993196453193617,0,1,positive regulation of maternal process involved in parturition,BP,
20131,GO:1904304,1,0.96930532765554,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20132,GO:1904306,1,0.96930532765554,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20133,GO:1904313,1,0.993345835634699,0,1,response to methamphetamine hydrochloride,BP,
20135,GO:1904316,1,0.993196453193617,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20136,GO:1904317,1,0.993196453193617,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20137,GO:1904321,1,0.914809682806959,0,11,response to forskolin,BP,
20138,GO:1904322,1,0.914809682806959,0,11,cellular response to forskolin,BP,
20139,GO:1904323,1,0.994120638582788,0,1,regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20140,GO:1904325,1,0.994120638582788,0,1,positive regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20141,GO:1904327,1,0.985039140781417,0,2,protein localization to cytosolic proteasome complex,BP,
20143,GO:1904338,1,0.942104307805975,0,9,regulation of dopaminergic neuron differentiation,BP,
20144,GO:1904339,1,0.985063450446728,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20145,GO:1904340,1,0.978028721033399,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20146,GO:1904341,1,0.99224214601651,0,1,regulation of colon smooth muscle contraction,BP,
20147,GO:1904343,1,0.99224214601651,0,1,positive regulation of colon smooth muscle contraction,BP,
20148,GO:1904344,1,0.994654979429419,0,1,regulation of gastric mucosal blood circulation,BP,
20149,GO:1904346,1,0.994654979429419,0,1,positive regulation of gastric mucosal blood circulation,BP,
20150,GO:1904347,1,0.986938179294135,0,2,regulation of small intestine smooth muscle contraction,BP,
20151,GO:1904349,1,0.986938179294135,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20152,GO:1904350,1,0.926677403517094,0,9,regulation of protein catabolic process in the vacuole,BP,
20153,GO:1904351,1,0.981707685050605,0,3,negative regulation of protein catabolic process in the vacuole,BP,
20154,GO:1904352,1,0.949318902245972,0,5,positive regulation of protein catabolic process in the vacuole,BP,
20155,GO:1904353,1,0.831837553198131,0,26,regulation of telomere capping,BP,
20156,GO:1904354,1,0.937585767294696,0,8,negative regulation of telomere capping,BP,
20157,GO:1904355,1,0.894442780547074,0,17,positive regulation of telomere capping,BP,
20158,GO:1904356,1,0.672094194061953,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20159,GO:1904357,1,0.83147261711535,0,25,negative regulation of telomere maintenance via telomere lengthening,BP,
20160,GO:1904358,1,0.790531398421446,0,36,positive regulation of telomere maintenance via telomere lengthening,BP,
20161,GO:1904373,1,0.994570911091284,0,1,response to kainic acid,BP,
20164,GO:1904377,1,0.690450228740204,0,53,positive regulation of protein localization to cell periphery,BP,
20165,GO:1904378,1,0.978468923843233,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20166,GO:1904379,1,0.985039140781417,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20167,GO:1904380,1,0.872709429161322,0,20,endoplasmic reticulum mannose trimming,BP,
20168,GO:1904381,1,0.979323239737858,0,3,Golgi apparatus mannose trimming,BP,
20169,GO:1904382,1,0.971199669184398,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20170,GO:1904383,1,0.988602505413757,0,2,response to sodium phosphate,BP,
20171,GO:1904385,1,0.881280657952741,0,20,cellular response to angiotensin,BP,
20172,GO:1904386,1,0.968776612269347,0,5,response to L-phenylalanine derivative,BP,
20173,GO:1904387,1,0.987602563914689,0,2,cellular response to L-phenylalanine derivative,BP,
20174,GO:1904389,1,0.994570911091284,0,1,rod bipolar cell differentiation,BP,
20175,GO:1904391,1,0.994570911091284,0,1,response to ciliary neurotrophic factor,BP,
20176,GO:1904393,1,0.978716069547025,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20177,GO:1904394,1,0.994376192188773,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20178,GO:1904395,1,0.984252190882353,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20179,GO:1904396,1,0.9494576142001,0,7,regulation of neuromuscular junction development,BP,
20180,GO:1904397,1,0.98897733143442,0,2,negative regulation of neuromuscular junction development,BP,
20181,GO:1904398,1,0.974625601599586,0,3,positive regulation of neuromuscular junction development,BP,
20182,GO:1904399,1,0.994570911091284,0,1,heparan sulfate binding,MF,
20183,GO:1904400,1,0.994006780387232,0,1,response to Thyroid stimulating hormone,BP,
20184,GO:1904404,1,0.990203688922681,0,1,response to formaldehyde,BP,
20185,GO:1904406,1,0.923534807603918,0,12,negative regulation of nitric oxide metabolic process,BP,
20187,GO:1904408,1,0.994622869842464,0,1,melatonin binding,MF,
20188,GO:1904412,1,0.993628847729139,0,1,regulation of cardiac ventricle development,BP,
20189,GO:1904414,1,0.993628847729139,0,1,positive regulation of cardiac ventricle development,BP,
20190,GO:1904415,1,0.96392426385738,0,6,regulation of xenophagy,BP,
20191,GO:1904417,1,0.96392426385738,0,6,positive regulation of xenophagy,BP,
20192,GO:1904424,1,0.930891267691921,0,10,regulation of GTP binding,BP,
20193,GO:1904425,1,0.993509340608061,0,1,negative regulation of GTP binding,BP,
20194,GO:1904426,1,0.98536165891093,0,2,positive regulation of GTP binding,BP,
20196,GO:1904428,1,0.973778683311375,0,3,negative regulation of tubulin deacetylation,BP,
20197,GO:1904429,1,0.963486317449739,0,6,regulation of t-circle formation,BP,
20198,GO:1904430,1,0.980817462322624,0,3,negative regulation of t-circle formation,BP,
20199,GO:1904431,1,0.982333290984525,0,3,positive regulation of t-circle formation,BP,
20200,GO:1904432,1,0.989157056978244,0,2,regulation of ferrous iron binding,BP,
20201,GO:1904434,1,0.989157056978244,0,2,positive regulation of ferrous iron binding,BP,
20202,GO:1904435,1,0.989157056978244,0,2,regulation of transferrin receptor binding,BP,
20203,GO:1904437,1,0.989157056978244,0,2,positive regulation of transferrin receptor binding,BP,
20204,GO:1904447,1,0.974558463085453,0,2,folic acid import across plasma membrane,BP,
20205,GO:1904448,1,0.992492201901996,0,1,regulation of aspartate secretion,BP,
20206,GO:1904450,1,0.992492201901996,0,1,positive regulation of aspartate secretion,BP,
20207,GO:1904454,1,0.989683495567633,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20208,GO:1904455,1,0.98371672019208,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20209,GO:1904456,1,0.994508439459796,0,1,negative regulation of neuronal action potential,BP,
20210,GO:1904457,1,0.994352008191647,0,1,positive regulation of neuronal action potential,BP,
20211,GO:1904464,1,0.994537030649287,0,1,regulation of matrix metallopeptidase secretion,BP,
20212,GO:1904465,1,0.994537030649287,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20213,GO:1904467,1,0.886004541186679,0,17,regulation of tumor necrosis factor secretion,BP,
20214,GO:1904468,1,0.970327858979339,0,5,negative regulation of tumor necrosis factor secretion,BP,
20215,GO:1904469,1,0.913123124916741,0,12,positive regulation of tumor necrosis factor secretion,BP,
20216,GO:1904475,1,0.982043286838657,0,2,regulation of Ras GTPase binding,BP,
20217,GO:1904477,1,0.991132725832899,0,1,positive regulation of Ras GTPase binding,BP,
20218,GO:1904478,1,0.970996414226342,0,5,regulation of intestinal absorption,BP,
20219,GO:1904479,1,0.988938024909983,0,2,negative regulation of intestinal absorption,BP,
20220,GO:1904481,1,0.994331051157947,0,1,response to tetrahydrofolate,BP,
20221,GO:1904482,1,0.994331051157947,0,1,cellular response to tetrahydrofolate,BP,
20222,GO:1904491,1,0.978228705205596,0,4,protein localization to ciliary transition zone,BP,
20223,GO:1904492,1,0.994272090267979,0,1,Ac-Asp-Glu binding,MF,
20224,GO:1904493,1,0.994272090267979,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20225,GO:1904498,1,0.978060145538437,0,3,protein localization to mitotic actomyosin contractile ring,BP,
20226,GO:1904499,1,0.993779015227969,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20227,GO:1904501,1,0.993779015227969,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20228,GO:1904502,1,0.958754853140257,0,5,regulation of lipophagy,BP,
20229,GO:1904504,1,0.958754853140257,0,5,positive regulation of lipophagy,BP,
20230,GO:1904505,1,0.972155590865773,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20231,GO:1904506,1,0.972155590865773,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20232,GO:1904515,1,0.993839209719658,0,1,positive regulation of TORC2 signaling,BP,
20233,GO:1904526,1,0.94487854477836,0,9,regulation of microtubule binding,BP,
20234,GO:1904527,1,0.980197161101797,0,3,negative regulation of microtubule binding,BP,
20235,GO:1904528,1,0.964309292463067,0,6,positive regulation of microtubule binding,BP,
20236,GO:1904529,1,0.985864290791857,0,2,regulation of actin filament binding,BP,
20237,GO:1904530,1,0.994003611723475,0,1,negative regulation of actin filament binding,BP,
20238,GO:1904531,1,0.991812068390637,0,1,positive regulation of actin filament binding,BP,
20239,GO:1904533,1,0.981150740961939,0,3,regulation of telomeric loop disassembly,BP,
20240,GO:1904534,1,0.988261087851807,0,2,negative regulation of telomeric loop disassembly,BP,
20241,GO:1904535,1,0.99280604044364,0,1,positive regulation of telomeric loop disassembly,BP,
20242,GO:1904542,1,0.994244505801108,0,1,regulation of free ubiquitin chain polymerization,BP,
20243,GO:1904544,1,0.994244505801108,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20244,GO:1904550,1,0.994459603418009,0,1,response to arachidonic acid,BP,
20245,GO:1904555,1,0.994327130902036,0,1,L-proline transmembrane transport,BP,
20246,GO:1904556,1,0.994327130902036,0,1,L-tryptophan transmembrane transport,BP,
20247,GO:1904562,1,0.980399803080131,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20248,GO:1904565,1,0.993986349357149,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20249,GO:1904566,1,0.993986349357149,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20250,GO:1904567,1,0.994058968473674,0,1,response to wortmannin,BP,
20251,GO:1904568,1,0.994058968473674,0,1,cellular response to wortmannin,BP,
20252,GO:1904569,1,0.994536046457936,0,1,regulation of selenocysteine incorporation,BP,
20253,GO:1904570,1,0.994536046457936,0,1,negative regulation of selenocysteine incorporation,BP,
20254,GO:1904572,1,0.994536046457936,0,1,negative regulation of mRNA binding,BP,
20255,GO:1904573,1,0.994536046457936,0,1,regulation of selenocysteine insertion sequence binding,BP,
20256,GO:1904574,1,0.994536046457936,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20257,GO:1904576,1,0.988736515554338,0,2,response to tunicamycin,BP,
20258,GO:1904577,1,0.988736515554338,0,2,cellular response to tunicamycin,BP,
20259,GO:1904578,1,0.981750154601735,0,3,response to thapsigargin,BP,
20260,GO:1904579,1,0.981750154601735,0,3,cellular response to thapsigargin,BP,
20261,GO:1904580,1,0.988621356150508,0,2,regulation of intracellular mRNA localization,BP,
20262,GO:1904582,1,0.988621356150508,0,2,positive regulation of intracellular mRNA localization,BP,
20263,GO:1904585,1,0.994434001959065,0,1,response to putrescine,BP,
20264,GO:1904586,1,0.994434001959065,0,1,cellular response to putrescine,BP,
20265,GO:1904587,1,0.960173791623555,0,6,response to glycoprotein,BP,
20266,GO:1904588,1,0.994611703443189,0,1,cellular response to glycoprotein,BP,
20267,GO:1904589,1,0.702528833357622,0,51,regulation of protein import,BP,
20268,GO:1904590,1,0.94041680284587,0,10,negative regulation of protein import,BP,
20269,GO:1904591,1,0.782346006630253,0,33,positive regulation of protein import,BP,
20270,GO:1904594,1,0.98704162678125,0,1,regulation of termination of RNA polymerase II transcription,BP,
20271,GO:1904595,1,0.98704162678125,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20272,GO:1904596,1,0.994600258828157,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20273,GO:1904597,1,0.994600258828157,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20274,GO:1904599,1,0.994600258828157,0,1,advanced glycation end-product binding,MF,
20275,GO:1904602,1,0.988958975048077,0,2,serotonin-activated cation-selective channel complex,CC,
20276,GO:1904603,1,0.994600258828157,0,1,regulation of advanced glycation end-product receptor activity,BP,
20277,GO:1904604,1,0.994600258828157,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20278,GO:1904606,1,0.993779751963204,0,1,fat cell apoptotic process,BP,
20279,GO:1904612,1,0.978531325083554,0,3,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20280,GO:1904613,1,0.984432166036322,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20281,GO:1904616,1,0.985864290791857,0,2,regulation of actin binding,BP,
20282,GO:1904617,1,0.994003611723475,0,1,negative regulation of actin binding,BP,
20283,GO:1904618,1,0.991812068390637,0,1,positive regulation of actin binding,BP,
20284,GO:1904627,1,0.988816334149462,0,2,response to phorbol 13-acetate 12-myristate,BP,
20285,GO:1904628,1,0.988816334149462,0,2,cellular response to phorbol 13-acetate 12-myristate,BP,
20286,GO:1904631,1,0.994408543528506,0,1,response to glucoside,BP,
20287,GO:1904633,1,0.991164447768179,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20288,GO:1904635,1,0.991164447768179,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20289,GO:1904636,1,0.972382936065928,0,4,response to ionomycin,BP,
20290,GO:1904637,1,0.972382936065928,0,4,cellular response to ionomycin,BP,
20291,GO:1904638,1,0.991164447768179,0,1,response to resveratrol,BP,
20292,GO:1904639,1,0.991164447768179,0,1,cellular response to resveratrol,BP,
20293,GO:1904640,1,0.985449096929877,0,2,response to methionine,BP,
20294,GO:1904645,1,0.812875958129642,0,27,response to amyloid-beta,BP,
20295,GO:1904646,1,0.822000593182863,0,25,cellular response to amyloid-beta,BP,
20296,GO:1904647,1,0.988627638141655,0,1,response to rotenone,BP,
20297,GO:1904649,1,0.993779751963204,0,1,regulation of fat cell apoptotic process,BP,
20298,GO:1904651,1,0.993779751963204,0,1,positive regulation of fat cell apoptotic process,BP,
20299,GO:1904659,1,0.529899409270908,0,92,glucose transmembrane transport,BP,
20300,GO:1904666,1,0.893656746680939,0,19,regulation of ubiquitin protein ligase activity,BP,
20301,GO:1904667,1,0.962239543223967,0,7,negative regulation of ubiquitin protein ligase activity,BP,
20302,GO:1904668,1,0.928752318395806,0,12,positive regulation of ubiquitin protein ligase activity,BP,
20303,GO:1904672,1,0.967226977136019,0,5,regulation of somatic stem cell population maintenance,BP,
20304,GO:1904673,1,0.980072474009355,0,3,negative regulation of somatic stem cell population maintenance,BP,
20305,GO:1904674,1,0.986895939846308,0,2,positive regulation of somatic stem cell population maintenance,BP,
20306,GO:1904675,1,0.994102481539163,0,1,regulation of somatic stem cell division,BP,
20307,GO:1904677,1,0.994102481539163,0,1,positive regulation of somatic stem cell division,BP,
20308,GO:1904680,1,0.875179905899254,0,22,peptide transmembrane transporter activity,MF,
20309,GO:1904681,1,0.994229231381529,0,1,response to 3-methylcholanthrene,BP,
20310,GO:1904683,1,0.953244210222255,0,6,regulation of metalloendopeptidase activity,BP,
20311,GO:1904684,1,0.965912178837934,0,4,negative regulation of metalloendopeptidase activity,BP,
20312,GO:1904685,1,0.986889482941058,0,2,positive regulation of metalloendopeptidase activity,BP,
20313,GO:1904688,1,0.96714876454114,0,5,regulation of cytoplasmic translational initiation,BP,
20314,GO:1904689,1,0.994624247775424,0,1,negative regulation of cytoplasmic translational initiation,BP,
20315,GO:1904690,1,0.972377486163924,0,4,positive regulation of cytoplasmic translational initiation,BP,
20316,GO:1904691,1,0.994442492080431,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20317,GO:1904692,1,0.993609124988001,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20318,GO:1904693,1,0.976424987834718,0,3,midbrain morphogenesis,BP,
20319,GO:1904694,1,0.973700775593424,0,3,negative regulation of vascular smooth muscle contraction,BP,
20320,GO:1904695,1,0.994497393747748,0,1,positive regulation of vascular smooth muscle contraction,BP,
20321,GO:1904700,1,0.994272971124939,0,1,granulosa cell apoptotic process,BP,
20322,GO:1904701,1,0.994523216867324,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20323,GO:1904705,1,0.785331114699827,0,36,regulation of vascular smooth muscle cell proliferation,BP,
20324,GO:1904706,1,0.916176898279665,0,14,negative regulation of vascular smooth muscle cell proliferation,BP,
20325,GO:1904707,1,0.852624864407099,0,23,positive regulation of vascular smooth muscle cell proliferation,BP,
20326,GO:1904708,1,0.994272971124939,0,1,regulation of granulosa cell apoptotic process,BP,
20327,GO:1904711,1,0.994523216867324,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20328,GO:1904713,1,0.982776333187566,0,2,beta-catenin destruction complex binding,MF,
20329,GO:1904714,1,0.954043112869043,0,8,regulation of chaperone-mediated autophagy,BP,
20330,GO:1904715,1,0.982957311608858,0,3,negative regulation of chaperone-mediated autophagy,BP,
20331,GO:1904716,1,0.994365542801251,0,1,positive regulation of chaperone-mediated autophagy,BP,
20333,GO:1904719,1,0.994336096519607,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20334,GO:1904720,1,0.988398045063045,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20335,GO:1904721,1,0.994019679090279,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20336,GO:1904722,1,0.994344883062311,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20337,GO:1904723,1,0.994523216867324,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20339,GO:1904729,1,0.982762010701331,0,3,regulation of intestinal lipid absorption,BP,
20340,GO:1904730,1,0.994239849298598,0,1,negative regulation of intestinal lipid absorption,BP,
20341,GO:1904732,1,0.983914014331861,0,2,regulation of electron transfer activity,BP,
20342,GO:1904734,1,0.994667802235339,0,1,positive regulation of electron transfer activity,BP,
20343,GO:1904738,1,0.880524161451033,0,16,vascular associated smooth muscle cell migration,BP,
20344,GO:1904742,1,0.968433384193517,0,4,regulation of telomeric DNA binding,BP,
20345,GO:1904743,1,0.979086243327901,0,2,negative regulation of telomeric DNA binding,BP,
20346,GO:1904744,1,0.989121876199243,0,2,positive regulation of telomeric DNA binding,BP,
20347,GO:1904746,1,0.968650926748831,0,5,negative regulation of apoptotic process involved in development,BP,
20348,GO:1904747,1,0.980597584579315,0,3,positive regulation of apoptotic process involved in development,BP,
20349,GO:1904748,1,0.942466126402528,0,9,regulation of apoptotic process involved in development,BP,
20350,GO:1904749,1,0.967924858563603,0,5,regulation of protein localization to nucleolus,BP,
20351,GO:1904750,1,0.990849469430641,0,1,negative regulation of protein localization to nucleolus,BP,
20352,GO:1904751,1,0.976865780537242,0,4,positive regulation of protein localization to nucleolus,BP,
20353,GO:1904752,1,0.880524161451033,0,16,regulation of vascular associated smooth muscle cell migration,BP,
20354,GO:1904753,1,0.964601811168465,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20355,GO:1904754,1,0.912866917528037,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20356,GO:1904760,1,0.978913755874709,0,3,regulation of myofibroblast differentiation,BP,
20357,GO:1904761,1,0.985500952057622,0,2,negative regulation of myofibroblast differentiation,BP,
20358,GO:1904762,1,0.99331686309492,0,1,positive regulation of myofibroblast differentiation,BP,
20359,GO:1904764,1,0.994468714795154,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20360,GO:1904766,1,0.990625472602169,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20362,GO:1904772,1,0.994257567836224,0,1,response to tetrachloromethane,BP,
20363,GO:1904776,1,0.958547687431127,0,6,regulation of protein localization to cell cortex,BP,
20364,GO:1904777,1,0.994184768585909,0,1,negative regulation of protein localization to cell cortex,BP,
20365,GO:1904778,1,0.964156521847229,0,5,positive regulation of protein localization to cell cortex,BP,
20366,GO:1904779,1,0.944855702324141,0,7,regulation of protein localization to centrosome,BP,
20367,GO:1904781,1,0.950230667854552,0,6,positive regulation of protein localization to centrosome,BP,
20368,GO:1904782,1,0.992530003773513,0,1,negative regulation of NMDA glutamate receptor activity,BP,
20369,GO:1904783,1,0.98681707597499,0,2,positive regulation of NMDA glutamate receptor activity,BP,
20370,GO:1904784,1,0.991951172254257,0,1,NLRP1 inflammasome complex assembly,BP,
20371,GO:1904790,1,0.994103341683755,0,1,regulation of shelterin complex assembly,BP,
20372,GO:1904792,1,0.994103341683755,0,1,positive regulation of shelterin complex assembly,BP,
20373,GO:1904793,1,0.993779015227969,0,1,regulation of euchromatin binding,BP,
20374,GO:1904796,1,0.967999466194918,0,5,regulation of core promoter binding,BP,
20375,GO:1904797,1,0.991384504393222,0,1,negative regulation of core promoter binding,BP,
20376,GO:1904798,1,0.976413753179333,0,4,positive regulation of core promoter binding,BP,
20377,GO:1904799,1,0.993355174210614,0,1,regulation of neuron remodeling,BP,
20378,GO:1904800,1,0.993355174210614,0,1,negative regulation of neuron remodeling,BP,
20379,GO:1904803,1,0.994661465429014,0,1,regulation of translation involved in cellular response to UV,BP,
20380,GO:1904806,1,0.988403017609477,0,2,regulation of protein oxidation,BP,
20381,GO:1904808,1,0.988403017609477,0,2,positive regulation of protein oxidation,BP,
20382,GO:1904812,1,0.993356446296021,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20383,GO:1904813,1,0.473090624957657,0,123,ficolin-1-rich granule lumen,CC,
20384,GO:1904814,1,0.925493036514388,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20385,GO:1904815,1,0.988632155757893,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20386,GO:1904816,1,0.936141942493713,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20387,GO:1904823,1,0.983028197219453,0,3,purine nucleobase transmembrane transport,BP,
20388,GO:1904826,1,0.989972718603745,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20389,GO:1904828,1,0.989972718603745,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20390,GO:1904829,1,0.994535156464788,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20391,GO:1904831,1,0.994535156464788,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20392,GO:1904833,1,0.98377405870361,0,3,positive regulation of removal of superoxide radicals,BP,
20393,GO:1904835,1,0.994320787029434,0,1,dorsal root ganglion morphogenesis,BP,
20394,GO:1904837,1,0.789498795029669,0,34,beta-catenin-TCF complex assembly,BP,
20395,GO:1904842,1,0.994433705021114,0,1,response to nitroglycerin,BP,
20396,GO:1904843,1,0.994433705021114,0,1,cellular response to nitroglycerin,BP,
20397,GO:1904844,1,0.982228362682937,0,3,response to L-glutamine,BP,
20398,GO:1904845,1,0.982228362682937,0,3,cellular response to L-glutamine,BP,
20399,GO:1904847,1,0.965692012951657,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20400,GO:1904848,1,0.994616672573995,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20401,GO:1904849,1,0.977301649443058,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20402,GO:1904850,1,0.994103341683755,0,1,negative regulation of establishment of protein localization to telomere,BP,
20403,GO:1904851,1,0.950207066763656,0,9,positive regulation of establishment of protein localization to telomere,BP,
20404,GO:1904854,1,0.988342596135664,0,2,proteasome core complex binding,MF,
20406,GO:1904862,1,0.97838990366309,0,3,inhibitory synapse assembly,BP,
20407,GO:1904863,1,0.993484331129768,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20408,GO:1904864,1,0.993484331129768,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20409,GO:1904867,1,0.95036795435714,0,9,protein localization to Cajal body,BP,
20410,GO:1904868,1,0.976497439750325,0,2,telomerase catalytic core complex assembly,BP,
20411,GO:1904869,1,0.955615271612261,0,8,regulation of protein localization to Cajal body,BP,
20412,GO:1904871,1,0.955615271612261,0,8,positive regulation of protein localization to Cajal body,BP,
20413,GO:1904872,1,0.898298452767742,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20414,GO:1904874,1,0.919294368312563,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20415,GO:1904875,1,0.988603096254662,0,2,regulation of DNA ligase activity,BP,
20416,GO:1904876,1,0.994123997675265,0,1,negative regulation of DNA ligase activity,BP,
20417,GO:1904877,1,0.994446792671483,0,1,positive regulation of DNA ligase activity,BP,
20418,GO:1904878,1,0.987517708009592,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20419,GO:1904879,1,0.987561919616429,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20420,GO:1904880,1,0.980088459064372,0,3,response to hydrogen sulfide,BP,
20421,GO:1904881,1,0.985688380488448,0,2,cellular response to hydrogen sulfide,BP,
20422,GO:1904882,1,0.976497439750325,0,2,regulation of telomerase catalytic core complex assembly,BP,
20423,GO:1904884,1,0.976497439750325,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20424,GO:1904885,1,0.960242034052015,0,5,beta-catenin destruction complex assembly,BP,
20425,GO:1904886,1,0.877521244064797,0,18,beta-catenin destruction complex disassembly,BP,
20426,GO:1904887,1,0.988525498597407,0,1,Wnt signalosome assembly,BP,
20428,GO:1904889,1,0.988757498988629,0,2,regulation of excitatory synapse assembly,BP,
20429,GO:1904891,1,0.988757498988629,0,2,positive regulation of excitatory synapse assembly,BP,
20433,GO:1904895,1,0.994550115901387,0,1,ESCRT complex assembly,BP,
20434,GO:1904896,1,0.94347624884421,0,10,ESCRT complex disassembly,BP,
20435,GO:1904897,1,0.993855184595991,0,1,regulation of hepatic stellate cell proliferation,BP,
20436,GO:1904899,1,0.993855184595991,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20437,GO:1904902,1,0.994550115901387,0,1,ESCRT III complex assembly,BP,
20438,GO:1904903,1,0.94347624884421,0,10,ESCRT III complex disassembly,BP,
20439,GO:1904907,1,0.975321953424054,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20440,GO:1904908,1,0.975321953424054,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20441,GO:1904910,1,0.994103341683755,0,1,regulation of establishment of RNA localization to telomere,BP,
20442,GO:1904911,1,0.994103341683755,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20443,GO:1904913,1,0.994103341683755,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20444,GO:1904914,1,0.994103341683755,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20445,GO:1904923,1,0.917589733183246,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20446,GO:1904924,1,0.99435107751118,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20447,GO:1904925,1,0.922806775455142,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20448,GO:1904928,1,0.980193634464808,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20449,GO:1904929,1,0.959402825174899,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20450,GO:1904933,1,0.99162298711725,0,1,regulation of cell proliferation in midbrain,BP,
20451,GO:1904934,1,0.99162298711725,0,1,negative regulation of cell proliferation in midbrain,BP,
20452,GO:1904936,1,0.966462925537687,0,5,interneuron migration,BP,
20453,GO:1904938,1,0.95816596574676,0,5,planar cell polarity pathway involved in axon guidance,BP,
20454,GO:1904947,1,0.994049895239077,0,1,folic acid import into mitochondrion,BP,
20455,GO:1904948,1,0.906256396528659,0,15,midbrain dopaminergic neuron differentiation,BP,
20456,GO:1904949,1,0.510383221727955,0,95,ATPase complex,CC,
20459,GO:1904953,1,0.934310752310686,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20460,GO:1904954,1,0.9825967549553,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20461,GO:1904955,1,0.99162298711725,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20462,GO:1904956,1,0.970941817124265,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20463,GO:1904958,1,0.983305556633873,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20464,GO:1904959,1,0.983914014331861,0,2,regulation of cytochrome-c oxidase activity,BP,
20465,GO:1904960,1,0.994667802235339,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20466,GO:1904970,1,0.978229914227246,0,3,brush border assembly,BP,
20467,GO:1904971,1,0.992762593882542,0,1,regulation of viral translation,BP,
20468,GO:1904973,1,0.992762593882542,0,1,positive regulation of viral translation,BP,
20469,GO:1904975,1,0.98567992866363,0,2,response to bleomycin,BP,
20470,GO:1904976,1,0.98567992866363,0,2,cellular response to bleomycin,BP,
20471,GO:1904977,1,0.994134539224412,0,1,lymphatic endothelial cell migration,BP,
20472,GO:1904978,1,0.9776715126634,0,3,regulation of endosome organization,BP,
20473,GO:1904979,1,0.994410939735775,0,1,negative regulation of endosome organization,BP,
20474,GO:1904980,1,0.990454106813969,0,1,positive regulation of endosome organization,BP,
20475,GO:1904983,1,0.994443357115276,0,1,glycine import into mitochondrion,BP,
20476,GO:1904990,1,0.99433859771922,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20477,GO:1904992,1,0.99433859771922,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20478,GO:1904994,1,0.929178689906001,0,12,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20479,GO:1904995,1,0.972835283110803,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20480,GO:1904996,1,0.955136458713801,0,7,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20481,GO:1904997,1,0.988687266584695,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20482,GO:1904998,1,0.994105345251549,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20483,GO:1904999,1,0.994550115901387,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20484,GO:1905000,1,0.989157945758762,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20485,GO:1905005,1,0.959354455290237,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20486,GO:1905006,1,0.986776254880163,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20487,GO:1905007,1,0.964657549995733,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20488,GO:1905008,1,0.994281698680658,0,1,regulation of L-lysine import across plasma membrane,BP,
20489,GO:1905010,1,0.994281698680658,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20490,GO:1905024,1,0.972940417531377,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20491,GO:1905025,1,0.994024671939509,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20492,GO:1905026,1,0.986291337700756,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20493,GO:1905030,1,0.992100162087756,0,1,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20494,GO:1905031,1,0.962388870365576,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20495,GO:1905032,1,0.994024671939509,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20496,GO:1905033,1,0.986291337700756,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20497,GO:1905034,1,0.994107058760088,0,1,regulation of antifungal innate immune response,BP,
20498,GO:1905035,1,0.994107058760088,0,1,negative regulation of antifungal innate immune response,BP,
20499,GO:1905037,1,0.542174552069601,0,90,autophagosome organization,BP,
20500,GO:1905038,1,0.92497359367927,0,13,regulation of membrane lipid metabolic process,BP,
20501,GO:1905039,1,0.47865004913819,0,107,carboxylic acid transmembrane transport,BP,
20502,GO:1905040,1,0.994320787029434,0,1,otic placode development,BP,
20503,GO:1905041,1,0.994408062285494,0,1,regulation of epithelium regeneration,BP,
20504,GO:1905042,1,0.994408062285494,0,1,negative regulation of epithelium regeneration,BP,
20505,GO:1905044,1,0.994184768585909,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20506,GO:1905045,1,0.994184768585909,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20509,GO:1905050,1,0.958569283292021,0,7,positive regulation of metallopeptidase activity,BP,
20510,GO:1905051,1,0.989206429432213,0,2,regulation of base-excision repair,BP,
20511,GO:1905053,1,0.989206429432213,0,2,positive regulation of base-excision repair,BP,
20512,GO:1905062,1,0.994222766309399,0,1,positive regulation of cardioblast proliferation,BP,
20513,GO:1905063,1,0.948825483499373,0,8,regulation of vascular smooth muscle cell differentiation,BP,
20514,GO:1905064,1,0.982113261434214,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20515,GO:1905065,1,0.966111982046481,0,5,positive regulation of vascular smooth muscle cell differentiation,BP,
20516,GO:1905066,1,0.988922341180946,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20517,GO:1905067,1,0.994523216867324,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20518,GO:1905068,1,0.994368589361908,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20519,GO:1905069,1,0.987757729781542,0,2,allantois development,BP,
20520,GO:1905071,1,0.977649914429238,0,3,occluding junction disassembly,BP,
20521,GO:1905073,1,0.977649914429238,0,3,regulation of occluding junction disassembly,BP,
20522,GO:1905075,1,0.977649914429238,0,3,positive regulation of occluding junction disassembly,BP,
20523,GO:1905076,1,0.994482332589535,0,1,regulation of interleukin-17 secretion,BP,
20524,GO:1905077,1,0.994482332589535,0,1,negative regulation of interleukin-17 secretion,BP,
20525,GO:1905089,1,0.986039016502554,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20526,GO:1905090,1,0.986039016502554,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20527,GO:1905097,1,0.955766472556026,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
20528,GO:1905098,1,0.973247491062025,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20529,GO:1905099,1,0.991132725832899,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20530,GO:1905103,1,0.99331429908418,0,1,integral component of lysosomal membrane,CC,
20532,GO:1905123,1,0.986006784051892,0,2,regulation of glucosylceramidase activity,BP,
20533,GO:1905132,1,0.994045937555551,0,1,regulation of meiotic chromosome separation,BP,
20534,GO:1905133,1,0.994045937555551,0,1,negative regulation of meiotic chromosome separation,BP,
20535,GO:1905143,1,0.994569455231371,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20536,GO:1905144,1,0.874646701883533,0,21,response to acetylcholine,BP,
20537,GO:1905145,1,0.874646701883533,0,21,cellular response to acetylcholine,BP,
20538,GO:1905146,1,0.920756837531719,0,10,lysosomal protein catabolic process,BP,
20539,GO:1905150,1,0.978520869285446,0,3,regulation of voltage-gated sodium channel activity,BP,
20540,GO:1905152,1,0.991555896398954,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20541,GO:1905153,1,0.921732829954348,0,12,regulation of membrane invagination,BP,
20542,GO:1905154,1,0.986728526267455,0,2,negative regulation of membrane invagination,BP,
20543,GO:1905155,1,0.939560181857454,0,9,positive regulation of membrane invagination,BP,
20544,GO:1905161,1,0.992181627661619,0,1,protein localization to phagocytic vesicle,BP,
20545,GO:1905162,1,0.992181627661619,0,1,regulation of phagosome maturation,BP,
20546,GO:1905165,1,0.937173892984286,0,7,regulation of lysosomal protein catabolic process,BP,
20547,GO:1905166,1,0.981707685050605,0,3,negative regulation of lysosomal protein catabolic process,BP,
20548,GO:1905167,1,0.960069240432824,0,3,positive regulation of lysosomal protein catabolic process,BP,
20549,GO:1905168,1,0.993559627034712,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
20550,GO:1905169,1,0.992181627661619,0,1,regulation of protein localization to phagocytic vesicle,BP,
20551,GO:1905171,1,0.992181627661619,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20552,GO:1905172,1,0.992762593882542,0,1,RISC complex binding,MF,
20553,GO:1905174,1,0.988677365607901,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
20554,GO:1905176,1,0.994134814661725,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20555,GO:1905202,1,0.987912894644403,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20556,GO:1905203,1,0.987375992946176,0,2,regulation of connective tissue replacement,BP,
20557,GO:1905204,1,0.994600258828157,0,1,negative regulation of connective tissue replacement,BP,
20558,GO:1905205,1,0.992736905139985,0,1,positive regulation of connective tissue replacement,BP,
20559,GO:1905206,1,0.966447408033458,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20560,GO:1905207,1,0.761576497776491,0,39,regulation of cardiocyte differentiation,BP,
20561,GO:1905208,1,0.906259524934885,0,14,negative regulation of cardiocyte differentiation,BP,
20562,GO:1905209,1,0.845259552088677,0,24,positive regulation of cardiocyte differentiation,BP,
20563,GO:1905214,1,0.931115423399116,0,11,regulation of RNA binding,BP,
20564,GO:1905215,1,0.994536046457936,0,1,negative regulation of RNA binding,BP,
20565,GO:1905216,1,0.950331183969085,0,8,positive regulation of RNA binding,BP,
20566,GO:1905217,1,0.994006780387232,0,1,response to astaxanthin,BP,
20567,GO:1905222,1,0.99397989160078,0,1,atrioventricular canal morphogenesis,BP,
20568,GO:1905223,1,0.991131793278266,0,1,epicardium morphogenesis,BP,
20569,GO:1905224,1,0.985066427954758,0,2,clathrin-coated pit assembly,BP,
20570,GO:1905225,1,0.98865045565945,0,2,response to thyrotropin-releasing hormone,BP,
20571,GO:1905226,1,0.994607284390444,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20572,GO:1905229,1,0.994611703443189,0,1,cellular response to thyrotropin-releasing hormone,BP,
20573,GO:1905230,1,0.993327106956322,0,1,response to borneol,BP,
20574,GO:1905231,1,0.993327106956322,0,1,cellular response to borneol,BP,
20575,GO:1905232,1,0.966600267660483,0,5,cellular response to L-glutamate,BP,
20576,GO:1905233,1,0.993327106956322,0,1,response to codeine,BP,
20577,GO:1905235,1,0.993327106956322,0,1,response to quercetin,BP,
20578,GO:1905237,1,0.993327106956322,0,1,response to cyclosporin A,BP,
20579,GO:1905239,1,0.992394769976729,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20580,GO:1905240,1,0.992394769976729,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20581,GO:1905242,1,0.988080457036371,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20582,GO:1905243,1,0.994234682761264,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20583,GO:1905244,1,0.944376165192523,0,8,regulation of modification of synaptic structure,BP,
20584,GO:1905245,1,0.941793355718151,0,8,regulation of aspartic-type peptidase activity,BP,
20585,GO:1905246,1,0.98155166786929,0,2,negative regulation of aspartic-type peptidase activity,BP,
20586,GO:1905247,1,0.95950180760981,0,6,positive regulation of aspartic-type peptidase activity,BP,
20587,GO:1905255,1,0.991043316065622,0,1,regulation of RNA binding transcription factor activity,BP,
20588,GO:1905258,1,0.989241089570645,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20589,GO:1905259,1,0.989241089570645,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20590,GO:1905267,1,0.987918431464433,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20591,GO:1905268,1,0.72207995199705,0,45,negative regulation of chromatin organization,BP,
20592,GO:1905269,1,0.546450664659389,0,88,positive regulation of chromatin organization,BP,
20593,GO:1905271,1,0.994659397226476,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20594,GO:1905273,1,0.994659397226476,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20595,GO:1905274,1,0.990337313481602,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20596,GO:1905276,1,0.879600109156602,0,18,regulation of epithelial tube formation,BP,
20597,GO:1905277,1,0.994023737535236,0,1,negative regulation of epithelial tube formation,BP,
20598,GO:1905278,1,0.974427306088359,0,4,positive regulation of epithelial tube formation,BP,
20599,GO:1905279,1,0.982776333187566,0,2,regulation of retrograde transport, endosome to Golgi,BP,
20600,GO:1905285,1,0.993628847729139,0,1,fibrous ring of heart morphogenesis,BP,
20601,GO:1905286,1,0.982826977327844,0,3,serine-type peptidase complex,CC,
20602,GO:1905288,1,0.955606044657541,0,6,vascular associated smooth muscle cell apoptotic process,BP,
20603,GO:1905289,1,0.988525498597407,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20604,GO:1905292,1,0.980187615535151,0,3,regulation of neural crest cell differentiation,BP,
20605,GO:1905294,1,0.980187615535151,0,3,positive regulation of neural crest cell differentiation,BP,
20606,GO:1905301,1,0.99283293585568,0,1,regulation of macropinocytosis,BP,
20607,GO:1905302,1,0.99283293585568,0,1,negative regulation of macropinocytosis,BP,
20608,GO:1905304,1,0.988951803627041,0,1,regulation of cardiac myofibril assembly,BP,
20609,GO:1905305,1,0.988951803627041,0,1,negative regulation of cardiac myofibril assembly,BP,
20610,GO:1905309,1,0.987771295481469,0,1,positive regulation of cohesin loading,BP,
20611,GO:1905310,1,0.980187615535151,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20612,GO:1905312,1,0.980187615535151,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20613,GO:1905313,1,0.994420977895971,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20614,GO:1905314,1,0.893066648238021,0,15,semi-lunar valve development,BP,
20615,GO:1905317,1,0.99272587850566,0,1,inferior endocardial cushion morphogenesis,BP,
20616,GO:1905319,1,0.994184768585909,0,1,mesenchymal stem cell migration,BP,
20617,GO:1905320,1,0.994184768585909,0,1,regulation of mesenchymal stem cell migration,BP,
20618,GO:1905322,1,0.994184768585909,0,1,positive regulation of mesenchymal stem cell migration,BP,
20619,GO:1905323,1,0.954173481782667,0,6,telomerase holoenzyme complex assembly,BP,
20620,GO:1905327,1,0.994566168695361,0,1,tracheoesophageal septum formation,BP,
20622,GO:1905331,1,0.882239389038638,0,18,negative regulation of morphogenesis of an epithelium,BP,
20623,GO:1905332,1,0.818753490050511,0,30,positive regulation of morphogenesis of an epithelium,BP,
20625,GO:1905335,1,0.985068516831003,0,1,regulation of aggrephagy,BP,
20626,GO:1905337,1,0.985068516831003,0,1,positive regulation of aggrephagy,BP,
20627,GO:1905340,1,0.977574580825813,0,4,regulation of protein localization to kinetochore,BP,
20628,GO:1905341,1,0.994236566898091,0,1,negative regulation of protein localization to kinetochore,BP,
20629,GO:1905342,1,0.977574580825813,0,4,positive regulation of protein localization to kinetochore,BP,
20630,GO:1905344,1,0.994184768585909,0,1,prostaglandin catabolic process,BP,
20631,GO:1905348,1,0.838389855218208,0,29,endonuclease complex,CC,
20632,GO:1905349,1,0.989205726173044,0,2,ciliary transition zone assembly,BP,
20633,GO:1905354,1,0.872363722254822,0,22,exoribonuclease complex,CC,
20634,GO:1905355,1,0.992286988716793,0,1,spine apparatus assembly,BP,
20635,GO:1905359,1,0.994045937555551,0,1,protein localization to meiotic spindle,BP,
20637,GO:1905365,1,0.994410939735775,0,1,regulation of intralumenal vesicle formation,BP,
20638,GO:1905366,1,0.994410939735775,0,1,negative regulation of intralumenal vesicle formation,BP,
20639,GO:1905368,1,0.614303068671135,0,83,peptidase complex,CC,
20640,GO:1905369,1,0.691031434843849,0,63,endopeptidase complex,CC,
20641,GO:1905370,1,0.99435107751118,0,1,serine-type endopeptidase complex,CC,
20642,GO:1905371,1,0.985955992328027,0,2,ceramide phosphoethanolamine metabolic process,BP,
20643,GO:1905373,1,0.985955992328027,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20644,GO:1905383,1,0.98338114265056,0,3,protein localization to presynapse,BP,
20645,GO:1905384,1,0.988677366793096,0,2,regulation of protein localization to presynapse,BP,
20646,GO:1905386,1,0.988677366793096,0,2,positive regulation of protein localization to presynapse,BP,
20647,GO:1905392,1,0.994651281344248,0,1,plant organ morphogenesis,BP,
20648,GO:1905394,1,0.979755357404336,0,3,retromer complex binding,MF,
20649,GO:1905395,1,0.980934957657745,0,3,response to flavonoid,BP,
20650,GO:1905397,1,0.989083699570302,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20651,GO:1905402,1,0.989083699570302,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20652,GO:1905403,1,0.994482332589535,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20653,GO:1905404,1,0.99457171375683,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20654,GO:1905405,1,0.987771295481469,0,1,regulation of mitotic cohesin loading,BP,
20655,GO:1905406,1,0.987771295481469,0,1,positive regulation of mitotic cohesin loading,BP,
20656,GO:1905407,1,0.988416589582615,0,2,regulation of creatine transmembrane transporter activity,BP,
20657,GO:1905408,1,0.988416589582615,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20658,GO:1905419,1,0.994517576093017,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20659,GO:1905421,1,0.994651281344248,0,1,regulation of plant organ morphogenesis,BP,
20660,GO:1905422,1,0.994651281344248,0,1,negative regulation of plant organ morphogenesis,BP,
20661,GO:1905424,1,0.988721181377835,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20662,GO:1905426,1,0.988721181377835,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20664,GO:1905430,1,0.994457141210401,0,1,cellular response to glycine,BP,
20665,GO:1905432,1,0.993238578892015,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20666,GO:1905433,1,0.993238578892015,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20667,GO:1905435,1,0.994184768585909,0,1,regulation of histone H3-K4 trimethylation,BP,
20668,GO:1905437,1,0.994184768585909,0,1,positive regulation of histone H3-K4 trimethylation,BP,
20669,GO:1905438,1,0.986251441654325,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20670,GO:1905443,1,0.992877455384035,0,1,regulation of clathrin coat assembly,BP,
20671,GO:1905445,1,0.992877455384035,0,1,positive regulation of clathrin coat assembly,BP,
20672,GO:1905446,1,0.972144661032129,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20673,GO:1905447,1,0.993958996997799,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20674,GO:1905448,1,0.978054398955231,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20675,GO:1905449,1,0.985888213354894,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20676,GO:1905451,1,0.985888213354894,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20677,GO:1905456,1,0.946714681552225,0,7,regulation of lymphoid progenitor cell differentiation,BP,
20678,GO:1905457,1,0.977820252320536,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20679,GO:1905458,1,0.993339883885943,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20680,GO:1905459,1,0.955606044657541,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20681,GO:1905460,1,0.990301354533528,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20682,GO:1905461,1,0.96496824701952,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20683,GO:1905462,1,0.985021287838042,0,2,regulation of DNA duplex unwinding,BP,
20684,GO:1905463,1,0.991729057835543,0,1,negative regulation of DNA duplex unwinding,BP,
20685,GO:1905464,1,0.993236847114163,0,1,positive regulation of DNA duplex unwinding,BP,
20686,GO:1905468,1,0.992181627661619,0,1,regulation of clathrin-coated pit assembly,BP,
20687,GO:1905469,1,0.992181627661619,0,1,negative regulation of clathrin-coated pit assembly,BP,
20688,GO:1905474,1,0.994578590289335,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20692,GO:1905483,1,0.986563326491222,0,1,regulation of motor neuron migration,BP,
20693,GO:1905485,1,0.986563326491222,0,1,positive regulation of motor neuron migration,BP,
20694,GO:1905502,1,0.994617738920653,0,1,acetyl-CoA binding,MF,
20695,GO:1905508,1,0.802063419120138,0,28,protein localization to microtubule organizing center,BP,
20696,GO:1905512,1,0.994287720904879,0,1,regulation of short-term synaptic potentiation,BP,
20697,GO:1905513,1,0.994287720904879,0,1,negative regulation of short-term synaptic potentiation,BP,
20698,GO:1905515,1,0.734925849974912,0,47,non-motile cilium assembly,BP,
20699,GO:1905516,1,0.94445906619674,0,8,positive regulation of fertilization,BP,
20701,GO:1905518,1,0.992490332986896,0,1,regulation of presynaptic active zone assembly,BP,
20702,GO:1905520,1,0.992490332986896,0,1,positive regulation of presynaptic active zone assembly,BP,
20704,GO:1905522,1,0.969132361772815,0,5,negative regulation of macrophage migration,BP,
20706,GO:1905524,1,0.989911520590302,0,1,negative regulation of protein autoubiquitination,BP,
20707,GO:1905535,1,0.992194874813158,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20708,GO:1905537,1,0.992194874813158,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20709,GO:1905538,1,0.992762593882542,0,1,polysome binding,MF,
20710,GO:1905541,1,0.994281698680658,0,1,regulation of L-arginine import across plasma membrane,BP,
20711,GO:1905546,1,0.994394980276072,0,1,cellular response to phenylpropanoid,BP,
20712,GO:1905547,1,0.994555166933378,0,1,regulation of telomeric heterochromatin assembly,BP,
20713,GO:1905549,1,0.994555166933378,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20714,GO:1905550,1,0.988978484737108,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20715,GO:1905552,1,0.988978484737108,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20716,GO:1905553,1,0.981084657913656,0,3,regulation of blood vessel branching,BP,
20717,GO:1905555,1,0.986411374452522,0,2,positive regulation blood vessel branching,BP,
20718,GO:1905562,1,0.903233863514482,0,14,regulation of vascular endothelial cell proliferation,BP,
20719,GO:1905563,1,0.978505668851405,0,3,negative regulation of vascular endothelial cell proliferation,BP,
20720,GO:1905564,1,0.923090786772794,0,11,positive regulation of vascular endothelial cell proliferation,BP,
20721,GO:1905572,1,0.994157852669258,0,1,ganglioside GM1 transport to membrane,BP,
20722,GO:1905573,1,0.988688241819304,0,2,ganglioside GM1 binding,MF,
20723,GO:1905574,1,0.994157852669258,0,1,ganglioside GM2 binding,MF,
20724,GO:1905575,1,0.994157852669258,0,1,ganglioside GM3 binding,MF,
20725,GO:1905576,1,0.98310166204509,0,3,ganglioside GT1b binding,MF,
20726,GO:1905577,1,0.994157852669258,0,1,ganglioside GP1c binding,MF,
20727,GO:1905578,1,0.994337252693284,0,1,regulation of ERBB3 signaling pathway,BP,
20728,GO:1905580,1,0.994337252693284,0,1,positive regulation of ERBB3 signaling pathway,BP,
20730,GO:1905589,1,0.994281698680658,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20731,GO:1905590,1,0.99398409306727,0,1,fibronectin fibril organization,BP,
20732,GO:1905594,1,0.994622869842464,0,1,resveratrol binding,MF,
20734,GO:1905596,1,0.993613080661637,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20736,GO:1905598,1,0.993613080661637,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20739,GO:1905601,1,0.993613080661637,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20741,GO:1905603,1,0.992405097966755,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20742,GO:1905604,1,0.992405097966755,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,
20743,GO:1905606,1,0.972795246637427,0,4,regulation of presynapse assembly,BP,
20744,GO:1905608,1,0.992490332986896,0,1,positive regulation of presynapse assembly,BP,
20745,GO:1905610,1,0.992194874813158,0,1,regulation of mRNA cap binding,BP,
20746,GO:1905612,1,0.992194874813158,0,1,positive regulation of mRNA cap binding,BP,
20747,GO:1905616,1,0.986424581254958,0,2,regulation of miRNA mediated inhibition of translation,BP,
20748,GO:1905618,1,0.986424581254958,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20749,GO:1905634,1,0.959071288360766,0,5,regulation of protein localization to chromatin,BP,
20750,GO:1905636,1,0.994611019451608,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20751,GO:1905642,1,0.994184768585909,0,1,negative regulation of DNA methylation,BP,
20752,GO:1905643,1,0.991501656617448,0,1,positive regulation of DNA methylation,BP,
20753,GO:1905647,1,0.994327130902036,0,1,proline import across plasma membrane,BP,
20754,GO:1905651,1,0.975952448990123,0,3,regulation of artery morphogenesis,BP,
20755,GO:1905653,1,0.975952448990123,0,3,positive regulation of artery morphogenesis,BP,
20756,GO:1905661,1,0.988045485197384,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20757,GO:1905663,1,0.988045485197384,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20758,GO:1905664,1,0.977098706118307,0,4,regulation of calcium ion import across plasma membrane,BP,
20759,GO:1905665,1,0.988266946763386,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20760,GO:1905666,1,0.934551640156542,0,9,regulation of protein localization to endosome,BP,
20761,GO:1905668,1,0.934551640156542,0,9,positive regulation of protein localization to endosome,BP,
20762,GO:1905671,1,0.981600997831117,0,3,regulation of lysosome organization,BP,
20763,GO:1905672,1,0.994436367391314,0,1,negative regulation of lysosome organization,BP,
20764,GO:1905687,1,0.991688778444706,0,1,regulation of diacylglycerol kinase activity,BP,
20765,GO:1905689,1,0.991688778444706,0,1,positive regulation of diacylglycerol kinase activity,BP,
20766,GO:1905693,1,0.994436661814452,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20767,GO:1905695,1,0.994436661814452,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20768,GO:1905696,1,0.985013397363163,0,2,regulation of polysome binding,BP,
20769,GO:1905698,1,0.992762593882542,0,1,positive regulation of polysome binding,BP,
20770,GO:1905705,1,0.99058782531848,0,1,cellular response to paclitaxel,BP,
20771,GO:1905709,1,0.969143243035323,0,5,negative regulation of membrane permeability,BP,
20772,GO:1905710,1,0.699385502682823,0,60,positive regulation of membrane permeability,BP,
20773,GO:1905711,1,0.993485153846078,0,1,response to phosphatidylethanolamine,BP,
20774,GO:1905719,1,0.988341593811167,0,2,protein localization to perinuclear region of cytoplasm,BP,
20775,GO:1905720,1,0.990353712774273,0,1,cytoplasmic microtubule bundle,CC,
20776,GO:1905747,1,0.994609170365369,0,1,negative regulation of saliva secretion,BP,
20777,GO:1905748,1,0.994609170365369,0,1,hard palate morphogenesis,BP,
20778,GO:1905764,1,0.979201400799308,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20779,GO:1905765,1,0.979201400799308,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20780,GO:1905767,1,0.990754342776535,0,1,regulation of double-stranded telomeric DNA binding,BP,
20781,GO:1905768,1,0.990754342776535,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20782,GO:1905770,1,0.963979042358291,0,6,regulation of mesodermal cell differentiation,BP,
20783,GO:1905771,1,0.978177145800475,0,4,negative regulation of mesodermal cell differentiation,BP,
20784,GO:1905773,1,0.977919163930666,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
20785,GO:1905774,1,0.993236847114163,0,1,regulation of DNA helicase activity,BP,
20786,GO:1905776,1,0.993236847114163,0,1,positive regulation of DNA helicase activity,BP,
20787,GO:1905777,1,0.982531159002599,0,3,regulation of exonuclease activity,BP,
20788,GO:1905778,1,0.988261087851807,0,2,negative regulation of exonuclease activity,BP,
20789,GO:1905779,1,0.994202692183443,0,1,positive regulation of exonuclease activity,BP,
20790,GO:1905793,1,0.979499114061449,0,2,protein localization to pericentriolar material,BP,
20791,GO:1905794,1,0.98781202288354,0,1,response to puromycin,BP,
20792,GO:1905795,1,0.98781202288354,0,1,cellular response to puromycin,BP,
20793,GO:1905799,1,0.994657082501017,0,1,regulation of intraciliary retrograde transport,BP,
20794,GO:1905802,1,0.994149266808764,0,1,regulation of cellular response to manganese ion,BP,
20795,GO:1905809,1,0.854930789642174,0,22,negative regulation of synapse organization,BP,
20796,GO:1905818,1,0.685132544257558,0,55,regulation of chromosome separation,BP,
20797,GO:1905819,1,0.798797492166641,0,33,negative regulation of chromosome separation,BP,
20798,GO:1905820,1,0.93813820372741,0,9,positive regulation of chromosome separation,BP,
20799,GO:1905832,1,0.962766019543017,0,4,positive regulation of spindle assembly,BP,
20800,GO:1905838,1,0.988261087851807,0,2,regulation of telomeric D-loop disassembly,BP,
20801,GO:1905839,1,0.988261087851807,0,2,negative regulation of telomeric D-loop disassembly,BP,
20802,GO:1905843,1,0.986983587939928,0,1,regulation of cellular response to gamma radiation,BP,
20803,GO:1905853,1,0.994619104948451,0,1,regulation of heparan sulfate binding,BP,
20804,GO:1905855,1,0.994619104948451,0,1,positive regulation of heparan sulfate binding,BP,
20805,GO:1905858,1,0.994619104948451,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20806,GO:1905860,1,0.994619104948451,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20808,GO:1905867,1,0.977718224976496,0,4,epididymis development,BP,
20809,GO:1905874,1,0.974631903564625,0,4,regulation of postsynaptic density organization,BP,
20810,GO:1905875,1,0.994105059322381,0,1,negative regulation of postsynaptic density organization,BP,
20811,GO:1905878,1,0.988079606809972,0,1,invadopodium disassembly,BP,
20812,GO:1905879,1,0.935971841638252,0,10,regulation of oogenesis,BP,
20813,GO:1905880,1,0.973026932539981,0,4,negative regulation of oogenesis,BP,
20814,GO:1905881,1,0.973064365985576,0,4,positive regulation of oogenesis,BP,
20815,GO:1905890,1,0.994619104948451,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20816,GO:1905891,1,0.994152498934816,0,1,regulation of cellular response to thapsigargin,BP,
20817,GO:1905892,1,0.994152498934816,0,1,negative regulation of cellular response to thapsigargin,BP,
20818,GO:1905894,1,0.994152498934816,0,1,regulation of cellular response to tunicamycin,BP,
20819,GO:1905895,1,0.994152498934816,0,1,negative regulation of cellular response to tunicamycin,BP,
20820,GO:1905897,1,0.626176630356792,0,73,regulation of response to endoplasmic reticulum stress,BP,
20821,GO:1905898,1,0.799757690023873,0,35,positive regulation of response to endoplasmic reticulum stress,BP,
20822,GO:1905899,1,0.994566168695361,0,1,regulation of smooth muscle tissue development,BP,
20823,GO:1905900,1,0.994566168695361,0,1,negative regulation of smooth muscle tissue development,BP,
20824,GO:1905901,1,0.994566168695361,0,1,positive regulation of smooth muscle tissue development,BP,
20825,GO:1905902,1,0.963979042358291,0,6,regulation of mesoderm formation,BP,
20826,GO:1905903,1,0.978177145800475,0,4,negative regulation of mesoderm formation,BP,
20827,GO:1905906,1,0.955983668365037,0,7,regulation of amyloid fibril formation,BP,
20828,GO:1905907,1,0.981082432479785,0,3,negative regulation of amyloid fibril formation,BP,
20829,GO:1905908,1,0.974146784740125,0,4,positive regulation of amyloid fibril formation,BP,
20830,GO:1905912,1,0.99451464502751,0,1,regulation of calcium ion export across plasma membrane,BP,
20831,GO:1905913,1,0.99451464502751,0,1,negative regulation of calcium ion export across plasma membrane,BP,
20832,GO:1905918,1,0.994433407802725,0,1,regulation of CoA-transferase activity,BP,
20833,GO:1905920,1,0.994433407802725,0,1,positive regulation of CoA-transferase activity,BP,
20834,GO:1905927,1,0.988079606809972,0,1,regulation of invadopodium disassembly,BP,
20835,GO:1905929,1,0.988079606809972,0,1,positive regulation of invadopodium disassembly,BP,
20836,GO:1905936,1,0.978201536508777,0,4,regulation of germ cell proliferation,BP,
20837,GO:1905937,1,0.983476386161885,0,3,negative regulation of germ cell proliferation,BP,
20838,GO:1905938,1,0.99463741868846,0,1,positive regulation of germ cell proliferation,BP,
20839,GO:1905939,1,0.891239817927781,0,18,regulation of gonad development,BP,
20840,GO:1905940,1,0.969692842422155,0,5,negative regulation of gonad development,BP,
20841,GO:1905941,1,0.939910144571495,0,10,positive regulation of gonad development,BP,
20842,GO:1905942,1,0.994337252693284,0,1,regulation of formation of growth cone in injured axon,BP,
20843,GO:1905943,1,0.994337252693284,0,1,negative regulation of formation of growth cone in injured axon,BP,
20845,GO:1905953,1,0.802897653572144,0,31,negative regulation of lipid localization,BP,
20847,GO:1905957,1,0.993007983950641,0,1,regulation of cellular response to alcohol,BP,
20848,GO:1905959,1,0.993007983950641,0,1,positive regulation of cellular response to alcohol,BP,
20849,GO:1905961,1,0.951191618043865,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
20850,GO:1990000,1,0.91200043545274,0,14,amyloid fibril formation,BP,
20851,GO:1990001,1,0.925200699158119,0,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
20852,GO:1990003,1,0.991443266410328,0,1,IDP phosphatase activity,MF,
20853,GO:1990005,1,0.988757689826789,0,2,granular vesicle,CC,
20854,GO:1990008,1,0.994541494738355,0,1,neurosecretory vesicle,CC,
20855,GO:1990009,1,0.985780634840878,0,2,retinal cell apoptotic process,BP,
20856,GO:1990015,1,0.994350144764933,0,1,ensheathing process,CC,
20857,GO:1990023,1,0.912058612873613,0,12,mitotic spindle midzone,CC,
20858,GO:1990026,1,0.986141249177352,0,2,hippocampal mossy fiber expansion,CC,
20859,GO:1990030,1,0.993391928478874,0,1,pericellular basket,CC,
20860,GO:1990031,1,0.99396425321157,0,1,pinceau fiber,CC,
20861,GO:1990032,1,0.99289059145741,0,1,parallel fiber,CC,
20862,GO:1990034,1,0.963069313275921,0,5,calcium ion export across plasma membrane,BP,
20863,GO:1990036,1,0.984017590758222,0,2,calcium ion import into sarcoplasmic reticulum,BP,
20864,GO:1990037,1,0.983547105059537,0,3,Lewy body core,CC,
20865,GO:1990038,1,0.994487904399225,0,1,Lewy body corona,CC,
20866,GO:1990046,1,0.994607995983347,0,1,stress-induced mitochondrial fusion,BP,
20867,GO:1990047,1,0.994395645871501,0,1,spindle matrix,CC,
20868,GO:1990048,1,0.994184768585909,0,1,anterograde neuronal dense core vesicle transport,BP,
20869,GO:1990050,1,0.978398796874996,0,4,phosphatidic acid transporter activity,MF,
20870,GO:1990051,1,0.98564224590669,0,2,activation of protein kinase C activity,BP,
20871,GO:1990070,1,0.994651932648359,0,1,TRAPPI protein complex,CC,
20872,GO:1990071,1,0.98525583694067,0,2,TRAPPII protein complex,CC,
20873,GO:1990072,1,0.988867491865911,0,2,TRAPPIII protein complex,CC,
20874,GO:1990074,1,0.993710856834497,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20875,GO:1990075,1,0.967165766524727,0,4,periciliary membrane compartment,CC,
20876,GO:1990079,1,0.99463588443103,0,1,cartilage homeostasis,BP,
20877,GO:1990086,1,0.973749855072747,0,4,lens fiber cell apoptotic process,BP,
20878,GO:1990089,1,0.685118555720642,0,52,response to nerve growth factor,BP,
20879,GO:1990090,1,0.698449090087191,0,49,cellular response to nerve growth factor stimulus,BP,
20880,GO:1990108,1,0.983349741989073,0,2,protein linear deubiquitination,BP,
20881,GO:1990111,1,0.974519201454184,0,4,spermatoproteasome complex,CC,
20882,GO:1990112,1,0.988403017609477,0,2,RQC complex,CC,
20883,GO:1990116,1,0.988403017609477,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
20884,GO:1990117,1,0.994649325112124,0,1,B cell receptor apoptotic signaling pathway,BP,
20885,GO:1990124,1,0.942584344046091,0,8,messenger ribonucleoprotein complex,CC,
20886,GO:1990126,1,0.899089114056854,0,16,retrograde transport, endosome to plasma membrane,BP,
20887,GO:1990127,1,0.993149677273809,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20888,GO:1990130,1,0.969894477400438,0,5,GATOR1 complex,CC,
20889,GO:1990131,1,0.976267586074912,0,4,Gtr1-Gtr2 GTPase complex,CC,
20890,GO:1990134,1,0.992378328840551,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20891,GO:1990136,1,0.994309880226086,0,1,linoleate 9S-lipoxygenase activity,MF,
20893,GO:1990144,1,0.965280438333686,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20894,GO:1990145,1,0.987782610140494,0,2,maintenance of translational fidelity,BP,
20895,GO:1990164,1,0.988202947721039,0,2,histone H2A phosphorylation,BP,
20896,GO:1990165,1,0.994472120183136,0,1,single-strand break-containing DNA binding,MF,
20897,GO:1990166,1,0.994367516758308,0,1,protein localization to site of double-strand break,BP,
20898,GO:1990167,1,0.982294698088302,0,2,protein K27-linked deubiquitination,BP,
20899,GO:1990168,1,0.983755719432527,0,2,protein K33-linked deubiquitination,BP,
20900,GO:1990169,1,0.937642172011859,0,11,stress response to copper ion,BP,
20901,GO:1990170,1,0.994473677481634,0,1,stress response to cadmium ion,BP,
20902,GO:1990172,1,0.99158611854615,0,1,G-protein coupled receptor catabolic process,BP,
20903,GO:1990173,1,0.943070338598577,0,10,protein localization to nucleoplasm,BP,
20904,GO:1990174,1,0.993440055495113,0,1,phosphodiesterase decapping endonuclease activity,MF,
20905,GO:1990175,1,0.99337717664904,0,1,EH domain binding,MF,
20906,GO:1990179,1,0.978060145538437,0,3,protein localization to actomyosin contractile ring,BP,
20907,GO:1990180,1,0.983313996898391,0,3,mitochondrial tRNA 3'-end processing,BP,
20908,GO:1990182,1,0.902418780263585,0,17,exosomal secretion,BP,
20909,GO:1990183,1,0.994646746530207,0,1,lymphatic vascular process in circulatory system,BP,
20910,GO:1990186,1,0.994646746530207,0,1,regulation of lymphatic vessel size,BP,
20911,GO:1990188,1,0.994261179211587,0,1,euchromatin binding,MF,
20912,GO:1990189,1,0.983158265358734,0,3,peptide-serine-N-acetyltransferase activity,MF,
20913,GO:1990190,1,0.989249250744038,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20914,GO:1990192,1,0.994646746530207,0,1,collecting lymphatic vessel constriction,BP,
20915,GO:1990204,1,0.572792759066965,0,95,oxidoreductase complex,CC,
20916,GO:1990226,1,0.965629183832323,0,6,histone methyltransferase binding,MF,
20917,GO:1990234,1,0.00623135133301181,0,744,transferase complex,CC,
20918,GO:1990239,1,0.959541227084557,0,6,steroid hormone binding,MF,
20919,GO:1990246,1,0.976939194758801,0,4,uniplex complex,CC,
20920,GO:1990247,1,0.951279842698556,0,7,N6-methyladenosine-containing RNA binding,MF,
20921,GO:1990253,1,0.93797151464044,0,9,cellular response to leucine starvation,BP,
20923,GO:1990256,1,0.986402498566577,0,1,signal clustering,BP,
20924,GO:1990258,1,0.994620140326158,0,1,histone glutamine methylation,BP,
20925,GO:1990259,1,0.994620140326158,0,1,histone-glutamine methyltransferase activity,MF,
20926,GO:1990261,1,0.994184768585909,0,1,pre-mRNA catabolic process,BP,
20927,GO:1990262,1,0.994203686887394,0,1,anti-Mullerian hormone signaling pathway,BP,
20928,GO:1990264,1,0.988298320214193,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20930,GO:1990267,1,0.993923299380449,0,1,response to transition metal nanoparticle,BP,
20931,GO:1990268,1,0.993923299380449,0,1,response to gold nanoparticle,BP,
20932,GO:1990269,1,0.986862168378332,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20933,GO:1990275,1,0.99413094931425,0,1,preribosome binding,MF,
20934,GO:1990280,1,0.990699512717009,0,1,RNA localization to chromatin,BP,
20935,GO:1990298,1,0.99443533471489,0,1,bub1-bub3 complex,CC,
20936,GO:1990314,1,0.939364195778026,0,8,cellular response to insulin-like growth factor stimulus,BP,
20937,GO:1990316,1,0.941299932421325,0,8,Atg1/ULK1 kinase complex,CC,
20938,GO:1990332,1,0.993299747117968,0,1,Ire1 complex,CC,
20939,GO:1990349,1,0.994477020653939,0,1,gap junction-mediated intercellular transport,BP,
20941,GO:1990356,1,0.994616672573995,0,1,sumoylated E2 ligase complex,CC,
20942,GO:1990357,1,0.982715995008399,0,3,terminal web,CC,
20943,GO:1990379,1,0.989073320058338,0,2,lipid transport across blood brain barrier,BP,
20944,GO:1990380,1,0.937870229283564,0,7,Lys48-specific deubiquitinase activity,MF,
20945,GO:1990381,1,0.91473480693899,0,13,ubiquitin-specific protease binding,MF,
20946,GO:1990384,1,0.994607877748261,0,1,hyaloid vascular plexus regression,BP,
20947,GO:1990386,1,0.994483082595611,0,1,mitotic cleavage furrow ingression,BP,
20948,GO:1990390,1,0.993747079864795,0,1,protein K33-linked ubiquitination,BP,
20949,GO:1990391,1,0.791563495304673,0,33,DNA repair complex,CC,
20950,GO:1990393,1,0.965019105198456,0,5,3M complex,CC,
20951,GO:1990399,1,0.994408062285494,0,1,epithelium regeneration,BP,
20952,GO:1990401,1,0.994191137745906,0,1,embryonic lung development,BP,
20953,GO:1990402,1,0.994420977895971,0,1,embryonic liver development,BP,
20954,GO:1990403,1,0.936092417372892,0,10,embryonic brain development,BP,
20955,GO:1990404,1,0.987860182800814,0,2,protein ADP-ribosylase activity,MF,
20956,GO:1990405,1,0.955488293028899,0,6,protein antigen binding,MF,
20957,GO:1990406,1,0.987094861418785,0,2,CGRP receptor complex,CC,
20958,GO:1990407,1,0.994642946638896,0,1,calcitonin gene-related peptide binding,MF,
20959,GO:1990408,1,0.987094861418785,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20960,GO:1990409,1,0.987102895812299,0,2,adrenomedullin binding,MF,
20962,GO:1990414,1,0.970508985522177,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
20963,GO:1990415,1,0.981707812109649,0,3,Pex17p-Pex14p docking complex,CC,
20964,GO:1990416,1,0.943939555995279,0,8,cellular response to brain-derived neurotrophic factor stimulus,BP,
20965,GO:1990418,1,0.982898274504837,0,3,response to insulin-like growth factor stimulus,BP,
20966,GO:1990421,1,0.986945640841821,0,1,subtelomeric heterochromatin,CC,
20967,GO:1990423,1,0.978705974708646,0,3,RZZ complex,CC,
20968,GO:1990425,1,0.968936076698008,0,3,ryanodine receptor complex,CC,
20969,GO:1990426,1,0.981220809925568,0,2,mitotic recombination-dependent replication fork processing,BP,
20970,GO:1990427,1,0.990190990905559,0,1,stereocilia tip-link density,CC,
20971,GO:1990428,1,0.986348226253656,0,2,miRNA transport,BP,
20972,GO:1990429,1,0.981707812109649,0,3,peroxisomal importomer complex,CC,
20973,GO:1990430,1,0.968785448474116,0,4,extracellular matrix protein binding,MF,
20974,GO:1990435,1,0.990190990905559,0,1,upper tip-link density,CC,
20975,GO:1990439,1,0.994095857841098,0,1,MAP kinase serine/threonine phosphatase activity,MF,
20976,GO:1990440,1,0.937558758095175,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20977,GO:1990441,1,0.976963816185668,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20978,GO:1990442,1,0.983940885976835,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20979,GO:1990446,1,0.978388627290315,0,4,U1 snRNP binding,MF,
20980,GO:1990448,1,0.990890187588965,0,1,exon-exon junction complex binding,MF,
20981,GO:1990452,1,0.987495565716465,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20982,GO:1990454,1,0.941377044973018,0,7,L-type voltage-gated calcium channel complex,CC,
20983,GO:1990456,1,0.99345583713759,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
20984,GO:1990459,1,0.956373194803724,0,7,transferrin receptor binding,MF,
20985,GO:1990460,1,0.978467588227635,0,3,leptin receptor binding,MF,
20986,GO:1990462,1,0.95752139828676,0,7,omegasome,CC,
20987,GO:1990478,1,0.994494788018925,0,1,response to ultrasound,BP,
20988,GO:1990481,1,0.977327538787391,0,4,mRNA pseudouridine synthesis,BP,
20989,GO:1990498,1,0.979903831657215,0,2,mitotic spindle microtubule,CC,
20990,GO:1990502,1,0.985054678613704,0,2,dense core granule maturation,BP,
20991,GO:1990504,1,0.946627764669887,0,6,dense core granule exocytosis,BP,
20992,GO:1990505,1,0.981220809925568,0,2,mitotic DNA replication maintenance of fidelity,BP,
20993,GO:1990511,1,0.974432050334362,0,4,piRNA biosynthetic process,BP,
20994,GO:1990518,1,0.992762593882542,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
20995,GO:1990519,1,0.987352678048917,0,2,pyrimidine nucleotide import into mitochondrion,BP,
20997,GO:1990535,1,0.962283325377931,0,5,neuron projection maintenance,BP,
20998,GO:1990539,1,0.994381755056307,0,1,fructose import across plasma membrane,BP,
20999,GO:1990542,1,0.66571658942525,0,67,mitochondrial transmembrane transport,BP,
21000,GO:1990546,1,0.994561275999617,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21001,GO:1990564,1,0.972101518727781,0,5,protein polyufmylation,BP,
21002,GO:1990565,1,0.994548645624522,0,1,HSP90-CDC37 chaperone complex,CC,
21003,GO:1990569,1,0.985193395330265,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
21004,GO:1990570,1,0.994184768585909,0,1,GDP-mannose transmembrane transport,BP,
21005,GO:1990572,1,0.993313444145808,0,1,TERT-RMRP complex,CC,
21006,GO:1990573,1,0.942877432271902,0,9,potassium ion import across plasma membrane,BP,
21007,GO:1990575,1,0.98770266683921,0,2,mitochondrial L-ornithine transmembrane transport,BP,
21008,GO:1990578,1,0.991648533624227,0,1,perinuclear endoplasmic reticulum membrane,CC,
21009,GO:1990579,1,0.993299747117968,0,1,peptidyl-serine trans-autophosphorylation,BP,
21010,GO:1990583,1,0.994483082595611,0,1,phospholipase D activator activity,MF,
21011,GO:1990584,1,0.984011541784291,0,3,cardiac Troponin complex,CC,
21012,GO:1990589,1,0.982710211617446,0,2,ATF4-CREB1 transcription factor complex,CC,
21013,GO:1990590,1,0.988909444566289,0,2,ATF1-ATF4 transcription factor complex,CC,
21014,GO:1990592,1,0.972101518727781,0,5,protein K69-linked ufmylation,BP,
21015,GO:1990597,1,0.980708855618815,0,3,AIP1-IRE1 complex,CC,
21016,GO:1990599,1,0.979201400799308,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21017,GO:1990603,1,0.993874503447871,0,1,dark adaptation,BP,
21018,GO:1990604,1,0.9800356059331,0,3,IRE1-TRAF2-ASK1 complex,CC,
21019,GO:1990613,1,0.993705525213526,0,1,mitochondrial membrane fusion,BP,
21020,GO:1990617,1,0.98921212427664,0,2,CHOP-ATF4 complex,CC,
21021,GO:1990619,1,0.988040918615773,0,2,histone H3-K9 deacetylation,BP,
21022,GO:1990622,1,0.98913788318307,0,2,CHOP-ATF3 complex,CC,
21023,GO:1990630,1,0.993299747117968,0,1,IRE1-RACK1-PP2A complex,CC,
21024,GO:1990635,1,0.972339048325944,0,4,proximal dendrite,CC,
21025,GO:1990637,1,0.978897220423837,0,3,response to prolactin,BP,
21026,GO:1990641,1,0.982167025453745,0,3,response to iron ion starvation,BP,
21027,GO:1990646,1,0.994058968473674,0,1,cellular response to prolactin,BP,
21028,GO:1990654,1,0.992491734691833,0,1,sebum secreting cell proliferation,BP,
21029,GO:1990666,1,0.985818749108749,0,2,PCSK9-LDLR complex,CC,
21031,GO:1990668,1,0.970546814320091,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21032,GO:1990682,1,0.987694354689473,0,2,CSF1-CSF1R complex,CC,
21033,GO:1990696,1,0.980307905867104,0,2,USH2 complex,CC,
21034,GO:1990697,1,0.994414424138659,0,1,protein depalmitoleylation,BP,
21035,GO:1990698,1,0.987918361223137,0,2,palmitoleoyltransferase activity,MF,
21036,GO:1990699,1,0.994414424138659,0,1,palmitoleyl hydrolase activity,MF,
21037,GO:1990700,1,0.993366187988499,0,1,nucleolar chromatin organization,BP,
21038,GO:1990705,1,0.988950931178037,0,1,cholangiocyte proliferation,BP,
21039,GO:1990707,1,0.986945640841821,0,1,nuclear subtelomeric heterochromatin,CC,
21040,GO:1990708,1,0.99245478670028,0,1,conditioned place preference,BP,
21041,GO:1990709,1,0.976869929037594,0,3,presynaptic active zone organization,BP,
21042,GO:1990712,1,0.956039296477347,0,7,HFE-transferrin receptor complex,CC,
21043,GO:1990715,1,0.993267085316631,0,1,mRNA CDS binding,MF,
21044,GO:1990716,1,0.973295008414217,0,3,axonemal central apparatus,CC,
21045,GO:1990718,1,0.988140294032529,0,1,axonemal central pair projection,CC,
21046,GO:1990723,1,0.980602142509999,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21047,GO:1990726,1,0.973272046572991,0,5,Lsm1-7-Pat1 complex,CC,
21048,GO:1990729,1,0.99448753674817,0,1,primary miRNA modification,BP,
21049,GO:1990730,1,0.987152728523539,0,2,VCP-NSFL1C complex,CC,
21050,GO:1990736,1,0.993255870882139,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
21051,GO:1990737,1,0.980572885815,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21052,GO:1990739,1,0.988950931178037,0,1,granulosa cell proliferation,BP,
21053,GO:1990742,1,0.985944475726849,0,2,microvesicle,CC,
21055,GO:1990744,1,0.99448753674817,0,1,primary miRNA methylation,BP,
21056,GO:1990745,1,0.979406512992727,0,3,EARP complex,CC,
21057,GO:1990748,1,0.596226528911512,0,86,cellular detoxification,BP,
21058,GO:1990751,1,0.990337313481602,0,1,Schwann cell chemotaxis,BP,
21059,GO:1990752,1,0.804812416548949,0,25,microtubule end,CC,
21060,GO:1990755,1,0.994184768585909,0,1,mitotic spindle microtubule depolymerization,BP,
21061,GO:1990756,1,0.982322719822199,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
21062,GO:1990758,1,0.994516603423338,0,1,mitotic sister chromatid biorientation,BP,
21063,GO:1990761,1,0.975994533507916,0,3,growth cone lamellipodium,CC,
21064,GO:1990763,1,0.957736694913978,0,6,arrestin family protein binding,MF,
21066,GO:1990765,1,0.99224214601651,0,1,colon smooth muscle contraction,BP,
21067,GO:1990768,1,0.994654979429419,0,1,gastric mucosal blood circulation,BP,
21068,GO:1990769,1,0.982996339222345,0,3,proximal neuron projection,CC,
21069,GO:1990770,1,0.986938179294135,0,2,small intestine smooth muscle contraction,BP,
21070,GO:1990771,1,0.991377929237756,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21071,GO:1990773,1,0.994537030649287,0,1,matrix metallopeptidase secretion,BP,
21072,GO:1990774,1,0.880487373508399,0,18,tumor necrosis factor secretion,BP,
21073,GO:1990776,1,0.860470475623258,0,23,response to angiotensin,BP,
21074,GO:1990777,1,0.806668570896641,0,32,lipoprotein particle,CC,
21076,GO:1990782,1,0.626404632253339,0,67,protein tyrosine kinase binding,MF,
21077,GO:1990784,1,0.993285157639336,0,1,response to dsDNA,BP,
21078,GO:1990785,1,0.974553307881359,0,3,response to water-immersion restraint stress,BP,
21079,GO:1990786,1,0.993285157639336,0,1,cellular response to dsDNA,BP,
21080,GO:1990791,1,0.982185074270818,0,3,dorsal root ganglion development,BP,
21081,GO:1990796,1,0.994097302169045,0,1,photoreceptor cell terminal bouton,CC,
21082,GO:1990809,1,0.977306382354717,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21083,GO:1990812,1,0.981105429796514,0,3,growth cone filopodium,CC,
21084,GO:1990817,1,0.994396973404851,0,1,RNA adenylyltransferase activity,MF,
21085,GO:1990822,1,0.947793796568908,0,8,basic amino acid transmembrane transport,BP,
21087,GO:1990825,1,0.946128665092523,0,9,sequence-specific mRNA binding,MF,
21088,GO:1990828,1,0.994434001959065,0,1,hepatocyte dedifferentiation,BP,
21089,GO:1990829,1,0.994488149200091,0,1,C-rich single-stranded DNA binding,MF,
21091,GO:1990832,1,0.994468714795154,0,1,slow axonal transport,BP,
21092,GO:1990833,1,0.994468714795154,0,1,clathrin-uncoating ATPase activity,MF,
21095,GO:1990839,1,0.987495025943911,0,2,response to endothelin,BP,
21096,GO:1990841,1,0.766743528723077,0,38,promoter-specific chromatin binding,MF,
21097,GO:1990843,1,0.991164447768179,0,1,subsarcolemmal mitochondrion,CC,
21098,GO:1990844,1,0.991164447768179,0,1,interfibrillar mitochondrion,CC,
21099,GO:1990845,1,0.919788901857606,0,13,adaptive thermogenesis,BP,
21100,GO:1990851,1,0.974262358023054,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21101,GO:1990859,1,0.994386215805125,0,1,cellular response to endothelin,BP,
21102,GO:1990868,1,0.965015010021035,0,5,response to chemokine,BP,
21103,GO:1990869,1,0.965015010021035,0,5,cellular response to chemokine,BP,
21104,GO:1990874,1,0.785331114699827,0,36,vascular smooth muscle cell proliferation,BP,
21105,GO:1990876,1,0.990880003470552,0,1,cytoplasmic side of nuclear pore,CC,
21106,GO:1990879,1,0.988403017609477,0,2,CST complex,CC,
21107,GO:1990882,1,0.993356446296021,0,1,rRNA acetylation,BP,
21108,GO:1990883,1,0.993356446296021,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21109,GO:1990884,1,0.993356446296021,0,1,RNA acetylation,BP,
21110,GO:1990889,1,0.994510230053668,0,1,H4K20me3 modified histone binding,MF,
21112,GO:1990907,1,0.921161863965323,0,11,beta-catenin-TCF complex,CC,
21113,GO:1990909,1,0.918934236302924,0,10,Wnt signalosome,CC,
21114,GO:1990910,1,0.982027887320205,0,3,response to hypobaric hypoxia,BP,
21115,GO:1990911,1,0.977060589602261,0,4,response to psychosocial stress,BP,
21116,GO:1990913,1,0.994296200941556,0,1,sperm head plasma membrane,CC,
21117,GO:1990917,1,0.994296200941556,0,1,ooplasm,CC,
21118,GO:1990918,1,0.987032681681716,0,2,double-strand break repair involved in meiotic recombination,BP,
21119,GO:1990922,1,0.993855184595991,0,1,hepatic stellate cell proliferation,BP,
21120,GO:1990923,1,0.982222483080941,0,3,PET complex,CC,
21121,GO:1990926,1,0.981708825850686,0,3,short-term synaptic potentiation,BP,
21122,GO:1990927,1,0.985084488353675,0,2,calcium ion regulated lysosome exocytosis,BP,
21123,GO:1990928,1,0.984379406524841,0,2,response to amino acid starvation,BP,
21124,GO:1990930,1,0.994566168695361,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21125,GO:1990931,1,0.993061423099223,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
21126,GO:1990936,1,0.988677365607901,0,2,vascular smooth muscle cell dedifferentiation,BP,
21127,GO:1990938,1,0.99331429908418,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21128,GO:1990939,1,0.639532449949884,0,48,ATP-dependent microtubule motor activity,MF,
21129,GO:1990948,1,0.97332529654533,0,5,ubiquitin ligase inhibitor activity,MF,
21130,GO:1990955,1,0.993236847114163,0,1,G-rich single-stranded DNA binding,MF,
21131,GO:1990962,1,0.993327106956322,0,1,drug transport across blood-brain barrier,BP,
21132,GO:1990963,1,0.993327106956322,0,1,establishment of blood-retinal barrier,BP,
21133,GO:1990966,1,0.974763753779561,0,4,ATP generation from poly-ADP-D-ribose,BP,
21134,GO:1990967,1,0.988748509634437,0,2,multi-organism toxin transport,BP,
21135,GO:1990968,1,0.991043316065622,0,1,modulation by host of RNA binding by virus,BP,
21136,GO:1990969,1,0.991043316065622,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21137,GO:1990971,1,0.993375487741975,0,1,EMILIN complex,CC,
21138,GO:1990983,1,0.994278660745289,0,1,tRNA demethylation,BP,
21139,GO:1990984,1,0.994278660745289,0,1,tRNA demethylase activity,MF,
21140,GO:2000001,1,0.907755497634226,0,16,regulation of DNA damage checkpoint,BP,
21141,GO:2000002,1,0.970615965156859,0,5,negative regulation of DNA damage checkpoint,BP,
21142,GO:2000003,1,0.994184768585909,0,1,positive regulation of DNA damage checkpoint,BP,
21143,GO:2000004,1,0.994527376974531,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21144,GO:2000005,1,0.994527376974531,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21145,GO:2000006,1,0.994527376974531,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21146,GO:2000007,1,0.994527376974531,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21147,GO:2000008,1,0.79905229431581,0,33,regulation of protein localization to cell surface,BP,
21148,GO:2000009,1,0.922331718155053,0,12,negative regulation of protein localization to cell surface,BP,
21149,GO:2000010,1,0.913596131812547,0,13,positive regulation of protein localization to cell surface,BP,
21150,GO:2000011,1,0.994420049489966,0,1,regulation of adaxial/abaxial pattern formation,BP,
21151,GO:2000015,1,0.977215154554322,0,4,regulation of determination of dorsal identity,BP,
21152,GO:2000016,1,0.989181856044492,0,2,negative regulation of determination of dorsal identity,BP,
21153,GO:2000017,1,0.987903734232912,0,2,positive regulation of determination of dorsal identity,BP,
21154,GO:2000018,1,0.95021694314476,0,8,regulation of male gonad development,BP,
21155,GO:2000019,1,0.993400756729801,0,1,negative regulation of male gonad development,BP,
21156,GO:2000020,1,0.956532128191321,0,7,positive regulation of male gonad development,BP,
21158,GO:2000027,1,0.219302315513462,0,231,regulation of organ morphogenesis,BP,
21159,GO:2000035,1,0.951080343138519,0,8,regulation of stem cell division,BP,
21160,GO:2000036,1,0.847939504082004,0,24,regulation of stem cell population maintenance,BP,
21161,GO:2000040,1,0.987428455141441,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21162,GO:2000041,1,0.987428455141441,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21163,GO:2000042,1,0.932262033314101,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
21164,GO:2000043,1,0.994373027526835,0,1,regulation of cardiac cell fate specification,BP,
21166,GO:2000047,1,0.948009825630311,0,9,regulation of cell-cell adhesion mediated by cadherin,BP,
21167,GO:2000048,1,0.977894933435966,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21168,GO:2000049,1,0.969446077768067,0,5,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21169,GO:2000050,1,0.852969469574471,0,22,regulation of non-canonical Wnt signaling pathway,BP,
21170,GO:2000051,1,0.952637789252382,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21171,GO:2000052,1,0.92417109690866,0,12,positive regulation of non-canonical Wnt signaling pathway,BP,
21172,GO:2000053,1,0.980813400534738,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21173,GO:2000054,1,0.992909132662584,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21174,GO:2000055,1,0.987818746204725,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21175,GO:2000056,1,0.994506634650739,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21176,GO:2000057,1,0.994506634650739,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21177,GO:2000058,1,0.409305474095296,0,135,regulation of ubiquitin-dependent protein catabolic process,BP,
21178,GO:2000059,1,0.77677479599968,0,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21179,GO:2000060,1,0.553344231753754,0,90,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21180,GO:2000061,1,0.994566168695361,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21181,GO:2000062,1,0.994566168695361,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21182,GO:2000063,1,0.994566168695361,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21183,GO:2000064,1,0.96292319131896,0,6,regulation of cortisol biosynthetic process,BP,
21184,GO:2000065,1,0.976414551179982,0,4,negative regulation of cortisol biosynthetic process,BP,
21185,GO:2000066,1,0.993400756729801,0,1,positive regulation of cortisol biosynthetic process,BP,
21186,GO:2000067,1,0.994651281344248,0,1,regulation of root morphogenesis,BP,
21187,GO:2000074,1,0.949511376603333,0,8,regulation of type B pancreatic cell development,BP,
21188,GO:2000077,1,0.984924494432557,0,2,negative regulation of type B pancreatic cell development,BP,
21189,GO:2000078,1,0.983331291243854,0,3,positive regulation of type B pancreatic cell development,BP,
21190,GO:2000079,1,0.992909132662584,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21191,GO:2000080,1,0.992909132662584,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21192,GO:2000095,1,0.918667697122191,0,13,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21193,GO:2000096,1,0.94935697398014,0,8,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21196,GO:2000101,1,0.994102481539163,0,1,regulation of mammary stem cell proliferation,BP,
21197,GO:2000103,1,0.994102481539163,0,1,positive regulation of mammary stem cell proliferation,BP,
21198,GO:2000104,1,0.874667081071415,0,19,negative regulation of DNA-dependent DNA replication,BP,
21199,GO:2000105,1,0.906922922141496,0,14,positive regulation of DNA-dependent DNA replication,BP,
21201,GO:2000107,1,0.760952447643461,0,43,negative regulation of leukocyte apoptotic process,BP,
21203,GO:2000109,1,0.95553073841907,0,7,regulation of macrophage apoptotic process,BP,
21204,GO:2000110,1,0.981182986090422,0,3,negative regulation of macrophage apoptotic process,BP,
21205,GO:2000111,1,0.979397687344629,0,3,positive regulation of macrophage apoptotic process,BP,
21208,GO:2000114,1,0.872800742762984,0,18,regulation of establishment of cell polarity,BP,
21211,GO:2000118,1,0.987318176750739,0,2,regulation of sodium-dependent phosphate transport,BP,
21212,GO:2000119,1,0.994080987337973,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21213,GO:2000121,1,0.943437698434242,0,10,regulation of removal of superoxide radicals,BP,
21214,GO:2000124,1,0.987360088100959,0,2,regulation of endocannabinoid signaling pathway,BP,
21215,GO:2000134,1,0.528573758340421,0,96,negative regulation of G1/S transition of mitotic cell cycle,BP,
21216,GO:2000136,1,0.89804736573888,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21217,GO:2000137,1,0.98080461835238,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21218,GO:2000138,1,0.965912286233249,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21219,GO:2000142,1,0.784749117338761,0,36,regulation of DNA-templated transcription, initiation,BP,
21220,GO:2000143,1,0.962771482519013,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21221,GO:2000144,1,0.831179262633149,0,27,positive regulation of DNA-templated transcription, initiation,BP,
21225,GO:2000152,1,0.97746051719079,0,4,regulation of ubiquitin-specific protease activity,BP,
21226,GO:2000156,1,0.98760746429031,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21227,GO:2000157,1,0.989275957911691,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21228,GO:2000158,1,0.988057757687456,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21229,GO:2000167,1,0.992045150398547,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21230,GO:2000169,1,0.946307152875108,0,7,regulation of peptidyl-cysteine S-nitrosylation,BP,
21231,GO:2000170,1,0.986773419571671,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21232,GO:2000171,1,0.822652438555873,0,26,negative regulation of dendrite development,BP,
21233,GO:2000172,1,0.970506617100145,0,4,regulation of branching morphogenesis of a nerve,BP,
21234,GO:2000173,1,0.993355174210614,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21235,GO:2000174,1,0.993339883885943,0,1,regulation of pro-T cell differentiation,BP,
21236,GO:2000176,1,0.993339883885943,0,1,positive regulation of pro-T cell differentiation,BP,
21237,GO:2000177,1,0.60347873390253,0,71,regulation of neural precursor cell proliferation,BP,
21238,GO:2000178,1,0.872173360944291,0,20,negative regulation of neural precursor cell proliferation,BP,
21239,GO:2000179,1,0.751314191651726,0,40,positive regulation of neural precursor cell proliferation,BP,
21241,GO:2000182,1,0.978043493933802,0,3,regulation of progesterone biosynthetic process,BP,
21242,GO:2000184,1,0.991164447768179,0,1,positive regulation of progesterone biosynthetic process,BP,
21243,GO:2000191,1,0.896097329036265,0,16,regulation of fatty acid transport,BP,
21244,GO:2000192,1,0.96147607262005,0,5,negative regulation of fatty acid transport,BP,
21245,GO:2000193,1,0.941749823331706,0,10,positive regulation of fatty acid transport,BP,
21246,GO:2000194,1,0.925761743739171,0,12,regulation of female gonad development,BP,
21247,GO:2000195,1,0.976136153679685,0,4,negative regulation of female gonad development,BP,
21248,GO:2000196,1,0.982630318148272,0,3,positive regulation of female gonad development,BP,
21249,GO:2000197,1,0.957923610915953,0,6,regulation of ribonucleoprotein complex localization,BP,
21250,GO:2000199,1,0.994003928987086,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21251,GO:2000200,1,0.994003928987086,0,1,regulation of ribosomal subunit export from nucleus,BP,
21252,GO:2000202,1,0.994003928987086,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21253,GO:2000206,1,0.994003928987086,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21254,GO:2000208,1,0.994003928987086,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21255,GO:2000209,1,0.866198662689487,0,21,regulation of anoikis,BP,
21256,GO:2000210,1,0.964518182663807,0,6,positive regulation of anoikis,BP,
21257,GO:2000211,1,0.986854634512483,0,2,regulation of glutamate metabolic process,BP,
21258,GO:2000212,1,0.992375979100907,0,1,negative regulation of glutamate metabolic process,BP,
21259,GO:2000213,1,0.994436661814452,0,1,positive regulation of glutamate metabolic process,BP,
21260,GO:2000224,1,0.982746598550369,0,3,regulation of testosterone biosynthetic process,BP,
21261,GO:2000225,1,0.98806902866719,0,2,negative regulation of testosterone biosynthetic process,BP,
21262,GO:2000226,1,0.994585137910175,0,1,regulation of pancreatic A cell differentiation,BP,
21263,GO:2000227,1,0.994585137910175,0,1,negative regulation of pancreatic A cell differentiation,BP,
21264,GO:2000229,1,0.989148395214517,0,2,regulation of pancreatic stellate cell proliferation,BP,
21265,GO:2000230,1,0.994511452894922,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21266,GO:2000231,1,0.994607640841943,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21267,GO:2000232,1,0.92962679446706,0,11,regulation of rRNA processing,BP,
21268,GO:2000233,1,0.985642099532205,0,2,negative regulation of rRNA processing,BP,
21269,GO:2000234,1,0.950611783080998,0,8,positive regulation of rRNA processing,BP,
21272,GO:2000243,1,0.736698356157853,0,47,positive regulation of reproductive process,BP,
21273,GO:2000249,1,0.795316705032807,0,35,regulation of actin cytoskeleton reorganization,BP,
21274,GO:2000251,1,0.898851730542681,0,18,positive regulation of actin cytoskeleton reorganization,BP,
21275,GO:2000252,1,0.959592023602267,0,7,negative regulation of feeding behavior,BP,
21276,GO:2000253,1,0.963135929951174,0,5,positive regulation of feeding behavior,BP,
21277,GO:2000254,1,0.978201536508777,0,4,regulation of male germ cell proliferation,BP,
21278,GO:2000255,1,0.983476386161885,0,3,negative regulation of male germ cell proliferation,BP,
21279,GO:2000256,1,0.99463741868846,0,1,positive regulation of male germ cell proliferation,BP,
21282,GO:2000259,1,0.98054074269736,0,3,positive regulation of protein activation cascade,BP,
21283,GO:2000269,1,0.901904308173292,0,15,regulation of fibroblast apoptotic process,BP,
21284,GO:2000270,1,0.951695839628601,0,7,negative regulation of fibroblast apoptotic process,BP,
21285,GO:2000271,1,0.951801723980062,0,7,positive regulation of fibroblast apoptotic process,BP,
21286,GO:2000272,1,0.824899823064529,0,28,negative regulation of signaling receptor activity,BP,
21287,GO:2000273,1,0.815714313007445,0,29,positive regulation of signaling receptor activity,BP,
21288,GO:2000275,1,0.978216901921654,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21289,GO:2000276,1,0.98900363706188,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21290,GO:2000277,1,0.994640893629188,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21291,GO:2000278,1,0.532036909963595,0,96,regulation of DNA biosynthetic process,BP,
21292,GO:2000279,1,0.801747708650292,0,32,negative regulation of DNA biosynthetic process,BP,
21293,GO:2000280,1,0.994651281344248,0,1,regulation of root development,BP,
21294,GO:2000282,1,0.983602325067994,0,2,regulation of cellular amino acid biosynthetic process,BP,
21295,GO:2000283,1,0.988902548506595,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21296,GO:2000284,1,0.994640893629188,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21297,GO:2000286,1,0.982124120465291,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21298,GO:2000287,1,0.994407419587681,0,1,positive regulation of myotome development,BP,
21299,GO:2000288,1,0.948474568715308,0,9,positive regulation of myoblast proliferation,BP,
21300,GO:2000290,1,0.994407419587681,0,1,regulation of myotome development,BP,
21301,GO:2000291,1,0.91714596373491,0,14,regulation of myoblast proliferation,BP,
21302,GO:2000295,1,0.983312834911204,0,3,regulation of hydrogen peroxide catabolic process,BP,
21303,GO:2000296,1,0.989289779671285,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21304,GO:2000297,1,0.979483923871068,0,3,negative regulation of synapse maturation,BP,
21305,GO:2000298,1,0.988215451114719,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21306,GO:2000299,1,0.993825603885961,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21308,GO:2000301,1,0.981702014597044,0,3,negative regulation of synaptic vesicle exocytosis,BP,
21309,GO:2000302,1,0.976598154203279,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21310,GO:2000303,1,0.92497359367927,0,13,regulation of ceramide biosynthetic process,BP,
21311,GO:2000304,1,0.952882203034509,0,8,positive regulation of ceramide biosynthetic process,BP,
21314,GO:2000309,1,0.993971119153192,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21315,GO:2000310,1,0.878053117463828,0,18,regulation of NMDA receptor activity,BP,
21317,GO:2000312,1,0.978370663792911,0,3,regulation of kainate selective glutamate receptor activity,BP,
21318,GO:2000313,1,0.989084899398519,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21319,GO:2000314,1,0.994550664131612,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21320,GO:2000316,1,0.947611985347916,0,9,regulation of T-helper 17 type immune response,BP,
21321,GO:2000317,1,0.970641237864895,0,5,negative regulation of T-helper 17 type immune response,BP,
21322,GO:2000318,1,0.976281176274769,0,4,positive regulation of T-helper 17 type immune response,BP,
21323,GO:2000319,1,0.953441803970453,0,8,regulation of T-helper 17 cell differentiation,BP,
21324,GO:2000320,1,0.970641237864895,0,5,negative regulation of T-helper 17 cell differentiation,BP,
21325,GO:2000321,1,0.982285574807091,0,3,positive regulation of T-helper 17 cell differentiation,BP,
21326,GO:2000322,1,0.949352594329124,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21327,GO:2000323,1,0.960740939469477,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21328,GO:2000324,1,0.988151008984055,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21329,GO:2000325,1,0.991298187490562,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21330,GO:2000327,1,0.991298187490562,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21331,GO:2000328,1,0.977570714789562,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21332,GO:2000329,1,0.988302424531862,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21333,GO:2000330,1,0.989142541414013,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21334,GO:2000331,1,0.987295489253096,0,2,regulation of terminal button organization,BP,
21335,GO:2000332,1,0.989038527385328,0,2,regulation of blood microparticle formation,BP,
21336,GO:2000334,1,0.989038527385328,0,2,positive regulation of blood microparticle formation,BP,
21337,GO:2000338,1,0.988526082880454,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21338,GO:2000340,1,0.988526082880454,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21340,GO:2000342,1,0.988504663939134,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21342,GO:2000344,1,0.951719465613902,0,7,positive regulation of acrosome reaction,BP,
21343,GO:2000345,1,0.931251828273377,0,11,regulation of hepatocyte proliferation,BP,
21344,GO:2000346,1,0.981833485119301,0,3,negative regulation of hepatocyte proliferation,BP,
21345,GO:2000347,1,0.961100600051204,0,6,positive regulation of hepatocyte proliferation,BP,
21346,GO:2000348,1,0.96303934656968,0,6,regulation of CD40 signaling pathway,BP,
21347,GO:2000349,1,0.987454534114658,0,2,negative regulation of CD40 signaling pathway,BP,
21348,GO:2000350,1,0.994631297741194,0,1,positive regulation of CD40 signaling pathway,BP,
21351,GO:2000353,1,0.911514264587155,0,14,positive regulation of endothelial cell apoptotic process,BP,
21352,GO:2000354,1,0.964241410403792,0,6,regulation of ovarian follicle development,BP,
21353,GO:2000355,1,0.988995193239832,0,2,negative regulation of ovarian follicle development,BP,
21354,GO:2000356,1,0.994566168695361,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21355,GO:2000357,1,0.994566168695361,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21356,GO:2000358,1,0.994566168695361,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21357,GO:2000359,1,0.989030081854295,0,2,regulation of binding of sperm to zona pellucida,BP,
21358,GO:2000360,1,0.989030081854295,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21359,GO:2000361,1,0.985569749756702,0,2,regulation of prostaglandin-E synthase activity,BP,
21360,GO:2000363,1,0.985569749756702,0,2,positive regulation of prostaglandin-E synthase activity,BP,
21361,GO:2000367,1,0.989115323773677,0,2,regulation of acrosomal vesicle exocytosis,BP,
21362,GO:2000368,1,0.989115323773677,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21364,GO:2000370,1,0.972962073065136,0,4,positive regulation of clathrin-dependent endocytosis,BP,
21365,GO:2000371,1,0.96565678823811,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21366,GO:2000373,1,0.96565678823811,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21367,GO:2000374,1,0.983853696285345,0,3,regulation of oxygen metabolic process,BP,
21368,GO:2000376,1,0.989329032783552,0,2,positive regulation of oxygen metabolic process,BP,
21370,GO:2000378,1,0.751992695608792,0,45,negative regulation of reactive oxygen species metabolic process,BP,
21372,GO:2000380,1,0.904975598662716,0,15,regulation of mesoderm development,BP,
21373,GO:2000381,1,0.950429857246081,0,8,negative regulation of mesoderm development,BP,
21374,GO:2000382,1,0.97150562282438,0,4,positive regulation of mesoderm development,BP,
21375,GO:2000383,1,0.993447538755277,0,1,regulation of ectoderm development,BP,
21376,GO:2000384,1,0.993447538755277,0,1,negative regulation of ectoderm development,BP,
21377,GO:2000386,1,0.987900669182628,0,2,positive regulation of ovarian follicle development,BP,
21378,GO:2000387,1,0.994593689207107,0,1,regulation of antral ovarian follicle growth,BP,
21379,GO:2000388,1,0.994593689207107,0,1,positive regulation of antral ovarian follicle growth,BP,
21380,GO:2000389,1,0.980698889512236,0,3,regulation of neutrophil extravasation,BP,
21381,GO:2000391,1,0.980698889512236,0,3,positive regulation of neutrophil extravasation,BP,
21383,GO:2000393,1,0.986495523505937,0,2,negative regulation of lamellipodium morphogenesis,BP,
21384,GO:2000394,1,0.951580358916465,0,7,positive regulation of lamellipodium morphogenesis,BP,
21385,GO:2000395,1,0.989236042342321,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21386,GO:2000397,1,0.989236042342321,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21391,GO:2000405,1,0.98662080141265,0,2,negative regulation of T cell migration,BP,
21393,GO:2000407,1,0.983415441380407,0,3,regulation of T cell extravasation,BP,
21394,GO:2000409,1,0.988858752588757,0,2,positive regulation of T cell extravasation,BP,
21395,GO:2000410,1,0.983127104530372,0,3,regulation of thymocyte migration,BP,
21396,GO:2000412,1,0.988617872704523,0,2,positive regulation of thymocyte migration,BP,
21397,GO:2000413,1,0.993971119153192,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21398,GO:2000415,1,0.993971119153192,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21399,GO:2000416,1,0.976725841635131,0,4,regulation of eosinophil migration,BP,
21400,GO:2000417,1,0.988327455157316,0,2,negative regulation of eosinophil migration,BP,
21401,GO:2000418,1,0.988262737849716,0,2,positive regulation of eosinophil migration,BP,
21402,GO:2000419,1,0.993789304501779,0,1,regulation of eosinophil extravasation,BP,
21403,GO:2000420,1,0.993789304501779,0,1,negative regulation of eosinophil extravasation,BP,
21404,GO:2000422,1,0.994257341326422,0,1,regulation of eosinophil chemotaxis,BP,
21405,GO:2000424,1,0.994257341326422,0,1,positive regulation of eosinophil chemotaxis,BP,
21407,GO:2000426,1,0.988346218150541,0,2,negative regulation of apoptotic cell clearance,BP,
21409,GO:2000434,1,0.989321479516698,0,2,regulation of protein neddylation,BP,
21410,GO:2000435,1,0.989321479516698,0,2,negative regulation of protein neddylation,BP,
21411,GO:2000437,1,0.978530262534636,0,3,regulation of monocyte extravasation,BP,
21412,GO:2000438,1,0.990733598244629,0,1,negative regulation of monocyte extravasation,BP,
21413,GO:2000439,1,0.987683664354615,0,2,positive regulation of monocyte extravasation,BP,
21414,GO:2000446,1,0.993020484456629,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21415,GO:2000449,1,0.983415441380407,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21416,GO:2000451,1,0.988858752588757,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21417,GO:2000452,1,0.98903898491731,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21418,GO:2000454,1,0.994513109717654,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21419,GO:2000458,1,0.988873348708464,0,2,regulation of astrocyte chemotaxis,BP,
21421,GO:2000464,1,0.994314759125492,0,1,positive regulation of astrocyte chemotaxis,BP,
21422,GO:2000465,1,0.956133569309206,0,6,regulation of glycogen (starch) synthase activity,BP,
21423,GO:2000466,1,0.978939828056527,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21424,GO:2000467,1,0.977028061385018,0,3,positive regulation of glycogen (starch) synthase activity,BP,
21425,GO:2000468,1,0.982553126727996,0,2,regulation of peroxidase activity,BP,
21426,GO:2000469,1,0.988525498597407,0,1,negative regulation of peroxidase activity,BP,
21427,GO:2000470,1,0.993958996997799,0,1,positive regulation of peroxidase activity,BP,
21428,GO:2000471,1,0.986733184707268,0,2,regulation of hematopoietic stem cell migration,BP,
21429,GO:2000473,1,0.986733184707268,0,2,positive regulation of hematopoietic stem cell migration,BP,
21430,GO:2000474,1,0.987651986031619,0,2,regulation of opioid receptor signaling pathway,BP,
21431,GO:2000479,1,0.913161441717837,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21432,GO:2000480,1,0.953827317471405,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21433,GO:2000481,1,0.967891121856827,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21436,GO:2000484,1,0.920960159280566,0,14,positive regulation of interleukin-8 secretion,BP,
21437,GO:2000485,1,0.988144160259168,0,2,regulation of glutamine transport,BP,
21438,GO:2000486,1,0.993779751963204,0,1,negative regulation of glutamine transport,BP,
21439,GO:2000487,1,0.994329487160654,0,1,positive regulation of glutamine transport,BP,
21440,GO:2000489,1,0.961959750668607,0,6,regulation of hepatic stellate cell activation,BP,
21441,GO:2000490,1,0.988071100852918,0,2,negative regulation of hepatic stellate cell activation,BP,
21442,GO:2000491,1,0.973576539625622,0,4,positive regulation of hepatic stellate cell activation,BP,
21443,GO:2000492,1,0.994073310137837,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21444,GO:2000494,1,0.994073310137837,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21447,GO:2000503,1,0.983836491493508,0,3,positive regulation of natural killer cell chemotaxis,BP,
21448,GO:2000504,1,0.986835577762802,0,2,positive regulation of blood vessel remodeling,BP,
21449,GO:2000508,1,0.956330510564919,0,8,regulation of dendritic cell chemotaxis,BP,
21450,GO:2000510,1,0.956330510564919,0,8,positive regulation of dendritic cell chemotaxis,BP,
21451,GO:2000511,1,0.994614608811986,0,1,regulation of granzyme A production,BP,
21452,GO:2000513,1,0.994614608811986,0,1,positive regulation of granzyme A production,BP,
21456,GO:2000517,1,0.994614608811986,0,1,regulation of T-helper 1 cell activation,BP,
21457,GO:2000518,1,0.994614608811986,0,1,negative regulation of T-helper 1 cell activation,BP,
21460,GO:2000522,1,0.994430720184273,0,1,positive regulation of immunological synapse formation,BP,
21461,GO:2000523,1,0.988196590364093,0,2,regulation of T cell costimulation,BP,
21462,GO:2000525,1,0.988196590364093,0,2,positive regulation of T cell costimulation,BP,
21463,GO:2000526,1,0.994430720184273,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21464,GO:2000527,1,0.994645056734846,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21465,GO:2000529,1,0.994645056734846,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21466,GO:2000532,1,0.994311919238431,0,1,regulation of renal albumin absorption,BP,
21467,GO:2000533,1,0.994311919238431,0,1,negative regulation of renal albumin absorption,BP,
21468,GO:2000535,1,0.959642883076947,0,6,regulation of entry of bacterium into host cell,BP,
21469,GO:2000536,1,0.990589660791941,0,1,negative regulation of entry of bacterium into host cell,BP,
21470,GO:2000537,1,0.987664315906594,0,2,regulation of B cell chemotaxis,BP,
21471,GO:2000538,1,0.987664315906594,0,2,positive regulation of B cell chemotaxis,BP,
21473,GO:2000543,1,0.977667238689561,0,4,positive regulation of gastrulation,BP,
21474,GO:2000544,1,0.965692012951657,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21475,GO:2000545,1,0.994616672573995,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21476,GO:2000546,1,0.977301649443058,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21477,GO:2000547,1,0.983819610778237,0,3,regulation of dendritic cell dendrite assembly,BP,
21478,GO:2000548,1,0.994645056734846,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21479,GO:2000549,1,0.99465667194305,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21480,GO:2000551,1,0.954284449446859,0,8,regulation of T-helper 2 cell cytokine production,BP,
21481,GO:2000552,1,0.988900356261912,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21482,GO:2000553,1,0.964999398026283,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21483,GO:2000554,1,0.994614608811986,0,1,regulation of T-helper 1 cell cytokine production,BP,
21484,GO:2000556,1,0.994614608811986,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21485,GO:2000557,1,0.994614608811986,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21486,GO:2000558,1,0.994614608811986,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21487,GO:2000559,1,0.990733598244629,0,1,regulation of CD24 biosynthetic process,BP,
21488,GO:2000560,1,0.990733598244629,0,1,positive regulation of CD24 biosynthetic process,BP,
21489,GO:2000561,1,0.964568699485603,0,6,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21490,GO:2000562,1,0.977361570896999,0,4,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21491,GO:2000563,1,0.976246503420057,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21492,GO:2000564,1,0.982937731171114,0,3,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21493,GO:2000566,1,0.98919139957024,0,2,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21494,GO:2000567,1,0.994420049489966,0,1,regulation of memory T cell activation,BP,
21495,GO:2000568,1,0.994420049489966,0,1,positive regulation of memory T cell activation,BP,
21496,GO:2000569,1,0.993888408517662,0,1,regulation of T-helper 2 cell activation,BP,
21497,GO:2000570,1,0.993888408517662,0,1,positive regulation of T-helper 2 cell activation,BP,
21498,GO:2000571,1,0.993731305369998,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21499,GO:2000572,1,0.993731305369998,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21500,GO:2000573,1,0.671598232093247,0,63,positive regulation of DNA biosynthetic process,BP,
21501,GO:2000574,1,0.947426527387337,0,9,regulation of microtubule motor activity,BP,
21502,GO:2000576,1,0.966785385820885,0,6,positive regulation of microtubule motor activity,BP,
21503,GO:2000580,1,0.972441938122087,0,5,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21504,GO:2000582,1,0.972441938122087,0,5,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21505,GO:2000583,1,0.993449199815763,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21506,GO:2000584,1,0.993449199815763,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21507,GO:2000586,1,0.92032178203498,0,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21508,GO:2000587,1,0.936015897112435,0,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21509,GO:2000588,1,0.983244042943868,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21510,GO:2000589,1,0.980178441941452,0,3,regulation of metanephric mesenchymal cell migration,BP,
21511,GO:2000591,1,0.980178441941452,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21512,GO:2000592,1,0.986693766028451,0,2,regulation of metanephric DCT cell differentiation,BP,
21513,GO:2000594,1,0.986693766028451,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21514,GO:2000595,1,0.993222108242155,0,1,regulation of optic nerve formation,BP,
21515,GO:2000597,1,0.993222108242155,0,1,positive regulation of optic nerve formation,BP,
21516,GO:2000601,1,0.960076391539537,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21517,GO:2000606,1,0.994023737535236,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21518,GO:2000607,1,0.994023737535236,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21519,GO:2000609,1,0.976618313927182,0,4,regulation of thyroid hormone generation,BP,
21520,GO:2000611,1,0.982014748628053,0,3,positive regulation of thyroid hormone generation,BP,
21521,GO:2000612,1,0.993427552906125,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21522,GO:2000615,1,0.92792022679771,0,11,regulation of histone H3-K9 acetylation,BP,
21523,GO:2000616,1,0.98679557887541,0,2,negative regulation of histone H3-K9 acetylation,BP,
21524,GO:2000617,1,0.95133628285213,0,7,positive regulation of histone H3-K9 acetylation,BP,
21525,GO:2000618,1,0.96441639113051,0,5,regulation of histone H4-K16 acetylation,BP,
21526,GO:2000619,1,0.982076102582466,0,3,negative regulation of histone H4-K16 acetylation,BP,
21527,GO:2000620,1,0.982021201519534,0,2,positive regulation of histone H4-K16 acetylation,BP,
21528,GO:2000622,1,0.971405178465337,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21529,GO:2000623,1,0.971405178465337,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21530,GO:2000625,1,0.987045248250515,0,2,regulation of miRNA catabolic process,BP,
21531,GO:2000627,1,0.987045248250515,0,2,positive regulation of miRNA catabolic process,BP,
21532,GO:2000628,1,0.957986685882265,0,7,regulation of miRNA metabolic process,BP,
21533,GO:2000630,1,0.969512669460839,0,5,positive regulation of miRNA metabolic process,BP,
21534,GO:2000631,1,0.993907666384269,0,1,regulation of pre-miRNA processing,BP,
21535,GO:2000632,1,0.993907666384269,0,1,negative regulation of pre-miRNA processing,BP,
21536,GO:2000637,1,0.877923445227429,0,20,positive regulation of gene silencing by miRNA,BP,
21537,GO:2000638,1,0.987792254598377,0,2,regulation of SREBP signaling pathway,BP,
21538,GO:2000639,1,0.987792254598377,0,2,negative regulation of SREBP signaling pathway,BP,
21539,GO:2000641,1,0.895044229360659,0,17,regulation of early endosome to late endosome transport,BP,
21540,GO:2000642,1,0.989277886579472,0,2,negative regulation of early endosome to late endosome transport,BP,
21541,GO:2000643,1,0.947208839726645,0,8,positive regulation of early endosome to late endosome transport,BP,
21544,GO:2000646,1,0.96535587739548,0,5,positive regulation of receptor catabolic process,BP,
21546,GO:2000648,1,0.782228345115343,0,35,positive regulation of stem cell proliferation,BP,
21547,GO:2000649,1,0.717804580713741,0,46,regulation of sodium ion transmembrane transporter activity,BP,
21548,GO:2000650,1,0.918321084764151,0,11,negative regulation of sodium ion transmembrane transporter activity,BP,
21549,GO:2000651,1,0.906813380381686,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21550,GO:2000653,1,0.98078448936125,0,3,regulation of genetic imprinting,BP,
21551,GO:2000654,1,0.993450445158367,0,1,regulation of cellular response to testosterone stimulus,BP,
21552,GO:2000655,1,0.993450445158367,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21553,GO:2000656,1,0.994506634650739,0,1,regulation of apolipoprotein binding,BP,
21554,GO:2000657,1,0.994506634650739,0,1,negative regulation of apolipoprotein binding,BP,
21555,GO:2000659,1,0.956424030684073,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
21556,GO:2000660,1,0.969001404549129,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21557,GO:2000661,1,0.992497807452188,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21558,GO:2000662,1,0.965159962512534,0,6,regulation of interleukin-5 secretion,BP,
21559,GO:2000663,1,0.99362018691196,0,1,negative regulation of interleukin-5 secretion,BP,
21560,GO:2000664,1,0.971358846610705,0,5,positive regulation of interleukin-5 secretion,BP,
21561,GO:2000665,1,0.960063174402818,0,7,regulation of interleukin-13 secretion,BP,
21562,GO:2000666,1,0.988137371021436,0,2,negative regulation of interleukin-13 secretion,BP,
21563,GO:2000667,1,0.971592116082654,0,5,positive regulation of interleukin-13 secretion,BP,
21564,GO:2000668,1,0.940252659636349,0,10,regulation of dendritic cell apoptotic process,BP,
21565,GO:2000669,1,0.960035719452872,0,7,negative regulation of dendritic cell apoptotic process,BP,
21566,GO:2000670,1,0.979401730741439,0,3,positive regulation of dendritic cell apoptotic process,BP,
21568,GO:2000672,1,0.976265005227875,0,4,negative regulation of motor neuron apoptotic process,BP,
21569,GO:2000674,1,0.935466127627679,0,11,regulation of type B pancreatic cell apoptotic process,BP,
21570,GO:2000675,1,0.963235975195626,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21571,GO:2000676,1,0.971180901659631,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
21572,GO:2000677,1,0.741199416970634,0,44,regulation of transcription regulatory region DNA binding,BP,
21573,GO:2000678,1,0.87646721325708,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21574,GO:2000679,1,0.878113535324236,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21575,GO:2000683,1,0.988220121488382,0,2,regulation of cellular response to X-ray,BP,
21576,GO:2000685,1,0.99416184066975,0,1,positive regulation of cellular response to X-ray,BP,
21577,GO:2000690,1,0.99309640786257,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21578,GO:2000691,1,0.99309640786257,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21579,GO:2000696,1,0.897501730612704,0,15,regulation of epithelial cell differentiation involved in kidney development,BP,
21580,GO:2000697,1,0.976796005657416,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21581,GO:2000698,1,0.968474792907366,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21582,GO:2000699,1,0.994023737535236,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21583,GO:2000701,1,0.994023737535236,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21584,GO:2000702,1,0.994023737535236,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21585,GO:2000703,1,0.994023737535236,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21586,GO:2000705,1,0.977176758495083,0,3,regulation of dense core granule biogenesis,BP,
21587,GO:2000706,1,0.993598814561107,0,1,negative regulation of dense core granule biogenesis,BP,
21588,GO:2000707,1,0.983473198008574,0,2,positive regulation of dense core granule biogenesis,BP,
21589,GO:2000718,1,0.99464436348237,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21590,GO:2000719,1,0.99464436348237,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21591,GO:2000721,1,0.977551755860009,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21592,GO:2000722,1,0.979275420745672,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21593,GO:2000723,1,0.994240316674479,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21594,GO:2000724,1,0.98494927455635,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21595,GO:2000725,1,0.822419074898003,0,27,regulation of cardiac muscle cell differentiation,BP,
21596,GO:2000726,1,0.923132545545067,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21597,GO:2000727,1,0.890982597499195,0,16,positive regulation of cardiac muscle cell differentiation,BP,
21598,GO:2000729,1,0.988831867350445,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21599,GO:2000733,1,0.994023737535236,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21600,GO:2000734,1,0.994023737535236,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21601,GO:2000736,1,0.486837646724607,0,115,regulation of stem cell differentiation,BP,
21602,GO:2000737,1,0.876981209175148,0,18,negative regulation of stem cell differentiation,BP,
21603,GO:2000738,1,0.892942461153988,0,17,positive regulation of stem cell differentiation,BP,
21604,GO:2000739,1,0.953450361052614,0,6,regulation of mesenchymal stem cell differentiation,BP,
21605,GO:2000740,1,0.993598814561107,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21606,GO:2000741,1,0.96839411610631,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21607,GO:2000742,1,0.99445465763235,0,1,regulation of anterior head development,BP,
21608,GO:2000744,1,0.99445465763235,0,1,positive regulation of anterior head development,BP,
21609,GO:2000752,1,0.994181688827792,0,1,regulation of glucosylceramide catabolic process,BP,
21610,GO:2000753,1,0.994181688827792,0,1,positive regulation of glucosylceramide catabolic process,BP,
21611,GO:2000754,1,0.994181688827792,0,1,regulation of sphingomyelin catabolic process,BP,
21612,GO:2000755,1,0.994181688827792,0,1,positive regulation of sphingomyelin catabolic process,BP,
21613,GO:2000756,1,0.689315709188323,0,57,regulation of peptidyl-lysine acetylation,BP,
21614,GO:2000757,1,0.872635655998636,0,21,negative regulation of peptidyl-lysine acetylation,BP,
21615,GO:2000758,1,0.827251697584657,0,29,positive regulation of peptidyl-lysine acetylation,BP,
21616,GO:2000759,1,0.992535130779427,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21617,GO:2000761,1,0.992535130779427,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21618,GO:2000763,1,0.994366261730916,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21619,GO:2000764,1,0.994366261730916,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21620,GO:2000765,1,0.86421109734302,0,22,regulation of cytoplasmic translation,BP,
21621,GO:2000766,1,0.949292072479421,0,7,negative regulation of cytoplasmic translation,BP,
21622,GO:2000767,1,0.953923277586266,0,7,positive regulation of cytoplasmic translation,BP,
21623,GO:2000768,1,0.993378864949064,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21624,GO:2000772,1,0.797979058992657,0,33,regulation of cellular senescence,BP,
21625,GO:2000773,1,0.890264520146757,0,16,negative regulation of cellular senescence,BP,
21626,GO:2000774,1,0.948237671323673,0,9,positive regulation of cellular senescence,BP,
21627,GO:2000775,1,0.994453268578291,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21628,GO:2000777,1,0.988886980827294,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21629,GO:2000778,1,0.884880632221181,0,19,positive regulation of interleukin-6 secretion,BP,
21630,GO:2000779,1,0.708647747867299,0,50,regulation of double-strand break repair,BP,
21631,GO:2000780,1,0.863813927883526,0,20,negative regulation of double-strand break repair,BP,
21632,GO:2000781,1,0.919607121822531,0,12,positive regulation of double-strand break repair,BP,
21633,GO:2000785,1,0.786347593187802,0,35,regulation of autophagosome assembly,BP,
21634,GO:2000786,1,0.929076239817165,0,10,positive regulation of autophagosome assembly,BP,
21635,GO:2000790,1,0.983009462644458,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21636,GO:2000791,1,0.983009462644458,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21637,GO:2000793,1,0.969989485711377,0,3,cell proliferation involved in heart valve development,BP,
21638,GO:2000794,1,0.947094901189733,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21639,GO:2000795,1,0.989492109412354,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21640,GO:2000797,1,0.993598814561107,0,1,regulation of amniotic stem cell differentiation,BP,
21641,GO:2000798,1,0.993598814561107,0,1,negative regulation of amniotic stem cell differentiation,BP,
21642,GO:2000800,1,0.994551028674317,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21643,GO:2000802,1,0.994551028674317,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21644,GO:2000804,1,0.98704162678125,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21645,GO:2000806,1,0.98704162678125,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21646,GO:2000807,1,0.945084914487788,0,7,regulation of synaptic vesicle clustering,BP,
21647,GO:2000808,1,0.991895144947715,0,1,negative regulation of synaptic vesicle clustering,BP,
21648,GO:2000809,1,0.962799905561475,0,5,positive regulation of synaptic vesicle clustering,BP,
21649,GO:2000810,1,0.872424628978485,0,20,regulation of bicellular tight junction assembly,BP,
21650,GO:2000811,1,0.900702587393292,0,15,negative regulation of anoikis,BP,
21651,GO:2000812,1,0.993419197016076,0,1,regulation of barbed-end actin filament capping,BP,
21652,GO:2000816,1,0.798797492166641,0,33,negative regulation of mitotic sister chromatid separation,BP,
21653,GO:2000818,1,0.988723272578625,0,2,negative regulation of myoblast proliferation,BP,
21654,GO:2000819,1,0.987784101120453,0,2,regulation of nucleotide-excision repair,BP,
21655,GO:2000820,1,0.980258978236244,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21656,GO:2000821,1,0.964359458045099,0,5,regulation of grooming behavior,BP,
21657,GO:2000822,1,0.955459503524251,0,7,regulation of behavioral fear response,BP,
21658,GO:2000823,1,0.96205160252797,0,6,regulation of androgen receptor activity,BP,
21659,GO:2000824,1,0.987686344970354,0,2,negative regulation of androgen receptor activity,BP,
21660,GO:2000825,1,0.974048839194459,0,4,positive regulation of androgen receptor activity,BP,
21661,GO:2000826,1,0.804762576551902,0,32,regulation of heart morphogenesis,BP,
21662,GO:2000827,1,0.994321186110909,0,1,mitochondrial RNA surveillance,BP,
21663,GO:2000828,1,0.986355934501712,0,2,regulation of parathyroid hormone secretion,BP,
21664,GO:2000830,1,0.991807797202965,0,1,positive regulation of parathyroid hormone secretion,BP,
21665,GO:2000831,1,0.910552070065612,0,16,regulation of steroid hormone secretion,BP,
21666,GO:2000832,1,0.985141500944702,0,2,negative regulation of steroid hormone secretion,BP,
21667,GO:2000833,1,0.950602721879603,0,9,positive regulation of steroid hormone secretion,BP,
21668,GO:2000834,1,0.993885637384576,0,1,regulation of androgen secretion,BP,
21669,GO:2000836,1,0.993885637384576,0,1,positive regulation of androgen secretion,BP,
21670,GO:2000843,1,0.984554131550098,0,2,regulation of testosterone secretion,BP,
21671,GO:2000845,1,0.984554131550098,0,2,positive regulation of testosterone secretion,BP,
21672,GO:2000846,1,0.926198849578505,0,13,regulation of corticosteroid hormone secretion,BP,
21673,GO:2000847,1,0.985141500944702,0,2,negative regulation of corticosteroid hormone secretion,BP,
21674,GO:2000848,1,0.961584765171263,0,7,positive regulation of corticosteroid hormone secretion,BP,
21675,GO:2000849,1,0.9479383003765,0,9,regulation of glucocorticoid secretion,BP,
21676,GO:2000850,1,0.985141500944702,0,2,negative regulation of glucocorticoid secretion,BP,
21677,GO:2000851,1,0.973017240645601,0,5,positive regulation of glucocorticoid secretion,BP,
21678,GO:2000852,1,0.97830605293471,0,4,regulation of corticosterone secretion,BP,
21679,GO:2000854,1,0.989260150337885,0,2,positive regulation of corticosterone secretion,BP,
21680,GO:2000855,1,0.97707872414095,0,4,regulation of mineralocorticoid secretion,BP,
21681,GO:2000857,1,0.988253688097916,0,2,positive regulation of mineralocorticoid secretion,BP,
21682,GO:2000858,1,0.97707872414095,0,4,regulation of aldosterone secretion,BP,
21683,GO:2000860,1,0.988253688097916,0,2,positive regulation of aldosterone secretion,BP,
21686,GO:2000870,1,0.989168095866787,0,2,regulation of progesterone secretion,BP,
21687,GO:2000872,1,0.994665748525024,0,1,positive regulation of progesterone secretion,BP,
21688,GO:2000878,1,0.988828301877708,0,2,positive regulation of oligopeptide transport,BP,
21689,GO:2000880,1,0.988828301877708,0,2,positive regulation of dipeptide transport,BP,
21690,GO:2000896,1,0.993968507967003,0,1,amylopectin metabolic process,BP,
21691,GO:2000909,1,0.994184768585909,0,1,regulation of sterol import,BP,
21692,GO:2000969,1,0.959546238615919,0,5,positive regulation of AMPA receptor activity,BP,
21693,GO:2000970,1,0.994348648066218,0,1,regulation of detection of glucose,BP,
21694,GO:2000971,1,0.994348648066218,0,1,negative regulation of detection of glucose,BP,
21695,GO:2000973,1,0.953065246730033,0,6,regulation of pro-B cell differentiation,BP,
21696,GO:2000974,1,0.977820252320536,0,3,negative regulation of pro-B cell differentiation,BP,
21697,GO:2000977,1,0.97722410585179,0,4,regulation of forebrain neuron differentiation,BP,
21698,GO:2000978,1,0.989219056404866,0,2,negative regulation of forebrain neuron differentiation,BP,
21699,GO:2000979,1,0.994022802320081,0,1,positive regulation of forebrain neuron differentiation,BP,
21700,GO:2000980,1,0.955090399082362,0,7,regulation of inner ear receptor cell differentiation,BP,
21701,GO:2000981,1,0.971814870093555,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21702,GO:2000983,1,0.989299821358726,0,2,regulation of ATP citrate synthase activity,BP,
21703,GO:2000984,1,0.989299821358726,0,2,negative regulation of ATP citrate synthase activity,BP,
21704,GO:2000987,1,0.969424197611352,0,5,positive regulation of behavioral fear response,BP,
21705,GO:2001012,1,0.958686197410676,0,7,mesenchymal cell differentiation involved in renal system development,BP,
21706,GO:2001013,1,0.970221148477269,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21707,GO:2001014,1,0.885943868977095,0,18,regulation of skeletal muscle cell differentiation,BP,
21708,GO:2001015,1,0.958125065667773,0,6,negative regulation of skeletal muscle cell differentiation,BP,
21709,GO:2001016,1,0.966801523696249,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21710,GO:2001020,1,0.324430499091073,0,171,regulation of response to DNA damage stimulus,BP,
21711,GO:2001021,1,0.655820390802827,0,65,negative regulation of response to DNA damage stimulus,BP,
21712,GO:2001022,1,0.627027194354944,0,72,positive regulation of response to DNA damage stimulus,BP,
21713,GO:2001023,1,0.620887488336726,0,74,regulation of response to drug,BP,
21714,GO:2001024,1,0.849301413117387,0,25,negative regulation of response to drug,BP,
21715,GO:2001025,1,0.858680269467545,0,25,positive regulation of response to drug,BP,
21716,GO:2001026,1,0.885480539181358,0,16,regulation of endothelial cell chemotaxis,BP,
21717,GO:2001027,1,0.974947830343718,0,3,negative regulation of endothelial cell chemotaxis,BP,
21718,GO:2001028,1,0.914229381421341,0,12,positive regulation of endothelial cell chemotaxis,BP,
21719,GO:2001029,1,0.991915087118089,0,1,regulation of cellular glucuronidation,BP,
21720,GO:2001031,1,0.991915087118089,0,1,positive regulation of cellular glucuronidation,BP,
21721,GO:2001032,1,0.924719833533793,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
21722,GO:2001033,1,0.971827811951791,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21723,GO:2001034,1,0.96390798230445,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21724,GO:2001035,1,0.987461740926244,0,2,regulation of tongue muscle cell differentiation,BP,
21725,GO:2001037,1,0.987461740926244,0,2,positive regulation of tongue muscle cell differentiation,BP,
21726,GO:2001038,1,0.838330040866685,0,27,regulation of cellular response to drug,BP,
21727,GO:2001039,1,0.896328767175987,0,17,negative regulation of cellular response to drug,BP,
21728,GO:2001040,1,0.960825379396686,0,6,positive regulation of cellular response to drug,BP,
21730,GO:2001045,1,0.984836579238657,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21731,GO:2001046,1,0.959339449088083,0,6,positive regulation of integrin-mediated signaling pathway,BP,
21732,GO:2001049,1,0.994479816653063,0,1,regulation of tendon cell differentiation,BP,
21733,GO:2001051,1,0.994479816653063,0,1,positive regulation of tendon cell differentiation,BP,
21734,GO:2001053,1,0.935574328058883,0,11,regulation of mesenchymal cell apoptotic process,BP,
21735,GO:2001054,1,0.946038773985048,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
21736,GO:2001055,1,0.9889447763053,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21739,GO:2001065,1,0.994600003450564,0,1,mannan binding,MF,
21740,GO:2001069,1,0.988468211054914,0,2,glycogen binding,MF,
21741,GO:2001070,1,0.98634824958735,0,2,starch binding,MF,
21742,GO:2001074,1,0.988621804221987,0,2,regulation of metanephric ureteric bud development,BP,
21743,GO:2001076,1,0.988621804221987,0,2,positive regulation of metanephric ureteric bud development,BP,
21744,GO:2001106,1,0.982043286838657,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21745,GO:2001108,1,0.991132725832899,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21746,GO:2001109,1,0.983549571270326,0,2,regulation of lens epithelial cell proliferation,BP,
21747,GO:2001111,1,0.983549571270326,0,2,positive regulation of lens epithelial cell proliferation,BP,
21748,GO:2001112,1,0.992440736563162,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21749,GO:2001113,1,0.992440736563162,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21750,GO:2001135,1,0.937263780116222,0,9,regulation of endocytic recycling,BP,
21751,GO:2001136,1,0.993834209295313,0,1,negative regulation of endocytic recycling,BP,
21752,GO:2001137,1,0.967729804873317,0,4,positive regulation of endocytic recycling,BP,
21753,GO:2001138,1,0.945141978970148,0,8,regulation of phospholipid transport,BP,
21754,GO:2001140,1,0.945141978970148,0,8,positive regulation of phospholipid transport,BP,
21756,GO:2001142,1,0.994287720904879,0,1,nicotinate transport,BP,
21757,GO:2001144,1,0.994426797638421,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21758,GO:2001145,1,0.994426797638421,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21759,GO:2001148,1,0.988828301877708,0,2,regulation of dipeptide transmembrane transport,BP,
21760,GO:2001150,1,0.988828301877708,0,2,positive regulation of dipeptide transmembrane transport,BP,
21761,GO:2001151,1,0.993924650737727,0,1,regulation of renal water transport,BP,
21762,GO:2001153,1,0.993924650737727,0,1,positive regulation of renal water transport,BP,
21763,GO:2001160,1,0.987684855437408,0,2,regulation of histone H3-K79 methylation,BP,
21764,GO:2001162,1,0.987684855437408,0,2,positive regulation of histone H3-K79 methylation,BP,
21765,GO:2001163,1,0.994397800641409,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21766,GO:2001165,1,0.994397800641409,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21767,GO:2001166,1,0.968655773768245,0,5,regulation of histone H2B ubiquitination,BP,
21768,GO:2001168,1,0.974071731781328,0,4,positive regulation of histone H2B ubiquitination,BP,
21769,GO:2001169,1,0.613915169630918,0,69,regulation of ATP biosynthetic process,BP,
21770,GO:2001170,1,0.911682215732476,0,13,negative regulation of ATP biosynthetic process,BP,
21771,GO:2001171,1,0.845318802109286,0,24,positive regulation of ATP biosynthetic process,BP,
21772,GO:2001173,1,0.99444133485863,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
21773,GO:2001176,1,0.988641702330571,0,2,regulation of mediator complex assembly,BP,
21774,GO:2001178,1,0.988641702330571,0,2,positive regulation of mediator complex assembly,BP,
21775,GO:2001179,1,0.961133292947117,0,7,regulation of interleukin-10 secretion,BP,
21776,GO:2001180,1,0.982371358958915,0,3,negative regulation of interleukin-10 secretion,BP,
21777,GO:2001181,1,0.978384624172711,0,4,positive regulation of interleukin-10 secretion,BP,
21778,GO:2001182,1,0.958163832464647,0,7,regulation of interleukin-12 secretion,BP,
21779,GO:2001183,1,0.981892230745897,0,3,negative regulation of interleukin-12 secretion,BP,
21780,GO:2001184,1,0.982051521688673,0,3,positive regulation of interleukin-12 secretion,BP,
21781,GO:2001185,1,0.959221816069095,0,7,regulation of CD8-positive, alpha-beta T cell activation,BP,
21782,GO:2001186,1,0.988665651986589,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21783,GO:2001187,1,0.982650295287169,0,3,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21786,GO:2001190,1,0.989176235532088,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21787,GO:2001191,1,0.994142758058285,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21788,GO:2001193,1,0.994142758058285,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21789,GO:2001197,1,0.955939962256976,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21790,GO:2001198,1,0.943978967781766,0,10,regulation of dendritic cell differentiation,BP,
21791,GO:2001199,1,0.965982233864619,0,6,negative regulation of dendritic cell differentiation,BP,
21792,GO:2001200,1,0.976132566068908,0,4,positive regulation of dendritic cell differentiation,BP,
21794,GO:2001202,1,0.983489123533383,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21798,GO:2001206,1,0.982903329520277,0,3,positive regulation of osteoclast development,BP,
21799,GO:2001207,1,0.993478979029256,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21800,GO:2001208,1,0.993478979029256,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
21802,GO:2001213,1,0.991707255659884,0,1,negative regulation of vasculogenesis,BP,
21806,GO:2001224,1,0.889271440116046,0,13,positive regulation of neuron migration,BP,
21807,GO:2001225,1,0.93403329503519,0,10,regulation of chloride transport,BP,
21808,GO:2001226,1,0.98204274011158,0,3,negative regulation of chloride transport,BP,
21809,GO:2001228,1,0.972240795422789,0,2,regulation of response to gamma radiation,BP,
21810,GO:2001229,1,0.985064714149881,0,1,negative regulation of response to gamma radiation,BP,
21817,GO:2001239,1,0.760597421621942,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21818,GO:2001240,1,0.824623941565115,0,32,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21819,GO:2001241,1,0.924083433445607,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21820,GO:2001242,1,0.415957532264854,0,144,regulation of intrinsic apoptotic signaling pathway,BP,
21821,GO:2001243,1,0.576758782619073,0,90,negative regulation of intrinsic apoptotic signaling pathway,BP,
21822,GO:2001244,1,0.752824490970274,0,48,positive regulation of intrinsic apoptotic signaling pathway,BP,
21823,GO:2001245,1,0.981144619155537,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21824,GO:2001246,1,0.993358565708716,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21825,GO:2001247,1,0.993040979812482,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21826,GO:2001248,1,0.994436661814452,0,1,regulation of ammonia assimilation cycle,BP,
21827,GO:2001250,1,0.994436661814452,0,1,positive regulation of ammonia assimilation cycle,BP,
21828,GO:2001251,1,0.434266103645507,0,116,negative regulation of chromosome organization,BP,
21829,GO:2001252,1,0.356628969973172,0,152,positive regulation of chromosome organization,BP,
21830,GO:2001253,1,0.994059570370626,0,1,regulation of histone H3-K36 trimethylation,BP,
21831,GO:2001256,1,0.928613516062024,0,12,regulation of store-operated calcium entry,BP,
21833,GO:2001258,1,0.802583183356963,0,36,negative regulation of cation channel activity,BP,
21834,GO:2001259,1,0.677739996721318,0,54,positive regulation of cation channel activity,BP,
21835,GO:2001260,1,0.994366261730916,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21836,GO:2001262,1,0.994366261730916,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21837,GO:2001267,1,0.87040002187481,0,23,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21838,GO:2001268,1,0.972762344499797,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21839,GO:2001269,1,0.894799006596301,0,18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21840,GO:2001270,1,0.973907711258407,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21841,GO:2001271,1,0.979149805216128,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21842,GO:2001272,1,0.994647405411136,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21843,GO:2001273,1,0.865194246630752,0,20,regulation of glucose import in response to insulin stimulus,BP,
21844,GO:2001274,1,0.980836970002274,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21845,GO:2001275,1,0.887633502816134,0,16,positive regulation of glucose import in response to insulin stimulus,BP,
21848,GO:2001286,1,0.970881056397731,0,4,regulation of caveolin-mediated endocytosis,BP,
21849,GO:2001287,1,0.988063859414069,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21850,GO:2001288,1,0.989269236511746,0,1,positive regulation of caveolin-mediated endocytosis,BP,
21851,GO:2001293,1,0.982990052490279,0,2,malonyl-CoA metabolic process,BP,
21852,GO:2001294,1,0.994423440946932,0,1,malonyl-CoA catabolic process,BP,
21853,GO:2001295,1,0.988503133742174,0,1,malonyl-CoA biosynthetic process,BP,
21854,GO:2001300,1,0.966852277163049,0,6,lipoxin metabolic process,BP,
21855,GO:2001301,1,0.966852277163049,0,6,lipoxin biosynthetic process,BP,
21856,GO:2001302,1,0.988631335009537,0,2,lipoxin A4 metabolic process,BP,
21857,GO:2001303,1,0.988631335009537,0,2,lipoxin A4 biosynthetic process,BP,
21858,GO:2001304,1,0.994365902427248,0,1,lipoxin B4 metabolic process,BP,
21859,GO:2001306,1,0.994365902427248,0,1,lipoxin B4 biosynthetic process,BP,
21860,GO:2001311,1,0.994521105664414,0,1,lysobisphosphatidic acid metabolic process,BP,
10792,GO:0042572,1,0.850238465421518,0,27,retinol metabolic process,BP,
8575,GO:0032689,1,0.857531581657134,0,26,negative regulation of interferon-gamma production,BP,
18815,GO:1901186,1,0.801093187781694,0,34,positive regulation of ERBB signaling pathway,BP,
19396,GO:1902751,1,0.852521376359176,0,25,positive regulation of cell cycle G2/M phase transition,BP,
13086,GO:0048536,1.00000000000001,0.803202712887215,0,33,spleen development,BP,
12723,GO:0046966,1.00000000000001,0.820519171884281,0,26,thyroid hormone receptor binding,MF,
1294,GO:0002833,1.00000000000001,0.79892246067798,0,34,positive regulation of response to biotic stimulus,BP,
5659,GO:0016024,1.00000000000001,0.923413193462806,0,11,CDP-diacylglycerol biosynthetic process,BP,
